PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ruiz, MF; Sarno, F; Zorrilla, S; Rivas, G; Sanchez, L				Fernanda Ruiz, Maria; Sarno, Francesca; Zorrilla, Silvia; Rivas, German; Sanchez, Lucas			Biochemical and Functional Analysis of Drosophila-Sciara Chimeric Sex-Lethal Proteins	PLOS ONE			English	Article							DOSAGE COMPENSATION REGULATORS; MSL-2 MESSENGER-RNA; DETERMINING GENE; TRANSLATIONAL REPRESSION; X-CHROMOSOME; SWITCH GENE; SPLICE-SITE; BINDING; MELANOGASTER; EXPRESSION	Background: The Drosophila SXL protein controls sex determination and dosage compensation. It is a sex-specific factor controlling splicing of its own Sxl pre-mRNA (auto-regulation), tra pre-mRNA (sex determination) and msl-2 pre-mRNA plus translation of msl-2 mRNA (dosage compensation). Outside the drosophilids, the same SXL protein has been found in both sexes so that, in the non-drosophilids, SXL does not appear to play the key discriminating role in sex determination and dosage compensation that it plays in Drosophila. Comparison of SXL proteins revealed that its spatial organisation is conserved, with the RNA-binding domains being highly conserved, whereas the N- and C-terminal domains showing significant variation. This manuscript focuses on the evolution of the SXL protein itself and not on regulation of its expression. Methodology: Drosophila-Sciara chimeric SXL proteins were produced. Sciara SXL represents the non-sex-specific function of ancient SXL in the non-drosophilids from which presumably Drosophila SXL evolved. Two questions were addressed. Did the Drosophila SXL protein have affected their functions when their N- and C-terminal domains were replaced by the corresponding ones of Sciara? Did the Sciara SXL protein acquire Drosophila sex-specific functions when the Drosophila Nand C-terminal domains replaced those of Sciara? The chimeric SXL proteins were analysed in vitro to study their binding affinity and cooperative properties, and in vivo to analyse their effect on sex determination and dosage compensation by producing Drosophila flies that were transgenic for the chimeric SXL proteins. Conclusions: The sex-specific properties of extant Drosophila SXL protein depend on its global structure rather than on a specific domain. This implies that the modifications, mainly in the N- and C-terminal domains, that occurred in the SXL protein during its evolution within the drosophilid lineage represent co-evolutionary changes that determine the appropriate folding of SXL to carry out its sex-specific functions.	[Fernanda Ruiz, Maria; Sarno, Francesca; Rivas, German; Sanchez, Lucas] CSIC, Ctr Invest Biol, Madrid, Spain; [Zorrilla, Silvia] CSIC, Inst Quim Fis Rocasolano, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR)	Sanchez, L (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.	lsanchez@cib.csic.es	Sarno, Francesca/AAA-8460-2019; Rivas, German/AAG-7458-2022; Rivas, German/AFL-7528-2022; Ruiz, Maria Fernanda/F-3290-2016; Sánchez, Lucas/K-4238-2015; Zorrilla, Silvia/J-9771-2014	Rivas, German/0000-0003-3450-7478; Rivas, German/0000-0003-3450-7478; Sánchez, Lucas/0000-0002-7725-8961; Ruiz, Maria Fernanda/0000-0002-1649-2105; Zorrilla, Silvia/0000-0002-6309-9058	Spanish Government	Spanish Government(Spanish GovernmentEuropean Commission)	This study was supported by the Spanish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaza I, 2006, GENE DEV, V20, P380, DOI 10.1101/gad.371906; ALBRECHT EB, 1993, GENETICS, V134, P801; BACHILLER D, 1991, GENET RES, V57, P23, DOI 10.1017/S0016672300028998; BACHILLER D, 1986, DEV BIOL, V118, P379, DOI 10.1016/0012-1606(86)90007-2; Bashaw GJ, 1997, CELL, V89, P789, DOI 10.1016/S0092-8674(00)80262-7; BELL LR, 1991, CELL, V65, P229, DOI 10.1016/0092-8674(91)90157-T; BELL LR, 1988, CELL, V55, P1037, DOI 10.1016/0092-8674(88)90248-6; Bopp D, 1996, DEVELOPMENT, V122, P971; BOPP D, 1991, GENE DEV, V5, P403, DOI 10.1101/gad.5.3.403; Cline TW, 2010, GENETICS, V186, P1321, DOI 10.1534/genetics.110.121202; CLINE TW, 1984, GENETICS, V107, P231; Conrad T, 2012, NAT REV GENET, V13, P123, DOI 10.1038/nrg3124; DACUNHA PR, 1994, GENETICS, V138, P787; Deng XX, 2011, NAT GENET, V43, P1179, DOI 10.1038/ng.948; Deshpande G, 1999, DEVELOPMENT, V126, P2841; Duncan K, 2006, GENE DEV, V20, P368, DOI 10.1101/gad.371406; Gebauer F, 1999, EMBO J, V18, P6146, DOI 10.1093/emboj/18.21.6146; Gerbi S.A., 1986, Results and Problems in Cell Differentiation, V13, P71; Granadino B, 1997, P NATL ACAD SCI USA, V94, P7343, DOI 10.1073/pnas.94.14.7343; GRANADINO B, 1990, EMBO J, V9, P2597, DOI 10.1002/j.1460-2075.1990.tb07441.x; Granadino B, 1996, MOL GEN GENET, V253, P26, DOI 10.1007/s004380050292; Gupta Vaijayanti, 2006, J Biol, V5, P3, DOI 10.1186/jbiol30; Hatters DM, 2002, J BIOL CHEM, V277, P7824, DOI 10.1074/jbc.M110429200; HILFIKER A, 1991, ROUX ARCH DEV BIOL, V200, P240, DOI 10.1007/BF00241293; Hilfiker A, 1995, DEVELOPMENT, V121, P4017; INOUE K, 1990, NATURE, V344, P461, DOI 10.1038/344461a0; KANAAR R, 1995, EMBO J, V14, P4530, DOI 10.1002/j.1460-2075.1995.tb00132.x; KELLEY RL, 1995, CELL, V81, P867, DOI 10.1016/0092-8674(95)90007-1; Kelley RL, 1997, NATURE, V387, P195, DOI 10.1038/387195a0; KEYES LN, 1992, CELL, V68, P933, DOI 10.1016/0092-8674(92)90036-C; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lagos D, 2005, GENE, V348, P111, DOI 10.1016/j.gene.2004.12.053; Lallena MJ, 2002, CELL, V109, P285, DOI 10.1016/S0092-8674(02)00730-4; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Lucchesi JC, 2009, CURR OPIN GENET DEV, V19, P550, DOI 10.1016/j.gde.2009.10.004; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Meiklejohn CD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001126; Meise M, 1998, DEVELOPMENT, V125, P1487; Moore AD, 2008, TRENDS BIOCHEM SCI, V33, P444, DOI 10.1016/j.tibs.2008.05.008; MULLERHOLTKAMP F, 1995, J MOL EVOL, V41, P467, DOI 10.1007/BF00160318; Mullon C, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-5; Niimi T, 2006, GENOME, V49, P263, DOI 10.1139/G05-108; Oliver B, 2002, INT REV CYTOL, V219, P1; Penalva LOF, 2003, MICROBIOL MOL BIOL R, V67, P343, DOI 10.1128/MMBR.67.3.343-359.2003; Penalva LOF, 1996, GENETICS, V144, P1653; RASTELLI L, 1995, MECH DEVELOP, V53, P223, DOI 10.1016/0925-4773(95)00438-7; Rastelli L, 1998, MECH DEVELOP, V71, P107, DOI 10.1016/S0925-4773(98)00009-4; Ruiz MF, 2003, GENE EXPR PATTERNS, V3, P341, DOI 10.1016/S1567-133X(03)00031-0; Ruiz MF, 2000, GENETICS, V156, P1853; Saccone G, 1998, DEVELOPMENT, V125, P1495; Sakashita E, 1996, J BIOCHEM, V120, P1028; Salz HK, 1996, GENETICS, V144, P95; Samuels M, 1998, NUCLEIC ACIDS RES, V26, P2625, DOI 10.1093/nar/26.11.2625; SAMUELS ME, 1994, MOL CELL BIOL, V14, P4975, DOI 10.1128/MCB.14.7.4975; SANCHEZ L, 1983, EMBO J, V2, P485, DOI 10.1002/j.1460-2075.1983.tb01451.x; Sanchez L, 2008, INT J DEV BIOL, V52, P1059, DOI 10.1387/ijdb.072439ls; Serna E, 2004, GENETICS, V168, P907, DOI 10.1534/genetics.104.031278; Sievert V, 2000, GENOME, V43, P382, DOI 10.1139/gen-43-2-382; Sievert V, 1997, GENOME, V40, P211, DOI 10.1139/g97-030; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SOSNOWSKI BA, 1989, CELL, V58, P449, DOI 10.1016/0092-8674(89)90426-1; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Traut W, 2006, GENOME, V49, P254, DOI 10.1139/G05-107; VALCARCEL J, 1993, NATURE, V362, P171, DOI 10.1038/362171a0; Vibranovski MD, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-49; Wang JW, 1997, J BIOL CHEM, V272, P22227, DOI 10.1074/jbc.272.35.22227; WANG JW, 1994, GENE DEV, V8, P2072, DOI 10.1101/gad.8.17.2072; Yanowitz JL, 1999, MOL CELL BIOL, V19, P3018; ZHOU SB, 1995, EMBO J, V14, P2884, DOI 10.1002/j.1460-2075.1995.tb07288.x	69	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65171	10.1371/journal.pone.0065171	http://dx.doi.org/10.1371/journal.pone.0065171			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762307	Green Published, gold			2022-12-27	WOS:000320440500030
J	Mehta, R; Katta, H; Alimirah, F; Patel, R; Murillo, G; Peng, XJ; Muzzio, M; Mehta, RG				Mehta, Rajeshwari; Katta, Harshadadevi; Alimirah, Fatouma; Patel, Rutulkumar; Murillo, Genoveva; Peng, Xinjian; Muzzio, Miguel; Mehta, Rajendra G.			Deguelin Action Involves c-Met and EGFR Signaling Pathways in Triple Negative Breast Cancer Cells	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; NF-KAPPA-B; HEPATOCYTE GROWTH; AKT INHIBITOR; UNPHOSPHORYLATED STAT3; GENE-EXPRESSION; CARCINOMA; ACTIVATION; APOPTOSIS; LINES	Background: Treatment of breast cancer patients with antiestrogens and aromatase inhibitor(s) or Herceptin have shown significant success in steroid receptor positive or Her-2+ breast cancers respectively. However, choice of treatments for breast cancer patients with negative status for estrogen, progesterone receptors and HER2/neu is limited. As a result, search for appropriate therapy regimen for these triple negative breast cancers (TNBC) has become a major focus of investigations for many laboratories. Recently, Deguelin, a natural product isolated from African plant Mundulea sericea (Leguminossae) has shown both antiproliferative actions in various cancers including breast as well as chemoprenventive activity against carcinogen induced experimental cancers. In this report we evaluated efficacy and mechanism of action of Deguelin in triple negative breast cancer cell lines. Methods/Findings: In vitro, Deguelin in a dose and time dependent manner inhibited the growth of MDA-MB-231, MDA-MB-468, BT-549 and BT-20 cells. Deguelin (2 or 4 mg/kg body weight), when injected intraperitoneally, reduced the in vivo tumor growth of MDA-MB-231 cells transplanted subcutaneously in athymic mice. Moreover it was nontoxic as evident from daily observations on mobility, food and water consumption and comparison of bodyweight and other visceral organ weights with those in control animals at the termination of the study. The western blot analyses and immunostaining studies indicated that the deguelin effects may be mediated through EGFR-PAKT/c-Met p-ERK and NF-kappa B by down regulating their downstream targets such as p-STAT3, c-Myc, Survivin. Conclusion/Significance: These results suggest that Deguelin may have a significant therapeutic value for the treatment of TNBC patients.	[Mehta, Rajendra G.] IIT Res Inst, Div Canc Biol, Chicago, IL USA; IIT Res Inst, Div Analyt Chem, Chicago, IL USA	Illinois Institute of Technology; Illinois Institute of Technology	Mehta, RG (corresponding author), IIT Res Inst, Div Canc Biol, Chicago, IL USA.	RMehta@iitri.org		Patel, Rutulkumar/0000-0001-6652-6070	National Institutes of Health (NIH), National Cancer Institute (NCI) [R01-140321]; NATIONAL CANCER INSTITUTE [R01CA140321] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Health (NIH), National Cancer Institute (NCI) grant R01-140321. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adida C, 1998, LANCET, V351, P882, DOI 10.1016/S0140-6736(05)70294-4; Aggarwal BB, 2011, CANCER DISCOV, V1, P469, DOI 10.1158/2159-8290.CD-11-0260; Andre F, 2012, ANN ONCOL, V23, P46, DOI 10.1093/annonc/mds195; Bilici A, 2012, J BUON, V17, P209; Bonine-Summers AR, 2007, CANCER BIOL THER, V6, P561, DOI 10.4161/cbt.6.4.3851; Brouckaert O, 2012, INT J WOMENS HEALTH, V4, P511, DOI 10.2147/IJWH.S18541; Caboni P, 2004, CHEM RES TOXICOL, V17, P1540, DOI 10.1021/tx049867r; Chen Q, 2009, BIOCHIM BIOPHYS ACTA, V1796, P162; Chu Zhao-hui, 2011, Zhong Xi Yi Jie He Xue Bao, V9, P533; CIARDIELLO F, 1991, ANN ONCOL, V2, P169; DAVIDSON NE, 1987, MOL ENDOCRINOL, V1, P216, DOI 10.1210/mend-1-3-216; Dell'Eva R, 2007, CARCINOGENESIS, V28, P404, DOI 10.1093/carcin/bgl162; Eckert LB, 2004, CANCER RES, V64, P4585, DOI 10.1158/0008-5472.CAN-04-0396; Griffiths Carrie L, 2012, J Pharm Pract, V25, P319, DOI 10.1177/0897190012442062; Gumuskaya B, 2010, CANCER GENET CYTOGEN, V203, P222, DOI 10.1016/j.cancergencyto.2010.07.118; Huang WL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-309; Kang HW, 2012, DIGEST DIS SCI, V57, P2873, DOI 10.1007/s10620-012-2237-x; KOZMA SC, 1987, NUCLEIC ACIDS RES, V15, P5963; Martinez-Carpio PA, 1999, CELL SIGNAL, V11, P753, DOI 10.1016/S0898-6568(99)00048-0; Masuda H, 2012, BREAST CANCER RES TR, V136, P331, DOI 10.1007/s10549-012-2289-9; Matteucci E, 2009, CARCINOGENESIS, V30, P937, DOI 10.1093/carcin/bgp080; Mehta Rajendra G, 2002, Curr Oncol Rep, V4, P478, DOI 10.1007/s11912-002-0059-2; Morris GJ, 2007, CANCER-AM CANCER SOC, V110, P876, DOI 10.1002/cncr.22836; Murillo G, 2003, INT J CANCER, V104, P7, DOI 10.1002/ijc.10901; Murillo G, 2009, CANCER PREV RES, V2, P942, DOI 10.1158/1940-6207.CAPR-08-0232; Nair AS, 2006, J IMMUNOL, V177, P5612, DOI 10.4049/jimmunol.177.8.5612; Nakajima H, 2012, BREAST CANC; Raghav KP, 2012, CLIN CANCER RES, V18, P2269, DOI 10.1158/1078-0432.CCR-11-2830; RONG S, 1992, MOL CELL BIOL, V12, P5152, DOI 10.1128/MCB.12.11.5152; Sizemore N, 1999, GASTROENTEROLOGY, V117, P567, DOI 10.1016/S0016-5085(99)70449-X; Takabatake D, 2007, INT J CANCER, V120, P181, DOI 10.1002/ijc.22187; Tamm I, 1998, CANCER RES, V58, P5315; Thamilselvan V, 2011, INT J CANCER, V129, P2916, DOI 10.1002/ijc.25949; Tischkowitz M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-134; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Waligorska-Stachura J, 2012, GINEKOL POL, V83, P537; Xu C., 2012, BREAST CANC; Yan Y, 2005, NEOPLASIA, V7, P1053, DOI 10.1593/neo.05532; Yang J, 2005, CANCER RES, V65, P939; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yuen HF, 2012, BIOSCIENCE REP, V32, P413, DOI 10.1042/BSR20120050; Zhang YW, 2010, CANCER RES, V70, P6880, DOI 10.1158/0008-5472.CAN-10-0898	43	46	49	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65113	10.1371/journal.pone.0065113	http://dx.doi.org/10.1371/journal.pone.0065113			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762292	Green Submitted, Green Published, gold			2022-12-27	WOS:000320440500024
J	Betanzos, A; Javier-Reyna, R; Garcia-Rivera, G; Banuelos, C; Gonzalez-Mariscal, L; Schnoor, M; Orozco, E				Betanzos, Abigail; Javier-Reyna, Rosario; Garcia-Rivera, Guillermina; Banuelos, Cecilia; Gonzalez-Mariscal, Lorenza; Schnoor, Michael; Orozco, Esther			The EhCPADH112 Complex of Entamoeba histolytica Interacts with Tight Junction Proteins Occludin and Claudin-1 to Produce Epithelial Damage	PLOS ONE			English	Article							LIVER-ABSCESS FORMATION; CYSTEINE PROTEASE; CELLS; PARASITE; ADHESIN; LECTIN; PHOSPHORYLATION; IDENTIFICATION; PERMEABILITY; EHADH112	Entamoeba histolytica, the protozoan responsible for human amoebiasis, causes between 30,000 and 100,000 deaths per year worldwide. Amoebiasis is characterized by intestinal epithelial damage provoking severe diarrhea. However, the molecular mechanisms by which this protozoan causes epithelial damage are poorly understood. Here, we studied the initial molecular interactions between the E. histolytica EhCPADH112 virulence complex and epithelial MDCK and Caco-2 cells. By confocal microscopy, we discovered that after contact with trophozoites or trophozoite extracts (TE), EhCPADH112 and proteins forming this complex (EhCP112 and EhADH112) co-localize with occludin and claudin-1 at tight junctions (TJ). Immunoprecipitation assays revealed interaction between EhCPADH112 and occludin, claudin-1, ZO-1 and ZO-2. Overlay assays confirmed an interaction of EhCP112 and EhADH112 with occludin and claudin-1, whereas only EhADH112 interacted also with ZO-2. We observed degradation of all mentioned TJ proteins after incubation with TE. Importantly, inhibiting proteolytic activity or blocking the complex with a specific antibody not only prevented TJ protein degradation but also epithelial barrier disruption. Furthermore, we discovered that TE treatment induces autophagy and apoptosis in MDCK cells that could contribute to the observed barrier disruption. Our results suggest a model in which epithelial damage caused by E. histolytica is initiated by the interaction of EhCP112 and EhADH112 with TJ proteins followed by their degradation. Disruption of TJs then induces increased paracellular permeability, thus facilitating the entry of more proteases and other parasite molecules leading eventually to tissue destruction.	[Betanzos, Abigail; Javier-Reyna, Rosario; Garcia-Rivera, Guillermina; Orozco, Esther] Natl Polytech Inst, Ctr Res & Adv Studies, Dept Infect & Mol Pathogenesis, Distrito Fed, Mexico; [Gonzalez-Mariscal, Lorenza] Natl Polytech Inst, Ctr Res & Adv Studies, Dept Physiol Biophys & Neurosci, Distrito Fed, Mexico; [Schnoor, Michael] Natl Polytech Inst, Ctr Res & Adv Studies, Dept Mol Biomed, Distrito Fed, Mexico; [Banuelos, Cecilia] Inst Sci & Technol Fed Dist, Distrito Fed, Mexico; [Orozco, Esther] Autonomous Univ Mexico City, Distrito Fed, Mexico	Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico	Orozco, E (corresponding author), Natl Polytech Inst, Ctr Res & Adv Studies, Dept Infect & Mol Pathogenesis, Distrito Fed, Mexico.	orozco.esther@gmail.com	Schnoor, Michael/H-1863-2016	Schnoor, Michael/0000-0002-0269-5884; Gonzalez-Mariscal, Lorenza/0000-0003-4914-7671; Betanzos, Abigail/0000-0003-1761-0481	European Economic Community [ICA4-CT-2001-10073]; Institute of Science and Technology of the Federal District [64/2012]	European Economic Community; Institute of Science and Technology of the Federal District	This study was supported by the European Economic Community (Phagoamoeba project ICA4-CT-2001-10073) and the Institute of Science and Technology of the Federal District (grant number 64/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almonte-Becerril M, 2010, APOPTOSIS, V15, P631, DOI 10.1007/s10495-010-0458-z; ARROYO R, 1987, MOL BIOCHEM PARASIT, V23, P151, DOI 10.1016/0166-6851(87)90150-2; Avila-Flores A, 2001, BIOCHEM J, V360, P295, DOI 10.1042/0264-6021:3600295; Bansal D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000551; Banuelos C, 2005, EXP PARASITOL, V110, P292, DOI 10.1016/j.exppara.2005.03.005; Banuelos C, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/657942; BERTI PJ, 1995, J MOL BIOL, V246, P273, DOI 10.1006/jmbi.1994.0083; Betanzos A, 2004, EXP CELL RES, V292, P51, DOI 10.1016/j.yexcr.2003.08.007; Bruchhaus I, 2003, EUKARYOT CELL, V2, P501, DOI 10.1128/EC.2.3.501-509.2003; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Feldman GJ, 2005, ADV DRUG DELIVER REV, V57, P883, DOI 10.1016/j.addr.2005.01.009; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Garcia-Rivera G, 1999, MOL MICROBIOL, V33, P556, DOI 10.1046/j.1365-2958.1999.01500.x; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Gonzalez-Mariscal L, 2000, SEMIN CELL DEV BIOL, V11, P315, DOI 10.1006/scdb.2000.0178; GONZALEZMARISCAL L, 1985, J MEMBRANE BIOL, V86, P113, DOI 10.1007/BF01870778; Guttman JA, 2009, BBA-BIOMEMBRANES, V1788, P832, DOI 10.1016/j.bbamem.2008.10.028; Horwitz AF, 1997, SCI AM, V276, P68, DOI 10.1038/scientificamerican0597-68; Hou YZ, 2010, J BIOL CHEM, V285, P35497, DOI 10.1074/jbc.M109.066035; JESAITIS LA, 1994, J CELL BIOL, V124, P949, DOI 10.1083/jcb.124.6.949; Joyce M. P., 1988, Amebiasis: human infection by Entamoeba histolytica., P129; KARRER KM, 1993, P NATL ACAD SCI USA, V90, P3063, DOI 10.1073/pnas.90.7.3063; KENNEDY MB, 1995, TRENDS BIOCHEM SCI, V20, P350, DOI 10.1016/S0968-0004(00)89074-X; Kim KA, 2013, KOREAN J PARASITOL, V51, P61, DOI 10.3347/kjp.2013.51.1.61; Kissoon-Singh V, 2013, AM J PATHOL, V182, P852, DOI 10.1016/j.ajpath.2012.11.035; Lauwaet T, 2004, INT J PARASITOL, V34, P549, DOI 10.1016/j.ijpara.2003.11.013; Leippe M, 1997, PARASITOL TODAY, V13, P178, DOI 10.1016/S0169-4758(97)01038-7; Lejeune M, 2011, AM J PATHOL, V179, P807, DOI 10.1016/j.ajpath.2011.05.001; LEROY A, 1995, INFECT IMMUN, V63, P4253, DOI 10.1128/IAI.63.11.4253-4260.1995; Leroy A, 2000, ARCH MED RES, V31, pS218, DOI 10.1016/S0188-4409(00)00145-4; Leroy A, 2000, FASEB J, V14, P1139, DOI 10.1096/fasebj.14.9.1139; Leroy Ancy, 1997, Invasion and Metastasis, V17, P138; LI E, 1994, INFECT IMMUN, V62, P5112, DOI 10.1128/IAI.62.11.5112-5119.1994; Lopez-Vancell R, 2000, PARASITOL RES, V86, P226, DOI 10.1007/s004360050035; Martinez-Lopez C, 2004, CELL MICROBIOL, V6, P367, DOI 10.1111/j.1462-5822.2004.00363.x; MARTINEZPALOMO A, 1985, J PROTOZOOL, V32, P166, DOI 10.1111/j.1550-7408.1985.tb03033.x; Mortimer L, 2010, EXP PARASITOL, V126, P366, DOI 10.1016/j.exppara.2010.03.005; Ocadiz R, 2005, CELL MICROBIOL, V7, P221, DOI 10.1111/j.1462-5822.2004.00453.x; OROZCO E, 1983, J EXP MED, V158, P1511, DOI 10.1084/jem.158.5.1511; Perez-Tamayo R., 1986, Amebiasis. (Human Parasitic Diseases Vol. 2.), P45; PETRI WA, 1995, METHOD ENZYMOL, V253, P98; Petri WA, 2002, ANNU REV MICROBIOL, V56, P39, DOI 10.1146/annurev.micro.56.012302.160959; Rodriguez MA, 2000, MOL BIOCHEM PARASIT, V108, P199, DOI 10.1016/S0166-6851(00)00216-4; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; Sakakibara A, 1997, J CELL BIOL, V137, P1393, DOI 10.1083/jcb.137.6.1393; Shen L, 2006, AM J PHYSIOL-GASTR L, V290, pG577, DOI 10.1152/ajpgi.00439.2005; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Tapia R, 2009, MOL BIOL CELL, V20, P1102, DOI 10.1091/mbc.E08-03-0277; Van Itallie CM, 2011, J BIOL CHEM, V286, P3442, DOI 10.1074/jbc.M110.195578; Yan L, 2001, INFECT IMMUN, V69, P7911, DOI 10.1128/IAI.69.12.7911-7914.2001	51	35	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65100	10.1371/journal.pone.0065100	http://dx.doi.org/10.1371/journal.pone.0065100			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762290	gold, Green Published, Green Submitted			2022-12-27	WOS:000321094800018
J	Cai, QQ; Huang, HQ; Qian, D; Chen, KL; Luo, JH; Tian, Y; Lin, TX; Lin, TY				Cai, Qingqing; Huang, Huiqiang; Qian, Dong; Chen, Kailin; Luo, Junhua; Tian, Ying; Lin, Tianxin; Lin, Tongyu			13-Methyltetradecanoic Acid Exhibits Anti-Tumor Activity on T-Cell Lymphomas In Vitro and In Vivo by Down-Regulating p-AKT and Activating Caspase-3	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; NF-KAPPA-B; CANCER-CELLS; MULTIDRUG-RESISTANCE; FATTY-ACIDS; MEDIATED APOPTOSIS; ENDOTHELIAL-CELLS; GERMINAL CENTER; OVARIAN-CANCER; EXPRESSION	13-Methyltetradecanoic acid (13-MTD), a saturated branched-chain fatty acid purified from soy fermentation products, induces apoptosis in human cancer cells. We investigated the inhibitory effects and mechanism of action of 13-MTD on T-cell non-Hodgkin's lymphoma (T-NHL) cell lines both in vitro and in vivo. Growth inhibition in response to 13-MTD was evaluated by the cell counting kit-8 (CCK-8) assay in three T-NHL cell lines (Jurkat, Hut78, EL4 cells). Flow cytometry analyses were used to monitor the cell cycle and apoptosis. Proteins involved in 13-MTD-induced apoptosis were examined in Jurkat cells by western blotting. We found that 13-MTD inhibited proliferation and induced the apoptosis of T-NHL cell lines. 13-MTD treatment also induced a concentration-dependent arrest of Jurkat cells in the G(1)-phase. During 13-MTD-induced apoptosis in Jurkat cells, the cleavage of caspase-3 and poly ADP-ribose polymerase (PARP, a caspase enzymolysis product) were detected after incubation for 2 h, and increased after extending the incubation time. However, there was no change in the expression of Bcl-2 or c-myc proteins. The appearance of apoptotic Jurkat cells was accompanied by the inhibition of AKT and nuclear factor-kappa B (NF-kappa B) phosphorylation. In addition, 13-MTD could also effectively inhibit the growth of T-NHL tumors in vivo in a xenograft model. The tumor inhibition rate in the experimental group was 40%. These data indicate that 13-MTD inhibits proliferation and induces apoptosis through the down-regulation of AKT phosphorylation followed by caspase activation, which may provide a new approach for treating T-cell lymphomas.	[Cai, Qingqing; Huang, Huiqiang; Chen, Kailin; Lin, Tongyu] Sun Yat Sen Univ, Dept Med Oncol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Cai, Qingqing; Huang, Huiqiang; Qian, Dong; Chen, Kailin; Tian, Ying; Lin, Tongyu] State Key Lab Oncol Southern China, Guangzhou, Guangdong, Peoples R China; [Luo, Junhua; Lin, Tianxin] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China; [Luo, Junhua; Lin, Tianxin] Sun Yat Sen Univ, Lin Bai Xin Med Res Ctr, Affiliated Hosp 2, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Lin, TX (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China.	tianxinl@sina.com; tongyulin@hotmail.com			National Nature Scientific Research Fund of China [81001052]; Science and Technology Planning Project of Guangdong Province, China [2011B031800222]; Young Talents project of Sun Yat-sen University Cancer Center; Yat-sen Scholarship for Young Scientists; Program for New Century Excellent Talents in University [NCET-10-0852]; Guangdong Province Natural Scientific Grant [8151008901000043]	National Nature Scientific Research Fund of China; Science and Technology Planning Project of Guangdong Province, China; Young Talents project of Sun Yat-sen University Cancer Center; Yat-sen Scholarship for Young Scientists; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Guangdong Province Natural Scientific Grant	This work was supported by National Nature Scientific Research Fund of China (grant number: 81001052); Science and Technology Planning Project of Guangdong Province, China (grant number: 2011B031800222); Young Talents project of Sun Yat-sen University Cancer Center; Yat-sen Scholarship for Young Scientists (to Tianxin, Lin) and Program for New Century Excellent Talents in University (NCET-10-0852), to Tianxin, Lin and Guangdong Province Natural Scientific Grant (8151008901000043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMITAGE JO, 1989, J CLIN ONCOL, V7, P1783, DOI 10.1200/JCO.1989.7.12.1783; Bailey HH, 2006, CANCER-AM CANCER SOC, V107, P2462, DOI 10.1002/cncr.22308; Bao-hua Yu, 2011, Chinese Journal of Pathology, V40, P246, DOI 10.3760/cma.j.issn.0529-5807.2011.04.006; Barancik M, 2006, EUR J PHARM SCI, V29, P426, DOI 10.1016/j.ejps.2006.08.006; Bartling B, 2000, BIOCHEM BIOPH RES CO, V278, P740, DOI 10.1006/bbrc.2000.3873; BUTTKE TM, 1984, IMMUNOLOGY, V53, P235; Cai QQ, 2012, CL LYMPH MYELOM LEUK, V12, P106, DOI 10.1016/j.clml.2011.12.002; Calviello G, 1999, LIPIDS, V34, P599, DOI 10.1007/s11745-999-0404-6; Coiffier B, 1990, J CLIN ONCOL, V9, P45; Creagh EM, 2003, IMMUNOL REV, V193, P10, DOI 10.1034/j.1600-065X.2003.00048.x; Dahia PLM, 1999, HUM MOL GENET, V8, P185, DOI 10.1093/hmg/8.2.185; El-Deiry Wafik S., 1997, Current Opinion in Oncology, V9, P79; Fraser M, 2003, CANCER RES, V63, P7081; Garcia MG, 2009, LEUKEMIA RES, V33, P288, DOI 10.1016/j.leukres.2008.06.010; Ghia P, 1998, BLOOD, V91, P244, DOI 10.1182/blood.V91.1.244.244_244_251; Graham SH, 2001, J CEREBR BLOOD F MET, V21, P99, DOI 10.1097/00004647-200102000-00001; GROGAN TM, 1985, AM J CLIN PATHOL, V83, P279, DOI 10.1093/ajcp/83.3.279; Henshall DC, 2002, J NEUROSCI, V22, P8458; Ip MM, 1999, EXP CELL RES, V250, P22, DOI 10.1006/excr.1999.4499; Jiang YH, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-70; Jillella AP, 2000, CANCER INVEST, V18, P609, DOI 10.3109/07357900009032827; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; Lam LT, 2005, CLIN CANCER RES, V11, P28; Lin TX, 2012, UROL ONCOL-SEMIN ORI, V30, P339, DOI 10.1016/j.urolonc.2010.04.011; Liu XG, 2009, JPN J CLIN ONCOL, V39, P418, DOI 10.1093/jjco/hyp037; Liu YH, 2008, HUM PATHOL, V39, P875, DOI 10.1016/j.humpath.2007.10.013; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Miles RR, 2008, PEDIATR BLOOD CANCER, V51, P369, DOI 10.1002/pbc.21619; Nakata S, 2004, ONCOGENE, V23, P6261, DOI 10.1038/sj.onc.1207830; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Qiao M, 2008, CELL CYCLE, V7, P2991, DOI 10.4161/cc.7.19.6784; Russo RIC, 2008, INT J CANCER, V122, P1012, DOI 10.1002/ijc.23122; Shao WL, 2010, INT J CANCER, V127, P2199, DOI 10.1002/ijc.25218; Singh AV, 2004, CARCINOGENESIS, V25, P83, DOI 10.1093/carcin/bgg178; Sun XC, 2000, AM J PHYSIOL-CELL PH, V279, pC1648, DOI 10.1152/ajpcell.2000.279.5.C1648; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Uddin S, 2006, BLOOD, V108, P4178, DOI 10.1182/blood-2006-04-016907; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Volbracht C, 2001, MOL MED, V7, P36, DOI 10.1007/BF03401837; Vose JM, 2008, HEMATOL ONCOL CLIN N, V22, P997, DOI 10.1016/j.hoc.2008.07.010; Wongtangtintharn Sawitree, 2005, Lipids Health Dis, V4, P29, DOI 10.1186/1476-511X-4-29; Yang XK, 2006, CANCER RES, V66, P3126, DOI 10.1158/0008-5472.CAN-05-0425; Yang ZH, 2000, CANCER RES, V60, P505; Yao D, 2010, PLOS ONE, V5; ZHANG CL, 1992, THROMB RES, V65, P65; Zhang LJ, 2010, EUR J PHARMACOL, V643, P195, DOI 10.1016/j.ejphar.2010.06.045	48	19	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65308	10.1371/journal.pone.0065308	http://dx.doi.org/10.1371/journal.pone.0065308			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762338	Green Submitted, Green Published, gold			2022-12-27	WOS:000321094800037
J	Song, LG; Zhu, QQ; Liu, TW; Yu, M; Xiao, KW; Kong, QN; Zhao, RL; Li, GD; Zhou, Y				Song, Lige; Zhu, Qianqian; Liu, Tianwei; Yu, Ming; Xiao, Kewei; Kong, Qingnuan; Zhao, Renliang; Li, Guo-Dong; Zhou, Yu			Ghrelin Modulates Lateral Amygdala Neuronal Firing and Blocks Acquisition for Conditioned Taste Aversion	PLOS ONE			English	Article							ACYLATED-GHRELIN; MESSENGER-RNA; MEMORY; RECEPTOR; EXCITABILITY; RAT; EXPRESSION; CONSOLIDATION; INACTIVATION; HIPPOCAMPUS	Ghrelin is an orexigenic brain-gut hormone promoting feeding and regulating energy metabolism in human and rodents. An increasing number of studies have reported that ghrelin and its identified receptor, the growth hormone secretagogue receptor 1a (GHS-R1a), produces remarkably wide and complex functions and biological effects on specific populations of neurons in central nervous system. In this study, we sought to explore the in vivo effects of acute ghrelin exposure on lateral amygdala (LA) neurons at the physiological and behavioral levels. In vivo extracellular single-unit recordings showed that ghrelin with the concentration of several nanomolars (nM) stimulated spontaneous firing of the LA neurons, an effect that was dose-dependent and could be blocked by co-application of a GHS-R1a antagonist D-Lys3-GHRP-6. We also found that D-Lys3-GHRP-6 inhibited spontaneous firing of the LA neurons in a dose-dependent manner, revealing that tonic GHS-R1a activity contributes to orchestrate the basal activity of the LA neurons. Behaviorally, we found that microinfusion of ghrelin (12 ng) into LA before training interfered with the acquisition of conditioned taste aversion (CTA) as tested at 24 h after conditioning. Pre-treatment with either purified IgG against GHS-R1a or GHS-R1a antagonist blocked ghrelin's effect on CTA memory acquisition. Ghrelin (12 ng) had no effect on CTA memory consolidation or the expression of acquired CTA memory; neither did it affect the total liquid consumption of tested rats. Altogether, our data indicated that ghrelin locally infused into LA blocks acquisition of CTA and its modulation effects on neuronal firing may be involved in this process.	[Song, Lige; Zhu, Qianqian; Liu, Tianwei; Yu, Ming; Xiao, Kewei; Kong, Qingnuan; Zhou, Yu] Qingdao Univ, Coll Med, Dept Physiol, Qingdao 266071, Shandong, Peoples R China; [Song, Lige; Zhao, Renliang] Affiliated Gen Hosp, Coll Med, Dept Neurol, Qingdao, Shandong, Peoples R China; [Liu, Tianwei] Qingdao Univ, Coll Med, Res Inst Cerebrovas Dis, Qingdao 266071, Shandong, Peoples R China; [Li, Guo-Dong] Univ Calif Los Angeles, Geffen Sch Med, Dept Anesthesiol, Los Angeles, CA 90095 USA	Qingdao University; Qingdao University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Li, GD (corresponding author), Univ Calif Los Angeles, Geffen Sch Med, Dept Anesthesiol, Los Angeles, CA 90095 USA.	guodongli@mednet.ucla.edu; yuzhou7310@gmail.com			National Natural Science Foundation of China [31171079, 81070881, 31222027]; Provincial Natural Science Foundation of Shandong [JQ201209]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Natural Science Foundation of Shandong(Natural Science Foundation of Shandong Province)	This work was supported by grants from the National Natural Science Foundation of China (31171079, 81070881 and 31222027 to YZ) and the Provincial Natural Science Foundation of Shandong (JQ201209 to YZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Crespo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046321; Andrews ZB, 2009, J NEUROSCI, V29, P14057, DOI 10.1523/JNEUROSCI.3890-09.2009; Bahar A, 2003, EUR J NEUROSCI, V17, P1527, DOI 10.1046/j.1460-9568.2003.02551.x; Carlini VP, 2008, NEUROSCIENCE, V153, P929, DOI 10.1016/j.neuroscience.2008.03.015; Carlini VP, 2010, PHYSIOL BEHAV, V101, P117, DOI 10.1016/j.physbeh.2010.04.026; Carlini VP, 2002, BIOCHEM BIOPH RES CO, V299, P739, DOI 10.1016/S0006-291X(02)02740-7; Carlini VP, 2004, BIOCHEM BIOPH RES CO, V313, P635, DOI 10.1016/j.bbrc.2003.11.150; Carvajal P, 2009, NEUROBIOL LEARN MEM, V91, P402, DOI 10.1016/j.nlm.2008.12.008; Chen LA, 2011, EUR J NEUROSCI, V33, P266, DOI 10.1111/j.1460-9568.2010.07491.x; Chung H, 2007, ENDOCRINOLOGY, V148, P148, DOI 10.1210/en.2006-0991; Cong WN, 2010, CNS NEUROL DISORD-DR, V9, P557, DOI 10.2174/187152710793361513; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Davis JF, 2011, PHYSIOL BEHAV, V103, P39, DOI 10.1016/j.physbeh.2010.10.017; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Dresler M, 2010, PHARMACOPSYCHIATRY, V43, P277, DOI 10.1055/s-0030-1263175; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Faber ESL, 2001, J NEUROPHYSIOL, V85, P714, DOI 10.1152/jn.2001.85.2.714; Ferrini F, 2009, CURR NEUROPHARMACOL, V7, P37, DOI 10.2174/157015909787602779; Frago LM, 2011, FRONT MOL NEUROSCI, V4, DOI [10.3389/fnmo1.2011.00023, 10.3389/fnmol.2011.00023]; Garcia-DeLaTorre P, 2009, LEARN MEMORY, V16, P514, DOI 10.1101/lm.1356509; Giese KP, 2001, PHYSIOL BEHAV, V73, P803, DOI 10.1016/S0031-9384(01)00517-0; Giese KP, 1998, LEARN MEMORY, V5, P257; Goshadrou F, 2012, BEHAV BRAIN RES, V232, P391, DOI 10.1016/j.bbr.2012.03.035; Granata R, 2007, ENDOCRINOLOGY, V148, P512, DOI 10.1210/en.2006-0266; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Hansson C, 2011, NEUROSCIENCE, V180, P201, DOI 10.1016/j.neuroscience.2011.02.002; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Jacoby SM, 2011, NEUROSCI LETT, V504, P316, DOI 10.1016/j.neulet.2011.09.056; Jiang H, 2006, MOL ENDOCRINOL, V20, P1772, DOI 10.1210/me.2005-0084; Kern A, 2012, NEURON, V73, P317, DOI 10.1016/j.neuron.2011.10.038; Kim MJ, 2010, NEUROBIOL LEARN MEM, V93, P406, DOI 10.1016/j.nlm.2009.12.007; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lodeiro M, 2011, MOL BIOL CELL, V22, P4182, DOI 10.1091/mbc.E11-04-0373; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; MCDONALD AJ, 1982, J COMP NEUROL, V212, P293, DOI 10.1002/cne.902120307; McGaugh JL, 2002, TRENDS NEUROSCI, V25, P456, DOI 10.1016/S0166-2236(02)02211-7; Mitchell V, 2001, J COMP NEUROL, V429, P469, DOI 10.1002/1096-9861(20010115)429:3<469::AID-CNE8>3.0.CO;2-#; Mozzachiodi R, 2010, TRENDS NEUROSCI, V33, P17, DOI 10.1016/j.tins.2009.10.001; Nanzer AM, 2004, EUR J ENDOCRINOL, V151, P233, DOI 10.1530/eje.0.1510233; Nicholls JGM, 2012, NEURON BRAIN, P229; Osterstock G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009159; Rosenkranz JA, 1999, J NEUROSCI, V19, P11027, DOI 10.1523/JNEUROSCI.19-24-11027.1999; Sato T, 2005, ENDOCRINOLOGY, V146, P2510, DOI 10.1210/en.2005-0174; Shi LM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2439; Soom M, 2001, FEBS LETT, V490, P49, DOI 10.1016/S0014-5793(01)02136-6; Spitznagel MB, 2010, PSYCHIAT CLIN NEUROS, V64, P608, DOI 10.1111/j.1440-1819.2010.02145.x; Toth K, 2008, BRAIN RES BULL, V77, P105, DOI 10.1016/j.brainresbull.2008.06.008; Toth K, 2009, BEHAV BRAIN RES, V202, P308, DOI 10.1016/j.bbr.2009.03.031; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; van den Top M, 2004, NAT NEUROSCI, V7, P493, DOI 10.1038/nn1226; Viosca J, 2009, LEARN MEMORY, V16, P198, DOI 10.1101/lm.1220309; Viosca J, 2009, LEARN MEMORY, V16, P193, DOI 10.1101/lm.1254209; Welzl H, 2001, BEHAV BRAIN RES, V125, P205, DOI 10.1016/S0166-4328(01)00302-3; Xue Y, 2007, EXP NEUROL, V205, P108, DOI 10.1016/j.expneurol.2007.01.031; Yasoshima Y, 1995, NEUROREPORT, V6, P2424, DOI 10.1097/00001756-199511270-00034; Yasoshima Y, 1998, NEUROSCIENCE, V84, P1, DOI 10.1016/S0306-4522(97)00636-2; Yasoshima Y, 2000, BRAIN RES, V869, P15, DOI 10.1016/S0006-8993(00)02397-0; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823	62	51	53	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65422	10.1371/journal.pone.0065422	http://dx.doi.org/10.1371/journal.pone.0065422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762368	Green Published, gold, Green Submitted			2022-12-27	WOS:000321094800048
J	Armstrong, SP; Seeber, RM; Ayoub, MA; Feldman, BJ; Pfleger, KDG				Armstrong, Stephen P.; Seeber, Ruth M.; Ayoub, Mohammed Akli; Feldman, Brian J.; Pfleger, Kevin D. G.			Characterization of Three Vasopressin Receptor 2 Variants: An Apparent Polymorphism (V266A) and Two Loss-of-Function Mutations (R181C and M311V)	PLOS ONE			English	Article							NEPHROGENIC DIABETES-INSIPIDUS; PROTEIN-PROTEIN INTERACTIONS; V2 VASOPRESSIN; HORMONE-RECEPTORS; COUPLED RECEPTORS; AVPR2 VARIANTS; IDENTIFICATION; AGONIST; STIMULATION; INSIGHTS	Arginine vasopressin (AVP) is released from the posterior pituitary and controls water homeostasis. AVP binding to vasopressin V2 receptors (V2Rs) located on kidney collecting duct epithelial cells triggers activation of Gs proteins, leading to increased cAMP levels, trafficking of aquaporin-2 water channels, and consequent increased water permeability and antidiuresis. Typically, loss-of-function V2R mutations cause nephrogenic diabetes insipidus (NDI), whereas gain-of-function mutations cause nephrogenic syndrome of inappropriate antidiuresis (NSIAD). Here we provide further characterization of two mutant V2Rs, R181C and M311V, reported to cause complete and partial NDI respectively, together with a V266A variant, in a patient diagnosed with NSIAD. Our data in HEK293FT cells revealed that for cAMP accumulation, AVP was about 500- or 30-fold less potent at the R181C and M311V mutants than at the wild-type receptor respectively (and about 4000- and 60-fold in COS7 cells respectively). However, in contrast to wild type V2R, the R181C mutant failed to increase inositol phosphate production, while with the M311V mutant, AVP exhibited only partial agonism in addition to a 37-fold potency decrease. Similar responses were detected in a BRET assay for beta-arrestin recruitment, with the R181C receptor unresponsive to AVP, and partial agonism with a 23-fold decrease in potency observed with M311V in both HEK293FT and COS7 cells. Notably, the V266A V2R appeared functionally identical to the wild-type receptor in all assays tested, including cAMP and inositol phosphate accumulation, b-arrestin interaction, and in a BRET assay of receptor ubiquitination. Each receptor was expressed at comparable levels. Hence, the M311V V2R retains greater activity than the R181C mutant, consistent with the milder phenotype of NDI associated with this mutant. Notably, the R181C mutant appears to be a Gs protein-biased receptor incapable of signaling to inositol phosphate or recruiting b-arrestin. The etiology of NSIAD in the patient with V266A V2R remains unknown.	[Armstrong, Stephen P.; Seeber, Ruth M.; Ayoub, Mohammed Akli; Pfleger, Kevin D. G.] Univ Western Australia, Western Australian Inst Med Res, Lab Mol Endocrinol G Prot Coupled Receptors, Perth, WA 6009, Australia; [Armstrong, Stephen P.; Seeber, Ruth M.; Ayoub, Mohammed Akli; Pfleger, Kevin D. G.] Univ Western Australia, Med Res Ctr, Perth, WA 6009, Australia; [Ayoub, Mohammed Akli] King Saud Univ, Coll Sci, Dept Biochem, Prot Res Chair, Riyadh 11451, Saudi Arabia; [Feldman, Brian J.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA	University of Western Australia; University of Western Australia; King Saud University; Stanford University	Pfleger, KDG (corresponding author), Univ Western Australia, Western Australian Inst Med Res, Lab Mol Endocrinol G Prot Coupled Receptors, Perth, WA 6009, Australia.	kevin.pfleger@waimr.uwa.edu.au	Seeber, Ruth/AAS-9411-2021; Pfleger, Kevin/H-5629-2014	Seeber, Ruth/0000-0003-3265-7931; Pfleger, Kevin/0000-0001-8261-9189; AYOUB, Mohammed Akli/0000-0003-0022-578X	Australian Research Council [FT100100271]; Raine Medical Research Foundation	Australian Research Council(Australian Research Council); Raine Medical Research Foundation	This research was funded by the Australian Research Council (www.arc.gov.au) Future Fellowship (FT100100271) and a Priming Grant from the Raine Medical Research Foundation (www.raine.uwa.edu.au), both awarded to KDGP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong SP, 2011, MOL CELL ENDOCRINOL, V331, P194, DOI 10.1016/j.mce.2010.07.008; Audet M, 2012, CELL, V151, P14, DOI 10.1016/j.cell.2012.09.003; Balasubramanian L, 2008, PFLUG ARCH EUR J PHY, V456, P747, DOI 10.1007/s00424-007-0371-7; Ball SG, 2007, ANN CLIN BIOCHEM, V44, P417, DOI 10.1258/000456307781646030; Baylis PH, 2003, INT J BIOCHEM CELL B, V35, P1495, DOI 10.1016/S1357-2725(03)00139-0; Bernier V, 2006, J AM SOC NEPHROL, V17, P232, DOI 10.1681/ASN.2005080854; BICHET DG, 1994, AM J HUM GENET, V55, P278; BIRNBAUMER M, 1992, NATURE, V357, P333, DOI 10.1038/357333a0; Carpentier E, 2012, J AM SOC NEPHROL, V23, P1635, DOI 10.1681/ASN.2012010077; Chang WC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001317; Dalrymple MB, 2011, J BIOL CHEM, V286, P16726, DOI 10.1074/jbc.M111.223537; Feldman BJ, 2005, NEW ENGL J MED, V352, P1884, DOI 10.1056/NEJMoa042743; Finch AR, 2010, MOL ENDOCRINOL, V24, P423, DOI 10.1210/me.2009-0343; Grasberger H, 2007, J CLIN ENDOCR METAB, V92, P2816, DOI 10.1210/jc.2007-0366; Hermosilla R, 2004, TRAFFIC, V5, P993, DOI 10.1111/j.1600-0854.2004.00239.x; Kenakin T, 2001, FASEB J, V15, P598, DOI 10.1096/fj.00-0438rev; KNOERS NVAM, 1994, KIDNEY INT, V46, P170, DOI 10.1038/ki.1994.256; Kocan Martina, 2010, Front Endocrinol (Lausanne), V1, P12, DOI 10.3389/fendo.2010.00012; Kocan M, 2009, MOL ENDOCRINOL, V23, P559, DOI 10.1210/me.2008-0321; Lan HX, 2009, MOL PHARMACOL, V75, P113, DOI 10.1124/mol.108.050534; Leach K, 2012, ENDOCRINOLOGY, V153, P4304, DOI 10.1210/en.2012-1449; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; LOLAIT SJ, 1992, NATURE, V357, P336, DOI 10.1038/357336a0; Martin NP, 2003, J BIOL CHEM, V278, P45954, DOI 10.1074/jbc.M308285200; Morello JP, 2001, ANNU REV PHYSIOL, V63, P607, DOI 10.1146/annurev.physiol.63.1.607; Mustafa S, 2012, J BIOL CHEM, V287, P12952, DOI 10.1074/jbc.M111.322834; Nakajima K, 2012, MOL PHARMACOL, V82, P575, DOI 10.1124/mol.112.080358; PAN Y, 1994, J BIOL CHEM, V269, P31933; PAN Y, 1992, NAT GENET, V2, P103, DOI 10.1038/ng1092-103; Perroy J, 2004, NAT METHODS, V1, P203, DOI 10.1038/NMETH722; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Pfleger KDG, 2006, NAT PROTOC, V1, P337, DOI 10.1038/nprot.2006.52; Pfleger KDG, 2006, CELL SIGNAL, V18, P1664, DOI 10.1016/j.cellsig.2006.01.004; Rahmeh R, 2012, P NATL ACAD SCI USA, V109, P6733, DOI 10.1073/pnas.1201093109; Rochdi MD, 2010, MOL PHARMACOL, V77, P836, DOI 10.1124/mol.109.061804; ROSENTHAL W, 1993, J BIOL CHEM, V268, P13030; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Sahakitrungruang T, 2010, HORM RES PAEDIAT, V73, P349, DOI 10.1159/000308167; Sands JM, 2006, ANN INTERN MED, V144, P186, DOI 10.7326/0003-4819-144-3-200602070-00007; Schoneberg T, 1998, HUM MUTAT, V12, P196, DOI 10.1002/(SICI)1098-1004(1998)12:3<196::AID-HUMU7>3.0.CO;2-F; Schulein R, 2001, J BIOL CHEM, V276, P8384, DOI 10.1074/jbc.M007045200; Schulz A, 2000, J BIOL CHEM, V275, P2381, DOI 10.1074/jbc.275.4.2381; Schulz A, 2002, J CLIN ENDOCR METAB, V87, P5247, DOI 10.1210/jc.2002-020286; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Slusarz MJ, 2006, J PEPT SCI, V12, P180, DOI 10.1002/psc.714; Spanakis E, 2008, J CELL PHYSIOL, V217, P605, DOI 10.1002/jcp.21552; Takahashi K, 2012, J BIOL CHEM, V287, P2099, DOI 10.1074/jbc.M111.268797; Tenenbaum J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008383; Vassart G, 2011, NAT REV ENDOCRINOL, V7, P362, DOI 10.1038/nrendo.2011.20; Wildin RS, 1998, KIDNEY INT, V54, P1909, DOI 10.1046/j.1523-1755.1998.00214.x; Zhong M, 2007, AM J PHYSIOL-ENDOC M, V292, pE977, DOI 10.1152/ajpendo.00531.2005; Zhu X, 1996, P NATL ACAD SCI USA, V93, P2827, DOI 10.1073/pnas.93.7.2827	52	20	21	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65885	10.1371/journal.pone.0065885	http://dx.doi.org/10.1371/journal.pone.0065885			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762448	Green Published, Green Submitted, gold			2022-12-27	WOS:000321099000116
J	Coy, S; Volanakis, A; Shah, S; Vasiljeva, L				Coy, Sarah; Volanakis, Adam; Shah, Sneha; Vasiljeva, Lidia			The Sm Complex Is Required for the Processing of Non-Coding RNAs by the Exosome	PLOS ONE			English	Article							NUCLEOLAR RNP PROTEINS; SMALL NUCLEAR-RNA; SACCHAROMYCES-CEREVISIAE; TELOMERASE RNA; RIBOSOMAL-RNA; SECONDARY STRUCTURE; STRUCTURAL DOMAIN; IN-VITRO; YEAST; SNRNA	A key question in the field of RNA regulation is how some exosome substrates, such as spliceosomal snRNAs and telomerase RNA, evade degradation and are processed into stable, functional RNA molecules. Typical feature of these non-coding RNAs is presence of the Sm complex at the 3 ' end of the mature RNA molecule. Here, we report that in Saccharomyces cerevisiae presence of intact Sm binding site is required for the exosome-mediated processing of telomerase RNA from a polyadenylated precursor into its mature form and is essential for its function in elongating telomeres. Additionally, we demonstrate that the same pathway is involved in the maturation of snRNAs. Furthermore, the insertion of an Sm binding site into an unstable RNA that is normally completely destroyed by the exosome, leads to its partial stabilization. We also show that telomerase RNA accumulates in Schizosaccharomyces pombe exosome mutants, suggesting a conserved role for the exosome in processing and degradation of telomerase RNA. In summary, our data provide important mechanistic insight into the regulation of exosome dependent RNA processing as well as telomerase RNA biogenesis.	[Coy, Sarah; Volanakis, Adam; Shah, Sneha; Vasiljeva, Lidia] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford	Vasiljeva, L (corresponding author), Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.	lidia.vasilieva@bioch.ox.ac.uk	Vasilieva, Lidia/AAU-1473-2020	Shah, Sneha/0000-0002-0691-9566; Volanakis, Adam/0000-0002-9074-4825; Vasiljeva, Lidia/0000-0002-1244-8772; Coy, Sarah/0000-0003-2548-2045	Wellcome Trust [WT088359MA]	Wellcome Trust(Wellcome TrustEuropean Commission)	The work is funded by the Wellcome Trust Career Development grant (WT088359MA)(http://www.wellcome.ac.uk/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Arigo JT, 2006, MOL CELL, V23, P841, DOI 10.1016/j.molcel.2006.07.024; Azzouz N, 2009, RNA, V15, P377, DOI 10.1261/rna.1348209; Beggs JD, 2005, BIOCHEM SOC T, V33, P433, DOI 10.1042/BST0330433; Bernard P, 2010, MOL CELL BIOL, V30, P1145, DOI 10.1128/MCB.01317-09; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bonneau F, 2009, CELL, V139, P547, DOI 10.1016/j.cell.2009.08.042; Bosoy D, 2003, J BIOL CHEM, V278, P3882, DOI 10.1074/jbc.M210645200; Box JA, 2008, J BIOL CHEM, V283, P24224, DOI 10.1074/jbc.M802043200; Box JA, 2008, NATURE, V456, P910, DOI 10.1038/nature07584; BRANLANT C, 1982, EMBO J, V1, P1259, DOI 10.1002/j.1460-2075.1982.tb00022.x; Butler JS, 2010, ADV EXP MED BIOL, V702, P91, DOI 10.1007/978-1-4419-7841-7_8; Callahan KP, 2008, NUCLEIC ACIDS RES, V36, P6645, DOI 10.1093/nar/gkn743; Chanfreau G, 1997, GENE DEV, V11, P2741, DOI 10.1101/gad.11.20.2741; Chapon C, 1997, RNA, V3, P1337; Dandjinou AT, 2004, CURR BIOL, V14, P1148, DOI 10.1016/j.cub.2004.05.054; Dez C, 2001, NUCLEIC ACIDS RES, V29, P598, DOI 10.1093/nar/29.3.598; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Flynt AS, 2010, MOL CELL, V38, P900, DOI 10.1016/j.molcel.2010.06.014; Franke J, 2008, J CELL SCI, V121, P3553, DOI 10.1242/jcs.033308; Gallardo F, 2008, EMBO J, V27, P748, DOI 10.1038/emboj.2008.21; Ganot P, 1997, GENE DEV, V11, P941, DOI 10.1101/gad.11.7.941; Graham AC, 2006, MOL BIOL CELL, V17, P1399, DOI 10.1091/mbc.e05-08-0805; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Houseley J, 2007, EMBO J, V26, P4996, DOI 10.1038/sj.emboj.7601921; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Jamonnak N, 2011, RNA, V17, P2011, DOI 10.1261/rna.2840711; Kim HS, 2009, NAT STRUCT MOL BIOL, V16, P1286, DOI 10.1038/nsmb.1688; Kiss T, 2010, MOL CELL, V37, P597, DOI 10.1016/j.molcel.2010.01.032; Kufel J, 2000, MOL CELL BIOL, V20, P5415, DOI 10.1128/MCB.20.15.5415-5424.2000; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lafontaine DLJ, 1998, GENE DEV, V12, P527, DOI 10.1101/gad.12.4.527; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Lendvay TS, 1996, GENETICS, V144, P1399; Leonardi J, 2008, NAT STRUCT MOL BIOL, V15, P26, DOI 10.1038/nsmb1343; LIAUTARD JP, 1982, J MOL BIOL, V162, P623, DOI 10.1016/0022-2836(82)90392-8; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Malet H, 2010, EMBO REP, V11, P936, DOI 10.1038/embor.2010.164; MATTAJ IW, 1986, CELL, V46, P905, DOI 10.1016/0092-8674(86)90072-3; Milligan L, 2005, MOL CELL BIOL, V25, P9996, DOI 10.1128/MCB.25.22.9996-10004.2005; Milligan L, 2008, MOL CELL BIOL, V28, P5446, DOI 10.1128/MCB.00463-08; Mitchell P, 2003, MOL CELL BIOL, V23, P6982, DOI 10.1128/MCB.23.19.6982-6992.2003; Mouaikel J, 2002, MOL CELL, V9, P891, DOI 10.1016/S1097-2765(02)00484-7; Mozdy AD, 2006, RNA, V12, P1721, DOI 10.1261/rna.134706; Noel JF, 2012, NUCL ACIDS RES; PLESSEL G, 1994, MOL CELL BIOL, V14, P4160, DOI 10.1128/MCB.14.6.4160; PORTER G, 1990, MOL CELL BIOL, V10, P2874, DOI 10.1128/MCB.10.6.2874; Prescott J, 1997, GENE DEV, V11, P528, DOI 10.1101/gad.11.4.528; Prescott J, 1997, GENE DEV, V11, P2790, DOI 10.1101/gad.11.21.2790; Qiu ZCR, 2011, NUCLEIC ACIDS RES, V39, P5633, DOI 10.1093/nar/gkr083; Raker VA, 1999, MOL CELL BIOL, V19, P6554; Raker VA, 1996, EMBO J, V15, P2256, DOI 10.1002/j.1460-2075.1996.tb00579.x; RYMOND BC, 1993, P NATL ACAD SCI USA, V90, P848, DOI 10.1073/pnas.90.3.848; Salgado-Garrido J, 1999, EMBO J, V18, P3451, DOI 10.1093/emboj/18.12.3451; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Schilders G, 2007, NUCLEIC ACIDS RES, V35, P2564, DOI 10.1093/nar/gkm082; Seipelt RL, 1999, NUCLEIC ACIDS RES, V27, P587, DOI 10.1093/nar/27.2.587; SERAPHIN B, 1991, NUCLEIC ACIDS RES, V19, P3857, DOI 10.1093/nar/19.14.3857; Seto AG, 1999, NATURE, V401, P177, DOI 10.1038/43694; SILICIANO PG, 1987, CELL, V50, P585, DOI 10.1016/0092-8674(87)90031-6; Stead JA, 2007, NUCLEIC ACIDS RES, V35, P5556, DOI 10.1093/nar/gkm614; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; STUTZ F, 1993, MOL CELL BIOL, V13, P2126, DOI 10.1128/MCB.13.4.2126; Tang W, 2012, NATURE; Teixeira MT, 2002, EMBO REP, V3, P652, DOI 10.1093/embo-reports/kvf133; Teng SC, 1999, MOL CELL BIOL, V19, P8083; Tharun S, 2000, NATURE, V404, P515, DOI 10.1038/35006676; Uguen P, 2004, NUCLEIC ACIDS RES, V32, P2987, DOI 10.1093/nar/gkh619; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; Vasilieva L, 2008, MOL CELL, V29, P313, DOI 10.1016/j.molcel.2008.01.011; Vasiljeva L, 2006, MOL CELL, V21, P239, DOI 10.1016/j.molcel.2005.11.028; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; Weber G, 2010, EMBO J, V29, P4172, DOI 10.1038/emboj.2010.295; Weir JR, 2010, P NATL ACAD SCI USA, V107, P12139, DOI 10.1073/pnas.1004953107; Yamashita A, 2005, NAT STRUCT MOL BIOL, V12, P1054, DOI 10.1038/nsmb1016; Zhang D, 2001, MOL CELL, V7, P319, DOI 10.1016/S1097-2765(01)00180-0	76	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65606	10.1371/journal.pone.0065606	http://dx.doi.org/10.1371/journal.pone.0065606			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755256	Green Published, Green Submitted, gold			2022-12-27	WOS:000321099000082
J	Hau, AM; Greenwood, JA; Lohr, CV; Serrill, JD; Proteau, PJ; Ganley, IG; McPhail, KL; Ishmael, JE				Hau, Andrew M.; Greenwood, Jeffrey A.; Loehr, Christiane V.; Serrill, Jeffrey D.; Proteau, Philip J.; Ganley, Ian G.; McPhail, Kerry L.; Ishmael, Jane E.			Coibamide A Induces mTOR-Independent Autophagy and Cell Death in Human Glioblastoma Cells	PLOS ONE			English	Article							MALIGNANT GLIOMA-CELLS; MARINE CYANOBACTERIA; RADIATION-THERAPY; NATURAL-PRODUCTS; IN-VITRO; INHIBITORS; RAPAMYCIN; SURVIVAL; APOPTOSIS; CANCER	Coibamide A is an N-methyl-stabilized depsipeptide that was isolated from a marine cyanobacterium as part of an International Cooperative Biodiversity Groups (ICBG) program based in Panama. Previous testing of coibamide A in the NCI in vitro 60 cancer cell line panel revealed a potent anti-proliferative response and "COMPARE-negative" profile indicative of a unique mechanism of action. We report that coibamide A is a more potent and efficacious cytotoxin than was previously appreciated, inducing concentration-and time-dependent cytotoxicity (EC50<100 nM) in human U87-MG and SF-295 glioblastoma cells and mouse embryonic fibroblasts (MEFs). This activity was lost upon linearization of the molecule, highlighting the importance of the cyclized structure for both anti-proliferative and cytotoxic responses. We show that coibamide A induces autophagosome accumulation in human glioblastoma cell types and MEFs via an mTOR-independent mechanism; no change was observed in the phosphorylation state of ULK1 (Ser-757), p70 S6K1 (Thr-389), S6 ribosomal protein (Ser-235/236) and 4EBP-1 (Thr-37/46). Coibamide A also induces morphologically and biochemically distinct forms of cell death according to cell type. SF-295 glioblastoma cells showed caspase-3 activation and evidence of apoptotic cell death in a pattern that was also seen in wild-type and autophagy-deficient (ATG5-null) MEFs. In contrast, cell death in U87-MG glioblastoma cells was characterized by extensive cytoplasmic vacuolization and lacked clear apoptotic features. Cell death was attenuated, but still triggered, in Apaf-1-null MEFs lacking a functional mitochondria-mediated apoptotic pathway. From the study of ATG5-null MEFs we conclude that a conventional autophagy response is not required for coibamide A-induced cell death, but likely occurs in dying cells in response to treatment. Coibamide A represents a natural product scaffold with potential for the study of mTOR-independent signaling and cell death mechanisms in apoptotic-resistant cancer cells.	[Hau, Andrew M.; Serrill, Jeffrey D.; Proteau, Philip J.; McPhail, Kerry L.; Ishmael, Jane E.] Oregon State Univ, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Greenwood, Jeffrey A.] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA; [Loehr, Christiane V.] Oregon State Univ, Dept Biomed Sci, Corvallis, OR 97331 USA; [Ganley, Ian G.] Univ Dundee, Coll Life Sci, MRC Prot Phosphorylat Unit, Dundee, Scotland	Oregon State University; Oregon State University; Oregon State University; University of Dundee	McPhail, KL (corresponding author), Oregon State Univ, Dept Pharmaceut Sci, Corvallis, OR 97331 USA.	kerry.mcphail@oregonstate.edu; jane.ishmael@oregonstate.edu	Löhr, C. V./AAU-4902-2020	Löhr, C. V./0000-0003-3787-5583; Greenwood, Juliet/0000-0001-6438-964X; McPhail, Kerry/0000-0003-2076-1002; Ganley, Ian/0000-0003-1481-9407	NIH Fogarty International Center ICBG [TW006634-06]; Medical Research Foundation of Oregon; American Foundation for Pharmaceutical Education; OSU College of Pharmacy and Division of Health Sciences; Cell Imaging and Analysis Facilities and Services Core of the OSU Environmental Heath Sciences Center (NIEHS) [P30-ES000210]; MRC [MC_UU_12016/4, MC_UP_A500_1019] Funding Source: UKRI; Medical Research Council [MC_UP_A500_1019, MC_UU_12016/4] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTER [U01TW006634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER	NIH Fogarty International Center ICBG; Medical Research Foundation of Oregon; American Foundation for Pharmaceutical Education; OSU College of Pharmacy and Division of Health Sciences; Cell Imaging and Analysis Facilities and Services Core of the OSU Environmental Heath Sciences Center (NIEHS); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Financial support was provided by: the NIH Fogarty International Center ICBG grant TW006634-06, the Medical Research Foundation of Oregon, the American Foundation for Pharmaceutical Education and the OSU College of Pharmacy and Division of Health Sciences. We are also grateful for services provided by the Cell Imaging and Analysis Facilities and Services Core of the OSU Environmental Heath Sciences Center (NIEHS grant P30-ES000210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Brennan C, 2011, CURR NEUROL NEUROSCI, V11, P291, DOI 10.1007/s11910-011-0198-7; Brown PD, 2008, J CLIN ONCOL, V26, P5603, DOI 10.1200/JCO.2008.18.0612; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; Collins A, 2007, TOXICOL LETT, V171, P60, DOI 10.1016/j.toxlet.2007.04.004; Fan QW, 2011, AUTOPHAGY, V7, P536, DOI 10.4161/auto.7.5.14779; Gammoh N, 2012, P NATL ACAD SCI USA, V109, P6561, DOI 10.1073/pnas.1204429109; Ganley IG, 2011, MOL CELL, V42, P731, DOI 10.1016/j.molcel.2011.04.024; Gerwick WH, 2001, ALKALOIDS, V57, P75, DOI 10.1016/S0099-9598(01)57003-0; Hammerova J, 2012, BIOL CHEM, V393, P647, DOI 10.1515/hsz-2011-0279; Hosoi H, 1998, MOL PHARMACOL, V54, P815, DOI 10.1124/mol.54.5.815; Korsnes MS, 2012, TOXINS, V4, P568, DOI 10.3390/toxins4070568; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Krakstad C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-135; Kreuzaler P, 2012, NAT REV CANCER, V12, P411, DOI 10.1038/nrc3264; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Medina RA, 2008, J AM CHEM SOC, V130, P6324, DOI 10.1021/ja801383f; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Molinski TF, 2009, NAT REV DRUG DISCOV, V8, P69, DOI 10.1038/nrd2487; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Munafo DB, 2001, J CELL SCI, V114, P3619; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Prados MD, 2009, J CLIN ONCOL, V27, P579, DOI 10.1200/JCO.2008.18.9639; Reubold TF, 2012, CELL SIGNAL, V24, P1420, DOI 10.1016/j.cellsig.2012.03.007; Shao YF, 2004, P NATL ACAD SCI USA, V101, P18030, DOI 10.1073/pnas.0408345102; Sheen JH, 2011, CANCER CELL, V19, P613, DOI 10.1016/j.ccr.2011.03.012; Shen HM, 2011, AUTOPHAGY, V7, P457, DOI 10.4161/auto.7.5.14226; Shingu T, 2009, INT J CANCER, V124, P1060, DOI 10.1002/ijc.24030; Simmons TL, 2009, J NAT PROD, V72, P1011, DOI 10.1021/np9001674; Sini P, 2010, AUTOPHAGY, V6, P553, DOI 10.4161/auto.6.4.11671; Takeuchi H, 2005, CANCER RES, V65, P3336, DOI 10.1158/0008-5472.CAN-04-3640; Tan LT, 2007, PHYTOCHEMISTRY, V68, P954, DOI 10.1016/j.phytochem.2007.01.012; Thoreen CC, 2009, AUTOPHAGY, V5, P725, DOI 10.4161/auto.5.5.8504; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tripathi A, 2010, J NAT PROD, V73, P1810, DOI 10.1021/np100442x; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X	45	52	53	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65250	10.1371/journal.pone.0065250	http://dx.doi.org/10.1371/journal.pone.0065250			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762328	Green Published, gold, Green Submitted			2022-12-27	WOS:000321099000049
J	Jha, RM; Chrenek, R; Magnotti, LM; Cardozo, DL				Jha, Ruchira M.; Chrenek, Ryan; Magnotti, Laura M.; Cardozo, David L.			The Isolation, Differentiation, and Survival In Vivo of Multipotent Cells from the Postnatal Rat filum terminale	PLOS ONE			English	Article							NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; ADULT MAMMALIAN FOREBRAIN; SPINAL-CORD; PROGENITOR CELLS; MOTOR-NEURONS; CHOLINERGIC NEURONS; DOPAMINERGIC DIFFERENTIATION; STEM/PROGENITOR CELLS; SUBEPENDYMAL CELLS	Neural stem cells (NSCs) are undifferentiated cells in the central nervous system (CNS) that are capable of self-renewal and can be induced to differentiate into neurons and glia. Current sources of mammalian NSCs are confined to regions of the CNS that are critical to normal function and surgically difficult to access, which limits their therapeutic potential in human disease. We have found that the filum terminale (FT), a previously unexplored, expendable, and easily accessible tissue at the caudal end of the spinal cord, is a source of multipotent cells in postnatal rats and humans. In this study, we used a rat model to isolate and characterize the potential of these cells. Neurospheres derived from the rat FT are amenable to in vitro expansion in the presence of a combination of growth factors. These proliferating, FT-derived cells formed neurospheres that could be induced to differentiate into neural progenitor cells, neurons, astrocytes, and oligodendrocytes by exposure to serum and/or adhesive substrates. Through directed differentiation using sonic hedgehog and retinoic acid in combination with various neurotrophic factors, FT-derived neurospheres generated motor neurons that were capable of forming neuromuscular junctions in vitro. In addition, FT-derived progenitors that were injected into chick embryos survived and could differentiate into both neurons and glia in vivo.	[Jha, Ruchira M.; Chrenek, Ryan; Magnotti, Laura M.; Cardozo, David L.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Chrenek, Ryan] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Magnotti, LM (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	laura_magnotti@hms.harvard.edu			Vertex Pharmaceuticals	Vertex Pharmaceuticals(Vertex Pharmaceuticals)	This work was supported by a grant from Vertex Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht PJ, 2002, EXP NEUROL, V173, P46, DOI 10.1006/exnr.2001.7834; Alvarez-Buylla A, 2002, BRAIN RES BULL, V57, P751, DOI 10.1016/S0361-9230(01)00770-5; Arvidsson L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027393; Ashkenazi E, 1998, J SPINAL DISORD, V11, P540; BAKKERNIEZEN SH, 1984, Z KINDERCHIR, V39, P100; Bez A, 2003, BRAIN RES, V993, P18, DOI 10.1016/j.brainres.2003.08.061; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Carpenter MK, 1999, EXP NEUROL, V158, P265, DOI 10.1006/exnr.1999.7098; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; Chipperfield H, 2005, BRAIN RES PROTOC, V14, P146, DOI 10.1016/j.brainresprot.2004.12.003; CHOI BH, 1992, HUM PATHOL, V23, P916, DOI 10.1016/0046-8177(92)90405-R; Coles BLK, 2004, P NATL ACAD SCI USA, V101, P15772, DOI 10.1073/pnas.0401596101; Deshpande DM, 2006, ANN NEUROL, V60, P32, DOI 10.1002/ana.20901; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Durston AJ, 1998, CURR TOP DEV BIOL, V40, P111, DOI 10.1016/S0070-2153(08)60366-X; Dyer MA, 2000, NAT NEUROSCI, V3, P873, DOI 10.1038/78774; Fontes RBV, 2006, NEUROSURGERY, V58, P978, DOI 10.1227/01.NEU.0000210224.54816.40; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.neuro.18.1.159; GAGLIARDI FM, 1993, CHILD NERV SYST, V9, P3, DOI 10.1007/BF00301925; Ge D., 2012, AFR J BIOTECHNOL, V11, P3976; Goldman SA, 2006, PHILOS T R SOC B, V361, P1463, DOI 10.1098/rstb.2006.1886; Gritti A, 1996, J NEUROSCI, V16, P1091; Harmeier JW, 1933, ARCH NEURO PSYCHIATR, V29, P308, DOI 10.1001/archneurpsyc.1933.02240080098008; Harper JM, 2004, P NATL ACAD SCI USA, V101, P7123, DOI 10.1073/pnas.0401103101; Hirano M, 2003, DEV DYNAM, V228, P664, DOI 10.1002/dvdy.10425; Horner PJ, 2000, J NEUROSCI, V20, P2218; Jha RM, 2013, NEUROSURGERY, V72, P118, DOI 10.1227/NEU.0b013e318276b445; Jordan PM, 2008, J NEUROSCI RES, V86, P35, DOI 10.1002/jnr.21460; JOYCE GF, 2005, HLTH AFF MILLWOOD S2, V24; KAMALIAN N, 1987, J NEUROL, V235, P56, DOI 10.1007/BF00314201; Kasahara K, 2006, SPINE, V31, P2059, DOI 10.1097/01.brs.0000231893.21964.f2; Kawasaki H, 2002, P NATL ACAD SCI USA, V99, P1580, DOI 10.1073/pnas.032662199; Kim YT, 2006, EXP NEUROL, V199, P222, DOI 10.1016/j.expneurol.2006.03.015; Koeller KK, 2000, RADIOGRAPHICS, V20, P1721, DOI 10.1148/radiographics.20.6.g00nv151721; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lad Shivanand P, 2007, Neurosurg Focus, V23, pE3; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Lobo MVT, 2003, J HISTOCHEM CYTOCHEM, V51, P89, DOI 10.1177/002215540305100111; Lu FL, 1998, PEDIATR NEUROL, V19, P230, DOI 10.1016/S0887-8994(98)00046-0; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Merkle FT, 2006, CURR OPIN CELL BIOL, V18, P704, DOI 10.1016/j.ceb.2006.09.008; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; MILLER C, 1968, J COMP NEUROL, V132, P547, DOI 10.1002/cne.901320405; Mori H, 2006, J NEUROSCI RES, V84, P1682, DOI 10.1002/jnr.21082; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Muhr J, 1999, NEURON, V23, P689, DOI 10.1016/S0896-6273(01)80028-3; Ooto S, 2003, INVEST OPHTH VIS SCI, V44, P2689, DOI 10.1167/iovs.02-1168; Pagano SF, 2000, STEM CELLS, V18, P295, DOI 10.1634/stemcells.18-4-295; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Rakowicz WP, 2002, J NEUROSCI, V22, P3953, DOI 10.1523/JNEUROSCI.22-10-03953.2002; Ray J, 2006, MOL CELL NEUROSCI, V31, P560, DOI 10.1016/j.mcn.2005.11.010; Ren WW, 2006, NEUROL RES, V28, P87, DOI 10.1179/016164106X91933; Rethelyi M, 2004, BRAIN RES, V1028, P133, DOI 10.1016/j.brainres.2004.08.069; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Roy NS, 2000, NAT MED, V6, P271; Shihabuddin LS, 1999, MOL MED TODAY, V5, P474, DOI 10.1016/S1357-4310(99)01596-8; Soundararajan P, 2006, J NEUROSCI, V26, P3256, DOI 10.1523/JNEUROSCI.5537-05.2006; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; Storch A, 2001, EXP NEUROL, V170, P317, DOI 10.1006/exnr.2001.7706; Streeter GL, 1919, AM J ANAT, V22, P1; Suslov ON, 2002, P NATL ACAD SCI USA, V99, P14506, DOI 10.1073/pnas.212525299; Suzuki M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000689; Tang Jun, 2007, Neurosci Bull, V23, P263, DOI 10.1007/s12264-007-0039-5; Tarasenko YI, 2004, J NEUROSCI RES, V78, P625, DOI 10.1002/jnr.20316; Tarlov IM, 1938, ARCH NEURO PSYCHIATR, V40, P1; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Varghese M, 2009, STEM CELLS DEV, V18, P603, DOI 10.1089/scd.2008.0144; Vugler A, 2007, MECH DEVELOP, V124, P807, DOI 10.1016/j.mod.2007.08.002; Wang TTH, 2006, NEUROREPORT, V17, P1433, DOI 10.1097/01.wnr.0000227980.06013.31; Weiss S, 1996, J NEUROSCI, V16, P7599; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Yamasaki TR, 2007, J NEUROSCI, V27, P11925, DOI 10.1523/JNEUROSCI.1627-07.2007; Yasuhara T, 2006, J NEUROSCI, V26, P12497, DOI 10.1523/JNEUROSCI.3719-06.2006; Yu YQ, 2007, J NEUROL SCI, V255, P81, DOI 10.1016/j.jns.2007.01.076; Zeng XM, 2004, STEM CELLS, V22, P925, DOI 10.1634/stemcells.22-6-925	80	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65974	10.1371/journal.pone.0065974	http://dx.doi.org/10.1371/journal.pone.0065974			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762453	gold, Green Published, Green Submitted			2022-12-27	WOS:000321099000121
J	Wild, AT; Gandhi, N; Chettiar, ST; Aziz, K; Gajula, RP; Williams, RD; Kumar, R; Taparra, K; Zeng, J; Cades, JA; Velarde, E; Menon, S; Geschwind, JF; Cosgrove, D; Pawlik, TM; Maitra, A; Wong, J; Hales, RK; Torbenson, MS; Herman, JM; Tran, PT				Wild, Aaron T.; Gandhi, Nishant; Chettiar, Sivarajan T.; Aziz, Khaled; Gajula, Rajendra P.; Williams, Russell D.; Kumar, Rachit; Taparra, Kekoa; Zeng, Jing; Cades, Jessica A.; Velarde, Esteban; Menon, Siddharth; Geschwind, Jean F.; Cosgrove, David; Pawlik, Timothy M.; Maitra, Anirban; Wong, John; Hales, Russell K.; Torbenson, Michael S.; Herman, Joseph M.; Tran, Phuoc T.			Concurrent versus Sequential Sorafenib Therapy in Combination with Radiation for Hepatocellular Carcinoma	PLOS ONE			English	Article							PHASE-II; TRANSARTERIAL CHEMOEMBOLIZATION; RAF/MEK/ERK PATHWAY; TUMOR PROGRESSION; UNITED-STATES; RAF KINASE; GROWTH; BAY-43-9006; INHIBITOR; ANGIOGENESIS	Sorafenib (SOR) is the only systemic agent known to improve survival for hepatocellular carcinoma (HCC). However, SOR prolongs survival by less than 3 months and does not alter symptomatic progression. To improve outcomes, several phase I-II trials are currently examining SOR with radiation (RT) for HCC utilizing heterogeneous concurrent and sequential treatment regimens. Our study provides preclinical data characterizing the effects of concurrent versus sequential RT-SOR on HCC cells both in vitro and in vivo. Concurrent and sequential RT-SOR regimens were tested for efficacy among 4 HCC cell lines in vitro by assessment of clonogenic survival, apoptosis, cell cycle distribution, and gamma-H2AX foci formation. Results were confirmed in vivo by evaluating tumor growth delay and performing immunofluorescence staining in a hind-flank xenograft model. In vitro, concurrent RT-SOR produced radioprotection in 3 of 4 cell lines, whereas sequential RT-SOR produced decreased colony formation among all 4. Sequential RT-SOR increased apoptosis compared to RT alone, while concurrent RT-SOR did not. Sorafenib induced reassortment into less radiosensitive phases of the cell cycle through G(1)-S delay and cell cycle slowing. More double-strand breaks (DSBs) persisted 24 h post-irradiation for RT alone versus concurrent RT-SOR. In vivo, sequential RT-SOR produced the greatest tumor growth delay, while concurrent RT-SOR was similar to RT alone. More persistent DSBs were observed in xenografts treated with sequential RT-SOR or RT alone versus concurrent RT-SOR. Sequential RT-SOR additionally produced a greater reduction in xenograft tumor vascularity and mitotic index than either concurrent RT-SOR or RT alone. In conclusion, sequential RT-SOR demonstrates greater efficacy against HCC than concurrent RT-SOR both in vitro and in vivo. These results may have implications for clinical decision-making and prospective trial design.	[Wild, Aaron T.; Gandhi, Nishant; Chettiar, Sivarajan T.; Aziz, Khaled; Gajula, Rajendra P.; Williams, Russell D.; Kumar, Rachit; Taparra, Kekoa; Zeng, Jing; Velarde, Esteban; Menon, Siddharth; Wong, John; Hales, Russell K.; Herman, Joseph M.; Tran, Phuoc T.] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA; [Cades, Jessica A.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Geschwind, Jean F.] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA; [Cosgrove, David; Herman, Joseph M.; Tran, Phuoc T.] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; [Pawlik, Timothy M.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Maitra, Anirban; Torbenson, Michael S.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Tran, Phuoc T.] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Herman, JM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA.	jherma15@jhmi.edu; tranp@jhmi.edu	Pawlik, Timothy/AAO-9335-2020; Chettiar, Sivarajan T/K-2766-2014; Aziz, Khaled/AAZ-7061-2021; Tran, Phuoc/W-2084-2019	Chettiar, Sivarajan T/0000-0002-6864-7308; Tran, Phuoc/0000-0002-0147-0376; Taparra, Kekoa/0000-0001-8493-3868	RSNA Research Medical Student Grant; National Institutes of Health (NIH) [1R01CA158100, P30 CA006973]; ASTRO; Parker B. Francis Fellowship; Phyllis and Brian L. Harvey Scholar Award from the Patrick C. Walsh Cancer Research Fund; DoD [W81XWH-11-1-0272]; NATIONAL CANCER INSTITUTE [P50CA103175, T32CA121937, R01CA158100, P30CA006973] Funding Source: NIH RePORTER	RSNA Research Medical Student Grant; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ASTRO; Parker B. Francis Fellowship; Phyllis and Brian L. Harvey Scholar Award from the Patrick C. Walsh Cancer Research Fund; DoD(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	AT Wild was funded by an RSNA Research Medical Student Grant (https://www.rsna.org/Research_Medical_Student_Grant.aspx). RD Williams was a Johns Hopkins Laboratory Radiation Oncology Training Fellow (NIH-T32CA121937) (http://www.nih.gov/). J Wong was funded by the National Institutes of Health (NIH) (1R01CA158100) (http://www.nih.gov/). PT Tran was funded by an ASTRO Junior Faculty Career Research Training Award (https://www.astro.org/Research/Funding-Opportunities/ASTRO-Supported-Grants/Junior-Faculty/Index.aspx), Parker B. Francis Fellowship (http://www.francisfellowships.org/), the Phyllis and Brian L. Harvey Scholar Award from the Patrick C. Walsh Cancer Research Fund (http://prostatecancerprogram.onc.jhmi.edu/PCW/) and a DoD Cancer Physician Research Training Award (W81XWH-11-1-0272) (http://www.grants.gov/search/search.do?mode = VIEW&oppId = 88953). The Sidney Kimmel Comprehensive Cancer Center was funded by the NIH (P30 CA006973) (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Alfa GK, 2010, JAMA-J AM MED ASSOC, V304, P2154, DOI 10.1001/jama.2010.1672; ALBELDA SM, 1991, J CELL BIOL, V114, P1059, DOI 10.1083/jcb.114.5.1059; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Biade S, 1997, RADIAT RES, V147, P416, DOI 10.2307/3579497; Cao ZW, 2011, CANCER RES, V71, P2286, DOI 10.1158/0008-5472.CAN-10-3367; Chang YS, 2007, CANCER CHEMOTH PHARM, V59, P561, DOI 10.1007/s00280-006-0393-4; Chen HH, 2011, RADIAT RES, V175, P214, DOI 10.1667/RR2323.1; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Choi BI, 2010, J HEPATO-BIL-PAN SCI, V17, P369, DOI 10.1007/s00534-009-0227-y; Clark JW, 2005, CLIN CANCER RES, V11, P5472, DOI 10.1158/1078-0432.CCR-04-2658; Degos F, 2000, GUT, V47, P131, DOI 10.1136/gut.47.1.131; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; FERTIL B, 1984, RADIAT RES, V99, P73, DOI 10.2307/3576448; GERDES J, 1985, INT J CANCER, V35, P169, DOI 10.1002/ijc.2910350205; Heim M, 2005, ANTI-CANCER DRUG, V16, P129, DOI 10.1097/00001813-200502000-00003; Hill AA, 1999, INT J RADIAT BIOL, V75, P1395, DOI 10.1080/095530099139269; Hsu CH, 2010, J HEPATOL, V53, P126, DOI 10.1016/j.jhep.2010.01.035; Huynh H, 2003, BMC GASTROENTEROL, V3, DOI 10.1186/1471-230X-3-19; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim S, 2007, MOL CANCER THER, V6, P1785, DOI 10.1158/1535-7163.MCT-06-0595; Li QQ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-485; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; London WT, 2006, CANC EPIDEMIOLOGY PR, P763, DOI DOI 10.1093/ACPROF:OSO/9780195149616.003.0039; Milas L, 2000, CLIN CANCER RES, V6, P701; Morgan MA, 2008, CLIN CANCER RES, V14, P5142, DOI 10.1158/1078-0432.CCR-07-4072; Murphy DA, 2006, AM J PATHOL, V169, P1875, DOI 10.2353/ajpath.2006.050711; Park JW, 2012, J HEPATOL, V56, P1336, DOI 10.1016/j.jhep.2012.01.006; Pawlik TM, 2011, J CLIN ONCOL, V29, P3960, DOI 10.1200/JCO.2011.37.1021; Petrini I, 2012, CANCER CHEMOTH PHARM, V69, P773, DOI 10.1007/s00280-011-1753-2; Plastaras JP, 2007, CANCER RES, V67, P9443, DOI 10.1158/0008-5472.CAN-07-1473; Plaza-Menacho I, 2007, J BIOL CHEM, V282, P29230, DOI 10.1074/jbc.M703461200; Qu XD, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-263; Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Sanoff Hanna K, 2011, Gastrointest Cancer Res, V4, P78; Stobbe CC, 2002, INT J RADIAT BIOL, V78, P1149, DOI 10.1080/09553000210166570; Sugimoto K, 2012, EUR RADIOL, V22, P1205, DOI 10.1007/s00330-011-2372-3; Surveillance Epidemiology and End Results (SEER) Program, SEER STAT DAT INC SE; TERASIMA T, 1963, SCIENCE, V140, P490, DOI 10.1126/science.140.3566.490; TERASIMA T, 1961, NATURE, V190, P1210, DOI 10.1038/1901210a0; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Wong J, 2008, INT J RADIAT ONCOL, V71, P1591, DOI 10.1016/j.ijrobp.2008.04.025; Xie BR, 2012, DIGEST DIS SCI, V57, P1122, DOI 10.1007/s10620-012-2136-1; Zaidi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035436	46	31	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65726	10.1371/journal.pone.0065726	http://dx.doi.org/10.1371/journal.pone.0065726			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762417	Green Published, gold, Green Submitted			2022-12-27	WOS:000321099000098
J	Xue, G; He, QH; Lu, ZL; Levin, IP; Dong, Q; Bechara, A				Xue, Gui; He, Qinghua; Lu, Zhong-Lin; Levin, Irwin P.; Dong, Qi; Bechara, Antoine			Agency Modulates the Lateral and Medial Prefrontal Cortex Responses in Belief-Based Decision Making	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; SOMATIC MARKER HYPOTHESIS; IOWA GAMBLING TASK; EVENT-RELATED FMRI; HOT HAND; GAMBLERS FALLACY; INDIVIDUAL-DIFFERENCES; PREDICTION ERRORS; FRONTAL-CORTEX; SELF-CONTROL	Many real-life decisions in complex and changing environments are guided by the decision maker's beliefs, such as her perceived control over decision outcomes (i.e., agency), leading to phenomena like the "illusion of control". However, the neural mechanisms underlying the "agency" effect on belief-based decisions are not well understood. Using functional imaging and a card guessing game, we revealed that the agency manipulation (i.e., either asking the subjects (SG) or the computer (CG) to guess the location of the winning card) not only affected the size of subjects' bets, but also their "world model" regarding the outcome dependency. Functional imaging results revealed that the decision-related activation in the lateral and medial prefrontal cortex (PFC) was significantly modulated by agency and previous outcome. Specifically, these PFC regions showed stronger activation when subjects made decisions after losses than after wins under the CG condition, but the pattern was reversed under the SG condition. Furthermore, subjects with high external attribution of negative events were more affected by agency at the behavioral and neural levels. These results suggest that the prefrontal decision-making system can be modulated by abstract beliefs, and are thus vulnerable to factors such as false agency and attribution.	[Xue, Gui; Dong, Qi] Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [He, Qinghua; Bechara, Antoine] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [He, Qinghua; Bechara, Antoine] Univ So Calif, Brain & Creat Inst, Los Angeles, CA USA; [Lu, Zhong-Lin] Ohio State Univ, Ctr Cognit & Behav Brain Imaging, Columbus, OH 43210 USA; [Lu, Zhong-Lin] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Levin, Irwin P.] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA	Beijing Normal University; University of Southern California; University of Southern California; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Iowa	Xue, G (corresponding author), Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	guixue@gmail.com	Xue, Gui/A-1762-2009; He, Qinghua/B-2573-2008	Xue, Gui/0000-0001-7891-8151; He, Qinghua/0000-0001-6396-6273; Bechara, Antoine/0000-0001-5127-2549; Lu, Zhong-Lin/0000-0002-7295-727X	National Science Foundation of China [31130025]; Advancing Scholarship in the Humanities and Social Sciences; National Institute on Drug Abuse (NIDA) [R01 DA023051]; National Cancer Institute (NCI) [R01 CA152062]; NATIONAL CANCER INSTITUTE [R01CA152062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023051] Funding Source: NIH RePORTER	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Advancing Scholarship in the Humanities and Social Sciences; National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the following grants from the National Science Foundation of China (31130025), the Advancing Scholarship in the Humanities and Social Sciences, the National Institute on Drug Abuse (NIDA) R01 DA023051 and National Cancer Institute (NCI) R01 CA152062. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni E, 2008, ANN NY ACAD SCI, V1124, P145, DOI 10.1196/annals.1440.007; Akitsuki Y, 2003, NEUROIMAGE, V19, P1674, DOI 10.1016/S1053-8119(03)00250-7; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Andersson J.L.R, 2007, TR07JA2 FMRIB; Ayton P, 2004, MEM COGNITION, V32, P1369, DOI 10.3758/BF03206327; Barriga AQ, 1996, AGGRESSIVE BEHAV, V22, P333; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 2005, TRENDS COGN SCI, V9, P159, DOI 10.1016/j.tics.2005.02.002; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; Bechara A, 1999, J NEUROSCI, V19, P5473; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Beck A, 1979, COGNITIVE THERAPY DE; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Burns BD, 2004, PSYCHON B REV, V11, P179, DOI 10.3758/BF03206480; Clark L, 2009, NEURON, V61, P481, DOI 10.1016/j.neuron.2008.12.031; Coricelli G, 2009, P NATL ACAD SCI USA, V106, P9163, DOI 10.1073/pnas.0807721106; Coventry KR, 1998, BRIT J PSYCHOL, V89, P629, DOI 10.1111/j.2044-8295.1998.tb02707.x; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Croson R, 2005, J RISK UNCERTAINTY, V30, P195, DOI 10.1007/s11166-005-1153-2; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Davis D, 2000, J APPL SOC PSYCHOL, V30, P1224, DOI 10.1111/j.1559-1816.2000.tb02518.x; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Farrer C, 2002, NEUROIMAGE, V15, P596, DOI 10.1006/nimg.2001.1009; Figner B, 2010, NAT NEUROSCI, V13, P538, DOI 10.1038/nn.2516; Frank MJ, 2009, NAT NEUROSCI, V12, P1062, DOI 10.1038/nn.2342; GILOVICH T, 1985, COGNITIVE PSYCHOL, V17, P295, DOI 10.1016/0010-0285(85)90010-6; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Hecht D, 2010, J NEUROSCI, V30, P4241, DOI 10.1523/JNEUROSCI.2924-09.2010; Huettel SA, 2002, NAT NEUROSCI, V5, P485, DOI 10.1038/nn841; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; KRUEGER N, 1994, DECISION SCI, V25, P385, DOI 10.1111/j.1540-5915.1994.tb01849.x; LANGER EJ, 1975, J PERS SOC PSYCHOL, V32, P311, DOI 10.1037/0022-3514.32.2.311; Laplace P S, 1951, PHILOS ESSAY PROBABI; Lee DY, 2007, ANN NY ACAD SCI, V1104, P108, DOI 10.1196/annals.1390.007; Lesieur HR, 1987, AM J PSYCHIAT, P144; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Maia TV, 2004, P NATL ACAD SCI USA, V101, P16075, DOI 10.1073/pnas.0406666101; Mumford J., 2007, GUIDE CALCULAT UNPUB; Naqvi NH, 2009, TRENDS NEUROSCI, V32, P56, DOI 10.1016/j.tins.2008.09.009; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Persaud N, 2007, NAT NEUROSCI, V10, P257, DOI 10.1038/nn1840; PETERSON C, 1988, J ABNORM PSYCHOL, V97, P87, DOI 10.1037/0021-843X.97.1.87; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Rushworth MFS, 2007, CURR OPIN NEUROBIOL, V17, P220, DOI 10.1016/j.conb.2007.03.001; Shiv B, 2005, PSYCHOL SCI, V16, P435; Sohn MH, 2000, P NATL ACAD SCI USA, V97, P13448, DOI 10.1073/pnas.240460497; Sperduti M, 2011, BRAIN STRUCT FUNCT, V216, P151, DOI 10.1007/s00429-010-0298-1; Steinbeis N, 2012, NEURON, V73, P1040, DOI 10.1016/j.neuron.2011.12.027; Studer B, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00046; Studer B, 2011, COGN AFFECT BEHAV NE, V11, P144, DOI 10.3758/s13415-011-0025-2; Sundali J, 2006, JUDGM DECIS MAK, V1, P1; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Tohka J, 2008, NEUROIMAGE, V39, P1227, DOI 10.1016/j.neuroimage.2007.10.013; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Toneatto T, 1997, J Gambl Stud, V13, P253, DOI 10.1023/A:1024983300428; Tricomi EM, 2004, NEURON, V41, P281, DOI 10.1016/S0896-6273(03)00848-1; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Walton ME, 2007, NEUROIMAGE, V36, pT142, DOI 10.1016/j.neuroimage.2007.03.029; Woolrich M, 2008, NEUROIMAGE, V41, P286, DOI 10.1016/j.neuroimage.2008.02.042; Worsley K.J., 2001, FUNCTIONAL MRI AN IN, P251, DOI [10.1093/acprof:oso/ 9780192630711.003.0014, DOI 10.1093/ACPROF:OSO/9780192630711.003.0014]; Xue G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047019; Xue G, 2012, P NATL ACAD SCI USA, V109, P4401, DOI 10.1073/pnas.1111927109; Xue G, 2011, HUM BRAIN MAPP, V32, P271, DOI 10.1002/hbm.21015; Xue G, 2010, NEUROIMAGE, V50, P709, DOI 10.1016/j.neuroimage.2009.12.097; Xue G, 2009, CEREB CORTEX, V19, P1019, DOI 10.1093/cercor/bhn147; Yechiam E, 2005, PSYCHOL SCI, V16, P973, DOI 10.1111/j.1467-9280.2005.01646.x; Yeung N, 2005, CEREB CORTEX, V15, P535, DOI 10.1093/cercor/bhh153; Zhu LS, 2012, P NATL ACAD SCI USA, V109, P1419, DOI 10.1073/pnas.1116783109	77	8	8	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65274	10.1371/journal.pone.0065274	http://dx.doi.org/10.1371/journal.pone.0065274			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	173SK	23762332	Green Submitted, Green Published, gold			2022-12-27	WOS:000321099000051
J	Yang, HJ; Kim, HJ; Yu, J; Lee, E; Jung, YH; Kim, HY; Seo, JH; Kwon, GY; Park, JH; Gwack, J; Youn, SK; Kwon, JW; Jun, BY; Kim, KW; Ahn, K; Lee, SY; Park, JD; Kwon, JW; Kim, BJ; Lee, MS; Do, KH; Jang, SJ; Pyun, BY; Hong, SJ				Yang, Hyeon-Jong; Kim, Hwa-Jung; Yu, Jinho; Lee, Eun; Jung, Young-Ho; Kim, Hyung-Young; Seo, Ju-Hee; Kwon, Geun-Yong; Park, Ji-Hyuk; Gwack, Jin; Youn, Seung-Ki; Kwon, Jun-Wook; Jun, Byung-Yool; Kim, Kyung Won; Ahn, Kangmo; Lee, Soo-Young; Park, June-Dong; Kwon, Ji-Won; Kim, Byoung-Ju; Lee, Moo-Song; Do, Kyung-Hyun; Jang, Se-Jin; Pyun, Bok-Yang; Hong, Soo-Jong			Inhalation Toxicity of Humidifier Disinfectants as a Risk Factor of Children's Interstitial Lung Disease in Korea: A Case-Control Study	PLOS ONE			English	Article							DIDECYLDIMETHYLAMMONIUM CHLORIDE; POLYHEXAMETHYLENE BIGUANIDE; CONSUMER PRODUCTS; CHEMICALS; INJURY; HEALTH; NANOPARTICLES; FIBROSIS; MICE	Background: The occurrence of numerous cases of interstitial lung disease in children (chILD) every spring in Korea starting in 2006 raised suspicion about a causal relationship with the use of humidifier disinfectants (HDs). The aim of this study was to evaluate the association between HD use and the risk of chILD. Methods: This retrospective, 1:3 matched case-control study consisted of 16 cases of chILD that had developed between 2010 and 2011. The three groups of parallel controls (patients with acute lobar pneumonia, asthma, and healthy children) were matched by age, gender, and index date. Indoor/outdoor environmental risk factors, including HD use, were investigated by asking the guardians to complete a questionnaire. Results: The median age of the affected children (43.8% male) was 26 months (18.25-36.25). The chILD group did not differ significantly from the control groups with respect to socio-demographic and clinical variables. Indoor and outdoor environmental factors were not associated with a risk of chILD. However, the previous use of HDs (OR; 2.73. 95% CI; 1.41-5.90, P = 0.00) were independently associated with an increased risk. Conclusions: This study showed that HDs, which are widely used in South Korea in the winter season, independently increased the risk of chILD in spring. Therefore, continuous monitoring and, if needed, changes in policy are essential to prevent and control pediatric diseases caused by toxic chemicals.	[Yang, Hyeon-Jong; Pyun, Bok-Yang] Soonchunhyang Univ, Coll Med, Soonchunhyang Univ Hosp, Dept Pediat,Pediat Allergy & Resp Ctr, Seoul, South Korea; [Kim, Hwa-Jung] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Clin Epidemiol & Biostat,Asan Canc Ctr, Seoul, South Korea; [Yu, Jinho; Lee, Eun; Jung, Young-Ho; Kim, Hyung-Young; Hong, Soo-Jong] Univ Ulsan, Coll Med, Childrens Hosp, Dept Pediat,Childhood Asthma Atopy Ctr,Asan Med C, Seoul, South Korea; [Lee, Eun; Jung, Young-Ho; Kim, Hyung-Young; Hong, Soo-Jong] Univ Ulsan, Coll Med, Childrens Hosp, Res Ctr Standardizat Allerg Dis,Asan Med Ctr, Seoul, South Korea; [Seo, Ju-Hee] Korean Canc Ctr Hosp, Dept Pediat, Seoul, South Korea; [Kwon, Geun-Yong; Park, Ji-Hyuk; Gwack, Jin; Youn, Seung-Ki; Jun, Byung-Yool] Korea Ctr Dis Control & Prevent, Div Epidem Intelligence Serv, Osong, South Korea; [Kwon, Jun-Wook; Jun, Byung-Yool] Korea Ctr Dis Control & Prevent, Ctr Infect Dis Surveillance & Response, Osong, South Korea; [Kim, Kyung Won] Yonsei Univ, Coll Med, Dept Pediat, Seoul, South Korea; [Kim, Kyung Won] Yonsei Univ, Coll Med, Inst Allergy, Biomol Secret Res Ctr, Seoul, South Korea; [Ahn, Kangmo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul, South Korea; [Lee, Soo-Young] Ajou Univ, Sch Med, Dept Pediat, Ajou Univ Hosp, Suwon 441749, South Korea; [Park, June-Dong] Univ Seoul, Coll Med, Seoul Natl Univ, Dept Pediat,Childrens Hosp, Seoul, South Korea; [Kwon, Ji-Won] Univ Seoul, Coll Med, Seoul Natl Univ, Dept Pediat,Bundang Hosp, Seungnam, South Korea; [Kim, Byoung-Ju] Univ Inje, Coll Med, Haeundae Paik Hosp, Dept Pediat, Pusan, South Korea; [Lee, Moo-Song] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Prevent Med,Asan Canc Ctr, Seoul, South Korea; [Do, Kyung-Hyun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea; [Jang, Se-Jin] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea	Soonchunhyang University; Soonchunhyang University Hospital; University of Ulsan; Asan Medical Center; University of Ulsan; University of Ulsan; National Cancer Center - Korea (NCC); Korea Centers for Disease Control & Prevention (KCDC); Korea CDC Center for Disease Prevention; Korea CDC Center for Infectious Disease Control; Korea Centers for Disease Control & Prevention (KCDC); Korea CDC Center for Disease Prevention; Korea CDC Center for Infectious Disease Control; Korea National Institute of Health (KNIH); Korea CDC Center for Infectious Disease; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Sungkyunkwan University (SKKU); Samsung Medical Center; Ajou University; Ajou University Hospital; Seoul National University (SNU); Seoul National University Hospital; University of Seoul; Seoul National University (SNU); University of Seoul; Inje University; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Pyun, BY (corresponding author), Soonchunhyang Univ, Coll Med, Soonchunhyang Univ Hosp, Dept Pediat,Pediat Allergy & Resp Ctr, Seoul, South Korea.	bypyun@schmc.ac.kr; sjhong@amc.seoul.kr	Yu, Jinho/P-4293-2014; Ahn, Kangmo/F-4609-2014; Hong, Soo-Jong/AAR-1788-2020	Yu, Jinho/0000-0002-1226-8077; Hong, Soo-Jong/0000-0003-1409-2113; Park, June Dong/0000-0001-8113-1384; Kim, Kyung Won/0000-0003-4529-6135; Kim, Byoung-Ju/0000-0003-0271-9417				Allen MJ, 2006, MICROBIOL-SGM, V152, P989, DOI 10.1099/mic.0.28643-0; [Anonymous], 2006, RER EL DEC AL ALK QU; Bonner James C, 2010, Proc Am Thorac Soc, V7, P138, DOI 10.1513/pats.200907-061RM; Chang M. H., 2012, ENV HLTH TOXICOL, V27; Daftary AS, 2011, PEDIATRICS, V127, pE509, DOI 10.1542/peds.2010-1312; Deterding R, 2007, SEMIN RESP CRIT CARE, V28, P333, DOI 10.1055/s-2007-981654; Dishop MK, 2011, PAEDIATR RESPIR REV, V12, P230, DOI 10.1016/j.prrv.2011.01.002; 김병주, 2009, Clinical and Experimental Pediatrics, V52, P324; European Commission on the Environment, REACH; Fayaz AM, 2010, NANOMED-NANOTECHNOL, V6, P103, DOI 10.1016/j.nano.2009.04.006; 전종근, 2008, Clinical and Experimental Pediatrics, V51, P383; Hubbs AF, 1997, TOXICOL APPL PHARM, V143, P37, DOI 10.1006/taap.1996.8053; Hubner NO, 2010, SKIN PHARMACOL PHYS, V23, P17, DOI 10.1159/000318264; Jeon B.H., 2012, ENV HLTH TOXICOL, V27, DOI DOI 10.5620/EHT.2012.27.E2012002; KCDC (Korea Centers for Disease Control and Prevention), 2011, PUBLIC HLTH WKLY REP, P820; Kim JY, 2012, CARDIOVASC TOXICOL; Korea Centers for Disease Control and Prevention, 2011, PUBLIC HLTH WKLY REP, P831; Landrigan PJ, 2011, HEALTH AFFAIR, V30, P842, DOI 10.1377/hlthaff.2011.0151; Landrigan PJ, 2011, MT SINAI J MED, V78, P1, DOI 10.1002/msj.20236; Lee E, 2012, ALLERGY ASTHMA IMMUN, V4, P240, DOI 10.4168/aair.2012.4.4.240; Lee JH, 2012, ENVIRON SCI TECHNOL, V46, P2498, DOI 10.1021/es300567j; Lucas AD, 2012, B ENVIRON CONTAM TOX, V88, P322, DOI 10.1007/s00128-011-0436-3; Makri A, 2004, J TOXICOL ENV HEAL B, V7, P417, DOI 10.1080/10937400490512465; Muller-Wening D, 2006, DEUT MED WOCHENSCHR, V131, P491, DOI 10.1055/s-2006-932548; Ohnuma A, 2011, INHAL TOXICOL, V23, P476, DOI 10.3109/08958378.2011.584080; Ohnuma A, 2010, EXP TOXICOL PATHOL, V62, P643, DOI 10.1016/j.etp.2009.08.007; Pauluhn J, 2008, INHAL TOXICOL, V20, P1245, DOI [10.1080/08958370802220634, 10.1080/08958370802220634 ]; Solodun Yuriy V, 2011, Interdiscip Toxicol, V4, P198, DOI 10.2478/v10102-011-0030-x; Spivey A, 2007, ENVIRON HEALTH PERSP, V115, pA192, DOI 10.1289/ehp.115-a192; United States Environmental Protection Agency, 2004, RER EL DEC AL ALK QU	30	53	54	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64430	10.1371/journal.pone.0064430	http://dx.doi.org/10.1371/journal.pone.0064430			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755124	Green Submitted, gold, Green Published			2022-12-27	WOS:000320579400015
J	Balint, Z; Zabini, D; Konya, V; Nagaraj, C; Vegh, AG; Varo, G; Wilhelm, I; Fazakas, C; Krizbai, IA; Heinemann, A; Olschewski, H; Olschewski, A				Balint, Zoltan; Zabini, Diana; Konya, Viktoria; Nagaraj, Chandran; Vegh, Attila G.; Varo, Gyoergy; Wilhelm, Imola; Fazakas, Csilla; Krizbai, Istvan A.; Heinemann, Akos; Olschewski, Horst; Olschewski, Andrea			Double-Stranded RNA Attenuates the Barrier Function of Human Pulmonary Artery Endothelial Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-3; ENDOPLASMIC-RETICULUM STRESS; ATOMIC-FORCE MICROSCOPY; EXTRACELLULAR RNA; CA2+ ENTRY; ATPASE 2B; PERMEABILITY; TLR3; ACTIVATION; CHANNELS	Circulating RNA may result from excessive cell damage or acute viral infection and can interact with vascular endothelial cells. Despite the obvious clinical implications associated with the presence of circulating RNA, its pathological effects on endothelial cells and the governing molecular mechanisms are still not fully elucidated. We analyzed the effects of double stranded RNA on primary human pulmonary artery endothelial cells (hPAECs). The effect of natural and synthetic double-stranded RNA (dsRNA) on hPAECs was investigated using trans-endothelial electric resistance, molecule trafficking, calcium (Ca2+) homeostasis, gene expression and proliferation studies. Furthermore, the morphology and mechanical changes of the cells caused by synthetic dsRNA was followed by in-situ atomic force microscopy, by vascular-endothelial cadherin and F-actin staining. Our results indicated that exposure of hPAECs to synthetic dsRNA led to functional deficits. This was reflected by morphological and mechanical changes and an increase in the permeability of the endothelial monolayer. hPAECs treated with synthetic dsRNA accumulated in the G1 phase of the cell cycle. Additionally, the proliferation rate of the cells in the presence of synthetic dsRNA was significantly decreased. Furthermore, we found that natural and synthetic dsRNA modulated Ca2+ signaling in hPAECs by inhibiting the sarco-endoplasmic Ca2+-ATPase (SERCA) which is involved in the regulation of the intracellular Ca2+ homeostasis and thus cell growth. Even upon synthetic dsRNA stimulation silencing of SERCA3 preserved the endothelial monolayer integrity. Our data identify novel mechanisms by which dsRNA can disrupt endothelial barrier function and these may be relevant in inflammatory processes.	[Balint, Zoltan; Zabini, Diana; Nagaraj, Chandran; Olschewski, Andrea] Med Univ Graz, Dept Anesthesia & Intens Care Med, Graz, Austria; [Balint, Zoltan; Olschewski, Andrea] Ludwig Boltzmann Inst Lung Vasc Res, Graz, Austria; [Olschewski, Horst] Med Univ Graz, Div Pulmonol, Dept Internal Med, Graz, Austria; [Vegh, Attila G.; Varo, Gyoergy; Wilhelm, Imola; Fazakas, Csilla; Krizbai, Istvan A.] Hungarian Acad Sci, Biol Res Ctr, Inst Biophys, H-6701 Szeged, Hungary; [Konya, Viktoria; Heinemann, Akos] Med Univ Graz, Inst Expt & Clin Pharmacol, Graz, Austria	Medical University of Graz; Ludwig Boltzmann Institute; Medical University of Graz; Hungarian Academy of Sciences; Hungarian Biological Research Center; Medical University of Graz	Olschewski, A (corresponding author), Med Univ Graz, Dept Anesthesia & Intens Care Med, Graz, Austria.	andrea.olschewski@medunigraz.at	Bálint, Zoltán/AAJ-3080-2020; Chandran, Nagaraj/AAP-2007-2020; Végh, Attila Gergely/A-4789-2011; Olschewski, Horst/L-3547-2019	Chandran, Nagaraj/0000-0003-3825-8587; Végh, Attila Gergely/0000-0003-0524-0946; Olschewski, Horst/0000-0002-2834-7466; Balint, Zoltan/0000-0001-8598-2784; Krizbai, Istvan/0000-0002-0764-1527; Heinemann, Akos/0000-0002-8554-2372; Konya, Viktoria/0000-0002-7999-9093; Olschewski, Andrea/0000-0002-8189-3634	Medical University of Graz (PhD Program Molecular Medicine); EU FP6 "PULMOTENSION'' [LSHM-CT-2005-018725]; National Science Fund of Hungary [OTKA K 81180]; Austrian-Hungarian Joint Grant [AT-4/2009]	Medical University of Graz (PhD Program Molecular Medicine); EU FP6 "PULMOTENSION''; National Science Fund of Hungary(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Austrian-Hungarian Joint Grant	This study was funded by the Medical University of Graz (PhD Program Molecular Medicine) to CN, DZ and VK, EU FP6 "PULMOTENSION'' (LSHM-CT-2005-018725) to AO and HO, National Science Fund of Hungary OTKA K 81180 to GV, and Austrian-Hungarian Joint Grant AT-4/2009 to GV and AO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeffner F, 2011, AM J PHYSIOL-LUNG C, V301, pL99, DOI 10.1152/ajplung.00398.2010; Ahmmed GU, 2005, PFLUG ARCH EUR J PHY, V451, P131, DOI 10.1007/s00424-005-1461-z; Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; Auer-Grumbach M, 2010, NAT GENET, V42, P160, DOI 10.1038/ng.508; Balint Z, 2007, EUR BIOPHYS J BIOPHY, V36, P113, DOI 10.1007/s00249-006-0112-4; Birukova AA, 2009, NANOMED-NANOTECHNOL, V5, P30, DOI 10.1016/j.nano.2008.07.002; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Caspersen C, 2000, J BIOL CHEM, V275, P22363, DOI 10.1074/jbc.M001569200; Cheng GM, 1996, ARCH BIOCHEM BIOPHYS, V329, P65, DOI 10.1006/abbi.1996.0192; Chiang ET, 2006, J CLIN IMMUNOL, V26, P406, DOI 10.1007/s10875-006-9024-4; Cooper PR, 2009, AM J PHYSIOL-LUNG C, V297, pL530, DOI 10.1152/ajplung.00133.2009; Dellis O, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-59; Dewi BE, 2008, J GEN VIROL, V89, P642, DOI 10.1099/vir.0.83356-0; Fischer L, 2004, AM J PHYSIOL-GASTR L, V287, pG1200, DOI 10.1152/ajpgi.00212.2004; Fischer S, 2007, BLOOD, V110, P2457, DOI 10.1182/blood-2006-08-040691; Fischer S, 2009, FASEB J, V23, P2100, DOI 10.1096/fj.08-121608; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Harcourt JL, 2000, J INTERF CYTOK RES, V20, P1007, DOI 10.1089/10799900050198453; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Kannemeier C, 2007, P NATL ACAD SCI USA, V104, P6388, DOI 10.1073/pnas.0608647104; Khan I, 2000, MOL CELL BIOCHEM, V203, P11, DOI 10.1023/A:1007093516593; Konya V, 2010, J ALLERGY CLIN IMMUN, V125, P1105, DOI 10.1016/j.jaci.2009.12.002; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Kumar P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001112; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Londhe VA, 2005, PEDIATR RES, V58, P919, DOI 10.1203/01.PDR.0000181377.78061.3E; Lundberg AM, 2007, BLOOD, V110, P3245, DOI 10.1182/blood-2007-02-072934; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Malli R, 2007, CELL CALCIUM, V41, P63, DOI 10.1016/j.ceca.2006.05.001; Malli R, 2003, J BIOL CHEM, V278, P44769, DOI 10.1074/jbc.M302511200; Moore TM, 1998, AM J PHYSIOL-LUNG C, V275, pL574, DOI 10.1152/ajplung.1998.275.3.L574; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; O'Callaghan R, 2011, AM J PHYSIOL-LUNG C, V301, pL353, DOI 10.1152/ajplung.00342.2010; Pirher N, 2008, NAT STRUCT MOL BIOL, V15, P761, DOI 10.1038/nsmb.1453; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Schroder M, 2005, TRENDS IMMUNOL, V26, P462, DOI 10.1016/j.it.2005.07.002; Shibamiya A, 2009, BLOOD, V113, P714, DOI 10.1182/blood-2008-02-137901; Siflinger-Birnboim A, 2003, AM J PHYSIOL-LUNG C, V284, pL435, DOI 10.1152/ajplung.00106.2002; Stowell NC, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-43; Sutliff RL, 1999, CIRC RES, V84, P360, DOI 10.1161/01.RES.84.3.360; Szewczyk MM, 2007, J CELL MOL MED, V11, P129, DOI 10.1111/j.1582-4934.2007.00010.x; Tiruppathi C, 2006, MICROCIRCULATION, V13, P693, DOI 10.1080/10739680600930347; Tissari J, 2005, J IMMUNOL, V174, P4289, DOI 10.4049/jimmunol.174.7.4289; Torres D, 2010, J IMMUNOL, V185, P451, DOI 10.4049/jimmunol.0902833; Tsuji Y, 2011, CIRCULATION, V123, P2192, DOI 10.1161/CIRCULATIONAHA.110.016683; Wilhelm I, 2007, PHYS MED BIOL, V52, P6261, DOI 10.1088/0031-9155/52/20/012; Zimmer S, 2011, CIRC RES, V108, P1358, DOI 10.1161/CIRCRESAHA.111.243246	48	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e63776	10.1371/journal.pone.0063776	http://dx.doi.org/10.1371/journal.pone.0063776			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755110	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000319872300014
J	Hamer, M; Stamatakis, E				Hamer, Mark; Stamatakis, Emmanuel			Screen-Based Sedentary Behavior, Physical Activity, and Muscle Strength in the English Longitudinal Study of Ageing	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; BODY-COMPOSITION; GRIP STRENGTH; HEALTH; TELEVISION; MEN; WOMEN; RISK; ASSOCIATIONS; PERFORMANCE	Background: Sarcopenia is associated with loss of independence and ill-health in the elderly although the causes remain poorly understood. We examined the association between two screen-based leisure time sedentary activities (daily TV viewing time and internet use) and muscle strength. Methods and Results: We studied 6228 men and women (aged 64.9 +/- 9.1 yrs) from wave 4 (2008-09) of the English Longitudinal Study of Ageing, a prospective study of community dwelling older adults. Muscle strength was assessed by a hand grip test and the time required to complete five chair rises. TV viewing and internet usage were inversely associated with one another. Participants viewing TV >= 6hrs/d had lower grip strength (Men, B = -1.20 kg, 95% Cl, -2.26, -0.14; Women, -0.75 kg, 95% Cl, -1.48, -0.03) in comparison to <2hrs/d TV, after adjustment for age, physical activity, smoking, alcohol, chronic disease, disability, depressive symptoms, social status, and body mass index. In contrast, internet use was associated with higher grip strength (Men, B = 2.43 kg, 95% Cl, 1.74, 3.12; Women, 0.76 kg, 95% Cl, 0.32, 1.20). These associations persisted after mutual adjustment for both types of sedentary behaviour. Conclusions: In older adults, the association between sedentary activities and physical function is context specific (TV viewing vs. computer use). Adverse effects of TV viewing might reflect the prolonged sedentary nature of this behavior.	[Hamer, Mark; Stamatakis, Emmanuel] UCL, Populat Hlth Domain Phys Act Res Grp, London, England; [Hamer, Mark; Stamatakis, Emmanuel] UCL, Dept Epidemiol & Publ Hlth, London, England; [Hamer, Mark] North West Univ, Sch Physiol Nutr & Consumer Sci, Potchefstroom, South Africa; [Stamatakis, Emmanuel] Univ Sydney, Sch Publ Hlth, Prevent Res Collaborat, Sydney, NSW 2006, Australia	University of London; University College London; University of London; University College London; North West University - South Africa; University of Sydney	Hamer, M (corresponding author), UCL, Populat Hlth Domain Phys Act Res Grp, London, England.	m.hamer@ucl.ac.uk	Hamer, Mark/C-1602-2008; Stamatakis, Emmanuel/C-4958-2009; Hamer, Mark/AAJ-6814-2021	Hamer, Mark/0000-0002-8726-7992; Stamatakis, Emmanuel/0000-0001-7323-3225; Hamer, Mark/0000-0002-8726-7992	National Institute on Aging in the United States [2RO1AG7644-01A1, 2RO1AG017644]; British Heart Foundation [RE/10/005/28296]; National Institute for Health Research Career Development Fellowship; NATIONAL INSTITUTE ON AGING [R01AG017644] Funding Source: NIH RePORTER; National Institute for Health Research [CDF-2010-03-30] Funding Source: researchfish	National Institute on Aging in the United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); National Institute for Health Research Career Development Fellowship; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute for Health Research(National Institute for Health Research (NIHR))	National Institute on Aging in the United States (grants 2RO1AG7644-01A1 and 2RO1AG017644) and a consortium of UK government departments coordinated by the Office for National Statistics. MH is supported by the British Heart Foundation (RE/10/005/28296); ES is supported by a National Institute for Health Research Career Development Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cooper R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4467; Daly RM, 2008, J AM GERIATR SOC, V56, P2252, DOI 10.1111/j.1532-5415.2008.02039.x; Demakakos P, 2010, DIABETOLOGIA, V53, P1877, DOI 10.1007/s00125-010-1785-x; Ekelund U, 2005, AM J CLIN NUTR, V81, P964; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Hamer M, 2010, AM J PREV MED, V38, P375, DOI 10.1016/j.amepre.2009.12.030; Hughes VA, 2002, AM J CLIN NUTR, V76, P473, DOI 10.1093/ajcn/76.2.473; Irwin M, 1999, ARCH INTERN MED, V159, P1701, DOI 10.1001/archinte.159.15.1701; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; Kuh D, 2005, J GERONTOL A-BIOL, V60, P224, DOI 10.1093/gerona/60.2.224; Kyle UG, 2001, MED SCI SPORT EXER, V33, P576; Lader D, 2006, TIME USE SURVEY 2005; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lee JSW, 2007, GERONTOLOGY, V53, P404, DOI 10.1159/000107355; Manini TM, 2009, AM J CLIN NUTR, V90, P1336, DOI 10.3945/ajcn.2009.27659; Metter EJ, 2002, J GERONTOL A-BIOL, V57, pB359, DOI 10.1093/gerona/57.10.B359; Onder G, 2005, J GERONTOL A-BIOL, V60, P74, DOI 10.1093/gerona/60.1.74; Paalanne NP, 2009, MED SCI SPORT EXER, V41, P1997, DOI 10.1249/MSS.0b013e3181a7f3a6; Park H, 2010, EUR J APPL PHYSIOL, V109, P953, DOI 10.1007/s00421-010-1424-8; Pereira SMP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031132; Pierce MB, 2009, DIABETIC MED, V26, P679, DOI 10.1111/j.1464-5491.2009.02755.x; Pulsford RM, 2013, AM J PREV MED, V44, P132, DOI 10.1016/j.amepre.2012.10.009; Rantanen T, 1999, JAMA-J AM MED ASSOC, V281, P558, DOI 10.1001/jama.281.6.558; Rhodes RE, 2012, AM J PREV MED, V42, pE3, DOI 10.1016/j.amepre.2011.10.020; Stamatakis E, 2012, DIABETOLOGIA, V55, P311, DOI 10.1007/s00125-011-2358-3; Stamatakis E, 2009, J EPIDEMIOL COMMUN H, V63, P734, DOI 10.1136/jech.2008.085902; Stamatakis E, 2012, PREV MED, V54, P82, DOI 10.1016/j.ypmed.2011.10.009; Stamatakis E, 2011, J AM COLL CARDIOL, V57, P292, DOI 10.1016/j.jacc.2010.05.065; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004	29	76	80	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e66222	10.1371/journal.pone.0066222	http://dx.doi.org/10.1371/journal.pone.0066222			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	157CD	23755302	Green Published, gold, Green Submitted			2022-12-27	WOS:000319872300105
J	Menzaghi, C; Bacci, S; Salvemini, L; Mendonca, C; Palladino, G; Fontana, A; De Bonis, C; Marucci, A; Goheen, E; Prudente, S; Morini, E; Rizza, S; Kanagaki, A; Fini, G; Mangiacotti, D; Federici, M; De Cosmo, S; Pellegrini, F; Doria, A; Trischitta, V				Menzaghi, Claudia; Bacci, Simonetta; Salvemini, Lucia; Mendonca, Christine; Palladino, Giuseppe; Fontana, Andrea; De Bonis, Concetta; Marucci, Antonella; Goheen, Elizabeth; Prudente, Sabrina; Morini, Eleonora; Rizza, Stefano; Kanagaki, Alyssa; Fini, Grazia; Mangiacotti, Davide; Federici, Massimo; De Cosmo, Salvatore; Pellegrini, Fabio; Doria, Alessandro; Trischitta, Vincenzo			Serum Resistin, Cardiovascular Disease and All-Cause Mortality in Patients with Type 2 Diabetes	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; ADIPOSE-TISSUE; INSULIN-RESISTANCE; HORMONE RESISTIN; ARTERY-DISEASE; RISK; MARKER; ASSOCIATION; ADIPONECTIN	Background: High serum resistin has been associated with increased risk of cardiovascular disease in the general population, Only sparse and conflicting results, limited to Asian individuals, have been reported, so far, in type 2 diabetes. We studied the role of serum resistin on coronary artery disease, major cardiovascular events and all-cause mortality in type 2 diabetes. Methods: We tested the association of circulating resistin concentrations with coronary artery disease, major cardiovascular events (cardiovascular death, non-fatal myocardial infarction and non-fatal stroke) and all-cause mortality in 2,313 diabetic patients of European ancestry from two cross-sectional and two prospective studies. In addition, the expression of resistin gene (RETN) was measured in blood cells of 68 diabetic patients and correlated with their serum resistin levels. Results: In a model comprising age, sex, smoking habits, BMI, HbA1c, and insulin, antihypertensive and antidyslipidemic therapies, serum resistin was associated with coronary artery disease in both cross-sectional studies: OR (95%CI) per SD increment = 1.35 (1.101.64) and 1.99 (1.552.55). Additionally, serum resistin predicted incident major cardiovascular events (HR per SD increment = 1.31; 1.101.56) and all-cause mortality (HR per SD increment = 1.16; 1.061.26). Adjusting also for fibrinogen levels affected the association with coronary artery disease and incident cardiovascular events, but not that with all cause-mortality. Finally, serum resistin was positively correlated with RETN mRNA expression (rho = 0.343). Conclusions: This is the first study showing that high serum resistin (a likely consequence, at least partly, of increased RETN expression) is a risk factor for cardiovascular disease and all-cause mortality in diabetic patients of European ancestry.	[Menzaghi, Claudia; Salvemini, Lucia; Palladino, Giuseppe; De Bonis, Concetta; Marucci, Antonella; Morini, Eleonora; Fini, Grazia; Mangiacotti, Davide; Trischitta, Vincenzo] IRCCS Casa Sollievo Sofferenza, Res Unit Diabet & Endocrine Dis, San Giovanni Rotondo, Italy; [Bacci, Simonetta; De Cosmo, Salvatore] IRCCS Casa Sollievo Sofferenza, Unit Endocrinol, San Giovanni Rotondo, Italy; [Mendonca, Christine; Goheen, Elizabeth; Kanagaki, Alyssa; Doria, Alessandro] Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; [Fontana, Andrea; Pellegrini, Fabio] IRCCS Casa Sollievo Sofferenza, Unit Biostat, San Giovanni Rotondo, Italy; [Prudente, Sabrina; Trischitta, Vincenzo] IRCSS Casa Sollievo Sofferenza, Mendel Lab, Rome, Italy; [Rizza, Stefano; Federici, Massimo] Univ Roma Tor Vergata, Dept Internal Med, Rome, Italy; [Pellegrini, Fabio] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Unit Biostat, I-66030 Santa Maria Imbaro, Italy; [Doria, Alessandro] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Trischitta, Vincenzo] Univ Roma La Sapienza, Dept Expt Med, Rome, Italy	IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; Harvard University; Joslin Diabetes Center, Inc.; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; University of Rome Tor Vergata; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Harvard University; Harvard Medical School; Sapienza University Rome	Menzaghi, C (corresponding author), IRCCS Casa Sollievo Sofferenza, Res Unit Diabet & Endocrine Dis, San Giovanni Rotondo, Italy.	c.menzaghi@operapadrepio.it; v.trischitta@operapadrepio.it	Trischitta, Vincenzo/K-1487-2016; Bacci, Simonetta/AAB-8598-2022; mangiacotti, davide/AAM-8142-2020; fini, grazia/AAM-3320-2020; marucci, antonella/B-8722-2017; DE BONIS, CONCETTA/AAM-8146-2020; Federici, Massimo/G-9940-2012; Fontana, Andrea/J-8584-2016; Palladino, Giuseppe/GOP-0198-2022; Menzaghi, Claudia/J-7210-2016; Doria, Alessandro/H-9157-2018; De Cosmo, Salvatore/J-7420-2016; Rizza, Stefano/AFI-4801-2022; Prudente, Sabrina/H-2886-2016; Salvemini, Lucia/K-2121-2016	Trischitta, Vincenzo/0000-0003-1174-127X; Bacci, Simonetta/0000-0002-5024-8958; marucci, antonella/0000-0001-8131-8317; Federici, Massimo/0000-0003-4989-5194; Fontana, Andrea/0000-0002-6660-5315; Menzaghi, Claudia/0000-0002-7438-8955; Doria, Alessandro/0000-0002-3830-4304; De Cosmo, Salvatore/0000-0001-8787-8286; Rizza, Stefano/0000-0001-5496-4890; Prudente, Sabrina/0000-0001-9220-8981; Salvemini, Lucia/0000-0001-8776-9477	Accordo Programma Quadro in Materia di Ricerca Scientifica nella Regione Puglia-PST; PO Puglia FESR; Italian Ministry of Health [RC2011, RC2012]; European Foundation for the Study of Diabetes/Pfizer; National Institutes of Health [HL073168]; EFSD/Pfizer; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073168] Funding Source: NIH RePORTER	Accordo Programma Quadro in Materia di Ricerca Scientifica nella Regione Puglia-PST; PO Puglia FESR; Italian Ministry of Health(Ministry of Health, Italy); European Foundation for the Study of Diabetes/Pfizer; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EFSD/Pfizer(Pfizer); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by Accordo Programma Quadro in Materia di Ricerca Scientifica nella Regione Puglia-PST 2006 and PO Puglia FESR 2007-2013, Italian Ministry of Health grants RC2011, RC2012, European Foundation for the Study of Diabetes/Pfizer grant (CM) and National Institutes of Health grant HL073168 (AD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CM received funding from the EFSD/Pfizer. MF is a PLOS ONE Editorial Board member. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.	Bacci S, 2004, DIABETES CARE, V27, P2015, DOI 10.2337/diacare.27.8.2015; Bacci S, 2011, DIABETES, V60, P1000, DOI 10.2337/db10-1300; Burnett MS, 2005, ATHEROSCLEROSIS, V182, P241, DOI 10.1016/j.atherosclerosis.2005.02.014; Butler J, 2009, ARTERIOSCL THROM VAS, V29, P1144, DOI 10.1161/ATVBAHA.109.186783; Chamnan P, 2009, DIABETOLOGIA, V52, P2001, DOI 10.1007/s00125-009-1454-0; Coleman RL, 2007, DIABETES CARE, V30, P1292, DOI 10.2337/dc06-1358; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; D'Agostino RB, 2004, HDB STAT, V23; Frankel DS, 2009, J AM COLL CARDIOL, V53, P754, DOI 10.1016/j.jacc.2008.07.073; Ghali WA, 2001, JAMA-J AM MED ASSOC, V286, P1494, DOI 10.1001/jama.286.12.1494; Haffner SM, 2006, AM J CARDIOL, V97, p3A, DOI 10.1016/j.amjcard.2005.11.010; Hoefle G, 2007, CLIN CHIM ACTA, V386, P1, DOI 10.1016/j.cca.2007.07.001; Langheim S, 2010, AM J PHYSIOL-HEART C, V298, pH746, DOI 10.1152/ajpheart.00617.2009; Lee SH, 2009, CORONARY ARTERY DIS, V20, P33, DOI 10.1097/MCA.0b013e328318ecb0; Lim S, 2008, ATHEROSCLEROSIS, V196, P398, DOI 10.1016/j.atherosclerosis.2006.11.017; Lubos E, 2007, ATHEROSCLEROSIS, V193, P121, DOI 10.1016/j.atherosclerosis.2006.05.039; Luc G, 2010, INT J OBESITY, V34, P118, DOI 10.1038/ijo.2009.204; Menzaghi C, 2010, DIABETOLOGIA, V53, P226, DOI 10.1007/s00125-009-1589-z; Menzaghi C, 2006, J CLIN ENDOCR METAB, V91, P2792, DOI 10.1210/jc.2005-2715; Ohmori R, 2005, J AM COLL CARDIOL, V46, P379, DOI 10.1016/j.jacc.2005.04.022; On YK, 2007, CIRC J, V71, P868, DOI 10.1253/circj.71.868; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Pilz S, 2007, CLIN ENDOCRINOL, V66, P380, DOI 10.1111/j.1365-2265.2007.02743.x; Pischon T, 2005, OBES RES, V13, P1764, DOI 10.1038/oby.2005.215; Preis SR, 2009, CIRCULATION, V120, P212, DOI 10.1161/CIRCULATIONAHA.108.846519; Prudente S, 2011, ATHEROSCLEROSIS, V219, P667, DOI 10.1016/j.atherosclerosis.2011.08.019; Qi L, 2011, J AM COLL CARDIOL, V58, P2675, DOI 10.1016/j.jacc.2011.08.054; Reilly MP, 2005, CIRCULATION, V111, P932, DOI 10.1161/01.CIR.0000155620.10387.43; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Stevens RJ, 2001, CLIN SCI, V101, P671, DOI 10.1042/CS20000335; Tsukahara T, 2009, DIABETES RES CLIN PR, V84, P179, DOI 10.1016/j.diabres.2008.10.021; Uno H, 2011, STAT MED, V30, P1105, DOI 10.1002/sim.4154; von Eynatten M, 2005, DIABETES CARE, V28, P754, DOI 10.2337/diacare.28.3.754; Weikert C, 2008, J CLIN ENDOCR METAB, V93, P2647, DOI 10.1210/jc.2007-2735; Weikert C, 2007, CLIN CHEM LAB MED, V45, P899, DOI 10.1515/CCLM.2007.148; Zhang MH, 2011, J CARD FAIL, V17, P24, DOI 10.1016/j.cardfail.2010.08.007	40	62	64	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64729	10.1371/journal.pone.0064729	http://dx.doi.org/10.1371/journal.pone.0064729			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755138	Green Published, gold, Green Submitted			2022-12-27	WOS:000319872300025
J	Bassler, C; Hothorn, T; Brandl, R; Muller, J				Baessler, Claus; Hothorn, Torsten; Brandl, Roland; Mueller, Joerg			Insects Overshoot the Expected Upslope Shift Caused by Climate Warming	PLOS ONE			English	Article							RANGE SHIFTS; NATIONAL-PARK; SPECIES RICHNESS; PLANTS; BIODIVERSITY; 20TH-CENTURY; BUTTERFLIES; INDICATORS; RESPONSES; IMPACTS	Along elevational gradients, climate warming may lead to an upslope shift of the lower and upper range margin of organisms. A recent meta-analysis concluded that these shifts are species specific and considerably differ among taxonomic lineages. We used the opportunity to compare upper range margins of five lineages (plants, beetles, flies, hymenoptera, and birds) between 1902-1904 and 2006-2007 within one region (Bavarian Forest, Central Europe). Based on the increase in the regional mean annual temperature during this period and the regional lapse rate, the upslope shift is expected to be between 51 and 201 m. Averaged across species within lineages, the range margin of all animal lineages shifted upslope, but that of plants did not. For animals, the observed shifts were probably due to shifts in temperature and not to changes in habitat conditions. The range margin of plants is therefore apparently not constrained by temperature, a result contrasting recent findings. The mean shift of birds (165 m) was within the predicted range and consistent with a recent global meta-analysis. However, the upslope shift of the three insect lineages (>260 m) exceeded the expected shift even after considering several sources of uncertainty, which indicated a non-linear response to temperature. Our analysis demonstrated broad differences among lineages in their response to climate change even within one region. Furthermore, on the considered scale, the response of ectothermic animals was not consistent with expectations based on shifts in the mean annual temperature. Irrespective of the reasons for the overshooting of the response of the insects, these shifts lead to reorganizations in the composition of assemblages with consequences for ecosystem processes.	[Baessler, Claus; Mueller, Joerg] Bavarian Forest Natl Pk, Dept Res, Grafenau, Germany; [Hothorn, Torsten] Univ Munich, Inst Stat, Munich, Germany; [Brandl, Roland] Univ Marburg, Fac Biol, Dept Anim Ecol, Marburg, Germany	University of Munich; Philipps University Marburg	Bassler, C (corresponding author), Bavarian Forest Natl Pk, Dept Res, Grafenau, Germany.	claus.baessler@npv-bw.bayern.de		Bassler, Claus/0000-0001-8177-8997; Muller, Jorg/0000-0002-1409-1586	Bavarian State Ministry of the Environment and Public Health	Bavarian State Ministry of the Environment and Public Health	The study was financed by the Bavarian State Ministry of the Environment and Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angert AL, 2011, ECOL LETT, V14, P677, DOI 10.1111/j.1461-0248.2011.01620.x; Bassler C, 2010, FOLIA GEOBOT, V45, P163, DOI 10.1007/s12224-010-9059-4; Bassler C, 2010, ECOL INDIC, V10, P341, DOI 10.1016/j.ecolind.2009.06.014; Bassler C., 2004, KLIMA NATIONALPARK B; Bassler C., 2008, SILVA GABRETA, V14, P1; Buse J, 2007, BIOL CONSERV, V137, P372, DOI 10.1016/j.biocon.2007.02.025; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Davis M.B., 1986, COMMUNITY ECOL, P269; Dillon ME, 2010, NATURE, V467, P704, DOI 10.1038/nature09407; EBER S, 1994, J ANIM ECOL, V63, P187, DOI 10.2307/5594; Gavrilov L.A., 1991, BIOL LIFE SPAN QUANT; Gehrig-Fasel J, 2007, J VEG SCI, V18, P571, DOI 10.1111/j.1654-1103.2007.tb02571.x; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; HENNEVOGEL FE, 1905, KAFERFAUNA BOHMERWAL; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hill JK, 2002, P ROY SOC B-BIOL SCI, V269, P2163, DOI 10.1098/rspb.2002.2134; Jentsch A, 2007, FRONT ECOL ENVIRON, V5, P365, DOI 10.1890/1540-9295(2007)5[365:ANGOCE]2.0.CO;2; Lehnert L, 2013, J NAT CONSE IN PRESS; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lenoir J, 2010, ECOGRAPHY, V33, P295, DOI 10.1111/j.1600-0587.2010.06279.x; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Muller J, 2008, BIODIVERS CONSERV, V17, P2979, DOI 10.1007/s10531-008-9409-1; Muller J, 2008, MALACOLOGIA, V51, P133; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Partel M, 2002, ECOLOGY, V83, P1199, DOI 10.1890/0012-9658(2002)083[1199:RDASPI]2.0.CO;2; Pauli H, 2007, GLOBAL CHANGE BIOL, V13, P147, DOI 10.1111/j.1365-2486.2006.01282.x; Popy S, 2010, J BIOGEOGR, V37, P57, DOI 10.1111/j.1365-2699.2009.02197.x; R Development Core Team, LANG ENV STAT COMP; Scherrer D, 2011, J BIOGEOGR, V38, P406, DOI 10.1111/j.1365-2699.2010.02407.x; Shoo LP, 2006, AUSTRAL ECOL, V31, P22, DOI 10.1111/j.1442-9993.2006.01539.x; Sibly R. M., 2012, METABOLIC ECOLOGY SC; Somodi I, 2008, APPL VEG SCI, V11, P187, DOI 10.3170/2008-7-18354; Tackenberg O, 2003, ECOL MONOGR, V73, P191, DOI 10.1890/0012-9615(2003)073[0191:AOWDPI]2.0.CO;2; Thiem F.M., 1906, ABHANDLUNGEN NATURHI, V16, P6; Walentowski H., 2004, HDB NATURLICHEN WALD; Walther GR, 2005, J VEG SCI, V16, P541, DOI 10.1111/j.1654-1103.2005.tb02394.x; WATT WB, 1968, EVOLUTION, V22, P437, DOI 10.1111/j.1558-5646.1968.tb03985.x; WIEGAND T, 1995, ECOLOGY, V76, P2205, DOI 10.2307/1941694; Wilson RJ, 2005, ECOL LETT, V8, P1138, DOI 10.1111/j.1461-0248.2005.00824.x; Wilson RJ, 2007, GLOBAL CHANGE BIOL, V13, P1873, DOI 10.1111/j.1365-2486.2007.01418.x; [No title captured]	45	38	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65842	10.1371/journal.pone.0065842	http://dx.doi.org/10.1371/journal.pone.0065842			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762439	Green Published, gold, Green Submitted			2022-12-27	WOS:000321094800079
J	Brega, S; Caliot, E; Trieu-Cuot, P; Dramsi, S				Brega, Sara; Caliot, Elise; Trieu-Cuot, Patrick; Dramsi, Shaynoor			SecA Localization and SecA-Dependent Secretion Occurs at New Division Septa in Group B Streptococcus	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; SURFACE-PROTEINS; CELL-WALL; STAPHYLOCOCCUS-AUREUS; CAMP-FACTOR; EPITHELIAL-CELLS; VIRULENCE; AGALACTIAE; PEPTIDOGLYCAN; PYOGENES	Exported proteins of Streptococcus agalactiae (GBS), which include proteins localized to the bacterial surface or secreted into the extracellular environment, are key players for commensal and pathogenic interactions in the mammalian host. These proteins are transported across the cytoplasmic membrane via the general SecA secretory pathway and those containing the so-called LPXTG sorting motif are covalently attached to the peptidoglycan by sortase A. How SecA, sortase A, and LPXTG proteins are spatially distributed in GBS is not known. In the close relative Streptococcus pyogenes, it was shown that presence of the YSIRKG/S motif (literally YSIRK(X3)Gx(2)S) in the signal peptide (SP) constitutes the targeting information for secretion at the septum. Here, using conventional and deconvolution immunofluorescence analyses, we have studied in GBS strain NEM316 the localization of SecA, SrtA, and the secreted protein Bsp whose signal peptide contains a canonical YSIRKG/S motif (YSLRKykfGlaS). Replacing the SP of Bsp with four other SPs containing or not the YSIRKG/S motif did not alter the localized secretion of Bsp at the equatorial ring. Our results indicate that secretion and cell wall-anchoring machineries are localized at the division septum. Cell wall- anchored proteins displayed polar (PilB, Gbs0791), punctuate (CspA) or uniform distribution (Alp2) on the bacterial surface. De novo secretion of Gbs0791 following trypsin treatment indicates that it is secreted at the septum, then redistributed along the lateral sides, and finally accumulated to the poles. We conclude that the +/- YSIRK SP rule driving compartimentalized secretion is not true in S. agalactiae.	[Brega, Sara; Caliot, Elise; Trieu-Cuot, Patrick; Dramsi, Shaynoor] Inst Pasteur, Unite Biol Bacteries Pathogenes Gram Positif, Paris, France; [Brega, Sara; Caliot, Elise; Trieu-Cuot, Patrick; Dramsi, Shaynoor] CNRS, ERL 3526, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Dramsi, S (corresponding author), Inst Pasteur, Unite Biol Bacteries Pathogenes Gram Positif, Paris, France.	shaynoor.dramsi@pasteur.fr		TRIEU-CUOT, Patrick/0000-0002-2768-9587; Brega, Sara/0000-0001-6378-842X	Agence Nationale de la Recherche [ANR-06-PATHO-001-01]; Institut Pasteur; French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases'' [nuANR-10-LABX-62-IBEID]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut Pasteur(European Commission); French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases''(French National Research Agency (ANR))	This work was supported in part by grant ANR-06-PATHO-001-01 from the Agence Nationale de la Recherche "ERA-NET PathoGenoMics'' (to P.T.-C.) and by the Institut Pasteur. The authors also acknowledge funding from the French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases'' (grant nuANR-10-LABX-62-IBEID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae T, 2003, J BACTERIOL, V185, P2910, DOI 10.1128/JB.185.9.2910-2919.2003; Bierne H, 2012, CURR OPIN MICROBIOL, V15, P715, DOI 10.1016/j.mib.2012.10.010; Bryan JD, 2009, J BACTERIOL, V191, P1847, DOI 10.1128/JB.01124-08; Campo N, 2004, MOL MICROBIOL, V53, P1583, DOI 10.1111/j.1365-2958.2004.04278.x; Carlsson F, 2006, NATURE, V442, P943, DOI 10.1038/nature05021; Chaffin DO, 2000, J BACTERIOL, V182, P4466, DOI 10.1128/JB.182.16.4466-4477.2000; DeDent A, 2008, EMBO J, V27, P2656, DOI 10.1038/emboj.2008.185; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Edmond KM, 2012, LANCET, V379, P547, DOI 10.1016/S0140-6736(11)61651-6; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Harris TO, 2003, J CLIN INVEST, V111, P61, DOI 10.1172/JCI200316270; Hensler ME, 2008, MICROB PATHOGENESIS, V44, P84, DOI 10.1016/j.micpath.2007.08.005; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Lalioui L, 2005, INFECT IMMUN, V73, P3342, DOI 10.1128/IAI.73.6.3342-3350.2005; Lamy MC, 2004, MOL MICROBIOL, V54, P1250, DOI 10.1111/j.1365-2958.2004.04365.x; Lang SH, 2003, J BIOL CHEM, V278, P38167, DOI 10.1074/jbc.M303544200; Lee SG, 2006, J BACTERIOL, V188, P389, DOI 10.1128/JB.188.2.389-398.2006; Lee SG, 2002, J BIOL CHEM, V277, P46912, DOI 10.1074/jbc.M208660200; Lindahl G, 2005, CLIN MICROBIOL REV, V18, P102, DOI 10.1128/CMR.18.1.102-127.2005; Mazmanian SK, 2001, MOL MICROBIOL, V40, P1049, DOI 10.1046/j.1365-2958.2001.02411.x; Mistou MY, 2009, J BACTERIOL, V191, P4195, DOI 10.1128/JB.01673-08; Ng WL, 2004, MOL MICROBIOL, V53, P1161, DOI 10.1111/j.1365-2958.2004.04196.x; Perry AM, 2002, J BIOL CHEM, V277, P16241, DOI 10.1074/jbc.M109194200; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; PODBIELSKI A, 1994, MED MICROBIOL IMMUN, V183, P239, DOI 10.1007/BF00198458; Poyart C, 2001, INFECT IMMUN, V69, P5098, DOI 10.1128/IAI.69.8.5098-5106.2001; Raz A, 2012, MOL MICROBIOL, V84, P631, DOI 10.1111/j.1365-2958.2012.08047.x; Reinscheid DJ, 2002, MICROBIOL-SGM, V148, P3245, DOI 10.1099/00221287-148-10-3245; Rioux S, 2001, INFECT IMMUN, V69, P5162, DOI 10.1128/IAI.69.8.5162-5165.2001; Rosch J, 2004, SCIENCE, V304, P1513, DOI 10.1126/science.1097404; Rosch JW, 2007, J BACTERIOL, V189, P801, DOI 10.1128/JB.01549-06; Rosch JW, 2005, MOL MICROBIOL, V58, P959, DOI 10.1111/j.1365-2958.2005.04887.x; RUBENS CE, 1993, MOL MICROBIOL, V8, P843, DOI 10.1111/j.1365-2958.1993.tb01631.x; Sambrook J., 2002, MOL CLONING LAB MANU; Stalhammar-Carlemalm M, 1999, MOL MICROBIOL, V33, P208, DOI 10.1046/j.1365-2958.1999.01470.x; Tiyanont K, 2006, P NATL ACAD SCI USA, V103, P11033, DOI 10.1073/pnas.0600829103; Tsui HCT, 2011, MBIO, V2, DOI 10.1128/mBio.00202-11; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Yu WQ, 2012, PLOS ONE, V7, P384, DOI 10.1371/journal.pone.0030076; Zapun A, 2008, FEMS MICROBIOL REV, V32, P345, DOI 10.1111/j.1574-6976.2007.00098.x	40	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65832	10.1371/journal.pone.0065832	http://dx.doi.org/10.1371/journal.pone.0065832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762438	Green Published, Green Submitted, gold			2022-12-27	WOS:000321094800078
J	Cheng, HH; Yi, HS; Kim, Y; Kroh, EM; Chien, JW; Eaton, KD; Goodman, MT; Tait, JF; Tewari, M; Pritchard, CC				Cheng, Heather H.; Yi, Hye Son; Kim, Yeonju; Kroh, Evan M.; Chien, Jason W.; Eaton, Keith D.; Goodman, Marc T.; Tait, Jonathan F.; Tewari, Muneesh; Pritchard, Colin C.			Plasma Processing Conditions Substantially Influence Circulating microRNA Biomarker Levels	PLOS ONE			English	Article							PLATELET MICRORNA; LUNG-CANCER; BLOOD; SERUM; THROMBOCYTOSIS; MARKERS; AGENTS; PCR	Circulating, cell-free microRNAs (miRNAs) are promising candidate biomarkers, but optimal conditions for processing blood specimens for miRNA measurement remain to be established. Our previous work showed that the majority of plasma miRNAs are likely blood cell-derived. In the course of profiling lung cancer cases versus healthy controls, we observed a broad increase in circulating miRNA levels in cases compared to controls and that higher miRNA expression correlated with higher platelet and particle counts. We therefore hypothesized that the quantity of residual platelets and microparticles remaining after plasma processing might impact miRNA measurements. To systematically investigate this, we subjected matched plasma from healthy individuals to stepwise processing with differential centrifugation and 0.22 mm filtration and performed miRNA profiling. We found a major effect on circulating miRNAs, with the majority (72%) of detectable miRNAs substantially affected by processing alone. Specifically, 10% of miRNAs showed 4-30x variation, 46% showed 30-1,000x variation, and 15% showed >1,000x variation in expression solely from processing. This was predominantly due to platelet contamination, which persisted despite using standard laboratory protocols. Importantly, we show that platelet contamination in archived samples could largely be eliminated by additional centrifugation, even in frozen samples stored for six years. To minimize confounding effects in microRNA biomarker studies, additional steps to limit platelet contamination for circulating miRNA biomarker studies are necessary. We provide specific practical recommendations to help minimize confounding variation attributable to plasma processing and platelet contamination.	[Cheng, Heather H.; Chien, Jason W.; Tewari, Muneesh] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Cheng, Heather H.; Eaton, Keith D.; Tewari, Muneesh] Univ Washington, Dept Med, Seattle, WA USA; [Yi, Hye Son; Tait, Jonathan F.; Pritchard, Colin C.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Kim, Yeonju; Tewari, Muneesh] Univ Hawaii, Program Epidemiol, Honolulu, HI 96822 USA; [Kroh, Evan M.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98104 USA; [Goodman, Marc T.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA USA; [Tewari, Muneesh] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Hawaii System; Fred Hutchinson Cancer Center; Cedars Sinai Medical Center; Fred Hutchinson Cancer Center	Pritchard, CC (corresponding author), Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.	cpritch@uw.edu	Kim, Yeonju/D-8948-2013	Kim, Yeonju/0000-0002-2570-750X; Cheng, Heather/0000-0002-1365-0702; Eaton, Keith/0000-0001-5025-2001; Goodman, Marc/0000-0002-4839-3021	NIH [T32CA009515-28, R01CA058598-13, TR01 5R01DK085714]; Canary Foundation; Damon Runyon-Rachleff Innovation Award; NATIONAL CANCER INSTITUTE [R01CA058598, T32CA009515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085714] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canary Foundation; Damon Runyon-Rachleff Innovation Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported by: NIH T32CA009515-28 (HHC), NIH R01CA058598-13(MG), Canary Foundation (MT), Damon Runyon-Rachleff Innovation Award (MT), NIH TR01 5R01DK085714 (MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoe K, 2004, RESPIRATION, V71, P170, DOI 10.1159/000076679; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Dancey JE, 2010, CLIN CANCER RES, V16, P1745, DOI 10.1158/1078-0432.CCR-09-2167; de Boer HC, 2013, EUR HEART J, DOI 10.1093/eurheartj/eht007; Duttagupta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020769; Goodman MT, 2007, CANCER RES, V67, P5987, DOI 10.1158/0008-5472.CAN-07-0313; Hastings ML, 2012, METHODS; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Kim DJ, 2012, J MOL DIAGN, V14, P71, DOI 10.1016/j.jmoldx.2011.09.002; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mostert B, 2011, EXPERT REV MOL DIAGN, V11, P259, DOI [10.1586/ERM.11.11, 10.1586/erm.11.11]; Nagalla S, 2011, BLOOD, V117, P5189, DOI 10.1182/blood-2010-09-299719; Osman A, 2011, PLATELETS, V22, P433, DOI 10.3109/09537104.2011.560305; Pedersen LM, 1996, EUR RESPIR J, V9, P1826; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Simak J, 2006, TRANSFUS MED REV, V20, P1, DOI 10.1016/j.tmrv.2005.08.001; Tomita Masaki, 2008, Interact Cardiovasc Thorac Surg, V7, P613, DOI 10.1510/icvts.2007.174391; Tsujiura M, 2010, BRIT J CANCER, V102, P1174, DOI 10.1038/sj.bjc.6605608; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang L, 2009, CANCER RES, V69, P9490, DOI 10.1158/0008-5472.CAN-09-2183; Willeit P, 2013, CIRC RES, V112, P595, DOI 10.1161/CIRCRESAHA.111.300539; Xu JA, 2011, MOL CARCINOGEN, V50, P136, DOI 10.1002/mc.20712; Zeng X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046367; Zhao XY, 2012, J IMMUNOL METHODS, V378, P72, DOI 10.1016/j.jim.2012.02.007	28	217	223	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e64795	10.1371/journal.pone.0064795	http://dx.doi.org/10.1371/journal.pone.0064795			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762257	Green Submitted, Green Published, gold			2022-12-27	WOS:000321094800008
J	Holliday, CM; Tsai, HP; Skiljan, RJ; George, ID; Pathan, S				Holliday, Casey M.; Tsai, Henry P.; Skiljan, Rebecca J.; George, Ian D.; Pathan, Sami			A 3D Interactive Model and Atlas of the Jaw Musculature of Alligator mississippiensis	PLOS ONE			English	Article							MORPHOLOGY; EVOLUTION; MICROCT	Modern imaging and dissemination methods enable morphologists to share complex, three-dimensional (3D) data in ways not previously possible. Here we present a 3D interactive model of the jaw musculature of the American Alligator (Alligator mississippiensis). Alligator and crocodylian jaw musculature is notoriously challenging to inspect and interpret because of the derived nature of the feeding apparatus. Using Iodine-contrast enhanced microCT imaging, a segmented model of jaw muscles, trigeminal nerve, brain and skull are presented as a cross-sectional atlas and 3D, interactive pdf of the rendered model. Modern 3D dissemination methods like this 3D Alligator hold great potential for morphologists to share anatomical information to scientists, educators, and the public in an easily downloadable format.	[Holliday, Casey M.; Tsai, Henry P.; Skiljan, Rebecca J.; George, Ian D.; Pathan, Sami] Univ Missouri, Dept Pathol & Anat Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Holliday, CM (corresponding author), Univ Missouri, Dept Pathol & Anat Sci, Columbia, MO 65211 USA.	hollidayca@missouri.edu		Holliday, Casey/0000-0001-8210-8434	University of Missouri Research Council; University of Missouri School of Medicine Department of Pathology and Anatomical Sciences; MU Life Sciences Fellowships; MU-HHMI C3 Fellowship	University of Missouri Research Council; University of Missouri School of Medicine Department of Pathology and Anatomical Sciences; MU Life Sciences Fellowships; MU-HHMI C3 Fellowship	This study was funded by the University of Missouri Research Council (http://research.missouri.edu/internal/researchcouncil), University of Missouri School of Medicine Department of Pathology and Anatomical Sciences (http://pathology-anatomy.missouri.edu/). HPT and IDG were funded by the MU Life Sciences Fellowships (http://bondlsc.missouri.edu/fellowships). RJS was funded by the MU-HHMI C3 Fellowship (http://hhmi.missouri.edu/). No current external funding sources funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bona P, 2011, J MORPHOL, V272, P780, DOI 10.1002/jmor.10894; BUSBEY AB, 1989, J MORPHOL, V202, P99, DOI 10.1002/jmor.1052020108; Curtis N, 2010, J R SOC INTERFACE, V7, P153, DOI 10.1098/rsif.2009.0139; Dumont ER, 2011, J ANAT, V218, P151, DOI 10.1111/j.1469-7580.2010.01247.x; George ID, 2013, ANAT REC, V296, P670, DOI 10.1002/ar.22666; Handschuh S, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-41; Holliday CM, 2007, J MORPHOL, V268, P457, DOI 10.1002/jmor.10524; Iordansky Nikolai N., 2000, Russian Journal of Herpetology, V7, P41; Jeffery NS, 2011, J BIOMECH, V44, P189, DOI 10.1016/j.jbiomech.2010.08.027; Johnston P, 2011, COMPUT TOMOGR, P259, DOI [-10.5772/21982, DOI 10.5772/21982]; Lakjer T., 1926, TRIGEMINUS VERSORGTE; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; Ruthensteiner B, 2008, MICROSC RES TECHNIQ, V71, P778, DOI 10.1002/jemt.20618; Schumacher GH, 1973, BIOL REPTILIA, V4, P101; Tsai HP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024935	16	69	69	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e62806	10.1371/journal.pone.0062806	http://dx.doi.org/10.1371/journal.pone.0062806			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762228	Green Published, Green Submitted, gold			2022-12-27	WOS:000321094800001
J	Li, J; Sung, MH; Rutkove, SB				Li, Jia; Sung, Minhee; Rutkove, Seward B.			Electrophysiologic Biomarkers for Assessing Disease Progression and the Effect of Riluzole in SOD1 G93A ALS Mice	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ELECTRICAL-IMPEDANCE MYOGRAPHY; TRANSGENIC MOUSE MODEL; UNIT NUMBER ESTIMATION; MOTOR FUNCTION; TRIAL; SURVIVAL; ONSET	Objective: To compare electrical impedance myography (EIM) 50 kHz phase to weight, motor score, paw grip endurance (PGE), CMAP amplitude, and MUNE for the identification of disease progression and the effect of riluzole in the SOD1 G93A mouse. Methods: Twenty-three animals received 8 mg/kg/day riluzole in the drinking water starting at 6 weeks of age; 22 animals served as controls. Weight, motor score, PGE, CMAP, MUNE, and EIM were performed weekly to evaluate disease progression. Results: No difference in clinical disease onset or survival was found between treated and untreated groups. In addition, all methods failed to identify any beneficial effect of riluzole. Thus, data from all animals were combined for additional analyses. Of the 4 parameters, EIM phase showed the earliest change from baseline and the most linear decline throughout the entire measurement period. In addition, EIM phase correlated with PGE, CMAP amplitude, and MUNE (Spearman r = 0.92, 0.90, and 0.72, respectively, p<0.01 for all). The rate of EIM phase decline also correlated with individual animal survival (Spearman r = -0.31, p<0.05). Conclusions: At this dose, riluzole is ineffective in slowing progression of ALS. However, EIM phase shows early linear declines, supporting its potential as a useful new biomarker for preclinical drug testing.	[Li, Jia; Sung, Minhee; Rutkove, Seward B.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Rutkove, SB (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA.	srutkove@bidmc.harvard.edu		Rutkove, Seward/0000-0002-6375-3312	National Institutes of Health/National Institute of Neurological Disorders and Stroke [R01 NS055099]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055099] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health/National Institute of Neurological Disorders and Stroke grant R01 NS055099. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzouz M, 1997, MUSCLE NERVE, V20, P45, DOI 10.1002/(SICI)1097-4598(199701)20:1<45::AID-MUS6>3.0.CO;2-H; BENSIMON G, 1994, NEW ENGL J MED, V330, P585, DOI 10.1056/NEJM199403033300901; Cudkowicz M, 2011, NAT MED, V17, P1652, DOI 10.1038/nm.2579; Cudkowicz ME, 2006, ANN NEUROL, V60, P22, DOI 10.1002/ana.20903; Cudkowicz ME, 2010, AMYOTROPH LATERAL SC, V11, P259, DOI 10.3109/17482960903358865; Frey D, 2000, J NEUROSCI, V20, P2534; Gordon PH, 2008, AMYOTROPH LATERAL SC, V9, P212, DOI 10.1080/17482960802195632; Gurney ME, 1998, NEUROLOGY, V50, P62, DOI 10.1212/WNL.50.1.62; Gurney ME, 1996, ANN NEUROL, V39, P147, DOI 10.1002/ana.410390203; Hu WT, 2010, NEUROLOGY, V75, P595, DOI 10.1212/WNL.0b013e3181ed9c52; Jafarpoor M, 2013, T BIOMED EN IN PRESS; Kennel P, 2000, J NEUROL SCI, V180, P55, DOI 10.1016/S0022-510X(00)00423-8; Knippenberg S, 2010, BEHAV BRAIN RES, V213, P82, DOI 10.1016/j.bbr.2010.04.042; Lewelt A, 2010, MUSCLE NERVE, V42, P703, DOI 10.1002/mus.21838; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045004; Ludolph Albert C, 2009, Ther Adv Neurol Disord, V2, P319, DOI 10.1177/1756285609336399; Mattson MP, 2008, CRIT REV TOXICOL, V38, P633, DOI 10.1080/10408440802026406; Pambo-Pambo A, 2009, J NEUROPHYSIOL, V102, P3627, DOI 10.1152/jn.00482.2009; Poonawalla AH, 2010, MULT SCLER J, V16, P1117, DOI 10.1177/1352458510374892; Rutkove SB, 2006, CLIN NEUROPHYSIOL, V117, P1244, DOI 10.1016/j.clinph.2005.12.029; Rutkove SB, 2012, AMYOTROPHIC LATERAL; Rutkove SB, 2009, MUSCLE NERVE, V40, P936, DOI 10.1002/mus.21362; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Shefner JM, 2011, NEUROLOGY, V77, P235, DOI 10.1212/WNL.0b013e318225aabf; Shefner JM, 2006, MUSCLE NERVE, V34, P603, DOI 10.1002/mus.20628; Wang LL, 2011, CLIN NEUROPHYSIOL, V122, P2505, DOI 10.1016/j.clinph.2011.04.021; Weydt P, 2003, NEUROREPORT, V14, P1051, DOI 10.1097/01.wnr.0000073685.00308.89	27	12	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65976	10.1371/journal.pone.0065976	http://dx.doi.org/10.1371/journal.pone.0065976			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762454	Green Published, Green Submitted, gold			2022-12-27	WOS:000321099000122
J	Wang, XL; Wu, EX; Wu, J; Wang, TL; Hsieh, HP; Liu, XL				Wang, Xiaolei; Wu, Erxi; Wu, Jun; Wang, Tian-Li; Hsieh, Hsing-Pang; Liu, Xinli			An Antimitotic and Antivascular Agent BPR0L075 Overcomes Multidrug Resistance and Induces Mitotic Catastrophe in Paclitaxel-Resistant Ovarian Cancer Cells	PLOS ONE			English	Article							HELA S3 CELLS; BREAST-CANCER; SPINDLE CHECKPOINT; TUMOR-CELLS; TUBULIN ISOTYPES; ALTERED EXPRESSION; CASPASE ACTIVATION; INDUCED APOPTOSIS; DRUG-RESISTANCE; CARCINOMA CELLS	Paclitaxel plays a major role in the treatment of ovarian cancer; however, resistance to paclitaxel is frequently observed. Thus, new therapy that can overcome paclitaxel resistance will be of significant clinical importance. We evaluated antiproliferative effects of an antimitotic and antivascular agent BPR0L075 in paclitaxel-resistant ovarian cancer cells. BPR0L075 displays potent and broad-spectrum cytotoxicity at low nanomolar concentrations (IC50 = 2-7 nM) against both parental ovarian cancer cells (OVCAR-3, SKOV-3, and A2780-1A9) and paclitaxel-resistant sublines (OVCAR-3-TR, SKOV-3-TR, 1A9-PTX10), regardless of the expression levels of the multidrug resistance transporter P-gp and class III beta-tubulin or mutation of beta-tubulin. BPR0L075 blocks cell cycle at the G2/M phase in paclitaxel-resistant cells while equal concentration of paclitaxel treatment was ineffective. BPR0L075 induces cell death by a dual mechanism in parental and paclitaxel-resistant ovarian cancer cells. In the parental cells (OVCAR-3 and SKOV-3), BPR0L075 induced apoptosis, evidenced by poly(ADPribose) polymerase (PARP) cleavage and DNA ladder formation. BPR0L075 induced cell death in paclitaxel-resistant ovarian cancer cells (OVCAR-3-TR and SKOV-3-TR) is primarily due to mitotic catastrophe, evidenced by formation of giant, multinucleated cells and absence of PARP cleavage. Immunoblotting analysis shows that BPR0L075 treatment induced up-regulation of cyclin B1, BubR1, MPM-2, and survivin protein levels and Bcl-XL phosphorylation in parental cells; however, in resistant cells, the endogenous expressions of BubR1 and survivin were depleted, BPR0L075 treatment failed to induce MPM-2 expression and phosphorylation of Bcl-XL. BPR0L075 induced cell death in both parental and paclitaxel-resistant ovarian cancer cells proceed through caspase-3 independent mechanisms. In conclusion, BPR0L075 displays potent cytotoxic effects in ovarian cancer cells with a potential to overcome paclitaxel resistance by bypassing efflux transporters and inducing mitotic catastrophe. BPR0L075 represents a novel microtubule therapeutic to overcome multidrug resistance and trigger alternative cell death by mitotic catastrophe in ovarian cancer cells that are apoptosis-resistant.	[Wang, Xiaolei; Liu, Xinli] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX USA; [Wu, Erxi] N Dakota State Univ, Dept Pharmaceut Sci, Fargo, ND 58105 USA; [Wu, Jun] City Hope Natl Med Ctr, Beckman Res Inst, Div Comparat Med, Duarte, CA USA; [Wang, Tian-Li] Johns Hopkins Univ, Dept Gynecol Obstet, Baltimore, MD USA; [Wang, Tian-Li] Johns Hopkins Univ, Dept Oncol, Baltimore, MD USA; [Hsieh, Hsing-Pang] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Taipei, Taiwan	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; North Dakota State University Fargo; City of Hope; Beckman Research Institute of City of Hope; Johns Hopkins University; Johns Hopkins University; National Health Research Institutes - Taiwan	Liu, XL (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX USA.	xinli.liu@ttuhsc.edu	Hsieh, Hsing-Pang/B-2649-2010	Hsieh, Hsing-Pang/0000-0002-1332-005X; Wu, Erxi/0000-0002-1680-3639	Texas Tech University Health Sciences Center (TTUHSC) School of Pharmacy; NATIONAL CANCER INSTITUTE [R01CA148826] Funding Source: NIH RePORTER	Texas Tech University Health Sciences Center (TTUHSC) School of Pharmacy; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by Texas Tech University Health Sciences Center (TTUHSC) School of Pharmacy (X. Liu). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JD, 1999, CANCER RES, V59, P4237; ARCECI RJ, 1993, BLOOD, V81, P2215; Belotti D, 1996, CLIN CANCER RES, V2, P1725; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Carvalho A, 2003, J CELL SCI, V116, P2987, DOI 10.1242/jcs.00612; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Cenciarelli C, 2008, APOPTOSIS, V13, P659, DOI 10.1007/s10495-008-0200-2; Chen CP, 2010, ANTICANCER RES, V30, P2813; Cheung CHA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-43; Clarke-Pearson DL, 2009, NEW ENGL J MED, V361, P170, DOI 10.1056/NEJMcp0901926; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; DEMARCQ C, 1994, CELL GROWTH DIFFER, V5, P983; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Friedrich TD, 1998, CYTOMETRY, V31, P260, DOI 10.1002/(SICI)1097-0320(19980401)31:4<260::AID-CYTO5>3.0.CO;2-N; Fu YF, 2007, GYNECOL ONCOL, V105, P66, DOI 10.1016/j.ygyno.2006.10.061; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gazitt Y, 1998, INT J ONCOL, V13, P839; Giannakakou P, 2000, P NATL ACAD SCI USA, V97, P2904, DOI 10.1073/pnas.040546297; Giannakakou P, 1997, J BIOL CHEM, V272, P17118, DOI 10.1074/jbc.272.27.17118; Gonzalez-Garay ML, 1999, J BIOL CHEM, V274, P23875, DOI 10.1074/jbc.274.34.23875; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Ianzini F, 1997, INT J RADIAT BIOL, V72, P409, DOI 10.1080/095530097143185; Ianzini F, 1998, MUTAGENESIS, V13, P337, DOI 10.1093/mutage/13.4.337; Jinawath N, 2009, ONCOGENE, V28, P1941, DOI 10.1038/onc.2009.37; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kanakkanthara A, 2011, MOL CANCER THER, V10, P1419, DOI 10.1158/1535-7163.MCT-10-1057; Kavallaris M, 1997, J CLIN INVEST, V100, P1282, DOI 10.1172/JCI119642; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Knauer SK, 2007, CELL CYCLE, V6, P518, DOI 10.4161/cc.6.5.3902; Kuo CC, 2004, CANCER RES, V64, P4621, DOI 10.1158/0008-5472.CAN-03-3474; Lamers F, 2011, ENDOCR-RELAT CANCER, V18, P657, DOI 10.1530/ERC-11-0207; Lens SMA, 2003, EMBO J, V22, P2934, DOI 10.1093/emboj/cdg307; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Liou JP, 2002, J MED CHEM, V45, P2556, DOI 10.1021/jm010365+; Liu JR, 1998, GYNECOL ONCOL, V70, P398, DOI 10.1006/gyno.1998.5125; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043314; Lock RB, 1996, CANCER RES, V56, P4006; Mansilla S, 2006, CELL CYCLE, V5, P53, DOI 10.4161/cc.5.1.2267; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; Montgomery RB, 2000, J BIOL CHEM, V275, P17358, DOI 10.1074/jbc.M000966200; Monzo M, 1999, J CLIN ONCOL, V17, P1786, DOI 10.1200/JCO.1999.17.6.1786; Mozzetti S, 2005, CLIN CANCER RES, V11, P298; Nabha SM, 2002, CLIN CANCER RES, V8, P2735; NAKAGAWA M, 1992, CANCER RES, V52, P6175; Nakahata K, 2002, INT J HYPERTHER, V18, P332, DOI 10.1080/02656730210129736; Ogretmen B, 1996, INT J CANCER, V67, P608, DOI 10.1002/(SICI)1097-0215(19960904)67:5<608::AID-IJC3>3.0.CO;2-Y; Okada H, 2004, NAT REV CANCER, V4, P592, DOI 10.1038/nrc1412; Orr GA, 2003, ONCOGENE, V22, P7280, DOI 10.1038/sj.onc.1206934; Ozols RF, 2006, ANN ONCOL, V17, pV181, DOI 10.1093/annonc/mdj978; Panvichian R, 1998, CANCER RES, V58, P4667; Paradiso A, 2005, ANN ONCOL, V16, P14, DOI 10.1093/annonc/mdi902; Poruchynsky MS, 1998, CANCER RES, V58, P3331; Roninson IB, 2001, DRUG RESIST UPDATE, V4, P303, DOI 10.1054/drup.2001.0213; Ross DD, 1999, J NATL CANCER I, V91, P429, DOI 10.1093/jnci/91.5.429; ROWINSKY EK, 1995, NEW ENGL J MED, V332, P1004, DOI 10.1056/NEJM199504133321507; Scheffer GL, 2000, CANCER RES, V60, P2589; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Shankar SL, 2001, J NEUROCHEM, V79, P426, DOI 10.1046/j.1471-4159.2001.00596.x; Singh R, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-4; Stauber RH, 2007, CANCER RES, V67, P5999, DOI 10.1158/0008-5472.CAN-07-0494; Sudo T, 2004, CANCER RES, V64, P2502, DOI 10.1158/0008-5472.CAN-03-2013; Tseng HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036006; Tu SP, 2003, CANCER RES, V63, P7724; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P555, DOI 10.1038/sj.cdd.4402286; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; Verdier-Pinard P, 2003, BIOCHEMISTRY-US, V42, P5349, DOI 10.1021/bi027293o; Vitale I, 2007, APOPTOSIS, V12, P155, DOI 10.1007/s10495-006-0491-0; Wang YF, 2005, CELL CYCLE, V4, P1847, DOI 10.4161/cc.4.12.2264; Yu DH, 1998, ONCOGENE, V16, P2087, DOI 10.1038/sj.onc.1201729; Zhang R, 2010, CANCER GENE THER, V17, P275, DOI 10.1038/cgt.2009.68; Zhou J, 2004, CANCER RES, V64, P8708, DOI 10.1158/0008-5472.CAN-04-2538	72	21	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65686	10.1371/journal.pone.0065686	http://dx.doi.org/10.1371/journal.pone.0065686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762410	Green Published, Green Submitted, gold			2022-12-27	WOS:000321099000093
J	Zinetti, F; Dapporto, L; Vovlas, A; Chelazzi, G; Bonelli, S; Balletto, E; Ciofi, C				Zinetti, Francesca; Dapporto, Leonardo; Vovlas, Alessio; Chelazzi, Guido; Bonelli, Simona; Balletto, Emilio; Ciofi, Claudio			When the Rule Becomes the Exception. No Evidence of Gene Flow between Two Zerynthia Cryptic Butterflies Suggests the Emergence of a New Model Group	PLOS ONE			English	Article							PARNASSIINAE LEPIDOPTERA; POLYXENA LEPIDOPTERA; MOLECULAR PHYLOGENY; ARISTOLOCHIC ACIDS; PAPILIONIDAE; MITOCHONDRIAL; HYBRIDIZATION; SWALLOWTAIL; PATTERNS; DIFFERENTIATION	There is increasing evidence that most parapatric cryptic/sister taxa are reproductively compatible across their areas of contact. Consequently, the biological species concept, which assumes absence of interbreeding, is becoming a not so effective criterion in evolutionary ecology. Nevertheless, the few parapatric sister taxa showing complete reproductive barriers represent interesting models to study speciation processes and the evolution of reproductive isolation. In this study, we examined contact populations in northwestern Italy of two butterfly species, Zerynthia polyxena and Z. cassandra, characterized by different genitalic morphotypes. We studied levels of divergence among 21 populations distributed from Sicily to France using three genetic markers (the mitochondrial COI and ND1 genes and the nuclear wingless gene) and genitalic geometric morphometrics. Moreover, we performed species distribution modelling to estimate different climatic requirements of Z. polyxena and Z. cassandra. We projected climatic data into glacial maximum scenarios in order to verify if and to which extent glacial cycles could have contributed to speciation processes. Genetic and morphometric analyses identified two main groups. All specimens showed a concordant pattern of diversification, including those individuals sampled in the contact area. Haplotype distribution and climatic models showed that during glacial maxima both species experienced a strong range contraction and presumably remained separated into different microrefugia in southern France, in the Italian Peninsula and on the islands of Elba and Sicily. Long term separation was probably favoured by reduced dispersal ability and high phylopatry, while genitalic diversification probably favoured interbreeding avoidance. Conversely, the aposematic wing pattern remained almost identical. We compared our results with those obtained in other species and concluded that Z. polyxena and Z. cassandra represent a valuable model in the study of speciation.	[Zinetti, Francesca; Chelazzi, Guido; Ciofi, Claudio] Univ Florence, Dipartimento Biol, Florence, Italy; [Dapporto, Leonardo] Ist Comprens Materna Elementare Media Convenevole, Prato, Italy; [Vovlas, Alessio; Bonelli, Simona; Balletto, Emilio] Univ Turin, Dipartimento Sci Vita & Biol Sistemi, Turin, Italy	University of Florence; University of Turin	Dapporto, L (corresponding author), Ist Comprens Materna Elementare Media Convenevole, Prato, Italy.	leonadap@gmail.com	Dapporto, Leonardo/E-5752-2010; Ciofi, Claudio/AAH-9461-2019	Dapporto, Leonardo/0000-0001-7129-4526; CIOFI, CLAUDIO/0000-0001-8537-8659; BALLETTO, Emilio/0000-0003-1168-2791; Vovlas, Alessio/0000-0003-1682-7101; Bonelli, Simona/0000-0001-5185-8136	Italian Ministry of University and Research; Spanish Ministerio de Ciencia e Innovacion [CGL2010-21226/BOS]; "Definizione dello status di conservazione delle falene e della malacofauna terrestre dell'Arcipelago Toscano'' project	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); "Definizione dello status di conservazione delle falene e della malacofauna terrestre dell'Arcipelago Toscano'' project	This study was part of the program "A multitaxa approach to study the impact of climate change on the biodiversity of Italian ecosystems" funded by the Italian Ministry of University and Research, the Spanish Ministerio de Ciencia e Innovacion project CGL2010-21226/BOS and the "Definizione dello status di conservazione delle falene e della malacofauna terrestre dell'Arcipelago Toscano'' project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	[Anonymous], 2011, DISTRIBUTION ATLAS B; Aubert J, 1999, MOL PHYLOGENET EVOL, V12, P156, DOI 10.1006/mpev.1998.0605; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Balletto E., 2007, CHECKLIST DISTRIBUTI, V17, P257; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bollino M., 2012, BUTTERFLIES WORL S20; Bookstein F L, 1997, Med Image Anal, V1, P225; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Celik T, 2012, EUR J ENTOMOL, V109, P217, DOI 10.14411/eje.2012.028; Cianchi R, 2003, MOL ECOL, V12, P1461, DOI 10.1046/j.1365-294X.2003.01813.x; Coyne FM, 2004, SPECIATION; Currat M, 2008, EVOLUTION, V62, P1908, DOI 10.1111/j.1558-5646.2008.00413.x; Dapporto L, 2012, DIVERS DISTRIB, V18, P1066, DOI 10.1111/j.1472-4642.2012.00903.x; Dapporto L, 2011, BIOL J LINN SOC, V103, P571, DOI 10.1111/j.1095-8312.2011.01639.x; Dapporto L, 2010, J ZOOL SYST EVOL RES, V48, P229, DOI 10.1111/j.1439-0469.2009.00550.x; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Dasmahapatra KK, 2010, MOL ECOL, V19, P4283, DOI 10.1111/j.1365-294X.2010.04802.x; Descimon Henri, 2009, P219; Dinca V, 2011, MOL ECOL, V20, P3921, DOI 10.1111/j.1365-294X.2011.05223.x; Dinca V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1329; Dinca V, 2011, P ROY SOC B-BIOL SCI, V278, P347, DOI 10.1098/rspb.2010.1089; Elith Jane, 2002, P39; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Friberg M, 2008, BEHAV ECOL SOCIOBIOL, V62, P873, DOI 10.1007/s00265-007-0511-2; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Habel JC, 2013, J HERED, V104, P234, DOI 10.1093/jhered/ess092; Habel JC, 2010, BIOL J LINN SOC, V99, P818, DOI 10.1111/j.1095-8312.2010.01394.x; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hausdorf B, 2011, EVOLUTION, V65, P923, DOI 10.1111/j.1558-5646.2011.01231.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Kim MI, 2009, MOL CELLS, V28, P347, DOI 10.1007/s10059-009-0129-5; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lorkovic Zdravko, 1993, Natura Croatica, V2, P1; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; MALLET J, 1995, TRENDS ECOL EVOL, V10, P294, DOI 10.1016/0169-5347(95)90031-4; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; Mallet J, 2011, INSECT CONSERV DIVER, V4, P192, DOI 10.1111/j.1752-4598.2010.00122.x; MAYR E., 1942, Systematics and the origin of species from the viewpoint of a zoologist.; Michel F, 2008, ANN SOC ENTOMOL FR, V44, P1; Nazari V, 2007, INSECT SYST EVOL, V38, P121, DOI 10.1163/187631207788783996; Nazari V, 2007, MOL PHYLOGENET EVOL, V42, P131, DOI 10.1016/j.ympev.2006.06.022; Otto-Bliesner BL, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029475; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Porter Adam H., 2009, P296; Posada D., 2003, CURRENT PROTOCOLS BI; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rohlf F, 2010, TPSDIG DIGITIZE LAND; Rohlf F., 2012, TPSUTIL FILE UTILITY; Rohlf FJ, 2010, TPSDIG VERSION 2 16; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F, 2010, ANNU REV ENTOMOL, V55, P189, DOI 10.1146/annurev.ento.54.110807.090529; ROTHSCHILD M, 1972, INSECT BIOCHEM, V2, P334, DOI 10.1016/0020-1790(72)90038-8; Sanudo-Restrepo CP, 2012, MOL PHYLOGE IN PRESS; Sime KR, 2000, CHEMOECOLOGY, V10, P169, DOI 10.1007/PL00001819; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Wiemers Martin, 2010, Entomologische Zeitschrift, V120, P111; Wu CI, 2001, J EVOLUTION BIOL, V14, P851, DOI 10.1046/j.1420-9101.2001.00335.x	60	40	40	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65746	10.1371/journal.pone.0065746	http://dx.doi.org/10.1371/journal.pone.0065746			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755277	Green Published, gold, Green Submitted			2022-12-27	WOS:000321099000100
J	Zhang, JD; Himes, JH; Guo, Y; Jiang, JX; Yang, L; Lu, QZ; Ruan, HY; Shi, SH				Zhang, Jianduan; Himes, John H.; Guo, Yuan; Jiang, Jingxiong; Yang, Liu; Lu, Qiaozhen; Ruan, Haiyan; Shi, Shuhua			Birth Weight, Growth and Feeding Pattern in Early Infancy Predict Overweight/Obesity Status at Two Years of Age: A Birth Cohort Study of Chinese Infants	PLOS ONE			English	Article							BODY-MASS INDEX; CHILDHOOD OBESITY; PRESCHOOL-CHILDREN; UNITED-STATES; FOLLOW-UP; PREVALENCE; TRENDS; RISK; GAIN; BEHAVIORS	Objectives: To investigate the early determinants of overweight and obesity status at age two years. Methods: A total of 1098 healthy neonates (563 boys and 535 girls) were involved in this community-based prospective study in China. Data on body weight and length were collected at birth, the 3rd and 24th month. A self-administered questionnaire was used to collect data on social demography and feeding patterns of children, etc. Three multivariable logistic regression models were employed to make various comparisons of weight status, i.e., model 1 (obesity vs. non-obesity), model 2 (combined overweight and obesity vs. normal weight, and model 3 (obesity, overweight and normal weight). Results: Prevalences of overweight/obesity (95th > BMI >= 85th p and BMI >= 95th p, referring to WHO BMI standards) at 2 years of age are 15.8%/11.2% for boys and 12.9%/9.0% for girls, respectively. Being born with macrosomia (OR: 1.80-1.88), relatively greater BMI increment in the first 3 months (OR: 1.15-1.16) and bottle emptying by encouragement at age two (OR: 1.30-1.57) were found in all three models to be significant risk factors for higher BMI status at 2 years. Pre-pregnancy maternal BMI (OR: 1.09-1.12), paternal BMI (OR: 1.06), and mixed breastfeeding (OR: 1.54-1.57) or formula feeding (OR: 1.90-1.93) in the first month were identified as significant in models 2 and 3. Child-initiated bottle emptying at age two was observed to increase the risk of obesity by 1.31 times but only in model 1. Conclusion: Fetal and early postnatal growth and feeding pattern appear to have significant impacts on early childhood overweight and obesity status independent of parental BMI. Policy-based and multidisciplinary approaches to promote breastfeeding and enhancement of feeding skills of care takers may be promising intervention strategies.	[Zhang, Jianduan; Guo, Yuan; Shi, Shuhua] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Woman & Childs Care & Adolescence Hlth, Wuhan 430074, Hubei, Peoples R China; [Himes, John H.] Univ Minnesota, Sch Publ Hlth, Dept Epidemiol & Community Hlth, Minneapolis, MN USA; [Jiang, Jingxiong] Chinese Ctr Dis Control & Prevent, Natl Ctr Women & Childrens Hlth Care, Dept Child Hlth, Beijing, Peoples R China; [Yang, Liu] Shenyang Municipal Maternal & Child Hlth Care Ctr, Dept Maternal Hlth, Shenyang, Liaoning, Peoples R China; [Lu, Qiaozhen] Haizhu Maternal & Child Hlth Hosp, Dept Child Hlth, Guangzhou, Guangdong, Peoples R China; [Ruan, Haiyan] Panyu Dist Maternal & Child Hlth Hosp, Dept Child Hlth, Guangzhou, Guangdong, Peoples R China	Huazhong University of Science & Technology; University of Minnesota System; University of Minnesota Twin Cities; Chinese Center for Disease Control & Prevention	Zhang, JD (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Woman & Childs Care & Adolescence Hlth, Wuhan 430074, Hubei, Peoples R China.	jd_zh@mail.hust.edu.cn	Zhang, Jianduan/K-9698-2015	Zhang, Jianduan/0000-0002-7942-8362	National Natural Science Fund (NNSF) of China [30800917]; Special Fund for Basic Scientific Research of Central Colleges [2011TS017]	National Natural Science Fund (NNSF) of China(National Natural Science Foundation of China (NSFC)); Special Fund for Basic Scientific Research of Central Colleges	This work was supported by: 1. National Natural Science Fund (NNSF) of China (Grand No. 30800917). 2. The Special Fund for Basic Scientific Research of Central Colleges (Grant No. 2011TS017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker JL, 2008, EPIDEMIOLOGY, V19, P197, DOI 10.1097/EDE.0b013e31816339c6; Breitfelder A, 2009, ECON HUM BIOL, V9, P302; Brophy S, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-467; Bruss MB, 2003, J AM DIET ASSOC, V103, P1042, DOI 10.1016/S0002-8223(03)00472-3; Clark HR, 2008, PUBLIC HEALTH NUTR, V11, P1030, DOI 10.1017/S1368980007001401; De Kroon MLA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009155; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Dennison BA, 2006, OBESITY, V14, P491, DOI 10.1038/oby.2006.64; Dietz WH, 1998, J NUTR, V128, p411S, DOI 10.1093/jn/128.2.411S; Dietz WH, 2001, ANNU REV PUBL HEALTH, V22, P337, DOI 10.1146/annurev.publhealth.22.1.337; Engeland A, 2003, AM J EPIDEMIOL, V157, P517, DOI 10.1093/aje/kwf219; Eriksson J, 2003, INT J OBESITY, V27, P722, DOI 10.1038/sj.ijo.0802278; Gubbels JS, 2009, J PEDIATR-US, V155, P194, DOI 10.1016/j.jpeds.2009.02.027; Gunnell DJ, 1998, AM J CLIN NUTR, V67, P1111, DOI 10.1093/ajcn/67.6.1111; Haisma H, 2003, EUR J CLIN NUTR, V57, P1633, DOI 10.1038/sj.ejcn.1601735; Harrington JW, 2010, CLIN PEDIATR, V49, P638, DOI 10.1177/0009922809359418; Huus K, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-42; Ji CY, 2009, INT J CARDIOL, V132, P1, DOI 10.1016/j.ijcard.2008.07.003; Jiang JX, 2007, APPETITE, V48, P377, DOI 10.1016/j.appet.2006.10.004; Karaolis-Danckert N, 2007, AM J CLIN NUTR, V86, P1700, DOI 10.1093/ajcn/86.5.1700; Leung GM, 2002, BIRTH-ISS PERINAT C, V29, P162, DOI 10.1046/j.1523-536X.2002.00183.x; Li RW, 2008, PEDIATRICS, V122, pS77, DOI 10.1542/peds.2008-1315j; Li RW, 2005, PEDIATRICS, V115, pE31, DOI 10.1542/peds.2004-0481; Lindberg SM, 2012, MATERN CHILD HLTH J, V16, P1879, DOI 10.1007/s10995-012-1024-9; Lobstein T, 2003, Obes Rev, V4, P195, DOI 10.1046/j.1467-789X.2003.00116.x; Lu L, 2004, CHILD FAMILY ED, V10, P6; Luo J, 2002, INT J OBESITY, V26, P553, DOI 10.1038/sj.ijo.0801944; Ma YN, 2011, ARCH MED RES, V42, P633, DOI 10.1016/j.arcmed.2011.10.011; Nader PR, 2006, PEDIATRICS, V118, pE594, DOI 10.1542/peds.2005-2801; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Ong KK, 2006, ACTA PAEDIATR, V95, P904, DOI 10.1080/08035250600719754; Qiu Liqian, 2008, Asia Pac J Public Health, V20 Suppl, P220; Rosenberg KD, 2008, AM J PUBLIC HEALTH, V98, P290, DOI 10.2105/AJPH.2006.103218; Sanigorski AM, 2007, OBESITY, V15, P1908, DOI 10.1038/oby.2007.226; Schonbeck Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027608; Spurgeon David, 2002, BMJ, V324, P1416; Stamatakis E, 2005, ARCH DIS CHILD, V90, P999, DOI 10.1136/adc.2004.068932; Stamatakis E, 2010, INT J OBESITY, V34, P41, DOI 10.1038/ijo.2009.217; Stockton MB, 2009, J PEDIATR PSYCHOL, V34, P1144, DOI 10.1093/jpepsy/jsp023; van den Hurk K, 2007, ARCH DIS CHILD, V92, P992, DOI 10.1136/adc.2006.115402; Whitaker KL, 2010, AM J CLIN NUTR, V91, P1560, DOI 10.3945/ajcn.2009.28838; World Health Organization, 2000, WHO TECH REP SER, V894, p[i, 1]; Yan S, 2012, OBES REV, V13, P810, DOI 10.1111/j.1467-789X.2012.01016.x; Zhang JD, 2012, AM J HUM BIOL, V24, P633, DOI 10.1002/ajhb.22284; Zhao Yao, 2006, Zhonghua Yufang Yixue Zazhi, V40, P46	47	36	40	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64542	10.1371/journal.pone.0064542	http://dx.doi.org/10.1371/journal.pone.0064542			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166TB	23755127	Green Submitted, gold, Green Published			2022-12-27	WOS:000320579400018
J	Gabasa, M; Royo, D; Molina-Molina, M; Roca-Ferrer, J; Pujols, L; Picado, C; Xaubet, A; Pereda, J				Gabasa, Marta; Royo, Dolores; Molina-Molina, Maria; Roca-Ferrer, Jordi; Pujols, Laura; Picado, Cesar; Xaubet, Antoni; Pereda, Javier			Lung Myofibroblasts Are Characterized by Down-Regulated Cyclooxygenase-2 and Its Main Metabolite, Prostaglandin E2	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; TRANSFORMING GROWTH-FACTOR-BETA-1; INHIBITS FIBROBLAST; ARACHIDONIC-ACID; GROWTH; E-2; TRANSITION; EXPRESSION; TGF-BETA-1; APOPTOSIS	Background: Prostaglandin E2 (PGE(2)), the main metabolite of cyclooxygenase (COX), is a well-known anti-fibrotic agent. Moreover, myofibroblasts expressing alpha-smooth muscle actin (alpha-SMA), fibroblast expansion and epithelial-mesenchymal transition (EMT) are critical to the pathogenesis of idiopathic pulmonary fibrosis (IPF). Our aim was to investigate the expression of COX-2 and PGE(2) in human lung myofibroblasts and establish whether fibroblast-myofibroblast transition (FMT) and EMT are associated with COX-2 and PGE(2) down-regulation. Methods: Fibroblasts obtained from IPF patients (n = 6) and patients undergoing spontaneous pneumothorax (control, n = 6) and alveolar epithelial cell line A549 were incubated with TGF-beta 1 and FMT and EMT markers were evaluated. COX-2 and alpha-SMA expression, PGE(2) secretion and cell proliferation were measured after IL-1 beta and PGE(2) incubation. Results: Myofibroblasts from both control and IPF fibroblast cultures stimulated with IL-1 beta showed no COX-2 expression. IPF fibroblasts showed increased myofibroblast population and reduced COX-2 expression in response to IL-1 beta. TGF-beta 1 increased the number of myofibroblasts in a time-dependent manner. In contrast, TGF-beta 1 induced slight COX-2 expression at 4 h (without increase in myofibroblasts) and 24 h, but not at 72 h. Both IPF and control cultures incubated with TGF-beta 1 for 72 h showed diminished COX-2 induction, PGE(2) secretion and alpha-SMA expression after IL-1 beta addition. The latter decreased proliferation in fibroblasts but not in myofibroblasts. A549 cells incubated with TGF-beta 1 for 72 h showed down-regulated COX-2 expression and low basal PGE(2) secretion in response to IL-1 beta. Immuno-histochemical analysis of IPF lung tissue showed no COX-2 immuno-reactivity in myofibroblast foci. Conclusions: Myofibroblasts are associated with COX-2 down-regulation and reduced PGE(2) production, which could be crucial in IPF development and progression.	[Gabasa, Marta; Royo, Dolores; Roca-Ferrer, Jordi; Pujols, Laura; Pereda, Javier] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Gabasa, Marta; Royo, Dolores; Molina-Molina, Maria; Roca-Ferrer, Jordi; Pujols, Laura; Picado, Cesar; Xaubet, Antoni; Pereda, Javier] Hosp Llobregat, Hosp Univ Bellvitge, Inst Invest Biomed Bellvitge IDIBEL, Serv Pneumol,Grp Recerca Pneumol, Barcelona, Spain; [Molina-Molina, Maria] Univ Barcelona, Hosp Clin, Inst Clin Torax, Serv Pneumol & Al Lergia Resp, E-08007 Barcelona, Spain; [Picado, Cesar; Xaubet, Antoni] Univ Valencia, Fac Farm, Dept Fisiol, E-46010 Valencia, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Valencia		axaubet@clinic.ub.es	/AFX-9519-2022; Pereda, Javier/N-2424-2014; Pujols, Laura/G-8920-2015; /AAL-7347-2021; Roca-Ferrer, Jordi/AFQ-4652-2022	Pereda, Javier/0000-0002-8690-8938; Pujols, Laura/0000-0003-3708-5098; Roca-Ferrer, Jordi/0000-0002-9527-2273; MOLINA MOLINA, MARIA/0000-0002-1852-1723; Gabasa Ferrandez, Marta/0000-0002-3758-2265	SEPAR Fundacion Respira;  [FIS PI060064]	SEPAR Fundacion Respira; 	This study was supported by FIS PI060064 grant and SEPAR Fundacion Respira. The funders had no role in study design, data collection and analysis, decision to publish, or reparation of the manuscript.	Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Anscher MS, 2010, ONCOLOGIST, V15, P350, DOI 10.1634/theoncologist.2009-S101; Bonner JC, 2002, AM J PATHOL, V161, P459, DOI 10.1016/S0002-9440(10)64202-2; BOROK Z, 1991, AM REV RESPIR DIS, V144, P1080, DOI 10.1164/ajrccm/144.5.1080; Brock TG, 1999, J BIOL CHEM, V274, P11660, DOI 10.1074/jbc.274.17.11660; BROEKELMANN TJ, 1991, P NATL ACAD SCI USA, V88, P6642, DOI 10.1073/pnas.88.15.6642; Coward WR, 2009, MOL CELL BIOL, V29, P4325, DOI 10.1128/MCB.01776-08; Diaz A, 1998, EXP CELL RES, V241, P222, DOI 10.1006/excr.1998.4050; ELIAS JA, 1985, AM REV RESPIR DIS, V131, P94; Fang HY, 2010, EXP LUNG RES, V36, P323, DOI 10.3109/01902141003628579; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hodges RJ, 2004, AM J PATHOL, V165, P1663, DOI 10.1016/S0002-9440(10)63423-2; Horowitz JC, 2010, AM J RESP CRIT CARE, V182, P2, DOI 10.1164/rccm.201002-0239ED; Huang SK, 2009, FASEB J, V23, P4317, DOI 10.1096/fj.08-128801; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Keerthisingam CB, 2001, AM J PATHOL, V158, P1411, DOI 10.1016/S0002-9440(10)64092-8; Kohyama T, 2001, AM J PHYSIOL-LUNG C, V281, pL1257, DOI 10.1152/ajplung.2001.281.5.L1257; Kolodsick JE, 2003, AM J RESP CELL MOL, V29, P537, DOI 10.1165/rcmb.2002-0243OC; KUHN C, 1991, AM J PATHOL, V138, P1257; Lappi-Blanco E, 2006, AM J CLIN PATHOL, V126, P717, DOI 10.1309/PFGXCLNG2N17PJX9; Ling H, 2010, MOL CARCINOGEN, V49, P271, DOI 10.1002/mc.20597; Maher TM, 2010, AM J RESP CRIT CARE, V182, P73, DOI 10.1164/rccm.200905-0674OC; Matsumura T, 2009, J BIOL CHEM, V284, P35861, DOI 10.1074/jbc.M109.014639; MCANULTY RJ, 1995, BIOCHEM J, V307, P63, DOI 10.1042/bj3070063; MITCHELL JA, 1994, BRIT J PHARMACOL, V113, P1008, DOI 10.1111/j.1476-5381.1994.tb17093.x; Ramos C, 2001, AM J RESP CELL MOL, V24, P591, DOI 10.1165/ajrcmb.24.5.4333; Ramos C, 2010, AM J PHYSIOL-LUNG C, V299, pL222, DOI 10.1152/ajplung.00070.2010; Roca-Ferrer J, 2011, J ALLERGY CLIN IMMUN, V128, P66, DOI 10.1016/j.jaci.2011.01.065; SALTZMAN LE, 1982, BIOCHEM J, V204, P25, DOI 10.1042/bj2040025; Singh Shailendra R, 2008, Proc Am Thorac Soc, V5, P127, DOI 10.1513/pats.200706-070VS; Uhal BD, 2007, CURR PHARM DESIGN, V13, P1247, DOI 10.2174/138161207780618885; WILBORN J, 1995, J CLIN INVEST, V95, P1861, DOI 10.1172/JCI117866; Willis Brigham C, 2006, Proc Am Thorac Soc, V3, P377, DOI 10.1513/pats.200601-004TK; Xaubet A, 2004, SARCOIDOSIS VASC DIF, V21, P35	34	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65445	10.1371/journal.pone.0065445	http://dx.doi.org/10.1371/journal.pone.0065445			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755232	Green Published, Green Submitted, gold			2022-12-27	WOS:000319872300082
J	Gao, JF; Wang, Z; Yang, Y; Zhang, WJ; Tao, CY; Guan, JA; Rao, NN				Gao, Junfeng; Wang, Zhao; Yang, Yong; Zhang, Wenjia; Tao, Chunyi; Guan, Jinan; Rao, Nini			A Novel Approach for Lie Detection Based on F-Score and Extreme Learning Machine	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; FEATURE-SELECTION; P300; CLASSIFICATION; NETWORKS; ACCURATE; TRUTH; TIME; PCA	A new machine learning method referred to as F-score_ELM was proposed to classify the lying and truth-telling using the electroencephalogram (EEG) signals from 28 guilty and innocent subjects. Thirty-one features were extracted from the probe responses from these subjects. Then, a recently-developed classifier called extreme learning machine (ELM) was combined with F-score, a simple but effective feature selection method, to jointly optimize the number of the hidden nodes of ELM and the feature subset by a grid-searching training procedure. The method was compared to two classification models combining principal component analysis with back-propagation network and support vector machine classifiers. We thoroughly assessed the performance of these classification models including the training and testing time, sensitivity and specificity from the training and testing sets, as well as network size. The experimental results showed that the number of the hidden nodes can be effectively optimized by the proposed method. Also, F-score_ELM obtained the best classification accuracy and required the shortest training and testing time.	[Gao, Junfeng; Zhang, Wenjia; Tao, Chunyi; Guan, Jinan] South Cent Univ Nationalities, Coll Biomed Engn, Wuhan, Peoples R China; [Wang, Zhao] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Yang, Yong] Jiangxi Univ Finance & Econ, Sch Informat Technol, Nanchang, Peoples R China; [Rao, Nini] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Peoples R China	South Central Minzu University; Case Western Reserve University; Jiangxi University of Finance & Economics; University of Electronic Science & Technology of China	Guan, JA (corresponding author), South Cent Univ Nationalities, Coll Biomed Engn, Wuhan, Peoples R China.	guanja@tom.com; raonini@uestc.edu.cn	Wang, Zhao/E-3515-2015; Guan, Jinan/AHA-4376-2022	Wang, Zhao/0000-0002-3628-5699; Guan, Jinan/0000-0003-1094-733X	National Nature Science Foundation of China [81271659, 61262034, 91120017, 81171411]; Science and Technology Research Project of the Education Department of Jiangxi Province [GJJ13302]; Special Fund for Basic Scientific Research of Central Colleges, South-Central University for Nationalities [CZY12011]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Research Project of the Education Department of Jiangxi Province; Special Fund for Basic Scientific Research of Central Colleges, South-Central University for Nationalities	The work is supported by National Nature Science Foundation of China (No. 81271659, 61262034, 91120017 and 81171411), by the Science and Technology Research Project of the Education Department of Jiangxi Province (No. GJJ13302) and by the Special Fund for Basic Scientific Research of Central Colleges, South-Central University for Nationalities (No. CZY12011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abootalebi V, 2009, COMPUT METH PROG BIO, V94, P48, DOI 10.1016/j.cmpb.2008.10.001; Acharya UR, 2012, INT J NEURAL SYST, V22, DOI [10.1142/S0129065712500025, 10.1142/S0129065712500116]; Akay MF, 2009, EXPERT SYST APPL, V36, P3240, DOI 10.1016/j.eswa.2008.01.009; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Cao JW, 2012, INFORM SCIENCES, V185, P66, DOI 10.1016/j.ins.2011.09.015; Chawla MPS, 2009, NEURAL COMPUT APPL, V18, P539, DOI 10.1007/s00521-008-0195-1; Chen FL, 2011, EXPERT SYST APPL, V38, P1336, DOI 10.1016/j.eswa.2010.07.014; Chen FL, 2010, EXPERT SYST APPL, V37, P4902, DOI 10.1016/j.eswa.2009.12.025; Choi K, 2011, PATTERN RECOGN, V44, P386, DOI 10.1016/j.patcog.2010.08.009; Dash M, 2002, 2002 IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P115, DOI 10.1109/ICDM.2002.1183893; Davatzikos C, 2005, NEUROIMAGE, V28, P663, DOI 10.1016/j.neuroimage.2005.08.009; FARWELL LA, 1991, PSYCHOPHYSIOLOGY, V28, P531, DOI 10.1111/j.1469-8986.1991.tb01990.x; Faust O, 2010, INT J NEURAL SYST, V20, P159, DOI 10.1142/S0129065710002334; Feng GR, 2009, IEEE T NEURAL NETWOR, V20, P1352, DOI 10.1109/TNN.2009.2024147; Gao JF, 2012, CLIN EEG NEUROSCI, V43, P54, DOI 10.1177/1550059411428715; Gao JF, 2011, COMPUT METH PROG BIO, V104, P410, DOI 10.1016/j.cmpb.2010.10.002; Han F, 2006, INT J NEURAL SYST, V16, P39, DOI 10.1142/S0129065706000494; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; Hsu WY, 2012, INT J NEURAL SYST, V22, P51, DOI 10.1142/S0129065712002979; Hsu WY, 2011, INT J NEURAL SYST, V21, P335, DOI 10.1142/S0129065711002870; Huang CJ, 2008, EXPERT SYST APPL, V34, P2870, DOI 10.1016/j.eswa.2007.05.035; Huang GB, 2008, NEUROCOMPUTING, V71, P3460, DOI 10.1016/j.neucom.2007.10.008; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Huang GB, 2006, IEEE T NEURAL NETWOR, V17, P879, DOI 10.1109/TNN.2006.875977; Huang GB, 2012, IEEE T SYST MAN CY B, V42, P513, DOI 10.1109/TSMCB.2011.2168604; Huang GB, 2011, INT J MACH LEARN CYB, V2, P107, DOI 10.1007/s13042-011-0019-y; Huynh HT, 2008, INT J NEURAL SYST, V18, P433, DOI 10.1142/S0129065708001695; Ihrke M, 2011, INT J NEURAL SYST, V21, P65, DOI 10.1142/S0129065711002651; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Langleben DD, 2005, HUM BRAIN MAPP, V26, P262, DOI 10.1002/hbm.20191; Lee MC, 2009, EXPERT SYST APPL, V36, P10896, DOI 10.1016/j.eswa.2009.02.038; Liang NY, 2006, IEEE T NEURAL NETWOR, V17, P1411, DOI 10.1109/TNN.2006.880583; Liang NY, 2006, INT J NEURAL SYST, V16, P29, DOI 10.1142/S0129065706000482; Lin C-J, 2003, NIPS 2003 FEATURE SE, P1; Lopez-Gordo MA, 2012, INT J NEURAL SYST, V22, DOI 10.1142/S0129065712500098; Malhi A, 2004, IEEE T INSTRUM MEAS, V53, P1517, DOI 10.1109/TIM.2004.834070; Meijer EH, 2007, INT J PSYCHOPHYSIOL, V66, P231, DOI 10.1016/j.ijpsycho.2007.08.001; Miche Y, 2011, NEUROCOMPUTING, V74, P2413, DOI 10.1016/j.neucom.2010.12.042; Phan KL, 2005, ACAD RADIOL, V12, P164, DOI 10.1016/j.acra.2004.11.023; Polat K, 2009, EXPERT SYST APPL, V36, P10367, DOI 10.1016/j.eswa.2009.01.041; Polich J, 2000, INT J PSYCHOPHYSIOL, V38, P3, DOI 10.1016/S0167-8760(00)00127-6; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Rong HJ, 2008, NEUROCOMPUTING, V72, P359, DOI 10.1016/j.neucom.2008.01.005; Rosenfeld JP, 2008, PSYCHOPHYSIOLOGY, V45, P906, DOI 10.1111/j.1469-8986.2008.00708.x; Rosenfeld JP, 1999, INT J PSYCHOPHYSIOL, V33, P3, DOI 10.1016/S0167-8760(99)00021-5; Rosenfeld JP, 2002, HDB POLYGRAPH TESTIN, P265; Shao SY, 2009, IEEE T BIO-MED ENG, V56, P336, DOI 10.1109/TBME.2008.2005969; Shi LC, 2013, NEUROCOMPUTING, V102, P135, DOI 10.1016/j.neucom.2012.02.041; Vapnik V., 1998, STAT LEARNING THEORY; Yuan Q, 2011, EPILEPSY RES, V96, P29, DOI 10.1016/j.eplepsyres.2011.04.013; Yuedong Song, 2010, Journal of Biomedical Science & Engineering, V3, P556, DOI 10.4236/jbise.2010.36078	53	98	104	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64704	10.1371/journal.pone.0064704	http://dx.doi.org/10.1371/journal.pone.0064704			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755136	gold, Green Submitted, Green Published			2022-12-27	WOS:000319872300024
J	Liang, DY; Liu, LM; Ye, CG; Zhao, L; Yu, FP; Gao, DY; Wang, YY; Yang, ZW; Wang, YY				Liang, Dong-yu; Liu, Liang-ming; Ye, Chang-gen; Zhao, Liang; Yu, Fang-ping; Gao, De-yong; Wang, Ying-ying; Yang, Zhi-wen; Wang, Yan-yan			Inhibition of UII/UTR System Relieves Acute Inflammation of Liver through Preventing Activation of NF-kappa B Pathway in ALF Mice	PLOS ONE			English	Article							UROTENSIN-II; D-GALACTOSAMINE; CYTOKINE PRODUCTION; PLASMA UROTENSIN; HEPATIC-FAILURE; EXPRESSION; RECEPTOR; APOPTOSIS; PROTECTS; CLONING	Urotensin II (UII) is implicated in immune inflammatory diseases through its specific high-affinity UT receptor (UTR). Enhanced expression of UII/UTR was recently demonstrated in the liver with acute liver failure (ALF). Here, we analysed the relationship between UII/UTR expression and ALF in lipopolysaccharide (LPS)/D-galactosamine (GalN)-challenged mice. Thereafter, we investigated the effects produced by the inhibition of UII/UTR system using urantide, a special antagonist of UTR, and the potential molecular mechanisms involved in ALF. Urantide was administered to mice treated with LPS/GalN. Expression of UII/UTR, releases of proinflammatory cytokines including tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta) and interferon-gamma (IFN-gamma), and activation of nuclear factor kappa B (NF-kappa B) signaling pathway were assessed in the lethal ALF with or without urantide pretreatment. We found that LPS/GalN-challenged mice showed high mortality and marked hepatic inflammatory infiltration and cell apoptosis as well as a significant increase of UII/UTR expression. Urantide pretreatment protected against the injury in liver following downregulation of UII/UTR expression. A close relationship between the acutely flamed hepatic injury and UII/UTR expression was observed. In addition, urantide prevented the increases of proinflammatory cytokines such as TNF-alpha, IL-1 beta and IFN-gamma, and activation of NF-kappa B signaling pathway induced by LPS/GalN in mice. Thus, we conclude that UII/UTR system plays a role in LPS/GalN-induced ALF. Urantide has a protective effect on the acutely inflamed injury of liver in part through preventing releases of proinflammatory cytokines and activation of NF-kappa B pathway.	[Liang, Dong-yu; Liu, Liang-ming; Ye, Chang-gen; Zhao, Liang; Yu, Fang-ping; Gao, De-yong; Wang, Ying-ying; Yang, Zhi-wen; Wang, Yan-yan] Shanghai Jiao Tong Univ, Peoples Hosp 1, Songjiang Hosp, Dept Hepatol, Shanghai 200030, Peoples R China; [Liu, Liang-ming; Ye, Chang-gen; Gao, De-yong] Shanghai Jiao Tong Univ, Peoples Hosp 1, Songjiang Hosp, Dept Infect, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Liu, LM (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 1, Songjiang Hosp, Dept Hepatol, Shanghai 200030, Peoples R China.	liuliangming@hotmail.com	liang, dy/GZA-4770-2022; 叶, 长根/GPW-6602-2022	叶, 长根/0000-0001-5750-7660	National Natural Science Foundation of China [81070357, 30660066]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by grants from National Natural Science Foundation of China (No. 81070357, No. 30660066) (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balat A, 2012, INT J NEPHROL; Birker-Robaczewska M, 2003, J RECEPT SIG TRANSD, V23, P289, DOI 10.1081/RRS-120026972; Cervantes CF, 2011, J MOL BIOL, V405, P754, DOI 10.1016/j.jmb.2010.10.055; Chai SB, 2010, HEART VESSELS, V25, P138, DOI 10.1007/s00380-009-1178-6; Chen Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044890; Cirillo P, 2008, J THROMB HAEMOST, V6, P726, DOI 10.1111/j.1538-7836.2008.02923.x; Coulouarn Y, 1999, FEBS LETT, V457, P28, DOI 10.1016/S0014-5793(99)01003-0; Coulouarn Y, 1998, P NATL ACAD SCI USA, V95, P15803, DOI 10.1073/pnas.95.26.15803; Deng T, 2012, IMMUNOL CEL IN PRESS; Desai N, 2008, CARDIOL REV, V16, P142, DOI 10.1097/CRD.0b013e31815c8048; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Dong X, 2012, HEART VESSELS; Douglas SA, 2004, TRENDS PHARMACOL SCI, V25, P76, DOI 10.1016/j.tips.2003.12.005; Dyson HJ, 2012, IUBMB LIFE, V64, P499, DOI 10.1002/iub.1044; Fukuda T, 2006, LIFE SCI, V79, P822, DOI 10.1016/j.lfs.2006.03.025; Gruson D, 2010, J CLIN HYPERTENS, V12, P653, DOI 10.1111/j.1751-7176.2010.00336.x; Hadem J, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00340; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Johns DG, 2004, N-S ARCH PHARMACOL, V370, P238, DOI 10.1007/s00210-004-0980-z; Kiss RS, 2011, PEPTIDES, V32, P956, DOI 10.1016/j.peptides.2011.02.016; Kuhla A, 2008, APOPTOSIS, V13, P1427, DOI 10.1007/s10495-008-0269-7; Lee WM, 2012, SEMIN RESP CRIT CARE, V33, P36, DOI 10.1055/s-0032-1301733; Leifeld L, 1999, AM J PATHOL, V154, P1711, DOI 10.1016/S0002-9440(10)65427-2; Leifeld L, 2010, DIGEST DIS SCI, V55, P1458, DOI 10.1007/s10620-009-0875-4; Liu DY, 2004, J BIOL CHEM, V279, P48434, DOI 10.1074/jbc.M407190200; Liu LM, 2010, EUR J CLIN INVEST, V40, P127, DOI 10.1111/j.1365-2362.2009.02235.x; Mignon A, 1999, AM J RESP CRIT CARE, V159, P1308, DOI 10.1164/ajrccm.159.4.9712012; Nakama T, 2001, HEPATOLOGY, V33, P1441, DOI 10.1053/jhep.2001.24561; Ng LL, 2002, CIRCULATION, V106, P2877, DOI 10.1161/01.CIR.0000044388.19119.02; PEARSON D, 1980, P NATL ACAD SCI-BIOL, V77, P5021, DOI 10.1073/pnas.77.8.5021; PORSTMANN T, 1992, J IMMUNOL METHODS, V150, P5, DOI 10.1016/0022-1759(92)90061-W; Ren S, 2013, INT J BIOCHEM CELL B, V45, P335, DOI 10.1016/j.biocel.2012.11.012; Rodrigo R, 2011, HYPERTENS RES, V34, P431, DOI 10.1038/hr.2010.264; Romanelli RG, 2011, DIGEST LIVER DIS, V43, P314, DOI 10.1016/j.dld.2010.08.012; Ross B, 2010, AM J PHYSIOL-REG I, V298, pR1156, DOI 10.1152/ajpregu.00706.2009; Rutherford A, 2012, GASTROENTEROLOGY, V143, P1237, DOI 10.1053/j.gastro.2012.07.113; Segain JP, 2007, J IMMUNOL, V179, P901, DOI 10.4049/jimmunol.179.2.901; Sun DX, 2005, J SURG RES, V129, P114, DOI 10.1016/j.jss.2005.05.028; Trebicka J, 2008, HEPATOLOGY, V47, P1264, DOI 10.1002/hep.22170; van Meurs M, 2012, SHOCK, V37, P392, DOI 10.1097/SHK.0b013e318248225e; Watanabe T, 2009, CURR MED CHEM, V16, P550, DOI 10.2174/092986709787458515; Wu ZG, 2010, LIVER INT, V30, P782, DOI 10.1111/j.1478-3231.2010.02262.x; Zhang JY, 2012, CAN J PHYSIOL PHARM, V90, P637, DOI [10.1139/Y2012-048, 10.1139/y2012-048]; Zimmermann HW, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00056	44	36	43	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64895	10.1371/journal.pone.0064895	http://dx.doi.org/10.1371/journal.pone.0064895			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755157	gold, Green Submitted, Green Published			2022-12-27	WOS:000319872300036
J	Rehman, H; Krishnasamy, Y; Haque, K; Thurman, RG; Lemasters, JJ; Schnellmann, RG; Zhong, Z				Rehman, Hasibur; Krishnasamy, Yasodha; Haque, Khujista; Thurman, Ronald G.; Lemasters, John J.; Schnellmann, Rick G.; Zhong, Zhi			Green Tea Polyphenols Stimulate Mitochondrial Biogenesis and Improve Renal Function after Chronic Cyclosporin A Treatment in Rats	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; SKELETAL-MUSCLE; TRANSCRIPTIONAL COACTIVATOR; PROTEIN-KINASE; RADICAL PRODUCTION; ENERGY-METABOLISM; PGC-1-ALPHA; DYSFUNCTION; EXPRESSION; INJURY	Our previous studies showed that an extract from Camellia sinenesis (green tea), which contains several polyphenols, attenuates nephrotoxicity caused by cyclosporine A (CsA). Since polyphenols are stimulators of mitochondrial biogenesis (MB), this study investigated whether stimulation of MB plays a role in green tea polyphenol protection against CsA renal toxicity. Rats were fed a powdered diet containing green tea polyphenolic extract (0.1%) starting 3 days prior to CsA treatment (25 mg/kg, i.g. daily for 3 weeks). CsA alone decreased renal nuclear DNA-encoded oxidative phosphorylation (OXPHOS) protein ATP synthase-beta (AS-beta) by 42%, mitochondrial DNA (mtDNA)-encoded OXPHOS protein NADH dehydrogenase-3 (ND3) by 87% and their associated mRNAs. Mitochondrial DNA copy number was also decreased by 78% by CsA. Immunohistochemical analysis showed decreased cytochrome c oxidase subunit IV (COX-IV), an OXPHOS protein, in tubular cells. Peroxisome proliferator-activated receptor-gamma coactivator (PGC)-1 alpha, the master regulator of MB, and mitochondrial transcription factor-A (Tfam), the transcription factor that regulates mtDNA replication and transcription, were 42% and 90% lower, respectively, in the kidneys of CsA-treated than in untreated rats. These results indicate suppression of MB by chronic CsA treatment. Green tea polyphenols alone and following CsA increased AS-beta, ND3, COX-IV, mtDNA copy number, PGC-1 alpha mRNA and protein, decreased acetylated PGC-1 alpha, and increased Tfam mRNA and protein. In association with suppressed MB, CsA increased serum creatinine, caused loss of brush border and dilatation of proximal tubules, tubular atrophy, vacuolization, apoptosis, calcification, and increased neutrophil gelatinase-associated lipocalin expression, leukocyte infiltration, and renal fibrosis. Green tea polyphenols markedly attenuated CsA-induced renal injury and improved renal function. Together, these results demonstrate that green tea polyphenols attenuate CsA-induced kidney injury, at least in part, through the stimulation of MB.	[Rehman, Hasibur; Krishnasamy, Yasodha; Haque, Khujista; Lemasters, John J.; Schnellmann, Rick G.; Zhong, Zhi] Med Univ S Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA; [Lemasters, John J.; Schnellmann, Rick G.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Lemasters, John J.; Schnellmann, Rick G.; Zhong, Zhi] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Thurman, Ronald G.; Zhong, Zhi] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [Schnellmann, Rick G.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; University of North Carolina; University of North Carolina Chapel Hill; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Zhong, Z (corresponding author), Med Univ S Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA.	zhong@musc.edu	Rehman, Hasibur/K-5224-2019	Rehman, Hasibur/0000-0003-1551-6520	National Institutes of Health [DK70844, DK37034, GM 084147]; South Carolina COBRE in Oxidants, Redox Balance and Stress Signaling [P20 GM103542]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073336, R56DK037034, R01DK037034, R01DK070844, R37DK037034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103542, R01GM084147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Carolina COBRE in Oxidants, Redox Balance and Stress Signaling; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported, in part, by Grants DK70844, DK37034, and GM 084147 from the National Institutes of Health and South Carolina COBRE in Oxidants, Redox Balance and Stress Signaling [P20 GM103542]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany I, 2010, AM J PHYSIOL-RENAL, V298, pF1214, DOI 10.1152/ajprenal.00639.2009; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; BARROS EJG, 1987, KIDNEY INT, V32, P19, DOI 10.1038/ki.1987.166; Beeson CC, 2010, ANAL BIOCHEM, V404, P75, DOI 10.1016/j.ab.2010.04.040; Bennett M, 2008, CLIN J AM SOC NEPHRO, V3, P665, DOI 10.2215/CJN.04010907; Biswas S, 2012, CURR MED CHEM; Bolignano D, 2009, CLIN J AM SOC NEPHRO, V4, P337, DOI 10.2215/CJN.03530708; Bolignano D, 2009, KIDNEY BLOOD PRESS R, V32, P91, DOI 10.1159/000209379; BOREL JF, 1976, AGENTS ACTIONS, V6, P468, DOI 10.1007/BF01973261; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; COTE J, 1993, SCIENCE, V261, P765, DOI 10.1126/science.7688144; Darvesh AS, 2013, NUTR CANCER, V65, P329, DOI 10.1080/01635581.2013.767367; Devaux F, 2010, FEBS LETT, V584, P4273, DOI 10.1016/j.febslet.2010.09.030; DIEDERICH D, 1994, HYPERTENSION, V23, P957, DOI 10.1161/01.HYP.23.6.957; Duluc L, 2013, INT J BIOCHEM CELL B, V45, P783, DOI 10.1016/j.biocel.2013.01.007; FARTHING MJG, 1981, BIOCHEM PHARMACOL, V30, P3311, DOI 10.1016/0006-2952(81)90604-3; FOURNIER N, 1987, J BIOENERG BIOMEMBR, V19, P297, DOI 10.1007/BF00762419; Frankel EN, 1999, ANTIOXIDANT FOOD SUP, P385, DOI 10.1016/b978-012543590-1/50026-3; Funk JA, 2012, AM J PHYSIOL-RENAL, V302, pF853, DOI 10.1152/ajprenal.00035.2011; Funk JA, 2010, J PHARMACOL EXP THER, V333, P593, DOI 10.1124/jpet.109.161992; Garnier A, 2005, FASEB J, V19, P43, DOI 10.1096/fj.04-2173com; Goldstein SL, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-135; Gundimeda U, 2012, J BIOL CHEM, V287, P34694, DOI 10.1074/jbc.M112.356899; Guo QN, 1996, BBA-LIPID LIPID MET, V1304, P210, DOI 10.1016/S0005-2760(96)00122-1; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; Halloran PF, 1996, CLIN TRANSPLANT, V10, P118; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; HARA Y, 1994, AM BIOTECHNOL LAB, V12, P48; Herrmann JM, 2012, ADV EXP MED BIOL, V748, P41, DOI 10.1007/978-1-4614-3573-0_3; Hugel HM, 2012, MINI-REV MED CHEM, V12, P380; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; JUNG K, 1985, FEBS LETT, V183, P167, DOI 10.1016/0014-5793(85)80977-7; KADA T, 1985, MUTAT RES, V150, P127, DOI 10.1016/0027-5107(85)90109-5; Kishimoto Y, 2013, EUR J CLIN NUTR, V67, P532, DOI 10.1038/ejcn.2013.29; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Lee SH, 2001, PHARMACOL RES, V43, P161, DOI 10.1006/phrs.2000.0759; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lim SW, 2005, TRANSPLANTATION, V80, P691, DOI 10.1097/01.tp.0000173594.69089.a0; Lin AMY, 1998, CHINESE J PHYSIOL, V41, P189; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Liu QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041834; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Marechal X, 2011, CLIN SCI, V121, P405, DOI 10.1042/CS20110069; MARGREITER R, 1983, TRANSPLANTATION, V36, P203, DOI 10.1097/00007890-198308000-00020; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Mitscher LA, 1997, MED RES REV, V17, P327, DOI 10.1002/(SICI)1098-1128(199707)17:4<327::AID-MED2>3.0.CO;2-Y; Miyagawa C, 1997, BIOSCI BIOTECH BIOCH, V61, P1901, DOI 10.1271/bbb.61.1901; Naesens M, 2009, CLIN J AM SOC NEPHRO, V4, P481, DOI 10.2215/CJN.04800908; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Nieman DC, 2009, MED SCI SPORT EXER, V41, P1467, DOI 10.1249/MSS.0b013e318199491f; Niemann CU, 2002, J PHARMACOL EXP THER, V302, P1123, DOI 10.1124/jpet.102.036848; Nogueira L, 2011, J PHYSIOL-LONDON, V589, P4615, DOI 10.1113/jphysiol.2011.209924; Norrbom J, 2004, J APPL PHYSIOL, V96, P189, DOI 10.1152/japplphysiol.00765.2003; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rasbach KA, 2008, J PHARMACOL EXP THER, V325, P536, DOI 10.1124/jpet.107.134882; Rasbach KA, 2007, BIOCHEM BIOPH RES CO, V355, P734, DOI 10.1016/j.bbrc.2007.02.023; Rasbach KA, 2010, J PHARMACOL EXP THER, V332, P632, DOI 10.1124/jpet.109.159947; Recio MC, 2012, CURR MED CHEM, V19, P2088; Rehman H, 2008, J PHARMACOL EXP THER, V327, P699, DOI 10.1124/jpet.108.143578; Reichert AS, 2004, TRENDS GENET, V20, P555, DOI 10.1016/j.tig.2004.08.012; ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Ryder JW, 2003, J BIOL CHEM, V278, P44298, DOI 10.1074/jbc.M304510200; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Scarpulla RC, 2002, GENE, V286, P81, DOI 10.1016/S0378-1119(01)00809-5; Schaeffer PJ, 2004, J BIOL CHEM, V279, P39593, DOI 10.1074/jbc.M403649200; Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490; Serkova N, 2003, TRANSPLANT INT, V16, P748, DOI 10.1007/s00147-003-0631-1; Serkova N, 1996, BBA-MOL CELL RES, V1314, P93, DOI 10.1016/S0167-4889(96)00081-X; Serkova N, 2001, BRIT J PHARMACOL, V133, P875, DOI 10.1038/sj.bjp.0704142; SHEHATA M, 1995, KIDNEY INT, V48, P1487, DOI 10.1038/ki.1995.438; SIBLEY RK, 1983, SURGERY, V94, P225; Taub PR, 2012, CTS-CLIN TRANSL SCI, V5, P43, DOI 10.1111/j.1752-8062.2011.00357.x; Tedesco D, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/230386; TEXTOR SC, 1995, KIDNEY INT, V47, P1426, DOI 10.1038/ki.1995.200; Thurman RG, 1997, TRANSPLANTATION, V63, P1661, DOI 10.1097/00007890-199706150-00021; Vinson JA, 2000, BIOFACTORS, V13, P127, DOI 10.1002/biof.5520130121; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Wenz T, 2009, IUBMB LIFE, V61, P1051, DOI 10.1002/iub.261; Williams D, 2006, ADV CHRONIC KIDNEY D, V13, P47, DOI 10.1053/j.ackd.2005.11.001; Wills LP, 2012, J PHARMACOL EXP THER, V342, P106, DOI 10.1124/jpet.112.191528; Winder WW, 2006, MED SCI SPORT EXER, V38, P1945, DOI 10.1249/01.mss.0000233798.62153.50; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yan J, 2012, J NUTR BIOCHEM, V23, P716, DOI 10.1016/j.jnutbio.2011.03.014; Yoshino M, 1998, ANAL BIOCHEM, V257, P40, DOI 10.1006/abio.1997.2522; Yoshioka N, 1999, CANCER LETT, V136, P79, DOI 10.1016/S0304-3835(98)00313-9; Yun JM, 2010, BRIT J NUTR, V103, P1771, DOI 10.1017/S000711451000005X; Zhong Z, 1999, MOL PHARMACOL, V56, P455, DOI 10.1124/mol.56.3.455; Zhong Z, 2005, GASTROENTEROLOGY, V129, P652, DOI [10.1053/j.gastro.2005.05.060, 10.1016/j.gastro.2005.05.060]; Zhong Z, 2003, AM J PHYSIOL-GASTR L, V285, pG1004, DOI 10.1152/ajpgi.00008.2003; Zhong Z, 2002, AM J PHYSIOL-GASTR L, V283, pG957, DOI 10.1152/ajpgi.00216.2001; Zhong Z, 1998, AM J PHYSIOL-RENAL, V275, pF595, DOI 10.1152/ajprenal.1998.275.4.F595; Zhong Z, 2006, J PHARM PHARMACOL, V58, P1533, DOI 10.1211/jpp.58.11.0015; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	97	34	37	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65029	10.1371/journal.pone.0065029	http://dx.doi.org/10.1371/journal.pone.0065029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755172	Green Published, Green Submitted, gold			2022-12-27	WOS:000319872300044
J	Flajollet, S; Rachez, C; Ploton, M; Schulz, C; Gallais, R; Metivier, R; Pawlak, M; Leray, A; Issulahi, A; Heliot, L; Staels, B; Salbert, G; Lefebvre, P				Flajollet, Sebastien; Rachez, Christophe; Ploton, Maheul; Schulz, Celine; Gallais, Rozenn; Metivier, Raphael; Pawlak, Michal; Leray, Aymeric; Issulahi, Al Amine; Heliot, Laurent; Staels, Bart; Salbert, Gilles; Lefebvre, Philippe			The Elongation Complex Components BRD4 and MLLT3/AF9 Are Transcriptional Coactivators of Nuclear Retinoid Receptors	PLOS ONE			English	Article							BROMODOMAIN PROTEIN BRD4; P-TEFB; ESTROGEN-RECEPTOR; ACTIVATE TRANSCRIPTION; P21-ACTIVATED KINASE; GENE-EXPRESSION; STEM-CELLS; HIV-1 TAT; ACID; INTERACTS	Nuclear all-trans retinoic acid receptors (RARs) initiate early transcriptional events which engage pluripotent cells to differentiate into specific lineages. RAR-controlled transactivation depends mostly on agonist-induced structural transitions in RAR C-terminus (AF-2), thus bridging coactivators or corepressors to chromatin, hence controlling preinitiation complex assembly. However, the contribution of other domains of RAR to its overall transcriptional activity remains poorly defined. A proteomic characterization of nuclear proteins interacting with RAR regions distinct from the AF-2 revealed unsuspected functional properties of the RAR N-terminus. Indeed, mass spectrometry fingerprinting identified the Bromodomain-containing protein 4 (BRD4) and ALL1-fused gene from chromosome 9 (AF9/MLLT3), known to associate with and regulates the activity of Positive Transcription Elongation Factor b (P-TEFb), as novel RAR coactivators. In addition to promoter sequences, RAR binds to genomic, transcribed regions of retinoid-regulated genes, in association with RNA polymerase II and as a function of P-TEFb activity. Knockdown of either AF9 or BRD4 expression affected differentially the neural differentiation of stem cell-like P19 cells. Clusters of retinoid-regulated genes were selectively dependent on BRD4 and/or AF9 expression, which correlated with RAR association to transcribed regions. Thus RAR establishes physical and functional links with components of the elongation complex, enabling the rapid retinoid-induced induction of genes required for neuronal differentiation. Our data thereby extends the previously known RAR interactome from classical transcriptional modulators to components of the elongation machinery, and unravel a functional role of RAR in transcriptional elongation.	[Flajollet, Sebastien; Ploton, Maheul; Pawlak, Michal; Staels, Bart; Lefebvre, Philippe] EGID, FR 3508, Lille, France; [Flajollet, Sebastien; Ploton, Maheul; Pawlak, Michal; Staels, Bart; Lefebvre, Philippe] INSERM, UMR1011, F-59045 Lille, France; [Flajollet, Sebastien; Ploton, Maheul; Pawlak, Michal; Staels, Bart; Lefebvre, Philippe] Univ Lille 2, Lille, France; [Flajollet, Sebastien; Ploton, Maheul; Pawlak, Michal; Staels, Bart; Lefebvre, Philippe] Inst Pasteur, F-59019 Lille, France; [Rachez, Christophe] Inst Pasteur, CNRS, Dept Dev Biol, Unite Regulat Epigenet,URA 2578, Paris, France; [Schulz, Celine; Leray, Aymeric; Issulahi, Al Amine; Heliot, Laurent] Univ Lille 1, CNRS, USR Biophoton Cellulaire Fonct 3078, Interdisciplinary Res Inst, F-59655 Villeneuve Dascq, France; [Gallais, Rozenn; Metivier, Raphael; Salbert, Gilles] Univ Rennes 1, Equipe SPARTE, CNRS, UMR 6026, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Lefebvre, P (corresponding author), EGID, FR 3508, Lille, France.	philippe-claude.lefebvre@inserm.fr	Staels, Bart/N-9497-2016; Pawlak, Michal/ABF-1129-2020; Salbert, Gilles/W-9196-2019; Lefebvre, Philippe/F-2685-2010; Pawlak, Michal/E-2765-2014; Rachez, Christophe/GLR-0102-2022	Staels, Bart/0000-0002-3784-1503; Pawlak, Michal/0000-0001-7679-5493; Salbert, Gilles/0000-0001-6115-4140; Lefebvre, Philippe/0000-0002-9366-5129; PLOTON, Maheul/0000-0002-1569-0070; Rachez, Christophe/0000-0001-8502-4738; Schulz, Celine/0000-0003-3867-1443	La Ligue Nationale contre le Cancer; European Genomic Institute for Diabetes (E.G.I.D.) [ANR-10-LABX-46]; Contrat Plan Etat-Region "Campus Intelligent"; ANR "MULtimodal"	La Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); European Genomic Institute for Diabetes (E.G.I.D.); Contrat Plan Etat-Region "Campus Intelligent"; ANR "MULtimodal"(French National Research Agency (ANR))	This work was funded by grants from La Ligue Nationale contre le Cancer (to PL), from European Genomic Institute for Diabetes (E.G.I.D., ANR-10-LABX-46), Contrat Plan Etat-Region "Campus Intelligent" to LH, and ANR "MULtimodal" to LH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann PM, 2011, CURR MED CHEM, V18, P1405; Bartholomeeusen K, 2012, J BIOL CHEM, V287, P36609, DOI 10.1074/jbc.M112.410746; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Brand Celine, 2002, BMC Pharmacol, V2, P13, DOI 10.1186/1471-2210-2-13; Bres V, 2008, CURR OPIN CELL BIOL, V20, P334, DOI 10.1016/j.ceb.2008.04.008; Briand O, 2012, MOL ENDOCRINOL, V26, P399, DOI 10.1210/me.2011-1317; Chen RC, 2008, GENE DEV, V22, P1356, DOI 10.1101/gad.1636008; De Falco G, 2000, ONCOGENE, V19, P373, DOI 10.1038/sj.onc.1203305; Depoix C, 2001, J BIOL CHEM, V276, P9452, DOI 10.1074/jbc.M008004200; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Flajollet S, 2006, J BIOL CHEM, V281, P20338, DOI 10.1074/jbc.M603023200; Glover-Cutter K, 2009, MOL CELL BIOL, V29, P5455, DOI 10.1128/MCB.00637-09; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; Iankova I, 2006, MOL ENDOCRINOL, V20, P1494, DOI 10.1210/me.2005-0222; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Keriel A, 2002, CELL, V109, P125, DOI 10.1016/S0092-8674(02)00692-X; Le May N, 2010, MOL CELL, V38, P54, DOI 10.1016/j.molcel.2010.03.004; Lee DK, 2001, J BIOL CHEM, V276, P9978, DOI 10.1074/jbc.M002285200; Lee SR, 2002, MOL ENDOCRINOL, V16, P85, DOI 10.1210/me.16.1.85; Lefebvre B, 2002, EMBO REP, V3, P335, DOI 10.1093/embo-reports/kvf066; Lefebvre B, 2006, MOL ENDOCRINOL, V20, P2109, DOI 10.1210/me.2005-0321; Lefebvre B, 2010, J CLIN INVEST, V120, P1454, DOI 10.1172/JCI38606; Lefebvre P, 1998, J BIOL CHEM, V273, P12288, DOI 10.1074/jbc.273.20.12288; Leray A, 2009, MICROSC RES TECHNIQ, V72, P371, DOI 10.1002/jemt.20665; Lin CQ, 2011, GENE DEV, V25, P1486, DOI 10.1101/gad.2059211; Luo ZJ, 2012, MOL CELL BIOL, V32, P2608, DOI 10.1128/MCB.00182-12; Mahony S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r2; Martin PJ, 2005, NUCLEIC ACIDS RES, V33, P4311, DOI 10.1093/nar/gki745; Mendoza-Parra MA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.73; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; NAGPAL S, 1993, EMBO J, V12, P2349, DOI 10.1002/j.1460-2075.1993.tb05889.x; Ottinger M, 2006, J VIROL, V80, P10772, DOI 10.1128/JVI.00804-06; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Rachez C, 1998, GENE DEV, V12, P1787, DOI 10.1101/gad.12.12.1787; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; RochetteEgly C, 1997, CELL, V90, P97, DOI 10.1016/S0092-8674(00)80317-7; Ross-Innes CS, 2010, GENE DEV, V24, P171, DOI 10.1101/gad.552910; Sacchetti P, 2006, NUCLEIC ACIDS RES, V34, P5515, DOI 10.1093/nar/gkl712; Samarut E, 2012, MOL CELL ENDOCRINOL, V348, P348, DOI 10.1016/j.mce.2011.03.025; SCHOORLEMMER J, 1994, MOL CELL BIOL, V14, P1122, DOI 10.1128/MCB.14.2.1122; Slany RK, 2009, HAEMATOL-HEMATOL J, V94, P984, DOI 10.3324/haematol.2008.002436; Smith E, 2011, GENE DEV, V25, P661, DOI 10.1101/gad.2015411; Sobhian B, 2010, MOL CELL, V38, P439, DOI 10.1016/j.molcel.2010.04.012; Soprano DR, 2007, VITAM HORM, V75, P69, DOI 10.1016/S0083-6729(06)75003-8; Wittmann BM, 2005, ONCOGENE, V24, P5576, DOI 10.1038/sj.onc.1208728; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Yang F, 2001, J BIOL CHEM, V276, P15345, DOI 10.1074/jbc.M010311200; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Zhou MS, 2009, J VIROL, V83, P1036, DOI 10.1128/JVI.01316-08; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	53	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e64880	10.1371/journal.pone.0064880	http://dx.doi.org/10.1371/journal.pone.0064880			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762261	Green Published, gold, Green Submitted			2022-12-27	WOS:000320440500008
J	Stauffert, M; Cravo-Laureau, C; Jezequel, R; Barantal, S; Cuny, P; Gilbert, F; Cagnon, C; Militon, C; Amouroux, D; Mahdaoui, F; Bouyssiere, B; Stora, G; Merlin, FX; Duran, R				Stauffert, Magalie; Cravo-Laureau, Cristiana; Jezequel, Ronan; Barantal, Sandra; Cuny, Philippe; Gilbert, Franck; Cagnon, Christine; Militon, Cecile; Amouroux, David; Mahdaoui, Fatima; Bouyssiere, Brice; Stora, Georges; Merlin, Francois-Xavier; Duran, Robert			Impact of Oil on Bacterial Community Structure in Bioturbated Sediments	PLOS ONE			English	Article							POLYCHAETE NEREIS-DIVERSICOLOR; POLYCYCLIC AROMATIC-HYDROCARBONS; 16S RIBOSOMAL-RNA; MARINE-SEDIMENTS; PETROLEUM-HYDROCARBONS; MICROBIAL-DEGRADATION; DEGRADING BACTERIA; OXIDIZING BACTERIA; BENTHIC METABOLISM; SEQUENCE ALIGNMENT	Oil spills threaten coastlines where biological processes supply essential ecosystem services. Therefore, it is crucial to understand how oil influences the microbial communities in sediments that play key roles in ecosystem functioning. Ecosystems such as sediments are characterized by intensive bioturbation due to burrowing macrofauna that may modify the microbial metabolisms. It is thus essential to consider the bioturbation when determining the impact of oil on microbial communities. In this study, an experimental laboratory device maintaining pristine collected mudflat sediments in microcosms closer to true environmental conditions - with tidal cycles and natural seawater - was used to simulate an oil spill under bioturbation conditions. Different conditions were applied to the microcosms including an addition of: standardized oil (Blend Arabian Light crude oil, 25.6 mg.g(-1) wet sediment), the common burrowing organism Hediste (Nereis) diversicolor and both the oil and H. diversicolor. The addition of H. diversicolor and its associated bioturbation did not affect the removal of petroleum hydrocarbons. After 270 days, 60% of hydrocarbons had been removed in all microcosms irrespective of the H. diversicolor addition. However, 16S-rRNA gene and 16S-cDNA T-RFLP and RT-PCR-amplicon libraries analysis showed an effect of the condition on the bacterial community structure, composition, and dynamics, supported by PerMANOVA analysis. The 16S-cDNA libraries from microcosms where H. diversicolor was added (oiled and un-oiled) showed a marked dominance of sequences related to Gammaproteobacteria. However, in the oiled-library sequences associated to Deltaproteobacteria and Bacteroidetes were also highly represented. The 16S-cDNA libraries from oiled-microcosms (with and without H. diversicolor addition) revealed two distinct microbial communities characterized by different phylotypes associated to known hydrocarbonoclastic bacteria and dominated by Gammaproteobacteria and Deltaproteobacteria. In the oiled-microcosms, the addition of H. diversicolor reduced the phylotype-richness, sequences associated to Actinobacteria, Firmicutes and Plantomycetes were not detected. These observations highlight the influence of the bioturbation on the bacterial community structure without affecting the biodegradation capacities.	[Stauffert, Magalie; Cravo-Laureau, Cristiana; Barantal, Sandra; Cagnon, Christine; Duran, Robert] Univ Pau & Pays Adour, Inst Pluridisciplinaire Rech Environm & Mat, Equipe Environm & Microbiol, Pau, France; [Jezequel, Ronan; Merlin, Francois-Xavier] Ctr Documentat Rech & Experimentat Pollut Acciden, Brest, France; [Cuny, Philippe; Militon, Cecile; Stora, Georges] Aix Marseille Univ, Mediterranean Inst Oceanog, Equipe Microbiol Environm & Biotechnol, Marseille, France; [Gilbert, Franck] Univ Toulouse, Lab Ecol Fonct & Environm, Toulouse, France; [Amouroux, David; Mahdaoui, Fatima; Bouyssiere, Brice] Univ Pau & Pays Adour, Inst Pluridisciplinaire Rech Environm & Mat, Equipe Chim Analyt Bioinorgan & Environm, Pau, France	Universite de Pau et des Pays de l'Adour; UDICE-French Research Universities; Aix-Marseille Universite; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite de Pau et des Pays de l'Adour	Duran, R (corresponding author), Univ Pau & Pays Adour, Inst Pluridisciplinaire Rech Environm & Mat, Equipe Environm & Microbiol, Pau, France.	robert.duran@univ-pau.fr	militon, cecile/G-1027-2017; Gilbert, Franck/G-3294-2010; Cagnon, Christine/B-8874-2013; Duran, Robert/F-1521-2011	militon, cecile/0000-0002-5230-1732; Gilbert, Franck/0000-0002-2989-3776; Cagnon, Christine/0000-0003-0622-8754; Duran, Robert/0000-0002-2351-8553; Amouroux, David/0000-0002-0056-8590; BOUYSSIERE, Brice/0000-0001-5878-6067	French program ANR DHYVA [ANR-06-SEST-09]	French program ANR DHYVA(French National Research Agency (ANR))	This work was supported by the French program ANR DHYVA (project ANR-06-SEST-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Gonzalez A, 2013, ENVIRON MICROBIOL, V15, P77, DOI 10.1111/j.1462-2920.2012.02782.x; ALLER RC, 1994, CHEM GEOL, V114, P331, DOI 10.1016/0009-2541(94)90062-0; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alzaga R, 2004, J CHROMATOGR A, V1025, P133, DOI 10.1016/j.chroma.2003.10.080; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; ATLAS RM, 1972, CAN J MICROBIOL, V18, P1851, DOI 10.1139/m72-289; Banta GT, 2003, VIE MILIEU, V53, P233; Beazley MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041305; Berthe-Corti L, 2005, PALAEOGEOGR PALAEOCL, V219, P171, DOI 10.1016/j.palaeo.2004.10.020; Bertics VJ, 2010, ENVIRON MICROBIOL, V12, P3022, DOI 10.1111/j.1462-2920.2010.02279.x; Bertics VJ, 2009, ISME J, V3, P1269, DOI 10.1038/ismej.2009.62; Cheong CJ, 2001, WATER SCI TECHNOL, V43, P171, DOI 10.2166/wst.2001.0087; Christensen M, 2002, MAR ECOL PROG SER, V237, P159, DOI 10.3354/meps237159; Chung IY, 2004, MAR POLLUT BULL, V49, P959, DOI 10.1016/j.marpolbul.2004.06.021; Coates JD, 1997, APPL ENVIRON MICROB, V63, P3589, DOI 10.1128/AEM.63.9.3589-3593.1997; Cuny P, 2007, MAR POLLUT BULL, V54, P452, DOI 10.1016/j.marpolbul.2006.12.008; Dunbar J, 2001, APPL ENVIRON MICROB, V67, P190, DOI 10.1128/AEM.67.1.190-197.2001; Duport E, 2006, J EXP MAR BIOL ECOL, V336, P33, DOI 10.1016/j.jembe.2006.04.005; Fenchel T, 1996, MAR BIOL, V127, P289, DOI 10.1007/BF00942114; GILBERT F, 1994, CHEMOSPHERE, V29, P1, DOI 10.1016/0045-6535(94)90084-1; Gilbert F, 1996, CHEMOSPHERE, V33, P1449, DOI 10.1016/0045-6535(96)00283-4; Gilbert F, 2007, J EXP MAR BIOL ECOL, V348, P133, DOI 10.1016/j.jembe.2007.04.015; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Greenwood PF, 2009, ORG GEOCHEM, V40, P293, DOI 10.1016/j.orggeochem.2008.12.009; Gribsholt B, 2003, LIMNOL OCEANOGR, V48, P2151, DOI 10.4319/lo.2003.48.6.2151; Grossi V, 2002, CHEMOSPHERE, V48, P947, DOI 10.1016/S0045-6535(02)00122-4; Grossi V, 2008, ORG GEOCHEM, V39, P1197, DOI 10.1016/j.orggeochem.2008.02.010; Hansen K, 1998, J EXP MAR BIOL ECOL, V231, P201, DOI 10.1016/S0022-0981(98)00070-7; Hansen K, 1996, AQUAT MICROB ECOL, V10, P181, DOI 10.3354/ame010181; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Head IM, 2006, NAT REV MICROBIOL, V4, P173, DOI 10.1038/nrmicro1348; Holmer M, 1997, MAR BIOL, V128, P679, DOI 10.1007/s002270050135; Kleikemper J, 2002, APPL ENVIRON MICROB, V68, P1516, DOI 10.1128/AEM.68.4.1516-1523.2002; Kostka JE, 2011, APPL ENVIRON MICROB, V77, P7962, DOI 10.1128/AEM.05402-11; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Laverock B, 2010, ISME J; LEAHY JG, 1990, MICROBIOL REV, V54, P305, DOI 10.1128/MMBR.54.3.305-315.1990; Lohrer AM, 2004, NATURE, V431, P1092, DOI 10.1038/nature03042; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; Mayer LM, 1997, J MAR RES, V55, P785, DOI 10.1357/0022240973224247; Mayer LM, 1996, ENVIRON SCI TECHNOL, V30, P2641, DOI 10.1021/es960110z; MCKENNA EJ, 1971, P NATL ACAD SCI USA, V68, P1552, DOI 10.1073/pnas.68.7.1552; Mermillod-Blondin F, 2004, AQUAT MICROB ECOL, V36, P271, DOI 10.3354/ame036271; Mills HJ, 2004, APPL ENVIRON MICROB, V70, P5447, DOI 10.1128/AEM.70.9.5447-5458.2004; Miralles G, 2007, MICROB ECOL, V54, P646, DOI 10.1007/s00248-007-9221-6; Naslund J, 2010, ISME J, V4, P1421, DOI 10.1038/ismej.2010.63; Oksanen J., 2016, R PACKAG; Paisse S, 2008, FEMS MICROBIOL ECOL, V66, P295, DOI 10.1111/j.1574-6941.2008.00589.x; Pinheiro J, 2007, NLME LINEAR NONLINEA, V31, P339; Quintana CO, 2007, J EXP MAR BIOL ECOL, V352, P392, DOI 10.1016/j.jembe.2007.08.015; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rothermich MM, 2002, ENVIRON SCI TECHNOL, V36, P4811, DOI 10.1021/es0200241; Sasaki T, 1998, ENVIRON SCI TECHNOL, V32, P3618, DOI 10.1021/es980287o; Satoh H, 2007, APPL ENVIRON MICROB, V73, P1341, DOI 10.1128/AEM.02073-06; Sauret C, 2012, MAR ENVIRON RES, V79, P70, DOI 10.1016/j.marenvres.2012.05.006; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Shao MF, 2010, APPL MICROBIOL BIOT, V88, P1027, DOI 10.1007/s00253-010-2847-1; SIMBERLOFF D, 1972, AM NAT, V106, P414, DOI 10.1086/282781; Sorokin DY, 2007, ARCH MICROBIOL, V187, P441, DOI 10.1007/s00203-006-0208-3; Sorokin DY, 2001, INT J SYST EVOL MICR, V51, P565, DOI 10.1099/00207713-51-2-565; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wada M., 2005, MICROBES ENVIRON, V20, P191, DOI DOI 10.1264/JSME2.20.191; Warnes GR, 2011, GPLOTS VARIOUS R PRO; Wright AL, 1997, WATER AIR SOIL POLL, V95, P179, DOI 10.1023/A:1026408107505; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Yakimov MM, 2005, ENVIRON MICROBIOL, V7, P1426, DOI 10.1111/j.1462-5822.2005.00829.x; Yoshida A, 2006, MAR POLLUT BULL, V52, P89, DOI 10.1016/j.marpolbul.2005.08.015	68	49	50	0	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65347	10.1371/journal.pone.0065347	http://dx.doi.org/10.1371/journal.pone.0065347			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762350	Green Submitted, Green Published, gold			2022-12-27	WOS:000320440500032
J	Jonas, A; Gweshe, J; Siboleka, M; DeKlerk, M; Gawanab, M; Badi, A; Sumbi, V; Pereko, D; Blom, A; Mwinga, S; Jordan, MR; Jerger, L; Lau, K; Hong, SY				Jonas, Anna; Gweshe, Justice; Siboleka, Milner; DeKlerk, Michael; Gawanab, Michael; Badi, Alfons; Sumbi, Victor; Pereko, Dawn; Blom, Abraham; Mwinga, Samson; Jordan, Michael R.; Jerger, Logan; Lau, Kiger; Hong, Steven Y.			HIV Drug Resistance Early Warning Indicators in Namibia for Public Health Action	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; COUNTRIES; PREVENTION	Background: HIV drug resistance (HIVDR) testing is not routinely available in many resource-limited settings, therefore antiretroviral therapy (ART) program and site factors known to be associated with emergence of HIVDR should be monitored to optimize the quality of patient care and minimize the emergence of preventable HIVDR. Methods: In 2010, Namibia selected five World Health Organization Early Warning Indicators (EWIs) and scaled-up monitoring from 9 to 33 ART sites: ART prescribing practices, Patients lost to follow-up (LTFU) at 12 months, Patients switched to a second-line regimen at 12 months, On-time antiretroviral (ARV) drug pick-up, and ARV drug-supply continuity. Results: Records allowed reporting on three of the five selected EWIs. 22 of 33 (67%) sites met the target of 100% initiated on appropriate first-line regimens. 17 of 33 (52%) sites met the target of <= 20% LTFU. 15 of 33 (45%) sites met the target of 0% switched to a second-line regimen. Conclusions: EWI monitoring directly resulted in public health action which will optimize the quality of care, specifically the strengthening of ART record systems, engagement of ART sites, and operational research for improved adherence assessment and ART patient defaulter tracing.	[Jonas, Anna; Gweshe, Justice; Siboleka, Milner; DeKlerk, Michael; Gawanab, Michael; Badi, Alfons; Blom, Abraham] Republ Namibia Minist Hlth & Social Serv, Directorate Special Programmes, Windhoek, Namibia; [Sumbi, Victor; Mwinga, Samson] Management Sci Hlth, Windhoek, Namibia; [Pereko, Dawn] Abt Associate Inc, Strengthening Hlth Outcomes Private Sect, Windhoek, Namibia; [Jordan, Michael R.; Jerger, Logan; Lau, Kiger; Hong, Steven Y.] Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA; [Jordan, Michael R.; Hong, Steven Y.] Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA USA	ABT Associates; Massachusetts Department of Public Health; Tufts University; Tufts Medical Center	Hong, SY (corresponding author), Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA.	shong@tuftsmedicalcenter.org			Republic of Namibia Ministry of Health and Social Services; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI097010] Funding Source: NIH RePORTER	Republic of Namibia Ministry of Health and Social Services; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funding from the Republic of Namibia Ministry of Health and Social Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, WORLD FACTB; Bennett DE, 2008, ANTIVIR THER, V13, P25; Bennett DE, 2008, ANTIVIR THER, V13, P1; Bennett DE, 2012, CLIN INFECT DIS, V54, pS280, DOI 10.1093/cid/cis207; Billong SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036777; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Daoni E, 2012, CLIN INFECT DIS, V54, pS303, DOI 10.1093/cid/cir994; Dzangare J, 2012, CLIN INFECT DIS, V54, pS313, DOI 10.1093/cid/cir1014; Eholie SP, 2007, JAIDS-J ACQ IMM DEF, V45, P355; Hong SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056307; Hong SY, 2010, JAIDS-J ACQ IMM DEF, V55, pE27, DOI 10.1097/QAI.0b013e3181f5376d; Jordan MR, 2008, ANTIVIR THER, V13, P15; Jordan MR, 2011, CLIN INFECT DIS, V52, P1058, DOI 10.1093/cid/cir093; Ma Y, 2012, CLIN INFECT DIS, V54, pS300, DOI 10.1093/cid/cir1018; Marcellin F, 2008, TROP MED INT HEALTH, V13, P1470, DOI 10.1111/j.1365-3156.2008.02170.x; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Parienti JJ, 2004, CLIN INFECT DIS, V38, P1311, DOI 10.1086/383572; Republic of Namibia Ministry of Health and Social Services, 2012, REP 2012 NAT HIV SEN; Republic of Namibia Ministry of Health and Social Services Directorate of Special Programmes, 2010, NAT GUID ANT THER; Sigaloff KCE, 2012, CLIN INFECT DIS, V54, pS294, DOI 10.1093/cid/cir1015; Tuller DM, 2010, AIDS BEHAV, V14, P778, DOI 10.1007/s10461-009-9533-2; UNAIDS, 2012, TOG WE WILL END AIDS; van Oosterhout JJ, 2005, TROP MED INT HEALTH, V10, P464, DOI 10.1111/j.1365-3156.2005.01409.x; Vergne L, 2002, J ACQ IMMUN DEF SYND, V29, P165, DOI 10.1097/00042560-200202010-00009; WHO, 2012, ASS WHO HIV DRUG RES; WHO UNAIDS, 2011, UN ACC SCAL PRIOR HI; World Health Organization, 2010, WHO IND MON HIV DRUG	27	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65653	10.1371/journal.pone.0065653	http://dx.doi.org/10.1371/journal.pone.0065653			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762406	Green Published, gold, Green Submitted			2022-12-27	WOS:000321094800068
J	Ding, GY; Zhang, Y; Gao, L; Ma, W; Li, XJ; Liu, J; Liu, QY; Jiang, BF				Ding, Guoyong; Zhang, Ying; Gao, Lu; Ma, Wei; Li, Xiujun; Liu, Jing; Liu, Qiyong; Jiang, Baofa			Quantitative Analysis of Burden of Infectious Diarrhea Associated with Floods in Northwest of Anhui Province, China: A Mixed Method Evaluation	PLOS ONE			English	Article							CASE-CROSSOVER ANALYSES; HEALTH IMPACTS; REFERENT SELECTION; BANGLADESH; EPIDEMICS; ILLNESS; DHAKA; RISK	Background: Persistent and heavy rainfall in the upper and middle Huaihe River of China brought about severe floods during the end of June and July 2007. However, there has been no assessment on the association between the floods and infectious diarrhea. This study aimed to quantify the impact of the floods in 2007 on the burden of disease due to infectious diarrhea in northwest of Anhui Province. Methods: A time-stratified case-crossover analysis was firstly conducted to examine the relationship between daily cases of infectious diarrhea and the 2007 floods in Fuyang and Bozhou of Anhui Province. Odds ratios (ORs) of the flood risk were quantified by conditional logistic regression. The years lived with disability (YLDs) of infectious diarrhea attributable to floods were then estimated based on the WHO framework of the calculating potential impact fraction in the Burden of Disease study. Results: A total of 197 infectious diarrheas were notified during the exposure and control periods in the two study areas. The strongest effect was shown with a 2-day lag in Fuyang and a 5-day lag in Bozhou. Multivariable analysis showed that floods were significantly associated with an increased risk of the number cases of infectious diarrhea (OR = 3.175, 95% CI: 1.126-8.954 in Fuyang; OR = 6.754, 95% CI: 1.954-23.344 in Bozhou). Attributable YLD per 1000 of infectious diarrhea resulting from the floods was 0.0081 in Fuyang and 0.0209 in Bozhou. Conclusions: Our findings confirm that floods have significantly increased the risks of infectious diarrhea in the study areas. In addition, prolonged moderate flood may cause more burdens of infectious diarrheas than severe flood with a shorter duration. More attention should be paid to particular vulnerable groups, including younger children and elderly, in developing public health preparation and intervention programs. Findings have significant implications for developing strategies to prevent and reduce health impact of floods.	[Ding, Guoyong; Gao, Lu; Ma, Wei; Li, Xiujun; Liu, Jing; Jiang, Baofa] Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Jinan 250100, Shandong, Peoples R China; [Zhang, Ying] Univ Sydney, Sch Publ Hlth, China Studies Ctr, Sydney, NSW 2006, Australia; [Liu, Qiyong] China CDC, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China	Shandong University; University of Sydney; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Jiang, BF (corresponding author), Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Jinan 250100, Shandong, Peoples R China.	bjiang@sdu.edu.cn	Ma, Wei/L-2374-2019; Zhang, Ying/ABE-2275-2021; Ma, Wei/C-4748-2019	Ma, Wei/0000-0002-8092-3280; Zhang, Ying/0000-0001-6214-2440; Ma, Wei/0000-0002-8092-3280	National Basic Research Program of China (973 Program) [2012CB955500-955502]; Australian National Health and Medical Research Council Public Health Training Fellowship [627049]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Australian National Health and Medical Research Council Public Health Training Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the National Basic Research Program of China (973 Program) (Grant NO. 2012CB955500-955502). Ying Zhang received the Australian National Health and Medical Research Council Public Health Training Fellowship (627049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaya SW, 2009, GLOBAL HEALTH ACTION, V2, DOI 10.3402/gha.v2i0.2019; Ahern M, 2005, EPIDEMIOL REV, V27, P36, DOI 10.1093/epirev/mxi004; Alderman K, 2012, ENVIRON INT, V47, P37, DOI 10.1016/j.envint.2012.06.003; [Anonymous], YB METEROROLOGICAL D; [Anonymous], 2001, NATL BURDEN DIS STUD; [Anonymous], 2011, ANN DISASTER STAT RE; Borchardt MA, 2003, APPL ENVIRON MICROB, V69, P1172, DOI 10.1128/AEM.69.2.1172-1180.2003; Campbell-Lendrum D., 2007, Climate change: quantifying the health impact at national and local levels; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P369; Curriero FC, 2001, AM J PUBLIC HEALTH, V91, P1194, DOI 10.2105/AJPH.91.8.1194; Du WW, 2010, PREHOSP DISASTER MED, V25, P265, DOI 10.1017/S1049023X00008141; E JP, 2008, B FLOOD DROUGHT DISA; Fewtrell L, 2008, PUBLIC HEALTH, V122, P446, DOI 10.1016/j.puhe.2007.09.010; Harris AM, 2008, AM J TROP MED HYG, V79, P708, DOI 10.4269/ajtmh.2008.79.708; Hashizume M, 2007, INT J EPIDEMIOL, V36, P1030, DOI 10.1093/ije/dym148; Janes H, 2005, STAT MED, V24, P285, DOI 10.1002/sim.1889; Janes H, 2005, EPIDEMIOLOGY, V16, P717, DOI 10.1097/01.ede.0000181315.18836.9d; Kunii O, 2002, PUBLIC HEALTH, V116, P68, DOI [10.1016/S0033-3506(02)00506-1, 10.1038/sj.ph.1900828]; Last JM., 2001, DICT EPIDEMIOLOGY, V4th; Levy D, 2001, EPIDEMIOLOGY, V12, P186, DOI 10.1097/00001648-200103000-00010; Li XL, 2007, T ROY SOC TROP MED H, V101, P299, DOI 10.1016/j.trstmh.2006.05.011; Milojevic A, 2012, EPIDEMIOLOGY, V23, P107, DOI 10.1097/EDE.0b013e31823ac606; Pruss-Ustun A, 2003, ENV BURDEN DIS SERIE, V1; Reacher M, 2004, COMMUN DIS PUBLIC HL, V7, P717; Reynolds KA, 2008, REV ENVIRON CONTAM T, V192, P117, DOI 10.1007/978-0-387-71724-1_4; Schnitzler J, 2007, J PUBLIC HEALTH MAN, V13, P461; Schwartz BS, 2006, AM J TROP MED HYG, V74, P1067, DOI 10.4269/ajtmh.2006.74.1067; SHEARS P, 1988, LANCET, V2, P517, DOI 10.1016/S0140-6736(88)90173-0; SIDDIQUE AK, 1991, J DIARRHOEAL DIS RES, V9, P310; Su C.-L, 2006, BETABUSTER; Sur D, 2000, INDIAN J MED RES, V112, P178; Viera AJ, 2008, SOUTH MED J, V101, P730, DOI 10.1097/SMJ.0b013e31817a7ee4; Wade TJ, 2004, AM J EPIDEMIOL, V159, P398, DOI 10.1093/aje/kwh050; Wang JN, 2008, STAT YB ANHUI PROVIN; Waring S, 2005, INT J HYG ENVIR HEAL, V208, P109, DOI 10.1016/j.ijheh.2005.01.020; *WHO, 2004, CHANG HIST; Zhang Y, 2007, J INFECTION, V55, P194, DOI 10.1016/j.jinf.2006.12.002; Zhao ZL, 2007, ANHUI J PREV MED, V13, P15	38	57	61	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65112	10.1371/journal.pone.0065112	http://dx.doi.org/10.1371/journal.pone.0065112			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762291	gold, Green Published, Green Submitted			2022-12-27	WOS:000321099000032
J	Hanrahan, CF; Selibas, K; Deery, CB; Dansey, H; Clouse, K; Bassett, J; Scott, L; Stevens, W; Sanne, I; Van Rie, A				Hanrahan, Colleen F.; Selibas, Katerina; Deery, Christopher B.; Dansey, Heather; Clouse, Kate; Bassett, Jean; Scott, Lesley; Stevens, Wendy; Sanne, Ian; Van Rie, Annelies			Time to Treatment and Patient Outcomes among TB Suspects Screened by a Single Point-of-Care Xpert MTB/RIF at a Primary Care Clinic in Johannesburg, South Africa	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; ANTIRETROVIRAL THERAPY; ASSAY; DIAGNOSIS; RESISTANCE; ACCURACY; COST	Introduction: In December 2010, the World Health Organization recommended a single Xpert MTB/RIF assay as the initial diagnostic in people suspected of HIV-associated or drug resistant tuberculosis. Few data are available on the impact of this recommendation on patient outcomes. We describe the diagnostic follow-up, clinical characteristics and outcomes of a cohort of tuberculosis suspects screened using a single point-of-care Xpert. Methods: Consecutive tuberculosis suspects at a primary care clinic in Johannesburg, South Africa were assessed for tuberculosis using point-of-care Xpert. Sputum smear microscopy and liquid culture were performed as reference standards. Xpert-negatives were evaluated clinically, and further assessed at the discretion of clinicians. Participants were followed for six months. Results: From July-September 2011, 641 tuberculosis suspects were enrolled, of whom 69% were HIV-infected. Eight percent were positive by a single Xpert. Among 116 individuals diagnosed with TB, 66 (57%) were Xpert negative, of which 44 (67%) were empirical or radiological diagnoses and 22 (33%) were Xpert negative/culture-positive. The median time to tuberculosis treatment was 0 days (IQR:0-0) for Xpert positives, 14 days ( IQR: 5-35) for those diagnosed empirically, 14 days ( IQR: 7-29) for radiological diagnoses, and 144 days ( IQR: 28-180) for culture positives. Xpert negative tuberculosis cases were clinically similar to Xpert positives, including HIV status and CD4 count, and had similar treatment outcomes including mortality and time to antiretroviral treatment initiation. Conclusions: In a high HIV-burden setting, a single Xpert identified less than half of those started on tuberculosis treatment, highlighting the complexity of TB diagnosis even in the Xpert era. Xpert at point-of-care resulted in same day treatment initiation in Xpert-positives, but had no impact on tuberculosis treatment outcomes or mortality.	[Hanrahan, Colleen F.; Clouse, Kate; Van Rie, Annelies] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Selibas, Katerina; Deery, Christopher B.; Clouse, Kate; Sanne, Ian] Univ Witwatersrand, Dept Med, Clin HIV Res Unit, ZA-2001 Johannesburg, South Africa; [Dansey, Heather; Bassett, Jean] Witkoppen Hlth & Welf Ctr, Johannesburg, South Africa; [Scott, Lesley; Stevens, Wendy] Univ Witwatersrand, Dept Mol Med & Hematol, Johannesburg, South Africa; [Stevens, Wendy] Natl Hlth Lab Serv, Johannesburg, South Africa	University of North Carolina; University of North Carolina Chapel Hill; University of Witwatersrand; University of Witwatersrand; National Health Laboratory Service	Hanrahan, CF (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA.	colleen_hanrahan@unc.edu	Sanne, Ian/ABH-2231-2020; Van Rie, Annelies/C-2082-2017; Trajman, Anete/C-7679-2016	Van Rie, Annelies/0000-0001-7666-3263; Trajman, Anete/0000-0002-4000-4984; Clouse, Kate/0000-0002-0190-7398; Hanrahan, Colleen/0000-0002-4544-4591; Scott, Lesley/0000-0001-6573-9525	PEPFAR; National Institutes of Health [UM1 AI069463]; United States Agency for International Development in a grant to Right to Care [674-A-00-08-00007]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069463] Funding Source: NIH RePORTER	PEPFAR; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Agency for International Development in a grant to Right to Care(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by PEPFAR and National Institutes of Health grant UM1 AI069463, United States Agency for International Development in a grant to Right to Care 674-A-00-08-00007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GLOB TUB CONTR; Banada PP, 2010, J CLIN MICROBIOL, V48, P3551, DOI 10.1128/JCM.01053-10; Blakemore R, 2011, AM J RESP CRIT CARE, V184, P1076, DOI 10.1164/rccm.201103-0536OC; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Chang K, 2012, J INFECTION, V64, P580, DOI 10.1016/j.jinf.2012.02.012; Clouse K, 2012, SAMJ S AFR MED J, V102, P805, DOI [10.7196/SAMJ.5851, 10.7196/samj.5851]; Harries AD, 1997, PHARMACOL THERAPEUT, V73, P1, DOI 10.1016/S0163-7258(96)00115-5; Kufa T, 2012, JAIDS-J ACQ IMM DEF, V60, pE22, DOI 10.1097/QAI.0b013e318251ae0b; Lawn SD, 2012, INT J TUBERC LUNG D, V16, P701, DOI 10.5588/ijtld.12.0131; Lawn SD, 2012, CLIN INFECT DIS, V54, P1071, DOI 10.1093/cid/cir1039; Lawn SD, 2012, LANCET INFECT DIS, V12, P201, DOI 10.1016/S1473-3099(11)70251-1; Meyer-Rath G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036966; Schnippel K, 2012, TROP MED INT HEALTH, V17, P1142, DOI 10.1111/j.1365-3156.2012.03028.x; Scott LE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001061; Straetemans M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020755; Theron G, 2012, EUR RESPIR J, V40, P161, DOI 10.1183/09031936.00145511; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; WHO, 2011, POL STAT AUT REAL TI; Yoon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048599; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	20	69	69	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65421	10.1371/journal.pone.0065421	http://dx.doi.org/10.1371/journal.pone.0065421			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762367	Green Submitted, gold, Green Published			2022-12-27	WOS:000321099000065
J	Knapp, B; Dorffner, G; Schreiner, W				Knapp, Bernhard; Dorffner, Georg; Schreiner, Wolfgang			Early Relaxation Dynamics in the LC 13 T Cell Receptor in Reaction to 172 Altered Peptide Ligands: A Molecular Dynamics Simulation Study	PLOS ONE			English	Article							CONFORMATIONAL-CHANGES; ANTIGEN RECOGNITION; BINDING-AFFINITY; STRUCTURAL BASIS; COMPLEX; PROTEIN; TCR; PREDICTION; MODEL; FLEXIBILITY	The interaction between the T cell receptor and the major histocompatibility complex is one of the most important events in adaptive immunology. Although several different models for the activation process of the T cell via the T cell receptor have been proposed, it could not be shown that a structural mechanism, which discriminates between peptides of different immunogenicity levels, exists within the T cell receptor. In this study, we performed systematic molecular dynamics simulations of 172 closely related altered peptide ligands in the same T cell receptor/major histocompatibility complex system. Statistical evaluations yielded significant differences in the initial relaxation process between sets of peptides at four different immunogenicity levels.	[Knapp, Bernhard; Schreiner, Wolfgang] Med Univ Vienna, Sect Biosimulat & Bioinformat, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria; [Knapp, Bernhard] Univ Oxford, Dept Stat, Prot Informat Grp, Oxford OX1 3TG, England; [Dorffner, Georg] Med Univ Vienna, Sect Artificial Intelligence, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria	Medical University of Vienna; University of Oxford; Medical University of Vienna	Knapp, B (corresponding author), Med Univ Vienna, Sect Biosimulat & Bioinformat, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria.	bernhard.knapp@meduniwien.ac.at	Dorffner, Georg/AAQ-1455-2020	Dorffner, Georg/0000-0002-3181-2576	Austrian Science Fund [FWF P22258-B12]; Austrian Science Fund (FWF) [P 22258] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/I017909/1] Funding Source: researchfish; EPSRC [EP/I017909/1] Funding Source: UKRI	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This study was supported by the Austrian Science Fund (FWF P22258-B12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armstrong KM, 2008, BIOCHEM J, V415, P183, DOI 10.1042/BJ20080850; Beddoe T, 2009, IMMUNITY, V30, P777, DOI 10.1016/j.immuni.2009.03.018; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Burrows SR, 1997, EUR J IMMUNOL, V27, P178, DOI 10.1002/eji.1830270126; Camacho CJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000231; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Choudhuri K, 2007, SEMIN IMMUNOL, V19, P255, DOI 10.1016/j.smim.2007.04.005; Cuendet MA, 2008, BIOPHYS J, V95, P3575, DOI 10.1529/biophysj.108.131383; Cuendet MA, 2011, PROTEINS, V79, P3007, DOI 10.1002/prot.23104; De Rosa MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011550; Feenstra KA, 1999, J COMPUT CHEM, V20, P786, DOI 10.1002/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B; Frankild S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001831; Gregoire C, 1996, P NATL ACAD SCI USA, V93, P7184, DOI 10.1073/pnas.93.14.7184; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guy CS, 2009, IMMUNOL REV, V232, P7, DOI 10.1111/j.1600-065X.2009.00843.x; Haidar JN, 2009, PROTEINS, V74, P948, DOI 10.1002/prot.22203; Hansson T, 2002, CURR OPIN STRUC BIOL, V12, P190, DOI 10.1016/S0959-440X(02)00308-1; Hemmer B, 1998, J IMMUNOL, V160, P3631; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Kim ST, 2009, J BIOL CHEM, V284, P31028, DOI 10.1074/jbc.M109.052712; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Kjer-Nielsen L, 2002, J IMMUNOL, V169, P5153, DOI 10.4049/jimmunol.169.9.5153; Kjer-Nielsen L, 2002, STRUCTURE, V10, P1521, DOI 10.1016/S0969-2126(02)00878-X; Knapp B, 2008, PROTEIN SCI, V17, P977, DOI 10.1110/ps.073402508; Knapp B, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-43; Knapp B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011653; Knapp B, 2009, MOL IMMUNOL, V46, P1839, DOI 10.1016/j.molimm.2009.01.009; Knapp B, 2009, J COMPUT AID MOL DES, V23, P301, DOI 10.1007/s10822-009-9259-2; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Ma JP, 2000, J MOL BIOL, V302, P303, DOI 10.1006/jmbi.2000.4014; Ma ZY, 2008, FASEB J, V22, P1002, DOI 10.1096/fj.07-9331hyp; Ma ZY, 2010, TRENDS IMMUNOL, V31, P1, DOI 10.1016/j.it.2009.09.008; Manning TC, 1998, IMMUNITY, V8, P413, DOI 10.1016/S1074-7613(00)80547-6; Mazur AK, 1998, J PHYS CHEM B, V102, P473, DOI 10.1021/jp972381h; Mishra S, 2009, J BIOMOL STRUCT DYN, V27, P293, DOI 10.1080/07391102.2009.10507317; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; Narzi D, 2012, J MOL BIOL, V415, P429, DOI 10.1016/j.jmb.2011.11.021; Omasits U, 2008, MOL SIMULAT, V34, P781, DOI 10.1080/08927020802256298; Painter CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002403; ROGNAN D, 1992, EUR J BIOCHEM, V208, P101, DOI 10.1111/j.1432-1033.1992.tb17163.x; Rognan D, 2000, J COMPUT AID MOL DES, V14, P53, DOI 10.1023/A:1008142830353; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Schamel WWA, 2007, P NATL ACAD SCI USA, V104, P16398, DOI 10.1073/pnas.0708462104; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Stavrakoudis A, 2011, CELL BIOCHEM BIOPHYS, V60, P283, DOI 10.1007/s12013-011-9151-2; Tai K, 2001, BIOPHYS J, V81, P715, DOI 10.1016/S0006-3495(01)75736-0; Toh H, 2000, PROTEIN ENG, V13, P423, DOI 10.1093/protein/13.6.423; Tong JC, 2007, BRIEF BIOINFORM, V8, P96, DOI 10.1093/bib/bbl038; Tung CW, 2007, BIOINFORMATICS, V23, P942, DOI 10.1093/bioinformatics/btm061; Tung CW, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-446; Vitkup D, 2000, NAT STRUCT BIOL, V7, P34; Wan S, 2008, MOL IMMUNOL, V45, P1221, DOI 10.1016/j.molimm.2007.09.022; Wan SZ, 2005, J IMMUNOL, V175, P1715, DOI 10.4049/jimmunol.175.3.1715; Wan SZ, 2004, J COMPUT CHEM, V25, P1803, DOI 10.1002/jcc.20100; Wucherpfennig KW, 2007, SEMIN IMMUNOL, V19, P216, DOI 10.1016/j.smim.2007.02.012; Yaneva R, 2009, BIOPOLYMERS, V91, P14, DOI 10.1002/bip.21078; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4; Zacharias M, 2004, BIOPHYS J, V87, P2203, DOI 10.1529/biophysj.104.044743; Zoete V, 2007, PROTEINS, V67, P1026, DOI 10.1002/prot.21395	64	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64464	10.1371/journal.pone.0064464	http://dx.doi.org/10.1371/journal.pone.0064464			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762240	Green Published, gold, Green Submitted			2022-12-27	WOS:000321099000008
J	Sleiman, D; Barraud, P; Brachet, F; Tisne, C				Sleiman, Dona; Barraud, Pierre; Brachet, Franck; Tisne, Carine			The Interaction between tRNA(3)(Lys) and the Primer Activation Signal Deciphered by NMR Spectroscopy	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-1 REVERSE TRANSCRIPTION; BINDING-SITE COMPLEMENTARY; ACID-CHAPERONE ACTIVITY; TRANSFER-RNA PRIMER; NUCLEOCAPSID PROTEIN; INITIATION COMPLEX; EFFICIENT INITIATION; SECONDARY STRUCTURE; VIRAL-RNA	The initiation of reverse transcription of the human immunodeficiency virus type 1 (HIV-1) requires the opening of the three-dimensional structure of the primer tRNA(3)(Lys) for its annealing to the viral RNA at the primer binding site (PBS). Despite the fact that the result of this rearrangement is thermodynamically more stable, there is a high-energy barrier that requires the chaperoning activity of the viral nucleocapsid protein. In addition to the nucleotide complementarity to the PBS, several regions of tRNA(3)(Lys) have been described as interacting with the viral genomic RNA. Among these sequences, a sequence of the viral genome called PAS for "primer activation signal" was proposed to interact with the T-arm of tRNA(3)(Lys), this interaction stimulating the initiation of reverse transcription. In this report, we investigate the formation of this additional interaction with NMR spectroscopy, using a simple system composed of the primer tRNA(3)(Lys), the 18 nucleotides of the PBS, the PAS (8 nucleotides) encompassed or not in a hairpin structure, and the nucleocapsid protein. Our NMR study provides molecular evidence of the existence of this interaction and highlights the role of the nucleocapsid protein in promoting this additional RNA-RNA annealing. This study presents the first direct observation at a single base-pair resolution of the PAS/anti-PAS association, which has been proposed to be involved in the chronological regulation of the reverse transcription.	[Sleiman, Dona; Barraud, Pierre; Brachet, Franck; Tisne, Carine] Univ Paris 05, Paris Sorbonne Cite, CNRS, Lab Cristallog & RMN Biol, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Tisne, C (corresponding author), Univ Paris 05, Paris Sorbonne Cite, CNRS, Lab Cristallog & RMN Biol, Paris, France.	carine.tisne@parisdescartes.fr	Barraud, Pierre/AAT-9884-2020	Barraud, Pierre/0000-0003-4460-8360; Sleiman, Dona/0000-0002-4005-6514; Tisne, Carine/0000-0001-5534-4650	"Ministere de la Recherche"; French National Agency for Research on AIDS and Viral Hepatitis (ANRS)	"Ministere de la Recherche"(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, FranceSpanish Government); French National Agency for Research on AIDS and Viral Hepatitis (ANRS)(ANRSFrench National Research Agency (ANR))	D.S. was the recipient of a studentship from the "Ministere de la Recherche". This work was supported by grants from the French National Agency for Research on AIDS and Viral Hepatitis (ANRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink TEM, 2004, J VIROL, V78, P10706, DOI 10.1128/jvi.78.19.10706-10714.2004; Abbink TEM, 2007, ADV PHARMACOL, V55, P99, DOI 10.1016/S1054-3589(07)55003-9; Abbink TEM, 2008, VIRUS RES, V134, P4, DOI 10.1016/j.virusres.2007.12.009; AIYAR A, 1992, J VIROL, V66, P2464, DOI 10.1128/JVI.66.4.2464-2472.1992; Azoulay J, 2003, J MOL BIOL, V326, P691, DOI 10.1016/S0022-2836(02)01430-4; BARAT C, 1989, EMBO J, V8, P3279, DOI 10.1002/j.1460-2075.1989.tb08488.x; Barraud P, 2007, BIOCHIMIE, V89, P1204, DOI 10.1016/j.biochi.2007.01.016; BAUDIN F, 1993, J MOL BIOL, V229, P382, DOI 10.1006/jmbi.1993.1041; Beerens N, 2002, J VIROL, V76, P2329, DOI 10.1128/JVI.76.5.2329-2339.2002; Beerens N, 2002, RNA, V8, P357, DOI 10.1017/S1355838202028194; Beerens N, 2001, J BIOL CHEM, V276, P31247, DOI 10.1074/jbc.M102441200; Beerens N, 2013, RNA; Beltz H, 2004, J MOL BIOL, V338, P711, DOI 10.1016/j.jmb.2004.03.019; Berkhout B, 1996, PROG NUCLEIC ACID RE, V54, P1, DOI 10.1016/S0079-6603(08)60359-1; Cen S, 2000, J VIROL, V74, P10796, DOI 10.1128/JVI.74.22.10796-10800.2000; Cruceanu M, 2006, NUCLEIC ACIDS RES, V34, P593, DOI 10.1093/nar/gkj458; Cruceanu M, 2006, J MOL BIOL, V363, P867, DOI 10.1016/j.jmb.2006.08.070; Darlix J L, 2000, Adv Pharmacol, V48, P345; Das AT, 2004, J VIROL, V78, P2601, DOI 10.1128/JVI.78.5.2601-2605.2004; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; Dupuy LC, 2003, J VIROL, V77, P8756, DOI 10.1128/JVI.77.16.8756-8764.2003; Freund F, 2001, NUCLEIC ACIDS RES, V29, P2757, DOI 10.1093/nar/29.13.2757; Goldschmidt V, 2004, J BIOL CHEM, V279, P35923, DOI 10.1074/jbc.M404473200; Goldschmidt V, 2003, NUCLEIC ACIDS RES, V31, P850, DOI 10.1093/nar/gkg187; Hargittai MRS, 2004, J MOL BIOL, V337, P951, DOI 10.1016/j.jmb.2004.01.054; Houzet L, 2008, NUCLEIC ACIDS RES, V36, P2311, DOI 10.1093/nar/gkn069; Isel C, 1998, NUCLEIC ACIDS RES, V26, P1198, DOI 10.1093/nar/26.5.1198; ISEL C, 1993, J BIOL CHEM, V268, P25269; Isel C, 1999, EMBO J, V18, P1038, DOI 10.1093/emboj/18.4.1038; ISEL C, 1995, J MOL BIOL, V247, P236, DOI 10.1006/jmbi.1994.0136; Iwatani Y, 2003, J BIOL CHEM, V278, P14185, DOI 10.1074/jbc.M211618200; Kang SM, 1999, VIROLOGY, V257, P95, DOI 10.1006/viro.1999.9615; Kang SM, 1997, J VIROL, V71, P207, DOI 10.1128/JVI.71.1.207-217.1997; Lee BM, 1998, J MOL BIOL, V279, P633, DOI 10.1006/jmbi.1998.1766; Levin JG, 2005, PROG NUCLEIC ACID RE, V80, P217, DOI 10.1016/S0079-6603(05)80006-6; Levin JG, 2010, RNA BIOL, V7, P754, DOI 10.4161/rna.7.6.14115; LI XG, 1994, J VIROL, V68, P6198, DOI 10.1128/JVI.68.10.6198-6206.1994; Liang C, 1997, J VIROL, V71, P5750, DOI 10.1128/JVI.71.8.5750-5757.1997; Mak J, 1997, J VIROL, V71, P8087, DOI 10.1128/JVI.71.11.8087-8095.1997; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; MARQUET R, 1995, BIOCHIMIE, V77, P113, DOI 10.1016/0300-9084(96)88114-4; Miller JT, 2001, J BIOL CHEM, V276, P27721, DOI 10.1074/jbc.M100513200; Ooms M, 2007, NUCLEIC ACIDS RES, V35, P1649, DOI 10.1093/nar/gkm046; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Puglisi EV, 2011, J MOL BIOL, V410, P863, DOI 10.1016/j.jmb.2011.04.024; Rein A, 1998, TRENDS BIOCHEM SCI, V23, P297, DOI 10.1016/S0968-0004(98)01256-0; Saadatmand J, 2009, VIROLOGY, V391, P334, DOI 10.1016/j.virol.2009.06.036; Sleiman D, 2012, VIRUS RES, V169, P324, DOI 10.1016/j.virusres.2012.06.006; Tisne C, 2000, RNA, V6, P1403, DOI 10.1017/S1355838200000947; Tisne C, 2005, CURR HIV RES, V3, P147, DOI 10.2174/1570162053506919; Tisne C, 2004, J BIOL CHEM, V279, P3588, DOI 10.1074/jbc.M310368200; Tisne C, 2001, J MOL BIOL, V306, P443, DOI 10.1006/jmbi.2000.4391; WAKEFIELD JK, 1995, J VIROL, V69, P6021, DOI 10.1128/JVI.69.10.6021-6029.1995; Wakefield JK, 1996, J VIROL, V70, P966, DOI 10.1128/JVI.70.2.966-975.1996; Weigelt J, 1998, J AM CHEM SOC, V120, P10778, DOI 10.1021/ja982649y; Williams MC, 2001, P NATL ACAD SCI USA, V98, P6121, DOI 10.1073/pnas.101033198; Zhang ZJ, 1996, VIROLOGY, V226, P306, DOI 10.1006/viro.1996.0658	58	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64700	10.1371/journal.pone.0064700	http://dx.doi.org/10.1371/journal.pone.0064700			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762248	Green Published, Green Submitted, gold			2022-12-27	WOS:000321099000016
J	Takenaka, M; Zehrmann, A; Brennicke, A; Graichen, K				Takenaka, Mizuki; Zehrmann, Anja; Brennicke, Axel; Graichen, Knut			Improved Computational Target Site Prediction for Pentatricopeptide Repeat RNA Editing Factors	PLOS ONE			English	Article							PPR PROTEIN; MITOCHONDRIA; GENE; MOTIF	Pentatricopeptide repeat (PPR) proteins with an E domain have been identified as specific factors for C to U RNA editing in plant organelles. These PPR proteins bind to a unique sequence motif 59 of their target editing sites. Recently, involvement of a combinatorial amino acid code in the P (normal length) and S type (short) PPR domains in sequence specific RNA binding was reported. PPR proteins involved in RNA editing, however, contain not only P and S motifs but also their long variants L (long) and L2 (long2) and the S2 (short2) motifs. We now find that inclusion of these motifs improves the prediction of RNA editing target sites. Previously overlooked RNA editing target sites are suggested from the PPR motif structures of known E-class PPR proteins and are experimentally verified. RNA editing target sites are assigned for the novel PPR protein MEF32 (mitochondrial editing factor 32) and are confirmed in the cDNA.	[Takenaka, Mizuki; Zehrmann, Anja; Brennicke, Axel] Univ Ulm, D-89069 Ulm, Germany; [Graichen, Knut] Univ Ulm, Inst Mess Regel & Mikrotech, D-89069 Ulm, Germany	Ulm University; Ulm University	Takenaka, M (corresponding author), Univ Ulm, D-89069 Ulm, Germany.	mizuki.takenaka@uni-ulm.de	Takenaka, Mizuki/AAK-9884-2020	Takenaka, Mizuki/0000-0002-3242-5092; Graichen, Knut/0000-0003-2865-8093	DFG [TA624/2-2, TA624/3-1, TA624/4-1, BR726/11-1]	DFG(German Research Foundation (DFG))	This work was supported by grants TA624/2-2, TA624/3-1, TA624/4-1 and BR726/11-1 from the DFG (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres C, 2007, PHYSIOL PLANTARUM, V129, P14, DOI 10.1111/j.1399-3054.2006.00766.x; Arenas A, 2013, FEBS LETT, V587, P887, DOI 10.1016/j.febslet.2013.02.009; Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Doniwa Y, 2010, GENE, V454, P39, DOI 10.1016/j.gene.2010.01.008; Fujii S, 2011, NEW PHYTOL, V191, P37, DOI 10.1111/j.1469-8137.2011.03746.x; Fujii S, 2011, P NATL ACAD SCI USA, V108, P1723, DOI 10.1073/pnas.1007667108; Giege P, 1999, P NATL ACAD SCI USA, V96, P15324, DOI 10.1073/pnas.96.26.15324; Kobayashi K, 2012, NUCLEIC ACIDS RES, V40, P2712, DOI 10.1093/nar/gkr1084; Kondo J, 2011, NUCLEIC ACIDS RES, V39, P8628, DOI 10.1093/nar/gkr452; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Nakamura T, 2012, PLANT CELL PHYSIOL, V53, P1171, DOI 10.1093/pcp/pcs069; Okuda K, 2009, PLANT CELL, V21, P146, DOI 10.1105/tpc.108.064667; Rivals E, 2006, PLANT PHYSIOL, V141, P825, DOI 10.1104/pp.106.077826; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Takenaka M, 2012, NAT PROTOC, V7, P1931, DOI 10.1038/nprot.2012.117; Takenaka M, 2010, J BIOL CHEM, V285, P27122, DOI 10.1074/jbc.M110.128611; Verbitskiy D, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.397992; Verbitskiy D, 2012, PLANT CELL PHYSIOL, V53, P358, DOI 10.1093/pcp/pcr182; Verbitskiy D, 2010, PLANT J, V61, P446, DOI 10.1111/j.1365-313X.2009.04076.x; Yagi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057286; Zhu Q, 2012, PLANT J, V71, P836, DOI 10.1111/j.1365-313X.2012.05036.x	24	146	148	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65343	10.1371/journal.pone.0065343	http://dx.doi.org/10.1371/journal.pone.0065343			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762347	Green Submitted, Green Published, gold			2022-12-27	WOS:000321099000057
J	Boesten, DMPHJ; Berger, A; de Cock, P; Dong, H; Hammock, BD; den Hartog, GJM; Bast, A				Boesten, Danielle M. P. H. J.; Berger, Alvin; de Cock, Peter; Dong, Hua; Hammock, Bruce D.; den Hartog, Gertjan J. M.; Bast, Aalt			Multi-Targeted Mechanisms Underlying the Endothelial Protective Effects of the Diabetic-Safe Sweetener Erythritol	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MITOCHONDRIAL SUPEROXIDE-PRODUCTION; HIGH GLUCOSE; OXIDATIVE STRESS; TRANSCRIPTIONAL ACTIVATION; GENECHIP DATA; PROBE LEVEL; RAT AORTA; CELLS; DYSFUNCTION	Diabetes is characterized by hyperglycemia and development of vascular pathology. Endothelial cell dysfunction is a starting point for pathogenesis of vascular complications in diabetes. We previously showed the polyol erythritol to be a hydroxyl radical scavenger preventing endothelial cell dysfunction onset in diabetic rats. To unravel mechanisms, other than scavenging of radicals, by which erythritol mediates this protective effect, we evaluated effects of erythritol in endothelial cells exposed to normal (7 mM) and high glucose (30 mM) or diabetic stressors (e.g. SIN-1) using targeted and transcriptomic approaches. This study demonstrates that erythritol (i.e. under non-diabetic conditions) has minimal effects on endothelial cells. However, under hyperglycemic conditions erythritol protected endothelial cells against cell death induced by diabetic stressors (i.e. high glucose and peroxynitrite). Also a number of harmful effects caused by high glucose, e.g. increased nitric oxide release, are reversed. Additionally, total transcriptome analysis indicated that biological processes which are differentially regulated due to high glucose are corrected by erythritol. We conclude that erythritol protects endothelial cells during high glucose conditions via effects on multiple targets. Overall, these data indicate a therapeutically important endothelial protective effect of erythritol under hyperglycemic conditions.	[Boesten, Danielle M. P. H. J.; den Hartog, Gertjan J. M.; Bast, Aalt] Maastricht Univ, Dept Toxicol, Maastricht, Netherlands; [Berger, Alvin] Cargill, Global Food Res, Wayzata, MN USA; [de Cock, Peter] Cargill RandD Ctr Europe, Vilvoorde, Belgium; [Dong, Hua; Hammock, Bruce D.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Dong, Hua; Hammock, Bruce D.] Univ Calif Davis, UCD Comprehens Canc Ctr, Davis, CA 95616 USA	Maastricht University; Cargill; Cargill; University of California System; University of California Davis; University of California System; University of California Davis	Boesten, DMPHJ (corresponding author), Maastricht Univ, Dept Toxicol, Maastricht, Netherlands.	danielle.boesten@maastrichtuniversity.nl	Berger, Alvin/AAE-5353-2022; Bast, Aalt/I-7809-2013	Bast, Aalt/0000-0002-5383-2789; de Cock, Peter/0000-0002-7367-7560	Cargill; Alvin Berger and Peter de Cock	Cargill; Alvin Berger and Peter de Cock	This research was financially supported by Cargill (http://www.cargill.com/). The funders were helpful in the preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish.; Research was financially supported by Cargill, the employer of Alvin Berger and Peter de Cock. Erythritol was provided by Cargill. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Bernt WO, 1996, REGUL TOXICOL PHARM, V24, pS191, DOI 10.1006/rtph.1996.0098; Bhasin M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-342; Bolstad B, 2005, BIOINFORMATICS COMPU; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Ceriello A, 2003, DIABETES CARE, V26, P1589, DOI 10.2337/diacare.26.5.1589; Chakrabarti S, 2012, AM J PHYSIOL-CELL PH, V302, pC666, DOI 10.1152/ajpcell.00181.2011; Channon KM, 2002, J PHYSIOL PHARMACOL, V53, P515; Chen JQ, 1999, TOXICOL SCI, V51, P224, DOI 10.1093/toxsci/51.2.224; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; den Hartog GJM, 2010, NUTRITION, V26, P449, DOI 10.1016/j.nut.2009.05.004; den Hartog GJM, 2003, TOXICOL IN VITRO, V17, P165, DOI 10.1016/S0887-2333(03)00007-9; Ding H, 2007, J CELL PHYSIOL, V212, P682, DOI 10.1002/jcp.21063; Dobrian AD, 2011, PROG LIPID RES, V50, P115, DOI 10.1016/j.plipres.2010.10.005; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FURCHGOTT RF, 1991, BLOOD VESSELS, V28, P52; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grieve DJ, 1998, EUR J PHARMACOL, V348, P181, DOI 10.1016/S0014-2999(98)00142-3; Hedrick CC, 1999, ADV EXP MED BIOL, V469, P455; Hippeli S, 1997, Z NATURFORSCH C, V52, P564; Horn D, 2008, MOL CELL BIOL, V28, P4354, DOI 10.1128/MCB.01920-07; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kageyama S, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-73; Koshimura K, 2002, NEUROSCI RES, V43, P31, DOI 10.1016/S0168-0102(02)00016-0; Li JM, 2011, J BIOL CHEM, V286, P4912, DOI 10.1074/jbc.M110.199729; Liu JY, 2010, P NATL ACAD SCI USA, V107, P17017, DOI 10.1073/pnas.1011278107; Lundstrom SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033780; MONCADA S, 1991, PHARMACOL REV, V43, P109; Moran JH, 2001, TOXICOL APPL PHARM, V172, P150, DOI 10.1006/taap.2001.9149; Munro IC, 1998, FOOD CHEM TOXICOL, V36, P1139, DOI 10.1016/S0278-6915(98)00091-X; Nanda N, 2005, J BIOL CHEM, V280, P24680, DOI 10.1074/jbc.M413411200; Natarajan R, 2002, DIABETOLOGIA, V45, P125, DOI 10.1007/s125-002-8253-x; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; NODA K, 1994, EUR J CLIN NUTR, V48, P286; Oguro A, 2009, DRUG METAB PHARMACOK, V24, P438, DOI 10.2133/dmpk.24.438; Pakala R, 1999, ATHEROSCLEROSIS, V147, P25, DOI 10.1016/S0021-9150(99)00144-6; Pandolfi A, 2010, CARDIOVASC RES, V86, P9, DOI 10.1093/cvr/cvq055; Paquay JBG, 1999, BRIT J PHARMACOL, V127, P331, DOI 10.1038/sj.bjp.0702552; Pendurthi UR, 1997, ARTERIOSCL THROM VAS, V17, P940, DOI 10.1161/01.ATV.17.5.940; Pratico D, 2005, ATHEROSCLEROSIS, V181, P215, DOI 10.1016/j.atherosclerosis.2005.03.005; Ramasamy R, 2005, TRENDS CARDIOVAS MED, V15, P237, DOI 10.1016/j.tcm.2005.08.003; Rathel Thomas R., 2003, Biol Proced Online, V5, P136, DOI 10.1251/bpo55; Risso A, 2001, AM J PHYSIOL-ENDOC M, V281, pE924, DOI 10.1152/ajpendo.2001.281.5.E924; Seol GH, 2004, AM J PHYSIOL-HEART C, V286, pH329, DOI 10.1152/ajpheart.00503.2003; Simionescu N, 1988, ENDOTHELIAL CELL BIO, P385; Sorescu GP, 2003, J BIOL CHEM, V278, P31128, DOI 10.1074/jbc.M300703200; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; TANG DG, 1995, J CELL SCI, V108, P2629; *TEAM RDC, 2003, R LANG ENV STAT COMP; Tsuneki H, 2007, EUR J PHARMACOL, V566, P1, DOI 10.1016/j.ejphar.2007.03.006; Ulker S, 2003, HYPERTENSION, V41, P534, DOI 10.1161/01.HYP.0000057421.28533.37; van Iersel MP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-399; Wadham C, 2007, DIABETES, V56, P2715, DOI 10.2337/db06-1294; Wattanapitayakul SK, 2001, PHARMACOL THERAPEUT, V89, P187, DOI 10.1016/S0163-7258(00)00114-5; Weseler AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028460; Yang J, 2009, ANAL CHEM, V81, P8085, DOI 10.1021/ac901282n; Yokozawa T, 2002, J AGR FOOD CHEM, V50, P5485, DOI 10.1021/jf020168z; Zou MH, 2002, DIABETES, V51, P198, DOI 10.2337/diabetes.51.1.198	59	11	11	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65741	10.1371/journal.pone.0065741	http://dx.doi.org/10.1371/journal.pone.0065741			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755276	Green Submitted, Green Published, gold			2022-12-27	WOS:000320579400076
J	Bognar, E; Sarszegi, Z; Szabo, A; Debreceni, B; Kalman, N; Tucsek, Z; Sumegi, B; Gallyas, F				Bognar, Eszter; Sarszegi, Zsolt; Szabo, Aliz; Debreceni, Balazs; Kalman, Nikoletta; Tucsek, Zsuzsanna; Sumegi, Balazs; Gallyas, Ferenc, Jr.			Antioxidant and Anti-Inflammatory Effects in RAW264.7 Macrophages of Malvidin, a Major Red Wine Polyphenol	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; EPITHELIAL-CELL LINES; RAW 264.7 MACROPHAGES; TOLL-LIKE RECEPTORS; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; IKK-BETA; CYCLOOXYGENASE-2 EXPRESSION; POLYMERASE-1 INHIBITOR	Background: Red wine polyphenols can prevent cardiovascular and inflammatory diseases. Resveratrol, the most extensively studied constituent, is unlikely to solely account for these beneficial effects because of its rather low abundance and bioavailability. Malvidin is far the most abundant polyphenol in red wine; however, very limited data are available about its effect on inflammatory processes and kinase signaling pathways. Methods & Findings: The present study was carried out by using RAW 264.7 macrophages stimulated by bacterial lipopolysaccharide in the presence and absence of malvidin. From the cells, activation of nuclear factor-kappaB, mitogen-activated protein kinase, protein kinase B/Akt and poly ADP-ribose polymerase, reactive oxygen species production, mitogen-activated protein kinase phosphatase-1 expression and mitochondrial depolarization were determined. We found that malvidin attenuated lipopolysaccharide-induced nuclear factor-kappaB, poly ADP-ribose polymerase and mitogen-activated protein kinase activation, reactive oxygen species production and mitochondrial depolarization, while upregulated the compensatory processes; mitogen-activated protein kinase phosphatase-1 expression and Akt activation. Conclusions: These effects of malvidin may explain the previous findings and at least partially account for the positive effects of moderate red wine consumption on inflammation-mediated chronic maladies such as obesity, diabetes, hypertension and cardiovascular disease.	[Bognar, Eszter; Szabo, Aliz; Debreceni, Balazs; Kalman, Nikoletta; Tucsek, Zsuzsanna; Sumegi, Balazs; Gallyas, Ferenc, Jr.] Univ Pecs, Sch Med, Dept Biochem & Med Chem, Pecs, Hungary; [Sarszegi, Zsolt] Univ Pecs, Sch Med, Inst Heart, Pecs, Hungary; [Bognar, Eszter; Sumegi, Balazs; Gallyas, Ferenc, Jr.] Hungarian Acad Sci, Nuclear Mitochondrial Interact Res Grp, Budapest, Hungary; [Szabo, Aliz; Kalman, Nikoletta; Sumegi, Balazs; Gallyas, Ferenc, Jr.] Szentagothai Res Ctr, Pecs, Hungary	University of Pecs; University of Pecs; Hungarian Academy of Sciences	Gallyas, F (corresponding author), Univ Pecs, Sch Med, Dept Biochem & Med Chem, Pecs, Hungary.	ferenc.gallyas@aok.pte.hu	Gallyas, Ferenc/AAY-5343-2020; Gallyas, Ferenc/C-2272-2012; Sarszegi, Zsolt/AAU-9051-2021	Gallyas, Ferenc/0000-0002-1906-4333	 [SROP-4.2.1.B-10/2/KONV-2010-0002];  [SROP-4.2.2/B-10/1-2010-0029];  [OTKA K73738];  [34039/KA-OTKA/11-06]	; ; ; 	This work was supported by Hungarian grants SROP-4.2.1.B-10/2/KONV-2010-0002, SROP-4.2.2/B-10/1-2010-0029, OTKA K73738 and 34039/KA-OTKA/11-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Cario E, 2000, J IMMUNOL, V164, P966, DOI 10.4049/jimmunol.164.2.966; Chen CC, 1999, MOL PHARMACOL, V55, P481; Chun OK, 2008, J NUTR, V138, P753; de la Lastra CA, 2005, MOL NUTR FOOD RES, V49, P405; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Gescher AJ, 2003, CANCER EPIDEM BIOMAR, V12, P953; Haller D, 2002, J BIOL CHEM, V277, P38168, DOI 10.1074/jbc.M205737200; Hou DX, 2010, J AGR FOOD CHEM, V58, P12735, DOI 10.1021/jf103605j; Hou DX, 2005, BIOCHEM PHARMACOL, V70, P417, DOI 10.1016/j.bcp.2005.05.003; Joung SM, 2011, J IMMUNOL, V186, P499, DOI 10.4049/jimmunol.0903534; Kim HJ, 2006, TOXICOLOGY, V225, P36, DOI 10.1016/j.tox.2006.04.053; Kim HK, 1999, BIOCHEM PHARMACOL, V58, P759, DOI 10.1016/S0006-2952(99)00160-4; Kroon PA, 2010, CURR MED CHEM, V17, P2442; Lee HS, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-23; Li DY, 2012, CELL PHYSIOL BIOCHEM, V29, P9, DOI 10.1159/000337581; Liu Ling, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P89, DOI 10.2174/187153008784534385; Lorne E, 2010, INTENS CARE MED, V36, P1826, DOI 10.1007/s00134-010-1983-5; Lu Y, 2012, J CELL BIOCHEM, V113, P1022, DOI 10.1002/jcb.23434; Manukyan MC, 2010, SHOCK, V34, P442, DOI 10.1097/SHK.0b013e3181e14ea9; Marko D, 2004, MOL NUTR FOOD RES, V48, P318, DOI 10.1002/mnfr.200400034; Matern U., 1993, POLYPHENOLIC PHENOME, P143; Miyamoto S, 2009, J BIOENERG BIOMEMBR, V41, P169, DOI 10.1007/s10863-009-9205-y; Nikfardjam MSP, 2006, FOOD CHEM, V98, P453, DOI 10.1016/j.foodchem.2005.06.014; Palfi A, 2009, J NUTR BIOCHEM, V20, P418, DOI 10.1016/j.jnutbio.2008.04.009; Poulose SM, 2012, J AGR FOOD CHEM, V60, P1084, DOI 10.1021/jf203989k; Purkayastha S, 2011, NAT MED, V17, P883, DOI 10.1038/nm.2372; Quintieri AM, 2012, J NUTR BIOC IN PRESS; Racz B, 2010, FREE RADICAL BIO MED, V49, P1978, DOI 10.1016/j.freeradbiomed.2010.09.026; Shabalina IG, 2011, BIOCHEM SOC T, V39, P1305, DOI 10.1042/BST0391305; Sizemore N, 1999, MOL CELL BIOL, V19, P4798; Soleas GJ, 1997, J CLIN LAB ANAL, V11, P287, DOI 10.1002/(SICI)1098-2825(1997)11:5<287::AID-JCLA6>3.0.CO;2-4; Sun AY, 2002, FREE RADICAL BIO MED, V32, P314, DOI 10.1016/S0891-5849(01)00803-6; Sun BS, 2009, J AGR FOOD CHEM, V57, P8623, DOI 10.1021/jf901610h; Tang CH, 2007, J CELL PHYSIOL, V211, P45, DOI 10.1002/jcp.20896; Udenigwe CC, 2008, NUTR REV, V66, P445, DOI 10.1111/j.1753-4887.2008.00076.x; Ulloa L, 2005, TRENDS MOL MED, V11, P56, DOI 10.1016/j.molmed.2004.12.007; Veres B, 2003, BIOCHEM PHARMACOL, V65, P1373, DOI 10.1016/S0006-2952(03)00077-7; Veres B, 2004, J PHARMACOL EXP THER, V310, P247, DOI 10.1124/jpet.104.065151; Virag L, 2001, FASEB J, V15, P99, DOI 10.1096/fj.00-0299com; Virgili F, 1998, FREE RADICAL BIO MED, V24, P1120, DOI 10.1016/S0891-5849(97)00430-9; Visioli F, 2011, MINI-REV MED CHEM, V11, P1186; Wang J, 2002, J AGR FOOD CHEM, V50, P4183, DOI 10.1021/jf011613d; Wu GS, 2007, CANCER METAST REV, V26, P579, DOI 10.1007/s10555-007-9079-6; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Yeh CT, 2005, J AGR FOOD CHEM, V53, P1740, DOI 10.1021/jf048955e; Yi WG, 2005, J AGR FOOD CHEM, V53, P8804, DOI 10.1021/jf0515328; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794; Zhao QF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044956; Zhong J, 2007, J BIOL CHEM, V282, P24246, DOI 10.1074/jbc.M703422200	51	105	109	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65355	10.1371/journal.pone.0065355	http://dx.doi.org/10.1371/journal.pone.0065355			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755222	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000320579400054
J	McDonald, RI; Girvetz, EH				McDonald, Robert I.; Girvetz, Evan H.			Two Challenges for U. S. Irrigation Due to Climate Change: Increasing Irrigated Area in Wet States and Increasing Irrigation Rates in Dry States	PLOS ONE			English	Article							CHANGE IMPACTS; INTEGRATED ASSESSMENT; WATER AVAILABILITY; FOOD SECURITY; RIVER-BASINS; ELEVATED CO2; AGRICULTURE; DEMAND; CROP; EVAPOTRANSPIRATION	Agricultural irrigation practices will likely be affected by climate change. In this paper, we use a statistical model relating observed water use by U. S. producers to the moisture deficit, and then use this statistical model to project climate changes impact on both the fraction of agricultural land irrigated and the irrigation rate (m(3)ha(-1)). Data on water withdrawals for US states (1985-2005) show that both quantities are highly positively correlated with moisture deficit (precipitation - PET). If current trends hold, climate change would increase agricultural demand for irrigation in 2090 by 4.5-21.9 million ha (B1 scenario demand: 4.5-8.7 million ha, A2 scenario demand: 9.1-21.9 million ha). Much of this new irrigated area would occur in states that currently have a wet climate and a small fraction of their agricultural land currently irrigated, posing a challenge to policymakers in states with less experience with strict regulation of agriculture water use. Moreover, most of this expansion will occur in states where current agricultural production has relatively low market value per hectare, which may make installation of irrigation uneconomical without significant changes in crops or practices by producers. Without significant increases in irrigation efficiency, climate change would also increase the average irrigation rate from 7,963 to 8,400-10,415 m(3)ha(-1) (B1 rate: 8,400-9,145 m(3)ha(-1), A2 rate: 9,380-10,415 m(3)ha(-1)). The irrigation rate will increase the most in states that already have dry climates and large irrigation rates, posing a challenge for water supply systems in these states. Accounting for both the increase in irrigated area and irrigation rate, total withdrawals might increase by 47.7-283.4 billion m(3) (B1 withdrawal: 47.7-106.0 billion m(3), A2 withdrawal: 117.4-283.4 billion m(3)). Increases in irrigation water-use efficiency, particularly by reducing the prevalence of surface irrigation, could eliminate the increase in total irrigation withdrawals in many states.	[McDonald, Robert I.] Nature Conservancy, Cent Sci Program, Arlington, VA USA; [Girvetz, Evan H.] Nature Conservancy, Global Climate Change Program, Seattle, WA USA	Nature Conservancy; Nature Conservancy	McDonald, RI (corresponding author), Nature Conservancy, Cent Sci Program, 1815 N Lynn St, Arlington, VA USA.	rob_mcdonald@tnc.org		McDonald, Robert/0000-0002-7273-6549	Nature Conservancy	Nature Conservancy	The authors are supported by The Nature Conservancy and its members. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcamo J, 2007, HYDROLOG SCI J, V52, P247, DOI 10.1623/hysj.52.2.247; Connor J, 2009, AUST J AGR RESOUR EC, V53, P437, DOI 10.1111/j.1467-8489.2009.00460.x; DALY C, 1994, J APPL METEOROL, V33, P140, DOI 10.1175/1520-0450(1994)033&lt;0140:ASTMFM&gt;2.0.CO;2; Drake BG, 1997, ANNU REV PLANT PHYS, V48, P609, DOI 10.1146/annurev.arplant.48.1.609; Easterling WE, 1996, AGR FOREST METEOROL, V80, P1, DOI 10.1016/0168-1923(95)02315-1; Elbakidze L, 2006, J AM WATER RESOUR AS, V42, P841, DOI 10.1111/j.1752-1688.2006.tb04498.x; Fischer G, 2005, PHILOS T R SOC B, V360, P2067, DOI 10.1098/rstb.2005.1744; Fischer G, 2007, TECHNOL FORECAST SOC, V74, P1083, DOI 10.1016/j.techfore.2006.05.021; Girvetz EH, 2009, PLOS ONE, V4; Hellegers PJGJ, 2006, INT J WATER RESOUR D, V22, P79, DOI 10.1080/07900620500405643; Hooker MA, 1998, J AM WATER RESOUR AS, V34, P497, DOI 10.1111/j.1752-1688.1998.tb00949.x; Howden SM, 2007, P NATL ACAD SCI USA, V104, P19691, DOI 10.1073/pnas.0701890104; Huang JG, 2007, CRIT REV PLANT SCI, V26, P265, DOI 10.1080/07352680701626978; Hunsaker DJ, 2000, AGR FOREST METEOROL, V104, P85, DOI 10.1016/S0168-1923(00)00157-X; IPCC (Intergovernmental Panel on Climate Change), 2000, SPECIAL REPORT EMISS; Kenny J.F., 2009, ESTIMATED USE WATER; Kingston DG, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040267; Lu JB, 2005, J AM WATER RESOUR AS, V41, P621, DOI 10.1111/j.1752-1688.2005.tb03759.x; Luedeling E, 2011, GLOBAL CHANGE BIOL, V17, P228, DOI 10.1111/j.1365-2486.2010.02227.x; Manderscheid R, 2007, AGRON SUSTAIN DEV, V27, P79, DOI 10.1051/agro:2006035; Medlyn BE, 2001, NEW PHYTOL, V149, P247, DOI 10.1046/j.1469-8137.2001.00028.x; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Moore BD, 1999, PLANT CELL ENVIRON, V22, P567, DOI 10.1046/j.1365-3040.1999.00432.x; Morgan JA, 2004, OECOLOGIA, V140, P11, DOI 10.1007/s00442-004-1550-2; Palmer MA, 2008, FRONT ECOL ENVIRON, V6, P81, DOI 10.1890/060148; Penuelas J, 2011, GLOBAL ECOL BIOGEOGR, V20, P597, DOI 10.1111/j.1466-8238.2010.00608.x; Rosegrant MW, 2009, ANNU REV ENV RESOUR, V34, P205, DOI 10.1146/annurev.environ.030308.090351; Rosenzweig C, 2004, GLOBAL ENVIRON CHANG, V14, P345, DOI 10.1016/j.gloenvcha.2004.09.003; Savenije HHG, 2002, WATER INT, V27, P98, DOI 10.1080/02508060208686982; Schlenker W, 2005, AM ECON REV, V95, P395, DOI 10.1257/0002828053828455; Schlenker W, 2007, CLIMATIC CHANGE, V81, P19, DOI 10.1007/s10584-005-9008-z; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Schmidhuber J, 2007, P NATL ACAD SCI USA, V104, P19703, DOI 10.1073/pnas.0701976104; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sun G, 2008, J AM WATER RESOUR AS, V44, P1441, DOI 10.1111/j.1752-1688.2008.00250.x; Tardieu H, 2002, IRRIG DRAIN, V51, P97, DOI 10.1002/ird.44; Taylor RG, 2013, NAT CLIM CHANGE, V3, P322, DOI [10.1038/nclimate1744, 10.1038/NCLIMATE1744]; Thomson AM, 2005, CLIMATIC CHANGE, V69, P89, DOI 10.1007/s10584-005-3611-x; Tubiello FN, 2007, P NATL ACAD SCI USA, V104, P19686, DOI 10.1073/pnas.0701728104; Tubiello FN, 2007, TECHNOL FORECAST SOC, V74, P1030, DOI 10.1016/j.techfore.2006.05.027; USDA, 2008, FARM RANCH IRR SURV; USDA, 2009, US CENS AGR 2007; Vorosmarty CJ, 1998, J HYDROL, V207, P147, DOI 10.1016/S0022-1694(98)00109-7; Wullschleger SD, 2002, PLANT CELL ENVIRON, V25, P319, DOI 10.1046/j.1365-3040.2002.00796.x	44	45	45	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65589	10.1371/journal.pone.0065589	http://dx.doi.org/10.1371/journal.pone.0065589			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166TB	23755255	Green Published, gold, Green Submitted			2022-12-27	WOS:000320579400069
J	Bush, CO; Greenstein, AE; Delaney, WE; Beran, RKF				Bush, Caroline O.; Greenstein, Andrew E.; Delaney, William E.; Beran, Rudolf K. F.			Hepatitis C Viral Entry Inhibitors Prolong Viral Suppression by Replication Inhibitors in Persistently-Infected Huh7 Cultures	PLOS ONE			English	Article							VIRUS ENTRY; IN-VITRO; RESISTANCE; REQUIRES; RECEPTOR; CELLS; CORECEPTOR; BMS-790052; THERAPY; BINDING	Efforts to treat HCV patients are focused on developing antiviral combinations that lead to the eradication of infection. Thus, it is important to identify optimal combinations from the various viral inhibitor classes. Based on viral dynamic models, HCV entry inhibitors are predicted to reduce viral load in a monophasic manner reflecting the slow death rate of infected hepatocytes (t(1/2) = 2-70 days) and the protection of naive, un-infected cells from HCV infection. In contrast, replication inhibitors are predicted to reduce viral load in a biphasic manner. The initial rapid reduction phase is due to the inhibition of virus production and elimination of plasma virus (t(1/2)similar to 3 hours). The second, slower reduction phase results from the elimination of infected hepatocytes. Here we sought to compare the ability of HCV entry and replication inhibitors as well as combinations thereof to reduce HCV infection in persistently-infected Huh7 cells. Treatment with 5xEC(50) of entry inhibitors anti-CD81 Ab or EI-1 resulted in modest (<= 1 log(10) RNA copies/ml), monophasic declines in viral levels during 3 weeks of treatment. In contrast, treatment with 5xEC(50) of the replication inhibitors BILN-2016 or BMS-790052 reduced extracellular virus levels more potently (similar to 2 log(10) RNA copies/ml) over time in a biphasic manner. However, this was followed by a slow rise to steady-state virus levels due to the emergence of resistance mutations. Combining an entry inhibitor with a replication inhibitor did not substantially enhance the rate of virus reduction. However, entry/replication inhibitor and replication/replication inhibitor combinations reduced viral levels further than monotherapies (up to 3 log(10) RNA copies/ml) and prolonged this reduction relative to monotherapies. Our results demonstrated that HCV entry inhibitors combined with replication inhibitors can prolong antiviral suppression, likely due to the delay of viral resistance emergence.	[Bush, Caroline O.; Greenstein, Andrew E.; Delaney, William E.; Beran, Rudolf K. F.] Gilead Sci Inc, Dept Biol, Foster City, CA 94404 USA	Gilead Sciences	Beran, RKF (corresponding author), Gilead Sci Inc, Dept Biol, 353 Lakeside Dr, Foster City, CA 94404 USA.	rudolf.beran@gilead.com		Greenstein, Andrew/0000-0002-1470-1970				Baldick CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001086; Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Bauhofer O, 2012, GASTROENTEROLOGY, V143, P429, DOI 10.1053/j.gastro.2012.04.018; Beran RKF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030286; Chan KT, 2012, VIROLOGY, V422, P224, DOI 10.1016/j.virol.2011.10.022; Ciesek S, 2011, HEPATOLOGY, V54, P1947, DOI 10.1002/hep.24610; Coburn GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035351; Cormier EG, 2004, P NATL ACAD SCI USA, V101, P7270, DOI 10.1073/pnas.0402253101; de Bruijne J, 2010, ANTIVIR THER, V15, P765, DOI 10.3851/IMP1606; Deng L, 2008, J VIROL, V82, P10375, DOI 10.1128/JVI.00395-08; Dorner M, 2011, NATURE, V474, P208, DOI 10.1038/nature10168; Dvory-Sobol H, 2012, ANTIMICROB AGENTS CH; Dvory-Sobol H, 2012, ANTIMICROB AGENTS CH, V56, P5289, DOI 10.1128/AAC.00780-12; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Fridell RA, 2011, HEPATOLOGY, V54, P1924, DOI 10.1002/hep.24594; Fridell RA, 2011, J VIROL, V85, P7312, DOI 10.1128/JVI.00253-11; Goldwasser J, 2011, J HEPATOL, V55, P963, DOI 10.1016/j.jhep.2011.02.011; Herker E, 2010, NAT MED, V16, P1295, DOI 10.1038/nm.2238; Keck ZY, 2011, J VIROL, V85, P10451, DOI 10.1128/JVI.05259-11; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Lenz O, 2010, ANTIMICROB AGENTS CH, V54, P1878, DOI 10.1128/AAC.01452-09; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Mittapalli GK, 2012, BIOORG MED CHEM LETT; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Pelosi LA, 2012, ANTIMICROB AGENTS CH; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Pokrovskii MV, 2011, J VIROL, V85, P3978, DOI 10.1128/JVI.01760-10; Powdrill MH, 2011, P NATL ACAD SCI USA, V108, P20509, DOI 10.1073/pnas.1105797108; Sainz B, 2006, J VIROL, V80, P10253, DOI 10.1128/JVI.01059-06; Sainz B, 2012, NAT MED, V18, P281, DOI 10.1038/nm.2581; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Schultz B, 2011, CURR PROTOC PHARM; Sulkowski M, 2013, RANDOMIZED DOUBLE BL; Summa V., 2012, ANTIMICROB AGENTS CH; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Zhu HH, 2012, J INFECT DIS, V205, P656, DOI 10.1093/infdis/jir802	38	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65273	10.1371/journal.pone.0065273	http://dx.doi.org/10.1371/journal.pone.0065273			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755208	Green Submitted, Green Published, gold			2022-12-27	WOS:000319872300067
J	Hyder, A; Buckeridge, DL; Leung, B				Hyder, Ayaz; Buckeridge, David L.; Leung, Brian			Predictive Validation of an Influenza Spread Model	PLOS ONE			English	Article							PANDEMIC INFLUENZA; EPIDEMIC; DYNAMICS; SURVEILLANCE; SARS	Background: Modeling plays a critical role in mitigating impacts of seasonal influenza epidemics. Complex simulation models are currently at the forefront of evaluating optimal mitigation strategies at multiple scales and levels of organization. Given their evaluative role, these models remain limited in their ability to predict and forecast future epidemics leading some researchers and public-health practitioners to question their usefulness. The objective of this study is to evaluate the predictive ability of an existing complex simulation model of influenza spread. Methods and Findings: We used extensive data on past epidemics to demonstrate the process of predictive validation. This involved generalizing an individual-based model for influenza spread and fitting it to laboratory-confirmed influenza infection data from a single observed epidemic (1998-1999). Next, we used the fitted model and modified two of its parameters based on data on real-world perturbations (vaccination coverage by age group and strain type). Simulating epidemics under these changes allowed us to estimate the deviation/error between the expected epidemic curve under perturbation and observed epidemics taking place from 1999 to 2006. Our model was able to forecast absolute intensity and epidemic peak week several weeks earlier with reasonable reliability and depended on the method of forecasting-static or dynamic. Conclusions: Good predictive ability of influenza epidemics is critical for implementing mitigation strategies in an effective and timely manner. Through the process of predictive validation applied to a current complex simulation model of influenza spread, we provided users of the model (e.g. public-health officials and policy-makers) with quantitative metrics and practical recommendations on mitigating impacts of seasonal influenza epidemics. This methodology may be applied to other models of communicable infectious diseases to test and potentially improve their predictive ability.	[Hyder, Ayaz; Leung, Brian] McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada; [Buckeridge, David L.] McGill Univ, Surveillance Lab, Montreal, PQ, Canada; [Buckeridge, David L.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Buckeridge, David L.] Direct Sante Publ, Agence Sante & Serv Sociaux Montreal, Montreal, PQ, Canada; [Leung, Brian] McGill Univ, Sch Environm, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University	Hyder, A (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	ayaz.hyder@yale.edu	Hyder, Ayaz/AFJ-8944-2022; Hyder, Ayaz/A-3738-2016	Hyder, Ayaz/0000-0003-4865-6482; 	Natural Sciences and Engineering Research Council of Canada (NSERC); Understanding Epidemics in Special Populations: Guiding Intervention and Planning Canadian Institutes for Health Research (CIHR) [PAN-83152, 03/2007-03/2009]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Understanding Epidemics in Special Populations: Guiding Intervention and Planning Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	B. Leung was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (NSERC). A. Hyder was supported by funding from B. Leung. Data was obtained through funding for D. Buckeridge from the following grant, Understanding Epidemics in Special Populations: Guiding Intervention and Planning (PAN-83152) (03/2007-03/2009) Canadian Institutes for Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advisory Committee on Immunization Practices, 2006, MMWR Recomm Rep, V55, P1; ANDERSON R M, 1991; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Barrett C, 2011, EPIDEMICS-NETH, V3, P19, DOI 10.1016/j.epidem.2010.11.002; BART J, 1995, ECOL APPL, V5, P411, DOI 10.2307/1942032; Chan EH, 2011, J BIOMED INFORM, V44, P221, DOI 10.1016/j.jbi.2010.10.001; CHOI K, 1981, AM J EPIDEMIOL, V113, P215, DOI 10.1093/oxfordjournals.aje.a113090; Colizza V, 2006, B MATH BIOL, V68, P1893, DOI 10.1007/s11538-006-9077-9; Colizza V, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-34; Colizza Vittoria, 2009, PLoS Curr, V1, pRRN1129; Cooley P, 2008, MATH COMPUT MODEL, V48, P929, DOI 10.1016/j.mcm.2007.11.016; degli Atti MLC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001790; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fiore Anthony E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Flahault A, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-129; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Goldstein E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001051; Grais R F, 2004, Health Care Manag Sci, V7, P127, DOI 10.1023/B:HCMS.0000020652.38181.da; Hall IM, 2007, EPIDEMIOL INFECT, V135, P372, DOI 10.1017/S0950268806007084; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Hollingsworth TD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001076; Kopec JA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-710; Kuhn K., 2005, USING CLIMATE PREDIC; Lee BY, 2008, TRANSL RES, V151, P275, DOI 10.1016/j.trsl.2008.02.004; Liao CM, 2010, EPIDEMIOL INFECT, V138, P825, DOI 10.1017/S0950268809991178; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Mahmoud A, 2006, MODELING COMMUNITY C; Mao L, 2010, COMPUT ENVIRON URBAN, V34, P204, DOI 10.1016/j.compenvurbsys.2010.03.004; Marks Robert Ernest, 2007, Computational Economics, V30, P265, DOI 10.1007/s10614-007-9101-7; Merler S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002205; Nishiura H, 2011, EUR J EPIDEMIOL, V26, P583, DOI 10.1007/s10654-011-9597-y; Nishiura H, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-15; Nougairede A, 2011, EUR J EPIDEMIOL, V26, P183, DOI 10.1007/s10654-010-9533-6; Okais C, 2010, VACCINE, V28, P8132, DOI 10.1016/j.vaccine.2010.09.099; Ong JBS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010036; Perez L, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-50; Polgreen PM, 2007, CLIN INFECT DIS, V44, P272, DOI 10.1086/510427; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Sargent RG, 1998, VERIFICATION VALIDAT, V121, P121; Shaman J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020743; Shaman J, 2011, AM J EPIDEMIOL, V173, P127, DOI 10.1093/aje/kwq347; Smieszek T, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-115; Stroud P, 2007, JASSS-J ARTIF SOC S, V10; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Weinstein M C, 2001, Value Health, V4, P348, DOI 10.1046/j.1524-4733.2001.45061.x; Wenger JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010187; Woolhouse M, 2011, PHILOS T R SOC B, V366, P2045, DOI 10.1098/rstb.2010.0387; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	50	17	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65459	10.1371/journal.pone.0065459	http://dx.doi.org/10.1371/journal.pone.0065459			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755236	Green Published, gold, Green Submitted			2022-12-27	WOS:000319872300083
J	Takata, N; Yokota, K; Ohki, S; Mori, M; Taniguchi, T; Kurita, M				Takata, Naoki; Yokota, Kiyonobu; Ohki, Shinya; Mori, Masashi; Taniguchi, Toru; Kurita, Manabu			Evolutionary Relationship and Structural Characterization of the EPF/EPFL Gene Family	PLOS ONE			English	Article							LIGAND-RECEPTOR PAIRS; STOMATAL DENSITY; SECRETORY PEPTIDE; LAND PLANTS; GENERATION; ALIGNMENT	EPF1-EPF2 and EPFL9/Stomagen act antagonistically in regulating leaf stomatal density. The aim of this study was to elucidate the evolutionary functional divergence of EPF/EPFL family genes. Phylogenetic analyses showed that AtEPFL9/Stomagen-like genes are conserved only in vascular plants and are closely related to AtEPF1/EPF2-like genes. Modeling showed that EPF/EPFL peptides share a common 3D structure that is constituted of a scaffold and loop. Molecular dynamics simulation suggested that AtEPF1/EPF2-like peptides form an additional disulfide bond in their loop regions and show greater flexibility in these regions than AtEPFL9/Stomagen-like peptides. This study uncovered the evolutionary relationship and the conformational divergence of proteins encoded by the EPF/EPFL family genes.	[Takata, Naoki; Taniguchi, Toru; Kurita, Manabu] Forestry & Forest Prod Res Inst, Forest Biores Ctr, Hitachi, Ibaraki, Japan; [Yokota, Kiyonobu] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan; [Ohki, Shinya] Japan Adv Inst Sci & Technol, Ctr Nanomat & Technol, Nomi, Japan; [Mori, Masashi] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa, Japan; [Taniguchi, Toru; Kurita, Manabu] Forestry & Forest Prod Res Inst, Forest Tree Breeding Ctr, Hitachi, Ibaraki, Japan	Forestry & Forest Products Research Institute - Japan; Kanazawa University; Japan Advanced Institute of Science & Technology (JAIST); Ishikawa Prefecture University; Forestry & Forest Products Research Institute - Japan	Kurita, M (corresponding author), Forestry & Forest Prod Res Inst, Forest Biores Ctr, Hitachi, Ibaraki, Japan.	mkuri@affrc.go.jp	Takata, Naoki/AAD-9822-2020	Takata, Naoki/0000-0002-8479-8165	JST Advanced Low Carbon Technology Research and Development Program (ALCA) from the Japan Science and Technology Agency (JST); JST-SENTAN; Grants-in-Aid for Scientific Research [25850124] Funding Source: KAKEN	JST Advanced Low Carbon Technology Research and Development Program (ALCA) from the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); JST-SENTAN(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was principally supported by the JST Advanced Low Carbon Technology Research and Development Program (ALCA) from the Japan Science and Technology Agency (JST) (to NT, TT and MK). This work was supported in part by JST-SENTAN (to SO and MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Beerling DJ, 2001, NATURE, V410, P352, DOI 10.1038/35066546; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Duche D, 1996, J BIOL CHEM, V271, P15401, DOI 10.1074/jbc.271.26.15401; Edwards D, 1998, J EXP BOT, V49, P255, DOI 10.1093/jexbot/49.suppl_1.255; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Hara K, 2007, GENE DEV, V21, P1720, DOI 10.1101/gad.1550707; Hara K, 2009, PLANT CELL PHYSIOL, V50, P1019, DOI 10.1093/pcp/pcp068; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hunt L, 2009, CURR BIOL, V19, P864, DOI 10.1016/j.cub.2009.03.069; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Joo H, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002234; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lee JS, 2012, GENE DEV, V26, P126, DOI 10.1101/gad.179895.111; Lehti-Shiu MD, 2009, PLANT PHYSIOL, V150, P12, DOI 10.1104/pp.108.134353; MCELWAIN JC, 1995, ANN BOT-LONDON, V76, P389, DOI 10.1006/anbo.1995.1112; Ohki S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1520; PATON JEAN A., 1957, TRANS BRIT BRYOL SOC, V3, P228; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Peterson KM, 2010, PLANT CELL, V22, P296, DOI 10.1105/tpc.109.072777; Rychel AL, 2010, J PLANT RES, V123, P275, DOI 10.1007/s10265-010-0330-9; SOLOVYEV VV, 1994, NUCLEIC ACIDS RES, V22, P5156, DOI 10.1093/nar/22.24.5156; Sugano SS, 2010, NATURE, V463, P241, DOI 10.1038/nature08682; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torii KU, 2012, TRENDS PLANT SCI, V17, P711, DOI 10.1016/j.tplants.2012.06.013; Vaten A, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-11	32	30	36	8	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65183	10.1371/journal.pone.0065183	http://dx.doi.org/10.1371/journal.pone.0065183			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755192	Green Published, gold, Green Submitted			2022-12-27	WOS:000319872300056
J	Willems, C; Wierda, SM; van Viegen, E; Martens, S				Willems, Charlotte; Wierda, Stefan M.; van Viegen, Eva; Martens, Sander			Individual Differences in the Attentional Blink: The Temporal Profile of Blinkers and Non-Blinkers	PLOS ONE			English	Article							SERIAL VISUAL PRESENTATION; RESOURCE DEPLETION ACCOUNTS; WORKING-MEMORY; SELECTIVE ATTENTION; HUMAN ELECTROPHYSIOLOGY; DISTRACTOR INHIBITION; SPATIAL ATTENTION; MAGNITUDE; CAPACITY; BINDING	Background: When two targets are presented in close temporal succession, the majority of people frequently fail to report the second target. This phenomenon, known as the 'attentional blink' (AB), has been a major topic in attention research for the past twenty years because it is informative about the rate at which stimuli can be encoded into consciously accessible representations. An aspect of the AB that has long been ignored, however, is individual differences. Methodology/Principal Findings: Here we compare a group of blinkers (who show an AB) and non-blinkers (who show little or no AB), and investigate the boundary conditions of the non-blinkers' remarkable ability. Second, we directly test the properties of temporal selection by analysing response errors, allowing us to uncover individual differences in suppression, delay, and diffusion of selective attention across time. Thirdly, we test the hypothesis that information concerning temporal order is compromised when an AB is somehow avoided. Surprisingly, compared to earlier studies, only a modest amount of suppression was found for blinkers. Non-blinkers showed no suppression, were more precise in selecting the second target, and made less order reversals than blinkers did. In contrast, non-blinkers made relatively more intrusions and showed a selection delay when the second target immediately followed the first target (at lag 1). Conclusion/Significance: The findings shed new light on the mechanisms that may underlie individual differences in selective attention. The notable ability of non-blinkers to accurately perceive targets presented in close temporal succession might be due to a relatively faster and more precise target selection process compared to large blinkers.	[Willems, Charlotte; Wierda, Stefan M.; Martens, Sander] Univ Groningen, Neuroimaging Ctr, Groningen, Netherlands; [Willems, Charlotte; Wierda, Stefan M.; Martens, Sander] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, NL-9713 AV Groningen, Netherlands; [van Viegen, Eva] Univ Groningen, Dept Artificial Intelligence, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Martens, S (corresponding author), Univ Groningen, Neuroimaging Ctr, Groningen, Netherlands.	s.martens@med.umcg.nl		Martens, Sander/0000-0001-8237-7984	Behavioural and Cognitive Neurosciences (BCN) Research School	Behavioural and Cognitive Neurosciences (BCN) Research School	This research was supported by a grant of the Behavioural and Cognitive Neurosciences (BCN) Research School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnell KM, 2006, MEM COGNITION, V34, P1472, DOI 10.3758/BF03195912; Arnell KM, 2010, PSYCHOL RES-PSYCH FO, V74, P457, DOI 10.1007/s00426-009-0265-8; Arnell KM, 2009, PSYCHOL RES, V74, P1; Botella J, 2011, ATTEN PERCEPT PSYCHO, V73, P1361, DOI 10.3758/s13414-011-0112-z; Chua FK, 2005, PERCEPT PSYCHOPHYS, V67, P770, DOI 10.3758/BF03193532; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Chun MM, 1997, PERCEPT PSYCHOPHYS, V59, P1191, DOI 10.3758/BF03214207; Colzato LS, 2007, PSYCHON B REV, V14, P1051, DOI 10.3758/BF03193090; Colzato LS, 2008, J EXP PSYCHOL LEARN, V34, P302, DOI 10.1037/0278-7393.34.2.302; Colzato LS, 2010, FRONTIERS PSYCHOL; Dale G, 2010, ATTEN PERCEPT PSYCHO, V72, P602, DOI 10.3758/APP.72.3.602; Dell'Acqua R, 2006, PSYCHOPHYSIOLOGY, V43, P394, DOI 10.1111/j.1469-8986.2006.00411.x; Dell'Acqua R, 2012, PSYCHON B REV, V19, P232, DOI 10.3758/s13423-011-0209-3; Dell'Acqua R, 2009, J EXP PSYCHOL HUMAN, V35, P338, DOI 10.1037/a0013555; Di Lollo V, 2005, PSYCHOL RES-PSYCH FO, V69, P191, DOI 10.1007/s00426-004-0173-x; Dux PE, 2008, PSYCHON B REV, V15, P809, DOI 10.3758/PBR.15.4.809; Dux PE, 2007, PSYCHON B REV, V14, P723, DOI 10.3758/BF03196828; Dux PE, 2009, ATTEN PERCEPT PSYCHO, V71, P1683, DOI 10.3758/APP.71.8.1683; Dux PE, 2009, PSYCHON B REV, V16, P219, DOI 10.3758/PBR.16.1.219; Dux PE, 2006, COGNITION, V99, P355, DOI 10.1016/j.cognition.2005.04.002; DUX PE, 2008, PLOS ONE, V3; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Harris IM, 2010, J EXP PSYCHOL HUMAN, V36, P1595, DOI 10.1037/a0019218; Jolicoeur P, 2006, EUR J COGN PSYCHOL, V18, P560, DOI 10.1080/09541440500423210; Jolicoeur P, 2006, PSYCHOL RES-PSYCH FO, V70, P414, DOI 10.1007/s00426-005-0008-4; Kihara K, 2011, J EXP PSYCHOL HUMAN, V37, P168, DOI 10.1037/a0019948; Loach D, 2003, VIS COGN, V10, P513, DOI 10.1080/13506280244000203; MacLean MH, 2010, PSYCHON B REV, V17, P556, DOI 10.3758/PBR.17.4.556; Martens S., 2010, PLOS ONE, V5; Martens S, 2009, EXP BRAIN RES, V192, P43, DOI 10.1007/s00221-008-1551-1; Martens S, 2006, J COGNITIVE NEUROSCI, V18, P1423, DOI 10.1162/jocn.2006.18.9.1423; Martens S, 2010, NEUROSCI BIOBEHAV R, V34, P947, DOI 10.1016/j.neubiorev.2009.12.005; Martens S, 2009, EXP PSYCHOL, V56, P33, DOI 10.1027/1618-3169.56.1.33; Martens S, 2009, EXP PSYCHOL, V56, P18, DOI 10.1027/1618-3169.56.1.18; McLaughlin EN, 2001, Q J EXP PSYCHOL-A, V54, P169, DOI 10.1080/02724980042000075; Nieuwenstein MR, 2006, J EXP PSYCHOL HUMAN, V32, P973, DOI 10.1037/0096-1523.32.4.973; Nieuwenstein MR, 2006, PSYCHOL SCI, V17, P471, DOI 10.1111/j.1467-9280.2006.01730.x; Nieuwenstein MR, 2005, J EXP PSYCHOL HUMAN, V31, P1463, DOI 10.1037/0096-1523.31.6.1463; Olivers CNL, 2008, VIS COGN, V16, P439, DOI 10.1080/13506280701825861; Olivers CNL, 2007, CURR DIR PSYCHOL SCI, V16, P11, DOI 10.1111/j.1467-8721.2007.00466.x; Olivers CNL, 2007, PSYCHOL RES-PSYCH FO, V71, P126, DOI 10.1007/s00426-005-0029-z; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P364, DOI 10.1037/0096-1523.32.2.364; Olivers CNL, 2005, PSYCHOL SCI, V16, P265, DOI 10.1111/j.0956-7976.2005.01526.x; Popple AV, 2007, VISION RES, V47, P2973, DOI 10.1016/j.visres.2007.06.022; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Rotte M, 1997, BIOL PSYCHOL, V46, P199, DOI 10.1016/S0301-0511(97)00018-5; Shapiro K, 2006, NEUROREPORT, V17, P163, DOI 10.1097/01.wnr.0000195670.37892.1a; SHAPIRO KL, 1994, J EXP PSYCHOL HUMAN, V20, P357, DOI 10.1037/0096-1523.20.2.357; Slagter HA, 2007, PLOS BIOL, V5, P1228, DOI 10.1371/journal.pbio.0050138; Slagter HA, 2012, J COGNITIVE NEUROSCI, V24, P1932, DOI 10.1162/jocn_a_00255; Slagter HA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010556; Smid HGOM, 1997, BIOL PSYCHOL, V44, P161, DOI 10.1016/S0301-0511(96)05216-7; Taatgen NA, 2009, COGNITIVE PSYCHOL, V59, P1, DOI 10.1016/j.cogpsych.2008.12.002; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656; Vogel EK, 2002, PSYCHON B REV, V9, P739, DOI 10.3758/BF03196329; Vul E, 2008, VISION RES, V48, P1902, DOI 10.1016/j.visres.2008.06.009; Vul E, 2008, PSYCHOL SCI, V19, P55, DOI 10.1111/j.1467-9280.2008.02046.x; Wierda SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015024; Wijers AA, 1989, THESIS U GRONINGEN G; Wyble B, 2009, J EXP PSYCHOL HUMAN, V35, P787, DOI 10.1037/a0013902	60	10	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e66185	10.1371/journal.pone.0066185	http://dx.doi.org/10.1371/journal.pone.0066185			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	157CD	23755299	Green Submitted, Green Published, gold			2022-12-27	WOS:000319872300102
J	Ng, T; Ryu, JR; Sohn, JH; Tan, T; Song, HJ; Ming, GL; Goh, ELK				Ng, Teclise; Ryu, Jae Ryun; Sohn, Jae Ho; Tan, Terence; Song, Hongjun; Ming, Guo-li; Goh, Eyleen L. K.			Class 3 Semaphorin Mediates Dendrite Growth in Adult Newborn Neurons through Cdk5/FAK Pathway	PLOS ONE			English	Article							FOCAL ADHESION KINASE; NEWLY GENERATED NEURONS; HIPPOCAMPAL NEUROGENESIS; SYNAPTIC INTEGRATION; SECRETED SEMAPHORINS; GUIDANCE SIGNALS; PRIMARY CILIA; STEM-CELLS; FAK; BRAIN	Class 3 semaphorins are well-known axonal guidance cues during the embryonic development of mammalian nervous system. However, their activity on postnatally differentiated neurons in neurogenic regions of adult brains has not been characterized. We found that silencing of semaphorin receptors neuropilins (NRP) 1 or 2 in neural progenitors at the adult mouse dentate gyrus resulted in newly differentiated neurons with shorter dendrites and simpler branching in vivo. Tyrosine phosphorylation (Tyr 397) and serine phosphorylation (Ser 732) of FAK were essential for these effects. Semaphorin 3A and 3F mediate serine phosphorylation of FAK through the activation of Cdk5. Silencing of either Cdk5 or FAK in newborn neurons phenocopied the defects in dendritic development seen upon silencing of NRP1 or NRP2. Furthermore, in vivo overexpression of Cdk5 or FAK rescued the dendritic phenotypes seen in NRP1 and NRP2 deficient neurons. These results point to a novel role for class 3 semaphorins in promoting dendritic growth and branching during adult hippocampal neurogenesis through the activation of Cdk5-FAK signaling pathway.	[Ng, Teclise; Ryu, Jae Ryun; Tan, Terence; Goh, Eyleen L. K.] Duke NUS Grad Med Sch, Program Neurosci & Behav Disorder, Singapore, Singapore; [Goh, Eyleen L. K.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore; [Sohn, Jae Ho; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD USA; [Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA	National University of Singapore; National University of Singapore; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Goh, ELK (corresponding author), Duke NUS Grad Med Sch, Program Neurosci & Behav Disorder, Singapore, Singapore.	eyleen.goh@duke-nus.edu.sg	Ming, Guo-li/J-7880-2013	Ming, Guo-li/0000-0002-2517-6075; Goh, Eyleen/0000-0002-8244-6959	Duke-NUS Graduate Medical School, Singapore; Competitive Research Program, Singapore National Research Foundation [NRF-CRP002-082]; National Institutes of Health [HD069184, NS048271]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048271] Funding Source: NIH RePORTER	Duke-NUS Graduate Medical School, Singapore; Competitive Research Program, Singapore National Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the startup fund from Duke-NUS Graduate Medical School, Singapore and partially supported by the Competitive Research Program, Singapore National Research Foundation (NRF-CRP002-082) to ELKG and by National Institutes of Health (HD069184, NS048271) to GLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnard D, 1998, DEVELOPMENT, V125, P5043; Bechara A, 2008, EMBO J, V27, P1549, DOI 10.1038/emboj.2008.86; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Bouzioukh F, 2006, EUR J NEUROSCI, V23, P2247, DOI 10.1111/j.1460-9568.2006.04783.x; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Chacon MR, 2011, CELL ADHES MIGR, V5, P52, DOI 10.4161/cam.5.1.13681; Chacon MR, 2010, MOL CELL NEUROSCI, V44, P30, DOI 10.1016/j.mcn.2010.02.001; Degano AL, 2009, MOL CELL NEUROSCI, V42, P243, DOI 10.1016/j.mcn.2009.07.009; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Fenstermaker V, 2004, J NEUROBIOL, V58, P403, DOI 10.1002/neu.10304; Gant JC, 2009, EPILEPSIA, V50, P629, DOI 10.1111/j.1528-1167.2008.01725.x; Garrett AM, 2012, NEURON, V74, P269, DOI 10.1016/j.neuron.2012.01.028; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Giger RJ, 2000, NEURON, V25, P29, DOI 10.1016/S0896-6273(00)80869-7; Goh ELK, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-10; Good PF, 2004, J NEUROCHEM, V91, P716, DOI 10.1111/j.1471-4159.2004.02766.x; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Gu Y, 2012, NAT NEUROSCI, V15, P1700, DOI 10.1038/nn.3260; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Heiz M, 2004, J BIOL CHEM, V279, P31149, DOI 10.1074/jbc.M403587200; Holtmaat AJGD, 2003, EXP NEUROL, V182, P142, DOI 10.1016/S0014-4886(03)00035-9; Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x; Kaneko S, 2006, NAT MED, V12, P1380, DOI 10.1038/nm1505; Kempermann G, 2008, CURR OPIN PSYCHIATR, V21, P290, DOI 10.1097/YCO.0b013e3282fad375; Kim JY, 2012, CELL, V148, P1051, DOI 10.1016/j.cell.2011.12.037; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kumamoto N, 2012, NAT NEUROSCI, V15, P399, DOI 10.1038/nn.3042; Le Boeuf F, 2006, MOL BIOL CELL, V17, P3508, DOI 10.1091/mbc.E05-12-1158; Li WQ, 2004, NAT NEUROSCI, V7, P1213, DOI 10.1038/nn1329; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lin EH, 2004, EXP CELL RES, V293, P1, DOI 10.1016/j.yexcr.2003.09.008; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Morita A, 2006, J NEUROSCI, V26, P2971, DOI 10.1523/JNEUROSCI.5453-05.2006; Nakamura F, 2009, J COMP NEUROL, V516, P360, DOI 10.1002/cne.22125; Nishiyama M, 2011, NAT CELL BIOL, V13, P676, DOI 10.1038/ncb2255; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Park AYJ, 2009, J BIOL CHEM, V284, P9418, DOI 10.1074/jbc.M809040200; Pasterkamp RJ, 2009, CURR OPIN NEUROBIOL, V19, P263, DOI 10.1016/j.conb.2009.06.001; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; Rosario AL, 2012, NATURE NEUROSCIENCE; Sahay A, 2005, J NEUROSCI, V25, P3613, DOI 10.1523/JNEUROSCI.5255-04.2005; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schlomann U, 2009, J CELL SCI, V122, P2034, DOI 10.1242/jcs.038232; Shivaraj MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042935; Suo L, 2012, J MOL CELL BIOL, V4, P362, DOI 10.1093/jmcb/mjs034; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Tran TS, 2009, NATURE, V462, P1065, DOI 10.1038/nature08628; Wang Y, 2011, MOL BIOL CELL, V22, P1529, DOI 10.1091/mbc.E10-09-0785; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6	53	35	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65572	10.1371/journal.pone.0065572	http://dx.doi.org/10.1371/journal.pone.0065572			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762397	Green Published, Green Submitted, gold			2022-12-27	WOS:000320440500044
J	Wang, F; Shao, NM; Cheng, YY				Wang, Fei; Shao, Naimin; Cheng, Yiyun			Paramagnetic NMR Investigation of Dendrimer-Based Host-Guest Interactions	PLOS ONE			English	Article							RELAXATION ENHANCEMENT; MOLECULAR ELECTRONICS; STARBURST DENDRIMERS; SURFACTANTS; DIFFUSION; ENCAPSULATION; COBALT(II); COMPLEXES; CHEMISTRY; DELIVERY	In this study, the host-guest behavior of poly(amidoamine) (PAMAM) dendrimers bearing amine, hydroxyl, or carboxylate surface functionalities were investigated by paramagnetic NMR studies. 2,2,6,6-Tetramethylpiperidinyloxy (TEMPO) derivatives were used as paramagnetic guest molecules. The results showed that TEMPO-COOH significantly broaden the H-1 NMR peaks of amine- and hydroxyl-terminated PAMAM dendrimers. In comparison, no paramagnetic relaxation enhancement (PRE) was observed between TEMPO-NH2, TEMPO-OH and the three types of PAMAM dendrimers. The PRE phenomenon observed is correlated with the encapsulation of TEMPO-COOH within dendrimer pockets. Protonation of the tertiary amine groups within PAMAM dendrimers plays an important role during this process. Interestingly, the absence of TEMPO-COOH encapsulation within carboxylate-terminated PAMAM dendrimer is observed due to the repulsion of TEMPO-COO- anion and anionic dendrimer surface. The combination of paramagnetic probes and H-1 NMR linewidth analysis can be used as a powerful tool in the analysis of dendrimer-based host-guest systems.	[Wang, Fei; Shao, Naimin; Cheng, Yiyun] E China Normal Univ, Sch Life Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200062, Peoples R China; [Cheng, Yiyun] E China Normal Univ, Dept Phys, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China	East China Normal University; East China Normal University	Cheng, YY (corresponding author), E China Normal Univ, Sch Life Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200062, Peoples R China.	yycheng@mail.ustc.edu.cn			Science and Technology of Shanghai Municipality [11DZ2260300]; Talent Program of East China Normal University [77202201]; Program for New Century Excellent Talents in University of Ministry of Education of China	Science and Technology of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Talent Program of East China Normal University; Program for New Century Excellent Talents in University of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET))	The authors are thankful for financial support from the Science and Technology of Shanghai Municipality (11DZ2260300), the Talent Program of East China Normal University (No.77202201), and the Program for New Century Excellent Talents in University of Ministry of Education of China on this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astruc D, 2008, ACCOUNTS CHEM RES, V41, P841, DOI 10.1021/ar8000074; Astruc D, 2010, CHEM REV, V110, P1857, DOI 10.1021/cr900327d; Aulenta F, 2003, EUR POLYM J, V39, P1741, DOI 10.1016/S0014-3057(03)00100-9; Baars MWPL, 1997, CHEM COMMUN, P1959; Boisselier E, 2008, CHEM-EUR J, V14, P5577, DOI 10.1002/chem.200701607; Boisselier E, 2010, CHEM-EUR J, V16, P6056, DOI 10.1002/chem.200902995; Caminade AM, 2005, ADV DRUG DELIVER REV, V57, P2130, DOI 10.1016/j.addr.2005.09.011; Caminade AM, 2012, CHEM SOC REV, DOI [10.1039/C2CS35030K: ASAP, DOI 10.1039/C2CS35030K:ASAP]; Caminade AM, 2008, CHEM-EUR J, V14, P7422, DOI 10.1002/chem.200800584; Caminade AM, 2010, CHEM SOC REV, V39, P2034, DOI 10.1039/b926408f; Cheng YY, 2008, J PHYS CHEM B, V112, P12674, DOI 10.1021/jp804954j; Cheng YY, 2011, CHEM SOC REV, V40, P2673, DOI 10.1039/c0cs00097c; Clore GM, 2009, CHEM REV, V109, P4108, DOI 10.1021/cr900033p; COHEN EA, 1975, ORG MAGN RESONANCE, V7, P605, DOI 10.1002/mrc.1270071210; D'Emanuele A, 2005, ADV DRUG DELIVER REV, V57, P2147, DOI 10.1016/j.addr.2005.09.012; Epperson JD, 1999, INORG CHEM, V38, P4498, DOI 10.1021/ic9906860; Epperson JD, 2001, J AM CHEM SOC, V123, P8583, DOI 10.1021/ja015856y; Esfand R, 2001, DRUG DISCOV TODAY, V6, P427, DOI 10.1016/S1359-6446(01)01757-3; Fang M, 2012, J PHYS CHEM B, V116, P3075, DOI 10.1021/jp211384p; Fang M, 2010, J PHYS CHEM B, V114, P6048, DOI 10.1021/jp100805u; Feng XY, 2011, J PHYS CHEM B, V115, P3777, DOI 10.1021/jp2003613; Furtado F, 2011, ENVIRON SCI TECHNOL, V45, P8866, DOI 10.1021/es2010946; Hu JJ, 2012, CHEM REV, V112, P3856, DOI 10.1021/cr200333h; Hu JJ, 2009, J PHYS CHEM B, V113, P64, DOI 10.1021/jp8078919; JANSEN JFGA, 1994, SCIENCE, V266, P1226, DOI 10.1126/science.266.5188.1226; JANSEN JFGA, 1995, ANGEW CHEM INT EDIT, V34, P1206, DOI 10.1002/anie.199512061; JANSEN JFGA, 1995, J AM CHEM SOC, V117, P4417, DOI 10.1021/ja00120a032; Menjoge AR, 2010, DRUG DISCOV TODAY, V15, P171, DOI 10.1016/j.drudis.2010.01.009; NAYLOR AM, 1989, J AM CHEM SOC, V111, P2339, DOI 10.1021/ja00188a079; Ottaviani MF, 1997, J PHYS CHEM B, V101, P6057, DOI 10.1021/jp963271y; Ottaviani MF, 1996, COLLOID SURFACE A, V115, P9, DOI 10.1016/0927-7757(96)03597-2; Pintacuda G, 2007, ACCOUNTS CHEM RES, V40, P206, DOI 10.1021/ar050087z; Tomalia DA, 2005, PROG POLYM SCI, V30, P294, DOI 10.1016/j.progpolymsci.2005.01.007; Tomalia DA, 2012, NEW J CHEM, V36, P264, DOI 10.1039/c1nj20501c; Tomalia DA, 2010, SOFT MATTER, V6, P456, DOI 10.1039/b917370f; van Duijvenbode RC, 2000, MACROMOLECULES, V33, P46, DOI 10.1021/ma990968j; Wang MM, 2011, J PHYS CHEM B, V115, P12728, DOI 10.1021/jp207817f; Xue Y, 2009, PROTEIN SCI, V18, P1401, DOI 10.1002/pro.153; Yang K, 2011, J PHYS CHEM B, V115, P2185, DOI 10.1021/jp111044k; Yang K, 2010, J PHYS CHEM B, V114, P7265, DOI 10.1021/jp1026493; Zhao LB, 2010, J AM CHEM SOC, V132, P13182, DOI 10.1021/ja106128u	41	2	2	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e64722	10.1371/journal.pone.0064722	http://dx.doi.org/10.1371/journal.pone.0064722			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762249	Green Published, Green Submitted, gold			2022-12-27	WOS:000320440500006
J	Yang, YB; Sun, YF; Zhang, Y; Jiang, Y; Tang, JJ; Zhu, X; Miao, DM				Yang, Yebing; Sun, Yunfeng; Zhang, Ying; Jiang, Yuan; Tang, Jingjing; Zhu, Xia; Miao, Danmin			Bifactor Item Response Theory Model of Acute Stress Response	PLOS ONE			English	Article							DISORDER; TRAUMA	Background: Better understanding of acute stress responses is important for revision of DSM-5. However, the latent structure and relationship between different aspects of acute stress responses haven't been clarified comprehensively. Bifactor item response model may help resolve this problem. Objective: The purpose of this study is to develop a statistical model of acute stress responses, based on data from earthquake rescuers using Acute Stress Response Scale (ASRS). Through this model, we could better understand acute stress responses comprehensively, and provide preliminary information for computerized adaptive testing of stress responses. Methods: Acute stress responses of earthquake rescuers were evaluated using ASRS, and state/trait anxiety were assessed using State-trait Anxiety Inventory (STAI). A hierarchical item response model (bifactor model) was used to analyze the data. Additionally, we tested this hierarchical model with model fit comparisons with one-dimensional and five-dimensional models. The correlations among acute stress responses and state/trait anxiety were compared, based on both the five-dimensional and bifactor models. Results: Model fit comparisons showed bifactor model fit the data best. Item loadings on general and specific factors varied greatly between different aspects of stress responses. Many symptoms (40%) of physiological responses had positive loadings on general factor, and negative loadings on specific factor of physiological responses, while other stress responses had positive loadings on both general and specific factors. After extracting general factor of stress responses using bifactor analysis, significant positive correlations between physiological responses and state/trait anxiety (r = 0.185/0.112, p < 0.01) changed into negative ones (r = -0.177/-0.38, p < 0.01). Conclusion: Our results demonstrated bifactor structure of acute stress responses, and positive and negative correlations between physiological responses and stress responses suggested physiological responses could have negative feedback on severity of stress responses. This finding has not been convincingly demonstrated in previous research.	[Yang, Yebing; Sun, Yunfeng; Jiang, Yuan; Zhu, Xia; Miao, Danmin] Fourth Mil Med Univ, Dept Psychol, Xian 710032, Shaanxi Provinc, Peoples R China; [Yang, Yebing] Navy Gen Hosp, Aviat & Diving Med Ctr, Beijing, Peoples R China; [Sun, Yunfeng] Natl Def Univ, Force Dev & Mil Polit Work Acad Dept, Beijing, Peoples R China; [Zhang, Ying] Chinese Peoples Liberat Army, Hosp 309, Dept Psychol, Beijing, Peoples R China; [Tang, Jingjing] Second Leading Cadre Nanjing Mil Command, Dept Publ Hlth, Nanjing, Jiangsu, Peoples R China	Air Force Military Medical University; Sixth Medical Center of Chinese PLA General Hospital	Zhu, X (corresponding author), Fourth Mil Med Univ, Dept Psychol, Xian 710032, Shaanxi Provinc, Peoples R China.	zhuxia@fmmu.edu.cn; miaodanmin@hotmail.com			Department of Psychology, Fourth Military Medical University	Department of Psychology, Fourth Military Medical University	This study was supported by the Department of Psychology, Fourth Military Medical University, where it was conducted, and the authors received no external funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; American Psychiatric Association, 2011, DIAGN STAT MAN MENT; Bryant RA, 2012, J PSYCHIATR RES, V46, P168, DOI 10.1016/j.jpsychires.2011.10.007; Bryant RA, 2011, DEPRESS ANXIETY, V28, P802, DOI 10.1002/da.20737; Campbell J, 2012, PSYCHONEUROENDOCRINO, V37, P1111, DOI 10.1016/j.psyneuen.2011.12.010; Coronas R, 2011, EUR PSYCHIAT, V26, P508, DOI 10.1016/j.eurpsy.2010.06.006; Delahanty DL, 2005, PSYCHONEUROENDOCRINO, V30, P121, DOI 10.1016/j.psyneuen.2004.06.004; Gibbons RD, 2012, ARCH GEN PSYCHIAT, V69, P1104, DOI 10.1001/archgenpsychiatry.2012.14; Gibbons RD, 2009, J PSYCHIATR RES, V43, P401, DOI 10.1016/j.jpsychires.2008.04.013; Grinker RR, 1945, MEN STRESS, P82; Phillips AC, 2011, INT J PSYCHOPHYSIOL, V81, P332, DOI 10.1016/j.ijpsycho.2011.08.002; Reise SP, 2011, PSYCHOL ASSESSMENT, V23, P245, DOI 10.1037/a0021501; Shalev AY, 2002, BIOL PSYCHIAT, V51, P532, DOI 10.1016/S0006-3223(02)01335-5; Simms Leonard J, 2008, Depress Anxiety, V25, pE34, DOI 10.1002/da.20432; Spielberger C. D., 1983, MIND GARDEN; Thomas ML, 2011, ASSESSMENT, V18, P291, DOI 10.1177/1073191110374797; Xie JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047577; Yang YB, 2011, SOC BEHAV PERSONAL, V39, P713, DOI 10.2224/sbp.2011.39.5.713; Yehuda R, 1998, BIOL PSYCHIAT, V44, P1305, DOI 10.1016/S0006-3223(98)00276-5	20	4	5	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65291	10.1371/journal.pone.0065291	http://dx.doi.org/10.1371/journal.pone.0065291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	173QU	23762336	Green Submitted, Green Published, gold			2022-12-27	WOS:000321094800035
J	Heimer, SR; Evans, DJ; Mun, JJ; Stern, ME; Fleiszig, SMJ				Heimer, Susan R.; Evans, David J.; Mun, James J.; Stern, Michael E.; Fleiszig, Suzanne M. J.			Surfactant Protein D Contributes to Ocular Defense against Pseudomonas aeruginosa in a Murine Model of Dry Eye Disease	PLOS ONE			English	Article							HUMAN TEAR FLUID; CORNEAL EPITHELIAL-CELLS; DESICCATING STRESS; CONJUNCTIVAL EPITHELIUM; MICROBIAL KERATITIS; BACTERIAL KERATITIS; INFECTIVE KERATITIS; CYTOKINE PROFILES; SJOGRENS-SYNDROME; MOUSE MODEL	Dry eye disease can cause ocular surface inflammation that disrupts the corneal epithelial barrier. While dry eye patients are known to have an increased risk of corneal infection, it is not known whether there is a direct causal relationship between these two conditions. Here, we tested the hypothesis that experimentally-induced dry eye (EDE) increases susceptibility to corneal infection using a mouse model. In doing so, we also examined the role of surfactant protein D (SP-D), which we have previously shown is involved in corneal defense against infection. Scopolamine injections and fan-driven air were used to cause EDE in C57BL/6 or Black Swiss mice (wild-type and SP-D gene-knockout). Controls received PBS injections and were housed normally. After 5 or 10 days, otherwise uninjured corneas were inoculated with 10(9) cfu of Pseudomonas aeruginosa strain PAO1. Anesthesia was maintained for 3 h post-inoculation. Viable bacteria were quantified in ocular surface washes and corneal homogenates 6 h post-inoculation. SP-D was measured by Western immunoblot, and corneal pathology assessed from 6 h to 4 days. EDE mice showed reduced tear volumes after 5 and 10 days (each by similar to 75%, p<0.001) and showed fluorescein staining (i.e. epithelial disruption). Surprisingly, there was no significant difference in corneal pathology between EDE mice and controls (similar to 10-14% incidence). Before bacterial inoculation, EDE mice showed elevated SP-D in ocular washes. After inoculation, fewer bacteria were recovered from ocular washes of EDE mice (<2% of controls, p = 0.0004). Furthermore, SP-D knockout mice showed a significant increase in P. aeruginosa corneal colonization under EDE conditions. Taken together, these data suggest that SP-D contributes to corneal defense against P. aeruginosa colonization and infection in EDE despite the loss of barrier function to fluorescein.	[Heimer, Susan R.; Evans, David J.; Mun, James J.; Fleiszig, Suzanne M. J.] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [Heimer, Susan R.; Evans, David J.; Fleiszig, Suzanne M. J.] Touro Univ Calif, Coll Pharm, Vallejo, CA USA; [Stern, Michael E.] Allergan Pharmaceut Inc, Irvine, CA USA; [Fleiszig, Suzanne M. J.] Univ Calif Berkeley, Grad Grp Vis Sci, Berkeley, CA 94720 USA; [Fleiszig, Suzanne M. J.] Univ Calif Berkeley, Grad Grp Microbiol, Berkeley, CA 94720 USA; [Fleiszig, Suzanne M. J.] Univ Calif Berkeley, Grad Grp Infect Dis & Immun, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Touro University California; AbbVie; Allergan; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Fleiszig, SMJ (corresponding author), Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA.	fleiszig@berkeley.edu		Evans, David/0000-0002-6885-2053; Fleiszig, Suzanne/0000-0001-6324-3462	National Institutes of Health (NIH) [EY011221]; Allergan Inc.; University of California, Berkeley; NATIONAL EYE INSTITUTE [R01EY011221] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Allergan Inc.(AbbVieAllergan); University of California, Berkeley(University of California System); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by the National Institutes of Health (NIH) EY011221 (SMJF) and by Allergan Inc. Funding from Allergan Inc. was provided under a research agreement with the University of California, Berkeley. The NIH had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Stern is a paid employee of Allergan Inc., and contributed to this work in his capacity as an expert in dry eye disease. Dr. Stern contributed to conception of the project idea, and to the study design and writing of the manuscript. No other external funding was received for this work.	Al-Yousuf N, 2009, MIDDLE EAST AFR J OP, V16, P3, DOI 10.4103/0974-9233.48855; Argueso P, 2002, INVEST OPHTH VIS SCI, V43, P1004; Augustin DK, 2011, INFECT IMMUN, V79, P595, DOI 10.1128/IAI.00854-10; Beardsley RM, 2008, CORNEA, V27, P935, DOI 10.1097/ICO.0b013e3181757997; Bourcier T, 2003, BRIT J OPHTHALMOL, V87, P834, DOI 10.1136/bjo.87.7.834; Bufler P, 2003, AM J RESP CELL MOL, V28, P249, DOI 10.1165/rcmb.4896; Butler TKH, 2005, BRIT J OPHTHALMOL, V89, P591, DOI 10.1136/bjo.2004.049072; Caffery B, 2008, OPTOMETRY VISION SCI, V85, P661, DOI 10.1097/OPX.0b013e318181ae4f; Caffery B, 2010, MOL VIS, V16, P1720; Chauhan SK, 2009, J IMMUNOL, V182, P1247, DOI 10.4049/jimmunol.182.3.1247; Chen DM, 2009, EXP EYE RES, V88, P880, DOI 10.1016/j.exer.2008.11.035; Corrales RM, 2007, CORNEA, V26, P579, DOI 10.1097/ICO.0b013e318033a729; Corrales RM, 2006, INVEST OPHTH VIS SCI, V47, P3293, DOI 10.1167/iovs.05-1382; Danjo Y, 1998, INVEST OPHTH VIS SCI, V39, P2602; De Paiva CS, 2009, MUCOSAL IMMUNOL, V2, P243, DOI 10.1038/mi.2009.5; De Paiva CS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1625, DOI 10.1001/archophthalmol.2009.316; Douda DN, 2011, J IMMUNOL, V187, P1856, DOI 10.4049/jimmunol.1004201; Dursun D, 2002, INVEST OPHTH VIS SCI, V43, P632; Enriquez-de-Salamanca A, 2010, MOL VIS, V16, P862; FLEISZIG SMJ, 1994, INFECT IMMUN, V62, P1799, DOI 10.1128/IAI.62.5.1799-1804.1994; Fleiszig SMJ, 2003, INFECT IMMUN, V71, P3866, DOI 10.1128/IAI.71.7.3866-3874.2003; FLEISZIG SMJ, 1994, ADV EXP MED BIOL, V350, P359; Giannoni E, 2006, AM J RESP CELL MOL, V34, P704, DOI 10.1165/rcmb.2005-0461OC; Gipson IK, 2011, CORNEA, V30, P1346, DOI 10.1097/ICO.0b013e31820d852a; Green M, 2008, CORNEA, V27, P22, DOI 10.1097/ICO.0b013e318156caf2; Hazlett Linda D, 2007, Chem Immunol Allergy, V92, P185, DOI 10.1159/000099269; He YC, 2000, J BIOL CHEM, V275, P31051, DOI 10.1074/jbc.M003499200; Jhanji V, 2009, BRIT J OPHTHALMOL, V93, P1639, DOI 10.1136/bjo.2008.154468; Kawasaki S, 2003, EXP EYE RES, V77, P17, DOI 10.1016/S0014-4835(03)00087-3; Kwong MSF, 2007, INFECT IMMUN, V75, P2325, DOI 10.1128/IAI.01404-06; Lam H, 2009, AM J OPHTHALMOL, V147, P198, DOI 10.1016/j.ajo.2008.08.032; Lee EJ, 2003, INVEST OPHTH VIS SCI, V44, P5220, DOI 10.1167/iovs.03-0229; Luo LH, 2004, INVEST OPHTH VIS SCI, V45, P4293, DOI 10.1167/iovs.03-1145; Madan T, 2005, J IMMUNOL, V174, P6943, DOI 10.4049/jimmunol.174.11.6943; McCormick CC, 2007, OCUL IMMUNOL INFLAMM, V15, P371, DOI 10.1080/09273940701486423; McDermott AM, 2009, OPHTHALMIC RES, V41, P60, DOI 10.1159/000187622; Mun JJ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00008; Mun JJ, 2009, INFECT IMMUN, V77, P2392, DOI 10.1128/IAI.00173-09; Narayanan S, 2003, INVEST OPHTH VIS SCI, V44, P3795, DOI 10.1167/iovs.02-1301; Ni M, 2005, INFECT IMMUN, V73, P2147, DOI 10.1128/IAI.73.4.2147-2156.2005; Ni MJ, 2008, FEMS IMMUNOL MED MIC, V54, P177, DOI 10.1111/j.1574-695X.2008.00461.x; Niederkorn JY, 2006, J IMMUNOL, V176, P3950, DOI 10.4049/jimmunol.176.7.3950; Pearlman E, 2008, OCUL SURF, V6, P108, DOI 10.1016/S1542-0124(12)70279-3; Pflugfelder SC, 2005, AM J PATHOL, V166, P61, DOI 10.1016/S0002-9440(10)62232-8; Pitcher JD, 2011, INVEST OPHTH VIS SCI, V52, P3221, DOI 10.1167/iovs.09-4212; Redfern RL, 2011, EXP EYE RES, V92, P209, DOI 10.1016/j.exer.2010.12.005; Schaefer F, 2001, BRIT J OPHTHALMOL, V85, P842, DOI 10.1136/bjo.85.7.842; Solomon A, 2001, INVEST OPHTH VIS SCI, V42, P2283; Stapleton F, 2012, EYE, V26, P185, DOI 10.1038/eye.2011.288; Stern ME, 2004, EXP EYE RES, V78, P409, DOI 10.1016/j.exer.2003.09.003; Tam C, 2010, INVEST OPHTH VIS SCI, V51, P3100, DOI 10.1167/iovs.09-4593; Wei Y, 2011, INVEST OPHTH VIS SCI, V52, P4780, DOI 10.1167/iovs.10-6350; Whitsett JA, 2010, INNATE IMMUN-LONDON, V16, P138, DOI 10.1177/1753425910366879; Wong T, 2003, BRIT J OPHTHALMOL, V87, P1103, DOI 10.1136/bjo.87.9.1103; Wu HX, 2003, J CLIN INVEST, V111, P1589, DOI 10.1172/JCI200316889; Yu DF, 2008, EXP EYE RES, V86, P403, DOI 10.1016/j.exer.2007.11.013; Zhou L, 2009, J PROTEOME RES, V8, P4889, DOI 10.1021/pr900686s	57	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65797	10.1371/journal.pone.0065797	http://dx.doi.org/10.1371/journal.pone.0065797			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762428	Green Published, gold, Green Submitted			2022-12-27	WOS:000321099000106
J	Jonnalagadda, M; Brown, CE; Chang, WC; Ostberg, JR; Forman, SJ; Jensen, MC				Jonnalagadda, Mahesh; Brown, Christine E.; Chang, Wen-Chung; Ostberg, Julie R.; Forman, Stephen J.; Jensen, Michael C.			Engineering Human T Cells for Resistance to Methotrexate and Mycophenolate Mofetil as an In Vivo Cell Selection Strategy	PLOS ONE			English	Article							HUMAN DIHYDROFOLATE-REDUCTASE; HEMATOPOIETIC STEM-CELLS; GENE-TRANSFER; IMMUNE-RESPONSES; VITRO SELECTION; LYMPHOCYTES; THERAPY; VECTOR; EXPANSION; TRANSPLANTATION	Gene transfer and drug selection systems that enforce ongoing transgene expression in vitro and in vivo which are compatible with human pharmaceutical drugs are currently underdeveloped. Here, we report on the utility of incorporating human enzyme muteins that confer resistance to the lymphotoxic/immunosuppressive drugs methotrexate (MTX) and mycophenolate mofetil (MMF) in a multicistronic lentiviral vector for in vivo T lymphocyte selection. We found that co-expression of human dihydrofolate reductase (DHFRFS; L22F, F31S) and inosine monophosphate dehydrogenase II (IMPDH2(IY); T333I, S351Y) conferred T cell resistance to the cytocidal and anti-proliferative effects of these drugs at concentrations that can be achieved clinically (up to 0.1 mu M MTX and 1.0 mu M MPA). Furthermore, using a immunodeficient mouse model that supports the engraftment of central memory derived human T cells, in vivo selection studies demonstrate that huEGFRt(+)DHFR(FS+)IMPDH2(IY+) T cells could be enriched following adoptive transfer either by systemic administration of MTX alone (4.4 -fold), MMF alone (2.9-fold), or combined MTX and MMF (4.9-fold). These findings demonstrate the utility of both DHFRFS/MTX and IMPDH2(IY)/MMF for in vivo selection of lentivirally transduced human T cells. Vectors incorporating these muteins in combination with other therapeutic transgenes may facilitate the selective engraftment of therapeutically active cells in recipients.	[Jonnalagadda, Mahesh; Brown, Christine E.; Chang, Wen-Chung; Ostberg, Julie R.; Forman, Stephen J.; Jensen, Michael C.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Immunotherapeut & Tumor Immunol, Duarte, CA USA; [Jonnalagadda, Mahesh; Brown, Christine E.; Chang, Wen-Chung; Ostberg, Julie R.; Forman, Stephen J.; Jensen, Michael C.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA; [Jensen, Michael C.] Seattle Childrens Res Inst, Ben Towne Ctr Childhood Canc Res, Seattle, WA USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; Seattle Children's Hospital	Jensen, MC (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Immunotherapeut & Tumor Immunol, Duarte, CA USA.	michael.jensen@seattlechildrens.org		Brown, Christine/0000-0003-4915-8207	National Institutes of Health [P50 CA107399, PO1 CA030206]; Lymphoma Research Foundation; Tim Nesvig Lymphoma Research Foundation; Neidorf Foundation; Marcus Foundation; Timothy Lindenfelser; NATIONAL CANCER INSTITUTE [P01CA030206, P50CA107399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lymphoma Research Foundation; Tim Nesvig Lymphoma Research Foundation; Neidorf Foundation; Marcus Foundation; Timothy Lindenfelser; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by National Institutes of Health P50 CA107399, PO1 CA030206, the Lymphoma Research Foundation, the Tim Nesvig Lymphoma Research Foundation, the Neidorf Foundation, the Marcus Foundation, and Timothy Lindenfelser. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abonour R, 2000, NAT MED, V6, P652, DOI 10.1038/76225; Allison AC, 2000, IMMUNOPHARMACOLOGY, V47, P85, DOI 10.1016/S0162-3109(00)00188-0; [Anonymous], 2005, MYC MOF CELLCEPT PAC; Berger C, 2006, BLOOD, V107, P2294, DOI 10.1182/blood-2005-08-3503; Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; CATAPANO CV, 1995, MOL PHARMACOL, V47, P948; Dubus I, 2002, KIDNEY INT, V62, P857, DOI 10.1046/j.1523-1755.2002.00514.x; ErcikanAbali EA, 1996, CANCER RES, V56, P4142; FLASSHOVE M, 1995, LEUKEMIA, V9, pS34; FLASSHOVE M, 1995, BLOOD, V85, P566; Fossati E, 2008, J BIOMOL SCREEN, V13, P504, DOI 10.1177/1087057108318783; FRANKLIN TJ, 1994, ADV ENZYME REGUL, V34, P107, DOI 10.1016/0065-2571(94)90011-6; Gatlin J, 2000, HUM GENE THER, V11, P1949, DOI 10.1089/10430340050129558; Jena B, 2010, BLOOD, V116, P1035, DOI 10.1182/blood-2010-01-043737; Jonnalagadda M, 2013, GENE THER; June CH, 2007, J CLIN INVEST, V117, P1466, DOI 10.1172/JCI32446; Kalos M, 2011, SCI TRANSL MED, V3; LEWIS WS, 1995, J BIOL CHEM, V270, P5057, DOI 10.1074/jbc.270.10.5057; Lobo ED, 2003, J PHARM SCI-US, V92, P1654, DOI 10.1002/jps.10431; McIvor RS, 1996, BONE MARROW TRANSPL, V18, pS50; Milsom MD, 2004, J GENE MED, V6, P133, DOI 10.1002/jgm.533; Morgan RA, 2003, J IMMUNOL, V171, P3287, DOI 10.4049/jimmunol.171.6.3287; Muul LM, 2007, CURR GENE THER, V7, P361, DOI 10.2174/156652307782151489; NGUYEN BT, 1984, CANCER RES, V44, P2272; Pankiewicz KW, 1999, CURR MED CHEM, V6, P629; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Quemeneur L, 2003, J IMMUNOL, V170, P4986, DOI 10.4049/jimmunol.170.10.4986; Riddell SR, 1996, NAT MED, V2, P216, DOI 10.1038/nm0296-216; Sangiolo D, 2007, GENE THER, V14, P1549, DOI 10.1038/sj.gt.3303018; Shimmura H, 2006, TRANSPLANTATION, V82, P175, DOI 10.1097/01.tp.0000226227.79142.31; Sorg UR, 2007, DNA REPAIR, V6, P1197, DOI 10.1016/j.dnarep.2007.03.021; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Treon SP, 1996, CLIN CHEM, V42, P1322; Volpato JP, 2011, J MOL RECOGNIT, V24, P188, DOI 10.1002/jmr.1037; Walker RE, 1998, NAT MED, V4, P852, DOI 10.1038/nm0798-852; Wang XL, 2012, J IMMUNOTHER, V35, P689, DOI 10.1097/CJI.0b013e318270dec7; Wang XL, 2011, BLOOD, V118, P1255, DOI 10.1182/blood-2011-02-337360; Wang XL, 2011, BLOOD, V117, P1888, DOI 10.1182/blood-2010-10-310599; Yam P, 2006, MOL THER, V14, P236, DOI 10.1016/j.ymthe.2006.02.017	39	21	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65519	10.1371/journal.pone.0065519	http://dx.doi.org/10.1371/journal.pone.0065519			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755242	Green Published, Green Submitted, gold			2022-12-27	WOS:000321099000074
J	Li, CY; Song, B; Wang, YY; Meng, H; Guo, SB; Liu, LN; Lv, HC; Wu, QJ				Li, Chun-Yan; Song, Bo; Wang, Ying-Yan; Meng, Hua; Guo, Shi-Bin; Liu, Li-Na; Lv, Hai-Chen; Wu, Qi-Jun			Age at Menarche and Risk of Colorectal Cancer: A Meta-Analysis	PLOS ONE			English	Article							HORMONE REPLACEMENT THERAPY; ORAL-CONTRACEPTIVE USE; GENOME-WIDE ASSOCIATION; REPRODUCTIVE FACTORS; COLON-CANCER; MENSTRUAL FACTORS; HISTORY; WOMEN; EXPRESSION; MORTALITY	Background: Various observational studies have focused on the relationship between menarcheal age and the risk of colorectal cancer (CRC). However, the association is still controversial because of inconsistent results. Therefore, we performed a meta-analysis to assess this issue from epidemiological studies. Methods: After a literature search in MEDLINE, EMBASE, and Web of Science for studies of menarcheal age and CRC risk published through the end of January 2013, we pooled the relative risks (RRs) from included studies using a fixed-or random-effects model and performed heterogeneity and publication bias analyses. All statistical tests were two-sided. Results: Eleven case-control and 11 cohort studies were eligible for inclusion in our analysis. The random-effects pooled RR for oldest versus youngest menarcheal age was 0.95 [95% confidence intervals (CIs) = 0.85-1.06], with significant heterogeneity (Q = 61.03, P, 0.001, I-2 = 65.6%). When separately analyzed, case-control (RR = 0.95, 95% CI = 0.75-1.21) and cohort studies (RR = 0.97, 95% CI = 0.90-1.04) yielded similar results. Moreover, similar results were also observed among the subgroup analyses by study quality, population, exposure assessment, anatomic cancer site, subsite of colon cancer, and several potential important confounders and risk factors. There was no evidence of publication bias and significant heterogeneity between subgroups detected by meta-regression analyses. Conclusions: Findings from this meta-analysis demonstrated that menarcheal age was not associated with the risk of CRC in humans. Further studies are warranted to stratify results by the subsite of colon cancer and menopause status in the future.	[Li, Chun-Yan; Meng, Hua; Guo, Shi-Bin; Liu, Li-Na] Dalian Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Dalian, Peoples R China; [Song, Bo] Dalian Med Univ, Dept Pathol, Dalian, Peoples R China; [Wang, Ying-Yan] Dalian Med Univ, Lab Ctr Diagnost, Dalian, Peoples R China; [Lv, Hai-Chen] Fudan Univ, Shanghai 200433, Peoples R China; [Wu, Qi-Jun] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Epidemiol,Shanghai Canc Inst, Shanghai, Peoples R China	Dalian Medical University; Dalian Medical University; Dalian Medical University; Fudan University; Shanghai Jiao Tong University	Li, CY (corresponding author), Dalian Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Dalian, Peoples R China.	Lichunyan_dl@163.com						Akhter M, 2008, EUR J CANCER PREV, V17, P515, DOI 10.1097/CEJ.0b013e3282f521f8; ARMSTRONG B, 1975, INT J CANCER, V15, P617, DOI 10.1002/ijc.2910150411; Aune D, 2011, GASTROENTEROLOGY, V141, P106, DOI 10.1053/j.gastro.2011.04.013; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Beral V, 2012, LANCET ONCOL, V13, P1141, DOI 10.1016/S1470-2045(12)70425-4; Bosetti C, 2009, HUM REPROD UPDATE, V15, P489, DOI 10.1093/humupd/dmp017; BOSTICK RM, 1994, CANCER CAUSE CONTROL, V5, P38, DOI 10.1007/BF01830725; CHUTE CG, 1991, EPIDEMIOLOGY, V2, P395, DOI 10.1097/00001648-199109000-00019; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DEVERDIER MG, 1992, CANCER CAUSE CONTROL, V3, P355, DOI 10.1007/BF00146889; DiDomenico M, 1996, CANCER RES, V56, P4516; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; English MA, 1999, J CLIN ENDOCR METAB, V84, P2080, DOI 10.1210/jc.84.6.2080; Fernandez E, 1996, BRIT J CANCER, V73, P1431, DOI 10.1038/bjc.1996.272; Ferris JS, 2010, PAEDIATR PERINAT EP, V24, P515, DOI 10.1111/j.1365-3016.2010.01154.x; FRANCESCHI S, 1991, EUR J CANCER, V27, P604, DOI 10.1016/0277-5379(91)90228-6; Gong TT, 2013, INT J CANCER, V132, P2894, DOI 10.1002/ijc.27952; HAENSZEL W, 1980, JNCI-J NATL CANCER I, V64, P17; Hamling J, 2008, STAT MED, V27, P954, DOI 10.1002/sim.3013; He CY, 2009, NAT GENET, V41, P724, DOI 10.1038/ng.385; Hennessy BA, 2005, MOL CELL ENDOCRINOL, V229, P39, DOI 10.1016/j.mce.2004.10.001; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kabat GC, 2008, INT J CANCER, V122, P643, DOI 10.1002/ijc.23079; Kampman E, 1994, Eur J Cancer Prev, V3, P329, DOI 10.1097/00008469-199407000-00005; Kampman E, 1997, CANCER CAUSE CONTROL, V8, P146, DOI 10.1023/A:1018459911147; Kono S, 2004, EUR J CANCER PREV, V13, P127, DOI 10.1097/00008469-200404000-00006; KVALE G, 1991, INT J CANCER, V47, P390, DOI 10.1002/ijc.2910470314; Lin J, 2007, AM J EPIDEMIOL, V165, P794, DOI 10.1093/aje/kwk068; Liu YZ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000420; Lo AC, 2010, DIS COLON RECTUM, V53, P830, DOI 10.1007/DCR.0b013e3181d320b1; Mandel D, 2004, J PEDIATR ENDOCR MET, V17, P1507; Marcus Pamela M., 1995, Annals of Epidemiology, V5, P303, DOI 10.1016/1047-2797(94)00097-D; Martinez ME, 1997, CANCER EPIDEM BIOMAR, V6, P1; MCMICHAEL AJ, 1980, J NATL CANCER I, V65, P1201; MOISAN J, 1991, Medicine and Science in Sports and Exercise, V23, P1170; Nanda K, 1999, OBSTET GYNECOL, V93, P880, DOI 10.1016/S0029-7844(98)00424-4; NEGRI E, 1989, CANCER RES, V49, P7158; Nichols HB, 2005, CANCER EPIDEM BIOMAR, V14, P1212, DOI 10.1158/1055-9965.EPI-04-0845; Oduwole OO, 2002, INT J CANCER, V97, P1, DOI 10.1002/ijc.1567; PAPADIMITRIOU C, 1984, INT J EPIDEMIOL, V13, P155, DOI 10.1093/ije/13.2.155; PETERS RK, 1990, BRIT J CANCER, V61, P741, DOI 10.1038/bjc.1990.166; Richards MA, 2011, J ADOLESCENCE, V34, P1065, DOI 10.1016/j.adolescence.2010.11.001; RONNEMAA T, 1991, ANN MED, V23, P67, DOI 10.3109/07853899109147933; Sato R, 2009, CANCER RES, V69, P914, DOI 10.1158/0008-5472.CAN-08-0906; Shin A, 2011, INT J EPIDEMIOL, V40, P1261, DOI 10.1093/ije/dyr121; Siegert S, 2013, HUM GENET, V132, P219, DOI 10.1007/s00439-012-1239-2; SLATTERY ML, 1995, CANCER CAUSE CONTROL, V6, P332, DOI 10.1007/BF00051408; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sulem P, 2009, NAT GENET, V41, P734, DOI 10.1038/ng.383; Talamini R, 1998, EUR J CANCER, V34, P1070, DOI 10.1016/S0959-8049(98)00019-7; Tamakoshi K, 2004, CANCER SCI, V95, P602, DOI 10.1111/j.1349-7006.2004.tb02494.x; Troisi R, 1997, EPIDEMIOLOGY, V8, P75, DOI 10.1097/00001648-199701000-00012; Tsilidis KK, 2010, BRIT J CANCER, V103, P1755, DOI 10.1038/sj.bjc.6605965; VIHKO R, 1984, J STEROID BIOCHEM, V20, P231, DOI 10.1016/0022-4731(84)90209-7; Wells G.A., NEWCASTLE OTTAWA SCA; Wernli KJ, 2009, J WOMENS HEALTH, V18, P995, DOI 10.1089/jwh.2008.1068; WU AH, 1987, BRIT J CANCER, V55, P687, DOI 10.1038/bjc.1987.140; Wu QJ, 2013, ANN ONCOL, V24, P1079, DOI 10.1093/annonc/mds601; WUWILLIAMS AH, 1991, CANCER RES, V51, P2307; Yoo KY, 1999, BRIT J CANCER, V79, P1901, DOI 10.1038/sj.bjc.6690302; Zervoudakis A, 2011, J NATL CANCER I, V103, P826, DOI 10.1093/jnci/djr101; Zhong R, 2013, CARCINOGENESIS, V34, P936, DOI 10.1093/carcin/bgs395	65	17	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65645	10.1371/journal.pone.0065645	http://dx.doi.org/10.1371/journal.pone.0065645			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762403	Green Submitted, gold, Green Published			2022-12-27	WOS:000321099000086
J	Lorin, J; Guilland, JC; Korandji, C; Touzery, C; Bichat, F; Chagnon, A; Cottin, Y; Rochette, L; Vergely, C; Zeller, M				Lorin, Julie; Guilland, Jean-Claude; Korandji, Claudia; Touzery, Claude; Bichat, Florence; Chagnon, Aline; Cottin, Yves; Rochette, Luc; Vergely, Catherine; Zeller, Marianne			High Levels of Asymmetric Dimethylarginine Are Strongly Associated with Low HDL in Patients with Acute Myocardial Infarction	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; CORONARY-ARTERY-DISEASE; NITRIC-OXIDE SYNTHASE; ENDOTHELIUM-DEPENDENT VASODILATION; RANDOMIZED CLINICAL-TRIAL; CARDIOVASCULAR-DISEASE; ENDOGENOUS INHIBITOR; METABOLIC SYNDROME; RENAL-FAILURE; HEART-DISEASE	Objectives: Low levels of high-density lipoprotein (HDL) cholesterol are associated with an increased risk of acute myocardial infarction possibly through impaired endothelial atheroprotection and decreased nitric oxide (NO) bioavailability. Asymmetric dimethylarginine (ADMA) mediates endothelial function by inhibiting nitric oxide synthase activity. In patients with acute myocardial infarction, we investigated the relationship between serum levels of HDL and ADMA. Approach and Results: Blood samples from 612 consecutive patients hospitalized for acute MI <24 hours after symptom onset were taken on admission. Serum levels of ADMA, its stereoisomer, symmetric dimethylarginine (SDMA) and L-arginine were determined using high-performance liquid chromatography. Patients with low HDL (<40 mg/dL for men and <50 mg/dL for women) were compared with patients with higher HDL. Most patients (59%) had low HDL levels. Median ADMA levels were markedly higher in the low HDL group (0.69 vs. 0.50 mmole/L, p<0.001). In contrast, SDMA and L-arginine levels were similar for the two groups (p = 0.120 and p = 0.064). Notably, ADMA, but not SDMA or L-arginine, was inversely correlated with HDL (r = 20.311, p<0.001). In stratified analysis, this relationship was only found for low HDL levels (r = 20.265, p<0.001), but not when HDL levels were higher (r = 20.077, p = 0.225). By multivariate logistic regression analysis, ADMA level was strongly associated with low HDL levels (OR(95% CI): 6.06(3.48-10.53), p<0.001), beyond traditional confounding factors. Conclusions: Our large population-based study showed for the first time a strong inverse relationship between HDL and ADMA in myocardial infarction patients, suggesting a functional interaction between HDL and endothelium, beyond metabolic conditions associated with low HDL levels.	[Lorin, Julie; Guilland, Jean-Claude; Korandji, Claudia; Cottin, Yves; Rochette, Luc; Vergely, Catherine; Zeller, Marianne] Univ Burgundy, Lab Cardiometab Physiopathol & Pharmacol, INSERM, UMR866, Dijon, France; [Touzery, Claude; Bichat, Florence; Chagnon, Aline; Cottin, Yves] Univ Hosp, Dept Cardiol, Dijon, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; CHU Dijon Bourgogne	Zeller, M (corresponding author), Univ Burgundy, Lab Cardiometab Physiopathol & Pharmacol, INSERM, UMR866, Dijon, France.	marianne.zeller@u-bourgogne.fr	COTTIN, YVES/ABA-4622-2020; Vergely, Catherine/L-9534-2015	Vergely, Catherine/0000-0003-4009-776X	University Hospital of Dijon; Association de Cardiologie de Bourgogne; Agence Regionale de Sante (ARS) de Bourgogne; French Ministry of Research from the Institut National de la Sante et de la Recherche Medicale (INSERM); Regional Council of Burgundy	University Hospital of Dijon; Association de Cardiologie de Bourgogne; Agence Regionale de Sante (ARS) de Bourgogne(Region Bourgogne-Franche-Comte); French Ministry of Research from the Institut National de la Sante et de la Recherche Medicale (INSERM); Regional Council of Burgundy(Region Bourgogne-Franche-Comte)	This work was supported by the University Hospital of Dijon, the Association de Cardiologie de Bourgogne, and by grants from the Agence Regionale de Sante (ARS) de Bourgogne, the French Ministry of Research from the Institut National de la Sante et de la Recherche Medicale (INSERM) and from the Regional Council of Burgundy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achan V, 2003, ARTERIOSCL THROM VAS, V23, P1455, DOI 10.1161/01.ATV.0000081742.92006.59; [Anonymous], JAMA, V285, P2486; Antoniades C, 2009, EUR HEART J, V30, P1142, DOI 10.1093/eurheartj/ehp061; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Besler C, 2012, EMBO MOL MED, V4, P251, DOI 10.1002/emmm.201200224; Besler C, 2011, J CLIN INVEST, V121, P2693, DOI 10.1172/JCI42946; Boger GI, 2007, J AM COLL CARDIOL, V49, P2274, DOI 10.1016/j.jacc.2007.02.051; Boger RH, 1998, CIRCULATION, V98, P1842, DOI 10.1161/01.CIR.98.18.1842; Boger RH, 2001, CLIN SCI, V100, P161, DOI 10.1042/CS20000173; Boger RH, 2003, CARDIOVASC RES, V59, P824, DOI 10.1016/S0008-6363(03)00500-5; Chao CL, 2000, CIRCULATION, V101, P485, DOI 10.1161/01.CIR.101.5.485; Cooke JP, 2004, CIRCULATION, V109, P1813, DOI 10.1161/01.CIR.0000126823.07732.D5; Fard A, 2000, ARTERIOSCL THROM VAS, V20, P2039, DOI 10.1161/01.ATV.20.9.2039; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Gepner AD, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.09.023; Gossett LK, 2009, J CLIN LIPIDOL, V3, P372, DOI 10.1016/j.jacl.2009.10.008; Hermann F, 2009, THROMB RES, V123, P460, DOI 10.1016/j.thromres.2008.06.022; Ivanova M, 2010, CLIN CHIM ACTA, V411, P1632, DOI 10.1016/j.cca.2010.06.001; Juonala M, 2007, CIRCULATION, V116, P1367, DOI 10.1161/CIRCULATIONAHA.107.690016; Kajimoto H, 2012, KIDNEY INT, V81, P762, DOI 10.1038/ki.2011.476; Kontush A, 2006, NAT CLIN PRACT CARD, V3, P144, DOI 10.1038/ncpcardio0500; Kontush A, 2006, PHARMACOL REV, V58, P342, DOI 10.1124/pr.58.3.1; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Li XP, 2000, INT J CARDIOL, V73, P231, DOI 10.1016/S0167-5273(00)00221-7; Litvinov D, 2012, N AM J MED SCI, V4, P523, DOI 10.4103/1947-2714.103310; Luscher TF, 2012, EUR HEART J, V33, P857, DOI 10.1093/eurheartj/ehs019; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; Meinitzer A, 2007, CLIN CHEM, V53, P273, DOI 10.1373/clinchem.2006.076711; Mineo C, 2012, CIRC RES, V111, P1079, DOI 10.1161/CIRCRESAHA.111.258673; Paneni F, 2012, INT J CARDIOL, V158, P158, DOI 10.1016/j.ijcard.2012.04.032; Peng ZY, 2011, MOL CELL BIOCHEM, V351, P243, DOI 10.1007/s11010-011-0731-7; Prosser HC, 2012, CURR OPIN LIPIDOL, V23, P182, DOI 10.1097/MOL.0b013e328352c4dd; ROSENSON RS, 1993, J AM COLL CARDIOL, V22, P933; RYDER REJ, 1984, BRIT MED J, V289, P1651, DOI 10.1136/bmj.289.6459.1651; Spieker LE, 2002, CIRCULATION, V105, P1399, DOI 10.1161/01.CIR.0000013424.28206.8F; Thorne S, 1998, J AM COLL CARDIOL, V32, P110, DOI 10.1016/S0735-1097(98)00211-3; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; VALLANCE P, 1992, LANCET, V339, P572; Warnholtz A, 2009, ATHEROSCLEROSIS, V204, P216, DOI 10.1016/j.atherosclerosis.2008.08.003; WARNICK GR, 1990, SCAND J CLIN LAB INV, V50, P9, DOI 10.3109/00365519009091079; Witting PK, 2011, FREE RADICAL BIO MED, V51, P1390, DOI 10.1016/j.freeradbiomed.2011.06.031; Yasuda S, 2006, EUR HEART J, V27, P1159, DOI 10.1093/eurheartj/ehi876; Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986; Zeller M, 2008, ARTERIOSCL THROM VAS, V28, P954, DOI 10.1161/ATVBAHA.108.162768; Zeller M, 2007, J AM COLL CARDIOL, V50, P1948, DOI 10.1016/j.jacc.2007.06.052; Zelzer S, 2011, CLIN CHIM ACTA, V412, P1345, DOI 10.1016/j.cca.2011.03.031; Zheng CY, 2012, J AM COLL CARDIOL, V60, P2380, DOI 10.1016/j.jacc.2012.08.999	47	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64796	10.1371/journal.pone.0064796	http://dx.doi.org/10.1371/journal.pone.0064796			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755144	gold, Green Published, Green Submitted			2022-12-27	WOS:000321099000024
J	Conde, KAP; Silva, E; Silva, CO; Ferreira, E; Freitas, FGR; Castro, I; Rea-Neto, A; Grion, CMC; Moura, AD; Lobo, SM; Azevedo, LCP; Machado, FR				Pessoa Conde, Katia Aparecida; Silva, Eliezer; Silva, Carla Oliveira; Ferreira, Elaine; Rezende Freitas, Flavio Geraldo; Castro, Isac; Rea-Neto, Alvaro; Carvalho Grion, Cintia Magalhaes; Moura, Anselmo Dornas; Lobo, Suzana Margareth; Pontes Azevedo, Luciano Cesar; Machado, Flavia Ribeiro			Differences in Sepsis Treatment and Outcomes between Public and Private Hospitals in Brazil: A Multicenter Observational Study	PLOS ONE			English	Article							PROPENSITY SCORE METHODS; SURVIVING SEPSIS; EPIDEMIOLOGY; CARE; MORTALITY; IMPACT	Background: Previous studies showed higher sepsis mortality rates in Brazil compared to other developed or developing countries. Moreover, another trial demonstrated an increased mortality rate in public hospitals compared to private hospitals in Brazil. The reasons for these findings may include delayed recognition and inadequate treatment of sepsis in public facilities. We designed this study to evaluate the factors associated with mortality in septic patients admitted to intensive care units in a network of public and private institutions. Materials and Methods: This study is a retrospective analysis of a prospective cohort of sepsis patients in 19 private and public institutions in Brazil. We analyzed data from the original database and collected additional data to assess compliance to the treatment guidelines and to determine the time from the onset of organ dysfunction and the sepsis diagnosis by the healthcare team. Results: A total of 396 patients were analyzed. Patients in public hospitals were younger, had a greater number of dysfunctional organs at baseline and a lower chance to have sepsis diagnosed within two hours of the onset of organ dysfunction. Private hospitals had a better compliance to lactate and blood culture sampling and maintenance of glycemic control. The multivariate analysis showed that age, disease severity at baseline and being treated at a public hospital were independent risk factors for mortality. A delay in the sepsis diagnosis of longer than two hours was associated with mortality only in the public setting. Conclusions: We confirmed a lower sepsis mortality rate in the private hospitals of this network. Being treated in a public hospital was an independent factor for mortality. Delayed recognition of sepsis was more frequent in public institutions and this might have been associated with a higher mortality. Improving sepsis recognition and early diagnosis may be important targets in public institutions.	[Pessoa Conde, Katia Aparecida; Rezende Freitas, Flavio Geraldo; Pontes Azevedo, Luciano Cesar; Machado, Flavia Ribeiro] Univ Fed Sao Paulo, Dept Anestesiol Dor & Terapia Intens, Sao Paulo, Brazil; [Silva, Eliezer; Silva, Carla Oliveira; Ferreira, Elaine; Castro, Isac; Pontes Azevedo, Luciano Cesar; Machado, Flavia Ribeiro] Latin Amer Sepsis Inst, Sao Paulo, Brazil; [Rea-Neto, Alvaro] Ctr Estudos & Pesquisas Terapia Intens CEPETI, Curitiba, Parana, Brazil; [Carvalho Grion, Cintia Magalhaes] Hosp Univ Londrina, Div Terapia Intens, Londrina, PR, Brazil; [Moura, Anselmo Dornas] Hosp Mater Dei, Intens Care Unit, Belo Horizonte, MG, Brazil; [Lobo, Suzana Margareth] Hosp Base, Fac Med Sao Jose Rio Preto, Serv Terapia Intens, Sao Jose Do Rio Preto, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP)	Machado, FR (corresponding author), Univ Fed Sao Paulo, Dept Anestesiol Dor & Terapia Intens, Sao Paulo, Brazil.	frmachado@unifesp.br	Grion, Cintia M. C./C-2039-2014; Réa-Neto, Álvaro/AAR-7909-2020; Azevedo, Luciano CP/H-2652-2012; Machado, Flavia R/G-4651-2012; Grion, Cintia/AAU-1919-2021; Castro, Isac de/J-1984-2015; de Castro, Isac/AAA-8990-2021; Rea, Nanda/I-2853-2015	Grion, Cintia M. C./0000-0001-9669-2010; Azevedo, Luciano CP/0000-0001-6759-3910; Machado, Flavia R/0000-0002-2356-4867; Grion, Cintia/0000-0001-9669-2010; Castro, Isac de/0000-0002-1160-3064; Rea, Nanda/0000-0003-2177-6388; Rea-Neto, Alvaro/0000-0001-5524-0907	Eli Lilly; Latin America Sepsis Institute	Eli Lilly(Eli Lilly); Latin America Sepsis Institute	This study was partially supported by an unrestricted research grant from Eli Lilly in a partnership with the Latin America Sepsis Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus Derek C., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P207; Annane D, 2003, AM J RESP CRIT CARE, V168, P165, DOI 10.1164/rccm.2201087; Assuncao M, 2010, J CRIT CARE, V25, P545, DOI 10.1016/j.jcrc.2010.03.012; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Beale R, 2009, INFECTION, V37, P222, DOI 10.1007/s15010-008-8203-z; Becker JU, 2009, LANCET INFECT DIS, V9, P577, DOI 10.1016/S1473-3099(09)70135-5; Bozza FA, 2010, LANCET INFECT DIS, V10, P290, DOI 10.1016/S1473-3099(10)70074-8; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Cardoso LTQ, 2011, CRIT CARE, V15, DOI 10.1186/cc9975; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Freitas FGR, 2008, CLINICS, V63, P483, DOI 10.1590/S1807-59322008000400012; Institute LAS, 2012, SURV SEPS CAMP NAT R; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Patrick AR, 2011, PHARMACOEPIDEM DR S, V20, P551, DOI 10.1002/pds.2098; Shiramizo SCPL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026790; Rezende E, 2008, CLINICS, V63, P457, DOI 10.1590/S1807-59322008000400008; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sales Jr JAL, 2006, REV BRAS TER INTENSI, V18, P09; Silva E, 2004, CRIT CARE, V8, pR251, DOI 10.1186/cc2892; Silva E, 2012, MINERVA ANESTESIOL; Sogayar AMC, 2008, PHARMACOECONOMICS, V26, P425, DOI 10.2165/00019053-200826050-00006; Ranzani OT, 2012, CRIT CARE MED, V40, P2552, DOI 10.1097/CCM.0b013e318259203d; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wang JL, 2009, J FORMOS MED ASSOC, V108, P778, DOI 10.1016/S0929-6646(09)60405-8; Westphal GA, 2011, J CRIT CARE, V26, P76, DOI 10.1016/j.jcrc.2010.08.001	28	37	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64790	10.1371/journal.pone.0064790	http://dx.doi.org/10.1371/journal.pone.0064790			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762255	Green Published, gold, Green Submitted			2022-12-27	WOS:000321099000022
J	Sandoval-Montiel, AA; Zentella-de-Pina, M; Ventura-Gallegos, JL; Frias-Gonzalez, S; Lopez-Macay, A; Zentella-Dehesa, A				Sandoval-Montiel, Alvaro A.; Zentella-de-Pina, Martha; Ventura-Gallegos, Jose L.; Frias-Gonzalez, Susana; Lopez-Macay, Ambar; Zentella-Dehesa, Alejandro			HSP-72 Accelerated Expression in Mononuclear Cells Induced In Vivo by Acetyl Salicylic Acid Can Be Reproduced In Vitro when Combined with H2O2	PLOS ONE			English	Article							HEAT-SHOCK RESPONSE; SODIUM-SALICYLATE; OXIDATIVE STRESS; TRANSCRIPTIONAL REGULATION; ANTIINFLAMMATORY DRUGS; INDUCED APOPTOSIS; DNA-BINDING; ACTIVATION; ASPIRIN; PHOSPHORYLATION	Background: Among NSAIDs acetyl salicylic acid remains as a valuable tool because of the variety of benefic prophylactic and therapeutic effects. Nevertheless, the molecular bases for these responses have not been complete understood. We explored the effect of acetyl salicylic acid on the heat shock response. Results: Peripheral blood mononuclear cells from rats challenged with acetyl salicylic acid presented a faster kinetics of expression of HSP-72 messenger RNA and protein in response to in vitro heat shock. This effect reaches its maximum 2 h after treatment and disappeared after 5 h. On isolated peripheral blood mononuclear cells from untreated rats, incubation with acetyl salicylic acid was ineffective to produce priming, but this effect was mimicked when the cells were incubated with the combination of H2O2 + ASA. Conclusions: Administration of acetyl salicylic acid to rats alters HSP-72 expression mechanism in a way that it becomes more efficient in response to in vitro heat shock. The fact that in vitro acetyl salicylic acid alone did not induce this priming effect implies that in vivo other signals are required. Priming could be reproduces in vitro with the combination of acetyl salicylic acid+H2O2.	[Sandoval-Montiel, Alvaro A.; Ventura-Gallegos, Jose L.; Frias-Gonzalez, Susana; Zentella-Dehesa, Alejandro] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Med Genom & Toxicol Ambiental, Mexico City 04510, DF, Mexico; [Sandoval-Montiel, Alvaro A.; Zentella-Dehesa, Alejandro] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Unidad Bioquim, Mexico City, DF, Mexico; [Zentella-de-Pina, Martha] Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Mexico City 04510, DF, Mexico; [Lopez-Macay, Ambar] Inst Nacl Rehabil, Lab Liquido Sinovial, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Nacional Autonoma de Mexico	Zentella-Dehesa, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Med Genom & Toxicol Ambiental, Mexico City 04510, DF, Mexico.	azentell@biomedicas.unam.mx	Zentella-Dehesa, Alejandro/AAW-1647-2020; Macay, ambar Lopez/ABH-9850-2020	Zentella-Dehesa, Alejandro/0000-0002-5595-1466; Lopez Macay, Ambar/0000-0002-2916-7424	DGAPA-UNAM [IN 229607]; CONACyT-Mexico [45519-M, 45003-M]; Posgrado de Ciencias Biologicas; UNAM; Comecyt	DGAPA-UNAM(Universidad Nacional Autonoma de Mexico); CONACyT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Posgrado de Ciencias Biologicas; UNAM(Universidad Nacional Autonoma de Mexico); Comecyt	This work was supported by DGAPA-UNAM grant IN 229607 and CONACyT-Mexico grants 45519-M and 45003-M. ASM was supported by a doctoral fellowship from CONACyT-Mexico, the Posgrado de Ciencias Biologicas, UNAM and Comecyt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2007, HISTOL HISTOPATHOL, V22, P437, DOI 10.14670/HH-22.437; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chong KY, 1998, J MOL CELL CARDIOL, V30, P599, DOI 10.1006/jmcc.1997.0623; Chung YM, 2003, FREE RADICAL BIO MED, V34, P434, DOI 10.1016/S0891-5849(02)01301-1; Cotto JJ, 1996, J BIOL CHEM, V271, P3355; de Pina MZ, 2002, J PHARM PHARMACOL, V54, P577, DOI 10.1211/0022357021778709; Fawcett TW, 1997, CELL STRESS CHAPERON, V2, P104, DOI 10.1379/1466-1268(1997)002<0104:POHSIH>2.3.CO;2; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; Horowitz M, 2007, PROG BRAIN RES, V162, P433, DOI 10.1016/S0079-6123(06)62021-9; JURIVICH DA, 1992, SCIENCE, V255, P1243, DOI 10.1126/science.1546322; JURIVICH DA, 1995, J BIOL CHEM, V270, P24489, DOI 10.1074/jbc.270.41.24489; LEE BS, 1995, P NATL ACAD SCI USA, V92, P7207, DOI 10.1073/pnas.92.16.7207; Liu EJ, 2005, CANCER EPIDEM BIOMAR, V14, P1315, DOI 10.1158/1055-9965.EPI-05-0032; Liu PCC, 1999, J BIOL CHEM, V274, P17219, DOI 10.1074/jbc.274.24.17219; MAYS DC, 1984, J CHROMATOGR, V311, P301, DOI 10.1016/S0378-4347(00)84723-4; Morimoto R I, 1996, EXS, V77, P139; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; MORIMOTO RI, 1992, J BIOL CHEM, V267, P21987; Mosser DD, 1997, MOL CELL BIOL, V17, P5317, DOI 10.1128/MCB.17.9.5317; Nakahara T, 2006, METABOLISM, V55, P843, DOI 10.1016/j.metabol.2006.02.009; Rodondi Nicolas, 2005, Comprehensive Therapy, V31, P186, DOI 10.1385/COMP:31:3:186; Saito T, 2004, J MOL CELL CARDIOL, V37, P71, DOI 10.1016/j.yjmcc.2004.04.002; Scandalios JG, 2005, BRAZ J MED BIOL RES, V38, P995, DOI 10.1590/S0100-879X2005000700003; Schoffl F, 1998, PLANT PHYSIOL, V117, P1135, DOI 10.1104/pp.117.4.1135; Seo MS, 2005, INT J MOL MED, V16, P841; Silva AM, 2007, J BIOL CHEM, V282, P10164, DOI 10.1074/jbc.M609996200; Soncin F, 2003, BIOCHEM BIOPH RES CO, V303, P700, DOI 10.1016/S0006-291X(03)00398-X; Ulcova-Gallova Z, 2005, CHEM IMMUNOL ALLERGY, V88, P139, DOI 10.1159/000087831; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Xu QB, 1997, J CLIN INVEST, V100, P1089, DOI 10.1172/JCI119619; Yenari MA, 1999, MOL MED TODAY, V5, P525, DOI 10.1016/S1357-4310(99)01599-3; YOKOYAMA H, 1995, BIOCHEM PHARMACOL, V49, P991, DOI 10.1016/0006-2952(94)00542-T; de Pina MZ, 2007, ARCH MED RES, V38, P269, DOI 10.1016/j.arcmed.2006.09.019	33	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65449	10.1371/journal.pone.0065449	http://dx.doi.org/10.1371/journal.pone.0065449			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762376	Green Submitted, Green Published, gold			2022-12-27	WOS:000321099000068
J	Schick, RS; Kraus, SD; Rolland, RM; Knowlton, AR; Hamilton, PK; Pettis, HM; Kenney, RD; Clark, JS				Schick, Robert S.; Kraus, Scott D.; Rolland, Rosalind M.; Knowlton, Amy R.; Hamilton, Philip K.; Pettis, Heather M.; Kenney, Robert D.; Clark, James S.			Using Hierarchical Bayes to Understand Movement, Health, and Survival in the Endangered North Atlantic Right Whale	PLOS ONE			English	Article							EUBALAENA-GLACIALIS; CAPTURE-RECAPTURE; BODY CONDITION; UNITED-STATES; REPRODUCTIVE STATUS; SUCCESS; POPULATIONS; DEMOGRAPHY; AUSTRALIS; TELEMETRY	Body condition is an indicator of health, and it plays a key role in many vital processes for mammalian species. While evidence of individual body condition can be obtained, these observations provide just brief glimpses into the health state of the animal. An analytical framework is needed for understanding how health of animals changes over space and time. Through knowledge of individual health we can better understand the status of populations. This is particularly important in endangered species, where the consequences of disruption of critical biological functions can push groups of animals rapidly toward extinction. Here we built a state-space model that provides estimates of movement, health, and survival. We assimilated 30+ years of photographic evidence of body condition and three additional visual health parameters in individual North Atlantic right whales, together with survey data, to infer the true health status as it changes over space and time. We also included the effect of reproductive status and entanglement status on health. At the population level, we estimated differential movement patterns in males and females. At the individual level, we estimated the likely animal locations each month. We estimated the relationship between observed and latent health status. Observations of body condition, skin condition, cyamid infestation on the blowholes, and rake marks all provided measures of the true underlying health. The resulting time series of individual health highlight both normal variations in health status and how anthropogenic stressors can affect the health and, ultimately, the survival of individuals. This modeling approach provides information for monitoring of health in right whales, as well as a framework for integrating observational data at the level of individuals up through the health status of the population. This framework can be broadly applied to a variety of systems - terrestrial and marine - where sporadic observations of individuals exist.	[Schick, Robert S.; Clark, James S.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Schick, Robert S.] Univ St Andrews, Ctr Res Ecol & Environm Modeling, St Andrews, Fife, Scotland; [Kraus, Scott D.; Rolland, Rosalind M.; Knowlton, Amy R.; Hamilton, Philip K.; Pettis, Heather M.] New England Aquarium, John H Prescott Marine Lab, Boston, MA USA; [Kenney, Robert D.] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA	Duke University; University of St Andrews; University of Rhode Island	Schick, RS (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	rss5@st-andrews.ac.uk		Kraus, Scott/0000-0003-4367-6548	United States Office of Naval Research [N00014-10-1-0516, N00014-12-1-0286, N00014-12-1-0389]; Office of Naval Research [N00014-09-1-0896, N00014-12-1-0274]	United States Office of Naval Research(Office of Naval Research); Office of Naval Research(Office of Naval Research)	This work was supported by the United States Office of Naval Research grants N00014-10-1-0516 and N00014-12-1-0286 to Duke University and University of St. Andrews, as well as N00014-12-1-0389 to the New England Aquarium. This work benefited from discussions with participants in a working group supported by Office of Naval Research grants N00014-09-1-0896 to the University of California, Santa Barbara and N00014-12-1-0274 to the University of California, Davis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner MF, 2005, CAN J FISH AQUAT SCI, V62, P527, DOI 10.1139/F04-238; Bestley S, 2010, ECOLOGY, V91, P2373, DOI 10.1890/08-2019.1; Bradford AL, 2012, J MAMMAL, V93, P251, DOI 10.1644/11-MAMM-A-091.1; Brown Moira W., 2007, P105; Brown Moira W., 2001, Journal of Cetacean Research and Management Special Issue, V2, P245; CHASTEL O, 1995, ECOLOGY, V76, P2240, DOI 10.2307/1941698; Clark J. S, 2007, MODELS ECOLOGICAL DA; Clark JS, 2003, ECOLOGY, V84, P1370, DOI 10.1890/0012-9658(2003)084[1370:UAVIDA]2.0.CO;2; Clark JS, 2005, ECOLOGY, V86, P2232, DOI 10.1890/04-1348; CLOBERT J, 1985, BIOMETRICS, V41, P1031, DOI 10.2307/2530974; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; Clutton-Brock T, 2010, TRENDS ECOL EVOL, V25, P562, DOI 10.1016/j.tree.2010.08.002; Dupuis JA, 1995, BIOMETRIKA, V82, P761, DOI 10.1093/biomet/82.4.761; Festa-Bianchet M, 1998, ECOL LETT, V1, P91; Firestone J, 2008, BIOL CONSERV, V141, P221, DOI 10.1016/j.biocon.2007.09.024; Fonnesbeck Christopher J., 2008, Endangered Species Research, V6, P87, DOI 10.3354/esr00134; Fujiwara M, 2001, NATURE, V414, P537, DOI 10.1038/35107054; Goldstein J, 2007, MAR BIOL, V151, P2063, DOI 10.1007/s00227-007-0638-8; Greene CH, 2007, SCIENCE, V315, P1084, DOI 10.1126/science.1136495; Hamilton P, 2007, URBAN WHALE N ATLANT; Hamilton P, 2012, N ATL RIGHT WHAL CON; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; KENNEY RD, 1986, FISH B-NOAA, V84, P345; King R, 2012, INTERFACE FOCUS, V2, P190, DOI 10.1098/rsfs.2011.0078; Knowlton AR, 2012, MAR ECOL PROG SER, V466, P293, DOI 10.3354/meps09923; Knowlton Amy R., 2001, Journal of Cetacean Research and Management Special Issue, V2, P193; KNOWLTON AR, 1994, CAN J ZOOL, V72, P1297, DOI 10.1139/z94-173; KNOWLTON AR, 1992, MAR MAMMAL SCI, V8, P397, DOI 10.1111/j.1748-7692.1992.tb00054.x; Knowlton AR, 2002, RIGHT WHALE SIGHTING; Kraus S, 1986, USE PHOTOGRAPHS IDEN, V10, P145; Kraus S.D., 2009, URBAN WHALE N ATLANT; Kraus SD, 2005, SCIENCE, V309, P561, DOI 10.1126/science.1111200; Kraus SD, 1986, REP INT WHAL COMM, V10, P139; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Malik S, 1999, CAN J ZOOL, V77, P1217, DOI 10.1139/cjz-77-8-1217; Mate BR, 1997, J WILDLIFE MANAGE, V61, P1393, DOI 10.2307/3802143; Miller CA, 2012, MAR ECOL PROG SER, V459, P135, DOI 10.3354/meps09675; Miller CA, 2011, MAR ECOL PROG SER, V438, P267, DOI 10.3354/meps09174; Moore MJ, 2012, MARINE MAMMAL SCI; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; NMFS, 2005, REC PLAN N ATL RIGHT; Pettis HM, 2004, CAN J ZOOL, V82, P8, DOI [10.1139/z03-207, 10.1139/Z03-207]; Pettis HM, 2012, 2012 ANN N ATLANTIC; POLLOCK KH, 1991, J AM STAT ASSOC, V86, P225, DOI 10.2307/2289733; Robinson PW, 2010, J ANIM ECOL, V79, P1146, DOI 10.1111/j.1365-2656.2010.01735.x; Rolland Rosalind M., 2007, P273; Schick RS, 2009, CAN J FISH AQUAT SCI, V66, P1399, DOI 10.1139/F09-115; Schick RS, 2012, ESTIMATING RESOURCE; SHOOP CR, 1992, HERPETOL MONOGR, V6, P43; Vanderlaan Angelia S. M., 2008, Endangered Species Research, V4, P283, DOI 10.3354/esr00083; Weimerskirch H, 1997, ECOLOGY, V78, P2051; Weinrich MT, 2000, MAR MAMMAL SCI, V16, P326, DOI 10.1111/j.1748-7692.2000.tb00928.x; Winn H.E., 1986, Reports of the International Whaling Commission Special Issue, P129	53	39	41	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64166	10.1371/journal.pone.0064166	http://dx.doi.org/10.1371/journal.pone.0064166			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762237	Green Published, gold			2022-12-27	WOS:000321099000006
J	Wang, J; Yu, TT; Yin, L; Li, J; Yu, L; Shen, Y; Yu, YG; Shen, YN; Fu, QH				Wang, Jian; Yu, Tingting; Yin, Lei; Li, Jing; Yu, Li; Shen, Ye; Yu, Yongguo; Shen, Yongnian; Fu, Qihua			Novel Mutations in the SCNN1A Gene Causing Pseudohypoaldosteronism Type 1	PLOS ONE			English	Article							EPITHELIAL SODIUM-CHANNEL; NA+ CHANNEL; HYPERKALEMIA; SUBUNITS	Pseudohypoaldosteronism type 1 (PHA1) is a rare inherited disease characterized by resistance to the actions of aldosterone. Mutations in the subunit genes (SCNN1A, SCNN1B, SCNN1G) of the epithelial sodium channel (ENaC) and the NR3C2 gene encoding the mineralocorticoid receptor, result in systemic PHA1 and renal PHA1 respectively. Common clinical manifestations of PHA1 include salt wasting, hyperkalaemia, metabolic acidosis and elevated plasma aldosterone levels in the neonatal period. In this study, we describe the clinical and biochemical manifestations in two Chinese patients with systemic PHA1. Sequence analysis of the SCNN1A gene revealed a compound heterozygous mutation (c.1311delG and c. 1439+1G>C) in one patient and a homozygous mutation (c. 814_815insG) in another patient, all three variants are novel. Further analysis of the splicing pattern in a minigene construct showed that the c. 1439+1G>C mutation can lead to the retainment of intron 9 as the 5'-donor splice site disappears during post-transcriptional processing of mRNA. In conclusion, our study identified three novel SCNN1A gene mutations in two Chinese patients with systemic PHA1.	[Wang, Jian; Yu, Tingting; Yu, Yongguo; Fu, Qihua] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Res Div Birth Defects,Inst Pediat Translat Med, Shanghai, Peoples R China; [Wang, Jian; Yu, Li] Boston Childrens Hosp, Dept Lab Med, Boston, MA USA; [Yin, Lei; Li, Jing; Shen, Ye; Yu, Yongguo; Shen, Yongnian] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Pediat, Shanghai, Peoples R China	Shanghai Jiao Tong University; Harvard University; Boston Children's Hospital; Shanghai Jiao Tong University	Fu, QH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Res Div Birth Defects,Inst Pediat Translat Med, Shanghai, Peoples R China.	qfu@shsmu.edu.cn	yu, lijian/GSE-1701-2022; Fu, Qihua/AAW-9989-2020	yu, yongguo/0000-0002-4472-0910	National Natural Science Foundation of China [81201353]; Health Bureau of Shanghai Municipality [20114y072]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Health Bureau of Shanghai Municipality	The study was supported by the National Natural Science Foundation of China (Grant No. 81201353) and Research Fund of Health Bureau of Shanghai Municipality (Grant No. 20114y072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belot A, 2008, NEPHROL DIAL TRANSPL, V23, P1636, DOI 10.1093/ndt/gfm862; Bonny O, 2002, PEDIATR NEPHROL, V17, P804, DOI 10.1007/s00467-002-0945-8; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Chang SS, 1996, NAT GENET, V12, P248, DOI 10.1038/ng0396-248; CHEEK DB, 1958, ARCH DIS CHILD, V33, P252, DOI 10.1136/adc.33.169.252; Choi MJ, 2008, J AM SOC NEPHROL, V19, P424, DOI 10.1681/ASN.2007091017; Dirlewanger M, 2011, AM J PHYSIOL-ENDOC M, V301, pE467, DOI 10.1152/ajpendo.00066.2011; Edelheit O, 2005, CLIN ENDOCRINOL, V62, P547, DOI 10.1111/j.1365-2265.2005.02255.x; Furgeson SB, 2010, J AM SOC NEPHROL, V21, P1842, DOI 10.1681/ASN.2010050457; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Guran T, 2011, J CLIN RES PEDIATR E, V3, P98, DOI 10.4274/jcrpe.v3i2.20; Hubert EL, 2011, J AM SOC NEPHROL, V22, P1997, DOI 10.1681/ASN.2011030245; Huppmann S, 2011, J PERINATOL, V31, P802, DOI 10.1038/jp.2011.46; Kerem E, 1999, NEW ENGL J MED, V341, P156, DOI 10.1056/NEJM199907153410304; Manikam L, 2011, ANN CLIN BIOCHEM, V48, P380, DOI 10.1258/acb.2011.010264; Riepe FG, 2009, HORM RES, V72, P1, DOI 10.1159/000224334; Schaedel C, 1999, J PEDIATR-US, V135, P739, DOI 10.1016/S0022-3476(99)70094-6; Schweiger B, 2009, CURR OPIN PEDIATR, V21, P269, DOI 10.1097/MOP.0b013e328325a55f	18	4	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65676	10.1371/journal.pone.0065676	http://dx.doi.org/10.1371/journal.pone.0065676			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762408	gold, Green Submitted, Green Published			2022-12-27	WOS:000321099000091
J	Zemp, FJ; McKenzie, BA; Lun, XQ; Maxwell, L; Reilly, KM; McFadden, G; Yong, VW; Forsyth, PA				Zemp, Franz J.; McKenzie, Brienne A.; Lun, Xueqing; Maxwell, Lori; Reilly, Karlyne M.; McFadden, Grant; Yong, V. Wee; Forsyth, Peter A.			Resistance to Oncolytic Myxoma Virus Therapy in Nf1(-/-)/Trp53(-/-) Syngeneic Mouse Glioma Models Is Independent of Anti-Viral Type-I Interferon	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; CENTRAL-NERVOUS-SYSTEM; IMMUNOCOMPETENT ANIMAL-MODELS; MALIGNANT GLIOMAS; PANCREATIC-CANCER; GLIOBLASTOMA; CELLS; MUTANT; MICE; VIROTHERAPY	Despite promising preclinical studies, oncolytic viral therapy for malignant gliomas has resulted in variable, but underwhelming results in clinical evaluations. Of concern are the low levels of tumour infection and viral replication within the tumour. This discrepancy between the laboratory and the clinic could result from the disparity of xenograft versus syngeneic models in determining in vivo viral infection, replication and treatment efficacy. Here we describe a panel of primary mouse glioma lines derived from Nf1(+/-)Trp53(+/-) mice in the C57Bl/6J background for use in the preclinical testing of the oncolytic virus Myxoma (MYXV). These lines show a range of susceptibility to MYXV replication in vitro, but all succumb to viral-mediated cell death. Two of these lines orthotopically grafted produced aggressive gliomas. Intracranial injection of MYXV failed to result in sustained viral replication or treatment efficacy, with minimal tumour infection that was completely resolved by 7 days post-infection. We hypothesized that the stromal production of Type-I interferons (IFN alpha/beta) could explain the resistance seen in these models; however, we found that neither the cell lines in vitro nor the tumours in vivo produce any IFN alpha/beta in response to MYXV infection. To confirm IFN alpha/beta did not play a role in this resistance, we ablated the ability of tumours to respond to IFN alpha/beta via IRF9 knockdown, and generated identical results. Our studies demonstrate that these syngeneic cell lines are relevant preclinical models for testing experimental glioma treatments, and show that IFN alpha/beta is not responsible for the MYXV treatment resistance seen in syngeneic glioma models.	[Zemp, Franz J.; McKenzie, Brienne A.; Lun, Xueqing; Maxwell, Lori; Forsyth, Peter A.] Univ Calgary, Southern Alberta Canc Res Inst, Tom Baker Canc Ctr, Clark H Smith Brain Tumor Ctr,Dept Oncol, Calgary, AB, Canada; [Zemp, Franz J.; McKenzie, Brienne A.; Lun, Xueqing; Maxwell, Lori; Forsyth, Peter A.] Univ Calgary, Clark H Smith Brain Tumor Ctr, Calgary, AB, Canada; [Reilly, Karlyne M.] NCI, Mouse Canc Genet Program, Frederick, MD 21701 USA; [McFadden, Grant] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Yong, V. Wee] Univ Calgary, Dept Clin Neurosci, Hotchkiss Brain Inst, Calgary, AB, Canada; [Yong, V. Wee] Univ Calgary, Dept Oncol, Hotchkiss Brain Inst, Calgary, AB, Canada; [Forsyth, Peter A.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Forsyth, Peter A.] Univ S Florida, Tampa, FL USA	Tom Baker Cancer Clinic; University of Calgary; University of Calgary; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); State University System of Florida; University of Florida; University of Calgary; University of Calgary; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Forsyth, PA (corresponding author), Univ Calgary, Southern Alberta Canc Res Inst, Tom Baker Canc Ctr, Clark H Smith Brain Tumor Ctr,Dept Oncol, Calgary, AB, Canada.	Peter.Forsyth@moffitt.org	Reilly, Karlyne/V-4475-2019; McKenzie, Brienne/AAY-6533-2020	Reilly, Karlyne/0000-0001-9109-4409; McFadden, Grant/0000-0002-2556-3526; Yong, V. Wee/0000-0002-2600-3563; McKenzie, Brienne/0000-0001-6829-9828	Canadian Cancer Society Research Institute (CCSRI); Canadian Cancer Society (PAF); Terry Fox Foundation; V Foundation; Canadian Institutes of Health Research (CIHR); Alberta Innovates Health Solutions; Izaak Walton Killam scholarship; NIH [R01 AI080607, R21 CA149869, R01 CA138541]; Bankhead Coley Foundation [1BT02]; NIH, NCI [ZIA BC 010541]; NATIONAL CANCER INSTITUTE [R21CA149869, R01CA138541, ZIABC010540, ZIABC010541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080607] Funding Source: NIH RePORTER	Canadian Cancer Society Research Institute (CCSRI)(Canadian Cancer Society (CCS)); Canadian Cancer Society (PAF); Terry Fox Foundation; V Foundation; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions; Izaak Walton Killam scholarship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bankhead Coley Foundation; NIH, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Canadian Cancer Society Research Institute (CCSRI) with funds raised by the Canadian Cancer Society (PAF), a Program Project Grant from the Terry Fox Foundation (PAF), the V Foundation (PAF), and the Canadian Institutes of Health Research (CIHR) (VWY). During this work FJZ was funded by Alberta Innovates Health Solutions, Vanier Scholarship from CIHR, and the Izaak Walton Killam scholarship. BAM was funded by CIHR. GM's lab is funded by NIH grants (R01 AI080607, R21 CA149869 and R01 CA138541) and by the Bankhead Coley Foundation (1BT02). KMR's lab is funded by the Intramural Research Program of NIH, NCI (ZIA BC 010541). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain T, 2010, P NATL ACAD SCI USA, V107, P1576, DOI 10.1073/pnas.0912344107; [Anonymous], 2009, ASTR SEC GLIOBL DISS, P93; [Anonymous], 2008, NATURE, V455, P1061; Balachandran S, 2004, CANCER CELL, V5, P51, DOI 10.1016/S1535-6108(03)00330-1; Barth RF, 2009, J NEURO-ONCOL, V94, P299, DOI 10.1007/s11060-009-9875-7; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Cantin E, 1999, J VIROL, V73, P3418, DOI 10.1128/JVI.73.4.3418-3423.1999; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Christensen JE, 2012, J VIROL, V86, P7384, DOI 10.1128/JVI.07090-11; Collins SE, 2004, J VIROL, V78, P1706, DOI 10.1128/JVI.78.4.1706-1717.2004; France MR, 2011, J GEN VIROL, V92, P195, DOI 10.1099/vir.0.026690-0; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; GRAY PW, 1983, P NATL ACAD SCI-BIOL, V80, P5842, DOI 10.1073/pnas.80.19.5842; Gursel DB, 2011, NEURO-ONCOLOGY, V13, P610, DOI 10.1093/neuonc/nor035; Hamilton SR, WHO CLASSIFICATION T; Hellums EK, 2005, NEURO-ONCOLOGY, V7, P213, DOI 10.1215/S1152851705000074; Kastrukoff Lorne F, 2012, Herpesviridae, V3, P4, DOI 10.1186/2042-4280-3-4; Kelly JJP, 2009, STEM CELLS, V27, P1722, DOI 10.1002/stem.98; LANDO Z, 1980, NATURE, V287, P551, DOI 10.1038/287551a0; Lasner TM, 1996, J NEUROPATH EXP NEUR, V55, P1259, DOI 10.1097/00005072-199612000-00010; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lun XQ, 2005, CANCER RES, V65, P9982, DOI 10.1158/0008-5472.CAN-05-1201; Lun XQ, 2007, CANCER RES, V67, P8818, DOI 10.1158/0008-5472.CAN-07-1214; Lun XQ, 2010, MOL THER, V18, P1927, DOI 10.1038/mt.2010.183; Lun XQ, 2010, CANCER RES, V70, P598, DOI 10.1158/0008-5472.CAN-09-1510; Markert JM, 2009, MOL THER, V17, P199, DOI 10.1038/mt.2008.228; MCKEEVER PE, 1991, CRIT REV NEUROBIOL, V6, P119; MINETA T, 1995, NAT MED, V1, P938, DOI 10.1038/nm0995-938; Motomura K, 2011, CANCER-AM CANCER SOC, V117, P1721, DOI 10.1002/cncr.25637; Noyce RS, 2011, J VIROL, V85, P10926, DOI 10.1128/JVI.00862-11; Oertel Joachim, 2005, Neurosurg Focus, V18, pe12; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Papanastassiou V, 2002, GENE THER, V9, P398, DOI 10.1038/sj.gt.3301664; Paul S, 2007, BIOCHIMIE, V89, P770, DOI 10.1016/j.biochi.2007.02.009; PAULUS W, 1994, INT J CANCER, V58, P841, DOI 10.1002/ijc.2910580616; Qin XQ, 2001, MOL THER, V4, P356, DOI 10.1006/mthe.2001.0464; Reilly KM, 2000, NAT GENET, V26, P109, DOI 10.1038/79075; Reilly KM, 2004, P NATL ACAD SCI USA, V101, P13008, DOI 10.1073/pnas.0401236101; Savarin C, 2008, CURR OPIN PHARMACOL, V8, P472, DOI 10.1016/j.coph.2008.05.002; Smallwood Sherin E, 2010, Curr Protoc Microbiol, VChapter 14, DOI 10.1002/9780471729259.mc14a01s17; Stojdl DF, 2000, NAT MED, V6, P821, DOI 10.1038/77558; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tada H, 2001, J CLIN INVEST, V108, P83, DOI 10.1172/JCI9841; UZE G, 1992, P NATL ACAD SCI USA, V89, P4774, DOI 10.1073/pnas.89.10.4774; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang F, 2004, NAT IMMUNOL, V5, P1266, DOI 10.1038/ni1132; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wennier S, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001876; Wennier ST, 2012, MOL THER, V20, P759, DOI 10.1038/mt.2011.293; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Wollmann G, 2012, CANCER J, V18, P69, DOI 10.1097/PPO.0b013e31824671c9; Yoshino A, 2005, J NEURO-ONCOL, V74, P249, DOI 10.1007/s11060-004-7316-1; Yuki K, 2009, CANCER LETT, V284, P71, DOI 10.1016/j.canlet.2009.04.020; Zemp F, 2013, NEURO-ONCOLOGY, DOI [10.1093/neuonc/not035, DOI 10.1093/NEU0NC/N0T035]; Zemp FJ, 2010, CYTOKINE GROWTH F R, V21, P103, DOI 10.1016/j.cytogfr.2010.04.001	56	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65801	10.1371/journal.pone.0065801	http://dx.doi.org/10.1371/journal.pone.0065801			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762429	gold, Green Submitted, Green Published			2022-12-27	WOS:000321099000107
J	Bruehl, H; Preissler, S; Heuser, I; Heekeren, HR; Roepke, S; Dziobek, I				Bruehl, Hannah; Preissler, Sandra; Heuser, Isabella; Heekeren, Hauke R.; Roepke, Stefan; Dziobek, Isabel			Increased Prefrontal Cortical Thickness Is Associated with Enhanced Abilities to Regulate Emotions in PTSD-Free Women with Borderline Personality Disorder	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; STRUCTURAL BRAIN ABNORMALITIES; HIPPOCAMPAL VOLUME; FEMALE-PATIENTS; PHYSICAL ABUSE; SEXUAL-ABUSE; GRAY-MATTER; AXIS-I; DSM-IV; AMYGDALA	Previous studies suggest that amygdala, insula and prefrontal cortex (PFC) disintegrity play a crucial role in the failure to adequately regulate emotions in Borderline Personality Disorder (BPD). However, prior results are confounded by the high rate of comorbidity with Posttraumatic Stress Disorder (PTSD), which itself has been associated with changes in frontolimbic circuitry. We thus scrutinized the link between PFC, amygdala, insula, and the ability to regulate emotions, contrasting 17 women with BPD without comorbid PTSD to 27 non-clinical control women and in addition to those with BPD and PTSD (n = 14). BPD women without PTSD, but not those with comorbid PTSD, had increased cortical thickness in the dorsolateral PFC (DLPFC) in comparison to control women. Furthermore, cortical thickness in the DLPFC of BPD women without PTSD positively correlated with emotion regulation scores and furthermore was positively associated with amygdala volume, as well as cortical thickness of the insula. Our findings highlight the importance of disentangling the impact of BPD and PTSD on the brain and suggest possible compensatory mechanisms for the impaired emotion regulation in BPD women without PTSD.	[Bruehl, Hannah; Heekeren, Hauke R.] Free Univ Berlin, Dept Psychol Emot & Affect Neurosci, Berlin, Germany; [Preissler, Sandra] Univ Jena, Dept Biol & Clin Psychol, Jena, Germany; [Heuser, Isabella; Roepke, Stefan] Charite, Dept Psychiat, D-13353 Berlin, Germany; [Heuser, Isabella; Heekeren, Hauke R.; Roepke, Stefan; Dziobek, Isabel] Free Univ Berlin, Berlin, Germany	Free University of Berlin; Friedrich Schiller University of Jena; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin	Bruehl, H (corresponding author), Free Univ Berlin, Dept Psychol Emot & Affect Neurosci, Berlin, Germany.	hannah.bruehl@fu-berlin.de	Bruehl, Hannah/A-1610-2015; Dziobek, isabel/ABB-4928-2020	Heekeren, Hauke/0000-0001-7912-6826	German Federal Ministry of Education and Research [BMBF] [01GO0518, 01GW0783]	German Federal Ministry of Education and Research [BMBF](Federal Ministry of Education & Research (BMBF))	This study was supported by a grant from the German Federal Ministry of Education and Research [BMBF, No.: 01GO0518 and No.: 01GW0783]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, WST WORTSCHATZTEST; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Beauregard M, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-18-j0001.2001; Behr M., 2004, SKALEN ZUM ERLEBEN E; Bohus M, 2007, PSYCHOPATHOLOGY, V40, P126, DOI 10.1159/000098493; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; Brambilla P, 2004, PSYCHIAT RES-NEUROIM, V131, P125, DOI 10.1016/j.pscychresns.2004.04.003; Bremner JD, 2007, NEUROIMAG CLIN N AM, V17, P523, DOI 10.1016/j.nic.2007.07.003; BROWNE A, 1986, PSYCHOL BULL, V99, P66, DOI 10.1037/0033-2909.99.1.66; Brunner R, 2010, NEUROIMAGE, V49, P114, DOI 10.1016/j.neuroimage.2009.07.070; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dewey J, 2010, NEUROIMAGE, V51, P1334, DOI 10.1016/j.neuroimage.2010.03.033; Diaz-Marsa M, 2011, J AFFECT DISORD; Donegan NH, 2003, BIOL PSYCHIAT, V54, P1284, DOI 10.1016/S0006-3223(03)00636-X; Driessen M, 2004, BIOL PSYCHIAT, V55, P603, DOI 10.1016/j.biopsych.2003.08.018; Dziobek I, 2010, ARCH GEN PSYCHIAT, V67, P397, DOI 10.1001/archgenpsychiatry.2010.31; Eckart C, 2011, J PSYCHIATR NEUROSCI, V36, P176, DOI 10.1503/jpn.100010; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; First M. B., 1997, STRUCTURED CLIN INTE; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Foa E.B., 1995, PDS POSTTRAUMATIC ST; Glenn CR, 2009, J PERS DISORD, V23, P20, DOI 10.1521/pedi.2009.23.1.20; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Hayes JP, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00230; Hazlett EA, 2005, BIOL PSYCHIAT, V58, P614, DOI 10.1016/j.biopsych.2005.04.029; Heffernan K, 2000, J NERV MENT DIS, V188, P589, DOI 10.1097/00005053-200009000-00005; Horn W., 1983, L P S LEISTUNGSPR FS, V2; Juengling FD, 2003, J PSYCHIAT RES, V37, P109, DOI 10.1016/S0022-3956(02)00084-5; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Koenigsberg HW, 2009, BIOL PSYCHIAT, V66, P854, DOI 10.1016/j.biopsych.2009.06.010; Koenigsberg HW, 2009, PSYCHIAT RES-NEUROIM, V172, P192, DOI 10.1016/j.pscychresns.2008.07.010; Kraus A, 2010, ACTA PSYCHIAT SCAND, V121, P41, DOI 10.1111/j.1600-0447.2009.01417.x; Kuhn S, 2013, BIOL PSYCHIAT, V73, P70, DOI 10.1016/j.biopsych.2012.06.029; Landre L, 2010, PSYCHIAT RES-NEUROIM, V183, P181, DOI 10.1016/j.pscychresns.2010.01.015; Lieb K, 2004, LANCET, V364, P453, DOI 10.1016/S0140-6736(04)16770-6; Lis E, 2007, J PSYCHIATR NEUROSCI, V32, P162; Mauchnik J, 2010, CURR PSYCHIAT REP, V12, P46, DOI 10.1007/s11920-009-0089-7; Mazza M, 2013, EUR ARCH PSYCHIAT CL; Minzenberg MJ, 2008, J PSYCHIATR RES, V42, P727, DOI 10.1016/j.jpsychires.2007.07.015; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Nepon J, 2010, DEPRESS ANXIETY, V27, P791, DOI 10.1002/da.20674; New AS, 2007, NEUROPSYCHOPHARMACOL, V32, P1629, DOI 10.1038/sj.npp.1301283; Niedtfeld I, 2010, BIOL PSYCHIAT, V68, P383, DOI 10.1016/j.biopsych.2010.04.015; Nunes PM, 2009, J PERS DISORD, V23, P333, DOI 10.1521/pedi.2009.23.4.333; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; OGATA SN, 1990, AM J PSYCHIAT, V147, P1008; OLDHAM JM, 1995, AM J PSYCHIAT, V152, P571; Rodrigues E, 2011, EUR PSYCHIAT, V26, P452, DOI 10.1016/j.eurpsy.2010.07.005; Roth S, 1997, J TRAUMA STRESS, V10, P539, DOI 10.1002/jts.2490100403; Ruocco AC, 2013, BIOL PSYCHIAT, V73, P153, DOI 10.1016/j.biopsych.2012.07.014; Ruocco AC, 2012, PSYCHIAT RES-NEUROIM, V201, P245, DOI 10.1016/j.pscychresns.2012.02.012; Rusch N, 2003, NEUROIMAGE, V20, P385, DOI 10.1016/S1053-8119(03)00297-0; Sala M, 2011, J AFFECT DISORDERS, V131, P417, DOI 10.1016/j.jad.2010.11.036; Salzman CD, 2010, ANNU REV NEUROSCI, V33, P173, DOI 10.1146/annurev.neuro.051508.135256; Schmahl C, 2006, J PSYCHIATR RES, V40, P419, DOI 10.1016/j.jpsychires.2005.08.011; Schmahl Christian, 2009, J Psychiatry Neurosci, V34, P289; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shin LM, 2004, ARCH GEN PSYCHIAT, V61, P168, DOI 10.1001/archpsyc.61.2.168; Silbersweig D, 2007, AM J PSYCHIAT, V164, P1832, DOI 10.1176/appi.ajp.2007.06010126; Soloff P, 2008, PSYCHIAT RES-NEUROIM, V164, P223, DOI 10.1016/j.pscychresns.2008.02.003; Soloff PH, 2003, PSYCHIAT RES-NEUROIM, V123, P153, DOI 10.1016/S0925-4927(03)00064-7; Takahashi T, 2009, PROG NEURO-PSYCHOPH, V33, P1395, DOI 10.1016/j.pnpbp.2009.07.017; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; van Elst LT, 2003, BIOL PSYCHIAT, V54, P163, DOI 10.1016/S0006-3223(03)01743-2; Vrticka P, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00095; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Weniger G, 2009, J PSYCHIATR NEUROSCI, V34, P383; Zanarini MC, 1998, AM J PSYCHIAT, V155, P1733, DOI 10.1176/ajp.155.12.1733; Zlotnick C, 1999, J NERV MENT DIS, V187, P296, DOI 10.1097/00005053-199905000-00005	73	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65584	10.1371/journal.pone.0065584	http://dx.doi.org/10.1371/journal.pone.0065584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755254	gold, Green Published, Green Submitted			2022-12-27	WOS:000320579400068
J	Burkert, NT; Rasky, E; Grossschadl, F; Muckenhuber, J; Freidl, W				Burkert, Nathalie T.; Rasky, Eva; Grossschaedl, Franziska; Muckenhuber, Johanna; Freidl, Wolfgang			The Influence of Socioeconomic Factors on Health Parameters in Overweight and Obese Adults	PLOS ONE			English	Article							BODY-MASS INDEX; RISK-FACTORS; DETERMINANTS; INEQUALITIES; GRADIENT; MEN	The prevalence of being overweight and of obesity is increasing worldwide, and is associated with a high risk to health. Therefore, the aim of our study was to investigate whether normal weight, overweight and obese subjects of low, middle or high socioeconomic status (SES) differ with regard to their health behavior, health, quality of life, and the use of medical care. Data from the Austrian Health Interview Survey (ATHIS) 2006/07, comprising 3 groups of 1,077 individuals, each of whom were normal weight, overweight, or obese, respectively, and matched according to their age, sex and SES, were analyzed concerning health outcomes. The results show that subjects with a low SES differ significantly from those of high SES in terms of their health behavior, self-perceived health, levels of impairment, chronic conditions, quality of life, and health care. Additionally, obesity in adults is associated with sub-optimal dietary practices and worse health, poorer quality of life and medical care than normal weight and overweight individuals. A significant interaction between the weight class and SES was found concerning physical exercise, impairment due to health problems and chronic diseases. A low SES has a strong negative impact on health, especially in obese individuals. Therefore a continuous target group-oriented, nondiscriminatory public health program is required, prioritizing obese subjects with low SES.	[Burkert, Nathalie T.; Rasky, Eva; Grossschaedl, Franziska; Muckenhuber, Johanna; Freidl, Wolfgang] Med Univ Graz, Inst Social Med & Epidemiol, Graz, Styria, Austria	Medical University of Graz	Burkert, NT (corresponding author), Med Univ Graz, Inst Social Med & Epidemiol, Graz, Styria, Austria.	nathalie.burkert@medunigraz.at		Grossschadl, Franziska/0000-0002-6726-0443				Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60; Ahn S, 2012, INT J PUBLIC HEALTH, V57, P269, DOI 10.1007/s00038-011-0249-5; Amarasinghe A, 2009, INT J ENV RES PUB HE, V6, P2271, DOI 10.3390/ijerph6082271; [Anonymous], 2010, STRAT REV HLTH IN EN; Bauer GF, 2009, INT J PUBLIC HEALTH, V54, P23, DOI 10.1007/s00038-008-7077-2; Branca F., 2007, CHALLENGE OBESITY WH; Brennan SL, 2010, J MENS HEALTH, V7, P31, DOI 10.1016/j.jomh.2009.10.004; Brennan SL, 2009, PREV MED, V49, P165, DOI 10.1016/j.ypmed.2009.06.021; Burkert N, 2012, WIEN KLIN WOCHENSCHR, V124, P256, DOI 10.1007/s00508-012-0164-7; Burkert NT, 2012, WIEN KLIN WOCHENSCHR, V124, P271, DOI 10.1007/s00508-012-0160-y; Burkert NI, 2012, GESUNDHEITSWESEN, V2012, P11; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Grossschaedel F, 2012, WIEN KLIN WOCHENSCHR, V8-9, P560; Grossschadl F, 2013, EUR J PUBLIC HEALTH, V23, P306, DOI 10.1093/eurpub/cks033; Holstein BE, 2009, INT J PUBLIC HEALTH, V54, P260, DOI 10.1007/s00038-009-5418-4; Garcia-Mendizabal MJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-120; Kilicarslan A, 2006, J NATL MED ASSOC, V98, P1313; Kinge JM, 2010, SOC SCI MED, V71, P1864, DOI 10.1016/j.socscimed.2010.09.001; Klimont J, 2007, AUSTR HLTH INTERVIEW; Kuipers Y, 2010, FOCUSING OBESITY HLT; Lantz PM, 2010, SOC SCI MED, V70, P1558, DOI 10.1016/j.socscimed.2010.02.003; Leach Corinne R, 2007, Prev Chronic Dis, V4, pA95; Mackenbach, 2006, HLTH INEQUALITIES EU; Richardson Harriet, 2007, Open Med, V1, pe3; Roskam AJR, 2010, INT J EPIDEMIOL, V39, P392, DOI 10.1093/ije/dyp329; Schumacher MC, 2008, CANCER CAUSE CONTROL, V19, P725, DOI 10.1007/s10552-008-9135-8; Toschke AM, 2005, INT J OBESITY, V29, P875, DOI 10.1038/sj.ijo.0802989; von Lengerke T, 2006, GESUNDHEITSWESEN, V68, P110, DOI 10.1055/s-2005-858994; Wamala SP, 1997, PREV MED, V26, P734, DOI 10.1006/pmed.1997.0199; Wee HL, 2010, INT J OBESITY, V34, P1034, DOI 10.1038/ijo.2010.24; WHO, 1998, CONS OB OB PREV MAN; World Health Organization [WHO], 1996, WHOQOL BREF INTR ADM; Zago CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029894	33	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65407	10.1371/journal.pone.0065407	http://dx.doi.org/10.1371/journal.pone.0065407			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166TB	23755228	gold, Green Published, Green Submitted			2022-12-27	WOS:000320579400058
J	Lori, C; Lantella, A; Pasquo, A; Alexander, LT; Knapp, S; Chiaraluce, R; Consalvi, V				Lori, Clorinda; Lantella, Antonella; Pasquo, Alessandra; Alexander, Leila T.; Knapp, Stefan; Chiaraluce, Roberta; Consalvi, Valerio			Effect of Single Amino Acid Substitution Observed in Cancer on Pim-1 Kinase Thermodynamic Stability and Structure	PLOS ONE			English	Article							CIRCULAR-DICHROISM; INHIBITORS; MUTATION; ACTIVATION; PROTEINS; GENOMES	Pim-1 kinase, a serine/threonine protein kinase encoded by the pim proto-oncogene, is involved in several signalling pathways such as the regulation of cell cycle progression and apoptosis. Many cancer types show high expression levels of Pim kinases and particularly Pim-1 has been linked to the initiation and progression of the malignant phenotype. In several cancer tissues somatic Pim-1 mutants have been identified. These natural variants are nonsynonymous single nucleotide polymorphisms, variations of a single nucleotide occurring in the coding region and leading to amino acid substitutions. In this study we investigated the effect of amino acid substitution on the structural stability and on the activity of Pim-1 kinase. We expressed and purified some of the mutants of Pim-1 kinase that are expressed in cancer tissues and reported in the single nucleotide polymorphisms database. The point mutations in the variants significantly affect the conformation of the native state of Pim-1. All the mutants, expressed as soluble recombinant proteins, show a decreased thermal and thermodynamic stability and a lower activation energy values for kinase activity. The decreased stability accompanied by an increased flexibility suggests that Pim-1 variants may be involved in a wider network of protein interactions. All mutants bound ATP and ATP mimetic inhibitors with comparable IC50 values suggesting that the studied Pim-1 kinase mutants can be efficiently targeted with inhibitors developed for the wild type protein.	[Lori, Clorinda; Lantella, Antonella; Chiaraluce, Roberta; Consalvi, Valerio] Univ Roma La Sapienza, Dept Biochem Sci A Rossi Fanelli, I-00185 Rome, Italy; [Pasquo, Alessandra] UT BIORAD FARM CR Casaccia ENEA, Rome, Italy; [Alexander, Leila T.; Knapp, Stefan] Univ Oxford, Nuffield Dept Clin Med, Oxford, England	Sapienza University Rome; Italian National Agency New Technical Energy & Sustainable Economics Development; University of Oxford	Chiaraluce, R (corresponding author), Univ Roma La Sapienza, Dept Biochem Sci A Rossi Fanelli, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	roberta.chiaraluce@uniroma1.it	consalvi, valerio/F-1918-2011; Knapp, Stefan/AAG-2347-2019	Knapp, Stefan/0000-0001-5995-6494	Wellcome Trust [092809] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Akagi T, 2009, HAEMATOL-HEMATOL J, V94, P1301, DOI 10.3324/haematol.2009.005744; Akue-Gedu R, 2009, J MED CHEM, V52, P6369, DOI 10.1021/jm901018f; Allali-Hassani A, 2009, BIOCHEM J, V424, P15, DOI 10.1042/BJ20090723; Anizon F, 2010, CURR MED CHEM, V17, P4114, DOI 10.2174/092986710793348554; Benjwal S, 2006, PROTEIN SCI, V15, P635, DOI 10.1110/ps.051917406; Brault L, 2010, HAEMATOL-HEMATOL J, V95, P1004, DOI 10.3324/haematol.2009.017079; Bromberg Y, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S8-S8; Bullock AN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007112; Bullock AN, 2005, J BIOL CHEM, V280, P41675, DOI 10.1074/jbc.M510711200; CUYPERS HT, 1984, CELL, V37, P141; Dixit A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007485; Doudou S, 2010, J CHEM INF MODEL, V50, P368, DOI 10.1021/ci9003514; EFTINK MR, 1994, BIOPHYS J, V66, P482, DOI 10.1016/S0006-3495(94)80799-4; Fedorov O, 2012, METHODS MOL BIOL, V795, P109, DOI 10.1007/978-1-61779-337-0_7; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Geierhaas CD, 2007, PROTEIN SCI, V16, P125, DOI 10.1110/ps.062383807; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; HOOVER D, 1991, J BIOL CHEM, V266, P14018; Huber K, 2012, J MED CHEM, V55, P403, DOI 10.1021/jm201286z; Hung HC, 2003, B MATH BIOL, V65, P553, DOI 10.1016/S0092-8240(03)00024-7; Muralidhar D, 2005, J BIOL CHEM, V280, P15569, DOI 10.1074/jbc.M414243200; Ormond KE, 2010, LANCET, V375, P1749, DOI 10.1016/S0140-6736(10)60599-5; Patel S, 2004, BIOCHEMISTRY-US, V43, P1724, DOI 10.1021/bi0347104; Pogacic V, 2007, CANCER RES, V67, P6916, DOI 10.1158/0008-5472.CAN-07-0320; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SARIS CJM, 1991, EMBO J, V10, P655, DOI 10.1002/j.1460-2075.1991.tb07994.x; Stenson PD, 2008, J MED GENET, V45, P124, DOI 10.1136/jmg.2007.055210; VANDERLUGT NMT, 1995, EMBO J, V14, P2536, DOI 10.1002/j.1460-2075.1995.tb07251.x; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Yue P, 2006, J MOL BIOL, V356, P1263, DOI 10.1016/j.jmb.2005.12.025; Zhang Z, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/805827; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	33	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64824	10.1371/journal.pone.0064824	http://dx.doi.org/10.1371/journal.pone.0064824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755147	Green Published, gold, Green Submitted			2022-12-27	WOS:000320579400027
J	Poojari, S; Alabi, OJ; Fofanov, VY; Naidu, RA				Poojari, Sudarsana; Alabi, Olufemi J.; Fofanov, Viacheslav Y.; Naidu, Rayapati A.			A Leafhopper-Transmissible DNA Virus with Novel Evolutionary Lineage in the Family Geminiviridae Implicated in Grapevine Redleaf Disease by Next-Generation Sequencing	PLOS ONE			English	Article							RECOMBINATION EVENTS; COAT PROTEIN; SMALL RNAS; INFECTION; DIVERSITY; PLANTS; ALIGNMENT; SYNERGISM; REVEALS	A graft-transmissible disease displaying red veins, red blotches and total reddening of leaves in red-berried wine grape (Vitis vinifera L.) cultivars was observed in commercial vineyards. Next-generation sequencing technology was used to identify etiological agent(s) associated with this emerging disease, designated as grapevine redleaf disease (GRD). High quality RNA extracted from leaves of grape cultivars Merlot and Cabernet Franc with and without GRD symptoms was used to prepare cDNA libraries. Assembly of highly informative sequence reads generated from Illumina sequencing of cDNA libraries, followed by bioinformatic analyses of sequence contigs resulted in specific identification of taxonomically disparate viruses and viroids in samples with and without GRD symptoms. A single-stranded DNA virus, tentatively named Grapevine redleaf-associated virus (GRLaV), and Grapevine fanleaf virus were detected only in grapevines showing GRD symptoms. In contrast, Grapevine rupestris stem pitting-associated virus, Hop stunt viroid, Grapevine yellow speckle viroid 1, Citrus exocortis viroid and Citrus exocortis Yucatan viroid were present in both symptomatic and non-symptomatic grapevines. GRLaV was transmitted by the Virginia creeper leafhopper (Erythroneura ziczac Walsh) from grapevine-to-grapevine under greenhouse conditions. Molecular and phylogenetic analyses indicated that GRLaV, almost identical to recently reported Grapevine Cabernet Franc-associated virus from New York and Grapevine red blotch-associated virus from California, represents an evolutionarily distinct lineage in the family Geminiviridae with genome characteristics distinct from other leafhopper-transmitted geminiviruses. GRD significantly reduced fruit yield and affected berry quality parameters demonstrating negative impacts of the disease. Higher quantities of carbohydrates were present in symptomatic leaves suggesting their possible role in the expression of redleaf symptoms.	[Poojari, Sudarsana; Alabi, Olufemi J.; Naidu, Rayapati A.] Washington State Univ, Irrigated Agr Res & Extens Ctr, Dept Plant Pathol, Prosser, WA 99350 USA; [Fofanov, Viacheslav Y.] Eureka Genom, Sugar Land, TX USA	Washington State University	Naidu, RA (corresponding author), Washington State Univ, Irrigated Agr Res & Extens Ctr, Dept Plant Pathol, Prosser, WA 99350 USA.	naidu.rayapati@wsu.edu	Alabi, Olufemi J./ABD-9930-2020; Poojari, Sudarsana/Y-7587-2019	Alabi, Olufemi J./0000-0002-2471-7052; Poojari, Sudarsana/0000-0001-9258-1612; Rayapati, Naidu/0000-0002-7273-5116	Washington State University's Agricultural Research Center in the College of Agricultural, Human, and Natural Resource Sciences; Wine Advisory Committee of the Washington Wine Commission; USDA-Northwest Center for Small Fruits Research, USDA-NIFA Specialty Crop Research Initiative [2009-51181-06027]; Washington State Department of Agriculture Nursery Assessment Funds; Washington State Commission on Pesticide Registration; USDA-APHIS National Clean Plant Network	Washington State University's Agricultural Research Center in the College of Agricultural, Human, and Natural Resource Sciences; Wine Advisory Committee of the Washington Wine Commission; USDA-Northwest Center for Small Fruits Research, USDA-NIFA Specialty Crop Research Initiative; Washington State Department of Agriculture Nursery Assessment Funds; Washington State Commission on Pesticide Registration; USDA-APHIS National Clean Plant Network	This work was supported, in part, by Washington State University's Agricultural Research Center in the College of Agricultural, Human, and Natural Resource Sciences, Wine Advisory Committee of the Washington Wine Commission, USDA-Northwest Center for Small Fruits Research, USDA-NIFA Specialty Crop Research Initiative (Award Number 2009-51181-06027), Washington State Department of Agriculture Nursery Assessment Funds, Washington State Commission on Pesticide Registration and USDA-APHIS National Clean Plant Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Rwahnih M, 2009, VIROLOGY, V387, P395, DOI 10.1016/j.virol.2009.02.028; Al Rwahnih M, 2012, P 17 C INT COUNC STU, P104; Alabi OJ, 2012, P 17 C INT COUNC STU, P170; Alabi OJ, 2012, MOL PLANT PATHOL, V13, P1060, DOI 10.1111/j.1364-3703.2012.00815.x; Alabi OJ, 2010, J GEN VIROL, V91, P265, DOI 10.1099/vir.0.014423-0; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Arnett R. H, 2000, AM INSECTS HDB INSEC, V2nd; Beerenwinkel N, 2011, CURR OPIN VIROL, V1, P413, DOI 10.1016/j.coviro.2011.07.008; BRIDDON RW, 1990, VIROLOGY, V177, P85, DOI 10.1016/0042-6822(90)90462-Z; Brown JK, 2011, VIRUS TAXONOMY CLASS, P251; Coetzee B, 2010, VIROLOGY, V400, P157, DOI 10.1016/j.virol.2010.01.023; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fauquet CM, 2008, ARCH VIROL, V153, P783, DOI 10.1007/s00705-008-0037-6; Giampetruzzi A, 2012, VIRUS RES, V163, P262, DOI 10.1016/j.virusres.2011.10.010; Herbers K, 2000, MOL PLANT PATHOL, V1, P51, DOI 10.1046/j.1364-3703.2000.00007.x; Iland P., 2000, TECHNIQUES CHEM ANAL; Isakov O, 2011, BIOINFORMATICS, V27, P2027, DOI 10.1093/bioinformatics/btr349; Jiang DM, 2009, ARCH VIROL, V154, P1563, DOI 10.1007/s00705-009-0454-1; Jones RAC, 2009, VIRUS RES, V141, P113, DOI 10.1016/j.virusres.2008.07.028; Kawaguchi-Ito Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008386; Kirthi N, 2003, ARCH VIROL, V148, P2369, DOI 10.1007/s00705-003-0174-x; Komar V, 2010, AM J ENOL VITICULT, V61, P68; KRAKE LR, 1999, GRAFT TRANSMITTED DI; Krenz B, 2012, J VIROL, V86, P7715, DOI 10.1128/JVI.00943-12; Kriesel JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031886; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Latham JR, 2008, MOL PLANT PATHOL, V9, P85, DOI [10.1111/j.1364-3703.2007.00441.x, 10.1111/J.1364-3703.2007.00441.X]; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Little A, 2003, VIROIDS, p[2003, 95]; Martelli GP, 2012, J PLANT PATHOL, V94, P7; Martelli G.P., 2006, OPTIONS MEDITERR B, V55, P11; MCKENZIE LM, 1972, CAN ENTOMOL, V104, P1229, DOI 10.4039/Ent1041229-8; Mekuria TA, 2009, PHYTOPATHOLOGY, V99, P1394, DOI 10.1094/PHYTO-99-12-1394; Nash TE, 2011, J VIROL, V85, P1182, DOI 10.1128/JVI.02143-10; Oliver JE, 2011, AM J ENOL VITICULT, V62, P438, DOI 10.5344/ajev.2011.11036; Olsen K, 1997, EXTENSION B WASHINGT, V1828; Olsen KN, 1998, ENVIRON ENTOMOL, V27, P401, DOI 10.1093/ee/27.2.401; Petrie PR, 2000, VITIS, V39, P31; Prosser SW, 2007, VIRUS RES, V124, P151, DOI 10.1016/j.virusres.2006.10.014; Pruss G, 1997, PLANT CELL, V9, P859, DOI 10.1105/tpc.9.6.859; Radford AD, 2012, J GEN VIROL, V93, P1853, DOI 10.1099/vir.0.043182-0; Rayapati N, 2008, WASHINGTON STATE U E; Roossinck MJ, 2005, NAT REV MICROBIOL, V3, P917, DOI 10.1038/nrmicro1285; Rowhani A., 2000, P 13 INT COUNC STUD; Solfanelli C, 2006, PLANT PHYSIOL, V140, P637, DOI 10.1104/pp.105.072579; Soto MJ, 2005, VIROLOGY, V341, P257, DOI 10.1016/j.virol.2005.07.009; Sudarsana MR, 2012, GRAPEVINE RED BLOTCH; Szychowski JA, 1998, VIROLOGY, V248, P432, DOI 10.1006/viro.1998.9292; Szychowski JA, 1995, VITIS, V34, P229; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tecsi LI, 1996, PLANT PHYSIOL, V111, P975, DOI 10.1104/pp.111.4.975; Tsagris EM, 2008, CELL MICROBIOL, V10, P2168, DOI 10.1111/j.1462-5822.2008.01231.x; Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009; Zapata C, 2004, J PLANT PHYSIOL, V161, P1031, DOI 10.1016/j.jplph.2003.11.009; Zhang Y, 2011, PHYTOPATHOLOGY, V101, P1081, DOI 10.1094/PHYTO-02-11-0034; Zhao D, 2010, CROP SCI, V50, P1537, DOI 10.2135/cropsci2009.09.0521; [No title captured]	58	88	96	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64194	10.1371/journal.pone.0064194	http://dx.doi.org/10.1371/journal.pone.0064194			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755117	Green Submitted, Green Published, gold			2022-12-27	WOS:000320579400010
J	Qaim, M; Kouser, S				Qaim, Matin; Kouser, Shahzad			Genetically Modified Crops and Food Security	PLOS ONE			English	Article							BT COTTON; GOLDEN-RICE; IMPACT; INDIA; WORLD; POOR; AGRICULTURE; ADOPTION; POVERTY; CHINA	The role of genetically modified (GM) crops for food security is the subject of public controversy. GM crops could contribute to food production increases and higher food availability. There may also be impacts on food quality and nutrient composition. Finally, growing GM crops may influence farmers' income and thus their economic access to food. Smallholder farmers make up a large proportion of the undernourished people worldwide. Our study focuses on this latter aspect and provides the first ex post analysis of food security impacts of GM crops at the micro level. We use comprehensive panel data collected over several years from farm households in India, where insect-resistant GM cotton has been widely adopted. Controlling for other factors, the adoption of GM cotton has significantly improved calorie consumption and dietary quality, resulting from increased family incomes. This technology has reduced food insecurity by 15-20% among cotton-producing households. GM crops alone will not solve the hunger problem, but they can be an important component in a broader food security strategy.	[Qaim, Matin; Kouser, Shahzad] Univ Gottingen, Dept Agr Econ & Rural Dev, Gottingen, Germany; [Kouser, Shahzad] Univ Agr Faisalabad, Inst Agr & Resource Econ, Faisalabad, Pakistan	University of Gottingen; University of Agriculture Faisalabad	Qaim, M (corresponding author), Univ Gottingen, Dept Agr Econ & Rural Dev, Gottingen, Germany.	mqaim@uni-goettingen.de	Qaim, Matin/P-4489-2016; Kouser, Shahzad/ABD-7680-2020	Qaim, Matin/0000-0003-4143-0763; 	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	This research was supported by the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2010, J AGR ECON, V61, P175, DOI 10.1111/j.1477-9552.2009.00227.x; Borlaug N, 2007, SCIENCE, V318, P359, DOI 10.1126/science.1151062; BOUIS HE, 1994, J DEV ECON, V44, P199, DOI 10.1016/0304-3878(94)00012-3; Cameron C., 2005, MICROECONOMETRICS US, P1056; de Haen H, 2011, FOOD POLICY, V36, P760, DOI 10.1016/j.foodpol.2011.08.003; De Janvry A, 2002, J DEV STUD, V38, P1, DOI 10.1080/00220380412331322401; De Steur H, 2012, NEW BIOTECHNOL, V29, P432, DOI 10.1016/j.nbt.2011.11.012; European Commission, 2010, DECADE EU FUNDED GMO; FAO, 2013, STATE HUNGER BUILDIN; FAO, 2001, 1 FAO UN; Fedoroff NV, 2010, SCIENCE, V327, P833, DOI 10.1126/science.1186834; Friends of the Earth, 2011, WHO BEN GM CROPS IND; Gopalan C., 2004, NUTR VALUE INDIAN FO; Huang JK, 2010, SCI CHINA LIFE SCI, V53, P981, DOI 10.1007/s11427-010-4036-y; Jayaraman K, 2012, NAT BIOTECHNOL, V30, P1017, DOI 10.1038/nbt1112-1017a; Jensen R.T., 2010, REVEALED PREFERENCE; Juma C, 2011, NATURE, V479, P471, DOI 10.1038/479471a; Kathage J, 2012, P NATL ACAD SCI USA, V109, P11652, DOI 10.1073/pnas.1203647109; Kouser S, 2011, ECOL ECON, V70, P2105, DOI 10.1016/j.ecolecon.2011.06.008; Krishna VV, 2012, AGR SYST, V107, P47, DOI 10.1016/j.agsy.2011.11.005; Leathers Howard, 2004, WORLD FOOD PROBLEM T; National Sample Survey Organization, 2007, 513 GOV IND NAT SAMP; Paine JA, 2005, NAT BIOTECHNOL, V23, P482, DOI 10.1038/nbt1082; Qaim M, 2009, ANNU REV RESOUR ECON, V1, P665, DOI 10.1146/annurev.resource.050708.144203; Rao C. H. H., 2005, AGR FOOD SECURITY PO; Sexton S., 2012, INTENDED UNINTENDED, P269, DOI DOI 10.7208/CHICAGO/9780226988061.003.0009; Shiva Vandana N., 2011, GMO EMPEROR HAS NO C; Stein AJ, 2008, WORLD DEV, V36, P144, DOI 10.1016/j.worlddev.2007.02.013; Subramanian A, 2010, J DEV STUD, V46, P295, DOI 10.1080/00220380903002954; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; United Nations, 2012, MILLENNIUM DEV GOALS; *WORLD BANK, 2007, WORLD DEV REP 2008 A	32	96	105	5	377	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64879	10.1371/journal.pone.0064879	http://dx.doi.org/10.1371/journal.pone.0064879			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166TB	23755155	gold, Green Published			2022-12-27	WOS:000320579400029
J	Bugler, M; Rempoulakis, P; Shacham, R; Keasar, T; Thuijsman, F				Buegler, Max; Rempoulakis, Polychronis; Shacham, Roei; Keasar, Tamar; Thuijsman, Frank			Sex Allocation in a Polyembryonic Parasitoid with Female Soldiers: An Evolutionary Simulation and an Experimental Test	PLOS ONE			English	Article							COPIDOSOMA-KOEHLERI HYMENOPTERA; LOCAL MATE COMPETITION; RATIO; WASP; CONFLICT; CONSPECIFICS; PROTOCOL; BEHAVIOR; SIZE	Parasitoid wasps are convenient subjects for testing sex allocation theory. However, their intricate life histories are often insufficiently captured in simple analytical models. In the polyembryonic wasp Copidosoma koehleri, a clone of genetically identical offspring develops from each egg. Male clones contain fewer individuals than female clones. Some female larvae develop into soldiers that kill within-host competitors, while males do not form soldiers. These features complicate the prediction of Copidosoma's sex allocation. We developed an individual-based simulation model, where numerous random starting strategies compete and recombine until a single stable sex allocation evolves. Life-history parameter values (e.g., fecundity, clone-sizes, larval survival) are estimated from experimental data. The model predicts a male-biased sex allocation, which becomes more extreme as the probability of superparasitism (hosts parasitized more than once) increases. To test this prediction, we reared adult parasitoids at either low or high density, mated them, and presented them with unlimited hosts. As predicted, wasps produced more sons than daughters in all treatments. Males reared at high density (a potential cue for superparasitism) produced a higher male bias in their offspring than low-density males. Unexpectedly, female density did not affect offspring sex ratios. We discuss possible mechanisms for paternal control over offspring sex.	[Buegler, Max] Tech Univ Munich, Chair Computat Modeling & Simulat, D-80290 Munich, Germany; [Rempoulakis, Polychronis; Keasar, Tamar] Univ Haifa, Tivon, Israel; [Shacham, Roei] Univ Haifa, IL-31999 Haifa, Israel; [Thuijsman, Frank] Maastricht Univ, Maastricht, Netherlands	Technical University of Munich; University of Haifa; University of Haifa; Maastricht University	Keasar, T (corresponding author), Univ Haifa, Tivon, Israel.	tkeasar@research.haifa.ac.il	Rempoulakis, Polychronis/P-2731-2019	Rempoulakis, Polychronis/0000-0002-3947-0064; Bugler, Maximilian/0000-0002-2591-017X	Israel Science Foundation [414/10]	Israel Science Foundation(Israel Science Foundation)	The study was supported by the Israel Science Foundation (http://www.isf.org.il/), grant number 414/10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berlinger M. J., 1997, TRENDS ENTOMOLOGY, V1, P137; BROCKMANN HJ, 1989, ANIM BEHAV, V37, P232, DOI 10.1016/0003-3472(89)90113-9; Colinet H, 2005, ECOL ENTOMOL, V30, P473, DOI 10.1111/j.0307-6946.2005.00716.x; Crowley PH, 2009, ECOL ENTOMOL, V34, P163, DOI 10.1111/j.1365-2311.2008.01052.x; Drewell RA, 2012, TRENDS ECOL EVOL, V27, P367, DOI 10.1016/j.tree.2012.02.005; Gardner A, 2007, AM NAT, V169, P519, DOI 10.1086/512107; Godfray H. C. J., 1994, Parasitoids: behavioral and evolutionary ecology.; Grant VJ, 2010, REPRODUCTION, V140, P425, DOI 10.1530/REP-10-0137; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Henter HJ, 2004, J EVOLUTION BIOL, V17, P886, DOI 10.1111/j.1420-9101.2004.00746.x; House CM, 2011, EVOL ECOL, V25, P363, DOI 10.1007/s10682-010-9423-0; HUNTER MS, 1993, OECOLOGIA, V93, P421, DOI 10.1007/BF00317887; Keasar T, 2006, ECOL ENTOMOL, V31, P277, DOI 10.1111/j.1365-2311.2006.00788.x; Keinan Y, 2012, BEHAV ECOL, V23, P1263, DOI 10.1093/beheco/ars111; KFIR R, 1981, ANN APPL BIOL, V99, P225, DOI 10.1111/j.1744-7348.1981.tb04790.x; King BH, 2012, BEHAV ECOL SOCIOBIOL, V66, P1165, DOI 10.1007/s00265-012-1369-5; King BH, 2002, BEHAV ECOL SOCIOBIOL, V52, P17, DOI 10.1007/s00265-002-0492-0; Lebreton S, 2010, BEHAV ECOL, V21, P107, DOI 10.1093/beheco/arp156; Lewis HM, 2010, J EVOLUTION BIOL, V23, P1708, DOI 10.1111/j.1420-9101.2010.02038.x; Lindsay CB, 2009, THESIS U GEORGIA; Macke E, 2011, SCIENCE, V334, P1127, DOI 10.1126/science.1212177; Morag N, 2011, ANIM BEHAV, V81, P865, DOI 10.1016/j.anbehav.2011.01.026; Ode PJ, 2002, BIOL CONTROL, V24, P31, DOI 10.1016/S1049-9644(02)00003-8; Seger J, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P2, DOI 10.1017/CBO9780511542053.002; Segoli M, 2009, ARTHROPOD STRUCT DEV, V38, P84, DOI 10.1016/j.asd.2008.05.003; Segoli M, 2010, PHYSIOL ENTOMOL, V35, P40, DOI 10.1111/j.1365-3032.2009.00708.x; Segoli M, 2009, BEHAV ECOL, V20, P761, DOI 10.1093/beheco/arp057; Shuker DM, 2007, ANIM BEHAV, V73, P971, DOI 10.1016/j.anbehav.2006.07.013; Shuker DM, 2009, BIOL LETTERS, V5, P682, DOI 10.1098/rsbl.2009.0427; Shuker DM, 2006, BEHAV ECOL SOCIOBIOL, V59, P829, DOI 10.1007/s00265-005-0129-1; Shuker DM, 2005, AM NAT, V166, P301, DOI 10.1086/432562; Sykes EM, 2007, BEHAV ECOL SOCIOBIOL, V61, P1751, DOI 10.1007/s00265-007-0407-1; Van Vugt JJFA, 2009, P ROY SOC B-BIOL SCI, V276, P4149, DOI 10.1098/rspb.2009.1238; Verhulst EC, 2010, SCIENCE, V328, P620, DOI 10.1126/science.1185805; West SA, 2009, MONOGR POPUL BIOL, V44, P1	37	5	5	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64780	10.1371/journal.pone.0064780	http://dx.doi.org/10.1371/journal.pone.0064780			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755142	gold, Green Published, Green Submitted			2022-12-27	WOS:000319872300027
J	Mez, J; Cosentino, S; Brickman, AM; Huey, ED; Manly, JJ; Mayeux, R				Mez, Jesse; Cosentino, Stephanie; Brickman, Adam M.; Huey, Edward D.; Manly, Jennifer J.; Mayeux, Richard			Faster Cognitive and Functional Decline in Dysexecutive versus Amnestic Alzheimer's Subgroups: A Longitudinal Analysis of the National Alzheimer's Coordinating Center (NACC) Database	PLOS ONE			English	Article							DATA SET UDS; EXECUTIVE DYSFUNCTION; RACIAL-DIFFERENCES; OLDER-ADULTS; DISEASE; MILD; IMPAIRMENT; PHENOTYPES; EDUCATION	Objective: To compare the rate of cognitive and functional decline in dysexecutive, typical and amnestic subgroups of Alzheimer's disease. Methods: 943 participants from the National Alzheimer's Coordinating Center (NACC) database who had a diagnosis of probable AD were followed for a mean of 2.3 years. A dysexecutive subgroup (n = 165) was defined as having executive performance >1.5 SD worse than memory performance, an amnestic subgroup (n = 157) was defined as having memory performance >1.5 SD worse than executive performance and a typical subgroup (n = 621) was defined as having a difference in executive and memory performance of <1.5 SD. Generalized estimating equations (GEE) were used to model decline on the Folstein Mini Mental Status Exam (MMSE), rise on the Clinical Dementia Rating (CDR) sum of boxes and rise on the total Functional Assessment Questionnaire (FAQ). Results: Compared with the amnestic subgroup, the dysexecutive subgroup declined 2.2X faster on the Folstein MMSE (p < .001), rose 42% faster on the CDR sum of boxes (p = .03) and rose 33% faster on the total FAQ (p = .01). Rate of change for the typical subgroup fell between that of the amnestic and dysexecutive subgroups for the MMSE, CDR sum of boxes and total FAQ. Among a subset of participants (n = 129) who underwent autopsy, the dysexecutive, amnestic and typical subgroups did not differ in odds of having an AD pathologic diagnosis, suggesting that variation in non-AD pathologies across subtypes did not lead to the observed differences. Conclusions: A dysexecutive subgroup of AD has a unique disease course in addition to cognitive phenotype.	[Mez, Jesse; Cosentino, Stephanie; Brickman, Adam M.; Huey, Edward D.; Manly, Jennifer J.; Mayeux, Richard] Columbia Univ, Coll Phys & Surg, Gertrude H Sergievsky Ctr, New York, NY 10027 USA; [Mez, Jesse; Cosentino, Stephanie; Brickman, Adam M.; Huey, Edward D.; Manly, Jennifer J.; Mayeux, Richard] Columbia Univ, Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY USA; [Mez, Jesse; Cosentino, Stephanie; Brickman, Adam M.; Huey, Edward D.; Manly, Jennifer J.; Mayeux, Richard] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY USA; [Mez, Jesse] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; [Huey, Edward D.; Mayeux, Richard] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA; [Mayeux, Richard] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Mez, J (corresponding author), Columbia Univ, Coll Phys & Surg, Gertrude H Sergievsky Ctr, New York, NY 10027 USA.	jbm2154@columbia.edu	Mayeux, Richard/E-9788-2013	Mayeux, Richard/0000-0001-6519-9696; Mez, Jesse/0000-0003-1438-5442	National Institute of Neurological Disorders and Stroke [5T32NS007153-27]; National Institute on Aging [U01AG016976]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG027295, P50AG008702, U01AG016976] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was supported by the National Institute of Neurological Disorders and Stroke 5T32NS007153-27. The NACC database is funded by the National Institute on Aging U01AG016976. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alladi S, 2007, BRAIN, V130, P2636, DOI 10.1093/brain/awm213; Barnes LL, 2005, AM J GERIAT PSYCHIAT, V13, P959, DOI 10.1176/appi.ajgp.13.11.959; Beekly DL, 2004, ALZ DIS ASSOC DIS, V18, P270; Binetti G, 1996, J NEUROL NEUROSUR PS, V60, P91, DOI 10.1136/jnnp.60.1.91; Bondi MW, 2008, NEUROPSYCHOL REV, V18, P73, DOI 10.1007/s11065-008-9054-1; Boyle PA, 2003, AM J GERIAT PSYCHIAT, V11, P214, DOI 10.1176/appi.ajgp.11.2.214; Bracco L, 2007, J NEUROL, V254, P1052, DOI 10.1007/s00415-006-0488-1; Chen ST, 1998, J NEUROPSYCH CLIN N, V10, P426, DOI 10.1176/jnp.10.4.426; Cosentino S, 2008, NEUROLOGY, V70, P1842, DOI 10.1212/01.wnl.0000304038.37421.cc; Dickerson BC, 2011, J NEUROL NEUROSUR PS, V82, P45, DOI 10.1136/jnnp.2009.199505; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Johnson JK, 1999, ARCH NEUROL-CHICAGO, V56, P1233, DOI 10.1001/archneur.56.10.1233; Johnson JK, 2004, DEMENT GERIATR COGN, V17, P360, DOI 10.1159/000078183; Marshall GA, 2011, ALZHEIMERS DEMENT, V7, P300, DOI 10.1016/j.jalz.2010.04.005; Mez J, 2013, ALZ DIS ASSOC DIS, V27, P218, DOI 10.1097/WAD.0b013e31826a94bd; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Morris JC, 2006, ALZ DIS ASSOC DIS, V20, P210, DOI 10.1097/01.wad.0000213865.09806.92; Murray ME, 2011, LANCET NEUROL, V10, P785, DOI 10.1016/S1474-4422(11)70156-9; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Razani J, 2007, APPL NEUROPSYCHOL, V14, P208, DOI 10.1080/09084280701509125; Sachs-Ericsson N, 2005, AM J GERIAT PSYCHIAT, V13, P968, DOI 10.1176/appi.ajgp.13.11.968; Scarmeas N, 2006, J NEUROL NEUROSUR PS, V77, P308, DOI 10.1136/jnnp.2005.072306; Snowden JS, 2007, CORTEX, V43, P835, DOI 10.1016/S0010-9452(08)70683-X; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; Tekin S, 2001, AM J GERIAT PSYCHIAT, V9, P81, DOI 10.1176/appi.ajgp.9.1.81; Weintraub S, 2009, ALZ DIS ASSOC DIS, V23, P91, DOI 10.1097/WAD.0b013e318191c7dd; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	28	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65246	10.1371/journal.pone.0065246	http://dx.doi.org/10.1371/journal.pone.0065246			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755200	gold, Green Published, Green Submitted			2022-12-27	WOS:000319872300063
J	Sarathy, JP; Lee, E; Dartois, V				Sarathy, Jansy Passiflora; Lee, Edmund; Dartois, Veronique			Polyamines Inhibit Porin-Mediated Fluoroquinolone Uptake in Mycobacteria	PLOS ONE			English	Article							OUTER-MEMBRANE PERMEABILITY; MULTIDRUG EFFLUX PUMP; ESCHERICHIA-COLI; TUBERCULOSIS H37RV; PROTEIN EXPRESSION; SMEGMATIS; GENE; STARVATION; CHANNEL; DIFFUSION	Polyamines decrease the permeability of the outer membrane of Escherichia coli to fluoroquinolones and beta-lactams. In this study, we tested the effect of four polyamines (spermidine, spermine, cadaverine and putrescine) on fluoroquinolone uptake in Mycobacterium bovis BCG. Our results show that polyamines are also capable of reducing the permeability of the mycobacterial outer membrane to fluoroquinolones. Spermidine was most effective and demonstrated reversible dose-and pH-dependent inhibition of ciprofloxacin accumulation. The extent of this inhibition was demonstrated across the fluoroquinolone compound class to varying degrees. Furthermore, we have shown that the addition of spermidine increases the survival of M. bovis BCG after a 5-day exposure to ciprofloxacin by up to 25 times. The treatment of actively-replicating Mycobacterium tuberculosis with spermidine reduced ciprofloxacin accumulation by half while non-replicating nutrient-starved M. tuberculosis cultures lacked similar sensitivity to polyamines. Gene expression studies showed that several outer membrane proteins are significantly down-regulated during the shift to non-replication. Collectively, these characteristics of fluoroquinolone uptake in M. bovis BCG are consistent with facilitated transport by porin-like proteins and suggest that a reduction in intracellular uptake contributes to the phenotypic drug resistance demonstrated by M. tuberculosis in the non-replicating state.	[Sarathy, Jansy Passiflora; Dartois, Veronique] Novartis Inst Trop Dis Pte Ltd, Singapore, Singapore; [Lee, Edmund] Natl Univ Singapore, Yong Loo Lin Sch Med, Clin Res Ctr, Dept Pharmacol, Singapore 117595, Singapore; [Dartois, Veronique] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Novartis; National University of Singapore; National University of Singapore	Sarathy, JP (corresponding author), Publ Hlth Res Inst Ctr, Newark, NJ USA.	jansy_sarathy@hotmail.com		Sarathy, Jansy/0000-0002-1532-146X				Babbar N, 2011, RECENT RESULTS CANC, V188, P49, DOI 10.1007/978-3-642-10858-7_4; Basle A, 2004, BACTERIAL EUKARYOTIC, P79; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Chevalier J, 2000, BIOCHEM J, V348, P223, DOI 10.1042/0264-6021:3480223; CLARKE JR, 1991, J MED VIROL, V34, P212, DOI 10.1002/jmv.1890340403; COLOMBATTO S, 1989, BIOL CHEM H-S, V370, P745, DOI 10.1515/bchm3.1989.370.2.745; Cunningham AF, 1998, J BACTERIOL, V180, P801, DOI 10.1128/JB.180.4.801-808.1998; Danilchanka O, 2008, ANTIMICROB AGENTS CH, V52, P3127, DOI 10.1128/AAC.00239-08; Darcan C, 2009, POL J MICROBIOL, V58, P307; De Rossi E, 2006, FEMS MICROBIOL REV, V30, P36, DOI 10.1111/j.1574-6976.2005.00000.x; delaVega AL, 1996, J BACTERIOL, V178, P3715, DOI 10.1128/jb.178.13.3715-3721.1996; DELAVEGA AL, 1995, EMBO J, V14, P6058, DOI 10.1002/j.1460-2075.1995.tb00294.x; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Gengenbacher M, 2010, MICROBIOL-SGM, V156, P81, DOI 10.1099/mic.0.033084-0; HAEMERS A, 1990, ANTIMICROB AGENTS CH, V34, P496, DOI 10.1128/AAC.34.3.496; Hillmann D, 2007, J BACTERIOL, V189, P958, DOI 10.1128/JB.01474-06; HIRSCH JG, 1952, J EXP MED, V95, P191, DOI 10.1084/jem.95.2.191; Hooper D.C., 2003, QUINOLONE ANTIMICROB, V3rd ed., P41, DOI [10.1128/9781555817817.ch3, DOI 10.1128/9781555817817.CH3]; Iyer R, 1997, J BIOL CHEM, V272, P18595, DOI 10.1074/jbc.272.30.18595; Liu J, 1996, J BACTERIOL, V178, P3791, DOI 10.1128/jb.178.13.3791-3795.1996; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mah N, 2010, MICROBIOL-SGM, V156, P2506, DOI 10.1099/mic.0.040089-0; Mailaender C, 2004, MICROBIOL-SGM, V150, P853, DOI 10.1099/mic.0.26902-0; Ozkanca R, 2002, LETT APPL MICROBIOL, V35, P533, DOI 10.1046/j.1472-765X.2002.01230.x; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Pasca MR, 2005, ANTIMICROB AGENTS CH, V49, P4775, DOI 10.1128/AAC.49.11.4775-4777.2005; Pasca MR, 2004, ANTIMICROB AGENTS CH, V48, P3175, DOI 10.1128/AAC.48.8.3175-3178.2004; Piddock LJV, 2001, J ANTIMICROB CHEMOTH, V48, P787, DOI 10.1093/jac/48.6.787; ROCK DM, 1992, MOL PHARMACOL, V42, P157; Samartzidou H, 1999, J BACTERIOL, V181, P791, DOI 10.1128/JB.181.3.791-798.1999; Samartzidou H, 2003, J BACTERIOL, V185, P13, DOI 10.1128/JB.185.1.13-19.2003; Seiler P, 2003, J INFECT DIS, V188, P1326, DOI 10.1086/378563; Senaratne RH, 1998, J BACTERIOL, V180, P3541, DOI 10.1128/JB.180.14.3541-3547.1998; Silva PEA, 2001, ANTIMICROB AGENTS CH, V45, P800, DOI 10.1128/AAC.45.3.800-804.2001; Siroy A, 2008, J BIOL CHEM, V283, P17827, DOI 10.1074/jbc.M800866200; Song HH, 2011, MOL MICROBIOL, V80, P900, DOI 10.1111/j.1365-2958.2011.07619.x; Song H, 2008, TUBERCULOSIS, V88, P526, DOI 10.1016/j.tube.2008.02.004; Stephan J, 2005, MOL MICROBIOL, V58, P714, DOI 10.1111/j.1365-2958.2005.04878.x; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; Teriete P, 2010, BIOCHEMISTRY-US, V49, P2768, DOI 10.1021/bi100158s; Xie ZF, 2005, ANTIMICROB AGENTS CH, V49, P4778, DOI 10.1128/AAC.49.11.4778-4780.2005	41	22	24	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65806	10.1371/journal.pone.0065806	http://dx.doi.org/10.1371/journal.pone.0065806			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755283	Green Submitted, gold, Green Published			2022-12-27	WOS:000319872300096
J	van Loenhout, MTJ; De Vlaminck, I; Flebus, B; den Blanken, JF; Zweifel, LP; Hooning, KM; Kerssemakers, JWJ; Dekker, C				van Loenhout, Marijn T. J.; De Vlaminck, Iwijn; Flebus, Benedetta; den Blanken, Johan F.; Zweifel, Ludovit P.; Hooning, Koen M.; Kerssemakers, Jacob W. J.; Dekker, Cees			Scanning a DNA Molecule for Bound Proteins Using Hybrid Magnetic and Optical Tweezers	PLOS ONE			English	Article							SINGLE; MACROMOLECULES; RESOLUTION	The functional state of the genome is determined by its interactions with proteins that bind, modify, and move along the DNA. To determine the positions and binding strength of proteins localized on DNA we have developed a combined magnetic and optical tweezers apparatus that allows for both sensitive and label-free detection. A DNA loop, that acts as a scanning probe, is created by looping an optically trapped DNA tether around a DNA molecule that is held with magnetic tweezers. Upon scanning the loop along the lambda-DNA molecule, EcoRI proteins were detected with similar to 17 nm spatial resolution. An offset of 33 +/- 5 nm for the detected protein positions was found between back and forwards scans, corresponding to the size of the DNA loop and in agreement with theoretical estimates. At higher applied stretching forces, the scanning loop was able to remove bound proteins from the DNA, showing that the method is in principle also capable of measuring the binding strength of proteins to DNA with a force resolution of 0.1 pN/root Hz. The use of magnetic tweezers in this assay allows the facile preparation of many single-molecule tethers, which can be scanned one after the other, while it also allows for direct control of the supercoiling state of the DNA molecule, making it uniquely suitable to address the effects of torque on protein-DNA interactions.	[van Loenhout, Marijn T. J.; De Vlaminck, Iwijn; Flebus, Benedetta; den Blanken, Johan F.; Zweifel, Ludovit P.; Hooning, Koen M.; Kerssemakers, Jacob W. J.; Dekker, Cees] Delft Univ Technol, Kavli Inst Nanosci, Dept Bionanosci, Delft, Netherlands	Delft University of Technology	Dekker, C (corresponding author), Delft Univ Technol, Kavli Inst Nanosci, Dept Bionanosci, Delft, Netherlands.	c.dekker@tudelft.nl	De Vlaminck, Iwijn/P-6479-2015	De Vlaminck, Iwijn/0000-0001-6085-7311; Kerssemakers, Jacob Willem Jozef/0000-0002-6184-7913; Dekker, Cees/0000-0001-6273-071X	ERC-AdG Grant [247072 NANOFORBIO]	ERC-AdG Grant	This work was financially supported by ERC-2009-AdG Grant 247072 NANOFORBIO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao XR, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.265506; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Bouchiat C, 1999, BIOPHYS J, V76, P409, DOI 10.1016/S0006-3495(99)77207-3; Brewer LR, 1999, SCIENCE, V286, P120, DOI 10.1126/science.286.5437.120; Dame RT, 2006, NATURE, V444, P387, DOI 10.1038/nature05283; De Vlaminck I, 2012, MOL CELL, V46, P616, DOI 10.1016/j.molcel.2012.03.029; De Vlaminck I, 2012, ANNU REV BIOPHYS, V41, P453, DOI 10.1146/annurev-biophys-122311-100544; Frank J, 2002, ANNU REV BIOPH BIOM, V31, P303, DOI 10.1146/annurev.biophys.31.082901.134202; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Gosse C, 2002, BIOPHYS J, V82, P3314, DOI 10.1016/S0006-3495(02)75672-5; Greenleaf WJ, 2007, ANNU REV BIOPH BIOM, V36, P171, DOI 10.1146/annurev.biophys.36.101106.101451; Huisstede JHG, 2005, OPT EXPRESS, V13, P1113, DOI 10.1364/OPEX.13.001113; Kowalczyk SW, 2010, NANO LETT, V10, P324, DOI 10.1021/nl903631m; Le Gall A, 2010, OPT EXPRESS, V18, P26469, DOI 10.1364/OE.18.026469; LINDSAY SM, 1989, J BIOMOL STRUCT DYN, V7, P279, DOI 10.1080/07391102.1989.10507771; Moffitt JR, 2008, ANNU REV BIOCHEM, V77, P205, DOI 10.1146/annurev.biochem.77.043007.090225; Noom MC, 2007, NAT METHODS, V4, P1031, DOI 10.1038/nmeth1126; Spiering A, 2011, NANO LETT, V11, P2978, DOI 10.1021/nl201541y; STIGTER D, 1977, BIOPOLYMERS, V16, P1435, DOI 10.1002/bip.1977.360160705; Strick TR, 2003, REP PROG PHYS, V66, P1, DOI 10.1088/0034-4885/66/1/201; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; TAYLOR KA, 1974, SCIENCE, V186, P1036, DOI 10.1126/science.186.4168.1036; Tolic-Norrelykke SF, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2356852; van Loenhout MTJ, 2012, BIOPHYS J, V102, P2362, DOI 10.1016/j.bpj.2012.03.073; Vermeulen KC, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2165568; VIPOND IB, 1995, BIOCHEMISTRY-US, V34, P697, DOI 10.1021/bi00002a037; Vucinic D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000699; Wallin AE, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2940339; Wuite GJL, 2000, BIOPHYS J, V79, P1155, DOI 10.1016/S0006-3495(00)76369-7	29	16	16	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65329	10.1371/journal.pone.0065329	http://dx.doi.org/10.1371/journal.pone.0065329			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755219	Green Submitted, Green Published, gold			2022-12-27	WOS:000319872300075
J	Li, W; Wang, J; Chen, QD; Qian, X; Li, Q; Yin, Y; Shi, ZM; Wang, L; Lin, J; Liu, LZ; Jiang, BH				Li, Wei; Wang, Jing; Chen, Qiu-Dan; Qian, Xu; Li, Qi; Yin, Yu; Shi, Zhu-Mei; Wang, Lin; Lin, Jie; Liu, Ling-Zhi; Jiang, Bing-Hua			Insulin Promotes Glucose Consumption via Regulation of miR-99a/mTOR/PKM2 Pathway	PLOS ONE			English	Article							PYRUVATE-KINASE M2; HYPOXIA-INDUCIBLE FACTOR-1; FACTOR-I; DIABETES-MELLITUS; MAMMALIAN TARGET; SKELETAL-MUSCLE; METABOLISM; RESISTANCE; MICRORNAS; GROWTH	Insulin is known to regulate multiple cellular functions and is used for the treatment of diabetes. MicroRNAs have been demonstrated to be involved in many human diseases, including Type 2 diabetes. In this study, we showed that insulin decreased miR-99a expression levels, but induced glucose consumption and lactate production, and increased the expression of mTOR, HIF-1 alpha and PKM2 in HepG2 and HL7702 cells. Forced expression of miR-99a or rapamycin treatment blocked insulin-induced PKM2 and HIF-1 alpha expression, and glucose consumption and lactate production. Meanwhile, knockdown of HIF-1 alpha inhibited PKM2 expression and insulin-induced glucose consumption. Taken together, these findings will reveal the role and mechanism ofinsulin in regulating glycolytic activities via miR-99a/mTOR.	[Li, Wei; Wang, Jing; Chen, Qiu-Dan; Qian, Xu; Li, Qi; Yin, Yu; Wang, Lin; Jiang, Bing-Hua] Nanjing Med Univ, Dept Pathol, Ctr Canc, Nanjing, Jiangsu, Peoples R China; [Shi, Zhu-Mei] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Liu, Ling-Zhi; Jiang, Bing-Hua] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Lin, Jie] Fujian Normal Univ, Fac Software, Fuzhou, Peoples R China	Nanjing Medical University; Nanjing Medical University; Jefferson University; Fujian Normal University	Jiang, BH (corresponding author), Nanjing Med Univ, Dept Pathol, Ctr Canc, Nanjing, Jiangsu, Peoples R China.	binghjiang@yahoo.com		Hartl, Carla/0000-0001-9769-7462; Liu, Ling-Zhi/0000-0001-9234-457X; Jiang, Bing-Hua/0000-0003-4526-2031	National Key Basic Research Program of China [2011CB504003]; National Natural Science Foundation of China [81071642, 30871296]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the National Key Basic Research Program of China (2011CB504003), by National Natural Science Foundation of China (81071642 and 30871296). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Chakrabarti M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055652; Chan O, 2012, J BIOL CHEM, V287, P29406, DOI 10.1074/jbc.M112.348946; Chaneton B, 2012, TRENDS BIOCHEM SCI, V37, P309, DOI 10.1016/j.tibs.2012.04.003; Chavez JC, 2002, J NEUROSCI, V22, P8922; Cho DC, 2012, CURR CANC DRUG TARGE; Dehwah MAS, 2012, J GENET GENOMICS, V39, P11, DOI 10.1016/j.jgg.2011.11.007; Doghman M, 2010, CANCER RES, V70, P4666, DOI 10.1158/0008-5472.CAN-09-3970; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; Fang J, 2007, CELL SIGNAL, V19, P2487, DOI 10.1016/j.cellsig.2007.07.025; Ferguson EC, 2008, TRENDS BIOCHEM SCI, V33, P359, DOI 10.1016/j.tibs.2008.05.006; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Grunt TW, 2012, CURR CANC DRUG TARGE; Gupta V, 2010, PROTEIN SCI, V19, P2031, DOI 10.1002/pro.505; Hamar P, 2012, NUCLEIC ACID THER, V22, P289, DOI 10.1089/nat.2012.0381; Imam JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052397; Iqbal MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036764; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Jiang BH, 2008, DRUG RESIST UPDATE, V11, P63, DOI 10.1016/j.drup.2008.03.001; Kang C, 2012, FOOD CHEM, V135, P2350, DOI 10.1016/j.foodchem.2012.06.092; Kumar M, 2012, PROTEIN CELL, V3, P726, DOI 10.1007/s13238-012-2055-0; Lassmann-Vague V, 2010, DIABETES METAB, V36, P79, DOI 10.1016/j.diabet.2009.09.002; Li D, 2011, J BIOL CHEM, V286, P36677, DOI 10.1074/jbc.M111.270561; Liao L, 2010, CHINESE MED J-PEKING, V123, P3684, DOI 10.3760/cma.j.issn.0366-6999.2010.24.031; Ling HY, 2012, EXP CLIN ENDOCR DIAB, V120, P553, DOI 10.1055/s-0032-1311644; Liu EB, 2011, P NATL ACAD SCI USA, V108, P8680, DOI 10.1073/pnas.1100131108; Liu LZ, 2007, CANCER RES, V67, P6325, DOI 10.1158/0008-5472.CAN-06-4261; Luo WB, 2011, ONCOTARGET, V2, P551; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Matthiesen CF, 2010, ARCH ANIM NUTR, V64, P56, DOI 10.1080/17450390903299141; Mazurek S, 2008, ERNST SCHERING FOUND, V4, P99, DOI 10.1007/2789_2008_091; Meivar-Levy I, 2011, J TRANSPLANT, V2011, DOI 10.1155/2011/252387; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Ozaki I, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00078; Poulaki V, 2003, J CLIN ENDOCR METAB, V88, P5392, DOI 10.1210/jc.2003-030389; Ribback S, 2013, J HEPATOL; Simo R, 2002, REV ESP CARDIOL, V55, P845, DOI 10.1016/S0300-8932(02)76714-6; Stadlbauer K, 2009, AM J PHYSIOL-ENDOC M, V297, pE785, DOI 10.1152/ajpendo.00061.2009; Sun J, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0411-9; Sun QA, 2011, P NATL ACAD SCI USA, V108, P4129, DOI 10.1073/pnas.1014769108; Thirone ACP, 2006, TRENDS ENDOCRIN MET, V17, P70, DOI 10.1016/j.tem.2006.01.005; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Uniacke J, 2012, NATURE, V486, P126, DOI 10.1038/nature11055; vonManteuffel SR, 1997, MOL CELL BIOL, V17, P5426, DOI 10.1128/MCB.17.9.5426; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wijesekara N, 2012, DIABETES, V61, P653, DOI 10.2337/db11-0944; Xia HQ, 2011, MOL BIOL REP, V38, P3061, DOI 10.1007/s11033-010-9973-9; Xu CL, 2013, MOL CANCER THER, V12, P207, DOI 10.1158/1535-7163.MCT-12-0273; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yu J, 2012, BRAIN RES, V1430, P18, DOI 10.1016/j.brainres.2011.10.046; Zhang Y, 2011, J HYPERTENS, V29, P1560, DOI 10.1097/HJH.0b013e328348ef8e	56	29	33	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e64924	10.1371/journal.pone.0064924	http://dx.doi.org/10.1371/journal.pone.0064924			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762265	Green Published, Green Submitted, gold			2022-12-27	WOS:000320440500010
J	Lu, ZH; Huang, XL; Ouyang, YD; Yao, JL				Lu, Zhanhua; Huang, Xiaolong; Ouyang, Yidan; Yao, Jialing			Genome-Wide Identification, Phylogenetic and Co-Expression Analysis of OsSET Gene Family in Rice	PLOS ONE			English	Article							SET-DOMAIN PROTEINS; POLYCOMB-GROUP GENE; MADS-BOX PROTEIN; DNA METHYLATION; HISTONE H3; LYSINE METHYLTRANSFERASES; ARABIDOPSIS HOMOLOGS; TRANSCRIPTION FACTOR; CONTROLS EXPRESSION; MERISTEM IDENTITY	Background: SET domain is responsible for the catalytic activity of histone lysine methyltransferases (HKMTs) during developmental process. Histone lysine methylation plays a crucial and diverse regulatory function in chromatin organization and genome function. Although several SET genes have been identified and characterized in plants, the understanding of OsSET gene family in rice is still very limited. Methodology/Principal Findings: In this study, a systematic analysis was performed and revealed the presence of at least 43 SET genes in rice genome. Phylogenetic and structural analysis grouped SET proteins into five classes, and supposed that the domains out of SET domain were significant for the specific of histone lysine methylation, as well as the recognition of methylated histone lysine. Based on the global microarray, gene expression profile revealed that the transcripts of OsSET genes were accumulated differentially during vegetative and reproductive developmental stages and preferentially up or down-regulated in different tissues. Cis-elements identification, co-expression analysis and GO analysis of expression correlation of 12 OsSET genes suggested that OsSET genes might be involved in cell cycle regulation and feedback. Conclusions/Significance: This study will facilitate further studies on OsSET family and provide useful clues for functional validation of OsSETs.	[Lu, Zhanhua] Huazhong Agr Univ, Coll Hort & Forestry Sci, Wuhan, Peoples R China; [Huang, Xiaolong; Yao, Jialing] Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan, Peoples R China; [Ouyang, Yidan] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Ouyang, Yidan] Huazhong Agr Univ, Natl Ctr Plant Gene Res Wuhan, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University	Ouyang, YD (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	diana1983941@mail.hzau.edu.cn; yaojlmy@mail.hzau.edu.cn			National Natural Science Foundation of China [30971551]; Fundamental Research Funds for the Central Universities [2012MBDX012]; Specialized Research Fund for the Doctoral Program of Higher Education [20100146120034]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This research was supported by grants from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm; grant number 30971551), the Fundamental Research Funds for the Central Universities (http://www.dost.moe.edu.cn/; grant number 2012MBDX012), and the Specialized Research Fund for the Doctoral Program of Higher Education (http://www.cutech.edu.cn/cn/index.htm; grant number 20100146120034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Achour M, 2008, ONCOGENE, V27, P2187, DOI 10.1038/sj.onc.1210855; Adamczyk BJ, 2009, PLANT PHYSIOL, V149, P1713, DOI 10.1104/pp.109.135806; Ageez A, 2005, GENES GENET SYST, V80, P403, DOI 10.1266/ggs.80.403; Alvarez-Venegas R, 2003, CURR BIOL, V13, P627, DOI 10.1016/S0960-9822(03)00243-4; Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; Avramova Z, 2009, INT J DEV BIOL, V53, P371, DOI 10.1387/ijdb.082664za; Baroux U, 2006, GENE DEV, V20, P1081, DOI 10.1101/gad.378106; Baumbusch LO, 2001, NUCLEIC ACIDS RES, V29, P4319, DOI 10.1093/nar/29.21.4319; Boyer LA, 2004, NAT REV MOL CELL BIO, V5, P158, DOI 10.1038/nrm1314; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Caro E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002995; de Jager SM, 2001, PLANT MOL BIOL, V47, P555, DOI 10.1023/A:1011848528377; Valencia-Morales MD, 2012, J PLANT RES, V125, P679, DOI 10.1007/s10265-012-0485-7; Dimova DK, 2003, GENE DEV, V17, P2308, DOI 10.1101/gad.1116703; Ding B, 2007, PLANT SCI, V172, P1072, DOI 10.1016/j.plantsci.2007.03.009; Ding Y, 2007, PLANT CELL, V19, P9, DOI 10.1105/tpc.106.048124; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Ebbs ML, 2006, PLANT CELL, V18, P1166, DOI 10.1105/tpc.106.041400; Ebbs ML, 2005, MOL CELL BIOL, V25, P10507, DOI 10.1128/MCB.25.23.10507-10515.2005; Erilova A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000663; Fu FF, 2010, PLANT PHYSIOL, V154, P927, DOI 10.1104/pp.110.159517; Gao XC, 2010, PLANT PHYSIOL, V153, P728, DOI 10.1104/pp.110.156711; Gendler K, 2008, NUCLEIC ACIDS RES, V36, pD298, DOI 10.1093/nar/gkm768; Goodrich J, 1997, NATURE, V386, P44, DOI 10.1038/386044a0; Grini PE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007817; Grossniklaus U, 1998, SCIENCE, V280, P446, DOI 10.1126/science.280.5362.446; Guo J, 2007, PLANT MOL BIOL, V64, P349, DOI 10.1007/s11103-007-9154-y; GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155; Haas BJ, 2004, BIOINFORMATICS, V20, P3643, DOI 10.1093/bioinformatics/bth397; Helin K, 1998, CURR OPIN GENET DEV, V8, P28, DOI 10.1016/S0959-437X(98)80058-0; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Horton JR, 2007, PROTEINS, V67, P1198, DOI 10.1002/prot.21352; Hu P, 2008, J AM CHEM SOC, V130, P3806, DOI 10.1021/ja075896n; Jackson JP, 2004, CHROMOSOMA, V112, P308, DOI 10.1007/s00412-004-0275-7; Jenuwein T, 1998, CELL MOL LIFE SCI, V54, P80, DOI 10.1007/s000180050127; Jiang DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003404; Johnson LM, 2007, CURR BIOL, V17, P379, DOI 10.1016/j.cub.2007.01.009; Kim GT, 1998, PLANTA, V206, P175, DOI 10.1007/s004250050389; Kinoshita T, 1999, PLANT CELL, V11, P1945, DOI 10.1105/tpc.11.10.1945; Kobayashi K, 2012, PLANT CELL, V24, P1848, DOI 10.1105/tpc.112.097105; Kobayashi K, 2010, PLANT CELL PHYSIOL, V51, P47, DOI 10.1093/pcp/pcp166; Kohler C, 2010, CURR OPIN GENET DEV, V20, P541, DOI 10.1016/j.gde.2010.04.015; Kohler C, 2005, NAT GENET, V37, P28, DOI 10.1038/ng1495; Kosugi S, 2002, PLANT J, V29, P45, DOI 10.1046/j.1365-313x.2002.01196.x; Kyozuka J, 2000, PLANT CELL PHYSIOL, V41, P710, DOI 10.1093/pcp/41.6.710; La HG, 2006, MOL GENET GENOMICS, V275, P374, DOI 10.1007/s00438-005-0093-5; Lee JS, 2007, MUTAT RES-FUND MOL M, V618, P130, DOI 10.1016/j.mrfmmm.2006.08.014; Liang YK, 2003, J EXP BOT, V54, P1995, DOI 10.1093/jxb/erg201; Luo M, 2009, MOL PLANT, V2, P711, DOI 10.1093/mp/ssp036; Marmorstein R, 2003, TRENDS BIOCHEM SCI, V28, P59, DOI 10.1016/S0968-0004(03)00007-0; Ng DWK, 2007, BBA-GENE STRUCT EXPR, V1769, P316, DOI 10.1016/j.bbaexp.2007.04.003; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Nowack MK, 2012, DEV CELL, V22, P1030, DOI 10.1016/j.devcel.2012.02.015; Ouyang YD, 2012, BMC GENOMICS, V13, DOI [10.1186/1471-2164-13-100, 10.1186/1471-2164-14-396]; Ouyang YD, 2009, PLANT MOL BIOL, V70, P341, DOI 10.1007/s11103-009-9477-y; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pontvianne F, 2012, GENE DEV, V26, P945, DOI 10.1101/gad.182865.111; Pontvianne F, 2010, ADV BOT RES, V53, P1, DOI 10.1016/S0065-2296(10)53001-5; PRESTRIDGE DS, 1991, COMPUT APPL BIOSCI, V7, P203; Qi RH, 2007, PLANT PHYSIOL, V144, P1587, DOI 10.1104/pp.107.096834; Qin FJ, 2010, MOL PLANT, V3, P773, DOI 10.1093/mp/ssq030; Rattray AMJ, 2012, BIOCHEM SOC T, V40, P880, DOI 10.1042/BST20120065; Raynaud C, 2006, PLANT J, V47, P395, DOI 10.1111/j.1365-313X.2006.02799.x; ROBERTS MR, 1993, PLANT J, V3, P111, DOI 10.1111/j.1365-313X.1993.tb00014.x; Saleh A, 2008, PLANT CELL, V20, P568, DOI 10.1105/tpc.107.056614; Saleh A, 2007, NUCLEIC ACIDS RES, V35, P6290, DOI 10.1093/nar/gkm464; Sanchez MD, 2008, SEMIN CELL DEV BIOL, V19, P537, DOI 10.1016/j.semcdb.2008.07.014; Sang XC, 2012, PLANT PHYSIOL, V160, P788, DOI 10.1104/pp.112.200980; Schatlowski N, 2010, PLANT CELL, V22, P2291, DOI 10.1105/tpc.109.073403; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Schuettengruber B, 2011, NAT REV MOL CELL BIO, V12, P799, DOI 10.1038/nrm3230; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Shen WH, 2002, TRENDS PLANT SCI, V7, P505, DOI 10.1016/S1360-1385(02)02351-8; Shultz RW, 2007, PLANT PHYSIOL, V144, P1697, DOI 10.1104/pp.107.101105; Spiliotopoulos D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046902; Springer NM, 2003, PLANT PHYSIOL, V132, P907, DOI 10.1104/pp.102.013722; Stec I, 2000, FEBS LETT, V473, P1, DOI 10.1016/S0014-5793(00)01449-6; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Sun CH, 2012, PLANT CELL, V24, P3235, DOI 10.1105/tpc.112.101436; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thakur JK, 2003, GENE, V314, P1, DOI 10.1016/S0378-1119(03)00723-6; Thorstensen T, 2008, PLANT MOL BIOL, V66, P47, DOI 10.1007/s11103-007-9251-y; Trievel RC, 2003, NAT STRUCT BIOL, V10, P545, DOI 10.1038/nsb946; Unoki M, 2004, ONCOGENE, V23, P7601, DOI 10.1038/sj.onc.1208053; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; van Ingen H, 2008, STRUCTURE, V16, P1245, DOI 10.1016/j.str.2008.04.015; Vandepoele K, 2005, PLANT PHYSIOL, V139, P316, DOI 10.1104/pp.105.066290; Veiseth SV, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001325; Wang L, 2010, PLANT J, V61, P752, DOI 10.1111/j.1365-313X.2009.04100.x; Wang Y, 2009, MOL CELL, V33, P428, DOI 10.1016/j.molcel.2009.02.002; Williams L, 2000, TRENDS PLANT SCI, V5, P239, DOI 10.1016/S1360-1385(00)01653-8; Wu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018919; Xu L, 2008, CURR BIOL, V18, P1966, DOI 10.1016/j.cub.2008.11.019; Yao SG, 2008, PLANT CELL PHYSIOL, V49, P853, DOI 10.1093/pcp/pcn050; Yu Y, 2009, PROG NAT SCI-MATER, V19, P407, DOI 10.1016/j.pnsc.2008.07.015; Zhao XA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002847	100	20	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65426	10.1371/journal.pone.0065426	http://dx.doi.org/10.1371/journal.pone.0065426			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762371	gold, Green Published, Green Submitted			2022-12-27	WOS:000321094800049
J	Ogawa, Y; Imajo, K; Yoneda, M; Kessoku, T; Tomeno, W; Shinohara, Y; Kato, S; Mawatari, H; Nozaki, Y; Fujita, K; Kirikoshi, H; Maeda, S; Saito, S; Wada, K; Nakajima, A				Ogawa, Yuji; Imajo, Kento; Yoneda, Masato; Kessoku, Takaomi; Tomeno, Wataru; Shinohara, Yoshiyasu; Kato, Shingo; Mawatari, Hironori; Nozaki, Yuichi; Fujita, Koji; Kirikoshi, Hiroyuki; Maeda, Shin; Saito, Satoru; Wada, Koichiro; Nakajima, Atsushi			Soluble CD14 Levels Reflect Liver Inflammation in Patients with Nonalcoholic Steatohepatitis	PLOS ONE			English	Article							SAMPLING VARIABILITY; INSULIN-RESISTANCE; NATURAL-HISTORY; HEPATITIS; BIOPSY; DISEASE; NASH; ENDOTOXIN; CIRRHOSIS; RECEPTOR	Background & Aims: Liver inflammation is a risk factor for the progression of nonalcoholic fatty liver disease (NAFLD). However, the diagnosis of liver inflammation is very difficult and invasive liver biopsy is still the only method to reliably detect liver inflammation. We previously reported that overexpression of CD14 in Kupffer cells may trigger the progression to nonalcoholic steatohepatitis (NASH) via liver inflammation following hyper-reactivity to low-dose lipopolysaccharide. Therefore, the aim of this study was to investigate the relationship between soluble type of CD14 (sCD14) and histological features in patients with NAFLD. Methods: Our cohort consisted of 113 patients with liver biopsy-confirmed NAFLD and 21 age-matched healthy controls. Serum sCD14 levels were measured by an enzyme-linked immunosorbent assay. Results: Serum sCD14 levels were significantly associated with diagnosis of NASH and the area under the receiver operator characteristic curve (AUROC) to distinguish between not NASH and NASH was 0.802. Moreover, serum sCD14 levels were significantly associated with the disease activity based on NAFLD activity score and hepatic CD14 mRNA expression, which is correlated with membrane CD14 (mCD14) expression, in patients with NAFLD. In multiple regression analysis, the serum sCD14 levels were independently associated with liver inflammation. The AUROC to distinguish between mild and severe liver inflammation in patients with NAFLD was 0.752. Conclusions: We found that serum sCD14 levels increased significantly with increasing liver inflammation grade in patients with NAFLD, reflecting increased hepatic CD14 expression. Serum sCD14 is a promising tool to predict the worsening of liver inflammation, and may offer a potential biomarker for evaluation of therapeutic effects in NAFLD.	[Ogawa, Yuji; Imajo, Kento; Yoneda, Masato; Kessoku, Takaomi; Tomeno, Wataru; Shinohara, Yoshiyasu; Kato, Shingo; Mawatari, Hironori; Nozaki, Yuichi; Fujita, Koji; Kirikoshi, Hiroyuki; Maeda, Shin; Saito, Satoru; Nakajima, Atsushi] Yokohama City Univ, Grad Sch Med, Dept Gastroenterol, Yokohama, Kanagawa 232, Japan; [Wada, Koichiro] Osaka Univ, Grad Sch Dent, Dept Pharmacol, Suita, Osaka, Japan	Yokohama City University; Osaka University	Nakajima, A (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Gastroenterol, Yokohama, Kanagawa 232, Japan.	nakajima-tky@umin.ac.jp	Imajo, Kento/AAF-5744-2020	Imajo, Kento/0000-0002-1931-6326; Kessoku, Takaomi/0000-0002-5587-1386	Japan Science and Technology Agency (JST); Kiban-B, Shingakujuturyouiki; Japanese Ministry of Health, Labour and Welfare	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Kiban-B, Shingakujuturyouiki; Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	Work in the authors' laboratory was supported by the program "Step A'' from the Japan Science and Technology Agency (JST) and Kiban-B, Shingakujuturyouiki. In addition, the present work was supported in part by grants-in-aid from the Japanese Ministry of Health, Labour and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDI W, 1979, ARCH INTERN MED, V139, P667, DOI 10.1001/archinte.139.6.667; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; BAZIL V, 1991, J IMMUNOL, V147, P1567; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Brunt EM, 2001, SEMIN LIVER DIS, V21, P3, DOI 10.1055/s-2001-12925; Cadranel JF, 2002, GASTROEN CLIN BIOL, V26, P823; Chitturi S, 2001, SEMIN LIVER DIS, V21, P27, DOI 10.1055/s-2001-12927; Chou MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034903; Day CP, 2002, GUT, V50, P585, DOI 10.1136/gut.50.5.585; Day CP, 2002, J GASTROEN HEPATOL, V17, P377, DOI DOI 10.1046/J.1440-1746.17.S3.31.X; Fan JG, 2007, J GASTROEN HEPATOL, V22, P1086, DOI 10.1111/j.1440-1746.2006.04781.x; Farrell GC, 2003, J GASTROEN HEPATOL, V18, P124, DOI 10.1046/j.1440-1746.2003.02989.x; Hamaguchi M, 2005, ANN INTERN MED, V143, P722, DOI 10.7326/0003-4819-143-10-200511150-00009; Harrison SA, 2003, AM J GASTROENTEROL, V98, P2042, DOI 10.1016/S0002-9270(03)00622-1; Harte AL, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-15; Hui JM, 2004, HEPATOLOGY, V40, P46, DOI 10.1002/hep.20280; Hui JM, 2003, HEPATOLOGY, V38, P420, DOI 10.1053/jhep.2003.50320; Imajo K, 2012, CELL METAB, V16, P44, DOI 10.1016/j.cmet.2012.05.012; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kornek M, 2012, GASTROENTEROLOGY, V143, P448, DOI 10.1053/j.gastro.2012.04.031; Kugelmas M, 2003, HEPATOLOGY, V38, P413, DOI 10.1053/jhep.2003.50316; Luan X, 2012, TRANSPL P, V44, P937, DOI 10.1016/j.transproceed.2011.11.001; MAHARAJ B, 1986, LANCET, V1, P523; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; POWELL EE, 1990, HEPATOLOGY, V11, P74, DOI 10.1002/hep.1840110114; PUGIN J, 1994, IMMUNITY, V1, P509, DOI 10.1016/1074-7613(94)90093-0; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Sanyal A. J., 2002, Gastroenterology, V123, P1705, DOI 10.1053/gast.2002.36572; Sanyal AJ, 2002, J GASTROEN HEPATOL, V17, P385, DOI DOI 10.1046/j.1440-1746.17.s3.32.x; Sanyal Arun J, 2011, Hepatology, V54, P344, DOI 10.1002/hep.24376; SOLOWAY RD, 1971, AM J DIG DIS, V16, P1082, DOI 10.1007/BF02235164; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yoshizumi T, 1999, RADIOLOGY, V211, P283, DOI 10.1148/radiology.211.1.r99ap15283	36	38	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65211	10.1371/journal.pone.0065211	http://dx.doi.org/10.1371/journal.pone.0065211			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762319	Green Published, Green Submitted, gold			2022-12-27	WOS:000321094800026
J	Spate, LD; Murphy, CN; Prather, RS				Spate, Lee D.; Murphy, Clifton N.; Prather, Randall S.			High-Throughput Cryopreservation of In Vivo-Derived Swine Embryos	PLOS ONE			English	Article							LOW-TEMPERATURE PRESERVATION; VITRIFIED PORCINE EMBRYOS; VITRO-MATURED OOCYTES; LITTER SIZE; PIG EMBRYO; PIGLETS; BLASTOCYSTS; BIRTH; VITRIFICATION; DELIPATION	Cryopreservation of swine embryos is inefficient. Our goal was to develop a non-invasive method for "relatively" high-throughput cryopreservation of in vivo-produced swine embryos. Since removal of the lipid droplets within early swine embryos improves cryosurvival we wanted to apply a technique of high osmolality treatment followed by centrifugation that was first developed for in vitro-produced swine embryos to in vivo-produced swine embryos. The first aim was to determine how sensitive the in vivo-produced zygote and 2-cell stage embryo was to various high osmolality conditions for a short duration. Culture for 6, 12 or 18 min at 300, 400 or 500 milliosmoles (mOsm) had no detectable affect on the resulting blastocyst stage embryos (number of inner cell mass nuclei, trophectoderm nuclei, total number of nuclei, ratio of the trophectoderm to inner cell mass nuclei or percent blastocyst). However there was an effect of gilt on each of these parameters. For the second aim we focused on 300 mOsm for 6 min, 400 mOsm for 12 min, 500 mOsm for 12 min, and 500 mOsm for 18 min. The embryos were centrifuged for the duration of high osmolality treatment, then cultured to the blastocyst stage and vitrified. After vitrification and thawing the 500 mOsm for 18 min had the highest percent re-expansion with no difference in the total number of nuclei. While requiring a different base culture medium than in vitro-produced embryos, in vivo-derived embryos also survive cryopreservation without damage to their zona pellucida.	[Spate, Lee D.; Murphy, Clifton N.; Prather, Randall S.] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Prather, RS (corresponding author), Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA.	PratherR@Missouri.Edu		Prather, Randall/0000-0002-6012-4035	National Institutes of Health [R21 RR25879, U42 OD011140]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025879] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U42OD011140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by the National Institutes of Health R21 RR25879 and U42 OD011140. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beebe LFS, 2005, THERIOGENOLOGY, V64, P879, DOI 10.1016/j.theriogenology.2004.12.014; Beebe LFS, 2002, THERIOGENOLOGY, V57, P2155, DOI 10.1016/S0093-691X(01)00720-8; Berthelot F, 2001, REPROD NUTR DEV, V41, P267, DOI 10.1051/rnd:2001129; Cameron RDA, 2004, THERIOGENOLOGY, V61, P1533, DOI 10.1016/j.theriogenology.2003.09.003; Dobrinsky JR, 2000, BIOL REPROD, V62, P564, DOI 10.1095/biolreprod62.3.564; Dobrinsky JR, 2002, THERIOGENOLOGY, V57, P285, DOI 10.1016/S0093-691X(01)00672-0; Dobrinsky JR, 1996, THERIOGENOLOGY, V45, P17, DOI 10.1016/0093-691X(95)00351-8; Du Y, 2007, CRYOBIOLOGY, V54, P181, DOI 10.1016/j.cryobiol.2007.01.001; Esaki R, 2004, BIOL REPROD, V71, P432, DOI 10.1095/biolreprod.103.026542; Fujino Y, 2007, THERIOGENOLOGY, V67, P413, DOI 10.1016/j.theriogenology.2006.08.008; HAGEN DR, 1991, J ANIM SCI, V69, P1147; Im GS, 2004, THERIOGENOLOGY, V61, P1125, DOI 10.1016/j.theriogenology.2003.06.006; Kikuchi K, 2002, ZYGOTE, V10, P355, DOI 10.1017/S0967199402004100; Lai LX, 2006, NAT BIOTECHNOL, V24, P435, DOI 10.1038/nbt1198; Li R, 2002, CHINESE J SCI AGR SI, V35, P1125; Li R, 2006, BIOL REPROD, V75, P226, DOI 10.1095/biolreprod.106.052514; Li RF, 2009, BIOL REPROD, V80, P563, DOI 10.1095/biolreprod.108.073387; Machaty Z, 1998, BIOL REPROD, V59, P451, DOI 10.1095/biolreprod59.2.451; McEvoy TG, 2000, J REPROD FERTIL, V118, P163, DOI 10.1530/reprod/118.1.163; Men H, 2011, THERIOGENOLOGY, V76, P280, DOI 10.1016/j.theriogenology.2011.02.004; Men HS, 2006, THERIOGENOLOGY, V66, P2008, DOI 10.1016/j.theriogenology.2006.05.018; Men HS, 2005, CRYOBIOLOGY, V51, P119, DOI 10.1016/j.cryobiol.2005.05.005; Misumi K, 2003, THERIOGENOLOGY, V60, P253, DOI 10.1016/S0093-691X(02)01364-X; Mullen SF, 2007, CRYOBIOLOGY, V54, P281, DOI 10.1016/j.cryobiol.2007.03.005; NAGASHIMA H, 1994, BIOL REPROD, V51, P618, DOI 10.1095/biolreprod51.4.618; NAGASHIMA H, 1989, Japanese Journal of Animal Reproduction, V35, P130; NAGASHIMA H, 1992, THERIOGENOLOGY, V37, P839, DOI 10.1016/0093-691X(92)90045-S; NAGASHIMA H, 1995, NATURE, V374, P416, DOI 10.1038/374416a0; Nagashima H, 2007, BIOL REPROD, V76, P900, DOI 10.1095/biolreprod.106.052779; Nagashima Hiroshi, 1999, Journal of Reproduction and Development, V45, P167, DOI 10.1262/jrd.45.167; NORBERG HS, 1973, Z ANAT ENTWICKLUNGS, V143, P95, DOI 10.1007/BF00519913; PETTERS RM, 1990, J REPROD FERTIL, V89, P269, DOI 10.1530/jrf.0.0890269; POLGE C, 1974, CRYOBIOLOGY, V11, P560, DOI 10.1016/0011-2240(74)90195-3; PRATHER RS, 1995, THERIOGENOLOGY, V43, P1001, DOI 10.1016/0093-691X(95)00064-F; Stringfellow D. A, 1998, MANUAL INT EMBRYO TR, P79; WILMUT I, 1972, J REPROD FERTIL, V31, P513; Wrathall AE, 1998, MANUAL INT EMBRYO TR, P17; Yoshioka K, 2002, BIOL REPROD, V66, P112, DOI 10.1095/biolreprod66.1.112	38	6	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65545	10.1371/journal.pone.0065545	http://dx.doi.org/10.1371/journal.pone.0065545			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762391	Green Submitted, gold, Green Published			2022-12-27	WOS:000321094800062
J	Taegtmeyer, M; Davies, A; Mwangome, M; van der Elst, EM; Graham, SM; Price, MA; Sanders, EJ				Taegtmeyer, Miriam; Davies, Alun; Mwangome, Mary; van der Elst, Elisabeth M.; Graham, Susan M.; Price, Matt A.; Sanders, Eduard J.			Challenges in Providing Counselling to MSM in Highly Stigmatized Contexts: Results of a Qualitative Study from Kenya	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; MALE SEX WORKERS; HIV-INFECTION; SOCIAL CONSTRUCTION; AFRICAN MEN; CAPE-TOWN; RISK; MOMBASA; PREVENTION; PERCEPTIONS	The role of men who have sex with men (MSM) in the African HIV epidemic is gaining recognition yet capacity to address the HIV prevention needs of this group is limited. HIV testing and counselling is not only a critical entry point for biomedical HIV prevention interventions, such as pre-exposure prophylaxis, rectal microbicides and early treatment initiation, but is also an opportunity for focused risk reduction counselling that can support individuals living in difficult circumstances. For prevention efforts to succeed, however, MSM need to access services and they will only do so if these are non-judgmental, informative, focused on their needs, and of clear benefit. This study aimed to understand Kenyan providers' attitudes towards and experiences with counselling MSM in a research clinic targeting this group for HIV prevention. We used in-depth interviews to explore values, attitudes and cognitive and social constructs of 13 counsellors and 3 clinicians providing services to MSM at this clinic. Service providers felt that despite their growing experience, more targeted training would have been helpful to improve their effectiveness in MSM-specific risk reduction counselling. They wanted greater familiarity with MSM in Kenya to better understand the root causes of MSM risk-taking (e. g., poverty, sex work, substance abuse, misconceptions about transmission, stigma, and sexual desire) and felt frustrated at the perceived intractability of some of their clients' issues. In addition, they identified training needs on how to question men about specific risk behaviours, improved strategies for negotiating risk reduction with counselling clients, and improved support supervision from senior counsellors. This paper describes the themes arising from these interviews and makes practical recommendations on training and support supervision systems for nascent MSM HIV prevention programmes in Africa.	[Taegtmeyer, Miriam] Univ Liverpool Liverpool Sch Trop Med, Dept Int Publ Hlth, Liverpool, Merseyside, England; [Taegtmeyer, Miriam; Davies, Alun; Mwangome, Mary; van der Elst, Elisabeth M.; Graham, Susan M.; Sanders, Eduard J.] Ctr Geog Med Res Coast, Kenya Med Res Inst, Kilifi, Kenya; [Graham, Susan M.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Price, Matt A.] Int AIDS Vaccine Initiat, Dept Med Affairs, New York, NY USA; [Price, Matt A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Sanders, Eduard J.] Univ Oxford, Nuffield Dept Clin Med, Oxford, England	Liverpool School of Tropical Medicine; Kenya Medical Research Institute; University of Washington; University of Washington Seattle; International AIDS Vaccine Initiative; University of California System; University of California San Francisco; University of Oxford	Taegtmeyer, M (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Dept Int Publ Hlth, Liverpool, Merseyside, England.	M.Taegtmeyer@liverpool.ac.uk	Graham, Susan/W-6133-2019; Price, Matt/AAK-6881-2021	Graham, Susan/0000-0001-7847-8686; Price, Matt/0000-0002-2918-1373; Taegtmeyer, Miriam/0000-0002-5377-2536; Davies, Alun/0000-0001-7784-9000	International AIDS Vaccine Initiative, New York, United States of America; United States Agency for International Development (USAID); University of Washington's Center for AIDS Research [AI-27757]; National Institutes of Health [HD-055864]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD055864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	International AIDS Vaccine Initiative, New York, United States of America; United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); University of Washington's Center for AIDS Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support for this study was provided by the International AIDS Vaccine Initiative, New York, United States of America, and included support from the United States Agency for International Development (USAID). The contents are the responsibility of the study authors and do not necessarily reflect the views of USAID or the United States Government. Support is also provided by the University of Washington's Center for AIDS Research (grant AI-27757) and the National Institutes of Health (grant HD-055864). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baral S, 2012, AIDS BEHAV, V19, P19; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Baral S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-766; Beyrer C, 2010, SEX TRANSM INFECT, V86, P323, DOI 10.1136/sti.2009.040162; Bowers R, 2005, INT J ADV COUNS, V27, P471, DOI 10.1007/s10447-005-8207-7; Brown B, 2011, MEN WHO HAVE SEX MEN; Cloete A, 2008, AIDS CARE, V20, P1105, DOI 10.1080/09540120701842720; Das P, 2012, LANCET, V380, P309, DOI 10.1016/S0140-6736(12)61074-5; Eden A, 2003, KENYA NATL MANUAL TR; Fay H, 2011, AIDS BEHAV, V15, P1088, DOI 10.1007/s10461-010-9861-2; Geibel S, 2008, SEX TRANSM DIS, V35, P746, DOI 10.1097/OLQ.0b013e318170589d; Geibel S, 2007, AIDS, V21, P1349, DOI 10.1097/QAD.0b013e328017f843; Geibel S, 2012, SEX TRANSM INFECT, V88, P357, DOI 10.1136/sextrans-2011-050224; GERGEN KJ, 1985, AM PSYCHOL, V40, P266, DOI 10.1037/0003-066X.40.3.266; Graham SM, 2013, AIDS BEHAV, V15, P15; Grijsen ML, 2008, SEX TRANSM INFECT, V84, P364, DOI 10.1136/sti.2007.028852; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hamilton C, 2008, HEALTH POLICY PLANN, V23, P390, DOI 10.1093/heapol/czn029; Hamilton CJ, 2009, J COUNS PSYCHOL, V56, P132, DOI 10.1037/a0014440; Johnson CA, 2007, MAP HIV AIDS PROGRAM; Knox J, 2011, INT J STD AIDS, V22, P709, DOI 10.1258/ijsa.2011.010350; Kyomya M, 2012, LANCET, V380, P310, DOI 10.1016/S0140-6736(12)60682-5; Lane T, 2008, SEX TRANSM INFECT, V84, P430, DOI 10.1136/sti.2008.031567; Lane T, 2008, AIDS BEHAV, V12, pS78, DOI 10.1007/s10461-008-9389-x; Lane T, 2011, AIDS BEHAV, V15, P626, DOI 10.1007/s10461-009-9598-y; Lewis J, 2003, QUALITATIVE RES PRAC, P47; Marum E, 2006, JAMA-J AM MED ASSOC, V296, P859, DOI 10.1001/jama.296.7.859; Muraguri N, 2012, SAHARA J-J SOC ASP H, V9, P137, DOI 10.1080/17290376.2012.744176; Mutua G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033103; National AIDS and STI Control Programme Ministry of Public Health and Sanitation Kenya, 2008, GUID HIV TEST COUNS; Nel JA, 2012, AIDS BEHAV, V4, P4; Nzioka C, 1996, AIDS CARE, V8, P565, DOI 10.1080/09540129650125524; Okal J, 2009, CULT HEALTH SEX, V11, P811, DOI 10.1080/13691050902906488; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Poteat T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028760; Pretty J, 1993, PARTICIPATORY INQUIR, P13; Price MA, 2012, JAIDS-J ACQ IMM DEF, V59, P185, DOI 10.1097/QAI.0b013e31823d8693; Raymond HF, 2009, AIDS BEHAV, V13, P677, DOI 10.1007/s10461-009-9557-7; RINGHEIM K, 1995, SOC SCI MED, V40, P1691, DOI 10.1016/0277-9536(94)00279-3; Ritchie J, 2003, QUALITATIVE RES PRAC, P219, DOI DOI 10.1186/1471-2288-13-117; Sanders EJ, 2007, AIDS, V21, P2513, DOI 10.1097/QAD.0b013e3282f2704a; Sanders EJ, 2012, HIGH HIV 1 INCIDENCE; Semugoma P, 2012, LANCET, V380, P312, DOI 10.1016/S0140-6736(12)60901-5; Shahmanesh M, 2008, TROP MED INT HEALTH, V13, P659, DOI 10.1111/j.1365-3156.2008.02040.x; Shefer T, 2002, QUAL HEALTH RES, V12, P1373, DOI 10.1177/1049732302238749; Smith AD, 2009, LANCET, V374, P416, DOI 10.1016/S0140-6736(09)61118-1; Stromdahl S, 2012, AIDS RES HUM RETROV, V28, P1756, DOI [10.1089/aid.2012.0070, 10.1089/AID.2012.0070]; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Thoreson R, 2011, NOWHERE TURN BLACKMA; Trapence G, 2012, LANCET, V380, P400, DOI 10.1016/S0140-6736(12)60834-4; Turnbull S., 2002, ADV DEV HUM RESOUR, V4, P317, DOI DOI 10.1177/1523422302043006; Van der Elst EM, 2012, AIDS BEHAV, V19, P19; Vernon RF, 1998, COUNS PSYCHOL, V11, P201; Villaneuva MLM, 1998, SOCIAL CONSTRUCTION; Whitman N, 1993, Fam Med, V25, P517; *WHO, 2008, PRIOR INT HIV AIDS P	56	37	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e64527	10.1371/journal.pone.0064527	http://dx.doi.org/10.1371/journal.pone.0064527			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	173QU	23762241	Green Accepted, Green Published, gold			2022-12-27	WOS:000321094800007
J	Coni, S; Antonucci, L; D'Amico, D; Di Magno, L; Infante, P; De Smaele, E; Giannini, G; Di Marcotullio, L; Screpanti, I; Gulino, A; Canettieri, G				Coni, Sonia; Antonucci, Laura; D'Amico, Davide; Di Magno, Laura; Infante, Paola; De Smaele, Enrico; Giannini, Giuseppe; Di Marcotullio, Lucia; Screpanti, Isabella; Gulino, Alberto; Canettieri, Gianluca			Gli2 Acetylation at Lysine 757 Regulates Hedgehog-Dependent Transcriptional Output by Preventing Its Promoter Occupancy	PLOS ONE			English	Article							HISTONE DEACETYLASE; CANCER; CELLS	The morphogenic Hedgehog (Hh) signaling regulates postnatal cerebellar development and its aberrant activation leads to medulloblastoma. The transcription factors Gli1 and Gli2 are the activators of Hh pathway and their function is finely controlled by different covalent modifications, such as phosphorylation and ubiquitination. We show here that Gli2 is endogenously acetylated and that this modification represents a key regulatory step for Hedgehog signaling. The histone acetyltransferase (HAT) coactivator p300, but not other HATs, acetylates Gli2 at the conserved lysine K757 thus inhibiting Hh target gene expression. By generating a specific anti acetyl-Gli2(Lys757) antisera we demonstrated that Gli2 acetylation is readily detectable at endogenous levels and is attenuated by Hh agonists. Moreover, Gli2 K757R mutant activity is higher than wild type Gli2 and is no longer enhanced by Hh agonists, indicating that acetylation represents an additional level of control for signal dependent activation. Consistently, in sections of developing mouse cerebella Gli2 acetylation correlates with the activation status of Hedgehog signaling. Mechanistically, acetylation at K757 prevents Gli2 entry into chromatin. Together, these data illustrate a novel mechanism of regulation of the Hh signaling whereby, in concert with Gli1, Gli2 acetylation functions as a key transcriptional checkpoint in the control of morphogen-dependent processes.	[Coni, Sonia] CNRS, Ctr Biochim, Inst Biol Valrose iBV, UMR 7277,Inserm 1091, F-06034 Nice, France; [Coni, Sonia] Univ Nice Sophia Antipolis, F-06189 Nice, France; [Antonucci, Laura; D'Amico, Davide; Di Magno, Laura; Di Marcotullio, Lucia; Screpanti, Isabella; Gulino, Alberto; Canettieri, Gianluca] Univ Roma La Sapienza, Dept Mol Med, I-00185 Rome, Italy; [Infante, Paola; Screpanti, Isabella] Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, Rome, Italy; [De Smaele, Enrico; Giannini, Giuseppe] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Gulino, Alberto] IRCCS Neuromed, Pozzilli, Isernia, Italy	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Sapienza University Rome; Istituto Italiano di Tecnologia - IIT; Sapienza University Rome; IRCCS Neuromed	Gulino, A (corresponding author), Univ Roma La Sapienza, Dept Mol Med, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	alberto.gulino@uniroma1.it; gianluca.canettieri@uniroma1.it	De Smaele, Enrico/C-1124-2013; Giannini, Giuseppe/B-5672-2013; D'Amico, Davide/AAY-6183-2021; Infante, Paola/G-9094-2018	De Smaele, Enrico/0000-0003-4524-4423; Giannini, Giuseppe/0000-0003-0299-4056; D'Amico, Davide/0000-0002-8499-9514; Infante, Paola/0000-0003-0682-3916; Antonucci, Laura/0000-0001-8965-2432; CANETTIERI, Gianluca/0000-0001-6694-2613; Di Magno, Laura/0000-0001-9446-8752; DI MARCOTULLIO, LUCIA/0000-0003-0274-7178	AIRC (Associazione Italiana per la Ricerca sul Cancro); MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca); PRIN (Programmi di ricerca di Rilevante Interesse Nazionale); FIRB (Fondo per gli Investimenti della Ricerca di Base); IIT (Italian Institute of Technology); Istituto pasteur - Fondazione Cenci Bolognetti	AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca)(Ministry of Education, Universities and Research (MIUR)); PRIN (Programmi di ricerca di Rilevante Interesse Nazionale)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); FIRB (Fondo per gli Investimenti della Ricerca di Base)(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); IIT (Italian Institute of Technology)(Istituto Italiano di Tecnologia - IIT); Istituto pasteur - Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti)	This work was supported by the following grants: 1) AIRC (Associazione Italiana per la Ricerca sul Cancro) (www.airc.it); 2) MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca), PRIN (Programmi di ricerca di Rilevante Interesse Nazionale), FIRB (Fondo per gli Investimenti della Ricerca di Base) (www.istruzione.it); 3) IIT (Italian Institute of Technology)(www.iit.it); 4) Istituto pasteur - Fondazione Cenci Bolognetti (http://www.istitutopasteur.it/). The funders had no role in study design, data collection and analysis decision to publish, or preparation of the manuscript.	Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Canettieri G, 2010, NAT CELL BIOL, V12, P132, DOI 10.1038/ncb2013; Canettieri G, 2009, P NATL ACAD SCI USA, V106, P1445, DOI 10.1073/pnas.0808749106; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Coni S, 2013, BIOCHEM PHARMACOL, V85, P623, DOI 10.1016/j.bcp.2012.11.001; De Smaele E, 2011, NEOPLASIA, V13, P374, DOI 10.1593/neo.101630; Di Marcotullio L, 2011, ONCOGENE, V30, P65, DOI 10.1038/onc.2010.394; Di Marcotullio L, 2007, CELL CYCLE, V6, P390, DOI 10.4161/cc.6.4.3809; Di Marcotullio L, 2011, BBA-REV CANCER, V1815, P241, DOI 10.1016/j.bbcan.2011.01.002; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Altaba ARI, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002540; RUPPERT JM, 1991, MOL CELL BIOL, V11, P1724, DOI 10.1128/MCB.11.3.1724; Ryan KE, 2012, J BIOL CHEM, V287, P17905, DOI 10.1074/jbc.R112.356006; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Zhan XM, 2011, P NATL ACAD SCI USA, V108, P12758, DOI 10.1073/pnas.1018510108	18	56	57	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65718	10.1371/journal.pone.0065718	http://dx.doi.org/10.1371/journal.pone.0065718			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762415	Green Published, gold, Green Submitted			2022-12-27	WOS:000321099000097
J	Hoeboer, SH; Groeneveld, ABJ				Hoeboer, Sandra H.; Groeneveld, A. B. Johan			Changes in Circulating Procalcitonin Versus C-Reactive Protein in Predicting Evolution of Infectious Disease in Febrile, Critically Ill Patients	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; TIME-COURSE; PLASMA-CONCENTRATIONS; ANTIBIOTIC-THERAPY; SEPSIS; BIOMARKERS; KINETICS; RESOLUTION; PROGNOSIS; SURVIVAL	Objective: Although absolute values for C-reactive protein (CRP) and procalcitonin (PCT) are well known to predict sepsis in the critically ill, it remains unclear how changes in CRP and PCT compare in predicting evolution of: infectious disease, invasiveness and severity (e.g. development of septic shock, organ failure and non-survival) in response to treatment. The current study attempts to clarify these aspects. Methods: In 72 critically ill patients with new onset fever, CRP and PCT were measured on Day 0, 1, 2 and 7 after inclusion, and clinical courses were documented over a week with follow up to Day 28. Infection was microbiologically defined, while septic shock was defined as infection plus shock. The sequential organ failure assessment (SOFA) score was assessed. Results: From peak at Day 0-2 to Day 7, CRP decreased when (bloodstream) infection and septic shock (Day 0-2) resolved and increased when complications such as a new (bloodstream) infection or septic shock (Day 3-7) supervened. PCT decreased when septic shock resolved and increased when a new bloodstream infection or septic shock supervened. Increased or unchanged SOFA scores were best predicted by PCT increases and Day 7 PCT, in turn, was predictive for 28-day outcome. Conclusion: The data, obtained during ICU-acquired fever and infections, suggest that CRP may be favoured over PCT courses in judging response to antibiotic treatment. PCT, however, may better indicate the risk of complications, such as bloodstream infection, septic shock, organ failure and mortality, and therefore might help deciding on safe discontinuation of antibiotics. The analysis may thus help interpreting current literature and design future studies on guiding antibiotic therapy in the ICU.	[Hoeboer, Sandra H.; Groeneveld, A. B. Johan] Vrije Univ Amsterdam, Med Ctr, Dept Intens Care, Amsterdam, Netherlands; [Hoeboer, Sandra H.; Groeneveld, A. B. Johan] Erasmus MC, Dept Intens Care Med, Rotterdam, Netherlands	Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC	Hoeboer, SH (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Intens Care, Amsterdam, Netherlands.	s.hoeboer@erasmusmc.nl		Hoeboer, Sandra/0000-0002-0966-8459				Bruns AHW, 2008, EUR RESPIR J, V32, P726, DOI 10.1183/09031936.00003608; Calandra T, 2005, CRIT CARE MED, V33, P1538, DOI 10.1097/01.CCM.0000168253.91200.83; Castelli GP, 2009, CRIT CARE MED, V37, P1845, DOI 10.1097/CCM.0b013e31819ffd5b; Castelli GP, 2004, CRIT CARE, V8, pR234, DOI 10.1186/cc2877; Charles PE, 2009, CRIT CARE, V13, DOI 10.1186/cc7751; Coelho L, 2007, CRIT CARE, V11, DOI 10.1186/cc6105; Coelho LM, 2012, CRIT CARE, V16, DOI 10.1186/cc11291; Confalonieri M, 2005, AM J RESP CRIT CARE, V171, P242, DOI 10.1164/rccm.200406-808OC; Crouzet J, 2011, EUR J CLIN MICROBIOL, V30, P299, DOI 10.1007/s10096-010-1088-7; de Kruif MD, 2008, INTENS CARE MED, V34, P518, DOI 10.1007/s00134-007-0955-x; Gibot S, 2005, CRIT CARE MED, V33, P792, DOI 10.1097/01.CCM.0000159089.16462.4A; Hillas G, 2010, EUR RESPIR J, V35, P805, DOI 10.1183/09031936.00051309; Hoeboer SH, 2012, J INFECTION, V64, P484, DOI 10.1016/j.jinf.2012.01.002; Lacoma A, 2012, EUR J CLIN MICROBIOL, V31, P825, DOI 10.1007/s10096-011-1381-0; Lannergard A, 2009, SCAND J INFECT DIS, V41, P663, DOI 10.1080/00365540903127417; Laupland KB, 2008, CRIT CARE MED, V36, P1531, DOI 10.1097/CCM.0b013e318170efd3; Lavrentieva A, 2012, BURNS, V38, P356, DOI 10.1016/j.burns.2011.08.021; Levy Mitchell M, 2003, Intensive Care Med, V29, P530; Lisboa T, 2008, CRIT CARE MED, V36, P166, DOI 10.1097/01.CCM.0000297886.32564.CF; Luyt CE, 2005, AM J RESP CRIT CARE, V171, P48, DOI 10.1164/rccm.200406-746Oc; Luzzani A, 2003, CRIT CARE MED, V31, P1737, DOI 10.1097/01.CCM.0000063440.19188.ED; Meisner M, 1999, CRIT CARE, V3, P45, DOI 10.1186/cc306; Nijsten MWN, 2000, CRIT CARE MED, V28, P458, DOI 10.1097/00003246-200002000-00028; Persson L, 2005, EUR J HAEMATOL, V74, P297, DOI 10.1111/j.1600-0609.2004.00387.x; Povoa P, 2006, CRIT CARE, V10, DOI 10.1186/cc4892; Povoa P, 2011, CRIT CARE, V15, DOI 10.1186/cc10313; Rau BM, 2007, ARCH SURG-CHICAGO, V142, P134, DOI 10.1001/archsurg.142.2.134; Reynolds SC, 2012, CRIT CARE MED, V40, P2781, DOI 10.1097/CCM.0b013e31825b89cc; Schmit X, 2008, INFECTION, V36, P213, DOI 10.1007/s15010-007-7077-9; Schuetz P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007498.pub2; Seligman R, 2006, CRIT CARE, V10, DOI 10.1186/cc5036; Su LX, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-157; Theodorou VP, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-247; Tsangaris I, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-213; Viallon A, 2005, CRIT CARE, V9, pR344, DOI 10.1186/cc3722; von Lilienfeld-Toal M, 2006, SUPPORT CARE CANCER, V14, P1241, DOI 10.1007/s00520-006-0081-2; YENTIS SM, 1995, INTENS CARE MED, V21, P602, DOI 10.1007/BF01700168	37	27	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65564	10.1371/journal.pone.0065564	http://dx.doi.org/10.1371/journal.pone.0065564			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762396	Green Published, gold, Green Submitted			2022-12-27	WOS:000321099000079
J	Li, BQ; Niu, B; Chen, L; Wei, ZJ; Huang, T; Jiang, M; Lu, J; Zheng, MY; Kong, XY; Cai, YD				Li, Bi-Qing; Niu, Bing; Chen, Lei; Wei, Ze-Jun; Huang, Tao; Jiang, Min; Lu, Jing; Zheng, Ming-Yue; Kong, Xiang-Yin; Cai, Yu-Dong			Identifying Chemicals with Potential Therapy of HIV Based on Protein-Protein and Protein-Chemical Interaction Network	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE-TRANSCRIPTASE INHIBITORS; SMALL-MOLECULE INHIBITORS; T-CELL RESPONSES; NF-KAPPA-B; IFN-GAMMA; HUMAN CD4; COMPLEX; CCR5; ANTAGONIST	Acquired immune deficiency syndrome (AIDS) is a severe infectious disease that causes a large number of deaths every year. Traditional anti-AIDS drugs directly targeting the HIV-1 encoded enzymes including reverse transcriptase (RT), protease (PR) and integrase (IN) usually suffer from drug resistance after a period of treatment and serious side effects. In recent years, the emergence of numerous useful information of protein-protein interactions (PPI) in the HIV life cycle and related inhibitors makes PPI a new way for antiviral drug intervention. In this study, we identified 26 core human proteins involved in PPI between HIV-1 and host, that have great potential for HIV therapy. In addition, 280 chemicals that interact with three HIV drugs targeting human proteins can also interact with these 26 core proteins. All these indicate that our method as presented in this paper is quite promising. The method may become a useful tool, or at least plays a complementary role to the existing method, for identifying novel anti-HIV drugs.	[Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Li, Bi-Qing] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Niu, Bing] Shanghai Univ, Coll Life Sci, Shanghai, Peoples R China; [Chen, Lei] Shanghai Maritime Univ, Coll Informat Engn, Shanghai, Peoples R China; [Wei, Ze-Jun; Jiang, Min; Kong, Xiang-Yin] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Stem Cell Biol Inst Hlth Sci, Shanghai, Peoples R China; [Huang, Tao] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Lu, Jing; Zheng, Ming-Yue] Shanghai Inst Mat Med, Drug Discovery & Design Ctr, Shanghai, Peoples R China	Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai University; Shanghai Maritime University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Icahn School of Medicine at Mount Sinai; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Kong, XY (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Stem Cell Biol Inst Hlth Sci, Shanghai, Peoples R China.	xykong@sibs.ac.cn; cai_yud@yahoo.com.cn	Chen, Lei/A-2275-2011; Zheng, Mingyue/AAJ-8027-2020; Zheng, Mingyue/HHZ-4062-2022; Zheng, Mingyue/Z-3582-2019; Zheng, Mingyue/B-4860-2010	Chen, Lei/0000-0003-3068-1583; Zheng, Mingyue/0000-0002-3323-3092; Zheng, Mingyue/0000-0002-3323-3092; Zheng, Mingyue/0000-0002-3323-3092; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510102, 2011CB510101]; Innovation Program of Shanghai Municipal Education Commission [12ZZ087]; National Natural Science Foundation of China [81001399]; grant of "The First-class Discipline of Universities in Shanghai"	National Basic Research Program of China(National Basic Research Program of China); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); grant of "The First-class Discipline of Universities in Shanghai"	This work was supported by grants from National Basic Research Program of China (2011CB510102, 2011CB510101), Innovation Program of Shanghai Municipal Education Commission (12ZZ087), National Natural Science Foundation of China (Grant 81001399) and the grant of "The First-class Discipline of Universities in Shanghai". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Berg T, 2008, CURR OPIN DRUG DISC, V11, P666; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Boaz MJ, 2002, J IMMUNOL, V169, P6376, DOI 10.4049/jimmunol.169.11.6376; Bovolenta C, 1999, J IMMUNOL, V162, P323; Bres V, 2003, NAT CELL BIOL, V5, P754, DOI 10.1038/ncb1023; Busschots K, 2009, MOL BIOSYST, V5, P21, DOI 10.1039/b810306b; Cesarini S, 2008, BIOORGAN MED CHEM, V16, P4160, DOI 10.1016/j.bmc.2007.12.050; Chan JK, 2012, IMMUNOL REV, V246, P286, DOI 10.1111/j.1600-065X.2012.01094.x; Chan JKL, 2011, CURR OPIN HIV AIDS, V6, P12, DOI 10.1097/COH.0b013e32834124fd; Chen HF, 2010, CURR MED CHEM, V17, P750, DOI 10.2174/092986710790514444; Chen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056517; Chen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035254; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; DANLEY DE, 1989, BIOCHEM BIOPH RES CO, V165, P1043, DOI 10.1016/0006-291X(89)92707-1; De Clercq E, 2009, REV MED VIROL, V19, P287, DOI 10.1002/rmv.624; De Clercq E, 2009, INT J ANTIMICROB AG, V33, P307, DOI 10.1016/j.ijantimicag.2008.10.010; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; DeClercq E, 1996, MED RES REV, V16, P125, DOI 10.1002/(SICI)1098-1128(199603)16:2<125::AID-MED1>3.0.CO;2-2; Deregibus MC, 2002, J BIOL CHEM, V277, P25195, DOI 10.1074/jbc.M200921200; Dieffenbach CW, 2011, ANN INTERN MED, V154, P766, DOI 10.7326/0003-4819-154-11-201106070-00345; DING J, 1995, STRUCTURE, V3, P365, DOI 10.1016/S0969-2126(01)00168-X; DING JP, 1995, NAT STRUCT BIOL, V2, P407, DOI 10.1038/nsb0595-407; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; ESNOUF R, 1995, NAT STRUCT BIOL, V2, P303, DOI 10.1038/nsb0495-303; Fiume G, 2012, NUCLEIC ACIDS RES, V40, P3548, DOI 10.1093/nar/gkr1224; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Fu W, 2009, NUCLEIC ACIDS RES, V37, pD417, DOI 10.1093/nar/gkn708; Gerrard JA, 2007, MINI-REV MED CHEM, V7, P151, DOI 10.2174/138955707779802561; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Greene WC, 2008, ANTIVIR RES, V80, P251, DOI 10.1016/j.antiviral.2008.08.003; HO DD, 1994, J VIROL, V68, P2016, DOI 10.1128/JVI.68.3.2016-2020.1994; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Izumi T, 2010, P NATL ACAD SCI USA, V107, P20798, DOI 10.1073/pnas.1008076107; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jones RB, 2009, J VIROL, V83, P8722, DOI 10.1128/JVI.00433-09; Joy MP, 2005, J BIOMED BIOTECHNOL, P96, DOI 10.1155/JBB.2005.96; Ju SM, 2012, MOL CELLS, V33, P335, DOI 10.1007/s10059-012-2287-0; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; Kino T, 2004, DNA CELL BIOL, V23, P193, DOI 10.1089/104454904773819789; Kondru R, 2008, MOL PHARMACOL, V73, P789, DOI 10.1124/mol.107.042101; Kryworuchko M, 2003, CLIN EXP IMMUNOL, V131, P422, DOI 10.1046/j.1365-2249.2003.02065.x; Krzysztof A, 1993, PERSPECT DRUG DISCOV, V1, P23, DOI [10.1007/BF02171654, DOI 10.1007/BF02171654]; Kuhn M, 2008, NUCLEIC ACIDS RES, V36, pD684, DOI 10.1093/nar/gkm795; Kuhn M, 2010, NUCLEIC ACIDS RES, V38, pD552, DOI 10.1093/nar/gkp937; Li BQ, 2012, BIOCHIMIE, V94, P1910, DOI 10.1016/j.biochi.2012.05.005; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033393; Li W, 2011, J IMMUNOL, V186, P6771, DOI 10.4049/jimmunol.1100099; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Maeda K, 2006, J BIOL CHEM, V281, P12688, DOI 10.1074/jbc.M512688200; MITSUYA H, 1985, P NATL ACAD SCI USA, V82, P7096, DOI 10.1073/pnas.82.20.7096; Ng TTC, 1997, J IMMUNOL, V158, P2984; Nishikawa M, 2005, ANTIMICROB AGENTS CH, V49, P4708, DOI 10.1128/AAC.49.11.4708-4715.2005; Panel on Antiretroviral Guidelines for Adults and Adolescents, GUID US ANT AG HIV 1; Perry CM, 2009, DRUGS, V69, P843, DOI 10.2165/00003495-200969070-00005; Pinney JW, 2009, AIDS, V23, P549, DOI 10.1097/QAD.0b013e328325a495; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ptak RG, 2008, AIDS RES HUM RETROV, V24, P1497, DOI 10.1089/aid.2008.0113; Reitano KN, 2009, AIDS RES HUM RETROV, V25, P1029, DOI 10.1089/aid.2008.0311; REN JS, 1995, NAT STRUCT BIOL, V2, P293, DOI 10.1038/nsb0495-293; REN JS, 1995, STRUCTURE, V3, P915, DOI 10.1016/S0969-2126(01)00226-X; RICE AP, 2007, FUTURE HIV THER, V1, P369; Rom S, 2011, BBA-MOL CELL RES, V1813, P1836, DOI 10.1016/j.bbamcr.2011.06.012; RYU SE, 1994, STRUCTURE, V2, P59, DOI 10.1016/S0969-2126(00)00008-3; Shao W, 1997, P NATL ACAD SCI USA, V94, P2243, DOI 10.1073/pnas.94.6.2243; Spallarossa A, 2008, BIOCHEM BIOPH RES CO, V365, P764, DOI 10.1016/j.bbrc.2007.11.036; Spallarossa A, 2009, EUR J MED CHEM, V44, P1650, DOI 10.1016/j.ejmech.2008.09.024; TIERNEY M, 1995, J ACQ IMMUN DEF SYND, V10, P549, DOI 10.1097/00042560-199510050-00008; Tsamis F, 2003, J VIROL, V77, P5201, DOI 10.1128/JVI.77.9.5201-5208.2003; Wang Y, 2009, MINI-REV MED CHEM, V9, P379, DOI 10.2174/1389557510909030379; WEISS RA, 1993, SCIENCE, V260, P1273, DOI 10.1126/science.8493571; White Alex W., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000641; Wonderlich ER, 2011, J VIROL, V85, P12216, DOI 10.1128/JVI.00056-11; Yu MY, 2009, MINI-REV MED CHEM, V9, P60, DOI 10.2174/138955709787001677; Zhan P, 2010, CURR MED CHEM, V17, P495, DOI 10.2174/092986710790416335; Zhan P, 2009, CURR MED CHEM, V16, P3903, DOI 10.2174/092986709789178019; Zoughlami Y, 2012, BLOOD, V119, P2024, DOI 10.1182/blood-2011-06-364828	79	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65207	10.1371/journal.pone.0065207	http://dx.doi.org/10.1371/journal.pone.0065207			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762317	Green Published, gold, Green Submitted			2022-12-27	WOS:000321099000044
J	Pang, H; Yu, Q; Guo, BP; Jiang, Y; Wan, L; Li, J; Wu, YJ; Wan, KL				Pang, Hui; Yu, Qin; Guo, Buping; Jiang, Yi; Wan, Li; Li, Jun; Wu, Yanjun; Wan, Kanglin			Frequency of Regulatory T-Cells in the Peripheral Blood of Patients with Pulmonary Tuberculosis from Shanxi Province, China	PLOS ONE			English	Article							CYTOKINE RESPONSES; SUPPRESSION; GROWTH; BETA	Background: Tuberculosis (TB) is a disease caused by the chronic and continuous infection of the pathogen Mycobacterium tuberculosis (M. tuberculosis). M. tuberculosis is an intracellular bacterial pathogen and is eliminated mainly through CD4(+) effector Th cells. M. tuberculosis induces regulatory T lymphocytes (Tregs) that mediate immune suppression by cell-to-cell contact or by secreting cytokines such as transforming growth factor-beta (TGF-beta). To understand the role of regulatory T-cells in the pathogenesis of TB, we have measured the in vivo frequency of regulatory T-cells and associated in vivo cytokine production in pulmonary tuberculosis patients. Methodology/Principal Findings: In this study, we analyzed blood samples from 3 different populations (Group 1: patients with active TB, Group 2: patients recovered from TB and Group 3: healthy controls). We measured natural regulatory T-cell expression in peripheral blood using flow cytometry, and levels of blood serum IFN-gamma and TGF-beta 1 using ELISA. The in vivo function of inductive regulatory T cells was mainly indicated by the expression of IFN-gamma, TGF-beta 1, etc. Frequency of natural regulatory T cells and inductive regulatory T cells in the peripheral blood samples from Group 1 patients were all significantly higher (P<0.05) than those from Groups 2 and 3. Conclusion/Significance: Our results indicate that frequency of natural regulatory T cells and inductive regulatory T cells are significantly higher in the peripheral blood of patients with active pulmonary tuberculosis. These findings have potential application in improving TB diagnostic methods.	[Pang, Hui; Wu, Yanjun] Changzhi Med Coll, Dept Immunol, Changzhi, Shanxi Province, Peoples R China; [Yu, Qin; Jiang, Yi; Wan, Li; Wan, Kanglin] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Guo, Buping] Changzhi Med Coll, Dept Lab Med, Changzhi, Shanxi Province, Peoples R China; [Yu, Qin] Univ South China, Pathogen Biol Inst, Hengyang, Peoples R China; [Li, Jun] Peoples Hosp Changzhi City, Changzhi City, Shanxi Province, Peoples R China	Changzhi Medical College; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Changzhi Medical College; University of South China	Wan, KL (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	wankanglin@icdc.cn			National Key Program of Mega Infectious Disease [2008ZX100/03-010-02]	National Key Program of Mega Infectious Disease	This work was funded by the project "Transmission Mode of Tuberculosis'' (2008ZX100/03-010-02) of National Key Program of Mega Infectious Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chinese Antituberculosis Association, 1996, CHINESE J ANTITURBER, V18, P80; Chinese Centers for Disease Control and Prevention Chinese Anti-tuberculosis Association Chinese Medical Association, 2008, INSTR MAN ANT DRUGS, P6; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Handzel ZT, 2007, ISR MED ASSOC J, V9, P479; He XY, 2010, EUR J CLIN MICROBIOL, V29, P643, DOI 10.1007/s10096-010-0908-0; Hirsch CS, 1996, P NATL ACAD SCI USA, V93, P3193, DOI 10.1073/pnas.93.8.3193; HUYGEN K, 1988, SCAND J IMMUNOL, V27, P187, DOI 10.1111/j.1365-3083.1988.tb02338.x; IDIGBE EO, 1986, J TROP MED HYG, V89, P143; Joosten SA, 2007, P NATL ACAD SCI USA, V104, P8029, DOI 10.1073/pnas.0702257104; Kaplan G, 2003, INFECT IMMUN, V71, P7099, DOI 10.1128/IAI.71.12.7099-7108.2003; Kochi A, 2001, B WORLD HEALTH ORGAN, V79, P71; Mills KHG, 2004, NAT REV IMMUNOL, V4, P841, DOI 10.1038/nri1485; Mitra DK, 2009, MICROBES INFECT, V11, P1122, DOI 10.1016/j.micinf.2009.08.006; Mitra DK, 2005, EUR J IMMUNOL, V35, P2367, DOI 10.1002/eji.200525977; Cavalcanti YVN, 2012, PULM MED, V2012, DOI 10.1155/2012/745483; Rahman S, 2009, AM J PATHOL, V174, P2211, DOI 10.2353/ajpath.2009.080941; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; TORRES M, 1994, CLIN EXP IMMUNOL, V96, P75, DOI 10.1111/j.1365-2249.1994.tb06233.x; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Vrabelova Z, 2008, SCAND J IMMUNOL, V67, P404, DOI 10.1111/j.1365-3083.2008.02074.x; Wan YSY, 2006, IMMUNOL REV, V212, P114, DOI 10.1111/j.0105-2896.2006.00407.x; Welsh KJ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/307631; Winkler S, 2005, MICROBES INFECT, V7, P1161, DOI 10.1016/j.micinf.2005.03.020; Yi HF, 2006, CELL MOL IMMUNOL, V3, P189; ZHANG M, 1994, J CLIN INVEST, V94, P2435, DOI 10.1172/JCI117611	27	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65496	10.1371/journal.pone.0065496	http://dx.doi.org/10.1371/journal.pone.0065496			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755239	gold, Green Published, Green Submitted			2022-12-27	WOS:000321099000073
J	Qian, J; Liu, HP; Lin, Y; Chen, WQ; Gao, HJ				Qian, Jin; Liu, Haipei; Lin, Yuan; Chen, Weiqiu; Gao, Huajian			A Mechanochemical Model of Cell Reorientation on Substrates under Cyclic Stretch	PLOS ONE			English	Article							SLIPPING ADHESIVE CONTACT; STRESS FIBERS; ENDOTHELIAL-CELL; FOCAL ADHESIONS; ORIENTATION RESPONSE; FORCE; ALIGNMENT; DYNAMICS; ELASTICITY; REORGANIZATION	We report a theoretical study on the cyclic stretch-induced reorientation of spindle-shaped cells. Specifically, by taking into account the evolution of sub-cellular structures like the contractile stress fibers and adhesive receptor-ligand clusters, we develop a mechanochemical model to describe the dynamics of cell realignment in response to cyclically stretched substrates. Our main hypothesis is that cells tend to orient in the direction where the formation of stress fibers is energetically most favorable. We show that, when subjected to cyclic stretch, the final alignment of cells reflects the competition between the elevated force within stress fibers that accelerates their disassembly and the disruption of cell-substrate adhesion as well, and an effectively increased substrate rigidity that promotes more stable focal adhesions. Our model predictions are consistent with various observations like the substrate rigidity dependent formation of stable adhesions and the stretching frequency, as well as stretching amplitude, dependence of cell realignment. This theory also provides a simple explanation on the regulation of protein Rho in the formation of stretch-induced stress fibers in cells.	[Qian, Jin; Chen, Weiqiu] Zhejiang Univ, Soft Matter Res Ctr, Dept Engn Mech, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Haipei; Lin, Yuan] Univ Hong Kong, Dept Mech Engn, Hong Kong, Hong Kong, Peoples R China; [Gao, Huajian] Brown Univ, Sch Engn, Providence, RI 02912 USA	Zhejiang University; University of Hong Kong; Brown University	Lin, Y (corresponding author), Univ Hong Kong, Dept Mech Engn, Hong Kong, Hong Kong, Peoples R China.	ylin@hku.hk	Gao, Huajian/F-9360-2010; Qian, Jin/C-6115-2008	Gao, Huajian/0000-0002-8656-846X; 	"Thousand Young Talents Program" of China; Fundamental Research Funds for Central Universities of China [2012QNA4023, 2011XZZX002]; National Natural Science Foundation of China [11202184]; Research Grants Council of the Hong Kong Special Administration Region [HKU 7148/10E]; University of Hong Kong [201111159112]; University of Hong Kong through the Distinguished Visiting Scholars Scheme (DVSS)	"Thousand Young Talents Program" of China(Chinese Academy of Sciences); Fundamental Research Funds for Central Universities of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Grants Council of the Hong Kong Special Administration Region(Hong Kong Research Grants Council); University of Hong Kong(University of Hong Kong); University of Hong Kong through the Distinguished Visiting Scholars Scheme (DVSS)	This work was supported from the "Thousand Young Talents Program" of China, the Fundamental Research Funds for Central Universities (Nos. 2012QNA4023 and 2011XZZX002) of China, the National Natural Science Foundation of China (No. 11202184), the Research Grants Council (Project No. HKU 7148/10E) of the Hong Kong Special Administration Region, as well as a seed fund (Project No. 201111159112) from the University of Hong Kong. H. G. also gratefully acknowledges support from the University of Hong Kong through the Distinguished Visiting Scholars Scheme (DVSS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Berg, 2018, RANDOM WALKS BIOL; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Boal D. H., 2002, MECH CELL; Brown RA, 1998, J CELL PHYSIOL, V175, P323, DOI 10.1002/(SICI)1097-4652(199806)175:3<323::AID-JCP10>3.0.CO;2-6; Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595; Chen B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048346; Chen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012035; Chen SH, 2006, P ROY SOC A-MATH PHY, V462, P211, DOI 10.1098/rspa.2005.1553; Chen S, 2006, J MECH PHYS SOLIDS, V54, P1548, DOI 10.1016/j.jmps.2006.03.001; Collinsworth AM, 2000, CELL TISSUE RES, V302, P243, DOI 10.1007/s004410000224; DARTSCH PC, 1986, EUR J CELL BIOL, V41, P339; De R, 2008, BIOPHYS J, V94, pL29, DOI 10.1529/biophysj.107.126060; De R, 2007, NAT PHYS, V3, P655, DOI 10.1038/nphys680; Deguchi S, 2006, J BIOMECH, V39, P2603, DOI 10.1016/j.jbiomech.2005.08.026; Deng LH, 2006, NAT MATER, V5, P636, DOI 10.1038/nmat1685; Eastwood M, 1998, CELL MOTIL CYTOSKEL, V40, P13, DOI 10.1002/(SICI)1097-0169(1998)40:1<13::AID-CM2>3.0.CO;2-G; Endlich N, 2007, CELL MOTIL CYTOSKEL, V64, P966, DOI 10.1002/cm.20237; Faust U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028963; Fernandez P, 2006, BIOPHYS J, V90, P3796, DOI 10.1529/biophysj.105.072215; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Goldyn AM, 2010, CYTOSKELETON, V67, P241, DOI 10.1002/cm.20439; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Hsu HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004853; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Jannat RA, 2011, BIOPHYS J, V101, P575, DOI 10.1016/j.bpj.2011.05.040; Jungbauer S, 2008, BIOPHYS J, V95, P3470, DOI 10.1529/biophysj.107.128611; Kaunas R, 2005, P NATL ACAD SCI USA, V102, P15895, DOI 10.1073/pnas.0506041102; Kong D, 2008, BIOPHYS J, V95, P4034, DOI [10.1529/biophysj.108.131342, 10.1529/biophysj.l08.131342]; Krishnan R, 2012, AM J PHYSIOL-CELL PH, V303, pC368, DOI 10.1152/ajpcell.00074.2012; Krishnan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005486; Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506; Ladoux B, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/11/116601; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; Leckband D, 2001, Q REV BIOPHYS, V34, P105, DOI 10.1017/S0033583501003687; Lin Y, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.021909; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Lotters JC, 1997, J MICROMECH MICROENG, V7, P145, DOI 10.1088/0960-1317/7/3/017; Moretti M, 2004, J MATER SCI-MATER M, V15, P1159, DOI 10.1023/B:JMSM.0000046400.18607.72; Neidlinger-Wilke C, 2001, J ORTHOP RES, V19, P286, DOI 10.1016/S0736-0266(00)00029-2; NEIDLINGERWILKE C, 1994, J ORTHOP RES, V12, P70, DOI 10.1002/jor.1100120109; Nicolas A, 2006, BIOPHYS J, V91, P61, DOI 10.1529/biophysj.105.077115; Nicolas A, 2008, BIOPHYS J, V95, P527, DOI 10.1529/biophysj.107.127399; Novak IL, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.268109; Paszek MJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000604; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370; Qian J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012342; Qian J, 2009, BIOPHYS J, V97, P2438, DOI 10.1016/j.bpj.2009.08.027; Rinko LJ, 2004, BIOPHYS J, V86, P544, DOI 10.1016/S0006-3495(04)74133-8; Sabass B, 2008, BIOPHYS J, V94, P207, DOI 10.1529/biophysj.107.113670; Saez A, 2005, BIOPHYS J, V89, pL52, DOI 10.1529/biophysj.105.071217; Safran SA, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.060901; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Stricker J, 2011, BIOPHYS J, V100, P2883, DOI 10.1016/j.bpj.2011.05.023; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Trepat X, 2007, NATURE, V447, P592, DOI 10.1038/nature05824; Walcott S, 2010, P NATL ACAD SCI USA, V107, P7757, DOI 10.1073/pnas.0912739107; Wang HC, 1995, J BIOMECH, V28, P1543, DOI 10.1016/0021-9290(95)00101-8; Wang JHC, 2000, J BIOMECH, V33, P729, DOI 10.1016/S0021-9290(00)00013-0; Wang JHC, 2001, J BIOMECH, V34, P1563, DOI 10.1016/S0021-9290(01)00150-6; Wang JHC, 2000, J THEOR BIOL, V202, P33, DOI 10.1006/jtbi.1999.1035; Wei ZS, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907745; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zamir E, 2001, J CELL SCI, V114, P3577; Zhong Y, 2011, CELL MOL BIOENG, V4, P442, DOI 10.1007/s12195-011-0187-6	68	32	33	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65864	10.1371/journal.pone.0065864	http://dx.doi.org/10.1371/journal.pone.0065864			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762444	gold, Green Published			2022-12-27	WOS:000321099000113
J	Wang, LL; Tang, YF; Liu, S; Mao, ST; Ling, Y; Liu, D; He, XY; Wang, XG				Wang, Lingling; Tang, Yufu; Liu, Shuo; Mao, Shitao; Ling, Yuan; Liu, Dan; He, Xiaoyu; Wang, Xiaoge			Metabonomic Profiling of Serum and Urine by H-1 NMR-Based Spectroscopy Discriminates Patients with Chronic Obstructive Pulmonary Disease and Healthy Individuals	PLOS ONE			English	Article							AMINO-ACID; CARDIOVASCULAR RISK; SKELETAL-MUSCLE; COPD; INFLAMMATION; METABOLISM; EXPRESSION; PROTEIN; BURDEN; PLASMA	Chronic obstructive pulmonary disease (COPD) has seriously impacted the health of individuals and populations. In this study, proton nuclear magnetic resonance (H-1 NMR)-based metabonomics combined with multivariate pattern recognition analysis was applied to investigate the metabolic signatures of patients with COPD. Serum and urine samples were collected from COPD patients (n = 32) and healthy controls (n = 21), respectively. Samples were analyzed by high resolution H-1 NMR (600 MHz), and the obtained spectral profiles were then subjected to multivariate data analysis. Consistent metabolic differences have been found in serum as well as in urine samples from COPD patients and healthy controls. Compared to healthy controls, COPD patients displayed decreased lipoprotein and amino acids, including branched-chain amino acids (BCAAs), and increased glycerolphosphocholine in serum. Moreover, metabolic differences in urine were more significant than in serum. Decreased urinary 1-methylnicotinamide, creatinine and lactate have been discovered in COPD patients in comparison with healthy controls. Conversely, acetate, ketone bodies, carnosine, m-hydroxyphenylacetate, phenylace-tyglycine, pyruvate and alpha-ketoglutarate exhibited enhanced expression levels in COPD patients relative to healthy subjects. Our results illustrate the potential application of NMR-based metabonomics in early diagnosis and understanding the mechanisms of COPD.	[Wang, Lingling; Liu, Shuo; Mao, Shitao; Ling, Yuan; Liu, Dan; He, Xiaoyu; Wang, Xiaoge] China Med Univ, Affiliated Hosp 4, Dept Resp Med, Shenyang, Peoples R China; [Tang, Yufu] Chinese PLA, Hosp 202, Dept Gen Surg, Shenyang, Peoples R China	China Medical University	Wang, XG (corresponding author), China Med Univ, Affiliated Hosp 4, Dept Resp Med, Shenyang, Peoples R China.	cm4hwxgn2005@126.com			National Science & Technology Pillar Program of China [2007BAI24B04]; Science Foundation of Chinese Medical Association [07010320040, 08020680146]; Foundation of Science and Technology Bureau of Shenyang City [F12-277-1-71]	National Science & Technology Pillar Program of China; Science Foundation of Chinese Medical Association; Foundation of Science and Technology Bureau of Shenyang City	This study was supported by grants from the National Science & Technology Pillar Program of China during the Eleventh Five-year Plan Period (No. 2007BAI24B04); the Science Foundation of Chinese Medical Association (No. 07010320040 and No. 08020680146), and the Foundation of Science and Technology Bureau of Shenyang City (No. F12-277-1-71). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn JF, 2010, ANNU REV PHYSIOL, V72, P495, DOI 10.1146/annurev-physiol-021909-135926; Baraldo S, 2007, CHEST, V132, P1733, DOI 10.1378/chest.06-2819; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Basili S, 1999, ATHEROSCLEROSIS, V147, P249, DOI 10.1016/S0021-9150(99)00192-6; Beaglehole R, 2003, LANCET, V362, P903, DOI 10.1016/S0140-6736(03)14335-8; Berger JS, 2004, AM J CARDIOL, V94, P649, DOI 10.1016/j.amjcard.2004.05.034; Biedron R, 2008, ARCH IMMUNOL THER EX, V56, P127, DOI 10.1007/s00005-008-0009-2; Carrola J, 2011, J PROTEOME RES, V10, P221, DOI 10.1021/pr100899x; CHAN KM, 1994, CRIT REV FOOD SCI, V34, P403, DOI 10.1080/10408399409527669; Churg A, 2005, CURR OPIN PULM MED, V11, P153, DOI 10.1097/01.mcp.0000149592.51761.e3; de Laurentiis G, 2008, EUR RESPIR J, V32, P1175, DOI 10.1183/09031936.00072408; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; Demedts IK, 2007, AM J RESP CRIT CARE, V175, P998, DOI 10.1164/rccm.200608-1113OC; Devereux G, 2006, BRIT MED J, V332, P1142, DOI 10.1136/bmj.332.7550.1142; Di Stefano A, 2009, CLIN EXP IMMUNOL, V157, P316, DOI 10.1111/j.1365-2249.2009.03965.x; Duarte IF, 2007, NMR BIOMED, V20, P401, DOI 10.1002/nbm.1073; Engelen MPKJ, 2000, AM J CLIN NUTR, V72, P1480; Engstrom G, 2002, CIRCULATION, V106, P2555, DOI 10.1161/01.CIR.0000037220.00065.0D; Fang XC, 2011, CHEST, V139, P920, DOI 10.1378/chest.10-1393; Gooptu B, 2009, EUR RESPIR J, V34, P475, DOI 10.1183/09031936.00096508; Griffin JL, 2003, CURR OPIN CHEM BIOL, V7, P648, DOI 10.1016/j.cbpa.2003.08.008; Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605; HOFFORD JM, 1990, AM REV RESPIR DIS, V141, P902, DOI 10.1164/ajrccm/141.4_Pt_1.902; Hogg JC, 2009, ANNU REV PATHOL-MECH, V4, P435, DOI 10.1146/annurev.pathol.4.110807.092145; HOHMANN S, 1991, J BACTERIOL, V173, P7963, DOI 10.1128/jb.173.24.7963-7969.1991; Kao CC, 2012, J APPL PHYSIOL, V112, P42, DOI 10.1152/japplphysiol.00599.2011; Kennedy Susan M, 2007, Proc Am Thorac Soc, V4, P692, DOI 10.1513/pats.200707-094SD; Kim HC, 2010, AM J RESP CRIT CARE, V181, P797, DOI 10.1164/rccm.200906-0936OC; Klebanov GI, 1998, BIOL MEMBRANY, V15, P74; KUMARI S, 1995, J BACTERIOL, V177, P2878, DOI 10.1128/jb.177.10.2878-2886.1995; Lundback B, 2003, RESP MED, V97, P115, DOI 10.1053/rmed.2003.1446; MacNee William, 2005, Proc Am Thorac Soc, V2, P50, DOI 10.1513/pats.200411-056SF; Makinen VP, 2012, J INTERN MED; Marsh S, 2006, EUR RESPIR J, V28, P883, DOI 10.1183/09031936.06.00074806; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McClay JL, 2010, J PROTEOME RES, V9, P3083, DOI 10.1021/pr1000048; Nathell L, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-89; Nicholson JK, 2011, PHARMACOGENOMICS, V12, P103, DOI 10.2217/PGS.10.157; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Odunsi K, 2005, INT J CANCER, V113, P782, DOI 10.1002/ijc.20651; Ohta Y, 2010, INTERNAL MED, V49, P1483, DOI 10.2169/internalmedicine.49.3406; Opitz B, 2010, AM J RESP CRIT CARE, V181, P1294, DOI 10.1164/rccm.200909-1427SO; Qiu YP, 2010, J PROTEOME RES, V9, P1627, DOI 10.1021/pr901081y; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rahman I, 2006, EUR RESPIR J, V28, P219, DOI 10.1183/09031936.06.00053805; Rocha CM, 2011, J PROTEOME RES, V10, P4314, DOI 10.1021/pr200550p; Rogers D, 2005, J BIOMOL SCREEN, V10, P682, DOI 10.1177/1087057105281365; Schmidt CW, 2004, ENVIRON HEALTH PERSP, V112, pA410, DOI 10.1289/ehp.112-a410; Schols A M, 1993, Monaldi Arch Chest Dis, V48, P546; Shariff MIF, 2010, J PROTEOME RES, V9, P1096, DOI 10.1021/pr901058t; Sin DD, 2003, CIRCULATION, V107, P1514, DOI 10.1161/01.CIR.0000056767.69054.B3; Soininen P, 2009, ANALYST, V134, P1781, DOI 10.1039/b910205a; TISI GM, 1981, METABOLISM, V30, P340, DOI 10.1016/0026-0495(81)90113-X; Ubhi BK, 2012, MOL BIOSYST, V8, P3125, DOI 10.1039/c2mb25194a; Ubhi BK, 2012, EUR RESPIR J, V40, P345, DOI 10.1183/09031936.00112411; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0; YOUNG LH, 1991, J CLIN INVEST, V87, P554, DOI 10.1172/JCI115030	59	56	60	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65675	10.1371/journal.pone.0065675	http://dx.doi.org/10.1371/journal.pone.0065675			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755267	Green Published, Green Submitted, gold			2022-12-27	WOS:000321099000090
J	Yang, CY; Chen, JB; Tsai, TF; Tsai, YC; Tsai, CY; Liang, PH; Hsu, TL; Wu, CY; Netea, MG; Wong, CH; Hsieh, SL				Yang, Chih-Ya; Chen, Jiun-Bo; Tsai, Ting-Fen; Tsai, Yi-Chen; Tsai, Ching-Yen; Liang, Pi-Hui; Hsu, Tsui-Ling; Wu, Chung-Yi; Netea, Mihai G.; Wong, Chi-Huey; Hsieh, Shie-Liang			CLEC4F Is an Inducible C-Type Lectin in F4/80-Positive Cells and Is Involved in Alpha-Galactosylceramide Presentation in Liver	PLOS ONE			English	Article							FUCOSE-CONTAINING GLYCOPROTEINS; MOUSE YOLK-SAC; KILLER T-CELLS; KUPFFER CELLS; BINDING-SPECIFICITY; LANGERHANS CELLS; DENDRITIC CELLS; HEPATIC LECTINS; RECEPTORS; MACROPHAGES	CLEC4F, a member of C-type lectin, was first purified from rat liver extract with high binding affinity to fucose, galactose (Gal), N-acetylgalactosamine (GalNAc), and un-sialylated glucosphingolipids with GalNAc or Gal terminus. However, the biological functions of CLEC4F have not been elucidated. To address this question, we examined the expression and distribution of murine CLEC4F, determined its binding specificity by glycan array, and investigated its function using CLEC4F knockout (Clec4f(-/-)) mice. We found that CLEC4F is a heavily glycosylated membrane protein co-expressed with F4/80 on Kupffer cells. In contrast to F4/80, CLEC4F is detectable in fetal livers at embryonic day 11.5 (E11.5) but not in yolk sac, suggesting the expression of CLEC4F is induced as cells migrate from yolk cells to the liver. Even though CLEC4F is not detectable in tissues outside liver, both residential Kupffer cells and infiltrating mononuclear cells surrounding liver abscesses are CLEC4F-positive upon Listeria monocytogenes (L. monocytogenes) infection. While CLEC4F has strong binding to Gal and GalNAc, terminal fucosylation inhibits CLEC4F recognition to several glycans such as Fucosyl GM1, Globo H, Bb3 similar to 4 and other fucosyl-glycans. Moreover, CLEC4F interacts with alpha-galactosylceramide (alpha-GalCer) in a calcium-dependent manner and participates in the presentation of alpha-GalCer to natural killer T (NKT) cells. This suggests that CLEC4F is a C-type lectin with diverse binding specificity expressed on residential Kupffer cells and infiltrating monocytes in the liver, and may play an important role to modulate glycolipids presentation on Kupffer cells.	[Yang, Chih-Ya; Chen, Jiun-Bo; Tsai, Yi-Chen; Hsieh, Shie-Liang] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Yang, Chih-Ya] Natl Yang Ming Univ, Program Mol Med, Taipei 112, Taiwan; [Yang, Chih-Ya] Acad Sinica, Taipei 115, Taiwan; [Tsai, Ting-Fen] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Tsai, Ting-Fen] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Tsai, Ching-Yen] Acad Sinica, Inst Mol Biol, Transgen Core Facil, Taipei, Taiwan; [Liang, Pi-Hui] Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei 10764, Taiwan; [Hsu, Tsui-Ling; Wu, Chung-Yi; Wong, Chi-Huey; Hsieh, Shie-Liang] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Hsieh, Shie-Liang] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Hsieh, Shie-Liang] Natl Yang Ming Univ, Infect & Immun Ctr, Taipei 112, Taiwan; [Hsieh, Shie-Liang] Taipei Vet Gen Hosp, Ctr Immunol, Taipei, Taiwan; [Hsieh, Shie-Liang] Taipei Med Univ, Coll Med Sci & Technol, Inst Canc Biol & Drug Discovery, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Taiwan University; Academia Sinica - Taiwan; Radboud University Nijmegen; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Medical University	Hsieh, SL (corresponding author), Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan.	slhsieh@gate.sinica.edu.tw	Hsu, Tsui-Ling/AAE-8821-2019; Liang, Pi-hui/D-4166-2012; Hsu, Tsui-Ling/H-6704-2015; Netea, Mihai/N-5155-2014; Wu, Chung-Yi/K-8334-2018; Hsieh, Shie-Liang Edmond/ABA-9184-2021; Tsai, Ching-Yen/AEX-9366-2022	Hsu, Tsui-Ling/0000-0002-2912-3261; Liang, Pi-hui/0000-0001-6668-4642; Tsai, Ching-Yen/0000-0001-7964-6661; Hsieh, Shie-Liang/0000-0001-9415-346X	National Science Council [NSC 101-2325-B-010-006, NSC 101-2321-B-010-003]; Academia Sinica, Thematic Research Project [AS-101-TP-B06-2]; Infection and Immunity Center, National Yang-Ming University, Taiwan; Ministry of Education, Aim for the Top University Plan; Taipei Veterans General Hospital [V102E4-003]; Taichung Veterans General Hospital [TCVGH-YM1010202]; National Research Program for Biopharmaceuticals (NRPB) at the National Science Council (NSC) of Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica, Thematic Research Project; Infection and Immunity Center, National Yang-Ming University, Taiwan; Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); Taichung Veterans General Hospital; National Research Program for Biopharmaceuticals (NRPB) at the National Science Council (NSC) of Taiwan	This work was supported by the National Science Council (NSC 101-2325-B-010-006 and NSC 101-2321-B-010-003), Academia Sinica, Thematic Research Project (AS-101-TP-B06-2) and in part by the Infection and Immunity Center, National Yang-Ming University, Taiwan (a grant from Ministry of Education, Aim for the Top University Plan), Taipei Veterans General Hospital (V102E4-003), Taichung Veterans General Hospital (TCVGH-YM1010202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the; We thank the Taiwan Mouse Clinic which is funded by the National Research Program for Biopharmaceuticals (NRPB) at the National Science Council (NSC) of Taiwan and BioLegend for their technique support and related antibody preparation. We are also grateful to the technical services provided by the "Transgenic Mouse Model Core Facility of the National Core Facility Program for Biotechnology, National Science Council'' and the "Gene Knockout Mouse Core Laboratory of National Taiwan University Center of Genomic Medicine".manuscript.	Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Biburger M, 2005, J IMMUNOL, V175, P1540, DOI 10.4049/jimmunol.175.3.1540; Biburger M, 2008, J LEUKOCYTE BIOL, V84, P264, DOI 10.1189/jlb.0607352; Chang YJ, 2007, P NATL ACAD SCI USA, V104, P10299, DOI 10.1073/pnas.0703824104; Coombs PJ, 2006, GLYCOBIOLOGY, V16, p1C, DOI 10.1093/glycob/cwj126; Cousens LP, 2000, IMMUNOL REV, V174, P150, DOI 10.1034/j.1600-0528.2002.017407.x; CROFTON RW, 1978, J EXP MED, V148, P1, DOI 10.1084/jem.148.1.1; Depner CM, 2013, J NUTR, V143, P315, DOI 10.3945/jn.112.171322; Dory D, 2003, J LEUKOCYTE BIOL, V74, P49, DOI 10.1189/jlb.0302133; Eberl G, 1999, J IMMUNOL, V162, P6410; Fadden AJ, 2003, GLYCOBIOLOGY, V13, P529, DOI 10.1093/glycob/cwg068; Filler SG, 2006, CURR OPIN MICROBIOL, V9, P333, DOI 10.1016/j.mib.2006.06.005; Gehring S, 2009, WORLD J GASTROENTERO, V15, P1708, DOI 10.3748/wjg.15.1708; GOOSSENS PL, 1991, J IMMUNOL, V147, P3514; HALTIWANGER RS, 1986, J BIOL CHEM, V261, P7433; Hammond KJL, 2003, CURR OPIN IMMUNOL, V15, P683, DOI 10.1016/j.coi.2003.09.014; Hardison SE, 2012, NAT IMMUNOL, V13, P817, DOI 10.1038/ni.2369; HIRSCH S, 1981, J EXP MED, V154, P713, DOI 10.1084/jem.154.3.713; HOYLE GW, 1988, J BIOL CHEM, V263, P7487; Hsu TL, 2009, J BIOL CHEM, V284, P34479, DOI 10.1074/jbc.M109.065961; HUME DA, 1983, J EXP MED, V158, P1522, DOI 10.1084/jem.158.5.1522; Hunger RE, 2004, J CLIN INVEST, V113, P701, DOI 10.1172/JCI200419655; Ju C, 2002, CHEM RES TOXICOL, V15, P1504, DOI 10.1021/tx0255976; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Klein I, 2007, BLOOD, V110, P4077, DOI 10.1182/blood-2007-02-073841; Lee WY, 2010, NAT IMMUNOL, V11, P295, DOI 10.1038/ni.1855; LEHRMAN MA, 1986, J BIOL CHEM, V261, P7412; LEHRMAN MA, 1986, J BIOL CHEM, V261, P7426; Liang PH, 2008, J AM CHEM SOC, V130, P12348, DOI 10.1021/ja8012787; MATTHEWS CJ, 1985, J REPROD IMMUNOL, V7, P315, DOI 10.1016/0165-0378(85)90026-9; Naito M, 1996, J LEUKOCYTE BIOL, V59, P133, DOI 10.1002/jlb.59.2.133; Naito Makoto, 2004, Medical Electron Microscopy, V37, P16, DOI 10.1007/s00795-003-0228-x; OHTEKI T, 1994, J EXP MED, V180, P699, DOI 10.1084/jem.180.2.699; Osorio F, 2011, IMMUNITY, V34, P651, DOI 10.1016/j.immuni.2011.05.001; PRAANINGVANDALEN DP, 1982, FEBS LETT, V141, P229, DOI 10.1016/0014-5793(82)80054-9; Prigozy TI, 1997, IMMUNITY, V6, P187, DOI 10.1016/S1074-7613(00)80425-2; Sancho D, 2012, ANNU REV IMMUNOL, V30, P491, DOI 10.1146/annurev-immunol-031210-101352; Schmieg J, 2005, P NATL ACAD SCI USA, V102, P1127, DOI 10.1073/pnas.0408288102; Stienstra R, 2010, HEPATOLOGY, V51, P511, DOI 10.1002/hep.23337; TAKAHASHI K, 1989, J LEUKOCYTE BIOL, V45, P87, DOI 10.1002/jlb.45.2.87; TIEDEMANN K, 1977, CELL TISSUE RES, V183, P71; TIEMEYER M, 1992, J BIOL CHEM, V267, P12252; Trobonjaca Z, 2001, J IMMUNOL, V167, P1413, DOI 10.4049/jimmunol.167.3.1413; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Wang N, 2011, JOVE-J VIS EXP, DOI 10.3791/3076; Watarai H, 2008, NAT PROTOC, V3, P70, DOI 10.1038/nprot.2007.515; WEINBERG SR, 1976, BRIT J HAEMATOL, V32, P543, DOI 10.1111/j.1365-2141.1976.tb00958.x; Yamamoto T, 1996, AM J PATHOL, V149, P1271; Yang L, 2007, LAB INVEST, V87, P927, DOI 10.1038/labinvest.3700603	50	61	64	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65070	10.1371/journal.pone.0065070	http://dx.doi.org/10.1371/journal.pone.0065070			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762286	Green Published, Green Submitted, gold			2022-12-27	WOS:000321099000030
J	Lattuada, D; Crotta, K; Tonna, N; Casnici, C; Benfante, R; Fornasari, D; Bianco, F; Longhi, R; Marelli, O				Lattuada, Donatella; Crotta, Katia; Tonna, Noemi; Casnici, Claudia; Benfante, Roberta; Fornasari, Diego; Bianco, Fabio; Longhi, Renato; Marelli, Ornella			The Expression of GHS-R in Primary Neurons Is Dependent upon Maturation Stage and Regional Localization	PLOS ONE			English	Article							HORMONE SECRETAGOGUE-RECEPTOR; GROWTH-HORMONE; MESSENGER-RNA; GHRELIN RECEPTOR; SPATIAL MEMORY; RAT; MOUSE; HYPOTHALAMUS; BRAIN	Ghrelin is a hormone with a crucial role in the regulation of appetite, regulation of inflammation, glucose metabolism and cell proliferation. In the brain ghrelin neurons are located in the cortex (sensorimotor area, cingular gyrus), and the fibres of ghrelin neurons in hypothalamus project directly to the dorsal vagal complex (DVC). Ghrelin binds the growth hormone secretagogue receptor (GHS-R) a G-protein-coupled receptor with a widespread tissue distribution, indeed these receptors are localized both in nonnervous, organs/tissues (i.e. adipose tissue, myocardium, adrenals, gonads, lung, liver, arteries, stomach, pancreas, thyroid, and kidney) as well as in central nervous system (CNS) and higher levels of expression in the pituitary gland and the hypothalamus and lower levels of expression in other organs, including brain. A GHS-R specific monoclonal antibody has been developed and characterized and through it we demonstrate that GHS-R is expressed in primary neurons and that its expression is dependent upon their developmental stage and shows differences according to the brain region involved, with a more pronounced expression in hippocampal rather than cortical neurons. A characterization of GHS-R within the central nervous system is of extreme importance in order to gain insights on its role in the modulation of neurodegenerative events such as Alzheimer's disease.	[Lattuada, Donatella; Crotta, Katia; Casnici, Claudia; Benfante, Roberta; Fornasari, Diego; Marelli, Ornella] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy; [Tonna, Noemi; Bianco, Fabio] NeuroZone Srl, Milan, Italy; [Benfante, Roberta] CNR, Inst Neurosci, I-20133 Milan, Italy; [Longhi, Renato] CNR, Ist Chim Riconoscimento Mol, I-20133 Milan, Italy	University of Milan; Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR)	Marelli, O (corresponding author), Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy.	ornella.marelli@unimi.it	Benfante, Roberta/C-1513-2015; lattuada, donatella/F-1438-2016	Benfante, Roberta/0000-0001-5396-5429; MARELLI, ORNELLA/0000-0001-8522-9418; Fornasari, Diego/0000-0002-9668-3103; Casnici, Claudia/0000-0002-5478-0239	Santarelli Foundation, Lichtenstein; Regione Lombardia	Santarelli Foundation, Lichtenstein; Regione Lombardia(Regione Lombardia)	The study was supported by the Santarelli Foundation, Lichtenstein. Dr. Crotta would like to thank the Regione Lombardia for financial support related to the grant-Dote ricercatori: FSE, Regione Lombardia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Albarran-Zeckler RG, 2012, BEHAV BRAIN RES, V232, P13, DOI 10.1016/j.bbr.2012.03.012; Bennett PA, 1997, ENDOCRINOLOGY, V138, P4552, DOI 10.1210/en.138.11.4552; Bossard C, 2007, PEPTIDES, V28, P2030, DOI 10.1016/j.peptides.2007.06.030; Brewer GJ, 1997, J NEUROSCI METH, V71, P143, DOI 10.1016/S0165-0270(96)00136-7; Carlini VP, 2002, BIOCHEM BIOPH RES CO, V299, P739, DOI 10.1016/S0006-291X(02)02740-7; Carlini VP, 2004, BIOCHEM BIOPH RES CO, V313, P635, DOI 10.1016/j.bbrc.2003.11.150; Cassoni P, 2004, EUR J ENDOCRINOL, V150, P173, DOI 10.1530/eje.0.1500173; Chen LA, 2011, EUR J NEUROSCI, V33, P266, DOI 10.1111/j.1460-9568.2010.07491.x; Chollet C, 2009, J PEPT SCI, V15, P711, DOI 10.1002/psc.1177; Chung H, 2007, ENDOCRINOLOGY, V148, P148, DOI 10.1210/en.2006-0991; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Gahete MD, 2011, PEPTIDES, V32, P2225, DOI 10.1016/j.peptides.2011.09.019; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Guan XM, 1997, MOL BRAIN RES, V48, P23, DOI 10.1016/S0169-328X(97)00071-5; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Hou ZC, 2006, REGUL PEPTIDES, V134, P126, DOI 10.1016/j.regpep.2006.02.005; Koon HW, 2009, P NATL ACAD SCI USA, V106, P8766, DOI 10.1073/pnas.0903499106; Lago F, 2005, VITAM HORM, V71, P405, DOI 10.1016/S0083-6729(05)71014-1; Liu YJ, 2006, CHINESE J PHYSIOL, V49, P244; Lu S, 2002, NEUROSCI LETT, V321, P157, DOI 10.1016/S0304-3940(01)02544-7; Miao YY, 2007, BIOCHEM BIOPH RES CO, V359, P795, DOI 10.1016/j.bbrc.2007.05.192; Mitchell V, 2001, J COMP NEUROL, V429, P469, DOI 10.1002/1096-9861(20010115)429:3<469::AID-CNE8>3.0.CO;2-#; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Nakazawa M, 2010, METHODS MOL BIOL, V657, P75, DOI 10.1007/978-1-60761-783-9_6; Papotti M, 2000, J CLIN ENDOCR METAB, V85, P3803, DOI 10.1210/jc.85.10.3803; Pozzi D, 2008, P NATL ACAD SCI USA, V105, P323, DOI 10.1073/pnas.0706211105; Shuto YJ, 2001, LIFE SCI, V68, P991, DOI 10.1016/S0024-3205(00)01001-8; Tannenbaum GS, 1998, ENDOCRINOLOGY, V139, P4420, DOI 10.1210/en.139.10.4420; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; WILLIAMS G, 1991, METABOLISM, V40, P1112, DOI 10.1016/0026-0495(91)90139-N; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823	32	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64183	10.1371/journal.pone.0064183	http://dx.doi.org/10.1371/journal.pone.0064183			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755116	Green Published, gold			2022-12-27	WOS:000320579400009
J	Ouellet, JF; Vanpe, C; Guillemette, M				Ouellet, Jean-Francois; Vanpe, Cecile; Guillemette, Magella			The Body Size-Dependent Diet Composition of North American Sea Ducks in Winter	PLOS ONE			English	Article							EIDERS SOMATERIA-MOLLISSIMA; WHITE-WINGED SCOTERS; LONG-TAILED DUCKS; SAN-FRANCISCO BAY; COMMON-EIDERS; HARLEQUIN DUCKS; HABITAT SELECTION; SURF SCOTERS; TEMPORARY FLIGHTLESSNESS; FORAGING DECISIONS	Daily food requirements scale with body mass and activity in animals. While small species of birds have higher mass-specific field metabolic rates than larger species, larger species have higher absolute energy costs. Under energy balance, we thus expect the small species to have a higher energy value diet. Also the weight and time constraints for flighted and diurnal foragers should set a maximum to the amount of prey items taken in one meal and to the daily number of meals, respectively. Further, avoidance of competition causes the species to reduce the amount of shared prey in their diet. Some diet segregation is therefore to be expected between species. We tested these hypotheses and investigated the role of body mass in the diet composition of 12 sea duck species (Somateria mollissima, Somateria spectabilis, Somateria fischeri, Polysticta stelleri, Bucephala clangula, Bucephala islandica, Bucephala albeola, Melanitta nigra, Melanitta perspicillata, Melanitta deglandi, Histrionicus histrionicus and Clangula hyemalis) wintering in North America. This study was based on a literature survey with special emphasis given to the diet data from the former US Bureau of Biological Survey. The data supported our hypothesis that the energy value of winter diet of sea ducks scales negatively with body mass. Diet diversity also scaled negatively with body mass. Our results suggest the existence of a minimum for the energy value of avian diets.	[Ouellet, Jean-Francois; Vanpe, Cecile; Guillemette, Magella] Univ Quebec, Dept Biol Chim & Geog, Rimouski, PQ G5L 3A1, Canada; [Ouellet, Jean-Francois] Univ Laval, Quebec City, PQ G1K 7P4, Canada	University of Quebec; Laval University	Ouellet, JF (corresponding author), Univ Quebec, Dept Biol Chim & Geog, Rimouski, PQ G5L 3A1, Canada.	jean-francois_ouellet03@uqar.ca		Vanpe, Cecile/0000-0001-8136-1657	Fonds quebecois de la Recherche sur la Nature et les Technologies; CREPUQ; French Rhone-Alpes region	Fonds quebecois de la Recherche sur la Nature et les Technologies(FQRNT); CREPUQ; French Rhone-Alpes region(Region Auvergne-Rhone-Alpes)	JFO was supported by a grant from the Fonds quebecois de la Recherche sur la Nature et les Technologies. CV was supported by a CREPUQ international exchange grant from the French Rhone-Alpes region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EM, 2008, CONDOR, V110, P285, DOI 10.1525/cond.2008.8458; BECK DD, 1995, J HERPETOL, V29, P211, DOI 10.2307/1564558; BELOVSKY GE, 1986, AM ZOOL, V26, P51; Bond JC, 2006, CAN J ZOOL, V84, P1223, DOI 10.1139/Z06-111; BRAWN VM, 1968, J FISH RES BOARD CAN, V25, P1803, DOI 10.1139/f68-166; Bustnes JO, 2001, WATERBIRDS, V24, P407, DOI 10.2307/1522072; CARACO T, 1980, ANIM BEHAV, V28, P820, DOI 10.1016/S0003-3472(80)80142-4; CARACO T, 1990, ANIM BEHAV, V39, P338, DOI 10.1016/S0003-3472(05)80879-6; Cruz-Rivera E, 2000, ECOLOGY, V81, P201; de Leeuw JJ, 1999, J AVIAN BIOL, V30, P182, DOI 10.2307/3677128; Donne-Gousse C, 2002, MOL PHYLOGENET EVOL, V23, P339, DOI 10.1016/S1055-7903(02)00019-2; EDWARDS J, 1983, OECOLOGIA, V60, P185, DOI 10.1007/BF00379520; Ellis Hugh I., 2002, P359; Farnsworth KD, 1998, FUNCT ECOL, V12, P74, DOI 10.1046/j.1365-2435.1998.00163.x; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fischer JB, 2000, WILSON BULL, V112, P318, DOI 10.1676/0043-5643(2000)112[0318:FBAFHO]2.0.CO;2; FITZNER RE, 1994, NORTHWEST SCI, V68, P172; FRENCH TW, 1981, WILSON BULL, V93, P279; GOUDIE RI, 1988, ORNIS SCAND, V19, P249, DOI 10.2307/3676718; GOUDIE RI, 1986, ECOLOGY, V67, P1475, DOI 10.2307/1939078; Guillemette M, 1998, FUNCT ECOL, V12, P123, DOI 10.1046/j.1365-2435.1998.00164.x; Guillemette M, 2005, IBIS, V147, P301, DOI 10.1111/j.1474-919x.2005.00402.x; Guillemette M, 2005, IBIS, V147, P293, DOI 10.1111/j.1474-919x.2005.00401.x; GUILLEMETTE M, 1994, AUK, V111, P900, DOI 10.2307/4088822; GUILLEMETTE M, 1992, J ANIM ECOL, V61, P599, DOI 10.2307/5615; GUILLEMETTE M, 1993, CAN J ZOOL, V71, P1259, DOI 10.1139/z93-172; Guillemette M, 1991, THESIS U LAVAL QUEBE; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Heard DJ, 2008, J WILDLIFE DIS, V44, P486, DOI 10.7589/0090-3558-44.2.486; Heath JP, 2010, MAR ECOL PROG SER, V403, P279, DOI 10.3354/meps08482; Henny C.J., 1981, Wildfowl, V32, P117; Holm HJ, 2002, WATERBIRDS, V25, P312; Jamieson SE, 2001, WATERBIRDS, V24, P129, DOI 10.2307/1522253; Jenssen B.M., 1989, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, V173, P147; JENSSEN BM, 1989, CAN J ZOOL, V67, P669, DOI 10.1139/z89-096; JORDE DG, 1988, J WILDLIFE MANAGE, V52, P209, DOI 10.2307/3801224; Kacelnik A, 1996, AM ZOOL, V36, P402; KARASOV WH, 1986, AUK, V103, P453, DOI 10.1093/auk/103.3.453; Kirk MK, 2007, CAN J ZOOL, V85, P1207, DOI 10.1139/Z07-105; Koehl PS, 1982, MARINE BIRDS THEIR F, P1; Larsen JK, 2000, MAR ECOL PROG SER, V201, P301, DOI 10.3354/meps201301; Lewis TL, 2005, CONDOR, V107, P637, DOI 10.1650/0010-5422(2005)107[0637:NFBOWS]2.0.CO;2; LIFJELD JT, 1989, OIKOS, V55, P397, DOI 10.2307/3565600; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; LIVEZEY BC, 1995, CONDOR, V97, P233, DOI 10.2307/1368999; Livezey BC, 1997, ANN CARNEGIE MUS, V66, P457; Longcore J. R., 2000, BIRDS N AM ONLINE; Lovvorn JR, 2003, POLAR BIOL, V26, P259, DOI 10.1007/s00300-003-0477-0; McNab B.K, 2002, PHYSL ECOLOGY VERTEB, DOI DOI 10.1643/0045-8511(2002)002[1170:]2.0.CO;2; McNab BK, 2003, COMP BIOCHEM PHYS A, V135, P229, DOI 10.1016/S1095-6433(03)00085-0; Miller MR, 2006, CONDOR, V108, P166, DOI 10.1650/0010-5422(2006)108[0166:TARBRM]2.0.CO;2; Moore PG, 2001, J MAR BIOL ASSOC UK, V81, P1067; Morton E.S., 1978, P123; Nagy KA, 1999, ANNU REV NUTR, V19, P247, DOI 10.1146/annurev.nutr.19.1.247; NAGY KA, 1987, ECOL MONOGR, V57, P111, DOI 10.2307/1942620; OHLENDORF HM, 1991, ENVIRON MONIT ASSESS, V18, P105, DOI 10.1007/BF00394973; Ouellet JF, 2008, CAN J ZOOL, V86, P462, DOI 10.1139/Z08-021; Ouellet JF, 2010, CAN J ZOOL, V88, P306, DOI 10.1139/Z09-144; Pelletier D, 2008, P ROY SOC B-BIOL SCI, V275, P2117, DOI 10.1098/rspb.2008.0422; Petersen Margaret R., 1999, Wildfowl, V49, P124; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Richman SE, 2011, PHYSIOL BIOCHEM ZOOL, V84, P316, DOI 10.1086/660008; Richman SE, 2009, J ANIM ECOL, V78, P1033, DOI 10.1111/j.1365-2656.2009.01556.x; Richman SE, 2004, ECOL APPL, V14, P1217, DOI 10.1890/03-5032; Richman SE, 2003, MAR ECOL PROG SER, V261, P283, DOI 10.3354/meps261283; Rizzolo DJ, 2005, CONDOR, V107, P173, DOI 10.1650/7611; Robert M, 2006, WATERBIRDS, V29, P437, DOI 10.1675/1524-4695(2006)29[437:TSLREA]2.0.CO;2; Rodway MS, 2003, CAN J ZOOL, V81, P504, DOI 10.1139/Z03-032; Rumohr H., 1987, BALT MAR BIOL, V9, P1; RYAN RR, 1972, J WILDLIFE MANAGE, V36, P759, DOI 10.2307/3799428; Savard JPL, 1990, SERIE RAPPORTS TECHN, V89; SECOR SM, 1995, J EXP BIOL, V198, P1313; STEIMLE F W JR, 1985, Journal of Northwest Atlantic Fishery Science, V6, P117; Stephens D.W., 1986, pi; STOTT RS, 1973, ECOLOGY, V54, P996, DOI 10.2307/1935566; STRANECK R, 1983, CONDOR, V85, P255, DOI 10.2307/1367268; SWANSON GA, 1970, J WILDLIFE MANAGE, V34, P739, DOI 10.2307/3799138; Systad GH, 2000, AUK, V117, P33, DOI 10.1642/0004-8038(2000)117[0033:BRTDDL]2.0.CO;2; THAYER GW, 1973, FISH B-NOAA, V71, P289; TODD CS, 1982, J WILDLIFE MANAGE, V46, P636, DOI 10.2307/3808554; TYLER AV, 1973, MAR BIOL, V19, P258, DOI 10.1007/BF02097146; Van Gils JA, 2005, J ANIM ECOL, V74, P105, DOI 10.1111/j.1365-2656.2004.00903.x; van Gils JA, 2004, J ANIM ECOL, V73, P386, DOI 10.1111/j.0021-8790.2004.00812.x; Vang Hirsh K, 1980, THESIS U WASHINGTON; Vermeer K., 1982, Wildfowl, V33, P22; VERMEER K, 1986, Murrelet, V67, P1, DOI 10.2307/3535529; WATSON J, 1992, IBIS, V134, P27, DOI 10.1111/j.1474-919X.1992.tb07225.x; Whelan CJ, 2005, OIKOS, V110, P481, DOI 10.1111/j.0030-1299.2005.13387.x; White TP, 2009, WATERBIRDS, V32, P293, DOI 10.1675/063.032.0209; Wright J, 1998, J ANIM ECOL, V67, P620, DOI 10.1046/j.1365-2656.1998.00221.x	90	14	14	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65667	10.1371/journal.pone.0065667	http://dx.doi.org/10.1371/journal.pone.0065667			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755266	Green Published, gold, Green Submitted			2022-12-27	WOS:000320579400073
J	Reissland, N; Francis, B; Mason, J				Reissland, Nadja; Francis, Brian; Mason, James			Can Healthy Fetuses Show Facial Expressions of "Pain" or "Distress"?	PLOS ONE			English	Article							SEX-DIFFERENCES; FETAL PAIN; 4-DIMENSIONAL SONOGRAPHY; NORMAL-PREGNANCY; ULTRASOUND; MOVEMENTS; RESPONSES; INFANTS; BRAIN; NEUROBEHAVIOR	Background: With advances of research on fetal behavioural development, the question of whether we can identify fetal facial expressions and determine their developmental progression, takes on greater importance. In this study we investigate longitudinally the increasing complexity of combinations of facial movements from 24 to 36 weeks gestation in a sample of healthy fetuses using frame-by-frame coding of 4-D ultrasound scans. The primary aim was to examine whether these complex facial movements coalesce into a recognisable facial expression of pain/distress. Methodology/Findings: Fifteen fetuses (8 girls, 7 boys) were observed four times in the second and third trimester of pregnancy. Fetuses showed significant progress towards more complex facial expressions as gestational age increased. Statistical analysis of the facial movements making up a specific facial configuration namely "pain/distress" also demonstrates that this facial expression becomes significantly more complete as the fetus matures. Conclusions/Significance: The study shows that one can determine the normal progression of fetal facial movements. Furthermore, our results suggest that healthy fetuses progress towards an increasingly complete pain/distress expression as they mature. We argue that this is an adaptive process which	[Reissland, Nadja] Univ Durham, Dept Psychol, Durham DH1 3HP, England; [Francis, Brian] Univ Lancaster, Dept Math & Stat, Lancaster, England; [Mason, James] Univ Durham, Sch Med Pharm & Hlth, Stockton On Tees DH1 3HP, England	Durham University; Lancaster University; Durham University	Reissland, N (corresponding author), Univ Durham, Dept Psychol, Durham DH1 3HP, England.	n.n.reissland@durham.ac.uk	Mason, James M/D-9904-2011; Reissland, Nadja/B-6079-2008; Francis, Brian J/A-1953-2011	Mason, James M/0000-0001-9210-4082; Reissland, Nadja/0000-0003-4976-7117; Francis, Brian J/0000-0001-7926-9085	Durham University; ESRC [RES-576-25-0019]	Durham University; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Funding was provided by Durham University (http://www.dur.ac.uk). The analysis of the data was supported by ESRC grant RES-576-25-0019 (http://www.esrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2010, ANAL ORDINAL CATEGOR, DOI [DOI 10.1002/9780470594001, 10.1002/9780470594001]; ANAND KJS, 1987, NEW ENGL J MED, V317, P1321, DOI 10.1056/NEJM198711193172105; Azumendi G, 2003, ULTRASOUND REV OBSTE, V3, P160; Bartocci M, 2006, PAIN, V122, P109, DOI 10.1016/j.pain.2006.01.015; Benatar D, 2001, BIOETHICS, V15, P57, DOI 10.1111/1467-8519.00212; Christensen R.H.B., 2011, ANAL ORDINAL DATA CU; Craig K. D., 2001, HDB PAIN ASSESSMENT, P153; CRAIG KD, 1993, PAIN, V52, P287, DOI 10.1016/0304-3959(93)90162-I; CRAIG KD, 1994, J PEDIATR PSYCHOL, V19, P305, DOI 10.1093/jpepsy/19.3.305; CRAIG KD, 1985, J PERS SOC PSYCHOL, V48, P1080, DOI 10.1037/0022-3514.48.4.1089; Craig KD, 1991, PAIN CHILDREN CLIN R, P171; Derbyshire SWG, 2010, BEST PRACT RES CL OB, V24, P647, DOI 10.1016/j.bpobgyn.2010.02.013; DEVRIES JIP, 1982, EARLY HUM DEV, V7, P301, DOI 10.1016/0378-3782(82)90033-0; Fernandez-Dols JM, 2013, EMOT REV, V5, P24, DOI 10.1177/1754073912457229; Friesen E., 1978, CONSULTING PSYCHOL P, V3, P1; GIANNAKOULOPOULOS X, 1994, LANCET, V344, P77, DOI 10.1016/S0140-6736(94)91279-3; GRUNAU RVE, 1990, PAIN, V42, P295, DOI 10.1016/0304-3959(90)91142-6; Hartzel J, 2001, STAT MODEL, V1, P81, DOI 10.1177/1471082X0100100201; Hata T, 2010, INFANT CHILD DEV, V19, P99, DOI 10.1002/icd.659; Hepper PG, 2012, DEVELOPMENTAL SCI, V15, P373, DOI 10.1111/j.1467-7687.2011.01132.x; Hepper PG, 1997, LANCET, V350, P1820, DOI 10.1016/S0140-6736(05)63635-5; Humprey T, 1967, 2 S OR SENS PERC, P195; Kawai N, 2010, INFANT CHILD DEV, V19, P55, DOI 10.1002/icd.654; Kisilevsky BS, 2010, INFANT CHILD DEV, V19, P60, DOI 10.1002/icd.655; Kisilevsky BS, 2003, PSYCHOL SCI, V14, P220, DOI 10.1111/1467-9280.02435; Kostovic I, 2010, ACTA PAEDIATR, V99, P1119, DOI 10.1111/j.1651-2227.2010.01811.x; Kurjak A, 2005, J PERINAT MED, V33, P46, DOI 10.1515/JPM.2005.008; Kurjak A, 2006, J PERINAT MED, V34, P56, DOI 10.1515/JPM.2006.007; Kurjak A, 2003, J PERINAT MED, V31, P496, DOI 10.1515/JPM.2003.076; Kurjak A, 2002, J PERINAT MED, V30, P57, DOI 10.1515/JPM.2002.008; Kurjak A, 2010, J PERINAT MED, V38, P77, DOI [10.1515/JPM.2010.012, 10.1515/jpm.2010.012]; Kurjak A, 2008, J MATERN-FETAL NEO M, V21, P675, DOI 10.1080/14767050802212166; Lee SJ, 2005, JAMA-J AM MED ASSOC, V294, P947, DOI 10.1001/jama.294.8.947; LERESCHE L, 1988, PAIN, V35, P71, DOI 10.1016/0304-3959(88)90278-3; LERESCHE L, 1982, J NONVERBAL BEHAV, V7, P46, DOI 10.1007/BF01001777; Mathew PJ, 2003, POSTGRAD MED J, V79, P438, DOI 10.1136/pmj.79.934.438; Mellor DJ, 2005, BRAIN RES REV, V49, P455, DOI 10.1016/j.brainresrev.2005.01.006; Miller JL, 2006, DEV MED CHILD NEUROL, V48, P465, DOI 10.1017/S0012162206001009; Oberlander TF, 2002, PEDIATRICS, V110, P570, DOI 10.1542/peds.110.3.570; PATRICK CJ, 1986, J PERS SOC PSYCHOL, V50, P1291, DOI 10.1037/0022-3514.50.6.1291; Piontelli A, 2010, DEVELOPMENT OF NORMAL FETAL MOVEMENTS: THE FIRST 25 WEEKS OF GESTATION, P1, DOI 10.1007/978-88-470-1402-2; Prkachin KM, 2005, WHAT FACE REVEALS BA, P181; Reissland N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050569; Reissland N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024081; ROODENBURG PJ, 1991, EARLY HUM DEV, V25, P19, DOI 10.1016/0378-3782(91)90203-F; Slater R, 2006, J NEUROSCI, V26, P3662, DOI 10.1523/JNEUROSCI.0348-06.2006; Slater R, 2008, PLOS MED, V5, P928, DOI 10.1371/journal.pmed.0050129; Smith RP, 2000, EUR J OBSTET GYN R B, V92, P161, DOI 10.1016/S0301-2115(00)00441-3; Tutz G, 1996, COMPUT STAT DATA AN, V22, P537, DOI 10.1016/0167-9473(96)00004-7; Waxman SG, 1996, PROG BRAIN RES, V107, P595; Yan F, 2006, INT J GYNECOL OBSTET, V94, P108, DOI 10.1016/j.ijgo.2006.05.004	51	36	36	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65530	10.1371/journal.pone.0065530	http://dx.doi.org/10.1371/journal.pone.0065530			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166TB	23755245	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000320579400062
J	Vitale, A; Thorne, N; Lovell, S; Battaile, KP; Hu, X; Shen, M; D'Auria, S; Auld, DS				Vitale, Annalisa; Thorne, Natasha; Lovell, Scott; Battaile, Kevin P.; Hu, Xin; Shen, Min; D'Auria, Sabato; Auld, Douglas S.			Physicochemical Characterization of a Thermostable Alcohol Dehydrogenase from Pyrobaculum aerophilum	PLOS ONE			English	Article							CLOSTRIDIUM-BEIJERINCKII; CRYSTAL-STRUCTURE; ZINC; BINDING; IDENTIFICATION; SPECIFICITY; VALIDATION; STABILITY; SUBSTRATE; RESIDUES	In this work we characterize an alcohol dehydrogenase (ADH) from the hyperthermophilic archaeon Pyrobaculum aerophilum (PyAeADHII). We have previously found that PyAeADHII has no activity when standard ADH substrates are used but is active when alpha-tetralone is used as substrate. Here, to gain insights into enzyme function, we screened several chemical libraries for enzymatic modulators using an assay employing alpha-tetralone. The results indicate that PyAeADHII activity in the presence of alpha-tetralone was inhibited by compounds such as flunarizine. We also examined metal coordination of the enzyme in solution by performing metal substitution of the enzyme-bound zinc (Zn2+) with cobalt. The solution-based absorption spectra for cobalt substituted PyAeADHII supports substitution at the structural Zn2+ site. To gain structural insight, we obtained the crystal structure of both wild-type and cobalt-substituted PyAeADHII at 1.75 angstrom and 2.20 angstrom resolution, respectively. The X-ray data confirmed one metal ion per monomer present only at the structural site with otherwise close conservation to other ADH enzymes. We next determined the co-crystal structure of the NADPH-bound form of the enzyme at 2.35 angstrom resolution to help define the active site region of the enzyme and this data shows close structural conservation with horse ADH, despite the lack of a catalytic Zn2+ ion in PyAeADHII. Modeling of alpha-tetralone into the NADPH bound structure suggests an arginine as a possible catalytic residue. The data presented here can yield a better understanding of alcohol dehydrogenases lacking the catalytic zinc as well as the structural features inherent to thermostable enzymes.	[Vitale, Annalisa; Thorne, Natasha; Hu, Xin; Shen, Min; Auld, Douglas S.] Natl Ctr Adv Translat Sci, Bethesda, MD USA; [Vitale, Annalisa; D'Auria, Sabato] NRC, Inst Prot Biochem, Naples, Italy; [Lovell, Scott] Univ Kansas, Prot Struct Lab, Del Shankel Struct Biol Ctr, Lawrence, KS 66045 USA; [Battaile, Kevin P.] Hauptman Woodward Med Res Inst, Ind Macromol Crystallog Assoc Collaborat Access T, Argonne, IL USA	National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); University of Kansas; Hauptman Woodward Medical Research Institute	Auld, DS (corresponding author), Novartis Inst Biomed Res, Cambridge, MA 02139 USA.	douglas.auld@novartis.com		Battaile, Kevin/0000-0003-0833-3259	Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research; National Human Genome Research Institute, National Institutes of Health; Industrial Macromolecular Crystallography Association; Hauptman-Woodward Medical Research Institute; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; National Center for Research Resources [5P20RR017708-10]; National Institute of General Medical Sciences from the National Institutes of Health [8 P20 GM103420-10]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000002] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103420] Funding Source: NIH RePORTER	Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Industrial Macromolecular Crystallography Association; Hauptman-Woodward Medical Research Institute; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research and the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health. Use of the IMCA-CAT beamline 17-ID at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with Hauptman-Woodward Medical Research Institute. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. Use of the KU COBRE-PSF Protein Structure Laboratory was supported by grants from the National Center for Research Resources (5P20RR017708-10) and the National Institute of General Medical Sciences (8 P20 GM103420-10) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Auld DS, 2008, CELL MOL LIFE SCI, V65, P3961, DOI 10.1007/s00018-008-8593-1; Barzegar A, 2009, ENZYME MICROB TECH, V45, P73, DOI 10.1016/j.enzmictec.2009.04.007; Bergman T, 2008, CELL MOL LIFE SCI, V65, P4019, DOI 10.1007/s00018-008-8379-5; Bogin O, 1998, PROTEIN SCI, V7, P1156, DOI 10.1002/pro.5560070509; BUHNER M, 1969, EUR J BIOCHEM, V11, P73, DOI 10.1111/j.1432-1033.1969.tb00741.x; Burdette DS, 2002, APPL ENVIRON MICROB, V68, P1914, DOI 10.1128/AEM.68.4.1914-1918.2002; Case D, 2010, AMBER, V11; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; EKLUND H, 1976, J MOL BIOL, V102, P27, DOI 10.1016/0022-2836(76)90072-3; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esposito L, 2002, J MOL BIOL, V318, P463, DOI 10.1016/S0022-2836(02)00088-8; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fitz-Gibbon ST, 2002, P NATL ACAD SCI USA, V99, P984, DOI 10.1073/pnas.241636498; Hu X, 2012, BIOCHEMISTRY-US, V51, P1199, DOI 10.1021/bi200987b; Inglese J, 2007, NAT CHEM BIOL, V3, P466, DOI 10.1038/nchembio.2007.17; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; KAGI JHR, 1960, J BIOL CHEM, V235, P3188; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Korkhin Y, 1998, J MOL BIOL, V278, P967, DOI 10.1006/jmbi.1998.1750; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Littlechild JA, 2004, BIOCHEM SOC T, V32, P255, DOI 10.1042/BST0320255; Louie AY, 1998, P NATL ACAD SCI USA, V95, P6663, DOI 10.1073/pnas.95.12.6663; MARET W, 1979, EUR J BIOCHEM, V98, P501, DOI 10.1111/j.1432-1033.1979.tb13211.x; MARET W, 1989, BIOCHEMISTRY-US, V28, P9944, DOI 10.1021/bi00452a011; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Pennacchio A, 2008, APPL ENVIRON MICROB, V74, P3949, DOI 10.1128/AEM.00217-08; PERSSON B, 1991, EUR J BIOCHEM, V200, P537, DOI 10.1111/j.1432-1033.1991.tb16215.x; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Radianingtyas H, 2003, FEMS MICROBIOL REV, V27, P593, DOI 10.1016/S0168-6445(03)00068-8; READ RJ, 1988, J APPL CRYSTALLOGR, V21, P490, DOI 10.1107/S002188988800562X; Schlieben NH, 2005, J MOL BIOL, V349, P801, DOI 10.1016/j.jmb.2005.04.029; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shukla SJ, 2009, ASSAY DRUG DEV TECHN, V7, P143, DOI 10.1089/adt.2009.193; Simeonov A, 2008, J MED CHEM, V51, P2363, DOI 10.1021/jm701301m; Thorne N, 2010, CURR OPIN CHEM BIOL, V14, P315, DOI 10.1016/j.cbpa.2010.03.020; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Vitale A, 2010, GENE, V461, P26, DOI 10.1016/j.gene.2010.04.004; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	45	6	6	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e63828	10.1371/journal.pone.0063828	http://dx.doi.org/10.1371/journal.pone.0063828			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755111	gold, Green Published, Green Submitted			2022-12-27	WOS:000320579400006
J	Manojlovic, Z; Blackmon, J; Stefanovic, B				Manojlovic, Zarko; Blackmon, John; Stefanovic, Branko			Tacrolimus (FK506) Prevents Early Stages of Ethanol Induced Hepatic Fibrosis by Targeting LARP6 Dependent Mechanism of Collagen Synthesis	PLOS ONE			English	Article							ALPHA-1(I) MESSENGER-RNA; INDUCED LIVER FIBROSIS; STELLATE CELLS; CARBON-TETRACHLORIDE; CYCLOSPORINE-A; KUPFFER CELLS; IN-VIVO; NEUTROPHIL INFILTRATION; REPERFUSION INJURY; BINDING-PROTEIN	Tacrolimus (FK506) is a widely used immunosuppressive drug. Its effects on hepatic fibrosis have been controversial and attributed to immunosuppression. We show that in vitro FK506, inhibited synthesis of type I collagen polypeptides, without affecting expression of collagen mRNAs. In vivo, administration of FK506 at a dose of 4 mg/kg completely prevented development of alcohol/carbon tetrachloride induced liver fibrosis in rats. Activation of hepatic stellate cells (HSCs) was absent in the FK506 treated livers and expression of collagen alpha 2(I) mRNA was at normal levels. Collagen alpha 1(I) mRNA was increased in the FK506 treated livers, but this mRNA was not translated into alpha 1(I) polypeptide. No significant inflammation was associated with the fibrosis model used. FK506 binding protein 3 (FKBP3) is one of cellular proteins which binds FK506 with high affinity. We discovered that FKBP3 interacts with LARP6 and LARP6 is the major regulator of translation and stability of collagen mRNAs. In the presence of FK506 the interaction between FKBP3 and LARP6 is weakened and so is the pull down of collagen mRNAs with FKBP3. We postulate that FK506 inactivates FKBP3 and that lack of interaction of LARP6 and FKBP3 results in aberrant translation of collagen mRNAs and prevention of fibrosis. This is the first report of such activity of FK506 and may renew the interest in using this drug to alleviate hepatic fibrosis.	[Manojlovic, Zarko; Blackmon, John; Stefanovic, Branko] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Stefanovic, B (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA.	branko.stefanovic@med.fsu.edu			National Institutes of Health [5R01DK059466-08]; National Institute on Alcohol Abuse and Alcoholism, National Research Service Award [AA019845-01A1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F31AA019845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Alcohol Abuse and Alcoholism, National Research Service Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Funding: R01 National Institutes of Health 5R01DK059466-08 to BS, F31 National Institute on Alcohol Abuse and Alcoholism, National Research Service Award AA019845-01A1 to ZM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYCOCK RS, 1989, CONNECT TISSUE RES, V23, P19, DOI 10.3109/03008208909103901; BITTERMAN PB, 1991, CHEST, V99, pS81, DOI 10.1378/chest.99.3_Supplement.81S; Cai L, 2010, J MOL BIOL, V401, P564, DOI 10.1016/j.jmb.2010.06.057; Cai L, 2010, J MOL BIOL, V395, P309, DOI 10.1016/j.jmb.2009.11.020; Canbay A, 2004, HEPATOLOGY, V39, P273, DOI 10.1002/hep.20051; Cetinkale O, 1999, BURNS, V25, P105, DOI 10.1016/S0305-4179(98)00147-8; Challa AA, 2011, MOL CELL BIOL, V31, P3773, DOI 10.1128/MCB.05263-11; Cook RT, 1998, ALCOHOL CLIN EXP RES, V22, P1927, DOI 10.1097/00000374-199812000-00007; de Graaf IAM, 2010, NAT PROTOC, V5, P1540, DOI 10.1038/nprot.2010.111; Friedman S L, 1996, Prog Liver Dis, V14, P101; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97; Friedman SL, 2006, HEPATOLOGY, V43, pS82, DOI 10.1002/hep.20974; Friedman SL, 1999, ALCOHOL CLIN EXP RES, V23, P904, DOI 10.1097/00000374-199905000-00020; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; FRIZELL E, 1994, GASTROENTEROLOGY, V107, P492, DOI 10.1016/0016-5085(94)90176-7; GarciaCriado FJ, 1997, TRANSPLANTATION, V64, P594, DOI 10.1097/00007890-199708270-00008; Gotkin MG, 1997, MOL BIOL CELL, V8, P2617; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Guo MZ, 2002, ACTA PHARMACOL SIN, V23, P739; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Iwasaki K, 2007, DRUG METAB PHARMACOK, V22, P328, DOI 10.2133/dmpk.22.328; JIN YJ, 1992, J BIOL CHEM, V267, P10942; JIN YJ, 1993, P NATL ACAD SCI USA, V90, P7769, DOI 10.1073/pnas.90.16.7769; KAWANO K, 1994, EUR SURG RES, V26, P108, DOI 10.1159/000129325; Keeley EC, 2010, INT J BIOCHEM CELL B, V42, P535, DOI 10.1016/j.biocel.2009.10.014; KINO T, 1987, J ANTIBIOT, V40, P1256, DOI 10.7164/antibiotics.40.1256; Kivirikko KI, 1998, MATRIX BIOL, V16, P355, DOI 10.1016/S0945-053X(98)90008-7; Kondo H, 2004, J RHEUMATOL, V31, P243; Lamande SR, 1999, SEMIN CELL DEV BIOL, V10, P455, DOI 10.1006/scdb.1999.0317; Lieber CS, 2004, ALCOHOL, V34, P9, DOI 10.1016/j.alcohol.2004.07.008; Lindquist JN, 2004, J BIOL CHEM, V279, P23822, DOI 10.1074/jbc.M314060200; Makareeva E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001029; Manojlovic Z, 2012, RNA, V18, P321, DOI 10.1261/rna.030288.111; McCaughan GW, 2000, IMMUNOL REV, V174, P172, DOI 10.1034/j.1600-0528.2002.017420.x; MICHNICK SW, 1991, SCIENCE, V252, P836, DOI 10.1126/science.1709301; Nagano J, 2006, EUR RESPIR J, V27, P460, DOI 10.1183/09031936.06.00070705; Nieto N, 2006, HEPATOLOGY, V44, P1487, DOI 10.1002/hep.21427; Ochocka AM, 2009, FEBS LETT, V583, P621, DOI 10.1016/j.febslet.2009.01.009; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; PANDURO A, 1988, HEPATOLOGY, V8, P259, DOI 10.1002/hep.1840080212; Patsenker E, 2011, J HEPATOL, V55, P388, DOI 10.1016/j.jhep.2010.10.044; PUGIN J, 1993, P NATL ACAD SCI USA, V90, P2744, DOI 10.1073/pnas.90.7.2744; Ripley CR, 1997, EXP CELL RES, V236, P147, DOI 10.1006/excr.1997.3707; Sakuma S, 2000, BRIT J PHARMACOL, V130, P1655, DOI 10.1038/sj.bjp.0703472; Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; Shigeki TA, 2006, CLIN CHIM ACTA, V364, P33, DOI 10.1016/j.cca.2005.06.014; SIEGERS CP, 1982, AGENTS ACTIONS, V12, P743, DOI 10.1007/BF01965096; Stefanovic A, 2000, NUCLEIC ACIDS RES, V28, P641, DOI 10.1093/nar/28.2.641; Stefanovic B, 1999, MOL CELL BIOL, V19, P4334; Stefanovic B, 1997, MOL CELL BIOL, V17, P5201, DOI 10.1128/MCB.17.9.5201; Stefanovic B, 2003, J BIOL CHEM, V278, P927, DOI 10.1074/jbc.M209175200; STEINMANN B, 1991, LANCET, V337, P439, DOI 10.1016/0140-6736(91)91225-J; Stienstra R, 2011, HEPATOLOGY, V53, P1415, DOI 10.1002/hep.24258; Su GL, 2002, AM J PHYSIOL-GASTR L, V283, pG640, DOI 10.1152/ajpgi.00253.2001; SUZUKI S, 1993, TRANSPLANTATION, V55, P1265; Takeda Y, 2002, CIRCULATION, V105, P677, DOI 10.1161/hc0602.104675; Tunon MJ, 2003, BIOCHEM PHARMACOL, V66, P439, DOI 10.1016/S0006-2952(03)00288-0; Uchida J, 1998, JPN J PHARMACOL, V76, P39, DOI 10.1254/jjp.76.39; Weiskirchen R, 2005, METH MOLEC MED, V117, P99; WIEDERRECHT G, 1993, ANN NY ACAD SCI, V696, P9, DOI 10.1111/j.1749-6632.1993.tb17137.x; Yang WM, 2001, EMBO J, V20, P4814, DOI 10.1093/emboj/20.17.4814; YOUNES M, 1983, XENOBIOTICA, V13, P47, DOI 10.3109/00498258309052214; Zhang X, 2004, WORLD J GASTROENTERO, V10, P610, DOI 10.3748/wjg.v10.i4.610; Zimmermann M, 2009, CYTOTECHNOLOGY, V61, P145, DOI 10.1007/s10616-009-9246-4	66	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65897	10.1371/journal.pone.0065897	http://dx.doi.org/10.1371/journal.pone.0065897			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755290	Green Published, gold, Green Submitted			2022-12-27	WOS:000319872300097
J	Osgood, RS; Upham, BL; Hill, T; Helms, KL; Velmurugan, K; Babica, P; Bauer, AK				Osgood, Ross S.; Upham, Brad L.; Hill, Thomas, III; Helms, Katherine L.; Velmurugan, Kalpana; Babica, Pavel; Bauer, Alison K.			Polycyclic Aromatic Hydrocarbon-Induced Signaling Events Relevant to Inflammation and Tumorigenesis in Lung Cells Are Dependent on Molecular Structure	PLOS ONE			English	Article							JUNCTIONAL INTERCELLULAR COMMUNICATION; LIVER EPITHELIAL-CELLS; OBSTRUCTIVE PULMONARY-DISEASE; PROTEIN-KINASE PATHWAY; MOUSE LUNG; RAT-LIVER; TUMOR PROMOTION; TOBACCO-SMOKE; BUTYLATED HYDROXYTOLUENE; PHOSPHORYLATION SITES	Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous environmental and occupational toxicants, which are a major human health concern in the U.S. and abroad. Previous research has focused on the genotoxic events caused by high molecular weight PAHs, but not on non-genotoxic events elicited by low molecular weight PAHs. We used an isomeric pair of low molecular weight PAHs, namely 1-Methylanthracene (1-MeA) and 2-Methylanthracene (2-MeA), in which only 1-MeA possessed a bay-like region, and hypothesized that 1-MeA, but not 2-MeA, would affect non-genotoxic endpoints relevant to tumor promotion in murine C10 lung cells, a non-tumorigenic type II alveolar pneumocyte and progenitor cell type of lung adenocarcinoma. The non-genotoxic endpoints assessed were dysregulation of gap junction intercellular communication function and changes in the major pulmonary connexin protein, connexin 43, using fluorescent redistribution and immunoblots, activation of mitogen activated protein kinases (MAPK) using phosphospecific MAPK antibodies for immunoblots, and induction of inflammatory genes using quantitative RT-PCR. 2-MeA had no effect on any of the endpoints, but 1-MeA dysregulated gap junctional communication in a dose and time dependent manner, reduced connexin 43 protein expression, and altered membrane localization. 1-MeA also activated ERK1/2 and p38 MAP kinases. Inflammatory genes, such as cyclooxygenase 2, and chemokine ligand 2 (macrophage chemoattractant 2), were also upregulated in response to 1-MeA only. These results indicate a possible structure-activity relationship of these low molecular weight PAHs relevant to non-genotoxic endpoints of the promoting aspects of cancer. Therefore, our novel findings may improve the ability to predict outcomes for future studies with additional toxicants and mixtures, identify novel targets for biomarkers and chemotherapeutics, and have possible implications for future risk assessment for these PAHs.	[Osgood, Ross S.] Univ Colorado Anschutz, Med Ctr, Dept Pharmaceut Sci, Aurora, CO USA; [Hill, Thomas, III; Velmurugan, Kalpana; Bauer, Alison K.] Univ Colorado Anschutz, Med Ctr, Dept Environm & Occupat Hlth, Aurora, CO USA; [Upham, Brad L.; Helms, Katherine L.; Babica, Pavel] Michigan State Univ, Dept Pediat & Human Dev, E Lansing, MI 48824 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Michigan State University	Bauer, AK (corresponding author), Univ Colorado Anschutz, Med Ctr, Dept Environm & Occupat Hlth, Aurora, CO USA.	Alison.bauer@ucdenver.edu	Babica, Pavel/GWC-6437-2022; Babica, Pavel/B-2587-2013; Bauer, Alison/AHD-3288-2022; Bauer, Alison K./K-2372-2019	Babica, Pavel/0000-0001-6399-3554; Bauer, Alison/0000-0003-4477-9899; Upham, Brad/0000-0003-4905-9145; Hill III, Thomas/0000-0002-7507-7331	intramural Colorado School of Public Health, CU funds; NIEHS [ES013268-01A2]; Department of Pharmaceutical Sciences Toxicology Graduate Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013268, R56ES013268] Funding Source: NIH RePORTER	intramural Colorado School of Public Health, CU funds; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Department of Pharmaceutical Sciences Toxicology Graduate Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by intramural Colorado School of Public Health, CU funds (A.K.B.), NIEHS ES013268-01A2 (B.L.U.), and the Department of Pharmaceutical Sciences Toxicology Graduate Program (RSO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2003, J BIOL CHEM, V278, P38360, DOI 10.1074/jbc.M306785200; Allavena P, 2012, CLIN EXP IMMUNOL, V167, P195, DOI 10.1111/j.1365-2249.2011.04515.x; American Cancer Society, 2012, WHAT IS NONSM CELL L; ATSDR, 2005, TOX PROF POL HYDR; Avanzo JL, 2004, CARCINOGENESIS, V25, P1973, DOI 10.1093/carcin/bgh193; Bauer AK, 2009, VET PATHOL, V46, P369, DOI 10.1354/vp.08-VP-0217-B-REV; Bauer AK, 2004, AM J PHYSIOL-LUNG C, V287, pL685, DOI 10.1152/ajplung.00223.2003; Bauer AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026590; Bauer AK, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-107; BENLEVY R, 1995, EMBO J, V14, P5920, DOI 10.1002/j.1460-2075.1995.tb00280.x; Bernert H, 2003, MOL CARCINOGEN, V38, P117, DOI 10.1002/mc.10151; Blaha L, 2002, TOXICOL SCI, V65, P43, DOI 10.1093/toxsci/65.1.43; Brook M, 2000, FEBS LETT, V483, P57, DOI 10.1016/S0014-5793(00)02084-6; Caixeta Roberta B., 2012, Morbidity and Mortality Weekly Report, V61, P877; CHAUDHURI R, 1993, CANCER LETT, V71, P11, DOI 10.1016/0304-3835(93)90090-V; Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501; COHEN BH, 1977, LANCET, V2, P523; Duperron C, 1997, CARCINOGENESIS, V18, P1001, DOI 10.1093/carcin/18.5.1001; Dwyer-Nield LD, 2005, CARCINOGENESIS, V26, P1196, DOI 10.1093/carcin/bgi061; Eugenin EA, 2012, J NEUROIMMUNE PHARM, V7, P499, DOI 10.1007/s11481-012-9352-5; Feng FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051690; Fujino N, 2012, BMJ OPEN, P2; Ghoshal S, 1999, ENVIRON SCI TECHNOL, V33, P1044, DOI 10.1021/es9809511; Guadagni F, 2007, IN VIVO, V21, P147; GUAN X, 1995, CARCINOGENESIS, V16, P2575, DOI 10.1093/carcin/16.10.2575; Guan XJ, 1996, MOL CARCINOGEN, V16, P157; Hazelton WD, 2005, CANCER EPIDEM BIOMAR, V14, P1171, DOI 10.1158/1055-9965.EPI-04-0756; He Y, 2012, CHEST; Huang RC, 2002, CANCER RES, V62, P2806; Husoy T, 2001, CARCINOGENESIS, V22, P221, DOI 10.1093/carcin/22.2.221; Ito S, 2010, BIOCHEM BIOPH RES CO, V400, P230, DOI 10.1016/j.bbrc.2010.08.045; Ji HB, 2007, CANCER RES, V67, P4933, DOI 10.1158/0008-5472.CAN-06-4592; Johnson LN, 2009, ANTIOXID REDOX SIGN, V11, P355, DOI 10.1089/ars.2008.2183; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kisley LR, 2002, CANCER RES, V62, P6850; Klaunig JE, 2000, HUM EXP TOXICOL, V19, P543, DOI 10.1191/096032700701546442; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; Lee HL, 2010, CHEMOSPHERE, DOI [10.1016/j.chemosphere.2010.09.045, DOI 10.1016/J.CHEM0SPHERE.2010.09.045]; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lloyd CM, 2010, NAT MED, V16, P273, DOI 10.1038/nm0310-273; Malkinson AM, 1997, TOXICOLOGY, V123, P53, DOI 10.1016/S0300-483X(97)00108-X; Marin V, 2001, BLOOD, V98, P667, DOI 10.1182/blood.V98.3.667; Meyer AM, 2006, AM J PHYSIOL-LUNG C, V290, pL1260, DOI 10.1152/ajplung.00182.2005; Miller RL, 2004, CHEST, V126, P1071, DOI 10.1378/chest.126.4.1071; Moghaddam SJ, 2011, INT J CHRONIC OBSTR, V6, P113, DOI 10.2147/COPD.S15417; Moir D, 2008, CHEM RES TOXICOL, V21, P494, DOI 10.1021/tx700275p; MUSIL LS, 1991, J CELL BIOL, V115, P1357, DOI 10.1083/jcb.115.5.1357; Pahujaa M, 2007, EXP CELL RES, V313, P4083, DOI 10.1016/j.yexcr.2007.09.010; PALITTI F, 1986, MUTAT RES, V174, P125, DOI 10.1016/0165-7992(86)90102-8; Rice PL, 2010, EXP LUNG RES, V36, P558, DOI 10.3109/01902148.2010.491891; Rivedal E, 2001, CARCINOGENESIS, V22, P1543, DOI 10.1093/carcin/22.9.1543; Rondini EA, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-9; Rosenkranz M, 1997, MUTAT RES-FUND MOL M, V381, P171, DOI 10.1016/S0027-5107(97)00165-6; ROSZINSKYKOCHER G, 1979, MUTAT RES, V66, P65, DOI 10.1016/0165-1218(79)90008-9; Ruch RJ, 2001, J CELL BIOCHEM, V83, P163, DOI 10.1002/jcb.1227; Rummel AM, 1999, TOXICOL SCI, V49, P232, DOI 10.1093/toxsci/49.2.232; Schmeck B, 2004, J BIOL CHEM, V279, P53241, DOI 10.1074/jbc.M313702200; Schottenfeld D, 2000, LUNG CANC PRINCIPLES, P367; Services USDoHaH, 2002, TOX PROF WOOD CREOS, P225; Smith LA, 2010, IMMUNOL RES, V46, P94, DOI 10.1007/s12026-009-8133-6; Sorensen CM, 2012, MICROCIRCULATION, V19, P451, DOI 10.1111/j.1549-8719.2011.00149.x; Sung FL, 2001, MOL CELL BIOCHEM, V216, P121, DOI 10.1023/A:1017383916068; Tacheau C, 2008, J CELL PHYSIOL, V216, P438, DOI 10.1002/jcp.21412; Tai MH, 2007, INT J CANCER, V120, P1855, DOI 10.1002/ijc.22530; Thompson DC, 1998, AM J PHYSIOL-LUNG C, V274, pL922, DOI 10.1152/ajplung.1998.274.6.L922; Tithof PK, 2002, FASEB J, V16, P1463, DOI 10.1096/fj.02-0092fje; Tong QS, 2006, AM J RESP CELL MOL, V34, P28, DOI 10.1165/rcmb.2005-0172OC; Trosko JE, 2001, MOL CARCINOGEN, V30, P131; Trovato-Salinaro A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-122; UPHAM BL, 1994, FUND APPL TOXICOL, V23, P470, DOI 10.1006/faat.1994.1129; Upham BL, 1998, ENVIRON HEALTH PERSP, V106, P975, DOI 10.2307/3434140; Upham BL, 1996, FUND APPL TOXICOL, V34, P260, DOI 10.1006/faat.1996.0195; Upham BL, 2008, CANCER SCI, V99, P696, DOI 10.1111/j.1349-7006.2008.00752.x; Upham Brad L, 2011, Curr Protoc Toxicol, VChapter 2, DOI 10.1002/0471140856.tx0218s47; Upham BL, 2009, ENVIRON HEALTH PERSP, V117, P545, DOI 10.1289/ehp.11728; Van Laere S, 2010, CANCER-AM CANCER SOC, V116, P2794, DOI 10.1002/cncr.25180; VANG O, 1995, ARCH TOXICOL, V69, P415, DOI 10.1007/s002040050193; Walters DM, 2005, AM J PATHOL, V167, P1221, DOI 10.1016/S0002-9440(10)61210-2; Wan B, 2006, SAR QSAR ENVIRON RES, V17, P597, DOI 10.1080/10629360601033374; WarnCramer BJ, 1996, J BIOL CHEM, V271, P3779; WARSHAWSKY D, 1993, FUND APPL TOXICOL, V20, P376, DOI 10.1006/faat.1993.1048; Wattenberg LW, 1997, CARCINOGENESIS, V18, P2015, DOI 10.1093/carcin/18.10.2015; Weis LM, 1998, ENVIRON HEALTH PERSP, V106, P17, DOI 10.1289/ehp.9810617; Wilson KM, 2011, PEDIATRICS, V127, P85, DOI 10.1542/peds.2010-2046; Woodruff ML, 1999, AM J PHYSIOL-LUNG C, V276, pL669, DOI 10.1152/ajplung.1999.276.4.L669; WU AH, 1995, AM J EPIDEMIOL, V141, P1023, DOI 10.1093/oxfordjournals.aje.a117366; Yan ZP, 2000, J BIOL CHEM, V275, P4949, DOI 10.1074/jbc.275.7.4949; Yang SR, 2005, J VET MED SCI, V67, P291, DOI 10.1292/jvms.67.291	88	37	37	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65150	10.1371/journal.pone.0065150	http://dx.doi.org/10.1371/journal.pone.0065150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755184	Green Submitted, gold, Green Published			2022-12-27	WOS:000319872300052
J	Velders, MA; Hofma, SH; Brouwer, J; de Vries, CJ; Quere, M; van Boven, AJ				Velders, Matthijs A.; Hofma, Sjoerd H.; Brouwer, Jan; de Vries, Cees Jan; Quere, Michel; van Boven, Adrianus J.			Two-Year Results of an Open-Label Randomized Comparison of Everolimus-Eluting Stents and Sirolimus-Eluting Stents	PLOS ONE			English	Article							BARE-METAL STENTS; CORONARY STENTS; BIODEGRADABLE POLYMER; CONTROLLED-TRIAL; FOLLOW-UP; OUTCOMES; RESOLUTE; EFFICACY; SAFETY	Background: Second generation drug-eluting stents were developed to improve the safety and efficacy of first generation stents. So far, limited long term randomized data exist comparing the second generation everolimus-eluting stents (EES) with first generation sirolimus-eluting stents (SES). Methods: A prospective, open-label, randomized, single center trial comparing EES and SES in all-comer patients. The primary endpoint was a composite of cardiac mortality, myocardial infarction and target vessel revascularization. Secondary endpoints included individual components of the composite, along with target lesion revascularization and stent thrombosis. Results: In total, 977 patients were randomized, of which 498 patients to EES and 479 to SES. Average age was 65.2 +/- 11.2 years and 71.6% of the population was male. Fifty percent of patients were treated for acute coronary syndrome, more often for ST-elevation myocardial infarctions in EES patients (13.7% vs. 9.2% in SES). In contrast, SES patients more often had prior interventions and showed more calcified lesions. Two-year follow-up was available in 98% of patients. The primary endpoint occurred in 10.7% of EES patients compared to 10.6% of SES patients (HR 1.00, 95% CI 0.68-1.48). Additionally, secondary endpoints were similar between groups. The rate of stent thrombosis was low for both stent types. Conclusion: In this all-comer population, there were no differences in endpoints between EES and SES during two-year follow-up. Stent thrombosis rates were low, supporting the safety of drug-eluting stent appliance in clinical practice.	[Velders, Matthijs A.; Hofma, Sjoerd H.; Brouwer, Jan; de Vries, Cees Jan; Quere, Michel; van Boven, Adrianus J.] Med Ctr Leeuwarden, Leeuwarden, Netherlands; [Velders, Matthijs A.] Leiden Univ, Med Ctr, Leiden, Netherlands	Medical Center Leeuwarden; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Velders, MA (corresponding author), Med Ctr Leeuwarden, Leeuwarden, Netherlands.	m.a.velders@lumc.nl			Abbott Vascular	Abbott Vascular(Abbott Laboratories)	The Cardiology Research Foundation of the Medical Center Leeuwarden received a unrestricted research grant from Abbott Vascular. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Byrne RA, 2011, J AM COLL CARDIOL, V58, P1325, DOI 10.1016/j.jacc.2011.06.027; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Diletti R, 2012, AM HEART J, V164, P654, DOI 10.1016/j.ahj.2012.08.010; Hofma SH, 2012, J AM COLL CARDIOL, V60, P381, DOI 10.1016/j.jacc.2012.01.073; Jensen LO, 2012, J AM COLL CARDIOL, V60, P1140, DOI 10.1016/j.jacc.2012.07.004; Joner M, 2008, J AM COLL CARDIOL, V52, P333, DOI 10.1016/j.jacc.2008.04.030; Kimura T, 2012, CIRCULATION, V126, P1225, DOI 10.1161/CIRCULATIONAHA.112.104059; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; Park KW, 2011, J AM COLL CARDIOL, V58, P1844, DOI 10.1016/j.jacc.2011.07.031; Silber S, 2011, LANCET, V377, P1241, DOI 10.1016/S0140-6736(11)60395-4; Smits PC, 2011, J AM COLL CARDIOL, V58, P11, DOI 10.1016/j.jacc.2011.02.023; Stefanini GG, 2011, LANCET, V378, P1940, DOI 10.1016/S0140-6736(11)61672-3; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Stone GW, 2011, J AM COLL CARDIOL, V58, P19, DOI 10.1016/j.jacc.2011.02.022; von Birgelen C, 2012, J AM COLL CARDIOL, V59, P1350, DOI 10.1016/j.jacc.2012.01.008	16	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64424	10.1371/journal.pone.0064424	http://dx.doi.org/10.1371/journal.pone.0064424			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755123	Green Published, gold, Green Submitted			2022-12-27	WOS:000319872300018
J	Anderson, EL; Fraser, A; McNally, W; Sattar, N; Lashen, H; Fleming, R; Nelson, SM; Lawlor, DA				Anderson, Emma L.; Fraser, Abigail; McNally, William; Sattar, Naveed; Lashen, Hany; Fleming, Richard; Nelson, Scott M.; Lawlor, Debbie A.			Anti-Mullerian Hormone Is Not Associated with Cardiometabolic Risk Factors in Adolescent Females	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; INTIMA-MEDIA THICKNESS; INSULIN-RESISTANCE; CARDIOVASCULAR RISK; SERUM-LEVELS; WOMEN; AGE; AMH; ADULTHOOD; CHILDREN	Objectives: Epidemiological evidence for associations of Anti-Mullerian hormone (AMH) with cardiometabolic risk factors is lacking. Existing evidence comes from small studies in select adult populations, and findings are conflicting. We aimed to assess whether AMH is associated with cardiometabolic risk factors in a general population of adolescent females. Methods: AMH, fasting insulin, glucose, HDLc, LDLc, triglycerides and C-reactive protein (CRP) were measured at a mean age 15.5 years in 1,308 female participants in the Avon Longitudinal Study of Parents and Children (ALSPAC). Multivariable linear regression was used to examine associations of AMH with these cardiometabolic outcomes. Results: AMH values ranged from 0.16-35.84 ng/ml and median AMH was 3.57 ng/ml (IQR: 2.41, 5.49). For females classified as post-pubertal (n = 848) at the time of assessment median (IQR) AMH was 3.81 ng/ml (2.55, 5.82) compared with 3.25 ng/ml (2.23, 5.05) in those classed as early pubertal (n = 460, P <= 0.001). After adjusting for birth weight, gestational age, pubertal stage, age, ethnicity, socioeconomic position, adiposity and use of hormonal contraceptives, there were no associations with any of the cardiometabolic outcomes. For example fasting insulin changed by 0% per doubling of AMH (95% CI: -3%,+2%) p = 0.70, with identical results if HOMA-IR was used. Results were similar after additional adjustment for smoking, physical activity and age at menarche, after exclusion of 3% of females with the highest AMH values, after excluding those that had not started menarche and after excluding those using hormonal contraceptives. Conclusion: Our results suggest that in healthy adolescent females, AMH is not associated with cardiometabolic risk factors.	[Anderson, Emma L.; Fraser, Abigail; Lawlor, Debbie A.] Univ Bristol, MRC CAiTE Ctr, Bristol, Avon, England; [McNally, William; Fleming, Richard; Nelson, Scott M.] Univ Glasgow, Sch Med, Glasgow, Lanark, Scotland; [Sattar, Naveed] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Lashen, Hany] Univ Sheffield, Sect Reprod & Dev Med, Sheffield, S Yorkshire, England	University of Bristol; University of Glasgow; University of Glasgow; University of Sheffield	Anderson, EL (corresponding author), Univ Bristol, MRC CAiTE Ctr, Oakfield House, Bristol, Avon, England.	emma.louise.anderson@bristol.ac.uk	Lashen, Hany/A-6936-2008	Lashen, Hany/0000-0002-7219-3492; Anderson, Emma/0000-0002-1508-0598; Nelson, Scott/0000-0002-9099-3047; Fraser, Abigail/0000-0002-7741-9470; Lawlor, Debbie A/0000-0002-6793-2262	Glasgow Centre for Reproductive Medicine Ltd.; Wellcome Trust [WT087997, WT076467]; United States National Institutes of Health (NIH): National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK077659]; UK Medical Research Council (MRC) [G0600705]; UK MRC [G0600705, 0701594, G074882]; University of Bristol; MRC [G0600705, G0701594, MC_UU_12013/5] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077659] Funding Source: NIH RePORTER; Medical Research Council [1046610, G0701594, G0600705, MC_UU_12013/5] Funding Source: researchfish	Glasgow Centre for Reproductive Medicine Ltd.; Wellcome Trust(Wellcome TrustEuropean Commission); United States National Institutes of Health (NIH): National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bristol; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from Glasgow Centre for Reproductive Medicine Ltd., Wellcome Trust (Grant ref: WT087997) and United States National Institutes of Health (NIH): National Institute of Diabetes and Digestive and Kidney Diseases (Grant ref: R01 DK077659). EA is funded by a UK Medical Research Council (MRC) studentship (Grant ref: G0600705). AF is funded by a UK MRC research fellowship (Grant ref: 0701594). The UK MRC (Grant ref: G074882), the Wellcome Trust (Grant ref: WT076467) and the University of Bristol provide core funding support for ALSPAC. The UK MRC (Grant ref: G0600705) and the University of Bristol provide core funding for the MRC Centre of Causal Analyses in Translational Epidemiology. The views expressed in this paper are those of the authors and not necessarily those of any funding body or others whose support is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksglaede L, 2010, J CLIN ENDOCR METAB, V95, P5357, DOI 10.1210/jc.2010-1207; Appt SE, 2012, MENOPAUSE; Atsma F, 2006, MENOPAUSE, V13, P265, DOI 10.1097/01.gme.0000218683.97338.ea; Bayrak A, 2007, FERTIL STERIL, V87, P870, DOI 10.1016/j.fertnstert.2006.08.096; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Blanck HM, 2000, EPIDEMIOLOGY, V11, P641, DOI 10.1097/00001648-200011000-00005; Boyd A., 2012, INT J EPIDEMIOLOGY, DOI 10.1093/ije/dys064; Buyuk E, 2011, FERTIL STERIL, V95, P2364, DOI 10.1016/j.fertnstert.2011.03.081; Chen MJ, 2008, HUM REPROD, V23, P952, DOI 10.1093/humrep/den015; Chu MC, 2003, HUM REPROD, V18, P1570, DOI 10.1093/humrep/deg330; Codner E, 2011, CLIN ENDOCRINOL, V74, P73, DOI 10.1111/j.1365-2265.2010.03887.x; Fleming R, 2012, FERTIL STERIL, V98, P1097, DOI 10.1016/j.fertnstert.2012.07.1114; Fraser A, 2012, INT J EPIDEMIOLOGY; Freeman EW, 2007, FERTIL STERIL, V87, P101, DOI 10.1016/j.fertnstert.2006.05.074; Freour T, 2008, REPROD BIOMED ONLINE, V16, P96, DOI 10.1016/S1472-6483(10)60561-5; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gladen BC, 2000, J PEDIATR-US, V136, P490, DOI 10.1016/S0022-3476(00)90012-X; Gungor N, 2004, J PEDIATR-US, V144, P47, DOI 10.1016/j.jpeds.2003.09.045; Hagen CP, 2012, HUM REPROD, V27, P861, DOI 10.1093/humrep/der435; Hagen CP, 2010, J CLIN ENDOCR METAB, V95, P5003, DOI 10.1210/jc.2010-0930; Hansen KR, 2011, FERTIL STERIL, V95, P170, DOI 10.1016/j.fertnstert.2010.04.006; Hart R, 2010, FERTIL STERIL, V94, P1118, DOI 10.1016/j.fertnstert.2009.11.002; Hehenkamp WJK, 2007, HUM REPROD, V22, P1996, DOI 10.1093/humrep/dem105; Hergenroeder AC, 1999, J ADOLESCENT HEALTH, V24, P201, DOI 10.1016/S1054-139X(98)00110-4; Hickey M, 2011, HUM REPROD, V26, P1469, DOI 10.1093/humrep/der102; Hu FB, 1999, ARCH INTERN MED, V159, P1061, DOI 10.1001/archinte.159.10.1061; Johnstone EB, 2010, J CLIN ENDOCR METAB, V95, P4965, DOI 10.1210/jc.2010-0202; Juonala M, 2010, CIRCULATION, V122, P2514, DOI 10.1161/CIRCULATIONAHA.110.966465; Kelsey TW, 2012, MOL HUM REPROD, V18, P79, DOI 10.1093/molehr/gar059; Kelsey TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022024; Kerkhof GF, 2010, EUR J ENDOCRINOL, V163, P937, DOI 10.1530/EJE-10-0528; La Marca A, 2004, FERTIL STERIL, V82, P970, DOI 10.1016/j.fertnstert.2004.06.001; La Marca A, 2012, EUR J OBSTET GYN R B, V163, P180, DOI 10.1016/j.ejogrb.2012.04.013; Lawlor DA, 2010, BMJ, V341; Levy-Marchal C, 2010, J CLIN ENDOCR METAB, V95, P5189, DOI 10.1210/jc.2010-1047; Lin YH, 2011, FERTIL STERIL, V96, P230, DOI 10.1016/j.fertnstert.2011.04.003; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; Mattocks C, 2008, J PHYS ACT HEALTH, V5, pS98, DOI 10.1123/jpah.5.s1.s98; McCarron P, 2000, LANCET, V355, P1430, DOI 10.1016/S0140-6736(00)02146-2; MORRIS NM, 1980, J YOUTH ADOLESCENCE, V9, P271, DOI 10.1007/BF02088471; Nardo LG, 2009, HUM REPROD, V24, P2917, DOI 10.1093/humrep/dep225; Nelson SM, 2010, FERTIL STERIL, V93, P1356, DOI 10.1016/j.fertnstert.2009.07.1676; Palomba S, 2009, ENDOCR REV, V30, P1, DOI 10.1210/er.2008-0030; Park HT, 2010, CLIN ENDOCRINOL, V72, P26, DOI 10.1111/j.1365-2265.2009.03614.x; Piouka A, 2009, AM J PHYSIOL-ENDOC M, V296, pE238, DOI 10.1152/ajpendo.90684.2008; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Riddoch CJ, 2007, ARCH DIS CHILD, V92, P963, DOI 10.1136/adc.2006.112136; Rockett JC, 2004, ENVIRON HEALTH PERSP, V112, P105, DOI 10.1289/ehp.6265; Schwartz B, 2008, DIABETES CARE, V31, P783, DOI 10.2337/dc07-1376; Sir-Petermann T, 2006, J CLIN ENDOCR METAB, V91, P3105, DOI 10.1210/jc.2005-2693; Skalba P, 2011, EUR J OBSTET GYN R B, V158, P254, DOI 10.1016/j.ejogrb.2011.06.006; Steiner AZ, 2010, CONTRACEPTION, V81, P245, DOI 10.1016/j.contraception.2009.10.004; Strong JP, 1999, JAMA-J AM MED ASSOC, V281, P727, DOI 10.1001/jama.281.8.727; Thomson RL, 2009, HUM REPROD, V24, P1976, DOI 10.1093/humrep/dep101; van Rooij Ilse A J, 2004, Menopause, V11, P601, DOI 10.1097/01.GME.0000123642.76105.6E; vanderSchouw YT, 1996, LANCET, V347, P714, DOI 10.1016/S0140-6736(96)90075-6; Villarroel C, 2011, HUM REPROD, V26, P2861, DOI 10.1093/humrep/der223; Wallace AM, 2011, ANN CLIN BIOCHEM, V48, P370, DOI 10.1258/acb.2011.010172; Woo HY, 2012, ENDOCR J, V59, P781, DOI 10.1507/endocrj.EJ12-0055	59	26	29	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64510	10.1371/journal.pone.0064510	http://dx.doi.org/10.1371/journal.pone.0064510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23762215	Green Published, gold, Green Accepted			2022-12-27	WOS:000319799900046
J	Labrecque, P; Roy, SJ; Frechette, L; Iorio-Morin, C; Gallant, MA; Parent, JL				Labrecque, Pascale; Roy, Sebastien J.; Frechette, Louis; Iorio-Morin, Christian; Gallant, Maxime A.; Parent, Jean-Luc			Inverse Agonist and Pharmacochaperone Properties of MK-0524 on the Prostanoid DP1 Receptor	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; PROSTAGLANDIN D-2 RECEPTOR; PHARMACOLOGICAL CHAPERONE ACTION; BETA(2) ADRENERGIC-RECEPTOR; PARATHYROID-HORMONE PTH; ENDOPLASMIC-RETICULUM; DRUG DISCOVERY; HYPOGONADOTROPIC HYPOGONADISM; INTRACELLULAR TRAFFICKING; FUNCTIONAL SELECTIVITY	Prostaglandin D-2 (PGD(2)) acts through two G protein-coupled receptors (GPCRs), the prostanoid DP receptor and CRTH2 also known as DP1 and DP2, respectively. Several previously characterized GPCR antagonists are now classified as inverse agonists and a number of GPCR ligands are known to display pharmacochaperone activity towards a given receptor. Here, we demonstrate that a DP1 specific antagonist, MK-0524 (also known as laropiprant), decreased basal levels of intracellular cAMP produced by DP1, a G alpha(s)-coupled receptor, in HEK293 cells. This reduction in cAMP levels was not altered by pertussis toxin treatment, indicating that MK-0524 did not induce coupling of DP1 to G alpha(i/o) proteins and that this ligand is a DP1 inverse agonist. Basal ERK1/2 activation by DP1 was not modulated by MK-0524. Interestingly, treatment of HEK293 cells expressing Flag-tagged DP1 with MK-0524 promoted DP1 cell surface expression time-dependently to reach a maximum increase of 50% compared to control after 24 h. In contrast, PGD(2) induced the internalization of 75% of cell surface DP1 after the same time of stimulation. The increase in DP1 cell surface targeting by MK-0524 was inhibited by Brefeldin A, an inhibitor of transport from the endoplasmic reticulum-Golgi to the plasma membrane. Confocal microscopy confirmed that a large population of DP1 remained trapped intracellularly and co-localized with calnexin, an endoplasmic reticulum marker. Redistribution of DP1 from intracellular compartments to the plasma membrane was observed following treatment with MK-0524 for 24 h. Furthermore, MK-0524 promoted the interaction between DP1 and the ANKRD13C protein, which we showed previously to display chaperone-like effects towards the receptor. We thus report that MK-0524 is an inverse agonist and a pharmacochaperone of DP1. Our findings may have important implications during therapeutic treatments with MK-0524 and for the development of new molecules targeting DP1.	[Labrecque, Pascale; Roy, Sebastien J.; Frechette, Louis; Iorio-Morin, Christian; Gallant, Maxime A.; Parent, Jean-Luc] Univ Sherbrooke, Dept Med, Sherbrooke, PQ J1K 2R1, Canada; [Labrecque, Pascale; Roy, Sebastien J.; Frechette, Louis; Iorio-Morin, Christian; Gallant, Maxime A.; Parent, Jean-Luc] Ctr Rech Clin Etienne Le Bel, Sherbrooke, PQ, Canada; [Labrecque, Pascale; Roy, Sebastien J.; Frechette, Louis; Iorio-Morin, Christian; Gallant, Maxime A.; Parent, Jean-Luc] Inst Pharmacol Sherbrooke, Sherbrooke, PQ, Canada	University of Sherbrooke	Parent, JL (corresponding author), Univ Sherbrooke, Dept Med, Sherbrooke, PQ J1K 2R1, Canada.	Jean-Luc.Parent@USherbrooke.ca	Iorio-Morin, Christian/I-8696-2019; Fréchette, Luc G./AAF-2042-2020	Iorio-Morin, Christian/0000-0003-2995-7255; Fréchette, Luc G./0000-0001-7138-0811	Canadian Institutes of Health Research [MOP184095]; Fonds de la Recherche en Sante du Quebec; Institut de Pharmacologie de Sherbrooke/Centre de Recherche en Inflammation de l'Universite de Sherbrroke	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Institut de Pharmacologie de Sherbrooke/Centre de Recherche en Inflammation de l'Universite de Sherbrroke	This work was supported by a grant from the Canadian Institutes of Health Research No MOP184095 to JLP. CIM and SJR received a PhD scholarships from the Fonds de la Recherche en Sante du Quebec and Institut de Pharmacologie de Sherbrooke/Centre de Recherche en Inflammation de l'Universite de Sherbrroke, respectively, during this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVING K, 1991, ACTA PHYSIOL SCAND, V143, P93, DOI 10.1111/j.1748-1716.1991.tb09204.x; Andersson H, 2003, MOL PHARMACOL, V64, P570, DOI 10.1124/mol.64.3.570; Arai I, 2004, EUR J PHARMACOL, V505, P229, DOI 10.1016/j.ejphar.2004.10.031; Arai I, 2007, EUR J PHARMACOL, V556, P207, DOI 10.1016/j.ejphar.2006.10.064; Arakawa T, 2006, BBA-PROTEINS PROTEOM, V1764, P1677, DOI 10.1016/j.bbapap.2006.08.012; Arimura A, 2001, J PHARMACOL EXP THER, V298, P411; Audet N, 2005, J BIOL CHEM, V280, P7808, DOI 10.1074/jbc.M411695200; Baker JG, 2003, MOL PHARMACOL, V64, P1357, DOI 10.1124/mol.64.6.1357; Bernier V, 2004, CURR OPIN PHARMACOL, V4, P528, DOI 10.1016/j.coph.2004.08.001; Bernier V, 2004, MOL ENDOCRINOL, V18, P2074, DOI 10.1210/me.2004-0080; Bhattacherjee P, 1996, EXP EYE RES, V62, P491, DOI 10.1006/exer.1996.0059; BOIE Y, 1995, J BIOL CHEM, V270, P18910, DOI 10.1074/jbc.270.32.18910; Bond RA, 2006, TRENDS PHARMACOL SCI, V27, P92, DOI 10.1016/j.tips.2005.12.007; Bosier B, 2007, TRENDS PHARMACOL SCI, V28, P438, DOI 10.1016/j.tips.2007.06.001; Canals M, 2009, BIOCHEM J, V417, P161, DOI 10.1042/BJ20081227; CASTELEIJN E, 1988, BIOCHEM J, V250, P77, DOI 10.1042/bj2500077; Charest PG, 2007, CELL SIGNAL, V19, P32, DOI 10.1016/j.cellsig.2006.05.020; Chiba T, 2006, INT ARCH ALLERGY IMM, V141, P300, DOI 10.1159/000095436; Conn PM, 2006, MOL ENDOCRINOL, V20, P3035, DOI 10.1210/me.2006-0066; Conn PM, 2006, J ENDOCRINOL, V190, P13, DOI 10.1677/joe.1.06771; COSTA T, 1989, P NATL ACAD SCI USA, V86, P7321, DOI 10.1073/pnas.86.19.7321; Crider JY, 1999, BRIT J PHARMACOL, V127, P204, DOI 10.1038/sj.bjp.0702490; DARIUS H, 1994, EUR J PHARMACOL, V258, P207, DOI 10.1016/0014-2999(94)90482-0; Durand M, 2008, J BONE MINER RES, V23, P1097, DOI [10.1359/jbmr.080228, 10.1359/JBMR.080228]; Evanko DS, 2000, J BIOL CHEM, V275, P1327, DOI 10.1074/jbc.275.2.1327; FISHBURN CS, 1995, J BIOL CHEM, V270, P29819; FORSTERMANN U, 1985, PROSTA LEUKOTR MED, V18, P301, DOI 10.1016/0262-1746(85)90062-9; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; Galandrin S, 2006, MOL PHARMACOL, V70, P1575, DOI 10.1124/mol.106.026716; Gallant MA, 2005, J BONE MINER RES, V20, P672, DOI 10.1359/JBMR.041211; Gallant MA, 2007, EUR J PHARMACOL, V557, P115, DOI 10.1016/j.ejphar.2006.11.058; Gallant MA, 2010, J RHEUMATOL, V37, P644, DOI 10.3899/jrheum.090622; Gardella TJ, 1996, ENDOCRINOLOGY, V137, P3936, DOI 10.1210/en.137.9.3936; Gbahou F, 2003, P NATL ACAD SCI USA, V100, P11086, DOI 10.1073/pnas.1932276100; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; GILES H, 1989, BRIT J PHARMACOL, V96, P291, DOI 10.1111/j.1476-5381.1989.tb11816.x; Greasley PJ, 2006, EUR J PHARMACOL, V553, P1, DOI 10.1016/j.ejphar.2006.09.032; Grisaru-Granovsky S, 2010, J PERINATOL, V30, P33, DOI 10.1038/jp.2009.127; Hamelin E, 2005, J BIOL CHEM, V280, P36195, DOI 10.1074/jbc.M503438200; HAMIDBLOOMFIELD S, 1989, BRIT J PHARMACOL, V96, P307, DOI 10.1111/j.1476-5381.1989.tb11818.x; Hammad H, 2007, J EXP MED, V204, P357, DOI 10.1084/jem.20061196; HARDY CC, 1984, NEW ENGL J MED, V311, P209, DOI 10.1056/NEJM198407263110401; Hayaishi O, 2002, NEUROSCIENTIST, V8, P12, DOI 10.1177/107385840200800105; Hirai H, 2001, J EXP MED, V193, P255, DOI 10.1084/jem.193.2.255; HIRATA M, 1994, P NATL ACAD SCI USA, V91, P11192, DOI 10.1073/pnas.91.23.11192; Ishizuka T, 2004, CARDIOVASC DRUG REV, V22, P71; Janovick JA, 2002, J CLIN ENDOCR METAB, V87, P3255, DOI 10.1210/jc.87.7.3255; Jean-Alphonse F, 2009, J AM SOC NEPHROL, V20, P2190, DOI 10.1681/ASN.2008121289; Jones RL, 2009, BRIT J PHARMACOL, V158, P104, DOI 10.1111/j.1476-5381.2009.00317.x; Kabashima K, 2003, PROSTAG LEUKOTR ESS, V69, P187, DOI 10.1016/S0952-3278(03)00080-2; Kenakin T, 2004, MOL PHARMACOL, V65, P2, DOI 10.1124/mol.65.1.2; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Lai E, 2007, CLIN PHARMACOL THER, V81, P849, DOI 10.1038/sj.clpt.6100180; Leanos-Miranda A, 2005, J CLIN ENDOCR METAB, V90, P3001, DOI 10.1210/jc.2004-2071; Leff P, 1997, TRENDS PHARMACOL SCI, V18, P355, DOI 10.1016/S0165-6147(97)90664-7; Leurs R, 2002, CLIN EXP ALLERGY, V32, P489, DOI 10.1046/j.0954-7894.2002.01314.x; Liu YJ, 1996, EUR J PHARMACOL, V304, P117, DOI 10.1016/0014-2999(96)00129-X; Lu M, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-34; Lu M, 2003, TRAFFIC, V4, P416, DOI 10.1034/j.1600-0854.2003.00097.x; Luttrell LM, 2010, PHARMACOL REV, V62, P305, DOI 10.1124/pr.109.002436; Maicas N, 2012, ARTHRITIS RHEUM-US, V64, P130, DOI 10.1002/art.30656; Malaga-Dieguez L, 2010, MOL PHARMACOL, V77, P940, DOI 10.1124/mol.110.063511; Mathurin K, 2011, J BIOL CHEM, V286, P2696, DOI 10.1074/jbc.M110.178277; MATSUGI T, 1995, EUR J PHARMACOL, V275, P245, DOI 10.1016/0014-2999(94)00788-9; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; Milligan G, 2003, MOL PHARMACOL, V64, P1271, DOI 10.1124/mol.64.6.1271; Murata T, 2013, P NATL ACAD SCI USA, V110, P5205, DOI 10.1073/pnas.1218091110; Nagata K, 2003, PROSTAG LEUKOTR ESS, V69, P169, DOI 10.1016/S0952-3278(03)00078-4; NARUMIYA S, 1985, BRIT J PHARMACOL, V85, P367, DOI 10.1111/j.1476-5381.1985.tb08870.x; Nelson CP, 2007, BIOCHEM PHARMACOL, V73, P737, DOI 10.1016/j.bcp.2006.09.005; Parent A, 2010, J BIOL CHEM, V285, P40838, DOI 10.1074/jbc.M110.142257; Parent JL, 2001, J BIOL CHEM, V276, P7079, DOI 10.1074/jbc.M009375200; Parent JL, 1999, J BIOL CHEM, V274, P8941, DOI 10.1074/jbc.274.13.8941; Parra S, 2007, CURR OPIN PHARMACOL, V7, P146, DOI 10.1016/j.coph.2006.10.005; Perez DM, 2005, PHARMACOL REV, V57, P147, DOI 10.1124/pr.57.2.2; Petaja-Repo UE, 2002, EMBO J, V21, P1628, DOI 10.1093/emboj/21.7.1628; Petaja-Repo UE, 2001, J BIOL CHEM, V276, P4416, DOI 10.1074/jbc.M007151200; Philip G, 2009, J ALLERGY CLIN IMMUN, V124, P942, DOI 10.1016/j.jaci.2009.07.006; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Roy SJ, 2010, EUR J PHARMACOL, V630, P10, DOI 10.1016/j.ejphar.2009.12.022; Sawyer N, 2002, BRIT J PHARMACOL, V137, P1163, DOI 10.1038/sj.bjp.0704973; Shapiro DA, 2003, NEUROPSYCHOPHARMACOL, V28, P1400, DOI 10.1038/sj.npp.1300203; Sharif NA, 2000, J PHARMACOL EXP THER, V293, P321; Sneddon WB, 2004, ENDOCRINOLOGY, V145, P2815, DOI 10.1210/en.2003-1185; Sturino CF, 2007, J MED CHEM, V50, P794, DOI 10.1021/jm0603668; Sturzebecher S, 1989, Prog Clin Biol Res, V301, P365; Sugimoto M, 2007, EUR J PHARMACOL, V564, P196, DOI 10.1016/j.ejphar.2007.01.080; TRIST DG, 1989, BRIT J PHARMACOL, V96, P301, DOI 10.1111/j.1476-5381.1989.tb11817.x; Trivedi RR, 2012, BIOCHEM BIOPH RES CO, V427, P185, DOI 10.1016/j.bbrc.2012.09.040; Ulloa-Aguirre A, 2004, TRAFFIC, V5, P821, DOI 10.1111/j.1600-0854.2004.00232.x; Ulloa-Aguirre A, 2009, FRONT BIOSCI-LANDMRK, V14, P973, DOI 10.2741/3290; Werry TD, 2005, J NEUROCHEM, V93, P1603, DOI 10.1111/j.1471-4159.2005.03161.x; Woodward DF, 2011, PHARMACOL REV, V63, P471, DOI 10.1124/pr.110.003517; Wright DH, 1998, BRIT J PHARMACOL, V123, P1317; Wuller S, 2004, J BIOL CHEM, V279, P47254, DOI 10.1074/jbc.M408154200; Yue L, 2012, BONE, V51, P338, DOI 10.1016/j.bone.2012.06.003	97	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65767	10.1371/journal.pone.0065767	http://dx.doi.org/10.1371/journal.pone.0065767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762421	Green Submitted, gold, Green Published			2022-12-27	WOS:000320440500050
J	Ma, JJ; Tian, L; Cheng, J; Chen, ZW; Xu, B; Wang, LW; Li, CY; Huang, Q				Ma, Jingjing; Tian, Ling; Cheng, Jin; Chen, Zhiwei; Xu, Bing; Wang, Liwei; Li, Chuanyuan; Huang, Qian			Sonic Hedgehog Signaling Pathway Supports Cancer Cell Growth during Cancer Radiotherapy	PLOS ONE			English	Article							REPOPULATION; PROLIFERATION; ACTIVATION; RADIATION; BLOCKADE; THERAPY	Tumor growth after radiotherapy is a commonly recognized cause of therapeutic failure. In this way, we examined tumor cell growth after radiotherapy by establishing a cancer cell growth model in vitro. We accomplished this model by seeding non-irradiated firefly luciferase2 and green fluorescent protein fusion gene (Fluc) labeled living cancer reporter cells onto a feeder layer of irradiated cancer cells. The living tumor cell growth was monitored by bioluminescence imaging. The living reporter cells grew faster when seeded onto lethally irradiated feeder cells than when seeded onto non-irradiated feeder cells or when seeded in the absence of feeder cells. We found that the expression levels of the Shh and Gli1 proteins, both of which are critical proteins in Sonic hedgehog (SHH) signaling, were increased after irradiation and that this expression was positively correlated with reporter cell growth. Moreover, the dying cell stimulation of living tumor cell growth was enhanced by the addition of SHH signaling agonists and inhibited by SHH signaling antagonists. SHH agonists also enhanced reporter cell growth in the absence of irradiated feeder cells, suggesting this mechanism plays a role in feeder cell growth stimulation. Given these results, we conclude that SHH signaling activation plays an important role during tumor repopulation after radiotherapy.	[Ma, Jingjing; Tian, Ling; Cheng, Jin; Huang, Qian] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 1, Expt Res Ctr, Shanghai 200030, Peoples R China; [Chen, Zhiwei; Xu, Bing] Shanghai Jiao Tong Univ, Sch Med, Dept Radiat Oncol, Peoples Hosp 1, Shanghai 200030, Peoples R China; [Wang, Liwei] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 1, Dept Oncol & Lab Pancreat Dis, Shanghai 200030, Peoples R China; [Li, Chuanyuan] Duke Univ, Med Ctr, Dept Dermatol, Durham, NC 27706 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Duke University	Li, CY (corresponding author), Duke Univ, Med Ctr, Dept Dermatol, Durham, NC 27706 USA.	chuan.li@duke.edu; qhuang2007@gmail.com	Li, Chuan-Yuan/H-4148-2013		National Natural Science Foundation [81120108017, 81172030]; National Basic Research Program of China [2010CB529902]; United States National Cancer Institute [CA131408, CA136748, CA155270]; NATIONAL CANCER INSTITUTE [R01CA131408, R01CA136748, R01CA155270] Funding Source: NIH RePORTER	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); United States National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants from National Natural Science Foundation (81120108017, 81172030) and National Basic Research Program of China (2010CB529902) (to Q Huang and L Tian) and in part by grants from the United States National Cancer Institute (CA131408, CA136748, CA155270)(to C-Y Li). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brade AM, 2006, J CLIN ONCOL, V24, P1020, DOI 10.1200/JCO.2005.04.9676; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Feldmann G, 2008, GUT, V57, P1420, DOI 10.1136/gut.2007.148189; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Hu WG, 2007, ACTA PHARMACOL SIN, V28, P1224, DOI 10.1111/j.1745-7254.2007.00620.x; Huang Q, 2011, NAT MED, V17, P860, DOI 10.1038/nm.2385; Jimeno A, 2009, MOL CANCER THER, V8, P310, DOI 10.1158/1535-7163.MCT-08-0924; Kelleher FC, 2011, CARCINOGENESIS, V32, P445, DOI 10.1093/carcin/bgq280; Kim JJ, 2005, NAT REV CANCER, V5, P516, DOI 10.1038/nrc1650; Li F, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000634; Merchant AA, 2010, CLIN CANCER RES, V16, P3130, DOI 10.1158/1078-0432.CCR-09-2846; Metcalfe C, 2011, CANCER RES, V71, P5057, DOI 10.1158/0008-5472.CAN-11-0923; Moraes RC, 2007, DEVELOPMENT, V134, P1231, DOI 10.1242/dev.02797; Nishioka T, 2011, CELL STRUCT FUNCT, V36, P13, DOI 10.1247/csf.10008; Pazzaglia S, 2002, ONCOGENE, V21, P7580, DOI 10.1038/sj.onc.1205973; Rodova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046083; Rohatgi R, 2009, P NATL ACAD SCI USA, V106, P3196, DOI 10.1073/pnas.0813373106; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Ryoo HD, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008797; Shin K, 2011, NATURE, V472, P110, DOI 10.1038/nature09851; Sims-Mourtada J, 2006, CLIN CANCER RES, V12, P6565, DOI 10.1158/1078-0432.CCR-06-0176; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; WITHERS HR, 1988, ACTA ONCOL, V27, P131, DOI 10.3109/02841868809090333	25	15	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65032	10.1371/journal.pone.0065032	http://dx.doi.org/10.1371/journal.pone.0065032			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762282	Green Published, gold, Green Submitted			2022-12-27	WOS:000320440500020
J	Bonato, FOB; Lemos, MM; Cassiolato, JL; Canziani, MEF				Bastos Bonato, Fabiana Oliveira; Lemos, Marcelo Montebello; Cassiolato, Jose Luiz; Fernandes Canziani, Maria Eugenia			Prevalence of Ventricular Arrhythmia and Its Associated Factors in Nondialyzed Chronic Kidney Disease Patients	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; HEART-RATE-VARIABILITY; STAGE RENAL-DISEASE; HEMODIALYSIS-PATIENTS; VASCULAR CALCIFICATION; CORONARY CALCIFICATION; PARATHYROID-HORMONE; GENDER-DIFFERENCES; RISK-FACTORS; HEMOGLOBIN	Background and Objectives: Sudden cardiac death is the most common cause of mortality in chronic kidney disease patients, and it occurs mostly due to ventricular arrhythmias. In this study, we aimed at investigating the prevalence of ventricular arrhythmia and the factors associated with its occurrence in nondialyzed chronic kidney disease patients. Design, Setting, Participants and Measurements: This cross-sectional study evaluated 111 chronic kidney disease patients (estimated glomerular filtration rate 34.7 +/- 16.1 mL/min/1.73 m(2), 57 +/- 11.4 years, 60% male, 24% diabetics). Ventricular arrhythmia was assessed by 24-hour electrocardiogram. Left ventricular hypertrophy (echocardiogram), 24-hour ambulatory blood pressure monitoring, and coronary artery calcification (multi-slice computed tomography) and laboratory parameters were also evaluated. Results: Ventricular arrhythmia was found in 35% of the patients. Non-controlled hypertension was observed in 21%, absence of systolic decency in 29%, left ventricular hypertrophy in 27%, systolic dysfunction in 10%, and coronary artery calcification in 49%. Patients with ventricular arrhythmia were older (p<0.001), predominantly men (p = 0.009), had higher estimated glomerular filtration rate (p = 0.03) and hemoglobin (p = 0.005), and lower intact parathyroid hormone (p = 0.024) and triglycerides (p = 0.011) when compared to patients without ventricular arrhythmia. In addition, a higher left ventricular mass index (p = 0.002) and coronary calcium score (p = 0.002), and a lower ejection fraction (p = 0.001) were observed among patients with ventricular arrhythmia. In the multiple logistic regression analysis, aging, increased hemoglobin levels and reduced ejection fraction were independently related to the presence of ventricular arrhythmia. Conclusions: Ventricular arrhythmia is prevalent in nondialyzed chronic kidney disease patients. Age, hemoglobin levels and ejection fraction were the factors associated with ventricular arrhythmia in these patients.	[Bastos Bonato, Fabiana Oliveira; Lemos, Marcelo Montebello; Fernandes Canziani, Maria Eugenia] Univ Fed Sao Paulo, Dept Internal Med, Div Nephrol, Sao Paulo, Brazil; [Cassiolato, Jose Luiz] Cardiol Res Inst, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Canziani, MEF (corresponding author), Univ Fed Sao Paulo, Dept Internal Med, Div Nephrol, Sao Paulo, Brazil.	dialisefor@uol.com.br	Canziani, Maria E F/AGI-3240-2022; Bonato, Fabiana O Bastos/K-1253-2014	Bonato, Fabiana O Bastos/0000-0003-1566-4224				AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Barreto DV, 2005, KIDNEY INT, V67, P1576, DOI 10.1111/j.1523-1755.2005.00239.x; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; BIGGER JT, 1984, CIRCULATION, V69, P250, DOI 10.1161/01.CIR.69.2.250; Bleyer AJ, 2006, KIDNEY INT, V69, P2268, DOI 10.1038/sj.ki.5000446; Busari O, 2010, CARDIOL J, V17, P281; Canziani M E, 1993, Perit Dial Int, V13 Suppl 2, pS409; Chen SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060008; Cheung AK, 2004, KIDNEY INT, V65, P2380, DOI 10.1111/j.1523-1755.2004.00657.x; Chugh SS, 2008, PROG CARDIOVASC DIS, V51, P213, DOI 10.1016/j.pcad.2008.06.003; Churchill DN, 1996, J AM SOC NEPHROL, V7, P198; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Eloot S, 2011, CLIN J AM SOC NEPHRO, V6, P1266, DOI 10.2215/CJN.09981110; Floege J, 2004, NEPHROL DIAL TRANSPL, V19, P59, DOI 10.1093/ndt/gfh1058; Ganesh SK, 2001, J AM SOC NEPHROL, V12, P2131, DOI 10.1681/ASN.V12102131; Gottdiener JS, 2004, J AM SOC ECHOCARDIOG, V17, P1086, DOI 10.1016/j.echo.2004.07.013; GOWDA R.M., 2006, CARDIOLOGY, V15, P296; Herzog CA, 2008, SEMIN DIALYSIS, V21, P300, DOI 10.1111/j.1525-139X.2008.00455.x; Huikuri HV, 2001, NEW ENGL J MED, V345, P1473, DOI 10.1056/NEJMra000650; Kalantar-Zadeh K, 2009, J AM SOC NEPHROL, V20, P479, DOI 10.1681/ASN.2007070728; Kleiger RE, 2005, ANN NONINVAS ELECTRO, V10, P88, DOI 10.1111/j.1542-474X.2005.10101.x; Kong MH, 2011, CARDIOL J, V18, P503, DOI 10.5603/CJ.2011.0005; Lampert R, 2004, J AM COLL CARDIOL, V43, P2293, DOI 10.1016/j.jacc.2004.03.031; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Marcassi AP, 2011, TRANSPL INT, V24, P67, DOI 10.1111/j.1432-2277.2010.01149.x; McCullough PA, 2011, AM J KIDNEY DIS, V57, pS1, DOI 10.1053/j.ajkd.2010.11.011; Moe SM, 2004, NEPHROL DIAL TRANSPL, V19, P2387, DOI 10.1093/ndt/gfh303; MUKHARJI J, 1984, AM J CARDIOL, V54, P31, DOI 10.1016/0002-9149(84)90299-6; Neirynck N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044201; OBRIEN E, 1988, LANCET, V2, P397; Oxenham H, 2003, EUR J HEART FAIL, V5, P427, DOI 10.1016/S1388-9842(03)00011-4; Paoletti E, 2004, NEPHROL DIAL TRANSPL, V19, P1829, DOI 10.1093/ndt/gfh288; Parfrey PS, 2005, J AM SOC NEPHROL, V16, P2180, DOI 10.1681/ASN.2004121039; Pun PH, 2012, BLOOD PURIFICAT, V33, P183, DOI 10.1159/000334154; Pun PH, 2009, KIDNEY INT, V76, P652, DOI 10.1038/ki.2009.219; Raggi P, 2002, J AM COLL CARDIOL, V39, P695, DOI 10.1016/S0735-1097(01)01781-8; Ranpuria R, 2008, NEPHROL DIAL TRANSPL, V23, P444, DOI 10.1093/ndt/gfm634; Reed MJ, 2005, QJM-INT J MED, V98, P87, DOI 10.1093/qjmed/hci018; Regidor DL, 2006, J AM SOC NEPHROL, V17, P1181, DOI 10.1681/ASN.2005090997; Rivero A, 2010, CURR OPIN CARDIOL, V25, P8, DOI 10.1097/HCO.0b013e328333f95f; Roberts MA, 2011, AM J KIDNEY DIS, V58, P64, DOI 10.1053/j.ajkd.2011.01.024; Royal College of Physicians (The National Collaborating Centre for Chronic Conditions - UK), 2008, NATL I HLTH CLIN EXC, V73, P1; Russo D, 2004, AM J KIDNEY DIS, V44, P1024, DOI 10.1053/j.ajkd.2004.07.022; SARAGOCA MA, 1991, J CARDIOVASC PHARM, V17, pS136, DOI 10.1097/00005344-199117002-00032; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Slinin Y, 2005, J AM SOC NEPHROL, V16, P1788, DOI 10.1681/ASN.2004040275; Tomiyama C, 2006, NEPHROL DIAL TRANSPL, V21, P2464, DOI 10.1093/ndt/gfl291; Verrier RL, 2004, CURR OPIN CARDIOL, V19, P2, DOI 10.1097/00001573-200401000-00003; Wang AYM, 2010, HYPERTENSION, V56, P210, DOI 10.1161/HYPERTENSIONAHA.110.151167; Watanabe R, 2010, CLIN J AM SOC NEPHRO, V5, P189, DOI 10.2215/CJN.06240909; WEBB JG, 1986, CAN MED ASSOC J, V135, P753; Wolbrette D, 2002, CLIN CARDIOL, V25, P49, DOI 10.1002/clc.4950250203; Yang W, 2007, J AM SOC NEPHROL, V18, P3164, DOI 10.1681/ASN.2007010058; Zoccali C, 2010, HYPERTENSION, V56, P187, DOI 10.1161/HYPERTENSIONAHA.110.151829	54	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66036	10.1371/journal.pone.0066036	http://dx.doi.org/10.1371/journal.pone.0066036			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762460	Green Published, Green Submitted, gold			2022-12-27	WOS:000321094800084
J	Casteels, C; Vunckx, K; Aelvoet, SA; Baekelandt, V; Bormans, G; Van Laere, K; Koole, M				Casteels, Cindy; Vunckx, Kathleen; Aelvoet, Sarah-Ann; Baekelandt, Veerle; Bormans, Guy; Van Laere, Koen; Koole, Michel			Construction and Evaluation of Quantitative Small-Animal PET Probabilistic Atlases for [F-18]FDG and [F-18]FECT Functional Mapping of the Mouse Brain	PLOS ONE			English	Article							PERFORMANCE EVALUATION; GLUCOSE-METABOLISM; TRANSPORTER; SPECT; REGISTRATION; MICE; QUANTIFICATION; STABILITY; MICROPET; F-18-FDG	Automated voxel-based or pre-defined volume-of-interest (VOI) analysis of small-animal PET data in mice is necessary for optimal information usage as the number of available resolution elements is limited. We have mapped metabolic ([F-18]FDG) and dopamine transporter ([F-18]FECT) small-animal PET data onto a 3D Magnetic Resonance Microscopy (MRM) mouse brain template and aligned them in space to the Paxinos co-ordinate system. In this way, ligand-specific templates for sensitive analysis and accurate anatomical localization were created. Next, using a pre-defined VOI approach, test-retest and intersubject variability of various quantification methods were evaluated. Also, the feasibility of mouse brain statistical parametric mapping (SPM) was explored for [F-18]FDG and [F-18]FECT imaging of 6-hydroxydopamine-lesioned (6-OHDA) mice. Methods: Twenty-three adult C57BL6 mice were scanned with [F-18]FDG and [F-18]FECT. Registrations and affine spatial normalizations were performed using SPM8. [F-18]FDG data were quantified using (1) an image-derived-input function obtained from the liver (cMR(glc)), using (2) standardized uptake values (SUVglc) corrected for blood glucose levels and by (3) normalizing counts to the whole-brain uptake. Parametric [F-18]FECT binding images were constructed by reference to the cerebellum. Registration accuracy was determined using random simulated misalignments and vectorial mismatch determination. Results: Registration accuracy was between 0.21-1.11 mm. Regional intersubject variabilities of cMR(glc) ranged from 15.4% to 19.2%, while test-retest values were between 5.0% and 13.0%. For [F-18]FECT uptake in the caudate-putamen, these values were 13.0% and 10.3%, respectively. Regional values of cMR(glc) positively correlated to SUVglc measured within the 45-60 min time frame (spearman r = 0.71). Next, SPM analysis of 6-OHDA-lesioned mice showed hypometabolism in the bilateral caudate-putamen and cerebellum, and an unilateral striatal decrease in DAT availability. Conclusion: MRM-based small-animal PET templates facilitate accurate assessment and spatial localization of mouse brain function using VOI or voxel-based analysis. Regional intersubject- and test-retest variations indicate that for these targets accuracy comparable to humans can be achieved.	[Casteels, Cindy; Vunckx, Kathleen; Van Laere, Koen; Koole, Michel] Katholieke Univ Leuven, Dept Imaging & Pathol, Div Nucl Med, Louvain, Belgium; [Casteels, Cindy; Aelvoet, Sarah-Ann; Baekelandt, Veerle; Bormans, Guy; Van Laere, Koen; Koole, Michel] Katholieke Univ Leuven, MoSAIC Mol Small Anim Imaging Ctr, Louvain, Belgium; [Vunckx, Kathleen] Univ Hosp, MIRC, Louvain, Belgium; [Vunckx, Kathleen] Katholieke Univ Leuven, Louvain, Belgium; [Aelvoet, Sarah-Ann; Baekelandt, Veerle] Katholieke Univ Leuven, Dept Neurosci, Lab Neurobiol & Gene Therapy, Louvain, Belgium; [Bormans, Guy] Katholieke Univ Leuven, Lab Radiopharmaceut Chem, Dept Pharmaceut & Pharmacol Sci, Louvain, Belgium	KU Leuven; KU Leuven; KU Leuven; KU Leuven; KU Leuven	Casteels, C (corresponding author), Katholieke Univ Leuven, Dept Imaging & Pathol, Div Nucl Med, Louvain, Belgium.	cindy.casteels@med.kuleuven.be	Van der Linden, Annemie/L-7855-2017; Baekelandt, Veerle/ABB-9736-2020	Van der Linden, Annemie/0000-0003-2941-6520; Baekelandt, Veerle/0000-0001-8966-2921; Koole, Michel/0000-0001-5862-640X	government agency for Innovation by Science and Technology (IWT) [IWT-SBO-060819 Quantiviam]; European Commission (INMiND) [278850]; KU Leuven In Vivo Molecular Imaging (IMIR) Consortium [KUL PF/10/017]	government agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); European Commission (INMiND); KU Leuven In Vivo Molecular Imaging (IMIR) Consortium	Financial support of the government agency for Innovation by Science and Technology (IWT; IWT-SBO-060819 Quantiviam), the European Commission (FP7/2007-2013, INMiND, grant agreement number 278850) and the KU Leuven In Vivo Molecular Imaging (IMIR) Consortium (KUL PF/10/017) is gratefully acknowledged. Cindy Casteels and Kathleen Vunckx are postdoctoral fellows of the Flemish Fund for Scientific Research (FWO), Sarah-Ann Aelvoet is a doctoral fellow of the IWT and Koen Van Laere is a senior clinical investigator of FWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blandini F, 2012, FEBS J, V279, P1156, DOI 10.1111/j.1742-4658.2012.08491.x; Boellaard R, 2001, J NUCL MED, V42, P808; Boellaard R, 2010, EUR J NUCL MED MOL I, V37, P181, DOI 10.1007/s00259-009-1297-4; Casteels C, 2006, J NUCL MED, V47, P1858; Chitneni SK, 2008, NUCL MED BIOL, V35, P75, DOI 10.1016/j.nucmedbio.2007.09.001; Constantinescu CC, 2009, PHYS MED BIOL, V54, P2885, DOI 10.1088/0031-9155/54/9/020; Dogdas B, 2007, PHYS MED BIOL, V52, P577, DOI 10.1088/0031-9155/52/3/003; Eberl S, 1996, J NUCL MED, V37, P137; Fischer K, 2012, NEUROIMAGE, V59, P2413, DOI 10.1016/j.neuroimage.2011.08.109; FOX PT, 1985, J COMPUT ASSIST TOMO, V9, P141, DOI 10.1097/00004728-198501000-00025; Ghosh A, 2005, J BIOL CHEM, V280, P11114, DOI 10.1074/jbc.M410894200; Gutierrez DF, 2012, EUR J NUCL MED MOL I, V39, P1807, DOI 10.1007/s00259-012-2188-7; Haller J, 2012, CURR OPIN PSYCHIATR, V25, P59, DOI 10.1097/YCO.0b013e32834de34f; Hjornevik Trine, 2007, Front Neuroinform, V1, P4, DOI 10.3389/neuro.11.004.2007; Huang SC, 2000, NUCL MED BIOL, V27, P643; Ichise M, 2003, J CEREBR BLOOD F MET, V23, P1096, DOI 10.1097/01.WCB.0000085441.37552.CA; Johnson GA, 2002, RADIOLOGY, V222, P789, DOI 10.1148/radiol.2223010531; KEYES JW, 1995, J NUCL MED, V36, P1836; Kovacevic N, 2005, CEREB CORTEX, V15, P639, DOI 10.1093/cercor/bhh165; Ma Y, 2008, FRONT NEUROANAT, V2, DOI 10.3389/neuro.05.001.2008; MacKenzie-Graham A, 2004, J ANAT, V204, P93, DOI 10.1111/j.1469-7580.2004.00264.x; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Paxinos G., 2001, MOUSE BRAIN ATLAS ST; Poisnel G, 2012, NEUROBIOL AGING, V33, P1995, DOI 10.1016/j.neurobiolaging.2011.09.026; Rowland DJ, 2008, SEMIN NUCL MED, V38, P209, DOI 10.1053/j.semnuclmed.2008.01.004; Rubins DJ, 2003, NEUROIMAGE, V20, P2100, DOI 10.1016/j.neuroimage.2003.07.011; Schiffer WK, 2007, J NUCL MED, V48, P277; Schweinhardt P, 2003, J NEUROSCI METH, V129, P105, DOI 10.1016/S0165-0270(03)00192-4; St James S, 2009, PHYS MED BIOL, V54, P4605, DOI 10.1088/0031-9155/54/14/015; SYCHRA JJ, 1994, MED PHYS, V21, P1585, DOI 10.1118/1.597412; Tai YC, 2005, J NUCL MED, V46, P455; Toyama H, 2004, NUCL MED BIOL, V31, P251, DOI 10.1016/S0969-8051(03)00124-0; Tsuchida T, 2004, ANN NUCL MED, V18, P609, DOI 10.1007/BF02984583; TYLER JL, 1988, J NUCL MED, V29, P631; Van Laere KJ, 2002, J NUCL MED, V43, P458; Votaw JR, 2004, ANESTHESIOLOGY, V101, P1128, DOI 10.1097/00000542-200411000-00012; Wong KP, 2011, J NUCL MED, V52, P800, DOI 10.2967/jnumed.110.085092; Wu HM, 2007, J NUCL MED, V48, P837, DOI 10.2967/jnumed.106.038182; Yu AS, 2009, J NUCL MED, V50, P966, DOI 10.2967/jnumed.108.060533	39	16	16	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65286	10.1371/journal.pone.0065286	http://dx.doi.org/10.1371/journal.pone.0065286			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762335	Green Published, gold, Green Submitted			2022-12-27	WOS:000321094800034
J	Fiorini, A; Koudriavtseva, T; Bucaj, E; Coccia, R; Foppoli, C; Giorgi, A; Schinina, ME; Di Domenico, F; De Marco, F; Perluigi, M				Fiorini, Ada; Koudriavtseva, Tatiana; Bucaj, Elona; Coccia, Raffaella; Foppoli, Cesira; Giorgi, Alessandra; Schinina, M. Eugenia; Di Domenico, Fabio; De Marco, Federico; Perluigi, Marzia			Involvement of Oxidative Stress in Occurrence of Relapses in Multiple Sclerosis: The Spectrum of Oxidatively Modified Serum Proteins Detected by Proteomics and Redox Proteomics Analysis	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; BINDING PROTEIN; GELSOLIN; PLASMA; PATHOGENESIS; ACTIN; BRAIN; NEURODEGENERATION; COAGULATION; EXPRESSION	Multiple sclerosis (MS) is an autoimmune inflammatory demyelinating disease of the central nervous system. Several evidences suggest that MS can be considered a multi-factorial disease in which both genetics and environmental factors are involved. Among proposed candidates, growing results support the involvement of oxidative stress (OS) in MS pathology. The aim of this study was to investigate the role of OS in event of exacerbations in MS on serum of relapsing-remitting (RR-MS) patients, either in relapsing or remitting phase, with respect to serum from healthy subjects. We applied proteomics and redox proteomics approaches to identify differently expressed and oxidatively modified proteins in the low-abundant serum protein fraction. Among differently expressed proteins ceruloplasmin, antithrombin III, clusterin, apolipoprotein E, and complement C3, were up-regulated in MS patients compared with healthy controls. Further by redox proteomics, vitamin D-binding protein showed a progressive trend of oxidation from remission to relapse, respect with controls. Similarly, the increase of oxidation of apolipoprotein A-IV confirmed that levels of OS are elevated with the progression of the disease. Our findings support the involvement of OS in MS and suggest that dysfunction of target proteins occurs upon oxidative damage and correlates with the pathology.	[Fiorini, Ada; Coccia, Raffaella; Giorgi, Alessandra; Schinina, M. Eugenia; Di Domenico, Fabio; Perluigi, Marzia] Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy; [Koudriavtseva, Tatiana] Regina Elena Inst Canc Res, SSD Neurol, Rome, Italy; [Bucaj, Elona; De Marco, Federico] Regina Elena Inst Canc Res, Virol Lab, Rome, Italy; [Foppoli, Cesira] CNR, Inst Mol Biol & Pathol, Rome, Italy	Sapienza University Rome; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	De Marco, F (corresponding author), Regina Elena Inst Canc Res, Virol Lab, Rome, Italy.	demarco@ifo.it; marzia.perluigi@uniroma1.it	Di Domenico, Fabio/AAA-9241-2022; perluigi, marzia/D-3260-2009; Koudriavtseva, Tatiana/H-8866-2017; Di Domenico, Fabio/J-4767-2018; De Marco, Federico/H-5160-2018; Foppoli, Cesira/AAL-4119-2021	Di Domenico, Fabio/0000-0002-2013-209X; Koudriavtseva, Tatiana/0000-0001-9984-1827; Di Domenico, Fabio/0000-0002-2013-209X; De Marco, Federico/0000-0002-1173-2843; COCCIA, Raffaella/0000-0001-5161-4094; FOPPOLI, CESIRA/0000-0001-9170-1336	FISM-Fondazione Italiana Sclerosi Multipla [2010/R/29]; Italian Ministry of Health; Italian Ministry of Foreign Affairs, DGSP; Ministry of Foreign Affairs, DGCS	FISM-Fondazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM)); Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of Foreign Affairs, DGSP; Ministry of Foreign Affairs, DGCS	This work was supported by FISM-Fondazione Italiana Sclerosi Multipla grant 2010/R/29, by the Italian Ministry of Health and by the Italian Ministry of Foreign Affairs, DGSP. Dr Elona Bucaj was supported by a PhD fellowship granted by the Ministry of Foreign Affairs, DGCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaif M, 2012, PROTEOM CLIN APPL, V6, P297, DOI 10.1002/prca.201100061; Antequera D, 2009, NEUROBIOL DIS, V36, P42, DOI 10.1016/j.nbd.2009.06.018; Beilin O, 2005, J NEUROSCI RES, V79, P351, DOI 10.1002/jnr.20270; BERESFORD CH, 1990, INT J BIOCHEM, V22, P121, DOI 10.1016/0020-711X(90)90172-Y; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Bijl M, 2003, ARTHRITIS RHEUM, V48, P248, DOI 10.1002/art.10737; Bizzozero OA, 2005, J NEUROSCI RES, V81, P687, DOI 10.1002/jnr.20587; Bradl M, 2009, SEMIN IMMUNOPATHOL, V31, P455, DOI 10.1007/s00281-009-0182-3; Butterfield DA, 2006, EUR J PHARMACOL, V545, P39, DOI 10.1016/j.ejphar.2006.06.026; Chapman J, 2006, AUTOIMMUN REV, V5, P528, DOI 10.1016/j.autrev.2006.02.011; Chiasserini D, 2008, EUR J NEUROL, V15, P998, DOI 10.1111/j.1468-1331.2008.02239.x; Cicala C, 1998, LIFE SCI, V62, P1817, DOI 10.1016/S0024-3205(97)01167-3; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; D'Aguanno S, 2008, J NEUROIMMUNOL, V193, P156, DOI 10.1016/j.jneuroim.2007.10.004; Dalle-Donne I, 2005, MASS SPECTROM REV, V24, P55, DOI 10.1002/mas.20006; Del Boccio P, 2011, J PROTEOMICS, V74, P2826, DOI 10.1016/j.jprot.2011.06.023; Disanto G, 2011, J NEUROL, V258, P353, DOI 10.1007/s00415-010-5797-8; Esmon CT, 2001, THROMB HAEMOSTASIS, V86, P51; Ortiz GG, 2009, DIS MARKERS, V26, P35, DOI [10.1155/2009/325847, 10.3233/DMA-2009-0602]; Gilgun-Sherki Y, 2004, J NEUROL, V251, P261, DOI 10.1007/s00415-004-0348-9; Gonsette RE, 2008, J NEUROL SCI, V274, P48, DOI 10.1016/j.jns.2008.06.029; Greco A, 1999, NEUROLOGY, V53, P1876, DOI 10.1212/WNL.53.8.1876; Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875; Inaba Y, 1999, CELL IMMUNOL, V198, P96, DOI 10.1006/cimm.1999.1588; Koya RC, 2000, J BIOL CHEM, V275, P15343, DOI 10.1074/jbc.275.20.15343; Kulakowska A, 2008, EUR J NEUROL, V15, P584, DOI 10.1111/j.1468-1331.2008.02133.x; Kulakowska A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-107; KWIATKOWSKI DJ, 1986, NATURE, V323, P455, DOI 10.1038/323455a0; LIND SE, 1986, J CLIN INVEST, V78, P736, DOI 10.1172/JCI112634; Liu SL, 2009, J CELL MOL MED, V13, P1586, DOI 10.1111/j.1582-4934.2009.00850.x; Luessi F, 2012, EXPERT REV NEUROTHER, V12, P1061, DOI [10.1586/ERN.12.59, 10.1586/ern.12.59]; Miller E, 2012, CLIN BIOCHEM, V45, P26, DOI 10.1016/j.clinbiochem.2011.09.021; Nedelkov D, 2005, P NATL ACAD SCI USA, V102, P10852, DOI 10.1073/pnas.0500426102; Oliveira SR, 2012, J NEUROL SCI, V321, P49, DOI 10.1016/j.jns.2012.07.045; Olmarker K, 1996, SPINE, V21, P411, DOI 10.1097/00007632-199602150-00002; Pappin Darryl J C, 2003, Methods Mol Biol, V211, P211; Perluigi M, 2009, J CELL MOL MED, V13, P1809, DOI 10.1111/j.1582-4934.2008.00465.x; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Qin XF, 1998, AM J PHYSIOL-HEART C, V274, pH1836, DOI 10.1152/ajpheart.1998.274.5.H1836; Rithidech KN, 2009, MULT SCLER J, V15, P455, DOI 10.1177/1352458508100047; Roussel BD, 2009, BRAIN, V132, P2219, DOI 10.1093/brain/awp162; SCHUMACHER GA, 1965, ANN NY ACAD SCI, V122, P552; Silber E, 1999, J NEUROL SCI, V170, P11, DOI 10.1016/S0022-510X(99)00178-1; Singh V, 2012, J NEUROIMMUNOL, V248, P40, DOI 10.1016/j.jneuroim.2011.11.004; Stavropoulou C, 2011, FREE RADICAL BIO MED, V51, P713, DOI 10.1016/j.freeradbiomed.2011.04.043; Stoop MP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012442; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; Tasset I, 2012, CLIN BIOCHEM, V45, P440, DOI 10.1016/j.clinbiochem.2012.01.023; Teunissen CE, 2011, MULT SCLER J, V17, P838, DOI 10.1177/1352458511399614; Trapp BD, 1999, CURR OPIN NEUROL, V12, P295, DOI 10.1097/00019052-199906000-00008; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Trougakos IP, 2006, FREE RADICAL RES, V40, P1324, DOI 10.1080/10715760600902310; Turk R, 2012, J PROTEOMICS, V75, P4412, DOI 10.1016/j.jprot.2012.05.021; Zipp F, 2000, CELL TISSUE RES, V301, P163, DOI 10.1007/s004410000179	55	63	66	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65184	10.1371/journal.pone.0065184	http://dx.doi.org/10.1371/journal.pone.0065184			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762311	Green Published, gold, Green Submitted			2022-12-27	WOS:000321094800023
J	McRae, AF; Richter, MM; Lind, PA				McRae, Allan F.; Richter, Melinda M.; Lind, Penelope A.			Case-Control Association Testing of Common Variants from Sequencing of DNA Pools	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ADH4 GENE VARIATION; ALCOHOL DEPENDENCE; ETHANOL-METABOLISM; DRUG-DEPENDENCE; RISK	While genome-wide association studies (GWAS) have been successful in identifying a large number of variants associated with disease, the challenge of locating the underlying causal loci remains. Sequencing of case and control DNA pools provides an inexpensive method for assessing all variation in a genomic region surrounding a significant GWAS result. However, individual variants need to be ranked in terms of the strength of their association to disease in order to prioritise follow-up by individual genotyping. A simple method for testing for case-control association in sequence data from DNA pools is presented that allows the partitioning of the variance in allele frequency estimates into components due to the sampling of chromosomes from the pool during sequencing, sampling individuals from the population and unequal contribution from individuals during pool construction. The utility of this method is demonstrated on a sequence from the alcohol dehydrogenase (ADH) gene cluster on a case-control sample for heavy alcohol consumption.	[McRae, Allan F.] Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia; [McRae, Allan F.; Richter, Melinda M.; Lind, Penelope A.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia	University of Queensland; QIMR Berghofer Medical Research Institute	McRae, AF (corresponding author), Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia.	a.mcrae@uq.edu.au	McRae, Allan F/J-2644-2014; Lind, Penelope A/B-2553-2009; Lind, Penelope A/ABC-5341-2021	McRae, Allan F/0000-0001-5286-5485; Lind, Penelope A/0000-0002-3887-2598; Lind, Penelope A/0000-0002-3887-2598	Alcohol and Health Research Grant Scheme; Lion Nathan Limited; Australian National Health and Medical Research Council [NHMRC 552482, 1010374]	Alcohol and Health Research Grant Scheme; Lion Nathan Limited; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by a grant from the Alcohol and Health Research Grant Scheme funded by Lion Nathan Limited and Australian National Health and Medical Research Council project grants (NHMRC 552482 and 1010374). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Anderson CA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000580; Bain BJ, 1996, J CLIN PATHOL, V49, P664, DOI 10.1136/jcp.49.8.664; Bansal V, 2010, BIOINFORMATICS, V26, pi318, DOI 10.1093/bioinformatics/btq214; Chen XW, 2012, GENET EPIDEMIOL, V36, P549, DOI 10.1002/gepi.21648; Chen YC, 2009, CHEM-BIOL INTERACT, V178, P2, DOI 10.1016/j.cbi.2008.10.029; Craig JE, 2009, GENOME RES, V19, P2075, DOI 10.1101/gr.094680.109; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Druley TE, 2009, NAT METHODS, V6, P263, DOI [10.1038/NMETH.1307, 10.1038/nmeth.1307]; Edenberg HJ, 2006, HUM MOL GENET, V15, P1539, DOI 10.1093/hmg/ddl073; Grant JD, 2009, BIOL PSYCHIAT, V66, P795, DOI 10.1016/j.biopsych.2009.05.018; Heath AC, 2011, BIOL PSYCHIAT, V70, P513, DOI 10.1016/j.biopsych.2011.02.028; Johnson AD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-6; Kim SY, 2010, GENET EPIDEMIOL, V34, P479, DOI 10.1002/gepi.20501; Kimura Y, 2009, J TOXICOL SCI, V34, P89, DOI 10.2131/jts.34.89; Lee JS, 2011, GENET EPIDEMIOL, V35, P139, DOI 10.1002/gepi.20561; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luo XG, 2006, NEUROPSYCHOPHARMACOL, V31, P1085, DOI 10.1038/sj.npp.1300925; Luo XG, 2005, PHARMACOGENET GENOM, V15, P755, DOI 10.1097/01.fpc.0000180141.77036.dc; Macgregor S, 2009, HUM MOL GENET, V18, P580, DOI 10.1093/hmg/ddn372; Macgregor S, 2007, EUR J HUM GENET, V15, P501, DOI 10.1038/sj.ejhg.5201768; Niranjan TS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r93; Preuss UW, 2011, ADDICT BIOL, V16, P323, DOI 10.1111/j.1369-1600.2010.00236.x; Quertemont E, 2004, MOL PSYCHIATR, V9, P570, DOI 10.1038/sj.mp.4001497; Turchi C, 2012, PHARMACOGENET GENOM, V22, P79, DOI 10.1097/FPC.0b013e32834d05c8; Visscher PM, 2003, GENET EPIDEMIOL, V24, P291, DOI 10.1002/gepi.10240; Wang T, 2010, GENET EPIDEMIOL, V34, P492, DOI 10.1002/gepi.20502; Wray NR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000579	29	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65410	10.1371/journal.pone.0065410	http://dx.doi.org/10.1371/journal.pone.0065410			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762362	Green Published, Green Submitted, gold			2022-12-27	WOS:000321094800045
J	Pal, P; Lochab, S; Kanaujiya, JK; Kapoor, I; Sanyal, S; Behre, G; Trivedi, AK				Pal, Pooja; Lochab, Savita; Kanaujiya, Jitendra Kumar; Kapoor, Isha; Sanyal, Sabyasachi; Behre, Gerhard; Trivedi, Arun Kumar			E3 Ubiquitin Ligase E6AP Negatively Regulates Adipogenesis by Downregulating Proadipogenic Factor C/EBPalpha	PLOS ONE			English	Article							ENHANCER-BINDING-PROTEIN; ADIPOCYTE DIFFERENTIATION; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; PROTEOMIC IDENTIFICATION; ANGELMAN-SYNDROME; ALPHA; DEGRADATION; MULTIPLE; PROMOTES	CCAAT/Enhancer Binding Protein Alpha (C/EBP alpha) is a key transcription factor involved in the adipocyte differentiation. Here for the first time we demonstrate that E6AP, an E3 ubiquitin ligase inhibits adipocyte differentiation in 3T3-L1 cells as revealed by reduced lipid staining with oil red. Knock down of E6AP in mouse 3T3L1 preadipocytes is sufficient to convert them to adipocytes independent of external hormonal induction. C/EBP alpha protein level is drastically increased in E6AP deficient 3T3L1 preadipocytes while inverse is observed when wild type E6AP is over expressed. We show that transient transfection of wild type E6AP downregulates C/EBP alpha protein expression in a dose dependent manner while catalytically inactive E6AP-C843A rather stabilizes it. In addition, wild type E6AP inhibits expression of proadipogenic genes while E6AP-C843A enhances them. More importantly, overexpression of E6AP-C843A in mesenchymal progenitor cells promotes accumulation of lipid droplets while there is drastically reduced lipid droplet formation when E6AP is over expressed. Taken together, our finding suggests that E6AP may negatively control adipogenesis by inhibiting C/EBP alpha expression by targeting it to ubiquitin-proteasome pathway for degradation.	[Pal, Pooja; Lochab, Savita; Kanaujiya, Jitendra Kumar; Kapoor, Isha; Sanyal, Sabyasachi; Trivedi, Arun Kumar] CSIR Cent Drug Res Inst, DTDD Div, LSS008, Lucknow, Uttar Pradesh, India; [Behre, Gerhard] Univ Hosp Leipzig, Div Hematol & Oncol, Leipzig, Germany	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Leipzig University	Trivedi, AK (corresponding author), CSIR Cent Drug Res Inst, DTDD Div, LSS008, Lucknow, Uttar Pradesh, India.	arun3vedi@cdri.res.in	Sanyal, Sabyasachi/E-8034-2010; Kanaujiya, Jitendra Kumar/W-1688-2019; Trivedi, Arun Kumar/W-1883-2019	Sanyal, Sabyasachi/0000-0002-8603-3828; Kanaujiya, Jitendra Kumar/0000-0002-0701-2210; Trivedi, Arun Kumar/0000-0002-6316-0947	CSIR-Central Drug Research Institute; CSIR [HCP0004, BSC0201i]; DBT grant [GAP00068]; ICMR Senior research fellowship	CSIR-Central Drug Research Institute; CSIR(Council of Scientific & Industrial Research (CSIR) - India); DBT grant; ICMR Senior research fellowship	The authors are sincerely thankful to CSIR-Central Drug Research Institute for its financial support in the completion of this project. This work was supported by CSIR grants HCP0004, BSC0201i and DBT grant GAP00068 to AKT, and ICMR Senior research fellowship to P Pal. Institutional (CSIR-CDRI), Institutional manuscript number for this article is 49/2012/AKT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attie AD, 2009, J LIPID RES, V50, pS395, DOI 10.1194/jlr.R800057-JLR200; Auld CA, 2006, OBESITY, V14, P2136, DOI 10.1038/oby.2006.250; Bengoechea-Alonso MT, 2010, P NATL ACAD SCI USA, V107, P11817, DOI 10.1073/pnas.0913367107; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Cassidy SB, 1997, J MED GENET, V34, P917, DOI 10.1136/jmg.34.11.917; CHRISTY RJ, 1989, GENE DEV, V3, P1323, DOI 10.1101/gad.3.9.1323; Cooke PS, 2004, EXP BIOL MED, V229, P1127, DOI 10.1177/153537020422901107; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Eastman SW, 2009, J CELL BIOL, V184, P881, DOI 10.1083/jcb.200808041; FREYTAG SO, 1994, GENE DEV, V8, P1654, DOI 10.1101/gad.8.14.1654; Gillessen-Kaesbach G, 1999, EUR J HUM GENET, V7, P638, DOI 10.1038/sj.ejhg.5200362; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Gregoire FM, 2001, EXP BIOL MED, V226, P997, DOI 10.1177/153537020122601106; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P5249, DOI 10.1073/pnas.92.11.5249-a; Lane MD, 1999, BIOCHEM BIOPH RES CO, V266, P677, DOI 10.1006/bbrc.1999.1885; Lochab S, 2012, PROTEOMICS, V12, P1363, DOI 10.1002/pmic.201100572; Louria-Hayon I, 2009, CELL DEATH DIFFER, V16, P1156, DOI 10.1038/cdd.2009.31; MACDOUGALD OA, 1995, P NATL ACAD SCI USA, V92, P9034, DOI 10.1073/pnas.92.20.9034; MACDOUGALD OA, 1995, CURR BIOL, V5, P618, DOI 10.1016/S0960-9822(95)00125-4; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Mishra A, 2009, NEUROBIOL DIS, V36, P26, DOI 10.1016/j.nbd.2009.06.010; Morrison RF, 1999, J BIOL CHEM, V274, P17088, DOI 10.1074/jbc.274.24.17088; Muraglia A, 2000, J CELL SCI, V113, P1161; Pal P SL, 2013, CELL DEATH DIS, V4, DOI [10.1038/cddis.2013.1120, DOI 10.1038/CDDIS.2013.1120]; Pal P, 2011, PROTEOMICS, V11, P1517, DOI 10.1002/pmic.201000720; Pal P, 2010, MOL CELL BIOCHEM, V337, P111, DOI 10.1007/s11010-009-0290-3; Poyatos D, 2002, J Med Genet, V39, pE4, DOI 10.1136/jmg.39.2.e4; Rosen ED, 2000, GENE DEV, V14, P1293; Seufert J, 2004, DIABETES, V53, pS152, DOI 10.2337/diabetes.53.2007.S152; Shimoji T, 2009, J CELL BIOCHEM, V106, P1123, DOI 10.1002/jcb.22096; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Subramanian L, 2003, J BIOL CHEM, V278, P9134, DOI 10.1074/jbc.M210440200; Talis AL, 1998, J BIOL CHEM, V273, P6439, DOI 10.1074/jbc.273.11.6439; Trivedi AK, 2008, EUR J CANCER, V44, P1516, DOI 10.1016/j.ejca.2008.04.022; Trivedi AK, 2007, ONCOGENE, V26, P1789, DOI 10.1038/sj.onc.1209964; UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644; Van Buggenhout G, 2009, EUR J HUM GENET, V17, P1367, DOI 10.1038/ejhg.2009.67	38	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65330	10.1371/journal.pone.0065330	http://dx.doi.org/10.1371/journal.pone.0065330			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762344	Green Published, Green Submitted, gold			2022-12-27	WOS:000321094800040
J	Cooley, MB; Jay-Russell, M; Atwill, ER; Carychao, D; Nguyen, K; Quinones, B; Patel, R; Walker, S; Swimley, M; Pierre-Jerome, E; Gordus, AG; Mandrell, RE				Cooley, Michael B.; Jay-Russell, Michele; Atwill, Edward R.; Carychao, Diana; Nguyen, Kimberly; Quinones, Beatriz; Patel, Ronak; Walker, Samarpita; Swimley, Michelle; Pierre-Jerome, Edith; Gordus, Andrew G.; Mandrell, Robert E.			Development of a Robust Method for Isolation of Shiga Toxin-Positive Escherichia coli (STEC) from Fecal, Plant, Soil and Water Samples from a Leafy Greens Production Region in California	PLOS ONE			English	Article							REAL-TIME PCR; IMMUNOMAGNETIC-SEPARATION; CONTAMINATED MANURE; VARIABLE-NUMBER; 5'-NUCLEASE PCR; UNITED-STATES; GROUND-BEEF; GENES STX1; O157; CATTLE	During a 2.5-year survey of 33 farms and ranches in a major leafy greens production region in California, 13,650 produce, soil, livestock, wildlife, and water samples were tested for Shiga toxin (stx)-producing Escherichia coli (STEC). Overall, 357 and 1,912 samples were positive for E. coli O157:H7 (2.6%) or non-O157 STEC (14.0%), respectively. Isolates differentiated by O-typing ELISA and multilocus variable number tandem repeat analysis (MLVA) resulted in 697 O157: H7 and 3,256 non-O157 STEC isolates saved for further analysis. Cattle (7.1%), feral swine (4.7%), sediment (4.4%), and water (3.3%) samples were positive for E. coli O157: H7; 7/32 birds, 2/145 coyotes, 3/88 samples from elk also were positive. Non-O157 STEC were at approximately 5-fold higher incidence compared to O157 STEC: cattle (37.9%), feral swine (21.4%), birds (2.4%), small mammals (3.5%), deer or elk (8.3%), water (14.0%), sediment (12.3%), produce (0.3%) and soil adjacent to produce (0.6%). stx1, stx2 and stx1/stx2 genes were detected in 63%, 74% and 35% of STEC isolates, respectively. Subtilase, intimin and hemolysin genes were present in 28%, 25% and 79% of non-O157 STEC, respectively; 23% were of the "Top 60" O-types. The initial method was modified twice during the study revealing evidence of culture bias based on differences in virulence and O-antigen profiles. MLVA typing revealed a diverse collection of O157 and non-O157 STEC strains isolated from multiple locations and sources and O157 STEC strains matching outbreak strains. These results emphasize the importance of multiple approaches for isolation of non-O157 STEC, that livestock and wildlife are common sources of potentially virulent STEC, and evidence of STEC persistence and movement in a leafy greens production environment.	[Cooley, Michael B.; Carychao, Diana; Nguyen, Kimberly; Quinones, Beatriz; Walker, Samarpita; Swimley, Michelle; Mandrell, Robert E.] USDA ARS, Produce Safety & Microbiol Res Unit, Albany, CA USA; [Jay-Russell, Michele; Atwill, Edward R.] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA; [Jay-Russell, Michele; Atwill, Edward R.] Univ Calif Davis, Western Inst Food Safety & Secur, Davis, CA 95616 USA; [Patel, Ronak] USDA ARS, Natl Clonal Germplasm Repository Citrus & Dates, Riverside, CA USA; [Pierre-Jerome, Edith] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Gordus, Andrew G.] Calif Dept Fish & Game, Fresno, CA USA	United States Department of Agriculture (USDA); University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Agriculture (USDA); University of Washington; University of Washington Seattle	Cooley, MB (corresponding author), USDA ARS, Produce Safety & Microbiol Res Unit, Albany, CA USA.	michael.cooley@ars.usda.gov	Mandrell, Robert E/O-9814-2018	Quinones, Beatriz/0000-0001-5010-9889	National Research Initiative Competitive from the USDA National Institute of Food and Agriculture [2006-55212-16927, 2007-35212-18239]; USDA Agricultural Research Service CRIS [5325-42000-044, 5325-42000-045]	National Research Initiative Competitive from the USDA National Institute of Food and Agriculture; USDA Agricultural Research Service CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This project was supported by National Research Initiative Competitive Grant nos. 2006-55212-16927 and 2007-35212-18239 from the USDA National Institute of Food and Agriculture and USDA Agricultural Research Service CRIS projects 5325-42000-044 and -045. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allerberger F., 2009, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V4, P1, DOI 10.1079/PAVSNNR20094019; Amezquita-Lopez BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051565; [Anonymous], 2010, FEDERAL STATE OFFICI; [Anonymous], 2007, MMWR-MORBID MORTAL W, V56, P29; Arthur TM, 2009, APPL ENVIRON MICROB, V75, P6515, DOI 10.1128/AEM.00081-09; Auvray F, 2009, LETT APPL MICROBIOL, V48, P554, DOI 10.1111/j.1472-765X.2009.02561.x; Barkocy-Gallagher GA, 2003, J FOOD PROTECT, V66, P1978, DOI 10.4315/0362-028X-66.11.1978; BARRETT TJ, 1980, J CLIN MICROBIOL, V11, P385, DOI 10.1128/JCM.11.4.385-388.1980; Belanger SD, 2002, J CLIN MICROBIOL, V40, P1436, DOI 10.1128/JCM.40.4.1436-1440.2002; Beutin L, 2004, J CLIN MICROBIOL, V42, P1099, DOI 10.1128/JCM.42.3.1099-1108.2004; Bielaszewska M, 2000, WORLD J MICROB BIOT, V16, P711, DOI 10.1023/A:1008972605514; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Bonardi S, 1999, VET MICROBIOL, V67, P203, DOI 10.1016/S0378-1135(99)00039-5; Bonardi S, 2007, J FOOD PROTECT, V70, P1493, DOI 10.4315/0362-028X-70.6.1493; Bosilevac JM, 2011, APPL ENVIRON MICROB, V77, P2103, DOI 10.1128/AEM.02833-10; Brooks JT, 2005, J INFECT DIS, V192, P1422, DOI 10.1086/466536; Chassagne L, 2009, DIAGN MICR INFEC DIS, V64, P98, DOI 10.1016/j.diagmicrobio.2009.01.031; Cooley M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001159; Cooley MB, 2010, APPL ENVIRON MICROB, V76, P3398, DOI 10.1128/AEM.02373-09; Fedio WM, 2011, INT J FOOD MICROBIOL, V148, P87, DOI 10.1016/j.ijfoodmicro.2011.05.005; Feng PCH, 2011, APPL ENVIRON MICROB, V77, P6699, DOI 10.1128/AEM.00370-11; Feng PCH, 2010, FEMS MICROBIOL LETT, V308, P62, DOI 10.1111/j.1574-6968.2010.01990.x; Frank C., 2011, EUROSURVEILLANCE, V16, P1; Fratamico PM, 2011, FOODBORNE PATHOG DIS, V8, P601, DOI 10.1089/fpd.2010.0773; Friedrich AW, 2002, J INFECT DIS, V185, P74, DOI 10.1086/338115; Galli L, 2010, VET MICROBIOL, V143, P307, DOI 10.1016/j.vetmic.2009.11.028; Garthright WE, 2003, FOOD MICROBIOL, V20, P439, DOI 10.1016/S0740-0020(02)00144-2; Grys TE, 2009, J CLIN MICROBIOL, V47, P2008, DOI 10.1128/JCM.02013-08; Guion CE, 2008, J CLIN MICROBIOL, V46, P1752, DOI 10.1128/JCM.02341-07; Hedican EB, 2009, CLIN INFECT DIS, V49, P358, DOI 10.1086/600302; Hussein HS, 2005, J FOOD PROTECT, V68, P2224, DOI 10.4315/0362-028X-68.10.2224; Hyytia-Trees E, 2006, FOODBORNE PATHOG DIS, V3, P118, DOI 10.1089/fpd.2006.3.118; Ibekwe AM, 2002, APPL ENVIRON MICROB, V68, P4853, DOI 10.1128/AEM.68.10.4853-4862.2002; Ingham SC, 2005, J FOOD PROTECT, V68, P1134, DOI 10.4315/0362-028X-68.6.1134; Islam M, 2005, FOOD MICROBIOL, V22, P63, DOI 10.1016/j.fm.2004.04.007; Jay MT, 2007, EMERG INFECT DIS, V13, P1908, DOI 10.3201/eid1312.070763; Jelacic JK, 2003, J INFECT DIS, V188, P719, DOI 10.1086/376999; Jinneman KC, 2003, APPL ENVIRON MICROB, V69, P6327, DOI 10.1128/AEM.69.10.6327-6333.2003; Johannessen GS, 2005, APPL ENVIRON MICROB, V71, P2221, DOI 10.1128/AEM.71.5.2221-2225.2005; Johnson KE, 2006, CLIN INFECT DIS, V43, P1587, DOI 10.1086/509573; Kanki M, 2011, LETT APPL MICROBIOL, V53, P167, DOI 10.1111/j.1472-765X.2011.03085.x; Karmali MA, 2003, J CLIN MICROBIOL, V41, P4930, DOI 10.1128/JCM.41.11.4930-4940.2003; Lindstedt BA, 2007, J MICROBIOL METH, V69, P197, DOI 10.1016/j.mimet.2007.01.001; Mandrell RE, 2010, WOODHEAD PUBL FOOD S, P548; Manning SD, 2008, P NATL ACAD SCI USA, V105, P4868, DOI 10.1073/pnas.0710834105; Manning SD, 2007, EMERG INFECT DIS, V13, P318, DOI 10.3201/eid1302.060813; Matthews L, 2006, P NATL ACAD SCI USA, V103, P547, DOI 10.1073/pnas.0503776103; Nielsen EM, 2003, J CLIN MICROBIOL, V41, P2884, DOI 10.1128/JCM.41.7.2884-2893.2003; Ogden ID, 2004, FEMS MICROBIOL LETT, V233, P297, DOI 10.1111/j.1574-6968.2004.tb09495.x; Ogden ID, 2001, J APPL MICROBIOL, V91, P373, DOI 10.1046/j.1365-2672.2001.01397.x; Parham N, 2003, J MICROBIOL METH, V53, P1, DOI 10.1016/S0167-7012(02)00206-3; Paton AW, 1999, J CLIN MICROBIOL, V37, P3357, DOI 10.1128/JCM.37.10.3357-3361.1999; Pavlovic M, 2010, FOODBORNE PATHOG DIS, V7, P801, DOI 10.1089/fpd.2009.0457; Perelle S, 2004, MOL CELL PROBE, V18, P185, DOI 10.1016/j.mcp.2003.12.004; Quinones B, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00061; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Reischl U, 2002, J CLIN MICROBIOL, V40, P2555, DOI 10.1128/JCM.40.7.2555-2565.2002; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Rivera-Betancourt M, 2000, APPL ENVIRON MICROB, V66, P4124, DOI 10.1128/AEM.66.9.4124-4127.2000; Schmidt H, 2000, APPL ENVIRON MICROB, V66, P1205, DOI 10.1128/AEM.66.3.1205-1208.2000; Schuurman T, 2007, J MICROBIOL METH, V70, P406, DOI 10.1016/j.mimet.2007.05.016; Sekse C, 2005, MOL CELL PROBE, V19, P363, DOI 10.1016/j.mcp.2005.06.006; Sharma VK, 2003, VET MICROBIOL, V93, P247, DOI 10.1016/S0378-1135(03)00039-7; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; Solomon EB, 2002, APPL ENVIRON MICROB, V68, P397, DOI 10.1128/AEM.68.1.397-400.2002; Stephens PJ, 1998, LETT APPL MICROBIOL, V27, P147; Sugiyama K, 2001, LETT APPL MICROBIOL, V33, P193, DOI 10.1046/j.1472-765X.2001.00974.x; Synge BA, 2003, EPIDEMIOL INFECT, V130, P301, DOI 10.1017/S0950268802008208; Teunis P, 2004, RISK ANAL, V24, P401, DOI 10.1111/j.0272-4332.2004.00441.x; Tillman GE, 2012, J FOOD PROTECT, V75, P1548, DOI 10.4315/0362-028X.JFP-12-110; Toma C, 2004, J CLIN MICROBIOL, V42, P4937, DOI 10.1128/JCM.42.11.4937-4946.2004; Tomoyasu T, 1998, APPL ENVIRON MICROB, V64, P376; Toth I, 2009, APPL ENVIRON MICROB, V75, P6282, DOI 10.1128/AEM.00873-09; Tzschoppe M, 2012, INT J FOOD MICROBIOL, V152, P19, DOI 10.1016/j.ijfoodmicro.2011.10.009; Verstraete K, 2010, VET MICROBIOL, V145, P106, DOI 10.1016/j.vetmic.2010.03.004; Willford J, 2009, J FOOD PROTECT, V72, P741, DOI 10.4315/0362-028X-72.4.741; Yang JR, 2007, J CLIN MICROBIOL, V45, P3620, DOI 10.1128/JCM.00596-07; Yoshitomi KJ, 2006, MOL CELL PROBE, V20, P31, DOI 10.1016/j.mcp.2005.09.002; Zheng J, 2008, APPL ENVIRON MICROB, V74, P5645, DOI 10.1128/AEM.00503-08	79	82	83	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65716	10.1371/journal.pone.0065716	http://dx.doi.org/10.1371/journal.pone.0065716			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762414	Green Submitted, gold, Green Published			2022-12-27	WOS:000321099000096
J	Wu, W; Xu, WB; Chen, L; Chen, HL; Liu, Q; Wang, DL; Chen, YJ; Yao, W; Li, G; Feng, B; Shu, BH; Zhou, YK; He, YQ				Wu, Wei; Xu, Wen-Bo; Chen, Long; Chen, Hui-Ling; Liu, Qu; Wang, Dong-Li; Chen, Ying-Jian; Yao, Wei; Li, Gang; Feng, Bin; Shu, Bai-Hua; Zhou, Yi-Kai; He, Ya-Qing			Molecular Identification and Analysis of Human Enteroviruses Isolated from Healthy Children in Shenzhen, China from 2010 to 2011	PLOS ONE			English	Article							VACCINE-DERIVED POLIOVIRUS; MOUTH-DISEASE; SPECIES C; OUTBREAK; INFECTIONS; CIRCULATION; HAND; EPIDEMIC; COXSACKIEVIRUSES; POLIOMYELITIS	Objective: To determine the prevalence and distribution of human enteroviruses (HEVs) among healthy children in Shenzhen, China. Method: Clinical specimens were obtained from 320 healthy children under 5 years old in Shenzhen, China from 2010 to 2011. The specimens were evaluated using real-time PCR and cell cultures. The positive specimens were further tested using reverse transcription-seminested PCR (RT-snPCR). Molecular typing and phylogenetic analysis were based on the sequence determined. Results: Among the 320 samples, 34 were tested positive for HEVs (10.6%) and 22 different serotypes were identified using RT-snPCR. PV1 and PV2 were also detected. The predominant serotype observed was EV71 (17.6%), followed by CV-B4 (14.7%). HEV-B was detected most frequently, with an overall prevalence of 47.1%. HEV-A and HEV-C were found in 32.3% and 20.6% of the samples, respectively. No HEV-D was identified. Molecular phylogeny indicated that all EV71 strains were of C4 genotype. Conclusion: Although a variety of HEVs was detected in healthy children, HEV-B was relatively more prevalent than other HEV species. Considering HEV-A is more prevalent than HEV-B among patients with hand-foot-mouth disease, additional long-term surveillance of HEV is warranted in both asymptomatic and symptomatic populations.	[Wu, Wei; Chen, Hui-Ling; Shu, Bai-Hua; Zhou, Yi-Kai] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE Key Lab Environm & Hlth,Inst Environm Med, Wuhan 430074, Hubei, Peoples R China; [Xu, Wen-Bo] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Chen, Long] Shenzhen Univ, Sch Life Sci, Shenzhen, Peoples R China; [He, Ya-Qing] Shenzhen Ctr Dis Control & Prevent, Major Infect Dis Control Key Lab, Shenzhen, Peoples R China; [Liu, Qu; Chen, Ying-Jian; Yao, Wei; Li, Gang] Shenzhen Longgang Dist Ctr Dis Control & Prevent, Shenzhen, Peoples R China; [Wang, Dong-Li; Feng, Bin] Shenzhen Guangming Dist Ctr Dis Control & Prevent, Shenzhen, Peoples R China	Huazhong University of Science & Technology; Chinese Center for Disease Control & Prevention; Shenzhen University; Shenzhen Center for Disease Control & Prevention (SZCDC)	Zhou, YK (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE Key Lab Environm & Hlth,Inst Environm Med, Wuhan 430074, Hubei, Peoples R China.	zhouyikai_tongji@163.com; heyaqing1019@126.com	Chen, Long/N-4705-2019; chen, hui/HDO-2955-2022	Chen, Long/0000-0003-1110-6495; 	Key Projects in the National Science and Technology Pillar Program in the Eleventh Five-year Plan Period	Key Projects in the National Science and Technology Pillar Program in the Eleventh Five-year Plan Period	This study was financed by the Key Projects in the National Science and Technology Pillar Program in the Eleventh Five-year Plan Period. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar S, 1999, SCAND J INFECT DIS, V31, P331, DOI 10.1080/00365549950163734; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P169; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P337; [Anonymous], 2001, FIELDS VIROLOGY; Bahri O, 2005, J MED MICROBIOL, V54, P63, DOI 10.1099/jmm.0.45695-0; Bhambhani V, 2007, TROP DOCT, V37, P188, DOI 10.1258/004947507781524728; Bingjun T, 2008, J MED VIROL, V80, P670, DOI 10.1002/jmv.21122; Blomqvist S, 2010, J CLIN VIROL, V48, P49, DOI 10.1016/j.jcv.2010.02.002; Brown BA, 2009, J GEN VIROL, V90, P1713, DOI 10.1099/vir.0.008540-0; Combelas N, 2011, VIRUSES-BASEL, V3, P1460, DOI 10.3390/v3081460; COOK I, 1969, MED J AUSTRALIA, V2, P789, DOI 10.5694/j.1326-5377.1969.tb107421.x; Faden H, 2006, PEDIATR INFECT DIS J, V25, P687, DOI 10.1097/01.inf.0000226842.23106.a2; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Kim H, 2012, SPACE, P38; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; KyoungAh B, 2011, VIROL J, V8; Liang XF, 2006, J INFECT DIS, V194, P545, DOI 10.1086/506359; Liu HM, 2003, J VIROL, V77, P10994, DOI 10.1128/JVI.77.20.10994-11005.2003; Lo CW, 2010, J MICROBIOL IMMUNOL, V43, P354, DOI 10.1016/S1684-1182(10)60056-4; NAGY G, 1982, ARCH VIROL, V71, P217, DOI 10.1007/BF01314873; Nasri D, 2007, EXPERT REV MOL DIAGN, V7, P419, DOI 10.1586/14737159.7.4.419; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Oberste MS, 1999, J CLIN MICROBIOL, V37, P1288, DOI 10.1128/JCM.37.5.1288-1293.1999; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Romero JR, 2009, REVERSE TRANSCRIPTIO; Rose TM, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-20; Rose TM, 1998, NUCLEIC ACIDS RES, V26, P1628, DOI 10.1093/nar/26.7.1628; ROTBART HA, 1995, CLIN INFECT DIS, V20, P971, DOI 10.1093/clinids/20.4.971; Roth B, 2007, J MED VIROL, V79, P956, DOI 10.1002/jmv.20917; Rousset D, 2003, EMERG INFECT DIS, V9, P885; Sano T, 2008, JPN J INFECT DIS, V61, P162; Simonen-Tikka ML, 2012, J MED VIROL, V84, P923, DOI 10.1002/jmv.23284; Smura T, 2007, J GEN VIROL, V88, P2520, DOI 10.1099/vir.0.82866-0; Tsao KC, 2010, J VIROL METHODS, V165, P330, DOI 10.1016/j.jviromet.2010.03.001; Witso E, 2006, J CLIN MICROBIOL, V44, P4095, DOI 10.1128/JCM.00653-06; Wu Y, 2010, INT J INFECT DIS, V14, pE1076, DOI 10.1016/j.ijid.2010.07.006; Xu AQ, 2011, VIRUS GENES, V42, P323, DOI 10.1007/s11262-011-0584-x; Yamashita T, 2005, JPN J INFECT DIS, V58, P390; Yang CF, 2003, J VIROL, V77, P8366, DOI 10.1128/JVI.77.15.8366-8377.2003; Yang Y, 2009, HUM PATHOL, V40, P1288, DOI 10.1016/j.humpath.2009.01.015	41	5	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64889	10.1371/journal.pone.0064889	http://dx.doi.org/10.1371/journal.pone.0064889			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762262	Green Published, gold, Green Submitted			2022-12-27	WOS:000321099000027
J	Clarin, TMA; Ruczynski, I; Page, RA; Siemers, BM				Clarin, Theresa M. A.; Ruczynski, Ireneusz; Page, Rachel A.; Siemers, Bjoern M.			Foraging Ecology Predicts Learning Performance in Insectivorous Bats	PLOS ONE			English	Article							MYOTIS-CAPACCINII BONAPARTE; LONG-FINGERED BAT; MOUSE-EARED BATS; ECHOLOCATION BEHAVIOR; EXPLORATORY-BEHAVIOR; HABITAT SELECTION; HUNTING BEHAVIOR; PREY DETECTION; BRAIN SIZE; EVOLUTION	Bats are unusual among mammals in showing great ecological diversity even among closely related species and are thus well suited for studies of adaptation to the ecological background. Here we investigate whether behavioral flexibility and simple- and complex-rule learning performance can be predicted by foraging ecology. We predict faster learning and higher flexibility in animals hunting in more complex, variable environments than in animals hunting in more simple, stable environments. To test this hypothesis, we studied three closely related insectivorous European bat species of the genus Myotis that belong to three different functional groups based on foraging habitats: M. capaccinii, an open water forager, M. myotis, a passive listening gleaner, and M. emarginatus, a clutter specialist. We predicted that M. capaccinii would show the least flexibility and slowest learning reflecting its relatively unstructured foraging habitat and the stereotypy of its natural foraging behavior, while the other two species would show greater flexibility and more rapid learning reflecting the complexity of their natural foraging tasks. We used a purposefully unnatural and thus species-fair crawling maze to test simple- and complex-rule learning, flexibility and re-learning performance. We found that M. capaccinii learned a simple rule as fast as the other species, but was slower in complex rule learning and was less flexible in response to changes in reward location. We found no differences in re-learning ability among species. Our results corroborate the hypothesis that animals' cognitive skills reflect the demands of their ecological niche.	[Clarin, Theresa M. A.; Ruczynski, Ireneusz; Siemers, Bjoern M.] Max Planck Inst Ornithol, Sensory Ecol Grp, Seewiesen, Germany; [Ruczynski, Ireneusz] Mammal Res Inst PAS, Bialowieza, Poland; [Page, Rachel A.] Smithonian Trop Res Inst, Panama City, Panama	Max Planck Society; Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences; Smithsonian Institution; Smithsonian Tropical Research Institute	Clarin, TMA (corresponding author), Max Planck Inst Ornithol, Sensory Ecol Grp, Seewiesen, Germany.	tclarin@orn.mpg.de	Page, Rachel/AAE-4816-2021; Vazquez-Dominguez, Guillermo GVD/L-7818-2014; Page, Rachel A/GQQ-2818-2022	Page, Rachel A/0000-0001-7072-0669; Ruczynski, Ireneusz/0000-0002-2308-3211	Polish Ministry of Science and Higher Education; Tabachka Bat Research Station Team	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Tabachka Bat Research Station Team	The study was undertaken with the budget of the Max Planck Society (www.mpg.de). IR was supported by the Polish Ministry of Science and Higher Education (http://www.nauka.gov.pl). Program: "Support for International Mobility of Scientists". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge Angela Clarin and Katharina Clarin for help with the logistic flow of the experiment, Renate Heckel and Leonie Baier for drawing the bats in figure 1 and 2, the Tabachka Bat Research Station Team 2010 for support, and John Ratcliffe and Irmgard Teschke for helpful comments on the manuscript. Our work was supported by the International Max Planck Research School (IMPRS) for Organismal Biology. Sadly, PD Dr. Bjorn Siemers, head of the Sensory Ecology Group in Seewiesen, Germany, passed away in May 2012. We are deeply thankful for his support, friendship, and inspiration.	Aihartza J, 2008, ACTA CHIROPTEROL, V10, P287, DOI 10.3161/150811008X414863; Aihartza JR, 2003, ACTA CHIROPTEROL, V5, P193, DOI 10.3161/001.005.0204; Almenar D, 2006, ACTA CHIROPTEROL, V8, P157, DOI 10.3161/1733-5329(2006)8[157:HSASUB]2.0.CO;2; Arlettaz R, 1997, J ANIM ECOL, V66, P897, DOI 10.2307/6005; Arlettaz R, 1996, ANIM BEHAV, V51, P1, DOI 10.1006/anbe.1996.0001; BENUS RF, 1991, EXPERIENTIA, V47, P1008, DOI 10.1007/BF01923336; Biscardi S, 2007, J ZOOL, V273, P372, DOI 10.1111/j.1469-7998.2007.00337.x; BITTERMAN ME, 1975, SCIENCE, V188, P699, DOI 10.1126/science.188.4189.699; Boonman AM, 1998, BEHAV ECOL SOCIOBIOL, V44, P99, DOI 10.1007/s002650050521; Byrne RW, 2007, CURR BIOL, V17, pR714, DOI 10.1016/j.cub.2007.05.069; Ciechanowski M, 2007, CAN J ZOOL, V85, P1249, DOI 10.1139/Z07-090; Ciechanowski M, 2010, ACTA THERIOL, V55, P301, DOI 10.4098/j.at.0001-7051.093.2009; Day LB, 1999, ANIM BEHAV, V57, P393, DOI 10.1006/anbe.1998.1007; Ruiz-Gomez MD, 2011, PHYSIOL BEHAV, V102, P317, DOI 10.1016/j.physbeh.2010.11.023; Dietz C., 2009, BATS BRITAIN EUROPE; Dingemanse NJ, 2004, BEHAV ECOL, V15, P1023, DOI 10.1093/beheco/arh115; Dukas R., 2009, COGNITIVE ECOLOGY; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; EISENBERG JF, 1978, EVOLUTION, V32, P740, DOI 10.1111/j.1558-5646.1978.tb04627.x; Flaquer C, 2008, ACTA CHIROPTEROL, V10, P61, DOI 10.3161/150811008X331090; Gibson BM, 2005, LEARN BEHAV, V33, P59; Godfrey-Smith P, 2002, EVOLUTION OF INTELLIGENCE, P223; Goerlitz HR, 2007, FUNCT ECOL, V21, P143, DOI 10.1111/j.1365-2435.2006.01212.x; Greif S, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1110; Haupt M, 2010, ANIM COGN, V13, P783, DOI 10.1007/s10071-010-0327-8; Henry M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023773; Jones G, 2006, TRENDS ECOL EVOL, V21, P149, DOI 10.1016/j.tree.2006.01.001; Jones G, 2007, P R SOC B, V274, P905, DOI 10.1098/rspb.2006.0200; Jones PL, 2011, BEHAV ECOL SOCIOBIOL, V65, P333, DOI 10.1007/s00265-010-1050-9; KALKO EKV, 1989, BEHAV ECOL SOCIOBIOL, V24, P225, DOI 10.1007/BF00295202; KRAPP F., 2011, FLEDERMAUSE EUROPAS; KRULL D, 1991, BEHAV ECOL SOCIOBIOL, V28, P247; Lefebvre L, 2008, BRAIN BEHAV EVOLUT, V72, P135, DOI 10.1159/000151473; Levin E, 2006, MAMM BIOL, V71, P139, DOI 10.1016/j.mambio.2006.01.002; Mettke-Hofmann C, 2003, P NATL ACAD SCI USA, V100, P5863, DOI 10.1073/pnas.1037505100; Meyer CFJ, 2005, J MAMMAL, V86, P587, DOI 10.1644/1545-1542(2005)86[587:HSASPO]2.0.CO;2; Micheli F, 1997, ANIM BEHAV, V53, P1149, DOI 10.1006/anbe.1996.0349; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Overington SE, 2008, BEHAV ECOL, V19, P836, DOI 10.1093/beheco/arn037; Page RA, 2012, ANIM COGN, V15, P495, DOI 10.1007/s10071-012-0474-1; PARKER ST, 1977, J HUM EVOL, V6, P623, DOI 10.1016/S0047-2484(77)80135-8; R Development Core Team, 2012, R LANG ENV STAT COMP; Ratcliffe JM, 2006, BRAIN BEHAV EVOLUT, V67, P165, DOI 10.1159/000090980; Reader SM, 2002, P NATL ACAD SCI USA, V99, P4436, DOI 10.1073/pnas.062041299; ROZIN P, 1971, PSYCHOL REV, V78, P459, DOI 10.1037/h0031878; Ruczynski I, 2011, BIOL LETTERS, V7, P153, DOI 10.1098/rsbl.2010.0585; Russo D, 2007, J EXP BIOL, V210, P166, DOI 10.1242/jeb.02644; Safi K, 2005, P ROY SOC B-BIOL SCI, V272, P179, DOI 10.1098/rspb.2004.2924; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; SCHNITZLER HU, 1994, BEHAV ECOL SOCIOBIOL, V35, P327, DOI 10.1007/BF00184422; SCHUMM A, 1991, BEHAV ECOL SOCIOBIOL, V28, P255; Siemers BM, 2004, NATURE, V429, P657, DOI 10.1038/nature02547; Siemers BM, 2006, CURR BIOL, V16, pR157, DOI 10.1016/j.cub.2006.02.056; Siemers BM, 2005, NATURWISSENSCHAFTEN, V92, P272, DOI 10.1007/s00114-005-0622-4; Siemers BM, 2001, ACTA CHIROPTEROL, V3, P211; Siemers BM, 2001, J EXP BIOL, V204, P3843; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Simmons NB, 2005, SCIENCE, V307, P527, DOI 10.1126/science.1108871; Sol D, 2005, P NATL ACAD SCI USA, V102, P5460, DOI 10.1073/pnas.0408145102; Stadelmann B, 2007, MOL PHYLOGENET EVOL, V43, P32, DOI 10.1016/j.ympev.2006.06.019; Tebbich S, 2012, ETHOLOGY, V118, P135, DOI 10.1111/j.1439-0310.2011.02001.x; Tsoar A, 2011, P NATL ACAD SCI USA, V108, pE718, DOI 10.1073/pnas.1107365108; VERBEEK MEM, 1994, ANIM BEHAV, V48, P1113, DOI 10.1006/anbe.1994.1344; Wang J, 2010, MAMMALIA, V74, P257, DOI 10.1515/MAMM.2010.034; Weinbeer M, 2007, BEHAV ECOL SOCIOBIOL, V61, P1337, DOI 10.1007/s00265-007-0364-8; Zahn A, 2009, EUROPEAN J WILDLIFE, V56, P395	67	20	20	3	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64823	10.1371/journal.pone.0064823	http://dx.doi.org/10.1371/journal.pone.0064823			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755146	gold, Green Submitted, Green Published			2022-12-27	WOS:000320579400026
J	Ketley, A; Warren, A; Holmes, E; Gering, M; Aboobaker, AA; Brook, JD				Ketley, Ami; Warren, Anne; Holmes, Emily; Gering, Martin; Aboobaker, A. Aziz; Brook, J. David			The miR-30 MicroRNA Family Targets smoothened to Regulate Hedgehog Signalling in Zebrafish Early Muscle Development	PLOS ONE			English	Article							PROTEIN-KINASE-A; SONIC-HEDGEHOG; POLARITY GENE; FEEDBACK LOOP; NEURAL-TUBE; EXPRESSION; INDUCTION; GROWTH; MUTATIONS; MEMBERS	The importance of microRNAs in development is now widely accepted. However, identifying the specific targets of individual microRNAs and understanding their biological significance remains a major challenge. We have used the zebrafish model system to evaluate the expression and function of microRNAs potentially involved in muscle development and study their interaction with predicted target genes. We altered expression of the miR-30 microRNA family and generated phenotypes that mimicked misregulation of the Hedgehog pathway. Inhibition of the miR-30 family increases activity of the pathway, resulting in elevated ptc1 expression and increased numbers of superficial slow-muscle fibres. We show that the transmembrane receptor smoothened is a target of this microRNA family. Our results indicate that fine coordination of smoothened activity by the miR-30 family allows the correct specification and differentiation of distinct muscle cell types during zebrafish embryonic development.	[Ketley, Ami; Warren, Anne; Holmes, Emily; Gering, Martin; Aboobaker, A. Aziz; Brook, J. David] Univ Nottingham, Ctr Genet & Gen, Nottingham NG7 2RD, England	University of Nottingham	Brook, JD (corresponding author), Univ Nottingham, Ctr Genet & Gen, Nottingham NG7 2RD, England.	David.Brook@nottingham.ac.uk		Aboobaker, Aziz/0000-0003-4902-5797; Gering, Martin/0000-0003-3763-0885; Brook, John David/0000-0002-5946-6740	British Heart Foundation; Muscular Dystrophy Campaign; Muscular Dystrophy Association; Wellcome Trust; Medical Research Council; British Heart Foundation [RG/07/010/23676] Funding Source: researchfish; Medical Research Council [MR/J000841/1, G0601134, G0802629] Funding Source: researchfish; MRC [G0601134, MR/J000841/1, G0802629] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission); Muscular Dystrophy Association(Muscular Dystrophy Association); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the British Heart Foundation, Muscular Dystrophy Campaign, Muscular Dystrophy Association and Wellcome Trust. A.K. was supported by a Medical Research Council PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Bazzini AA, 2011, DEV CELL, V20, P3, DOI 10.1016/j.devcel.2010.12.013; Blagden CS, 1997, GENE DEV, V11, P2163, DOI 10.1101/gad.11.17.2163; CHANG DT, 1994, DEVELOPMENT, V120, P3339; Chen WB, 2001, DEVELOPMENT, V128, P2385; Chhabra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-232; Choi WY, 2007, SCIENCE, V318, P271, DOI 10.1126/science.1147535; Concordet JP, 1996, DEVELOPMENT, V122, P2835; Currie PD, 1996, NATURE, V382, P452, DOI 10.1038/382452a0; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Du SJ, 1997, J CELL BIOL, V139, P145, DOI 10.1083/jcb.139.1.145; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Eberhart JK, 2008, NAT GENET, V40, P290, DOI 10.1038/ng.82; Ferretti E, 2008, EMBO J, V27, P2616, DOI 10.1038/emboj.2008.172; Flynt AS, 2007, NAT GENET, V39, P259, DOI 10.1038/ng1953; Friggi-Grelin F, 2008, GENETICS, V179, P429, DOI 10.1534/genetics.107.083733; Gao L, 2013, CELL SIGNAL; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Hammerschmidt M, 1996, GENE DEV, V10, P647, DOI 10.1101/gad.10.6.647; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Henry CA, 2004, DEV CELL, V7, P917, DOI 10.1016/j.devcel.2004.09.017; Hofacker IL, 2007, NAT GENET, V39, P1191, DOI 10.1038/ng1007-1191; Ichimi T, 2009, INT J CANCER, V125, P345, DOI 10.1002/ijc.24390; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; JOHNSON RL, 1994, CELL, V79, P1165, DOI 10.1016/0092-8674(94)90008-6; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kloosterman WP, 2007, PLOS BIOL, V5, P1738, DOI 10.1371/journal.pbio.0050203; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Jun-cai, 2010, Xibei Zhiwu Xuebao, V30, P30; Li Y, 2012, MOL BIOL CELL, V23, P1423, DOI 10.1091/mbc.E11-09-0777; Lin J, 2011, LEUKEMIA, V25, P145, DOI 10.1038/leu.2010.230; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Marcet B, 2011, NAT CELL BIOL, V13, P693, DOI 10.1038/ncb2241; MARIGO V, 1995, GENOMICS, V28, P44, DOI 10.1006/geno.1995.1104; Martin V, 2001, CURR BIOL, V11, P601, DOI 10.1016/S0960-9822(01)00178-6; MOHLER J, 1988, GENETICS, V120, P1061; MUNSTERBERG AE, 1995, GENE DEV, V9, P2911, DOI 10.1101/gad.9.23.2911; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Ozcan S, 2009, ISLETS, V1, P283, DOI 10.4161/isl.1.3.9968; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; ROBERTS DJ, 1995, DEVELOPMENT, V121, P3163; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Staton AA, 2011, NAT PROTOC, V6, P2035, DOI 10.1038/nprot.2011.423; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Thatcher EJ, 2007, DEV DYNAM, V236, P2172, DOI 10.1002/dvdy.21211; Ulitsky I, 2012, GENOME RES, V22, P2054, DOI 10.1101/gr.139733.112; Varga ZM, 2001, DEVELOPMENT, V128, P3497; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5; Wu FT, 2009, CLIN CANCER RES, V15, P1550, DOI 10.1158/1078-0432.CCR-08-0820; Wu TT, 2012, J BIOL CHEM, V287, P7503, DOI 10.1074/jbc.M111.292722; Xiao JN, 2007, J CELL PHYSIOL, V212, P285, DOI 10.1002/jcp.21062; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yu J, 2006, BIOCHEM BIOPH RES CO, V349, P59, DOI 10.1016/j.bbrc.2006.07.207; Zaragosi LE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r64; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503	64	28	36	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65170	10.1371/journal.pone.0065170	http://dx.doi.org/10.1371/journal.pone.0065170			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755189	Green Published, gold			2022-12-27	WOS:000320579400044
J	Ansmann, IC; Lanyon, JM; Seddon, JM; Parra, GJ				Ansmann, Ina C.; Lanyon, Janet M.; Seddon, Jennifer M.; Parra, Guido J.			Monitoring Dolphins in an Urban Marine System: Total and Effective Population Size Estimates of Indo-Pacific Bottlenose Dolphins in Moreton Bay, Australia	PLOS ONE			English	Article							CAPTURE-RECAPTURE DATA; LINKAGE DISEQUILIBRIUM; TURSIOPS-TRUNCATUS; MARKED ANIMALS; DOUBTFUL SOUND; POWER ANALYSIS; ABUNDANCE; CONSERVATION; ADUNCUS; TRENDS	Moreton Bay, Queensland, Australia is an area of high biodiversity and conservation value and home to two sympatric sub-populations of Indo-Pacific bottlenose dolphins (Tursiops aduncus). These dolphins live in close proximity to major urban developments. Successful management requires information regarding their abundance. Here, we estimate total and effective population sizes of bottlenose dolphins in Moreton Bay using photo-identification and genetic data collected during boat-based surveys in 2008-2010. Abundance (N-e) was estimated using open population mark-recapture models based on sighting histories of distinctive individuals. Effective population size (Ne) was estimated using the linkage disequilibrium method based on nuclear genetic data at 20 microsatellite markers in skin samples, and corrected for bias caused by overlapping generations (N(e)c). A total of 174 sightings of dolphin groups were recorded and 365 different individuals identified. Over the whole of Moreton Bay, a population size N of 554 +/- 22.2 (SE) (95% CI: 510-598) was estimated. The southern bay sub-population was small at an estimated N = 193 +/- 6.4 (SE) (95% CI: 181-207), while the North sub-population was more numerous, with 446 +/- 56 (SE) (95% CI: 336-556) individuals. The small estimated effective population size of the southern sub-population (N(e)c = 56, 95% CI: 33-128) raises conservation concerns. A power analysis suggested that to reliably detect small (5%) declines in size of this population would require substantial survey effort (>4 years of annual mark-recapture surveys) at the precision levels achieved here. To ensure that ecological as well as genetic diversity within this population of bottlenose dolphins is preserved, we consider that North and South sub-populations should be treated as separate management units. Systematic surveys over smaller areas holding locally-adapted sub-populations are suggested as an alternative method for increasing ability to detect abundance trends.	[Ansmann, Ina C.; Lanyon, Janet M.] Univ Queensland, Sch Biol Sci, Marine Vertebrate Ecol Res Grp, St Lucia, Qld, Australia; [Seddon, Jennifer M.] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia; [Parra, Guido J.] Flinders Univ S Australia, Sch Biol Sci, Cetacean Ecol Behav & Evolut Lab, Adelaide, SA 5001, Australia; [Parra, Guido J.] SARDI, West Beach, SA, Australia	University of Queensland; University of Queensland; Flinders University South Australia	Ansmann, IC (corresponding author), Univ Queensland, Sch Biol Sci, Marine Vertebrate Ecol Res Grp, St Lucia, Qld, Australia.	a.ina@gmx.net	Seddon, Jennifer/A-1402-2010; Seddon, Jennifer/AAM-3827-2021	Seddon, Jennifer/0000-0003-3789-6878; Seddon, Jennifer/0000-0003-3789-6878; Parra, Guido J./0000-0002-1284-4898; Lanyon, Janet/0000-0003-1453-5594	Winifred V. Scott Foundation; University of Queensland Research Scholarship (UQRS); University of Queensland International Research Award (UQIRA)	Winifred V. Scott Foundation; University of Queensland Research Scholarship (UQRS)(University of Queensland); University of Queensland International Research Award (UQIRA)(University of Queensland)	This study was supported by the Winifred V. Scott Foundation. ICA was supported during the course of this study by a University of Queensland Research Scholarship (UQRS) and University of Queensland International Research Award (UQIRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENDORF FW, 1986, ZOO BIOL, V5, P181, DOI 10.1002/zoo.1430050212; Ansmann I. C., 2011, THESIS U QUEENSLAND; Ansmann IC, 2012, MOL ECOL, V21, P4472, DOI 10.1111/j.1365-294X.2012.05722.x; Australian Bureau of Statistics, 2006, POP PROJ AUSTR 2004; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chilvers B. L., 2001, THESIS J COOK U TOWN; Chilvers BL, 2005, BIOL CONSERV, V122, P559, DOI 10.1016/j.biocon.2004.08.013; Chilvers BL, 2003, MAR MAMMAL SCI, V19, P85, DOI 10.1111/j.1748-7692.2003.tb01094.x; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Choy Darryl Low, 1998, P621; CORKERON PJ, 1989, THESIS U QUEENSLAND; Cunningham-Smith Petra, 2006, Aquatic Mammals, V32, P346, DOI 10.1578/AM.32.3.2006.346; DAFF, 2012, RECR FISH DAT; Davie P., 2011, WILD GUIDE MORETON B, V1; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; GERRODETTE T, 1987, ECOLOGY, V68, P1364, DOI 10.2307/1939220; GILBERT RO, 1973, BIOMETRICS, V29, P501, DOI 10.2307/2529173; Hale P. T., 2000, Aquatic Mammals, V26, P101; Hale Peter, 1998, P477; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Hoelzel AR, 1998, J HERED, V89, P451, DOI 10.1093/jhered/89.5.451; Hoelzel AR, 1998, J HERED, V89, P121, DOI 10.1093/jhered/89.2.121; Hooker Sascha K., 2011, Endangered Species Research, V13, P203, DOI 10.3354/esr00322; Hooker SK, 2004, BIOSCIENCE, V54, P27, DOI 10.1641/0006-3568(2004)054[0027:MRAATF]2.0.CO;2; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JOLLY GM, 1965, BIOMETRIKA, V52, P225, DOI 10.2307/2333826; Kendall WL, 1997, ECOLOGY, V78, P563; Krutzen M, 2002, MAR MAMMAL SCI, V18, P863, DOI 10.1111/j.1748-7692.2002.tb01078.x; Krutzen M, 2001, MOL ECOL NOTES, V1, P170, DOI 10.1046/j.1471-8278.2001.00065.x; Lear RJ, 1980, AUSTR NATL PARKS WIL, V4, P1; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lukoschek V, 2008, WILDLIFE RES, V35, P593, DOI 10.1071/WR07021; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; MACE GM, 1991, CONSERV BIOL, V5, P148, DOI 10.1111/j.1523-1739.1991.tb00119.x; Mann J, 2000, BEHAV ECOL, V11, P210, DOI 10.1093/beheco/11.2.210; Nater A, 2009, MOL ECOL RESOUR, V9, P531, DOI 10.1111/j.1755-0998.2008.02246.x; Neil David T., 1998, P3; NUNNEY L, 1994, CONSERV BIOL, V8, P175, DOI 10.1046/j.1523-1739.1994.08010175.x; Orams MB, 2002, TOURISM MANAGE, V23, P281, DOI 10.1016/S0261-5177(01)00080-2; Parra GJ, 2006, BIOL CONSERV, V129, P167, DOI 10.1016/j.biocon.2005.10.031; Pollock KH, 1990, WILDLIFE MONOGR, P3; Pradel R., 1993, P29; Preen AR, 1997, WILDLIFE RES, V24, P185, DOI 10.1071/WR95078; Pritchard JK, 2000, GENETICS, V155, P945; Robinson JD, 2013, EVOL APPL, V6, P290, DOI 10.1111/j.1752-4571.2012.00289.x; Schwarz CJ, 1996, BIOMETRICS, V52, P860, DOI 10.2307/2533048; SEBER GAF, 1965, BIOMETRIKA, V52, P249; Shinohara M, 1997, MOL ECOL, V6, P695, DOI 10.1046/j.1365-294X.1997.00231.x; Skinner James L., 1998, P67; State of Queensland, 2008, MAR PARKS MOR BAY ZO; Tallmon DA, 2010, MOL ECOL RESOUR, V10, P684, DOI 10.1111/j.1755-0998.2010.02831.x; Taylor BL, 2007, MAR MAMMAL SCI, V23, P157, DOI 10.1111/j.1748-7692.2006.00092.x; Thompson PM, 2000, CONSERV BIOL, V14, P1253, DOI 10.1046/j.1523-1739.2000.00099-410.x; Waples R.S., 1991, Reports of the International Whaling Commission Special Issue, P279; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; Waples RS, 2011, GENETICS, V189, P633, DOI 10.1534/genetics.111.132233; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; Wells R. S., 2002, ENCY MARINE MAMMALS, P122; Wells RS, 1998, FISH B-NOAA, V96, P647; Wells RS, 1987, CURRENT MAMMALOGY, P247; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Williams B. K., 2002, ANAL MANAGEMENT ANIM; WILLIAMS JA, 1993, CAN J ZOOL, V71, P2080, DOI 10.1139/z93-293; Wright S, 1931, GENETICS, V16, P0097; WURSIG B, 1977, SCIENCE, V198, P755, DOI 10.1126/science.198.4318.755; Wursig B., 1990, Reports of the International Whaling Commission Special Issue, P43	67	23	23	0	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65239	10.1371/journal.pone.0065239	http://dx.doi.org/10.1371/journal.pone.0065239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755197	Green Published, gold, Green Submitted			2022-12-27	WOS:000319872300060
J	van der Linde, RM; Mavaddat, N; Luben, R; Brayne, C; Simmons, RK; Khaw, KT; Kinmonth, AL				van der Linde, Rianne M.; Mavaddat, Nahal; Luben, Robert; Brayne, Carol; Simmons, Rebecca K.; Khaw, Kay Tee; Kinmonth, Ann Louise			Self-Rated Health and Cardiovascular Disease Incidence: Results from a Longitudinal Population-Based Cohort in Norfolk, UK	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; BIOMEDICAL RISK-FACTORS; EPIC-NORFOLK; PRIMARY PREVENTION; REPORTED HEALTH; MORTALITY; WOMEN; MEN; CANCER; LIFE	Introduction: Self-rated health (SRH) predicts chronic disease morbidity including cardiovascular disease (CVD). In a population-based cohort, we examined the association between SRH and incident CVD and whether this association was independent of socio-demographic, clinical and behavioural participant characteristics. Methods: Population-based prospective cohort study (European Prospective Investigation of Cancer-Norfolk). 20,941 men and women aged 39-74 years without prevalent CVD attended a baseline health examination (1993-1998) and were followed for CVD events/death until March 2007 (mean 11 years). We used a Cox proportional hazards model to quantify the association between baseline SRH (reported on a four point scale - excellent, good, fair, poor) and risk of developing CVD at follow-up after adjusting for socio-demographic, clinical and behavioural risk factors. Results: Baseline SRH was reported as excellent by 17.8% participants, good by 65.1%, fair by 16.0% and poor by 1.2%. During 225,508 person-years of follow-up, there were 55 (21.2%) CVD events in the poor SRH group and 259 (7.0%) in the excellent SRH group (HR 3.7, 95% CI 2.8-4.9). The HR remained significant after adjustment for behavioural risk factors (HR 2.6, 95% CI 1.9-3.5) and after adjustment for all socio-demographic, clinical and behavioural risk factors (HR 3.3, 95% CI 2.4-4.4). Associations were strong for both fatal and non-fatal events and remained strong over time. Conclusions: SRH is a strong predictor of incident fatal and non-fatal CVD events in this healthy, middle-aged population. Some of the association is explained by lifestyle behaviours, but SRH remains a strong predictor after adjustment for sociodemographic, clinical and behavioural risk factors and after a decade of follow-up. This easily accessible patient-centred measure of health status may be a useful indicator of individual and population health for those working in primary care and public health.	[van der Linde, Rianne M.; Mavaddat, Nahal; Luben, Robert; Brayne, Carol; Khaw, Kay Tee; Kinmonth, Ann Louise] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, Cambs, England; [Simmons, Rebecca K.] Univ Cambridge, Epidemiol Unit, Med Res Council, Cambridge, Cambs, England	University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge	van der Linde, RM (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, Cambs, England.	rmv23@medschl.cam.ac.uk	Khaw, Kay-Tee/AAZ-3209-2021; Brayne, Carol/AAA-4285-2020; Luben, Robert N/H-5519-2015	Brayne, Carol/0000-0001-5307-663X; Luben, Robert N/0000-0002-5088-6343; Simmons, Rebecca/0000-0002-7726-8529	Medical Research Council and Cancer Research UK; NIHR National School of Primary Care Research; NIHR Clinical Lectureship in Primary Care Research; MRC [MC_UU_12015/4, G0200391, MC_U106179474] Funding Source: UKRI; Medical Research Council [G1000143, MC_U106179474, G0200391, MC_UU_12015/4, G0401527] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10072, CL-2008-14-006] Funding Source: researchfish	Medical Research Council and Cancer Research UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR National School of Primary Care Research; NIHR Clinical Lectureship in Primary Care Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The EPIC-Norfolk study is supported by programme grants from the Medical Research Council and Cancer Research UK. The work was funded by the NIHR National School of Primary Care Research. Ann Louise Kinmonth and Kay Tee Khaw are NIHR Senior Investigators. Nahal Mavaddat was funded by an NIHR Clinical Lectureship in Primary Care Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appels A, 1996, SOC SCI MED, V42, P681, DOI 10.1016/0277-9536(95)00195-6; Bailis DS, 2003, SOC SCI MED, V56, P203, DOI 10.1016/S0277-9536(02)00020-5; Benjamins MR, 2004, SOC SCI MED, V59, P1297, DOI 10.1016/j.socscimed.2003.01.001; Benyamini Y, 2000, J GERONTOL B-PSYCHOL, V55, pP107, DOI 10.1093/geronb/55.2.P107; Boekholdt MS, 2004, AM J MED, V117, P390, DOI 10.1016/j.amjmed.2004.04.010; Chiuve SE, 2006, CIRCULATION, V114, P160, DOI 10.1161/CIRCULATIONAHA.106.621417; Day N, 1999, BRIT J CANCER, V80, P95; DeSalvo KB, 2006, QUAL LIFE RES, V15, P191, DOI 10.1007/s11136-005-0887-2; Ellison RC, 2004, AM HEART J, V147, P529, DOI 10.1016/j.ahj.2003.10.033; Emmelin M, 2003, J HYPERTENS, V21, P887, DOI 10.1097/00004872-200305000-00012; Heidrich J, 2002, ANN EPIDEMIOL, V12, P338, DOI 10.1016/S1047-2797(01)00300-3; Heistaro S, 2001, J EPIDEMIOL COMMUN H, V55, P227, DOI 10.1136/jech.55.4.227; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Jylha M, 2006, J CLIN EPIDEMIOL, V59, P465, DOI 10.1016/j.jclinepi.2005.12.004; Kaaks R, 1997, INT J EPIDEMIOL, V26, pS26, DOI 10.1093/ije/26.suppl_1.S26; Kamphuis MH, 2009, J AFFECT DISORDERS, V114, P184, DOI 10.1016/j.jad.2008.07.005; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Kaplan GA, 1996, INT J EPIDEMIOL, V25, P259, DOI 10.1093/ije/25.2.259; Kennedy BS, 2001, AM J EPIDEMIOL, V153, P232, DOI 10.1093/aje/153.3.232; Kuper H, 2006, AM J EPIDEMIOL, V164, P349, DOI 10.1093/aje/kwj212; LEAVEY R, 1988, SOC SCI MED, V27, P269, DOI 10.1016/0277-9536(88)90131-1; Lekander M, 2004, PSYCHOSOM MED, V66, P559, DOI 10.1097/01.psy.0000130491.95823.94; Lundberg O, 1996, SCAND J SOC MED, V24, P218, DOI 10.1177/140349489602400314; May M, 2006, HEART, V92, P1396, DOI 10.1136/hrt.2005.085381; McFadden E, 2009, SOC SCI MED, V68, P275, DOI 10.1016/j.socscimed.2008.10.012; McFadden E, 2008, EUR J EPIDEMIOL, V23, P449, DOI 10.1007/s10654-008-9262-2; McFadden E, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-230; Moller L, 1996, J EPIDEMIOL COMMUN H, V50, P423, DOI 10.1136/jech.50.4.423; Myint PK, 2007, PSYCHOSOM MED, V69, P410, DOI 10.1097/psy.0b013e318068fcd4; Newell SA, 1999, AM J PREV MED, V17, P211, DOI 10.1016/S0749-3797(99)00069-0; RIEMERSMA RA, 1990, EUR J CLIN NUTR, V44, P143; Ronksley Paul E, 2011, BMJ, V342, pd671, DOI 10.1136/bmj.d671; Rutledge T, 2010, PSYCHOSOM MED, V72, P549, DOI 10.1097/PSY.0b013e3181dc0259; Salomon JA, 2004, BMJ-BRIT MED J, V328, P258, DOI 10.1136/bmj.37963.691632.44; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; Surtees P, 2003, AM J EPIDEMIOL, V158, P1202, DOI 10.1093/aje/kwg272; Surtees PG, 2008, AM J PSYCHIAT, V165, P515, DOI 10.1176/appi.ajp.2007.07061018; WANNAMETHEE G, 1991, INT J EPIDEMIOL, V20, P239, DOI 10.1093/ije/20.1.239; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Weinehall L, 1998, J INTERN MED, V243, P99	40	51	52	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65290	10.1371/journal.pone.0065290	http://dx.doi.org/10.1371/journal.pone.0065290			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	157CD	23755212	Green Published, Green Submitted, gold			2022-12-27	WOS:000319872300070
J	Halbherr, SJ; Brostoff, T; Tippenhauer, M; Locher, S; Rentsch, MB; Zimmer, G				Halbherr, Stefan J.; Brostoff, Terza; Tippenhauer, Merve; Locher, Samira; Rentsch, Marianne Berger; Zimmer, Gert			Vaccination with Recombinant RNA Replicon Particles Protects Chickens from H5N1 Highly Pathogenic Avian Influenza Virus	PLOS ONE			English	Article							A VIRUS; SINGLE VACCINATION; CELL-DEATH; TRANSMISSION; HEMAGGLUTININS; HOST; SUBTYPES; VACCINES; DUCKS; H2	Highly pathogenic avian influenza viruses (HPAIV) of subtype H5N1 not only cause a devastating disease in domestic chickens and turkeys but also pose a continuous threat to public health. In some countries, H5N1 viruses continue to circulate and evolve into new clades and subclades. The rapid evolution of these viruses represents a problem for virus diagnosis and control. In this work, recombinant vesicular stomatitis virus (VSV) vectors expressing HA of subtype H5 were generated. To comply with biosafety issues the G gene was deleted from the VSV genome. The resulting vaccine vector VSV*Delta G(HA) was propagated on helper cells providing the VSV G protein in trans. Vaccination of chickens with a single intramuscular dose of 2x10(8) infectious replicon particles without adjuvant conferred complete protection from lethal H5N1 infection. Subsequent application of the same vaccine strongly boosted the humoral immune response and completely prevented shedding of challenge virus and transmission to sentinel birds. The vaccine allowed serological differentiation of infected from vaccinated animals (DIVA) by employing a commercially available ELISA. Immunized chickens produced antibodies with neutralizing activity against multiple H5 viruses representing clades 1, 2.2, 2.5, and low-pathogenic avian influenza viruses (classical clade). Studies using chimeric H1/H5 hemagglutinins showed that the neutralizing activity was predominantly directed against the globular head domain. In summary, these results suggest that VSV replicon particles are safe and potent DIVA vaccines that may help to control avian influenza viruses in domestic poultry.	[Halbherr, Stefan J.; Brostoff, Terza; Tippenhauer, Merve; Locher, Samira; Rentsch, Marianne Berger; Zimmer, Gert] Inst Immunol & Virol, Mittelhausern, Switzerland; [Brostoff, Terza] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA	University of California System; University of California Davis	Zimmer, G (corresponding author), Inst Immunol & Virol, Mittelhausern, Switzerland.	gert.zimmer@ivi.admin.ch		Zimmer, Gert/0000-0002-2708-2507	Swiss National Science Foundation [129669]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by Swiss National Science Foundation (www.snf.ch), grant no. 129669. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brownie C, 2011, BIOLOGICALS, V39, P224, DOI 10.1016/j.biologicals.2011.06.007; Cai ZP, 2012, J MOL BIOL, V422, P145, DOI 10.1016/j.jmb.2012.05.011; Capua I, 2004, DEV BIOLOGICALS, V119, P229; Capua I, 2009, REV SCI TECH OIE, V28, P245, DOI 10.20506/rst.28.1.1861; Cattoli G, 2011, J VIROL, V85, P8718, DOI 10.1128/JVI.02403-10; Chen HL, 2009, SCI CHINA SER C, V52, P419, DOI 10.1007/s11427-009-0068-6; Eggert D, 2010, AVIAN DIS, V54, P1224, DOI 10.1637/9410-052810-Reg.1; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Fung K P, 1989, J Singapore Paediatr Soc, V31, P129; Gambaryan AS, 2012, INFLUENZA OTHER RESP, V6, P188, DOI 10.1111/j.1750-2659.2011.00291.x; Gambotto A, 2008, LANCET, V371, P1464, DOI 10.1016/S0140-6736(08)60627-3; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Grund C, 2011, VACCINE, V29, P5567, DOI 10.1016/j.vaccine.2011.01.006; Hai R, 2012, J VIROL, V86, P5774, DOI 10.1128/JVI.00137-12; Han T, 2011, ANN NY ACAD SCI, V1217, P178, DOI 10.1111/j.1749-6632.2010.05829.x; Hanika A, 2005, J GEN VIROL, V86, P1455, DOI 10.1099/vir.0.80788-0; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hoffmann M, 2010, J GEN VIROL, V91, P2782, DOI 10.1099/vir.0.023978-0; Hofmann MA, 2008, VIRUS GENES, V37, P407, DOI 10.1007/s11262-008-0285-2; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Isoda N, 2008, ARCH VIROL, V153, P1685, DOI 10.1007/s00705-008-0171-1; Kalhoro NH, 2009, VACCINE, V27, P1174, DOI 10.1016/j.vaccine.2008.12.019; Kayali G, 2013, POULTRY SCI, V92, P114, DOI 10.3382/ps.2012-02637; Kepp O, 2009, CELL CYCLE, V8, P860, DOI 10.4161/cc.8.6.7939; Klenk Hans-Dieter, 1994, Trends in Microbiology, V2, P39, DOI 10.1016/0966-842X(94)90123-6; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; Lyles DS, 2000, MICROBIOL MOL BIOL R, V64, P709, DOI 10.1128/MMBR.64.4.709-724.2000; Manzoor R, 2009, J VIROL, V83, P1572, DOI 10.1128/JVI.01879-08; Marangon S, 2008, ZOONOSES PUBLIC HLTH, V55, P65, DOI 10.1111/j.1863-2378.2007.01086.x; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Nicolson C, 2005, VACCINE, V23, P2943, DOI 10.1016/j.vaccine.2004.08.054; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Poetri ON, 2009, VACCINE, V27, P2864, DOI 10.1016/j.vaccine.2009.02.085; Poetri O, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-74; Rentsch MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025858; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Sakabe S, 2010, ANTIVIR RES, V88, P249, DOI 10.1016/j.antiviral.2010.09.007; Schwartz JA, 2007, VIROLOGY, V366, P166, DOI 10.1016/j.virol.2007.04.021; Smirnov YA, 1999, ACTA VIROL, V43, P237; Smith GJD, 2012, INFLUENZA OTHER RESP, V6, P1, DOI 10.1111/j.1750-2659.2011.00298.x; Soda K, 2008, JPN J VET RES, V55, P93; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Stech J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn646; SUTTER G, 1995, FEBS LETT, V371, P9, DOI 10.1016/0014-5793(95)00843-X; Swayne DE, 2012, AVIAN DIS, V56, P818, DOI 10.1637/10183-041012-Review.1; van der Goot JA, 2005, P NATL ACAD SCI USA, V102, P18141, DOI 10.1073/pnas.0505098102; van der Goot JA, 2008, VIROLOGY, V382, P91, DOI 10.1016/j.virol.2008.08.037; Van Hoeven N, 2009, P NATL ACAD SCI USA, V106, P3366, DOI 10.1073/pnas.0813172106; Veits J, 2012, P NATL ACAD SCI USA, V109, P2579, DOI 10.1073/pnas.1109397109; Webster RG, 2006, EMERG INFECT DIS, V12, P3, DOI 10.3201/eid1201.051024; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; Wu WL, 2008, J VIROL, V82, P1798, DOI 10.1128/JVI.02256-07	55	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e66059	10.1371/journal.pone.0066059	http://dx.doi.org/10.1371/journal.pone.0066059			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762463	Green Submitted, Green Published, gold			2022-12-27	WOS:000320440500060
J	Wozniak, DF; Diggs-Andrews, KA; Conyers, S; Yuede, CM; Dearborn, JT; Brown, JA; Tokuda, K; Izumi, Y; Zorumski, CF; Gutmann, DH				Wozniak, David F.; Diggs-Andrews, Kelly A.; Conyers, Sara; Yuede, Carla M.; Dearborn, Joshua T.; Brown, Jacquelyn A.; Tokuda, Kazuhiro; Izumi, Yukitoshi; Zorumski, Charles F.; Gutmann, David H.			Motivational Disturbances and Effects of L-dopa Administration in Neurofibromatosis-1 Model Mice	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ATTENTION-DEFICIT; NONSELECTIVE ATTENTION; MOUSE MODEL; TYPE-1; HYPERACTIVITY; ACQUISITION; DISRUPTION; DEPRESSION; OLFACTION	Children with neurofibromatosis type 1 (NF1) frequently have cognitive and behavioral deficits. Some of these deficits have been successfully modeled in Nf1 genetically-engineered mice that develop optic gliomas (Nf1 OPG mice). In the current study, we show that abnormal motivational influences affect the behavior of Nf1 OPG mice, particularly with regard to their response to novel environmental stimuli. For example, Nf1 OPG mice made fewer spontaneous alternations in a Y-maze and fewer arm entries relative to WT controls. However, analysis of normalized alternation data demonstrated that these differences were not due to a spatial working memory deficit. Other reported behavioral results (e. g., open-field test, below) suggest that differential responses to novelty and/or other motivational influences may be more important determinants of these kinds of behavior than simple differences in locomotor activity/spontaneous movements. Importantly, normal long-term depression was observed in hippocampal slices from Nf1 OPG mice. Results from elevated plus maze testing showed that differences in exploratory activity between Nf1 OPG and WT control mice may be dependent on the environmental context (e. g., threatening or non-threatening) under which exploration is being measured. Nf1 OPG mice also exhibited decreased exploratory hole poking in a novel holeboard and showed abnormal olfactory preferences, although L-dopa (50 mg/kg) administration resolved the abnormal olfactory preference behaviors. Nf1 OPG mice displayed an attenuated response to a novel open field in terms of decreased ambulatory activity and rearing but only during the first 10 min of the session. Importantly, Nf1 OPG mice demonstrated investigative rearing deficits with regard to a novel hanging object suspended on one side of the field which were not rescued by L-dopa administration. Collectively, our results provide new data important for evaluating therapeutic treatments aimed at ameliorating NF1-associated cognitive/behavioral deficits.	[Wozniak, David F.; Conyers, Sara; Dearborn, Joshua T.; Tokuda, Kazuhiro; Izumi, Yukitoshi; Zorumski, Charles F.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Diggs-Andrews, Kelly A.; Yuede, Carla M.; Brown, Jacquelyn A.; Gutmann, David H.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Wozniak, David F.; Izumi, Yukitoshi; Zorumski, Charles F.] Washington Univ, Sch Med, Taylor Family Inst Innovat Psychiat Res, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Wozniak, DF (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.	wozniakd@psychiatry.wustl.edu		Brown, Jacquelyn/0000-0002-2002-3010; Gutmann, David/0000-0002-3127-5045; Dearborn, Joshua/0000-0003-0335-1087	Department of Defense; National Cancer Institute [U01-CA141549]; National Cancer Center Diversity Supplement Award (KADA); National Institute of Health and Human Development Center [P30 HD062171]; Neuroscience Blueprint Center Core Grant [P30 NS057105]; National Institute of Mental Health [MH077791]; Bantly Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD062171] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA141549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Center Diversity Supplement Award (KADA); National Institute of Health and Human Development Center; Neuroscience Blueprint Center Core Grant; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Bantly Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants from the Department of Defense (DHG, DFW), the National Cancer Institute (U01-CA141549; DHG), National Cancer Center Diversity Supplement Award (KADA), National Institute of Health and Human Development Center Grant P30 HD062171 (DFW), Neuroscience Blueprint Center Core Grant (P30 NS057105) to Washington University (DFW, CFZ), National Institute of Mental Health (MH077791; CFZ), and the Bantly Foundation (CFZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspide R, 2000, NEUROSCI BIOBEHAV R, V24, P59, DOI 10.1016/S0149-7634(99)00045-7; Bajenaru ML, 2003, CANCER RES, V63, P8573; BRANNAN CI, 1994, GENE DEV, V8, P1019, DOI 10.1101/gad.8.9.1019; Brosnan-Watters G, 1997, BRAIN RES PROTOC, V1, P331, DOI 10.1016/S1385-299X(97)00007-X; Brown JA, 2011, EXP NEUROL, V232, P333, DOI 10.1016/j.expneurol.2011.09.005; Brown JA, 2010, HUM MOL GENET, V19, P4515, DOI 10.1093/hmg/ddq382; Cave JW, 2009, ADV EXP MED BIOL, V651, P15; Cui YJ, 2008, CELL, V135, P549, DOI 10.1016/j.cell.2008.09.060; Diggs-Andrews KA, 2013, ANN NEUROL, V73, P309, DOI 10.1002/ana.23793; Doty RL, 2012, NEUROBIOL DIS, V46, P527, DOI 10.1016/j.nbd.2011.10.026; Dougherty JD, 2013, J NEUROSCI, V33, P2732, DOI 10.1523/JNEUROSCI.4762-12.2013; Etkin A, 2006, NEURON, V50, P127, DOI 10.1016/j.neuron.2006.03.013; FILE SE, 1975, PSYCHOPHARMACOLOGIA, V44, P53, DOI 10.1007/BF00421184; Gallitano-Mendel A, 2007, NEUROSCIENCE, V148, P633, DOI 10.1016/j.neuroscience.2007.05.050; Ghoshal N, 2012, NEUROBIOL DIS, V45, P395, DOI 10.1016/j.nbd.2011.08.029; Guilding C, 2007, EUR J NEUROSCI, V25, P99, DOI 10.1111/j.1460-9568.2006.05238.x; Gutmann DH, 1997, JAMA-J AM MED ASSOC, V278, P51, DOI 10.1001/jama.278.1.51; Hyman SL, 2006, DEV MED CHILD NEUROL, V48, P973, DOI 10.1017/S0012162206002131; Hyman SL, 2005, NEUROLOGY, V65, P1037, DOI 10.1212/01.wnl.0000179303.72345.ce; Kemp A, 2004, P NATL ACAD SCI USA, V101, P8192, DOI 10.1073/pnas.0402650101; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Lemon N, 2006, J NEUROSCI, V26, P7723, DOI 10.1523/JNEUROSCI.1454-06.2006; Li WD, 2005, CURR BIOL, V15, P1961, DOI 10.1016/j.cub.2005.09.043; Manahan-Vaughan D, 1999, P NATL ACAD SCI USA, V96, P8739, DOI 10.1073/pnas.96.15.8739; Mautner VF, 2002, DEV MED CHILD NEUROL, V44, P164, DOI 10.1017/S0012162201001876; Moy SS, 2008, BEHAV BRAIN RES, V188, P178, DOI 10.1016/j.bbr.2007.10.029; Nakao K, 2002, EUR J NEUROSCI, V16, P970, DOI 10.1046/j.1460-9568.2002.02159.x; North KN, 1997, NEUROLOGY, V48, P1121, DOI 10.1212/WNL.48.4.1121; Sato C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048180; Schaefer ML, 2000, J NEUROSCI, V20, P4809; Schecklmann M, 2013, J NEURAL TRANSM, V120, P121, DOI 10.1007/s00702-012-0855-2; Vallone D, 2002, BEHAV BRAIN RES, V130, P141, DOI 10.1016/S0166-4328(01)00428-4; Wozniak DF, 2007, NEUROBIOL DIS, V26, P14, DOI 10.1016/j.nbd.2006.11.014; Wozniak DF, 2004, NEUROBIOL DIS, V17, P403, DOI 10.1016/j.nbd.2004.08.006; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	35	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e66024	10.1371/journal.pone.0066024	http://dx.doi.org/10.1371/journal.pone.0066024			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762458	Green Submitted, gold, Green Published			2022-12-27	WOS:000320440500059
J	Zhang, LF; Mousel, MR; Wu, XL; Michal, JJ; Zhou, X; Ding, B; Dodson, MV; El-Halawany, NK; Lewis, GS; Jiang, ZH				Zhang, Lifan; Mousel, Michelle R.; Wu, Xiaolin; Michal, Jennifer J.; Zhou, Xiang; Ding, Bo; Dodson, Michael V.; El-Halawany, Nermin K.; Lewis, Gregory S.; Jiang, Zhihua			Genome-Wide Genetic Diversity and Differentially Selected Regions among Suffolk, Rambouillet, Columbia, Polypay, and Targhee Sheep	PLOS ONE			English	Article							ASSOCIATION; DROSOPHILA; RECEPTOR; FURRY; EXPRESSION; INTERACTS; TRAITS; WEIGHT; KINASE; SET	Sheep are among the major economically important livestock species worldwide because the animals produce milk, wool, skin, and meat. In the present study, the Illumina OvineSNP50 BeadChip was used to investigate genetic diversity and genome selection among Suffolk, Rambouillet, Columbia, Polypay, and Targhee sheep breeds from the United States. After quality-control filtering of SNPs (single nucleotide polymorphisms), we used 48,026 SNPs, including 46,850 SNPs on autosomes that were in Hardy-Weinberg equilibrium and 1,176 SNPs on chromosome x for analysis. Phylogenetic analysis based on all 46,850 SNPs clearly separated Suffolk from Rambouillet, Columbia, Polypay, and Targhee, which was not surprising as Rambouillet contributed to the synthesis of the later three breeds. Based on pair-wise estimates of F-ST, significant genetic differentiation appeared between Suffolk and Rambouillet (F-ST = 0.1621), while Rambouillet and Targhee had the closest relationship (F-ST = 0.0681). A scan of the genome revealed 45 and 41 differentially selected regions (DSRs) between Suffolk and Rambouillet and among Rambouillet-related breed populations, respectively. Our data indicated that regions 13 and 24 between Suffolk and Rambouillet might be good candidates for evaluating breed differences. Furthermore, ovine genome v3.1 assembly was used as reference to link functionally known homologous genes to economically important traits covered by these differentially selected regions. In brief, our present study provides a comprehensive genome-wide view on within-and between-breed genetic differentiation, biodiversity, and evolution among Suffolk, Rambouillet, Columbia, Polypay, and Targhee sheep breeds. These results may provide new guidance for the synthesis of new breeds with different breeding objectives.	[Zhang, Lifan; Michal, Jennifer J.; Zhou, Xiang; Ding, Bo; Dodson, Michael V.; Jiang, Zhihua] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA; [Mousel, Michelle R.; Lewis, Gregory S.] USDA ARS US Sheep Expt Stn, Dubois, ID USA; [Wu, Xiaolin] Univ Wisconsin Madison, Dept Dairy Sci, Madison, WI USA; [El-Halawany, Nermin K.] Natl Res Ctr, Dept Cell Biol, Div Genet Engn & Biotechnol, Dokki, Gueza, Egypt	Washington State University; University of Wisconsin System; University of Wisconsin Madison; Egyptian Knowledge Bank (EKB); National Research Centre (NRC)	Jiang, ZH (corresponding author), Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA.	jiangz@wsu.edu	Jiang, Zhihua/A-3378-2008; Wu, Xiaolin/GPX-5124-2022; Mousel, Michelle/I-6398-2013	Jiang, Zhihua/0000-0003-1986-088X; Wu, Xiaolin/0000-0002-5604-9220; Mousel, Michelle/0000-0003-1367-7005; El-Halawany, Nermin/0000-0003-4761-6550; , Lifan/0000-0002-8166-9173	USDA/FAS [58-3148-0-138]	USDA/FAS(United States Department of Agriculture (USDA))	This work was supported by USDA/FAS grant (58-3148-0-138) to ZJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald AL, 2010, ANIM GENET, V41, P449, DOI 10.1111/j.1365-2052.2010.02100.x; Bai WL, 2011, MOL BIOL REP, V38, P471, DOI 10.1007/s11033-010-0130-2; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Becker D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008689; Blackburn HD, 2011, J ANIM SCI, V89, P2336, DOI 10.2527/jas.2010-3354; Bromley CM, 2000, J ANIM SCI, V78, P846; Cong JL, 2001, DEVELOPMENT, V128, P2793; Croteau-Chonka DC, 2011, OBESITY, V19, P1019, DOI 10.1038/oby.2010.256; Dalrymple BP, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r152; Engelsma KA, 2012, J ANIM BREED GENET, V129, P195, DOI 10.1111/j.1439-0388.2012.00987.x; Fang XL, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-40; Flori L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006595; Garcia-Gamez E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021158; Gautier M, 2007, GENETICS, V177, P1059, DOI 10.1534/genetics.107.075804; Gautier M, 2011, MOL ECOL, V20, P3128, DOI 10.1111/j.1365-294X.2011.05163.x; Goldammer T, 2009, CYTOGENET GENOME RES, V126, P63, DOI 10.1159/000245907; Goudet J, 2002, FSTAT PROGRAM ESTIMA, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A111627; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; He Y, 2005, MOL BIOL CELL, V16, P689, DOI 10.1091/mbc.E04-09-0828; Herrmann E, 1997, J COMPUT GRAPH STAT, V6, P35, DOI 10.2307/1390723; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HULET CV, 1984, J ANIM SCI, V58, P15, DOI 10.2527/jas1984.58115x; Ikeda M, 2012, J BIOL CHEM, V287, P27670, DOI 10.1074/jbc.M112.378968; Johnston SE, 2011, MOL ECOL, V20, P2555, DOI 10.1111/j.1365-294X.2011.05076.x; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Li MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026256; Li RW, 2005, J COMP NEUROL, V488, P11, DOI 10.1002/cne.20566; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; McPhee HC, 1947, SCI FARMING YB AGR 1; Mejias R, 2011, P NATL ACAD SCI USA, V108, P4920, DOI 10.1073/pnas.1102233108; Michelizzi VN, 2011, INT J BIOL SCI, V7, P18, DOI 10.7150/ijbs.7.18; Miller JM, 2011, MOL ECOL RESOUR, V11, P314, DOI 10.1111/j.1755-0998.2010.02918.x; Nicholson G, 2002, J ROY STAT SOC B, V64, P695, DOI 10.1111/1467-9868.00357; Norris BJ, 2008, GENOME RES, V18, P1282, DOI 10.1101/gr.072090.107; Parker CC, 2011, MAMM GENOME, V22, P563, DOI 10.1007/s00335-011-9349-z; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Salle G, 2012, J ANIM SCI, V90, P4690, DOI 10.2527/jas.2012-5121; Sawalha RM, 2005, J ANIM SCI, V83, P786; Sherman EL, 2008, J ANIM SCI, V86, P1, DOI 10.2527/jas.2006-799; Takamiya K, 2008, J NEUROSCI, V28, P5752, DOI 10.1523/JNEUROSCI.0654-08.2008; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Zhao X, 2012, ANIM GENET, V43, P9, DOI 10.1111/j.1365-2052.2011.02304.x; Zhao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021739	45	37	37	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65942	10.1371/journal.pone.0065942	http://dx.doi.org/10.1371/journal.pone.0065942			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762451	gold, Green Published, Green Submitted			2022-12-27	WOS:000320440500057
J	Ozhand, A; Lee, E; Wu, AH; Ellingjord-Dale, M; Akslen, LA; McKean-Cowdin, R; Ursin, G				Ozhand, Ali; Lee, Eunjung; Wu, Anna H.; Ellingjord-Dale, Merete; Akslen, Lars A.; McKean-Cowdin, Roberta; Ursin, Giske			Variation in Inflammatory Cytokine/Growth-Factor Genes and Mammographic Density in Premenopausal Women Aged 50-55	PLOS ONE			English	Article							SINGAPORE CHINESE WOMEN; BREAST-CANCER RISK; POSTMENOPAUSAL HORMONE-THERAPY; IGF-BINDING PROTEIN-3; GROWTH-FACTOR; SUSCEPTIBILITY LOCI; PARENCHYMAL PATTERNS; MULTIETHNIC COHORT; RANDOMIZED-TRIAL; NORWEGIAN WOMEN	Background: Mammographic density (MD) has been found to be an independent risk factor for breast cancer. Although data from twin studies suggest that MD has a strong genetic component, the exact genes involved remain to be identified. Alterations in stromal composition and the number of epithelial cells are the most predominant histopathological determinants of mammographic density. Interactions between the breast stroma and epithelium are critically important in the maturation and development of the mammary gland and the cross-talk between these cells are mediated by paracrine growth factors and cytokines. The potential impact of genetic variation in growth factors and cytokines on MD is largely unknown. Methods: We investigated the association between 89 single nucleotide polymorphisms (SNPs) in 7 cytokine/growth-factor genes (FGFR2, IGFBP1, IGFBP3, TGFB1, TNF, VEGF, IL6) and percent MD in 301 premenopausal women (aged 50 to 55 years) participating in the Norwegian Breast Cancer Screening Program. We evaluated the suggestive associations in 216 premenopausal Singapore Chinese Women of the same age. Results: We found statistically significant associations between 9 tagging SNPs in the IL6 gene and MD in Norwegian women; the effect ranged from 3-5% in MD per variant allele (p-values = 0.02 to 0.0002). One SNP in the IL6 (rs10242595) significantly influenced MD in Singapore Chinese women. Conclusion: Genetic variations in IL6 may be associated with MD and therefore may be an indicator of breast cancer risk in premenopausal women.	[Ozhand, Ali; Lee, Eunjung; Wu, Anna H.; McKean-Cowdin, Roberta; Ursin, Giske] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90033 USA; [Ellingjord-Dale, Merete; Ursin, Giske] Univ Oslo, Inst Basic Med Sci, Oslo, Norway; [Akslen, Lars A.] Univ Bergen, Dept Clin Med, Gade Laboratorium Pathol, Ctr Canc Biomarkers, Bergen, Norway; [Ursin, Giske] Canc Registry Norway, Oslo, Norway	University of Southern California; University of Oslo; University of Bergen; University of Oslo	Ursin, G (corresponding author), Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90033 USA.	giske.ursin@kreftregisteret.no	Akslen, Lars A./AAG-6097-2021; Akslen, Lars A/C-1202-2017; Ursin, Giske/U-6637-2017	Akslen, Lars A./0000-0003-2710-9543; Akslen, Lars A/0000-0003-2710-9543; Ursin, Giske/0000-0002-0835-9507; Lee, Eunjung/0000-0002-8287-6131				Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Alowami S, 2003, BREAST CANCER RES, V5, pR129, DOI 10.1186/bcr622; Andersson N, 2010, INT J OBESITY, V34, P1011, DOI 10.1038/ijo.2010.27; BASOLO F, 1993, INT J CANCER, V55, P926, DOI 10.1002/ijc.2910550609; Biong M, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-9; Boyd NF, 1998, CANCER EPIDEM BIOMAR, V7, P1133; Boyd NF, 2002, NEW ENGL J MED, V347, P886, DOI 10.1056/NEJMoa013390; Boyd NF, 2002, BRIT J CANCER, V87, P876, DOI 10.1038/sj.bjc.6600537; BOYD NF, 1995, J NATL CANCER I, V87, P670, DOI 10.1093/jnci/87.9.670; Boyd NF, 1998, BREAST IMAGING, P113, DOI 10.3233/BD-1998-103-412; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; Bremnes Y, 2007, CANCER EPIDEM BIOMAR, V16, P57, DOI 10.1158/1055-9965.EPI-06-0788; Byrne C, 2000, CANCER RES, V60, P3744; Cullen K J, 1992, Cancer Treat Res, V61, P413; DICKSON RB, 1995, ENDOCR REV, V16, P559, DOI 10.1210/er.16.5.559; Diorio C, 2005, CANCER EPIDEM BIOMAR, V14, P1065, DOI 10.1158/1055-9965.EPI-04-0706; Edlund CK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-174; Ellingjord-Dale M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3337; Fletcher O, 2011, JNCI-J NATL CANCER I, V103, P425, DOI 10.1093/jnci/djq563; Greendale GA, 2003, J NATL CANCER I, V95, P30, DOI 10.1093/jnci/95.1.30; Guo YP, 2001, CANCER EPIDEM BIOMAR, V10, P243; Hawes D, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1408; Hofvind S, 2007, EUR J EPIDEMIOL, V22, P447, DOI 10.1007/s10654-007-9137-y; Jakes RW, 2002, CANCER EPIDEM BIOMAR, V11, P608; Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008; Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025; KLEINBAUM DG, 2007, APPL REGRESSION ANAL; Knupfer H, 2007, BREAST CANCER RES TR, V102, P129, DOI 10.1007/s10549-006-9328-3; Lee E, 2008, CANCER EPIDEM BIOMAR, V17, P258, DOI 10.1158/1055-9965.EPI-07-2749; Lee E, 2012, CANCER EPIDEM BIOMAR, V21, P635, DOI 10.1158/1055-9965.EPI-11-1042; Lindstrom S, 2011, NAT GENET, V43, P185, DOI 10.1038/ng.760; McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965.EPI-06-0034; McTiernan A, 2005, JNCI-J NATL CANCER I, V97, P1366, DOI 10.1093/jnci/dji279; Mulhall C, 2005, CANCER EPIDEM BIOMAR, V14, P2648, DOI 10.1158/1055-9965.EPI-04-0374; Ng EH, 1998, CANCER-AM CANCER SOC, V82, P1521, DOI 10.1002/(SICI)1097-0142(19980415)82:8<1521::AID-CNCR14>3.3.CO;2-B; Purohit A, 2002, BREAST CANCER RES, V4, P65, DOI 10.1186/bcr425; Qureshi SA, 2011, NUTR CANCER, V63, P1011, DOI 10.1080/01635581.2011.605983; Reeves KW, 2010, BREAST CANC RES TREA; SAKAKURA T, 1991, INT REV CYTOL, V125, P165, DOI 10.1016/S0074-7696(08)61219-X; Silva ID, 2006, CANCER EPIDEM BIOMAR, V15, P449, DOI 10.1158/1055-9965.EPI-05-0555; Sternlicht MD, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1368; Stone J, 2007, CANCER EPIDEM BIOMAR, V16, P1479, DOI 10.1158/1055-9965.EPI-07-0107; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Tamimi RM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1655; Taverne CW, 2010, BREAST CANCER RES TR, V123, P843, DOI 10.1007/s10549-010-0778-2; Ursin G, 2003, CANCER EPIDEM BIOMAR, V12, P332; Ursin G, 2009, CANCER EPIDEM BIOMAR, V18, P102, DOI 10.1158/1055-9965.EPI-07-2857; Ursin G, 2006, NUTR CANCER, V56, P128, DOI 10.1207/s15327914nc5602_2; Vachon CM, 2000, CANCER CAUSE CONTROL, V11, P653, DOI 10.1023/A:1008926607428; Verheus M, 2008, BREAST CANCER RES TR, V112, P109, DOI 10.1007/s10549-007-9827-x; Verheus M, 2010, INT J CANCER, V127, P1115, DOI 10.1002/ijc.25142; Woolcott CG, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2229; Wu AH, 2008, CANCER EPIDEM BIOMAR, V17, P3358, DOI 10.1158/1055-9965.EPI-08-0132; Yang WT, 2010, BREAST CANCER RES TR, V119, P305, DOI 10.1007/s10549-009-0350-0; Zhang XQ, 2009, INT J MOL MED, V23, P485, DOI 10.3892/ijmm_00000155	55	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65313	10.1371/journal.pone.0065313	http://dx.doi.org/10.1371/journal.pone.0065313			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762340	Green Submitted, gold, Green Published			2022-12-27	WOS:000321094800039
J	Wang, Y; Xu, LX; Pan, YL; Wang, ZX; Zhang, ZB				Wang, Yu; Xu, Linxi; Pan, Yongliang; Wang, Zuoxin; Zhang, Zhibin			Species Differences in the Immunoreactive Expression of Oxytocin, Vasopressin, Tyrosine Hydroxylase and Estrogen Receptor Alpha in the Brain of Mongolian Gerbils (Meriones unguiculatus) and Chinese Striped Hamsters (Cricetulus barabensis)	PLOS ONE			English	Article							MEDIAL PREOPTIC AREA; ANTEROVENTRAL PERIVENTRICULAR NUCLEUS; VOLES MICROTUS-OCHROGASTER; MESSENGER-RIBONUCLEIC-ACID; FEMALE SEXUAL RECEPTIVITY; PAIR BOND FORMATION; MATERNAL-BEHAVIOR; PRAIRIE VOLES; ANTERIOR HYPOTHALAMUS; AGGRESSIVE-BEHAVIOR	Species differences in neurochemical expression and activity in the brain may play an important role in species-specific patterns of social behavior. In the present study, we used immunoreactive (ir) labeling to compare the regional density of cells containing oxytocin (OT), vasopressin (AVP), tyrosine hydroxylase (TH), or estrogen receptor alpha (ER alpha) staining in the brains of social Mongolian gerbils (Meriones unguiculatus) and solitary Chinese striped hamsters (Cricetulus barabensis). Multiple region-and neurochemical-specific species differences were found. In the anterior hypothalamus (AH), Mongolian gerbils had higher densities of AVP-ir and ER alpha-ir cells than Chinese striped hamsters. In the lateral hypothalamus (LH), Mongolian gerbils also had higher densities of AVP-ir and TH-ir cells, but a lower density of OT-ir cells, than Chinese striped hamsters. Furthermore, in the anterior nucleus of the medial preoptic area (MPOAa), Mongolian gerbils had higher densities of OT-ir and AVP-ir cells than Chinese striped hamsters, and an opposite pattern was found in the posterior nucleus of the MPOA (MPOAp). Some sex differences were also observed. Females of both species had higher densities of TH-ir cells in the MPOAa and of OT-ir cells in the intermediate nucleus of the MPOA (MPOAi) than males. Given the role of these neurochemicals in social behaviors, our data provide additional evidence to support the notion that species-specific patterns of neurochemical expression in the brain may be involved in species differences in social behaviors associated with different life strategies.	[Wang, Yu; Xu, Linxi; Pan, Yongliang; Zhang, Zhibin] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Wang, Yu; Xu, Linxi] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Zuoxin] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; [Wang, Zuoxin] Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Zhang, ZB (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	zhangzb@ioz.ac.cn			National Natural Science Foundation of China [30930016, 31272321]; National Basic Research Program of China [2007CB109101]; National Science and Technology Ministry [2009BAI83B01]; Chinese Academy of Sciences [CZBZX-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National Science and Technology Ministry; Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was supported by grants from the National Natural Science Foundation of China (30930016 and 31272321), the National Basic Research Program of China (2007CB109101), the National Science and Technology Ministry (2009BAI83B01) and the Chinese Academy of Sciences (CZBZX-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGREN G, 1989, ANIM BEHAV, V37, P11, DOI 10.1016/0003-3472(89)90002-X; AGREN G, 1989, ANIM BEHAV, V37, P28, DOI 10.1016/0003-3472(89)90003-1; AGREN G, 1984, ANIM BEHAV, V32, P528, DOI 10.1016/S0003-3472(84)80291-2; AKAISHI T, 1985, BRAIN RES, V335, P302, DOI 10.1016/0006-8993(85)90481-0; Aragona BJ, 2006, NAT NEUROSCI, V9, P133, DOI 10.1038/nn1613; Aragona BJ, 2003, J NEUROSCI, V23, P3483, DOI 10.1523/jneurosci.23-08-03483.2003; Aragona Brandon J., 2002, Hormones and Behavior, V41, P455; BAMSHAD M, 1993, J NEUROENDOCRINOL, V5, P247, DOI 10.1111/j.1365-2826.1993.tb00480.x; BARTFAI T, 1988, ANNU REV PHARMACOL, V28, P285, DOI 10.1146/annurev.pa.28.040188.001441; Beery AK, 2008, J COMP NEUROL, V507, P1847, DOI 10.1002/cne.21638; Bester-Meredith JK, 2003, BEHAV NEUROSCI, V117, P455, DOI 10.1037/0735-7044.117.3.455; Bester-Meredith JK, 2001, HORM BEHAV, V40, P51, DOI 10.1006/hbeh.2001.1666; Bester-Meredith JK, 1999, HORM BEHAV, V36, P25, DOI 10.1006/hbeh.1999.1522; Bodo C, 2006, ENDOCRINOLOGY, V147, P415, DOI 10.1210/en.2005-0834; Bridges NJ, 2004, PHYSIOL BEHAV, V83, P119, DOI 10.1016/j.physbeh.2004.08.002; Buccafusco JJ, 2000, J PHARMACOL EXP THER, V295, P438; Caldwell HK, 2004, HORM BEHAV, V46, P444, DOI 10.1016/j.yhbeh.2004.04.006; CALDWELL JD, 1989, BEHAV NEUROSCI, V103, P655, DOI 10.1037/0735-7044.103.3.655; CALDWELL JD, 1987, NEUROENDOCRINOLOGY, V46, P39, DOI 10.1159/000124794; Caldwell JD, 1999, HORM BEHAV, V35, P38, DOI 10.1006/hbeh.1998.1494; Champagne FA, 2006, ENDOCRINOLOGY, V147, P2909, DOI 10.1210/en.2005-1119; Consiglio AR, 2005, PHYSIOL BEHAV, V85, P354, DOI 10.1016/j.physbeh.2005.05.002; Cushing BS, 2008, J NEUROSCI, V28, P10399, DOI 10.1523/JNEUROSCI.1928-08.2008; Cushing BS, 2006, J COMP NEUROL, V494, P595, DOI 10.1002/cne.20826; Cushing BS, 2004, BRAIN RES, V1016, P247, DOI 10.1016/j.brainres.2004.05.010; DASILVA RKP, 1995, J AUTONOM NERV SYST, V53, P195, DOI 10.1016/0165-1838(94)00176-K; DELGADO JMR, 1953, AM J PHYSIOL, V172, P162, DOI 10.1152/ajplegacy.1952.172.1.162; Dellovade TL, 1999, J NEUROENDOCRINOL, V11, P1, DOI 10.1046/j.1365-2826.1999.00250.x; Delville W, 1996, PHYSIOL BEHAV, V60, P25, DOI 10.1016/0031-9384(95)02246-5; Delville Y, 2000, BRAIN BEHAV EVOLUT, V55, P53, DOI 10.1159/000006642; Dudas B, 2006, J NEUROENDOCRINOL, V18, P895, DOI 10.1111/j.1365-2826.2006.01487.x; ELWOOD RW, 1978, ANIM BEHAV, V26, P438, DOI 10.1016/0003-3472(78)90061-1; ELWOOD RW, 1975, ANIM BEHAV, V23, P766, DOI 10.1016/0003-3472(75)90104-9; ENGELMANN M, 1994, PHYSIOL BEHAV, V55, P145, DOI 10.1016/0031-9384(94)90022-1; EVERITT BJ, 1990, NEUROSCI BIOBEHAV R, V14, P217, DOI 10.1016/S0149-7634(05)80222-2; Ferguson JN, 2001, J NEUROSCI, V21, P8278; FERRIS CF, 1992, ANN NY ACAD SCI, V652, P456, DOI 10.1111/j.1749-6632.1992.tb34382.x; FERRIS CF, 1988, PHYSIOL BEHAV, V44, P235, DOI 10.1016/0031-9384(88)90144-8; Ferris CF, 1997, J NEUROSCI, V17, P4331; Fowler CD, 2005, J COMP NEUROL, V489, P166, DOI 10.1002/cne.20638; Francis DD, 2002, J NEUROENDOCRINOL, V14, P349, DOI 10.1046/j.0007-1331.2002.00776.x; Gammie SC, 1999, J NEUROSCI, V19, P8027; GERLING S, 1979, ANIM BEHAV, V27, P310, DOI 10.1016/0003-3472(79)90153-2; Gingrich B, 2000, BEHAV NEUROSCI, V114, P173, DOI 10.1037/0735-7044.114.1.173; Giovenardi M, 1998, PHYSIOL BEHAV, V63, P351, DOI 10.1016/S0031-9384(97)00434-4; Giuliano F, 1996, NEUROSCI LETT, V209, P1, DOI 10.1016/0304-3940(96)12594-5; Gobrogge KL, 2007, J COMP NEUROL, V502, P1109, DOI 10.1002/cne.21364; Gobrogge KL, 2009, P NATL ACAD SCI USA, V106, P19144, DOI 10.1073/pnas.0908620106; GRAY P, 1984, BEHAV NEUROSCI, V98, P703, DOI 10.1037/0735-7044.98.4.703; Greco B, 2001, ENDOCRINOLOGY, V142, P5172, DOI 10.1210/en.142.12.5172; GROMOV IM, 1963, FAUNA USSR, P513; HANSEN S, 1994, PHYSIOL BEHAV, V55, P615, DOI 10.1016/0031-9384(94)90034-5; Harmon AC, 2002, J NEUROENDOCRINOL, V14, P963, DOI 10.1046/j.1365-2826.2002.00863.x; HENNESSEY AC, 1994, PHYSIOL BEHAV, V55, P905, DOI 10.1016/0031-9384(94)90078-7; INSEL TR, 1994, J NEUROSCI, V14, P5381; INSEL TR, 1992, P NATL ACAD SCI USA, V89, P5981, DOI 10.1073/pnas.89.13.5981; Kawamata M, 2004, BIOCHEM BIOPH RES CO, V321, P695, DOI 10.1016/j.bbrc.2004.07.019; Keer SE, 1999, PHYSIOL BEHAV, V67, P659, DOI 10.1016/S0031-9384(99)00116-X; Landgraf R, 2003, EUR J NEUROSCI, V18, P403, DOI 10.1046/j.1460-9568.2003.02750.x; Lei K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008931; Liu W, 2009, J ZOOL, V278, P249, DOI 10.1111/j.1469-7998.2009.00574.x; Liu Y, 2003, NEUROSCIENCE, V121, P537, DOI 10.1016/S0306-4522(03)00555-4; Liu Y, 2001, BEHAV NEUROSCI, V115, P910, DOI 10.1037//0735-7044.115.4.910; Lonstein JS, 2000, NEUROENDOCRINOLOGY, V72, P91, DOI 10.1159/000054576; Lubin DA, 2003, PHARMACOL BIOCHEM BE, V74, P449, DOI 10.1016/S0091-3057(02)01027-4; Luo Z.X., 2000, FAUNA SINICA MAMMALI, V6, P121; MADISON DM, 1984, AM MIDL NAT, V112, P201, DOI 10.2307/2425476; MALLON DP, 1985, MAMMAL REV, V15, P71, DOI 10.1111/j.1365-2907.1985.tb00389.x; MCDERMOTT JL, 1980, BEHAV NEURAL BIOL, V29, P63, DOI 10.1016/S0163-1047(80)92484-X; McGinnis MY, 2002, BRAIN RES BULL, V59, P227, DOI 10.1016/S0361-9230(02)00869-9; Mohankumar PS, 1997, BRAIN RES BULL, V42, P265, DOI 10.1016/S0361-9230(96)00210-9; NIELSEN S, 1995, P NATL ACAD SCI USA, V92, P1013, DOI 10.1073/pnas.92.4.1013; Northcutt KV, 2007, J COMP NEUROL, V500, P103, DOI 10.1002/cne.21148; Numan M, 2005, BEHAV NEUROSCI, V119, P1588, DOI 10.1037/0735-7044.119.6.1588; NYBY J, 1973, HORM BEHAV, V4, P283, DOI 10.1016/0018-506X(73)90027-5; Ogawa S, 1998, ENDOCRINOLOGY, V139, P5070, DOI 10.1210/en.139.12.5070; Olazabal DE, 2006, NEUROSCIENCE, V141, P559, DOI 10.1016/j.neuroscience.2006.04.017; OSTERMEYER MC, 1984, BEHAVIOUR, V91, P61, DOI 10.1163/156853984X00218; Pan Y, 2011, J NEUROENDOCRINOL, V23, P926, DOI 10.1111/j.1365-2826.2011.02210.x; PANAYOTACOPOULOU MT, 1994, DEV BRAIN RES, V83, P59, DOI 10.1016/0165-3806(94)90179-1; PEDERSEN CA, 1994, BEHAV NEUROSCI, V108, P1163, DOI 10.1037/0735-7044.108.6.1163; PELLIS SM, 1993, NEUROSCI LETT, V158, P13, DOI 10.1016/0304-3940(93)90600-P; PFAUS JG, 1991, BEHAV NEUROSCI, V105, P727, DOI 10.1037/0735-7044.105.5.727; Plumari L, 2002, J NEUROENDOCRINOL, V14, P971, DOI 10.1046/j.1365-2826.2002.00866.x; Popik P, 1991, Eur Neuropsychopharmacol, V1, P555, DOI 10.1016/0924-977X(91)90010-R; POPIK P, 1992, BEHAV PHARMACOL, V3, P351; Prates EJ, 2005, BEHAV PROCESS, V70, P104, DOI 10.1016/j.beproc.2005.04.010; Reuss S, 1999, NEUROSCI LETT, V266, P29, DOI 10.1016/S0304-3940(99)00245-1; Rissman EF, 2008, J NEUROENDOCRINOL, V20, P873, DOI 10.1111/j.1365-2826.2008.01738.x; Riters LV, 1997, ANN NY ACAD SCI, V807, P478, DOI 10.1111/j.1749-6632.1997.tb51943.x; Rosen GJ, 2008, NEUROSCIENCE, V155, P809, DOI 10.1016/j.neuroscience.2008.05.039; Rosenblatt JS, 1996, HORM BEHAV, V30, P201, DOI 10.1006/hbeh.1996.0025; Schradin C, 1999, NEWS PHYSIOL SCI, V14, P223, DOI 10.1152/physiologyonline.1999.14.6.223; Scordalakes EM, 2004, GENES BRAIN BEHAV, V3, P20, DOI 10.1111/j.1601-183X.2004.00036.x; SHUGHRUE PJ, 1992, ENDOCRINOLOGY, V131, P381, DOI 10.1210/en.131.1.381; Silva MRP, 2003, PHARMACOL TOXICOL, V93, P42, DOI 10.1034/j.1600-0773.2003.930106.x; SIMERLY RB, 1989, MOL BRAIN RES, V6, P297, DOI 10.1016/0169-328X(89)90075-2; SIMERLY RB, 1985, NEUROENDOCRINOLOGY, V40, P501, DOI 10.1159/000124122; Simerly RB, 1997, P NATL ACAD SCI USA, V94, P14077, DOI 10.1073/pnas.94.25.14077; Simerly RB, 1996, J NEUROENDOCRINOL, V8, P45, DOI 10.1111/j.1365-2826.1996.tb00685.x; SIMERLY RB, 1985, BRAIN RES, V330, P55, DOI 10.1016/0006-8993(85)90007-1; SKIRROW MH, 1976, CAN J ZOOL, V54, P361, DOI 10.1139/z76-040; Sorensen DB, 2005, APPL ANIM BEHAV SCI, V94, P181, DOI 10.1016/j.applanim.2005.02.004; Spiteri T, 2010, NEUROENDOCRINOLOGY, V91, P142, DOI 10.1159/000255766; Tabak J, 2010, ENDOCRINOLOGY, V151, P1806, DOI 10.1210/en.2009-1267; Tetel MJ, 2010, BBA-GEN SUBJECTS, V1800, P1084, DOI 10.1016/j.bbagen.2010.01.008; Trainor BC, 2006, HORM BEHAV, V50, P338, DOI 10.1016/j.yhbeh.2006.04.002; WANG MJ, 1998, ECOLOGY MANAGEMENT R, P221; Wang YZ, 1998, ECOLOGY MANAGEMENT R, P20; Wang ZX, 1996, J COMP NEUROL, V366, P726; Wang ZX, 1999, BEHAV NEUROSCI, V113, P602, DOI 10.1037/0735-7044.113.3.602; WANG ZX, 1995, BEHAV NEUROSCI, V109, P305, DOI 10.1037/0735-7044.109.2.305; Wang ZX, 1998, PROG BRAIN RES, V119, P483; Wang ZX, 1997, BRAIN RES, V767, P321, DOI 10.1016/S0006-8993(97)00617-3; WARNER RK, 1991, BRAIN RES, V540, P177, DOI 10.1016/0006-8993(91)90505-P; WEITZMAN RE, 1979, WESTERN J MED, V131, P373; Wu RY, 2011, J COMP PHYSIOL A, V197, P267, DOI 10.1007/s00359-010-0609-2; Xia W., 1982, Acta Theriologica Sinica, V2, P51; Xu L, 2010, NEUROSCIENCE, V169, P1235, DOI 10.1016/j.neuroscience.2010.05.064; Yang Yu-ping, 2002, NeiMongol Daxue Xuebao Ziran Kexue Ban, V33, P201; Young KA, 2008, COMP BIOCHEM PHYS C, V148, P401, DOI 10.1016/j.cbpc.2008.02.004; Young LJ, 2001, HORM BEHAV, V40, P133, DOI 10.1006/hbeh.2001.1691; Zup SL, 2003, J NEUROSCI, V23, P2357	124	11	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65807	10.1371/journal.pone.0065807	http://dx.doi.org/10.1371/journal.pone.0065807			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762431	Green Published, gold, Green Submitted			2022-12-27	WOS:000321094800074
J	Ahmed, N; Owen, TE; Rubinger, M; Williams, G; Nugent, Z; Ahmed, S; Cooke, A				Ahmed, Naseer; Owen, Timothy E.; Rubinger, Morel; Williams, Gaynor; Nugent, Zoann; Ahmed, Shahida; Cooke, Andrew			Early Stage WHO Grade I and II Follicular Lymphoma Treated with Radiation Therapy Alone	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; TERM-FOLLOW-UP; INTERNATIONAL PROGNOSTIC INDEX; INITIAL THERAPY; RADIOTHERAPY; FIELD; DISEASE; RECOMMENDATIONS; CLASSIFICATION; TRIAL	Objectives: This retrospective study was undertaken to evaluate the outcome of patients with stage I or II (limited stage), grade I-II follicular non-Hodgkin's lymphoma (FL) treated with radiation therapy (RT) alone as initial management. Methods: Patients with stage I or II and pathologically confirmed WHO grade I or II FL treated initially with RT alone between 1982 and 2008 were identified from a population based cancer registry. Results: Forty patients with a mean age 61.3 years at diagnosis were identified. The median follow up was 6.9 years from the end of radiation therapy. Stage was I (n = 26) and II (n = 14). None had B symptoms. The Follicular Lymphoma International Prognostic Index (FLIPI) was low risk in 26 patients and intermediate risk in 5. Doses ranged from 15 Gy to 48 Gy, with a median dose of 35 Gy. All patients achieved a complete clinical response (CR). 5 and 10 year overall survival (OS) was 86% and 59%, progression free survival (PFS) 67% and 54%. Age >= 60 at diagnosis was associated with reduced OS, p = 0.029, but did not affect PFS. No other clinical features including grade or FLIPI were significant for outcomes. Local failure was uncommon occurring in 8% (3/40) although this was 21% (3/14) of all recurrences. Conclusions: OS and PFS outcomes for radiation alone in limited stage low grade FL patients from this single institution study are consistent with previously published data. No predictors were prognostic for PFS. A dose of <= 35 Gy may be appropriate. In this highly selected homogeneous group the FLIPI loses discriminating ability. Local control is excellent, and a majority of patients are free of disease after 5 years.	[Ahmed, Naseer; Rubinger, Morel; Williams, Gaynor; Ahmed, Shahida; Cooke, Andrew] Univ Manitoba, Winnipeg, MB, Canada; [Ahmed, Naseer; Rubinger, Morel; Nugent, Zoann; Ahmed, Shahida; Cooke, Andrew] CancerCare Manitoba, Winnipeg, MB, Canada; [Owen, Timothy E.] Queens Univ, Kingston, ON, Canada; [Owen, Timothy E.] Canc Ctr Southeastern Ontario, Kingston, ON, Canada	University of Manitoba; CancerCare Manitoba Foundation; Queens University - Canada	Ahmed, N (corresponding author), Univ Manitoba, Winnipeg, MB, Canada.	naseer.ahmed@cancercare.mb.ca						Advani R, 2004, J CLIN ONCOL, V22, P1454, DOI 10.1200/JCO.2004.10.086; CARBONE PP, 1971, CANCER RES, V31, P1860; Chan WC, 1997, BLOOD, V89, P3909; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Dancey JE, 2009, EUR J CANCER, V45, P281, DOI 10.1016/j.ejca.2008.10.042; Dreyling M, 2009, ANN ONCOL, V20, P119, DOI 10.1093/annonc/mdp148; Eich HT, 2009, STRAHLENTHER ONKOL, V185, P288, DOI 10.1007/s00066-009-1937-4; Engelhard M, 2007, STRAHLENTHER ONKOL, V183, P129; Friedberg JW, 2012, J CLIN ONCOL, V30, P3368, DOI 10.1200/JCO.2011.40.6546; GOSPODAROWICZ MK, 1984, INT J RADIAT ONCOL, V10, P489, DOI 10.1016/0360-3016(84)90028-2; Group GLGLS, 2010, RIT INV FIELD RAD EA; Guadagnolo BA, 2006, INT J RADIAT ONCOL, V64, P928, DOI 10.1016/j.ijrobp.2005.08.010; Heinzelmann F, 2010, STRAHLENTHER ONKOL, V186, P191, DOI 10.1007/s00066-010-2090-9; HUDSON BV, 1994, BRIT J CANCER, V69, P1088, DOI 10.1038/bjc.1994.213; Kamath SS, 1999, INT J RADIAT ONCOL, V44, P563, DOI 10.1016/S0360-3016(99)00051-6; Katz MH, 2006, MULTIVARIABLE ANALYSIS: A PRACTICAL GUIDE FOR CLINICIANS, 2ND EDITION, P1, DOI 10.1017/CBO9780511811692; KELSEY SM, 1994, MED ONCOL, V11, P19, DOI 10.1007/BF02990087; Lowry L, 2011, RADIOTHER ONCOL, V100, P86, DOI 10.1016/j.radonc.2011.05.013; MacManus MP, 1996, J CLIN ONCOL, V14, P1282, DOI 10.1200/JCO.1996.14.4.1282; Neumann H, 2003, STRAHLENTHER ONKOL, V179, P840, DOI 10.1007/s00066-003-1025-0; Ott OJ, 2003, STRAHLENTHER ONKOL, V179, P694, DOI 10.1007/s00066-003-1062-8; PENDLEBURY S, 1995, RADIOTHER ONCOL, V36, P167, DOI 10.1016/0167-8140(95)01600-L; Petersen PM, 2004, J CLIN ONCOL, V22, p563S; Plancarte F, 2006, EUR J HAEMATOL, V76, P58, DOI 10.1111/j.1600-0609.2005.00564.x; Pugh TJ, 2010, CANCER-AM CANCER SOC, V116, P3843, DOI 10.1002/cncr.25149; Pulsoni A, 2007, BRIT J HAEMATOL, V137, P216, DOI 10.1111/j.1365-2141.2007.06545.x; Saad ED, 2009, ANN ONCOL, V20, P460, DOI 10.1093/annonc/mdn670; Solal-Celigny P, 2004, BLOOD, V104, P1258, DOI 10.1182/blood-2003-12-4434; Stuschke M, 1997, CANCER-AM CANCER SOC, V80, P2273, DOI 10.1002/(SICI)1097-0142(19971215)80:12<2273::AID-CNCR9>3.0.CO;2-V; Swerdlow SH, 2008, WHO CLASSIFICATION T; Tsang RW, 2007, SEMIN RADIAT ONCOL, V17, P198, DOI 10.1016/j.semradonc.2007.02.006; Tsang RW, 2005, HEMATOL ONCOL, V23, P10, DOI 10.1002/hon.743; Wilder RB, 2001, INT J RADIAT ONCOL, V51, P1219, DOI 10.1016/S0360-3016(01)01747-3	33	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65156	10.1371/journal.pone.0065156	http://dx.doi.org/10.1371/journal.pone.0065156			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762303	gold, Green Published, Green Submitted			2022-12-27	WOS:000321099000036
J	Chen, B; Xue, Z; Yang, GH; Shi, BY; Yang, B; Yan, YM; Wang, X; Han, DS; Huang, Y; Dong, WJ				Chen, Bo; Xue, Zheng; Yang, Guanghui; Shi, Bingyang; Yang, Ben; Yan, Yuemin; Wang, Xue; Han, Daishu; Huang, Yue; Dong, Wenji			Akt-Signal Integration Is Involved in the Differentiation of Embryonal Carcinoma Cells	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; LEUKEMIA-INITIATING CELLS; NANOG EXPRESSION; F9 CELLS; SATB1; PHOSPHORYLATION; PLURIPOTENCY; QUIESCENCE; GROWTH; OCT4	The mechanism by which Akt modulates stem cell homeostasis is still incompletely defined. Here we demonstrate that Akt phosphorylates special AT-rich sequences binding protein 1 (SATB1) at serine 47 and protects SATB1 from apoptotic cleavage. Meanwhile, Akt phosphorylates Oct4 at threonine 228 and Klf4 at threonine 399, and accelerates their degradation. Moreover, PI3K/Akt signaling enhances the binding of SATB1 to Sox2, thereby probably impairing the formation of Oct4/Sox2 regulatory complexes. During retinoic acid (RA)-induced differentiation of mouse F9 embryonal carcinoma cells (ECCs), the Akt activation profile as well as its substrate spectrum is strikingly correlated with the down-regulation of Oct4, Klf4 and Nanog, which suggests Akt activation is coupled to the onset of differentiation. Accordingly, Akt-mediated phosphorylation is crucial for the capability of SATB1 to repress Nanog expression and to activate transcription of Bcl2 and Nestin genes. Taken together, we conclude that Akt is involved in the differentiation of ECCs through coordinated phosphorylations of pluripotency/differentiation factors.	[Chen, Bo; Shi, Bingyang; Yang, Ben; Yan, Yuemin; Han, Daishu; Dong, Wenji] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Cell Biol, Beijing 100730, Peoples R China; [Chen, Bo; Xue, Zheng; Yang, Guanghui; Shi, Bingyang; Yang, Ben; Yan, Yuemin; Wang, Xue; Han, Daishu; Huang, Yue; Dong, Wenji] Peking Union Med Coll, Beijing 100021, Peoples R China; [Xue, Zheng; Yang, Guanghui] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Biochem, Beijing 100730, Peoples R China; [Wang, Xue; Huang, Yue] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Med Genet, Beijing 100730, Peoples R China; [Xue, Zheng; Yang, Guanghui; Wang, Xue; Huang, Yue] Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Huang, Y (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Med Genet, Beijing 100730, Peoples R China.	huangyue@pumc.edu.cn; wdong@ibms.pumc.edu.cn	Yang, Ben/AAA-5607-2021	Huang, Yue/0000-0003-1800-1282	National Basic Research Program of China [2011CB965203]; National High Technology Research and Development Program of China [2011AA020118];  [2010PY05]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); 	This work was supported by the National Basic Research Program of China (2011CB965203 to WD and YH); the National High Technology Research and Development Program of China (2011AA020118 to WD); and the intra-institutional funding program (2010PY05 to WD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrelo R, 2009, DEV CELL, V16, P507, DOI 10.1016/j.devcel.2009.03.006; Bastien J, 2006, ONCOGENE, V25, P2040, DOI 10.1038/sj.onc.1209241; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Brumbaugh J, 2012, P NATL ACAD SCI USA, V109, P7162, DOI 10.1073/pnas.1203874109; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Galande S, 2001, MOL CELL BIOL, V21, P5591, DOI 10.1128/MCB.21.16.5591-5604.2001; Ganguly S, 2010, AM J PATHOL, V177, P2701, DOI 10.2353/ajpath.2010.100617; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Ito K, 2009, CURR OPIN GENET DEV, V19, P51, DOI 10.1016/j.gde.2009.01.004; Jeong CH, 2010, STEM CELLS, V28, P2141, DOI 10.1002/stem.540; Kharas MG, 2010, BLOOD, V115, P1406, DOI 10.1182/blood-2009-06-229443; Kim JS, 2010, ARCH PHARM RES, V33, P1117, DOI 10.1007/s12272-010-0719-y; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Lin YJ, 2012, MOL CELL, V48, P627, DOI 10.1016/j.molcel.2012.08.030; Matsuoka S, 2008, GENE DEV, V22, P986, DOI 10.1101/gad.1621808; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Nechanitzky R, 2012, DEV CELL, V23, P866, DOI 10.1016/j.devcel.2012.09.018; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Savarese F, 2009, GENE DEV, V23, P2625, DOI 10.1101/gad.1815709; Saxe JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004467; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Sykes SM, 2011, CELL, V146, P697, DOI 10.1016/j.cell.2011.07.032; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan JAT, 2008, J BIOL CHEM, V283, P18124, DOI 10.1074/jbc.M800512200; Thompson BJ, 2008, J EXP MED, V205, P1395, DOI 10.1084/jem.20080277; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747	37	29	30	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64877	10.1371/journal.pone.0064877	http://dx.doi.org/10.1371/journal.pone.0064877			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762260	gold, Green Published, Green Submitted			2022-12-27	WOS:000321099000026
J	Sallam, MF; Al Ahmed, AM; Abdel-Dayem, MS; Abdullah, MAR				Sallam, Mohamed F.; Al Ahmed, Azzam M.; Abdel-Dayem, Mahmoud S.; Abdullah, Mohamed A. R.			Ecological Niche Modeling and Land Cover Risk Areas for Rift Valley Fever Vector, Culex tritaeniorhynchus Giles in Jazan, Saudi Arabia	PLOS ONE			English	Article							DAR-ES-SALAAM; JAPANESE ENCEPHALITIS; HABITAT CHARACTERIZATION; ENVIRONMENTAL VARIABLES; SPECIES DISTRIBUTIONS; MALARIA TRANSMISSION; DIPTERA-CULICIDAE; SEASONAL ACTIVITY; LARVAL HABITATS; MOSQUITO LARVAE	Background: The mosquito, Culex tritaeniorhynchus Giles is a prevalent and confirmed Rift Valley Fever virus (RVFV) vector. This vector, in association with Aedimorphus arabiensis (Patton), was responsible for causing the outbreak of 2000 in Jazan Province, Saudi Arabia. Methodology/Principal Findings: Larval occurrence records and a total of 19 bioclimatic and three topographic layers imported from Worldclim Database were used to predict the larval suitable breeding habitats for this vector in Jazan Province using ArcGIS ver.10 and MaxEnt modeling program. Also, a supervised land cover classification from SPOT5 imagery was developed to assess the land cover distribution within the suitable predicted habitats. Eleven bioclimatic and slope attributes were found to be the significant predictors for this larval suitable breeding habitat. Precipitation and temperature were strong predictors of mosquito distribution. Among six land cover classes, the linear regression model (LM) indicated wet muddy substrate is significantly associated with high-very high suitable predicted habitats (R-2 = 73.7%, P < 0.05). Also, LM indicated that total dissolved salts (TDS) was a significant contributor (R-2 = 23.9%, P<0.01) in determining mosquito larval abundance. Conclusion/Significance: This model is a first step in understanding the spatial distribution of Cx. tritaeniorhynchus and consequently the risk of RVFV in Saudi Arabia and to assist in planning effective mosquito surveillance and control programs by public health personnel and researchers.	[Sallam, Mohamed F.; Al Ahmed, Azzam M.; Abdel-Dayem, Mahmoud S.] King Saud Univ, Dept Plant Protect, Coll Food Sci & Agr, Riyadh, Saudi Arabia; [Abdullah, Mohamed A. R.] Jazan Univ, Jazan, Saudi Arabia	King Saud University; Jazan University	Sallam, MF (corresponding author), King Saud Univ, Dept Plant Protect, Coll Food Sci & Agr, Riyadh, Saudi Arabia.	mwsallam2009@aol.com	Abdel-Dayem, Mahmoud/AAM-2344-2021; Abdel-Dayem, Mahmoud/AAE-2687-2020	Abdel-Dayem, Mahmoud/0000-0002-6276-1740	king Abdul Azziz City for Science and Technology, Riyadh, Kingdom of Saudi Arabia [A-S-12-0892]; King Saud University of Scientific Research and College of Food and Agricultural Science Research Center; National Plan for Sciences and Technology, KSU, Riyadh, KSA; NATIONAL CANCER INSTITUTE [R21CA149869, R01CA138541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080607] Funding Source: NIH RePORTER	king Abdul Azziz City for Science and Technology, Riyadh, Kingdom of Saudi Arabia; King Saud University of Scientific Research and College of Food and Agricultural Science Research Center; National Plan for Sciences and Technology, KSU, Riyadh, KSA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is funded by king Abdul Azziz City for Science and Technology, Riyadh, Kingdom of Saudi Arabia through a scientific project # A-S-12-0892 (http://gdrg.kacst.edu.sa/). Also, the funding was shared by King Saud University, Deanship of Scientific Research and College of Food and Agricultural Science Research Center and The National Plan for Sciences and Technology, KSU, Riyadh, KSA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Dayem MS, 2012, J MED ENTOMOL, V49, P739, DOI 10.1603/ME11225; Ageel ARM, 1997, ANN TROP MED PARASIT, V91, P907, DOI 10.1080/00034989760293; Al Ahmad AM, 2011, J MED ENTOMOL, V48, P717, DOI 10.1603/ME10146; Al-Husseini H, 2009, SAUDI ARABIA AM BEDU; Al-Turbak AS, 1999, FUTURE WATER SUPPLY; Alahmedi A. M., 2009, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V39, P991; [Anonymous], P 21 INT C MACH LEAR; Anyamba A, 2002, PHOTOGRAMM ENG REM S, V68, P137; Balkhy HH, 2003, INT J ANTIMICROB AG, V21, P153, DOI 10.1016/S0924-8579(02)00295-9; Bogh C, 2007, AM J TROP MED HYG, V76, P875; CDSI, 2010, GEN CENS POP 2010; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P982; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P905; Dambach P, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-8; DILLAHA TA, 1985, WATER RES, V19, P741, DOI 10.1016/0043-1354(85)90121-6; Eisen L, 2011, ANNU REV ENTOMOL, V56, P41, DOI 10.1146/annurev-ento-120709-144847; Elfadil AA, 2006, REV SCI TECH OIE, V25, P1137, DOI 10.20506/rst.25.3.1722; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Foley Desmond H, 2008, US Army Med Dep J, P46; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hills SL, 2011, J TROP PEDIATRICS, V57, P241, DOI 10.1093/tropej/fmp133; Hills SL, 2010, AM J TROP MED HYG, V82, P930, DOI 10.4269/ajtmh.2010.09-0676; Jacob BG, 2005, J MED ENTOMOL, V42, P751, DOI 10.1603/0022-2585(2005)042[0751:EOEDFI]2.0.CO;2; Jupp PG, 2002, MED VET ENTOMOL, V16, P245, DOI 10.1046/j.1365-2915.2002.00371.x; Keating Joseph, 2004, Int J Health Geogr, V3, P9, DOI 10.1186/1476-072X-3-9; Kelly-Hope LA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-268; Kheir S. M., 2010, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V40, P215; Kulkarni MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009396; Lin Ting-Hsiang, 1995, Chinese Journal of Entomology, V15, P1; Madani TA, 2003, CLIN INFECT DIS, V37, P1084, DOI 10.1086/378747; Masuoka P, 2010, GEOSPATIAL HEALTH, V5, P45, DOI 10.4081/gh.2010.186; Murty US, 2010, J VECTOR DIS, V47, P26; Pandey B, 2003, EPIDEMIOL INFECT, V131, P881, DOI 10.1017/S0950268803008835; Parham PE, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-271; PEIRIS JSM, 1993, T ROY SOC TROP MED H, V87, P541, DOI 10.1016/0035-9203(93)90080-A; Peterson I, 2009, AM J TROP MED HYG, V81, P944, DOI 10.4269/ajtmh.2009.08-0662; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Rohani A, 2010, SE ASIAN J TROP MED, V41, P821; Sattler MA, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-4; SGS, 2012, KINGD SAUD AR FACTS, P144; Sheikho KMA, 2006, USE REMOTE SENSING G; Solomon T, 1998, LANCET, V351, P1094, DOI 10.1016/S0140-6736(97)07509-0; Vanek MJ, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-154; WILLS WM, 1985, T ROY SOC TROP MED H, V79, P63, DOI 10.1016/0035-9203(85)90238-X; Wood BL, 2000, ADV PARASIT, V47, P331, DOI 10.1016/S0065-308X(00)47014-4; Zhou G, 2007, AM J TROP MED HYG, V77, P29, DOI 10.4269/ajtmh.2007.77.29	47	29	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65786	10.1371/journal.pone.0065786	http://dx.doi.org/10.1371/journal.pone.0065786			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762424	Green Published, Green Submitted, gold			2022-12-27	WOS:000321099000105
J	Thomas, S; Sharma, N; Gonzalez, R; Pao, PW; Hofman, FM; Chen, TC; Louie, SG; Pirrung, MC; Schonthal, AH				Thomas, Simmy; Sharma, Natasha; Gonzalez, Reyna; Pao, Peng-Wen; Hofman, Florence M.; Chen, Thomas C.; Louie, Stan G.; Pirrung, Michael C.; Schoenthal, Axel H.			Repositioning of Verrucosidin, a Purported Inhibitor of Chaperone Protein GRP78, as an Inhibitor of Mitochondrial Electron Transport Chain Complex I	PLOS ONE			English	Article							COLON-CARCINOMA CELLS; ENDOPLASMIC-RETICULUM-STRESS; DOWN-REGULATOR; GLUCOSE DEPRIVATION; BREAST-CANCER; RESPIRATORY-CHAIN; OXIDATIVE-PHOSPHORYLATION; ANTITUMOR-ACTIVITY; CHEMICAL GENOMICS; BETA-SUBUNIT	Verrucosidin (VCD) belongs to a group of fungal metabolites that were identified in screening programs to detect molecules that preferentially kill cancer cells under glucose-deprived conditions. Its mode of action was proposed to involve inhibition of increased GRP78 (glucose regulated protein 78) expression during hypoglycemia. Because GRP78 plays an important role in tumorigenesis, inhibitors such as VCD might harbor cancer therapeutic potential. We therefore sought to characterize VCD's anticancer activity in vitro. Triple-negative breast cancer cell lines MDA-MB-231 and MDA-MB-468 were treated with VCD under different conditions known to trigger increased expression of GRP78, and a variety of cellular processes were analyzed. We show that VCD was highly cytotoxic only under hypoglycemic conditions, but not in the presence of normal glucose levels, and VCD blocked GRP78 expression only when glycolysis was impaired (due to hypoglycemia or the presence of the glycolysis inhibitor 2-deoxyglucose), but not when GRP78 was induced by other means (hypoxia, thapsigargin, tunicamycin). However, VCD's strictly hypoglycemia-specific toxicity was not due to the inhibition of GRP78. Rather, VCD blocked mitochondrial energy production via inhibition of complex I of the electron transport chain. As a result, cellular ATP levels were quickly depleted under hypoglycemic conditions, and common cellular functions, including general protein synthesis, deteriorated and resulted in cell death. Altogether, our study identifies mitochondria as the primary target of VCD. The possibility that other purported GRP78 inhibitors (arctigenin, biguanides, deoxyverrucosidin, efrapeptin, JBIR, piericidin, prunustatin, pyrvinium, rottlerin, valinomycin, versipelostatin) might act in a similar GRP78-independent fashion will be discussed.	[Thomas, Simmy; Gonzalez, Reyna; Pao, Peng-Wen; Schoenthal, Axel H.] Univ So Calif, Dept Mol Microbiol & Immunol, Los Angeles, CA 90089 USA; [Sharma, Natasha] Univ So Calif, Dept Pharmaceut Sci, Los Angeles, CA USA; [Hofman, Florence M.] Univ So Calif, Dept Pathol, Los Angeles, CA 90089 USA; [Chen, Thomas C.] Univ So Calif, Dept Neurosurg, Los Angeles, CA USA; [Louie, Stan G.] Univ So Calif, Dept Clin Pharm & Pharmaceut Econ & Policy, Los Angeles, CA USA; [Pirrung, Michael C.] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of California System; University of California Riverside	Schonthal, AH (corresponding author), Univ So Calif, Dept Mol Microbiol & Immunol, Los Angeles, CA 90089 USA.	schontha@usc.edu	Schonthal, Axel/ABH-3846-2020; Sharma, Natasha/AAY-3656-2021; Sharma, Natasha/AAI-9816-2021	Sharma, Natasha/0000-0001-8046-1752; Schonthal, Axel/0000-0003-0662-5653				Alberts B, 2008, MOL BIOL CELL; Apraiz Aintzane, 2011, Cancers (Basel), V3, P1042, DOI 10.3390/cancers3011042; Bost F, 2012, CURR OPIN ONCOL, V24, P103, DOI 10.1097/CCO.0b013e32834d8155; Bryden W. L., 1989, Proceedings of the Nutrition Society of Australia., V14, P45; Bui T, 2006, CANCER CELL, V9, P419, DOI 10.1016/j.ccr.2006.05.012; BURKA LT, 1983, J CHEM SOC CHEM COMM, P544, DOI 10.1039/c39830000544; Chen TC, 2011, CANCER LETT, V302, P100, DOI 10.1016/j.canlet.2010.11.008; Cheng G, 2012, CANCER RES, V72, P2634, DOI 10.1158/0008-5472.CAN-11-3928; Cheong JH, 2011, MOL CANCER THER, V10, P2350, DOI 10.1158/1535-7163.MCT-11-0497; Choo SJ, 2005, J ANTIBIOT, V58, P210, DOI 10.1038/ja.2005.26; de Ruijter TC, 2011, J CANCER RES CLIN, V137, P183, DOI 10.1007/s00432-010-0957-x; DEMETRAKOPOULOS GE, 1982, CANCER BIOCHEM BIOPH, V6, P65; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; ELBANNA AA, 1987, SYST APPL MICROBIOL, V10, P42, DOI 10.1016/S0723-2020(87)80008-5; ELBEIN AD, 1981, TRENDS BIOCHEM SCI, V6, P219, DOI 10.1016/0968-0004(81)90080-3; Fath MA, 2009, CANCER BIOL THER, V8, P1228, DOI 10.4161/cbt.8.13.8631; Fernandez PM, 2000, BREAST CANCER RES TR, V59, P15, DOI 10.1023/A:1006332011207; GALLAGHER RT, 1977, NEW ZEAL J AGR RES, V20, P431, DOI 10.1080/00288233.1977.10427356; Garcia J, 2010, J BIOL CHEM, V285, P39646, DOI 10.1074/jbc.M110.164160; GAUSE EM, 1981, J BIOL CHEM, V256, P557; Haga N, 2010, CANCER SCI, V101, P1125, DOI 10.1111/j.1349-7006.2010.01525.x; Hai T, 1999, GENE EXPRESSION, V7, P321; Hayakawa Y, 2008, J ANTIBIOT, V61, P365, DOI 10.1038/ja.2008.51; Healy SJM, 2009, EUR J PHARMACOL, V625, P234, DOI 10.1016/j.ejphar.2009.06.064; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Huang SL, 2012, DIABETOLOGIA, V55, P1469, DOI 10.1007/s00125-011-2366-3; Hwang JH, 2008, J CELL PHYSIOL, V215, P243, DOI 10.1002/jcp.21308; Inai Y, 1997, CELL STRUCT FUNCT, V22, P555, DOI 10.1247/csf.22.555; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Kato K, 2012, MOL CANCER THER, V11, P549, DOI 10.1158/1535-7163.MCT-11-0594; Kim JY, 2010, J CELL PHYSIOL, V224, P33, DOI 10.1002/jcp.22085; King T.E., 1967, METHOD ENZYMOL, V10, P275, DOI DOI 10.1016/0076-6879(67)10055-4; KOHLBRENNER WE, 1979, ARCH BIOCHEM BIOPHYS, V198, P598, DOI 10.1016/0003-9861(79)90536-8; Kozone I, 2009, J ANTIBIOT, V62, P593, DOI 10.1038/ja.2009.79; Lee E, 2006, CANCER RES, V66, P7849, DOI 10.1158/0008-5472.CAN-06-1660; Li QX, 2008, CELL DEATH DIFFER, V15, P1197, DOI 10.1038/cdd.2008.48; Little Edward, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P1; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; LUNARDI J, 1986, J BIOL CHEM, V261, P5350; Luo B, 2013, ONCOGENE, V32, P805, DOI 10.1038/onc.2012.130; MATTSON MP, 1993, EXP NEUROL, V121, P1, DOI 10.1006/exnr.1993.1066; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; NISHIOKA H, 1994, J ANTIBIOT, V47, P447, DOI 10.7164/antibiotics.47.447; Osweiler G.D, 1996, TOXICOLOGY; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Park HR, 2007, TOXICOLOGY, V229, P253, DOI 10.1016/j.tox.2006.11.049; Park HR, 2004, JNCI-J NATL CANCER I, V96, P1300, DOI 10.1093/jnci/djh243; PENNINGTON R, 1961, BIOCHEM J, V80, P649, DOI 10.1042/bj0800649; Pyrko P, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-19; Reddy KB, 2011, CURR ONCOL, V18, pE173; REDEGELD FAM, 1992, EUR J PHARM-ENVIRON, V228, P229, DOI 10.1016/0926-6917(92)90034-A; Robinson GL, 2012, ONCOGENE, V31, P4996, DOI 10.1038/onc.2012.13; Ryoo IJ, 2006, BIOL PHARM BULL, V29, P817, DOI 10.1248/bpb.29.817; Saito S, 2011, METHOD ENZYMOL, V491, P327, DOI 10.1016/B978-0-12-385928-0.00018-3; Saito S, 2009, CANCER RES, V69, P4225, DOI 10.1158/0008-5472.CAN-08-2689; Sausville EA, 2004, J NATL CANCER I, V96, P1266, DOI 10.1093/jnci/djh276; SAYOOD SF, 1989, ARCH BIOCHEM BIOPHYS, V270, P714, DOI 10.1016/0003-9861(89)90554-7; Schonthal AH, 2013, BIOCHEM PHARMACOL, V85, P653, DOI 10.1016/j.bcp.2012.09.012; Schonthal Axel H, 2012, Front Biosci (Schol Ed), V4, P412; Soltoff SP, 2001, J BIOL CHEM, V276, P37986; Sun SR, 2011, PLANTA MED, V77, P141, DOI 10.1055/s-0030-1250179; Tomitsuka E, 2012, J BIOCHEM, V152, P171, DOI 10.1093/jb/mvs041; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Umeda Y, 2005, J ANTIBIOT, V58, P206, DOI 10.1038/ja.2005.25; vanRaaij MJ, 1996, P NATL ACAD SCI USA, V93, P6913, DOI 10.1073/pnas.93.14.6913; Wang J, 2009, J CELL MOL MED, V13, P3888, DOI 10.1111/j.1582-4934.2009.00873.x; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Wey S, 2012, BLOOD, V119, P817, DOI 10.1182/blood-2011-06-357384; WHANG K, 1990, J AM CHEM SOC, V112, P8985, DOI 10.1021/ja00180a057; WILSON BJ, 1981, J AM VET MED ASSOC, V179, P480; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Xi H, 2013, BIOCH PHARM; YAMANISHI K, 1984, J CELL PHYSIOL, V119, P163, DOI 10.1002/jcp.1041190204; Yu DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003951; Zhang LH, 2010, J CELL BIOCHEM, V110, P1299, DOI 10.1002/jcb.22679	76	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65695	10.1371/journal.pone.0065695	http://dx.doi.org/10.1371/journal.pone.0065695			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755268	Green Submitted, Green Published, gold			2022-12-27	WOS:000321099000094
J	Warnier, MJ; Blom, MT; Bardai, A; Berdowksi, J; Souverein, PC; Hoes, AW; Rutten, FH; de Boer, A; Koster, RW; De Bruin, ML; Tan, HL				Warnier, Miriam Jacoba; Blom, Marieke Tabo; Bardai, Abdennasser; Berdowksi, Jocelyn; Souverein, Patrick Cyriel; Hoes, Arno Wilhelmus; Rutten, Frans Hendrik; de Boer, Anthonius; Koster, Rudolph Willem; De Bruin, Marie Louise; Tan, Han Liong			Increased Risk of Sudden Cardiac Arrest in Obstructive Pulmonary Disease: A Case-Control Study	PLOS ONE			English	Article							CARDIOVASCULAR MORTALITY; BETA-BLOCKERS; HEART-RATE; ASTHMA; DEATH; DETERMINANTS; SURVIVAL; AGONISTS; SAFETY; COPD	Background: We aimed to determine whether (1) patients with obstructive pulmonary disease (OPD) have an increased risk of sudden cardiac arrest (SCA) due to ventricular tachycardia or fibrillation (VT/VF), and (2) the SCA risk is mediated by cardiovascular risk-profile and/or respiratory drug use. Methods: A community-based case-control study was performed, with 1310 cases of SCA of the ARREST study and 5793 age, sex and SCA-date matched non-SCA controls from the PHARMO database. Only incident SCA cases, age older than 40 years, that resulted from unequivocal cardiac causes with electrocardiographic documentation of VT/VF were included. Conditional logistic regression analysis was used to assess the association between SCA and OPD. Pre-specified subgroup analyses were performed regarding age, sex, cardiovascular risk-profile, disease severity, and current use of respiratory drugs. Results: A higher risk of SCA was observed in patients with OPD (n = 190 cases [15%], 622 controls [11%]) than in those without OPD (OR adjusted for cardiovascular risk-profile 1.4 [1.2-1.6]). In OPD patients with a high cardiovascular risk-profile (OR 3.5 [2.7-4.4]) a higher risk of SCA was observed than in those with a low cardiovascular risk-profile (OR 1.3 [0.9-1.9]) The observed SCA risk was highest among OPD patients who received short-acting b2-adrenoreceptor agonists (SABA) or anticholinergics (AC) at the time of SCA (SABA OR: 3.9 [1.7-8.8], AC OR: 2.7 [1.5-4.8] compared to those without OPD). Conclusions: OPD is associated with an increased observed risk of SCA. The most increased risk was observed in patients with a high cardiovascular risk-profile, and in those who received SABA and, possibly, those who received AC at the time of SCA.	[Warnier, Miriam Jacoba; Souverein, Patrick Cyriel; de Boer, Anthonius; De Bruin, Marie Louise] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [Warnier, Miriam Jacoba; Hoes, Arno Wilhelmus; Rutten, Frans Hendrik; De Bruin, Marie Louise] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Blom, Marieke Tabo; Bardai, Abdennasser; Tan, Han Liong] Univ Amsterdam, Acad Med Ctr, Ctr Heart, NL-1105 AZ Amsterdam, Netherlands; [Bardai, Abdennasser] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [Berdowksi, Jocelyn; Koster, Rudolph Willem; Tan, Han Liong] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Interuniversity Cardiology Institute of the Netherlands; Utrecht University; University of Amsterdam; Academic Medical Center Amsterdam	Tan, HL (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Heart, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	h.l.tan@amc.nl	, Bardai/AAL-2340-2020; De Bruin, Marie Louise/O-5349-2016	De Bruin, Marie Louise/0000-0001-9197-7068; Blom, Marieke Tabo/0000-0002-8088-1105; Souverein, Patrick/0000-0002-7452-0477	Netherlands Organization for Scientific Research (NWO) [ZonMW Vici 918.86.616, Mozaiek 017.003.084]; Dutch Medicines Evaluation Board (MEB/CBG); European Community [241679]; BBMRI-NL; Dutch government [NWO 184-021-007]; Utrecht University; Utrecht University Medical Center; Dutch Medicines Evaluation Board (CBG-MEB)	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Medicines Evaluation Board (MEB/CBG); European Community(European Commission); BBMRI-NL; Dutch government; Utrecht University; Utrecht University Medical Center; Dutch Medicines Evaluation Board (CBG-MEB)	H.L. Tan was supported by the Netherlands Organization for Scientific Research (NWO, grant ZonMW Vici 918.86.616), the Dutch Medicines Evaluation Board (MEB/CBG), the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement nr. 241679 - the ARITMO project, and BBMRI-NL, a research infrastructure financed by the Dutch government (NWO 184-021-007). This study was conducted with unrestricted institutional funding from Utrecht University and the Utrecht University Medical Center. H.L. Tan was supported by the Netherlands Organization for Scientific Research (NWO, grant ZonMW Vici 918.86.616), the Dutch Medicines Evaluation Board (MEB/CBG), and the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement nr. 241679 - the ARITMO project and BBMRI-NL, a research infrastructure financed by the Dutch government (NWO 184-021-007). A. Bardai was supported by the Netherlands Organization for Scientific Research (NWO, grant Mozaiek 017.003.084). Both grants are unrestricted. M.L. De Bruin was supported by the Dutch Medicines Evaluation Board (CBG-MEB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleton SL, 2009, J ALLERGY CLIN IMMUN, V123, P124, DOI 10.1016/j.jaci.2008.10.032; Bardai A, 2011, J AM COLL CARDIOL, V57, P1822, DOI 10.1016/j.jacc.2010.11.054; Berdowski J, 2010, RESUSCITATION, V81, P1479, DOI 10.1016/j.resuscitation.2010.08.006; Blais L, 1998, THORAX, V53, P1025, DOI 10.1136/thx.53.12.1025; Blom MT, 2012, RESUSCITATI IN PRESS, DOI [10.1016/j.resuscitation.2012.10.009, DOI 10.1016/J.RESUSCITA-TI0N.2012.10.009]; Buurma H, 2008, J CLIN PHARM THER, V33, P17, DOI 10.1111/j.1365-2710.2008.00878.x; Canto JG, 2007, ARCH INTERN MED, V167, P2405, DOI 10.1001/archinte.167.22.2405; Celli B, 2009, AM J RESP CRIT CARE, V180, P948, DOI 10.1164/rccm.200906-0876OC; de Bruyne MC, 1999, EUR HEART J, V20, P278, DOI 10.1053/euhj.1998.1276; Engdahl J, 2000, AM J CARDIOL, V86, P610, DOI 10.1016/S0002-9149(00)01037-7; Engdahl J, 2002, RESUSCITATION, V52, P235, DOI 10.1016/S0300-9572(01)00464-6; Engstrom G, 2001, CIRCULATION, V103, P3086, DOI 10.1161/01.CIR.103.25.3086; Fox K, 2007, J AM COLL CARDIOL, V50, P823, DOI 10.1016/j.jacc.2007.04.079; Han MK, 2007, CIRCULATION, V116, P2992, DOI 10.1161/CIRCULATIONAHA.106.685206; Hua W, 2009, J AM COLL CARDIOL, V54, P1110, DOI 10.1016/j.jacc.2009.06.016; Jensen MT, 2013, EUR RESPIR J, V42, P341, DOI 10.1183/09031936.00072212; KANNEL WB, 1987, AM HEART J, V113, P1489, DOI 10.1016/0002-8703(87)90666-1; KENDALL MJ, 1995, ANN INTERN MED, V123, P358, DOI 10.7326/0003-4819-123-5-199509010-00007; Knol MJ, 2007, INT J EPIDEMIOL, V36, P1111, DOI 10.1093/ije/dym157; LIPWORTH BJ, 1992, BRIT J CLIN PHARMACO, V33, P129, DOI 10.1111/j.1365-2125.1992.tb04014.x; Magnussen Helgo, 2009, Proc Am Thorac Soc, V6, P648, DOI 10.1513/pats.200906-053DP; Matsue Y, 2013, INT J CARDIOL, V165, P519, DOI 10.1016/j.ijcard.2011.09.037; Michele TM, 2010, NEW ENGL J MED, V363, P1097, DOI 10.1056/NEJMp1008502; Myerburg RJ, 2001, J CARDIOVASC ELECTR, V12, P369, DOI 10.1046/j.1540-8167.2001.00369.x; Myerburg RJ., 2007, BRAUNWALDS HEART DIS, P933; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Priori SG, 2001, EUR HEART J, V22, P1374, DOI 10.1053/euhj.2001.2824; REID DD, 1976, LANCET, V2, P979; Salpeter S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003566.pub2; Salpeter SR, 2004, CHEST, V125, P2309, DOI 10.1378/chest.125.6.2309; Salpeter SR, 2004, DRUG AGING, V21, P405, DOI 10.2165/00002512-200421060-00005; Sidney S, 2005, CHEST, V128, P2068, DOI 10.1378/chest.128.4.2068; Sin DD, 2005, CHEST, V127, P1952, DOI 10.1378/chest.127.6.1952; Singh S, 2008, JAMA-J AM MED ASSOC, V300, P1439, DOI 10.1001/jama.300.12.1439; Suissa S, 1996, AM J RESP CRIT CARE, V154, P1598, DOI 10.1164/ajrccm.154.6.8970341; Teerlink JR, 2000, J CARD FAIL, V6, P25; VAUGHANWILLIAMS EM, 1975, PHARMACOL THER PT B, V1, P115; Velthove KJ, 2010, PHARMACOEPIDEM DR S, V19, P367, DOI 10.1002/pds.1892; Verrier RL, 2009, HEART RHYTHM, V6, pS68, DOI 10.1016/j.hrthm.2009.07.017; Wong CC, 2009, J COMMUN HEALTH, V34, P472, DOI 10.1007/s10900-009-9182-4; WONG CS, 1990, LANCET, V336, P1396, DOI 10.1016/0140-6736(90)93099-B; Wood LG, 2012, CHEST, V142, P86, DOI 10.1378/chest.11-1838; Wood-Baker R, 2010, INTERN MED J, V40, P94, DOI 10.1111/j.1445-5994.2009.02109.x	43	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65638	10.1371/journal.pone.0065638	http://dx.doi.org/10.1371/journal.pone.0065638			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755262	Green Submitted, Green Published, gold			2022-12-27	WOS:000321099000084
J	Young, HT; Edwards, SA; Grater, F				Young, Hui T.; Edwards, Scott A.; Graeter, Frauke			How Fast Does a Signal Propagate through Proteins?	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; HAIR-CELLS; MECHANOTRANSDUCTION; BIOMOLECULES; CRYSTALS; FLOW	As the molecular basis of signal propagation in the cell, proteins are regulated by perturbations, such as mechanical forces or ligand binding. The question arises how fast such a signal propagates through the protein molecular scaffold. As a first step, we have investigated numerically the dynamics of force propagation through a single (Ala) 40 protein following a sudden increase in the stretching forces applied to its end termini. The force propagates along the backbone into the center of the chain on the picosecond scale. Both conformational and tension dynamics are found in good agreement with a coarse-grained theory of force propagation through semiflexible polymers. The speed of force propagation of 50 angstrom ps(-1) derived from these simulations is likely to determine an upper speed limit of mechanical signal transfer in allosteric proteins or molecular machines.	[Young, Hui T.; Graeter, Frauke] CAS MPG Partner Inst, Shanghai, Peoples R China; [Young, Hui T.; Graeter, Frauke] Key Lab Computat Biol, Shanghai, Peoples R China; [Young, Hui T.] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Graeter, Frauke] Heidelberg Inst Theoret Studies GGmbH, Heidelberg, Germany; [Edwards, Scott A.] Shenzhen Univ, Coll Phys & Technol, Shenzhen, Guangdong, Peoples R China	Max Planck Society; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Heidelberg Institute for Theoretical Studies; Shenzhen University	Grater, F (corresponding author), CAS MPG Partner Inst, Shanghai, Peoples R China.	frauke.graeter@h-its.org	Gräter, Frauke/D-3450-2009	Gräter, Frauke/0000-0003-2891-3381	Klaus Tschira Foundation	Klaus Tschira Foundation	The authors thank the Klaus Tschira Foundation (http://www.klaus-tschira-stiftung.de) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATCHELOR GK, 1970, J FLUID MECH, V44, P419, DOI 10.1017/S002211207000191X; Berendsen H.J.C., 1981, INTERMOLECULAR FORCE, V11, P331, DOI DOI 10.1111/J.1574-695X.1996.TB00128.X; Botan V, 2007, P NATL ACAD SCI USA, V104, P12749, DOI 10.1073/pnas.0701762104; Dror RO, 2012, ANNU REV BIOPHYS, V41, P429, DOI 10.1146/annurev-biophys-042910-155245; DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gillespie PG, 2009, CELL, V139, P33, DOI 10.1016/j.cell.2009.09.010; Gomez GA, 2011, TRENDS CELL BIOL, V21, P499, DOI 10.1016/j.tcb.2011.05.006; Grandbois M, 1999, SCIENCE, V283, P1727, DOI 10.1126/science.283.5408.1727; Hallatschek O, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.077804; Hallatschek O, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.031905; Hallatschek O, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.031906; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Husson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019680; Isralewitz B, 2001, CURR OPIN STRUC BIOL, V11, P224, DOI 10.1016/S0959-440X(00)00194-9; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kachar B, 2000, P NATL ACAD SCI USA, V97, P13336, DOI 10.1073/pnas.97.24.13336; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Nam JH, 2008, BIOPHYS J, V95, P4948, DOI 10.1529/biophysj.108.138560; Obermayer B, 2007, EUR PHYS J E, V23, P375, DOI 10.1140/epje/i2006-10221-y; Obermayer B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.040801; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Samuel J, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.050801; Schuler B, 2005, P NATL ACAD SCI USA, V102, P2754, DOI 10.1073/pnas.0408164102; Shroff H, 2005, NANO LETT, V5, P1509, DOI 10.1021/nl050875h; Smith DE, 1999, SCIENCE, V283, P1724, DOI 10.1126/science.283.5408.1724; Snow CD, 2002, NATURE, V420, P102, DOI 10.1038/nature01160; Snow CD, 2005, ANNU REV BIOPH BIOM, V34, P43, DOI 10.1146/annurev.biophys.34.040204.144447; Stacklies W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-101; Takada S, 2012, CURR OPIN STRUC BIOL, V22, P130, DOI 10.1016/j.sbi.2012.01.010; Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905; Xu ZP, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.061910; Yu X, 2003, J PHYS CHEM B, V107, P1698, DOI 10.1021/jp026462b	35	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64746	10.1371/journal.pone.0064746	http://dx.doi.org/10.1371/journal.pone.0064746			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762251	Green Submitted, gold, Green Published			2022-12-27	WOS:000321099000018
J	Inman, DM; Lambert, WS; Calkins, DJ; Horner, PJ				Inman, Denise M.; Lambert, Wendi S.; Calkins, David J.; Horner, Philip J.			alpha-Lipoic Acid Antioxidant Treatment Limits Glaucoma-Related Retinal Ganglion Cell Death and Dysfunction	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; DBA/2J MOUSE MODEL; OXIDATIVE STRESS; NITRIC-OXIDE; TRABECULAR MESHWORK; PROTECTIVE ROLE; IRIS ATROPHY; RAT MODEL; KAPPA-B; NEURODEGENERATION	Oxidative stress has been implicated in neurodegenerative diseases, including glaucoma. However, due to the lack of clinically relevant models and expense of long-term testing, few studies have modeled antioxidant therapy for prevention of neurodegeneration. We investigated the contribution of oxidative stress to the pathogenesis of glaucoma in the DBA/2J mouse model of glaucoma. Similar to other neurodegenerative diseases, we observed lipid peroxidation and upregulation of oxidative stress-related mRNA and protein in DBA/2J retina. To test the role of oxidative stress in disease progression, we chose to deliver the naturally occurring, antioxidant alpha-lipoic acid (ALA) to DBA/2J mice in their diet. We used two paradigms for ALA delivery: an intervention paradigm in which DBA/2J mice at 6 months of age received ALA in order to intervene in glaucoma development, and a prevention paradigm in which DBA/2J mice were raised on a diet supplemented with ALA, with the goal of preventing glaucoma development. At 10 and 12 months of age (after 4 and 11 months of dietary ALA respectively), we measured changes in genes and proteins related to oxidative stress, retinal ganglion cell (RGC) number, axon transport, and axon number and integrity. Both ALA treatment paradigms showed increased antioxidant gene and protein expression, increased protection of RGCs and improved retrograde transport compared to control. Measures of lipid peroxidation, protein nitrosylation, and DNA oxidation in retina verified decreased oxidative stress in the prevention and intervention paradigms. These data demonstrate the utility of dietary therapy for reducing oxidative stress and improving RGC survival in glaucoma.	[Inman, Denise M.; Horner, Philip J.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Lambert, Wendi S.; Calkins, David J.] Vanderbilt Univ, Vanderbilt Eye Inst, Dept Ophthalmol & Visual Sci, Nashville, TN 37235 USA	University of Washington; University of Washington Seattle; Vanderbilt University	Inman, DM (corresponding author), Northeast Ohio Med Univ, Dept Pharmaceut Sci, Rootstown, OH 44272 USA.	dinman@neomed.edu	Inman, Denise/AAA-8074-2019; Horner, Philip J./AAF-7012-2021	Inman, Denise/0000-0002-8522-4112; Calkins, David/0000-0002-8475-9959	Glaucoma Research Foundation's Catalyst for a Cure initiative; Melza M. and Frank Theodore Barr Foundation through the Glaucoma Research Foundation	Glaucoma Research Foundation's Catalyst for a Cure initiative; Melza M. and Frank Theodore Barr Foundation through the Glaucoma Research Foundation	This study was supported by the Glaucoma Research Foundation's Catalyst for a Cure initiative and a grant from the Melza M. and Frank Theodore Barr Foundation through the Glaucoma Research Foundation (DJC and PJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Arai-Gaun S, 2004, INVEST OPHTH VIS SCI, V45, P4226, DOI 10.1167/iovs.04-0450; Aslan M, 2006, FREE RADICAL RES, V40, P147, DOI 10.1080/10715760500456219; Baltan S, 2010, J NEUROSCI, V30, P5644, DOI 10.1523/JNEUROSCI.5956-09.2010; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Biewenga GP, 1997, GEN PHARMACOL, V29, P315, DOI 10.1016/S0306-3623(96)00474-0; Bosco A, 2008, INVEST OPHTH VIS SCI, V49, P1437, DOI 10.1167/iovs.07-1337; Bosco A, 2011, J COMP NEUROL, V519, P599, DOI 10.1002/cne.22516; Buckingham BP, 2008, J NEUROSCI, V28, P2735, DOI 10.1523/JNEUROSCI.4443-07.2008; Chang B, 1999, NAT GENET, V21, P405, DOI 10.1038/7741; Chauhan BC, 2006, INVEST OPHTH VIS SCI, V47, P634, DOI 10.1167/iovs.05-1206; Chen F, 1999, CLIN CHEM, V45, P7; Chen H, 2004, BRAIN RES, V1011, P99, DOI 10.1016/j.brainres.2004.03.024; Chidlow G, 2002, NEUROPHARMACOLOGY, V43, P1015, DOI 10.1016/S0028-3908(02)00129-6; Connelly L, 2001, J IMMUNOL, V166, P3873, DOI 10.4049/jimmunol.166.6.3873; Cremer DR, 2006, REGUL TOXICOL PHARM, V46, P193, DOI 10.1016/j.yrtph.2006.06.003; dos Santos J, 2011, INVEST OPHTHALMOL, P1; Feilchenfeld Z, 2008, EXP EYE RES, V87, P409, DOI 10.1016/j.exer.2008.07.011; Ferreira SM, 2004, AM J OPHTHALMOL, V137, P62, DOI 10.1016/S0002-9394(03)00788-8; Floyd RA, 2002, NEUROBIOL AGING, V23, P795, DOI 10.1016/S0197-4580(02)00019-2; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Gionfriddo JR, 2009, VET OPHTHALMOL, V12, P325, DOI 10.1111/j.1463-5224.2009.00722.x; Hirooka K, 2004, CURR EYE RES, V28, P153, DOI 10.1076/ceyr.28.3.153.26246; Inman DM, 2007, GLIA, V55, P942, DOI 10.1002/glia.20516; Inman DM, 2006, INVEST OPHTH VIS SCI, V47, P986, DOI 10.1167/iovs.05-0925; Inoue K, 1999, J BIOL CHEM, V274, P27069, DOI 10.1074/jbc.274.38.27069; Javadiyan S, 2012, INVEST OPHTH VIS SCI, V53, P1923, DOI 10.1167/iovs.11-8420; John SWM, 1998, INVEST OPHTH VIS SCI, V39, P951; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Kim J, 2010, MUTAT RES-FUND MOL M, V690, P12, DOI 10.1016/j.mrfmmm.2009.09.007; Ko ML, 2005, FREE RADICAL BIO MED, V39, P365, DOI 10.1016/j.freeradbiomed.2005.03.025; Kobayashi A, 2004, METHOD ENZYMOL, V378, P273; Lambert WS, 2008, INVEST OPHTHALMOL VI, V49; Lander HM, 1997, J BIOL CHEM, V272, P17810, DOI 10.1074/jbc.272.28.17810; Libby RT, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-108; Liu YB, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-98; Luna C, 2009, FOOD CHEM TOXICOL, V47, P198, DOI 10.1016/j.fct.2008.10.029; Moreno MC, 2004, FREE RADICAL BIO MED, V37, P803, DOI 10.1016/j.freeradbiomed.2004.06.001; Onouchi H, 2012, INVEST OPHTHALMOL VI, DOI 10.11; Papadopoulos MC, 1998, NEUROSCIENCE, V82, P915; Qi XP, 2007, INVEST OPHTH VIS SCI, V48, P5360, DOI 10.1167/iovs.07-0254; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Reljanovic M, 1999, FREE RADICAL RES, V31, P171, DOI 10.1080/10715769900300721; Rema M., 1995, Indian Journal of Ophthalmology, V43, P17; Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; Rozen S, 2000, Methods Mol Biol, V132, P365; Sacca SC, 2005, ARCH OPHTHALMOL-CHIC, V123, P458, DOI 10.1001/archopht.123.4.458; Schipper HM, 2004, AGEING RES REV, V3, P265, DOI 10.1016/j.arr.2004.02.001; Schuettauf F, 2002, VISION RES, V42, P2333, DOI 10.1016/S0042-6989(02)00188-8; Shih AY, 2006, J NEUROSCI, V26, P10514, DOI 10.1523/JNEUROSCI.3178-06.2006; Shih AY, 2005, J NEUROSCI, V25, P10321, DOI 10.1523/JNEUROSCI.4014-05.2005; Shih AY, 2005, J BIOL CHEM, V280, P22925, DOI 10.1074/jbc.M414635200; Smith AR, 2004, CURR MED CHEM, V11, P1135, DOI 10.2174/0929867043365387; Steele MR, 2006, INVEST OPHTH VIS SCI, V47, P977, DOI 10.1167/iovs.05-0865; Sullivan TA, 2011, HUM GENE THER, V22, P1191, DOI 10.1089/hum.2011.052; Tezel G, 2005, INVEST OPHTH VIS SCI, V46, P3177, DOI 10.1167/iovs.05-0208; Underwood BR, 2010, HUM MOL GENET, V19, P3413, DOI 10.1093/hmg/ddq253; van Horssen J, 2008, FREE RADICAL BIO MED, V45, P1729, DOI 10.1016/j.freeradbiomed.2008.09.023; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Ward MS, 2006, NEUROPROTECTION RETI, P1, DOI [10.1002/jps, DOI 10.1002/JPS]; Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901; Wong AA, 2012, INVEST OPHTH VIS SCI, V53, P5956, DOI 10.1167/iovs.12-10020; YAN SD, 1994, J BIOL CHEM, V269, P9889; Yildirim O, 2005, EYE, V19, P580, DOI 10.1038/sj.eye.6701565; Zhong LC, 2007, INVEST OPHTH VIS SCI, V48, P1212, DOI 10.1167/iovs.06-0757; Zhou XH, 2007, DEV NEUROBIOL, V67, P603, DOI 10.1002/dneu.20373; ZIEGLER D, 1995, DIABETOLOGIA, V38, P1425, DOI 10.1007/BF00400603; Ziegler Dan, 2004, Treat Endocrinol, V3, P173, DOI 10.2165/00024677-200403030-00005	69	97	97	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65389	10.1371/journal.pone.0065389	http://dx.doi.org/10.1371/journal.pone.0065389			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755225	Green Published, Green Submitted, gold			2022-12-27	WOS:000320579400056
J	Knappova, J; Knapp, M; Munzbergova, Z				Knappova, Jana; Knapp, Michal; Muezbergova, Zuzana			Spatio-Temporal Variation in Contrasting Effects of Resident Vegetation on Establishment, Growth and Reproduction of Dry Grassland Plants: Implications for Seed Addition Experiments	PLOS ONE			English	Article							RECRUITMENT LIMITATION; SPECIES-RICHNESS; RESOURCE COMPETITION; MYCORRHIZAL FUNGI; SOIL DISTURBANCE; RESTORATION; COMMUNITIES; COLONIZATION; INVASIBILITY; FACILITATION	Successful establishment of plants is limited by both biotic and abiotic conditions and their interactions. Seedling establishment is also used as a direct measure of habitat suitability, but transient changes in vegetation might provide windows of opportunity allowing plant species to colonize sites which otherwise appear unsuitable. We aimed to study spatio-temporal variability in the effects of resident vegetation on establishment, growth and reproduction of dry grassland species in abandoned arable fields representing potentially suitable habitats. Seeds were sown in disturbed (bare of vegetation and roots) and undisturbed plots in three fields abandoned in the last 20 years. To assess the effects of temporal variation on plant establishment, we initiated our experiments in two years (2007 and 2008). Seventeen out of the 35 sown species flowered within two years after sowing, while three species completely failed to become established. The vegetation in the undisturbed plots facilitated seedling establishment only in the year with low spring precipitation, and the effect did not hold for all species. In contrast, growth and flowering rate were consistently much greater in the disturbed plots, but the effect size differed between the fields and years of sowing. We show that colonization is more successful when site opening by disturbance coincide with other suitable conditions such as weather or soil characteristics. Seasonal variability involved in our study emphasizes the necessity of temporal replication of sowing experiments. Studies assessing habitat suitability by seed sowing should either involve both vegetation removal treatments and untreated plots or follow the gradient of vegetation cover. We strongly recommend following the numbers of established individuals, their sizes and reproductive success when assessing habitat suitability by seed sowing since one can gain completely different results in different phases of plant life cycle.	[Knappova, Jana; Muezbergova, Zuzana] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic; [Knappova, Jana; Muezbergova, Zuzana] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic; [Knapp, Michal] Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Czech University of Life Sciences Prague	Knappova, J (corresponding author), Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic.	jana.knappova@ibot.cas.cz	Knappová, Jana/I-7197-2016; Münzbergová, Zuzana/F-6321-2013; Knapp, Michal/AAF-4864-2020	Knappová, Jana/0000-0002-8095-2583; Münzbergová, Zuzana/0000-0002-4026-6220; Knapp, Michal/0000-0003-4487-7317	Czech Science Foundation [P504/10/0456]; Czech Academy of Sciences [RVO 67985939]; Institute of Botany, Academy of Sciences, and by Ministry of Education; Czech Republic via Department of Botany, Faculty of Science, Charles University, Prague	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Academy of Sciences(Czech Academy of Sciences); Institute of Botany, Academy of Sciences, and by Ministry of Education; Czech Republic via Department of Botany, Faculty of Science, Charles University, Prague	The study was supported by the Czech Science Foundation (P504/10/0456) (www.gacr.cz), and partly by the Czech Academy of Sciences (RVO 67985939) (www.cas.cz) via the Institute of Botany, Academy of Sciences, and by Ministry of Education (www.msmt.cz) of the Czech Republic via Department of Botany, Faculty of Science, Charles University, Prague. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasekare P, 2003, ECOL LETT, V6, P1109, DOI 10.1046/j.1461-0248.2003.00530.x; Bakker JD, 2003, ECOL APPL, V13, P137, DOI 10.1890/1051-0761(2003)013[0137:COGROY]2.0.CO;2; Bartha S, 2003, APPL VEG SCI, V6, P205, DOI 10.1111/j.1654-109X.2003.tb00581.x; Bonser SP, 1998, ECOSCIENCE, V5, P207, DOI 10.1080/11956860.1998.11682462; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Burke MJW, 1996, ECOLOGY, V77, P776, DOI 10.2307/2265501; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; COTTRELL HJ, 1947, NATURE, V159, P748, DOI 10.1038/159748a0; Cramer VA, 2008, TRENDS ECOL EVOL, V23, P104, DOI 10.1016/j.tree.2007.10.005; Dahlstrom A, 2010, APPL VEG SCI, V13, P305, DOI 10.1111/j.1654-109X.2009.01068.x; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; DeSimone SA, 1999, ECOLOGY, V80, P2018, DOI 10.1890/0012-9658(1999)080[2018:SSRIUC]2.0.CO;2; Dickson TL, 2008, J ECOL, V96, P937, DOI 10.1111/j.1365-2745.2008.01420.x; Dickson TL, 2011, ECOL LETT, V14, P380, DOI 10.1111/j.1461-0248.2011.01599.x; DOERR TB, 1984, J RANGE MANAGE, V37, P135, DOI 10.2307/3898900; Ehrlen J, 2006, J ECOL, V94, P1224, DOI 10.1111/j.1365-2745.2006.01169.x; Ejrnaes R, 2006, ECOLOGY, V87, P1225, DOI 10.1890/0012-9658(2006)87[1225:CAIEGS]2.0.CO;2; Ellenberg H., 1992, ZEIGERWERTE GEFASSPL; Eriksson A, 1997, NORD J BOT, V17, P469, DOI 10.1111/j.1756-1051.1997.tb00344.x; Fagan KC, 2008, J APPL ECOL, V45, P1293, DOI 10.1111/j.1365-2664.2008.01492.x; Fayolle A, 2009, OECOLOGIA, V159, P817, DOI 10.1007/s00442-008-1254-0; Francis B, 1993, GLIM 4 STAT SYSTEM G, pxiv; GOLDBERG DE, 1991, J ECOL, V79, P1013, DOI 10.2307/2261095; Gomez-Aparicio L, 2009, J ECOL, V97, P1202, DOI 10.1111/j.1365-2745.2009.01573.x; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; Hellstrom K, 2009, J NAT CONSERV, V17, P236, DOI 10.1016/j.jnc.2009.04.007; Hofmann M, 2004, APPL VEG SCI, V7, P193, DOI 10.1111/j.1654-109X.2004.tb00610.x; Holmgren M, 2010, J ECOL, V98, P1269, DOI 10.1111/j.1365-2745.2010.01709.x; Howard TG, 2001, ECOLOGY, V82, P979, DOI 10.1890/0012-9658(2001)082[0979:CRHFGG]2.0.CO;2; Jakobsson A, 2000, OIKOS, V88, P494, DOI 10.1034/j.1600-0706.2000.880304.x; Janssens F, 1998, PLANT SOIL, V202, P69, DOI 10.1023/A:1004389614865; JASPER DA, 1991, NEW PHYTOL, V118, P471, DOI 10.1111/j.1469-8137.1991.tb00029.x; Jutila HM, 2002, J ECOL, V90, P291, DOI 10.1046/j.1365-2745.2001.00665.x; Kahmen S, 2004, J VEG SCI, V15, P21, DOI 10.1111/j.1654-1103.2004.tb02233.x; Kleijn D, 2003, RESTOR ECOL, V11, P131, DOI 10.1046/j.1526-100X.2003.00015.x; Knappova J, 2012, LANDSCAPE ECOL, V27, P97, DOI 10.1007/s10980-011-9680-5; Kosola KR, 1999, OECOLOGIA, V118, P69, DOI 10.1007/s004420050704; Lanta V, 2011, PERSPECT PLANT ECOL, V13, P189, DOI 10.1016/j.ppees.2011.05.003; Lavorel S, 1999, OIKOS, V84, P480, DOI 10.2307/3546427; McLellan AJ, 1997, J ECOL, V85, P479, DOI 10.2307/2960571; Milbau A, 2003, NEW PHYTOL, V159, P657, DOI 10.1046/j.1469-8137.2003.00833.x; Munzbergova Z, 2005, OECOLOGIA, V145, P1, DOI 10.1007/s00442-005-0052-1; Munzbergova Z, 2004, J ECOL, V92, P854, DOI 10.1111/j.0022-0477.2004.00919.x; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Oster M, 2009, J APPL ECOL, V46, P1266, DOI 10.1111/j.1365-2664.2009.01721.x; Pakeman RJ, 2002, APPL VEG SCI, V5, P75, DOI 10.1658/1402-2001(2002)005[0075:SSAPIF]2.0.CO;2; Pankova H, 2008, OECOLOGIA, V157, P211, DOI 10.1007/s00442-008-1064-4; Pywell RF, 2002, J APPL ECOL, V39, P294, DOI 10.1046/j.1365-2664.2002.00718.x; READER RJ, 1993, J ECOL, V81, P169, DOI 10.2307/2261232; Renne IJ, 2006, ECOLOGY, V87, P2264, DOI 10.1890/0012-9658(2006)87[2264:SIGIEO]2.0.CO;2; Roberts RE, 2010, APPL VEG SCI, V13, P270, DOI 10.1111/j.1654-109X.2009.01073.x; Roscher C, 2009, OIKOS, V118, P1524, DOI 10.1111/j.1600-0706.2009.17601.x; ROSS MA, 1972, J ECOL, V60, P77, DOI 10.2307/2258041; Ruprecht E, 2006, RESTOR ECOL, V14, P473, DOI 10.1111/j.1526-100X.2006.00155.x; RYSER P, 1993, J VEG SCI, V4, P195, DOI 10.2307/3236105; SCHUPP EW, 1995, AM J BOT, V82, P399, DOI 10.2307/2445586; Seabloom EW, 2011, OIKOS, V120, P291, DOI 10.1111/j.1600-0706.2010.18781.x; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Tilman D, 1997, ECOLOGY, V78, P81, DOI 10.1890/0012-9658(1997)078[0081:CIRLAG]2.0.CO;2; Turnbull LA, 2000, OIKOS, V88, P225, DOI 10.1034/j.1600-0706.2000.880201.x; Tutin TG, 1980, FLORA EUROPAEA, P5; Vaughn KJ, 2010, RESTOR ECOL, V18, P59, DOI 10.1111/j.1526-100X.2010.00714.x; Veblen KE, 2008, ECOLOGY, V89, P1532, DOI 10.1890/07-0973.1; Vitova A, 2011, PLANT ECOL, V212, P1231, DOI 10.1007/s11258-011-9900-8; Walker KJ, 2004, BIOL CONSERV, V119, P1, DOI 10.1016/j.biocon.2003.10.020; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; Zeiter M, 2006, ECOLOGY, V87, P942, DOI 10.1890/0012-9658(2006)87[942:RLCLSR]2.0.CO;2; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	69	23	23	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65879	10.1371/journal.pone.0065879	http://dx.doi.org/10.1371/journal.pone.0065879			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755288	Green Published, gold, Green Submitted			2022-12-27	WOS:000320579400080
J	Sapkota, Y; Mackey, JR; Lai, R; Franco-Villalobos, C; Lupichuk, S; Robson, PJ; Kopciuk, K; Cass, CE; Yasui, Y; Damaraju, S				Sapkota, Yadav; Mackey, John R.; Lai, Raymond; Franco-Villalobos, Conrado; Lupichuk, Sasha; Robson, Paula J.; Kopciuk, Karen; Cass, Carol E.; Yasui, Yutaka; Damaraju, Sambasivarao			Assessing SNP-SNP Interactions among DNA Repair, Modification and Metabolism Related Pathway Genes in Breast Cancer Susceptibility	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RISK; POLYMORPHISMS; MUTATIONS; CAPACITY; P53; PREDICTION; ALLELES; LINKAGE	Genome-wide association studies (GWASs) have identified low-penetrance common variants (i.e., single nucleotide polymorphisms, SNPs) associated with breast cancer susceptibility. Although GWASs are primarily focused on single-locus effects, gene-gene interactions (i.e., epistasis) are also assumed to contribute to the genetic risks for complex diseases including breast cancer. While it has been hypothesized that moderately ranked (P value based) weak single-locus effects in GWASs could potentially harbor valuable information for evaluating epistasis, we lack systematic efforts to investigate SNPs showing consistent associations with weak statistical significance across independent discovery and replication stages. The objectives of this study were i) to select SNPs showing single-locus effects with weak statistical significance for breast cancer in a GWAS and/or candidate-gene studies; ii) to replicate these SNPs in an independent set of breast cancer cases and controls; and iii) to explore their potential SNP-SNP interactions contributing to breast cancer susceptibility. A total of 17 SNPs related to DNA repair, modification and metabolism pathway genes were selected since these pathways offer a priori knowledge for potential epistatic interactions and an overall role in breast carcinogenesis. The study design included predominantly Caucasian women (2,795 cases and 4,505 controls) from Alberta, Canada. We observed two two-way SNP-SNP interactions (APEX1-rs1130409 and RPAP1-rs2297381; MLH1-rs1799977 and MDM2-rs769412) in logistic regression that conferred elevated risks for breast cancer (P-interaction < 7.3 x 10(-3)). Logic regression identified an interaction involving four SNPs (MBD2-rs4041245, MLH1-rs1799977, MDM2-rs769412, BRCA2-rs1799943) (P-permutation = 2.4 x 10(-3)). SNPs involved in SNP-SNP interactions also showed single-locus effects with weak statistical significance, while BRCA2-rs1799943 showed stronger statistical significance (P-correlation/trend = 3.2 x 10(-4)) than the others. These single-locus effects were independent of body mass index. Our results provide a framework for evaluating SNPs showing statistically weak but reproducible singlelocus effects for epistatic effects contributing to disease susceptibility.	[Sapkota, Yadav; Mackey, John R.; Cass, Carol E.; Damaraju, Sambasivarao] Alberta Hlth Serv, Cross Canc Inst, Edmonton, AB, Canada; [Sapkota, Yadav; Lai, Raymond; Damaraju, Sambasivarao] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Mackey, John R.; Cass, Carol E.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Franco-Villalobos, Conrado; Yasui, Yutaka] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Lupichuk, Sasha; Kopciuk, Karen] Univ Calgary, Dept Oncol, Calgary, AB, Canada; [Robson, Paula J.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Kopciuk, Karen] Univ Calgary, Dept Math & Stat, Calgary, AB T2N 1N4, Canada; [Robson, Paula J.] Alberta Hlth Serv Canc Care, Edmonton, AB, Canada; [Lupichuk, Sasha] Alberta Hlth Serv, Tom Baker Canc Ctr, Calgary, AB, Canada	Alberta Health Services (AHS); University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Calgary; University of Alberta; University of Calgary; Alberta Health Services (AHS); Alberta Health Services (AHS); Tom Baker Cancer Clinic; University of Calgary	Damaraju, S (corresponding author), Alberta Hlth Serv, Cross Canc Inst, Edmonton, AB, Canada.	Sambasivarao.Damaraju@albertahealthservices.ca	Robson, Paula J/Q-3351-2017; Yasui, Yutaka/E-2564-2015; Sapkota, Yadav/O-2142-2015	Robson, Paula J/0000-0003-4640-1371; Yasui, Yutaka/0000-0002-7717-8638; Sapkota, Yadav/0000-0001-5943-9454	Alberta Cancer Research Institute; Canadian Breast Cancer Foundation (CBCF); Alberta Cancer Board; CBCF-Prairies/NWT Region; Alberta Cancer Foundation; Alberta Cancer Prevention and Legacy Fund; Alberta Cancer Prevention Legacy	Alberta Cancer Research Institute; Canadian Breast Cancer Foundation (CBCF); Alberta Cancer Board; CBCF-Prairies/NWT Region(Region Auvergne-Rhone-AlpesRegion Bourgogne-Franche-ComteRegion Hauts-de-FranceRegion Nouvelle-Aquitaine); Alberta Cancer Foundation; Alberta Cancer Prevention and Legacy Fund; Alberta Cancer Prevention Legacy	This work was supported by Alberta Cancer Research Institute, Canadian Breast Cancer Foundation (CBCF) operating grants and Alberta Cancer Board operating grants to SD. The CBCF Tumor Bank was funded by the CBCF-Prairies/NWT Region, Alberta Cancer Foundation, Alberta Cancer Prevention and Legacy Fund (managed by the Alberta Innovates-Health Solutions). Funding for the Tomorrow Project was provided by the Alberta Cancer Foundation and the Alberta Cancer Prevention Legacy (managed by Alberta Innovates - ealth Solutions) and the Canadian Partnership Against Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Boersma BJ, 2006, J NATL CANCER I, V98, P911, DOI 10.1093/jnci/djj245; Conde J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-344; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Dinu I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043035; Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Economopoulos KP, 2010, BREAST CANCER RES TR, V121, P439, DOI 10.1007/s10549-009-0562-3; Feng QH, 2005, JNCI-J NATL CANCER I, V97, P273, DOI 10.1093/jnci/dji041; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; Gochhait S, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1780; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Kooperberg C, 2012, LOGICREG LOGIC REGRE; Leng SG, 2008, CANCER EPIDEM BIOMAR, V17, P2062, DOI 10.1158/1055-9965.EPI-08-0308; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lo SH, 2008, P NATL ACAD SCI USA, V105, P12387, DOI 10.1073/pnas.0805242105; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Mitra AK, 2008, ONCOL RES, V17, P127, DOI 10.3727/096504008785055567; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Moore JH, 2005, NAT GENET, V37, P13, DOI 10.1038/ng0105-13; Onay VU, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-114; Pharoah PDP, 2008, NEW ENGL J MED, V358, P2796, DOI 10.1056/NEJMsa0708739; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2012, R LANG ENV STAT COMP; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Rajaraman P, 2008, INT J CANCER, V123, P2713, DOI 10.1002/ijc.23779; Rao NM, 1998, CANCER GENET CYTOGEN, V102, P65, DOI 10.1016/S0165-4608(97)00303-8; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Roberts MR, 2011, CARCINOGENESIS, V32, P1223, DOI 10.1093/carcin/bgr096; Sapkota Y, 2012, EUR J HUM GENET, V20, P682, DOI 10.1038/ejhg.2011.273; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Sehrawat B, 2011, HUM GENET, V130, P529, DOI 10.1007/s00439-011-0973-1; Shen J, 2006, CANCER EPIDEM BIOMAR, V15, P1614, DOI 10.1158/1055-9965.EPI-06-0218; Smith TR, 2008, CARCINOGENESIS, V29, P2132, DOI 10.1093/carcin/bgn193; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	44	42	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64896	10.1371/journal.pone.0064896	http://dx.doi.org/10.1371/journal.pone.0064896			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755158	Green Submitted, gold, Green Published			2022-12-27	WOS:000319872300037
J	Tan, BK; Sivakumar, K; Bari, MF; Vatish, M; Randeva, HS				Tan, Bee K.; Sivakumar, Kavitha; Bari, Muhammad F.; Vatish, Manu; Randeva, Harpal S.			Lower Cerebrospinal Fluid/Plasma Fibroblast Growth Factor 21 (FGF21) Ratios and Placental FGF21 Production in Gestational Diabetes	PLOS ONE			English	Article							INSULIN-RESISTANCE; METABOLIC REGULATOR; OBESE WOMEN; PREGNANCY; MELLITUS; LEPTIN; BRAIN; ADIPONECTIN; GLUCOSE; FGF-21	Objectives: Circulating Fibroblast Growth Factor 21 (FGF21) levels are increased in insulin resistant states such as obesity, type 2 diabetes mellitus and gestational diabetes mellitus (GDM). In addition, GDM is associated with serious maternal and fetal complications. We sought to study human cerebrospinal fluid (CSF) and corresponding circulating FGF21 levels in women with gestational diabetes mellitus (GDM) and in age and BMI matched control subjects. We also assessed FGF21 secretion from GDM and control human placental explants. Design: CSF and corresponding plasma FGF21 levels of 24 women were measured by ELISA [12 GDM (age: 26-47 years, BMI: 24.3-36.3 kg/m(2)) and 12 controls (age: 22-40 years, BMI: 30.1-37.0 kg/m(2))]. FGF21 levels in conditioned media were secretion from GDM and control human placental explants were also measured by ELISA. Results: Glucose, HOMA-IR and circulating NEFA levels were significantly higher in women with GDM compared to control subjects. Plasma FGF21 levels were significantly higher in women with GDM compared to control subjects [234.3 (150.2-352.7) vs. 115.5 (60.5-188.7) pg/ml; P<0.05]. However, there was no significant difference in CSF FGF21 levels in women with GDM compared to control subjects. Interestingly, CSF/Plasma FGF21 ratio was significantly lower in women with GDM compared to control subjects [0.4 (0.3-0.6) vs. 0.8 (0.5-1.6); P<0.05]. FGF21 secretion into conditioned media was significantly lower in human placental explants from women with GDM compared to control subjects (P<0.05). Conclusions: The central actions of FGF21 in GDM subjects maybe pivotal in the pathogenesis of insulin resistance in GDM subjects. The significance of FGF21 produced by the placenta remains uncharted and maybe crucial in our understanding of the patho-physiology of GDM and its associated maternal and fetal complications. Future research should seek to elucidate these points.	[Tan, Bee K.; Sivakumar, Kavitha; Bari, Muhammad F.; Randeva, Harpal S.] Univ Warwick, Warwick Med Sch, Div Metab & Vasc Hlth, Coventry CV4 7AL, W Midlands, England; [Tan, Bee K.; Sivakumar, Kavitha; Bari, Muhammad F.; Randeva, Harpal S.] Univ Warwick, Warwick Med Sch, Div Reprod, Coventry CV4 7AL, W Midlands, England; [Vatish, Manu] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England	University of Warwick; University of Warwick; University of Oxford	Vatish, M (corresponding author), Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England.	Manu.Vatish@obs-gyn.ox.ac.uk	Vatish, Manu/B-4458-2018; vatish, manu/AAY-8750-2020	vatish, manu/0000-0002-6012-2574	Coventry General Charities	Coventry General Charities	This work was funded by a grant from Coventry General Charities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal MM, 2005, DIABETIC MED, V22, P1731, DOI 10.1111/j.1464-5491.2005.01706.x; Baptiste-Roberts K, 2009, AM J MED, V122, P207, DOI 10.1016/j.amjmed.2008.09.034; Butte NF, 2000, AM J CLIN NUTR, V71, p1256S, DOI 10.1093/ajcn/71.5.1256s; Catalano PM, 2003, J NUTR, V133, p1674S, DOI 10.1093/jn/133.5.1674S; Chen J, 2006, DIABETOLOGIA, V49, P1292, DOI 10.1007/s00125-006-0194-7; Chu SY, 2008, NEW ENGL J MED, V358, P1444, DOI 10.1056/NEJMoa0706786; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Hsuchou H, 2007, PEPTIDES, V28, P2382, DOI 10.1016/j.peptides.2007.10.007; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Lappas M, 2005, J ENDOCRINOL, V186, P457, DOI 10.1677/joe.1.06227; Li K, 2009, EUR J ENDOCRINOL, V161, P391, DOI 10.1530/EJE-09-0335; Li L, 2008, DIABETES RES CLIN PR, V82, P209, DOI 10.1016/j.diabres.2008.07.012; Lin ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018398; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Morkrid K, 2012, EUR J ENDOCRINOL, V167, P579, DOI 10.1530/EJE-12-0452; Nam SY, 2001, J CLIN ENDOCR METAB, V86, P4849, DOI 10.1210/jc.86.10.4849; Pathmaperuma AN, 2010, PLACENTA, V31, P230, DOI 10.1016/j.placenta.2009.12.013; Salihu HM, 2009, OBSTET GYNECOL, V114, P333, DOI 10.1097/AOG.0b013e3181ae9a47; Sarruf DA, 2010, DIABETES, V59, P1817, DOI 10.2337/db09-1878; Siman CM, 2001, AM J PHYSIOL-REG I, V280, pR1116, DOI 10.1152/ajpregu.2001.280.4.R1116; Smirnakis KV, 2005, DIABETES CARE, V28, P1207, DOI 10.2337/diacare.28.5.1207; Tan BK, 2011, DIABETES, V60, P2758, DOI 10.2337/db11-0672; Yamashita T, 2000, BIOCHEM BIOPH RES CO, V277, P494, DOI 10.1006/bbrc.2000.3696; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	27	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65254	10.1371/journal.pone.0065254	http://dx.doi.org/10.1371/journal.pone.0065254			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755203	Green Submitted, Green Published, gold			2022-12-27	WOS:000319872300066
J	Wilhelmi, V; Fischer, U; Weighardt, H; Schulze-Osthoff, K; Nickel, C; Stahlmecke, B; Kuhlbusch, TAJ; Scherbart, AM; Esser, C; Schins, RPF; Albrecht, C				Wilhelmi, Verena; Fischer, Ute; Weighardt, Heike; Schulze-Osthoff, Klaus; Nickel, Carmen; Stahlmecke, Burkhard; Kuhlbusch, Thomas A. J.; Scherbart, Agnes M.; Esser, Charlotte; Schins, Roel P. F.; Albrecht, Catrin			Zinc Oxide Nanoparticles Induce Necrosis and Apoptosis in Macrophages in a p47phox-and Nrf2-Independent Manner	PLOS ONE			English	Article							OXIDATIVE DNA-DAMAGE; SIGNALING PATHWAYS; CELL-DEATH; NRF2; ACTIVATION; PROTEIN; STRESS; LUNG; P53; DISSOLUTION	In view of the steadily increasing use of zinc oxide nanoparticles in various industrial and consumer applications, toxicological investigations to evaluate their safety are highly justified. We have investigated mechanisms of ZnO nanoparticle-induced apoptosis and necrosis in macrophages in relation to their important role in the clearance of inhaled particulates and the regulation of immune responses during inflammation. In the murine macrophage RAW 264.7 cell line, ZnO treatment caused a rapid induction of nuclear condensation, DNA fragmentation, and the formation of hypodiploid DNA nuclei and apoptotic bodies. The involvement of the essential effector caspase-3 in ZnO-mediated apoptosis could be demonstrated by immunocytochemical detection of activated caspase-3 in RAW 264.7 cells. ZnO specifically triggered the intrinsic apoptotic pathway, because Jurkat T lymphocytes deficient in the key mediator caspase-9 were protected against ZnO-mediated toxicity whereas reconstituted cells were not. ZnO also caused DNA strand breakage and oxidative DNA damage in the RAW 264.7 cells as well as p47(phox) NADPH oxidase-dependent superoxide generation in bone marrow-derived macrophages. However, ZnO-induced cell death was not affected in bone marrow-derived macrophages of mice deficient in p47(phox) or the oxidant responsive transcription factor Nrf2. Taken together, our data demonstrate that ZnO nanoparticles trigger p47(phox) NADPH oxidase-mediated ROS formation in macrophages, but that this is dispensable for caspase-9/3-mediated apoptosis. Execution of apoptotic cell death by ZnO nanoparticles appears to be NADPH oxidase and Nrf2-independent but rather triggered by alternative routes.	[Wilhelmi, Verena; Weighardt, Heike; Scherbart, Agnes M.; Esser, Charlotte; Schins, Roel P. F.; Albrecht, Catrin] IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany; [Fischer, Ute] Univ Dusseldorf, Fac Med, Ctr Child & Adolescent Hlth, Clin Pediat Oncol Haematol & Clin Immunol, D-40225 Dusseldorf, Germany; [Schulze-Osthoff, Klaus] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany; [Nickel, Carmen; Stahlmecke, Burkhard; Kuhlbusch, Thomas A. J.] Air Qual & Sustainable Nanotechnol, Inst Energy & Environm Technol, Duisburg, Germany	Leibniz Institut fur Umweltmedizinische Forschung (IUF); Heinrich Heine University Dusseldorf; Eberhard Karls University of Tubingen; University of Duisburg Essen	Albrecht, C (corresponding author), IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany.	catrin.albrecht@uni-duesseldorf.de	Schulze-Osthoff, Klaus/N-9025-2013; Ibrahim, Essam Hassan/G-1960-2018	Schulze-Osthoff, Klaus/0000-0003-1443-2720; Ibrahim, Essam Hassan/0000-0003-0130-2257; Kuhlbusch, Thomas/0000-0001-7847-9304; Stahlmecke, Burkhard/0000-0001-8035-5589; Wolf, Carmen/0000-0001-9362-942X	Research Commission of the Medical Faculty of the Heinrich-Heine-University Dusseldorf; German Research Council (Graduate Schools) [GRK1033, GRK1427]	Research Commission of the Medical Faculty of the Heinrich-Heine-University Dusseldorf; German Research Council (Graduate Schools)	This study was financially supported by the Research Commission of the Medical Faculty of the Heinrich-Heine-University Dusseldorf as well as the German Research Council (Graduate Schools GRK1033 and GRK1427). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed M, 2011, NANOMED-NANOTECHNOL, V7, P904, DOI 10.1016/j.nano.2011.04.011; Akhtar MJ, 2012, INT J NANOMED, V7, P845, DOI 10.2147/IJN.S29129; Castranova V, 2004, FREE RADICAL BIO MED, V37, P916, DOI 10.1016/j.freeradbiomed.2004.05.032; CHENG J, 1990, MOL CELL BIOL, V10, P5502, DOI 10.1128/MCB.10.10.5502; Cho HY, 2006, ANTIOXID REDOX SIGN, V8, P76, DOI 10.1089/ars.2006.8.76; Cho WS, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-27; Cho WS, 2010, ENVIRON HEALTH PERSP, V118, P1699, DOI 10.1289/ehp.1002201; Dhakshinamoorthy S, 2004, J BIOL CHEM, V279, P20096, DOI 10.1074/jbc.M312492200; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Forman HJ, 2002, AM J RESP CRIT CARE, V166, pS4, DOI 10.1164/rccm.2206007; Geiser M, 2010, J AEROSOL MED PULM D, V23, P207, DOI 10.1089/jamp.2009.0797; Gerloff K., 2012, NANOTOXICOLOGY; Gerloff K, 2012, CHEM RES TOXICOL, V25, P646, DOI 10.1021/tx200334k; Gerloff K, 2009, NANOTOXICOLOGY, V3, P355, DOI 10.3109/17435390903276933; Huang CC, 2010, TOXICOL IN VITRO, V24, P45, DOI 10.1016/j.tiv.2009.09.007; Hybertson BM, 2011, MOL ASPECTS MED, V32, P234, DOI 10.1016/j.mam.2011.10.006; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Iyer R, 1996, TOXICOL APPL PHARM, V141, P84, DOI 10.1006/taap.1996.0263; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; Kang SJ, 2012, TOXICOL APPL PHARM, V258, P89, DOI 10.1016/j.taap.2011.10.011; Kelleher P, 2000, ENVIRON HEALTH PERSP, V108, P685, DOI 10.2307/3454405; Kermanizadeh A, 2012, NANOTOXICOLOGY; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Kumar MA, 2011, SENSORS-BASEL, V11, P5087, DOI 10.3390/s110505087; Lee JM, 2004, J BIOCHEM MOL BIOL, V37, P139; Li J, 2005, TOXICOL SCI, V83, P313, DOI 10.1093/toxsci/kfi027; Lin WS, 2009, J NANOPART RES, V11, P25, DOI 10.1007/s11051-008-9419-7; Meyer K, 2011, TOXICOL IN VITRO, V25, P1721, DOI 10.1016/j.tiv.2011.08.011; Moos PJ, 2010, CHEM RES TOXICOL, V23, P733, DOI 10.1021/tx900203v; Morito N, 2003, ONCOGENE, V22, P9275, DOI 10.1038/sj.onc.1207024; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Musee N, 2011, J ENVIRON MONITOR, V13, P1164, DOI 10.1039/c1em10023h; Niture SK, 2012, J BIOL CHEM, V287, P9873, DOI 10.1074/jbc.M111.312694; Park JB, 2003, EXP MOL MED, V35, P325, DOI 10.1038/emm.2003.44; Rasmussen JW, 2010, EXPERT OPIN DRUG DEL, V7, P1063, DOI 10.1517/17425247.2010.502560; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Samraj AK, 2007, MOL BIOL CELL, V18, P84, DOI 10.1091/mbc.E06-04-0263; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schilling K, 2010, PHOTOCH PHOTOBIO SCI, V9, P495, DOI 10.1039/b9pp00180h; Sharma V, 2011, MUTAT RES, V745, P84; Sharma V, 2012, APOPTOSIS, V17, P852, DOI 10.1007/s10495-012-0705-6; Shi YG, 2002, STRUCTURE, V10, P285, DOI 10.1016/S0969-2126(02)00732-3; Smith PD, 2011, MUCOSAL IMMUNOL, V4, P31, DOI 10.1038/mi.2010.66; Speit G, 2004, TOXICOL LETT, V146, P151, DOI 10.1016/j.toxlet.2003.09.010; Stone V, 2009, CRIT REV TOXICOL, V39, P613, DOI 10.1080/10408440903120975; Tankhiwale R, 2012, COLLOID SURFACE B, V90, P16, DOI 10.1016/j.colsurfb.2011.09.031; Taylor RNK, 2011, ADV MATER, V23, P2554, DOI 10.1002/adma.201100541; Turney TW, 2012, CHEM RES TOXICOL; Unfried K, 2007, NANOTOXICOLOGY, V1, P52, DOI 10.1080/00222930701314932; van Berlo D, 2010, FREE RADICAL BIO MED, V49, P1685, DOI 10.1016/j.freeradbiomed.2010.08.031; Wells MA, 2012, NANOTOXICOLOGY, V6, P837, DOI 10.3109/17435390.2011.625131; Wilhelmi V, 2012, TOXICOL IN VITRO, V26, P323, DOI 10.1016/j.tiv.2011.12.006; Xia T, 2008, ACS NANO, V2, P2121, DOI 10.1021/nn800511k; Yu JY, 2011, TOXICOL IN VITRO, V25, P1654, DOI 10.1016/j.tiv.2011.07.002; Zhang JY, 2012, J HAZARD MATER, V219, P148, DOI 10.1016/j.jhazmat.2012.03.069	55	90	92	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65704	10.1371/journal.pone.0065704	http://dx.doi.org/10.1371/journal.pone.0065704			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755271	Green Published, Green Submitted, gold			2022-12-27	WOS:000319872300092
J	Zhang, CF; Qiu, SF; Wang, Y; Qi, LH; Hao, RZ; Liu, XL; Shi, Y; Hu, XF; An, DZ; Li, ZJ; Li, P; Wang, LG; Cui, JJ; Wang, P; Huang, LY; Klena, JD; Song, HB				Zhang, Chuanfu; Qiu, Shaofu; Wang, Yong; Qi, Lihua; Hao, Rongzhang; Liu, Xuelin; Shi, Yun; Hu, Xiaofeng; An, Daizhi; Li, Zhenjun; Li, Peng; Wang, Ligui; Cui, Jiajun; Wang, Pan; Huang, Liuyu; Klena, John D.; Song, Hongbin			Higher Isolation of NDM-1 Producing Acinetobacter baumannii from the Sewage of the Hospitals in Beijing	PLOS ONE			English	Article							WASTE-WATER TREATMENT; HUMAN HEALTH; IDENTIFICATION; BACTERIA	Multidrug resistant microbes present in the environment are a potential public health risk. In this study, we investigate the presence of New Delhi metallo-beta-lactamase 1 (NDM-1) producing bacteria in the 99 water samples in Beijing City, including river water, treated drinking water, raw water samples from the pools and sewage from 4 comprehensive hospitals. For the bla(NDM)-1 positive isolate, antimicrobial susceptibility testing was further analyzed, and Pulsed Field Gel Electrophoresis (PFGE) was performed to determine the genetic relationship among the NDM-1 producing isolates from sewage and human, as well as the clinical strains without NDM-1. The results indicate that there was a higher isolation of NDM-1 producing Acinetobacter baumannii from the sewage of the hospitals, while no NDM-1 producing isolates were recovered from samples obtained from the river, drinking, or fishpond water. Surprisingly, these isolates were markedly different from the clinical isolates in drug resistance and pulsed field gel electrophoresis profiles, suggesting different evolutionary relationships. Our results showed that the hospital sewage may be one of the diffusion reservoirs of NDM-1 producing bacteria.	[Zhang, Chuanfu; Qiu, Shaofu; Wang, Yong; Qi, Lihua; Hao, Rongzhang; Liu, Xuelin; Shi, Yun; Hu, Xiaofeng; An, Daizhi; Li, Peng; Wang, Ligui; Cui, Jiajun; Wang, Pan; Huang, Liuyu; Song, Hongbin] Acad Mil Med Sci, Inst Dis Control & Prevent, Beijing, Peoples R China; [Li, Zhenjun] China Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Klena, John D.] China US Collaborat Program Emerging & Reemerging, US Ctr Dis Control & Prevent, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Chinese Center for Disease Control & Prevention	Qiu, SF (corresponding author), Acad Mil Med Sci, Inst Dis Control & Prevent, Beijing, Peoples R China.	qiushf0613@hotmail.com; hongbinsong@263.net	Qi, LI/AAF-3389-2019; Qiu, Shaofu/CAJ-0602-2022		National Science and technology Major Project of China [2012ZX10004-215, 2013ZX10004-218, 2013ZX10004-07, 2012ZX10004-801, 2013ZX10004-203, 2013ZX10004-217-002]; National Natural Science Foundation of China [81000723, 81070969, 81171554]	National Science and technology Major Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the National Science and technology Major Project of China (2012ZX10004-215, 2013ZX10004-218, 2013ZX10004-07, 2012ZX10004-801, 2013ZX10004-203, 2013ZX10004-217-002) and the National Natural Science Foundation of China (81000723, 81070969, 81171554). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bushnell G, 2013, INT J INFECT DIS, V17, pE325, DOI 10.1016/j.ijid.2012.11.025; Clinical and Laboratory Standards Institute, 2008, M100S18 CLSI; Guardabassi L, 2002, WATER RES, V36, P1955, DOI 10.1016/S0043-1354(01)00429-8; Kim S, 2007, J TOXICOL ENV HEAL B, V10, P559, DOI 10.1080/15287390600975137; King SJ, 2002, J CLIN MICROBIOL, V40, P3671, DOI 10.1128/JCM.40.10.3671-3680.2002; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Toleman MA, 2012, ANTIMICROB AGENTS CH, V56, P2773, DOI 10.1128/AAC.06297-11; Vila J, 1996, J MED MICROBIOL, V44, P482, DOI 10.1099/00222615-44-6-482; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; Wang XS, 2013, CLIN INFECT DIS, V56, P161, DOI 10.1093/cid/cis782; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Zhou ZW, 2012, CAN J MICROBIOL, V58, P112, DOI [10.1139/W11-112, 10.1139/w11-112]; Zong ZY, 2013, J ANTIMICROB CHEMOTH, V68, P1007, DOI 10.1093/jac/dks505	13	42	45	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64857	10.1371/journal.pone.0064857	http://dx.doi.org/10.1371/journal.pone.0064857			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755152	gold, Green Published			2022-12-27	WOS:000319872300032
J	Essack, M; Radovanovic, A; Bajic, VB				Essack, Magbubah; Radovanovic, Aleksandar; Bajic, Vladimir B.			Information Exploration System for Sickle Cell Disease and Repurposing of Hydroxyfasudil	PLOS ONE			English	Article							FETAL-HEMOGLOBIN; RHO-KINASE; BETA-THALASSEMIA; DRAGON DATABASE; MINING TOOL; GENE; EXPRESSION; GLOBIN; HYDROXYUREA; IDENTIFICATION	Background: Sickle cell disease (SCD) is a fatal monogenic disorder with no effective cure and thus high rates of morbidity and sequelae. Efforts toward discovery of disease modifying drugs and curative strategies can be augmented by leveraging the plethora of information contained in available biomedical literature. To facilitate research in this direction we have developed a resource, Dragon Exploration System for Sickle Cell Disease (DESSCD) (http://cbrc.kaust.edu.sa/desscd/) that aims to promote the easy exploration of SCD-related data. Description: The Dragon Exploration System (DES), developed based on text mining and complemented by data mining, processed 419,612 MEDLINE abstracts retrieved from a PubMed query using SCD-related keywords. The processed SCD-related data has been made available via the DESSCD web query interface that enables: a/information retrieval using specified concepts, keywords and phrases, and b/the generation of inferred association networks and hypotheses. The usefulness of the system is demonstrated by: a/reproducing a known scientific fact, the "Sickle_Cell_Anemia-Hydroxyurea" association, and b/generating novel and plausible "Sickle_Cell_Anemia-Hydroxyfasudil" hypothesis. A PCT patent (PCT/US12/55042) has been filed for the latter drug repurposing for SCD treatment. Conclusion: We developed the DESSCD resource dedicated to exploration of text-mined and data-mined information about SCD. No similar SCD-related resource exists. Thus, we anticipate that DESSCD will serve as a valuable tool for physicians and researchers interested in SCD.	[Essack, Magbubah; Radovanovic, Aleksandar; Bajic, Vladimir B.] King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr, Comp Elect & Math Sci & Engn Div CEMSE, Thuwal, Saudi Arabia	King Abdullah University of Science & Technology	Bajic, VB (corresponding author), King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr, Comp Elect & Math Sci & Engn Div CEMSE, Thuwal, Saudi Arabia.	vladimir.bajic@kaust.edu.sa	Radovanovic, Aleksandar/M-3687-2019; Essack, Magbubah/R-2773-2019; Essack, Magbubah/G-5008-2013; Radovanovic, Aleksandar/D-1313-2012; Bajic, Vladimir/D-2810-2009	Radovanovic, Aleksandar/0000-0002-8749-7608; Essack, Magbubah/0000-0003-2709-5356; Radovanovic, Aleksandar/0000-0002-8749-7608; Bajic, Vladimir/0000-0001-5435-4750	KAUST CBRC Base Funds; KAUST Base Research Funds	KAUST CBRC Base Funds; KAUST Base Research Funds	ME and AR are supported by KAUST CBRC Base Funds of VBB. VBB is supported by KAUST Base Research Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2008, ORG BIOMOL CHEM, V6, P1665, DOI 10.1039/b801671b; Al Arrayed S, 2005, COMMUNITY GENET, V8, P52, DOI 10.1159/000083340; Arita R, 2009, DIABETES, V58, P215, DOI 10.2337/db08-0762; Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Bernaudin F, 2007, BLOOD, V110, P2749, DOI 10.1182/blood-2007-03-079665; Bryan L, 2008, MOL CANCER RES, V6, P1469, DOI 10.1158/1541-7786.MCR-08-0082; Cheng D, 2008, NUCLEIC ACIDS RES, V36, pW399, DOI 10.1093/nar/gkn296; Cokic VP, 2003, J CLIN INVEST, V111, P231, DOI 10.1172/JCI200316672; Conran N, 2004, BRIT J HAEMATOL, V124, P547, DOI 10.1111/j.1365-2141.2004.04810.x; Conran N, 2007, ANN HEMATOL, V86, P255, DOI 10.1007/s00277-006-0246-6; Costa FC, 2007, BRIT J HAEMATOL, V136, P333, DOI 10.1111/j.1365-2141.2006.06424.x; Dai ZK, 2011, PEDIATR PULM, V46, P45, DOI 10.1002/ppul.21323; Dawe AS, 2012, REPROD TOXICOL, V33, P99, DOI 10.1016/j.reprotox.2011.12.007; Ding J, 2010, J NEUROCHEM, V114, P1619, DOI 10.1111/j.1471-4159.2010.06876.x; Dvir E, 2007, CNS DRUG REV, V13, P260, DOI 10.1111/j.1527-3458.2007.00014.x; ESSACK M, Patent No. 1255042; Essack M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-219; Fathallah Hassana, 2006, Hematology Am Soc Hematol Educ Program, P58; Ferry AE, 1997, J BIOL CHEM, V272, P20030, DOI 10.1074/jbc.272.32.20030; Fibach E, 2006, EUR J HAEMATOL, V77, P437, DOI 10.1111/j.1600-0609.2006.00731.x; Fontaine JF, 2009, NUCLEIC ACIDS RES, V37, pW141, DOI 10.1093/nar/gkp353; Gambero S, 2007, EUR J HAEMATOL, V78, P144, DOI 10.1111/j.1600-0609.2006.00788.x; Goble C, 2008, J BIOMED INFORM, V41, P687, DOI 10.1016/j.jbi.2008.01.008; Hur J, 2009, BIOINFORMATICS, V25, P838, DOI 10.1093/bioinformatics/btp049; Jelier R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r96; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Kaur M, 2009, NUCLEIC ACIDS RES, V37, pD820, DOI 10.1093/nar/gkn593; Kumkhaek C, 2008, BRIT J HAEMATOL, V141, P254, DOI 10.1111/j.1365-2141.2008.07045.x; Kwofie SK, 2011, INFECT GENET EVOL, V11, P1971, DOI 10.1016/j.meegid.2011.09.001; Kwofie SK, 2011, INFECT GENET EVOL, V11, P734, DOI 10.1016/j.meegid.2010.12.006; Lanaro C, 2009, J LEUKOCYTE BIOL, V85, P235, DOI 10.1189/jlb.0708445; Lapoumeroulie C, 2005, HAEMATOLOGICA, V90, P401; Laurance S, 2010, PHARMACOGENET GENOM, V20, P257, DOI 10.1097/FPC.0b013e32833854d6; Lee A, 1995, BRIT MED J, V311, P1600, DOI 10.1136/bmj.311.7020.1600; LEY TJ, 1983, BLOOD, V62, P370; Liu K, 2010, BLOOD CELL MOL DIS, V45, P269, DOI 10.1016/j.bcmd.2010.09.004; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Makis AC, 2004, HAEMATOLOGICA, V89, P360; Maqungo M, 2011, NUCLEIC ACIDS RES, V39, pD980, DOI 10.1093/nar/gkq849; McGann PT, 2011, CURR OPIN HEMATOL, V18, P158, DOI 10.1097/MOH.0b013e32834521dd; MEILER SE, 2011, BLOOD; Natarajan J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-373; Patel N, 2010, J BIOL CHEM, V285, P20570, DOI 10.1074/jbc.M110.119495; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Sadelain M, 2006, CURR OPIN HEMATOL, V13, P142, DOI 10.1097/01.moh.0000219658.57915.d4; Sagar S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-622; Saleh AW, 1999, ACTA HAEMATOL-BASEL, V102, P31, DOI 10.1159/000040964; Santen S, 2010, INT J COLORECTAL DIS, V25, P1063, DOI 10.1007/s00384-010-0997-3; Satoh S, 2010, BRAIN RES BULL, V81, P191, DOI 10.1016/j.brainresbull.2009.08.021; Shiotani S, 2004, TRANSPLANTATION, V78, P375, DOI 10.1097/01.TP.0000128618.41619.E7; Smalheiser NR, 1996, NEUROLOGY, V46, P583, DOI 10.1212/WNL.46.2.583; Stein LD, 2003, NAT REV GENET, V4, P337, DOI 10.1038/nrg1065; Takata K, 2008, MOL CANCER THER, V7, P1551, DOI 10.1158/1535-7163.MCT-07-0428; Tsukamoto S, 2007, J NAT PROD, V70, P1658, DOI 10.1021/np070246i; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; WASHIDA N, 2011, NEPHROL DIAL TRANSPL; Weeber M, 2000, J AM MED INFORM ASSN, P903; Witt O, 2003, BLOOD, V101, P2001, DOI 10.1182/blood-2002-08-2617; Wren JD, 2004, BIOINFORMATICS, V20, P389, DOI 10.1093/bioinformatics/btg421; Zein S, 2010, EXP BIOL MED, V235, P1385, DOI 10.1258/ebm.2010.010129	60	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65190	10.1371/journal.pone.0065190	http://dx.doi.org/10.1371/journal.pone.0065190			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762313	Green Published, Green Submitted, gold			2022-12-27	WOS:000320440500031
J	Lingham-Soliar, T; Murugan, N				Lingham-Soliar, Theagarten; Murugan, Nelisha			A New Helical Crossed-Fibre Structure of beta-Keratin in Flight Feathers and Its Biomechanical Implications	PLOS ONE			English	Article							SELECTIVE BIODEGRADATION; SKIN; MORPHOLOGY; MECHANICS; PROTEINS; MATRIX; MODEL; SHARK; SHAPE; HAIR	The feather aerofoil is unequalled in nature. It is comprised of a central rachis, serial paired branches or barbs, from which arise further branches, the barbules. Barbs and barbules arise from the significantly thinner lateral walls (the epicortex) of the rachis and barbs respectively, as opposed to the thicker dorsal and ventral walls (the cortex). We hypothesized a microstructural design of the epicortex that would resist the vertical or shearing stresses. The microstructures of the cortex and epicortex of the rachis and barbs were investigated in several bird species by microbe-assisted selective disassembly and conventional methods via scanning electron microscopy. We report, preeminent of the finds, a novel system of crossed fibres (ranging from similar to 100-800 nm in diameter), oppositely oriented in alternate layers of the epicortex in the rachis and barbs. It represents the first cross-fibre microstructure, not only for the feather but in keratin per se. The cortex of the barbs is comprised of syncitial barbule cells, definitive structural units shown in the rachidial cortex in a related study. The structural connection between the cortex of the rachis and barbs appears uninterrupted. A new model on feather microstructure incorporating the findings here and in the related study is presented. The helical fibre system found in the integument of a diverse range of invertebrates and vertebrates has been implicated in profound functional strategies, perhaps none more so potentially than in the aerofoil microstructure of the feather here, which is central to one of the marvels of nature, bird flight.	[Lingham-Soliar, Theagarten] Univ KwaZulu Natal, Durban, Kwazulu Natal, South Africa; [Murugan, Nelisha] Univ KwaZulu Natal, Elect Microscopy Unit, Durban, Kwazulu Natal, South Africa	University of Kwazulu Natal; University of Kwazulu Natal	Lingham-Soliar, T (corresponding author), Univ KwaZulu Natal, Durban, Kwazulu Natal, South Africa.	linghamst@ukzn.ac.za		Murugan, Nelisha/0000-0003-3936-5798				ALEXANDER RM, 1987, J THEOR BIOL, V124, P97, DOI 10.1016/S0022-5193(87)80255-2; Alibardi L, 2008, PROG HISTOCHEM CYTO, V43, P1, DOI 10.1016/j.proghi.2008.01.001; Barthelat F, 2007, PHILOS T R SOC A, V365, P2907, DOI 10.1098/rsta.2007.0006; Bodde SG, 2011, J MECH BEHAV BIOMED, DOI [10.1016/j.jmbbm.2011.01.010, DOI 10.1016/J.JMBBM.2011.01.010)]; BONSER RHC, 1995, J EXP BIOL, V198, P1029; Bonser RHC, 2001, J MATER SCI LETT, V20, P941, DOI 10.1023/A:1010993219791; BOULIGAND Y, 1971, J MICROSC-PARIS, V11, P441; Bragulla HH, 2009, J ANAT, V214, P516, DOI 10.1111/j.1469-7580.2009.01066.x; Butler M, 2004, J EXP BIOL, V207, P285, DOI 10.1242/jeb.00746; CLARK RB, 1958, J EXP BIOL, V35, P731; D'Alba L, 2011, BIOL LETTERS, V7, P543, DOI 10.1098/rsbl.2010.1163; Dawson MA, 2006, PRESS WIT T ECOLOGY, V87; EARLAND C, 1962, NATURE, V196, P1287, DOI 10.1038/1961287a0; Eckhart L, 2008, P NATL ACAD SCI USA, V105, P18419, DOI 10.1073/pnas.0805154105; Ennos AR, 2010, P ROY SOC B-BIOL SCI, V277, P1253, DOI 10.1098/rspb.2009.2093; ENNOS AR, 1995, J EXP BIOL, V198, P1219; FILSHIE K, 1962, J CELL BIOL, V13, P1, DOI 10.1083/jcb.13.1.1; Fraser RDB, 2008, J STRUCT BIOL, V162, P1, DOI 10.1016/j.jsb.2008.01.011; Fraser RDB, 2011, J STRUCT BIOL, V173, P391, DOI 10.1016/j.jsb.2010.09.020; FREINKEL WD, 1975, S AFR J SCI, V71, P280; Gordon J.E., 1978, STRUCTURES; HARRIS JE, 1957, J EXP BIOL, V34, P116; HEBRANK MR, 1986, BIOL BULL, V171, P236, DOI 10.2307/1541920; HEBRANK MR, 1980, BIOL BULL, V158, P58, DOI 10.2307/1540758; Lingham-Soliar T, 1999, P ROY SOC B-BIOL SCI, V266, P2367, DOI 10.1098/rspb.1999.0933; Lingham-Soliar T, 2005, J MORPHOL, V264, P233, DOI 10.1002/jmor.10328; Lingham-Soliar T, 2005, J MORPHOL, V263, P1, DOI 10.1002/jmor.10207; Lingham-Soliar T, 2008, P ROY SOC B-BIOL SCI, V275, P2207, DOI 10.1098/rspb.2008.0489; Lingham-Soliar T, 2008, P ROY SOC B-BIOL SCI, V275, P775, DOI 10.1098/rspb.2007.1342; Lingham-Soliar T, 2010, P ROY SOC B-BIOL SCI, V277, P1161, DOI 10.1098/rspb.2009.1980; Maderson PFA, 2009, J MORPHOL, V270, P1166, DOI 10.1002/jmor.10747; Meyers MA, 2003, JOM, P36; MOTTA PJ, 1977, COPEIA, P454, DOI 10.2307/1443263; Naraghi M, 2010, ACS NANO, DOI [10.1021/nn101404u, DOI 10.1021/NN101404U)]; NEVILLE A C, 1969, Tissue and Cell, V1, P689, DOI 10.1016/S0040-8166(69)80041-8; Ng CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002748; Pabst DA, 1996, AM ZOOL, V36, P723; Pabst DA, 1996, J ZOOL, V238, P35, DOI 10.1111/j.1469-7998.1996.tb05378.x; PENNYCUICK CJ, 1976, J EXP BIOL, V64, P677; Shadwick RE, 2008, J EXP BIOL, V211, P289, DOI 10.1242/jeb.008912; Stettenheim PR, 2000, AM ZOOL, V40, P461, DOI 10.1668/0003-1569(2000)040[0461:TIMOMB]2.0.CO;2; Wainwright S.A., 1976, MECH DESIGN ORGANISM; WAINWRIGHT SA, 1978, SCIENCE, V202, P747, DOI 10.1126/science.202.4369.747; Weiss IM, 2010, J EXP ZOOL PART A, V313A, P690, DOI 10.1002/jez.641; Wilson AS, 2007, BRIT J DERMATOL, V157, P450, DOI 10.1111/j.1365-2133.2007.07973.x	45	27	27	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65849	10.1371/journal.pone.0065849	http://dx.doi.org/10.1371/journal.pone.0065849			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762440	gold, Green Published, Green Submitted			2022-12-27	WOS:000320440500053
J	Zinck, L; Lima, SQ				Zinck, Lea; Lima, Susana Q.			Mate Choice in Mus musculus Is Relative and Dependent on the Estrous State	PLOS ONE			English	Article							ANDROGEN-BINDING PROTEIN; HOUSE MOUSE; REPRODUCTIVE ISOLATION; SEXUAL ISOLATION; WILD MICE; RECOGNITION; PREFERENCES; BEHAVIOR; SIGNALS; MALES	Mate choice is a critical behavioral decision process with profound impact on evolution. However, the mechanistic basis of mate choice is poorly understood. In this study we focused on assortative mate choice, which is known to contribute to the reproductive isolation of the two European subspecies of house mouse, Mus musculus musculus and Mus musculus domesticus. To understand the decision process, we developed both full mating and limited-contact paradigms and tested musculus females' preference for musculus versus domesticus males, mimicking the natural musculus/domesticus contact zone. As hypothesized, when allowed to mate we found that sexually receptive musculus females exhibited a robust preference to mate with musculus males. In contrast, when non-receptive, females did not exhibit a preference and rather alternated between males in response to male mount attempts. Moreover in a no-choice condition, females mated readily with males from both subspecies. Finally, when no physical contact was allowed, and therefore male's behavior could not influence female's behavior, female's preference for its own subspecies was maintained independently of the estrous state. Together, our results suggest that the assortative preference is relative and based on a comparison of the options available rather than on an absolute preference. The results of the limited-contact experiments highlight the interplay between female's internal state and the nature of the interaction with prospective mates in the full mating conditions. With these experiments we believe we established an assortative mate preference assay that is appropriate for the investigation of its underlying substrates.	[Zinck, Lea; Lima, Susana Q.] Champalimaud Ctr Unknown, Champalimaud Neurosci Program, Lisbon, Portugal; [Zinck, Lea; Lima, Susana Q.] Inst Gulbenkian Ciencias, Oeiras, Portugal	Fundacao Champalimaud; Instituto Gulbenkian de Ciencia	Lima, SQ (corresponding author), Champalimaud Ctr Unknown, Champalimaud Neurosci Program, Lisbon, Portugal.	susana.lima@neuro.fchampalimaud.org		Lima, Susana/0000-0003-2446-9869	Fundacao Champalimaud; Instituto Gulbenkian de Ciencia; Fundacao Bial [176/08]; Marie Curie Reintegration [FP7-MC-IRG239546/MCM]; IEF Marie Curie Postdoctoral Fellowship [PIEF-GA-2009-236113]	Fundacao Champalimaud; Instituto Gulbenkian de Ciencia; Fundacao Bial(Bial Foundation); Marie Curie Reintegration(European Commission); IEF Marie Curie Postdoctoral Fellowship	This work was supported by Fundacao Champalimaud (www.fchampalimaud.org), Instituto Gulbenkian de Ciencia (www.igc.gulbenkian.pt), Fundacao Bial (176/08) (www.bial.com/en), a Marie Curie Reintegration grant to SQL (FP7-MC-IRG239546/MCM) and an IEF Marie Curie Postdoctoral Fellowship to LZ (PIEF-GA-2009-236113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agmo A., 2007, FUNCTIONAL DYSFUNCTI; Anderson M, 1994, SEXUAL SELECTION; Bateson M, 2005, TRENDS ECOL EVOL, V20, P659, DOI 10.1016/j.tree.2005.08.013; Bimova B, 2005, BIOL J LINN SOC, V84, P349, DOI 10.1111/j.1095-8312.2005.00439.x; Bimova B, 2009, BEHAV PROCESS, V80, P20, DOI 10.1016/j.beproc.2008.08.004; Bimova BV, 2011, MOL ECOL, V20, P2403, DOI 10.1111/j.1365-294X.2011.05106.x; Bolnick DI, 2012, CURR ZOOL, V58, P484, DOI 10.1093/czoolo/58.3.484; Bourne GR, 2003, NATURWISSENSCHAFTEN, V90, P402, DOI 10.1007/s00114-003-0444-1; BOURSOT P, 1993, ANNU REV ECOL SYST, V24, P119, DOI 10.1146/annurev.es.24.110193.001003; Caligioni C. S., 2009, CURRENT PROTOCOLS NE; Cheetham SA, 2007, CURR BIOL, V17, P1771, DOI 10.1016/j.cub.2007.10.007; Christophe N, 1998, ANIM BEHAV, V56, P365, DOI 10.1006/anbe.1998.0798; Clyne JD, 2008, CELL, V133, P354, DOI 10.1016/j.cell.2008.01.050; COLLINS SA, 1994, BEHAV ECOL SOCIOBIOL, V35, P21, DOI 10.1007/s002650050065; Dean MD, 2009, EVOLUTION, V63, P20, DOI 10.1111/j.1558-5646.2008.00499.x; DIXON, 2004, SOCIAL BEHAV MOUSE I; ERSKINE MS, 1989, HORM BEHAV, V23, P473, DOI 10.1016/0018-506X(89)90037-8; FOREJT J, 1974, GENET RES, V24, P189, DOI 10.1017/S0016672300015214; Ganem G, 2008, HEREDITY, V100, P594, DOI 10.1038/hdy.2008.20; Grant PR, 2008, P ROY SOC B-BIOL SCI, V275, P661, DOI 10.1098/rspb.2007.0898; Gregorova S, 2000, FOLIA BIOL-PRAGUE, V46, P31; Haga S, 2010, NATURE, V466, P118, DOI 10.1038/nature09142; Hurst JL, 2009, BEHAV BRAIN RES, V200, P295, DOI 10.1016/j.bbr.2008.12.020; Johansen JA, 2008, PHYSIOL BEHAV, V95, P425, DOI 10.1016/j.physbeh.2008.07.004; Kavaliers M, 2006, P NATL ACAD SCI USA, V103, P4293, DOI 10.1073/pnas.0600410103; Koide T, 2011, EXP ANIM TOKYO, V60, P347, DOI 10.1538/expanim.60.347; Kozak GM, 2011, P ROY SOC B-BIOL SCI, V278, P2604, DOI 10.1098/rspb.2010.2466; Laukaitis CM, 1997, EVOLUTION, V51, P2000, DOI [10.2307/2411020, 10.1111/j.1558-5646.1997.tb05121.x]; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Lin DY, 2005, NATURE, V434, P470, DOI 10.1038/nature03414; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; MARSDEN HM, 1964, SCIENCE, V144, P1469, DOI 10.1126/science.144.3625.1469; Mavarez J, 2006, NATURE, V441, P868, DOI 10.1038/nature04738; Mendelson TC, 2012, TRENDS ECOL EVOL, V27, P421, DOI 10.1016/j.tree.2012.04.001; Miller GF, 1998, TRENDS COGN SCI, V2, P190, DOI 10.1016/S1364-6613(98)01169-3; Padoa-Schioppa C, 2011, ANNU REV NEUROSCI, V34, P333, DOI 10.1146/annurev-neuro-061010-113648; Paredes RG, 1999, BEHAV BRAIN RES, V105, P117, DOI 10.1016/S0166-4328(99)00087-X; Roberts SA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-75; Rundle HD, 1998, EVOLUTION, V52, P200, DOI 10.1111/j.1558-5646.1998.tb05153.x; Schwartz JJ, 2001, BEHAV ECOL SOCIOBIOL, V49, P443, DOI 10.1007/s002650100317; Smadja C, 2005, J EVOLUTION BIOL, V18, P1485, DOI 10.1111/j.1420-9101.2005.00944.x; Smadja C, 2004, J EVOLUTION BIOL, V17, P165, DOI 10.1046/j.1420-9101.2003.00647.x; Smadja C, 2002, BEHAV ECOL, V13, P312, DOI 10.1093/beheco/13.3.312; Storchova R, 2004, MAMM GENOME, V15, P515, DOI 10.1007/s00335-004-2386-0; Teeter KC, 2008, GENOME RES, V18, P67, DOI 10.1101/gr.6757907; Winslow James T, 2003, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0816s22; YAMAZAKI K, 1976, J EXP MED, V144, P1324, DOI 10.1084/jem.144.5.1324; Yang HN, 2011, NAT GENET, V43, P648, DOI 10.1038/ng.847	48	23	23	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e66064	10.1371/journal.pone.0066064	http://dx.doi.org/10.1371/journal.pone.0066064			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762466	Green Published, Green Submitted, gold			2022-12-27	WOS:000320440500062
J	Ayer, A; Sanwald, J; Pillay, BA; Meyer, AJ; Perrone, GG; Dawes, IW				Ayer, Anita; Sanwald, Julia; Pillay, Bethany A.; Meyer, Andreas J.; Perrone, Gabriel G.; Dawes, Ian W.			Distinct Redox Regulation in Sub-Cellular Compartments in Response to Various Stress Conditions in Saccharomyces cerevisiae	PLOS ONE			English	Article							MITOCHONDRIAL INTERMEMBRANE SPACE; INDUCED CELL-DEATH; OXIDATIVE-STRESS; TRANSCRIPTIONAL RESPONSE; HYDROGEN-PEROXIDE; YEAST-CELLS; GLUTATHIONE; PROTEIN; SHOCK; PH	Responses to many growth and stress conditions are assumed to act via changes to the cellular redox status. However, direct measurement of pH-adjusted redox state during growth and stress has never been carried out. Organellar redox state (E-GSH) was measured using the fluorescent probes roGFP2 and pHluorin in Saccharomyces cerevisiae. In particular, we investigated changes in organellar redox state in response to various growth and stress conditions to better understand the relationship between redox-, oxidative-and environmental stress response systems. E-GSH values of the cytosol, mitochondrial matrix and peroxisome were determined in exponential and stationary phase in various media. These values (-340 to -350 mV) were more reducing than previously reported. Interestingly, sub-cellular redox state remained unchanged when cells were challenged with stresses previously reported to affect redox homeostasis. Only hydrogen peroxide and heat stress significantly altered organellar redox state. Hydrogen peroxide stress altered the redox state of the glutathione disulfide/glutathione couple (GSSG, 2H(+)/2GSH) and pH. Recovery from moderate hydrogen peroxide stress was most rapid in the cytosol, followed by the mitochondrial matrix, with the peroxisome the least able to recover. Conversely, the bulk of the redox shift observed during heat stress resulted from alterations in pH and not the GSSG, 2H(+)/2GSH couple. This study presents the first direct measurement of pH-adjusted redox state in sub-cellular compartments during growth and stress conditions. Redox state is distinctly regulated in organelles and data presented challenge the notion that perturbation of redox state is central in the response to many stress conditions.	[Ayer, Anita; Sanwald, Julia; Pillay, Bethany A.; Dawes, Ian W.] Univ New S Wales, Sydney, NSW, Australia; [Meyer, Andreas J.] Univ Bonn, INRES Chem Signalling, Bonn, Germany; [Perrone, Gabriel G.] Univ Western Sydney, Penrith, NSW 1797, Australia	University of New South Wales Sydney; University of Bonn; Western Sydney University	Dawes, IW (corresponding author), Univ New S Wales, Sydney, NSW, Australia.	i.dawes@unsw.edu.au	Meyer, Andreas J/C-4734-2013	Meyer, Andreas J/0000-0001-8144-4364; Rex, Julia/0000-0002-8189-9243; Ayer, Anita/0000-0002-7073-2835; Pillay, Bethany/0000-0001-7964-544X	Australian Research council; Deutsche Forschungsgemeinschaft (DFG) [ME1567/5-1]	Australian Research council(Australian Research Council); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This research was funded by Australian postgraduate award (AA), Discovery grant from (IWD and GGP) from the Australian Research council. Work in AJM's laboratory was funded by the Deutsche Forschungsgemeinschaft (DFG) (grant ME1567/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Ali R, 2004, J BIOL CHEM, V279, P4498, DOI 10.1074/jbc.M307446200; Ayer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044278; Ayer A, 2010, FREE RADICAL BIO MED, V49, P1956, DOI 10.1016/j.freeradbiomed.2010.09.023; Bjornberg O, 2006, ANTIOXID REDOX SIGN, V8, P354, DOI 10.1089/ars.2006.8.354; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Burhans WC, 2009, FREE RADICAL BIO MED, V47, P1282, DOI 10.1016/j.freeradbiomed.2009.05.026; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; COHEN G, 1985, MOL GEN GENET, V200, P74, DOI 10.1007/BF00383315; COLLINSON LP, 1992, J GEN MICROBIOL, V138, P329, DOI 10.1099/00221287-138-2-329; CORTASSA S, 1995, BIOTECHNOL BIOENG, V47, P193, DOI 10.1002/bit.260470211; Dardalhon M, 2012, FREE RADICAL BIO MED, V52, P2254, DOI 10.1016/j.freeradbiomed.2012.04.004; Davidson JF, 1996, P NATL ACAD SCI USA, V93, P5116, DOI 10.1073/pnas.93.10.5116; Drakulic T, 2005, FEMS YEAST RES, V5, P1215, DOI 10.1016/j.femsyr.2005.06.001; Evans MV, 1998, J BACTERIOL, V180, P483, DOI 10.1128/JB.180.3.483-490.1998; FLATTERYOBRIEN J, 1993, J GEN MICROBIOL, V139, P501, DOI 10.1099/00221287-139-3-501; GALIAZZO F, 1993, FEBS LETT, V315, P197, DOI 10.1016/0014-5793(93)81162-S; Garcera A, 2006, BIOCHEM J, V398, P187, DOI 10.1042/BJ20060034; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gutscher M, 2008, NAT METHODS, V5, P553, DOI 10.1038/NMETH.1212; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Henke B, 1998, J BIOL CHEM, V273, P3702, DOI 10.1074/jbc.273.6.3702; Hu JJ, 2008, J BIOL CHEM, V283, P29126, DOI 10.1074/jbc.M803028200; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; JAMIESON DJ, 1992, J BACTERIOL, V174, P6678, DOI 10.1128/JB.174.20.6678-6681.1992; JENSEN MA, 1984, BIOCHIM BIOPHYS ACTA, V764, P310, DOI 10.1016/0005-2728(84)90101-4; Kojer K, 2012, EMBO J, V31, P3169, DOI 10.1038/emboj.2012.165; Kumar C, 2011, EMBO J, V30, P2044, DOI 10.1038/emboj.2011.105; LEE F-J, 1985, Journal of Free Radicals in Biology and Medicine, V1, P319, DOI 10.1016/0748-5514(85)90138-2; Lopez-Mirabal HR, 2008, BBA-MOL CELL RES, V1783, P629, DOI 10.1016/j.bbamcr.2007.10.013; MATTHEWS JR, 1992, NUCLEIC ACIDS RES, V20, P3821, DOI 10.1093/nar/20.15.3821; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Ng CH, 2008, FREE RADICAL BIO MED, V44, P1131, DOI 10.1016/j.freeradbiomed.2007.12.008; Orij R, 2009, MICROBIOL-SGM, V155, P268, DOI 10.1099/mic.0.022038-0; Outten CE, 2005, BIOCHEM J, V388, P93, DOI 10.1042/BJ20041914; Petrova VY, 2004, BIOCHEM J, V380, P393, DOI 10.1042/BJ20040042; Posas F, 2000, J BIOL CHEM, V275, P17249, DOI 10.1074/jbc.M910016199; REICH JG, 1981, ENERGY METABOLISM CE; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Romero-Santacreu L, 2009, RNA, V15, P1110, DOI 10.1261/rna.1435709; ROSE M, 1983, METHOD ENZYMOL, V101, P167; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schwarzlander M, 2008, J MICROSC-OXFORD, V231, P299, DOI 10.1111/j.1365-2818.2008.02030.x; Shackelford RE, 2000, FREE RADICAL BIO MED, V28, P1387, DOI 10.1016/S0891-5849(00)00224-0; SORGER PK, 1987, EMBO J, V6, P3035, DOI 10.1002/j.1460-2075.1987.tb02609.x; Sugiyama K, 2000, J BIOL CHEM, V275, P15535, DOI 10.1074/jbc.275.20.15535; Sugiyama K, 2000, BIOCHEM J, V352, P71, DOI 10.1042/0264-6021:3520071; Thorpe GW, 2004, P NATL ACAD SCI USA, V101, P6564, DOI 10.1073/pnas.0305888101; Tucker CL, 2004, COMP FUNCT GENOM, V5, P216, DOI 10.1002/cfg.391; van Lith M, 2011, J CELL SCI, V124, P2349, DOI 10.1242/jcs.085530; van Roermund CWT, 2004, J CELL SCI, V117, P4231, DOI 10.1242/jcs.01305; WARDMAN P, 1989, J PHYS CHEM REF DATA, V18, P1637, DOI 10.1063/1.555843; Yano T, 2010, MOL CELL BIOL, V30, P3758, DOI 10.1128/MCB.00121-10; ZEHAVIWILLNER T, 1971, BIOCHIM BIOPHYS ACTA, V228, P245, DOI 10.1016/0005-2787(71)90564-8; ZEHAVIWILLNER T, 1973, ISRAEL J MED SCI, V9, P129	55	35	35	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65240	10.1371/journal.pone.0065240	http://dx.doi.org/10.1371/journal.pone.0065240			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762325	Green Published, gold, Green Submitted			2022-12-27	WOS:000321094800029
J	Geng, Y; Lin, DJ; Shao, LJ; Yan, F; Ju, HX				Geng, Yao; Lin, Dajie; Shao, Lijia; Yan, Feng; Ju, Huangxian			Cellular Delivery of Quantum Dot-Bound Hybridization Probe for Detection of Intracellular Pre-MicroRNA Using Chitosan/Poly(gamma-Glutamic Acid) Complex as a Carrier	PLOS ONE			English	Article							TRANSFECTION EFFICIENCY; MOLECULAR-WEIGHT; BREAST-CANCER; NANOPARTICLES; EXPRESSION; RNA; CHITOSAN; MECHANISMS; MIRNAS; GENES	A quantum dot (QD)-bound hybridization probe was designed for detection of intracellular pre-miRNA using chitosan (CS)/poly(gamma-glutamic acid) (gamma-PGA) complex as a gene vector. The probe was prepared by assembling thiolated RNA to gold nanoparticle (Au NP) via Au-S bond and then binding 3'- end amine of the RNA to the carboxy group capped on quantum dot surface. The QD-RNA-Au NP probe was assembled on the vector by mixing with aqueous gamma-PGA solution and then CS solution to construct a gene delivery system for highly effective cellular uptake and delivery. After the probe was released from CS/gamma-PGA complex to the cytoplasm by electrostatic repulsion at intracellular pH, it hybridized with pre-miRNA precursor as target. The formed product was then cleaved by RNase III Dicer, leading to the separation of QDs from Au NPs and fluorescence emission of QDs, which could be detected by confocal microscopic imaging to monitor the amount of the intracellular pre-miRNA precursor. The in vitro assays revealed that the QD-RNA-Au NP was a robust, sensitive and selective probe for quantitative detection of target pre-miRNA. Using MDA-MB231 and MCF-7 breast cancer cells as models, the relative amount of pre-miRNA let-7a could be successfully compared. Since the amount of miRNA is related to the progress and prognosis of cancer, this strategy could be expected to hold promising application potential in medical research and clinical diagnostics.	[Geng, Yao; Shao, Lijia; Yan, Feng] Jiangsu Inst Canc Prevent & Cure, Nanjing, Jiangsu, Peoples R China; [Geng, Yao; Lin, Dajie; Ju, Huangxian] Nanjing Univ, Sch Chem & Chem Engn, State Key Lab Analyt Chem Life Sci, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Yan, F (corresponding author), Jiangsu Inst Canc Prevent & Cure, Nanjing, Jiangsu, Peoples R China.	yanfeng2007@sohu.com; hxju@nju.edu.cn	Ju, Huangxian/B-2265-2010	Ju, Huangxian/0000-0002-6741-5302	National Basic Research Program [2010CB732400]; National Natural Science Foundation of China [21075055, 21135002, 21121091]; Department of Health of Jiangsu Province	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Health of Jiangsu Province	This work was financially supported by National Basic Research Program (2010CB732400), National Natural Science Foundation of China (21075055, 21135002, 21121091), and the Leading Medical Talents Program from Department of Health of Jiangsu Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Cissell KA, 2008, ANAL CHEM, V80, P2319, DOI 10.1021/ac702577a; Dong HF, 2012, ANGEW CHEM INT EDIT, V51, P4607, DOI 10.1002/anie.201108302; Dong HF, 2011, BIOMATERIALS, V32, P3875, DOI 10.1016/j.biomaterials.2011.02.001; Duceppe N, 2009, BIOMATERIALS, V30, P2625, DOI 10.1016/j.biomaterials.2009.01.017; Fang SP, 2006, J AM CHEM SOC, V128, P14044, DOI 10.1021/ja065223p; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Lavertu M, 2006, BIOMATERIALS, V27, P4815, DOI 10.1016/j.biomaterials.2006.04.029; Li JJ, 2010, BIOMATERIALS, V31, P5996, DOI 10.1016/j.biomaterials.2010.04.014; Liao ZX, 2010, BIOMATERIALS, V31, P8780, DOI 10.1016/j.biomaterials.2010.07.086; Liu WG, 2002, J CONTROL RELEASE, V83, P1; Liu XD, 2007, BIOMATERIALS, V28, P1280, DOI 10.1016/j.biomaterials.2006.11.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao HQ, 2001, J CONTROL RELEASE, V70, P399, DOI 10.1016/S0168-3659(00)00361-8; Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Noh SM, 2010, J CONTROL RELEASE, V145, P159, DOI 10.1016/j.jconrel.2010.04.005; Patel PC, 2011, MOL PHARMACEUT, V8, P1285, DOI 10.1021/mp200084y; Peng SF, 2011, BIOMATERIALS, V32, P239, DOI 10.1016/j.biomaterials.2010.08.081; Peng SF, 2009, BIOMATERIALS, V30, P1797, DOI 10.1016/j.biomaterials.2008.12.019; Poehlmann C, 2010, ANAL CHEM, V82, P4434, DOI 10.1021/ac100186p; Rudzinski WE, 2010, INT J PHARMACEUT, V399, P1, DOI 10.1016/j.ijpharm.2010.08.022; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tsay JM, 2004, J AM CHEM SOC, V126, P1926, DOI 10.1021/ja039227v; Valoczi A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh171; Zhang H, 2002, BIOMATERIALS, V23, P2761, DOI 10.1016/S0142-9612(02)00011-X	37	24	24	1	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65540	10.1371/journal.pone.0065540	http://dx.doi.org/10.1371/journal.pone.0065540			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762388	Green Published, gold, Green Submitted			2022-12-27	WOS:000321094800059
J	Reid, WDK; Sweeting, CJ; Wigham, BD; Zwirglmaier, K; Hawkes, JA; McGill, RAR; Linse, K; Polunin, NVC				Reid, William D. K.; Sweeting, Christopher J.; Wigham, Ben D.; Zwirglmaier, Katrin; Hawkes, Jeffrey A.; McGill, Rona A. R.; Linse, Katrin; Polunin, Nicholas V. C.			Spatial Differences in East Scotia Ridge Hydrothermal Vent Food Webs: Influences of Chemistry, Microbiology and Predation on Trophodynamics	PLOS ONE			English	Article							MID-ATLANTIC RIDGE; NITROGEN ISOTOPIC COMPOSITION; RIFTIA-PACHYPTILA; SEA-FLOOR; BACK-ARC; TROPHIC RELATIONSHIPS; GENUS ALVINICONCHA; STABLE-ISOTOPES; AXIAL-VOLCANO; AMINO-ACIDS	The hydrothermal vents on the East Scotia Ridge are the first to be explored in the Antarctic and are dominated by large peltospiroid gastropods, stalked barnacles (Vulcanolepas sp.) and anomuran crabs (Kiwa sp.) but their food webs are unknown. Vent fluid and macroconsumer samples were collected at three vent sites (E2, E9N and E9S) at distances of tens of metres to hundreds of kilometres apart with contrasting vent fluid chemistries to describe trophic interactions and identify potential carbon fixation pathways using stable isotopes. delta C-13 of dissolved inorganic carbon from vent fluids ranged from 24.6 parts per thousand to 0.8 parts per thousand at E2 and from -4.4 parts per thousand to 1.5 parts per thousand at E9. The lowest macroconsumer delta C-13 was observed in peltospiroid gastropods (-30.0 parts per thousand to -31.1 parts per thousand) and indicated carbon fixation via the Calvin-Benson-Bassham (CBB) cycle by endosymbiotic gamma-Proteobacteria. Highest delta C-13 occurred in Kiwa sp. (-19.0 parts per thousand to -10.5 parts per thousand), similar to that of the epibionts sampled from their ventral setae. Kiwa sp. delta C-13 differed among sites, which were attributed to spatial differences in the epibiont community and the relative contribution of carbon fixed via the reductive tricarboxylic acid (rTCA) and CBB cycles assimilated by Kiwa sp. Site differences in carbon fixation pathways were traced into higher trophic levels e.g. a stichasterid asteroid that predates on Kiwa sp. Sponges and anemones at the periphery of E2 assimilated a proportion of epipelagic photosynthetic primary production but this was not observed at E9N. Differences in the delta C-13 and delta S-34 values of vent macroconsumers between E2 and E9 sites suggest the relative contributions of photosynthetic and chemoautotrophic carbon fixation (rTCA v CBB) entering the hydrothermal vent food webs vary between the sites.	[Reid, William D. K.; Sweeting, Christopher J.; Polunin, Nicholas V. C.] Newcastle Univ, Sch Marine Sci & Technol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Wigham, Ben D.] Newcastle Univ, Sch Marine Sci & Technol, Dove Marine Lab, Cullercoats, England; [Zwirglmaier, Katrin; Linse, Katrin] British Antarctic Survey, NERC, Cambridge CB3 0ET, England; [Hawkes, Jeffrey A.] Univ Southampton, Natl Oceanog Ctr Southampton, Southampton, Hants, England; [McGill, Rona A. R.] Scottish Univ, Environm Res Ctr, NERC, Life Sci Mass Spectrometry Facil, E Kilbride, Lanark, Scotland	Newcastle University - UK; Newcastle University - UK; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; NERC National Oceanography Centre; University of Southampton; Scottish Universities Research & Reactor Center; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Reid, WDK (corresponding author), Newcastle Univ, Sch Marine Sci & Technol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	wdkreid@gmail.com	McGill, Rona/F-1793-2010; Zwirglmaier, Katrin/H-9799-2014; Reid, William/J-8528-2013	McGill, Rona/0000-0003-0400-7288; Zwirglmaier, Katrin/0000-0001-8598-9572; Reid, William/0000-0003-0190-0425; Polunin, Nick/0000-0002-1480-8794; Wigham, Ben/0000-0001-8408-5600; Linse, Katrin/0000-0003-3477-3047	Natural Environment Research Council (NERC) through ChEsSO consortium [NE/DO1249X/1, NE/F010664/1, NE/H524922]; NERC [LSMSFBRIS043_04/10_R_09/10]; Natural Environment Research Council [bas0100026, lsmsf010002, NE/D01249X/1, NE/D010470/2] Funding Source: researchfish; NERC [lsmsf010002, NE/D010470/2, bas0100026, NE/D01249X/1] Funding Source: UKRI	Natural Environment Research Council (NERC) through ChEsSO consortium(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The research was funded by the Natural Environment Research Council (NERC) through ChEsSO consortium grant NE/DO1249X/1 and studentships NE/F010664/1 (WDKR) and NE/H524922 (JAH). Sample analysis was funded via NERC Life Sciences Mass Spectrometry Facilities grant LSMSFBRIS043_04/10_R_09/10. The funders had no role in the study design, data collection and anlaysis, decision to publish, or preparation of the manuscript.	Bergquist DC, 2007, MAR ECOL PROG SER, V330, P49, DOI 10.3354/meps330049; BROOKS JM, 1987, SCIENCE, V238, P1138, DOI 10.1126/science.238.4830.1138; Campbell BJ, 2006, NAT REV MICROBIOL, V4, P458, DOI 10.1038/nrmicro1414; Campbell BJ, 2004, APPL ENVIRON MICROB, V70, P6282, DOI 10.1128/AEM.70.10.6282-6289.2004; Campbell BJ, 2003, APPL ENVIRON MICROB, V69, P5070, DOI 10.1128/AEM.69.9.5070-5078.2003; CAVANAUGH CM, 1981, SCIENCE, V213, P340, DOI 10.1126/science.213.4505.340; Chikaraishi Y, 2009, LIMNOL OCEANOGR-METH, V7, P740, DOI 10.4319/lom.2009.7.740; CHILDRESS JJ, 1992, OCEANOGR MAR BIOL, V30, P337; Colaco A, 2002, DEEP-SEA RES PT I, V49, P395, DOI 10.1016/S0967-0637(01)00060-7; Cuvelier D, 2011, LIMNOL OCEANOGR, V56, P1624, DOI 10.4319/lo.2011.56.5.1624; De Busserolles F, 2009, DEEP-SEA RES PT II, V56, P1649, DOI 10.1016/j.dsr2.2009.05.011; DESBRUYERES D, 1994, MAR GEOL, V116, P227, DOI 10.1016/0025-3227(94)90178-3; Erickson KL, 2009, DEEP-SEA RES PT II, V56, P1577, DOI 10.1016/j.dsr2.2009.05.002; FISHER CR, 1994, MAR ECOL PROG SER, V103, P45, DOI 10.3354/meps103045; Flores GE, 2011, ENVIRON MICROBIOL, V13, P2158, DOI 10.1111/j.1462-2920.2011.02463.x; German C.R., 2006, TREATISE GEOCHEMISTR, V6, P45, DOI 10.1016/B0-08-043751-6/06109-0; German CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023259; German CR, 2000, EARTH PLANET SC LETT, V184, P241, DOI 10.1016/S0012-821X(00)00319-8; GUY RD, 1993, PLANT PHYSIOL, V101, P37, DOI 10.1104/pp.101.1.37; Herzig PM, 1998, MINER DEPOSITA, V33, P226, DOI 10.1007/s001260050143; House CH, 2003, ORG GEOCHEM, V34, P345, DOI 10.1016/S0146-6380(02)00237-1; Hugler M, 2011, ANNU REV MAR SCI, V3, P261, DOI 10.1146/annurev-marine-120709-142712; Karl DM, 1995, MICR EXTREM UNUSUAL, P35; Kelley DS, 2001, NATURE, V412, P145, DOI 10.1038/35084000; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Levesque C, 2005, MAR ECOL PROG SER, V289, P43, DOI 10.3354/meps289043; Levesque C, 2003, MAR ECOL PROG SER, V246, P173, DOI 10.3354/meps246173; Levesque C, 2006, DEEP-SEA RES PT I, V53, P726, DOI 10.1016/j.dsr.2006.01.007; Levin LA, 2009, DEEP-SEA RES PT II, V56, P1632, DOI 10.1016/j.dsr2.2009.05.010; Limen H, 2006, CAH BIOL MAR, V47, P449; Luther GW, 2001, NATURE, V410, P813, DOI 10.1038/35071069; Markert S, 2007, SCIENCE, V315, P247, DOI 10.1126/science.1132913; Marsh L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048348; McClelland JW, 2002, ECOLOGY, V83, P2173, DOI 10.1890/0012-9658(2002)083[2173:TRATNI]2.0.CO;2; McCollom TM, 1997, GEOCHIM COSMOCHIM AC, V61, P4375, DOI 10.1016/S0016-7037(97)00241-X; Michener RH, 2007, ECOL METHOD CONCEPT, P238, DOI 10.1002/9780470691854.ch9; Nakagawa S, 2008, FEMS MICROBIOL ECOL, V65, P1, DOI 10.1111/j.1574-6941.2008.00502.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Core Team, 2011, R LANG ENV STAT COMP; RAU GH, 1979, SCIENCE, V203, P648, DOI 10.1126/science.203.4381.648; Reid WDK, 2012, MAR ECOL PROG SER, V463, P89, DOI 10.3354/meps09863; Riou V, 2010, MAR ECOL PROG SER, V405, P187, DOI 10.3354/meps08515; Robinson JJ, 2003, LIMNOL OCEANOGR, V48, P48, DOI 10.4319/lo.2003.48.1.0048; ROESKE CA, 1984, BIOCHEMISTRY-US, V23, P6275, DOI 10.1021/bi00320a058; Rogers AD, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001234; Shank TM, 1998, DEEP-SEA RES PT II, V45, P465, DOI 10.1016/S0967-0645(97)00089-1; Staudigel H, 2006, P NATL ACAD SCI USA, V103, P6448, DOI 10.1073/pnas.0600830103; Suzuki Y, 2006, APPL ENVIRON MICROB, V72, P1388, DOI 10.1128/AEM.72.2.1388-1393.2006; Suzuki Y, 2005, APPL ENVIRON MICROB, V71, P5440, DOI 10.1128/AEM.71.9.5440-5450.2005; Suzuki Y, 2005, FEMS MICROBIOL LETT, V249, P105, DOI 10.1016/j.femsle.2005.06.023; Takai K, 2009, GEOMICROBIOL J, V26, P552, DOI 10.1080/01490450903304949; Thurber AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026243; Trask JL, 1999, LIMNOL OCEANOGR, V44, P334, DOI 10.4319/lo.1999.44.2.0334; Tunnicliffe V, 2003, ECOSY WORLD, V28, P81; Van Dover CL, 2002, MAR BIOL, V141, P761, DOI 10.1007/s00227-002-0865-y; VANDOVER CL, 1989, MAR BIOL, V102, P257, DOI 10.1007/BF00428287; VANDOVER CL, 1994, LIMNOL OCEANOGR, V39, P51, DOI 10.4319/lo.1994.39.1.0051; Vetter RD, 1998, MAR BIOL, V132, P453, DOI 10.1007/s002270050411; Wirsen CO, 2002, APPL ENVIRON MICROB, V68, P316, DOI 10.1128/AEM.68.1.316-325.2002	59	50	51	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65553	10.1371/journal.pone.0065553	http://dx.doi.org/10.1371/journal.pone.0065553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762393	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000321094800064
J	Bienkowski, M; Piaskowski, S; Stoczynska-Fidelus, E; Szybka, M; Banaszczyk, M; Witusik-Perkowska, M; Jesien-Lewandowicz, E; Jaskolski, DJ; Radomiak-Zaluska, A; Jesionek-Kupnicka, D; Sikorska, B; Papierz, W; Rieske, P; Liberski, PP				Bienkowski, Michal; Piaskowski, Sylwester; Stoczynska-Fidelus, Ewelina; Szybka, Malgorzata; Banaszczyk, Mateusz; Witusik-Perkowska, Monika; Jesien-Lewandowicz, Emilia; Jaskolski, Dariusz J.; Radomiak-Zaluska, Anna; Jesionek-Kupnicka, Dorota; Sikorska, Beata; Papierz, Wielislaw; Rieske, Piotr; Liberski, Pawel P.			Screening for EGFR Amplifications with a Novel Method and Their Significance for the Outcome of Glioblastoma Patients	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; COPY NUMBER GAIN; GENE AMPLIFICATION; PROGNOSTIC-SIGNIFICANCE; ADJUVANT TEMOZOLOMIDE; CLINICAL-SIGNIFICANCE; MOLECULAR ANALYSIS; MULTIFORME; SURVIVAL; EXPRESSION	Glioblastoma is a highly aggressive tumour of the central nervous system, characterised by poor prognosis irrespective of the applied treatment. The aim of our study was to analyse whether the molecular markers of glioblastoma (i.e. TP53 and IDH1 mutations, CDKN2A deletion, EGFR amplification, chromosome 7 polysomy and EGFRvIII expression) could be associated with distinct prognosis and/or response to the therapy. Moreover, we describe a method which allows for a reliable, as well as time- and cost-effective, screening for EGFR amplification and chromosome 7 polysomy with quantitative Real-Time PCR at DNA level. In the clinical data, only the patient's age had prognostic significance (continuous: HR = 1.04; p<0.01). At the molecular level, EGFRvIII expression was associated with a better prognosis (HR = 0.37; p = 0.04). Intriguingly, EGFR amplification was associated with a worse outcome in younger patients (HR = 3.75; p<0.01) and in patients treated with radiotherapy (HR = 2.71; p = 0.03). We did not observe any difference between the patients with the amplification treated with radiotherapy and the patients without such a treatment. Next, EGFR amplification was related to a better prognosis in combination with the homozygous CDKN2A deletion (HR = 0.12; p = 0.01), but to a poorer prognosis in combination with chromosome 7 polysomy (HR = 14.88; p = 0.01). Importantly, the results emphasise the necessity to distinguish both mechanisms of the increased EGFR gene copy number (amplification and polysomy). To conclude, although the data presented here require validation in different groups of patients, they strongly advocate the consideration of the patient's tumour molecular characteristics in the selection of the therapy.	[Bienkowski, Michal; Piaskowski, Sylwester; Stoczynska-Fidelus, Ewelina; Szybka, Malgorzata; Banaszczyk, Mateusz; Witusik-Perkowska, Monika; Sikorska, Beata; Rieske, Piotr; Liberski, Pawel P.] Med Univ Lodz, Dept Mol Pathol & Neuropathol, Chair Oncol, Lodz, Poland; [Jesien-Lewandowicz, Emilia] Med Univ Lodz, Dept Radiotherapy, Chair Oncol, Lodz, Poland; [Jaskolski, Dariusz J.] Med Univ Lodz, Dept Neurosurg, Lodz, Poland; [Radomiak-Zaluska, Anna] Maria Sklodowska Curie Hosp Zgierz, Ward Neurosurg, Zgierz, Poland; [Jesionek-Kupnicka, Dorota] Med Univ Lodz, Dept Pathol, Chair Oncol, Lodz, Poland; [Papierz, Wielislaw] Med Univ Lodz, Dept Pathomorphol, Lodz, Poland	Medical University Lodz; Medical University Lodz; Medical University Lodz; Medical University Lodz; Medical University Lodz	Bienkowski, M (corresponding author), Med Univ Lodz, Dept Mol Pathol & Neuropathol, Chair Oncol, Lodz, Poland.	michal.bienkowski@gmail.com	Sikorska, Beata/H-7138-2016; Jaskólski, Dariusz/AAA-7656-2021; Stoczynska-Fidelus, Ewelina/S-9948-2016; Witusik-Perkowska, Monika/S-9942-2016; Jaskólski, Dariusz J/H-8051-2013; Bieńkowski, Michał/H-3046-2019; Rieske, Piotr/M-4821-2015; Stoczynska-Fidelus, Ewelina/M-4871-2015	Sikorska, Beata/0000-0002-6166-0729; Bieńkowski, Michał/0000-0002-9291-3928; Rieske, Piotr/0000-0002-2970-0970; Szybka, Malgorzata/0000-0003-2318-7923; Liberski, Pawel P./0000-0001-6507-4682; Jesionek-Kupnicka, Dorota/0000-0001-9319-9570; Jaskolski, Dariusz/0000-0002-9971-9677; Stoczynska-Fidelus, Ewelina/0000-0002-7779-3075	National Science Centre [N N401 047337]; Polpharma Science Foundation; Polish Ministry of Science and Higher Education	National Science Centre(National Science Centre, Poland); Polpharma Science Foundation; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by grants from: National Science Centre N N401 047337, Polpharma Science Foundation, Polish Ministry of Science and Higher Education "Diamond Grant''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algars A, 2012, BRIT J CANCER, V106, P428, DOI 10.1038/bjc.2011.571; Ang C, 2010, CAN J NEUROL SCI, V37, P625, DOI 10.1017/S0317167100010805; Backlund LM, 2003, CLIN CANCER RES, V9, P4151; Benito R, 2010, NEUROPATHOLOGY, V30, P392, DOI 10.1111/j.1440-1789.2009.01081.x; Eley GD, 2002, NEURO-ONCOLOGY, V4, P86, DOI 10.1093/neuonc/4.2.86; Felsberg J, 2009, CLIN CANCER RES, V15, P6683, DOI 10.1158/1078-0432.CCR-08-2801; Feng JJ, 2012, CANCER-AM CANCER SOC, V118, P232, DOI 10.1002/cncr.26250; Filippini G, 2008, NEURO-ONCOLOGY, V10, P79, DOI 10.1215/15228517-2007-038; Gilbert MR, 2012, J NEURO-ONCOL, V106, P147, DOI 10.1007/s11060-011-0650-1; Hartmann C, 2010, ACTA NEUROPATHOL, V120, P707, DOI 10.1007/s00401-010-0781-z; Hassler M, 2006, CANCER GENET CYTOGEN, V166, P46, DOI 10.1016/j.cancergencyto.2005.08.021; Heimberger AB, 2005, CLIN CANCER RES, V11, P1462, DOI 10.1158/1078-0432.CCR-04-1737; Heimberger AB, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-38; Houillier C, 2006, CANCER-AM CANCER SOC, V106, P2218, DOI 10.1002/cncr.21819; Kamiryo T, 2002, J NEUROSURG, V96, P815, DOI 10.3171/jns.2002.96.5.0815; Korshunov A, 2005, CANCER-AM CANCER SOC, V104, P825, DOI 10.1002/cncr.21221; Kraus JA, 2000, J NEURO-ONCOL, V48, P89, DOI 10.1023/A:1006402614838; LANG FF, 1994, J NEUROSURG, V81, P427, DOI 10.3171/jns.1994.81.3.0427; Layfield LJ, 2006, APPL IMMUNOHISTO M M, V14, P91, DOI 10.1097/01.pai.0000159772.73775.2e; Lee J, 2007, CANCER-AM CANCER SOC, V109, P1561, DOI 10.1002/cncr.22559; Liu L, 2005, J MOL MED, V83, P917, DOI 10.1007/s00109-005-0700-2; McDonald KL, 2013, FRONT NEUROL, V3, DOI 10.3389/fneur.2012.00188; Miller CT, 2003, CLIN CANCER RES, V9, P4819; Montano N, 2011, NEOPLASIA, V13, P1113, DOI 10.1593/neo.111338; Nobusawa S, 2009, CLIN CANCER RES, V15, P6002, DOI 10.1158/1078-0432.CCR-09-0715; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rapaport F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012028; Ruano Y, 2009, AM J CLIN PATHOL, V131, P257, DOI 10.1309/AJCP64YBDVCTIRWV; Sauter G, 1996, AM J PATHOL, V148, P1047; Sesboue R, 2012, BRIT J CANCER, V106, P426, DOI 10.1038/bjc.2011.570; Shinojima N, 2003, CANCER RES, V63, P6962; Simmons ML, 2001, CANCER RES, V61, P1122; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Takano T, 2005, J CLIN ONCOL, V23, P6829, DOI 10.1200/JCO.2005.01.0793; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; VONDEIMLING A, 1992, J NEUROSURG, V77, P295, DOI 10.3171/jns.1992.77.2.0295; Wang XY, 1998, ONCOGENE, V16, P191, DOI 10.1038/sj.onc.1201476; Wozniak K, 2008, CANCER GENET CYTOGEN, V183, P14, DOI 10.1016/j.cancergencyto.2008.01.020; Yin D, 2009, MOL CANCER RES, V7, P665, DOI 10.1158/1541-7786.MCR-08-0270; Yoshimoto K, 2008, CLIN CANCER RES, V14, P488, DOI 10.1158/1078-0432.CCR-07-1966	42	21	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65444	10.1371/journal.pone.0065444	http://dx.doi.org/10.1371/journal.pone.0065444			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762372	Green Published, Green Submitted, gold			2022-12-27	WOS:000321099000067
J	Chao, LL; DeCarli, C; Kriger, S; Truran, D; Zhang, Y; Laxamana, J; Villeneuve, S; Jagust, WJ; Sanossian, N; Mack, WJ; Chui, HC; Weiner, MW				Chao, Linda L.; DeCarli, Charles; Kriger, Stephen; Truran, Diana; Zhang, Yu; Laxamana, Joel; Villeneuve, Sylvia; Jagust, William J.; Sanossian, Nerses; Mack, Wendy J.; Chui, Helena C.; Weiner, Michael W.			Associations between White Matter Hyperintensities and beta Amyloid on Integrity of Projection, Association, and Limbic Fiber Tracts Measured with Diffusion Tensor MRI	PLOS ONE			English	Article							MILD-COGNITIVE-IMPAIRMENT; MAGNETIC-RESONANCE DIFFUSION; VASCULAR RISK-FACTORS; ALZHEIMERS-DISEASE; POSTERIOR CINGULATE; ELDERLY SUBJECTS; MOUSE MODEL; DEMENTIA; LESIONS; DEGENERATION	The goal of this study was to assess the relationship between A beta deposition and white matter pathology (i.e., white matter hyperintensities, WMH) on microstructural integrity of the white matter. Fifty-seven participants (mean age: 78 +/- 7 years) from an ongoing multi-site research program who spanned the spectrum of normal to mild cognitive impairment (Clinical dementia rating 0-0.5) and low to high risk factors for arteriosclerosis and WMH pathology (defined as WMH volume >0.5% total intracranial volume) were assessed with positron emission tomography (PET) with Pittsburg compound B (PiB) and magnetic resonance and diffusion tensor imaging (DTI). Multivariate analysis of covariance were used to investigate the relationship between A beta deposition and WMH pathology on fractional anisotropy (FA) from 9 tracts of interest (i.e., corona radiata, internal capsule, cingulum, parahippocampal white matter, corpus callosum, superior longitudinal, superior and inferior front-occipital fasciculi, and fornix). WMH pathology was associated with reduced FA in projection (i.e., internal capsule and corona radiate) and association (i.e., superior longitudinal, superior and inferior fronto-occipital fasciculi) fiber tracts. A beta deposition (i.e., PiB positivity) was associated with reduced FA in the fornix and splenium of the corpus callosum. There were interactions between PiB and WMH pathology in the internal capsule and parahippocampal white matter, where A beta deposition reduced FA more among subjects with WMH pathology than those without. However, accounting for apoE epsilon 4 genotype rendered these interactions insignificant. Although this finding suggests that apoE4 may increase amyloid deposition, both in the parenchyma (resulting in PiB positivity) and in blood vessels (resulting in amyloid angiopathy and WMH pathology), and that these two factors together may be associated with compromised white matter microstructural integrity in multiple brain regions, additional studies with a longitudinal design will be necessary to resolve this issue.	[Chao, Linda L.; Zhang, Yu; Weiner, Michael W.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Chao, Linda L.; Kriger, Stephen; Truran, Diana; Zhang, Yu; Laxamana, Joel; Weiner, Michael W.] Vet Affairs Med Ctr, Ctr Imaging Neurodegenerat Dis, San Francisco, CA 94121 USA; [DeCarli, Charles] Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA; [Villeneuve, Sylvia; Jagust, William J.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Jagust, William J.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Sanossian, Nerses; Chui, Helena C.] Univ So Calif, Dept Neurol, Los Angeles, CA USA; [Mack, Wendy J.] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California Davis; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Southern California; University of Southern California	Chao, LL (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.	linda.chao@ucsf.edu	DeCarli, Charles/B-5541-2009; Jagust, William/ABE-6426-2020	Chao, Linda/0000-0002-8593-2434	National Institutes of Health (NIH)/National Institute on Aging (NIA) [PO1 AG012435]; NIH/NIA [P30AG010129]; NIH/National Center for Research Resources [P41RR023953]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR023953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010129, P01AG012435] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH)/National Institute on Aging (NIA) PO1 AG012435, NIH/NIA P30AG010129 and the NIH/National Center for Research Resources P41RR023953, which were administered by the Northern California Institute for Research and Education, and with resources of the Veterans Affairs Medical Center, San Francisco, California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bendlin BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037720; BRETELER MMB, 1994, NEUROLOGY, V44, P1246, DOI 10.1212/WNL.44.7.1246; Buffon F, 2005, J CEREBR BLOOD F MET, V25, P641, DOI 10.1038/sj.jcbfm.9600054; Chabriat H, 1999, STROKE, V30, P2637, DOI 10.1161/01.STR.30.12.2637; Chen YW, 2006, NEUROLOGY, V67, P83, DOI 10.1212/01.wnl.0000223613.57229.24; Choo IH, 2010, NEUROBIOL AGING, V31, P772, DOI 10.1016/j.neurobiolaging.2008.06.015; Chua TC, 2008, CURR OPIN NEUROL, V21, P83, DOI 10.1097/WCO.0b013e3282f4594b; Chua TC, 2009, AM J GERIAT PSYCHIAT, V17, P602, DOI 10.1097/JGP.0b013e3181a76e0b; Chui HC, 2006, ANN NEUROL, V60, P677, DOI 10.1002/ana.21009; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; de Leeuw FE, 2002, BRAIN, V125, P765, DOI 10.1093/brain/awf077; de Leeuw FE, 2000, STROKE, V31, P425, DOI 10.1161/01.STR.31.2.425; DECARLI C, 1995, NEUROLOGY, V45, P2077, DOI 10.1212/WNL.45.11.2077; Delano-Wood L, 2010, NEUROBIOL AGING, V31, P1721, DOI 10.1016/j.neurobiolaging.2008.09.013; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Esiri MM, 2001, LANCET, V357, P169; Fellgiebel A, 2005, NEUROBIOL AGING, V26, P1193, DOI 10.1016/j.neurobiolaging.2004.11.006; Fernando MS, 2006, STROKE, V37, P1391, DOI 10.1161/01.STR.0000221308.94473.14; Forette F, 2002, ARCH INTERN MED, V162, P2046, DOI 10.1001/archinte.162.18.2046; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Gupta RK, 2006, J MAGN RESON IMAGING, V24, P549, DOI 10.1002/jmri.20677; Gurol ME, 2012, ANN NEUROL; Hadjidemetriou S, 2008, LECT NOTES COMPUT SC, V5241, P450, DOI 10.1007/978-3-540-85988-8_54; Hadjidemetriou S, 2009, MED IMAGE ANAL, V13, P36, DOI 10.1016/j.media.2008.05.003; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Jagust WJ, 2008, ANN NEUROL, V63, P72, DOI 10.1002/ana.21296; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Lee DY, 2009, NEUROLOGY, V73, P1722, DOI 10.1212/WNL.0b013e3181c33afb; Lee DY, 2010, STROKE, V41, P1791, DOI 10.1161/STROKEAHA.110.582163; Lee JH, 2011, NEUROLOGY, V77, P18, DOI 10.1212/WNL.0b013e318221acee; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Mathis CA, 2003, J MED CHEM, V46, P2740, DOI 10.1021/jm030026b; Mielke MM, 2009, NEUROIMAGE, V46, P47, DOI 10.1016/j.neuroimage.2009.01.054; Mielke MM, 2012, ALZHEIMERS DEMENT, V8, P105, DOI 10.1016/j.jalz.2011.05.2416; Mormino EC, 2012, NEUROIMAGE, V59, P1152, DOI 10.1016/j.neuroimage.2011.07.098; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Mungas D, 2005, NEUROLOGY, V65, P565, DOI 10.1212/01.wnl.0000172913.88973.0d; Mungas D, 2001, NEUROLOGY, V57, P2229, DOI 10.1212/WNL.57.12.2229; MUNOZ DG, 1993, ARCH NEUROL-CHICAGO, V50, P492, DOI 10.1001/archneur.1993.00540050044013; Nowrangi MA, 2012, ALZHEIMERS DEMENT; O'Sullivan M, 2004, J NEUROL NEUROSUR PS, V75, P441, DOI 10.1136/jnnp.2003.014910; O'Sullivan M, 2001, NEUROLOGY, V57, P2307, DOI 10.1212/WNL.57.12.2307; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Picard-Riera N, 2004, J NEUROSCI RES, V76, P223, DOI 10.1002/jnr.20040; Price JC, 2005, J CEREBR BLOOD F MET, V25, P1528, DOI 10.1038/sj.jcbfm.9600146; PRINCE M, 1994, NEUROLOGY, V44, P97; Prins ND, 2004, ARCH NEUROL-CHICAGO, V61, P1531, DOI 10.1001/archneur.61.10.1531; Qiu CX, 2010, J ALZHEIMERS DIS, V20, P293, DOI 10.3233/JAD-2010-1361; Ramanan VK, 2013, MOL PSYCHIAT; Reed BR, 2012, NEUROBIOL AGING, V33, P1979, DOI 10.1016/j.neurobiolaging.2011.10.002; Reitz C, 2010, ARCH NEUROL-CHICAGO, V67, P835, DOI 10.1001/archneurol.2010.136; Salat DH, 2006, STROKE, V37, P1759, DOI 10.1161/01.STR.0000227328.86353.a7; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Sexton CE, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.019; Song SK, 2004, NEUROBIOL DIS, V15, P640, DOI 10.1016/j.nbd.2003.12.003; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Sun SW, 2005, EXP NEUROL, V191, P77, DOI 10.1016/j.expneurol.2004.09.006; Tao R., 2009, INF PROCESS MED IMAG, V21, P651; Ukmar M, 2008, RADIOL MED, V113, P915, DOI 10.1007/s11547-008-0286-1; van Dijk EJ, 2005, CIRCULATION, V112, P900, DOI 10.1161/CIRCULATIONAHA.104.506337; Viswanathan A, 2009, NEUROLOGY, V72, P368, DOI 10.1212/01.wnl.0000341271.90478.8e; Werring DJ, 2000, J NEUROL NEUROSUR PS, V69, P269, DOI 10.1136/jnnp.69.2.269; Xu Q, 2010, DEMENT GERIATR COGN, V30, P317, DOI 10.1159/000320491; Zhan W, 2009, NEUROIMAGE, V47, pT58, DOI 10.1016/j.neuroimage.2009.02.004; Zhang Y, 2007, NEUROLOGY, V68, P13, DOI 10.1212/01.wnl.0000250326.77323.01	70	66	67	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65175	10.1371/journal.pone.0065175	http://dx.doi.org/10.1371/journal.pone.0065175			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762308	gold, Green Published, Green Submitted			2022-12-27	WOS:000321099000039
J	Jiang, YQ; Zhang, HG; Wang, YG; Chen, M; Ye, SF; Hou, ZQ; Ren, L				Jiang, Yuanqin; Zhang, Honggang; Wang, Yange; Chen, Min; Ye, Shefang; Hou, Zhenqing; Ren, Lei			Modulation of Apoptotic Pathways of Macrophages by Surface-Functionalized Multi-Walled Carbon Nanotubes	PLOS ONE			English	Article							FACTOR-KAPPA-B; OXIDATIVE STRESS; INDUCE APOPTOSIS; TOXICITY; MECHANISMS; CYTOTOXICITY; RESPONSES; FIBROSIS	Biomedical applications of carbon nanotubes (CNTs) often involve improving their hydrophilicity and dispersion in biological media by modifying them through noncovalent or covalent functionalization. However, the potential adverse effects of surface-functionalized CNTs have not been well characterized. In this study, we functionalized multi-walled CNTs (MWCNTs) via carboxylation, to produce MWCNTs-COOH, and via poly (ethylene glycol) linking, to produce MWCNTs-PEG. We used these functionalized MWCNTs to study the effect of surface functionalization on MWCNTs-induced toxicity to macrophages, and elucidate the underlying mechanisms of action. Our results revealed that MWCNTs-PEG were less cytotoxic and were associated with less apoptotic cell death of macrophages than MWCNTs-COOH. Additionally, MWCNTs-PEG induced less generation of reactive oxygen species (ROS) involving less activation of NADPH oxidase compared with MWCNTs-COOH, as evidenced by membrane translocation of p47(phox) and p67(phox) in macrophages. The less cytotoxic and apoptotic effect of MWCNTs-PEG compared with MWCNTs-COOH resulted from the lower cellular uptake of MWCNTs-PEG, which resulted in less activation of oxidative stress-responsive pathways, such as p38 mitogen-activated protein kinases (MAPK) and nuclear factor (NF)-kappa B. These results demonstrate that surface functionalization of CNTs may alter ROS-mediated cytotoxic and apoptotic response by modulating apoptotic signaling pathways. Our study thus provides new insights into the molecular basis for the surface properties affecting CNTs toxicity.	[Jiang, Yuanqin; Zhang, Honggang; Wang, Yange; Chen, Min; Ye, Shefang; Hou, Zhenqing; Ren, Lei] Xiamen Univ, Coll Mat, Dept Biomat, Xiamen, Peoples R China; [Jiang, Yuanqin] Xiamen Univ, Chenggong Hosp, Dept ENT, Xianmen, Peoples R China	Xiamen University; Xiamen University	Ye, SF (corresponding author), Xiamen Univ, Coll Mat, Dept Biomat, Xiamen, Peoples R China.	yeshefang@xmu.edu.cn	ren, lei/G-3459-2010	ren, lei/0000-0003-2131-1601; Ye, Shefang/0000-0002-9129-7123	National Natural Science Foundation of China [31271071, 30901175]; National Basic Research Program of China [2010CB732402]; Medical Science and Technology Innovation Foundation of Nanjing Military Command of Chinese People's Liberation Army [09Z019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Medical Science and Technology Innovation Foundation of Nanjing Military Command of Chinese People's Liberation Army	This study was financially supported by grants from the National Natural Science Foundation of China (31271071, 30901175), the National Basic Research Program of China (2010CB732402), and the Medical Science and Technology Innovation Foundation of Nanjing Military Command of Chinese People's Liberation Army (09Z019). The funders had no role in the study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	Andon FT, 2012, ACC CHEM RES; Azad N, 2013, NANOTOXICOLOGY, V7, P157, DOI 10.3109/17435390.2011.647929; Bottini M, 2011, BIOMACROMOLECULES, V12, P3381, DOI 10.1021/bm201020h; Bubici C, 2006, ONCOGENE, V25, P6731, DOI 10.1038/sj.onc.1209936; Chen X, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/10/105104; Cheng C, 2009, BIOMATERIALS, V30, P4152, DOI 10.1016/j.biomaterials.2009.04.019; Cheng JP, 2011, TOXICOL APPL PHARM, V250, P184, DOI 10.1016/j.taap.2010.10.012; Cui HF, 2010, CHEM RES TOXICOL, V23, P1131, DOI 10.1021/tx100050h; Dahiya Y, 2010, FEBS LETT, V584, P4227, DOI 10.1016/j.febslet.2010.09.009; De La Zerda A, 2008, NAT NANOTECHNOL, V3, P557, DOI 10.1038/nnano.2008.231; Ding LH, 2005, NANO LETT, V5, P2448, DOI 10.1021/nl051748o; He XQ, 2011, CHEM RES TOXICOL, V24, P2237, DOI 10.1021/tx200351d; Horie M, 2012, CHEM RES TOXICOL, V25, P605, DOI 10.1021/tx200470e; Jain KK, 2012, EXPERT OPIN DRUG DIS, V7, P1029, DOI 10.1517/17460441.2012.722078; Johnston HJ, 2010, NANOTOXICOLOGY, V4, P207, DOI 10.3109/17435390903569639; Krajcik R, 2008, BIOCHEM BIOPH RES CO, V369, P595, DOI 10.1016/j.bbrc.2008.02.072; Lehmann K, 2009, BIOCHEM J, V419, P603, DOI 10.1042/BJ20081268; Lin CL, 2011, COLLOID SURFACE B, V83, P367, DOI 10.1016/j.colsurfb.2010.12.011; Manna SK, 2005, NANO LETT, V5, P1676, DOI 10.1021/nl0507966; Mu QX, 2009, NANO LETT, V9, P4370, DOI 10.1021/nl902647x; Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111; Saito N, 2009, CHEM SOC REV, V38, P1897, DOI 10.1039/b804822n; Selim KMK, 2007, BIOMATERIALS, V28, P710, DOI 10.1016/j.biomaterials.2006.09.014; Shvedova AA, 2012, TOXICOL APPL PHARM, V261, P121, DOI 10.1016/j.taap.2012.03.023; Srivastava RK, 2011, NANOTOXICOLOGY, V5, P195, DOI 10.3109/17435390.2010.503944; Tabet L, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-3; Wang X, 2010, J NANOSCI NANOTECHNO, V10, P8516, DOI 10.1166/jnn.2010.2688; Wang X, 2012, TOXICOL IN VITRO, V26, P799, DOI 10.1016/j.tiv.2012.05.010; Wang X, 2012, NANO LETT, V12, P3050, DOI 10.1021/nl300895y; Wang X, 2011, ACS NANO, V5, P9772, DOI 10.1021/nn2033055; Ye SF, 2012, J NANOSCI NANOTECHNO, V12, P2101, DOI 10.1166/jnn.2012.5677; Ye SF, 2011, J NANOSCI NANOTECHNO, V11, P3773, DOI 10.1166/jnn.2011.3862; Zhang DY, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/17/175101; Zhang LW, 2009, TOXICOL SCI, V110, P138, DOI 10.1093/toxsci/kfp087; Zhang T, 2012, J HAZARD MATER, V219, P203, DOI 10.1016/j.jhazmat.2012.03.079; Zhang YB, 2011, ACS NANO, V5, P7020, DOI 10.1021/nn2016259; Zhou FF, 2011, SMALL, V7, P2727, DOI 10.1002/smll.201100669	37	207	210	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65756	10.1371/journal.pone.0065756	http://dx.doi.org/10.1371/journal.pone.0065756			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755279	Green Published, gold, Green Submitted			2022-12-27	WOS:000321099000101
J	Lesiak, A; Pelz, C; Ando, H; Zhu, MY; Davare, M; Lambert, TJ; Hansen, KF; Obrietan, K; Appleyard, SM; Impey, S; Wayman, GA				Lesiak, Adam; Pelz, Carl; Ando, Hideaki; Zhu, Mingyan; Davare, Monika; Lambert, Talley J.; Hansen, Katelin F.; Obrietan, Karl; Appleyard, Suzanne M.; Impey, Soren; Wayman, Gary A.			A Genome-Wide Screen of CREB Occupancy Identifies the RhoA Inhibitors Par6C and Rnd3 as Regulators of BDNF-Induced Synaptogenesis	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; CAMP-RESPONSE ELEMENT; CULTURED HIPPOCAMPAL-NEURONS; LONG-TERM POTENTIATION; DENDRITIC SPINE MORPHOGENESIS; TRANSCRIPTION FACTOR-BINDING; CYCLIC-AMP; INDUCED PHOSPHORYLATION; NEUROTROPHIC FACTOR; SECONDARY STRUCTURE	Neurotrophin-regulated gene expression is believed to play a key role in long-term changes in synaptic structure and the formation of dendritic spines. Brain-derived neurotrophic factor (BDNF) has been shown to induce increases in dendritic spine formation, and this process is thought to function in part by stimulating CREB-dependent transcriptional changes. To identify CREB-regulated genes linked to BDNF-induced synaptogenesis, we profiled transcriptional occupancy of CREB in hippocampal neurons. Interestingly, de novo motif analysis of hippocampal ChIP-Seq data identified a non-canonical CRE motif (TGGCG) that was enriched at CREB target regions and conferred CREB-responsiveness. Because cytoskeletal remodeling is an essential element of the formation of dendritic spines, within our screens we focused our attention on genes previously identified as inhibitors of RhoA GTPase. Bioinformatic analyses identified dozens of candidate CREB target genes known to regulate synaptic architecture and function. We showed that two of these, the RhoA inhibitors Par6C (Pard6A) and Rnd3 (RhoE), are BDNF-induced CREB-regulated genes. Interestingly, CREB occupied a cluster of non-canonical CRE motifs in the Rnd3 promoter region. Lastly, we show that BDNF-stimulated synaptogenesis requires the expression of Par6C and Rnd3, and that overexpression of either protein is sufficient to increase synaptogenesis. Thus, we propose that BDNF can regulate formation of functional synapses by increasing the expression of the RhoA inhibitors, Par6C and Rnd3. This study shows that genome-wide analyses of CREB target genes can facilitate the discovery of new regulators of synaptogenesis.	[Lesiak, Adam; Zhu, Mingyan; Lambert, Talley J.; Appleyard, Suzanne M.; Wayman, Gary A.] Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, Program Neurosci, Pullman, WA 99164 USA; [Davare, Monika] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; [Pelz, Carl; Ando, Hideaki; Impey, Soren] Oregon Hlth & Sci Univ, Oregon Stem Cell Ctr, Portland, OR 97201 USA; [Impey, Soren] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA; [Hansen, Katelin F.; Obrietan, Karl] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA	Washington State University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University System of Ohio; Ohio State University	Impey, S (corresponding author), Oregon Hlth & Sci Univ, Oregon Stem Cell Ctr, Portland, OR 97201 USA.	impeys@ohsu.edu; waymang@vetmed.wsu.edu	Lambert, Talley/B-4024-2015; Lambert, Talley/V-7602-2019; Ando, Hideaki/D-3876-2017	Lambert, Talley/0000-0002-2409-0181; Lambert, Talley/0000-0002-2409-0181; Davare, Monika/0000-0003-1802-7597; Lesiak, Atom/0000-0001-8413-6340	Hope for Depression Research Foundation; National institutes of medicine: NIMH [MH086032]; NIDDK [RDK083452]; NINS [NS066345]; HINS [NS066345]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066345] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23500458] Funding Source: KAKEN	Hope for Depression Research Foundation; National institutes of medicine: NIMH; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINS(National Institutes of Natural Sciences (NINS) - Japan); HINS; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding was provided by: Hope for Depression Research Foundation (GW, AL), National institutes of medicine: NIMH MH086032 (GW), NIDDK RDK083452 (SMA) NINS NS066345 (SI) HINS NS066345 (KO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 1999, NEURON, V23, P559, DOI 10.1016/S0896-6273(00)80808-9; Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; BAHR BA, 1995, J NEUROSCI RES, V42, P294, DOI 10.1002/jnr.490420303; Blanquet PR, 2003, NEUROSCIENCE, V118, P477, DOI 10.1016/S0306-4522(02)00963-6; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; CAESER M, 1991, J COMP NEUROL, V307, P87, DOI 10.1002/cne.903070109; Cardinaux JR, 2000, MOL CELL BIOL, V20, P1546, DOI 10.1128/MCB.20.5.1546-1552.2000; Cha-Molstad H, 2004, P NATL ACAD SCI USA, V101, P13572, DOI 10.1073/pnas.0405587101; CHU HM, 1991, NUCLEIC ACIDS RES, V19, P2721, DOI 10.1093/nar/19.10.2721; COMB M, 1988, EMBO J, V7, P3793, DOI 10.1002/j.1460-2075.1988.tb03264.x; De Cesare D, 1998, P NATL ACAD SCI USA, V95, P12202, DOI 10.1073/pnas.95.21.12202; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; FERRER I, 1990, ACTA NEUROPATHOL, V79, P680, DOI 10.1007/BF00294247; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; GALOFRE E, 1987, J NEUROL SCI, V81, P185, DOI 10.1016/0022-510X(87)90095-5; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; Goh LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012409; Gomes RA, 2006, J NEUROSCI, V26, P11487, DOI 10.1523/JNEUROSCI.2364-06.2006; Hajdo-Milasinovic A, 2007, J CELL SCI, V120, P555, DOI 10.1242/jcs.03364; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Horch HW, 2002, NAT NEUROSCI, V5, P1177, DOI 10.1038/nn927; HYMAN SE, 1988, MOL CELL BIOL, V8, P4225, DOI 10.1128/MCB.8.10.4225; IGUCHIARIGA SMM, 1989, GENE DEV, V3, P612, DOI 10.1101/gad.3.5.612; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Irwin SA, 2000, CEREB CORTEX, V10, P1038, DOI 10.1093/cercor/10.10.1038; Jiang X, 2008, P NATL ACAD SCI USA, V105, P341, DOI 10.1073/pnas.0710213105; Kasai H, 2010, EUR J NEUROSCI, V32, P241, DOI 10.1111/j.1460-9568.2010.07344.x; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kim JH, 2012, J NEUROCHEM, V120, P210, DOI 10.1111/j.1471-4159.2011.07555.x; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Korkotian E, 1999, NEUROREPORT, V10, P2875, DOI 10.1097/00001756-199909090-00032; Lee B, 2005, J NEUROSCI, V25, P1137, DOI 10.1523/JNEUROSCI.4288-04.2005; Luikart BW, 2008, J NEUROSCI, V28, P7006, DOI 10.1523/JNEUROSCI.0195-08.2008; Marie H, 2005, NEURON, V45, P741, DOI 10.1016/j.neuron.2005.01.039; Martianov I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-530; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; Mocholi E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019236; Nakayama AY, 2000, HIPPOCAMPUS, V10, P582, DOI 10.1002/1098-1063(2000)10:5<582::AID-HIPO8>3.0.CO;2-K; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Papa M, 1996, NEUROSCIENCE, V71, P1005, DOI 10.1016/0306-4522(95)00490-4; Pavesi Giulio, 2006, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0211s15; Penzes P, 2008, TRENDS NEUROSCI, V31, P419, DOI 10.1016/j.tins.2008.06.001; Pickett J, 2005, J NEUROPATH EXP NEUR, V64, P925, DOI 10.1097/01.jnen.0000186921.42592.6c; PURPURA DP, 1974, SCIENCE, V186, P1126, DOI 10.1126/science.186.4169.1126; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Riento K, 2005, BIOCHEM SOC T, V33, P649, DOI 10.1042/BST0330649; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; SchildPoulter C, 1996, NUCLEIC ACIDS RES, V24, P4751, DOI 10.1093/nar/24.23.4751; Schumacher MA, 2000, J BIOL CHEM, V275, P35242, DOI 10.1074/jbc.M007293200; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Segal M, 1998, NEURAL PLAST, V6, P1, DOI 10.1155/NP.1998.1; Sfakianos MK, 2007, J NEUROSCI, V27, P10982, DOI 10.1523/JNEUROSCI.0793-07.2007; Shen WH, 2006, NEURON, V50, P401, DOI 10.1016/j.neuron.2006.03.017; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Sinha S, 2003, NUCLEIC ACIDS RES, V31, P3586, DOI 10.1093/nar/gkg618; SPIRO C, 1993, P NATL ACAD SCI USA, V90, P4606, DOI 10.1073/pnas.90.10.4606; SPIRO C, 1995, J BIOL CHEM, V270, P27702, DOI 10.1074/jbc.270.46.27702; Spiro C, 1997, J BIOL CHEM, V272, P33145, DOI 10.1074/jbc.272.52.33145; STOLTENBURGDIDINGER G, 1983, DEV BRAIN RES, V11, P119, DOI 10.1016/0165-3806(83)90206-7; Storey John D, 2003, Methods Mol Biol, V224, P149; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Tolias KF, 2011, PROG NEUROBIOL, V94, P133, DOI 10.1016/j.pneurobio.2011.04.011; Vicario-Abejon C, 1998, J NEUROSCI, V18, P7256; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Zhang HY, 2008, DEV CELL, V14, P216, DOI 10.1016/j.devcel.2007.11.020; Zhao L, 2005, NEUROSCIENCE, V132, P299, DOI 10.1016/j.neuroscience.2004.11.054; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037; Zito K, 2009, NEURON, V61, P247, DOI 10.1016/j.neuron.2008.10.054	83	49	50	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64658	10.1371/journal.pone.0064658	http://dx.doi.org/10.1371/journal.pone.0064658			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762244	Green Published, gold, Green Submitted			2022-12-27	WOS:000321099000012
J	Li, JY; Yu, T; Chen, GC; Yuan, YH; Zhong, W; Zhao, LN; Chen, QK				Li, Jie-Yao; Yu, Tao; Chen, Guang-Cheng; Yuan, Yu-Hong; Zhong, Wa; Zhao, Li-Na; Chen, Qi-Kui			Enteral Nutrition within 48 Hours of Admission Improves Clinical Outcomes of Acute Pancreatitis by Reducing Complications: A Meta-Analysis	PLOS ONE			English	Article							TOTAL PARENTERAL-NUTRITION; BACTERIAL TRANSLOCATION; INTESTINAL PERMEABILITY; GUT BARRIER; GUIDELINES; SUPPORT; TRIAL; MECHANISMS; REDUCTION; MORTALITY	Background: Enteral nutrition is increasingly advocated in the treatment of acute pancreatitis, but its timing is still controversial. The aim of this meta-analysis was to find out the feasibility of early enteral nutrition within 48 hours of admission and its possible advantages. Methods and Findings: We searched PubMed, EMBASE Databases, Web of Science, the Cochrane library, and scholar.google.com for all the relevant articles about the effect of enteral nutrition initiated within 48 hours of admission on the clinical outcomes of acute pancreatitis from inception to December 2012. Eleven studies containing 775 patients with acute pancreatitis were analyzed. Results from a pooled analysis of all the studies demonstrated that early enteral nutrition was associated with significant reductions in all the infections as a whole (OR 0.38; 95% CI 0.21-0.68, P<0.05), in catheter-related septic complications (OR 0.26; 95% CI 0.11-0.58, P<0.05), in pancreatic infection (OR 0.49; 95% CI 0.31-0.78, P<0.05), in hyperglycemia (OR 0.24; 95% CI 0.11-0.52, P<0.05), in the length of hospitalization (mean difference 22.18; 95% CI -3.48-(-0.87); P<0.05), and in mortality (OR 0.31; 95% CI 0.14-0.71, P<0.05), but no difference was found in pulmonary complications (P>0.05). The stratified analysis based on the severity of disease revealed that, even in predicted severe or severe acute pancreatitis patients, early enteral nutrition still showed a protective power against all the infection complications as a whole, catheter-related septic complications, pancreatic infection complications, and organ failure that was only reported in the severe attack of the disease (all P<0.05). Conclusion: Enteral nutrition within 48 hours of admission is feasible and improves the clinical outcomes in acute pancreatitis as well as in predicted severe or severe acute pancreatitis by reducing complications.	[Li, Jie-Yao; Yu, Tao; Chen, Guang-Cheng; Yuan, Yu-Hong; Zhong, Wa; Zhao, Li-Na; Chen, Qi-Kui] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Gastroenterol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Chen, QK (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Gastroenterol, Guangzhou 510275, Guangdong, Peoples R China.	qikuichen@yahoo.com	YUAN, YUHONG/ABC-5917-2020; Zhao, Lina/GVR-7716-2022		National Natural Science Foundation of China [81270442, 81000152]; Youthful Teacher Foster Plan of Sun Yat-Sen University [09ykpy10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youthful Teacher Foster Plan of Sun Yat-Sen University	This study was supported by National Natural Science Foundation of China (No. 81270442 and No. 81000152) and Youthful Teacher Foster Plan of Sun Yat-Sen University (No. 09ykpy10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Assi S, 2002, AM J GASTROENTEROL, V97, P2255, DOI 10.1111/j.1572-0241.2002.05979.x; Al-Omran M, 2010, COCHRANE DB SYST REV, V20; Ammori BJ, 2003, PANCREAS, V26, P122, DOI 10.1097/00006676-200303000-00006; Ammori BJ, 2003, PANCREAS, V26, P18, DOI 10.1097/00006676-200301000-00004; [ASPEN Board of Directors Clinical Guidelines Task Force], 2002, JPEN J PARENTER E S1, V26, p1SA; Bakker OJ, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-73; Bakker OJ, 2009, GASTROENTEROLOGY, V136, pA75; Balzan S, 2007, J GASTROEN HEPATOL, V22, P464, DOI 10.1111/j.1440-1746.2007.04933.x; Laguna LB, 2011, NUTR HOSP, V26, P32, DOI 10.1590/S0212-16112011000800007; Cao YF, 2008, ANN NUTR METAB, V53, P268, DOI 10.1159/000189382; Capurso G, 2012, J CLIN GASTROENTEROL, V46, pS46, DOI 10.1097/MCG.0b013e3182652096; Casas M, 2007, REV ESP ENFERM DIG, V99, P264; Chen Jie, 2004, Zhonghua Yi Xue Za Zhi, V84, P1726; Eckerwall GE, 2006, ANN SURG, V244, P959, DOI 10.1097/01.sla.0000246866.01930.58; Elder ASF, 2012, PANCREATOLOGY, V12, P49, DOI 10.1016/j.pan.2011.12.012; Feng YJ, 2010, AM J PHYSIOL-GASTR L, V298, pG833, DOI 10.1152/ajpgi.00030.2010; FOITZIK T, 1994, ANN SURG, V220, P193, DOI 10.1097/00000658-199408000-00011; Fritz S, 2010, AM J SURG, V200, P111, DOI 10.1016/j.amjsurg.2009.08.019; Gupta R, 2003, PANCREATOLOGY, V3, P406, DOI 10.1159/000073657; Hajdu Nora, 2012, Magy Seb, V65, P44, DOI 10.1556/MaSeb.65.2012.2.2; Hegazi R, 2011, JPEN-PARENTER ENTER, V35, P91, DOI 10.1177/0148607110376196; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Jacobi J, 2012, CRIT CARE MED, V40, P3251, DOI 10.1097/CCM.0b013e3182653269; Kalfarentzos F, 1997, BRIT J SURG, V84, P1665, DOI 10.1002/bjs.1800841207; Koh YY, 2012, GUT LIVER, V6, P505, DOI 10.5009/gnl.2012.6.4.505; McClave SA, 1997, JPEN-PARENTER ENTER, V21, P14, DOI 10.1177/014860719702100114; Mikaeili H, 2012, BRATISL MED J, V113, P616, DOI 10.4149/BLL_2012_139; Mirtallo JM, 2012, JPEN-PARENTER ENTER, V36, P284, DOI 10.1177/0148607112440823; Olah A, 2002, NUTRITION, V18, P259, DOI 10.1016/S0899-9007(01)00755-9; Olah A, 1996, NUTRITION, V12, P580; Ong JPL, 2012, J DIGEST DIS, V13, P445, DOI 10.1111/j.1751-2980.2012.00611.x; Petrov M, 2012, GASTROENTEROLOGY, V142, pS94; Petrov MS, 2006, DIGEST SURG, V23, P336, DOI 10.1159/000097949; Petrov MS, 2010, GASTROENTEROLOGY, V139, P813, DOI 10.1053/j.gastro.2010.06.010; Petrov MS, 2009, BRIT J NUTR, V101, P787, DOI 10.1017/S0007114508123443; Pezzilli R, 2008, DIGEST LIVER DIS, V40, P803, DOI 10.1016/j.dld.2008.02.019; Pupelis G, 2001, NUTRITION, V17, P91, DOI 10.1016/S0899-9007(00)00508-6; Qin HL, 2008, EUR J CLIN NUTR, V62, P923, DOI 10.1038/sj.ejcn.1602792; Qin HL, 2002, CLIN NUTR, V21, P469, DOI 10.1054/clnu.2002.0574; Qin Huan-Long, 2002, Hepatobiliary Pancreat Dis Int, V1, P150; SAX HC, 1987, AM J SURG, V153, P117, DOI 10.1016/0002-9610(87)90211-X; Vieira JP, 2010, ACTA CIR BRAS, V25, P449, DOI 10.1590/S0102-86502010000500012; [吴大成 WU Dacheng], 2008, [肠外与肠内营养, Parenteral & Enteral Nutrition], V15, P285; Xu Chun-fang, 2011, Zhonghua Nei Ke Za Zhi, V50, P370; Yubero S, 2012, PULM PHARMACOL THER, V25, P319, DOI 10.1016/j.pupt.2012.05.009	45	62	74	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64926	10.1371/journal.pone.0064926	http://dx.doi.org/10.1371/journal.pone.0064926			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762266	gold, Green Published, Green Submitted			2022-12-27	WOS:000321099000028
J	Tsuji, A; Tominaga, K; Nishiyama, N; Yuasa, K				Tsuji, Akihiko; Tominaga, Keiko; Nishiyama, Nami; Yuasa, Keizo			Comprehensive Enzymatic Analysis of the Cellulolytic System in Digestive Fluid of the Sea Hare Aplysia kurodai. Efficient Glucose Release from Sea Lettuce by Synergistic Action of 45 kDa Endoglucanase and 210 kDa beta-Glucosidase	PLOS ONE			English	Article							ACID-SEQUENCE SIMILARITIES; CLAM CORBICULA-JAPONICA; GECARCINID LAND CRAB; TRICHODERMA-REESEI; MOLECULAR-CLONING; GLYCOSYL HYDROLASES; LIGNOCELLULOSIC BIOMASS; COPTOTERMES-FORMOSANUS; GECARCOIDEA-NATALIS; CELLULASE GENES	Although many endo-beta-1,4-glucanases have been isolated in invertebrates, their cellulolytic systems are not fully understood. In particular, gastropod feeding on seaweed is considered an excellent model system for production of bioethanol and renewable bioenergy from third-generation feedstocks (microalgae and seaweeds). In this study, enzymes involved in the conversion of cellulose and other polysaccharides to glucose in digestive fluids of the sea hare (Aplysia kurodai) were screened and characterized to determine how the sea hare obtains glucose from sea lettuce (Ulva pertusa). Four endo-beta-1,4-glucanases (21 K, 45 K, 65 K, and 95 K cellulase) and 2 beta-glucosidases (110 K and 210 K) were purified to a homogeneous state, and the synergistic action of these enzymes during cellulose digestion was analyzed. All cellulases exhibited cellulase and lichenase activities and showed distinct cleavage specificities against cellooligosaccharides and filter paper. Filter paper was digested to cellobiose, cellotriose, and cellotetraose by 21 K cellulase, whereas 45 K and 65 K enzymes hydrolyzed the filter paper to cellobiose and glucose. 210 K beta-glucosidase showed unique substrate specificity against synthetic and natural substrates, and 4-methylumbelliferyl (4MU)-beta-glucoside, 4MU-beta-galactoside, cellooligosaccharides, laminarin, and lichenan were suitable substrates. Furthermore, 210 K beta-glucosidase possesses lactase activity. Although beta-glucosidase and cellulase are necessary for efficient hydrolysis of carboxymethylcellulose to glucose, laminarin is hydrolyzed to glucose only by 210 K beta-glucosidase. Kinetic analysis of the inhibition of 210 K beta-glucosidase by D-glucono-1,5-lactone suggested the presence of 2 active sites similar to those of mammalian lactase-phlorizin hydrolase. Saccharification of sea lettuce was considerably stimulated by the synergistic action of 45 K cellulase and 210 K beta-glucosidase. Our results indicate that 45 K cellulase and 210 K beta-glucosidase are the core components of the sea hare digestive system for efficient production of glucose from sea lettuce. These findings contribute important new insights into the development of biofuel processing biotechnologies from seaweed.	[Tsuji, Akihiko; Tominaga, Keiko; Nishiyama, Nami; Yuasa, Keizo] Univ Tokushima, Grad Sch, Dept Biol Sci & Technol, Tokushima 770, Japan	Tokushima University	Tsuji, A (corresponding author), Univ Tokushima, Grad Sch, Dept Biol Sci & Technol, Tokushima 770, Japan.	tsuji@bio.tokushima-u.ac.jp			University of Tokushima	University of Tokushima	This work was supported by a grant for the promotion of pilot research from The University of Tokushima. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allardyce BJ, 2010, J EXP BIOL, V213, P2950, DOI 10.1242/jeb.041582; ANZAI H, 1984, J BIOCHEM-TOKYO, V96, P1381, DOI 10.1093/oxfordjournals.jbchem.a134966; Asada C, 2012, BIOCHEM ENG J, V60, P25, DOI 10.1016/j.bej.2011.09.013; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Byeon GM, 2005, COMP BIOCHEM PHYS B, V141, P418, DOI 10.1016/j.cbpc.2005.05.001; CHEN HZ, 1992, BIOCHIM BIOPHYS ACTA, V1121, P54, DOI 10.1016/0167-4838(92)90336-C; CHIRICO WJ, 1987, EUR J BIOCHEM, V165, P333, DOI 10.1111/j.1432-1033.1987.tb11446.x; CORNISHB.A, 1974, BIOCHEM J, V137, P143, DOI 10.1042/bj1370143; Dashtban M, 2009, INT J BIOL SCI, V5, P578, DOI 10.7150/ijbs.5.578; FERREIRA C, 1983, BIOCHEM J, V213, P43, DOI 10.1042/bj2130043; Fukuda K, 2002, BIOSCI BIOTECH BIOCH, V66, P2060, DOI 10.1271/bbb.66.2060; Ganner T, 2012, J BIOL CHEM, V287, P43215, DOI 10.1074/jbc.M112.419952; Gnansounou E, 2010, BIORESOURCE TECHNOL, V101, P4980, DOI 10.1016/j.biortech.2010.02.009; Guo R, 2008, J COMP PHYSIOL B, V178, P209, DOI 10.1007/s00360-007-0214-z; Hedge J.E., 1962, METHODS CARBOHYDRATE, P380; Hendriks ATWM, 2009, BIORESOURCE TECHNOL, V100, P10, DOI 10.1016/j.biortech.2008.05.027; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; IRWIN DC, 1993, BIOTECHNOL BIOENG, V42, P1002, DOI 10.1002/bit.260420811; Iwamatsu A, 1996, J BIOCHEM-TOKYO, V120, P29; John RP, 2011, BIORESOURCE TECHNOL, V102, P186, DOI 10.1016/j.biortech.2010.06.139; King AJ, 2010, P NATL ACAD SCI USA, V107, P5345, DOI 10.1073/pnas.0914228107; Kobayashi H, 2012, PLOS ONE, V7; Kumar R, 2008, J IND MICROBIOL BIOT, V35, P377, DOI 10.1007/s10295-008-0327-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li YH, 2009, COMP BIOCHEM PHYS B, V153, P149, DOI 10.1016/j.cbpb.2009.02.011; Lin Y, 2006, APPL MICROBIOL BIOT, V69, P627, DOI 10.1007/s00253-005-0229-x; Linton SM, 2011, COMP BIOCHEM PHYS B, V160, P44, DOI 10.1016/j.cbpb.2011.05.007; MANTEI N, 1988, EMBO J, V7, P2705, DOI 10.1002/j.1460-2075.1988.tb03124.x; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Menetrez MY, 2012, ENVIRON SCI TECHNOL, V46, P7073, DOI 10.1021/es300917r; Nagahama T, 2009, NEUROSCI RES, V64, P243, DOI 10.1016/j.neures.2009.03.007; Nakajima N, 2011, APPL MICROBIOL BIOT, DOI [10.1007/s00253-011-3538-2, DOI 10.1007/S00253-011-3538-2]; Nelson N, 1944, J BIOL CHEM, V153, P375; Nishida Y, 2007, BIOCHIMIE, V89, P1002, DOI 10.1016/j.biochi.2007.03.015; Peterson R, 2012, MICROBIOL-SGM, V158, P58, DOI 10.1099/mic.0.054031-0; Pitson SM, 1997, ENZYME MICROB TECH, V21, P182, DOI 10.1016/S0141-0229(96)00263-3; Sakamoto K, 2009, GENE, V435, P72, DOI 10.1016/j.gene.2009.01.011; Sakamoto K, 2009, COMP BIOCHEM PHYS B, V152, P390, DOI 10.1016/j.cbpb.2009.01.010; Scharf ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021709; Scharf ME, 2010, INSECT BIOCHEM MOLEC, V40, P611, DOI 10.1016/j.ibmb.2010.06.002; SKOVBJERG H, 1981, EUR J BIOCHEM, V114, P653, DOI 10.1111/j.1432-1033.1981.tb05193.x; Suzuki K, 2003, EUR J BIOCHEM, V270, P771, DOI 10.1046/j.1432-1033.2003.03443.x; SVENNERHOLM L, 1956, J NEUROCHEM, V1, P42, DOI 10.1111/j.1471-4159.1956.tb12053.x; TANAKA A, 1989, AGR BIOL CHEM TOKYO, V53, P1401, DOI 10.1080/00021369.1989.10869468; Todaka N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008636; Tokuda G, 2002, INSECT BIOCHEM MOLEC, V32, P1681, DOI 10.1016/S0965-1748(02)00108-X; Tokuda G, 2009, INSECT BIOCHEM MOLEC, V39, P931, DOI 10.1016/j.ibmb.2009.11.003; Tsuji A, 2004, J BIOCHEM, V136, P673, DOI 10.1093/jb/mvh163; Tsuji A, 2012, COMP BIOCHEM PHYS B, V163, P324, DOI 10.1016/j.cbpb.2012.08.005; van der Wal H, 2013, BIORESOURCE TECHNOL, V128, P431, DOI 10.1016/j.biortech.2012.10.094; Wacker W, 1992, J BIOL CHEM, V267, P18744; Wu Y, 2012, INSECT MOL BIOL, V21, P604, DOI 10.1111/j.1365-2583.2012.01164.x; Yamashita Y, 2010, J BIOSCI BIOENG, V110, P79, DOI 10.1016/j.jbiosc.2009.12.009; Zhang DH, 2012, J INSECT PHYSIOL, V58, P205, DOI 10.1016/j.jinsphys.2011.11.014; Zhang DH, 2010, INSECT SCI, V17, P245, DOI 10.1111/j.1744-7917.2010.01321.x	57	28	29	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65418	10.1371/journal.pone.0065418	http://dx.doi.org/10.1371/journal.pone.0065418			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762366	Green Published, gold, Green Submitted			2022-12-27	WOS:000321099000064
J	Abel, O; Powell, JF; Andersen, PM; Al-Chalabi, A				Abel, Olubunmi; Powell, John F.; Andersen, Peter M.; Al-Chalabi, Ammar			Credibility Analysis of Putative Disease-Causing Genes Using Bioinformatics	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SPEARMANS RHO; DIAGNOSIS; CRITERIA; FAMILY; ALS	Background: Genetic studies are challenging in many complex diseases, particularly those with limited diagnostic certainty, low prevalence or of old age. The result is that genes may be reported as disease-causing with varying levels of evidence, and in some cases, the data may be so limited as to be indistinguishable from chance findings. When there are large numbers of such genes, an objective method for ranking the evidence is useful. Using the neurodegenerative and complex disease amyotrophic lateral sclerosis (ALS) as a model, and the disease-specific database ALSoD, the objective is to develop a method using publicly available data to generate a credibility score for putative disease-causing genes. Methods: Genes with at least one publication suggesting involvement in adult onset familial ALS were collated following an exhaustive literature search. SQL was used to generate a score by extracting information from the publications and combined with a pathogenicity analysis using bioinformatics tools. The resulting score allowed us to rank genes in order of credibility. To validate the method, we compared the objective ranking with a rank generated by ALS genetics experts. Spearman's Rho was used to compare rankings generated by the different methods. Results: The automated method ranked ALS genes in the following order: SOD1, TARDBP, FUS, ANG, SPG11, NEFH, OPTN, ALS2, SETX, FIG4, VAPB, DCTN1, TAF15, VCP, DAO. This compared very well to the ranking of ALS genetics experts, with Spearman's Rho of 0.69 (P = 0.009). Conclusion: We have presented an automated method for scoring the level of evidence for a gene being disease-causing. In developing the method we have used the model disease ALS, but it could equally be applied to any disease in which there is genotypic uncertainty.	[Abel, Olubunmi; Al-Chalabi, Ammar] Kings Coll London, Kings Hlth Partners Ctr Neurodegenerat Res, Dept Clin Neurosci, London WC2R 2LS, England; [Powell, John F.] Kings Coll London, Dept Neurosci, London WC2R 2LS, England; [Andersen, Peter M.] Umea Univ, Inst Pharmacol & Clin Neurosci, Neurol Sect, Umea, Sweden; [Andersen, Peter M.] Univ Ulm, Dept Neurol, D-89069 Ulm, Germany	King's Health Partners; University of London; King's College London; University of London; King's College London; Umea University; Ulm University	Al-Chalabi, A (corresponding author), Kings Coll London, Kings Hlth Partners Ctr Neurodegenerat Res, Dept Clin Neurosci, London WC2R 2LS, England.	al-chalabi@kcl.ac.uk	Al-Chalabi, Ammar/E-5361-2010; Powell, John F/G-4412-2011	Al-Chalabi, Ammar/0000-0002-4924-7712; Powell, John F/0000-0001-6124-439X	ALS Association; ALS Canada; MNDA Iceland; ALS Therapy Alliance; European Community's Health Seventh Framework Programme [259867]; National Institute for Health Research (NIHR) Dementia Biomedical Research Unit at South London; Maudsley NHS Foundation Trust; King's College London; MND Association of Great Britain and Northern Ireland	ALS Association; ALS Canada; MNDA Iceland; ALS Therapy Alliance; European Community's Health Seventh Framework Programme; National Institute for Health Research (NIHR) Dementia Biomedical Research Unit at South London(National Institute for Health Research (NIHR)); Maudsley NHS Foundation Trust; King's College London(General Electric); MND Association of Great Britain and Northern Ireland	The authors are especially grateful for the long-standing and continued funding of this project from the ALS Association and the MND Association of Great Britain and Northern Ireland. They also thank ALS Canada, MNDA Iceland and the ALS Therapy Alliance for support. The research leading to these results has received funding from the European Community's Health Seventh Framework Programme FP7/2007-2013 under grant agreement number 259867. AA-C receives salary support from the National Institute for Health Research (NIHR) Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust and King's College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. Aleks Radunovic, Nigel Leigh, and Ian Gowrie originally conceived ALSoD. ALSoD is a joint project of the World Federation of Neurology (WFN) and European Network for the Cure ALS (ENCALS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Chalabi A, 2005, BRAIN, V128, P451, DOI 10.1093/brain/awh426; Al-Chalabi A, 2011, HUM HERED, V71, P281, DOI 10.1159/000330167; Andersen PM, 2011, NATURE REV NEUROLOGY; Boeve BF, 2011, NEURON; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Byrne S, 2011, J NEUROL NEUROSUR PS, V82, P623, DOI 10.1136/jnnp.2010.224501; Charcot J-M, 1869, ARCH PHYSL NORM PATH, V2, P744; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; DAVID FN, 1961, BIOMETRIKA, V48, P19, DOI 10.2307/2333126; Eisen A, 2008, AMYOTROPH LATERAL SC, V9, P108, DOI 10.1080/17482960801900073; Fong GCY, 2006, AMYOTROPH LATERAL SC, V7, P142, DOI 10.1080/17482960600732412; Hamosh A, 2000, HUM MUTAT, V15, P57, DOI 10.1002/(SICI)1098-1004(200001)15:1<57::AID-HUMU12>3.0.CO;2-G; Hanby MF, 2011, BRAIN; Ioannidis JPA, 2008, INT J EPIDEMIOL, V37, P120, DOI 10.1093/ije/dym159; Lill CM, 2011, AMYOTROPH LATERAL SC, V12, P238, DOI 10.3109/17482968.2011.584629; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; RAMSEY PH, 1989, J EDUC STAT, V14, P245, DOI 10.3102/10769986014003245; Renton AE, 2011, NEURON; Rosen D, 1993, MUTATIONS CU ZN SUPE; SIDDIQUE T, 1991, NEW ENGL J MED, V324, P1381, DOI 10.1056/NEJM199105163242001; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Yue S, 2002, J HYDROL, V259, P254, DOI 10.1016/S0022-1694(01)00594-7	25	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64899	10.1371/journal.pone.0064899	http://dx.doi.org/10.1371/journal.pone.0064899			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755159	Green Published, gold, Green Submitted			2022-12-27	WOS:000320579400030
J	Kamei, A; Watanabe, Y; Kondo, K; Okada, S; Shinozaki, F; Ishijima, T; Nakai, Y; Kondo, T; Arai, S; Abe, K				Kamei, Asuka; Watanabe, Yuki; Kondo, Kaori; Okada, Shinji; Shinozaki, Fumika; Ishijima, Tomoko; Nakai, Yuji; Kondo, Takashi; Arai, Soichi; Abe, Keiko			Influence of a Short-Term Iron-Deficient Diet on Hepatic Gene Expression Profiles in Rats	PLOS ONE			English	Article							KEY REGULATOR; HEPCIDIN; POWERFUL; ANEMIA; GLOBIN	Iron is an essential mineral for the body, and iron deficiency generally leads to anemia. However, because non-anemic iron deficiency can exist, we performed a comprehensive transcriptome analysis of the liver to define the effects of this condition on the body. Four-week-old male rats were fed a low-iron diet (approximately 3 ppm iron) for 3 days and compared with those fed a normal diet (48 ppm iron) by pair feeding as a control. The rats in the iron-deficient diet group developed a non-anemic iron-deficient state. DNA microarray analysis revealed that during this short time, this state conferred a variety of effects on nutrient metabolism in the liver. In comparison with long-term (17 days) iron-deficiency data from a previous study, some of the changed genes were found to be common to both short-and long-term iron deficiency models, some were specific to the short-term iron deficiency model, and the others were oppositely regulated between the two feeding terms. Taken together, these data suggest that although the blood hemoglobin level itself remains unchanged during non-anemic iron deficiency, a variety of metabolic processes involved in the maintenance of the energy balance are altered.	[Kamei, Asuka; Watanabe, Yuki; Shinozaki, Fumika; Ishijima, Tomoko; Nakai, Yuji; Arai, Soichi; Abe, Keiko] Kanagawa Acad Sci & Technol, Life Sci & Environm Res Ctr, Project Hlth & Antiaging, Kawasaki, Kanagawa, Japan; [Kondo, Kaori; Kondo, Takashi] RIKEN, Inst Phys & Chem Res, Res Ctr Allergy & Immunol, Yokohama, Kanagawa, Japan; [Okada, Shinji; Ishijima, Tomoko; Nakai, Yuji; Abe, Keiko] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan; [Arai, Soichi] Tokyo Univ Agr, Gen Res Inst, Setagaya Ku, Tokyo, Japan	Kanagawa Academy Science & Technology; RIKEN; University of Tokyo; Tokyo University of Agriculture	Abe, K (corresponding author), Kanagawa Acad Sci & Technol, Life Sci & Environm Res Ctr, Project Hlth & Antiaging, 4F C-4, Kawasaki, Kanagawa, Japan.	aka7308@mail.ecc.u-tokyo.ac.jp	Kamei, Asuka/GXH-4934-2022; NAKAI, Yuji/G-3433-2014	NAKAI, Yuji/0000-0002-2458-3875; Okada, Shinji/0000-0002-4465-9961	Kanagawa Academy of Science and Technology; grant-in-aid for science research [24780139, 24657115, 24700820, 23300273, 20380183]; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [23300273, 24780139] Funding Source: KAKEN	Kanagawa Academy of Science and Technology; grant-in-aid for science research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was supported by a grant from the Kanagawa Academy of Science and Technology (http://www.newkast.or.jp/english/index.html). This work was also supported in part by grant-in-aid for science research 24780139 (to AK), 24657115 (to SO), 24700820 (to TI), 23300273 (to YN), 20380183 (to KA) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (http://www.jsps.go.jp/english/index.html).	Aisen P, 2004, INT J BIOCHEM CELL B, V36, P2137, DOI 10.1016/j.biocel.2004.02.007; BENESCH R, 1967, BIOCHEM BIOPH RES CO, V26, P162, DOI 10.1016/0006-291X(67)90228-8; BENESCH R, 1968, P NATL ACAD SCI USA, V59, P526, DOI 10.1073/pnas.59.2.526; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Collins JF, 2005, AM J PHYSIOL-GASTR L, V288, pG964, DOI 10.1152/ajpgi.00489.2004; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; dos Santos CO, 2008, J BIOL CHEM, V283, P26956, DOI 10.1074/jbc.M802421200; Frazer DM, 2005, AM J PHYSIOL-GASTR L, V289, pG631, DOI 10.1152/ajpgi.00220.2005; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; HERS HG, 1983, ANNU REV BIOCHEM, V52, P617, DOI 10.1146/annurev.bi.52.070183.003153; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hutton JC, 2009, J BIOL CHEM, V284, P29241, DOI 10.1074/jbc.R109.025544; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kadota K, 2009, ALGORITHM MOL BIOL, V4, DOI 10.1186/1748-7188-4-7; Kamei A, 2010, PHYSIOL GENOMICS, V42, P149, DOI 10.1152/physiolgenomics.00150.2009; LU SJ, 1994, P NATL ACAD SCI USA, V91, P8398, DOI 10.1073/pnas.91.18.8398; Matsuo M, 2010, BIOSCI BIOTECH BIOCH, V74, P899, DOI 10.1271/bbb.90921; Mendel RR, 2007, NAT PROD REP, V24, P963, DOI 10.1039/b703112m; Mollan TL, 2010, ANTIOXID REDOX SIGN, V12, P219, DOI 10.1089/ars.2009.2780; Nicolas G, 2002, BLOOD CELL MOL DIS, V29, P327, DOI 10.1006/bcmd.2002.0573; R Development Core Team, 2006, R LANG ENV STAT COMP; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tsiftsoglou AS, 2006, PHARMACOL THERAPEUT, V111, P327, DOI 10.1016/j.pharmthera.2005.10.017; Uchida Tatsumi, 2004, Rinsho Ketsueki, V45, P1085; Viatte L, 2009, BIOCHIMIE, V91, P1223, DOI 10.1016/j.biochi.2009.06.012; Voon HPJ, 2008, HAEMATOL-HEMATOL J, V93, P1868, DOI 10.3324/haematol.13490	31	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65732	10.1371/journal.pone.0065732	http://dx.doi.org/10.1371/journal.pone.0065732			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755274	Green Submitted, Green Published, gold			2022-12-27	WOS:000320579400074
J	Sauco, S; Gomez, J; Barboza, FR; Lercari, D; Defeo, O				Sauco, Sebastian; Gomez, Julio; Barboza, Francisco R.; Lercari, Diego; Defeo, Omar			Modified Whole Effluent Toxicity Test to Assess and Decouple Wastewater Effects from Environmental Gradients	PLOS ONE			English	Article							CONTAMINATION; DISCHARGE; SEDIMENTS; BIOAVAILABILITY; COMMUNITY; STRESSORS; POLLUTION; IMPACT	Environmental gradients and wastewater discharges produce aggregated effects on marine populations, obscuring the detection of human impact. Classical assessment methods do not include environmental effects in toxicity tests designs, which could lead to incorrect conclusions. We proposed a modified Whole Effluent Toxicity test (mWET) that includes environmental gradients in addition to effluent dilutions, together with the application of Generalized Linear Mixed Models (GLMM) to assess and decouple those effects. We tested this approach, analyzing the lethal effects of wastewater on a marine sandy beach bivalve affected by an artificial canal freshwater discharge used for rice crops irrigation. To this end, we compared bivalve mortality between canal water dilutions (CWd) and salinity controls (SC: without canal water). CWd were prepared by diluting the water effluent (sampled during the pesticide application period) with artificial marine water. The salinity gradient was included in the design by achieving the same final salinities in both CWd and SC, allowing us to account for the effects of salinity by including this variable as a random factor in the GLMM. Our approach detected significantly higher mortalities in CWd, indicating potential toxic effects of the effluent discharge. mWET represents an improvement over the internationally standardized WET tests, since it considers environmental variability and uses appropriate statistical analyses.	[Sauco, Sebastian; Gomez, Julio; Barboza, Francisco R.; Lercari, Diego; Defeo, Omar] Univ Republica, Fac Ciencias, Dept Ecol & Evoluc, UNDECIMAR, Montevideo, Uruguay	Universidad de la Republica, Uruguay	Sauco, S (corresponding author), Univ Republica, Fac Ciencias, Dept Ecol & Evoluc, UNDECIMAR, Montevideo, Uruguay.	sebastiansauco@gmail.com	Lercari, Diego/AFZ-1141-2022	Lercari, Diego/0000-0001-7980-2193; Defeo, Omar/0000-0001-8318-528X; Barboza, Francisco Rafael/0000-0002-9100-2962	Environmental Facility [GCP URU 030 GFF]; Comision Sectorial de Investigacion Cientifica (CSIC Uruguay-Project) [2025]; Pew Charitable Trusts	Environmental Facility; Comision Sectorial de Investigacion Cientifica (CSIC Uruguay-Project); Pew Charitable Trusts	Fundings from Environmental Facility (GCP URU 030 GFF), Comision Sectorial de Investigacion Cientifica (CSIC Uruguay-Project 2025) and The Pew Charitable Trusts are acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D, 2011, IME4 LINEAR MIXED EF; Carbonell G, 2010, B ENVIRON CONTAM TOX, V85, P72, DOI 10.1007/s00128-010-0035-8; Castilla JC, 2001, REV FISH BIOL FISHER, V11, P1, DOI 10.1023/A:1014235924952; Chapman PM, 2007, ENVIRON INT, V33, P492, DOI 10.1016/j.envint.2006.09.001; Chapman PM, 2001, ENVIRON TOXICOL CHEM, V20, P3, DOI [10.1002/etc.5620200102, 10.1897/1551-5028(2001)020&lt;0003:ASCIE&gt;2.0.CO;2]; Dauvin JC, 2008, MAR POLLUT BULL, V57, P160, DOI 10.1016/j.marpolbul.2007.10.012; DEFEO O, 1992, J COASTAL RES, V8, P830; Defeo O., 1989, FISHBYTE, V7, P21; DELOSCAMPOS O, 1987, REV AGRARIA, V31, P21; Derycke S, 2007, AQUAT TOXICOL, V82, P110, DOI 10.1016/j.aquatox.2007.02.002; *DINAMA, 2011, MON PLAY TEMP 2010 2; Doney SC, 2010, SCIENCE, V328, P1512, DOI 10.1126/science.1185198; Eggleton J, 2004, ENVIRON INT, V30, P973, DOI 10.1016/j.envint.2004.03.001; Fent K, 2004, TOXICOLOGY, V205, P223, DOI 10.1016/j.tox.2004.06.060; Fiori S, 2006, J COASTAL RES, V22, P872, DOI 10.2112/04-0409.1; Goodsell PJ, 2009, MAR POLLUT BULL, V58, P323, DOI 10.1016/j.marpolbul.2008.10.011; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; *INE, 2004, CENS 2004 UR; Lercari D, 2003, ESTUAR COAST SHELF S, V58, P17, DOI 10.1016/S0272-7714(03)00043-X; Lercari D, 1999, ESTUAR COAST SHELF S, V49, P457, DOI 10.1006/ecss.1999.0521; Lozoya JP, 2006, MAR FRESHWATER RES, V57, P421, DOI 10.1071/MF05067; McKnight US, 2012, SCI TOTAL ENVIRON, V427, P319, DOI 10.1016/j.scitotenv.2012.04.011; Ramos MC, 2006, J ENVIRON MANAGE, V78, P97, DOI 10.1016/j.jenvman.2005.04.010; Relyea R, 2006, ECOL LETT, V9, P1157, DOI 10.1111/j.1461-0248.2006.00966.x; Sauco S, 2010, MAR ENVIRON RES, V70, P300, DOI 10.1016/j.marenvres.2010.06.002; Tang WZ, 2010, J HAZARD MATER, V176, P945, DOI 10.1016/j.jhazmat.2009.11.131; Traina SJ, 1999, P NATL ACAD SCI USA, V96, P3365, DOI 10.1073/pnas.96.7.3365; USEPA, 2002, METH MEAS AC TOX EFF, P275; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zuur Alain F., 2009, P1	31	5	5	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e66285	10.1371/journal.pone.0066285	http://dx.doi.org/10.1371/journal.pone.0066285			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755304	Green Published, gold, Green Submitted			2022-12-27	WOS:000320579400084
J	Sanchez-Zauco, NA; Torres, J; Perez-Figueroa, GE; Alvarez-Arellano, L; Camorlinga-Ponce, M; Gomez, A; Giono-Cerezo, S; Maldonado-Bernal, C				Angelica Sanchez-Zauco, Norma; Torres, Javier; Erandi Perez-Figueroa, Gloria; Alvarez-Arellano, Lourdes; Camorlinga-Ponce, Margarita; Gomez, Alejandro; Giono-Cerezo, Silvia; Maldonado-Bernal, Carmen			Impact of cagPAI and T4SS on the Inflammatory Response of Human Neutrophils to Helicobacter pylori Infection	PLOS ONE			English	Article							GASTRIC EPITHELIAL-CELLS; TOLL-LIKE RECEPTORS; KAPPA-B ACTIVATION; PATHOGENICITY ISLAND; MUCOSAL INTERLEUKIN-8; VIRULENCE FACTORS; IMMUNE-RESPONSE; IV SECRETION; HOST-CELLS; CAGA	Helicobacter pylori contains a pathogenicity island, cagPAI, with genes homologous to components of the type IV secretion system (T4SS) of Agrobacterium tumefaciens. The T4SS components assemble a structure that transfers CagA protein and peptidoglycan into host epithelial cells, causing the increased release of interleukin 8 (IL8) from the cells. The Toll-like receptors on neutrophils recognize H. pylori, initiating signaling pathways that enhance the activation of NF-kappa B. However, the roles of cagPAI and T4SS in the inflammatory response of neutrophils are unknown. We evaluated the participation of cagPAI and T4SS in the response of human neutrophils to H. pylori infection. Neutrophils were isolated from the blood of healthy donors and infected with H. pylori cagPAI(+), cagPAI(-), and cagPAI mutant strains virB4(-) and virD4(-). Whereas cagPAI(+) strain 26695 induced the greatest IL8 production, a proinflammatory response, cagPAI(-) strain 8822 induced the greatest IL10 production, an anti-inflammatory response. In contrast, the virB4(-) and virD4(-) mutant strains produced significantly more of the two proinflammatory cytokines IL1 beta and tumor necrosis factor athan the cagPAI(+) strain 26695. We observed that H. pylori downregulated the expression of TLRs 2 and 5 but upregulated TLR9 expression in a cagPAI and T4SS-independent manner. These results show for the first time that the response of human neutrophils to H. pylori may vary from a pro-inflammatory to an anti-inflammatory response, depending on cagPAI and the integrity of T4SS.	[Angelica Sanchez-Zauco, Norma; Erandi Perez-Figueroa, Gloria; Maldonado-Bernal, Carmen] Hosp Infantil Mexico Dr Federico Gomez, SS, Unidad Invest Enfermedades Oncol, Mexico City, DF, Mexico; [Angelica Sanchez-Zauco, Norma; Torres, Javier; Erandi Perez-Figueroa, Gloria; Camorlinga-Ponce, Margarita; Gomez, Alejandro] IMSS, Ctr Med Nacl Siglo 21, Unidad Invest Enfermedades Infecciosas, Mexico City, DF, Mexico; [Alvarez-Arellano, Lourdes] UNAM, Inst Biotecnol, Dept Med Mol & Bioproc, Lab Neuroinmunol, Cuernavaca, Morelos, Mexico; [Angelica Sanchez-Zauco, Norma; Giono-Cerezo, Silvia] IPN, Escuela Nacl Ciencias Biol, Lab Bacteriol Med, Mexico City 07738, DF, Mexico	Hospital Infantil de Mexico Federico Gomez; Instituto Mexicano del Seguro Social; Universidad Nacional Autonoma de Mexico; Instituto Politecnico Nacional - Mexico	Maldonado-Bernal, C (corresponding author), Hosp Infantil Mexico Dr Federico Gomez, SS, Unidad Invest Enfermedades Oncol, Mexico City, DF, Mexico.	cmaldobe@yahoo.com	Gómez, Alejandro/HGE-5641-2022	GIONO, SILVIA/0000-0003-1835-6788; Sanchez-Zauco, Norma/0000-0001-8375-1499; Maldonado-Bernal, Carmen/0000-0003-0663-2888; Alvarez-Arellano, Lourdes/0000-0002-3469-1407	Instituto Mexicano del Seguro Social (IMSS) [FIS/IMSS/PROT/C2007/053]	Instituto Mexicano del Seguro Social (IMSS)	This work was supported by Instituto Mexicano del Seguro Social (IMSS), grant FIS/IMSS/PROT/C2007/053. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelsadik A, 2011, HUM IMMUNOL, V72, P1188, DOI 10.1016/j.humimm.2011.08.015; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Alvarez-Arellano L, 2007, FEMS IMMUNOL MED MIC, V51, P473, DOI 10.1111/j.1574-695X.2007.00327.x; Backert S, 2006, CURR OPIN MICROBIOL, V9, P207, DOI 10.1016/j.mib.2006.02.008; Backhed F, 2003, J INFECT DIS, V187, P829; Basso D, 1996, INT J CLIN LAB RES, V26, P207, DOI 10.1007/BF02592984; BLASER MJ, 1992, GASTROENTEROLOGY, V102, P720, DOI 10.1016/0016-5085(92)90126-J; Camorlinga-Ponce M, 1998, AM J GASTROENTEROL, V93, P1264, DOI 10.1111/j.1572-0241.1998.00407.x; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; CRABTREE JE, 1995, J CLIN PATHOL, V48, P41, DOI 10.1136/jcp.48.1.41; CRABTREE JE, 1994, EUR J GASTROEN HEPAT, V6, pS33; DEKIGAI H, 1995, DIGEST DIS SCI, V40, P1332, DOI 10.1007/BF02065547; Ernst PB, 2000, ANNU REV MICROBIOL, V54, P615, DOI 10.1146/annurev.micro.54.1.615; Fiorentino M, 2013, INFECT IMMUN, V81, P876, DOI 10.1128/IAI.01406-12; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; Glocker E, 1998, INFECT IMMUN, V66, P2346, DOI 10.1128/IAI.66.5.2346-2348.1998; Graham DY, 2004, GUT, V53, P1235, DOI 10.1136/gut.2003.037499; Hofman V, 2000, INFECT IMMUN, V68, P5225, DOI 10.1128/IAI.68.9.5225-5233.2000; Ismail HF, 2003, J IMMUNOL, V170, P3782, DOI 10.4049/jimmunol.170.7.3782; Koller B, 2009, EUR J CLIN INVEST, V39, P535, DOI 10.1111/j.1365-2362.2009.02145.x; Moran AP, 1997, J BACTERIOL, V179, P6453, DOI 10.1128/jb.179.20.6453-6463.1997; Murata-Kamiya N, 2010, CELL HOST MICROBE, V7, P399, DOI 10.1016/j.chom.2010.04.005; Naumann M, 2005, INT J MED MICROBIOL, V295, P335, DOI 10.1016/j.ijmm.2005.06.007; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Ogura K, 2000, J EXP MED, V192, P1601, DOI 10.1084/jem.192.11.1601; Philpott DJ, 2002, CELL MICROBIOL, V4, P285, DOI 10.1046/j.1462-5822.2002.00189.x; Pinto-Santini DM, 2009, J BACTERIOL, V191, P7343, DOI 10.1128/JB.00946-09; Sabroe I, 2005, CLIN INFECT DIS, V41, pS421, DOI 10.1086/431992; Schmausser B, 2004, CLIN EXP IMMUNOL, V136, P521, DOI 10.1111/j.1365-2249.2004.02464.x; SHARMA SA, 1995, INFECT IMMUN, V63, P1681, DOI 10.1128/IAI.63.5.1681-1687.1995; Smith MF, 2003, J BIOL CHEM, V278, P32552, DOI 10.1074/jbc.M305536200; Sujanuma M, 2008, INT J CANCER, V123, P117, DOI 10.1002/ijc.23484; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Uno K, 2007, AM J PHYSIOL-GASTR L, V293, pG1004, DOI 10.1152/ajpgi.00096.2007; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; WALLACE JL, 1991, SCAND J GASTROENTERO, V26, P65, DOI 10.3109/00365529109098226; Yamaoka Y, 2000, P NATL ACAD SCI USA, V97, P7533, DOI 10.1073/pnas.130079797; Yamaoka Y, 2002, GASTROENTEROLOGY, V123, P414, DOI 10.1053/gast.2002.34781; Yamaoka Y, 1997, GUT, V41, P442, DOI 10.1136/gut.41.4.442; Yoshiyama H, 2000, MICROBES INFECT, V2, P55, DOI 10.1016/S1286-4579(00)00285-9; Zhao Y, 2007, J MED MICROBIOL, V56, P154, DOI 10.1099/jmm.0.46882-0	44	17	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64623	10.1371/journal.pone.0064623	http://dx.doi.org/10.1371/journal.pone.0064623			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755130	gold, Green Published, Green Submitted			2022-12-27	WOS:000319872300020
J	Catania, KC; Catania, EH; Sawyer, EK; Leitch, DB				Catania, Kenneth C.; Catania, Elizabeth H.; Sawyer, Eva K.; Leitch, Duncan B.			Barrelettes without Barrels in the American Water Shrew	PLOS ONE			English	Article							STEM TRIGEMINAL COMPLEX; ARCHITECTONIC VIBRISSAL REPRESENTATIONS; BRAIN-STEM; COLUMNAR ORGANIZATION; CEREBRAL-CORTEX; STRUCTURAL ORGANIZATION; CORTICAL COLUMN; SOREX-PALUSTRIS; DEFICIENT MICE; LAYER 4	Water shrews (Sorex palustris) depend heavily on their elaborate whiskers to navigate their environment and locate prey. They have small eyes and ears with correspondingly small optic and auditory nerves. Previous investigations have shown that water shrew neocortex is dominated by large representations of the whiskers in primary and secondary somatosensory cortex (S1 and S2). Flattened sections of juvenile cortex processed for cytochrome oxidase revealed clear borders of the whisker pad representation in S1, but no cortical barrels. We were therefore surprised to discover prominent barrelettes in brainstem of juvenile water shrews in the present investigation. These distinctive modules were found in the principal trigeminal nucleus (PrV), and in two of the three spinal trigeminal subnuclei (interpolaris - SpVi and caudalis - SpVc). Analysis of the shrew's whisker pad revealed the likely relationship between whiskers and barrelettes. Barrelettes persisted in adult water shrew PrV, but barrels were also absent from adult cortex. Thus in contrast to mice and rats, which have obvious barrels in primary somatosensory cortex and less clear barrelettes in the principal nucleus, water shrews have clear barrelettes in the brainstem and no barrels in the neocortex. These results highlight the diverse ways that similar mechanoreceptors can be represented in the central nervous systems of different species.	[Catania, Kenneth C.; Catania, Elizabeth H.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Sawyer, Eva K.; Leitch, Duncan B.] Vanderbilt Univ, Grad Program Neurosci, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Catania, KC (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	ken.catania@vanderbilt.edu	Leitch, Duncan/AAU-6744-2020	Leitch, Duncan/0000-0002-8513-888X	National Science Foundation [0844743]; MacArthur Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH064913] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [0844743] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); MacArthur Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Supported by National Science Foundation Award # 0844743 and the MacArthur Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DL, 2003, NAT NEUROSCI, V6, P113, DOI 10.1038/nn1004; [Anonymous], 1984, SCALING WHY IS ANIMA; BATES CA, 1985, J COMP NEUROL, V240, P265, DOI 10.1002/cne.902400305; BELFORD GR, 1979, J COMP NEUROL, V188, P63, DOI 10.1002/cne.901880106; Brecht M, 1997, BEHAV BRAIN RES, V84, P81, DOI 10.1016/S0166-4328(97)83328-1; CARROLL EW, 1984, J COMP NEUROL, V222, P1, DOI 10.1002/cne.902220102; Cases O, 1996, NEURON, V16, P297, DOI 10.1016/S0896-6273(00)80048-3; Catania KC, 2005, NATURE, V433, P519, DOI 10.1038/nature03250; Catania KC, 1999, J COMP NEUROL, V410, P55; Catania KC, 2013, J COMP PHYSL A; Catania KC, 2008, P NATL ACAD SCI USA, V105, P571, DOI 10.1073/pnas.0709534104; Catania KC, 2006, NATURE, V444, P1024, DOI 10.1038/4441024a; Catania KC, 2011, PHILOS T R SOC B, V366, P3016, DOI 10.1098/rstb.2011.0128; da Costa NM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00016; da Silva S, 2011, P NATL ACAD SCI USA, V108, P3395, DOI 10.1073/pnas.1014411108; Erzurumlu RS, 2010, NAT REV NEUROSCI, V11, P252, DOI 10.1038/nrn2804; Erzurumlu RS, 2006, ANAT REC PART A, V288A, P121, DOI 10.1002/ar.a.20285; Feldmeyer D, 2012, PROG NEUROBIOL; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Fox K, 2008, BARREL CORTEX, P1, DOI 10.1017/CBO9780511541636.003; Gusztak RW, 2005, J COMP PHYSIOL B, V175, P87, DOI 10.1007/s00360-004-0465-x; Horton JC, 2005, PHILOS T R SOC B, V360, P837, DOI 10.1098/rstb.2005.1623; Hsaki K, 2006, NEUROSCIENCE, V141, P1899, DOI 10.1016/j.neuroscience.2006.04.082; Jones EG, 2010, CEREB CORTEX, V20, P2261, DOI 10.1093/cercor/bhq127; Jurgens KD, 2002, J EXP BIOL, V205, P2161; KILLACKEY HP, 1995, TRENDS NEUROSCI, V18, P402, DOI 10.1016/0166-2236(95)93937-S; KILLACKEY HP, 1985, DEV BRAIN RES, V22, P141, DOI 10.1016/0165-3806(85)90077-X; Kim U, 1999, J COMP NEUROL, V408, P489; LEE KJ, 1975, BRAIN RES, V99, P349, DOI 10.1016/0006-8993(75)90035-9; Lee LJ, 2005, J COMP NEUROL, V485, P57, DOI 10.1002/cne.20514; Leitch DB, 2011, BRAIN BEHAV EVOLUT, V78, P261, DOI 10.1159/000330832; Lubke J, 2000, J NEUROSCI, V20, P5300, DOI 10.1523/JNEUROSCI.20-14-05300.2000; MA PM, 1993, J COMP NEUROL, V327, P376, DOI 10.1002/cne.903270306; MA PM, 1991, J COMP NEUROL, V309, P161, DOI 10.1002/cne.903090202; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Naumann RK, 2012, J COMP NEUROL, V520, P2512, DOI 10.1002/cne.23053; Rockland KS, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00022; Sehara K, 2011, MOL NEUROBIOL, V43, P155, DOI 10.1007/s12035-011-8170-8; SORENSON M. W., 1962, AMER MIDLAND NAT, V68, P445, DOI 10.2307/2422750; SWINDALE NV, 1990, TRENDS NEUROSCI, V13, P487, DOI 10.1016/0166-2236(90)90082-L; TOWE AL, 1975, BRAIN BEHAV EVOLUT, V11, P16, DOI 10.1159/000123621; Wimmer VC, 2010, CEREB CORTEX, V20, P2265, DOI 10.1093/cercor/bhq068; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X	44	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65975	10.1371/journal.pone.0065975	http://dx.doi.org/10.1371/journal.pone.0065975			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755296	Green Published, gold			2022-12-27	WOS:000319872300100
J	Li, L; Ding, C; Duan, JL; Yang, MF; Sun, Y; Wang, XQ; Xu, Y				Li, Lu; Ding, Cheng; Duan, Jun-lan; Yang, Mi-fang; Sun, Ying; Wang, Xiao-qian; Xu, Yan			A New Functional Site W115 in CdtA Is Critical for Aggregatibacter actinomycetemcomitans Cytolethal Distending Toxin	PLOS ONE			English	Article							CELL-CYCLE ARREST; HUMAN T-CELLS; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; BACTERIAL GENOTOXIN; G(2) ARREST; 3 SUBUNITS; IN-VITRO; EXPRESSION; PROTEIN; FAMILY	Aggregatibacter actinomycetemcomitans, a specific pathogen of localized aggressive periodontitis, produces a cytolethal distending toxin (CDT) that arrests eukaryotic cells irreversibly in G0/G1 or G2/M phase of the cell cycle. Although structural studies show that the aromatic patch region of CdtA plays an important role in its biological activity, the functional sites of CdtA have not been firmly established. In this study, site-specific mutagenesis strategy was employed for cdtA point mutations construction so as to examine the contributions of individual amino acids to receptor binding and the biological activity of holotoxin. The binding ability was reduced in CdtA(Y181A)BC holotoxin and the biological function of CDT was not weaken in CdtA(Y105A)BC, CdtA(Y125A)BC, CdtA(F109A)BC and CdtA(S106N)BC holotoxin suggesting that these sites were not critical to CDT. But the binding activity and cell cycle arrest ability of holotoxin complexes were inhibited in CdtA(W115G)BC. And this site did not affect the holotoxin assembly by size exclusion chromatography. Therefore, W115 might be a critical site of CdtA binding ability. These findings suggest that the functional sites of CdtA are not only in the aromatic patch region. W115, the new functional site is critical for receptor binding and cell cycle arrest, which provides potential targets for pharmacological disruption of CDT activity.	[Li, Lu; Ding, Cheng; Duan, Jun-lan; Yang, Mi-fang; Sun, Ying; Wang, Xiao-qian; Xu, Yan] Nanjing Med Univ, Inst Stomatol, Lab Oral Infect & Immunol, Nanjing, Jiangsu, Peoples R China; [Li, Lu; Ding, Cheng; Duan, Jun-lan; Sun, Ying; Wang, Xiao-qian; Xu, Yan] Nanjing Med Univ, Sch Stomatol, Dept Periodontol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Xu, Y (corresponding author), Nanjing Med Univ, Inst Stomatol, Lab Oral Infect & Immunol, Nanjing, Jiangsu, Peoples R China.	yanxu@njmu.edu.cn			National Natural Science Foundation of China [81170962]; Project of Science and Technology Department of Jiangsu Province [BK2011763]; Graduate student innovation project of Jiangsu province [CXZZ11_0732]; Priority Academic Program Development of Jiangsu Higher Education Institutions [PAPD2011-2013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Science and Technology Department of Jiangsu Province; Graduate student innovation project of Jiangsu province; Priority Academic Program Development of Jiangsu Higher Education Institutions	This study is supported by grants from the National Natural Science Foundation of China (Grant No. 81170962), Project of Science and Technology Department of Jiangsu Province (Grant No. BK2011763), Graduate student innovation project of Jiangsu province (Grant No. CXZZ11_0732) and Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (Grant No. PAPD2011-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akifusa S, 2005, MICROBIOL-SGM, V151, P1395, DOI 10.1099/mic.0.27671-0; Alaoui-El-Azher M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011714; Ando ES, 2010, J PERIODONTAL RES, V45, P471, DOI 10.1111/j.1600-0765.2009.01260.x; Belibasakis GN, 2008, APMIS, V116, P499, DOI 10.1111/j.1600-0463.2008.01017.x; Cao L, 2005, MOL MICROBIOL, V58, P1303, DOI 10.1111/j.1365-2958.2005.04905.x; Cao L, 2008, INFECT IMMUN, V76, P2812, DOI 10.1128/IAI.00126-08; Cao LS, 2006, INFECT IMMUN, V74, P4990, DOI 10.1128/IAI.00697-06; DiRienzo JM, 2009, FEMS MICROBIOL LETT, V291, P222, DOI 10.1111/j.1574-6968.2008.01457.x; Elwell CA, 2000, MOL MICROBIOL, V37, P952, DOI 10.1046/j.1365-2958.2000.02070.x; Eshraghi A, 2010, J BIOL CHEM, V285, P18199, DOI 10.1074/jbc.M110.112912; Heywood W, 2005, J MED MICROBIOL, V54, P207, DOI 10.1099/jmm.0.45694-0; Kanno F, 2005, J PERIODONTOL, V76, P1189, DOI 10.1902/jop.2005.76.7.1189; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Lara-Tejero M, 2002, TRENDS MICROBIOL, V10, P147, DOI 10.1016/S0966-842X(02)02316-8; Lara-Tejero M, 2001, INFECT IMMUN, V69, P4358, DOI 10.1128/IAI.69.7.4358-4365.2001; Lee RB, 2003, INFECT IMMUN, V71, P4883, DOI 10.1128/IAI.71.9.4883-4890.2003; Lewis DA, 2001, INFECT IMMUN, V69, P5626, DOI 10.1128/IAI.69.9.5626-5634.2001; Mao XQ, 2002, CELL MICROBIOL, V4, P245, DOI 10.1046/j.1462-5822.2002.00186.x; Mayer MPA, 1999, INFECT IMMUN, V67, P1227, DOI 10.1128/IAI.67.3.1227-1237.1999; Nesic D, 2004, NATURE, V429, P429, DOI 10.1038/nature02532; Nesic D, 2005, PLOS PATHOG, V1, P214, DOI 10.1371/journal.ppat.0010028; Ohara M, 2004, INFECT IMMUN, V72, P871, DOI 10.1128/IAI.72.2.871-879.2004; Pickett CL, 1999, TRENDS MICROBIOL, V7, P292, DOI 10.1016/S0966-842X(99)01537-1; Shenker BJ, 2005, J IMMUNOL, V174, P2228, DOI 10.4049/jimmunol.174.4.2228; Shenker BJ, 2004, J IMMUNOL, V172, P410, DOI 10.4049/jimmunol.172.1.410; Shenker BJ, 1999, J IMMUNOL, V162, P4773; Shenker BJ, 2000, J IMMUNOL, V165, P2612, DOI 10.4049/jimmunol.165.5.2612; Stevens MK, 1999, INFECT IMMUN, V67, P3900, DOI 10.1128/IAI.67.8.3900-3908.1999; Wising C, 2010, APMIS, V118, P143, DOI 10.1111/j.1600-0463.2009.02573.x; Yamada T, 2006, PROTEIN SCI, V15, P362, DOI 10.1110/ps.051790506; Yamamoto K, 2004, EUR J ORAL SCI, V112, P445, DOI 10.1111/j.1600-0722.2004.00157.x	31	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65729	10.1371/journal.pone.0065729	http://dx.doi.org/10.1371/journal.pone.0065729			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755273	Green Published, Green Submitted, gold			2022-12-27	WOS:000319872300094
J	Zheng, J; Xu, CM; Guo, J; Wei, Y; Ge, HJ; Li, XC; Zhang, CL; Jiang, HJ; Pan, L; Tang, WP; Xie, WW; Zhang, HY; Zhao, YY; Jiang, FM; Chen, SP; Wang, W; Xu, X; Chen, F; Huang, HF; Jiang, H				Zheng, Jing; Xu, Chenming; Guo, Jing; Wei, Yuan; Ge, Huijuan; Li, Xuchao; Zhang, Chunlei; Jiang, Haojun; Pan, Ling; Tang, Weiping; Xie, Weiwei; Zhang, Hongyun; Zhao, Yangyu; Jiang, Fuman; Chen, Shengpei; Wang, Wei; Xu, Xun; Chen, Fang; Huang, Hefeng; Jiang, Hui			Effective Noninvasive Zygosity Determination by Maternal Plasma Target Region Sequencing	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; PRENATAL-DIAGNOSIS; TWIN PREGNANCIES; DNA; CHORIONICITY	Background: Currently very few noninvasive molecular genetic approaches are available to determine zygosity for twin pregnancies in clinical laboratories. This study aimed to develop a novel method to determine zygosity by using maternal plasma target region sequencing. Methods: We constructed a statistic model to calculate the possibility of each zygosity type using likelihood ratios (Li) and empirical dynamic thresholds targeting at 4,524 single nucleotide polymorphisms (SNPs) loci on 22 autosomes. Then two dizygotic (DZ) twin pregnancies, two monozygotic (MZ) twin pregnancies and two singletons were recruited to evaluate the performance of our novel method. Finally we estimated the sensitivity and specificity of the model in silico under different cell-free fetal DNA (cff-DNA) concentration and sequence depth. Results/Conclusions: We obtained 8.90 Gbp sequencing data on average for six clinical samples. Two samples were classified as DZ with L values of 1.891 and 1.554, higher than the dynamic DZ cut-off values of 1.162 and 1.172, respectively. Another two samples were judged as MZ with 0.763 and 0.784 of L values, lower than the MZ cut-off values of 0.903 and 0.918. And the rest two singleton samples were regarded as MZ twins, with L values of 0.639 and 0.757, lower than the MZ cut-off values of 0.921 and 0.799. In silico, the estimated sensitivity of our noninvasive zygosity determination was 99.90% under 10% total cff-DNA concentration with 2 Gbp sequence data. As the cff-DNA concentration increased to 15%, the specificity was as high as 97% with 3.50 Gbp sequence data, much higher than 80% with 10% cff-DNA concentration. Significance: This study presents the feasibility to noninvasively determine zygosity of twin pregnancy using target region sequencing, and illustrates the sensitivity and specificity under various detecting condition. Our method can act as an alternative approach for zygosity determination of twin pregnancies in clinical practice.	[Zheng, Jing; Guo, Jing; Ge, Huijuan; Li, Xuchao; Zhang, Chunlei; Jiang, Haojun; Xie, Weiwei; Chen, Shengpei; Wang, Wei; Xu, Xun; Chen, Fang; Jiang, Hui] BGI Shenzhen, Shenzhen, Peoples R China; [Xu, Chenming; Pan, Ling; Huang, Hefeng] Zhejiang Univ, Key Lab Reprod Genet, Hangzhou 310003, Zhejiang, Peoples R China; [Zheng, Jing] Shenzhen Municipal Key Lab Genome Sci, Shenzhen, Peoples R China; [Guo, Jing; Jiang, Haojun] Southeast Univ, Dept Biomed Engn, Nanjing, Jiangsu, Peoples R China; [Wei, Yuan; Zhao, Yangyu] Peking Univ, Hosp 3, Dept Obstet & Gynaecol, Beijing 100871, Peoples R China; [Jiang, Haojun] Shenzhen Municipal Key Lab Birth Defects Screenin, Shenzhen, Peoples R China; [Tang, Weiping; Wang, Wei] BGI Shenzhen, East China Mkt Dept, Shenzhen, Peoples R China; [Zhang, Hongyun; Jiang, Fuman] Shenzhen Clin Lab, Shenzhen, Peoples R China; [Chen, Shengpei] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China; [Chen, Fang; Jiang, Hui] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Jiang, Hui] Guangdong Prov Key Lab Human Dis Genome, Guangzhou, Guangdong, Peoples R China	Beijing Genomics Institute (BGI); Zhejiang University; Southeast University - China; Peking University; Beijing Genomics Institute (BGI); Southeast University - China; University of Copenhagen	Chen, F (corresponding author), BGI Shenzhen, Shenzhen, Peoples R China.	fangchen@genomics.org.cn; huanghefg@hotmail.com; jianghui@genomics.org.cn	Huang, He-Feng/AAN-7985-2020; Xu, Xun/AAI-6763-2020; Huang, Hefeng/AAR-7184-2021; Huang, Hefeng/ABF-1117-2020	Huang, He-Feng/0000-0003-4344-8019; Xu, Xun/0000-0002-5338-5173; 	Key Laboratory Project in Shenzhen (Shenzhen Municipal Commission of Development and Reform) [861]; Key Laboratory Project in Guang Dong Provicine [2011A060906007]	Key Laboratory Project in Shenzhen (Shenzhen Municipal Commission of Development and Reform); Key Laboratory Project in Guang Dong Provicine	This project is supported by Key Laboratory Project in Shenzhen (Shenzhen Municipal Commission of Development and Reform (2011) (number 861) and Key Laboratory Project in Guang Dong Provicine (2011A060906007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, OFTEN DOES TTTS OCCU; Collins SL, 2012, EARLY HUM DEV, V88, P3, DOI 10.1016/j.earlhumdev.2011.11.003; Dan S, 2012, PRENATAL DIAG, V32, P1225, DOI 10.1002/pd.4002; EMERY AEH, 1977, NATURE, V266, P472, DOI 10.1038/266472a0; Glinianaia SV, 2011, HUM REPROD, V26, P2549, DOI 10.1093/humrep/der213; Kan ASY, 2012, J OBSTET GYNAECOL RE, V38, P376, DOI 10.1111/j.1447-0756.2011.01721.x; Lau TK, 2012, J MATERN-FETAL NEO M, V25, P1370, DOI 10.3109/14767058.2011.635730; Lee YM, 2006, AM J OBSTET GYNECOL, V195, P863, DOI 10.1016/j.ajog.2006.06.039; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; MacDorman Marian F, 2009, Natl Vital Stat Rep, V57, P1; National Guideline C, 2006, MAN MON TWIN PREGN; Prior TW, 2005, J MOL DIAGN, V7, P317, DOI 10.1016/S1525-1578(10)60560-0; Qu JZZ, 2013, CLIN CHEM, V59, P427, DOI 10.1373/clinchem.2012.194068; Simpson LL, 2012, AM J OBSTET GYNECOL; Stenhouse E, 2002, ULTRASOUND OBST GYN, V19, P350, DOI 10.1046/j.1469-0705.2002.00679.x; Tong S, 2004, ULTRASOUND OBST GYN, V23, P36, DOI 10.1002/uog.934	18	12	13	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65050	10.1371/journal.pone.0065050	http://dx.doi.org/10.1371/journal.pone.0065050			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762285	Green Published, gold, Green Submitted			2022-12-27	WOS:000320440500022
J	Baglo, Y; Gabrielsen, M; Sylte, I; Gederaas, OA				Baglo, Yan; Gabrielsen, Mari; Sylte, Ingebrigt; Gederaas, Odrun A.			Homology Modeling of Human gamma-Butyric Acid Transporters and the Binding of Pro-Drugs 5-Aminolevulinic Acid and Methyl Aminolevulinic Acid Used in Photodynamic Therapy	PLOS ONE			English	Article							GABA TRANSPORTERS; PROTOPORPHYRIN-IX; NEUROTRANSMITTER; CLONING; IDENTIFICATION; SYSTEM; LEUT; CLASSIFICATION; INHIBITOR; MECHANISM	Photodynamic therapy (PDT) is a safe and effective method currently used in the treatment of skin cancer. In ALA-based PDT, 5-aminolevulinic acid (ALA), or ALA esters, are used as pro-drugs to induce the formation of the potent photosensitizer protoporphyrin IX (PpIX). Activation of PpIX by light causes the formation of reactive oxygen species (ROS) and toxic responses. Studies have indicated that ALA and its methyl ester (MAL) are taken up into the cells via c-butyric acid (GABA) transporters (GATs). Uptake via GATs into peripheral sensory nerve endings may also account for one of the few adverse side effects of ALA-based PDT, namely pain. In the present study, homology models of the four human GAT subtypes were constructed using three x-ray crystal structures of the homologous leucine transporter (LeuT) as templates. Binding of the native substrate GABA and the possible substrates ALA and MAL was investigated by molecular docking of the ligands into the central putative substrate binding sites in the outward-occluded GAT models. Electrostatic potentials (ESPs) of the putative substrate translocation pathway of each subtype were calculated using the outward-open and inward-open homology models. Our results suggested that ALA is a substrate of all four GATs and that MAL is a substrate of GAT-2, GAT-3 and BGT-1. The ESP calculations indicated that differences likely exist in the entry pathway of the transporters (i.e. in outward-open conformations). Such differences may be exploited for development of inhibitors that selectively target specific GAT subtypes and the homology models may hence provide tools for design of therapeutic inhibitors that can be used to reduce ALA-induced pain.	[Baglo, Yan; Gederaas, Odrun A.] Norwegian Univ Sci & Technol, Fac Med, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Gabrielsen, Mari; Sylte, Ingebrigt] Univ Tromso, Fac Hlth Sci, Dept Med Biol, Tromso, Norway	Norwegian University of Science & Technology (NTNU); UiT The Arctic University of Tromso	Gederaas, OA (corresponding author), Norwegian Univ Sci & Technol, Fac Med, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway.	odrun.gederaas@ntnu.no	Gederaas, Odrun Arna/ABE-4912-2020	Gederaas, Odrun Arna/0000-0003-4877-4729; Gabrielsen, Mari/0000-0003-3898-1193; Sylte, Ingebrigt/0000-0002-3290-3736	BioStruct (the Norwegian national graduate school in structural biology)	BioStruct (the Norwegian national graduate school in structural biology)	The authors gratefully acknowledge support and training from BioStruct (the Norwegian national graduate school in structural biology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Issa MCA, 2010, AN BRAS DERMATOL, V85, P501, DOI 10.1590/S0365-05962010000400011; An JH, 2005, MOL CELL PROTEOMICS, V4, P752, DOI 10.1074/mcp.M400159-MCP200; Anderson CM, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq028; [Anonymous], PHOTODYNAMIC THERAPY; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; BORDEN LA, 1992, J BIOL CHEM, V267, P21098; BORDEN LA, 1995, J NEUROCHEM, V64, P977; BORDEN LA, 1994, RECEPTOR CHANNEL, V2, P207; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Brambilla P, 2003, MOL PSYCHIATR, V8, P721, DOI 10.1038/sj.mp.4001362; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; Christiansen B, 2007, J BIOL CHEM, V282, P19331, DOI 10.1074/jbc.M702111200; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Coyle JT, 2004, BIOCHEM PHARMACOL, V68, P1507, DOI 10.1016/j.bcp.2004.07.034; Di Venosa G, 2006, J PHOTOCH PHOTOBIO B, V83, P129, DOI 10.1016/j.jphotobiol.2006.01.002; Dodd JR, 2007, J BIOL CHEM, V282, P15528, DOI 10.1074/jbc.M611705200; DOUGHERTY TJ, 1984, CRC CR REV ONCOL-HEM, V2, P83, DOI 10.1016/S1040-8428(84)80016-5; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Gederaas OA, 2001, PHOTOCHEM PHOTOBIOL, V73, P164, DOI 10.1562/0031-8655(2001)073<0164:AAMETO>2.0.CO;2; Gholam P, 2011, DERMATOLOGY, V222, P358, DOI 10.1159/000329025; Goldberg NR, 2003, EUR J PHARMACOL, V479, P3, DOI 10.1016/j.ejphar.2003.08.052; Grapengiesser S, 2002, CLIN EXP DERMATOL, V27, P493, DOI 10.1046/j.1365-2230.2002.01065.x; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jasmin L, 2004, CNS NEUROL DISORD-DR, V3, P487, DOI 10.2174/1568007043336716; Kasche A, 2006, J Drugs Dermatol, V5, P353; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Moloney FJ, 2007, BRIT J DERMATOL, V157, P87, DOI 10.1111/j.1365-2133.2007.07946.x; Morton CA, 2008, BRIT J DERMATOL, V159, P1245, DOI 10.1111/j.1365-2133.2008.08882.x; NELSON H, 1990, FEBS LETT, V269, P181, DOI 10.1016/0014-5793(90)81149-I; NEMETHY G, 1992, J PHYS CHEM-US, V96, P6472, DOI 10.1021/j100194a068; Novak B, 2011, N-S ARCH PHARMACOL, V384, P583, DOI 10.1007/s00210-011-0683-1; Pagliaro J, 2004, DERMATOL SURG, V30, P63, DOI 10.1111/j.1524-4725.2004.30011.x; Pallo A, 2009, BIOCHEM BIOPH RES CO, V385, P210, DOI 10.1016/j.bbrc.2009.05.040; Peng Q, 1997, CANCER-AM CANCER SOC, V79, P2282; Rodriguez L, 2006, BRIT J PHARMACOL, V147, P825, DOI 10.1038/sj.bjp.0706668; Rud E, 2000, PHOTOCHEM PHOTOBIOL, V71, P640, DOI 10.1562/0031-8655(2000)071<0640:AABNAA>2.0.CO;2; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; Salat K, 2011, FUTURE MED CHEM, V3, P211, DOI 10.4155/FMC.10.298; Sarup A, 2003, CNS NEUROL DISORD-DR, V2, P269, DOI 10.2174/1568007033482788; Schapira M, 2003, J MED CHEM, V46, P3045, DOI 10.1021/jm0300173; SCHOENFELD N, 1988, CANCER LETT, V43, P43, DOI 10.1016/0304-3835(88)90211-X; Schulten R, 2012, NAUNYN SCHMIEDEBERGS; Scott J, 1955, BIOSYNTHESIS PORPHYR, P54; Shackley DC, 2002, BJU INT, V89, P665, DOI 10.1046/j.1464-410X.2002.02743.x; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Skovstrup S, 2010, CHEMMEDCHEM, V5, P986, DOI 10.1002/cmdc.201000100; Steinbauer JM, 2009, PHOTOCH PHOTOBIO SCI, V8, P1111, DOI 10.1039/b823378k; TANFORD C, 1983, P NATL ACAD SCI-BIOL, V80, P3701, DOI 10.1073/pnas.80.12.3701; Wein T, 2010, J MOL MODEL, V16, P155, DOI 10.1007/s00894-009-0520-3; Wong CGT, 2003, ANN NEUROL, V54, pS3, DOI 10.1002/ana.10696; Wu SM, 2003, CANCER LETT, V200, P123, DOI 10.1016/S0304-3835(03)00271-4; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	59	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65200	10.1371/journal.pone.0065200	http://dx.doi.org/10.1371/journal.pone.0065200			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762315	Green Published, Green Submitted, gold			2022-12-27	WOS:000321094800024
J	Mori, H; Kobara, H; Rafiq, K; Nishiyama, N; Fujihara, S; Oryu, M; Masaki, T				Mori, Hirohito; Kobara, Hideki; Rafiq, Kazi; Nishiyama, Noriko; Fujihara, Shintaro; Oryu, Makoto; Masaki, Tsutomu			Effects of Gastric Irrigation on Bacterial Counts before Endoscopic Submucosal Dissection: A Randomized Case Control Prospective Study	PLOS ONE			English	Article							HERNIA; MESH	Objective: The antiseptic effect of gastric irrigation before endoscopic submucosal dissection (ESD) has not yet been reported. The aim of the randomized prospective study is to evaluate the antiseptic effects of gastric irrigation of saline solution before ESD by evaluating bacterial count. Methods: This prospective randomized controlled trial included 50 patients diagnosed with early gastric cancer who were randomly divided into 2 groups (25 patients in each group) by using the opaque envelope method: the clean group (irrigation with 2 L saline solution before ESD) and the regular group (no irrigation). The gastric juice was collected and cultured before ESD. The entire stomach was irrigated using a water jet attached to an endoscope. After ESD with resection and removal of the tumor specimen, a postoperative culture of the gastric juice was obtained using the same method as the preoperative culture. Results: The mean log bacterial count of the post-gastric irrigation gastric juice was 5.08+/-0.75 in the regular group and 1.86+/-0.86 in the clean group. The difference in the bacterial counts was significant between the groups (P = 0.0004). The difference in the white blood cells (WBC) count on POD 1 was significant (P = 0.044). WBC count on POD 2 did not significantly differ between the groups (P = 0.3). The difference in the body temperature (BT) on POD 1 was significant (P = 0.017), On POD 2 the BT was not significant between the groups (P = 0.5). On POD 1, 88% of the patients in the regular group and 16% of the patients in the clean group had mild to moderate spontaneous pain (P = 0.0026). On POD 2 the proportion with mild to moderate spontaneous pain was 36% and 24% in the regular group and the clean group, respectively (P = 0.1). Conclusion: Pre-ESD gastric irrigation with saline solution is effective and feasible for suppressing infection during the ESD procedure with favorable clinical outcomes.	[Mori, Hirohito; Kobara, Hideki; Nishiyama, Noriko; Fujihara, Shintaro; Oryu, Makoto; Masaki, Tsutomu] Kagawa Univ, Fac Med, Dept Gastroenterol & Neurol, Takamatsu, Kagawa 760, Japan; [Rafiq, Kazi] Kagawa Univ, Fac Med, Dept Pharmacol, Takamatsu, Kagawa 760, Japan	Kagawa University; Kagawa University	Mori, H (corresponding author), Kagawa Univ, Fac Med, Dept Gastroenterol & Neurol, Takamatsu, Kagawa 760, Japan.	hiro4884@med.kagawa-u.ac.jp	Fujihara, Shintaro/AAW-6092-2021; Rafiq, Kazi/AEU-4834-2022	Fujihara, Shintaro/0000-0002-1250-6012	Kagawa university hospital, Japan	Kagawa university hospital, Japan	The authors acknowledge Kagawa university hospital, Japan for its support of this study.	AKKERSDIJK WL, 1995, ENDOSCOPY, V27, P313, DOI 10.1055/s-2007-1005699; Boyce JM, 2002, AM J INFECT CONTROL, V30, pS1, DOI 10.1067/mic.2002.130391; Fong DG, 2007, ENDOSCOPY, V39, P865, DOI 10.1055/s-2007-966916; HEYLAND D, 1992, CRIT CARE MED, V20, P1388, DOI 10.1097/00003246-199210000-00005; Hu B, 2007, ENDOSCOPY, V39, P390, DOI 10.1055/s-2007-966426; Kantsevoy Sergey V, 2008, Gastrointest Endosc Clin N Am, V18, P291, DOI 10.1016/j.giec.2008.01.004; Katsarelias D, 2007, SURG ENDOSC, V21, P1862, DOI 10.1007/s00464-007-9281-1; Miedema BW, 2009, SURG ENDOSC, V23, P1212, DOI 10.1007/s00464-009-0352-3; Rao G V, 2008, Gastrointest Endosc Clin N Am, V18, P361, DOI 10.1016/j.giec.2008.01.007; Steele K, 2008, GASTROINTEST ENDOSC, V68, P61, DOI 10.1016/j.gie.2007.09.040; Sugimoto Mitsushige, 2012, Diagn Ther Endosc, V2012, P791873, DOI 10.1155/2012/791873; Toyonaga T, 2012, SURG ENDOSC; Yoshida N, 2009, ENDOSCOPY, V41, P758, DOI 10.1055/s-0029-1215028; Zheng YZ, 2011, J DIGEST DIS, V12, P217, DOI 10.1111/j.1751-2980.2011.00499.x	14	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65377	10.1371/journal.pone.0065377	http://dx.doi.org/10.1371/journal.pone.0065377			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762354	Green Published, gold, Green Submitted			2022-12-27	WOS:000321094800042
J	Salazar, JJ; Gallego-Pinazo, R; de Hoz, R; Pinazo-Duran, MD; Rojas, B; Ramirez, AI; Serrano, M; Ramirez, JM				Salazar, Juan J.; Gallego-Pinazo, Roberto; de Hoz, Rosa; Pinazo-Duran, Maria D.; Rojas, Blanca; Ramirez, Ana I.; Serrano, Manuel; Ramirez, Jose M.			"Super p53'' Mice Display Retinal Astroglial Changes	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; INDUCED CELL-DEATH; OXIDATIVE STRESS; RAT RETINA; MACULAR DEGENERATION; GLIAL-CELLS; DNA-DAMAGE; P53-INDUCED APOPTOSIS; EXPERIMENTAL GLAUCOMA; ANTIOXIDANT FUNCTION	Tumour-suppressor genes, such as the p53 gene, produce proteins that inhibit cell division under adverse conditions, as in the case of DNA damage, radiation, hypoxia, or oxidative stress (OS). The p53 gene can arrest proliferation and trigger death by apoptosis subsequent to several factors. In astrocytes, p53 promotes cell-cycle arrest and is involved in oxidative stress-mediated astrocyte cell death. Increasingly, astrocytic p53 is proving fundamental in orchestrating neurodegenerative disease pathogenesis. In terms of ocular disease, p53 may play a role in hypoxia due to ischaemia and may be involved in the retinal response to oxidative stress (OS). We studied the influence of the p53 gene in the structural and quantitative characteristics of astrocytes in the retina. Adult mice of the C57BL/6 strain (12 months old) were distributed into two groups: 1) mice with two extra copies of p53 ("super p53''; n = 6) and 2) wild-type p53 age-matched control, as the control group (WT; n = 6). Retinas from each group were immunohistochemically processed to locate the glial fibrillary acidic protein (GFAP). GFAP+ astrocytes were manually counted and the mean area occupied for one astrocyte was quantified. Retinal-astrocyte distribution followed established patterns; however, morphological changes were seen through the retinas in relation to p53 availability. The mean GFAP+ area occupied by one astrocyte in "super p53'' eyes was significantly higher (p < 0.05; Student's t-test) than in the WT. In addition, astroglial density was significantly higher in the "super p53'' retinas than in the WT ones, both in the whole-retina (p < 0,01 Student's t-test) and in the intermediate and peripheral concentric areas of the retina (p < 0.05 Student's t-test). This fact might improve the resistance of the retinal cells against OS and its downstream signalling pathways.	[Salazar, Juan J.; de Hoz, Rosa; Rojas, Blanca; Ramirez, Ana I.; Ramirez, Jose M.] Univ Complutense Madrid, Inst Invest Oftalmolo Ramon Castroviejo, Madrid, Spain; [Salazar, Juan J.; de Hoz, Rosa; Ramirez, Ana I.] Univ Complutense Madrid, Fac Opt & Optometria, Madrid, Spain; [Rojas, Blanca; Ramirez, Jose M.] Univ Complutense Madrid, Fac Med, Madrid, Spain; [Serrano, Manuel] Spanish Natl Canc Res Ctr, Madrid, Spain; [Gallego-Pinazo, Roberto] Univ & Polytech Hosp Le Fe, Dept Ophthalmol, Valencia, Spain; [Gallego-Pinazo, Roberto; Pinazo-Duran, Maria D.] Univ Valencia, Santiago Grisolia Fac Med, Ophthalm Res Unit, Valencia, Spain	Complutense University of Madrid; Complutense University of Madrid; Complutense University of Madrid; Centro Nacional de Investigaciones Oncologicas (CNIO); University of Valencia	Ramirez, JM (corresponding author), Univ Complutense Madrid, Inst Invest Oftalmolo Ramon Castroviejo, Madrid, Spain.	ramirezs@med.ucm.es	De Hoz, Rosa/ABF-9295-2020; Salazar, Juan J/L-6887-2014; Serrano, Manuel/H-2634-2015; ROJAS, BLANCA/V-8292-2017; Ramírez, Ana I/ABF-4789-2021	De Hoz, Rosa/0000-0002-1581-087X; Salazar, Juan J/0000-0001-5480-5902; Serrano, Manuel/0000-0001-7177-9312; Ramírez, Ana I/0000-0002-2656-4723; Pinazo-Duran, Maria Dolores/0000-0002-0118-7837	RETICs Patologia Ocular del Envejecimiento, Calidad Visual y Calidad de Vida (Spanish Ministry of Science and Innovation) [ISCIII RD07/0062/0000]; RETICs Prevencion, deteccion precoz y tratamiento de la patologia ocular prevalente degenerative y cronica (Spanish Ministry of Science and Innovation) [ISCIII RD12/0034/0002, ISCIII RD12/0034/0008]; BSCH-UCM [GR35/10-A]; Universidad Complutense de Madrid	RETICs Patologia Ocular del Envejecimiento, Calidad Visual y Calidad de Vida (Spanish Ministry of Science and Innovation); RETICs Prevencion, deteccion precoz y tratamiento de la patologia ocular prevalente degenerative y cronica (Spanish Ministry of Science and Innovation); BSCH-UCM; Universidad Complutense de Madrid	Work at the Institute of Ophthalmic Research "Ramon Castroviejo'' (Madrid) has been funded by RETICs Patologia Ocular del Envejecimiento, Calidad Visual y Calidad de Vida (Grant ISCIII RD07/0062/0000, Spanish Ministry of Science and Innovation); RETICs Prevencion, deteccion precoz y tratamiento de la patologia ocular prevalente degenerative y cronica (Grant ISCIII RD12/0034/0002, Spanish Ministry of Science and Innovation); BSCH-UCM (GR35/10-A Programa de Grupos de Investigacion Santander-UCM); BIG is currently supported by a predoctoral fellowship from the Universidad Complutense de Madrid. Work at the Ophthalmic Research Unit "Santiago Grisolia'' (Valencia) has been funded by RETICs Prevencion, deteccion precoz y tratamiento de la patologia ocular prevalente degenerative y cronica (Grant ISCIII RD12/0034/0008, Spanish Ministry of Science and Innovation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Bensaad K, 2005, NAT MED, V11, P1278, DOI 10.1038/nm1205-1278; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bonini P, 2004, J NEUROSCI RES, V75, P83, DOI 10.1002/jnr.10822; Borges HL, 2004, CELL DEATH DIFFER, V11, P494, DOI 10.1038/sj.cdd.4401366; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; BUSSOW H, 1980, CELL TISSUE RES, V206, P367; Carson MJ, 2006, CLIN NEUROSCI RES, V6, P237, DOI 10.1016/j.cnr.2006.09.004; Cavallotti C, 2003, ANAT HISTOL EMBRYOL, V32, P12, DOI 10.1046/j.1439-0264.2003.00431.x; Collado M, 2005, CELL CYCLE, V4, P1722, DOI 10.4161/cc.4.12.2260; COX LS, 1995, BIOESSAYS, V17, P501, DOI 10.1002/bies.950170606; Davis DM, 2008, NAT REV MOL CELL BIO, V9, P431, DOI 10.1038/nrm2399; Dirnagl U, 2004, FOCAL CEREBRAL ISCHE, P520; Djebaili M, 2000, NEUROREPORT, V11, P2973, DOI 10.1097/00001756-200009110-00029; Gallego BI, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-92; Gallego-Pinazo R., 2008, Arch Soc Esp Oftalmol, V83, P105; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Gerdes HH, 2007, FEBS LETT, V581, P2194, DOI 10.1016/j.febslet.2007.03.071; Gu S, 2004, MOL CELL PROTEOMICS, V3, P998, DOI 10.1074/mcp.M400033-MCP200; Harada C, 2010, CELL DEATH DIFFER, V17, P1751, DOI 10.1038/cdd.2010.62; Hase K, 2009, NAT CELL BIOL, V11, P1427, DOI 10.1038/ncb1990; Hirrlinger PG, 2010, NEUROSCI LETT, V472, P73, DOI 10.1016/j.neulet.2010.01.062; HOLLANDER H, 1991, J COMP NEUROL, V313, P587, DOI 10.1002/cne.903130405; IKUI H, 1976, OPHTHALMIC RES, V8, P100, DOI 10.1159/000264803; Jebelli JD, 2012, GLIA, V60, P515, DOI 10.1002/glia.22268; Johnson TM, 1996, P NATL ACAD SCI USA, V93, P11848, DOI 10.1073/pnas.93.21.11848; Joo CK, 1999, INVEST OPHTH VIS SCI, V40, P713; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Lipton S A, 2001, Prog Brain Res, V131, P712; Ljungman M, 2000, NEOPLASIA, V2, P208, DOI 10.1038/sj.neo.7900073; Llanos S, 2006, CELL CYCLE, V5, P1880, DOI 10.4161/cc.5.16.3140; MADIGAN MC, 1994, RETINA-J RET VIT DIS, V14, P65, DOI 10.1097/00006982-199401000-00014; Malhotra A, 2011, SEMIN ULTRASOUND CT, V32, P2, DOI 10.1053/j.sult.2010.10.009; MALHOTRA SK, 1990, CYTOBIOS, V61, P133; Mancino R, 2011, MOL VIS, V17, P1298; Mansour H, 2008, AGING CELL, V7, P526, DOI 10.1111/j.1474-9726.2008.00402.x; Martin LJ, 2002, J NEUROBIOL, V50, P181, DOI 10.1002/neu.10026; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Miller TJ, 2006, NEUROTOXICOLOGY, V27, P44, DOI 10.1016/j.neuro.2005.06.001; Morgan SE, 1997, ADV CANCER RES, V71, P1, DOI 10.1016/S0065-230X(08)60095-0; Morrison RS, 1996, J NEUROSCI, V16, P1337; Napieralski JA, 1999, MOL BRAIN RES, V71, P78, DOI 10.1016/S0169-328X(99)00155-2; O'Connor JC, 2008, INVEST OPHTH VIS SCI, V49, P4237, DOI 10.1167/iovs.08-1963; Ohia SE, 2005, MUTAT RES-FUND MOL M, V579, P22, DOI 10.1016/j.mrfmmm.2005.03.025; Organisciak DT, 2010, PROG RETIN EYE RES, V29, P113, DOI 10.1016/j.preteyeres.2009.11.004; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pinazo-Duran MD, 2007, ARVO M, V48, P4180; Pluquet O, 2001, CANCER LETT, V174, P1, DOI 10.1016/S0304-3835(01)00698-X; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Qin ZH, 1999, J NEUROSCI, V19, P4023; Ramirez AI, 2006, EXP EYE RES, V83, P1423, DOI 10.1016/j.exer.2006.07.023; Ramirez AI, 2010, INVEST OPHTH VIS SCI, V51, P5690, DOI 10.1167/iovs.10-5248; Ramirez JM, 1996, VISION RES, V36, P2029, DOI 10.1016/0042-6989(95)00322-3; RAMIREZ JM, 1994, VISION RES, V34, P1935, DOI 10.1016/0042-6989(94)90024-8; Ramirez JM, 2001, EXP EYE RES, V73, P601, DOI 10.1006/exer.2001.1061; RAMSON BR, 2005, NEUROGLIA, P177; RIDET JL, 2000, ADV STR BIO, V6, P147; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; SAKHI S, 1994, P NATL ACAD SCI USA, V91, P7525, DOI 10.1073/pnas.91.16.7525; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Suzuki K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/978312; Tacconi MT, 1998, NEUROCHEM RES, V23, P759, DOI 10.1023/A:1022463527474; TRIVINO A, 1992, VISION RES, V32, P1601, DOI 10.1016/0042-6989(92)90153-A; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Ueki Y, 2012, GLIA, V60, P1579, DOI 10.1002/glia.22377; Velasco-Miguel S, 1999, ONCOGENE, V18, P127, DOI 10.1038/sj.onc.1202274; Villapol S, 2007, J NEUROSCI RES, V85, P3545, DOI 10.1002/jnr.21450; Villasante A, 2011, CELL CYCLE, V10, P1488, DOI 10.4161/cc.10.9.15658; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang MH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-173; Wasylyk C, 2000, MOL CELL BIOL, V20, P5554, DOI 10.1128/MCB.20.15.5554-5570.2000; Watanabe H, 1999, BRAIN RES, V837, P38, DOI 10.1016/S0006-8993(99)01652-2; WIEGAND RD, 1983, INVEST OPHTH VIS SCI, V24, P1433; Yoon KA, 2004, J HUM GENET, V49, P134, DOI 10.1007/s10038-003-0122-3; Yung HW, 2004, J NEUROCHEM, V89, P812, DOI 10.1111/j.1471-4159.2004.02395.x; Zahs KR, 1997, GLIA, V20, P10, DOI 10.1002/(SICI)1098-1136(199705)20:1<10::AID-GLIA2>3.3.CO;2-2; Zanon-Moreno V, 2008, J GLAUCOMA, V17, P263, DOI 10.1097/IJG.0b013e31815c3a7f; Zhang Yan, 2011, Commun Integr Biol, V4, P324, DOI 10.4161/cib.4.3.14855; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	84	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65446	10.1371/journal.pone.0065446	http://dx.doi.org/10.1371/journal.pone.0065446			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762373	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000321094800050
J	Verbeek, NE; van der Maas, NAT; Jansen, FE; van Kempen, MJA; Lindhout, D; Brilstra, EH				Verbeek, Nienke E.; van der Maas, Nicoline A. T.; Jansen, Floor E.; van Kempen, Marjan J. A.; Lindhout, Dick; Brilstra, Eva H.			Prevalence of SCN1A-Related Dravet Syndrome among Children Reported with Seizures following Vaccination: A Population-Based Ten-Year Cohort Study	PLOS ONE			English	Article							SEVERE MYOCLONIC EPILEPSY; WHOLE-CELL PERTUSSIS; ACELLULAR PERTUSSIS; FEBRILE SEIZURES; SCN1A MUTATIONS; ADVERSE EVENTS; RISK; MEASLES; MUMPS; SURVEILLANCE	Objectives: To determine the prevalence of Dravet syndrome, an epileptic encephalopathy caused by SCN1A-mutations, often with seizure onset after vaccination, among infants reported with seizures following vaccination. To determine differences in characteristics of reported seizures after vaccination in children with and without SCN1A-related Dravet syndrome. Methods: Data were reviewed of 1,269 children with seizures following immunization in the first two years of life, reported to the safety surveillance system of the Dutch national immunization program between 1 January 1997 and 31 December 2006. Selective, prospective follow-up was performed of children with clinical characteristics compatible with a diagnosis of Dravet syndrome. Results: In 21.9% (n = 279) of children, a diagnosis of Dravet syndrome could not be excluded based on available clinical data (median age at follow-up 16 months). Additional follow-up data were obtained in 83.9% (n = 234) of these children (median age 8.5 years). 15 (1.2% of 1,269; 95%CI:0.6 to 1.8%) children were diagnosed with SCN1A-related Dravet syndrome. Of all reported seizures following vaccinations in the first year of life, 2.5% (95%CI:1.3 to 3.6%) were due to SCN1A-related Dravet syndrome, as were 5.9% of reported seizures (95%CI:3.1 to 8.7%) after 2nd or 3rd DTP-IPV-Hib vaccination. Seizures in children with SCN1A-related Dravet syndrome occurred more often with a body temperature below 38.5 degrees C (57.9% vs. 32.6%, p = 0.020) and reoccurred more often after following vaccinations (26.7% vs. 4.0%, p = 0.003), than in children without a diagnosis of SCN1A-related Dravet Syndrome. Conclusions: Although Dravet syndrome is a rare genetic epilepsy syndrome, 2.5% of reported seizures following vaccinations in the first year of life in our cohort occurred in children with this disorder. Knowledge on the specific characteristics of vaccination-related seizures in this syndrome might promote early diagnosis and indirectly, public faith in vaccination safety.	[Verbeek, Nienke E.; van Kempen, Marjan J. A.; Lindhout, Dick; Brilstra, Eva H.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [van der Maas, Nicoline A. T.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Jansen, Floor E.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Child Neurol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center	Verbeek, NE (corresponding author), Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands.	n.verbeek@umcutrecht.nl	Lindhout, Dick/AAH-5765-2019; Brilstra, Eva/AAT-3092-2021	Lindhout, Dick/0000-0001-9580-624X	NutsOhra Fund [0801-064]; Stichting Vrienden UMC Utrecht [10.053]	NutsOhra Fund; Stichting Vrienden UMC Utrecht	The first author was supported by the NutsOhra Fund (grant no. 0801-064)(www.fondsnutsohra.nl) and by the "Stichting Vrienden UMC Utrecht" (project 10.053, www.vriendenumcutrecht.nl) on behalf of the Janivo Stichting (www.janivostichting.nl) to perform this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBINK F, 2006, 210021004 RIVM; Barlow WE, 2001, NEW ENGL J MED, V345, P656, DOI 10.1056/NEJMoa003077; Berkovic SF, 2006, LANCET NEUROL, V5, P488, DOI 10.1016/S1474-4422(06)70446-X; Bonhoeffer J, 2004, VACCINE, V22, P557, DOI 10.1016/j.vaccine.2003.09.008; Brunklaus A, 2012, BRAIN, V135, P2329, DOI 10.1093/brain/aws151; Burgess DC, 2006, VACCINE, V24, P3921, DOI 10.1016/j.vaccine.2006.02.033; Caraballo RH, 2006, EPILEPSY RES, V70, pS231, DOI 10.1016/j.eplepsyres.2005.11.026; Ceulemans B, 2004, J CHILD NEUROL, V19, P516, DOI 10.1177/08830738040190070701; David S, 2008, VACCINE, V26, P5883, DOI 10.1016/j.vaccine.2008.07.105; De Jonghe P, 2011, DEV MED CHILD NEUROL, V53, P7, DOI 10.1111/j.1469-8749.2011.03965.x; Depienne C, 2009, J MED GENET, V46, P183, DOI 10.1136/jmg.2008.062323; Depienne C, 2010, J MED GENET, V47, P404, DOI 10.1136/jmg.2009.074328; Dravet C, 2011, EPILEPSIA, V52, P3, DOI 10.1111/j.1528-1167.2011.02994.x; FARRINGTON P, 1995, LANCET, V345, P567, DOI 10.1016/S0140-6736(95)90471-9; Fountain-Capal JK, 2011, PEDIATR NEUROL, V45, P319, DOI 10.1016/j.pediatrneurol.2011.08.001; Gangarosa EJ, 1998, LANCET, V351, P356, DOI 10.1016/S0140-6736(97)04334-1; Greco D, 1996, NEW ENGL J MED, V334, P341, DOI 10.1056/NEJM199602083340601; GRIFFIN MR, 1991, PEDIATRICS, V88, P881; Hattori J, 2008, EPILEPSIA, V49, P626, DOI 10.1111/j.1528-1167.2007.01475.x; HURST DL, 1990, EPILEPSIA, V31, P397, DOI 10.1111/j.1528-1157.1990.tb05494.x; Marini C, 2007, EPILEPSIA, V48, P1678, DOI 10.1111/j.1528-1167.2007.01122.x; McIntosh AM, 2010, LANCET NEUROL, V9, P592, DOI 10.1016/S1474-4422(10)70107-1; Mulley JC, 2005, HUM MUTAT, V25, P535, DOI 10.1002/humu.20178; Nieto-Barrera M, 2000, REV NEUROLOGIA, V30, P620, DOI 10.33588/rn.3007.2000016; Ottman R, 2010, EPILEPSIA, V51, P655, DOI 10.1111/j.1528-1167.2009.02429.x; Reyes IS, 2011, PEDIATRICS, V128, pE699, DOI 10.1542/peds.2010-0887; Scheffer IE, 1997, BRAIN, V120, P479, DOI 10.1093/brain/120.3.479; Sun YL, 2012, JAMA-J AM MED ASSOC, V307, P823, DOI 10.1001/jama.2012.165; Tro-Baumann B, 2011, EPILEPSIA, V52, P175, DOI 10.1111/j.1528-1167.2010.02885.x; van der Maas N A T, 2007, Ned Tijdschr Geneeskd, V151, P2732; VANDERMAAS NA, 2007, 240071004 RIVM; VANLIER EA, 2008, 210021007 RIVM; Verbeek NE, 2011, EPILEPSIA, V52, pE23, DOI 10.1111/j.1528-1167.2011.02982.x; VERMEERDEBONDT PE, 2002, 000001006 RIVM; von Spiczak S, 2011, EPILEPSIA, V52, P1506, DOI 10.1111/j.1528-1167.2011.03134.x; Ward KN, 2007, PEDIATRICS, V120, P314, DOI 10.1542/peds.2006-3743; YAKOUB M, 1992, BRAIN DEV-JPN, V14, P299, DOI 10.1016/S0387-7604(12)80147-1	37	32	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65758	10.1371/journal.pone.0065758	http://dx.doi.org/10.1371/journal.pone.0065758			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762420	Green Submitted, Green Published, gold			2022-12-27	WOS:000321099000102
J	Rossi, MA; Sukharnikova, T; Hayrapetyan, VY; Yang, LC; Yin, HH				Rossi, Mark A.; Sukharnikova, Tatyana; Hayrapetyan, Volodya Y.; Yang, Lucie; Yin, Henry H.			Operant Self-Stimulation of Dopamine Neurons in the Substantia Nigra	PLOS ONE			English	Article							OPTOGENETIC INTERROGATION; NUCLEUS-ACCUMBENS; IN-VIVO; REWARD; BRAIN; RECOMBINASE; MECHANISMS	We examined the contribution of the nigrostriatal DA system to instrumental learning and behavior using optogenetics in awake, behaving mice. Using Cre-inducible channelrhodopsin-2 (ChR2) in mice expressing Cre recombinase driven by the tyrosine hydroxylase promoter (Th-Cre), we tested whether selective stimulation of DA neurons in the substantia nigra pars compacta (SNC), in the absence of any natural rewards, was sufficient to promote instrumental learning in naive mice. Mice expressing ChR2 in SNC DA neurons readily learned to press a lever to receive laser stimulation, but unlike natural food rewards the lever pressing did not decline with satiation. When the number of presses required to receive a stimulation was altered, mice adjusted their rate of pressing accordingly, suggesting that the rate of stimulation was a controlled variable. Moreover, extinction, i.e. the cessation of action-contingent stimulation, and the complete reversal of the relationship between action and outcome by the imposition of an omission contingency, rapidly abolished lever pressing. Together these results suggest that selective activation of SNC DA neurons can be sufficient for acquisition and maintenance of a new instrumental action.	[Rossi, Mark A.; Sukharnikova, Tatyana; Hayrapetyan, Volodya Y.; Yang, Lucie; Yin, Henry H.] Duke Univ, Dept Psychol & Neurosci, Durham, NC 27710 USA; [Yin, Henry H.] Duke Univ, Dept Neurobiol, Durham, NC USA; [Yin, Henry H.] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA	Duke University; Duke University; Duke University	Yin, HH (corresponding author), Duke Univ, Dept Psychol & Neurosci, Durham, NC 27710 USA.	Hy43@duke.edu		Rossi, Mark/0000-0002-5724-3615	NIH [AA021074]; National Science Foundation fellowship; Duke University; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA021074] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation fellowship(National Science Foundation (NSF)); Duke University; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by NIH grant AA021074 to HHY, a National Science Foundation fellowship to MAR, and Duke University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamantidis AR, 2011, J NEUROSCI, V31, P10829, DOI 10.1523/JNEUROSCI.2246-11.2011; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Borchers S, 2012, NAT REV NEUROSCI, V13, P63, DOI 10.1038/nrn3140; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Fan D, 2012, J NEUROSCI, V32, P5534, DOI 10.1523/JNEUROSCI.5924-11.2012; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; HOWARTH CI, 1962, SCIENCE, V137, P35, DOI 10.1126/science.137.3523.35; Kim KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033612; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; OLDS J, 1958, SCIENCE, V127, P315, DOI 10.1126/science.127.3294.315; Rossi M. A, 2012, CURR PROTOC NEUROSCI; Rossi MA, 2012, J NEUROPHYSIOL, V108, P1211, DOI 10.1152/jn.01060.2011; Salamone JD, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.013.2009; SANGHERA MK, 1984, NEUROSCIENCE, V12, P793, DOI 10.1016/0306-4522(84)90171-4; Satoh T, 2003, J NEUROSCI, V23, P9913; Sparta DR, 2012, NAT PROTOC, V7, P12, DOI 10.1038/nprot.2011.413; Stuber GD, 2010, J NEUROSCI, V30, P8229, DOI 10.1523/JNEUROSCI.1754-10.2010; Tritsch NX, 2012, NATURE, V490, P262, DOI 10.1038/nature11466; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; WISE RA, 1981, BRAIN RES, V213, P190, DOI 10.1016/0006-8993(81)91260-9; Wise RA, 2009, TRENDS NEUROSCI, V32, P517, DOI 10.1016/j.tins.2009.06.004; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; Yin HH, 2008, EUR J NEUROSCI, V28, P1437, DOI 10.1111/j.1460-9568.2008.06422.x; Yu CX, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00014; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226	26	72	72	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65799	10.1371/journal.pone.0065799	http://dx.doi.org/10.1371/journal.pone.0065799			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755282	Green Submitted, Green Published, gold			2022-12-27	WOS:000320579400078
J	Thorne, JH; Santos, MJ; Bjorkman, JH				Thorne, James H.; Santos, Maria J.; Bjorkman, Jacquelyn H.			Regional Assessment of Urban Impacts on Landcover and Open Space Finds a Smart Urban Growth Policy Performs Little Better than Business as Usual	PLOS ONE			English	Article							LAND-USE; CLIMATE-CHANGE; CALIFORNIA; URBANIZATION; CONSERVATION; LANDSCAPE; TRANSPORTATION; BIODIVERSITY; INFORMATION; ECOLOGY	Assessment of landscape change is critical for attainment of regional sustainability goals. Urban growth assessments are needed because over half the global population now lives in cities, which impact biodiversity, ecosystem structure and ecological processes. Open space protection is needed to preserve these attributes, and provide the resources humans need. The San Francisco Bay Area, California, is challenged to accommodate a population increase of 3.07 million while maintaining the region's ecosystems and biodiversity. Our analysis of 9275 km(2) in the Bay Area links historic trends for three measures: urban growth, protected open space, and landcover types over the last 70 years to future 2050 projections of urban growth and open space. Protected open space totaled 348 km(2) (3.7% of the area) in 1940, and expanded to 2221 km(2) (20.2%) currently. An additional 1038 km(2) of protected open space is targeted (35.1%). Urban area historically increased from 396.5 km(2) to 2239 km(2) (24.1% of the area). Urban growth during this time mostly occurred at the expense of agricultural landscapes (62.9%) rather than natural vegetation. Smart Growth development has been advanced as a preferred alternative in many planning circles, but we found that it conserved only marginally more open space than Business-as-usual when using an urban growth model to portray policies for future urban growth. Scenarios to 2050 suggest urban development on non-urban lands of 1091, 956, or 179 km(2), under Business-as-usual, Smart Growth and Infill policy growth scenarios, respectively. The Smart Growth policy converts 88% of natural lands and agriculture used by Business-as-usual, while Infill used only 40% of those lands. Given the historic rate of urban growth, 0.25%/ year, and limited space available, the Infill scenario is recommended. While the data may differ, the use of an historic and future framework to track these three variables can be easily applied to other metropolitan areas.	[Thorne, James H.; Bjorkman, Jacquelyn H.] Univ Calif Davis, Environm Informat Ctr, Davis, CA 95616 USA; [Santos, Maria J.] Stanford Univ, Spatial Hist Project, Stanford, CA 94305 USA; [Santos, Maria J.] Stanford Univ, Bill Lane Ctr Amer West, Stanford, CA 94305 USA	University of California System; University of California Davis; Stanford University; Stanford University	Thorne, JH (corresponding author), Univ Calif Davis, Environm Informat Ctr, Davis, CA 95616 USA.	jhthorne@ucdavis.edu	Santos, Maria Joao/M-5034-2013	Santos, Maria Joao/0000-0002-6558-7477; Thorne, James/0000-0002-9130-9921	NSF [0819493]; California Public Interest Energy Research [PIER-500-08-006, PIER-500-09-037]; Bill Lane Center for the American West; Spatial History Project; Wallenberg Foundation	NSF(National Science Foundation (NSF)); California Public Interest Energy Research; Bill Lane Center for the American West; Spatial History Project; Wallenberg Foundation(European Commission)	Funding for this project came from NSF award 0819493, California Public Interest Energy Research grants, PIER-500-08-006, PIER-500-09-037, and the Bill Lane Center for the American West, the Spatial History Project and the Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, BAY AR IPL HAB GOALS; [Anonymous], 2005, FIRE ECOL; Beardsley K, 2009, LANDSCAPE URBAN PLAN, V93, P172, DOI 10.1016/j.landurbplan.2009.07.003; Berling-Wolff S, 2004, ECOL RES, V19, P119, DOI 10.1111/j.1440-1703.2003.00611.x; Breuste J, 2008, LANDSCAPE ECOL, V23, P1139, DOI 10.1007/s10980-008-9273-0; Brown DG, 2005, ECOL APPL, V15, P1851, DOI 10.1890/03-5220; Byrd KB, 2009, LANDSCAPE URBAN PLAN, V92, P106, DOI 10.1016/j.landurbplan.2009.03.003; Cayan DR, 2008, CLIMATIC CHANGE, V87, pS21, DOI 10.1007/s10584-007-9377-6; Clarke KC, 1997, ENVIRON PLANN B, V24, P247, DOI 10.1068/b240247; Cox RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014508; Department of Finance, 2011, 1850 2010 HIST US CE; Foresman T. W., 1997, URBAN ECOSYST, V1, P201, DOI DOI 10.1023/A:1018583729727; Grimm NB, 2008, FRONT ECOL ENVIRON, V6, P264, DOI 10.1890/070147; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Grossinger RM, 2007, LANDSCAPE ECOL, V22, P103, DOI 10.1007/s10980-007-9122-6; Hansen AJ, 2005, ECOL APPL, V15, P1893, DOI 10.1890/05-5221; HEWETT CE, 1981, ANNU REV ENERGY, V6, P139, DOI 10.1146/annurev.eg.06.110181.001035; Huber PR, 2011, NAT AREA J, V31, P234, DOI 10.3375/043.031.0306; Jenerette GD, 2010, LANDSCAPE ECOL, V25, P657, DOI 10.1007/s10980-010-9457-2; Johnston RA, 2003, TRANSPORT RES REC, P202, DOI 10.3141/1831-23; Johnston RA, 2009, TRANSPORT RES REC, P23, DOI 10.3141/2133-03; LUNETTA RS, 1991, PHOTOGRAMM ENG REM S, V57, P677; Mayer K.E., 1988, GUIDE WILDLIFE HABIT; McDonald RI, 2008, FRONT ECOL ENVIRON, V6, P99, DOI 10.1890/070038; McDonald RI, 2011, P NATL ACAD SCI USA, V108, P6312, DOI 10.1073/pnas.1011615108; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; Miller JR, 2005, TRENDS ECOL EVOL, V20, P430, DOI 10.1016/j.tree.2005.05.013; Miller JR, 2002, CONSERV BIOL, V16, P330, DOI 10.1046/j.1523-1739.2002.00420.x; Press DM., 2002, SAVING OPEN SPACE PO; Public Policy Institute of California-PPIC, 2009, CEC5002009013D PUBL; Sanderson EW, 2011, CONSERV BIOL, V25, P421, DOI 10.1111/j.1523-1739.2011.01683.x; Sanstad AH, 2011, CLIMATIC CHANGE, V109, P21, DOI 10.1007/s10584-011-0296-1; Satterthwaite D, 2010, PHILOS T R SOC B, V365, P2809, DOI 10.1098/rstb.2010.0136; Schoellhamer DH, 2011, ESTUAR COAST, V34, P885, DOI 10.1007/s12237-011-9382-x; Schoennagel T, 2009, P NATL ACAD SCI USA, V106, P10706, DOI 10.1073/pnas.0900991106; Schwartz MW, 2006, BIOL CONSERV, V127, P282, DOI 10.1016/j.biocon.2005.05.017; Scott M, 1985, SAN FRANCISCO BAY AR; Song Y, 2005, INT REGIONAL SCI REV, V28, P239, DOI 10.1177/0160017604273854; Theobald DM, 2010, LANDSCAPE ECOL, V25, P999, DOI 10.1007/s10980-010-9484-z; Theobald DM, 2000, LANDSCAPE ECOL, V15, P35, DOI 10.1023/A:1008165311026; Thorne J.H., 2012, CALIFORNIA ENERGY CO; Thorne J. H., 2006, DEV 70 YEAR OLD WIES; Thorne James H., 2008, Madrono, V55, P223, DOI 10.3120/0024-9637-55.3.223; Tucci M., 2010, CARTOGRAPHICA, V45, P47, DOI DOI 10.3138/CARTO.45.1.47; U. S. Census Bureau, 2000, SPEC TAB REQ; United Nations Population Fund-UNPF, 2007, UNPFA STAT WORLD POP; US Bureau of the Census, 2000, SUMM FIL 3; Waddell P, 2002, J AM PLANN ASSOC, V68, P297, DOI 10.1080/01944360208976274; Walker RA., 2007, WEYERHAEUSER ENV BOO; Whipple AA, 2011, RESTOR ECOL, V19, P88, DOI 10.1111/j.1526-100X.2009.00633.x; WHITE KL, 1966, ECOLOGY, V47, P229, DOI 10.2307/1933769; Wieslander A.E., 1935, MADRONO, V3, P140; [No title captured]	53	14	15	2	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65258	10.1371/journal.pone.0065258	http://dx.doi.org/10.1371/journal.pone.0065258			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166TB	23755204	gold, Green Published, Green Submitted			2022-12-27	WOS:000320579400046
J	Kim, JK; Jackson, TL				Kim, Jae Kyoung; Jackson, Trachette L.			Mechanisms That Enhance Sustainability of p53 Pulses	PLOS ONE			English	Article							P53-MDM2 FEEDBACK LOOP; MAMMALIAN CIRCADIAN CLOCK; SINGLE NUCLEOTIDE POLYMORPHISM; DNA-DAMAGE RESPONSE; STOCHASTIC SIMULATION; SELECTIVE COMMUNICATION; P53-MEDIATED APOPTOSIS; HUMAN-CELLS; OSCILLATIONS; DYNAMICS	The tumor suppressor p53 protein shows various dynamic responses depending on the types and extent of cellular stresses. In particular, in response to DNA damage induced by gamma-irradiation, cells generate a series of p53 pulses. Recent research has shown the importance of sustaining repeated p53 pulses for recovery from DNA damage. However, far too little attention has been paid to understanding how cells can sustain p53 pulses given the complexities of genetic heterogeneity and intrinsic noise. Here, we explore potential molecular mechanisms that enhance the sustainability of p53 pulses by developing a new mathematical model of the p53 regulatory system. This model can reproduce many experimental results that describe the dynamics of p53 pulses. By simulating the model both deterministically and stochastically, we found three potential mechanisms that improve the sustainability of p53 pulses: 1) the recently identified positive feedback loop between p53 and Rora allows cells to sustain p53 pulses with high amplitude over a wide range of conditions, 2) intrinsic noise can often prevent the dampening of p53 pulses even after mutations, and 3) coupling of p53 pulses in neighboring cells via cytochrome-c significantly reduces the chance of failure in sustaining p53 pulses in the presence of heterogeneity among cells. Finally, in light of these results, we propose testable experiments that can reveal important mechanisms underlying p53 dynamics.	[Kim, Jae Kyoung; Jackson, Trachette L.] Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Jackson, TL (corresponding author), Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA.	tjacks@umich.edu	Kim, Jae Kyoung/F-1297-2015	Kim, Jae Kyoung/0000-0001-7842-2172	NSF [DMS-1026317]; Human Frontiers of Science Foundation [RPG 24/2012]; JSMF [220020079/SCS]	NSF(National Science Foundation (NSF)); Human Frontiers of Science Foundation; JSMF	This work was supported by NSF DMS-1026317 for computing resources, the Human Frontiers of Science Foundation (RPG 24/2012) and JSMF - 220020079/SCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Antoch MP, 2010, CIRC RES, V106, P68, DOI 10.1161/CIRCRESAHA.109.207076; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Banaz-Yasar F, 2008, J CELL BIOCHEM, V103, P149, DOI 10.1002/jcb.21395; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Barik D, 2008, BIOPHYS J, V95, P3563, DOI 10.1529/biophysj.108.129155; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Batchelor E, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.20; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Brown TM, 2007, J NEUROPHYSIOL, V97, P2553, DOI 10.1152/jn.01206.2006; Ciliberto A, 2005, CELL CYCLE, V4, P488, DOI 10.4161/cc.4.3.1548; Deguin-Chambon V, 2000, ONCOGENE, V19, P5831, DOI 10.1038/sj.onc.1203960; Filipski E, 2005, JNCI-J NATL CANCER I, V97, P507, DOI 10.1093/jnci/dji083; Forger DB, 2005, P NATL ACAD SCI USA, V102, P321, DOI 10.1073/pnas.0408465102; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gonze D, 2002, J BIOL PHYS, V28, P637, DOI 10.1023/A:1021286607354; Hamstra DA, 2006, CANCER RES, V66, P7482, DOI 10.1158/0008-5472.CAN-06-1405; HANSEL D, 1995, NEURAL COMPUT, V7, P307, DOI 10.1162/neco.1995.7.2.307; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; He M, 2011, ONCOGENE, V30, P1947, DOI 10.1038/onc.2010.567; Herzog ED, 2004, J BIOL RHYTHM, V19, P35, DOI 10.1177/0748730403260776; HODGKIN AL, 1948, J PHYSIOL-LONDON, V107, P165, DOI 10.1113/jphysiol.1948.sp004260; Hu WW, 2007, CANCER RES, V67, P2757, DOI 10.1158/0008-5472.CAN-06-2656; Huang LC, 1996, P NATL ACAD SCI USA, V93, P4827, DOI 10.1073/pnas.93.10.4827; Hunziker A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-94; Iwamoto K, 2011, BIOSYSTEMS, V103, P384, DOI 10.1016/j.biosystems.2010.11.011; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Izhikevich EM, 2002, BIOSYSTEMS, V67, P95, DOI 10.1016/S0303-2647(02)00067-9; Izhikevich EM, 2003, TRENDS NEUROSCI, V26, P161, DOI 10.1016/S0166-2236(03)00034-1; Jin SK, 2001, J CELL SCI, V114, P4139; Josic K, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002264; Kim H, 2011, MOL CELL, V44, P797, DOI 10.1016/j.molcel.2011.09.023; Kim JK, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.62; Kim JR, 2010, J CELL SCI, V123, P537, DOI 10.1242/jcs.060061; Kim J, 2007, PLOS COMPUT BIOL, V3, P2190, DOI 10.1371/journal.pcbi.0030218; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Ko CH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000513; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lahav G, 2008, ADV EXP MED BIOL, V641, P28; Li QS, 2007, BIOPHYS CHEM, V129, P23, DOI 10.1016/j.bpc.2007.05.001; Li Z, 2010, J THEORETICAL BIOL; Little JB, 2006, MUTAT RES-FUND MOL M, V597, P113, DOI 10.1016/j.mrfmmm.2005.12.001; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Loewer A, 2011, CURR OPIN GENET DEV, V21, P753, DOI 10.1016/j.gde.2011.09.010; Loewer A, 2010, CELL, V142, P89, DOI 10.1016/j.cell.2010.05.031; Ma L, 2005, P NATL ACAD SCI USA, V102, P14266, DOI 10.1073/pnas.0501352102; MACKEY MC, 1977, SCIENCE, V197, P287, DOI 10.1126/science.267326; Martoriati A, 2005, ONCOGENE, V24, P1461, DOI 10.1038/sj.onc.1208256; Mayo LD, 2002, J BIOL CHEM, V277, P5484, DOI 10.1074/jbc.M108302200; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Moortgat KT, 2000, J NEUROPHYSIOL, V83, P984, DOI 10.1152/jn.2000.83.2.984; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Ojima M, 2011, RADIAT RES, V175, P90, DOI 10.1667/RR2223.1; Ongusaha PP, 2003, EMBO J, V22, P1289, DOI 10.1093/emboj/cdg129; Ouattara DA, 2010, J THEOR BIOL, V264, P1177, DOI 10.1016/j.jtbi.2010.03.031; Peixoto PM, 2009, BIOCHEM BIOPH RES CO, V390, P38, DOI 10.1016/j.bbrc.2009.09.054; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Rao CV, 2003, J CHEM PHYS, V118, P4999, DOI 10.1063/1.1545446; Rosenblum M, 2003, CONTEMP PHYS, V44, P401, DOI 10.1080/00107510310001603129; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; SAVAGEAU MA, 1989, THEORETICAL BIOLOGY, P42; Sturrock M, 2011, J THEOR BIOL, V273, P15, DOI 10.1016/j.jtbi.2010.12.016; Sun TZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027882; Sun TZ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-190; Toettcher JE, 2010, P NATL ACAD SCI USA, V107, P17047, DOI 10.1073/pnas.1005615107; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034921; Zhang TL, 2007, CELL CYCLE, V6, P85, DOI 10.4161/cc.6.1.3705	73	35	36	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65242	10.1371/journal.pone.0065242	http://dx.doi.org/10.1371/journal.pone.0065242			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755198	Green Published, Green Submitted, gold			2022-12-27	WOS:000319872300061
J	Prokop, JW; Santos, RAS; Milsted, A				Prokop, Jeremy W.; Santos, Robson A. S.; Milsted, Amy			Differential Mechanisms of Activation of the Ang Peptide Receptors AT1, AT2, and MAS: Using In Silico Techniques to Differentiate the Three Receptors	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; ANGIOTENSIN-II RECEPTOR; AT(1) RECEPTOR; TRANSMEMBRANE DOMAIN; LIGAND-BINDING; BLOOD-PRESSURE; AGONIST; IDENTIFICATION; PHOSPHORYLATION; CONFORMATION	The renin-angiotensin system is involved in multiple conditions ranging from cardiovascular disorders to cancer. Components of the pathway, including ACE, renin and angiotensin receptors are targets for disease treatment. This study addresses three receptors of the pathway: AT1, AT2, and MAS and how the receptors are similar and differ in activation by angiotensin peptides. Combining biochemical and amino acid variation data with multiple species sequence alignments, structural models, and docking site predictions allows for visualization of how angiotensin peptides may bind and activate the receptors; allowing identification of conserved and variant mechanisms in the receptors. MAS differs from AT1 favoring Ang-(1-7) and not Ang II binding, while AT2 recently has been suggested to preferentially bind Ang III. A new model of Ang peptide binding to AT1 and AT2 is proposed that correlates data from site directed mutagenesis and photolabled experiments that were previously considered conflicting. Ang II binds AT1 and AT2 through a conserved initial binding mode involving amino acids 111 (consensus 325) of AT1 (Asn) interacting with Tyr (4) of Ang II and 199 and 256 (consensus 512 and 621, a Lys and His respectively) interacting with Phe (8) of Ang II. In MAS these sites are not conserved, leading to differential binding and activation by Ang-(1-7). In both AT1 and AT2, the Ang II peptide may internalize through Phe (8) of Ang II propagating through the receptors' conserved aromatic amino acids to the final photolabled positioning relative to either AT1 (amino acid 294, Asn, consensus 725) or AT2 (138, Leu, consensus 336). Understanding receptor activation provides valuable information for drug design and identification of other receptors that can potentially bind Ang peptides.	[Prokop, Jeremy W.; Milsted, Amy] Univ Akron, Dept Biol, Program Integrated Biosci, Akron, OH 44325 USA; [Santos, Robson A. S.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Fisiol & Biofis, Belo Horizonte, MG, Brazil	University of Akron; Universidade Federal de Minas Gerais	Milsted, A (corresponding author), Univ Akron, Dept Biol, Program Integrated Biosci, Akron, OH 44325 USA.	milsted@uakron.edu	Prokop, Jeremy/AAG-4931-2019; Santos, Robson A S/C-9336-2011	Santos, Robson A S/0000-0001-8738-5852; Prokop, Jeremy/0000-0002-1818-9695	Choose Ohio First Bioinformatics scholarship; University of Akron; American Heart Association [11PRE7380033]; Brazilian National Institute of Science and Technology in Hormones and Women's Health; Federal University of Minas Gerais	Choose Ohio First Bioinformatics scholarship; University of Akron; American Heart Association(American Heart Association); Brazilian National Institute of Science and Technology in Hormones and Women's Health; Federal University of Minas Gerais	Funding was through Choose Ohio First Bioinformatics scholarship, University of Akron, American Heart Association award 11PRE7380033, Brazilian National Institute of Science and Technology in Hormones and Women's Health, and Federal University of Minas Gerais. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdAlla S, 2001, J BIOL CHEM, V276, P39721, DOI 10.1074/jbc.M105253200; AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; AbdAlla S, 2001, NAT MED, V7, P1003, DOI 10.1038/nm0901-1003; Ali MS, 1997, J BIOL CHEM, V272, P23382, DOI 10.1074/jbc.272.37.23382; AUMELAS A, 1985, P NATL ACAD SCI USA, V82, P1881, DOI 10.1073/pnas.82.7.1881; Baleanu-Gogonea C, 2006, J MOL MODEL, V12, P325, DOI 10.1007/s00894-005-0049-z; Danser AHJ, 2007, NEPHROL DIAL TRANSPL, V22, P1288, DOI 10.1093/ndt/gfl846; DeMello WC, 2010, RENIN ANGIOTENSIN SY; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; FENG YH, 1995, J BIOL CHEM, V270, P12846, DOI 10.1074/jbc.270.21.12846; Ferre S, 2010, CURR OPIN PHARMACOL, V10, P1, DOI 10.1016/j.coph.2009.11.002; Gembardt F, 2008, MOL CELL BIOCHEM, V319, P115, DOI 10.1007/s11010-008-9884-4; Hines J, 2003, BIOCHEM PHARMACOL, V66, P251, DOI 10.1016/S0006-2952(03)00257-0; Holloway AC, 2002, MOL PHARMACOL, V61, P768, DOI 10.1124/mol.61.4.768; Hunyady L, 2003, TRENDS PHARMACOL SCI, V24, P81, DOI 10.1016/S0165-6147(02)00050-0; ICHIKI T, 1995, NATURE, V377, P748, DOI 10.1038/377748a0; ITO M, 1995, P NATL ACAD SCI USA, V92, P3521, DOI 10.1073/pnas.92.8.3521; JACKSON TR, 1988, NATURE, V335, P437, DOI 10.1038/335437a0; Kemp BA, 2012, HYPERTENSION, V60, P387, DOI 10.1161/HYPERTENSIONAHA.112.191403; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Kostenis E, 2005, CIRCULATION, V111, P1806, DOI 10.1161/01.CIR.0000160867.23556.7D; Morales R, 2012, J MOL BIOL, V421, P100, DOI 10.1016/j.jmb.2012.05.003; MURPHY TJ, 1991, NATURE, V351, P233, DOI 10.1038/351233a0; Nikiforovich GV, 2001, BIOCHEM BIOPH RES CO, V286, P1204, DOI 10.1006/bbrc.2001.5526; NODA K, 1995, J BIOL CHEM, V270, P28511, DOI 10.1074/jbc.270.48.28511; Noda K, 1996, BIOCHEMISTRY-US, V35, P16435, DOI 10.1021/bi961593m; Oliveira L, 2007, PHYSIOL REV, V87, P565, DOI 10.1152/physrev.00040.2005; Padia SH, 2013, PFLUG ARCH EUR J PHY, V465, P99, DOI 10.1007/s00424-012-1146-3; Perodin J, 2002, BIOCHEMISTRY-US, V41, P14348, DOI 10.1021/bi0258602; Prinster SC, 2005, PHARMACOL REV, V57, P289, DOI 10.1124/pr.57.3.1; Pulakat L, 1998, REGUL PEPTIDES, V73, P51, DOI 10.1016/S0167-0115(97)01059-8; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rozenfeld R, 2011, EMBO J, V30, P2350, DOI 10.1038/emboj.2011.139; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Santos RAS, 2008, EXP PHYSIOL, V93, P519, DOI 10.1113/expphysiol.2008.042002; SCHORB W, 1993, CIRC RES, V72, P1245, DOI 10.1161/01.RES.72.6.1245; Servant G, 1997, J BIOL CHEM, V272, P8653, DOI 10.1074/jbc.272.13.8653; Skold C, 2008, J MOL GRAPH MODEL, V26, P991, DOI 10.1016/j.jmgm.2007.08.005; Spyroulias GA, 2003, EUR J BIOCHEM, V270, P2163, DOI 10.1046/j.1432-1033.2003.03573.x; Steckelings UM, 2012, CURR OPIN NEPHROL HY, V21, P142, DOI 10.1097/MNH.0b013e328350261b; STOLL M, 1995, J CLIN INVEST, V95, P651, DOI 10.1172/JCI117710; Szalai B, 2012, BIOCHEM PHARMACOL, V84, P477, DOI 10.1016/j.bcp.2012.04.014; Thomas WG, 2000, J BIOL CHEM, V275, P2893, DOI 10.1074/jbc.275.4.2893; Turner CA, 1999, BIOCHEM BIOPH RES CO, V257, P704, DOI 10.1006/bbrc.1999.0207; Underwood D J, 1994, Chem Biol, V1, P211, DOI 10.1016/1074-5521(94)90013-2; Vauquelin G, 2005, FUND CLIN PHARMACOL, V19, P45, DOI 10.1111/j.1472-8206.2005.00319.x; YAMANO Y, 1992, BIOCHEM BIOPH RES CO, V187, P1426, DOI 10.1016/0006-291X(92)90461-S; Yasuda N, 2008, N-S ARCH PHARMACOL, V377, P393, DOI 10.1007/s00210-007-0215-1; Yasuda N, 2008, EMBO REP, V9, P179, DOI 10.1038/sj.embor.7401157; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2006, PLOS COMPUT BIOL, V2, P88, DOI 10.1371/journal.pcbi.0020013; Zhou AW, 2010, NATURE, V468, P108, DOI 10.1038/nature09505; Zini S, 1996, P NATL ACAD SCI USA, V93, P11968, DOI 10.1073/pnas.93.21.11968	54	10	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65307	10.1371/journal.pone.0065307	http://dx.doi.org/10.1371/journal.pone.0065307			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755216	gold, Green Submitted, Green Published			2022-12-27	WOS:000319872300073
J	Liu, ZX; Huang, SY; Zhang, DS				Liu, Zhenxing; Huang, Shengyun; Zhang, Dongsheng			High Dose Rate versus Low Dose Rate Brachytherapy for Oral Cancer - A Meta-Analysis of Clinical Trials	PLOS ONE			English	Article							RATE INTERSTITIAL BRACHYTHERAPY; CARCINOMA; RADIOTHERAPY; FRACTIONS; HEAD	Objective: To compare the efficacy and safety of high dose rate (HDR) and low dose rate (LDR) brachytherapy in treating early-stage oral cancer. Data Sources: A systematic search of MEDLINE, EMBASE and Cochrane Library databases, restricted to English language up to June 1, 2012, was performed to identify potentially relevant studies. Study Selection: Only randomized controlled trials (RCT) and controlled trials that compared HDR to LDR brachytherapy in treatment of early-stage oral cancer (stages I, II and III) were of interest. Data Extraction and Synthesis: Two investigators independently extracted data from retrieved studies and controversies were solved by discussion. Meta-analysis was performed using RevMan 5.1. One RCT and five controlled trials (607 patients: 447 for LDR and 160 for HDR) met the inclusion criteria. The odds ratio showed no statistically significant difference between LDR group and HDR group in terms of local recurrence (OR = 1.12, CI 95% 0.62-2.01), overall mortality (OR = 1.01, CI 95% 0.61-1.66) and Grade 3/4 complications (OR = 0.86, CI 95% 0.52-1.42). Conclusions: This meta-analysis indicated that HDR brachytherapy was a comparable alternative to LDR brachytherapy in treatment of oral cancer. HDR brachytherapy might become a routine choice for early-stage oral cancer in the future.	[Liu, Zhenxing; Huang, Shengyun; Zhang, Dongsheng] Shandong Univ, Dept Oral & Maxillofacial Surg, Prov Hosp, Jinan 250100, Peoples R China	Shandong University	Zhang, DS (corresponding author), Shandong Univ, Dept Oral & Maxillofacial Surg, Prov Hosp, Jinan 250100, Peoples R China.	ds63zhang@sdu.edu.cn			Shandong Provincial Science and Technology Development Plan [2006GG2202034]; Science and Technology Foundation of Shandong Province [2006GG20002046]; Shandong Provincial Natural Science Foundation [ZR2012HQ022]	Shandong Provincial Science and Technology Development Plan; Science and Technology Foundation of Shandong Province; Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province)	This study is supported by Shandong Provincial Science and Technology Development Plan (2006GG2202034), the Science and Technology Foundation of Shandong Province (2006GG20002046) and Shandong Provincial Natural Science Foundation (ZR2012HQ022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2012, J RADIAT RES, V53, P722, DOI 10.1093/jrr/rrs027; Ayerra Arrate Querejeta, 2010, J Contemp Brachytherapy, V2, P9, DOI 10.5114/jcb.2010.13717; Deng H, 2011, AUST DENT J, V56, P244, DOI 10.1111/j.1834-7819.2011.01349.x; Erickson BA, 2011, INT J RADIAT ONCOL, V79, P641, DOI 10.1016/j.ijrobp.2010.08.046; Genden EM, 2010, EUR ARCH OTO-RHINO-L, V267, P1001, DOI 10.1007/s00405-010-1206-2; Ghadjar P, 2012, INT J RADIAT ONCOL, V83, P1205, DOI 10.1016/j.ijrobp.2011.09.038; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Inoue T, 1998, INT J RADIAT ONCOL, V41, P53, DOI 10.1016/S0360-3016(98)00041-8; Inoue T, 2001, INT J RADIAT ONCOL, V51, P171, DOI 10.1016/S0360-3016(01)01561-9; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Katimoto N, 2003, RADIOTHER ONCOL, V68, P123, DOI 10.1016/S0167-8140(03)00055-0; Lau HY, 1996, RADIOTHER ONCOL, V39, P15, DOI 10.1016/0167-8140(95)01686-4; Leung TW, 2002, HEAD NECK-J SCI SPEC, V24, P274, DOI 10.1002/hed.10021; Leung TW, 1997, INT J RADIAT ONCOL, V39, P1113, DOI 10.1016/S0360-3016(97)00376-3; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Guinot JL, 2010, BRACHYTHERAPY, V9, P227, DOI 10.1016/j.brachy.2009.10.003; MANTEL N, 1959, J NATL CANCER I, V22, P719; Martinez A, 1997, PRINCIPLES PRACTICE, P569; Mazeron JJ, 2009, RADIOTHER ONCOL, V91, P150, DOI 10.1016/j.radonc.2009.01.005; Mikami M, 2011, BRACHYTHERAPY, V10, P318, DOI 10.1016/j.brachy.2010.11.006; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nag S, 2004, TECHNOL CANCER RES T, V3, P269, DOI 10.1177/153303460400300305; National Comprehensive Cancer Network, 2011, NCCN GUID HEAD NECK; Oxford Centre for Evidence-Based Medicine, 2009, LEVELS EVIDENCE; Petera J, 2009, NEOPLASMA, V56, P163, DOI 10.4149/neo_2009_02_163; Shibuya H, 2009, INT J CLIN ONCOL, V14, P2, DOI 10.1007/s10147-008-0859-y; Umeda M, 2000, ORAL SURG ORAL MED O, V90, P667, DOI 10.1067/moe.2000.110087; Umeda M, 2005, INT J ORAL MAX SURG, V34, P739, DOI 10.1016/j.ijom.2005.02.015; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Wells GA, 2012, NEWCASTLE OTTAWA SCA, DOI [10.2307/632432, DOI 10.2307/632432]; Yamazaki H, 2007, ANTICANCER RES, V27, P491; Yamazaki H, 2013, J RADIAT RES, V54, P1, DOI 10.1093/jrr/rrs103; Yoshida K, 2010, INT J RADIAT ONCOL, V77, P765, DOI 10.1016/j.ijrobp.2009.05.027	34	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65423	10.1371/journal.pone.0065423	http://dx.doi.org/10.1371/journal.pone.0065423			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762369	Green Published, gold, Green Submitted			2022-12-27	WOS:000320440500038
J	Ravoori, MK; Han, L; Singh, SP; Dixon, K; Duggal, J; Liu, P; Uthamanthil, R; Gupta, S; Wright, KC; Kundra, V				Ravoori, Murali K.; Han, Lin; Singh, Sheela P.; Dixon, Katherine; Duggal, Jyoti; Liu, Ping; Uthamanthil, Rajesh; Gupta, Sanjay; Wright, Kenneth C.; Kundra, Vikas			Noninvasive Assessment of Gene Transfer and Expression by In Vivo Functional and Morphologic Imaging in a Rabbit Tumor Model	PLOS ONE			English	Article							REPORTER GENE; MOUSE MODEL; ADENOVIRAL VECTOR; OVARIAN-CARCINOMA; LIVING ANIMALS; LIVER-CANCER; LUNG-CANCER; THERAPY; INTRAARTERIAL; QUANTIFICATION	Purpose: To evaluate the importance of morphology in quantifying expression after in vivo gene transfer and to compare gene expression after intra-arterial (IA) and intra-tumoral (IT) delivery of adenovirus expressing a SSTR2-based reporter gene in a large animal tumor model. Materials and Methods: Tumor directed IA or IT delivery of adenovirus containing a human somatostatin receptor type 2A (Ad-CMV-HA-SSTR2A) gene chimera or control adenovirus (Ad-CMV-GFP) was performed in VX2 tumors growing in both rabbit thighs. Three days later, In-111-octreotide was administered intravenously after CT imaging using a clinical scanner. In-111-octreotide uptake in tumors was evaluated the following day using a clinical gamma-camera. Gene expression was normalized to tumor weight with and without necrosis. This procedure was repeated on nine additional rabbits to investigate longitudinal gene expression both 5 days and 2 weeks after adenovirus delivery. CT images were used to evaluate tumor morphology and excised tissue samples were analyzed to determine In-111-octreotide biodistribution ex vivo. Results: VX2 tumors infected with Ad-CMV-HA-SSTR2 had greater In-111-octreotide uptake than with control virus (P<0.05). Intra-arterial and intra-tumoral routes resulted in similar levels of gene expression. Longitudinally, expression appeared to wane at 2 weeks versus 5 days after delivery. Areas of necrosis did not demonstrate significant uptake ex vivo. Morphology identified areas of necrosis on contrast enhanced CT and upon excluding necrosis, in vivo biodistribution analysis resulted in greater percent injected dose per gram (P<0.01) and corresponded better with ex vivo biodistribution(r = 0.72, P<0.01, Coefficient of the x-variable = .72) at 2 weeks than without excluding necrosis (P<0.01). Conclusion: Tumor specificity and high transgene expression can be achieved in tumors via both tumor directed intra-arterial and intra-tumoral delivery in a large animal tumor model. Using clinical machines, morphologic imaging contributes to functional imaging for quantifying SSTR2-based reporter expression in vivo.	[Ravoori, Murali K.; Han, Lin; Singh, Sheela P.; Duggal, Jyoti; Kundra, Vikas] Univ Texas MD Anderson Canc Ctr, Dept Expt Diagnost Imaging, Houston, TX 77030 USA; [Kundra, Vikas] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Radiol, Sect Body Imaging, Houston, TX 77030 USA; [Dixon, Katherine; Gupta, Sanjay; Wright, Kenneth C.] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Radiol, Sect Intervent Radiol, Houston, TX 77030 USA; [Liu, Ping] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Uthamanthil, Rajesh] Univ Texas MD Anderson Canc Ctr, Dept Vet Med & Surg, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Kundra, V (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Diagnost Imaging, Houston, TX 77030 USA.	vkundra@mdanderson.org		Gupta, Sanjay/0000-0001-7001-0130	National Cancer Institute [RCA123841, RCA129714]; John S. Dunn Research Foundation; National Institutes of Health through MD Anderson's Cancer Center Support Grant [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); John S. Dunn Research Foundation; National Institutes of Health through MD Anderson's Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research supported in part by grants from the National Cancer Institute (RCA123841, RCA129714), a grant from the John S. Dunn Research Foundation, and by the National Institutes of Health through MD Anderson's Cancer Center Support Grant CA016672. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Atencio IA, 2006, CANCER GENE THER, V13, P169, DOI 10.1038/sj.cgt.7700870; Bankson JA, 2008, J MAGN RESON IMAGING, V27, P57, DOI 10.1002/jmri.21221; Bradley J, 2001, MOL MED; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Chaudhuri TR, 2001, GYNECOL ONCOL, V83, P432, DOI 10.1006/gyno.2001.6333; Chen R, 2010, J NUCL MED, V51, P1456, DOI 10.2967/jnumed.109.063586; Fontanellas A, 2009, GENE THER, V16, P136, DOI 10.1038/gt.2008.122; Gambhir SS, 1999, NUCL MED BIOL, V26, P481, DOI 10.1016/S0969-8051(99)00021-9; Geschwind JFH, 2002, CANCER RES, V62, P3909; Griesenbach U, 2002, GENE THER, V9, P1344, DOI 10.1038/sj.gt.3301791; Han L, 2007, MOL IMAGING, V6, P427, DOI 10.2310/7290.2007.00038; Isner JM, J CLIN INVEST, V103, P1231; JAFFE HA, 1992, NAT GENET, V1, P372, DOI 10.1038/ng0892-372; Kay MA, 2000, NAT GENET, V24, P257, DOI 10.1038/73464; Khuri FR, 2000, NAT MED, V6, P879, DOI 10.1038/78638; Kidd JG, 1940, J EXP MED, V71, P813, DOI 10.1084/jem.71.6.813; Kim TJ, 2007, CANCER RES, V67, P9337, DOI 10.1158/0008-5472.CAN-06-4018; Ko YH, 2001, CANCER LETT, V173, P83, DOI 10.1016/S0304-3835(01)00667-X; Kundra V, 2002, J NUCL MED, V43, P406; Kwon HC, 2001, MOL CELLS, V11, P170; LI QT, 1993, HUM GENE THER, V4, P403, DOI 10.1089/hum.1993.4.4-403; Liang Q, 2001, GENE THER, V8, P1490, DOI 10.1038/sj.gt.3301542; Nemunaitis J, 2000, J CLIN ONCOL, V18, P609, DOI 10.1200/JCO.2000.18.3.609; Rajagopalan S, 2001, CIRCULATION, V104, P753, DOI 10.1161/hc3201.095192; Rampurwala M, 2009, TRANSL ONCOL, V2, P96, DOI 10.1593/tlo.08199; Reid T, 2001, GENE THER, V8, P1618, DOI 10.1038/sj.gt.3301512; Rogers BE, 2002, CANCER, V94, P1298, DOI 10.1002/cncr.10300; ROUS P, 1952, J EXP MED, V96, P159, DOI 10.1084/jem.96.2.159; Sandmair AM, 2000, HUM GENE THER, V11, P2197, DOI 10.1089/104303400750035726; Singh SP, 2011, HUM GENE THER, V22, P55, DOI 10.1089/hum.2010.109; Singh SP, 2009, RADIOLOGY, V252, P763, DOI 10.1148/radiol.2531081825; SWISTEL AJ, 1984, CANCER, V53, P1397, DOI 10.1002/1097-0142(19840315)53:6<1397::AID-CNCR2820530630>3.0.CO;2-E; TAYLOR S, 1982, NATURE, V297, P307, DOI 10.1038/297307a0; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Tjuvajev JG, 1996, CANCER RES, V56, P4087; Weisbroth SH, 1994, BIOL LAB RABBIT, P281; Yang D, 2005, RADIOLOGY, V235, P950, DOI 10.1148/radiol.2353040108; Yu YJ, 2000, NAT MED, V6, P933, DOI 10.1038/78704; ZLOTECKI R, 1986, P AM ASSOC CANC RES, V27, P406	39	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e62371	10.1371/journal.pone.0062371	http://dx.doi.org/10.1371/journal.pone.0062371			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762226	Green Submitted, Green Published, gold			2022-12-27	WOS:000320440500002
J	Bugaut, H; Bruchard, M; Berger, H; Derangere, V; Odoul, L; Euvrard, R; Ladoire, S; Chalmin, F; Vegran, F; Rebe, C; Apetoh, L; Ghiringhelli, F; Mignot, G				Bugaut, Helene; Bruchard, Melanie; Berger, Helene; Derangere, Valentin; Odoul, Ludivine; Euvrard, Romain; Ladoire, Sylvain; Chalmin, Fanny; Vegran, Frederique; Rebe, Cedric; Apetoh, Lionel; Ghiringhelli, Francois; Mignot, Gregoire			Bleomycin Exerts Ambivalent Antitumor Immune Effect by Triggering Both Immunogenic Cell Death and Proliferation of Regulatory T Cells	PLOS ONE			English	Article							CALRETICULIN EXPOSURE; PULMONARY-FIBROSIS; SUPPRESSOR-CELLS; MESSENGER-RNA; CUTTING EDGE; LUNG; RESPONSES; VINBLASTINE; MECHANISMS; EXPRESSION	Bleomycin (BLM) is an anticancer drug currently used for the treatment of testis cancer and Hodgkin lymphoma. This drug triggers cancer cell death via its capacity to generate radical oxygen species (ROS). However, the putative contribution of anticancer immune responses to the efficacy of BLM has not been evaluated. We make here the observation that BLM induces immunogenic cell death. In particular, BLM is able to induce ROS-mediated reticulum stress and autophagy, which result in the surface exposure of chaperones, including calreticulin and ERp57, and liberation of HMBG1 and ATP. BLM induces anti-tumor immunity which relies on calreticulin, CD8(+) T cells and interferon-gamma. We also find that, in addition to its capacity to trigger immunogenic cell death, BLM induces expansion of Foxp3+ regulatory T (Treg) cells via its capacity to induce transforming growth factor beta (TGF beta) secretion by tumor cells. Accordingly, Treg cells or TGF beta depletion dramatically potentiates the antitumor effect of BLM. We conclude that BLM induces both anti-tumor CD8(+) T cell response and a counteracting Treg proliferation. In the future, TGF beta or Treg inhibition during BLM treatment could greatly enhance BLM anti-tumor efficacy.	[Bugaut, Helene; Bruchard, Melanie; Berger, Helene; Derangere, Valentin; Euvrard, Romain; Ladoire, Sylvain; Chalmin, Fanny; Vegran, Frederique; Rebe, Cedric; Apetoh, Lionel; Ghiringhelli, Francois; Mignot, Gregoire] INSERM, U866, Dijon, France; [Bugaut, Helene; Bruchard, Melanie; Berger, Helene; Derangere, Valentin; Euvrard, Romain; Ladoire, Sylvain; Chalmin, Fanny; Vegran, Frederique; Rebe, Cedric; Apetoh, Lionel; Ghiringhelli, Francois; Mignot, Gregoire] INSERM, AVENIR Team, Dijon, France; [Bugaut, Helene; Bruchard, Melanie; Berger, Helene; Derangere, Valentin; Euvrard, Romain; Ladoire, Sylvain; Chalmin, Fanny; Vegran, Frederique; Rebe, Cedric; Apetoh, Lionel; Ghiringhelli, Francois; Mignot, Gregoire] Univ Bourgogne, Fac Med, Dijon, France; [Odoul, Ludivine] Univ Bern, Inst Pathol, Bern, Switzerland; [Ladoire, Sylvain; Rebe, Cedric; Ghiringhelli, Francois] Ctr Georges Francois Leclerc, Dijon, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; University of Bern; UNICANCER; Centre Georges-Francois Leclerc	Ghiringhelli, F (corresponding author), INSERM, U866, Dijon, France.	fghiringhelli@cgfl.fr; gregoire.mignot@free.fr	Apetoh, Lionel/G-3310-2014; Mignot, Grégoire/R-4976-2017; REBE, Cédric/AAD-4316-2019; VEGRAN, Frederique/O-9986-2018; Apetoh, Lionel/AIC-2384-2022; VEGRAN, Frédérique/H-4792-2017; Bruchard, Melanie/E-6508-2017	Apetoh, Lionel/0000-0002-2774-438X; Mignot, Grégoire/0000-0002-0682-0152; REBE, Cédric/0000-0001-8831-145X; VEGRAN, Frederique/0000-0002-4377-1441; Apetoh, Lionel/0000-0002-2774-438X; Bruchard, Melanie/0000-0003-0004-2887; LADOIRE, Sylvain/0000-0002-0331-9194; Chalmin, Fanny/0000-0002-0855-9453; EUVRARD, Romain/0000-0001-8259-2107; ghiringhelli, francois/0000-0002-5465-8305	Fondation de France; Association pour la Recherche sur le Cancer; Institut National de la Sante et de la Recherche Medicale; Ligue Contre le Cancer (Region Bourgogne); Fondation pour la Recherche Medicale; Institut National du Cancer; Ligue Nationale contre le cancer; Agence Nationale pour la Recherche [ANR-10-PDOC-014-01]; Ecole de l'Inserm Liliane Bettencourt	Fondation de France(Fondation de France); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ligue Contre le Cancer (Region Bourgogne); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Institut National du Cancer(Institut National du Cancer (INCA) France); Ligue Nationale contre le cancer(Ligue nationale contre le cancer); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Ecole de l'Inserm Liliane Bettencourt	This work was supported by special grants from the Fondation de France, the Association pour la Recherche sur le Cancer, the Institut National de la Sante et de la Recherche Medicale, the Ligue Contre le Cancer (Region Bourgogne), the Fondation pour la Recherche Medicale, and the Institut National du Cancer. GM was funded by the Association pour la Recherche sur le Cancer and FV by the Ligue Nationale contre le cancer. LA was supported by Agence Nationale pour la Recherche [ANR-10-PDOC-014-01]. HB is funded by Ecole de l'Inserm Liliane Bettencourt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Apetoh L, 2011, SEMIN IMMUNOL, V23, P42, DOI 10.1016/j.smim.2011.01.003; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; BREEN E, 1992, AM J RESP CELL MOL, V6, P146, DOI 10.1165/ajrcmb/6.2.146; Bruchard M, 2012, NAT MED; BURGER RM, 1981, J BIOL CHEM, V256, P1636; Calone I., 2012, Experimental Oncology, V34, P9; CASPARY WJ, 1982, BIOCHEMISTRY-US, V21, P334, DOI 10.1021/bi00531a021; Chalmin F, 2012, IMMUNITY, V36, P362, DOI 10.1016/j.immuni.2011.12.019; Chalmin F, 2010, J CLIN INVEST, V120, P457, DOI 10.1172/JCI40483; DRESP J, 1978, MUTAT RES, V56, P341, DOI 10.1016/0027-5107(78)90203-8; Garg AD, 2012, EMBO J, V31, P1062, DOI 10.1038/emboj.2011.497; Gauldie Jack, 2006, Proc Am Thorac Soc, V3, P696, DOI 10.1513/pats.200605-125SF; Ghiringhelli F, 2005, J EXP MED, V202, P919, DOI 10.1084/jem.20050463; Ghiringhelli F, 2007, CANCER IMMUNOL IMMUN, V56, P641, DOI 10.1007/s00262-006-0225-8; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; HAY J, 1991, ARCH TOXICOL, V65, P81, DOI 10.1007/BF02034932; Hervieu A, 2012, J INVEST DERMATOL; Huber S, 2004, J IMMUNOL, V173, P6526, DOI 10.4049/jimmunol.173.11.6526; KHALIL N, 1991, CIBA F SYMP, V157, P194; Li HC, 1996, CHINESE MED J-PEKING, V109, P533; Melencio L, 2006, INT IMMUNOL, V18, P1461, DOI 10.1093/intimm/dxl079; Menger L, 2012, NAT REV IMMUNOL, V2, P389; Meyer RM, 2012, NEW ENGL J MED, V366, P399, DOI 10.1056/NEJMoa1111961; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Mignot G, 2008, J IMMUNOL, V180, P6477, DOI 10.4049/jimmunol.180.10.6477; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Panaretakis T, 2008, CELL DEATH DIFFER, V15, P1499, DOI 10.1038/cdd.2008.67; Panaretakis T, 2009, EMBO J, V28, P578, DOI 10.1038/emboj.2009.1; Rech AJ, 2009, ANN NY ACAD SCI, V1174, P99, DOI 10.1111/j.1749-6632.2009.04939.x; RYZHKOV V K, 1977, Vestnik Rentgenologii i Radiologii, P41; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Suzuki E, 2005, CLIN CANCER RES, V11, P6713, DOI 10.1158/1078-0432.CCR-05-0883; Tanaka H, 2009, CANCER RES, V69, P6987, DOI 10.1158/0008-5472.CAN-09-1106; Tesniere A, 2008, CELL DEATH DIFFER, V15, P3, DOI 10.1038/sj.cdd.4402269; Tesniere A, 2010, ONCOGENE, V29, P482, DOI 10.1038/onc.2009.356; Thornton AM, 2004, J IMMUNOL, V172, P6519, DOI 10.4049/jimmunol.172.11.6519; Thornton CA, 2004, J IMMUNOL, V173, P3084, DOI 10.4049/jimmunol.173.5.3084; Vincent J, 2010, CANCER RES, V70, P3052, DOI 10.1158/0008-5472.CAN-09-3690; Wallach-Dayan SB, 2006, AM J PHYSIOL-LUNG C, V290, pL790, DOI 10.1152/ajplung.00300.2004; WILLIAMS SD, 1987, NEW ENGL J MED, V316, P1435, DOI 10.1056/NEJM198706043162302	43	76	79	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65181	10.1371/journal.pone.0065181	http://dx.doi.org/10.1371/journal.pone.0065181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762310	gold, Green Published, Green Submitted			2022-12-27	WOS:000321094800022
J	Miyamoto, DT; Viswanathan, AN				Miyamoto, David T.; Viswanathan, Akila N.			Concurrent Chemoradiation for Vaginal Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; GYNECOLOGIC-ONCOLOGY-GROUP; HIGH-DOSE-RATE; CERVICAL-CANCER; PREOPERATIVE CHEMORADIATION; INTERSTITIAL BRACHYTHERAPY; RADIATION-THERAPY; CHEMOTHERAPY; VULVA; OUTCOMES	Background: It is not known whether the addition of chemotherapy to radiation therapy improves outcomes in primary vaginal cancer. Here, we review clinical outcomes in patients with primary vaginal cancer treated with radiation therapy (RT) or concurrent chemoradiation therapy (CRT). Methods: Seventy-one patients with primary vaginal cancer treated with definitive RT with or without concurrent chemotherapy at a single institution were identified and their records reviewed. A total of 51 patients were treated with RT alone; 20 patients were treated with CRT. Recurrences were analyzed. Overall survival (OS) and disease-free survival (DFS) rates were estimated using the Kaplan-Meier method. Cox regression analysis was performed. Results: The median age at diagnosis was 61 years (range, 18-92 years) and the median follow-up time among survivors was 3.0 years. Kaplan-Meier estimates for OS and DFS differed significantly between the RT and CRT groups (3-yr OS = 56% vs. 79%, log-rank p=0.037; 3-yr DFS = 43% vs. 73%, log-rank p=0.011). Twenty-three patients (45%) in the RT group had a relapse at any site compared to 3 (15%) in the CRT group (p=0.027). With regard to the sites of first relapse, 10 patients (14%) had local only, 4 (6%) had local and regional, 9 (13%) had regional only, 1 (1%) had regional and distant, and 2 (3%) had distant only relapse. On univariate analysis, the use of concurrent chemotherapy, FIGO stage, tumor size, and date of diagnosis were significant predictors of DFS. On multivariate analysis, the use of concurrent chemotherapy remained a significant predictor of DFS (hazard ratio 0.31 (95% CI, 0.10-0.97; p = 0.04)). Conclusions: Vaginal cancer results in poor outcomes. Adequate radiation dose is essential to ensure curative management. Concurrent chemotherapy should be considered for vaginal cancer patients.	[Miyamoto, David T.] Harvard Univ, Sch Med, Harvard Radiat Oncol Program, Boston, MA USA; [Viswanathan, Akila N.] Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute	Viswanathan, AN (corresponding author), Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol, 75 Francis St, Boston, MA 02115 USA.	aviswanathan@lroc.harvard.edu		viswaanathan, akila/0000-0002-1896-2924	St. Laurent Family Fund	St. Laurent Family Fund	This research was supported by a donation to Dr Viswanathan by the St. Laurent Family Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beriwal S, 2012, BRACHYTHERAPY, V11, P68, DOI 10.1016/j.brachy.2011.06.008; Cardenes H, 2007, PRINCIPLES PRACTICE, P1657; Creasman WT, 1998, CANCER, V83, P1033, DOI 10.1002/(SICI)1097-0142(19980901)83:5<1033::AID-CNCR30>3.0.CO;2-6; Dalrymple JL, 2004, INT J GYNECOL CANCER, V14, P110, DOI 10.1111/j.1048-891x.2004.014066.x; Frank SJ, 2005, INT J RADIAT ONCOL, V62, P138, DOI 10.1016/j.ijrobp.2004.09.032; Hellman K, 2004, INT J GYNECOL CANCER, V14, P491, DOI 10.1111/j.1048-891x.2004.014310.x; Kapur T, 2012, MAGN RESON IMAGING, V30, P1279, DOI 10.1016/j.mri.2012.06.003; Landrum LM, 2008, GYNECOL ONCOL, V108, P584, DOI 10.1016/j.ygyno.2007.11.010; Lee LJ, 2012, INT J RADIAT ONCOL, V84, P1192, DOI 10.1016/j.ijrobp.2012.01.085; Mak RH, 2011, GYNECOL ONCOL, V120, P101, DOI 10.1016/j.ygyno.2010.09.004; Montana GS, 2000, INT J RADIAT ONCOL, V48, P1007, DOI 10.1016/S0360-3016(00)00762-8; Moore DH, 1998, INT J RADIAT ONCOL, V42, P79, DOI 10.1016/S0360-3016(98)00193-X; Morris M, 1999, NEW ENGL J MED, V340, P1137, DOI 10.1056/NEJM199904153401501; Nashiro T, 2008, INT J CLIN ONCOL, V13, P335, DOI 10.1007/s10147-007-0758-7; PEREZ CA, 1988, INT J RADIAT ONCOL, V15, P1283, DOI 10.1016/0360-3016(88)90222-2; Rose PG, 1999, NEW ENGL J MED, V340, P1144, DOI 10.1056/NEJM199904153401502; Samant R, 2007, INT J RADIAT ONCOL, V69, P746, DOI 10.1016/j.ijrobp.2007.04.015; Shah CA, 2009, OBSTET GYNECOL, V113, P1038, DOI 10.1097/AOG.0b013e31819fe844; Stewart AJ, 2006, CANCER, V107, P908, DOI 10.1002/cncr.22054; Tran PT, 2007, GYNECOL ONCOL, V105, P641, DOI 10.1016/j.ygyno.2007.01.033; Viswanathan AN, 2006, INT J RADIAT ONCOL, V66, P91, DOI 10.1016/j.ijrobp.2006.04.037; Viswanathan AN, 2011, GYNECOLOGIC RADIATION THERAPY: NOVEL APPROACHES TO IMAGE-GUIDANCE AND MANAGEMENT, P1	22	35	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65048	10.1371/journal.pone.0065048	http://dx.doi.org/10.1371/journal.pone.0065048			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762284	gold, Green Published, Green Submitted			2022-12-27	WOS:000321094800016
J	Wang, CJ; Lin, YS; Lin, YH; Chung, WH				Wang, Chaojen; Lin, Yisheng; Lin, Yinghong; Chung, Wenhsin			Modified Primers for the Identification of Nonpathogenic Fusarium oxysporum Isolates That Have Biological Control Potential against Fusarium Wilt of Cucumber in Taiwan	PLOS ONE			English	Article							INTERGENIC SPACER REGION; GENETIC DIVERSITY; PSEUDOMONAS-PUTIDA; BIOCONTROL AGENTS; SEQUENCE DATA; PATHOGENICITY; POPULATIONS; RDNA; DNA; DIFFERENTIATION	Previous investigations demonstrated that Fusarium oxysporum (Fo), which is not pathogenic to cucumbers, could serve as a biological control agent for managing Fusarium wilt of cucumber caused by Fo f. sp. cucumerinum (Foc) in Taiwan. However, thus far it has not been possible to separate the populations of pathogenic Fo from the nonpathogenic isolates that have biological control potential through their morphological characteristics. Although these two populations can be distinguished from one another using a bioassay, the work is laborious and time-consuming. In this study, a fragment of the intergenic spacer (IGS) region of ribosomal DNA from an Fo biological control agent, Fo366, was PCR-amplified with published general primers, FIGS11/FIGS12 and sequenced. A new primer, NPIGS-R, which was designed based on the IGS sequence, was paired with the FIGS11 primer. These primers were then evaluated for their specificity to amplify DNA from nonpathogenic Fo isolates that have biological control potential. The results showed that the modified primer pair, FIGS11/ NPIGS-R, amplified a 500-bp DNA fragment from five of seven nonpathogenic Fo isolates. These five Fo isolates delayed symptom development of cucumber Fusarium wilt in greenhouse bioassay tests. Seventy-seven Fo isolates were obtained from the soil and plant tissues and then subjected to amplification using the modified primer pair; six samples showed positive amplification. These six isolates did not cause symptoms on cucumber seedlings when grown in peat moss infested with the isolates and delayed disease development when the same plants were subsequently inoculated with a virulent isolate of Foc. Therefore, the modified primer pair may prove useful for the identification of Fo isolates that are nonpathogenic to cucumber which can potentially act as biocontrol agents for Fusarium wilt of cucumber.	[Wang, Chaojen; Lin, Yinghong; Chung, Wenhsin] Natl Chung Hsing Univ, Dept Plant Pathol, Taichung 40227, Taiwan; [Lin, Yisheng] Asia Univ, Dept Biotechnol, Taichung, Taiwan	National Chung Hsing University; Asia University Taiwan	Chung, WH (corresponding author), Natl Chung Hsing Univ, Dept Plant Pathol, Taichung 40227, Taiwan.	wenchung@dragon.nchu.edu.tw		Lin, Ying-Hong/0000-0002-7055-0652	Bureau of Animal and Plant Health Inspection and Quarantine in Taiwan [98AS-9.2.1-BQ-B2, 99AS-9.2.2-BQ-B3]	Bureau of Animal and Plant Health Inspection and Quarantine in Taiwan	Funding for this project was provided by the Bureau of Animal and Plant Health Inspection and Quarantine in Taiwan. The project numbers were 98AS-9.2.1-BQ-B2 and 99AS-9.2.2-BQ-B3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabouvette C, 1996, MANAGING SOILBORNE P, P192; Appel DJ, 1996, MOL PLANT MICROBE IN, V9, P125, DOI 10.1094/MPMI-9-0125; APPEL DJ, 1995, EXP MYCOL, V19, P120, DOI 10.1006/emyc.1995.1014; Chen JF, 1999, THESIS NATL CHUNG HS; Deacon JW, 2006, FUNGAL BIOL, P158; Dissanayake MLMC, 2009, J GEN PLANT PATHOL, V75, P37, DOI 10.1007/s10327-008-0135-z; Edel-Hermann V, 2012, PLANT PATHOL, V61, P787, DOI 10.1111/j.1365-3059.2011.02551.x; Erwin D.C., 1981, FUNGAL WILT DIS PLAN, P563; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fourie G, 2011, INFECT GENET EVOL, V11, P533, DOI 10.1016/j.meegid.2011.01.012; Fravel D, 2003, NEW PHYTOL, V157, P493, DOI 10.1046/j.1469-8137.2003.00700.x; Gordon TR, 1992, MOL ECOL, V1, P241, DOI 10.1111/j.1365-294X.1992.tb00183.x; GORDON TR, 1992, PHYTOPATHOLOGY, V82, P73, DOI 10.1094/Phyto-82-73; GORDON TR, 1990, PHYTOPATHOLOGY, V80, P381, DOI 10.1094/Phyto-80-381; Gorokhova E, 2002, P ROY SOC B-BIOL SCI, V269, P2373, DOI 10.1098/rspb.2002.2145; Guetsky R, 2002, PHYTOPATHOLOGY, V92, P976, DOI 10.1094/PHYTO.2002.92.9.976; Jurado M, 2006, SYST APPL MICROBIOL, V29, P681, DOI 10.1016/j.syapm.2006.01.014; Kawabe Masato, 2007, Journal of General Plant Pathology, V73, P353, DOI 10.1007/s10327-007-0036-6; Kawabe Masato, 2005, Journal of General Plant Pathology, V71, P263, DOI 10.1007/s10327-005-0203-6; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Larkin RP, 1999, PHYTOPATHOLOGY, V89, P1152, DOI 10.1094/PHYTO.1999.89.12.1152; Lazarovits G, 2001, AUSTRALAS PLANT PATH, V30, P111, DOI 10.1071/AP01009; LEMANCEAU P, 1992, APPL ENVIRON MICROB, V58, P2978, DOI 10.1128/AEM.58.9.2978-2982.1992; Lievens B, 2008, PEST MANAG SCI, V64, P781, DOI 10.1002/ps.1564; Lin YH, 2009, EUR J PLANT PATHOL, V123, P353, DOI 10.1007/s10658-008-9372-4; Lori G, 2004, PHYTOPATHOLOGY, V94, P661, DOI 10.1094/PHYTO.2004.94.6.661; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Mbofung GY, 2007, PHYTOPATHOLOGY, V97, P87, DOI 10.1094/PHYTO-97-0087; NASH SM, 1962, PHYTOPATHOLOGY, V52, P567; O'Donnell K, 2004, J CLIN MICROBIOL, V42, P5109, DOI 10.1128/JCM.42.11.5109-5120.2004; O'Donnell K, 2009, FUNGAL GENET BIOL, V46, P936, DOI 10.1016/j.fgb.2009.08.006; Ogura K, 1984, ANN PHYTOPATHOL SOC, p[50, 1]; Ortoneda M, 2004, INFECT IMMUN, V72, P1760, DOI 10.1128/IAI.72.3.1760-1766.2004; RAMBAUT A, 2000, SE AL SEQUENCE ALIGN; Recorbet G, 2003, NEW PHYTOL, V159, P73, DOI 10.1046/j.1469-8137.2003.00795.x; Saitoh Ken-ichiro, 2006, Journal of General Plant Pathology, V72, P348, DOI 10.1007/s10327-006-0300-1; SCHER FM, 1982, PHYTOPATHOLOGY, V72, P1567, DOI 10.1094/Phyto-72-1567; Schilling AG, 1996, PHYTOPATHOLOGY, V86, P515, DOI 10.1094/Phyto-86-515; Srinivasan K, 2012, PHYTOPARASITICA, V40, P157, DOI 10.1007/s12600-011-0207-z; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vakalounakis DJ, 1999, PHYTOPATHOLOGY, V89, P161, DOI 10.1094/PHYTO.1999.89.2.161; Wang CJ, 2006, THESIS NATL CHUNG HS; Wilson A, 2004, FEMS MICROBIOL LETT, V233, P69, DOI 10.1016/j.femsle.2004.01.040; Xu XM, 2011, PHYTOPATHOLOGY, V101, P1024, DOI 10.1094/PHYTO-08-10-0216; Yergeau E, 2005, J MICROBIOL METH, V60, P143, DOI 10.1016/j.mimet.2004.09.006; Zhang Z, 2001, PHYTOPATHOLOGY, V91, P204, DOI 10.1094/PHYTO.2001.91.2.204	46	5	6	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65093	10.1371/journal.pone.0065093	http://dx.doi.org/10.1371/journal.pone.0065093			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762289	Green Published, gold, Green Submitted			2022-12-27	WOS:000321094800017
J	Thaa, B; Sinhadri, BC; Tielesch, C; Krause, E; Veit, M				Thaa, Bastian; Sinhadri, Balaji Chandrasekhar; Tielesch, Claudia; Krause, Eberhard; Veit, Michael			Signal Peptide Cleavage from GP5 of PRRSV: A Minor Fraction of Molecules Retains the Decoy Epitope, a Presumed Molecular Cause for Viral Persistence	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; MAJOR ENVELOPE PROTEIN; NEUTRALIZING ANTIBODIES; PASSIVE TRANSFER; N-GLYCOSYLATION; STRAIN VR-2332; CELL-CULTURE; PIGS; INFECTION; IDENTIFICATION	Porcine reproductive and respiratory syndrome virus (PRRSV) is the major pathogen in the pig industry. Variability of the antigens and persistence are the biggest challenges for successful control and elimination of the disease. GP5, the major glycoprotein of PRRSV, is considered an important target of neutralizing antibodies, which however appear only late in infection. This was attributed to the presence of a "decoy epitope'' located near a hypervariable region of GP5. This region also harbors the predicted signal peptide cleavage sites and (dependent on the virus strain) a variable number of potential N-glycosylation sites. Molecular processing of GP5 has not been addressed experimentally so far: whether and where the signal peptide is cleaved and (as a consequence) whether the "decoy epitope'' is present in virus particles. We show that the signal peptide of GP5 from the American type 2 reference strain VR-2332 is cleaved, both during in vitro translation in the presence of microsomes and in transfected cells. This was found to be independent of neighboring glycosylation sites and occurred in a variety of porcine cells for GP5 sequences derived from various type 2 strains. The exact signal peptide cleavage site was elucidated by mass spectrometry of virus-derived and recombinant GP5. The results revealed that the signal peptide of GP5 is cleaved at two sites. As a result, a mixture of GP5 proteins exists in virus particles, some of which still contain the "decoy epitope'' sequence. Heterogeneity was also observed for the use of glycosylation sites in the hypervariable region. Lastly, GP5 mutants were engineered where one of the signal peptide cleavage sites was blocked. Wildtype GP5 exhibited exactly the same SDS-PAGE mobility as the mutant that is cleavable at site 2 only. This indicates that the overwhelming majority of all GP5 molecules does not contain the "decoy epitope''.	[Thaa, Bastian; Sinhadri, Balaji Chandrasekhar; Tielesch, Claudia; Veit, Michael] Free Univ Berlin, Dept Vet Med, Inst Virol, Berlin, Germany; [Krause, Eberhard] Leibniz Inst Mol Pharmacol FMP, Berlin, Germany	Free University of Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Veit, M (corresponding author), Free Univ Berlin, Dept Vet Med, Inst Virol, Berlin, Germany.	mveit@zedat.fu-berlin.de		Veit, Michael/0000-0002-7638-1829	German Research Foundation [Ve 141/11-1]; German Research Foundation through the Collaborative Research Center 740; EU FP7 through the Marie Curie Initial Trainig Network "Molecular Mechanism of cell entry of enveloped viruses"; Boehringer Ingelheim Vetmedica GmbH	German Research Foundation(German Research Foundation (DFG)); German Research Foundation through the Collaborative Research Center 740; EU FP7 through the Marie Curie Initial Trainig Network "Molecular Mechanism of cell entry of enveloped viruses"; Boehringer Ingelheim Vetmedica GmbH(Boehringer Ingelheim)	Funding was provided by the German Research Foundation (www.DFG.de) through project Ve 141/11-1 and through the Collaborative Research Center 740 (www.SFB740.de), by the EU FP7 through the Marie Curie Initial Trainig Network "Molecular Mechanism of cell entry of enveloped viruses" (www2.huberlin.de/virusentry) and by Boehringer Ingelheim Vetmedica GmbH through a PRRSV Research Award (www.boehringer-ingelheim.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende R, 2000, J VIROL, V74, P10834, DOI 10.1128/JVI.74.22.10834-10837.2000; Allende R, 2000, ARCH VIROL, V145, P1149, DOI 10.1007/s007050070115; Ansari IH, 2006, J VIROL, V80, P3994, DOI 10.1128/JVI.80.8.3994-4004.2006; Bieniossek C, 2012, TRENDS BIOCHEM SCI, V37, P49, DOI 10.1016/j.tibs.2011.10.005; BLOBEL G, 1975, J CELL BIOL, V67, P852, DOI 10.1083/jcb.67.3.852; Chand RJ, 2012, CURR OPIN VIROL, V2, P256, DOI 10.1016/j.coviro.2012.02.002; Chang CC, 2002, J VIROL, V76, P4750, DOI 10.1128/JVI.76.10.4750-4763.2002; Chavan M, 2006, TRENDS BIOCHEM SCI, V31, P17, DOI 10.1016/j.tibs.2005.11.010; Cheung JC, 2007, METHODS, V41, P451, DOI 10.1016/j.ymeth.2006.10.002; Cleveland SM, 2000, VIROLOGY, V266, P66, DOI 10.1006/viro.1999.0041; COLLINS JE, 1992, J VET DIAGN INVEST, V4, P117, DOI 10.1177/104063879200400201; COOPER VL, 1995, J VET DIAGN INVEST, V7, P313, DOI 10.1177/104063879500700303; Das PB, 2010, J VIROL, V84, P1731, DOI 10.1128/JVI.01774-09; Delisle B, 2012, INFECT GENET EVOL, V12, P1111, DOI 10.1016/j.meegid.2012.03.015; Done SH, 1996, BRIT VET J, V152, P153, DOI 10.1016/S0007-1935(96)80071-6; Ephraim E, 2009, EUR VET IMM WORKSH E, P45; Faaberg KS, 2006, VIRAL IMMUNOL, V19, P294, DOI 10.1089/vim.2006.19.294; FAABERG KS, 1995, VIROLOGY, V212, P512, DOI 10.1006/viro.1995.1509; Firth AE, 2011, J GEN VIROL, V92, P1097, DOI 10.1099/vir.0.029264-0; Gonin P, 1999, J VET DIAGN INVEST, V11, P20, DOI 10.1177/104063879901100103; Green MR, 2012, MOL CLONING LAB MANU, V1; Han J, 2007, J VIROL, V81, P9878, DOI 10.1128/JVI.00562-07; Johnson CR, 2011, J GEN VIROL, V92, P1107, DOI 10.1099/vir.0.030213-0; KIM HS, 1993, ARCH VIROL, V133, P477, DOI 10.1007/BF01313785; Kimman TG, 2009, VACCINE, V27, P3704, DOI 10.1016/j.vaccine.2009.04.022; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kwon B, 2008, VIROLOGY, V380, P371, DOI 10.1016/j.virol.2008.07.030; Lee YJ, 2010, J VIROL METHODS, V163, P410, DOI 10.1016/j.jviromet.2009.11.003; Li J, 2012, VIROLOGY, V433, P367, DOI 10.1016/j.virol.2012.08.026; Lopez OJ, 2007, CLIN VACCINE IMMUNOL, V14, P269, DOI 10.1128/CVI.00304-06; Lopez OJ, 2004, VET IMMUNOL IMMUNOP, V102, P155, DOI 10.1016/j.vetimm.2004.09.005; Lu ZC, 2012, VIROLOGY, V432, P99, DOI 10.1016/j.virol.2012.05.022; Mateu E, 2008, VET J, V177, P345, DOI 10.1016/j.tvjl.2007.05.022; Murtaugh MP, 2011, VACCINE, V29, P8192, DOI 10.1016/j.vaccine.2011.09.013; Osorio FA, 2002, VIROLOGY, V302, P9, DOI 10.1006/viro.2002.1612; Ostrowski M, 2002, J VIROL, V76, P4241, DOI 10.1128/JVI.76.9.4241-4250.2002; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pirzadeh B, 1997, J GEN VIROL, V78, P1867, DOI 10.1099/0022-1317-78-8-1867; Plagemann PGW, 2002, ARCH VIROL, V147, P2327, DOI 10.1007/s00705-002-0887-2; Rowland RRR, 1999, VIROLOGY, V259, P262, DOI 10.1006/viro.1999.9789; Snijder EJ, 2003, J VIROL, V77, P97, DOI 10.1128/JVI.77.1.97-104.2003; Snijder EJ, 1998, J GEN VIROL, V79, P961, DOI 10.1099/0022-1317-79-5-961; Thanawongnuwech Roongroje, 2000, Animal Health Research Reviews, V1, P95, DOI 10.1017/S1466252300000086; Tian DB, 2012, J VIROL, V86, P3701, DOI 10.1128/JVI.06836-11; Van Breedam W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000730; Vanhee M, 2010, VIRAL IMMUNOL, V23, P403, DOI 10.1089/vim.2010.0025; Veit Michael, 2002, Methods Mol Biol, V194, P159; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; Vu HLX, 2011, J VIROL, V85, P5555, DOI 10.1128/JVI.00189-11; WALTER P, 1983, METHOD ENZYMOL, V96, P84; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296; Wills RW, 2003, J CLIN MICROBIOL, V41, P58, DOI 10.1128/JCM.41.1.58-62.2003; Wissink EHJ, 2005, J VIROL, V79, P12495, DOI 10.1128/JVI.79.19.12495-12506.2005; Wissink EHJ, 2003, J GEN VIROL, V84, P1535, DOI 10.1099/vir.0.18957-0; Yang L, 2000, ARCH VIROL, V145, P1599, DOI 10.1007/s007050070079; YOON IJ, 1994, J VET DIAGN INVEST, V6, P289; Zhou L, 2010, VIRUS RES, V154, P31, DOI 10.1016/j.virusres.2010.07.016	57	42	47	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65548	10.1371/journal.pone.0065548	http://dx.doi.org/10.1371/journal.pone.0065548			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755249	gold, Green Published, Green Submitted			2022-12-27	WOS:000321099000077
J	Yang, Y; Igumenova, TI				Yang, Yuan; Igumenova, Tatyana I.			The C-Terminal V5 Domain of Protein Kinase C alpha Is Intrinsically Disordered, with Propensity to Associate with a Membrane Mimetic	PLOS ONE			English	Article							PHOSPHOINOSITIDE-DEPENDENT KINASE; PKC-BETA-II; SECONDARY STRUCTURE; BACKBONE DYNAMICS; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; NMR RELAXATION; CIRCULAR-DICHROISM; GAMMA-SYNUCLEIN; TURN MOTIF	The C-terminal V5 domain is one of the most variable domains in Protein Kinase C isoforms (PKCs). V5 confers isoform specificity on its parent enzyme through interactions with isoform-specific adaptor proteins and possibly through specific intra-molecular interactions with other PKC domains. The structural information about V5 domains in solution is sparse. The objective of this work was to determine the conformational preferences of the V5 domain from the a isoform of PKC (V5 alpha) and evaluate its ability to associate with membrane mimetics. We show that V5 alpha and its phosphorylation-mimicking variant, dmV5 alpha, are intrinsically disordered protein domains. Phosphorylation-mimicking mutations do not alter the overall conformation of the polypeptide backbone, as evidenced by the local nature of chemical shift perturbations and the secondary structure propensity scores. However, the population of the "cis-trans" conformer of the Thr(638)-Pro(639)-Pro(640) turn motif, which has been implicated in the down-regulation of PKC alpha via peptidyl-prolyl isomerase Pin1, increases in dmV5 alpha, along with the conformational flexibility of the region between the turn and hydrophobic motifs. Both wild type and dmV5 alpha associate with micelles made of a zwitterionic detergent, n-dodecylphosphocholine. Upon micelle binding, V5 alpha acquires a higher propensity to form helical structures at the conserved "NFD" motif and the entire C-terminal third of the domain. The ability of V5 alpha to partition into the hydrophobic micellar environment suggests that it may serve as a membrane anchor during the PKC maturation process.	[Yang, Yuan; Igumenova, Tatyana I.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Igumenova, TI (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	tigumenova@tamu.edu		Yang, Yuan/0000-0002-9538-6369	Welch Foundation [A-1784]	Welch Foundation(The Welch Foundation)	This work was supported by the Welch Foundation (http://www.welch1.org, award number A-1784). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen H, 2012, J BIOL CHEM, V287, P13262, DOI 10.1074/jbc.M112.349753; Abrial E, 2011, MOL NEUROBIOL, V44, P407, DOI 10.1007/s12035-011-8210-4; Bai YW, 2001, PROTEIN SCI, V10, P1056, DOI 10.1110/ps.00601; Behn-Krappa A, 1999, CURR BIOL, V9, P728, DOI 10.1016/S0960-9822(99)80332-7; Bornancin F, 1996, CURR BIOL, V6, P1114, DOI 10.1016/S0960-9822(02)70678-7; Bornancin F, 1997, J BIOL CHEM, V272, P3544, DOI 10.1074/jbc.272.6.3544; Churchill E, 2008, ANNU REV PHARMACOL, V48, P569, DOI 10.1146/annurev.pharmtox.48.121806.154902; CLUBB RT, 1992, J MAGN RESON, V97, P213, DOI 10.1016/0022-2364(92)90252-3; Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s; Edwards AS, 1997, J BIOL CHEM, V272, P18382, DOI 10.1074/jbc.272.29.18382; Edwards AS, 1999, J BIOL CHEM, V274, P6461, DOI 10.1074/jbc.274.10.6461; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FARROW NA, 1995, J BIOMOL NMR, V6, P153, DOI 10.1007/BF00211779; FARROW NA, 1995, BIOCHEMISTRY-US, V34, P868, DOI 10.1021/bi00003a021; Ferreira JCB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033175; Ferreira JCB, 2011, J MOL CELL CARDIOL, V51, P980, DOI 10.1016/j.yjmcc.2011.08.025; Gao TY, 2001, J BIOL CHEM, V276, P19588, DOI 10.1074/jbc.M101357200; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Grodsky N, 2006, BIOCHEMISTRY-US, V45, P13970, DOI 10.1021/bi061128h; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Jarymowycz VA, 2006, CHEM REV, V106, P1624, DOI 10.1021/cr040421p; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; Kazanietz MG, 2011, STRUCTURE, V19, P144, DOI 10.1016/j.str.2011.01.004; Kheifets V, 2007, PHARMACOL RES, V55, P467, DOI 10.1016/j.phrs.2007.04.014; Kim J, 2011, ONCOGENE, V30, P323, DOI 10.1038/onc.2010.415; Kim JW, 2008, CANCER RES, V68, P6831, DOI 10.1158/0008-5472.CAN-07-6195; KULIOPULOS A, 1994, J AM CHEM SOC, V116, P4599, DOI 10.1021/ja00090a008; Leonard TA, 2011, CELL, V144, P55, DOI 10.1016/j.cell.2010.12.013; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Messerschmidt A, 2005, J MOL BIOL, V352, P918, DOI 10.1016/j.jmb.2005.07.060; MOSIOR M, 1991, BIOPHYS J, V60, P149, DOI 10.1016/S0006-3495(91)82038-0; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Palaniyandi SS, 2011, J CELL MOL MED, V15, P1769, DOI 10.1111/j.1582-4934.2010.01174.x; PENG JW, 1992, BIOCHEMISTRY-US, V31, P8571, DOI 10.1021/bi00151a027; PENG JW, 1992, J MAGN RESON, V98, P308, DOI 10.1016/0022-2364(92)90135-T; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770; Schubert M, 2002, J BIOMOL NMR, V24, P149, DOI 10.1023/A:1020997118364; Schumann FH, 2007, J BIOMOL NMR, V39, P275, DOI 10.1007/s10858-007-9197-z; Schutkowski M, 1998, BIOCHEMISTRY-US, V37, P5566, DOI 10.1021/bi973060z; Solodukhin AS, 2007, CELL SIGNAL, V19, P2035, DOI 10.1016/j.cellsig.2007.05.010; Sonnenburg ED, 2001, J BIOL CHEM, V276, P45289, DOI 10.1074/jbc.M107416200; Stebbins EG, 2001, J BIOL CHEM, V276, P29644, DOI 10.1074/jbc.M101044200; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Stensman H, 2007, J BIOL CHEM, V282, P28627, DOI 10.1074/jbc.M702248200; Stewart MD, 2011, J MOL BIOL, V408, P949, DOI 10.1016/j.jmb.2011.03.020; Takimura T, 2010, ACTA CRYSTALLOGR D, V66, P577, DOI 10.1107/S0907444910005639; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; Wagner J, 2009, J MED CHEM, V52, P6193, DOI 10.1021/jm901108b; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Xu ZB, 2004, J BIOL CHEM, V279, P50401, DOI 10.1074/jbc.M409216200	59	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65699	10.1371/journal.pone.0065699	http://dx.doi.org/10.1371/journal.pone.0065699			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762412	Green Published, gold, Green Submitted			2022-12-27	WOS:000321099000095
J	Cipriano, M; Haggstrom, J; Hammarsten, P; Fowler, CJ				Cipriano, Mariateresa; Haggstrom, Jenny; Hammarsten, Peter; Fowler, Christopher J.			Association between Cannabinoid CB1 Receptor Expression and Akt Signalling in Prostate Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; ENDOCANNABINOID SYSTEM; ANDROGEN RECEPTOR; GLEASON SCORE; CELL-GROWTH; PC-3 CELLS; ACTIVATION; APOPTOSIS; PHOSPHORYLATION; PATHWAYS	Background: In prostate cancer, tumour expression of cannabinoid CB1 receptors is associated with a poor prognosis. One explanation for this association comes from experiments with transfected astrocytoma cells, where a high CB receptor expression recruits the Akt signalling survival pathway. In the present study, we have investigated the association between CB1 receptor expression and the Akt pathway in a well-characterised prostate cancer tissue microarray. Methodology/Principal Findings: Phosphorylated Akt immunoreactivity (pAkt-IR) scores were available in the database. CB1 receptor immunoreactivity (CB1IR) was rescored from previously published data using the same scale as pAkt-IR. There was a highly significant correlation between CB1IR and pAkt-IR. Further, cases with high expression levels of both biomarkers were much more likely to have a more severe form of the disease at diagnosis than those with low expression levels. The two biomarkers had additive effects, rather than an interaction, upon disease-specific survival. Conclusions/Significance: The present study provides data that is consistent with the hypothesis that at a high CB1 receptor expression, the Akt signalling pathway becomes operative.	[Cipriano, Mariateresa; Fowler, Christopher J.] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [Haggstrom, Jenny] Umea Univ, Dept Stat, Umea Sch Business & Econ, S-90187 Umea, Sweden; [Hammarsten, Peter] Umea Univ, Dept Med Biosci, Umea, Sweden	Umea University; Umea University; Umea University	Fowler, CJ (corresponding author), Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden.	cf@pharm.umu.se	Fowler, Christopher J./M-6313-2019	Fowler, Christopher J./0000-0002-6658-7874; Cipriano, Mariateresa/0000-0001-6644-7137; Haggstrom, Jenny/0000-0002-9086-7403	Swedish Research Council [12158]; Swedish Cancer Society [CAN2010/437]; Lion's Cancer Research Foundation; Umea University; Research Funds of the Medical Faculty	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Lion's Cancer Research Foundation; Umea University; Research Funds of the Medical Faculty	The authors thank the Swedish Research Council (Grant no. 12158, medicine); the Swedish Cancer Society (Grant no. CAN2010/437); Lion's Cancer Research Foundation, Umea University and the Research Funds of the Medical Faculty, Umea University for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala G, 2004, CLIN CANCER RES, V10, P6572, DOI 10.1158/1078-0432.CCR-04-0477; Chung SC, 2009, EUR J CANCER, V45, P174, DOI 10.1016/j.ejca.2008.10.010; Cudaback E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008702; Czifra G, 2009, J CANCER RES CLIN, V135, P507, DOI 10.1007/s00432-008-0482-3; del Pulgar T, 2000, BIOCHEM J, V347, P369, DOI 10.1042/bj3470369; delPeso L, 1997, SCIENCE, V278, P687; Diaz-Laviada I, 2011, NAT REV UROL, V8, P553, DOI 10.1038/nrurol.2011.130; Egevad L, 2002, BJU INT, V89, P538, DOI 10.1046/j.1464-410X.2002.02669.x; Endsley MP, 2008, INT J CANCER, V123, P1318, DOI 10.1002/ijc.23674; Fowler CJ, 2010, CURR TOP MED CHEM, V10, P814; Freimuth N, 2010, J PHARMACOL EXP THER, V332, P336, DOI 10.1124/jpet.109.157735; Ghosh PM, 2005, ENDOCR-RELAT CANCER, V12, P119, DOI 10.1677/erc.1.00835; Graff JR, 2000, J BIOL CHEM, V275, P24500, DOI 10.1074/jbc.M003145200; Guindon J, 2011, BRIT J PHARMACOL, V163, P1447, DOI 10.1111/j.1476-5381.2011.01327.x; Gustafsson SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023003; Hammarsten P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047994; Hammarsten P, 2010, CLIN CANCER RES, V16, P1245, DOI 10.1158/1078-0432.CCR-09-0103; Hart S, 2004, CANCER RES, V64, P1943, DOI 10.1158/0008-5472.CAN-03-3720; Islam TC, 2003, LEUKEMIA, V17, P1880, DOI 10.1038/sj.leu.2403057; Josefsson A, 2012, SCAND J UROL NEPHROL, V46, P247, DOI 10.3109/00365599.2012.669791; Kreisberg JI, 2004, CANCER RES, V64, P5232, DOI 10.1158/0008-5472.CAN-04-0272; Le Page C, 2006, BRIT J CANCER, V94, P1906, DOI 10.1038/sj.bjc.6603184; Le Page C, 2012, PROSTATE, V72, P777, DOI 10.1002/pros.21483; Lehmann R., 1977, BIOMETRICAL J, V19, P229; Malik SN, 2002, CLIN CANCER RES, V8, P1168; McCall P, 2008, BRIT J CANCER, V98, P1094, DOI 10.1038/sj.bjc.6604152; Melck D, 2000, ENDOCRINOLOGY, V141, P118, DOI 10.1210/en.141.1.118; Michalski CW, 2008, INT J CANCER, V122, P742, DOI 10.1002/ijc.23114; Mimeault M, 2003, PROSTATE, V56, P1, DOI 10.1002/pros.10190; Mimeault M, 2011, MOL MED, V17, P949, DOI 10.2119/molmed.2011.00115; Nithipatikom K, 1994, CANCER RES, V64, P8826; Nithipatikom K, 2012, ENDOCRINOLOGY, V153, P29, DOI 10.1210/en.2011-1144; Nithipatikom K, 2011, PROSTAG OTH LIPID M, V94, P34, DOI 10.1016/j.prostaglandins.2010.12.002; Nomura DK, 2011, CHEM BIOL, V18, P846, DOI 10.1016/j.chembiol.2011.05.009; Olea-Herrero N, 2009, BRIT J CANCER, V101, P940, DOI 10.1038/sj.bjc.6605248; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pisanti S, 2013, TRENDS PHARMACOL SCI, V34, P273, DOI 10.1016/j.tips.2013.03.003; R Core Team, 2012, R LANG ENV STAT COMP; Ruiz L, 1999, FEBS LETT, V458, P400, DOI 10.1016/S0014-5793(99)01073-X; Ruiz-Llorente L, 2003, PROSTATE, V54, P95, DOI 10.1002/pros.10165; Samatoro D, 2006, MOL PHARM, V70, P1298; Sanchez MG, 2003, FEBS LETT, V555, P561, DOI 10.1016/S0014-5793(03)01349-8; Sanchez MG, 2003, CELL SIGNAL, V15, P851, DOI 10.1016/S0898-6568(03)00036-6; Santoro A, 2009, INT J CANCER, V125, P996, DOI 10.1002/ijc.24483; Sarfaraz S, 2005, CANCER RES, V65, P1635, DOI 10.1158/0008-5472.CAN-04-3410; Sarfaraz S, 2006, J BIOL CHEM, V281, P39480, DOI 10.1074/jbc.M603495200; Sreevalsan S, 2011, ANTICANCER RES, V31, P3799; Thors L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012275; Velasco G, 2012, NAT REV CANCER, V12, P436, DOI 10.1038/nrc3247; Wang DZ, 2008, CANCER RES, V68, P6468, DOI 10.1158/0008-5472.CAN-08-0896; Xu XD, 2006, CANCER GENET CYTOGEN, V171, P31, DOI 10.1016/j.cancergencyto.2006.06.014	51	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65798	10.1371/journal.pone.0065798	http://dx.doi.org/10.1371/journal.pone.0065798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755281	Green Submitted, Green Published, gold			2022-12-27	WOS:000320579400077
J	Pitcher, BJ; Mesoudi, A; McElligott, AG				Pitcher, Benjamin J.; Mesoudi, Alex; McElligott, Alan G.			Sex-Biased Sound Symbolism in English-Language First Names	PLOS ONE			English	Article							FLUCTUATING ASYMMETRY; VOCAL-TRACT; BODY-SIZE; ATTRACTIVENESS; PREFERENCES; SUCCESS; VOICES; WEIGHT; HEIGHT; WOMEN	Sexual selection has resulted in sex-based size dimorphism in many mammals, including humans. In Western societies, average to taller stature men and comparatively shorter, slimmer women have higher reproductive success and are typically considered more attractive. This size dimorphism also extends to vocalisations in many species, again including humans, with larger individuals exhibiting lower formant frequencies than smaller individuals. Further, across many languages there are associations between phonemes and the expression of size (e.g. large /a, o/, small /i, e/), consistent with the frequency-size relationship in vocalisations. We suggest that naming preferences are a product of this frequency-size relationship, driving male names to sound larger and female names smaller, through sound symbolism. In a 10-year dataset of the most popular British, Australian and American names we show that male names are significantly more likely to contain larger sounding phonemes (e.g. "Thomas"), while female names are significantly more likely to contain smaller phonemes (e.g. "Emily"). The desire of parents to have comparatively larger, more masculine sons, and smaller, more feminine daughters, and the increased social success that accompanies more sex-stereotyped names, is likely to be driving English-language first names to exploit sound symbolism of size in line with sexual body size dimorphism.	[Pitcher, Benjamin J.; Mesoudi, Alex; McElligott, Alan G.] Univ London, Sch Biol & Chem Sci, London, England; [Mesoudi, Alex] Univ Durham, Dept Anthropol, Durham, England	University of London; Durham University	Pitcher, BJ (corresponding author), Univ London, Sch Biol & Chem Sci, London, England.	b.pitcher@qmul.ac.uk; a.g.mcelligott@qmul.ac.uk	Mesoudi, Alex/K-4410-2012; McElligott, Alan G./ABC-1179-2020	Mesoudi, Alex/0000-0002-7740-1625; McElligott, Alan G./0000-0001-5770-4568; Pitcher, Benjamin/0000-0002-8580-0343	Fyssen Foundation	Fyssen Foundation	BJP is supported by a grant from The Fyssen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlner F., 2010, SIGN SYST STUD, V38, P298, DOI [10.12697/SSS.2010.38.1-4.11, DOI 10.12697/SSS.2010.38.1-4.11]; Alford Richard D., 1988, NAMING IDENTITY CROS; Bentley RA, 2004, P ROY SOC B-BIOL SCI, V271, P1443, DOI 10.1098/rspb.2004.2746; Berlin B, 1994, SOUND SYMBOLISM; Boersma P., 2013, PRAAT DOING PHONETIC; Briefer E, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-35; Brown WM, 2008, P NATL ACAD SCI USA, V105, P12938, DOI 10.1073/pnas.0710420105; Bruckert L, 2006, P ROY SOC B-BIOL SCI, V273, P83, DOI 10.1098/rspb.2005.3265; BRUNING JL, 1972, DEV PSYCHOL, V7, P91, DOI 10.1037/h0032861; Bruning JL, 2000, J SOC PSYCHOL, V140, P197, DOI 10.1080/00224540009600459; Buunk AP, 2008, EVOL HUM BEHAV, V29, P133, DOI 10.1016/j.evolhumbehav.2007.11.006; Caplen Robert, 2010, SHAKEN STIRRED FEMIN; Cassidy KW, 1999, J EXP PSYCHOL GEN, V128, P362, DOI 10.1037/0096-3445.128.3.362; Chuenwattanapranithi S, 2008, PHONETICA, V65, P210, DOI 10.1159/000192793; Collins SA, 2003, ANIM BEHAV, V65, P997, DOI 10.1006/anbe.2003.2123; DAVIS R, 1961, BRIT J PSYCHOL, V52, P259, DOI 10.1111/j.2044-8295.1961.tb00788.x; Evans S, 2006, BIOL PSYCHOL, V72, P160, DOI 10.1016/j.biopsycho.2005.09.003; Fant G, 1960, ACOUSTIC THEORY SPEA; Fitch WT, 1999, J ACOUST SOC AM, V106, P1511, DOI 10.1121/1.427148; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Fitch WT, 2001, P ROY SOC B-BIOL SCI, V268, P1669, DOI 10.1098/rspb.2001.1704; Hillenbrand J, 1995, J ACOUST SOC AM, V24, P175; Hinton L., 1994, SOUND SYMBOLISM; Jasienska G, 2004, P ROY SOC B-BIOL SCI, V271, P1213, DOI 10.1098/rspb.2004.2712; JOHNSON RC, 1967, J VERB LEARN VERB BE, V6, P508, DOI 10.1016/S0022-5371(67)80008-2; Jones C, 2006, ENGLISH PRONUNCIATION IN THE EIGHTEENTH AND NINETEENTH CENTURIES, P1, DOI 10.1057/9780230503403; Kita S, 2008, ORIGINS LANGUAGE UNR; Kohler W., 1929, GESTALT PSYCHOL; Ku┬hler W., 1947, GESTALT PSYCHOL; MANNING JT, 1995, ETHOL SOCIOBIOL, V16, P145, DOI 10.1016/0162-3095(94)00074-H; Mesoudi A, 2009, EVOL HUM BEHAV, V30, P41, DOI 10.1016/j.evolhumbehav.2008.07.005; MORTON ES, 1977, AM NAT, V111, P855, DOI 10.1086/283219; Nuckolls JB, 1999, ANNU REV ANTHROPOL, V28, P225, DOI 10.1146/annurev.anthro.28.1.225; Ohala J., 1980, J ACOUST SOC AM, V68, pS33, DOI [10.1121/1.2004679, DOI 10.1121/1.2004679]; Ohala J.J., 1994, SOUND SYMBOLISM, DOI [10.1017/CBO9780511751806.022, DOI 10.1017/CBO9780511751806.022]; OHALA JJ, 1984, PHONETICA, V41, P1, DOI 10.1159/000261706; Pawlowski B, 2005, BIOL PSYCHOL, V70, P38, DOI 10.1016/j.biopsycho.2005.02.002; Pawlowski B, 2000, NATURE, V403, P156, DOI 10.1038/35003107; Pena M, 2011, PSYCHOL SCI, V22, P1419, DOI 10.1177/0956797611421791; PETERSON GE, 1952, J ACOUST SOC AM, V24, P175, DOI 10.1121/1.1906875; Puts DA, 2012, J SEX RES, V49, P227, DOI 10.1080/00224499.2012.658924; Puts DA, 2012, P ROY SOC B-BIOL SCI, V279, P601, DOI 10.1098/rspb.2011.0829; Puts DA, 2011, PERS INDIV DIFFER, V50, P111, DOI 10.1016/j.paid.2010.09.011; Puts DA, 2007, EVOL HUM BEHAV, V28, P340, DOI 10.1016/j.evolhumbehav.2007.05.002; Ramachandran V, 2001, J CONSCIOUSNESS STUD, V8, P3; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Sanvito S, 2007, ANIM BEHAV, V73, P287, DOI 10.1016/j.anbehav.2006.08.005; Sapir E, 1929, J EXP PSYCHOL, V12, P225, DOI 10.1037/h0070931; SINGH D, 1993, J PERS SOC PSYCHOL, V65, P293, DOI 10.1037/0022-3514.65.2.293; Stulp G, 2012, AM J HUM BIOL, V24, P486, DOI 10.1002/ajhb.22252; Stulp G, 2012, BEHAV ECOL SOCIOBIOL, V66, P375, DOI 10.1007/s00265-011-1283-2; Sueur J, 2008, BIOACOUSTICS, V18, P213, DOI 10.1080/09524622.2008.9753600; Szekely T., 2007, SEX SIZE GENDER ROLE; Taylor AM, 2010, J ZOOL, V280, P221, DOI 10.1111/j.1469-7998.2009.00661.x; Titze IR, 1994, PRINCIPLES VOCAL PRO; Tovee MJ, 2006, EVOL HUM BEHAV, V27, P443, DOI 10.1016/j.evolhumbehav.2006.05.004; Tovee MJ, 1998, LANCET, V352, P548, DOI 10.1016/S0140-6736(05)79257-6; Vannoni E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003113	58	27	27	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64825	10.1371/journal.pone.0064825	http://dx.doi.org/10.1371/journal.pone.0064825			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166TB	23755148	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000320579400028
J	Khademvatan, S; Rahim, F; Tavalla, M; Abdizadeh, R; Hashemitabar, M				Khademvatan, Shahram; Rahim, Fakher; Tavalla, Mahdi; Abdizadeh, Rahman; Hashemitabar, Mahmoud			PCR-Based Molecular Characterization of Toxocara spp. Using Feces of Stray Cats: A Study from Southwest Iran	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; PARASITES; CANIS; INFECTIONS; DOGS; IDENTIFICATION; CONSUMPTION; NEUROSPORA; INFERENCE; MRBAYES	Feces of stray cat are potential sources of gastrointestinal parasites and play a crucial role in spreading and transmitting parasite eggs, larvae, and oocysts through contamination of soil, food, or water. In this study, we investigated the prevalence of Toxocara spp. infection in stray cats in Ahvaz city, southwest Iran. Eggs of Toxocara spp. in feces of stray cats were detected by the sucrose flotation method, and identification was conducted by polymerase chain reaction (PCR) and DNA sequencing. Of the 140 fecal samples that were randomly collected from public environments during the months of January to May 2012, 45% were found to harbour Toxocara spp. eggs. The highest prevalence of Toxocara spp. eggs was found in the central area of Ahvaz city (28.6%). T. canis eggs were found in 4 (6.34%) of the 63 positive samples. Stray cats are found in parks, playgrounds, and other public places and may be a potential contamination risk. Identification of Toxocara spp. using molecular methods is sufficiently sensitive to detect low levels of parasites and identify the different Toxocara spp. in feces. The relatively high prevalence of Toxocara spp. infection may continue to increase due to lack of effective environmental hygiene control in Iran. Consequently, there is a need to plan adequate programs to detect, identify, and control this infection as well as stray cats in the region.	[Khademvatan, Shahram; Hashemitabar, Mahmoud] Ahvaz Jundishapur Univ Med Sci, Cellular & Mol Res Ctr, Ahvaz, Iran; [Khademvatan, Shahram; Tavalla, Mahdi; Abdizadeh, Rahman] Ahvaz Jundishapur Univ Med Sci, Dept Med Parasitol, Ahvaz, Iran; [Rahim, Fakher] Ahvaz Jundishapur Univ Med Sci, Toxicol Res Ctr, Ahvaz, Iran	Ahvaz Jundishapur University of Medical Sciences (AJUMS); Ahvaz Jundishapur University of Medical Sciences (AJUMS); Ahvaz Jundishapur University of Medical Sciences (AJUMS)	Khademvatan, S (corresponding author), Ahvaz Jundishapur Univ Med Sci, Cellular & Mol Res Ctr, Ahvaz, Iran.	khademvatan@yahoo.com; Fakherraheem@yahoo.com	rahim, fakher/AAC-3905-2019; Hashemitabar, Mahmoud/ABI-6615-2020; Abdizadeh, Rahman/K-2521-2017	rahim, fakher/0000-0002-2857-4562; Abdizadeh, Rahman/0000-0002-9977-1344; Tavalla, Mehdi/0000-0002-8337-6673; hashemitabar, mahmoud/0000-0002-8800-3761	Research Project of the Ahvaz Jundishpur University of Medical Science [CMRC-56]	Research Project of the Ahvaz Jundishpur University of Medical Science	This study was supported by the Research Project of the Ahvaz Jundishpur University of Medical Science, no: CMRC-56. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao N, 2007, PARASITOL INT, V56, P87, DOI 10.1016/j.parint.2007.01.009; Arbabi M, 2009, TROP BIOMED, V26, P16; BHOWMICK DILIP KUMAR, 1964, Z PARASITENK, V24, P121; Borecka A, 2008, J HELMINTHOL, V82, P119, DOI 10.1017/S0022149X07877522; DEOLIVEIRA CAF, 1992, REV SAUDE PUBL, V26, P332, DOI 10.1590/S0034-89101992000500006; Dettman JR, 2006, MYCOLOGIA, V98, P436, DOI 10.3852/mycologia.98.3.436; Dettman JR, 2003, EVOLUTION, V57, P2721; Durant JF, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-288; Fahrion AS, 2011, VET PARASITOL, V177, P186, DOI 10.1016/j.vetpar.2010.11.028; Fisher M, 2003, TRENDS PARASITOL, V19, P167, DOI 10.1016/S1471-4922(03)00027-8; Fogt-Wyrwas R, 2007, J HELMINTHOL, V81, P75, DOI 10.1017/S0022149X07241872; Gawor J, 2008, VET PARASITOL, V155, P217, DOI 10.1016/j.vetpar.2008.05.016; Hoffmeister B, 2007, AM J TROP MED HYG, V76, P600, DOI 10.4269/ajtmh.2007.76.600; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ishiwata K, 2004, PARASITOL RES, V92, P50, DOI 10.1007/s00436-003-1010-7; Jacobs DE, 1997, ACTA TROP, V68, P191, DOI 10.1016/S0001-706X(97)00093-4; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee ACY, 2010, TRENDS PARASITOL, V26, P155, DOI 10.1016/j.pt.2010.01.002; Li MW, 2007, MOL CELL PROBE, V21, P349, DOI 10.1016/j.mcp.2007.04.004; Magnaval Jean-Francois, 2001, Korean Journal of Parasitology, V39, P1, DOI 10.3347/kjp.2001.39.1.1; Ogden TH, 2007, SYST BIOL, V56, P182, DOI 10.1080/10635150701281102; Okulewicz A, 2012, HELMINTHOLOGIA, V49, P3, DOI 10.2478/s11687-012-0001-6; OLORCAIN P, 1994, J HELMINTHOL, V68, P331, DOI 10.1017/S0022149X00001590; Quattrocchi G, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001775; Rai SK, 2000, CONTAMINATION SOIL H; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roth B, 1971, BERL MUNCH TIERARZTL, V22, P436; Rubinsky-Elefant G, 2010, ANN TROP MED PARASIT, V104, P3, DOI 10.1179/136485910X12607012373957; Sadjjadi Seyed Mahmoud, 2001, Veterinarski Arhiv, V71, P149; Sharif M, 2007, J HELMINTHOL, V81, P63, DOI 10.1017/S0022149X07214117; Smith H, 2009, TRENDS PARASITOL, V25, P182, DOI 10.1016/j.pt.2009.01.006; Szabova E, 2007, HELMINTHOLOGIA, V44, P170, DOI 10.2478/s11687-007-0027-3; Talvik H, 2006, ACTA VET HUNG, V54, P399, DOI 10.1556/AVet.54.2006.3.10; Uga S, 2000, VET PARASITOL, V92, P287, DOI 10.1016/S0304-4017(00)00323-X; Uga S, 2009, Nepal Med Coll J, V11, P75; Walker MD, 2005, SEMIN NEUROL, V25, P252, DOI 10.1055/s-2005-917662; Wu ZL, 1997, J HELMINTHOL, V71, P77, DOI 10.1017/S0022149X00000845; Yaman M, 2005, TURKIYE PARAZITOLOJI, V30, P200; Yoshikawa M, 2008, PARASITOL INT, V57, P525, DOI 10.1016/j.parint.2008.08.002	39	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65293	10.1371/journal.pone.0065293	http://dx.doi.org/10.1371/journal.pone.0065293			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755213	Green Published, gold, Green Submitted			2022-12-27	WOS:000319872300071
J	Li, C; Xu, WC; Xie, ZS; Pan, K; Hu, J; Chen, J; Pang, DW; Yang, FQ; Liang, Y				Li, Cheng; Xu, Wen-Chang; Xie, Zhen-Sheng; Pan, Kai; Hu, Jiao; Chen, Jie; Pang, Dai-Wen; Yang, Fu-Quan; Liang, Yi			Cupric Ions Induce the Oxidation and Trigger the Aggregation of Human Superoxide Dismutase 1	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ISOTHERMAL TITRATION CALORIMETRY; METAL-BINDING; CU,ZN-SUPEROXIDE DISMUTASE; MUTANT SOD1; MOUSE MODEL; TRANSPORTER YIIP; COPPER CHAPERONE; TRANSGENIC MICE; CYSTEINE 111	Background: Amyotrophic lateral sclerosis (ALS), partly caused by the mutations and aggregation of human copper, zinc superoxide dismutase (SOD1), is a fatal degenerative disease of motor neurons. Because SOD1 is a major copper-binding protein present at relatively high concentration in motor neurons and copper can be a harmful pro-oxidant, we want to know whether aberrant copper biochemistry could underlie ALS pathogenesis. In this study, we have investigated and compared the effects of cupric ions on the aggregation of ALS-associated SOD1 mutant A4V and oxidized wild-type SOD1. Methodology/Principal Findings: As revealed by 90 degrees light scattering, dynamic light scattering, SDS-PAGE, and atomic force microscopy, free cupric ions in solution not only induce the oxidation of either apo A4V or Zn-2-A4V and trigger the oligomerization and aggregation of oxidized A4V under copper-mediated oxidative conditions, but also trigger the aggregation of non-oxidized form of such a pathogenic mutant. As evidenced by mass spectrometry and SDS-PAGE, Cys-111 is a primary target for oxidative modification of pathological human SOD1 mutant A4V by either excess Cu2+ or hydrogen peroxide. The results from isothermal titration calorimetry show that A4V possesses two sets of independent binding sites for Cu2+: a moderate-affinity site (10(6) M-1) and a high-affinity site (10(8) M-1). Furthermore, Cu2+ binds to wildtype SOD1 oxidized by hydrogen peroxide in a way similar to A4V, triggering the aggregation of such an oxidized form. Conclusions/ Significance: We demonstrate that excess cupric ions induce the oxidation and trigger the aggregation of A4V SOD1, and suggest that Cu2+ plays a key role in the mechanism of aggregation of both A4V and oxidized wild-type SOD1. A plausible model for how pathological SOD1 mutants aggregate in ALS-affected motor neurons with the disruption of copper homeostasis has been provided.	[Li, Cheng; Xu, Wen-Chang; Pan, Kai; Chen, Jie; Liang, Yi] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Xie, Zhen-Sheng; Yang, Fu-Quan] Chinese Acad Sci, Inst Biophys, Lab Prote, Beijing 100080, Peoples R China; [Hu, Jiao; Pang, Dai-Wen] Wuhan Univ, Coll Chem & Mol Sci, Wuhan 430072, Peoples R China; [Hu, Jiao; Pang, Dai-Wen] Wuhan Univ, State Key Lab Virol, Wuhan 430072, Peoples R China	Wuhan University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Wuhan University; Wuhan University	Liang, Y (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	liangyi@whu.edu.cn	Liang, Yi/V-1396-2017	Liang, Yi/0000-0002-7349-8300	National Key Basic Research Foundation of China [2013CB910702, 2012CB911003]; National Natural Science Foundation of China [31170744, 30970599]; Fundamental Research Funds for the Central Universities of China [1104006]	National Key Basic Research Foundation of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This study was supported by National Key Basic Research Foundation of China (http://www.most.gov.cn/, Grant nos. 2013CB910702 and 2012CB911003, YL), National Natural Science Foundation of China (http://www.nsfc.gov.cn/, Grant nos. 31170744 and 30970599, YL), and Fundamental Research Funds for the Central Universities of China (http://www.moe.edu.cn/, Grant no. 1104006, YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Ezzi S, 2007, J NEUROCHEM, V102, P170, DOI 10.1111/j.1471-4159.2007.04531.x; Anderson M, 2006, J MOL BIOL, V358, P580, DOI 10.1016/j.jmb.2006.02.007; Barmada S, 2010, NAT NEUROSCI, V13, P1303, DOI 10.1038/nn1110-1303; Beckman JS, 2002, FREE RADICAL BIO MED, V33, P1433, DOI 10.1016/S0891-5849(02)01092-4; Borchelt DR, 1998, NEUROBIOL DIS, V5, P27, DOI 10.1006/nbdi.1998.0178; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Bounds PL, 2002, METHOD ENZYMOL, V349, P115, DOI 10.1016/S0076-6879(02)49327-5; Brotherton TE, 2012, P NATL ACAD SCI USA, V109, P5505, DOI 10.1073/pnas.1115009109; Bush AI, 2002, NAT NEUROSCI, V5, P919, DOI 10.1038/nn1002-919a; Chang YM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002849; Chao Y, 2004, J BIOL CHEM, V279, P17173, DOI 10.1074/jbc.M400208200; Chattopadhyay M, 2009, ANTIOXID REDOX SIGN, V11, P1603, DOI [10.1089/ars.2009.2536, 10.1089/ARS.2009.2536]; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Chen XP, 2012, NEUROCHEM RES, V37, P835, DOI 10.1007/s11064-011-0679-8; COLOMBO MF, 1987, CAN J CHEM, V65, P821, DOI 10.1139/v87-139; DE Beus MD, 2004, PROTEIN SCI, V13, P1347, DOI 10.1110/ps.03576904; Desai V, 2008, AM J CLIN NUTR, V88, p855S, DOI 10.1093/ajcn/88.3.855S; Doucette PA, 2004, J BIOL CHEM, V279, P54558, DOI 10.1074/jbc.M409744200; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Gaggelli E, 2006, CHEM REV, V106, P1995, DOI 10.1021/cr040410w; Ghai R, 2012, J MOL RECOGNIT, V25, P32, DOI 10.1002/jmr.1167; Guareschi S, 2012, P NATL ACAD SCI USA, V109, P5074, DOI 10.1073/pnas.1115402109; Hwang YM, 2010, J BIOL CHEM, V285, P41701, DOI 10.1074/jbc.M110.113696; Ip P, 2011, J MOL BIOL, V409, P839, DOI 10.1016/j.jmb.2011.04.027; Jiao M, 2010, BIOPHYS J, V99, P914, DOI 10.1016/j.bpj.2010.05.013; Kepp KP, 2012, CHEM REV, V112, P5193, DOI 10.1021/cr300009x; Kerman A, 2010, ACTA NEUROPATHOL, V119, P335, DOI 10.1007/s00401-010-0646-5; Kiaei M, 2004, J NEUROSCI, V24, P7945, DOI 10.1523/JNEUROSCI.2000-04.2004; Kim HK, 2011, ARCH BIOCHEM BIOPHYS, V509, P177, DOI 10.1016/j.abb.2011.02.014; Kishigami H, 2010, FREE RADICAL BIO MED, V48, P945, DOI 10.1016/j.freeradbiomed.2010.01.008; Kong FL, 2011, CHEM-BIOL INTERACT, V194, P69, DOI 10.1016/j.cbi.2011.08.003; Leinartaite L, 2010, J AM CHEM SOC, V132, P13495, DOI 10.1021/ja1057136; Liu HB, 2000, BIOCHEMISTRY-US, V39, P8125, DOI 10.1021/bi000846f; Lyons TJ, 1998, J BIOL INORG CHEM, V3, P650, DOI 10.1007/s007750050279; Michel E, 2005, ARCH BIOCHEM BIOPHYS, V439, P234, DOI 10.1016/j.abb.2005.05.016; Mo ZY, 2009, J BIOL CHEM, V284, P34648, DOI 10.1074/jbc.M109.058883; Nagano S, 2003, EXP NEUROL, V179, P176, DOI 10.1016/S0014-4886(02)00014-6; Nagano S, 2011, AMYOTROPHIC LATERAL SCLEROSIS, P301; Nordlund A, 2009, P NATL ACAD SCI USA, V106, P9667, DOI 10.1073/pnas.0812046106; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Polymenidou M, 2011, CELL, V147, P498, DOI 10.1016/j.cell.2011.10.011; Potter SZ, 2007, J AM CHEM SOC, V129, P4575, DOI 10.1021/ja066690+; Prudencio M, 2012, J NEUROCHEM, V121, P475, DOI 10.1111/j.1471-4159.2012.07690.x; Que EL, 2008, CHEM REV, V108, P1517, DOI 10.1021/cr078203u; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Rakhit R, 2004, J BIOL CHEM, V279, P15499, DOI 10.1074/jbc.M313295200; Rakhit R, 2002, J BIOL CHEM, V277, P47551, DOI 10.1074/jbc.M207356200; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; Ray SS, 2004, BIOCHEMISTRY-US, V43, P4899, DOI 10.1021/bi030246r; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Son M, 2007, P NATL ACAD SCI USA, V104, P6072, DOI 10.1073/pnas.0610923104; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; Subramaniam JR, 2002, NAT NEUROSCI, V5, P301, DOI 10.1038/nn823; Tokuda E, 2008, EXP NEUROL, V213, P122, DOI 10.1016/j.expneurol.2008.05.011; Tokuda E, 2009, J NEUROCHEM, V111, P181, DOI 10.1111/j.1471-4159.2009.06310.x; Trumbull KA, 2009, ANTIOXID REDOX SIGN, V11, P1627, DOI 10.1089/ARS.2009.2574; Valentine JS, 2003, P NATL ACAD SCI USA, V100, P3617, DOI 10.1073/pnas.0730423100; van den Berg B, 1999, EMBO J, V18, P6927, DOI 10.1093/emboj/18.24.6927; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang Q, 2008, PLOS BIOL, V6, P1508, DOI 10.1371/journal.pbio.0060170; Watanabe S, 2007, FREE RADICAL BIO MED, V42, P1534, DOI 10.1016/j.freeradbiomed.2007.02.004; Wegmann S, 2010, J BIOL CHEM, V285, P27302, DOI 10.1074/jbc.M110.145318; Wei YN, 2005, J BIOL CHEM, V280, P33716, DOI 10.1074/jbc.M506107200; Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-3; Yim HS, 1997, J BIOL CHEM, V272, P8861; Yu JS, 2007, J BIOL CHEM, V282, P8895, DOI 10.1074/jbc.M609317200; Zhou BR, 2004, J BIOL CHEM, V279, P55109, DOI 10.1074/jbc.M409086200; Zhou Z, 2011, BIOPHYS J, V101, P1483, DOI 10.1016/j.bpj.2011.08.018; Zhou Z, 2009, J BIOL CHEM, V284, P30148, DOI 10.1074/jbc.M109.002832; Zhu HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025020; Zhu HL, 2010, J BIOL CHEM, V285, P3592, DOI 10.1074/jbc.M109.035691	72	7	8	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65287	10.1371/journal.pone.0065287	http://dx.doi.org/10.1371/journal.pone.0065287			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755211	Green Published, gold, Green Submitted			2022-12-27	WOS:000319872300069
J	Lu, YC; Wu, CC; Yang, TH; Lin, YH; Yu, IS; Lin, SW; Chang, Q; Lin, X; Wong, JM; Hsu, CJ				Lu, Ying-Chang; Wu, Chen-Chi; Yang, Ting-Hua; Lin, Yin-Hung; Yu, I-Shing; Lin, Shu-Wha; Chang, Qing; Lin, Xi; Wong, Jau-Min; Hsu, Chuan-Jen			Differences in the Pathogenicity of the p.H723R Mutation of the Common Deafness-Associated SLC26A4 Gene in Humans and Mice	PLOS ONE			English	Article							ENLARGED VESTIBULAR AQUEDUCT; NONSYNDROMIC HEARING IMPAIRMENT; GENOTYPE-PHENOTYPE CORRELATION; KCNJ10 PROTEIN EXPRESSION; PENDRED-SYNDROME GENE; SYNDROME MOUSE MODEL; INNER-EAR; UNIQUE SPECTRUM; PDS GENE; CELLS	Mutations in the SLC26A4 gene are a common cause of human hereditary hearing impairment worldwide. Previous studies have demonstrated that different SLC26A4 mutations have different pathogenetic mechanisms. By using a genotype-driven approach, we established a knock-in mouse model (i.e., Slc26a4(tm2Dontuh/tm2Dontuh) mice) homozygous for the common p.H723R mutation in the East Asian population. To verify the pathogenicity of the p. H723R allele in mice, we further generated mice with compound heterozygous mutations (i.e., Slc26a4(tm1Dontuh/tm2Dontuh)) by intercrossing Slc26a4(+/tm2Dontuh) mice with Slc26a4(tm1Dontuh/tm1Dontuh) mice, which segregated the c.919-2A>G mutation with an abolished Slc26a4 function. Mice were then subjected to audiologic assessments, a battery of vestibular evaluations, inner ear morphological studies, and noise exposure experiments. The results were unexpected; both Slc26a4(tm2Dontuh/tm2Dontuh) and Slc26a4(tm1Dontuh/tm2Dontuh) mice showed normal audiovestibular phenotypes and inner ear morphology, and they did not show significantly higher shifts in hearing thresholds after noise exposure than the wild-type mice. The results indicated not only the p. H723R allele was non-pathogenic in mice, but also a single p.H723R allele was sufficient to maintain normal inner ear physiology in heterozygous compound mice. There might be discrepancies in the pathogenicity of specific SLC26A4 mutations in humans and mice; therefore, precautions should be taken when extrapolating the results of animal studies to humans.	[Lu, Ying-Chang; Wong, Jau-Min] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan; [Lu, Ying-Chang; Wu, Chen-Chi; Yang, Ting-Hua; Lin, Yin-Hung; Hsu, Chuan-Jen] Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan; [Wu, Chen-Chi] Natl Taiwan Univ Hosp, Dept Med Genet, Taipei, Taiwan; [Yu, I-Shing; Lin, Shu-Wha] Natl Taiwan Univ, Res Ctr Med Excellence, Transgen Mouse Models Core, Div Genom Med, Taipei 10764, Taiwan; [Chang, Qing; Lin, Xi] Emory Univ, Sch Med, Dept Otolaryngol, Atlanta, GA USA; [Hsu, Chuan-Jen] Natl Taiwan Univ, Coll Med, Dept Otolaryngol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Emory University; National Taiwan University	Hsu, CJ (corresponding author), Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan.	cjhsu@ntu.edu.tw	lin, xi/GZL-4959-2022	LIN, SHU-WHA/0000-0001-6748-5581; WU, CHEN-CHI/0000-0002-5047-2204	National Health Research Institute [NHRI-EX101-10147PI]; National Science Council of the Executive Yuan of the Republic of China [NSC-99-2314-B-002-056-MY3]; National Taiwan University Hospital [NTUH-100-001597]	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council of the Executive Yuan of the Republic of China(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University)	This study was supported by research grants from the National Health Research Institute (NHRI-EX101-10147PI), National Science Council of the Executive Yuan of the Republic of China (NSC-99-2314-B-002-056-MY3), and National Taiwan University Hospital (NTUH-100-001597). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert S, 2006, EUR J HUM GENET, V14, P773, DOI 10.1038/sj.ejhg.5201611; Azaiez H, 2007, HUM GENET, V122, P451, DOI 10.1007/s00439-007-0415-2; Barbaric Ivana, 2007, Briefings in Functional Genomics & Proteomics, V6, P91, DOI 10.1093/bfgp/elm008; Belyantseva IA, 2000, J NEUROSCI, V20, part. no.; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Choi BY, 2011, J CLIN INVEST, V121, P4516, DOI 10.1172/JCI59353; Choi BY, 2009, HUM MUTAT, V30, P599, DOI 10.1002/humu.20884; Dror AA, 2010, J BIOL CHEM, V285, P21724, DOI 10.1074/jbc.M110.120188; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Everett LA, 2001, HUM MOL GENET, V10, P153, DOI 10.1093/hmg/10.2.153; Everett LA, 1999, P NATL ACAD SCI USA, V96, P9727, DOI 10.1073/pnas.96.17.9727; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Ishihara K, 2010, HEARING RES, V270, P110, DOI 10.1016/j.heares.2010.08.015; King KA, 2010, LARYNGOSCOPE, V120, P384, DOI 10.1002/lary.20722; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Li XC, 1998, NAT GENET, V18, P215, DOI 10.1038/ng0398-215; Lu YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022150; Mori T, 2008, J OTOLARYNGOL-HEAD N, V37, P112, DOI 10.2310/7070.2008.0016; Nakao I, 2008, J IMMUNOL, V180, P6262, DOI 10.4049/jimmunol.180.9.6262; Ohlemiller KK, 2007, HEARING RES, V224, P34, DOI 10.1016/j.heares.2006.11.005; Park HJ, 2005, CLIN GENET, V67, P160, DOI 10.1111/j.1399-0004.2004.00386.x; Park HJ, 2003, J MED GENET, V40, P242, DOI 10.1136/jmg.40.4.242; Pearson H, 2002, NATURE, V415, P8, DOI 10.1038/415008a; Pryor SP, 2005, J MED GENET, V42, P159, DOI 10.1136/jmg.2004.024208; Royaux IE, 2000, ENDOCRINOLOGY, V141, P839, DOI 10.1210/en.141.2.839; Royaux IE, 2001, P NATL ACAD SCI USA, V98, P4221, DOI 10.1073/pnas.071516798; Scott DA, 2000, HUM MOL GENET, V9, P1709, DOI 10.1093/hmg/9.11.1709; Shcheynikov N, 2008, J PHYSIOL-LONDON, V586, P3813, DOI 10.1113/jphysiol.2008.154468; Singh R, 2008, AM J PHYSIOL-RENAL, V294, pF139, DOI 10.1152/ajprenal.00433.2007; Soleimani M, 2001, AM J PHYSIOL-RENAL, V280, pF356, DOI 10.1152/ajprenal.2001.280.2.F356; Su KY, 2007, J NEUROSCI, V27, P2513, DOI 10.1523/JNEUROSCI.4497-06.2007; Sugiura M, 2005, EUR ARCH OTO-RHINO-L, V262, P737, DOI 10.1007/s00405-004-0884-z; Taylor JP, 2002, J CLIN ENDOCR METAB, V87, P1778, DOI 10.1210/jc.87.4.1778; Tsukamoto K, 2003, EUR J HUM GENET, V11, P916, DOI 10.1038/sj.ejhg.5201073; Wang QJ, 2007, CLIN GENET, V72, P245, DOI 10.1111/j.1399-0004.2007.00862.x; Wangemann P, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-30; Wangemann P, 2009, AM J PHYSIOL-RENAL, V297, pF1435, DOI 10.1152/ajprenal.00011.2009; Wu CC, 2005, LARYNGOSCOPE, V115, P1060, DOI 10.1097/01.MLG.0000163339.61909.D0; Wu CC, 2008, AUDIOL NEURO-OTOL, V13, P172, DOI 10.1159/000112425; Yang T, 2009, AM J HUM GENET, V84, P651, DOI 10.1016/j.ajhg.2009.04.014; Yoon JS, 2008, J MED GENET, V45, P411, DOI 10.1136/jmg.2007.054635; Yuan YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049984	42	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64906	10.1371/journal.pone.0064906	http://dx.doi.org/10.1371/journal.pone.0064906			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755160	Green Submitted, gold, Green Published			2022-12-27	WOS:000319872300038
J	Stretch, C; Khan, S; Asgarian, N; Eisner, R; Vaisipour, S; Damaraju, S; Graham, K; Bathe, OF; Steed, H; Greiner, R; Baracos, VE				Stretch, Cynthia; Khan, Sheehan; Asgarian, Nasimeh; Eisner, Roman; Vaisipour, Saman; Damaraju, Sambasivarao; Graham, Kathryn; Bathe, Oliver F.; Steed, Helen; Greiner, Russell; Baracos, Vickie E.			Effects of Sample Size on Differential Gene Expression, Rank Order and Prediction Accuracy of a Gene Signature	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; FALSE DISCOVERY RATE; MICROARRAY DATA; BREAST-CANCER; SEX; CLASSIFICATION; LIMITATIONS; SELECTION; PROFILES	Top differentially expressed gene lists are often inconsistent between studies and it has been suggested that small sample sizes contribute to lack of reproducibility and poor prediction accuracy in discriminative models. We considered sex differences (69 male, 65 female) in 134 human skeletal muscle biopsies using DNA microarray. The full dataset and subsamples (n = 10 (5 male, 5 female) to n = 120 (60 male, 60 female)) thereof were used to assess the effect of sample size on the differential expression of single genes, gene rank order and prediction accuracy. Using our full dataset (n = 134), we identified 717 differentially expressed transcripts (p<0.0001) and we were able predict sex with similar to 90% accuracy, both within our dataset and on external datasets. Both p-values and rank order of top differentially expressed genes became more variable using smaller subsamples. For example, at n = 10 (5 male, 5 female), no gene was considered differentially expressed at p < 0.0001 and prediction accuracy was similar to 50% (no better than chance). We found that sample size clearly affects microarray analysis results; small sample sizes result in unstable gene lists and poor prediction accuracy. We anticipate this will apply to other phenotypes, in addition to sex.	[Stretch, Cynthia; Damaraju, Sambasivarao; Graham, Kathryn; Steed, Helen; Baracos, Vickie E.] Univ Alberta, Cross Canc Inst, Dept Oncol, Edmonton, AB, Canada; [Khan, Sheehan; Asgarian, Nasimeh; Eisner, Roman; Vaisipour, Saman; Greiner, Russell] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada; [Damaraju, Sambasivarao] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Bathe, Oliver F.] Univ Calgary, Dept Oncol, Calgary, AB, Canada; [Bathe, Oliver F.] Univ Calgary, Dept Surg, Calgary, AB, Canada; [Asgarian, Nasimeh; Eisner, Roman; Vaisipour, Saman; Greiner, Russell] Alberta Innovates Ctr Machine Learning, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Calgary; University of Calgary; Alberta Innovates	Baracos, VE (corresponding author), Univ Alberta, Cross Canc Inst, Dept Oncol, Edmonton, AB, Canada.	vickie.baracos@albertahealthservices.ca	Greiner, Russell/AAQ-4502-2020	Greiner, Russell/0000-0001-8327-934X; Baracos, Vickie/0000-0002-9609-1001; Stretch, Cynthia/0000-0002-5152-2728	Canadian Institutes of Health Research; Alberta Innovates Centre for Machine Learning; Natural Sciences and Engineering Research Council of Canada; Alberta Cancer Foundation; Alberta Cancer Prevention Legacy Fund; Canadian Breast Cancer Foundation-Prairies/NWT chapter	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Centre for Machine Learning; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Cancer Foundation; Alberta Cancer Prevention Legacy Fund; Canadian Breast Cancer Foundation-Prairies/NWT chapter	This work was supported by the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca), the Alberta Innovates Centre for Machine Learning (www.aicml.ca) and Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca). The tumor bank was funded by the Alberta Cancer Foundation (www.albertacancer.ca), Alberta Cancer Prevention Legacy Fund and Canadian Breast Cancer Foundation-Prairies/NWT chapter (www.cbcf.org/prairies/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2004, INT REV NEUROBIOL, V60, P25; Damavandi B., 2012, ESTIMATING OVERLAP T; Diaz LK, 2005, ADV ANAT PATHOL, V12, P10, DOI 10.1097/00125480-200501000-00003; Dobbin KK, 2008, CLIN CANCER RES, V14, P108, DOI 10.1158/1078-0432.CCR-07-0443; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Eisner R, 2011, METABOLOMICS, V7, P25, DOI 10.1007/s11306-010-0232-9; Fluck M, 2005, J APPL PHYSIOL, V99, P397, DOI 10.1152/japplphysiol.00050.2005; Kim SY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-147; Klebanov L, 2007, BIOINFORMATION, V1, P429, DOI 10.6026/97320630001429; Kuo CL, 2011, GENETICS, V189, P329, DOI 10.1534/genetics.111.130542; Liu D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-659; Maher AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006335; Matsui S, 2009, STAT MED, V28, P2801, DOI 10.1002/sim.3666; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Murphy RA, 2011, CANCER-AM CANCER SOC, V117, P1775, DOI 10.1002/cncr.25709; Popovici V, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2468; Pusztai L, 2006, ONCOLOGIST, V11, P868, DOI 10.1634/theoncologist.11-8-868; Ramasamy A, 2008, PLOS MED, V5, P1320, DOI 10.1371/journal.pmed.0050184; Roth SM, 2002, PHYSIOL GENOMICS, V10, P181, DOI 10.1152/physiolgenomics.00028.2002; Shen W, 2004, J APPL PHYSIOL, V97, P2333, DOI 10.1152/japplphysiol.00744.2004; Simon R, 2003, BRIT J CANCER, V89, P1599, DOI 10.1038/sj.bjc.6601326; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Timmons JA, 2006, IUBMB LIFE, V58, P15, DOI 10.1080/15216540500507390; van Vliet MH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-375; Virtanen C, 2008, APPL PHYSIOL NUTR ME, V33, P124, DOI 10.1139/H07-150; Welle S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001385; Yekutieli D, 1999, J STAT PLAN INFER, V82, P171, DOI 10.1016/S0378-3758(99)00041-5	28	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65380	10.1371/journal.pone.0065380	http://dx.doi.org/10.1371/journal.pone.0065380			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755224	Green Published, Green Submitted, gold			2022-12-27	WOS:000319872300077
J	Wang, HJ; Liang, YG; Li, SX; Chang, JB				Wang, Hongjun; Liang, Youguang; Li, Sixin; Chang, Jianbo			Acute Toxicity, Respiratory Reaction, and Sensitivity of Three Cyprinid Fish Species Caused by Exposure to Four Heavy Metals	PLOS ONE			English	Article							MINNOW PIMEPHALES-PROMELAS; BLUEGILL LEPOMIS-MACROCHIRUS; BIOMONITORING SYSTEM; REAL-TIME; CADMIUM; REPRODUCTION; RAFINESQUE; SURVIVAL; BEHAVIOR; GROWTH	Using 3 cyprinid fish species zebra fish, rare minnow, and juvenile grass carp, we conducted assays of lethal reaction and ventilatory response to analyze sensitivity of the fish to 4 heavy metals. Our results showed that the 96 h LC50 of Hg2+ to zebra fish, juvenile grass carp, and rare minnow were 0.14 mg L-1, 0.23 mg L-1, and 0.10 mg L-1, respectively; of Cu2+ 0.17 mg L-1, 0.09 mg L-1, and 0.12 mg L-1 respectively; of Cd2+ 6.5 mg L-1, 18.47 mg L-1, 5.36 mg L-1, respectively; and of Zn2+ 44.48 mg L-1, 31.37 mg L-1, and 12.74 mg L-1, respectively. Under a 1-h exposure, the ventilatory response to the different heavy metals varied. Ventilatory frequency (Vf) and amplitude (Va) increased in zebra fish, juvenile grass carp, and rare minnows exposed to Hg2+ and Cu2+ (P<0.05), and the Vf and Va of the 3 species rose initially and then declined when exposed to Cd2+. Zn2+ had markedly different toxic effects than the other heavy metals, whose Vf and Va gradually decreased with increasing exposure concentration (P<0.05). The rare minnow was the most highly susceptible of the 3 fish species to the heavy metals, with threshold effect concentrations (TEC) of 0.019 mg L-1, 0.046 mg L-1, 2.142 mg L-1, and 0.633 mg L-1 for Hg2+, Cu2+, Cd2+, and Zn2+, respectively. Therefore, it is feasible to use ventilatory parameters as a biomarker for evaluating the pollution toxicity of metals and to recognize early warning signs by using rare minnows as a sensor.	[Wang, Hongjun] Minist Water Resources, Key Lab Ecol Impacts Hydraul Projects & Restorat, Inst Hydroecol, Wuhan, Peoples R China; Chinese Acad Sci, Wuhan, Peoples R China	Chinese Academy of Sciences; Ministry of Water Resources; Chinese Academy of Sciences	Wang, HJ (corresponding author), Minist Water Resources, Key Lab Ecol Impacts Hydraul Projects & Restorat, Inst Hydroecol, Wuhan, Peoples R China.	whj103392@163.com	Chang, Jianbo/F-6831-2013	Chang, Jianbo/0000-0002-1053-2540; Li, Sixin/0000-0001-9866-411X	National Science and Technology Major Project of Water Pollution Control and Management of China [2009ZX07528-003]; agricultural scientific and technological achievements of China [2011GB23320006]; National Natural Science Foundation of China [51209150]	National Science and Technology Major Project of Water Pollution Control and Management of China; agricultural scientific and technological achievements of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Science and Technology Major Project of Water Pollution Control and Management of China (Grant No. 2009ZX07528-003), the transforming program of agricultural scientific and technological achievements of China (Grant NO. 2011GB23320006) and National Natural Science Foundation of China (Grant 51209150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Society for Testing and Materials (ASTM) E96, 1995, E96 ASTM, P1; BENOIT DA, 1975, T AM FISH SOC, V104, P353, DOI 10.1577/1548-8659(1975)104&lt;353:CEOCOS&gt;2.0.CO;2; BRUNGS WA, 1969, T AM FISH SOC, V98, P272, DOI 10.1577/1548-8659(1969)98[272:CTOZTT]2.0.CO;2; Cairns Jr J, 1971, WATER POLLUT CONTROL, P1; Clarkson TW, 2003, NEW ENGL J MED, V349, P1731, DOI 10.1056/NEJMra022471; Cunha SR, 2008, ECOTOXICOLOGY, V17, P558, DOI 10.1007/s10646-008-0216-y; DIAMOND JM, 1990, ENVIRON TOXICOL CHEM, V9, P3, DOI 10.1002/etc.5620090102; Diehl P, 2006, HANDB ENVIRON CHEM, V5, P99; Drummond RA, 1977, ECOLOGICAL RES SERIE, P1; Duarte RM, 2009, ECOTOX ENVIRON SAFE, V72, P693, DOI 10.1016/j.ecoenv.2008.10.003; EATON JG, 1974, T AM FISH SOC, V103, P729, DOI 10.1577/1548-8659(1974)103&lt;729:CCTTTB&gt;2.0.CO;2; Felten V, 2008, AQUAT TOXICOL, V86, P413, DOI 10.1016/j.aquatox.2007.12.002; FIRTH BK, 1990, TAPPI J, V73, P169; Gail M, 1999, ECOTOXICOLOGY ENV SA, V42, P253; GERHARDT A, 1999, BIOMONITORING POLLUT, P95; GRUBER D, 1981, HYDROBIOLOGIA, V83, P387, DOI 10.1007/BF02187035; Gruber D, 2007, P 15 INT C SOFTW TEL, P1; [江敏 Jiang Min], 2005, [环境科学学报, Acta Scientiae Circumstantiae], V25, P1253; Kramer K.J.M., 1991, P95; MCKIM JM, 1971, J FISH RES BOARD CAN, V28, P655, DOI 10.1139/f71-097; MORGAN WSG, 1979, J WATER POLLUT CON F, V51, P580; MORGAN WSG, 1982, WATER SCI TECHNOL, V14, P151, DOI 10.2166/wst.1982.0095; Orun I, 2008, FRESEN ENVIRON BULL, V17, P1242; PICKERING QH, 1972, J FISH RES BOARD CAN, V29, P1099, DOI 10.1139/f72-164; Shedd TR, 2001, B ENVIRON CONTAM TOX, V66, P392; SLOOFF W, 1979, B ENVIRON CONTAM TOX, V23, P517, DOI 10.1007/BF01769997; SNARSKI VM, 1982, AQUAT TOXICOL, V2, P143, DOI 10.1016/0166-445X(82)90012-1; SPEHAR RL, 1976, J FISH RES BOARD CAN, V33, P1939, DOI 10.1139/f76-247; States S, 2007, P WAT TECHN C AL VA, P16; Svecevicius G, 2009, B ENVIRON CONTAM TOX, V82, P564, DOI 10.1007/s00128-009-9657-0; *USEPA, 2002, SHORT TIM METH EST C; van der Schalie WH, 2001, BIOSENS BIOELECTRON, V16, P457, DOI 10.1016/S0956-5663(01)00160-9	32	32	34	4	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65282	10.1371/journal.pone.0065282	http://dx.doi.org/10.1371/journal.pone.0065282			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755209	gold, Green Published			2022-12-27	WOS:000319872300068
J	Ammar, ED; Alessandro, R; Shatters, RG; Hall, DG				Ammar, El-Desouky; Alessandro, Rocco; Shatters, Robert G., Jr.; Hall, David G.			Behavioral, Ultrastructural and Chemical Studies on the Honeydew and Waxy Secretions by Nymphs and Adults of the Asian Citrus Psyllid Diaphorina citri (Hemiptera: Psyllidae)	PLOS ONE			English	Article							GREENING DISEASE; FINE-STRUCTURE; SURFACE WAX; PHLOEM-SAP; CICADELLIDAE; HOMOPTERA; PLANT; STERNORRHYNCHA; HYMENOPTERA; FORMICIDAE	The Asian citrus psyllid (ACP), Diaphorina citri (Hemiptera: Psyllidae) is the primary vector of the bacterium causing citrus huanglongbing (citrus greening), the most serious disease of citrus worldwide. Psyllids and other hemipterans produce large amounts of honeydew, which has been used previously as an indicator of phloem sap composition and insect feeding or metabolism. Behavioral, ultrastructural and chemical studies on ACP, its honeydew and waxy secretions showed important differences between nymphs, males and females, and suggested some mechanisms by which the psyllids, especially nymphs and adult females, can minimize their contamination with honeydew excretions. The anal opening in ACP, near the posterior end of the abdomen, is on the ventral side in nymphs and on the dorsal side in adult males and females. Video recordings showed that adult males produce clear sticky droplets of honeydew gently deposited behind their body on the leaf surface, whereas adult females produce whitish honeydew pellets powerfully propelled away from the female body, probably to get their excretions away from eggs and newly hatched nymphs. ACP nymphs produce long ribbons or tubes of honeydew that frequently stay attached to the exuviae after molting, or drop when feeding on the lower side of citrus leaves. Furthermore, honeydew excretions of both nymphs and adult females are covered with a thin layer of whitish waxy material ultrastructurally composed of a convoluted network of long fine filaments or ribbons. This material is extruded from intricate arrays of wax pores in the circumanal ring (around the anus) that is found in nymphs and females but not in males of ACP or other psyllid species. Infrared microscopy and mass spectroscopy revealed that, in addition to various sugars, honeydew excretions of ACP nymphs and females are covered with a thin layer of wax similar in profile to ester waxes.	[Ammar, El-Desouky; Alessandro, Rocco; Shatters, Robert G., Jr.; Hall, David G.] ARS, USDA, Hort Res Lab, Ft Pierce, FL USA	United States Department of Agriculture (USDA)	Ammar, ED (corresponding author), ARS, USDA, Hort Res Lab, Ft Pierce, FL USA.	Eldesouky.ammar@ars.usda.gov		Alessandro, Rocco/0000-0001-7983-0557; Shatters, Robert/0000-0002-3903-772X	Florida Citrus Research Foundation	Florida Citrus Research Foundation	Funding was provided by the Florida Citrus Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammar E, 2013, J ECON ENTOMOL, V106, P25, DOI 10.1603/EC12245; Ammar E, 2011, FLA ENTOMOL, V94, P340, DOI 10.1653/024.094.0229; Avery PB, 2011, BIOCONTROL SCI TECHN, V21, P1065, DOI 10.1080/09583157.2011.596927; Bove JM, 2006, J PLANT PATHOL, V88, P7; Brentassi ME, 2007, ANN SOC ENTOMOL FR, V43, P205, DOI 10.1080/00379271.2007.10697512; Brittain W. H., 1923, Proceedings Acadian Ent Soc Fredericton NB, V8, P23; Buckner JS, 1999, COMP BIOCHEM PHYS B, V124, P201, DOI 10.1016/S0305-0491(99)00117-0; CATLING HD, 1970, FAO PLANT PROTECT B, V18, P8; De Miranda MP, 2008, REV BRAS FRUTIC, V30, P913, DOI 10.1590/S0100-29452008000400013; Douglas AE, 2006, J EXP BOT, V57, P747, DOI 10.1093/jxb/erj067; FOLDI I, 1985, INT J INSECT MORPHOL, V14, P259, DOI 10.1016/0020-7322(85)90041-8; Gaigher R, 2011, BIOL INVASIONS, V13, P1717, DOI 10.1007/s10530-010-9934-1; Golan K, 2011, EUR J ENTOMOL, V108, P705, DOI 10.14411/eje.2011.090; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Gullan PJ, 1997, ANNU REV ENTOMOL, V42, P23, DOI 10.1146/annurev.ento.42.1.23; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Hall DG, 2013, ENTOMOL EXP APPL, V146, P207, DOI 10.1111/eea.12025; Hall DG, 2010, ANN ENTOMOL SOC AM, V103, P611, DOI 10.1603/AN10004; Hirae M, 2008, JPN J APPL ENTOMOL Z, V52, P207, DOI 10.1303/jjaez.2008.207; Husain M. A., 1927, MEMOIRS DEP AGR INDI, V10, P1; Jones ME, 2012, ENTOMOL EXP APPL, V143, P280, DOI 10.1111/j.1570-7458.2012.01261.x; Killiny N, 2012, ANN M ENT SOC AM NOV; Kumar V, 1997, ITAL J ZOOL, V64, P307, DOI 10.1080/11250009709356218; Lucchi A, 2004, ANN ENTOMOL SOC AM, V97, P1294, DOI 10.1603/0013-8746(2004)097[1294:WPIAOP]2.0.CO;2; Mansour R, 2012, BIOCONTROL SCI TECHN, V22, P527, DOI 10.1080/09583157.2012.665832; MENSAH RK, 1992, ENTOMOL EXP APPL, V62, P261, DOI 10.1007/BF00353445; Merritt SZ, 1996, J CHEM ECOL, V22, P1133, DOI 10.1007/BF02027950; MESFIN T, 1995, B ENTOMOL RES, V85, P387, DOI 10.1017/S0007485300036129; Milanez JM, 2003, FLA ENTOMOL, V86, P154, DOI 10.1653/0015-4040(2003)086[0154:FASOCS]2.0.CO;2; Moog J, 2005, INSECT SOC, V52, P169, DOI 10.1007/s00040-005-0791-3; Nelson DR, 2000, COMP BIOCHEM PHYS B, V125, P265, DOI 10.1016/S0305-0491(99)00177-7; Nelson DR, 1997, COMP BIOCHEM PHYS B, V117, P241, DOI 10.1016/S0305-0491(97)00047-3; Nelson DR, 1998, COMP BIOCHEM PHYS B, V119, P655, DOI 10.1016/S0305-0491(98)00041-8; Pyati P, 2011, J INSECT PHYSIOL, V57, P881, DOI 10.1016/j.jinsphys.2011.03.024; Rogers ME, 2006, ENY739 EDIS; Salvucci ME, 1998, ARCH INSECT BIOCHEM, V39, P155, DOI 10.1002/(SICI)1520-6327(1998)39:4&lt;155::AID-ARCH3&gt;3.0.CO;2-#; Smith RG, 1999, J NAT HIST, V33, P513, DOI 10.1080/002229399300227; Steiner FM, 2004, EUR J ENTOMOL, V101, P689, DOI 10.14411/eje.2004.090; Taylor SH, 2012, ENTOMOL EXP APPL, V142, P121, DOI 10.1111/j.1570-7458.2011.01206.x; Tsai JH, 2000, J ECON ENTOMOL, V93, P1721, DOI 10.1603/0022-0493-93.6.1721; WAKU Y, 1978, J MORPHOL, V158, P243, DOI 10.1002/jmor.1051580302; Wang J, 2012, ENTOMOL EXP APPL, V144, P191, DOI 10.1111/j.1570-7458.2012.01278.x	42	24	28	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e64938	10.1371/journal.pone.0064938	http://dx.doi.org/10.1371/journal.pone.0064938			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762268	gold, Green Published, Green Submitted			2022-12-27	WOS:000320440500011
J	McDavid, A; Crane, PK; Newton, KM; Crosslin, DR; McCormick, W; Weston, N; Ehrlich, K; Hart, E; Harrison, R; Kukull, WA; Rottscheit, C; Peissig, P; Stefanski, E; McCarty, CA; Zuvich, RL; Ritchie, MD; Haines, JL; Denny, JC; Schellenberg, GD; de Andrade, M; Kullo, I; Li, RL; Mirel, D; Crenshaw, A; Bowen, JD; Li, G; Tsuang, D; McCurry, S; Teri, L; Larson, EB; Jarvik, GP; Carlson, CS				McDavid, Andrew; Crane, Paul K.; Newton, Katherine M.; Crosslin, David R.; McCormick, Wayne; Weston, Noah; Ehrlich, Kelly; Hart, Eugene; Harrison, Robert; Kukull, Walter A.; Rottscheit, Carla; Peissig, Peggy; Stefanski, Elisha; McCarty, Catherine A.; Zuvich, Rebecca Lynn; Ritchie, Marylyn D.; Haines, Jonathan L.; Denny, Joshua C.; Schellenberg, Gerard D.; de Andrade, Mariza; Kullo, Iftikhar; Li, Rongling; Mirel, Daniel; Crenshaw, Andrew; Bowen, James D.; Li, Ge; Tsuang, Debby; McCurry, Susan; Teri, Linda; Larson, Eric B.; Jarvik, Gail P.; Carlson, Chris S.			Enhancing the Power of Genetic Association Studies through the Use of Silver Standard Cases Derived from Electronic Medical Records	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; VASCULAR DEMENTIA; COMMON VARIANTS; MISCLASSIFICATION; DIAGNOSIS; CRITERIA; LINKAGE; CD2AP; EPHA1; RISK	The feasibility of using imperfectly phenotyped "silver standard" samples identified from electronic medical record diagnoses is considered in genetic association studies when these samples might be combined with an existing set of samples phenotyped with a gold standard technique. An analytic expression is derived for the power of a chi-square test of independence using either research-quality case/control samples alone, or augmented with silver standard data. The subset of the parameter space where inclusion of silver standard samples increases statistical power is identified. A case study of dementia subjects identified from electronic medical records from the Electronic Medical Records and Genomics (eMERGE) network, combined with subjects from two studies specifically targeting dementia, verifies these results.	[McDavid, Andrew; Carlson, Chris S.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Crane, Paul K.; McCormick, Wayne; Larson, Eric B.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Newton, Katherine M.; Weston, Noah; Ehrlich, Kelly; Hart, Eugene; Harrison, Robert; Larson, Eric B.] Grp Hlth Res Inst, Seattle, WA USA; [Crosslin, David R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Kukull, Walter A.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Rottscheit, Carla; Peissig, Peggy] Marshfield Clin Res Fdn, Biomed Informat Res Ctr, Marshfield, WI USA; [Stefanski, Elisha] Marshfield Clin Res Fdn, Ctr Human Genet, Marshfield, WI USA; [McCarty, Catherine A.] Essentia Inst Rural Hlth, Duluth, MN USA; [Zuvich, Rebecca Lynn; Haines, Jonathan L.] Vanderbilt Univ, Sch Med, Ctr Human Genet Res, Nashville, TN 37212 USA; [Ritchie, Marylyn D.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Denny, Joshua C.] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Schellenberg, Gerard D.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA; [de Andrade, Mariza] Mayo Clin, Coll Med, Dept Hlth Sci Res, Rochester, MN USA; [Kullo, Iftikhar] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA; [Li, Rongling] NHGRI, NIH, Bethesda, MD 20892 USA; [Mirel, Daniel; Crenshaw, Andrew] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Bowen, James D.] Swedish Med Ctr, Dept Neurol, Seattle, WA USA; [Li, Ge; Tsuang, Debby] Univ Washington, Dept Psychiat, Sch Med, Seattle, WA 98195 USA; [Tsuang, Debby] VA Puget Sound Hlth Care Syst, Seattle, WA USA; [McCurry, Susan; Teri, Linda] Univ Washington, Sch Nursing, Dept Psychosocial & Community Hlth, Seattle, WA 98195 USA; [Jarvik, Gail P.] Univ Washington, Sch Med, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Jarvik, Gail P.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Vanderbilt University; University of Pennsylvania; Pennsylvania Medicine; Mayo Clinic; Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Swedish Medical Center; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	McDavid, A (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.	amcdavid@fhcrc.org	Denny, Josh/AAL-3359-2021; Tsuang, Debby/L-7234-2016; McCurry, Susan M/E-4731-2015; Jarvik, Gail P/N-6476-2014; Haines, Jonathan/C-3374-2012	Denny, Josh/0000-0002-3049-7332; Tsuang, Debby/0000-0002-4716-1894; McCurry, Susan M/0000-0001-8624-3772; Jarvik, Gail P/0000-0002-6710-8708; Haines, Jonathan/0000-0002-4351-4728; Kukull, Walter/0000-0001-8761-9014; McCarty, Catherine/0000-0003-1089-0142; Crane, Paul/0000-0003-4278-7465; McDavid, Andrew/0000-0002-6581-1213	National Institutes of Health (NIH) [HG004610, AG06781, U01HG004438]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006378, U01HG006375, U01HG004610, U01HG004438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG016976, U01AG006781] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by National Institutes of Health (NIH) award HG004610, AG06781 (Group Health Cooperative) and U01HG004438. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1429; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; [Anonymous], 2010, R LANG ENV STAT COMP; Barral S, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-24; CHUI HC, 1992, NEUROLOGY, V42, P473, DOI 10.1212/WNL.42.3.473; Clark TG, 2002, LANCET, V359, P1309, DOI 10.1016/S0140-6736(02)08272-7; Crane HM, 2006, CURR HIV RES, V4, P97, DOI 10.2174/157016206775197637; Edwards BJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-18; ESPELAND MA, 1985, J AM STAT ASSOC, V80, P663, DOI 10.2307/2288482; Ghebranious N, 2011, CLIN MED RES, V9, P17, DOI 10.3121/cmr.2010.894; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Kho AN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001807; Knopman DS, 2011, ALZHEIMERS DEMENT, V7, P53, DOI 10.1016/j.jalz.2010.11.001; Kukull WA, 1996, J CLIN EPIDEMIOL, V49, P1143, DOI 10.1016/0895-4356(96)00195-3; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Kullo IJ, 2010, J AM MED INFORM ASSN, V17, P568, DOI 10.1136/jamia.2010.004366; Larson E B, 1990, Aging (Milano), V2, P404; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; Londono D, 2010, HUM HERED, V70, P102, DOI 10.1159/000314470; McCarty Catherine A, 2005, Per Med, V2, P49, DOI 10.1517/17410541.2.1.49; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MITRA SK, 1958, ANN MATH STAT, V29, P1221, DOI 10.1214/aoms/1177706453; Moskvina V, 2006, HUM HERED, V61, P55, DOI 10.1159/000092553; MOTE VL, 1965, BIOMETRIKA, V52, P95, DOI 10.1093/biomet/52.1-2.95; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; TATEMICHI TK, 1993, ANN NEUROL, V33, P568, DOI 10.1002/ana.410330603; Turner S, 2011, QUALITY CONTROL PROC; Zhong H, 2008, BIOSTATISTICS, V9, P621, DOI 10.1093/biostatistics/kxn001	38	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e63481	10.1371/journal.pone.0063481	http://dx.doi.org/10.1371/journal.pone.0063481			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762230	Green Published, gold, Green Submitted			2022-12-27	WOS:000320440500003
J	Busacca, S; Chacko, AD; Klabatsa, A; Arthur, K; Sheaff, M; Gunasekharan, VK; Gorski, JJ; El-Tanani, M; Broaddus, VC; Gaudino, G; Fennell, DA				Busacca, Sara; Chacko, Alex D.; Klabatsa, Astero; Arthur, Kenneth; Sheaff, Michael; Gunasekharan, Vignesh K.; Gorski, Julia J.; El-Tanani, Mohamed; Broaddus, V. Courtney; Gaudino, Giovanni; Fennell, Dean A.			BAK and NOXA Are Critical Determinants of Mitochondrial Apoptosis Induced by Bortezomib in Mesothelioma	PLOS ONE			English	Article							MALIGNANT-PLEURAL-MESOTHELIOMA; RANDOMIZED PHASE-II; PROTEASOME INHIBITORS; BCL-2 FAMILY; C-MYC; MEDIATED APOPTOSIS; MOLECULAR-BASIS; RESISTANCE; CELLS; EXPRESSION	Based on promising preclinical efficacy associated with the 20S proteasome inhibitor bortezomib in malignant pleural mesothelioma (MPM), two phase II clinical trials have been initiated (EORTC 08052 and ICORG 05-10). However, the potential mechanisms underlying resistance to this targeted drug in MPM are still unknown. Functional genetic analyses were conducted to determine the key mitochondrial apoptotic regulators required for bortezomib sensitivity and to establish how their dysregulation may confer resistance. The multidomain proapoptotic protein BAK, but not its orthologue BAX, was found to be essential for bortezomib-induced apoptosis in MPM cell lines. Immunohistochemistry was performed on tissues from the ICORG-05 phase II trial and a TMA of archived mesotheliomas. Loss of BAK was found in 39% of specimens and loss of both BAX/BAK in 37% of samples. However, MPM tissues from patients who failed to respond to bortezomib and MPM cell lines selected for resistance to bortezomib conserved BAK expression. In contrast, c-Myc dependent transactivation of NOXA was abrogated in the resistant cell lines. In summary, the block of mitochondrial apoptosis is a limiting factor for achieving efficacy of bortezomib in MPM, and the observed loss of BAK expression or NOXA transactivation may be relevant mechanisms of resistance in the clinic.	[Busacca, Sara; Fennell, Dean A.] Univ Leicester, Dept Canc Studies & Mol Med, Leicester, Leics, England; [Chacko, Alex D.; Arthur, Kenneth; Gorski, Julia J.; El-Tanani, Mohamed] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Klabatsa, Astero] Kings Coll London, Dept Res Oncol, Div Canc Studies, London WC2R 2LS, England; [Sheaff, Michael] Barts & London NHS Trust, Dept Cellular Pathol, London, England; [Gunasekharan, Vignesh K.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Broaddus, V. Courtney] Univ Calif San Francisco, San Francisco Gen Hosp, Lung Biol Ctr, San Francisco, CA 94143 USA; [Gaudino, Giovanni] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA	University of Leicester; Queens University Belfast; University of London; King's College London; Barts Health NHS Trust; Northwestern University; Feinberg School of Medicine; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Cancer Research Center of Hawaii; University of Hawaii System	Fennell, DA (corresponding author), Univ Leicester, Dept Canc Studies & Mol Med, Leicester, Leics, England.	df132@le.ac.uk	Gunasekharan, Vignesh/ABH-5896-2020; Klampatsa, Astero/AAK-4419-2020	Klampatsa, Astero/0000-0003-0572-502X; Gunasekharan, Vignesh Kumar/0000-0002-2471-8485; Arthur, Kenneth/0000-0003-3045-4639; El-Tanani, Mohamed/0000-0002-4735-5445	NCI/NI R&D office joint research project in Cancer; Cancer Research UK Clinician Scientist Fellowship	NCI/NI R&D office joint research project in Cancer; Cancer Research UK Clinician Scientist Fellowship(Cancer Research UK)	SB was supported by an NCI/NI R&D office joint research project in Cancer. DAF was supported by a Cancer Research UK Clinician Scientist Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajanian C, 2002, CLIN CANCER RES, V8, P2505; Brenner C, 2005, EMBO J, V24, P336, DOI 10.1038/sj.emboj.7600509; Busse A, 2008, CANCER, V112, P659, DOI 10.1002/cncr.23224; Combaret V, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-50; Du X, 2010, MOL CELL BIOL, V30, P3444, DOI 10.1128/MCB.00813-09; Ehebauer M, 2006, SCIENCE, V314, P1414, DOI 10.1126/science.1134042; Fanucchi MP, 2006, J CLIN ONCOL, V24, P5025, DOI 10.1200/JCO.2006.06.1853; Fennell DA, 2008, ONCOGENE, V27, P1189, DOI 10.1038/sj.onc.1210744; Fennell DA, 2004, LANCET ONCOL, V5, P354, DOI 10.1016/S1470-2045(04)01492-5; Fennell DA, 2008, NAT CLIN PRACT ONCOL, V5, P136, DOI 10.1038/ncponc1039; Fennell DA, 2012, J THORAC ONCOL, V7, P1466, DOI 10.1097/JTO.0b013e318260dfb9; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Fernandez Y, 2005, CANCER RES, V65, P6294, DOI 10.1158/0008-5472.CAN-05-0686; Fuchs D, 2008, J CELL BIOCHEM, V103, P270, DOI 10.1002/jcb.21405; Gordon GJ, 2008, CANCER CHEMOTH PHARM, V61, P549, DOI 10.1007/s00280-007-0500-1; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hosey AM, 2007, J NATL CANCER I, V99, P1683, DOI 10.1093/jnci/djm207; Johnson TR, 2003, ONCOGENE, V22, P4953, DOI 10.1038/sj.onc.1206656; Liu WS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029466; Lu SQ, 2008, J PHARMACOL EXP THER, V326, P423, DOI 10.1124/jpet.108.138131; Lu SQ, 2008, EXP HEMATOL, V36, P1278, DOI 10.1016/j.exphem.2008.04.013; Lu SQ, 2009, EXP HEMATOL, V37, P831, DOI 10.1016/j.exphem.2009.04.001; MANNING LS, 1991, INT J CANCER, V47, P285, DOI 10.1002/ijc.2910470219; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; Nikiforov MA, 2007, P NATL ACAD SCI USA, V104, P19488, DOI 10.1073/pnas.0708380104; O'Kane SL, 2006, ACTA ONCOL, V45, P449, DOI 10.1080/02841860500468927; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Oerlemans R, 2008, BLOOD, V112, P2489, DOI 10.1182/blood-2007-08-104950; Pandit B, 2011, AM J PATHOL, V178, P355, DOI 10.1016/j.ajpath.2010.11.010; Pietruska JR, 2007, CANCER RES, V67, P3637, DOI 10.1158/0008-5472.CAN-05-3727; Qin JZ, 2005, CANCER RES, V65, P6282, DOI 10.1158/0008-5472.CAN-05-0676; Ri M, 2008, CANC SCI; Ri M, 2010, LEUKEMIA; Rzymski T, 2009, CELL CYCLE, V8, P3838, DOI 10.4161/cc.8.23.10086; Sartore-Bianchi A, 2007, CLIN CANCER RES, V13, P5942, DOI 10.1158/1078-0432.CCR-07-0536; Scagliotti GV, 2010, LUNG CANCER, V68, P420, DOI 10.1016/j.lungcan.2009.07.011; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; SMYTHE WR, 1994, ANN THORAC SURG, V57, P1395, DOI 10.1016/0003-4975(94)90090-6; Soini Y, 1999, CLIN CANCER RES, V5, P3508; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; van Meerbeeck JP, 2005, J CLIN ONCOL, V23, P6881, DOI 10.1200/JCO.20005.14.589; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Voortman J, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-73; Wang Q, 2009, P NATL ACAD SCI USA, V106, P2200, DOI 10.1073/pnas.0807611106; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wolf Jeffrey, 2008, Clin Adv Hematol Oncol, V6, P755; Xiong H, 2009, J CELL MOL MED, V13, P3668, DOI 10.1111/j.1582-4934.2009.00661.x	47	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65489	10.1371/journal.pone.0065489	http://dx.doi.org/10.1371/journal.pone.0065489			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762382	Green Published, gold, Green Submitted			2022-12-27	WOS:000321094800055
J	Prashar, A; Yildiz, J; McNicol, JW; Bryan, GJ; Jones, HG				Prashar, Ankush; Yildiz, Jane; McNicol, James W.; Bryan, Glenn J.; Jones, Hamlyn G.			Infra-red Thermography for High Throughput Field Phenotyping in Solanum tuberosum	PLOS ONE			English	Article							HIGHER STOMATAL CONDUCTANCE; GRAIN-YIELD; CANOPY TEMPERATURE; DROUGHT TOLERANCE; PIMA COTTON; ASSOCIATION; GLASSHOUSE; RESPONSES; GENOMICS; PROGRESS	The rapid development of genomic technology has made high throughput genotyping widely accessible but the associated high throughput phenotyping is now the major limiting factor in genetic analysis of traits. This paper evaluates the use of thermal imaging for the high throughput field phenotyping of Solanum tuberosum for differences in stomatal behaviour. A large multi-replicated trial of a potato mapping population was used to investigate the consistency in genotypic rankings across different trials and across measurements made at different times of day and on different days. The results confirmed a high degree of consistency between the genotypic rankings based on relative canopy temperature on different occasions. Genotype discrimination was enhanced both through normalising data by expressing genotype temperatures as differences from image means and through the enhanced replication obtained by using overlapping images. A Monte Carlo simulation approach was used to confirm the magnitude of genotypic differences that it is possible to discriminate. The results showed a clear negative association between canopy temperature and final tuber yield for this population, when grown under ample moisture supply. We have therefore established infrared thermography as an easy, rapid and non-destructive screening method for evaluating large population trials for genetic analysis. We also envisage this approach as having great potential for evaluating plant response to stress under field conditions.	[Prashar, Ankush; Yildiz, Jane; Bryan, Glenn J.] James Hutton Inst, Dundee, Scotland; [McNicol, James W.] James Hutton Inst, Biomath & Stat Scotland, Dundee, Scotland; [Jones, Hamlyn G.] Univ Dundee, James Hutton Inst, Plant Sci Div, Dundee, Scotland; [Jones, Hamlyn G.] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia	James Hutton Institute; James Hutton Institute; James Hutton Institute; University of Dundee; University of Western Australia	Prashar, A (corresponding author), James Hutton Inst, Dundee, Scotland.	Ankush.Prashar@hutton.ac.uk	Jones, Hamlyn/F-8014-2011	Jones, Hamlyn/0000-0002-3049-3163; Bryan, Glenn/0000-0002-7752-5740	Scottish Government Rural and Environment Science and Analytical Services Division (RESAS)	Scottish Government Rural and Environment Science and Analytical Services Division (RESAS)	The research work was supported by the Scottish Government Rural and Environment Science and Analytical Services Division (RESAS). Authors have no conflict of interest to declare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amani I, 1996, J AGRON CROP SCI, V176, P119, DOI 10.1111/j.1439-037X.1996.tb00454.x; Aminian R., 2010, Wheat Information Service, P25; Birch ANE, 2007, PEDOBIOLOGIA, V51, P251, DOI 10.1016/j.pedobi.2007.04.008; Cowan I. R., 1986, On the economy of plant form and function, P133; Fischer RA, 1998, CROP SCI, V38, P1467, DOI 10.2135/cropsci1998.0011183X003800060011x; Furbank RT, 2011, TRENDS PLANT SCI, V16, P635, DOI 10.1016/j.tplants.2011.09.005; Graham J, 2011, THEOR APPL GENET, V123, P585, DOI 10.1007/s00122-011-1609-5; Horie T, 2006, PLANT CELL ENVIRON, V29, P653, DOI 10.1111/j.1365-3040.2005.01445.x; Horie T., 2003, Rice science: innovations and impact for livelihood. Proceedings of the International Rice Research Conference, Beijing, China, 16-19 September 2002, P117; Jalink H, 2009, NLP184672; Jones H., 2004, WATER USE EFFICIENCY, P27; Jones H. G., 1992, Plants and microclimate: a quantitative approach to environmental plant physiology.; Jones H. G., 1987, Stomatal Function, P431; Jones HG, 2009, FUNCT PLANT BIOL, V36, P978, DOI 10.1071/FP09123; Jones HG, 2004, J EXP BOT, V55, P2427, DOI 10.1093/jxb/erh213; Jones HG, 2002, J EXP BOT, V53, P2249, DOI 10.1093/jxb/erf083; Jones HG, 1981, MATH PLANT PHYSL, P231; KNAPP SJ, 1990, GENETICS, V126, P769; Limpens J, 2012, NEW PHYTOL, V195, P408, DOI 10.1111/j.1469-8137.2012.04157.x; Lopes MS, 2012, FIELD CROP RES, V128, P129, DOI 10.1016/j.fcr.2011.12.017; LU ZM, 1994, PHYSIOL PLANTARUM, V92, P266, DOI 10.1111/j.1399-3054.1994.tb05336.x; Lu ZM, 1996, AUST J PLANT PHYSIOL, V23, P127, DOI 10.1071/PP9960127; Maes WH, 2012, J EXP BOT, V63, P4671, DOI 10.1093/jxb/ers165; Merlot S, 2002, PLANT J, V30, P601, DOI 10.1046/j.1365-313X.2002.01322.x; Mir RR, 2012, THEOR APPL GENET, V125, P625, DOI 10.1007/s00122-012-1904-9; Montes JM, 2007, TRENDS PLANT SCI, V12, P433, DOI 10.1016/j.tplants.2007.08.006; PATTERSON HD, 1976, BIOMETRIKA, V63, P83, DOI 10.1093/biomet/63.1.83; Poorter H, 2012, FUNCT PLANT BIOL, V39, P839, DOI 10.1071/FP12049; Price AH, 2002, J EXP BOT, V53, P989, DOI 10.1093/jexbot/53.371.989; Rattey AR, 2011, FIELD CROP RES, V124, P195, DOI 10.1016/j.fcr.2011.02.006; Rebetzke GJ, 2013, FUNCT PLANT BIOL, V40, P14, DOI 10.1071/FP12184; Sinclair TR, 2005, J EXP BOT, V56, P2777, DOI 10.1093/jxb/eri297; Stoll M., 2005, XIV International GESCO Viticulture Congress, Geisenheim, Germany, 23-27 August, 2005, P211; Takai T, 2006, FIELD CROP RES, V96, P328, DOI 10.1016/j.fcr.2005.08.001; Tuberosa R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00347; Witt S, 2012, MOL PLANT, V5, P401, DOI 10.1093/mp/ssr102; Zheng TC, 2011, FIELD CROP RES, V122, P225, DOI 10.1016/j.fcr.2011.03.015	37	55	56	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65816	10.1371/journal.pone.0065816	http://dx.doi.org/10.1371/journal.pone.0065816			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762433	gold, Green Submitted, Green Published			2022-12-27	WOS:000321094800076
J	Stryjek, R; Modlinska, K; Turlejski, K; Pisula, W				Stryjek, Rafal; Modlinska, Klaudia; Turlejski, Krzysztof; Pisula, Wojciech			Circadian Rhythm of Outside-Nest Activity in Wild (WWCPS), Albino and Pigmented Laboratory Rats	PLOS ONE			English	Article							SOCIAL INTERACTIONS; FOOD-INTAKE; WISTAR RAT; OPEN-FIELD; BEHAVIOR; LIGHT; PLACE; ENVIRONMENT; EXPLORATION; AGGRESSION	The domestication process of the laboratory rat has been going on for several hundred generations in stable environmental conditions, which may have affected their physiological and behavioural functions, including their circadian system. Rats tested in our ethological experiments were laboratory-bred wild Norway rats (WWCPS), two strains of pigmented laboratory rats (Brown Norway and Long Evans), and two strains of albino rats (Sprague-Dawley and Wistar). Rats were placed in purpose-built enclosures and their cycle of activity (time spent actively outside the nest) has been studied for one week in standard light conditions and for the next one in round-the-clock darkness. The analysis of circadian pattern of outside-nest activity revealed differences between wild, pigmented laboratory, and albino laboratory strains. During daytime, albino rats showed lower activity than pigmented rats, greater decrease in activity when the light was turned on and greater increase in activity when the light was switched off, than pigmented rats. Moreover albino rats presented higher activity during the night than wild rats. The magnitude of the change in activity between daytime and nighttime was also more pronounced in albino rats. Additionaly, they slept outside the nest more often during the night than during the day. These results can be interpreted in accordance with the proposition that intense light is an aversive stimulus for albino rats, due to lack of pigment in their iris and choroid, which reduces their ability to adapt to light. Pigmented laboratory rats were more active during lights on, not only in comparison to the albino, but also to the wild rats. Since the difference seems to be independent of light intensity, it is likely to be a result of the domestication process. Cosinor analysis revealed a high rhythmicity of circadian cycles in all groups.	[Stryjek, Rafal; Modlinska, Klaudia; Pisula, Wojciech] Polish Acad Sci, Inst Psychol, Warsaw, Poland; [Stryjek, Rafal; Modlinska, Klaudia] Helena Chodkowska Univ Management & Law, Warsaw, Poland; [Turlejski, Krzysztof] M Nencki Inst Expt Biol, PL-02093 Warsaw, Poland	Polish Academy of Sciences; Institute of Psychology of the Polish Academy of Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Stryjek, R (corresponding author), Polish Acad Sci, Inst Psychol, Warsaw, Poland.	rstryjek@wp.pl	Pisula, Wojciech/AAR-3618-2020	Pisula, Wojciech/0000-0001-5777-0549; Krzysztof, Turlejski/0000-0001-6708-7815; Stryjek, Rafal/0000-0003-3889-9341; Modlinska, Klaudia/0000-0002-2161-9019	Polish Ministry of Science [UMO-2011/01/B/HS6/06442]	Polish Ministry of Science(Ministry of Science and Higher Education, Poland)	This research project was funded by the Polish Ministry of Science #UMO-2011/01/B/HS6/06442. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antle MC, 2005, BEHAV LAB RAT, P183; Barker DJ, 2010, BEHAV BRAIN RES, V214, P402, DOI 10.1016/j.bbr.2010.06.020; BARNETT SA, 1969, J MAMMAL, V50, P321, DOI 10.2307/1378349; BARNETT SA, 1981, AGGRESSIVE BEHAV, V7, P259, DOI 10.1002/1098-2337(1981)7:3<259::AID-AB2480070309>3.0.CO;2-V; BARNETT SA, 1979, AGGRESSIVE BEHAV, V5, P105, DOI 10.1002/1098-2337(1979)5:2<105::AID-AB2480050202>3.0.CO;2-U; BARNETT SA, 1958, BRIT J PSYCHOL, V49, P195, DOI 10.1111/j.2044-8295.1958.tb00657.x; Barnett SA, 2009, RAT STUDY BEHAV; BEACH FA, 1949, P SOC EXP BIOL MED, V72, P78, DOI 10.3181/00379727-72-17337; Benca RM, 1998, SLEEP, V21, P451, DOI 10.1093/sleep/21.5.451; BLANCHARD DC, 1988, ANNU REV PSYCHOL, V39, P43, DOI 10.1146/annurev.ps.39.020188.000355; Blanchard R.J., 1989, ETHOEXPERIMENTAL APP; BLANCHARD RJ, 1986, J COMP PSYCHOL, V100, P101, DOI 10.1037/0735-7036.100.2.101; BLANCHARD RJ, 1984, PHYSIOL BEHAV, V33, P857, DOI 10.1016/0031-9384(84)90219-1; BLANCHARD RJ, 1988, PHYSIOL BEHAV, V43, P1, DOI 10.1016/0031-9384(88)90089-3; Calhoun J. B, 1963, ECOLOGY SOCIOLOGY NO; Campuzano A, 1999, BIOL RHYTHM RES, V30, P497, DOI 10.1076/brhm.30.5.497.1397; Castillo-Ruiz A, 2012, PROG BRAIN RES, V199, P267, DOI 10.1016/B978-0-444-59427-3.00016-2; Challet E, 2007, ENDOCRINOLOGY, V148, P5648, DOI 10.1210/en.2007-0804; COWAN PE, 1977, J COMP PHYSIOL PSYCH, V91, P63, DOI 10.1037/h0077297; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Everts HGJ, 1997, HORM BEHAV, V31, P136, DOI 10.1006/hbeh.1997.1375; Favreau A, 2009, ANIM BEHAV, V77, P983, DOI 10.1016/j.anbehav.2009.01.004; FISHMAN R, 1970, PSYCHOPHYSIOLOGY, V7, P304; Fukuhara C, 2005, NEUROSIGNALS, V14, P117, DOI 10.1159/000086294; Galsworthy MJ, 2005, BEHAV BRAIN RES, V157, P211, DOI 10.1016/j.bbr.2004.06.021; Garner JP, 2002, BEHAV BRAIN RES, V136, P83, DOI 10.1016/S0166-4328(02)00111-0; Gibb R. L., 2005, BEHAV LAB RAT, P321; Goldfarb AH, 1997, SPORTS MED, V24, P8, DOI 10.2165/00007256-199724010-00002; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Harker KT, 2002, BEHAV BRAIN RES, V134, P467; Himmler BT, 2013, J COMP PSYC IN PRESS; HOLLOWAY FA, 1973, BEHAV BIOL, V9, P1, DOI 10.1016/S0091-6773(73)80164-6; HUCK UW, 1975, J COMP PHYSIOL PSYCH, V89, P892, DOI 10.1037/h0077160; Jud C, 2005, BIOL PROCED ONLINE, V7, P101, DOI 10.1251/bpo109; Keeler CE, 1942, J HERED, V33, P371, DOI 10.1093/oxfordjournals.jhered.a105097; Klejbor I, 2012, ACTA NEUROBIOL EXP, V72, P452; LOCKARD RB, 1968, AM PSYCHOL, V23, P734, DOI 10.1037/h0026726; Ma WP, 2007, NEUROSCI RES, V59, P224, DOI 10.1016/j.neures.2007.06.1474; Marc RE, 2008, MOL VIS, V14, P782; Mistlberger RE, 2004, BIOL REV, V79, P533, DOI 10.1017/S1464793103006353; Montaudouin S, 2004, BEHAV PROCESS, V67, P235, DOI 10.1016/j.beproc.2004.02.008; Morin LP, 2006, BRAIN RES REV, V51, P1, DOI 10.1016/j.brainresrev.2005.08.003; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; NIKULINA EM, 1985, ZH VYSSH NERV DEYAT+, V35, P703; Paul MJ, 2007, COLD SPRING HARB SYM, V72, P615, DOI 10.1101/sqb.2007.72.042; Pisula W, 2012, BEHAV PROCESS, V91, P145, DOI 10.1016/j.beproc.2012.06.010; Plyusnina IZ, 2009, BEHAV GENET, V39, P202, DOI 10.1007/s10519-008-9248-6; Price EO, 1999, APPL ANIM BEHAV SCI, V65, P245, DOI 10.1016/S0168-1591(99)00087-8; Pruskey G. T, 2005, BEHAV LAB RAT, P49; Prusky GT, 2002, BEHAV BRAIN RES, V136, P339, DOI 10.1016/S0166-4328(02)00126-2; REFINETTI R, 1993, PHYSIOL BEHAV, V54, P869, DOI 10.1016/0031-9384(93)90294-P; RICHTER CP, 1959, AM PSYCHOL, V14, P18, DOI 10.1037/h0043834; ROSENWASSER AM, 1981, PHYSIOL BEHAV, V27, P33, DOI 10.1016/0031-9384(81)90296-1; Sachs BD, 1996, PHYSIOL BEHAV, V60, P803, DOI 10.1016/S0031-9384(96)00158-8; Schmitt U, 1998, PROG NEURO-PSYCHOPH, V22, P1197, DOI 10.1016/S0278-5846(98)00051-7; Sherwin CM, 1998, ANIM BEHAV, V56, P11, DOI 10.1006/anbe.1998.0836; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Stryjek R, 2008, POL PSYCHOL BULL, V39, P6770; Stryjek R, 2008, ACTA NEUROBIOL EXP, V68, P407; Stryjek R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040642; Stryjek R, 2010, LAB ANIMAL, V39, P279, DOI 10.1038/laban0910-279; Tanas L, 2011, BEHAV PROCESS, V86, P279, DOI 10.1016/j.beproc.2010.12.018; Vidal J, 2011, BEHAV PROCESS, V87, P176, DOI 10.1016/j.beproc.2011.03.004; Whishaw IQ, 2003, BEHAV BRAIN RES, V146, P31, DOI 10.1016/j.bbr.2003.09.027; Wideman CH, 2009, NUTR NEUROSCI, V12, P233, DOI 10.1179/147683009X423436; Yan J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000193	66	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66055	10.1371/journal.pone.0066055	http://dx.doi.org/10.1371/journal.pone.0066055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762462	Green Published, Green Submitted, gold			2022-12-27	WOS:000321094800086
J	Yebyo, HG; Kendall, C; Nigusse, D; Lemma, W				Yebyo, Henock Gebremedhin; Kendall, Carl; Nigusse, Daniel; Lemma, Wuleta			Outpatient Therapeutic Feeding Program Outcomes and Determinants in Treatment of Severe Acute Malnutrition in Tigray, Northern Ethiopia: A Retrospective Cohort Study	PLOS ONE			English	Article							CHILDREN; NUTRITION	Background: Outpatient Therapeutic feeding Program (OTP) brings the services for management of Severe Acute Malnutrition (SAM) closer to the community by making services available at decentralized treatment points within the primary health care settings, through the use of ready-to-use therapeutic foods, community outreach and mobilization. Little is known about the program outcomes. This study revealed the levels of program outcome indictors and determinant factors to recovery rate. Methods: A retrospective cohort study was conducted on 628 children who had been managed for SAM under OTP from April/2008 to January/2012. The children were selected using systematic random sampling from 12 health posts and 4 health centers. The study relied on information of demographic characteristics, anthropometries, Plumpy'Nut, medical problems and routine medications intakes. The results were estimated using Kaplan-Meier survival curves, log-rank test and Cox-regression. Results: The recovery, defaulter, mortality and weight gain rates were 61.78%, 13.85%, 3.02% and 5.23 gm/kg/day, respectively. Routine medications were administered partially and children with medical problems were managed inappropriately under the program. As a child consumed one more sachet of Plumpy'Nut, the recovery rate from SAM increased by 4% (HR = 1.04, 95%-CI = 1.03, 1.05, P < 0.001). The adjusted hazard ratios to recovery of children with diarrhea, appetite loss with Plumpy'Nut and failure to gain weight were 2.20 (HR = 2.20, 95%-CI = 1.31, 3.41, P = 0.001), 4.49 (HR = 1.74, 95%-CI = 1.07, 2.83, P = 0.046) and 3.88 (HR = 1.95, 95%-CI = 1.17, 3.23, P < 0.001), respectively. Children who took amoxicillin and de-worming had 95% (HR = 1.95, 95%-CI = 1.17, 3.23) and 74% (HR = 1.74, 95%-CI = 1.07, 2.83) more probability to recover from SAM as compared to those who didn't take them. Conclusions: The OTP was partially successful. Management of children with comorbidities under the program and partial administration of routine drugs were major threats for the program effectiveness. The stakeholders should focus on creating the capacity of the OTP providers on proper management of SAM to achieve fully effective program.	[Yebyo, Henock Gebremedhin; Nigusse, Daniel] Mekelle Univ, Coll Hlth Sci, Dept Publ Hlth, Mekelle, Ethiopia; [Kendall, Carl; Lemma, Wuleta] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Community Hlth & Behav Sci, New Orleans, LA USA	Mekelle University; Tulane University	Yebyo, HG (corresponding author), Mekelle Univ, Coll Hlth Sci, Dept Publ Hlth, Mekelle, Ethiopia.	henokyebyo@yahoo.com	Kendall, Carl/F-9002-2012	Kendall, Carl/0000-0002-0794-4333; Yebyo, Henock/0000-0001-5400-2448				Anna T, 2002, FIELD ARTICL, V16, P26; [Anonymous], TITLE ERROR; Briend A, 2010, INDIAN PEDIATR, V47, P655, DOI 10.1007/s13312-010-0094-2; [Central Statistical Agency [Ethiopia] ICF International], 2012, ETHIOPIA DEMOGRAPHIC; Central Statistical Authority, 2008, THE 2007 POPULATION; Chaiken MS, 2006, FOOD NUTR BULL, V27, P95, DOI 10.1177/156482650602700201; Chamois S, 2011, FILED ARTICLE, V2011, P39; Collins S, 2002, LANCET, V360, P1824, DOI 10.1016/S0140-6736(02)11770-3; Datiko DG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005443; Defourny I, 2006, FIELD EXCHANGE, V28, P2; Del R, 2008, MADAGASCARS PILOT PR; Econinck H, 2008, REVIEW OF COMMUNITY; Eklund M, 2008, FIELD EXCHANGE; Esubalew D, 2009, COMMUNITY BASED EMER; Federal Ministry of Health, 2008, TRAINING GUIDE LINE; Federal Ministry of Health, 2010, HEALTH SECTOR DEVELO; Federal Ministry of Health, 2007, PROTOCOL FOR THE MAN; Gera T, 2010, INDIAN PEDIATR, V47, P709, DOI 10.1007/s13312-010-0095-1; Hamois S, 2009, FIELD ARTICLE, V36, P12; Lapidus N, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000039; Patel MP, 2005, J HEALTH POPUL NUTR, V23, P351; Shils ME, 2006, MODERN NUTR HLTH DIS, V10th; Taylor A, 2002, FIELD EXCHANGE; UNICEF, 2007, TRAIN GUID COMM BAS; [WHO UNICEF SCN], 2005, INFORMAL CONSULTATIO; World Health Organization World Food Programme United Nations System Standing Committee on Nutrition The United Nations Children's Fund, 2007, COMMUNITY BASED MANA	26	51	51	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65840	10.1371/journal.pone.0065840	http://dx.doi.org/10.1371/journal.pone.0065840			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755286	gold, Green Submitted, Green Published			2022-12-27	WOS:000321099000111
J	Chen, X; Wen, ZK; Xu, W; Xiong, SD				Chen, Xi; Wen, Zhenke; Xu, Wei; Xiong, Sidong			Granulin Exacerbates Lupus Nephritis via Enhancing Macrophage M2b Polarization	PLOS ONE			English	Article							EPITHELIN PRECURSOR; GROWTH-FACTOR; HOST-DEFENSE; MURINE LUPUS; PROGRANULIN; ACTIVATION; INFLAMMATION; DISEASE; DNA; ERYTHEMATOSUS	Background and Aims: Lupus nephritis (LN), with considerable morbidity and mortality, is one of the most severe manifestations of systemic lupus erythematosus (SLE). Yet, the pathogenic mechanisms of LN have not been clearly elucidated, and efficient therapies are still in great need. Granulin (GRN), a multifunctional protein linked to inflammatory diseases, has recently been reported to correlate with the disease activity of autoimmune diseases. However, the role of GRN in the pathogenic process of LN still remains obscure. In this study, we explored its potential role and underlying mechanism in the pathogenesis of LN. Methodology/Principal Findings: We found that serum GRN levels were significantly up-regulated and were positively correlated with the severity of LN. Overexpression of GRN in vivo by transgenic injection remarkably exacerbated LN, whereas down-regulation of GRN with shRNA ameliorated LN, firmly demonstrating the critical role of GRN in the pathogenesis of LN. Notably, macrophage phenotype analysis revealed that overexpression of GRN could enhance macrophage polarization to M2b, a key mediator of the initiation and progression of LN. On the contrary, down-regulation of GRN resulted in impaired M2b differentiation, thus ameliorating LN. Moreover, we found that MAPK signals were necessary for the effect of GRN on macrophage M2b polarization. Conclusion/Significance: We first demonstrated that GRN could aggravate lupus nephritis (LN) via promoting macrophage M2b polarization, which might provide insights into the pathogenesis of LN as well as potential therapeutic strategies against LN.	[Chen, Xi; Wen, Zhenke; Xiong, Sidong] Fudan Univ, Shanghai Med Coll, Inst Immunobiol, Shanghai 200433, Peoples R China; [Xu, Wei; Xiong, Sidong] Soochow Univ, Inst Biol & Med Sci, Suzhou, Peoples R China	Fudan University; Soochow University - China	Xiong, SD (corresponding author), Fudan Univ, Shanghai Med Coll, Inst Immunobiol, Shanghai 200433, Peoples R China.	sdxiongfd@126.com			National Natural Science Foundation of China [30890141, 81273300]; Major State Basic Research Development Program of China [2013CB530501]; Jiangsu Provincial Innovative Research Team; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Program for Changjiang Scholars and Innovative Research Team in University [PCSIRT-IRT1075]; Jiangsu "333" project of cultivation of high-level talents; Qing Lan Project of the Jiangsu higher education institutions; Jiangsu "Pan-Deng" Project [BK2010004]; Shanghai STC grant [10JC1401400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China(National Basic Research Program of China); Jiangsu Provincial Innovative Research Team; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Jiangsu "333" project of cultivation of high-level talents; Qing Lan Project of the Jiangsu higher education institutions; Jiangsu "Pan-Deng" Project; Shanghai STC grant	This work was supported by grants from the National Natural Science Foundation of China (30890141, 81273300), Major State Basic Research Development Program of China (2013CB530501), Jiangsu Provincial Innovative Research Team, Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT-IRT1075), Jiangsu "333" project of cultivation of high-level talents, Qing Lan Project of the Jiangsu higher education institutions, Jiangsu "Pan-Deng" Project (BK2010004), Shanghai STC grant (10JC1401400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders HJ, 2011, KIDNEY INT, V80, P915, DOI 10.1038/ki.2011.217; BATEMAN A, 1990, BIOCHEM BIOPH RES CO, V173, P1161, DOI 10.1016/S0006-291X(05)80908-8; Bateman A, 2009, BIOESSAYS, V31, P1245, DOI 10.1002/bies.200900086; Bomback AS, 2010, J AM SOC NEPHROL, V21, P2028, DOI 10.1681/ASN.2010050472; Borchers AT, 2012, AUTOIMMUN REV, V12, P174, DOI 10.1016/j.autrev.2012.08.018; Cenik B, 2012, J BIOL CHEM, V287, P32298, DOI 10.1074/jbc.R112.399170; Chen M, 2011, MOL IMMUNOL, V48, P1532, DOI 10.1016/j.molimm.2011.04.016; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Feng JAQ, 2010, FASEB J, V24, P1879, DOI 10.1096/fj.09-144659; Gao B, 2009, HEPATOLOGY, V50, P424, DOI 10.1002/hep.23011; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gui J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046515; Hrabal R, 1996, NAT STRUCT BIOL, V3, P747, DOI 10.1038/nsb0996-747; Jian J, 2012, J LEUKOC BIOL; Justen H P, 2000, Mol Cell Biol Res Commun, V3, P165, DOI 10.1006/mcbr.2000.0211; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Lewis E, 2005, LUPUS, V14, P31, DOI 10.1191/0961203305lu2056oa; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Matsubara T, 2012, CELL METAB, V15, P38, DOI 10.1016/j.cmet.2011.12.002; Mok CC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/638413; Monami G, 2006, CANCER RES, V66, P7103, DOI 10.1158/0008-5472.CAN-06-0633; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; NEWCOMB JR, 1993, J IMMUNOL, V150, P499; Ong CHP, 2003, HISTOL HISTOPATHOL, V18, P1275, DOI 10.14670/HH-18.1275; Park B, 2011, IMMUNITY, V34, P505, DOI 10.1016/j.immuni.2011.01.018; Paulson JC, 2007, CELL, V130, P589, DOI 10.1016/j.cell.2007.08.009; PERRONE RD, 1992, CLIN CHEM, V38, P1933; PLOWMAN GD, 1992, J BIOL CHEM, V267, P13073; Puga I, 2012, NAT IMMUNOL, V13, P170, DOI 10.1038/ni.2194; Qiao B, 2005, RHEUMATOLOGY, V44, P1108, DOI 10.1093/rheumatology/keh656; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Sastry L, 2002, GENE THER, V9, P1155, DOI 10.1038/sj.gt.3301731; Schiffer L, 2008, J IMMUNOL, V180, P1938, DOI 10.4049/jimmunol.180.3.1938; SHOYAB M, 1990, P NATL ACAD SCI USA, V87, P7912, DOI 10.1073/pnas.87.20.7912; Sutterwala FS, 1997, J EXP MED, V185, P1977, DOI 10.1084/jem.185.11.1977; Tanaka A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4087; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Toh H, 2011, J MOL NEUROSCI, V45, P538, DOI 10.1007/s12031-011-9569-4; Triantafyllopoulou A, 2010, P NATL ACAD SCI USA, V107, P3012, DOI 10.1073/pnas.0914902107; Vercellino M, 2011, MULT SCLER J, V17, P1194, DOI 10.1177/1352458511406164; Wen Z, 2012, LUPUS, V21, P508, DOI 10.1177/0961203311434940; Wen ZK, 2007, RHEUMATOLOGY, V46, P1796, DOI 10.1093/rheumatology/kem275; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Youn BS, 2009, DIABETES, V58, P627, DOI 10.2337/db08-1147; Zanocco-Marani T, 1999, CANCER RES, V59, P5331; Zhang WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022659; Zhang WJ, 2011, J IMMUNOL, V187, P1764, DOI 10.4049/jimmunol.1002315; Zhang WJ, 2010, J IMMUNOL, V184, P6465, DOI 10.4049/jimmunol.0904016; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	52	17	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65542	10.1371/journal.pone.0065542	http://dx.doi.org/10.1371/journal.pone.0065542			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755248	gold, Green Published, Green Submitted			2022-12-27	WOS:000320579400064
J	Nieuwenhuis, ILC; Folia, V; Forkstam, C; Jensen, O; Petersson, KM				Nieuwenhuis, Ingrid L. C.; Folia, Vasiliki; Forkstam, Christian; Jensen, Ole; Petersson, Karl Magnus			Sleep Promotes the Extraction of Grammatical Rules	PLOS ONE			English	Article							SLOW-WAVE SLEEP; MEMORY CONSOLIDATION; ARTIFICIAL GRAMMARS; CHUNK STRENGTH; KNOWLEDGE; SYNTAX; CLASSIFICATION; NEUROBIOLOGY; ABSTRACTION; ACQUISITION	Grammar acquisition is a high level cognitive function that requires the extraction of complex rules. While it has been proposed that offline time might benefit this type of rule extraction, this remains to be tested. Here, we addressed this question using an artificial grammar learning paradigm. During a short-term memory cover task, eighty-one human participants were exposed to letter sequences generated according to an unknown artificial grammar. Following a time delay of 15 min, 12 h (wake or sleep) or 24 h, participants classified novel test sequences as Grammatical or Non-Grammatical. Previous behavioral and functional neuroimaging work has shown that classification can be guided by two distinct underlying processes: (1) the holistic abstraction of the underlying grammar rules and (2) the detection of sequence chunks that appear at varying frequencies during exposure. Here, we show that classification performance improved after sleep. Moreover, this improvement was due to an enhancement of rule abstraction, while the effect of chunk frequency was unaltered by sleep. These findings suggest that sleep plays a critical role in extracting complex structure from separate but related items during integrative memory processing. Our findings stress the importance of alternating periods of learning with sleep in settings in which complex information must be acquired.	[Nieuwenhuis, Ingrid L. C.; Folia, Vasiliki; Forkstam, Christian; Jensen, Ole; Petersson, Karl Magnus] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Nieuwenhuis, Ingrid L. C.] Univ Calif Berkeley, Dept Psychol, Sleep & Neuroimaging Lab, Berkeley, CA 94720 USA; [Folia, Vasiliki; Forkstam, Christian; Petersson, Karl Magnus] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Folia, Vasiliki] Dept Clin Neurosci, Karolinska Inst, Stockholm Brain Inst, Cognit Neurophysiol Res Grp, Stockholm, Sweden; [Forkstam, Christian; Petersson, Karl Magnus] Univ Algarve, Cognit Neurosci Res Grp, Inst Biotechnol & Bioengn, Ctr Mol & Struct Biomed, Faro, Portugal	Radboud University Nijmegen; University of California System; University of California Berkeley; Max Planck Society; Karolinska Institutet; Universidade do Algarve	Nieuwenhuis, ILC (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	inieuwenhuis@berkeley.edu	GNC, GNC/B-5716-2013; Jensenq, Ole/D-2120-2010; Petersson, Karl Magnus/E-8188-2012; Petersson, Karl Magnus/HDO-0143-2022	Jensenq, Ole/0000-0001-8193-8348; Petersson, Karl Magnus/0000-0002-8245-0392; Petersson, Karl Magnus/0000-0002-8245-0392; Folia, Vasiliki/0000-0002-2159-7032	Dutch National Science Foundation [NWO 051-04-100]; Fundacao para a Ciencia e Tecnologia [PTDC/PSI-PCO/110734/2009]; Max Planck Institute for Psycholinguistics; Donders Institute for Brain; Cognition and Behaviour; Vetenskapsradet; Fundação para a Ciência e a Tecnologia [PTDC/PSI-PCO/110734/2009] Funding Source: FCT	Dutch National Science Foundation(Netherlands Organization for Scientific Research (NWO)); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Max Planck Institute for Psycholinguistics(Max Planck Society); Donders Institute for Brain; Cognition and Behaviour; Vetenskapsradet(Swedish Research Council); Fundação para a Ciência e a Tecnologia	This work was supported by grants from the Dutch National Science Foundation (grant numbers NWO 051-04-100), Fundacao para a Ciencia e Tecnologia (PTDC/PSI-PCO/110734/2009; IBB/CBME, LA, FEDER/POCI 2010), Max Planck Institute for Psycholinguistics, Donders Institute for Brain, Cognition and Behaviour, and Vetenskapsradet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai DJ, 2009, P NATL ACAD SCI USA, V106, P10130, DOI 10.1073/pnas.0900271106; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Diekelmann S, 2009, SLEEP MED REV, V13, P309, DOI 10.1016/j.smrv.2008.08.002; Dienes Z, 2005, PSYCHOL RES-PSYCH FO, V69, P338, DOI 10.1007/s00426-004-0208-3; Dienes Z, 2010, CONSCIOUS COGN, V19, P674, DOI 10.1016/j.concog.2009.09.009; Durrant SJ, 2011, NEUROPSYCHOLOGIA, V49, P1322, DOI 10.1016/j.neuropsychologia.2011.02.015; Ellenbogen JM, 2007, P NATL ACAD SCI USA, V104, P7723, DOI 10.1073/pnas.0700094104; Folia V, 2011, BIOLINGUISTICS, V5, P105; Folia V, 2008, ANN NY ACAD SCI, V1145, P132, DOI 10.1196/annals.1416.012; Forkstam C, 2005, CURR OPIN NEUROL, V18, P435, DOI 10.1097/01.wco.0000171951.82995.c4; Forkstam C, 2008, BRAIN RES, V1221, P80, DOI 10.1016/j.brainres.2008.05.005; Forkstam C, 2006, NEUROIMAGE, V32, P956, DOI 10.1016/j.neuroimage.2006.03.057; Frankland PW, 2006, P NATL ACAD SCI USA, V103, P509, DOI 10.1073/pnas.0510133103; Gomez RL, 2006, PSYCHOL SCI, V17, P670, DOI 10.1111/j.1467-9280.2006.01764.x; Keppel G., 2004, DESIGN ANAL RES HDB; Knowlton BJ, 1996, J EXP PSYCHOL LEARN, V22, P169, DOI 10.1037/0278-7393.22.1.169; Kouider S, 2010, TRENDS COGN SCI, V14, P301, DOI 10.1016/j.tics.2010.04.006; Lau H, 2010, NEUROBIOL LEARN MEM, V93, P554, DOI 10.1016/j.nlm.2010.02.003; Lieberman MD, 2004, J COGNITIVE NEUROSCI, V16, P427, DOI 10.1162/089892904322926764; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; MCANDREWS MP, 1985, MEM COGNITION, V13, P469, DOI 10.3758/BF03198460; Meulemans T, 1997, J EXP PSYCHOL LEARN, V23, P1007; Peigneux P, 2003, NEUROIMAGE, V20, P125, DOI 10.1016/S1053-8119(03)00278-7; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; PERRUCHET P, 1990, J EXP PSYCHOL GEN, V119, P264, DOI 10.1037/0096-3445.119.3.264; Petersson KM, 2012, PHILOS T R SOC B, V367, P1971, DOI 10.1098/rstb.2012.0101; Petersson KM, 2012, BRAIN LANG, V120, P83, DOI 10.1016/j.bandl.2010.08.003; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; REBER AS, 1967, J VERB LEARN VERB BE, V6, P855, DOI 10.1016/S0022-5371(67)80149-X; REBER AS, 1989, J EXP PSYCHOL GEN, V118, P219, DOI 10.1037/0096-3445.118.3.219; Rudoy JD, 2009, SCIENCE, V326, P1079, DOI 10.1126/science.1179013; SEGER CA, 1994, PSYCHOL BULL, V115, P163, DOI 10.1037/0033-2909.115.2.163; SERVANSCHREIBER E, 1990, J EXP PSYCHOL LEARN, V16, P592, DOI 10.1037/0278-7393.16.4.592; Spencer RMC, 2006, CURR BIOL, V16, P1001, DOI 10.1016/j.cub.2006.03.094; Stadler M.A., 1998, HDB IMPLICIT LEARNIN; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Udden J, 2008, BRAIN RES, V1224, P69, DOI 10.1016/j.brainres.2008.05.070; Udden J, 2012, COGNITIVE SCI, V36, P1078, DOI 10.1111/j.1551-6709.2012.01235.x; Walker MP, 2010, NAT REV NEUROSCI, V11, DOI 10.1038/nrn2762-c1; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8	40	35	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65046	10.1371/journal.pone.0065046	http://dx.doi.org/10.1371/journal.pone.0065046			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166TB	23755173	gold, Green Published, Green Submitted			2022-12-27	WOS:000320579400037
J	Raitsos, DE; Pradhan, Y; Brewin, RJW; Stenchikov, G; Hoteit, I				Raitsos, Dionysios E.; Pradhan, Yaswant; Brewin, Robert J. W.; Stenchikov, Georgiy; Hoteit, Ibrahim			Remote Sensing the Phytoplankton Seasonal Succession of the Red Sea	PLOS ONE			English	Article							GENERAL-CIRCULATION; CLIMATE-CHANGE; OCEAN; MODEL	The Red Sea holds one of the most diverse marine ecosystems, primarily due to coral reefs. However, knowledge on large-scale phytoplankton dynamics is limited. Analysis of a 10-year high resolution Chlorophyll-a (Chl-a) dataset, along with remotely-sensed sea surface temperature and wind, provided a detailed description of the spatiotemporal seasonal succession of phytoplankton biomass in the Red Sea. Based on MODIS (Moderate-resolution Imaging Spectroradiometer) data, four distinct Red Sea provinces and seasons are suggested, covering the major patterns of surface phytoplankton production. The Red Sea Chl-a depicts a distinct seasonality with maximum concentrations seen during the winter time (attributed to vertical mixing in the north and wind-induced horizontal intrusion of nutrient-rich water in the south), and minimum concentrations during the summer (associated with strong seasonal stratification). The initiation of the seasonal succession occurs in autumn and lasts until early spring. However, weekly Chl-a seasonal succession data revealed that during the month of June, consistent anti-cyclonic eddies transfer nutrients and/or Chl-a to the open waters of the central Red Sea. This phenomenon occurs during the stratified nutrient depleted season, and thus could provide an important source of nutrients to the open waters. Remotely-sensed synoptic observations highlight that Chl-a does not increase regularly from north to south as previously thought. The Northern part of the Central Red Sea province appears to be the most oligotrophic area (opposed to southern and northern domains). This is likely due to the absence of strong mixing, which is apparent at the northern end of the Red Sea, and low nutrient intrusion in comparison with the southern end. Although the Red Sea is considered an oligotrophic sea, sporadic blooms occur that reach mesotrophic levels. The water temperature and the prevailing winds control the nutrient concentrations within the euphotic zone and enable the horizontal transportation of nutrients.	[Raitsos, Dionysios E.; Stenchikov, Georgiy; Hoteit, Ibrahim] King Abdullah Univ Sci & Technol, Earth Sci & Engn ErSE, Thuwal, Saudi Arabia; [Raitsos, Dionysios E.; Brewin, Robert J. W.] Plymouth Marine Lab, Remote Sensing Grp, Plymouth, Devon, England; [Pradhan, Yaswant] Met Off, Exeter, Devon, England	King Abdullah University of Science & Technology; Plymouth Marine Laboratory; Met Office - UK	Raitsos, DE (corresponding author), King Abdullah Univ Sci & Technol, Earth Sci & Engn ErSE, Thuwal, Saudi Arabia.	dra@pml.ac.uk	Raitsos, Dionysios/AAA-3031-2021; Pradhan, Yaswant/G-2040-2010; Stenchikov, Georgiy/AAA-4371-2022; Georgiy, Stenchikov/J-8569-2013	Raitsos, Dionysios/0000-0002-6714-2180; Pradhan, Yaswant/0000-0002-3680-4751; Hoteit, Ibrahim/0000-0002-3751-4393; Stenchikov, Georgiy Lvovich/0000-0001-9033-4925; Brewin, Robert/0000-0001-5134-8291	King Abdullah University for Science and Technology (KAUST), Kingdom of Saudi Arabia; NERC [earth010003, pml010009, pml010008] Funding Source: UKRI; Natural Environment Research Council [pml010008, pml010009, earth010003] Funding Source: researchfish	King Abdullah University for Science and Technology (KAUST), Kingdom of Saudi Arabia(King Abdullah University of Science & Technology); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was supported by the King Abdullah University for Science and Technology (KAUST), Kingdom of Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Acker J, 2008, J MARINE SYST, V69, P191, DOI 10.1016/j.jmarsys.2005.12.006; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Baars Martien A., 1998, P143; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Brown O.B., 1999, U MIAMI, V31, P098; Cantin NE, 2010, SCIENCE, V329, P322, DOI 10.1126/science.1190182; Edwards F.J., 1987, KEY ENV RED SEA, P45, DOI [10.1016/B978-0-08-028873-4.50008-6, DOI 10.1016/B978-0-08-028873-4.50008-6]; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Eshel G, 1997, J PHYS OCEANOGR, V27, P1233, DOI 10.1175/1520-0485(1997)027<1233:CCJCIW>2.0.CO;2; Feldman G. C., 2012, OCEAN COLOR WEB MODI; Irigoien X, 2002, NATURE, V419, P387, DOI 10.1038/nature01055; Johns WE, 1999, 20000160 RSMAS U MIA; Koblentz-Mishke OJ, 1970, SCI EXPLORATION S PA, P183; Lo-Yat A, 2011, GLOBAL CHANGE BIOL, V17, P1695, DOI 10.1111/j.1365-2486.2010.02355.x; Longhurst A.R, 2007, EC GEOGR SEA 2 ED; Maritorena S, 2002, APPL OPTICS, V41, P2705, DOI 10.1364/AO.41.002705; McClain CR, 2009, ANNU REV MAR SCI, V1, P19, DOI 10.1146/annurev.marine.010908.163650; Meissner T, 2009, IEEE T GEOSCI REMOTE, V47, P3065, DOI 10.1109/TGRS.2009.2027012; Miralto A, 1999, NATURE, V402, P173, DOI 10.1038/46023; Monterey G., 1997, NOAA ATLAS NESDIS; Morel A, 2007, REMOTE SENS ENVIRON, V111, P69, DOI 10.1016/j.rse.2007.03.012; Munday PL, 2008, FISH FISH, V9, P261, DOI 10.1111/j.1467-2979.2008.00281.x; Nybakken J. W., 1997, MARINE BIOL ECOLOGIC; OReilly J.E., 2000, SEAWIFS POSTLAUNCH C, P9; Paerl HW, 2003, BIOSCIENCE, V53, P953, DOI 10.1641/0006-3568(2003)053[0953:PPAIOE]2.0.CO;2; Papadopoulos VP, 2013, J CLIMATE, V26, P1685, DOI 10.1175/JCLI-D-12-00267.1; Raitsos DE, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047984; Sathyendranath S., 2000, REM SENS OC COL COAS, V3; Sofianos SS, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001185; Sofianos SS, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001184; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Weikert H., 1987, P90; Wilson C, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017770; Wilson C, 2008, PROG OCEANOGR, V78, P107, DOI 10.1016/j.pocean.2008.05.002	34	191	193	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64909	10.1371/journal.pone.0064909	http://dx.doi.org/10.1371/journal.pone.0064909			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755161	Green Published, Green Submitted, gold			2022-12-27	WOS:000320579400031
J	Zhang, RW; Liu, ZJ; Qu, YX; Xu, Y; Yang, Q				Zhang, Renwen; Liu, Zhijie; Qu, Youxing; Xu, Ying; Yang, Qing			Two Distinct Calmodulin Binding Sites in the Third Intracellular Loop and Carboxyl Tail of Angiotensin II (AT(1A)) Receptor	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; PROTEIN-KINASE-C; INTERACTING PROTEINS; SIGNAL-TRANSDUCTION; PARATHYROID-HORMONE; COUPLED RECEPTORS; G-BETA; PHOSPHORYLATION; TERMINUS; COMPLEX	In this study, we present data that support the presence of two distinct calmodulin binding sites within the angiotensin II receptor (AT(1A)), at juxtamembrane regions of the N-terminus of the third intracellular loop (i3, amino acids 214-231) and carboxyl tail of the receptor (ct, 302-317). We used bioluminescence resonance energy transfer assays to document interactions of calmodulin with the AT(1A) holo-receptor and GST-fusion protein pull-downs to demonstrate that i3 and ct interact with calmodulin in a Ca2+-dependent fashion. The former is a 1-12 motif and the latter belongs to 1-5-10 calmodulin binding motif. The apparent Kd of calmodulin for i3 is 177.0 +/- 9.1 nM, and for ct is 79.4 +/- 7.9 nM as assessed by dansyl-calmodulin fluorescence. Replacement of the tryptophan (W219) for alanine in i3, and phenylalanine (F309 or F313) for alanine in ct reduced their binding affinities for calmodulin, as predicted by computer docking simulations. Exogenously applied calmodulin attenuated interactions between G protein beta gamma-subunits and i3 and ct, somewhat more so for ct than i3. Mutations W219A, F309A, and F313A did not alter G beta gamma binding, but reduced the ability of calmodulin to compete with G beta gamma, suggesting that calmodulin and G beta gamma have overlapping, but not identical, binding requirements for i3 and ct. Calmodulin interference with the G beta gamma binding to i3 and ct regions of the AT(1A) receptor strongly suggests that calmodulin plays critical roles in regulating G beta gamma-dependent signaling of the receptor.	[Zhang, Renwen; Yang, Qing] Jilin Univ, Bethune Coll Med, Dept Pathogenobiol, Changchun 130023, Jilin, Peoples R China; [Liu, Zhijie; Qu, Youxing; Xu, Ying] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	Jilin University; University System of Georgia; University of Georgia	Yang, Q (corresponding author), Jilin Univ, Bethune Coll Med, Dept Pathogenobiol, Changchun 130023, Jilin, Peoples R China.	yangq@jlu.edu.cn	Yang, Qing/H-5342-2012	Yang, Qing/0000-0002-5068-6085	National Institutes of Health [DK63252]; Jilin University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK063252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jilin University(Jilin University); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was supported by the National Institutes of Health (DK63252 to Qing Yang, www2.niddk.nih.gov) and the Tang Aoqing professor award of Jilin University to Qing Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airas JM, 2001, FEBS LETT, V494, P60, DOI 10.1016/S0014-5793(01)02311-0; Ali MS, 1997, J BIOL CHEM, V272, P23382, DOI 10.1074/jbc.272.37.23382; Ango F, 2001, NATURE, V411, P962, DOI 10.1038/35082096; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; BERTRAND B, 1994, J BIOL CHEM, V269, P13703; Bofill-Cardona E, 2000, J BIOL CHEM, V275, P32672, DOI 10.1074/jbc.M002780200; Boute N, 2002, TRENDS PHARMACOL SCI, V23, P351, DOI 10.1016/S0165-6147(02)02062-X; Brady AE, 2002, CELL SIGNAL, V14, P297, DOI 10.1016/S0898-6568(01)00239-X; Buck F, 2000, ENDOCRINOLOGY, V141, P3717, DOI 10.1210/en.141.10.3717; Choi KY, 2011, J NEUROSCI, V31, P5921, DOI 10.1523/JNEUROSCI.6253-10.2011; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Daviet L, 1999, J BIOL CHEM, V274, P17058, DOI 10.1074/jbc.274.24.17058; Dev KK, 2001, TRENDS PHARMACOL SCI, V22, P355, DOI 10.1016/S0165-6147(00)01684-9; El Far O, 2001, J BIOL CHEM, V276, P30662, DOI 10.1074/jbc.M102573200; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/y96-124; Foord SM, 2005, PHARMACOL REV, V57, P279, DOI 10.1124/pr.57.2.5; Foord SM, 1999, TRENDS PHARMACOL SCI, V20, P184, DOI 10.1016/S0165-6147(99)01347-4; Guhan N, 2004, TRENDS NEUROSCI, V27, P645, DOI 10.1016/j.tins.2004.08.011; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Heuss C, 2000, TRENDS NEUROSCI, V23, P469, DOI 10.1016/S0166-2236(00)01643-X; Hultschig C, 2004, J MOL BIOL, V343, P559, DOI 10.1016/j.jmb.2004.08.012; Ishikawa K, 1999, GENES CELLS, V4, P381, DOI 10.1046/j.1365-2443.1999.00269.x; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; Kahl CR, 2003, ENDOCR REV, V24, P719, DOI 10.1210/er.2003-0008; Kim KM, 2005, J BIOL CHEM, V280, P12774, DOI 10.1074/jbc.M408901200; KINCAID RL, 1988, METHOD ENZYMOL, V159, P605; Kurokawa H, 2001, J MOL BIOL, V312, P59, DOI 10.1006/jmbi.2001.4822; Labasque M, 2008, MOL BIOL CELL, V19, P4640, DOI 10.1091/mbc.E08-04-0422; Liu GX, 2004, EMBO J, V23, P2196, DOI 10.1038/sj.emboj.7600228; Liu ZJ, 2004, J AM CHEM SOC, V126, P8515, DOI 10.1021/ja032018q; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; Mahon MJ, 2006, MOL ENDOCRINOL, V20, P136, DOI 10.1210/me.2005-0169; Mahon MJ, 2004, J BIOL CHEM, V279, P23550, DOI 10.1074/jbc.M313229200; Marrero MB, 1998, AM J PHYSIOL-CELL PH, V275, pC1216, DOI 10.1152/ajpcell.1998.275.5.C1216; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Minakami R, 1997, J BIOL CHEM, V272, P20291, DOI 10.1074/jbc.272.32.20291; Morgan KG, 2001, J APPL PHYSIOL, V91, P953, DOI 10.1152/jappl.2001.91.2.953; Mukhopadhyay S, 2002, CHEM PHYS LIPIDS, V121, P91, DOI 10.1016/S0009-3084(02)00153-6; Nakajima Y, 1999, J BIOL CHEM, V274, P27573, DOI 10.1074/jbc.274.39.27573; Nanoff C, 1997, PHYSIOL RES, V46, P79; Nickols HH, 2004, J BIOL CHEM, V279, P46969, DOI 10.1074/jbc.M407351200; O'Connor V, 1999, SCIENCE, V286, P1180, DOI 10.1126/science.286.5442.1180; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; Taylor JM, 1996, J BIOL CHEM, V271, P3336; Thomas WG, 1999, FEBS LETT, V455, P367, DOI 10.1016/S0014-5793(99)00904-7; Turner JH, 2005, J BIOL CHEM, V280, P30741, DOI 10.1074/jbc.M501696200; Turner JH, 2004, J BIOL CHEM, V279, P17027, DOI 10.1074/jbc.M313919200; Venema RC, 1998, J BIOL CHEM, V273, P7703, DOI 10.1074/jbc.273.13.7703; VORHERR T, 1990, BIOCHEMISTRY-US, V29, P355, DOI 10.1021/bi00454a008; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Wang DX, 1999, J BIOL CHEM, V274, P22081, DOI 10.1074/jbc.274.31.22081	59	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65266	10.1371/journal.pone.0065266	http://dx.doi.org/10.1371/journal.pone.0065266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755207	Green Published, Green Submitted, gold			2022-12-27	WOS:000320579400049
J	Erra, EO; Korhonen, EM; Voutilainen, L; Huhtamo, E; Vapalahti, O; Kantele, A				Erra, Elina O.; Korhonen, Essi M.; Voutilainen, Liina; Huhtamo, Eili; Vapalahti, Olli; Kantele, Anu			Dengue in Travelers: Kinetics of Viremia and NS1 Antigenemia and Their Associations with Clinical Parameters	PLOS ONE			English	Article							REVERSE TRANSCRIPTION-PCR; DISEASE SEVERITY; NONSTRUCTURAL PROTEIN-1; HEMORRHAGIC-FEVER; VIRUS-INFECTIONS; SHOCK SYNDROME; IMMUNE STATUS; DIAGNOSIS; SEROTYPE; ASSAY	Despite the increasing numbers of travel-acquired dengue, few studies have assessed virologic markers of the disease in non-endemic populations. We examined the kinetics of diagnostic markers and their associations with clinical parameters in 93 patients with travel-acquired dengue fever. Kinetics analyses suggested a longer average duration for viremia (9 days, CI95%: 8-10) and non-structural protein 1 (NS1) antigenemia (15 days, CI95%: 12-20) than reported in endemic populations. While none of the tests sufficed alone, the best diagnostic coverage was achieved by combining antibody detection with RNA or NS1 testing. Studied by regression models, early relative levels of viremia and NS1 antigenemia proved to be significantly associated with several clinical parameters: high viremia predicted greater likelihood and increased length of hospitalization, the degree of NS1 antigenemia correlated positively with hematocrit and liver transaminases, and both viremia and NS1 antigenemia levels negatively with platelet counts in follow-up. Levels of viremia and NS1 antigenemia may serve as predictors of the clinical manifestations in travel-acquired dengue.	[Erra, Elina O.; Kantele, Anu] Univ Helsinki, Cent Hosp, Dept Med, Div Infect Dis, Helsinki, Finland; [Erra, Elina O.; Kantele, Anu] Univ Helsinki, Fac Med, Haartman Inst, Dept Bacteriol & Immunol, Helsinki, Finland; [Korhonen, Essi M.; Voutilainen, Liina; Huhtamo, Eili; Vapalahti, Olli] Univ Helsinki, Fac Med, Haartman Inst, Dept Virol, Helsinki, Finland; [Voutilainen, Liina] Finnish Forest Res Inst, Vantaa Res Unit, Vantaa, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Natural Resources Institute Finland (Luke)	Erra, EO (corresponding author), Univ Helsinki, Cent Hosp, Dept Med, Div Infect Dis, Helsinki, Finland.	elina.erra@gmail.com	Huhtamo, Eili/GOJ-9502-2022; Kantele, Anu/AAS-4131-2021; Korhonen, Essi Marjaana/CAF-5553-2022	Kantele, Anu/0000-0002-0004-1000; Korhonen, Essi/0000-0003-4730-7715; Vapalahti, Olli/0000-0003-2270-6824; Huhtamo, Eili/0000-0001-9640-6547	Finnish governmental subsidy for health science research; Academy of Finland; Finnish Medical Foundation	Finnish governmental subsidy for health science research; Academy of Finland(Academy of Finland); Finnish Medical Foundation	This work was supported by the Finnish governmental subsidy for health science research, the Academy of Finland, and the Finnish Medical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002; Anders KL, 2011, AM J TROP MED HYG, V84, P127, DOI 10.4269/ajtmh.2011.10-0476; Baaten GGG, 2011, EMERG INFECT DIS, V17, P821, DOI 10.3201/eid1705.101125; Barton K., 2011, MUMIN MULTIMODEL INF; Burnham KP, 2000, MODEL SELECTION INFE, P353; Duong V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001244; Dussart P, 2006, CLIN VACCINE IMMUNOL, V13, P1185, DOI 10.1128/CVI.00229-06; Duyen HTL, 2011, J INFECT DIS, V203, P1292, DOI 10.1093/infdis/jir014; Fox A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000967; Fry SR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001199; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; HALSTEAD SB, 1970, YALE J BIOL MED, V42, P350; Hu DM, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-47; Huhtamo E, 2008, EMERG INFECT DIS, V14, P80, DOI 10.3201/eid1401.070865; Huhtamo E, 2010, J CLIN VIROL, V47, P49, DOI 10.1016/j.jcv.2009.11.001; Hunsperger EA, 2009, EMERG INFECT DIS, V15, P436, DOI 10.3201/eid1503.080923; Khor CC, 2011, NAT GENET, V43, P1139, DOI 10.1038/ng.960; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Lehtinen VA, 2008, J CLIN VIROL, V43, P93, DOI 10.1016/j.jcv.2008.05.001; Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365; Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813; Lindegren G, 2005, J CLIN MICROBIOL, V43, P2850, DOI 10.1128/JCM.43.6.2850-2855.2005; Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Tran NBC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000657; Tricou V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001309; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; VENE S, 1995, CLIN DIAGN VIROL, V4, P43, DOI 10.1016/0928-0197(94)00060-8; WHO, 1997, DENG HAEM FEV DIAGN; Wichmann O, 2007, J INFECT DIS, V195, P1089, DOI 10.1086/512680; Wilder-Smith A, 2005, NEW ENGL J MED, V353, P924, DOI 10.1056/NEJMra041927; Wood S., 2011, R PACKAGE VERSION, V0, P1; World Health Organization, 2009, DENGUE GUIDELINES DI; World Health Organization, 2012, DENG SEV DENG	37	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65900	10.1371/journal.pone.0065900	http://dx.doi.org/10.1371/journal.pone.0065900			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755291	gold, Green Published, Green Submitted			2022-12-27	WOS:000319872300098
J	Pierno, S; Camerino, GM; Cannone, M; Liantonio, A; De Bellis, M; Digennaro, C; Gramegna, G; De Luca, A; Germinario, E; Danieli-Betto, D; Betto, R; Dobrowolny, G; Rizzuto, E; Musaro, A; Desaphy, JF; Camerino, DC				Pierno, Sabata; Camerino, Giulia M.; Cannone, Maria; Liantonio, Antonella; De Bellis, Michela; Digennaro, Claudio; Gramegna, Gianluca; De Luca, Annamaria; Germinario, Elena; Danieli-Betto, Daniela; Betto, Romeo; Dobrowolny, Gabriella; Rizzuto, Emanuele; Musaro, Antonio; Desaphy, Jean-Francois; Camerino, Diana Conte			Paracrine Effects of IGF-1 Overexpression on the Functional Decline Due to Skeletal Muscle Disuse: Molecular and Functional Evaluation in Hindlimb Unloaded MLC/mIgf-1 Transgenic Mice	PLOS ONE			English	Article							GROWTH-FACTOR-I; CHANNEL REGULATION; GENE-EXPRESSION; ATROPHY; PROTEIN; ACTIVATION; EXERCISE; REGENERATION; HYPERTROPHY; SOLEUS	Slow-twitch muscles, devoted to postural maintenance, experience atrophy and weakness during muscle disuse due to bed-rest, aging or spaceflight. These conditions impair motion activities and can have survival implications. Human and animal studies demonstrate the anabolic role of IGF-1 on skeletal muscle suggesting its interest as a muscle disuse countermeasure. Thus, we tested the role of IGF-1 overexpression on skeletal muscle alteration due to hindlimb unloading (HU) by using MLC/mIgf-1 transgenic mice expressing IGF-1 under the transcriptional control of MLC promoter, selectively activated in skeletal muscle. HU produced atrophy in soleus muscle, in terms of muscle weight and fiber cross-sectional area (CSA) reduction, and up-regulation of atrophy gene MuRF1. In parallel, the disuse-induced slow-to-fast fiber transition was confirmed by an increase of the fast-type of the Myosin Heavy Chain (MHC), a decrease of PGC-1 alpha expression and an increase of histone deacetylase-5 (HDAC5). Consistently, functional parameters such as the resting chloride conductance (gCl) together with ClC-1 chloride channel expression were increased and the contractile parameters were modified in soleus muscle of HU mice. Surprisingly, IGF-1 overexpression in HU mice was unable to counteract the loss of muscle weight and the decrease of fiber CSA. However, the expression of MuRF1 was recovered, suggesting early effects on muscle atrophy. Although the expression of PGC-1 alpha and MHC were not improved in IGF-1-HU mice, the expression of HDAC5 was recovered. Importantly, the HU-induced increase of gCl was fully contrasted in IGF-1 transgenic mice, as well as the changes in contractile parameters. These results indicate that, even if local expression does not seem to attenuate HU-induced atrophy and slow-to-fast phenotype transition, it exerts early molecular effects on gene expression which can counteract the HU-induced modification of electrical and contractile properties. MuRF1 and HDAC5 can be attractive therapeutic targets for pharmacological countermeasures and then deserve further investigations.	[Pierno, Sabata; Camerino, Giulia M.; Cannone, Maria; Liantonio, Antonella; De Bellis, Michela; Digennaro, Claudio; Gramegna, Gianluca; De Luca, Annamaria; Desaphy, Jean-Francois; Camerino, Diana Conte] Univ Bari Aldo Moro, Dept Pharm & Drug Sci, Pharmacol Sect, Bari, Italy; [Germinario, Elena] Univ Padua, Dept Biomed Sci, Padua, Italy; [Betto, Romeo] CNR, Inst Neurosci, Padua, Italy; [Dobrowolny, Gabriella; Musaro, Antonio] Sapienza Univ Roma, Ist Italiano Tecnol, DAHFMO Unit Histol & Med Embryol, Inst Pasteur Cenci Bolognetti,IIM, Rome, Italy; [Rizzuto, Emanuele] Sapienza Univ Roma, Dept Mech & Aerosp Engn, IIM, Rome, Italy	Universita degli Studi di Bari Aldo Moro; University of Padua; Consiglio Nazionale delle Ricerche (CNR); Fondazione Cenci Bolognetti; Istituto Italiano di Tecnologia - IIT; Sapienza University Rome; Sapienza University Rome	Pierno, S (corresponding author), Univ Bari Aldo Moro, Dept Pharm & Drug Sci, Pharmacol Sect, Bari, Italy.	sabata.pierno@uniba.it	Rizzuto, Emanuele/K-9437-2016; Musaro, Antonio/P-2953-2019; Musarò, Antonio/K-9598-2016; Desaphy, Jean-Francois/T-6191-2019; De Bellis, Michela/ABE-2595-2020; Camerino, Giulia Maria/I-6896-2013	Rizzuto, Emanuele/0000-0003-2314-6128; Musaro, Antonio/0000-0002-2944-9739; Musarò, Antonio/0000-0002-2944-9739; Desaphy, Jean-Francois/0000-0001-8816-9369; Pierno, Sabata/0000-0003-3121-2666; Dobrowolny, Gabriella/0000-0001-8693-0724; Liantonio, Antonella/0000-0002-4103-7577; DANIELI, DANIELA/0000-0002-6186-8327; De Luca, Annamaria/0000-0002-5652-7341; De Bellis, Michela/0000-0001-8706-2885; Camerino, Giulia Maria/0000-0003-1410-6327	Italian Space Agency	Italian Space Agency(Agenzia Spaziale Italiana (ASI))	This work was supported by the Italian Space Agency grants to D. Conte Camerino (project OSMA Osteoporosis and Muscle Atrophy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GR, 2003, J APPL PHYSIOL, V95, P2185, DOI 10.1152/japplphysiol.00346.2003; Adams GR, 1998, J APPL PHYSIOL, V84, P1716, DOI 10.1152/jappl.1998.84.5.1716; Alamdari N, 2013, METABOLISM, V62, P1, DOI 10.1016/j.metabol.2012.03.019; Alamdari N, 2010, AM J PHYSIOL-REG I, V299, pR509, DOI 10.1152/ajpregu.00858.2009; Alzghoul MB, 2004, FASEB J, V18, P221, DOI 10.1096/fj.03-0293fje; Arya R, 2004, J CELL BIOL, V167, P1147, DOI 10.1083/jcb.200402033; Awede B, 1999, FEBS LETT, V461, P263, DOI 10.1016/S0014-5793(99)01469-6; Bae SK, 2012, J APPL PHYSIOL, V113, P114, DOI 10.1152/japplphysiol.00431.2011; Bajotto G, 2006, J NUTR SCI VITAMINOL, V52, P233, DOI 10.3177/jnsv.52.233; Barton ER, 2002, J CELL BIOL, V157, P137, DOI 10.1083/jcb.200108071; Barton-Davis ER, 1998, P NATL ACAD SCI USA, V95, P15603, DOI 10.1073/pnas.95.26.15603; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Blaauw B, 2009, FASEB J, V23, P3896, DOI 10.1096/fj.09-131870; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Brocca L, 2010, EXP PHYSIOL, V95, P331, DOI 10.1113/expphysiol.2009.050245; BRYANT SH, 1991, PFLUG ARCH EUR J PHY, V417, P605, DOI 10.1007/BF00372958; Burks TN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002227; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Chrysis D, 2011, HORM-INT J ENDOCRINO, V10, P46, DOI 10.14310/horm.2002.1292; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Criswell DS, 1998, AM J PHYSIOL-ENDOC M, V275, pE373; D'Andrea M, 2006, J CELL PHYSIOL, V207, P379, DOI 10.1002/jcp.20585; De Luca A, 1998, BRIT J PHARMACOL, V125, P477, DOI 10.1038/sj.bjp.0702107; De Luca A, 1999, NEUROMUSCULAR DISORD, V9, P11, DOI 10.1016/S0960-8966(98)00092-3; De Luca A, 2003, J PHARMACOL EXP THER, V304, P453, DOI 10.1124/jpet.102.041343; Del Prete Z, 2008, ANN BIOMED ENG, V36, P1281, DOI 10.1007/s10439-008-9496-x; Delbono O, 2000, J Nutr Health Aging, V4, P162; DELUCA A, 1992, PFLUG ARCH EUR J PHY, V420, P407, DOI 10.1007/BF00374477; Desaphy JF, 2010, PHARMACOL RES, V61, P553, DOI 10.1016/j.phrs.2010.01.012; Desaphy JF, 2005, NEUROBIOL DIS, V18, P356, DOI 10.1016/j.nbd.2004.09.016; Desaphy JF, 2001, BRAIN, V124, P1100, DOI 10.1093/brain/124.6.1100; Dumont N, 2010, AM J PATHOL, V176, P2228, DOI 10.2353/ajpath.2010.090884; Dupont E, 2011, AM J PHYSIOL-REG I, V300, pR408, DOI 10.1152/ajpregu.00793.2009; Fraysse B, 2006, NEUROBIOL DIS, V21, P372, DOI 10.1016/j.nbd.2005.07.012; Fraysse B, 2003, FASEB J, V17, P1916, DOI 10.1096/fj.02-1012fje; Goldspink G, 2004, EXP GERONTOL, V39, P1433, DOI 10.1016/j.exger.2004.08.010; Goldspink G, 2006, INT J BIOCHEM CELL B, V38, P480, DOI 10.1016/j.biocel.2005.10.013; Gonzalez E, 2003, J PHYSIOL-LONDON, V552, P833, DOI 10.1113/jphysiol.2003.048165; Gundersen K, 2010, BIOL REV CAMB PHILOS, V86, P564; Kim SJ, 2008, J APPL PHYSIOL, V105, P1246, DOI 10.1152/japplphysiol.90668.2008; Kunkel SD, 2011, CELL METAB, V13, P627, DOI 10.1016/j.cmet.2011.03.020; Lawler JM, 2012, MED SCI SPORT EXER, V44, P600, DOI 10.1249/MSS.0b013e31823ab37a; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; LINDERMAN JK, 1994, AM J PHYSIOL, V267, pR365, DOI 10.1152/ajpregu.1994.267.2.R365; Mcgee SL, 2011, J APPL PHYSIOL, V110, P258, DOI 10.1152/japplphysiol.00979.2010; Morey-Holton E, 2005, ADV SPACE B, V10, P7, DOI 10.1016/S1569-2574(05)10002-1; Murton AJ, 2008, BBA-MOL BASIS DIS, V1782, P730, DOI 10.1016/j.bbadis.2008.10.011; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Nakao R, 2009, MOL CELL BIOL, V29, P4798, DOI 10.1128/MCB.01347-08; Pelosi L, 2007, FASEB J, V21, P1393, DOI 10.1096/fj.06-7690com; Pierno S, 2002, BRAIN, V125, P1510, DOI 10.1093/brain/awf162; Pierno S, 2009, BRIT J PHARMACOL, V156, P1206, DOI 10.1111/j.1476-5381.2008.00079.x; Pierno S, 1999, FEBS LETT, V449, P12, DOI 10.1016/S0014-5793(99)00202-1; Pierno S, 2007, J PHYSIOL-LONDON, V584, P983, DOI 10.1113/jphysiol.2007.141358; Pierno S, 2012, AMINO ACIDS, V43, P431, DOI 10.1007/s00726-011-1099-4; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Rinaldi C, 2012, MOL MED, DOI [10.2119/molmed.2012.00271, DOI 10.2119/M0LMED.2012.00271.[]; Ringseis R, 2013, BBA-GEN SUBJECTS, V1830, P2105, DOI 10.1016/j.bbagen.2012.09.024; Sandona D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033232; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Schertzer JD, 2006, GENE THER, V13, P1657, DOI 10.1038/sj.gt.3302817; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Scicchitano BM, 2009, AGING-US, V1, P451, DOI 10.18632/aging.100050; Shavlakadze T, 2010, J APPL PHYSIOL, V108, P1829, DOI 10.1152/japplphysiol.00312.2010; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Trappe S, 2009, J APPL PHYSIOL, V106, P1159, DOI 10.1152/japplphysiol.91578.2008; Vernikos J, 1996, BIOESSAYS, V18, P1029, DOI 10.1002/bies.950181215; Willis MS, 2007, CIRC RES, V100, P456, DOI 10.1161/01.RES.0000259559.48597.32; Wu H, 2002, J CLIN INVEST, V109, P1327, DOI 10.1172/JCI200215417; Yang SY, 1996, J MUSCLE RES CELL M, V17, P487, DOI 10.1007/BF00123364	72	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65167	10.1371/journal.pone.0065167	http://dx.doi.org/10.1371/journal.pone.0065167			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755187	Green Submitted, Green Published, gold			2022-12-27	WOS:000319872300053
J	de la Cueva, A; de Molina, AR; Alvarez-Ayerza, N; Ramos, MA; Cebrian, A; del Pulgar, TG; Lacal, JC				de la Cueva, Ana; Ramirez de Molina, Ana; Alvarez-Ayerza, Nestor; Angeles Ramos, Ma; Cebrian, Arancha; Gomez del Pulgar, Teresa; Carlos Lacal, Juan			Combined 5-FU and ChoK alpha Inhibitors as a New Alternative Therapy of Colorectal Cancer: Evidence in Human Tumor-Derived Cell Lines and Mouse Xenografts	PLOS ONE			English	Article							THYMIDYLATE SYNTHASE EXPRESSION; CHOLINE KINASE-ALPHA; PHOSPHOLIPID-METABOLISM; PROTEIN EXPRESSION; 1ST-LINE TREATMENT; PLUS IRINOTECAN; HUMAN BREAST; PHASE-II; 5-FLUOROURACIL; FLUOROURACIL	Background: Colorectal cancer (CRC) is the third major cause of cancer related deaths in the world. 5-fluorouracil (5-FU) is widely used for the treatment of colorectal cancer but as a single-agent renders low response rates. Choline kinase alpha (ChoK alpha), an enzyme that plays a role in cell proliferation and transformation, has been reported overexpressed in many different tumors, including colorectal tumors. ChoK alpha inhibitors have recently entered clinical trials as a novel antitumor strategy. Methodology/Principal Findings: ChoK alpha specific inhibitors, MN58b and TCD-717, have demonstrated a potent antitumoral activity both in vitro and in vivo against several tumor-derived cell line xenografts including CRC-derived cell lines. The effect of ChoK alpha inhibitors in combination with 5-FU as a new alternative for the treatment of colon tumors has been investigated both in vitro in CRC-tumour derived cell lines, and in vivo in mouse xenografts models. The effects on thymidilate synthase (TS) and thymidine kinase (TK1) levels, two enzymes known to play an essential role in the mechanism of action of 5-FU, were analyzed by western blotting and quantitative PCR analysis. The combination of 5-FU with ChoK alpha inhibitors resulted in a synergistic effect in vitro in three different human colon cancer cell lines, and in vivo against human colon xenografts in nude mice. ChoK alpha inhibitors modulate the expression levels of TS and TK1 through inhibition of E2F production, providing a rational for its mechanism of action. Conclusion/Significance: Our data suggest that both drugs in combination display a synergistic antitumoral effect due to ChoK alpha inhibitors-driven modulation of the metabolization of 5-FU. The clinical relevance of these findings is strongly supported since TCD-717 has recently entered Phase I clinical trials against solid tumors.	[de la Cueva, Ana; Ramirez de Molina, Ana; Alvarez-Ayerza, Nestor; Angeles Ramos, Ma; Cebrian, Arancha; Gomez del Pulgar, Teresa; Carlos Lacal, Juan] CSIC, Inst Invest Biomed, Traslat Oncol Unit, Madrid, Spain; [Carlos Lacal, Juan] Inst Invest Sanitaria IdiPAZ, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Lacal, JC (corresponding author), CSIC, Inst Invest Biomed, Traslat Oncol Unit, Madrid, Spain.	jclacal@iib.uam.es	de Molina, Ana Ramirez/AAA-3848-2019; Lacal, Juan Carlos/AAL-2235-2020; Gomez del Pulgar, Teresa/GXV-5256-2022; Lacal, Juan Carlos/N-9064-2015	Lacal, Juan Carlos/0000-0002-1908-2777; Cebrian Aranda, Arancha/0000-0002-6260-1376	Comunidad de Madrid [S-BIO/0280/2006, S2010/BMD-2326]; Ministerio de Ciencia e Innovacion [SAF2008-03750, SAF2011-29699, RD06-0020-0016, RD12/0036/0019]; EU [259737]	Comunidad de Madrid(Comunidad de Madrid); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); EU(European Commission)	This work has been funded by the following grants: Comunidad de Madrid (S-BIO/0280/2006 and S2010/BMD-2326), Ministerio de Ciencia e Innovacion (SAF2008-03750, SAF2011-29699, RD06-0020-0016 and RD12/0036/0019) and EU #259737. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandres E, 2007, WORLD J GASTROENTERO, V13, P5888, DOI 10.3748/wjg.v13.i44.5888; Campos J, 2001, EUR J MED CHEM, V36, P215, DOI 10.1016/S0223-5234(01)01219-3; CANNON JG, 1994, MED RES REV, V14, P505, DOI 10.1002/med.2610140503; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; CHU E, 1991, MOL PHARMACOL, V39, P136; Chua BT, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-131; Clem BF, 2011, ONCOGENE, V30, P3370, DOI 10.1038/onc.2011.51; COPUR S, 1995, BIOCHEM PHARMACOL, V49, P1419, DOI 10.1016/0006-2952(95)00067-A; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; de Molina AR, 2002, ONCOGENE, V21, P4317, DOI 10.1038/sj.onc.1205556; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; DOU QP, 1992, P NATL ACAD SCI USA, V89, P3256, DOI 10.1073/pnas.89.8.3256; Douillard JY, 2003, ANN ONCOL, V14, P7, DOI 10.1093/annonc/mdg723; Douillard JY, 2000, LANCET, V355, P1041, DOI 10.1016/S0140-6736(00)02034-1; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Giacchetti S, 2000, J CLIN ONCOL, V18, P136, DOI 10.1200/JCO.2000.18.1.136; GREM JL, 1989, PHARMACOL THERAPEUT, V40, P349, DOI 10.1016/0163-7258(89)90084-3; HEIDELBERGER C, 1957, NATURE, V179, P663, DOI 10.1038/179663a0; Hernandez-Alcoceba R, 1999, CANCER RES, V59, P3112; HernandezAlcoceba R, 1997, ONCOGENE, V15, P2289, DOI 10.1038/sj.onc.1201414; Hernando E, 2009, ONCOGENE, V28, P2425, DOI 10.1038/onc.2009.91; Hong BS, 2010, J BIOL CHEM, V285, P16330, DOI 10.1074/jbc.M109.039024; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Iorio E, 2005, CANCER RES, V65, P9369, DOI 10.1158/0008-5472.CAN-05-1146; Iorio E, 2010, CANCER RES, V70, P2126, DOI 10.1158/0008-5472.CAN-09-3833; Johnston PG, 2003, J CLIN ONCOL, V21, P815, DOI 10.1200/JCO.2003.07.039; JOHNSTON PG, 1994, J CLIN ONCOL, V12, P2640, DOI 10.1200/JCO.1994.12.12.2640; JOHNSTON PG, 1992, CANCER RES, V52, P4306; JOHNSTON PG, 1995, CANCER RES, V55, P1407; Lacal J C, 2001, IDrugs, V4, P419; Lebedeva IV, 2007, ONCOGENE, V26, P733, DOI 10.1038/sj.onc.1209813; LLOVERAS J, 1985, BIOCHEM PHARMACOL, V34, P3987, DOI 10.1016/0006-2952(85)90377-6; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Machover D, 1996, ANN ONCOL, V7, P95; Milanese L, 2006, CHEMMEDCHEM, V1, P1216, DOI 10.1002/cmdc.200600158; Mizutani Y, 2003, CLIN CANCER RES, V9, P1453; Mori N, 2007, CANCER RES, V67, P11284, DOI 10.1158/0008-5472.CAN-07-2728; Nakagami K, 1999, JPN J CANCER RES, V90, P419, DOI 10.1111/j.1349-7006.1999.tb00764.x; Nomura T, 2002, INT J UROL, V9, P368, DOI 10.1046/j.1442-2042.2002.00479.x; PETERS GJ, 1991, ANN ONCOL, V2, P469, DOI 10.1093/oxfordjournals.annonc.a057994; Popat S, 2004, J CLIN ONCOL, V22, P529, DOI 10.1200/JCO.2004.05.064; Rahman L, 2004, CANCER CELL, V5, P341, DOI 10.1016/S1535-6108(04)00080-7; Rajesh D, 1999, MOL PHARMACOL, V56, P515, DOI 10.1124/mol.56.3.515; Ramirez de Molina A, 2002, BIOCHEM BIOPH RES CO, V296, P580, DOI 10.1016/S0006-291X(02)00920-8; Ramirez de Molina A, 2007, LANCET ONCOL, V8, P889, DOI 10.1016/S1470-2045(07)70279-6; Rodriguez-Gonzalez A, 2005, INT J ONCOL, V26, P999; Rodriguez-Gonzalez A, 2004, ONCOGENE, V23, P8247, DOI 10.1038/sj.onc.1208045; Russo P, 2002, INT J CANCER, V100, P266, DOI 10.1002/ijc.10461; Salonga D, 2000, CLIN CANCER RES, V6, P1322; Saltz LB, 2000, NEW ENGL J MED, V343, P905, DOI 10.1056/NEJM200009283431302; Srivani P, 2009, J MOL GRAPH MODEL, V27, P676, DOI 10.1016/j.jmgm.2008.10.010; Van Cutsem E, 1998, ANN ONCOL, V9, P1199, DOI 10.1023/A:1008478405634; Yalcin A, 2010, ONCOGENE, V29, P139, DOI 10.1038/onc.2009.317	53	38	40	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e64961	10.1371/journal.pone.0064961	http://dx.doi.org/10.1371/journal.pone.0064961			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762272	gold, Green Submitted, Green Published			2022-12-27	WOS:000320440500015
J	Chi, LJ; Galtseva, A; Chen, L; Mo, R; Hui, CC; Rosenblum, ND				Chi, Lijun; Galtseva, Alevtina; Chen, Lin; Mo, Rong; Hui, Chi-chung; Rosenblum, Norman D.			Kif3a Controls Murine Nephron Number Via GLI3 Repressor, Cell Survival, and Gene Expression in a Lineage-Specific Manner	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; PRIMARY CILIUM; INTRAFLAGELLAR TRANSPORT; URETERAL BUD; MUTANT MICE; KINESIN-II; MOUSE; MORPHOGENESIS; WNT11; ORGANOGENESIS	The primary cilium is required during early embryo patterning, epithelial tubulogenesis, and growth factor-dependent signal transduction. The requirement for primary cilia during renal epithelial-mesenchymal tissue interactions that give rise to nephrons is undefined. Here, we used Cre-mediated recombination to generate mice with Kif3a deficiency targeted to the ureteric and/or metanephric mesenchyme cell lineages in the embryonic kidney. Gradual loss of primary cilia in either lineage leads to a phenotype of reduced nephron number. Remarkably, in addition to cyst formation, loss of primary cilia in the ureteric epithelial cell leads to decreased expression of Wnt11 and Ret and reduced ureteric branching. Constitutive expression of GLI3 repressor (Gli3(Delta 699/+)) rescues these abnormalities. In embryonic metanephric mesenchyme cells, Kif3a deficiency limits survival of nephrogenic progenitor cells and expression of genes required for nephron formation. Together, our data demonstrate that Kif3a controls nephron number via distinct cell lineage-specific mechanisms.	[Chi, Lijun; Galtseva, Alevtina; Chen, Lin; Mo, Rong; Hui, Chi-chung; Rosenblum, Norman D.] Univ Toronto, Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Chi, Lijun; Rosenblum, Norman D.] Hosp Sick Children, Div Nephrol, Toronto, ON M5G 1X8, Canada; [Hui, Chi-chung] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Rosenblum, Norman D.] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada; [Rosenblum, Norman D.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Rosenblum, Norman D.] Univ Toronto, Dept Physiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University of Toronto	Rosenblum, ND (corresponding author), Univ Toronto, Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada.	norman.rosenblum@sickkids.ca	Rosenblum, Norman D/H-4737-2015	Rosenblum, Norman D/0000-0003-1767-6464	Canadian Institutes of Health Research; Kidney Foundation of Canada; Canada Research Chairs Program; Canadian Cancer Society Research Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada; Canada Research Chairs Program(Canada Research Chairs); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	This work was supported by grants from the Canadian Institutes of Health Research, the Kidney Foundation of Canada and the Canada Research Chairs Program (to NDR) and operating grants from the Canadian Cancer Society Research Institute (to CCH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bose J, 2002, HUM MOL GENET, V11, P1129, DOI 10.1093/hmg/11.9.1129; Bridgewater D, 2008, DEV BIOL, V317, P83, DOI 10.1016/j.ydbio.2008.02.010; Cain JE, 2011, J CLIN INVEST, V121, P1199, DOI 10.1172/JCI45523; Cain JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007313; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Chi LJ, 2006, ENDOCRINOLOGY, V147, P3777, DOI 10.1210/en.2006-0299; Chi Lijun, 2012, Methods Mol Biol, V886, P157, DOI 10.1007/978-1-61779-851-1_14; Chi LJ, 2004, DEVELOPMENT, V131, P3345, DOI 10.1242/dev.01200; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Di Giovanni V, 2011, DEVELOPMENT, V138, P2717, DOI 10.1242/dev.059030; Ding Q, 1998, DEVELOPMENT, V125, P2533; Evans MJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1263, DOI 10.1152/ajplung.00180.2002; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Grieshammer U, 2005, DEVELOPMENT, V132, P3847, DOI 10.1242/dev.01944; Hartwig S, 2008, J AM SOC NEPHROL, V19, P117, DOI 10.1681/ASN.2007010080; Hatini V, 1996, GENE DEV, V10, P1467, DOI 10.1101/gad.10.12.1467; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Hu MC, 2006, DEVELOPMENT, V133, P569, DOI 10.1242/dev.02220; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Jonassen JA, 2008, J CELL BIOL, V183, P377, DOI 10.1083/jcb.200808137; Kispert A, 1996, DEVELOPMENT, V122, P3627; Kobayashi A, 2005, DEVELOPMENT, V132, P2809, DOI 10.1242/dev.01858; Lancaster MA, 2009, NAT MED, V15, P1046, DOI 10.1038/nm.2010; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Michos O, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000809; Neugebauer JM, 2009, NATURE, V458, P651, DOI 10.1038/nature07753; Park JS, 2007, DEVELOPMENT, V134, P2533, DOI 10.1242/dev.006155; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Rosenquist TA, 1996, DEV DYNAM, V205, P379, DOI 10.1002/(SICI)1097-0177(199604)205:4<379::AID-AJA2>3.0.CO;2-F; Sainio K, 1997, DEVELOPMENT, V124, P4077; Saxen L., 1987, ORGANOGENESIS KIDNEY; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; Schuchardt A, 1996, DEVELOPMENT, V122, P1919; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Yoder BK, 2007, J AM SOC NEPHROL, V18, P1381, DOI 10.1681/ASN.2006111215; Zhao HT, 2004, DEV BIOL, V276, P403, DOI 10.1016/j.ydbio.2004.09.002	46	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65448	10.1371/journal.pone.0065448	http://dx.doi.org/10.1371/journal.pone.0065448			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762375	gold, Green Submitted, Green Published			2022-12-27	WOS:000321094800051
J	Khanolkar, A; Williams, MA; Harty, JT				Khanolkar, Aaruni; Williams, Matthew A.; Harty, John T.			Antigen Experience Shapes Phenotype and Function of Memory Th1 Cells	PLOS ONE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; LISTERIA-MONOCYTOGENES INFECTION; CD8(+) T-CELLS; NEUTRALIZING-ANTIBODY; ANTIVIRAL IMMUNITY; VIRAL-INFECTIONS; CLASS-II; RESPONSES; CD4(+); EFFECTOR	Primary and secondary (boosted) memory CD8 T cells exhibit differences in gene expression, phenotype and function. The impact of repeated antigen stimulations on memory CD4 T cells is largely unknown. To address this issue, we utilized LCMV and Listeria monocytogenes infection of mice to characterize primary and secondary antigen (Ag)-specific Th1 CD4 T cell responses. Ag-specific primary memory CD4 T cells display a CD62L(lo)CCR7(hi)CD27(hi)CD127(hi) phenotype and are polyfunctional (most produce IFN gamma, TNF alpha and IL-2). Following homologous prime-boost immunization we observed pathogen-specific differences in the rate of CD62L and CCR7 upregulation on memory CD4 T cells as well as in IL-2+IFN gamma co-production by secondary effectors. Phenotypic and functional plasticity of memory Th1 cells was observed following heterologous prime-boost immunization, wherein secondary memory CD4 T cells acquired phenotypic and functional characteristics dictated by the boosting agent rather than the primary immunizing agent. Our data also demonstrate that secondary memory Th1 cells accelerated neutralizing Ab formation in response to LCMV infection, suggesting enhanced capacity of this population to provide quality help for antibody production. Collectively these data have important implications for prime-boost vaccination strategies that seek to enhance protective immune responses mediated by Th1 CD4 T cell responses.	[Khanolkar, Aaruni; Harty, John T.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Khanolkar, Aaruni; Williams, Matthew A.] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA; [Harty, John T.] Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA USA; [Harty, John T.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA	University of Iowa; Utah System of Higher Education; University of Utah; University of Iowa; University of Iowa	Williams, MA (corresponding author), Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA.	matthew.williams@path.utah.edu; john-harty@uiowa.edu		Williams, Matthew/0000-0002-4721-4482; Harty, John/0000-0001-7266-2802	National Institutes of Health [R37AI042767-14, RO1AI080830]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042767, R01AI080830] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants R37AI042767-14 (JTH) and RO1AI080830 (MAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badovinac VP, 2003, NAT IMMUNOL, V4, P212, DOI 10.1038/ni0303-212; Barron L, 2010, J IMMUNOL, V185, P6426, DOI 10.4049/jimmunol.0903940; BATTEGAY M, 1993, J IMMUNOL, V151, P5408; Benhnia MREI, 2009, J VIROL, V83, P1201, DOI 10.1128/JVI.01797-08; Braun A, 2011, NAT IMMUNOL, V12, P879, DOI 10.1038/ni.2085; Colpitts SL, 2010, J IMMUNOL, V185, P2416, DOI 10.4049/jimmunol.1000483; Condotta SA, 2012, ADV IMMUNOL, V113, P51, DOI 10.1016/B978-0-12-394590-7.00005-1; Corbin GA, 2004, J IMMUNOL, V173, P5679, DOI 10.4049/jimmunol.173.9.5679; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Fuller MJ, 2004, J IMMUNOL, V172, P4204, DOI 10.4049/jimmunol.172.7.4204; Harrington LE, 2008, NATURE, V452, P356, DOI 10.1038/nature06672; Jabbari A, 2006, J EXP MED, V203, P919, DOI 10.1084/jem.20052237; Jabbari A, 2006, J IMMUNOL METHODS, V313, P161, DOI 10.1016/j.jim.2006.04.005; Khanolkar A, 2002, IMMUNOL RES, V26, P309, DOI 10.1385/IR:26:1-3:309; Khanolkar A, 2004, J IMMUNOL, V172, P2834, DOI 10.4049/jimmunol.172.5.2834; Kim C, 2012, J IMMUNOL, V189, P2348, DOI 10.4049/jimmunol.1200244; Ludewig B, 1998, J VIROL, V72, P3812, DOI 10.1128/JVI.72.5.3812-3818.1998; MacLeod MKL, 2008, P NATL ACAD SCI USA, V105, P14521, DOI 10.1073/pnas.0807449105; Marshall HD, 2011, IMMUNITY, V35, P633, DOI 10.1016/j.immuni.2011.08.016; Moyron-Quiroz JE, 2009, VACCINE, V28, P140, DOI 10.1016/j.vaccine.2009.09.086; Nolz JC, 2011, IMMUNITY, V34, P781, DOI 10.1016/j.immuni.2011.03.020; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.0.CO;2-O; Oxenius A, 1995, EUR J IMMUNOL, V25, P3402, DOI 10.1002/eji.1830251230; Pearce EL, 2007, J IMMUNOL, V179, P2074, DOI 10.4049/jimmunol.179.4.2074; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Pinschewer DD, 2004, J CLIN INVEST, V114, P988, DOI 10.1172/JCI200422374; Planz O, 1997, P NATL ACAD SCI USA, V94, P6874, DOI 10.1073/pnas.94.13.6874; Planz O, 1996, NATURE, V382, P726, DOI 10.1038/382726a0; Recher M, 2004, NAT IMMUNOL, V5, P934, DOI 10.1038/ni1102; ROTZSCHKE O, 1991, EUR J IMMUNOL, V21, P2891, DOI 10.1002/eji.1830211136; Sabatino JJ, 2011, J EXP MED, V208, P81, DOI 10.1084/jem.20101574; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Seiler P, 2000, J VIROL, V74, P5896, DOI 10.1128/JVI.74.13.5896-5901.2000; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Subramanian H, 2012, J IMMUNOL, V188, P3223, DOI 10.4049/jimmunol.1101032; Tvinnereim AR, 2002, INFECT IMMUN, V70, P153, DOI 10.1128/IAI.70.1.153-162.2002; Weber KS, 2012, P NATL ACAD SCI USA, V109, P9511, DOI 10.1073/pnas.1202408109; WEIBEL D, 1993, RES VIROLOGY, V144, P471, DOI 10.1016/S0923-2516(06)80062-2; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Whitmire JK, 2000, CURR OPIN IMMUNOL, V12, P448, DOI 10.1016/S0952-7915(00)00119-9; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Wirth TC, 2010, IMMUNITY, V33, P128, DOI 10.1016/j.immuni.2010.06.014; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	44	10	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65234	10.1371/journal.pone.0065234	http://dx.doi.org/10.1371/journal.pone.0065234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762323	Green Submitted, gold, Green Published			2022-12-27	WOS:000321094800028
J	Wang, JX; Chen, L; Wang, Y; Zhang, JF; Liang, YC; Xu, D				Wang, Juexin; Chen, Liang; Wang, Yan; Zhang, Jingfen; Liang, Yanchun; Xu, Dong			A Computational Systems Biology Study for Understanding Salt Tolerance Mechanism in Rice	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; QUANTITATIVE TRAIT LOCI; HIGH-SALINITY STRESSES; ORYZA-SATIVA; DIFFERENTIAL EXPRESSION; ION HOMEOSTASIS; DROUGHT; PROTEIN; COLD; BIOSYNTHESIS	Salinity is one of the most common abiotic stresses in agriculture production. Salt tolerance of rice (Oryza sativa) is an important trait controlled by various genes. The mechanism of rice salt tolerance, currently with limited understanding, is of great interest to molecular breeding in improving grain yield. In this study, a gene regulatory network of rice salt tolerance is constructed using a systems biology approach with a number of novel computational methods. We developed an improved volcano plot method in conjunction with a new machine-learning method for gene selection based on gene expression data and applied the method to choose genes related to salt tolerance in rice. The results were then assessed by quantitative trait loci (QTL), co-expression and regulatory binding motif analysis. The selected genes were constructed into a number of network modules based on predicted protein interactions including modules of phosphorylation activity, ubiquity activity, and several proteinase activities such as peroxidase, aspartic proteinase, glucosyltransferase, and flavonol synthase. All of these discovered modules are related to the salt tolerance mechanism of signal transduction, ion pump, abscisic acid mediation, reactive oxygen species scavenging and ion sequestration. We also predicted the three-dimensional structures of some crucial proteins related to the salt tolerance QTL for understanding the roles of these proteins in the network. Our computational study sheds some new light on the mechanism of salt tolerance and provides a systems biology pipeline for studying plant traits in general.	[Wang, Juexin; Chen, Liang; Wang, Yan; Liang, Yanchun; Xu, Dong] Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Peoples R China; [Wang, Juexin; Zhang, Jingfen; Xu, Dong] Univ Missouri, Dept Comp Sci, Digital Biol Lab, Columbia, MO USA; [Wang, Juexin; Zhang, Jingfen; Xu, Dong] Univ Missouri, Christopher S Bond Life Sci Ctr, Columbia, MO USA	Jilin University; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Liang, YC (corresponding author), Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Peoples R China.	ycliang@jlu.edu.cn; xudong@missouri.edu	Wang, Juexin/HHN-5377-2022; Chen, Liang/Y-4460-2018	Chen, Liang/0000-0001-6644-477X	National Natural Science Foundation of China [61073075, 61272207]; Science-Technology Development Project from Jilin Province of China [20120730]; National Institutes of Health [R21/R33-GM078601, R01-GM100701]; National Science Foundation [DBI-0421620]; Department of Energy [DE-SC0004898]; Direct For Biological Sciences [1025752] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM078601, R01GM100701] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science-Technology Development Project from Jilin Province of China; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful to the support of National Natural Science Foundation of China (grants 61073075 and 61272207), the Science-Technology Development Project from Jilin Province of China (grant 20120730), National Institutes of Health (R21/R33-GM078601 and R01-GM100701), National Science Foundation (#DBI-0421620), and Department of Energy (DE-SC0004898). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agati G, 2011, J PLANT PHYSIOL, V168, P204, DOI 10.1016/j.jplph.2010.07.016; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Balibrea ME, 2000, PHYSIOL PLANTARUM, V110, P503, DOI 10.1111/j.1399-3054.2000.1100412.x; Blum AL, 1997, ARTIF INTELL, V97, P245, DOI 10.1016/S0004-3702(97)00063-5; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonilla P, 2002, PHILIPP AGRIC SCI, V85, P68; Caesar R, 2004, J BIOL CHEM, V279, P38532, DOI 10.1074/jbc.M402939200; Chen XH, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-37; Chitteti BR, 2007, J PROTEOME RES, V6, P1718, DOI 10.1021/pr060678z; Cotsaftis O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039865; Cotsaftis O, 2011, MOL PLANT, V4, P25, DOI 10.1093/mp/ssq056; Cui XQ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-210; Davey NE, 2007, NUCLEIC ACIDS RES, V35, pW455, DOI 10.1093/nar/gkm400; de Wit PJGM, 2007, CELL MOL LIFE SCI, V64, P2726, DOI 10.1007/s00018-007-7284-7; Ding YY, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S12; Dionisio-Sese ML, 1998, PLANT SCI, V135, P1, DOI 10.1016/S0168-9452(98)00025-9; Dreher K, 2007, ANN BOT-LONDON, V99, P787, DOI 10.1093/aob/mcl255; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Duan K, 2004, CIBCB 04, V7-8, P49; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fini A, 2011, PLANT SIGNAL BEHAV, V6, P709, DOI 10.4161/psb.6.5.15069; FRIDOVICH I, 1986, ARCH BIOCHEM BIOPHYS, V247, P1, DOI 10.1016/0003-9861(86)90526-6; Furlanello C, 2003, NEURAL NETWORKS, V16, P641, DOI 10.1016/S0893-6080(03)00103-5; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Gupta K, 2012, ACTA PHYSIOL PLANT, V34, P29, DOI 10.1007/s11738-011-0802-0; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Huang XY, 2009, GENE DEV, V23, P1805, DOI 10.1101/gad.1812409; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; Jacoby RP, 2010, J PROTEOME RES, V9, P6595, DOI 10.1021/pr1007834; Jannink JL, 2001, TRENDS PLANT SCI, V6, P337, DOI 10.1016/S1360-1385(01)02017-9; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kawasaki S, 2001, PLANT CELL, V13, P889, DOI 10.1105/tpc.13.4.889; Kitahata N, 2005, BIOORGAN MED CHEM, V13, P4491, DOI 10.1016/j.bmc.2005.04.036; Ko JH, 2006, PLANT J, V47, P343, DOI 10.1111/j.1365-313X.2006.02782.x; Komatsu S, 1999, THEOR APPL GENET, V98, P1304, DOI 10.1007/s001220051196; Koyama ML, 2001, PLANT PHYSIOL, V125, P406, DOI 10.1104/pp.125.1.406; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; [来海锋 Lai Haifeng], 2010, [生物物理学报, Acta Biophysica Sinica], V26, P833; Liang YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021750; Liu JP, 1998, SCIENCE, V280, P1943, DOI 10.1126/science.280.5371.1943; Maas E. V., 1977, Journal of the Irrigation and Drainage Division, American Society of Civil Engineers, V103, P115; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Miller G, 2008, PHYSIOL PLANTARUM, V133, P481, DOI 10.1111/j.1399-3054.2008.01090.x; Mito T, 2011, PLANT BIOTECHNOL J, V9, P736, DOI 10.1111/j.1467-7652.2010.00578.x; Mizuno H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-121; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Niu XM, 1996, PLANT PHYSIOL, V111, P679, DOI 10.1104/pp.111.3.679; Ogawa I, 2009, PLANT SOIL, V325, P97, DOI 10.1007/s11104-009-0116-9; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Pauli S, 2004, J VIROL, V78, P12120, DOI 10.1128/JVI.78.22.12120-12128.2004; Pons R, 2011, PLANT PHYSIOL BIOCH, V49, P1399, DOI 10.1016/j.plaphy.2011.09.011; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; RHODES D, 1993, ANNU REV PLANT PHYS, V44, P357, DOI 10.1146/annurev.pp.44.060193.002041; Sapkota A, 2011, MOL BIOSYST, V7, P2615, DOI 10.1039/c1mb05120b; Schmidt R, 2012, AOB PLANTS, DOI 10.1093/aobpla/pls011; Seaton G, 2002, BIOINFORMATICS, V18, P339, DOI 10.1093/bioinformatics/18.2.339; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sreenivasulu N, 2012, GENE, V506, P265, DOI 10.1016/j.gene.2012.06.076; Tanji K.K., 1990, AGR SALINITY ASSESSM, P1; Teige M, 2004, MOL CELL, V15, P141, DOI 10.1016/j.molcel.2004.06.023; Thiery L, 2004, J BIOL CHEM, V279, P14812, DOI 10.1074/jbc.M308456200; Turoczy Z, 2011, PLANT MOL BIOL, V75, P399, DOI 10.1007/s11103-011-9735-7; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Vashisht AA, 2006, J PHOTOCH PHOTOBIO B, V84, P150, DOI 10.1016/j.jphotobiol.2006.02.010; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Walia H, 2005, PLANT PHYSIOL, V139, P822, DOI 10.1104/pp.105.065961; Wang RS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-216; Wang Y, 2000, J HORTIC SCI BIOTECH, V75, P623, DOI 10.1080/14620316.2000.11511297; White PJ, 2003, ANN BOT-LONDON, V92, P487, DOI 10.1093/aob/mcg164; WISE RR, 1987, PLANT PHYSIOL, V83, P278, DOI 10.1104/pp.83.2.278; WU R, 2003, ENG RICE PLANTS TREH; Xing W, 2007, NATURE, V449, P243, DOI 10.1038/nature06109; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zhang JF, 2011, PROTEINS, V79, P172, DOI 10.1002/prot.23184; Zhang JF, 2010, PROTEINS, V78, P1137, DOI 10.1002/prot.22634; Zhang T, 2006, PLANT PHYSIOL BIOCH, V44, P274, DOI 10.1016/j.plaphy.2006.06.004; Zhang XH, 2011, PLANT CELL TISS ORG, V107, P1, DOI 10.1007/s11240-011-9950-6; Zhou JL, 2007, PLANT MOL BIOL, V63, P591, DOI 10.1007/s11103-006-9111-1; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2	88	22	22	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e64929	10.1371/journal.pone.0064929	http://dx.doi.org/10.1371/journal.pone.0064929			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762267	Green Published, Green Submitted, gold			2022-12-27	WOS:000321094800010
J	Hoppe, AD; Scott, BL; Welliver, TP; Straight, SW; Swanson, JA				Hoppe, Adam D.; Scott, Brandon L.; Welliver, Timothy P.; Straight, Samuel W.; Swanson, Joel A.			N-Way FRET Microscopy of Multiple Protein-Protein Interactions in Live Cells	PLOS ONE			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; LIVING CELLS; FLUORESCENT PROTEIN; STOICHIOMETRY; ACTIVATION; CDC42	Fluorescence Resonance Energy Transfer (FRET) microscopy has emerged as a powerful tool to visualize nanoscale protein-protein interactions while capturing their microscale organization and millisecond dynamics. Recently, FRET microscopy was extended to imaging of multiple donor-acceptor pairs, thereby enabling visualization of multiple biochemical events within a single living cell. These methods require numerous equations that must be defined on a case-by-case basis. Here, we present a universal multispectral microscopy method (N-Way FRET) to enable quantitative imaging for any number of interacting and non-interacting FRET pairs. This approach redefines linear unmixing to incorporate the excitation and emission couplings created by FRET, which cannot be accounted for in conventional linear unmixing. Experiments on a three-fluorophore system using blue, yellow and red fluorescent proteins validate the method in living cells. In addition, we propose a simple linear algebra scheme for error propagation from input data to estimate the uncertainty in the computed FRET images. We demonstrate the strength of this approach by monitoring the oligomerization of three FP-tagged HIV Gag proteins whose tight association in the viral capsid is readily observed. Replacement of one FP-Gag molecule with a lipid raft-targeted FP allowed direct observation of Gag oligomerization with no association between FP-Gag and raft-targeted FP. The N-Way FRET method provides a new toolbox for capturing multiple molecular processes with high spatial and temporal resolution in living cells.	[Hoppe, Adam D.; Scott, Brandon L.] S Dakota State Univ, Dept Chem & Biochem, Brookings, SD 57007 USA; [Welliver, Timothy P.; Swanson, Joel A.] Univ Michigan, Sch Med, Program Immunol, Ann Arbor, MI USA; [Straight, Samuel W.; Swanson, Joel A.] Univ Michigan, Sch Med, Ctr Live Cell Imaging, Ann Arbor, MI USA; [Swanson, Joel A.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	South Dakota State University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Hoppe, AD (corresponding author), S Dakota State Univ, Dept Chem & Biochem, Brookings, SD 57007 USA.	adam.hoppe@sdstate.edu	Hoppe, Adam/U-8563-2019; Swanson, Joel A/P-4362-2014	Hoppe, Adam/0000-0003-4180-0840; Swanson, Joel A/0000-0003-0900-8212; Scott, Brandon/0000-0002-1950-0748	National Science Foundation [0953561]; South Dakota Governor's 2010 center for the Biological Control and Analysis by Applied Photonics (BCAAP); South Dakota State University Chemistry and Biochemistry startup funds; Department of Education GAANN Fellowship [P200A100103]; University of Michigan Basic Biomedical Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079414] Funding Source: NIH RePORTER; Direct For Biological Sciences [0953561] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); South Dakota Governor's 2010 center for the Biological Control and Analysis by Applied Photonics (BCAAP); South Dakota State University Chemistry and Biochemistry startup funds; Department of Education GAANN Fellowship(US Department of Education); University of Michigan Basic Biomedical Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This material is based on work supported by the National Science Foundation under Grant No. 0953561, the South Dakota Governor's 2010 center for the Biological Control and Analysis by Applied Photonics (BCAAP), and South Dakota State University Chemistry and Biochemistry startup funds to ADH. A Department of Education GAANN Fellowship No. P200A100103 supported BLS. Construction of one of the microscopes was supported by funds from the University of Michigan Basic Biomedical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson CA, 2000, CHEMOMETR INTELL LAB, V52, P1, DOI 10.1016/S0169-7439(00)00071-X; Becker PL, 1996, FLUORESCENCE IMAGING, P1; Beemiller P, 2006, PLOS BIOL, V4, P987, DOI 10.1371/journal.pbio.0040162; Beemiller P, 2010, MOL BIOL CELL, V21, P470, DOI 10.1091/mbc.E08-05-0494; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Bro R., 1998, MULTIWAY ANAL FOOD I; Bro R, 2009, J CHEMOMETR, V23, P324, DOI 10.1002/cem.1206; Cai DW, 2007, J CELL BIOL, V176, P51, DOI 10.1083/jcb.200605097; Chen YC, 2011, J MICROSC-OXFORD, V244, P21, DOI 10.1111/j.1365-2818.2011.03488.x; Clegg R. M, 1996, FLUORESCENCE IMAGING, V137, P179; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Galperin E, 2004, NAT METHODS, V1, P209, DOI 10.1038/NMETH720; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Hammond JW, 2009, PLOS BIOL, V7, P650, DOI 10.1371/journal.pbio.1000072; Hogue IB, 2009, J VIROL; Hohng S, 2004, BIOPHYS J, V87, P1328, DOI 10.1529/biophysj.104.043935; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Hoppe AD, 2008, 3D FRET RECONSTRUCTI; Hoppe Adam D., 2007, P157, DOI 10.1007/978-3-540-71331-9_6; Hoppe AD, 2009, CELL MICROBIOL, V11, P540, DOI 10.1111/j.1462-5822.2009.01283.x; Kawata S, 1996, FLUORESCENCE IMAGING, P55; Kim J, 2012, CYTOM PART A, V81A, P112, DOI 10.1002/cyto.a.21150; Koushik SV, 2006, BIOPHYS J, V91, pL99, DOI 10.1529/biophysj.106.096206; LAKOWICZ JR, 1999, PRINCIPLES FLUORESCE, pR23; Lee J, 2010, ANGEW CHEM INT EDIT, V49, P9922, DOI 10.1002/anie.201005402; Lichten CA, 2011, BMC BIOPHYS, V4, DOI 10.1186/2046-1682-4-10; Lu A, 2009, J CELL BIOL, V184, P863, DOI 10.1083/jcb.200807186; Meyer S., 1992, DATA ANAL SCI ENG; Nadrigny F, 2006, EUR BIOPHYS J BIOPHY, V35, P533, DOI 10.1007/s00249-005-0040-8; Neher R, 2004, J MICROSC-OXFORD, V213, P46, DOI 10.1111/j.1365-2818.2004.01262.x; Neher RA, 2004, MICROSC RES TECHNIQ, V64, P185, DOI 10.1002/jemt.20078; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shirakawa H, 2004, BIOPHYS J, V86, P1739, DOI 10.1016/S0006-3495(04)74242-3; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; Sun YS, 2010, BIOPHYS J, V99, P1274, DOI 10.1016/j.bpj.2010.06.004; Wlodarczyk J, 2008, BIOPHYS J, V94, P986, DOI 10.1529/biophysj.107.111773; Woehler A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061096; Woehler A, 2010, BIOPHYS J, V99, P2344, DOI 10.1016/j.bpj.2010.07.053; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zal T, 2002, IMMUNITY, V16, P521, DOI 10.1016/S1074-7613(02)00301-1	45	44	45	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64760	10.1371/journal.pone.0064760	http://dx.doi.org/10.1371/journal.pone.0064760			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762252	Green Published, Green Submitted, gold			2022-12-27	WOS:000321099000019
J	Inusa, BPD; Oyewo, A; Brokke, F; Santhikumaran, G; Jogeesvaran, KH				Inusa, Baba P. D.; Oyewo, Adeola; Brokke, Felicity; Santhikumaran, Gayathriy; Jogeesvaran, K. Haran			Dilemma in Differentiating between Acute Osteomyelitis and Bone Infarction in Children with Sickle Cell Disease: The Role of Ultrasound	PLOS ONE			English	Article							VASOOCCLUSIVE CRISIS; ENHANCED MRI; ULTRASONOGRAPHY; ANEMIA	Background: Distinguishing between acute presentations of osteomyelitis (OM) and vaso-occlusive crisis (VOC) bone infarction in children with sickle cell disease (SCD) remains challenging for clinicians, particularly in culture-negative cases. We examined the combined role of ultrasound scan (USS), C -reactive protein and White blood counts (WCC) in aiding early diagnosis in children with SCD presenting acutely with non-specific symptoms such as bone pain, fever or swelling which are common in acute osteomyelitis or VOC. Methods: We reviewed the records of all children with SCD who were discharged from our department from October 2003 to December 2010 with a diagnosis of osteomyelitis based on clinical features and the results of radiological and laboratory investigations. A case control group with VOC who were investigated for OM were identified over the same period. Results: In the osteomyelitis group, USS finding of periosteal elevation and/or fluid collection was reported in 76% cases with the first scan (day 0-6). Overall 84% were diagnosed with USS (initial + repeat). 16% had negative USS. With VOC group, USS showed no evidence of fluid collection in 53/58 admissions (91%), none of the repeated USS showed any fluid collection. Mean C-reactive protein (CRP), and white cell count (WCC) were significantly higher in the OM. Conclusion: The use of Ultrasound in combination with CRP and WCC is a reliable, cost-effective diagnostic tool for differentiating osteomyelitis from VOC bone infarction in SCD. A repeat ultrasound and/or magnetic resonance imaging (MRI) scan may be is necessary to confirm the diagnosis.	[Inusa, Baba P. D.; Oyewo, Adeola; Brokke, Felicity] Guys & St Thomas Natl Hlth Serv NHS Fdn Trust, Evelina Childrens Hosp, Dept Paediat, London, England; [Santhikumaran, Gayathriy] Kings Coll London, Sch Med, London WC2R 2LS, England; [Jogeesvaran, K. Haran] Guys & St Thomas NHS Fdn Trust, Evelina Childrens Hosp, Dept Paediat Radiol, London, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Inusa, BPD (corresponding author), Guys & St Thomas Natl Hlth Serv NHS Fdn Trust, Evelina Childrens Hosp, Dept Paediat, London, England.	baba.inusa@gstt.nhs.uk	Inusa, Baba/R-7447-2017	Inusa, Baba/0000-0003-2643-765X				Almeida A, 2005, BRIT J HAEMATOL, V129, P482, DOI 10.1111/j.1365-2141.2005.05476.x; Berger E, 2009, ARCH PEDIAT ADOL MED, V163, P251, DOI 10.1001/archpediatrics.2008.545; BONNEROT V, 1994, PEDIATR RADIOL, V24, P92, DOI 10.1007/BF02020160; Jain R, 2008, CLIN RADIOL, V63, P59, DOI 10.1016/j.crad.2007.07.017; KEELEY K, 1982, J PEDIATR-US, V101, P170, DOI 10.1016/S0022-3476(82)80111-X; Malcius D, 2009, MEDICINA-LITHUANIA, V45, P624, DOI 10.3390/medicina45080081; PIEHL FC, 1993, J PEDIATR ORTHOPED, V13, P225; Rifai A, 1997, ACTA RADIOL, V38, P139; Sadat-Ali M, 1998, J PEDIATR ORTHOPED, V18, P552, DOI 10.1097/00004694-199807000-00030; Skaggs DL, 2001, J BONE JOINT SURG AM, V83A, P1810, DOI 10.2106/00004623-200112000-00007; Streetly A, 2009, J CLIN PATHOL, V62, P26, DOI 10.1136/jcp.2008.058859; Umans H, 2000, MAGN RESON IMAGING, V18, P255, DOI 10.1016/S0730-725X(99)00137-X; William RR, 2000, CLIN RADIOL, V55, P307, DOI 10.1053/crad.1999.0377; Wong AL, 2001, PEDIATR EMERG CARE, V17, P60, DOI 10.1097/00006565-200102000-00018	14	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65001	10.1371/journal.pone.0065001	http://dx.doi.org/10.1371/journal.pone.0065001			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755165	Green Published, gold			2022-12-27	WOS:000321099000029
J	Garcia-Hernandez, JJ; Feregrino-Uribe, C; Cumplido, R				Juan Garcia-Hernandez, Jose; Feregrino-Uribe, Claudia; Cumplido, Rene			Collusion-Resistant Audio Fingerprinting System in the Modulated Complex Lapped Transform Domain	PLOS ONE			English	Article							SPREAD-SPECTRUM WATERMARKING	Collusion-resistant fingerprinting paradigm seems to be a practical solution to the piracy problem as it allows media owners to detect any unauthorized copy and trace it back to the dishonest users. Despite the billionaire losses in the music industry, most of the collusion-resistant fingerprinting systems are devoted to digital images and very few to audio signals. In this paper, state-of-the-art collusion-resistant fingerprinting ideas are extended to audio signals and the corresponding parameters and operation conditions are proposed. Moreover, in order to carry out fingerprint detection using just a fraction of the pirate audio clip, block-based embedding and its corresponding detector is proposed. Extensive simulations show the robustness of the proposed system against average collusion attack. Moreover, by using an efficient Fast Fourier Transform core and standard computer machines it is shown that the proposed system is suitable for real-world scenarios.	[Juan Garcia-Hernandez, Jose] CINVESTAV IPN, Lab Tecnol Informac, Tamaulipas, Mexico; [Feregrino-Uribe, Claudia; Cumplido, Rene] Inst Nacl Astrofis Opt & Electr, Puebla, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Nacional de Astrofisica, Optica y Electronica	Garcia-Hernandez, JJ (corresponding author), CINVESTAV IPN, Lab Tecnol Informac, Tamaulipas, Mexico.	jjuan@tamps.cinvestav.mx	Garcia-Hernandez, Jose Juan/E-8633-2010; Feregrino, Claudia/AAW-2607-2021	Garcia-Hernandez, Jose Juan/0000-0002-1249-5413; 	CONACyT [CB-2010-1-50910]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The work was supported by CONACyT (www.conacyt.gob.mx) under grant CB-2010-1-50910. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED N, 1974, IEEE T COMPUT, VC 23, P90, DOI 10.1109/T-C.1974.223784; [Anonymous], 2009, STEGANOGRAPHY DIGITA; Baluja S, 2008, PATTERN RECOGN, V41, P3467, DOI 10.1016/j.patcog.2008.05.006; Bellettini Carlo, 2010, Journal of Communications, V5, P409, DOI 10.4304/jcm.5.5.409-424; Brandenburg K., 1999, P AES 17 C HIGH QUAL, P1; Cano P, 2005, STUD COMP INTELL, V2, P233; Cano P, 2002, PROCEEDINGS OF THE 2002 IEEE WORKSHOP ON MULTIMEDIA SIGNAL PROCESSING, P169; Celik MU, 2004, IEEE SIGNAL PROC LET, V11, P831, DOI 10.1109/LSP.2004.835475; Cox I., 2007, DIGITAL WATERMARKING; Cox IJ, 1997, IEEE T IMAGE PROCESS, V6, P1673, DOI 10.1109/83.650120; de Castro Lopo E, 2011, LIBSNDFILE; Frigo M, 2005, P IEEE, V93, P216, DOI 10.1109/JPROC.2004.840301; Geetha S, 2010, EXPERT SYST APPL, V37, P7469, DOI 10.1016/j.eswa.2010.04.012; Jang D, 2006, 29 INT C AUD MOB HAN, P3; Garcia-Hernandez JJ, 2008, IEICE ELECTRON EXPR, V5, P217, DOI 10.1587/elex.5.217; Garcia-Hernandez JJ, 2011, J SIGNAL PROCESS SYS, V64, P457, DOI 10.1007/s11265-010-0503-8; Jupiter DC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000950; Kim W, 2006, LECT NOTES COMPUT SC, V4261, P106; Kirovski D, 2004, IEEE MULTIMEDIA, V11, P59, DOI 10.1109/MMUL.2004.1; Kirovski D, 2003, IEEE T SIGNAL PROCES, V51, P1020, DOI 10.1109/TSP.2003.809384; Kirovski D, 2001, LNCS, P354; Kiyavash N, 2009, IEEE T INF FOREN SEC, V4, P318, DOI 10.1109/TIFS.2009.2025855; Kuribayashi M, 2012, IEEE T INF FOREN SEC, V7, P403, DOI 10.1109/TIFS.2011.2170421; Kuribayashi M, 2011, EURASIP J INF SECUR, DOI 10.1155/2011/502782; Liss M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042465; Liu K. J. R., 2005, Multimedia Fingerprinting Forensics for Traitor Tracing; Malvar H, 1999, INT CONF ACOUST SPEE, P1421, DOI 10.1109/ICASSP.1999.756248; Malvar HS, 2003, IEEE SIGNAL PROC LET, V10, P8, DOI 10.1109/LSP.2002.806700; Siwek S., 2007, POLICY REPORT 188; Smith SW, 2002, DIGIT SIGNAL PROCESS; Tardos G, 2003, P 35 ANN ACM S THEOR, P116, DOI DOI 10.1145/780542.780561; Thiede T, 2000, J AUDIO ENG SOC, V48, P3; Tirkel A., 2011, P INT C SEC INF NETW, P5; Trappe W, 2003, IEEE T SIGNAL PROCES, V51, P1069, DOI 10.1109/TSP.2003.809378; Tsai MJ, 2009, EXPERT SYST APPL, V36, P10708, DOI 10.1016/j.eswa.2009.02.066; Wang ZJ, 2004, EURASIP J APPL SIG P, V2004, P2153, DOI 10.1155/S1110865704312151; Wang ZJ, 2005, IEEE T IMAGE PROCESS, V14, P804, DOI 10.1109/TIP.2005.847284; Zezula R, 2006, P 2 INT C DIG TEL IC, P40; Zhang XM, 2012, EXPERT SYST APPL, V39, P1388, DOI 10.1016/j.eswa.2011.08.021; Zhao HV, 2005, IEEE T IMAGE PROCESS, V14, P646, DOI 10.1109/TIP.2005.846035	41	3	3	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65985	10.1371/journal.pone.0065985	http://dx.doi.org/10.1371/journal.pone.0065985			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762455	Green Published, gold, Green Submitted			2022-12-27	WOS:000321099000123
J	Liu, X; Liao, S; Zhu, L; Xu, ZW; Zhou, YC				Liu, Xiao; Liao, Shan; Zhu, Ling; Xu, Zhiwen; Zhou, Yuancheng			Molecular Epidemiology of Porcine Cytomegalovirus (PCMV) in Sichuan Province, China: 2010-2012	PLOS ONE			English	Article							GLYCOPROTEIN-B GENE; HUMAN ENTEROVIRUSES; SEQUENCE; IDENTIFICATION; PACKAGE; DISEASE; PIGS	Porcine cytomegalovirus (PCMV) is an immunosuppressive virus that mainly inhibits the immune function of the macrophage and T-cell lymphatic systems, and has caused huge economic losses to the porcine breeding industry. Molecular epidemiological investigation of PCMV is important for prevention and treatment, and this study is the first such investigation in Sichuan Province, Southwest China. A PCMV positive infection rate of 84.4% (865/1025) confirmed that PCMV is widely distributed in Sichuan Province. A phylogenetic tree was constructed based on the PCMV glycoprotein B gene (gB) nucleotide and amino acid sequences from 24 novel Sichuan isolates and 18 other PCMV gB sequences from Genbank. PCMV does not appear to have evolved into different serotypes, and two distinct sequence groups were identified (A and B). However, whether PCMV from this region has evolved into different genotypes requires further research. Analysis of the amino acid sequences confirmed the conservation of gB, but amino acid substitutions in the major epitope region have caused antigenic drift, which may have altered the immunogenicity of PCMV.	[Liu, Xiao; Liao, Shan; Zhu, Ling; Xu, Zhiwen; Zhou, Yuancheng] Sichuan Agr Univ, Coll Vet Med, Anim Biotechnol Ctr, Yaan, Peoples R China; [Xu, Zhiwen] Sichuan Agr Univ, Coll Vet Med, Key Lab Anim Dis & Human Hlth, Yaan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Xu, ZW (corresponding author), Sichuan Agr Univ, Coll Vet Med, Anim Biotechnol Ctr, Yaan, Peoples R China.	abtcxzw@126.com		Zhu, Ling/0000-0003-0950-5905; Xu, Zhiwen/0000-0002-9508-6593; Zhu, Ling/0000-0002-8822-5460; Zhou, Yuancheng/0000-0001-5295-826X	Fund Project for Youth Science and Technology in Sichuan Province (FPYSTSP) [200930421]	Fund Project for Youth Science and Technology in Sichuan Province (FPYSTSP)	This study was supported by Fund Project for Youth Science and Technology in Sichuan Province (FPYSTSP; Project No. 200930421). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; BOOTH JC, 1967, RES VET SCI, V8, P338; Clark DA, 2003, XENOTRANSPLANTATION, V10, P142, DOI 10.1034/j.1399-3089.2003.01128.x; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; CORNER AH, 1964, J COMP PATHOL THERAP, V74, P192, DOI 10.1016/S0368-1742(64)80024-2; CRANAGE MP, 1986, EMBO J, V5, P3057, DOI 10.1002/j.1460-2075.1986.tb04606.x; EDINGTON N, 1976, J COMP PATHOL, V86, P191, DOI 10.1016/0021-9975(76)90043-8; Edington N, 1986, DIS SWINE, V138, P330; Gollackner B, 2003, TRANSPLANTATION, V75, P1841, DOI 10.1097/01.TP.0000065806.90840.C1; Goltz M, 2000, VIRUS GENES, V21, P249, DOI 10.1023/A:1008156017758; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; Kumar S, 2012, BIOINFORMATICS, V10, P1; McGregor A, 2004, J VIROL, V78, P9872, DOI 10.1128/JVI.78.18.9872-9889.2004; Mitchell DK, 2002, PEDIATR INFECT DIS J, V21, P133, DOI 10.1097/00006454-200202000-00009; Mocarski ES, 1996, INTERVIROLOGY, V39, P320, DOI 10.1159/000150503; Nielsen M, 2005, IMMUNOGENETICS, V57, P33, DOI 10.1007/s00251-005-0781-7; Oberste MS, 1999, J CLIN MICROBIOL, V37, P1288, DOI 10.1128/JCM.37.5.1288-1293.1999; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; PLOWRIGHT W, 1976, J HYG-CAMBRIDGE, V76, P125, DOI 10.1017/S0022172400055017; Roizmann B. (Corresponding Author), 1992, Archives of Virology, V123, P425, DOI 10.1007/BF01317276; Rupasinghe V, 2001, J VET MED SCI, V63, P609, DOI 10.1292/jvms.63.609; SCHLEISS MR, 1994, VIROLOGY, V202, P173, DOI 10.1006/viro.1994.1333; STACZEK J, 1990, MICROBIOL REV, V54, P247, DOI 10.1128/MMBR.54.3.247-265.1990; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tucker A, 1999, TRANSPLANTATION, V31, P1460; Widen F, 2001, VIRUS GENES, V23, P339, DOI 10.1023/A:1012581508733; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371	31	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64648	10.1371/journal.pone.0064648	http://dx.doi.org/10.1371/journal.pone.0064648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762243	Green Published, gold, Green Submitted			2022-12-27	WOS:000321099000011
J	Alexander, JC; Browne, S; Pandit, A; Rochev, Y				Alexander, Jennifer C.; Browne, Shane; Pandit, Abhay; Rochev, Yury			Biomaterial Constructs for Delivery of Multiple Therapeutic Genes: A Spatiotemporal Evaluation of Efficacy Using Molecular Beacons	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; NITRIC-OXIDE SYNTHASE; MESSENGER-RNA; LIVING CELLS; INTERLEUKIN-10; EXPRESSION; HYBRIDIZATION; PREDICTION; DISEASE; GROWTH	Gene therapy is emerging as a potential therapeutic approach for cardiovascular pathogenesis. An appropriate therapy may require multiple genes to enhance therapeutic outcome by modulating inflammatory response and angiogenesis in a controlled and time-dependent manner. Thus, the aim of this research was to assess the spatiotemporal efficacy of a dualgene therapy model based on 3D collagen scaffolds loaded with the therapeutic genes interleukin 10 (IL-10), a potent anti-inflammatory cytokine, and endothelial nitric oxide synthase (eNOS), a promoter of angiogenesis. A collagen-based scaffold loaded with plasmid IL-10 polyplexes and plasmid eNOS polyplexes encapsulated into microspheres was used to transfect HUVECs and HMSCs cells. The therapeutic efficacy of the system was monitored at 2, 7 and 14 days for eNOS and IL-10 mRNA expression using RT-PCR and live cell imaging molecular beacon technology. The dual gene releasing collagen-based scaffold provided both sustained and delayed release of functional polyplexes in vitro over a 14 day period which was corroborated with variation in expression levels seen using RT-PCR and MB imaging. Maximum fold increases in IL-10 mRNA and eNOS mRNA expression levels occurred at day 7 in HMSCs and HUVECs. However, IL-10 mRNA expression levels seemed dependent on frequency of media changes and/or ease of transfection of the cell type. It was demonstrated that molecular beacons are able to monitor changes in mRNA levels at various time points, in the presence of a 3D scaffolding gene carrier system and the results complemented those of RT-PCR.	[Alexander, Jennifer C.; Browne, Shane; Pandit, Abhay; Rochev, Yury] Natl Univ Ireland, Network Excellence Funct Biomat NFB, Galway, Ireland; [Rochev, Yury] Natl Univ Ireland, Natl Ctr Biomed Engn Sci, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Rochev, Y (corresponding author), Natl Univ Ireland, Network Excellence Funct Biomat NFB, Galway, Ireland.	yury.rochev@nuigalway.ie	Pandit, Abhay/B-6187-2008; Rochev, Yury/M-9077-2014	Pandit, Abhay/0000-0002-6292-4933; Rochev, Yury/0000-0003-4213-9476; Browne, Shane/0000-0002-1005-1712	Science Foundation Ireland; European Research Development Fund [07/SRC/B1163]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Research Development Fund	This material is based upon works supported by the Science Foundation Ireland and the European Research Development Fund [Grant no. 07/SRC/B1163]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JC, 2011, LAB CHIP, V11, P3908, DOI 10.1039/c1lc20447e; [Anonymous], 2012, EURO SURVEILL, P17; Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Bratu Diana P., 2006, V319, P1; Browne S, 2012, MOL PHARM; Cannon RO, 1998, CLIN CHEM, V44, P1809; Cattaruzza M, 2003, J BIOL CHEM, V278, P37874, DOI 10.1074/jbc.M301670200; Creager MA, 2003, CIRCULATION, V108, P1527, DOI 10.1161/01.CIR.0000091257.27563.32; Curtis MW, 2009, J CARDIOVASC NURS, V24, P87, DOI 10.1097/01.JCN.0000343562.06614.49; Dufes C, 2005, ADV DRUG DELIVER REV, V57, P2177, DOI 10.1016/j.addr.2005.09.017; Fleming I, 2003, AM J PHYSIOL-REG I, V284, pR1, DOI 10.1152/ajpregu.00323.2002; Helary C, 2012, ACTA BIOMATER; Hosseinkhani H, 2006, BIOMATERIALS, V27, P4269, DOI 10.1016/j.biomaterials.2006.02.033; Jay SM, 2010, BIOMATERIALS, V31, P3054, DOI 10.1016/j.biomaterials.2010.01.014; Kulltarni MM, 2011, MOL PHARMACEUT, V8, P439, DOI 10.1021/mp100295z; Minami T, 2005, TRENDS CARDIOVAS MED, V15, P174, DOI 10.1016/j.tcm.2005.06.002; Mooney E, 2008, NANO LETT, V8, P2137, DOI 10.1021/nl073300o; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Murphy JM, 2002, ARTHRITIS RHEUM-US, V46, P704, DOI 10.1002/art.10118; Pannier AK, 2004, MOL THER, V10, P19, DOI 10.1016/j.ymthe.2004.03.020; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Rhee WJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn039; Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029; Rissanen TT, 2003, CIRC RES, V92, P1098, DOI 10.1161/01.RES.0000073584.46059.E3; Rissanen TT, 2007, MOL THER, V15, P1233, DOI 10.1038/sj.mt.6300175; Santangelo PJ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh062; Sase K, 1997, TRENDS CARDIOVAS MED, V7, P28, DOI 10.1016/S1050-1738(96)00121-1; Schinkothe T, 2008, STEM CELLS DEV, V17, P199, DOI 10.1089/scd.2007.0175; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Tsutsui M, 2009, CIRC J, V73, P986, DOI 10.1253/circj.CJ-09-0208; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Yla-Herttuala S, 2003, NAT MED, V9, P694, DOI 10.1038/nm0603-694; Zeugolis DI, 2008, J BIOMED MATER RES A, V86A, P892, DOI 10.1002/jbm.a.31694; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	36	10	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65749	10.1371/journal.pone.0065749	http://dx.doi.org/10.1371/journal.pone.0065749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755278	Green Published, Green Submitted, gold			2022-12-27	WOS:000319872300095
J	Gao, J; Sun, L; Yang, XE; Liu, JX				Gao, Jun; Sun, Ling; Yang, Xiaoe; Liu, Jian-Xiang			Transcriptomic Analysis of Cadmium Stress Response in the Heavy Metal Hyperaccumulator Sedum alfredii Hance	PLOS ONE			English	Article							CRASSULACEAN ACID METABOLISM; RNA-SEQ; SUBCELLULAR-DISTRIBUTION; ARABIDOPSIS; ZINC; TOLERANCE; ECOTYPE; PLANTS; PHYTOREMEDIATION; SEQUESTRATION	The Sedum alfredii Hance hyperaccumulating ecotype (HE) has the ability to hyperaccumulate cadmium (Cd), as well as zinc (Zn) and lead (Pb) in above-ground tissues. Although many physiological studies have been conducted with these plants, the molecular mechanisms underlying their hyper-tolerance to heavy metals are largely unknown. Here we report on the generation of 9.4 gigabases of adaptor-trimmed raw sequences and the assembly of 57,162 transcript contigs in S. alfredii Hance (HE) shoots by the combination of Roche 454 and Illumina/Solexa deep sequencing technologies. We also have functionally annotated the transcriptome and analyzed the transcriptome changes upon Cd hyperaccumulation in S. alfredii Hance (HE) shoots. There are 110 contigs and 123 contigs that were up-regulated (Fold Change >= 2.0) and down-regulated (Fold Change <= 0.5) by chronic Cd treatment in S. alfredii Hance (HE) at q-value cutoff of 0.005, respectively. Quantitative RT-PCR was employed to compare gene expression patterns between S. alfredii Hance (HE) and non-hyperaccumulating ecotype (NHE). Our results demonstrated that several genes involved in cell wall modification, metal translocation and remobilization were more induced or constitutively expressed at higher levels in HE shoots than that in NHE shoots in response to Cd exposure. Together, our study provides large-scale expressed sequence information and genome-wide transcriptome profiling of Cd responses in S. alfredii Hance (HE) shoots.	[Gao, Jun; Yang, Xiaoe] Zhejiang Univ, Coll Nat Resource & Environm Sci, MOE Key Lab Environm Remediat & Ecol Hlth, Hangzhou 310003, Zhejiang, Peoples R China; [Sun, Ling; Liu, Jian-Xiang] Fudan Univ, Sch Life Sci, Inst Plant Biol, State Key Lab Genet Engn, Shanghai 200433, Peoples R China	Zhejiang University; Fudan University	Yang, XE (corresponding author), Zhejiang Univ, Coll Nat Resource & Environm Sci, MOE Key Lab Environm Remediat & Ecol Hlth, Hangzhou 310003, Zhejiang, Peoples R China.	xyang581@gmail.com; jianxiangliu@fudan.edu.cn	Liu, Jian-Xiang/L-8784-2019	Liu, Jian-Xiang/0000-0003-0791-1301	Education Ministry of China [310003]; National Basic Research Program of China (973 Program) [2012CB910500]; National Natural Science Foundation of China [30630046, 21177107, 31070233, 31171157]; Shanghai Pujiang Talent Program [11PJ1400700]; Fundamental Research Funds [2013FZA6005]	Education Ministry of China(Ministry of Education, China); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Talent Program; Fundamental Research Funds	This study was financially supported by grants from the Education Ministry of China (#310003), the National Basic Research Program of China (973 Program, 2012CB910500), the National Natural Science Foundation of China (#30630046; #21177107; #31070233; #31171157), Shanghai Pujiang Talent Program (11PJ1400700), and the Fundamental Research Funds for the Central Universities (2013FZA6005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borland AM, 2011, NEW PHYTOL, V191, P619, DOI 10.1111/j.1469-8137.2011.03781.x; Cai XN, 2006, J EXP BOT, V57, P2563, DOI 10.1093/jxb/erl022; Chen ZZ, 2005, PROG BIOCHEM BIOPHYS, V32, P187; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; DalCorso G, 2010, PLANT SIGNAL BEHAV, V5, P663, DOI 10.4161/psb.5.6.11425; Davin LB, 2008, NAT PROD REP, V25, P1015, DOI 10.1039/b510386j; Gupta PK, 1996, CURR SCI INDIA, V70, P45; Hanikenne M, 2008, NATURE, V453, P391, DOI 10.1038/nature06877; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kaneda M, 2011, J EXP BOT, V62, P2063, DOI 10.1093/jxb/erq416; Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157; Li TQ, 2006, PEDOSPHERE, V16, P616, DOI 10.1016/S1002-0160(06)60095-7; Liu JX, 2007, PLANT CELL, V19, P4111, DOI 10.1105/tpc.106.050021; Lu LL, 2008, J EXP BOT, V59, P3203, DOI 10.1093/jxb/ern174; Mallona I, 2011, PLANT PHYSIOL, V156, P1978, DOI 10.1104/pp.111.179275; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nawrot T, 2006, LANCET ONCOL, V7, P119, DOI 10.1016/S1470-2045(06)70545-9; Ni TH, 2003, ACTA BOT SIN, V45, P925; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pilon-Smits E, 2005, ANNU REV PLANT BIOL, V56, P15, DOI 10.1146/annurev.arplant.56.032604.144214; Pilon-Smits E, 2002, CRIT REV PLANT SCI, V21, P439, DOI 10.1080/0735-260291044313; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roosens NHCJ, 2008, TRENDS PLANT SCI, V13, P208, DOI 10.1016/j.tplants.2008.02.006; Satarug S, 2010, ENVIRON HEALTH PERSP, V118, P182, DOI 10.1289/ehp.0901234; Talke IN, 2006, PLANT PHYSIOL, V142, P148, DOI 10.1104/pp.105.076232; Tian SK, 2009, NEW PHYTOL, V182, P116, DOI 10.1111/j.1469-8137.2008.02740.x; Tian SK, 2011, PLANT PHYSIOL, V157, P1914, DOI 10.1104/pp.111.183947; Tian SK, 2010, ENVIRON SCI TECHNOL, V44, P5920, DOI 10.1021/es903921t; Ueno D, 2011, PLANT J, V66, P852, DOI 10.1111/j.1365-313X.2011.04548.x; Verbruggen N, 2009, NEW PHYTOL, V181, P759, DOI 10.1111/j.1469-8137.2008.02748.x; Verbruggen N, 2009, CURR OPIN PLANT BIOL, V12, P364, DOI 10.1016/j.pbi.2009.05.001; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xie F., 2011, PLOS ONE, V6; Xiong YH, 2004, J ENVIRON SCI HEAL A, V39, P2925, DOI 10.1081/LESA-200034269; Yang X, 2002, CHINESE SCI BULL, V47, P1634, DOI 10.1360/02tb9359; Yang XE, 2004, PLANT SOIL, V259, P181, DOI 10.1023/B:PLSO.0000020956.24027.f2; Yang X, 2006, PLANTA, V224, P185, DOI 10.1007/s00425-005-0194-8; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	41	85	93	9	188	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64643	10.1371/journal.pone.0064643	http://dx.doi.org/10.1371/journal.pone.0064643			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755133	Green Submitted, gold, Green Published			2022-12-27	WOS:000319872300021
J	Morizane, R; Monkawa, T; Fujii, S; Yamaguchi, S; Homma, K; Matsuzaki, Y; Okano, H; Itoh, H				Morizane, Ryuji; Monkawa, Toshiaki; Fujii, Shizuka; Yamaguchi, Shintaro; Homma, Koichiro; Matsuzaki, Yumi; Okano, Hideyuki; Itoh, Hiroshi			Kidney Specific Protein-Positive Cells Derived from Embryonic Stem Cells Reproduce Tubular Structures In Vitro and Differentiate into Renal Tubular Cells	PLOS ONE			English	Article							VASCULAR PROGENITOR CELLS; KSP-CADHERIN; GROWTH-FACTOR; MOUSE KIDNEY; EXPRESSION; METANEPHROS; CLONING; FAMILY; ADULT; ROLES	Embryonic stem cells and induced pluripotent stem cells have the ability to differentiate into various organs and tissues, and are regarded as new tools for the elucidation of disease mechanisms as well as sources for regenerative therapies. However, a method of inducing organ-specific cells from pluripotent stem cells is urgently needed. Although many scientists have been developing methods to induce various organ-specific cells from pluripotent stem cells, renal lineage cells have yet to be induced in vitro because of the complexity of kidney structures and the diversity of kidney-component cells. Here, we describe a method of inducing renal tubular cells from mouse embryonic stem cells via the cell purification of kidney specific protein (KSP)-positive cells using an anti-KSP antibody. The global gene expression profiles of KSP-positive cells derived from ES cells exhibited characteristics similar to those of cells in the developing kidney, and KSP-positive cells had the capacity to form tubular structures resembling renal tubular cells when grown in a 3D culture in Matrigel. Moreover, our results indicated that KSP-positive cells acquired the characteristics of each segment of renal tubular cells through tubular formation when stimulated with Wnt4. This method is an important step toward kidney disease research using pluripotent stem cells, and the development of kidney regeneration therapies.	[Morizane, Ryuji; Monkawa, Toshiaki; Fujii, Shizuka; Yamaguchi, Shintaro; Homma, Koichiro; Itoh, Hiroshi] Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, Tokyo, Japan; [Matsuzaki, Yumi; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 160, Japan	Keio University; Keio University	Monkawa, T (corresponding author), Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, Tokyo, Japan.	monkawa@z5.keio.jp	Monkawa, Toshiaki/F-2361-2010; Homma, Koichiro/J-3146-2015; Okano, Hideyuki/I-7584-2019; Morizane, R/AAC-3215-2021	Monkawa, Toshiaki/0000-0002-7876-7661; Morizane, R/0000-0002-0377-5667; Yamaguchi, Shintaro/0000-0002-4917-033X; Matsuzaki, Yumi/0000-0002-3729-2997	KAKENHI [23890203, 21591038, 24591211]; Daiwa Securities Health Foundation	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Daiwa Securities Health Foundation	This work was supported in part by Grant-in-Aid for Scientific Research (KAKENHI, 23890203, 21591038, 24591211) and a grant from Daiwa Securities Health Foundation (http://www.daiwa-grp.jp/dsh/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bariety J, 2006, J AM SOC NEPHROL, V17, P2770, DOI 10.1681/ASN.2006040325; Batchelder CA, 2009, DIFFERENTIATION, V78, P45, DOI 10.1016/j.diff.2009.05.001; Bruce SJ, 2007, DIFFERENTIATION, V75, P337, DOI 10.1111/j.1432-0436.2006.00149.x; ECHEVARRIA M, 1994, P NATL ACAD SCI USA, V91, P10997, DOI 10.1073/pnas.91.23.10997; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; HAMMERMAN MR, 1994, J AM SOC NEPHROL, V5, P1; Kim D, 2005, J AM SOC NEPHROL, V16, P3527, DOI 10.1681/ASN.2005050544; Kispert A, 1998, DEVELOPMENT, V125, P4225; Kobayashi T, 2005, BIOCHEM BIOPH RES CO, V336, P585, DOI 10.1016/j.bbrc.2005.08.136; Mae SI, 2010, BIOCHEM BIOPH RES CO, V393, P877, DOI 10.1016/j.bbrc.2010.02.111; Morizane R, 2009, BIOCHEM BIOPH RES CO, V390, P1334, DOI 10.1016/j.bbrc.2009.10.148; Nishinakamura R, 2006, J PHYSIOL SCI, V56, P131, DOI 10.2170/physiolsci.M95; Ogawa K, 2006, BIOCHEM BIOPH RES CO, V343, P159, DOI 10.1016/j.bbrc.2006.02.127; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Prozialeck Walter C, 2004, BMC Physiol, V4, P10, DOI 10.1186/1472-6793-4-10; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; ROGERS SA, 1991, J CELL BIOL, V113, P1447, DOI 10.1083/jcb.113.6.1447; Schmitt R, 1999, AM J PHYSIOL-RENAL, V276, pF367, DOI 10.1152/ajprenal.1999.276.3.F367; Sekine M, 2006, J BIOL CHEM, V281, P1008, DOI 10.1074/jbc.M509307200; Sekine M, 2012, TRANSGENIC RES, V21, P51, DOI 10.1007/s11248-011-9504-z; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016443.50138.CD; Sone M, 2003, CIRCULATION, V107, P2085, DOI 10.1161/01.CIR.0000070022.78747.1B; TAUB M, 1990, P NATL ACAD SCI USA, V87, P4002, DOI 10.1073/pnas.87.10.4002; Thomson RB, 1999, AM J PHYSIOL-RENAL, V277, pF146, DOI 10.1152/ajprenal.1999.277.1.F146; THOMSON RB, 1995, J BIOL CHEM, V270, P17594, DOI 10.1074/jbc.270.29.17594; Vigneau C, 2007, J AM SOC NEPHROL, V18, P1709, DOI 10.1681/ASN.2006101078; WOOLF AS, 1995, J CELL BIOL, V128, P171, DOI 10.1083/jcb.128.1.171; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yurugi-Kobayashi T, 2003, BLOOD, V101, P2675, DOI 10.1182/blood-2002-06-1877; Yurugi-Kobayashi T, 2006, ARTERIOSCL THROM VAS, V26, P1977, DOI 10.1161/01.ATV.0000234978.10658.41	30	36	36	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64843	10.1371/journal.pone.0064843	http://dx.doi.org/10.1371/journal.pone.0064843			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755150	Green Submitted, Green Published, gold			2022-12-27	WOS:000319872300030
J	Xie, L; Xu, F; Liu, SG; Ji, YJ; Zhou, QM; Wu, QY; Gong, W; Cheng, K; Li, J; Li, LL; Fang, L; Zhou, LK; Xie, P				Xie, Liang; Xu, Fan; Liu, Shigang; Ji, Yongjia; Zhou, Qinming; Wu, Qingyuan; Gong, Wei; Cheng, Ke; Li, Juan; Li, Leilei; Fang, Liang; Zhou, Linke; Xie, Peng			Age- and Sex-Based Hematological and Biochemical Parameters for Macaca fascicularis	PLOS ONE			English	Article							CYNOMOLGUS MONKEYS; REFERENCE INTERVALS; CLINICAL-CHEMISTRY; REFERENCE VALUES; DRUG ABSORPTION; BLOOD-CHEMISTRY; MACAQUES; MULATTA; PATHOLOGY; VARIABLES	Background: The cynomolgus monkey (Macaca fascicularis) has been increasingly used in biomedical research, making knowledge of its blood-based parameters essential to support the selection of healthy subjects and its use in preclinical research. As age and sex affect these blood-based parameters, it is important to establish baseline indices for these parameters on an age and sex basis and determine the effects of age and sex on these indices. Methods: A total of 917 cynomolgus monkeys (374 males and 543 females) were selected and segregated by age (five groups) and sex. A total of 30 hematological and 22 biochemical parameters were measured, and the effects of age and sex were analyzed. Results: Baseline indices for hematological and biochemical parameters were separately established by age and sex. Significant effects by age, sex, and age-sex interaction were observed in a number of blood parameters. In the 49-60 months and 61-72 months age groups, red blood cell count, hemoglobulin, and hematocrit showed significantly lower values (P<0.01) in females than males. Serum alkaline phosphatase varied with age in both sexes (P<0.01) and was significantly higher in females than males (P<0.05) in the groups aged 13-24 months and 25-36 months; however, in the three groups aged over 25-36 months, serum alkaline phosphatase was significantly lower in females than males (P<0.01). Creatinine concentration increased with age (P<0.01) in all age groups; specifically in the groups aged 49-60 months and 61-72 months, creatinine was significantly higher (P<0.01) in males than females. Total protein and globulin both increased with age (P<0.01). Conclusion: The baseline values of hematological and biochemical parameters reported herein establish reference indices of blood-based parameters in the cynomolgus monkey by age and sex, thereby aiding researchers in selecting healthy subjects and evaluating preclinical studies using this species.	[Xie, Liang; Xu, Fan; Ji, Yongjia; Zhou, Qinming; Wu, Qingyuan; Gong, Wei; Cheng, Ke; Li, Juan; Fang, Liang; Zhou, Linke; Xie, Peng] Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China; [Xie, Liang; Xu, Fan; Ji, Yongjia; Zhou, Qinming; Wu, Qingyuan; Gong, Wei; Cheng, Ke; Li, Juan; Fang, Liang; Zhou, Linke; Xie, Peng] Chongqing Key Lab Neurobiol, Chongqing, Peoples R China; [Xie, Liang; Ji, Yongjia; Zhou, Qinming; Wu, Qingyuan; Cheng, Ke; Li, Juan; Zhou, Linke; Xie, Peng] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Liu, Shigang] Suzhou Xishan Zhongke Lab Anim Co Ltd, Suzhou, Peoples R China; [Li, Leilei] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chinese Center for Disease Control & Prevention	Xie, P (corresponding author), Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China.	xiepeng@cqmu.edu.cn	Zhou, Qinming/GWZ-7229-2022; Cheng, Ke/HCH-8846-2022	Zhou, Qinming/0000-0001-6211-0588; 	National Basic Research Program of China (973 Program) [2009CB918300]; National Natural Science Foundation of China [31271189]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program; Grant No. 2009CB918300) and National Natural Science Foundation of China (Grant No. 31271189). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT BT, 1995, NONHUMAN PRIMATES BI, P377; Bonfanti U, 2009, J MED PRIMATOL, V38, P228, DOI 10.1111/j.1600-0684.2009.00345.x; Buchl SJ, 1997, LAB ANIM SCI, V47, P528; Carlson CS, 1996, J BONE MINER RES, V11, P1209; CASTRO OL, 1987, PUBLIC HEALTH REP, V102, P232; Chen Y, 2002, EXP ANIM TOKYO, V51, P125, DOI 10.1538/expanim.51.125; Chen YN, 2009, XENOTRANSPLANTATION, V16, P496, DOI 10.1111/j.1399-3089.2009.00554.x; DAVY CW, 1984, LAB ANIM, V18, P135, DOI 10.1258/002367784780891217; Delmas Pierre D., 1995, P319; DOLUISIO JT, 1969, J PHARM SCI-US, V58, P1200, DOI 10.1002/jps.2600581007; Drevon-Gaillot E, 2006, EXP TOXICOL PATHOL, V58, P77, DOI 10.1016/j.etp.2006.07.003; Eudey Ardith A., 2008, Primate Conservation, V23, P129, DOI 10.1896/052.023.0115; FA JE, 1989, MAMMAL REV, V19, P45, DOI 10.1111/j.1365-2907.1989.tb00401.x; FERNIE S, 1994, J TOXICOL ENV HEALTH, V42, P53, DOI 10.1080/15287399409531863; FORTMAN JD, 2002, LAB NONHUMAN PRIMATE, pCH1; Fujiwara T, 1974, Jikken Dobutsu, V23, P137; Harewood WJ, 1999, J MED PRIMATOL, V28, P19, DOI 10.1111/j.1600-0684.1999.tb00085.x; Herndon JG, 2001, COMPARATIVE MED, V51, P60; Ihrig M, 2001, COMPARATIVE MED, V51, P30; Institute of Laboratory Animal Resources. Commission on Life Sciences National Research Council, 1996, GUIDE CARE USE LAB A; JAYO MJ, 1994, CALCIFIED TISSUE INT, V54, P231, DOI 10.1007/BF00301684; Kim CY, 2005, J MED PRIMATOL, V34, P96, DOI 10.1111/j.1600-0684.2005.00097.x; Kimura N, 2003, BIOCHEM BIOPH RES CO, V310, P303, DOI 10.1016/j.bbrc.2003.09.012; Koga T, 2005, INT J TOXICOL, V24, P377, DOI 10.1080/10915810500208058; KRABBE S, 1980, ACTA PAEDIATR SCAND, V69, P49, DOI 10.1111/j.1651-2227.1980.tb07028.x; Liddie S, 2010, J MED PRIMATOL, V39, P389, DOI 10.1111/j.1600-0684.2010.00422.x; Lugo-Roman LA, 2010, J MED PRIMATOL, V39, P41, DOI 10.1111/j.1600-0684.2009.00394.x; MACARTHUR JA, 1979, J HYG-CAMBRIDGE, V83, P207, DOI 10.1017/S0022172400025985; MACKENZIE M, 1986, LAB ANIM SCI, V36, P14; OECD (Organization for Economic Cooperation and Development), 1995, TEST 107 PART COEFF; ORR JM, 1975, AM J DIG DIS, V20, P858, DOI 10.1007/BF01070955; OSULLIVAN MG, 1994, J CLIN INVEST, V93, P1571, DOI 10.1172/JCI117136; PERRETTA G, 1991, J MED PRIMATOL, V20, P345; Pierre PJ, 2011, J MED PRIMATOL, V40, P287, DOI 10.1111/j.1600-0684.2011.00466.x; Riviello MC, 2001, J MED PRIMATOL, V30, P308, DOI 10.1034/j.1600-0684.2001.300604.x; SAMMONS LS, 1976, AM J VET RES, V37, P725; Sato A, 2005, CONTEMP TOP LAB ANIM, V44, P29; Schuurman HJ, 2005, XENOTRANSPLANTATION, V12, P72, DOI 10.1111/j.1399-3089.2004.00186.x; Shchelkunov SN, 2001, FEBS LETT, V509, P66, DOI 10.1016/S0014-5793(01)03144-1; SHEVTSOVA ZV, 1988, J MED PRIMATOL, V17, P177; Smucny DA, 2001, J MED PRIMATOL, V30, P161, DOI 10.1111/j.1600-0684.2001.tb00005.x; SUGIMOTO Y, 1986, EXP ANIM TOKYO, V35, P443, DOI 10.1538/expanim1978.35.4_443; Suzuki T, 1996, EXP ANIM TOKYO, V45, P39, DOI 10.1538/expanim.45.39; SWITZER JW, 1970, LAB ANIM CARE, V20, P930; Van Esch E, 2008, TOXICOL PATHOL, V36, p171S, DOI 10.1177/0192623308327415; Venkatesan R, 2006, J AM ASSOC LAB ANIM, V45, P45; Warnick GR, 2008, CLIN CHEM, V54, P14, DOI 10.1373/clinchem.2007.098863; WEINGAND K, 1992, TOXICOL PATHOL, V20, P539, DOI 10.1177/0192623392020003217; Wirz A, 2008, AM J PRIMATOL, V70, P463, DOI 10.1002/ajp.20520; WOLFECOOTE S, 2005, LAB PRIMATE, P449; WOLFECOOTE S, 2005, LAB PRIMATE, P75; Wu J, 2008, J NEUROSCI, V28, P3, DOI 10.1523/JNEUROSCI.4405-07.2008; Xu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037486; YOSHIDA T, 1986, EXP ANIM TOKYO, V35, P329, DOI 10.1538/expanim1978.35.3_329; Zeng XC, 2011, J MED PRIMATOL, V40, P21, DOI 10.1111/j.1600-0684.2010.00444.x	55	61	65	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e64892	10.1371/journal.pone.0064892	http://dx.doi.org/10.1371/journal.pone.0064892			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762263	Green Published, Green Submitted, gold			2022-12-27	WOS:000320440500009
J	Karauzum, H; Adhikari, RP; Sarwar, J; Devi, VS; Abaandou, L; Haudenschild, C; Mahmoudieh, M; Boroun, AR; Vu, H; Nguyen, T; Warfield, KL; Shulenin, S; Aman, MJ				Karauzum, Hatice; Adhikari, Rajan P.; Sarwar, Jawad; Devi, V. Sathya; Abaandou, Laura; Haudenschild, Christian; Mahmoudieh, Mahta; Boroun, Atefeh R.; Hong Vu; Tam Nguyen; Warfield, Kelly L.; Shulenin, Sergey; Aman, M. Javad			Structurally Designed Attenuated Subunit Vaccines for S. aureus LukS-PV and LukF-PV Confer Protection in a Mouse Bacteremia Model	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; RESISTANT STAPHYLOCOCCUS-AUREUS; CRYSTAL-STRUCTURE; POLYMORPHONUCLEAR LEUKOCYTES; VIRULENCE DETERMINANTS; SKIN INFECTIONS; GAMMA-HEMOLYSIN; PORE FORMATION; COMMUNITY; LEUCOCIDIN	Previous efforts towards S. aureus vaccine development have largely focused on cell surface antigens to induce opsonophagocytic killing aimed at providing sterile immunity, a concept successfully applied to other Gram-positive pathogens such as Streptococcus pneumoniae. However, these approaches have largely failed, possibly in part due to the remarkable diversity of the staphylococcal virulence factors such as secreted immunosuppressive and tissue destructive toxins. S. aureus produces several pore-forming toxins including the single subunit alpha hemolysin as well as bicomponent leukotoxins such as Panton-Valentine leukocidin (PVL), gamma hemolysins (Hlg), and LukED. Here we report the generation of highly attenuated mutants of PVL subunits LukS-PV and LukF-PV that were rationally designed, based on an octameric structural model of the toxin, to be deficient in oligomerization. The attenuated subunit vaccines were highly immunogenic and showed significant protection in a mouse model of S. aureus USA300 sepsis. Protection against sepsis was also demonstrated by passive transfer of rabbit immunoglobulin raised against LukS-PV. Antibodies to LukS-PV inhibited the homologous oligomerization of LukS-PV with LukF-PV as well heterologous oligomerization with HlgB. Importantly, immune sera from mice vaccinated with the LukS mutant not only inhibited the PMN lytic activity produced by the PVL-positive USA300 but also blocked PMN lysis induced by supernatants of PVL-negative strains suggesting a broad protective activity towards other bicomponent toxins. These findings strongly support the novel concept of an anti-virulence, toxin-based vaccine intended for prevention of clinical S. aureus invasive disease, rather than achieving sterile immunity. Such a multivalent vaccine may include attenuated leukotoxins, alpha hemolysin, and superantigens.	[Karauzum, Hatice; Adhikari, Rajan P.; Sarwar, Jawad; Devi, V. Sathya; Abaandou, Laura; Haudenschild, Christian; Mahmoudieh, Mahta; Boroun, Atefeh R.; Hong Vu; Tam Nguyen; Warfield, Kelly L.; Shulenin, Sergey; Aman, M. Javad] Integrated Biotherapeut Inc, Gaithersburg, MD USA		Aman, MJ (corresponding author), Integrated Biotherapeut Inc, Gaithersburg, MD USA.	javad@integratedbiotherapeutics.com	Venkatarmani, Sathyadevi/AAP-1068-2020; Adhikari, Rajan/J-7396-2019	Venkatarmani, Sathyadevi/0000-0003-1242-8162; 	National Institute of Allergy and Infectious Diseases [5R43AI085665]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI085665] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by a grant from the National Institute of Allergy and Infectious Diseases (Grant number: 5R43AI085665). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari RP, 2012, J INFECT DIS, V206, P915, DOI 10.1093/infdis/jis462; Adhikari RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038567; Alonzo F, 2012, MOL MICROBIOL, V83, P423, DOI 10.1111/j.1365-2958.2011.07942.x; Aman MJ, 2010, J BIOMOL STRUCT DYN, V28, P1; Brown EL, 2009, CLIN MICROBIOL INFEC, V15, P156, DOI 10.1111/j.1469-0691.2008.02648.x; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; Coler RN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013677; Cremieux AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007204; Devi VS, 2006, BIOCHEMISTRY-US, V45, P1599, DOI 10.1021/bi052352u; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Fattom AI, 1996, INFECT IMMUN, V64, P1659, DOI 10.1128/IAI.64.5.1659-1665.1996; Ferreras M, 1998, BBA-BIOMEMBRANES, V1414, P108, DOI 10.1016/S0005-2736(98)00160-6; FINCKBARBANCON V, 1993, BIOCHIM BIOPHYS ACTA, V1182, P275, DOI 10.1016/0925-4439(93)90069-D; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Gravet A, 1998, FEBS LETT, V436, P202, DOI 10.1016/S0014-5793(98)01130-2; Guillet V, 2004, J BIOL CHEM, V279, P41028, DOI 10.1074/jbc.M406904200; He F, 2010, J PHARM SCI-US, V99, P1707, DOI 10.1002/jps.21955; Holzinger D, 2012, J LEUKOCYTE BIOL, V92, P1069, DOI 10.1189/jlb.0112014; Kaneko J, 2004, BIOSCI BIOTECH BIOCH, V68, P981, DOI 10.1271/bbb.68.981; Kaneko J, 1998, GENE, V215, P57, DOI 10.1016/S0378-1119(98)00278-9; KOTZIN BL, 1993, ADV IMMUNOL, V54, P99, DOI 10.1016/S0065-2776(08)60534-9; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Malachowa N, 2011, VIRULENCE, V2, P567, DOI 10.4161/viru.2.6.17732; Malachowa N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018617; Meyer R D, 2001, Int J Infect Dis, V5, P163, DOI 10.1016/S1201-9712(01)90093-1; Miles G, 2002, PROTEIN SCI, V11, P894, DOI 10.1110/ps.4360102; Mullen GED, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002940; Narita S, 2001, GENE, V268, P195, DOI 10.1016/S0378-1119(01)00390-0; Nilsson IM, 1999, INFECT IMMUN, V67, P1045, DOI 10.1128/IAI.67.3.1045-1049.1999; Nizet V, 2007, J ALLERGY CLIN IMMUN, V120, P13, DOI 10.1016/j.jaci.2007.06.005; Pedelacq JD, 2000, INT J MED MICROBIOL, V290, P395; Perret M, 2012, CELL MICROBIOL, V14, P1019, DOI 10.1111/j.1462-5822.2012.01772.x; PREVOST G, 1995, INFECT IMMUN, V63, P4121; RomeroSteiner S, 1997, CLIN DIAGN LAB IMMUN, V4, P415, DOI 10.1128/CDLI.4.4.415-422.1997; Schuberth HJ, 2001, VET MICROBIOL, V82, P187, DOI 10.1016/S0378-1135(01)00386-8; Supersac G, 1998, MICROB PATHOGENESIS, V24, P241, DOI 10.1006/mpat.1997.0192; Tristan A, 2007, J HOSP INFECT, V65, P105, DOI 10.1016/S0195-6701(07)60025-5; Varshney AK, 2009, J INFECT DIS; Ventura CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011634; Yamashita K, 2011, P NATL ACAD SCI USA, V108, P17314, DOI 10.1073/pnas.1110402108	43	37	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65384	10.1371/journal.pone.0065384	http://dx.doi.org/10.1371/journal.pone.0065384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762356	Green Submitted, Green Published, gold			2022-12-27	WOS:000321094800044
J	Ren, A; Li, MJ; Shi, L; Mu, DS; Jiang, AL; Han, Q; Zhao, MW				Ren, Ang; Li, Meng-Jiao; Shi, Liang; Mu, Da-Shuai; Jiang, Ai-Liang; Han, Qin; Zhao, Ming-Wen			Profiling and Quantifying Differential Gene Transcription Provide Insights into Ganoderic Acid Biosynthesis in Ganoderma lucidum in Response to Methyl Jasmonate	PLOS ONE			English	Article							SECONDARY METABOLISM; OXIDATIVE STRESS; PROTEIN-KINASE; SIGNAL-TRANSDUCTION; MOLECULAR-CLONING; GENOME SEQUENCE; HIGHER FUNGI; EXPRESSION; REDUCTASE; ANTITUMOR	Ganoderma lucidum is a mushroom with traditional medicinal properties that has been widely used in China and other countries in Eastern Asia. Ganoderic acids (GA) produced by G. lucidum exhibit important pharmacological activities. Previous studies have demonstrated that methyl jasmonate (MeJA) is a potent inducer of GA biosynthesis and the expression of genes involved in the GA biosynthesis pathway in G. lucidum. To further explore the mechanism of GA biosynthesis, cDNA-Amplified Fragment Length Polymorphism (cDNA-AFLP) was used to identify genes that are differentially expressed in response to MeJA. Using 64 primer combinations, over 3910 transcriptionally derived fragments (TDFs) were obtained. Reliable sequence data were obtained for 390 of 458 selected TDFs. Ninety of these TDFs were annotated with known functions through BLASTX searching the GenBank database, and 12 annotated TDFs were assigned into secondary metabolic pathways by searching the KEGGPATHWAY database. Twenty-five TDFs were selected for qRT-PCR analysis to confirm the expression patterns observed with cDNA-AFLP. The qRT-PCR results were consistent with the altered patterns of gene expression revealed by the cDNA-AFLP technique. Additionally, the transcript levels of 10 genes were measured at the mycelium, primordia, and fruiting body developmental stages of G. lucidum. The greatest expression levels were reached during primordia for all of the genes except cytochrome b2 reached its highest expression level in the mycelium stage. This study not only identifies new candidate genes involved in the regulation of GA biosynthesis but also provides further insight into MeJA-induced gene expression and secondary metabolic response in G. lucidum.	[Ren, Ang; Li, Meng-Jiao; Shi, Liang; Mu, Da-Shuai; Jiang, Ai-Liang; Han, Qin; Zhao, Ming-Wen] Nanjing Agr Univ, Key Lab Microbiol Engn Agr Environm, Coll Life Sci, Dept Microbiol,Minist Agr, Nanjing, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Zhao, MW (corresponding author), Nanjing Agr Univ, Key Lab Microbiol Engn Agr Environm, Coll Life Sci, Dept Microbiol,Minist Agr, Nanjing, Jiangsu, Peoples R China.	mwzhao@njau.edu.cn	Zhao, Ming-Wen/AAS-1510-2020	zhao, mingwen/0000-0002-9413-1743	National Natural Science Foundation of China [30970042]; Fundamental Research Funds for the Central Uni-versities [KYZ201121]; Chinese National Key Technology RD Program [2013BAD16B02]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Uni-versities(Fundamental Research Funds for the Central Universities); Chinese National Key Technology RD Program(National Key Technology R&D Program); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the National Natural Science Foundation of China (Project No. 30970042), the Fundamental Research Funds for the Central Uni-versities (Project No. KYZ201121), the Chinese National Key Technology R&D Program (Project No. 2013BAD16B02) and the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atoui A, 2008, APPL ENVIRON MICROB, V74, P3596, DOI 10.1128/AEM.02842-07; Bayram O, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002816; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; Chanda A, 2009, P NATL ACAD SCI USA, V106, P19533, DOI 10.1073/pnas.0907416106; Chen SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1923; CHOI D, 1994, P NATL ACAD SCI USA, V91, P2329, DOI 10.1073/pnas.91.6.2329; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CREELMAN RA, 1992, P NATL ACAD SCI USA, V89, P4938, DOI 10.1073/pnas.89.11.4938; Ding YX, 2008, BIOSCI BIOTECH BIOCH, V72, P1571, DOI 10.1271/bbb.80067; Hajjaj H, 2005, APPL ENVIRON MICROB, V71, P3653, DOI 10.1128/AEM.71.7.3653-3658.2005; HIROTANI M, 1990, J CHEM SOC PERK T 1, P2751, DOI 10.1039/p19900002751; Hong SY, 2008, APPL ENVIRON MICROB, V74, P6385, DOI 10.1128/AEM.01185-08; Hoppert M, 2001, ARCH MICROBIOL, V176, P285, DOI 10.1007/s002030100324; Jedinak A, 2011, INT J ONCOL, V38, P761, DOI 10.3892/ijo.2011.898; Joseph S, 2011, ACTA PHARMACEUT, V61, P335, DOI 10.2478/v10007-011-0030-6; Kimura Y, 2002, ANTICANCER RES, V22, P3309; LENDENFELD T, 1993, J BIOL CHEM, V268, P665; Li N, 2006, J MICROBIOL BIOTECHN, V16, P1940; Liang CX, 2010, APPL MICROBIOL BIOT, V86, P1367, DOI 10.1007/s00253-009-2415-8; Lin ZB, 1979, ACTA PHARM SIN, V14, P183; Liu DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036146; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mach-Aigner AR, 2010, APPL ENVIRON MICROB, V76, P1770, DOI 10.1128/AEM.02746-09; Meimaroglou Dido Maria, 2009, Int J Microbiol, V2009, P842626, DOI 10.1155/2009/842626; Mendez-Alvarez S, 2000, BIOCHEM BIOPH RES CO, V267, P953, DOI 10.1006/bbrc.1999.2070; Miyamoto I, 2009, EUR J PHARMACOL, V602, P1, DOI 10.1016/j.ejphar.2008.11.005; Mo C, 2003, BBA-MOL CELL BIOL L, V1633, P68, DOI 10.1016/S1388-1981(03)00088-X; Mu DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043737; Munemasa S, 2011, PLANT PHYSIOL, V155, P553, DOI 10.1104/pp.110.162750; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; Oh SY, 2005, INT J MOL MED, V16, P833; Quetglas JI, 2012, J VIROL, V86, P1758, DOI 10.1128/JVI.05666-11; Raina SK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-134; Raudaskoski M, 2012, BIOTECHNOL GENET ENG, V28, P61, DOI 10.5661/bger-28-61; Ren A, 2013, WORLD J MICROB BIOT, V29, P523, DOI 10.1007/s11274-012-1206-z; Ren A, 2010, BIORESOURCE TECHNOL, V101, P6785, DOI 10.1016/j.biortech.2010.03.118; Rochat T, 2006, APPL ENVIRON MICROB, V72, P5143, DOI 10.1128/AEM.00482-06; Shang CH, 2008, BIOSCI BIOTECH BIOCH, V72, P1333, DOI 10.1271/bbb.80011; Shang CH, 2010, BIOSCI BIOTECH BIOCH, V74, P974, DOI 10.1271/bbb.90833; Shi L, 2012, MOL BIOL REP, V39, P6149, DOI 10.1007/s11033-011-1431-9; Shi LA, 2010, APPL MICROBIOL BIOT, V88, P1243, DOI 10.1007/s00253-010-2871-1; SHIAO MS, 1992, J CHIN CHEM SOC-TAIP, V39, P669, DOI 10.1002/jccs.199200102; Sirikantaramas Supaart, 2008, Phytochemistry Reviews, V7, P467, DOI 10.1007/s11101-007-9080-2; Song J, 2006, AM J PHYSIOL-CELL PH, V290, pC1469, DOI 10.1152/ajpcell.00486.2005; Tang YJ, 2009, BIORESOURCE TECHNOL, V100, P1852, DOI 10.1016/j.biortech.2008.10.005; Vergopoulou S, 2001, J AGR FOOD CHEM, V49, P3494, DOI 10.1021/jf010074+; Vuylsteke M, 2007, NAT PROTOC, V2, P1399, DOI 10.1038/nprot.2007.174; Xu JW, 2012, APPL ENVIRON MICROB, V78, P7968, DOI 10.1128/AEM.01263-12; Xu YN, 2012, BIOTECHNOL ADV, V30, P1301, DOI 10.1016/j.biotechadv.2011.10.001; Yao HJ, 2005, J APPL MICROBIOL, V98, P941, DOI 10.1111/j.1365-2672.2004.02531.x; Yin WB, 2012, MOL MICROBIOL, V83, P1024, DOI 10.1111/j.1365-2958.2012.07986.x; Yonekura-Sakakibara K, 2008, PLANT CELL, V20, P2160, DOI 10.1105/tpc.108.058040; You BJ, 2012, FOOD RES INT, V49, P634, DOI 10.1016/j.foodres.2012.09.003; You BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053616; Yu GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044031; Yu JH, 2005, ANNU REV PHYTOPATHOL, V43, P437, DOI 10.1146/annurev.phyto.43.040204.140214; Zhang BB, 2011, J AGR FOOD CHEM, V59, P1210, DOI 10.1021/jf104425w; Zhang WX, 2010, BIOPROC BIOSYST ENG, V33, P683, DOI 10.1007/s00449-009-0379-9; Zhao MW, 2007, J MICROBIOL BIOTECHN, V17, P1106; Zheng W, 2009, FUNGAL GENET BIOL, V46, P450, DOI 10.1016/j.fgb.2009.03.005; Zhong JJ, 2009, ADV BIOCHEM ENG BIOT, V113, P79, DOI 10.1007/10_2008_26	62	41	50	6	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65027	10.1371/journal.pone.0065027	http://dx.doi.org/10.1371/journal.pone.0065027			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762280	gold, Green Published, Green Submitted			2022-12-27	WOS:000321094800015
J	Suito, H; Iwawaki, Y; Goto, T; Tomotake, Y; Ichikawa, T				Suito, Hideki; Iwawaki, Yuki; Goto, Takaharu; Tomotake, Yoritoki; Ichikawa, Tetsuo			Oral Factors Affecting Titanium Elution and Corrosion: An In Vitro Study Using Simulated Body Fluid	PLOS ONE			English	Article							ION RELEASE; IMPLANT; DISSEMINATION; HIP	Objectives: Ti, which is biocompatible and resistant to corrosion, is widely used for dental implants, particularly in patients allergic to other materials. However, numerous studies have reported on Ti allergy and the in vitro corrosion of Ti. This study investigated the conditions that promote the elution of Ti ions from Ti implants. Methods: Specimens of commercially pure Ti, pure nickel, a magnetic alloy, and a gold alloy were tested. Each specimen was immersed in a simulated body fluid (SBF) whose pH value was controlled (2.0, 3.0, 5.0, 7.4, and 9.0) using either hydrochloric or lactic acid. The parameters investigated were the following: duration of immersion, pH of the SBF, contact with a dissimilar metal, and mechanical stimulus. The amounts of Ti ions eluted were measured using a polarized Zeeman atomic absorption spectrophotometer. Results: Eluted Ti ions were detected after 24 h (pH of 2.0 and 3.0) and after 48 h (pH of 9.0). However, even after 4 weeks, eluted Ti ions were not detected in SBF solutions with pH values of 5.0 and 7.4. Ti elution was affected by immersion time, pH, acid type, mechanical stimulus, and contact with a dissimilar metal. Elution of Ti ions in a Candida albicans culture medium was observed after 72 h. Significance: Elution of Ti ions in the SBF was influenced by its pH and by crevice corrosion. The results of this study elucidate the conditions that lead to the elution of Ti ions in humans, which results in implant corrosion and Ti allergy.	[Suito, Hideki; Iwawaki, Yuki; Goto, Takaharu; Tomotake, Yoritoki; Ichikawa, Tetsuo] Univ Tokushima, Inst Anim Biosci, Dept Oral & Maxillofacial Prosthodont & Oral Impl, Tokushima 770, Japan	Tokushima University	Ichikawa, T (corresponding author), Univ Tokushima, Inst Anim Biosci, Dept Oral & Maxillofacial Prosthodont & Oral Impl, Tokushima 770, Japan.	ichi@tokushima-u.ac.jp	Goto, Takaharu/S-5766-2019	Goto, Takaharu/0000-0003-0962-7304	University of Tokushima	University of Tokushima	This study was supported by the University of Tokushima. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUCHANAN RA, 1987, J BIOMED MATER RES, V21, P367, DOI 10.1002/jbm.820210309; COLLIER JP, 1992, J BONE JOINT SURG BR, V74, P511, DOI 10.1302/0301-620X.74B4.1624507; Danko JC, 1998, MICROSTR SC, V25, P73; Edgar WM, 1996, SALIVA ORAL HLTH, P86; Egusa H, 2008, J PROSTHET DENT, V100, P344, DOI 10.1016/S0022-3913(08)60233-4; Foti B, 1999, J ORAL REHABIL, V26, P495, DOI 10.1046/j.1365-2842.1999.00404.x; Hirayama Teruhisa, 2008, Nihon Hotetsu Shika Gakkai Zasshi, V52, P501; Iimuro F T, 1993, Dent Mater J, V12, P136; Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017; KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607; Mine Y, 2010, J PROSTHODONT RES, V54, P1, DOI 10.1016/j.jpor.2009.07.003; Mu Y, 2000, J BIOMED MATER RES, V49, P238, DOI 10.1002/(SICI)1097-4636(200002)49:2<238::AID-JBM12>3.0.CO;2-J; Mudali UK, 2003, SADHANA-ACAD P ENG S, V28, P601, DOI 10.1007/bf02706450; Olmedo D, 2002, J MATER SCI-MATER M, V13, P793, DOI 10.1023/A:1016131310025; Olmedo DG, 2008, INT J ORAL MAX SURG, V37, P1032, DOI 10.1016/j.ijom.2008.05.013; POURBAIX M, 1984, BIOMATERIALS, V5, P122, DOI 10.1016/0142-9612(84)90046-2; RECLARU L, 1994, J DENT, V22, P159, DOI 10.1016/0300-5712(94)90200-3; SAMARANAYAKE LP, 1986, J ORAL PATHOL MED, V15, P251, DOI 10.1111/j.1600-0714.1986.tb00617.x; Sicilia A, 2008, CLIN ORAL IMPLAN RES, V19, P823, DOI 10.1111/j.1600-0501.2008.01544.x; Siddiqi A, 2011, CLIN ORAL IMPLAN RES, V22, P673, DOI 10.1111/j.1600-0501.2010.02081.x; Staffolani N, 1999, J DENT, V27, P449, DOI 10.1016/S0300-5712(98)00073-6; Tanji Y, 2002, CORROSION-US, V58, P232, DOI 10.5006/1.3279874; Urban RM, 2000, J BONE JOINT SURG AM, V82A, P457, DOI 10.2106/00004623-200004000-00002; Watanabe M, 2011, PLOS ONE, V22; Zhang BB, 2009, DENT MATER, V25, P672, DOI 10.1016/j.dental.2008.10.016	25	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66052	10.1371/journal.pone.0066052	http://dx.doi.org/10.1371/journal.pone.0066052			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762461	gold, Green Submitted, Green Published			2022-12-27	WOS:000321094800085
J	Halford, WP; Geltz, J; Gershburg, E				Halford, William P.; Geltz, Joshua; Gershburg, Edward			Pan-HSV-2 IgG Antibody in Vaccinated Mice and Guinea Pigs Correlates with Protection against Herpes Simplex Virus 2	PLOS ONE			English	Article							CD8(+) T-CELLS; PLACEBO-CONTROLLED TRIAL; GENITAL HERPES; GLYCOPROTEIN-D; HSV-1 REACTIVATION; IMMUNE-RESPONSES; NEURONAL SPREAD; ANIMAL-MODELS; DOUBLE-BLIND; DNA VACCINE	We lack a correlate of immunity to herpes simplex virus 2 (HSV-2) that may be used to differentiate whether a HSV-2 vaccine elicits robust or anemic protection against genital herpes. This gap in knowledge is often attributed to a failure to measure the correct component of the adaptive immune response to HSV-2. However, efforts to identify a correlate of immunity have focused on subunit vaccines that contain less than 3% of HSV-2 ' s 40,000-amino-acid proteome. We were interested to determine if a correlate of immunity might be more readily identified if 1. animals were immunized with a polyvalent immunogen such as a live virus and/or 2. the magnitude of the vaccine-induced immune response was gauged in terms of the IgG antibody response to all of HSV-2 ' s antigens (pan-HSV-2 IgG). Pre-challenge pan-HSV-2 IgG levels and protection against HSV-2 were compared in mice and/or guinea pigs immunized with a gD-2 subunit vaccine, wild-type HSV-2, or one of several attenuated HSV-2 ICP0- 2 viruses (0 Delta 254, 0 Delta 810, 0 Delta RING, or 0 Delta NLS). These six HSV-2 immunogens elicited a wide range of pan-HSV-2 IgG levels spanning an similar to 500-fold range. For 5 of the 6 immunogens tested, pre-challenge levels of pan-HSV-2 IgG quantitatively correlated with reductions in HSV-2 challenge virus shedding and increased survival frequency following HSV-2 challenge. Collectively, the results suggest that pan-HSV-2 IgG levels may provide a simple and useful screening tool for evaluating the potential of a HSV-2 vaccine candidate to elicit protection against HSV-2 genital herpes.	[Halford, William P.; Geltz, Joshua; Gershburg, Edward] So Illinois Univ, Sch Med, Dept Microbiol & Immunol, Springfield, IL USA	Southern Illinois University System; Southern Illinois University	Halford, WP (corresponding author), So Illinois Univ, Sch Med, Dept Microbiol & Immunol, Springfield, IL USA.	halford@siumed.edu		Gershburg, Edward/0000-0003-3584-9947	Excellence in Academic Medicine Committee of the Southern Illinois University School of Medicine; National Institutes of Health to study the Development of an Effective Genital Herpes Vaccine [R21 AI81072]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081072] Funding Source: NIH RePORTER	Excellence in Academic Medicine Committee of the Southern Illinois University School of Medicine; National Institutes of Health to study the Development of an Effective Genital Herpes Vaccine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Excellence in Academic Medicine Committee of the Southern Illinois University School of Medicine, as well as a grant from the National Institutes of Health to study the Development of an Effective Genital Herpes Vaccine (R21 AI81072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN E M, 1990, Viral Immunology, V3, P207, DOI 10.1089/vim.1990.3.207; Amanna IJ, 2008, HUM VACCINES, V4, P316, DOI 10.4161/hv.4.4.5751; Aurelian L, 1999, VACCINE, V17, P1951, DOI 10.1016/S0264-410X(98)00470-8; Awasthi S, 2012, J VIROL, V86, P4586, DOI 10.1128/JVI.07203-11; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; Bernstein D, 2005, EXPERT REV VACCINES, V4, P615, DOI 10.1586/14760584.4.5.615; Bernstein DI, 2011, VACCINE, V29, P2071, DOI 10.1016/j.vaccine.2011.01.005; Bernstein DI, 2010, VACCINE, V28, P3748, DOI 10.1016/j.vaccine.2009.10.025; Bourne N, 2005, J INFECT DIS, V192, P2117, DOI 10.1086/498247; Bourne N, 2003, J INFECT DIS, V187, P542, DOI 10.1086/374002; Brans R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-163; Brittle EE, 2008, J VIROL, V82, P8431, DOI 10.1128/JVI.00551-08; Chentoufi AA, 2010, J IMMUNOL, V184, P2561, DOI 10.4049/jimmunol.0902322; Chu CF, 2008, J REPROD IMMUNOL, V78, P58, DOI 10.1016/j.jri.2007.08.004; Cohen J, 2010, SCIENCE, V330, P304, DOI 10.1126/science.330.6002.304; Corey L, 1999, JAMA-J AM MED ASSOC, V282, P331, DOI 10.1001/jama.282.4.331; Delagrave S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046714; Divito S, 2006, IMMUNOL RES, V36, P119, DOI 10.1385/IR:36:1:119; Dropulic LK, 2012, EXPERT REV VACCINES, V11, P1429, DOI [10.1586/ERV.12.129, 10.1586/erv.12.129]; Dudek T, 2006, VIROLOGY, V344, P230, DOI 10.1016/j.virol.2005.09.020; Eo SK, 2001, J IMMUNOL, V166, P5473, DOI 10.4049/jimmunol.166.9.5473; GILMAN SC, 1981, INFECT IMMUN, V34, P880, DOI 10.1128/IAI.34.3.880-887.1981; Gyotoku T, 2002, VACCINE, V20, P2796, DOI 10.1016/S0264-410X(02)00199-8; Halford WP, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-56; Halford WP, 2011, VIRUSES AND INTERFERON: CURRENT RESEARCH, P85; Halford WP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017748; Halford WP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012251; Halford WP, 2005, J THEOR BIOL, V234, P439, DOI 10.1016/j.jtbi.2004.12.007; Hoshino Y, 2008, VACCINE, V26, P4034, DOI 10.1016/j.vaccine.2008.05.022; Hosken N, 2006, J VIROL, V80, P5509, DOI 10.1128/JVI.02659-05; Johnston C, 2011, J CLIN INVEST, V121, P4600, DOI 10.1172/JCI57148; Karem KL, 1997, J GEN VIROL, V78, P427, DOI 10.1099/0022-1317-78-2-427; Khanna KM, 2004, TRENDS IMMUNOL, V25, P230, DOI 10.1016/j.it.2004.02.010; Khanna KM, 2003, IMMUNITY, V18, P593, DOI 10.1016/S1074-7613(03)00112-2; Khodai T, 2011, CLIN VACCINE IMMUNOL, V18, P1702, DOI 10.1128/CVI.05071-11; Knickelbein JE, 2008, SCIENCE, V322, P268, DOI 10.1126/science.1164164; Koelle DM, 2008, ANNU REV MED, V59, P381, DOI 10.1146/annurev.med.59.061606.095540; Koelle DM, 1998, J CLIN INVEST, V101, P1500, DOI 10.1172/JCI1758; Kuklin N, 1997, J VIROL, V71, P3138, DOI 10.1128/JVI.71.4.3138-3145.1997; Laing KJ, 2012, CLIN EXP IMMUNOL, V167, P47, DOI 10.1111/j.1365-2249.2011.04502.x; Laing KJ, 2010, J CLIN IMMUNOL, V30, P703, DOI 10.1007/s10875-010-9441-2; Ledford H, 2012, NATURE, DOI [10.1038/nature.2012.9739, DOI 10.1038/NATURE.2012.9739]; Liu T, 2000, J EXP MED, V191, P1459, DOI 10.1084/jem.191.9.1459; Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109; MANICKAN E, 1995, J VIROL, V69, P4711, DOI 10.1128/JVI.69.8.4711-4716.1995; McClements WL, 1996, P NATL ACAD SCI USA, V93, P11414, DOI 10.1073/pnas.93.21.11414; MEIGNIER B, 1988, J INFECT DIS, V158, P602, DOI 10.1093/infdis/158.3.602; MERTZ GJ, 1990, J INFECT DIS, V161, P653, DOI 10.1093/infdis/161.4.653; Morello CS, 2012, VACCINE, V30, P6541, DOI 10.1016/j.vaccine.2012.08.049; Morrison LA, 1998, VIROLOGY, V243, P178, DOI 10.1006/viro.1998.9047; Morrison LA, 2002, DRUGS, V62, P1119, DOI 10.2165/00003495-200262080-00001; Morrison LA, 2001, J VIROL, V75, P1195, DOI 10.1128/JVI.75.3.1195-1204.2001; NAGAFUCHI S, 1979, J GEN VIROL, V44, P715, DOI 10.1099/0022-1317-44-3-715; Natuk RJ, 2006, J VIROL, V80, P4447, DOI 10.1128/JVI.80.9.4447-4457.2006; Nicola AV, 1996, J VIROL, V70, P3815, DOI 10.1128/JVI.70.6.3815-3822.1996; OAKES JE, 1975, INFECT IMMUN, V12, P166, DOI 10.1128/IAI.12.1.166-172.1975; Orr MT, 2007, J IMMUNOL, V178, P4731, DOI 10.4049/jimmunol.178.8.4731; Posavad CM, 2010, J IMMUNOL, V184, P3250, DOI 10.4049/jimmunol.0900722; Preacher K. J., 2001, CALCULATION FISHERS; Prichard MN, 2005, VACCINE, V23, P5424, DOI 10.1016/j.vaccine.2005.02.028; Pyles RB, 2002, J VIROL, V76, P11387, DOI 10.1128/JVI.76.22.11387-11396.2002; Rouse BT, 2006, CLIN INFECT DIS, V42, P810, DOI 10.1086/500141; Samaniego LA, 1998, J VIROL, V72, P3307, DOI 10.1128/JVI.72.4.3307-3320.1998; Schrimpf JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022772; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Shlapobersky M, 2012, J GEN VIROL, V93, P1305, DOI 10.1099/vir.0.040055-0; SIMMONS A, 1992, J EXP MED, V175, P1337, DOI 10.1084/jem.175.5.1337; SKINNER GRB, 1992, MED MICROBIOL IMMUN, V180, P305, DOI 10.1007/BF00191551; Skinner GRB, 1997, MED MICROBIOL IMMUN, V186, P31, DOI 10.1007/s004300050043; SKINNER GRB, 1978, MED MICROBIOL IMMUN, V166, P119, DOI 10.1007/BF02121141; St Leger AJ, 2011, J IMMUNOL, V186, P3927, DOI 10.4049/jimmunol.1003735; STAATS HF, 1991, J VIROL, V65, P6008, DOI 10.1128/JVI.65.11.6008-6014.1991; Stanberry LR, 2002, NEW ENGL J MED, V347, P1652, DOI 10.1056/NEJMoa011915; Straus SE, 1997, J INFECT DIS, V176, P1129, DOI 10.1086/514103; STRAUS SE, 1994, LANCET, V343, P1460, DOI 10.1016/S0140-6736(94)92581-X; Theil D, 2003, AM J PATHOL, V163, P2179, DOI 10.1016/S0002-9440(10)63575-4; Tirabassi RS, 2011, VACCINE, V29, P1090, DOI 10.1016/j.vaccine.2010.11.076; WEIR JP, 1989, J GEN VIROL, V70, P2587, DOI 10.1099/0022-1317-70-10-2587; Whitley RJ, 2002, J CLIN INVEST, V110, P145, DOI [10.1172/JCI200216126, 10.1172/JCI0216126]; Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792	80	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65523	10.1371/journal.pone.0065523	http://dx.doi.org/10.1371/journal.pone.0065523			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755244	Green Published, gold, Green Submitted			2022-12-27	WOS:000321099000076
J	Hisano, R; Sornette, D; Mizuno, T; Ohnishi, T; Watanabe, T				Hisano, Ryohei; Sornette, Didier; Mizuno, Takayuki; Ohnishi, Takaaki; Watanabe, Tsutomu			High Quality Topic Extraction from Business News Explains Abnormal Financial Market Volatility	PLOS ONE			English	Article							STOCK-PRICES; MEDIA; MOVES	Understanding the mutual relationships between information flows and social activity in society today is one of the cornerstones of the social sciences. In financial economics, the key issue in this regard is understanding and quantifying how news of all possible types (geopolitical, environmental, social, financial, economic, etc.) affects trading and the pricing of firms in organized stock markets. In this article, we seek to address this issue by performing an analysis of more than 24 million news records provided by Thompson Reuters and of their relationship with trading activity for 206 major stocks in the S&P US stock index. We show that the whole landscape of news that affects stock price movements can be automatically summarized via simple regularized regressions between trading activity and news information pieces decomposed, with the help of simple topic modeling techniques, into their "thematic" features. Using these methods, we are able to estimate and quantify the impacts of news on trading. We introduce network-based visualization techniques to represent the whole landscape of news information associated with a basket of stocks. The examination of the words that are representative of the topic distributions confirms that our method is able to extract the significant pieces of information influencing the stock market. Our results show that one of the most puzzling stylized facts in financial economies, namely that at certain times trading volumes appear to be "abnormally large," can be partially explained by the flow of news. In this sense, our results prove that there is no "excess trading," when restricting to times when news is genuinely novel and provides relevant financial information.	[Hisano, Ryohei; Sornette, Didier] ETH, Dept Management Technol & Econ, Zurich, Switzerland; [Hisano, Ryohei; Mizuno, Takayuki; Ohnishi, Takaaki; Watanabe, Tsutomu] Canon Inst Global Studies, Tokyo, Japan; [Sornette, Didier] Swiss Finance Inst, Zurich, Switzerland; [Mizuno, Takayuki] Univ Tsukuba, Doctoral Program Comp Sci, Grad Sch Syst & Informat Engn, Ibaraki, Japan; [Mizuno, Takayuki; Ohnishi, Takaaki; Watanabe, Tsutomu] Univ Tokyo, Grad Sch Econ, Tokyo, Japan	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Finance Institute (SFI); University of Tsukuba; University of Tokyo	Hisano, R (corresponding author), ETH, Dept Management Technol & Econ, Zurich, Switzerland.	em072010@yahoo.co.jp	Hisano, Ryohei/GSJ-4067-2022	Hisano, Ryohei/0000-0002-4452-0302	Japanese Student Services Organization; JSPS [24223003]; Grants-in-Aid for Scientific Research [24710156] Funding Source: KAKEN	Japanese Student Services Organization; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Ryohei Hisano is partially supported by funding from the Japanese Student Services Organization through a scholarship titled "Scholarship for Longterm Foreign Studies-2010." Tsutomu Watanabe is supported by funding from JSPS Grant-in-Aid for Scientific Research (24223003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], 2011, SCIENCE, DOI [DOI 10.21055/0370-1069-2020-1-51-60, DOI 10.1016/j.jocs.2010.12.007]; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; CUTLER DM, 1989, J PORTFOLIO MANAGE, V15, P4, DOI 10.3905/jpm.1989.409212; Dellavigna S, 2011, J FINANC, V64, P709; Endres DM, 2003, IEEE T INFORM THEORY, V49, P1858, DOI 10.1109/TIT.2003.813506; Engelberg JE, 2011, J FINANC, V66, P67, DOI 10.1111/j.1540-6261.2010.01626.x; Erdogan O, 2009, QUANT FINANC, V9, P897, DOI 10.1080/14697680802415495; Fair RC, 2002, J BUS, V75, P713, DOI 10.1086/341640; Filimonov V, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.056108; Fleming MJ, 1997, J PORTFOLIO MANAGE, P28; Goeman JJ, 2010, BIOMETRICAL J, V52, P70, DOI 10.1002/bimj.200900028; Griffiths TL, 2004, P NATL ACAD SCI USA, V101, P5228, DOI 10.1073/pnas.0307752101; Gurun UG, 2012, J FINANC, V67, P561, DOI 10.1111/j.1540-6261.2012.01725.x; Hastie T., 2008, ELEMENTS STAT LEARNI; Hinton G., 2010, TOP COGN SCI, P1; ITO T, 1987, J MONETARY ECON, V19, P255, DOI 10.1016/0304-3932(87)90049-3; Joulin A., 2008, WILMOTT MAGAZINE, V46; KOLLER D., 2009, PROBABILISTIC GRAPHI; LeRoy S., 1981, ECONOMETRICA     MAY, P555; LeRoy SF, 2008, NEW PALGRAVE DICT EC; MCQUEEN G, 1993, REV FINANC STUD, V6, P683, DOI 10.1093/rfs/6.3.683; Mimno D., 2011, EMPIRICAL METHODS NA; Mizuno T, 2012, PROG THEOR PHYS SUPP, P181; Reinhart CM, 2009, THIS TIME IS DIFFERENT: EIGHT CENTURIES OF FINANCIAL FOLLY, P1; SHILLER RJ, 1981, AM ECON REV, V71, P421; Smola A, 2010, P VLDB ENDOWMENT, V3; Soros G., 1994, ALCHEMY FINANCE READ; Tetlock PC, 2007, J FINANC, V62, P1139, DOI 10.1111/j.1540-6261.2007.01232.x; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Zhi D, 2011, J FINANCE, VLXVI	30	23	23	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64846	10.1371/journal.pone.0064846	http://dx.doi.org/10.1371/journal.pone.0064846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	173SK	23762258	Green Published, Green Submitted, gold			2022-12-27	WOS:000321099000025
J	Kuroda, T; Hirohashi, Y; Torigoe, T; Yasuda, K; Takahashi, A; Asanuma, H; Morita, R; Mariya, T; Asano, T; Mizuuchi, M; Saito, T; Sato, N				Kuroda, Takafumi; Hirohashi, Yoshihiko; Torigoe, Toshihiko; Yasuda, Kazuyo; Takahashi, Akari; Asanuma, Hiroko; Morita, Rena; Mariya, Tasuku; Asano, Takuya; Mizuuchi, Masahito; Saito, Tsuyoshi; Sato, Noriyuki			ALDH1-High Ovarian Cancer Stem-Like Cells Can Be Isolated from Serous and Clear Cell Adenocarcinoma Cells, and ALDH1 High Expression Is Associated with Poor Prognosis	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE; INITIATING CELLS; CD133 EXPRESSION; IDENTIFICATION; DEFINES; POPULATION; CARCINOMAS; MARKER; SOX2	Cancer stem-like cells (CSCs)/cancer-initiating cells (CICs) are defined as a small population of cancer cells that have high tumorigenicity. Furthermore, CSCs/CICs are resistant to several cancer therapies, and CSCs/CICs are therefore thought to be responsible for cancer recurrence after treatment and distant metastasis. In epithelial ovarian cancer (EOC) cases, disease recurrence after chemotherapy is frequently observed, suggesting ovarian CSCs/CICs are involved. There are four major histological subtypes in EOC, and serous adenocarcinoma and clear cell adenocarcinoma are high-grade malignancies. We therefore analyzed ovarian CSCs/CICs from ovarian carcinoma cell lines (serous adenocarcinoma and clear cell adenocarcinoma) and primary ovarian cancer cells in this study. We isolated ovarian CSCs/CICs as an aldehyde dehydrogenase 1 high (ALDH1 high) population from 6 EOC cell lines (3 serous adenocarcinomas and 3 clear cell adenocarcinomas) by the ALDEFLUOR assay. ALDH1 high cells showed greater sphere-forming ability, higher tumorigenicity and greater invasive capability, indicating that ovarian CSCs/CICs are enriched in ALDH1 high cells. ALDH1 high cells could also be isolated from 8 of 11 primary ovarian carcinoma samples. Immunohistochemical staining revealed that higher ALDH1 expression levels in ovary cancer cases are related to poorer prognosis in both serous adenocarcinoma cases and clear cell adenocarcinoma cases. Taken together, the results indicate that ALDH1 is a marker for ovarian CSCs/CICs and that the expression level of ALDH1 might be a novel biomarker for prediction of poor prognosis.	[Kuroda, Takafumi; Hirohashi, Yoshihiko; Torigoe, Toshihiko; Yasuda, Kazuyo; Takahashi, Akari; Asanuma, Hiroko; Morita, Rena; Mariya, Tasuku; Asano, Takuya; Mizuuchi, Masahito; Sato, Noriyuki] Sapporo Med Univ, Sch Med, Dept Pathol, Chuo Ku, Sapporo, Hokkaido, Japan; [Kuroda, Takafumi; Mariya, Tasuku; Asano, Takuya; Mizuuchi, Masahito; Saito, Tsuyoshi] Sapporo Med Univ, Sch Med, Dept Obstet & Gynecol, Chuo Ku, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University	Hirohashi, Y (corresponding author), Sapporo Med Univ, Sch Med, Dept Pathol, Chuo Ku, Sapporo, Hokkaido, Japan.	hirohash@sapmed.ac.jp; torigoe@sapmed.ac.jp	Hirohashi, Yoshihiko/AFQ-4227-2022		Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency, and for Cancer Research [16209013, 17016061, 15659097]; Ministry of Health, Labor and Welfare of Japan [15-17, 19-14]; Ono Cancer Research Fund; Takeda Science Foundation; National Cancer Center Research and Development Fund [23-A-44]; Grants-in-Aid for Scientific Research [24659165] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency, and for Cancer Research; Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ono Cancer Research Fund(Ono Cancer Research Fund); Takeda Science Foundation(Takeda Science Foundation (TSF)); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant numbers 16209013, 17016061 and 15659097) for Practical Application Research from the Japan Science and Technology Agency, and for Cancer Research (15-17 and 19-14) from the Ministry of Health, Labor and Welfare of Japan, Ono Cancer Research Fund (to NS) and Takeda Science Foundation (to YH). This work was supported in part by the National Cancer Center Research and Development Fund (23-A-44). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Burkert J, 2008, J PATHOL, V214, P564, DOI 10.1002/path.2307; Chan JK, 2008, GYNECOL ONCOL, V109, P370, DOI 10.1016/j.ygyno.2008.02.006; Chang B, 2009, MODERN PATHOL, V22, P817, DOI 10.1038/modpathol.2009.35; Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246; Curley MD, 2009, STEM CELLS, V27, P2875, DOI 10.1002/stem.236; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Deng S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010277; Gangavarpu KJ, 2011, CURR PROTOC TOXICOL; Gao MQ, 2010, ONCOGENE, V29, P2672, DOI 10.1038/onc.2010.35; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Goff B, 2012, CLIN OBSTET GYNECOL, V55, P36, DOI 10.1097/GRF.0b013e3182480523; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hirohashi Y, 2012, ONCOIMMUNOLOGY, V1, P124, DOI 10.4161/onci.1.1.18075; Hirohashi Y, 2010, IMMUNOTHERAPY-UK, V2, P201, DOI 10.2217/IMT.10.10; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Ishiwata I, 1987, Nihon Sanka Fujinka Gakkai Zasshi, V39, P831; Kitamura H, 2012, MOD PATHOL; Kobayashi S, 2012, STEM CELLS; Ledermann J, 2012, NEW ENGL J MED, V366, P1382, DOI 10.1056/NEJMoa1105535; Michifuri Y, 2012, PATHOL INT, V62, P684, DOI 10.1111/j.1440-1827.2012.02851.x; Miyamoto M, 2013, J GYNECOL ONCOL, V24, P37, DOI 10.3802/jgo.2013.24.1.37; Nakatsugawa M, 2011, LAB INVEST, V91, P1796, DOI 10.1038/labinvest.2011.140; Nishida S, 2012, J UROLOGY, V188, P294, DOI 10.1016/j.juro.2012.02.2555; Parmar MKB, 2003, LANCET, V361, P2099; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rich JN, 2007, CANCER RES, V67, P8980, DOI 10.1158/0008-5472.CAN-07-0895; Shi MF, 2010, CELL MOL LIFE SCI, V67, P3915, DOI 10.1007/s00018-010-0420-9; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Silva IA, 2011, CANCER RES, V71, P3991, DOI 10.1158/0008-5472.CAN-10-3175; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Vathipadiekal V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029079; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang YC, 2012, AM J PATHOL, V180, P1159, DOI 10.1016/j.ajpath.2011.11.015; Yabushita H, 1989, Nihon Sanka Fujinka Gakkai Zasshi, V41, P888; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050	40	74	81	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65158	10.1371/journal.pone.0065158	http://dx.doi.org/10.1371/journal.pone.0065158			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762304	Green Published, gold, Green Submitted			2022-12-27	WOS:000321099000037
J	Sanchez, N; Gallagher, M; Lao, N; Gallagher, C; Clarke, C; Doolan, P; Aherne, S; Blanco, A; Meleady, P; Clynes, M; Barron, N				Sanchez, Noelia; Gallagher, Mark; Lao, Nga; Gallagher, Clair; Clarke, Colin; Doolan, Padraig; Aherne, Sinead; Blanco, Alfonso; Meleady, Paula; Clynes, Martin; Barron, Niall			MiR-7 Triggers Cell Cycle Arrest at the G1/S Transition by Targeting Multiple Genes Including Skp2 and Psme3	PLOS ONE			English	Article							PROTEASOME ACTIVATOR PA28-GAMMA; TRANSCRIPTIONAL REPRESSOR; DNA-REPLICATION; PROTEIN-KINASE; P53; DEGRADATION; MICRORNAS; MYC; RECEPTOR; PROMOTES	MiR-7 acts as a tumour suppressor in many cancers and abrogates proliferation of CHO cells in culture. In this study we demonstrate that miR-7 targets key regulators of the G1 to S phase transition, including Skp2 and Psme3, to promote increased levels of p27(KIP) and temporary growth arrest of CHO cells in the G1 phase. Simultaneously, the down-regulation of DNA repair-specific proteins via miR-7 including Rad54L, and pro-apoptotic regulators such as p53, combined with the up-regulation of anti-apoptotic factors like p-Akt, promoted cell survival while arrested in G1. Thus miR-7 can co-ordinate the levels of multiple genes and proteins to influence G1 to S phase transition and the apoptotic response in order to maintain cellular homeostasis. This work provides further mechanistic insight into the role of miR-7 as a regulator of cell growth in times of cellular stress.	[Sanchez, Noelia; Gallagher, Mark; Gallagher, Clair; Clarke, Colin; Doolan, Padraig; Aherne, Sinead; Meleady, Paula; Clynes, Martin; Barron, Niall] Dublin City Univ, Natl Inst Cellular Biotechnol, Dublin 9, Ireland; [Lao, Nga; Blanco, Alfonso] Univ Coll Dublin, Conway Inst, Dublin 2, Ireland	Dublin City University; University College Dublin	Barron, N (corresponding author), Dublin City Univ, Natl Inst Cellular Biotechnol, Dublin 9, Ireland.	niall.barron@dcu.ie	Meleady, Paula/AAI-4726-2020	Clarke, Colin/0000-0003-2817-9527; Blanco, Alfonso/0000-0003-0439-0838; barron, niall/0000-0003-4602-326X	Science Foundation Ireland [07/IN.I/B1323]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	The funding for this study was provided by Science Foundation Ireland Grant No. 07/IN.I/B1323. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Barron N, 2011, J BIOTECHNOL, V151, P204, DOI 10.1016/j.jbiotec.2010.12.005; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Bretones G, 2011, J BIOL CHEM, V286, P9815, DOI 10.1074/jbc.M110.165977; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Cannell IG, 2010, CELL CYCLE, V9, P2726, DOI 10.4161/cc.9.14.12182; Challagundla KB, 2011, MOL CELL BIOL, V31, P4007, DOI 10.1128/MCB.05810-11; Chan CH, 2012, CELL, V149, P1098, DOI 10.1016/j.cell.2012.02.065; Chou YT, 2010, CANCER RES, V70, P8822, DOI 10.1158/0008-5472.CAN-10-0638; Clarke C, 2011, J BIOTECHNOL, V151, P159, DOI 10.1016/j.jbiotec.2010.11.016; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Fang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018067; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Heyer WD, 2006, NUCLEIC ACIDS RES, V34, P4115, DOI 10.1093/nar/gkl481; Hu HL, 2011, J MOL CELL BIOL, V3, P151, DOI 10.1093/jmcb/mjq042; Ichimura A, 2011, FEBS J, V278, P1610, DOI 10.1111/j.1742-4658.2011.08087.x; Ikeda Y, 2012, MOL CANCER RES, V10, P259, DOI 10.1158/1541-7786.MCR-11-0035; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Jiang L, 2010, BIOCHEM J, V432, P199, DOI 10.1042/BJ20100859; Kanaar R, 1996, CURR BIOL, V6, P828, DOI 10.1016/S0960-9822(02)00606-1; Kasof GM, 1999, MOL CELL BIOL, V19, P4390; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kim AH, 2003, J BIOL CHEM, V278, P29830, DOI 10.1074/jbc.M305349200; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kossatz U, 2004, GENE DEV, V18, P2602, DOI 10.1101/gad.321004; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Jun-cai, 2010, Xibei Zhiwu Xuebao, V30, P30; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Masson P, 2003, J MOL BIOL, V327, P1001, DOI 10.1016/S0022-2836(03)00188-8; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; McInnes N, 2012, ONCOGENE, V31, P1045, DOI 10.1038/onc.2011.293; Meleady P, 2012, J BIOTECHNOL, V160, P251, DOI 10.1016/j.jbiotec.2012.03.002; Mendez J, 2002, MOL CELL, V9, P481, DOI 10.1016/S1097-2765(02)00467-7; Muller D, 2008, TRENDS BIOTECHNOL, V26, P359, DOI 10.1016/j.tibtech.2008.03.010; Murata S, 1999, J BIOL CHEM, V274, P38211, DOI 10.1074/jbc.274.53.38211; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Rajewsky N, 2011, J MOL BIOL, V409, P70, DOI 10.1016/j.jmb.2011.03.021; Ross HH, 2008, STEM CELLS, V26, P3218, DOI 10.1634/stemcells.2008-0299; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sarras H, 2010, THESCIENTIFICWORLDJO, V10, P1450, DOI 10.1100/tsw.2010.132; Shi W, 2000, J CELL BIOL, V148, P591, DOI 10.1083/jcb.148.3.591; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Yamaguchi H, 2001, ONCOGENE, V20, P7779, DOI 10.1038/sj.onc.1204984; Yu ZK, 1998, P NATL ACAD SCI USA, V95, P11324, DOI 10.1073/pnas.95.19.11324; ZHANG H, 1995, CELL, V82, P915, DOI 10.1016/0092-8674(95)90271-6; Zhang Z, 2008, EMBO J, V27, P852, DOI 10.1038/emboj.2008.25; Zhao X, 2013, ONCOGENE, V32, P1363, DOI 10.1038/onc.2012.156	60	53	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65671	10.1371/journal.pone.0065671	http://dx.doi.org/10.1371/journal.pone.0065671			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762407	Green Published, gold, Green Submitted			2022-12-27	WOS:000321099000089
J	Wang, JQ; Chen, JH; Chen, YC; Chen, MY; Hsieh, CY; Teng, SC; Wu, KJ				Wang, Jian-Qiu; Chen, Jian-Hong; Chen, Yen-Chung; Chen, Mei-Yu; Hsieh, Chia-Ying; Teng, Shu-Chun; Wu, Kou-Juey			Interaction between NBS1 and the mTOR/Rictor/SIN1 Complex through Specific Domains	PLOS ONE			English	Article							NIJMEGEN BREAKAGE SYNDROME; DNA-REPAIR; PHOSPHOINOSITIDE 3-KINASE; TARGETED DISRUPTION; ACTIVATION; AKT; PHOSPHORYLATION; OVEREXPRESSION; PROMOTES; PATHWAY	Nijmegen breakage syndrome (NBS) is a chromosomal-instability syndrome. The NBS gene product, NBS1 (p95 or nibrin), is a part of the Mre11-Rad50-NBS1 complex. SIN1 is a component of the mTOR/Rictor/SIN1 complex mediating the activation of Akt. Here we show that NBS1 interacted with mTOR, Rictor, and SIN1. The specific domains of mTOR, Rictor, or SIN1 interacted with the internal domain (a.a. 221-402) of NBS1. Sucrose density gradient showed that NBS1 was located in the same fractions as the mTOR/Rictor/SIN1 complex. Knockdown of NBS1 decreased the levels of phosphorylated Akt and its downstream targets. Ionizing radiation (IR) increased the NBS1 levels and activated Akt activity. These results demonstrate that NBS1 interacts with the mTOR/Rictor/SIN1 complex through the a. a. 221-402 domain and contributes to the activation of Akt activity.	[Wang, Jian-Qiu; Chen, Jian-Hong; Chen, Yen-Chung; Chen, Mei-Yu; Hsieh, Chia-Ying; Wu, Kou-Juey] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Wang, Jian-Qiu] Hangzhou Normal Univ, Sch Med, Dept Basic Med Sci, Inst Aging Res, Hangzhou, Zhejiang, Peoples R China; [Teng, Shu-Chun] Natl Taiwan Univ, Coll Med, Inst Microbiol, Taipei 10764, Taiwan	National Yang Ming Chiao Tung University; Hangzhou Normal University; National Taiwan University	Wu, KJ (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan.	kjwu2@ym.edu.tw	Wu, Kou-Juey/P-4654-2015	TENG, SHU-CHUN/0000-0002-6492-2560; CHEN, MEI-YU/0000-0002-5765-9178	National Research Program for Genomic Medicine [NRPGM-DOH-99-TD-G-111-024, NSC100-3112-B-010-003]; National Science Council [NSC101-2321-B-010-002, NSC98-2320-B-010-023]; National Research Program for Biopharmaceuticals [NSC101-2325-B-010-004]; Ministry of Education, Aim for the Top University Plan [101AC-T505, 102AC-TC13, 102AC-TC15]; center of excellence for cancer research at Taipei Veterans General Hospital [DOH101-TD-C-111-007]; Taichung Veterans General Hospital [TCVGH-YM1000301, TCVGH-YM1010301]; National Health Research Institutes [NHRI-EX101-9931BI, NHRI-EX102-10230SI]	National Research Program for Genomic Medicine(Ministry of Science and Technology, Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); National Research Program for Biopharmaceuticals; Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan); center of excellence for cancer research at Taipei Veterans General Hospital(Taipei Veterans General Hospital); Taichung Veterans General Hospital; National Health Research Institutes(National Health Research Institutes, Japan)	This work was supported in part to KJW by National Research Program for Genomic Medicine (NRPGM-DOH-99-TD-G-111-024, NSC100-3112-B-010-003), National Science Council Frontier grant (NSC101-2321-B-010-002), National Research Program for Biopharmaceuticals (NSC101-2325-B-010-004), a grant from Ministry of Education, Aim for the Top University Plan (101AC-T505, 102AC-TC13), center of excellence for cancer research at Taipei Veterans General Hospital (DOH101-TD-C-111-007), Taichung Veterans General Hospital (TCVGH-YM1000301, TCVGH-YM1010301), and National Health Research Institutes (NHRI-EX101-9931BI, NHRI-EX102-10230SI); and to MYC by National Science Council (NSC98-2320-B-010-023) and a grant from Ministry of Education, Aim for the Top University Plan (102AC-TC15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoccia A, 2006, GENOME DYN, V1, P191, DOI 10.1159/000092508; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen YC, 2005, J BIOL CHEM, V280, P32505, DOI 10.1074/jbc.M501449200; Chen YC, 2008, J MOL MED, V86, P401, DOI 10.1007/s00109-008-0302-x; Chiang YC, 2003, J BIOL CHEM, V278, P19286, DOI 10.1074/jbc.M212043200; Contessa JN, 2002, ONCOGENE, V21, P4032, DOI 10.1038/sj.onc.1205500; Culjkovic B, 2008, J CELL BIOL, V181, P51, DOI 10.1083/jcb.200707018; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Damaraju S, 2010, ANAL BIOCHEM, V396, P69, DOI 10.1016/j.ab.2009.08.019; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Hematulin A, 2008, CELL SIGNAL, V20, P2276, DOI 10.1016/j.cellsig.2008.08.017; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kang J, 2002, EMBO J, V21, P1447, DOI 10.1093/emboj/21.6.1447; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Saidi A, 2010, MOL CELL BIOL, V30, P5572, DOI 10.1128/MCB.00917-10; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schroder W, 2004, GENE, V339, P17, DOI 10.1016/j.gene.2004.07.001; Suman S, 2012, INT J RADIAT ONCOL, V84, P500, DOI 10.1016/j.ijrobp.2011.12.033; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Toral-Barza L, 2005, BIOCHEM BIOPH RES CO, V332, P304, DOI 10.1016/j.bbrc.2005.04.117; Tsai YP, 2009, CARCINOGENESIS, V30, P1049, DOI 10.1093/carcin/bgp087; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Williams BR, 2002, CURR BIOL, V12, P648, DOI 10.1016/S0960-9822(02)00763-7; Woo SY, 2007, J BIOL CHEM, V282, P25604, DOI 10.1074/jbc.M704343200; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Yang MH, 2007, ONCOGENE, V26, P1459, DOI 10.1038/sj.onc.1209929; Yang MH, 2006, CLIN CANCER RES, V12, P507, DOI 10.1158/1078-0432.CCR-05-1231; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083; Zhu J, 2001, CURR BIOL, V11, P105, DOI 10.1016/S0960-9822(01)00019-7	35	7	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65586	10.1371/journal.pone.0065586	http://dx.doi.org/10.1371/journal.pone.0065586			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762398	Green Published, Green Submitted, gold			2022-12-27	WOS:000321099000080
J	Lukoschek, V; Cross, P; Torda, G; Zimmerman, R; Willis, BL				Lukoschek, Vimoksalehi; Cross, Peter; Torda, Gergely; Zimmerman, Rachel; Willis, Bette L.			The Importance of Coral Larval Recruitment for the Recovery of Reefs Impacted by Cyclone Yasi in the Central Great Barrier Reef	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; SCLERACTINIAN CORALS; TROPICAL CYCLONES; CLIMATE-CHANGE; PHASE-SHIFTS; DISTURBANCE; DISPERSAL; ACROPORA; GROWTH; HURRICANES	Cyclone Yasi, one of the most severe tropical storms on record, crossed the central Great Barrier Reef (GBR) in February 2011, bringing wind speeds of up to 285 km hr(-1) and wave heights of at least 10 m, and causing massive destruction to exposed reefs in the Palm Island Group. Following the cyclone, mean (+/- S.E.) hard coral cover ranged from just 2.1 (0.2) % to 5.3 (0.4) % on exposed reefs and no reproductively mature colonies of any species of Acropora remained. Although no fragments of Acropora were found at impacted exposed sites following the cyclone, small juvenile colonies of Acropora (<10 cm diameter) were present, suggesting that their small size and compact morphologies enabled them to survive the cyclone. By contrast, sheltered reefs appeared to be unaffected by the cyclone. Mean (+/- S.E.) hard coral cover ranged from 18.2 (2.4) % to 30.0 (1.0) % and a large proportion of colonies of Acropora were reproductively mature. Macroalgae accounted for 8 to 16% of benthic cover at exposed sites impacted by cyclone Yasi but were absent at sheltered sites. Mean (+/- S.E.) recruitment of acroporids to settlement tiles declined from 25.3 (4.8) recruits tile(-1) in the pre-cyclone spawning event (2010) to 15.4 (2.2) recruits tile(-1) in the first post-cyclone spawning event (2011). Yet, post-cyclone recruitment did not differ between exposed (15.2 +/- 2.1 S.E.) and sheltered sites (15.6 +/- 2.2 S.E.), despite the loss of reproductive colonies at the exposed sites, indicating larval input from external sources. Spatial variation in impacts, the survival of small colonies, and larval replenishment to impacted reefs suggest that populations of Acropora have the potential to recover from this severe disturbance, provided that the Palm Islands are not impacted by acute disturbances or suffer additional chronic stressors in the near future.	[Lukoschek, Vimoksalehi; Torda, Gergely; Zimmerman, Rachel; Willis, Bette L.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Cross, Peter; Torda, Gergely; Willis, Bette L.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Torda, Gergely] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Torda, Gergely] 4AIMS JCU, Townsville, Qld, Australia	James Cook University; James Cook University; Australian Institute of Marine Science	Lukoschek, V (corresponding author), James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia.	vimoksalehi.lukoschek@jcu.edu.au	Torda, Gergely/ABE-6388-2020; Torda, Gergely/ABE-6400-2020	Torda, Gergely/0000-0002-4585-3045	Queensland Smart Future Fellowship; ARC Centre of Excellence for Coral Reef Studies at James Cook University; Australian Research Council through the ARC Centre of Excellence for Coral Reef Studies' [ARC COE CEO561435]	Queensland Smart Future Fellowship; ARC Centre of Excellence for Coral Reef Studies at James Cook University(Australian Research Council); Australian Research Council through the ARC Centre of Excellence for Coral Reef Studies'(Australian Research Council)	Research funding was provided by a Queensland Smart Future Fellowship to V. Lukoschek (http://www.business.qld.gov.au/industry/science/smart-futures-fund/smart-futures-fellowships) co-sponsored by the ARC Centre of Excellence for Coral Reef Studies at James Cook University, and by the Australian Research Council (ARC COE CEO561435; http://www.arc.gov.au/) through the ARC Centre of Excellence for Coral Reef Studies' (http://www.coralcoe.org.au/) funding allocation to B. Willis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrego D, 2009, MOL ECOL, V18, P3532, DOI 10.1111/j.1365-294X.2009.04276.x; Adjeroud M, 2007, J EXP MAR BIOL ECOL, V341, P204, DOI 10.1016/j.jembe.2006.10.048; Andutta FP, 2012, ESTUAR COAST SHELF S, V101, P54, DOI 10.1016/j.ecss.2012.02.013; Ayre DJ, 2000, EVOLUTION, V54, P1590; BABCOCK RC, 1986, CORAL REEFS, V5, P111, DOI 10.1007/BF00298178; Babcock RC, 2003, ZOOL STUD, V42, P211; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berkelmans R, 1999, CORAL REEFS, V18, P55, DOI 10.1007/s003380050154; BLACK KP, 1991, MAR ECOL PROG SER, V74, P1, DOI 10.3354/meps074001; Brinkman R, 2011, HYDRODYNAMICS WHOLE; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Callaghan J, 2011, CLIM DYNAM, V37, P647, DOI 10.1007/s00382-010-0883-2; Coles SL, 2007, CORAL REEFS, V26, P705, DOI 10.1007/s00338-007-0257-3; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Connolly SR, 2010, ECOLOGY, V91, P3572, DOI 10.1890/10-0143.1; Crabbe MJC, 2008, MAR ENVIRON RES, V65, P364, DOI 10.1016/j.marenvres.2007.11.006; Crabbe MJC, 2002, B MAR SCI, V70, P939; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Diaz-Pulido G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005239; Done TJ, 2010, CORAL REEFS, V29, P815, DOI 10.1007/s00338-010-0637-y; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Fabricius KE, 2008, LIMNOL OCEANOGR, V53, P690, DOI 10.4319/lo.2008.53.2.0690; FISK DA, 1990, MAR BIOL, V107, P485, DOI 10.1007/BF01313433; GBRMPA, 2011, IMP TROP CYCL YAS GR; Gilmour JP, 2009, MAR BIOL, V156, P1297, DOI 10.1007/s00227-009-1171-8; Graham EM, 2008, CORAL REEFS, V27, P529, DOI 10.1007/s00338-008-0361-z; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Hall VR, 1996, ECOLOGY, V77, P950, DOI 10.2307/2265514; Harmelin-Vivien M.L., 1994, J COASTAL RES, V12, P211, DOI DOI 10.1111/NYAS.13322; HARRIOTT VJ, 1988, AUST J MAR FRESH RES, V39, P409; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Harrison P. L, 2006, P 10 INT COR REEF S, P78; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; HIGHSMITH RC, 1980, OECOLOGIA, V46, P322, DOI 10.1007/BF00346259; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2000, ECOLOGY, V81, P2241, DOI 10.1890/0012-9658(2000)081[2241:SSEWBW]2.0.CO;2; Hughes TP, 2002, ECOLOGY, V83, P436, DOI 10.2307/2680026; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Kool JT, 2011, GLOBAL ECOL BIOGEOGR, V20, P695, DOI 10.1111/j.1466-8238.2010.00637.x; Mallela J, 2009, MAR ENVIRON RES, V68, P158, DOI 10.1016/j.marenvres.2009.06.001; Markham C, 1999, TOP CONSULTANT; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Mundy CN, 2000, CORAL REEFS, V19, P124, DOI 10.1007/s003380000081; Osborne K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017516; Puotinen ML, 2007, INT J GEOGR INF SCI, V21, P97, DOI 10.1080/1365SS10600852230; Roff G, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2100; Salvat, 1985, P 5 INT COR REEF S, V5, P315; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Smith LD, 2005, MAR POLLUT BULL, V51, P399, DOI 10.1016/j.marpolbul.2004.11.021; Souter P, 2010, MAR ECOL PROG SER, V416, P35, DOI 10.3354/meps08740; Sweatman H, 2011, CORAL REEFS, V30, P521, DOI 10.1007/s00338-010-0715-1; van Oppen MJH, 2011, MOL ECOL, V20, P4899, DOI 10.1111/j.1365-294X.2011.05328.x; Veron J. E., 2000, CORALS WORLD, V1; Wachenleld D, 1995, GBRMPA WORKSHOP SERI, V23, P134; Wallace C.C., 1999, STAGHORN CORALS WORL, DOI 10.1071/9780643101388; WALLACE CC, 1985, MAR ECOL PROG SER, V21, P289, DOI 10.3354/meps021289; WALLACE CC, 1985, MAR BIOL, V88, P217, DOI 10.1007/BF00392585; Ward S, 2000, P 9 INT COR REEF S, V2, P1123; Webster PJ, 2005, SCIENCE, V309, P1844, DOI 10.1126/science.1116448; Wilkinson C., 2004, STATUS CORAL REEFS W; Willis B.L., 1988, P853; Willis B. L., 1985, P 5 INT CORAL REEF C, P343; WILLIS BL, 1990, OPHELIA, V32, P145, DOI 10.1080/00785236.1990.10422029; WOLANSKI E, 1989, CONT SHELF RES, V9, P479, DOI 10.1016/0278-4343(89)90011-3; Woolsey E, 2012, MAR BIOL, V159, P793, DOI 10.1007/s00227-011-1855-8	70	40	40	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65363	10.1371/journal.pone.0065363	http://dx.doi.org/10.1371/journal.pone.0065363			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755223	Green Published, gold, Green Accepted			2022-12-27	WOS:000320579400055
J	Pan, DN; Mao, CX; Wang, YX				Pan, Dongning; Mao, Chunxiao; Wang, Yong-Xu			Suppression of Gluconeogenic Gene Expression by LSD1-Mediated Histone Demethylation	PLOS ONE			English	Article							GLYCOGEN-STORAGE-DISEASE; HEPATOCELLULAR-CARCINOMA; GLUCOSE-PRODUCTION; DIABETES-MELLITUS; STEM-CELLS; LSD1; COMPLEX; GLUCOSE-6-PHOSPHATASE; DIFFERENTIATION; ACTIVATION	Aberrant gluconeogenic gene expression is associated with diabetes, glycogen storage disease, and liver cancer. However, little is known how these genes are regulated at the chromatin level. In this study, we investigated in HepG2 cells whether histone demethylation is a potential mechanism. We found that knockdown or pharmacological inhibition of histone demethylase LSD1 causes remarkable transcription activation of two gluconeogenic genes, FBP1 and G6Pase, and consequently leads to increased de novo glucose synthesis and decreased intracellular glycogen content. Mechanistically, LSD1 occupies the promoters of FBP1 and G6Pase, and modulates their H3K4 dimethylation levels. Thus, our work identifies an epigenetic pathway directly governing gluconeogenic gene expression, which might have important implications in metabolic physiology and diseases.	[Wang, Yong-Xu] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Wang, YX (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA.	yongxu.wang@umassmed.edu	Pan, Dongning/P-6523-2019	Pan, Dongning/0000-0001-5463-8155	NIH/NIDDK [R01DK076118]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520, R01DK076118] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by NIH/NIDDK (R01DK076118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo A, 2011, NAT CELL BIOL, V13, P652, DOI 10.1038/ncb2246; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Bannasch P, 1997, J BIOENERG BIOMEMBR, V29, P303, DOI 10.1023/A:1022438528634; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Chen MQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025564; Chopra AR, 2008, SCIENCE, V322, P1395, DOI 10.1126/science.1164847; Chou JY, 2010, NAT REV ENDOCRINOL, V6, P676, DOI 10.1038/nrendo.2010.189; Ciccone DN, 2009, NATURE, V461, P415, DOI 10.1038/nature08315; Franco LM, 2005, J INHERIT METAB DIS, V28, P153, DOI 10.1007/s10545-005-7500-2; Hall RK, 2007, MOL ENDOCRINOL, V21, P550, DOI 10.1210/me.2006-0307; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Herzog B, 2000, BIOCHEM J, V351, P385, DOI 10.1042/0264-6021:3510385; Kunert O, 2003, DIABETES, V52, P2475, DOI 10.2337/diabetes.52.10.2475; Labrune P, 1997, J PEDIATR GASTR NUTR, V24, P276, DOI 10.1097/00005176-199703000-00008; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; Lin BC, 1997, BIOCHEMISTRY-US, V36, P14096, DOI 10.1021/bi9703249; Lin HV, 2011, CELL METAB, V14, P9, DOI 10.1016/j.cmet.2011.06.003; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Liu X, 2010, ONCOGENE, V29, P442, DOI 10.1038/onc.2009.332; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997; Mutel E, 2011, J HEPATOL, V54, P529, DOI 10.1016/j.jhep.2010.08.014; Okamoto T, 2009, ARCH BIOCHEM BIOPHYS, V491, P46, DOI 10.1016/j.abb.2009.09.015; Pan DN, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002761; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Rake JP, 2002, EUR J PEDIATR, V161, pS20, DOI 10.1007/s00431-002-0999-4; Roesler WJ, 2000, MOL CELL ENDOCRINOL, V162, P1, DOI 10.1016/S0303-7207(00)00198-2; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Schmidt DMZ, 2007, BIOCHEMISTRY-US, V46, P4408, DOI 10.1021/bi0618621; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; TALENTE GM, 1994, ANN INTERN MED, V120, P218, DOI 10.7326/0003-4819-120-3-199402010-00008; Vander Kooi BT, 2005, MOL ENDOCRINOL, V19, P3001, DOI 10.1210/me.2004-0497; Wajngot A, 2001, METABOLISM, V50, P47, DOI 10.1053/meta.2001.19422; Wang B, 2012, HEPATOLOGY, V56, P186, DOI 10.1002/hep.25632; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454	42	28	28	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e66294	10.1371/journal.pone.0066294	http://dx.doi.org/10.1371/journal.pone.0066294			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755305	Green Published, gold			2022-12-27	WOS:000320579400085
J	Rosenbluth, KH; Gimenez, F; Kells, AP; Salegio, EA; Mittermeyer, GM; Modera, K; Kohal, A; Bankiewicz, KS				Rosenbluth, Kathryn Hammond; Gimenez, Francisco; Kells, Adrian P.; Salegio, Ernesto A.; Mittermeyer, Gabriele M.; Modera, Kevin; Kohal, Anmol; Bankiewicz, Krystof S.			Automated Segmentation Tool for Brain Infusions	PLOS ONE			English	Article							CONVECTION-ENHANCED DELIVERY; RECURRENT MALIGNANT GLIOMA; GENE-THERAPY; PARKINSON-DISEASE; NEUROTROPHIC FACTOR; IMAGE SEGMENTATION; PRIMATE BRAIN; MR-IMAGES; PHASE-I; TRIAL	This study presents a computational tool for auto-segmenting the distribution of brain infusions observed by magnetic resonance imaging. Clinical usage of direct infusion is increasing as physicians recognize the need to attain high drug concentrations in the target structure with minimal off-target exposure. By co-infusing a Gadolinium-based contrast agent and visualizing the distribution using real-time using magnetic resonance imaging, physicians can make informed decisions about when to stop or adjust the infusion. However, manual segmentation of the images is tedious and affected by subjective preferences for window levels, image interpolation and personal biases about where to delineate the edge of the sloped shoulder of the infusion. This study presents a computational technique that uses a Gaussian Mixture Model to efficiently classify pixels as belonging to either the high-intensity infusate or low-intensity background. The algorithm was implemented as a distributable plug-in for the widely used imaging platform OsiriX (R). Four independent operators segmented fourteen anonymized datasets to validate the tool's performance. The datasets were intra-operative magnetic resonance images of infusions into the thalamus or putamen of non-human primates. The tool effectively reproduced the manual segmentation volumes, while significantly reducing intra-operator variability by 67 +/- 18%. The tool will be used to increase efficiency and reduce variability in upcoming clinical trials in neuro-oncology and gene therapy.	[Rosenbluth, Kathryn Hammond; Gimenez, Francisco; Kells, Adrian P.; Salegio, Ernesto A.; Mittermeyer, Gabriele M.; Modera, Kevin; Kohal, Anmol; Bankiewicz, Krystof S.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Rosenbluth, KH (corresponding author), Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA.	Kate.Rosenbluth@ucsf.edu			NIH [PO1 CA118816]; NATIONAL CANCER INSTITUTE [P01CA118816] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH PO1 CA118816. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankiewicz KS, 2006, MOL THER, V14, P564, DOI 10.1016/j.ymthe.2006.05.005; BOBO RH, 1994, P NATL ACAD SCI USA, V91, P2076, DOI 10.1073/pnas.91.6.2076; Dalrymple LS, 2007, CLIN J AM SOC NEPHRO, V2, P715, DOI 10.2215/CJN.00470107; Dickinson PJ, 2008, J NEUROSURG, V108, P989, DOI 10.3171/JNS/2008/108/5/0989; Eberling JL, 2008, NEUROLOGY, V70, P1980, DOI 10.1212/01.wnl.0000312381.29287.ff; Fiandaca MS, 2011, TOXINS, V3, P369, DOI 10.3390/toxins3040369; Jagannathan J, 2008, J NEUROSURG, V109, P547, DOI 10.3171/JNS/2008/109/9/0547; Krauze MT, 2007, NEURO-ONCOLOGY, V9, P393, DOI 10.1215/15228517-2007-019; Krauze MT, 2005, J NEUROSURG, V103, P923, DOI 10.3171/jns.2005.103.5.0923; Kunwar S, 2007, J CLIN ONCOL, V25, P837, DOI 10.1200/JCO.2006.08.1117; Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737; LEI TH, 1992, IEEE T MED IMAGING, V11, P62, DOI 10.1109/42.126911; LIANG ZR, 1994, IEEE T MED IMAGING, V13, P441, DOI 10.1109/42.310875; Lidar Z, 2004, J NEUROSURG, V100, P472, DOI 10.3171/jns.2004.100.3.0472; Lonser RR, 2007, J NEUROSURG, V107, P190, DOI 10.3171/JNS-07/07/0190; Morrison PF, 2007, J NEUROSURG, V107, P74, DOI 10.3171/JNS-07/07/0074; Murad GJA, 2007, J NEUROSURG, V106, P351, DOI 10.3171/jns.2007.106.2.351; Nguyen TT, 2003, J NEUROSURG, V98, P584, DOI 10.3171/jns.2003.98.3.0584; Noble CO, 2006, CANCER RES, V66, P2801, DOI 10.1158/0008-5472.CAN-05-3535; Ostertag D, 2012, NEURO-ONCOLOGY, V14, P145, DOI 10.1093/neuonc/nor199; Pham DL, 2000, ANNU REV BIOMED ENG, V2, P315, DOI 10.1146/annurev.bioeng.2.1.315; Richardson RM, 2011, NEUROSURGERY, V69, P154, DOI 10.1227/NEU.0b013e318217217e; Richardson RM, 2011, MOL THER, V19, P1048, DOI 10.1038/mt.2011.11; Richardson RM, 2011, STEREOT FUNCT NEUROS, V89, P141, DOI 10.1159/000323544; Rosenbluth KH, 2012, NEUROIMAGE, V59, P2423, DOI 10.1016/j.neuroimage.2011.08.107; Saito R, 2004, CANCER RES, V64, P2572, DOI 10.1158/0008-5472.CAN-03-3631; SAMPSON JH, 2009, J NEUROSURG; Sampson JH, 2007, NEURO-ONCOLOGY, V9, P343, DOI 10.1215/15228517-2007-007; Sampson JH, 2007, AM J ROENTGENOL, V188, P703, DOI 10.2214/AJR.06.0428; Sampson JH, 2011, NEUROSURGERY, V69, P668, DOI 10.1227/NEU.0b013e3182181ba8; San Sebastian W, 2012, HUM GENE THER, V23, P210, DOI 10.1089/hum.2011.162; Su XM, 2009, HUM GENE THER, V20, P1627, DOI 10.1089/hum.2009.103; Tai CK, 2005, MOL THER, V12, P842, DOI 10.1016/j.ymthe.2005.03.017; Titterington D. M., 1985, STAT ANAL FINITE MIX; Valles F, 2010, NEUROSURGERY, V67, P1377, DOI 10.1227/NEU.0b013e3181f53a5c; Yin DL, 2011, NEUROIMAGE, V54, pS196, DOI 10.1016/j.neuroimage.2009.08.069	36	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64452	10.1371/journal.pone.0064452	http://dx.doi.org/10.1371/journal.pone.0064452			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755125	Green Published, gold, Green Submitted			2022-12-27	WOS:000320579400016
J	Wang, MQ; Ge, BS; Li, RM; Wang, XQ; Lao, J; Huang, F				Wang, Mingqing; Ge, Baosheng; Li, Renmin; Wang, Xiaoqiang; Lao, Jun; Huang, Fang			Milligram Production and Biological Activity Characterization of the Human Chemokine Receptor CCR3	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; EOSINOPHIL EOTAXIN RECEPTOR; HETEROLOGOUS EXPRESSION; MOLECULAR-CLONING; FUNCTIONAL EXPRESSION; PURIFICATION; SOLUBILIZATION; GPCR; TRAFFICKING; RECRUITMENT	Human chemokine receptor CCR3 (hCCR3) belongs to the G protein-coupled receptors (GPCRs) superfamily of membrane proteins and plays major roles in allergic diseases and angiogenesis. In order to study the structural and functional mechanism of hCCR3, it is essential to produce pure protein with biological functions on a milligram scale. Here we report the expression of hCCR3 gene in a tetracycline-inducible stable mammalian cell line. A cell clone with high hCCR3 expression was selected from 46 stably transfected cell clones and from this cell line pure hCCR3 on a milligram scale was obtained after two-step purification. Circular dichroism spectrum with a characteristic shape and magnitude for alpha-helix indicated proper folding of hCCR3 after purification. The biological activity of purified hCCR3 was verified by its high binding affinity with its endogenous ligands CCL11 and CCL24, with K-D in the range of 10(-8) M to 10(-6) M.	[Wang, Mingqing; Ge, Baosheng; Wang, Xiaoqiang; Lao, Jun; Huang, Fang] China Univ Petr Huadong, State Key Lab Heavy Oil Proc, Qingdao, Shandong, Peoples R China; [Wang, Mingqing; Ge, Baosheng; Wang, Xiaoqiang; Lao, Jun; Huang, Fang] China Univ Petr Huadong, Ctr Bioengn & Biotechnol, Qingdao, Shandong, Peoples R China; [Li, Renmin] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao, Shandong, Peoples R China	China University of Petroleum; China University of Petroleum; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS	Huang, F (corresponding author), China Univ Petr Huadong, State Key Lab Heavy Oil Proc, Qingdao, Shandong, Peoples R China.	fhuang@upc.edu.cn	Ge, Baosheng/AAT-4788-2020	Ge, Baosheng/0000-0001-9906-2081	National Key Basic Research Program of China [2012CB518000]; National Natural Science Foundation of China [31000377, 21073236, 21033005]; Shandong Province Natural Science Foundation [ZR2010BQ016]; program for New Century Excellent Talents in University of Ministry of Education of China [NCET-10-0815]; Natural Science Foundation for Distinguished Young Scholar of Shandong Province [JQ201008]; Fundamental Research Funds for the Central Universities [11CX04030A]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province); program for New Century Excellent Talents in University of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); Natural Science Foundation for Distinguished Young Scholar of Shandong Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was financially supported in part by the National Key Basic Research Program of China (2012CB518000), the National Natural Science Foundation of China (No. 31000377, 21073236, 21033005), Shandong Province Natural Science Foundation (No. ZR2010BQ016), the program for New Century Excellent Talents in University of Ministry of Education of China (NCET-10-0815), the Natural Science Foundation for Distinguished Young Scholar of Shandong Province (No. JQ201008), and the Fundamental Research Funds for the Central Universities (No. 11CX04030A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Allen SJ, 2009, PROTEIN EXPRES PURIF, V66, P73, DOI 10.1016/j.pep.2009.03.001; Bane SE, 2007, PROTEIN EXPRES PURIF, V52, P348, DOI 10.1016/j.pep.2006.10.017; Bennett LD, 2011, IMMUNOLOGY, V134, P246, DOI 10.1111/j.1365-2567.2011.03485.x; Blackburn PE, 2004, BIOCHEM J, V379, P263, DOI 10.1042/BJ20031266; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; COMBADIERE C, 1995, J BIOL CHEM, V270, P16491, DOI 10.1074/jbc.270.28.16491; Cook BL, 2009, P NATL ACAD SCI USA, V106, P11925, DOI 10.1073/pnas.0811089106; Corin K, 2011, SCI REP-UK, V1, DOI 10.1038/srep00172; Corin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025067; Corin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023036; Dairaghi DJ, 1997, J BIOL CHEM, V272, P28206, DOI 10.1074/jbc.272.45.28206; Daugherty BL, 1996, J EXP MED, V183, P2349, DOI 10.1084/jem.183.5.2349; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Forssmann U, 1997, J EXP MED, V185, P2171, DOI 10.1084/jem.185.12.2171; Grodecka M, 2012, GLYCOCONJUGATE J, V29, P93, DOI 10.1007/s10719-011-9367-9; Gutierrez J, 2004, J BIOL CHEM, V279, P14726, DOI 10.1074/jbc.M309689200; Huwiler KG, 2010, ASSAY DRUG DEV TECHN, V8, P356, DOI 10.1089/adt.2009.0257; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kitaura M, 1999, J BIOL CHEM, V274, P27975, DOI 10.1074/jbc.274.39.27975; Kitaura M, 1996, J BIOL CHEM, V271, P7725, DOI 10.1074/jbc.271.13.7725; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Menzies-Gow A, 2002, J IMMUNOL, V169, P2712, DOI 10.4049/jimmunol.169.5.2712; Neel NF, 2005, CYTOKINE GROWTH F R, V16, P637, DOI 10.1016/j.cytogfr.2005.05.008; O'Malley MA, 2009, PROTEIN SCI, V18, P2356, DOI 10.1002/pro.246; Ponath PD, 1996, J CLIN INVEST, V97, P604, DOI 10.1172/JCI118456; Ponath PD, 1996, J EXP MED, V183, P2437, DOI 10.1084/jem.183.6.2437; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Ren H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004509; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Roth BL, 2012, NATURE, V492, P57, DOI 10.1038/492057a; Schlyer S, 2006, DRUG DISCOV TODAY, V11, P481, DOI 10.1016/j.drudis.2006.04.008; Shukla AK, 2007, INT J BIOCHEM CELL B, V39, P931, DOI 10.1016/j.biocel.2007.01.016; Stone MJ, 2009, NEW BIOTECHNOL, V25, P299, DOI 10.1016/j.nbt.2009.03.011; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; Vukoti K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046290; Wang XQ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00102; Wang XQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023076; Wang XQ, 2011, P NATL ACAD SCI USA, V108, P9049, DOI 10.1073/pnas.1018185108; Wise E, 2007, BIOCHEM SOC T, V35, P755, DOI 10.1042/BST0350755; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xia HY, 2008, BBA-BIOMEMBRANES, V1778, P2203, DOI 10.1016/j.bbamem.2008.05.017; Zhang LW, 2002, J BIOL CHEM, V277, P33799, DOI 10.1074/jbc.M205488200; Zhu JZ, 2011, BIOCHEMISTRY-US, V50, P1524, DOI 10.1021/bi101240v; Zidek L, 1999, NAT STRUCT BIOL, V6, P1118; Zlotnik A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-243	47	13	14	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65500	10.1371/journal.pone.0065500	http://dx.doi.org/10.1371/journal.pone.0065500			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755240	gold, Green Published, Green Submitted			2022-12-27	WOS:000319872300084
J	Feng, JN; Zhang, ZF; Wu, XW; Mao, A; Chang, F; Deng, XT; Gao, H; Ouyang, C; Dery, KJ; Le, K; Longmate, J; Marek, C; St Amand, RP; Krontiris, TG; Shively, JE				Feng, Jinong; Zhang, Zhifang; Wu, Xiwei; Mao, Allen; Chang, Frances; Deng, Xutao; Gao, Harry; Ouyang, Ching; Dery, Kenneth J.; Le, Keith; Longmate, Jeffrey; Marek, Claudia; St Amand, R. Paul; Krontiris, Theodore G.; Shively, John E.			Discovery of Potential New Gene Variants and Inflammatory Cytokine Associations with Fibromyalgia Syndrome by Whole Exome Sequencing	PLOS ONE			English	Article							T102C POLYMORPHISM; PLASMA-LEVELS; POPULATION; FAMILY	Fibromyalgia syndrome (FMS) is a chronic musculoskeletal pain disorder affecting 2% to 5% of the general population. Both genetic and environmental factors may be involved. To ascertain in an unbiased manner which genes play a role in the disorder, we performed complete exome sequencing on a subset of FMS patients. Out of 150 nuclear families (trios) DNA from 19 probands was subjected to complete exome sequencing. Since >80,000 SNPs were found per proband, the data were further filtered, including analysis of those with stop codons, a rare frequency (<2.5%) in the 1000 Genomes database, and presence in at least 2/19 probands sequenced. Two nonsense mutations, W32X in C11orf40 and Q100X in ZNF77 among 150 FMS trios had a significantly elevated frequency of transmission to affected probands (p = 0.026 and p = 0.032, respectively) and were present in a subset of 13% and 11% of FMS patients, respectively. Among 9 patients bearing more than one of the variants we have described, 4 had onset of symptoms between the ages of 10 and 18. The subset with the C11orf40 mutation had elevated plasma levels of the inflammatory cytokines, MCP-1 and IP-10, compared with unaffected controls or FMS patients with the wild-type allele. Similarly, patients with the ZNF77 mutation have elevated levels of the inflammatory cytokine, IL-12, compared with controls or patients with the wild type allele. Our results strongly implicate an inflammatory basis for FMS, as well as specific cytokine dysregulation, in at least 35% of our FMS cohort.	[Feng, Jinong; Zhang, Zhifang; Mao, Allen; Chang, Frances; Dery, Kenneth J.; Le, Keith; Shively, John E.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, Duarte, CA USA; [Wu, Xiwei; Deng, Xutao; Ouyang, Ching; Krontiris, Theodore G.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA USA; [Longmate, Jeffrey] City Hope Natl Med Ctr, Beckman Res Inst, Dept Biostat, Duarte, CA USA; [Gao, Harry] City Hope Natl Med Ctr, Beckman Res Inst, DNA Sequencing Core, Duarte, CA USA; [Marek, Claudia; St Amand, R. Paul] RP St Amand MD Inc, Marina Del Rey, CA USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Shively, JE (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, Duarte, CA USA.	jshively@coh.org		Longmate, Jeffrey/0000-0002-0869-7928; Mao, Allen/0000-0002-7411-7100	City of Hope; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER	City of Hope; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	City of Hope supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold LM, 2004, ARTHRITIS RHEUM-US, V50, P944, DOI 10.1002/art.20042; Berkun Y, 2012, CLIN EXPT RHEUMATOLO; Bondy B, 1999, NEUROBIOL DIS, V6, P433, DOI 10.1006/nbdi.1999.0262; Buskila D, 1997, FAM PRACT, V14, P238, DOI 10.1093/fampra/14.3.238; Buskila D, 2007, PHARMACOGENOMICS, V8, P67, DOI 10.2217/14622416.8.1.67; Dan B, 2004, MOL PSYCHIATR, V9, P730, DOI 10.1038/sj.mp.4001506; Feng JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008480; Gursoy S, 2001, RHEUMATOL INT, V21, P58, DOI 10.1007/s002960100130; Kato K, 2006, ARCH INTERN MED, V166, P1649, DOI 10.1001/archinte.166.15.1649; Romano T J, 1988, W V Med J, V84, P16; Smith SB, 2012, ARTHRITIS RHEUM-US, V64, P584, DOI 10.1002/art.33338; Sperber AD, 2011, J NEUROGASTROENTEROL, V17, P67, DOI 10.5056/jnm.2011.17.1.67; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; WOLFE F, 1990, ARCH INTERN MED, V150, P460, DOI 10.1001/archinte.150.2.460; WOLFE F, 1995, ARTHRITIS RHEUM-US, V38, P19, DOI 10.1002/art.1780380104; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Zhang ZF, 2008, EXP BIOL MED, V233, P1171, DOI 10.3181/0712-RM-328	17	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65033	10.1371/journal.pone.0065033	http://dx.doi.org/10.1371/journal.pone.0065033			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762283	Green Published, Green Submitted, gold			2022-12-27	WOS:000320440500021
J	Huq, NL; Seers, CA; Toh, ECY; Dashper, SG; Slakeski, N; Zhang, LY; Ward, BR; Meuric, V; Chen, D; Cross, KJ; Reynolds, EC				Huq, N. Laila; Seers, Christine A.; Toh, Elena C. Y.; Dashper, Stuart G.; Slakeski, Nada; Zhang, Lianyi; Ward, Brent R.; Meuric, Vincent; Chen, Dina; Cross, Keith J.; Reynolds, Eric C.			Propeptide-Mediated Inhibition of Cognate Gingipain Proteinases	PLOS ONE			English	Article							C-TERMINAL-DOMAIN; PORPHYROMONAS-GINGIVALIS; CYSTEINE PROTEINASE; ACTIVE-SITE; PERIODONTAL-DISEASE; ARG-GINGIPAIN; ARGININE; PROTEASES; RGPB; IDENTIFICATION	Porphyromonas gingivalis is a major pathogen associated with chronic periodontitis. The organism's cell-surface cysteine proteinases, the Arg-specific proteinases (RgpA, RgpB) and the Lys-specific proteinase (Kgp), which are known as gingipains have been implicated as major virulence factors. All three gingipain precursors contain a propeptide of around 200 amino acids in length that is removed during maturation. The aim of this study was to characterize the inhibitory potential of the Kgp and RgpB propeptides against the mature cognate enzymes. Mature Kgp was obtained from P. gingivalis mutant ECR368, which produces a recombinant Kgp with an ABM1 motif deleted from the catalytic domain (rKgp) that enables the otherwise membrane bound enzyme to dissociate from adhesins and be released. Mature RgpB was obtained from P. gingivalis HG66. Recombinant propeptides of Kgp and RgpB were produced in Escherichia coli and purified using nickel-affinity chromatography. The Kgp and RgpB propeptides displayed non-competitive inhibition kinetics with K-i values of 2.04 mu M and 12 nM, respectively. Both propeptides exhibited selectivity towards their cognate proteinase. The specificity of both propeptides was demonstrated by their inability to inhibit caspase-3, a closely related cysteine protease, and papain that also has a relatively long propeptide. Both propeptides at 100 mg/L caused a 50% reduction of P. gingivalis growth in a protein-based medium. In summary, this study demonstrates that gingipain propeptides are capable of inhibiting their mature cognate proteinases.	[Huq, N. Laila; Seers, Christine A.; Toh, Elena C. Y.; Dashper, Stuart G.; Slakeski, Nada; Zhang, Lianyi; Ward, Brent R.; Meuric, Vincent; Chen, Dina; Cross, Keith J.; Reynolds, Eric C.] Univ Melbourne, Inst Mol Sci & Biotechnol Bio21, Melbourne Dent Sch, Oral Hlth Cooperat Res Ctr, Melbourne, Vic 3010, Australia	University of Melbourne	Reynolds, EC (corresponding author), Univ Melbourne, Inst Mol Sci & Biotechnol Bio21, Melbourne Dent Sch, Oral Hlth Cooperat Res Ctr, Melbourne, Vic 3010, Australia.	e.reynolds@unimelb.edu.au	Zhang, Lianyi/H-7491-2014; Cross, Keith J/N-4602-2013; Meuric, Vincent/AAW-7709-2020; Huq, Laila/A-2861-2012	Meuric, Vincent/0000-0001-5411-4001; Huq, Laila/0000-0001-7788-4797; Dashper, Stuart/0000-0003-0106-8691; Slakeski, Nada/0000-0001-9776-6018; Reynolds, Eric/0000-0002-6618-4856; Seers, Christine/0000-0002-7777-443X; Rahma, Indah/0000-0002-6855-1146	Australian National Health and Medical Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian National Health and Medical Research Council. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ally N, 2003, BIOCHEMISTRY-US, V42, P11693, DOI 10.1021/bi0349726; Aravind L, 2002, PROTEINS, V46, P355, DOI 10.1002/prot.10060; Bhogal PS, 1997, MICROBIOL-SGM, V143, P2485, DOI 10.1099/00221287-143-7-2485; Blat Y, 2010, CHEM BIOL DRUG DES, V75, P535, DOI 10.1111/j.1747-0285.2010.00972.x; Chen JM, 1998, FEBS LETT, V441, P361, DOI 10.1016/S0014-5793(98)01574-9; Cruz LJ, 2010, J CONTROL RELEASE, V144, P118, DOI 10.1016/j.jconrel.2010.02.013; Curtis MA, 1999, J PERIODONTAL RES, V34, P464, DOI 10.1111/j.1600-0765.1999.tb02282.x; Dasanayake AP, 2008, MCN-AM J MATERN-CHIL, V33, P45, DOI 10.1097/01.NMC.0000305657.24613.47; Dashper SG, 2012, ANTIMICROB AGENTS CH, V56, P1548, DOI 10.1128/AAC.05100-11; Dashper SG, 2009, J BACTERIOL, V191, P1044, DOI 10.1128/JB.01270-08; de Diego I, 2013, J BIOL CHEM; Demidyuk Ilya V, 2010, Biomol Concepts, V1, P305, DOI 10.1515/bmc.2010.025; Detert J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3106; Eichinger A, 1999, EMBO J, V18, P5453, DOI 10.1093/emboj/18.20.5453; Fowler J, 1997, PRACTICAL STAT FIELD; Grenier D, 2003, INFECT IMMUN, V71, P4742, DOI 10.1128/IAI.71.8.4742-4748.2003; Grenier D, 2001, INFECT IMMUN, V69, P5166, DOI 10.1128/IAI.69.8.5166-5172.2001; Guay J, 2000, EUR J BIOCHEM, V267, P6311, DOI 10.1046/j.1432-1327.2000.01730.x; Guo YH, 2010, PERIODONTOL 2000, V54, P15, DOI 10.1111/j.1600-0757.2010.00377.x; Hondoh T, 2006, PROTEIN SCI, V15, P871, DOI 10.1110/ps.051880406; Hujoel PP, 2003, ANN EPIDEMIOL, V13, P312, DOI 10.1016/S1047-2797(02)00425-8; Humphrey LL, 2008, J GEN INTERN MED, V23, P2079, DOI 10.1007/s11606-008-0787-6; Jackson CA, 2000, FEMS MICROBIOL LETT, V186, P133, DOI 10.1111/j.1574-6968.2000.tb09094.x; Kadowaki T, 2007, FRONT BIOSCI-LANDMRK, V12, P4800, DOI 10.2741/2428; Kamer AR, 2008, ALZHEIMERS DEMENT, V4, P242, DOI 10.1016/j.jalz.2007.08.004; Kato D, 2005, NAT CHEM BIOL, V1, P33, DOI 10.1038/nchembio707; Kontani M, 1999, INFECT IMMUN, V67, P4917, DOI 10.1128/IAI.67.9.4917-4920.1999; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Lecaille F, 2002, CHEM REV, V102, P4459, DOI 10.1021/cr0101656; Mikolajczyk J, 2003, J BIOL CHEM, V278, P10458, DOI 10.1074/jbc.M210564200; Mikolajczyk-Pawlinska J, 1998, BIOL CHEM, V379, P205, DOI 10.1515/bchm.1998.379.2.205; Nakayama K, 1996, J BACTERIOL, V178, P2818, DOI 10.1128/jb.178.10.2818-2824.1996; O'Brien-Simpson NM, 2005, J IMMUNOL, V175, P3980, DOI 10.4049/jimmunol.175.6.3980; O'Brien-Simpson NM, 2003, CURR PROTEIN PEPT SC, V4, P409, DOI 10.2174/1389203033487009; Oda H, 2007, J PERIODONTAL RES, V42, P438, DOI 10.1111/j.1600-0765.2006.00966.x; Pathirana RD, 2007, INFECT IMMUN, V75; PIKE R, 1994, J BIOL CHEM, V269, P406; Rangarajan M, 1997, BIOCHEM J, V323, P701, DOI 10.1042/bj3230701; Rawlings ND, 2004, NUCLEIC ACIDS RES, V32, pD160, DOI 10.1093/nar/gkp971; Renvert S, 2003, ORAL HLTH PREV DE S1, V1, P358; Renvert Stefan, 2003, Oral Health Prev Dent, V1 Suppl 1, P341; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Seers CA, 2006, J BACTERIOL, V188, P6376, DOI 10.1128/JB.00731-06; Sheets SM, 2006, INFECT IMMUN, V74, P5667, DOI 10.1128/IAI.01140-05; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Shi Y, 1999, J BIOL CHEM, V274, P17955, DOI 10.1074/jbc.274.25.17955; Shi Y, 2000, J BIOL CHEM, V275, P30002, DOI 10.1074/jbc.M001518200; Slakeski N, 1998, MICROBIOL-UK, V144, P1583, DOI 10.1099/00221287-144-6-1583; Slakeski N, 1999, ORAL MICROBIOL IMMUN, V14, P92, DOI 10.1034/j.1399-302X.1999.140203.x; Slakeski N, 2011, J BACTERIOL, V193, P132, DOI 10.1128/JB.00773-10; Sztukowska M, 2012, BIOL CHEM, V393, P971, DOI 10.1515/hsz-2012-0175; Toh ECY, 2011, ANTIMICROB AGENTS CH, V55, P1155, DOI 10.1128/AAC.00466-10; Tripos, 2011, SYBYL X 1 2; Wiederanders B, 2003, CURR PROTEIN PEPT SC, V4, P309, DOI 10.2174/1389203033487081; Wilkens M, 2002, J BIOL CHEM, V277, P9366, DOI 10.1074/jbc.M110848200; Yoshioka M, 2003, CURR MICROBIOL, V47, P1, DOI 10.1007/s00284-002-3916-1; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	58	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65447	10.1371/journal.pone.0065447	http://dx.doi.org/10.1371/journal.pone.0065447			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762374	Green Published, gold			2022-12-27	WOS:000320440500040
J	Levy, M; Bonnet, D; Mauge, L; Celermajer, DS; Gaussem, P; Smadja, DM				Levy, Marilyne; Bonnet, Damien; Mauge, Laetitia; Celermajer, David S.; Gaussem, Pascale; Smadja, David M.			Circulating Endothelial Cells in Refractory Pulmonary Hypertension in Children: Markers of Treatment Efficacy and Clinical Worsening	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; PROGENITOR CELLS; PROLIFERATION; TREPROSTINIL; CONTRIBUTES; DEFINITION; MECHANISMS; GUIDELINES; APOPTOSIS; DIAGNOSIS	Background: Pulmonary vasodilators in general and prostacyclin analogues in particular have improved the outcome of patients with pulmonary arterial hypertension (PAH). Endothelial dysfunction is a key feature of PAH and we previously described that circulating endothelial cell (CEC) level could be used as a biomarker of endothelial dysfunction in PAH. We now hypothesized that an efficient PAH-specific vasodilator therapy might decrease CEC level. Methods/Results: CECs were prospectively quantified by immunomagnetic separation with mAb CD146-coated beads in peripheral blood from children with idiopathic PAH (iPAH, n = 30) or PAH secondary to congenital heart disease (PAH-CHD, n = 30): before, after treatment and during follow up. Controls were 23 children with reversible PAH. Oral treatment with endothelin receptor antagonists (ERA) and/or phosphodiesterase 5 inhibitors (PDE5) significantly reduced CEC counts in children. In 10 children with refractory PAH despite oral combination therapy, subcutaneous (SC) treprostinil was added and we observed a significant decrease in CEC counts during the first month of such treatment. CECs were quantified during a 6 to 36 month-follow-up after initiation of SC treprostinil and we found that CEC counts changed over time, with rising counts always preceding clinical deterioration. Conclusion: CECs might be useful as a biomarker during follow-up of pediatric iPAH and PAH-CHD to assess response to treatment and to anticipate clinical worsening.	[Levy, Marilyne; Bonnet, Damien; Mauge, Laetitia; Gaussem, Pascale; Smadja, David M.] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Levy, Marilyne; Bonnet, Damien] Hop Necker Enfants Malad, AP HP, Ctr Reference Malformat Cardiaques Congenitales C, Paris, France; [Mauge, Laetitia; Gaussem, Pascale; Smadja, David M.] Fac Pharm, INSERM, UMR S765, Paris, France; [Mauge, Laetitia; Gaussem, Pascale; Smadja, David M.] Hop Europeen Georges Pompidou, AP HP, Serv Hematol Biol, Paris, France; [Celermajer, David S.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Sydney	Smadja, DM (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Paris, France.	david.smadja@egp.aphp.fr	Gaussem, Pascale/AGY-9723-2022; Gaussem, Pascale/ABA-2228-2020; Gaussem, P./ABA-1222-2020; Smadja, David/M-3872-2017	Gaussem, P./0000-0002-9139-2147; Celermajer, David/0000-0001-7640-0439; Smadja, David/0000-0001-7731-9202	INSERM; Leg Poix (Paris, France); ARCFA (Association pour la Recherche en Cardiologie du Foetus a l'Adulte)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Leg Poix (Paris, France); ARCFA (Association pour la Recherche en Cardiologie du Foetus a l'Adulte)	This work was supported by research grants from INSERM, Leg Poix (Paris, France) andARCFA (Association pour la Recherche en Cardiologie du Foetus a l'Adulte). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beghetti M, 2009, J AM COLL CARDIOL, V53, P733, DOI 10.1016/j.jacc.2008.11.025; Berger RMF, 2010, EUR RESPIR REV, V19, P321, DOI 10.1183/09059180.00008410; Blann AD, 2005, THROMB HAEMOSTASIS, V93, P228, DOI 10.1160/TH04-09-0578; Bull TM, 2003, THROMB HAEMOSTASIS, V90, P698, DOI 10.1160/TH03-04-0251; CELERMAJER DS, 1993, CIRCULATION, V87, P440, DOI 10.1161/01.CIR.87.2.440; Chan SY, 2008, J MOL CELL CARDIOL, V44, P14, DOI 10.1016/j.yjmcc.2007.09.006; Cordina RL, 2010, EUR RESPIR REV, V19, P300, DOI 10.1183/09059180.00004510; Delorme B, 2005, THROMB HAEMOSTASIS, V94, P1270, DOI 10.1160/TH05-07-0499; Dong F, 2005, BRIT J PHARMACOL, V145, P323, DOI 10.1038/sj.bjp.0706193; Farber HW, 2004, NEW ENGL J MED, V351, P1655, DOI 10.1056/NEJMra035488; Galie N, 2009, EUR RESPIR J, V34, P1219, DOI 10.1183/09031936.00139009; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Garbuzova-Davis S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010614; Hoeper MM, 2005, EUR RESPIR J, V26, P858, DOI 10.1183/09031936.05.00075305; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; Humbert M, 2008, VASC PHARMACOL, V49, P113, DOI 10.1016/j.vph.2008.06.003; Izikki M, 2009, J CLIN INVEST, V119, P512, DOI 10.1172/JCI35070; Lee SD, 1998, J CLIN INVEST, V101, P927, DOI 10.1172/JCI1910; Levy M, 2007, J AM COLL CARDIOL, V49, P803, DOI 10.1016/j.jacc.2006.09.049; Levy M, 2011, J PEDIATR-US, V158, P584, DOI 10.1016/j.jpeds.2010.09.025; O'Callaghan DS, 2010, RESP MED, V104, pS74, DOI 10.1016/j.rmed.2010.03.020; Rai PR, 2008, AM J RESP CRIT CARE, V178, P558, DOI 10.1164/rccm.200709-1369PP; Rizzo NO, 2010, ARTERIOSCL THROM VAS, V30, P758, DOI 10.1161/ATVBAHA.109.199893; Sabatier F, 2009, J CELL MOL MED, V13, P454, DOI 10.1111/j.1582-4934.2008.00639.x; Salani D, 2000, AM J PATHOL, V157, P1703, DOI 10.1016/S0002-9440(10)64807-9; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Smadja DM, 2010, EUR RESPIR J, V36, P1284, DOI 10.1183/09031936.00130809; Smadja DM, 2008, ARTERIOSCL THROM VAS, V28, P2137, DOI 10.1161/ATVBAHA.108.168815; Smadja DM, 2013, ANGIOGENESIS, V16, P147, DOI 10.1007/s10456-012-9306-9; Smadja DM, 2011, ANGIOGENESIS, V14, P17, DOI 10.1007/s10456-010-9192-y; Smadja DM, 2009, CIRCULATION, V119, P374, DOI 10.1161/CIRCULATIONAHA.108.808246; Smadja DM, 2005, ARTERIOSCL THROM VAS, V25, P2321, DOI 10.1161/01.ATV.0000184762.63888.bd; Widemann A, 2008, J THROMB HAEMOST, V6, P869, DOI 10.1111/j.1538-7836.2008.02931.x; Wort SJ, 2001, AM J RESP CELL MOL, V25, P104, DOI 10.1165/ajrcmb.25.1.4331; Wort SJ, 2000, J CARDIOVASC PHARM, V36, pS410; Woywodt A, 2006, J THROMB HAEMOST, V4, P671, DOI 10.1111/j.1538-7836.2006.01794.x; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471	37	28	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65114	10.1371/journal.pone.0065114	http://dx.doi.org/10.1371/journal.pone.0065114			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762293	Green Submitted, gold, Green Published			2022-12-27	WOS:000320440500025
J	Sun, LC; Ye, YT; Sun, HB; Yu, J; Zhang, L; Sun, Y; Zhang, DH; Ma, L; Shen, B; Zhu, CL				Sun, Linchun; Ye, Yuting; Sun, Haibo; Yu, Jing; Zhang, Li; Sun, Yan; Zhang, Donghui; Ma, Lei; Shen, Bo; Zhu, Changliang			Identification of Proteasome Subunit Beta Type 6 (PSMB6) Associated with Deltamethrin Resistance in Mosquitoes by Proteomic and Bioassay Analyses	PLOS ONE			English	Article							UBIQUITIN-SPECIFIC PROTEASE; INSECTICIDE RESISTANCE; ANOPHELES-GAMBIAE; EXPRESSION; INHIBITORS; GENES; DEGRADATION; PROTEINS; CLONING; ROLES	Deltamethrin (DM) insecticides are currently being promoted worldwide for mosquito control, because of the high efficacy, low mammalian toxicity and less environmental impact. Widespread and improper use of insecticides induced resistance, which has become a major obstacle for the insect-borne disease management. Resistance development is a complex and dynamic process involving many genes. To better understand the possible molecular mechanisms involved in DM resistance, a proteomic approach was employed for screening of differentially expressed proteins in DM-susceptible and resistant mosquito cells. Twenty-seven differentially expressed proteins were identified by two-dimensional electrophoresis (2-DE) and mass spectrometry (MS). Four members of the ubiquitin-proteasome system were significantly elevated in DM-resistant cells, suggesting that the ubiquitin-proteasome pathway may play an important role in DM resistance. Proteasome subunit beta type 6 (PSMB6) is a member of 20S proteasomal subunit family, which forms the proteolytic core of 26S proteasome. We used pharmaceutical inhibitor and molecular approaches to study the contributions of PSMB6 in DM resistance: the proteasome inhibitor MG-132 and bortezomib were used to suppress the proteasomal activity and siRNA was designed to block the function of PSMB6. The results revealed that both MG-132 and bortezomib increased the susceptibility in DM-resistant cells and resistance larvae. Moreover, PSMB6 knockdown decreased cellular viability under DM treatment. Taken together, our study indicated that PSMB6 is associated with DM resistance in mosquitoes and that proteasome inhibitors such as MG-132 or bortezomib are suitable for use as a DM synergist for vector control.	[Sun, Linchun; Ye, Yuting; Sun, Haibo; Yu, Jing; Zhang, Li; Sun, Yan; Zhang, Donghui; Ma, Lei; Shen, Bo; Zhu, Changliang] Nanjing Med Univ, Dept Pathogen Biol, Nanjing, Jiangsu, Peoples R China; [Sun, Linchun] Nanjing Med Univ, Nanjing Childrens Hosp, Pediat Res Ctr, Nanjing, Jiangsu, Peoples R China; [Zhang, Li] Jiangsu Prov Hosp Integrat Chinese & Western Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing University of Chinese Medicine	Zhu, CL (corresponding author), Nanjing Med Univ, Dept Pathogen Biol, Nanjing, Jiangsu, Peoples R China.	shenbo@njmu.edu.cn; clzhu@njmu.edu.cn	Sun, Haibo/R-1518-2016	Sun, Haibo/0000-0003-3635-7557	National Institutes of Health of US [2R01AI075746-05]; National Science and Technology Major Project of China [2008ZX10004-010]; National Natural Science Foundation of China [30972564, 30901244, 801101279, 81171900]; Natural Science Foundation of Jiangsu province [BK2011768]; Research Fund for the Doctoral Program of Higher Education of China [20113234120007]; Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075746] Funding Source: NIH RePORTER	National Institutes of Health of US(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science and Technology Major Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu province(Natural Science Foundation of Jiangsu Province); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health of US (2R01AI075746-05), National Science and Technology Major Project of China (No. 2008ZX10004-010), National Natural Science Foundation of China (No. 30972564, No. 30901244, No. 801101279 and No. 81171900), Natural Science Foundation of Jiangsu province (No. BK2011768), Research Fund for the Doctoral Program of Higher Education of China (No. 20113234120007), and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, World Health Organ Tech Rep Ser, V818, P1; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; Boonyuan W, 2011, J VECTOR ECOL, V36, P361, DOI 10.1111/j.1948-7134.2011.00177.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Butler D, 2007, NATURE, V450, P144, DOI 10.1038/450144b; Cardozo C, 2002, ARCH BIOCHEM BIOPHYS, V408, P103, DOI 10.1016/S0003-9861(02)00493-9; Casimiro S, 2006, J MED ENTOMOL, V43, P276, DOI 10.1603/0022-2585(2006)043[0276:IRIAAA]2.0.CO;2; Chauhan D, 2004, ONCOGENE, V23, P3597, DOI 10.1038/sj.onc.1207458; da Fonseca PCA, 2012, MOL CELL, V46, P54, DOI 10.1016/j.molcel.2012.03.026; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Denholm I, 2002, SCIENCE, V297, P2222, DOI 10.1126/science.1077266; Geng FQ, 2012, P NATL ACAD SCI USA, V109, P6060, DOI 10.1073/pnas.1200854109; Gilchrist CA, 1997, J BIOL CHEM, V272, P32280, DOI 10.1074/jbc.272.51.32280; Hemingway J, 2002, SCIENCE, V298, P96, DOI 10.1126/science.1078052; Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003; Jager S, 1999, J MOL BIOL, V291, P997, DOI 10.1006/jmbi.1999.2995; Kim HM, 2011, BBA-GENE REGUL MECH, V1809, P67, DOI 10.1016/j.bbagrm.2010.08.008; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Liu NN, 2007, GENE, V394, P61, DOI 10.1016/j.gene.2007.01.032; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206; Ma MY, 2008, J PROTEOME RES, V7, P4821, DOI 10.1021/pr800392s; Mahande AM, 2012, J GLOB INFECT DIS, V4, P114, DOI 10.4103/0974-777X.96776; Munkacsy G, 2010, BRIT J CANCER, V102, P361, DOI 10.1038/sj.bjc.6605478; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11; Quesada V, 2004, BIOCHEM BIOPH RES CO, V314, P54, DOI 10.1016/j.bbrc.2003.12.050; Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000; Roberts DR, 1998, T ROY SOC TROP MED H, V92, P687, DOI 10.1016/S0035-9203(98)90816-1; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Smith L, 2007, ONCOL RES, V16, P497, DOI 10.3727/096504007783438358; Smith L, 2007, EUR J CANCER, V43, P2330, DOI 10.1016/j.ejca.2007.07.023; Spataro V, 1997, J BIOL CHEM, V272, P30470, DOI 10.1074/jbc.272.48.30470; Stitzel ML, 2001, GENE DEV, V15, P128, DOI 10.1101/gad.863801; Takeuchi J, 1997, Tanpakushitsu Kakusan Koso, V42, P2247; TOBIAS JW, 1991, J BIOL CHEM, V266, P12021; Vais H, 2001, PEST MANAG SCI, V57, P877, DOI 10.1002/ps.392; Verbrugge SE, 2012, J PHARMACOL EXP THER, V341, P174, DOI 10.1124/jpet.111.187542; Walters KJ, 2003, P NATL ACAD SCI USA, V100, P12694, DOI 10.1073/pnas.1634989100; Wilding CS, 2012, INSECT BIOCHEM MOLEC, V42, P699, DOI 10.1016/j.ibmb.2012.06.003; Wu HW, 2004, PESTIC BIOCHEM PHYS, V79, P75, DOI 10.1016/j.pestbp.2004.04.004; Wu J, 2009, CHEM RES TOXICOL, V22, P668, DOI 10.1021/tx800406z; Wu X, 2011, MOL BIOL REP, V38, P5465, DOI 10.1007/s11033-011-0866-3; Zhu YF, 2006, J PROTEOME RES, V5, P2217, DOI 10.1021/pr0600733; Zimmermann J, 2001, J BIOL CHEM, V276, P10759, DOI 10.1074/jbc.M008567200	48	11	13	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65859	10.1371/journal.pone.0065859	http://dx.doi.org/10.1371/journal.pone.0065859			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762443	Green Published, Green Submitted, gold			2022-12-27	WOS:000320440500054
J	Pajak, A; Szafraniec, K; Kubinova, R; Malyutina, S; Peasey, A; Pikhart, H; Nikitin, Y; Marmot, M; Bobak, M				Pajak, Andrzej; Szafraniec, Krystyna; Kubinova, Ruzena; Malyutina, Sofia; Peasey, Anne; Pikhart, Hynek; Nikitin, Yuri; Marmot, Michael; Bobak, Martin			Binge Drinking and Blood Pressure: Cross-Sectional Results of the HAPIEE Study	PLOS ONE			English	Article							REPORTED ALCOHOL-CONSUMPTION; CARDIOVASCULAR-DISEASE; HEART-DISEASE; EASTERN-EUROPE; RISK; HYPERTENSION; PATTERN; ASSOCIATION; SAMPLE; POPULATION	Objectives: To investigate whether binge drinking pattern influences blood pressure independently from drinking volume or whether it modifies the effect of volume of drinking. Methods: We used cross-sectional data from population samples of 7559 men and 7471 women aged 45-69 years in 2002-05, not on antihypertensive medication, from Russia, Poland and Czech Republic. Annual alcohol intake, drinking frequency and binge drinking (>= 100 g in men and >= 60 g in women in one session at least once a month) were estimated from graduated frequency questionnaire. Blood pressure was analysed as continuous variables (systolic and diastolic pressure) and a binary outcome (>= 140/90 mm Hg). Results: In men, annual alcohol intake and drinking frequency were strongly associated with blood pressure. The odds ratio of high blood pressure for binge drinking in men was 1.62 (95% CI 1.45-1.82) after controlling for age, country, body mass index, education and smoking; additional adjustment for annual alcohol intake reduced it to 1.20 (1.03-1.39). In women, the fully adjusted odds ratio of high blood pressure for binge drinking was 1.31 (1.05-1.63). Binge drinking did not modify the effect of annual alcohol intake. Consuming alcohol as wine, beer or spirits had similar effects. Conclusions: The results suggest that the independent long-term effect of binge drinking was modest, that binge drinking did not modify the effect of alcohol intake, and that different alcoholic beverages had similar effects on blood pressure	[Pajak, Andrzej; Szafraniec, Krystyna] Jagiellonian Univ, Coll Med, Inst Publ Hlth, Krakow, Poland; [Kubinova, Ruzena] Natl Inst Publ Hlth, Ctr Hlth Monitoring, Prague, Czech Republic; [Malyutina, Sofia; Nikitin, Yuri] Russian Acad Med Sci, Siberian Branch, Inst Internal Med, Novosibirsk, Russia; [Peasey, Anne; Pikhart, Hynek; Marmot, Michael; Bobak, Martin] UCL, Dept Epidemiol & Publ Hlth, London, England	Jagiellonian University; Collegium Medicum Jagiellonian University; National Institute of Public Health (SZU) - Czech Republic; Russian Academy of Medical Sciences; Russian Academy of Sciences; University of London; University College London	Bobak, M (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	m.bobak@ucl.ac.uk	Pikhart, Hynek/E-3074-2010; Nikitin, Yuri/D-2774-2018; Marmot, M G/Y-3920-2019; Malyutina, Sofia/J-1651-2018	Pikhart, Hynek/0000-0001-5277-4049; Nikitin, Yuri/0000-0002-3932-2299; Marmot, M G/0000-0002-2431-6419; Malyutina, Sofia/0000-0001-6539-0466; Bobak, Martin/0000-0002-2633-6851; Peasey, Anne/0000-0001-7434-2079	Wellcome Trust [064947/Z, 081081/Z]; US National Institute of Aging [1R01 AG23522]; MacArthur Foundation; ESRC [ES/F02679X/1] Funding Source: UKRI; MRC [G1000616, G0701830, G0601647, G0902037] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [R01AG023522] Funding Source: NIH RePORTER; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Economic and Social Research Council [ES/F02679X/1] Funding Source: researchfish; Medical Research Council [G0100222, G19/35, G0601647, G0902037, G8802774, G1000616, G0701830] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); US National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MacArthur Foundation; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was supported by grants from the Wellcome Trust (064947/Z, 081081/Z), the US National Institute of Aging (1R01 AG23522) and the MacArthur Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson JL, 2010, AM J HYPERTENS, V23, P994, DOI 10.1038/ajh.2010.109; Bobak M, 2004, J EPIDEMIOL COMMUN H, V58, P238, DOI 10.1136/jech.2003.011825; Bobak M, 1999, ADDICTION, V94, P857, DOI 10.1046/j.1360-0443.1999.9468579.x; Britton A, 2000, J EPIDEMIOL COMMUN H, V54, P328, DOI 10.1136/jech.54.5.328; Chen L, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050052; CLARK LT, 1985, ALCOHOL CLIN EXP RES, V9, P125, DOI 10.1111/j.1530-0277.1985.tb05533.x; CRIQUI MH, 1982, PREV MED, V11, P391, DOI 10.1016/0091-7435(82)90043-3; Djousse L, 2009, REV ESP CARDIOL, V62, P603, DOI 10.1016/S0300-8932(09)71326-0; Fuchs FD, 2001, HYPERTENSION, V37, P1242, DOI 10.1161/01.HYP.37.5.1242; Husemoen LLN, 2008, ALCOHOL CLIN EXP RES, V32, P1984, DOI 10.1111/j.1530-0277.2008.00780.x; Klatsky AL, 2006, J STUD ALCOHOL, V67, P421, DOI 10.15288/jsa.2006.67.421; Laatikainen T, 2002, ALCOHOL ALCOHOLISM, V37, P282, DOI 10.1093/alcalc/37.3.282; MARMOT MG, 1994, BRIT MED J, V308, P1263, DOI 10.1136/bmj.308.6939.1263; Marques-Vidal P, 2001, HYPERTENSION, V38, P1361, DOI 10.1161/hy1101.095328; McKee M, 1998, J ROY SOC MED, V91, P402, DOI 10.1177/014107689809100802; Mukamal KJ, 2003, NEW ENGL J MED, V348, P109, DOI 10.1056/NEJMoa022095; NIKITIN YP, 2010, KARDIOLOGIYA, V48, P4; Nunez-Cordoba JM, 2009, REV ESP CARDIOL, V62, P633, DOI 10.1016/S0300-8932(09)71330-2; Peasey A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-255; PHILLIPS AN, 1991, J CLIN EPIDEMIOL, V44, P1223, DOI 10.1016/0895-4356(91)90155-3; Pomerleau J, 2008, ALCOHOL ALCOHOLISM, V43, P351, DOI 10.1093/alcalc/agm167; Puddey IB, 1999, ADDICTION, V94, P649, DOI 10.1046/j.1360-0443.1999.9456493.x; Rakic V, 1998, J HYPERTENS, V16, P165, DOI 10.1097/00004872-199816020-00006; Rehm J, 1998, ALCOHOL CLIN EXP RES, V22, p4S, DOI 10.1111/j.1530-0277.1998.tb04368.x; Rehm J, 2001, EUR ADDICT RES, V7, P138, DOI 10.1159/000050731; Rehm J, 2007, INT J EPIDEMIOL, V36, P458, DOI 10.1093/ije/dyl294; Roerecke M, 2010, AM J EPIDEMIOL, V171, P633, DOI 10.1093/aje/kwp451; Seppa K, 1999, HYPERTENSION, V33, P79, DOI 10.1161/01.HYP.33.1.79; SEPPA K, 1994, AM J HYPERTENS, V7, P249, DOI 10.1093/ajh/7.3.249; Sesso HD, 2008, HYPERTENSION, V51, P1080, DOI 10.1161/HYPERTENSIONAHA.107.104968; Sieri S, 2002, PUBLIC HEALTH NUTR, V5, P1287, DOI 10.1079/PHN2002405; Single E., 1998, DRINKING PATTERNS TH, P7; Steffens AA, 2006, J HYPERTENS, V24, P1489, DOI 10.1097/01.hjh.0000239282.27938.0f; Stranges S, 2004, HYPERTENSION, V44, P813, DOI 10.1161/01.HYP.0000146537.03103.f2; Sundell L, 2008, STROKE, V39, P3179, DOI 10.1161/STROKEAHA.108.520817; TREVISAN M, 1987, INT J EPIDEMIOL, V16, P520, DOI 10.1093/ije/16.4.520; Wakabayashi I, 2008, AM J HYPERTENS, V21, P1310, DOI 10.1038/ajh.2008.299; WANNAMETHEE G, 1991, J HUM HYPERTENS, V5, P59; Xin X, 2001, HYPERTENSION, V38, P1112, DOI 10.1161/hy1101.093424	39	25	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65856	10.1371/journal.pone.0065856	http://dx.doi.org/10.1371/journal.pone.0065856			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	173QU	23762441	Green Published, gold			2022-12-27	WOS:000321094800080
J	Phalen, DN; Frimberger, A; Pyecroft, S; Peck, S; Harmsen, C; Lola, S; Mattos, BD; Li, KM; McLachlan, AJ; Moore, A				Phalen, David N.; Frimberger, Angela; Pyecroft, Stephen; Peck, Sarah; Harmsen, Colette; Lola, Suzanneth; Mattos, Beatriz de Mello; Li, Kong M.; McLachlan, Andrew J.; Moore, Antony			Vincristine Chemotherapy Trials and Pharmacokinetics in Tasmanian Devils with Tasmanian Devil Facial Tumor Disease	PLOS ONE			English	Article							TRANSMISSION; POPULATION; CHILDREN; SULFATE; LIFE; DOGS	Tasmanian Devil Facial Tumor Disease (DFTD) is a transmissible cancer threatening to cause the extinction of Tasmanian Devils in the wild. The aim of this study was to determine the susceptibility of the DFTD to vincristine. Escalating dosage rates of vincristine (0.05 to 0.136 mg/kg) were given to Tasmanian devils in the early stages of DFTD (n = 8). None of these dosage rates impacted the outcome of the disease. A dosage rate of 0.105 mg/kg, a rate significantly higher than that given in humans or domestic animals, was found to the highest dosage rate that could be administered safely. Signs of toxicity included anorexia, vomiting, diarrhea and neutropenia. Pharmacokinetic studies showed that, as with other species, there was a rapid drop in blood concentration following a rapid intravenous infusion with a high volume of distribution (1.96 L/kg) and a relatively long elimination half life (11 h). Plasma clearance (1.8 ml/min/kg) was slower in the Tasmanian devil than in humans, suggesting that pharmacodynamics and not pharmacokinetics explain the Tasmanian devil's ability to tolerate high dosage rates of vincristine. While providing base-line data for the use of vincristine in Tasmanian devils and possibly other marsupials with vincristine susceptible cancers, these findings strongly suggest that vincristine will not be effective in the treatment of DFTD.	[Phalen, David N.; Peck, Sarah; Mattos, Beatriz de Mello] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Frimberger, Angela; Moore, Antony] Vet Oncol Consultants, Wauchope, NSW, Australia; [Pyecroft, Stephen; Peck, Sarah; Harmsen, Colette; Lola, Suzanneth] Tasmanian Dept Primary Ind & Water, Launceston, Tas, Australia; [Pyecroft, Stephen] Univ Adelaide, Sch Anim & Vet Sci, Adelaide, SA, Australia; [Li, Kong M.] Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia; [McLachlan, Andrew J.] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia	University of Sydney; University of Adelaide; University of Sydney; University of Sydney	Phalen, DN (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	david.phalen@sydney.edu.au	Li, Kong M./R-4655-2019	Li, Kong/0000-0003-2709-0344; Frimberger, Angela/0000-0003-2041-334X; McLachlan, Andrew/0000-0003-4674-0242	Tasmanian Government Project grant	Tasmanian Government Project grant	This trial was funded through a Tasmanian Government Project grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bander RA, 1990, CANC CHEMOTHERAPY PR, P253; Boscos C., 1988, Animalis Familiaris, V3, P10; CALVERT CA, 1982, J AM VET MED ASSOC, V181, P163; DAWSON TJ, 1970, AM J PHYSIOL, V218, P1233, DOI 10.1152/ajplegacy.1970.218.4.1233; DEGRAAF SSN, 1995, MED PEDIATR ONCOL, V24, P235, DOI 10.1002/mpo.2950240405; Embree L, 1997, J PHARMACEUT BIOMED, V16, P675, DOI 10.1016/S0731-7085(97)00087-3; GEHAN EA, 1961, J CHRON DIS, V13, P346, DOI 10.1016/0021-9681(61)90060-1; Gidding CEM, 1999, CANCER CHEMOTH PHARM, V44, P203, DOI 10.1007/s002800050968; Groninger E, 2005, EUR J CANCER, V41, P98, DOI 10.1016/j.ejca.2004.10.006; Hahn KA, 1996, VET CLIN PATH, V25, P121, DOI 10.1111/j.1939-165X.1996.tb00980.x; Hawkins CE, 2006, BIOL CONSERV, V131, P307, DOI 10.1016/j.biocon.2006.04.010; JORDAN MA, 1991, CANCER RES, V51, P2212; KANTER PM, 1994, ANTI-CANCER DRUG, V5, P579, DOI 10.1097/00001813-199410000-00010; Lachish S, 2009, J ANIM ECOL, V78, P427, DOI 10.1111/j.1365-2656.2008.01494.x; Ladds P., 2009, PATHOLOGY AUSTR NATI, P428; Leveque D, 2007, J CLIN PHARMACOL, V47, P579, DOI 10.1177/0091270007299430; Li KM, 2004, J CHROMATOGR B, V804, P319, DOI 10.1016/j.jchromb.2004.01.034; Lonnerholm G, 2008, BRIT J HAEMATOL, V142, P616, DOI 10.1111/j.1365-2141.2008.07235.x; McCallum H, 2009, ECOLOGY, V90, P3379, DOI 10.1890/08-1763.1; Mellanby RJ, 2003, J SMALL ANIM PRACT, V44, P100, DOI 10.1111/j.1748-5827.2003.tb00127.x; Moore A, 2009, PEDIATR BLOOD CANCER, V53, P1180, DOI 10.1002/pbc.22161; Moore AS, 2011, J PAEDIATR CHILD H, V47, P875, DOI 10.1111/j.1440-1754.2011.02103.x; Murchison E P, 2008, Oncogene, V27 Suppl 2, pS19, DOI 10.1038/onc.2009.350; Murchison EP, 2010, SCIENCE, V327, P84, DOI 10.1126/science.1180616; Pearse AM, 2006, NATURE, V439, P549, DOI 10.1038/439549a; Plasschaert SLA, 2004, CLIN PHARMACOL THER, V76, P220, DOI 10.1016/j.clpt.2004.05.007; Price GS, 1998, J VET INTERN MED, V12, P267, DOI 10.1111/j.1939-1676.1998.tb02121.x; Roundhill EA, 2012, BRIT J CANCER, V106, P1224, DOI 10.1038/bjc.2012.40; Rozanski EA, 2002, J AM VET MED ASSOC, V220, P477, DOI 10.2460/javma.2002.220.477; SABINE M, 1974, AUST J EXP BIOL MED, V52, P331, DOI 10.1038/icb.1974.31; Siddle HV, 2007, P NATL ACAD SCI USA, V104, P16221, DOI 10.1073/pnas.0704580104; Siddle HV, 2007, IMMUNOGENETICS, V59, P753, DOI 10.1007/s00251-007-0238-2; Simon D, 2008, J VET INTERN MED, V22, P394, DOI 10.1111/j.1939-1676.2008.0057.x; TODD GC, 1979, CANCER TREAT REP, V63, P35; Veterinary co-operative oncology group, 2007, VET COMP ONCOL, V2, P194	35	16	16	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65133	10.1371/journal.pone.0065133	http://dx.doi.org/10.1371/journal.pone.0065133			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762298	gold, Green Published, Green Submitted			2022-12-27	WOS:000321099000033
J	Topping, CJ; Odderskaer, P; Kahlert, J				Topping, Christopher J.; Odderskaer, Peter; Kahlert, Johnny			Modelling Skylarks (Alauda arvensis) to Predict Impacts of Changes in Land Management and Policy: Development and Testing of an Agent-Based Model	PLOS ONE			English	Article							AGRI-ENVIRONMENT SCHEMES; FARMLAND BIRDS; RISK-ASSESSMENT; POPULATIONS; FRAGMENTATION; DIVERSITY; ABUNDANCE	Agent-based simulation models provide a viable approach for developing applied models of species and systems for predictive management. However, there has been some reluctance to use these models for policy applications due to complexity and the need for improved testing and communication of the models. We present the development and testing of a comprehensive model for Skylark (Alauda arvensis) in Danish agricultural landscapes. The model is part of the ALMaSS system, which considers not only individual skylarks, but also the detailed dynamic environment from which they obtain the information necessary to simulate their behaviour. Population responses emerge from individuals interacting with each other and the environment. Model development and testing was carried out using pattern-oriented modelling. The testing procedure was based on the model's ability to represent detailed real world patterns of distribution and density, reproductive performance and seasonal changes in territory numbers. Data to support this was collected over a 13-year period and comprised detailed field observations of breeding birds and intensive surveys. The model was able to recreate the real world data patterns accurately; it was also able to simultaneously fit a number of other secondary system properties which were not formally a part of the testing procedure. The correspondence of model output to real world data and sensitivity analysis are presented and discussed, and the model's description is provided in ODdox format (a formal description inter-linked to the program code). Detailed and stringent tests for model performance were carried out, and standardised model description and open access to the source code were provided to open development of the skylark model to others. Over and above documenting the utility of the model, this open process is essential to engender the user trust and ensure continued development of these comprehensive systems for applied purposes.	[Topping, Christopher J.; Odderskaer, Peter; Kahlert, Johnny] Univ Aarhus, Dept Biosci, Ronde, Denmark	Aarhus University	Topping, CJ (corresponding author), Univ Aarhus, Dept Biosci, Ronde, Denmark.	cjt@dmu.dk	Topping, Christopher J/A-9167-2009	Topping, Christopher J/0000-0003-0874-7603; Topping, Christopher/0000-0003-2304-1916	'ARLAS' project under the Danish research program 'Jordbrugeren som landskabsforvalter'; Danish Environmental Agency; Danish Nature Agency	'ARLAS' project under the Danish research program 'Jordbrugeren som landskabsforvalter'; Danish Environmental Agency; Danish Nature Agency	This work was supported by the 'ARLAS' project under the Danish research program 'Jordbrugeren som landskabsforvalter' (1998-2000), by the Danish Environmental Agency (1990-1997, 2003-2005) and by the Danish Nature Agency (2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bian L, 2000, J ENVIRON MANAGE, V59, P235, DOI 10.1006/jema.2000.0374; Butler SJ, 2007, SCIENCE, V315, P381, DOI 10.1126/science.1136607; Chamberlain DE, 2000, J APPL ECOL, V37, P771, DOI 10.1046/j.1365-2664.2000.00548.x; Dalgaard T., 2002, GEOGR J, V3, P29; Dalkvist T, 2009, ECOTOX ENVIRON SAFE, V72, P1663, DOI 10.1016/j.ecoenv.2008.10.002; Dietterich T, 1995, ACM COMPUT SURV, V27, P326, DOI 10.1145/212094.212114; Drent R., 1975, AVIAN BIOL, P333; European_Communities,, 2007, 0062007 EUR COMM; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grimm V, 2012, PHILOS T R SOC B, V367, P298, DOI 10.1098/rstb.2011.0180; Hendrichsen Ditte K., 2009, BMC Ecology, V9, P10, DOI 10.1186/1472-6785-9-10; Holling C.S., 1978, ADAPTIVE ENV ASSESSM; Jepsen JU, 2005, AGR ECOSYST ENVIRON, V105, P581, DOI 10.1016/j.agee.2004.08.007; Jepsen JU, 2004, CAN J ZOOL, V82, P1528, DOI 10.1139/Z04-131; Kleijn D, 2003, J APPL ECOL, V40, P947, DOI 10.1111/j.1365-2664.2003.00868.x; Lenth R., 2019, Journal of Statistical Software, V60, P1; Lorek H, 1998, ECOL MODEL, V108, P77, DOI 10.1016/S0304-3800(98)00020-9; McCarthy MA, 2007, CONSERV BIOL, V21, P956, DOI 10.1111/j.1523-1739.2007.00677.x; Odderskaer P, 1997, AGR ECOSYST ENVIRON, V62, P21, DOI 10.1016/S0167-8809(96)01113-9; Odderskaer P, 2006, 105 BEK MIDD, P127; Odderskar P., 1997, BEKAEMPELSESMIDDELFO, V32; Parry HR, 2013, ENVIRON MODELL SOFTW, V45, P104, DOI 10.1016/j.envsoft.2012.08.006; Siriwardena GM, 1998, J APPL ECOL, V35, P24, DOI 10.1046/j.1365-2664.1998.00275.x; Smith Graham C., 2009, P53, DOI 10.1007/978-4-431-77134-0_4; Thorbek P, 2005, BIOCONTROL, V50, P1, DOI 10.1007/s10526-004-1114-8; Topping C, 2003, ANN ZOOL FENN, V40, P255; Topping C, 2005, VEGETATION GROWTH SI; Topping C, 2012, RELATIONSHIPS INSECT; Topping CJ, 2012, HUM ECOL RISK ASSESS, V18, P168, DOI 10.1080/10807039.2012.632292; Topping CJ, 2010, ECOL MODEL, V221, P245, DOI 10.1016/j.ecolmodel.2009.09.014; Topping CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045872; Topping CJ, 2011, ECOL ENG, V37, P2009, DOI 10.1016/j.ecoleng.2011.08.010; Topping CJ, 2010, ECOL MODEL, V221, P729, DOI 10.1016/j.ecolmodel.2009.11.004; Topping CJ, 2005, ECOTOXICOLOGY, V14, P925, DOI 10.1007/s10646-005-0027-3; Topping CJ, 2004, ENVIRON TOXICOL CHEM, V23, P509, DOI 10.1897/02-524a; Topping CJ, 2003, ECOL MODEL, V167, P65, DOI 10.1016/S0304-3800(03)00173-X; Vickery JA, 2004, BIOL CONSERV, V119, P19, DOI 10.1016/j.biocon.2003.06.004; Zurell D, 2010, OIKOS, V119, P622, DOI 10.1111/j.1600-0706.2009.18284.x; [No title captured]	39	16	16	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65803	10.1371/journal.pone.0065803	http://dx.doi.org/10.1371/journal.pone.0065803			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762430	Green Submitted, Green Published, gold			2022-12-27	WOS:000321099000108
J	Wu, X; Mao, QY; Yao, X; Chen, P; Chen, XM; Shao, J; Gao, F; Yu, X; Zhu, FC; Li, RC; Li, WH; Liang, ZL; Wang, JZ; Lu, FM				Wu, Xing; Mao, Qunying; Yao, Xin; Chen, Pan; Chen, Xiangmei; Shao, Jie; Gao, Fan; Yu, Xiang; Zhu, Fengcai; Li, Rongcheng; Li, Wenhui; Liang, Zhenglun; Wang, Junzhi; Lu, Fengmin			Development and Evaluation of a Pseudovirus-Luciferase Assay for Rapid and Quantitative Detection of Neutralizing Antibodies against Enterovirus 71	PLOS ONE			English	Article							COXSACKIEVIRUS A16; INFECTION; STRAINS; TAIWAN; ANTIGENICITY; IMMUNIZATION; VALIDATION; EPIDEMIC; PROTECTS; IMMUNITY	The level of neutralizing antibodies (NtAb) induced by vaccine inoculation is an important endpoint to evaluate the efficacy of EV71 vaccine. In order to evaluate the efficacy of EV71 vaccine, here, we reported the development of a novel pseudovirus system expression firefly luciferase (PVLA) for the quantitative measurement of NtAb. We first evaluated and validated the sensitivity and specificity of the PVLA method. A total of 326 serum samples from an epidemiological survey and 144 serum specimens from 3 clinical trials of EV71 vaccines were used, and the level of each specimen's neutralizing antibodies (NtAb) was measured in parallel using both the conventional CPE-based and PVLA-based assay. Against the standard neutralization assay based on the inhibition of the cytopathic effect (CPE), the sensitivity and specificity of the PVLA method are 98% and 96%, respectively. Then, we tested the potential interference of NtAb against hepatitis A virus, Polio-I, Polio-II, and Polio-III standard antisera (WHO) and goat anti-G10/CA16 serum, the PVLA based assay showed no cross-reactivity with NtAb against other specific sera. Importantly, unlike CPE based method, no live replication-competent EV71 is used during the measurement. Taken together, PVLA is a rapid and specific assay with higher sensitivity and accuracy. It could serve as a valuable tool in assessing the efficacy of EV71 vaccines in clinical trials and disease surveillance in epidemiology studies.	[Wu, Xing; Chen, Xiangmei; Lu, Fengmin] Peking Univ, Hlth Sci Ctr, Dept Microbiol, Beijing 100871, Peoples R China; [Wu, Xing; Chen, Xiangmei; Lu, Fengmin] Peking Univ, Hlth Sci Ctr, Ctr Infect Dis, Beijing 100871, Peoples R China; [Wu, Xing; Mao, Qunying; Yao, Xin; Shao, Jie; Gao, Fan; Liang, Zhenglun; Wang, Junzhi] Minist Hlth Res Qual & Standardizat Biotech Prod, Natl Inst Food & Drug Control, Dept Hepatitis Vaccine, Key Lab, Beijing, Peoples R China; [Chen, Pan; Li, Wenhui] Natl Inst Biol Sci, Beijing, Peoples R China; [Yu, Xiang] Hualan Biol Engn Inc, Xinxiang, Henan, Peoples R China; [Zhu, Fengcai] Jiangsu Prov Ctr Dis Prevent & Control, Nanjing, Jiangsu, Peoples R China; [Li, Rongcheng] Guangxi Zhuang Automomous Reg, Ctr Dis Control & Prevent, Nanning, Peoples R China	Peking University; Peking University; National Institute of Food & Drug Control - China; National Institute of Biological Sciences, Beijing; Chinese Center for Disease Control & Prevention	Liang, ZL (corresponding author), Minist Hlth Res Qual & Standardizat Biotech Prod, Natl Inst Food & Drug Control, Dept Hepatitis Vaccine, Key Lab, Beijing, Peoples R China.	lzlun@yahoo.com; lu.fengmin@hsc.pku.edu.cn		Li, Wenhui/0000-0003-1305-7404; Chen, Xiangmei/0000-0003-0302-6866	National Science Project [2008BAI69B01]; National 11th Five Major Special Projects Funding Program [2009ZX10004-804]	National Science Project; National 11th Five Major Special Projects Funding Program	The current study was sponsored by the National Science Project (No. 2008BAI69B01) and the National 11th Five Major Special Projects Funding Program (No. 2009ZX10004-804). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 2000, NEW ENGL J MED, V342, P355; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Cambron P, 2009, CLIN VACCINE IMMUNOL, V16, P1236, DOI 10.1128/CVI.00431-08; Chang Luan-Yin, 2008, Pediatrics and Neonatology, V49, P103, DOI 10.1016/S1875-9572(08)60023-6; Chang LY, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e88; Chang LY, 1999, PEDIATR INFECT DIS J, V18, P1092, DOI 10.1097/00006454-199912000-00013; Chen P, 2012, J BIOL CHEM, V287, P6406, DOI 10.1074/jbc.M111.301622; Chen YX, 2013, VACCINE, V31, P425, DOI 10.1016/j.vaccine.2012.10.032; Chung YC, 2008, VACCINE, V26, P1855, DOI 10.1016/j.vaccine.2008.01.058; Earl PL, 2003, J VIROL, V77, P10684, DOI 10.1128/JVI.77.19.10684-10688.2003; Findlay JWA, 2000, J PHARMACEUT BIOMED, V21, P1249, DOI 10.1016/S0731-7085(99)00244-7; Guang D, 2007, VIRUS RES, V125, P61, DOI 10.1016/j.virusres.2006.12.005; Hsu CH, 2011, J MICROBIOL IMMUNOL, V44, P265, DOI 10.1016/j.jmii.2011.01.029; Huang ML, 2010, J VIROL METHODS, V165, P42, DOI 10.1016/j.jviromet.2009.12.015; Kung SH, 2007, CLIN MICROBIOL INFEC, V13, P782, DOI 10.1111/j.1469-0691.2007.01745.x; Liu CC, 2007, VACCINE, V25, P19, DOI 10.1016/j.vaccine.2006.06.083; Liu CC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020005, 10.1371/journal.pone.0021464]; Mao QY, 2010, CHINESE MED J-PEKING, V123, P1679, DOI 10.3760/cma.j.issn.0366-6999.2010.13.012; Mao QY, 2012, ARCH VIROL, V157, P37, DOI 10.1007/s00705-011-1136-3; Mizuta K, 2009, VACCINE, V27, P3153, DOI 10.1016/j.vaccine.2009.03.060; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Oberste MS, 2004, J GEN VIROL, V85, P1597, DOI 10.1099/vir.0.79789-0; Qiu J, 2008, LANCET NEUROL, V7, P868, DOI 10.1016/S1474-4422(08)70207-2; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Sprangers MC, 2003, J CLIN MICROBIOL, V41, P5046, DOI 10.1128/JCM.41.11.5046-5052.2003; Wu CN, 2001, VACCINE, V20, P895, DOI 10.1016/S0264-410X(01)00385-1; Wu TC, 2007, J VIROL, V81, P10310, DOI 10.1128/JVI.00372-07; Wu XL, 2009, J MED VIROL, V81, P693, DOI 10.1002/jmv.21435; Yao Xin, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P729; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002	30	45	49	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64116	10.1371/journal.pone.0064116	http://dx.doi.org/10.1371/journal.pone.0064116			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755115	Green Published, gold, Green Submitted			2022-12-27	WOS:000320579400008
J	De Sanctis, T; Tarantino, V; Straulino, E; Begliomini, C; Castiello, U				De Sanctis, Teresa; Tarantino, Vincenza; Straulino, Elisa; Begliomini, Chiara; Castiello, Umberto			Co-Registering Kinematics and Evoked Related Potentials during Visually Guided Reach-to-Grasp Movements	PLOS ONE			English	Article							ANTERIOR INTRAPARIETAL SULCUS; CONTINGENT NEGATIVE-VARIATION; VENTRAL PREMOTOR AREA; 2 CORTICAL SYSTEMS; MACAQUE MONKEY; PARIETAL CORTEX; PREHENSION MOVEMENTS; FUNCTIONAL-PROPERTIES; VISUOMOTOR CONTROL; PRAXIS MOVEMENTS	Background: In non-human primates grasp-related sensorimotor transformations are accomplished in a circuit involving the anterior intraparietal sulcus (area AIP) and both the ventral and the dorsal sectors of the premotor cortex (vPMC and dPMC, respectively). Although a human homologue of such a circuit has been identified, the time course of activation of these cortical areas and how such activity relates to specific kinematic events has yet to be investigated. Methodology/Principal Findings: We combined kinematic and event-related potential techniques to explicitly test how activity within human grasping-related brain areas is modulated in time. Subjects were requested to reach towards and grasp either a small stimulus using a precision grip (i.e., the opposition of index finger and thumb) or a large stimulus using a whole hand grasp (i.e., the flexion of all digits around the stimulus). Results revealed a time course of activation starting at the level of parietal regions and continuing at the level of premotor regions. More specifically, we show that activity within these regions was tuned for specific grasps well before movement onset and this early tuning was carried over - as evidenced by kinematic analysis - during the preshaping period of the task. Conclusions/Significance: Data are discussed in terms of recent findings showing a marked differentiation across different grasps during premovement phases which was carried over into subsequent movement phases. These findings offer a substantial contribution to the current debate about the nature of the sensorimotor transformations underlying grasping. And provide new insights into the detailed movement information contained in the human preparatory activity for specific hand movements.	[De Sanctis, Teresa; Tarantino, Vincenza; Straulino, Elisa; Begliomini, Chiara; Castiello, Umberto] Univ Padua, Dept Gen Psychol, Padua, Italy	University of Padua	Castiello, U (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	umberto.castiello@unipd.it	BEGLIOMINI, CHIARA/D-1516-2014	BEGLIOMINI, CHIARA/0000-0001-7433-0414; Castiello, Umberto/0000-0003-0629-1286; Tarantino, Vincenza/0000-0002-5836-3811	Italian Ministry of University and Research [2008YTNXXZ]	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by the Italian Ministry of University and Research (Grant Number- 2008YTNXXZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battaglia-Mayer A, 2003, CEREB CORTEX, V13, P1009, DOI 10.1093/cercor/13.10.1009; Battaglini PP, 2002, EXP BRAIN RES, V144, P419, DOI 10.1007/s00221-002-1099-4; Begliomini C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001108; Begliomini C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003388; Berthier NE, 1996, J MOTOR BEHAV, V28, P187, DOI 10.1080/00222895.1996.9941744; Binkofski F, 1998, NEUROLOGY, V50, P1253, DOI 10.1212/WNL.50.5.1253; Bozzacchi C, 2012, BIOL PSYCHOL, V89, P503, DOI 10.1016/j.biopsycho.2011.12.020; Brochier T, 2004, J NEUROPHYSIOL, V92, P1770, DOI 10.1152/jn.00976.2003; Brochier T, 2007, CURR OPIN NEUROBIOL, V17, P637, DOI 10.1016/j.conb.2007.12.002; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; Castiello U, 1996, J EXP PSYCHOL HUMAN, V22, P582, DOI 10.1037/0096-1523.22.3.582; CASTIELLO U, 1993, EXP BRAIN RES, V94, P163; Castiello U, 2008, NEUROSCIENTIST, V14, P157, DOI 10.1177/1073858407312080; Cavina-Pratesi C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000424; Cavina-Pratesi C, 2010, J NEUROSCI, V30, P10306, DOI 10.1523/JNEUROSCI.2023-10.2010; Chapman H, 2002, EUR J NEUROSCI, V15, P2037, DOI 10.1046/j.1460-9568.2002.02021.x; CHIEFFI S, 1993, EXP BRAIN RES, V94, P471; Connolly JD, 2003, EXP BRAIN RES, V153, P140, DOI 10.1007/s00221-003-1587-1; Culham JC, 2006, CURR OPIN NEUROBIOL, V16, P205, DOI 10.1016/j.conb.2006.03.005; Culham JC, 2003, EXP BRAIN RES, V153, P180, DOI 10.1007/s00221-003-1591-5; Culham JC, 2006, NEUROPSYCHOLOGIA, V44, P2668, DOI 10.1016/j.neuropsychologia.2005.11.003; Davare M, 2006, J NEUROSCI, V26, P2260, DOI 10.1523/JNEUROSCI.3386-05.2006; Davare M, 2007, J NEUROSCI, V27, P3974, DOI 10.1523/JNEUROSCI.0426-07.2007; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Ehrsson HH, 2000, J NEUROPHYSIOL, V83, P528, DOI 10.1152/jn.2000.83.1.528; Ehrsson HH, 2002, J NEUROSCI, V22, P5074, DOI 10.1523/JNEUROSCI.22-12-05074.2002; Fagg AH, 1998, NEURAL NETWORKS, V11, P1277, DOI 10.1016/S0893-6080(98)00047-1; Faillenot I, 1997, CEREB CORTEX, V7, P77, DOI 10.1093/cercor/7.1.77; Fattori P, 2001, EUR J NEUROSCI, V13, P2309, DOI 10.1046/j.0953-816x.2001.01618.x; Fattori P, 2010, J NEUROSCI, V30, P342, DOI 10.1523/JNEUROSCI.3800-09.2010; Fattori P, 2009, J NEUROSCI, V29, P1928, DOI 10.1523/JNEUROSCI.4998-08.2009; Filimon F, 2010, NEUROSCIENTIST, V16, P388, DOI 10.1177/1073858410375468; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Frey SH, 2005, COGNITIVE BRAIN RES, V23, P397, DOI 10.1016/j.cogbrainres.2004.11.010; GAILLARD AWK, 1977, PSYCHOPHYSIOLOGY, V14, P563, DOI 10.1111/j.1469-8986.1977.tb01200.x; Gallivan JP, 2011, J NEUROSCI, V31, P9599, DOI 10.1523/JNEUROSCI.0080-11.2011; GENTILUCCI M, 1991, NEUROPSYCHOLOGIA, V29, P361, DOI 10.1016/0028-3932(91)90025-4; GODSCHALK M, 1981, EXP BRAIN RES, V44, P113; GORDON AM, 1994, NEUROPSYCHOLOGIA, V32, P555, DOI 10.1016/0028-3932(94)90144-9; Grafton ST, 2010, EXP BRAIN RES, V204, P475, DOI 10.1007/s00221-010-2315-2; Grafton ST, 1996, CEREB CORTEX, V6, P226, DOI 10.1093/cercor/6.2.226; Gregoriou GG, 2003, NEUROIMAGE, V19, P959, DOI 10.1016/S1053-8119(03)00176-9; Grol MJ, 2007, J NEUROSCI, V27, P11877, DOI 10.1523/JNEUROSCI.3923-07.2007; JAKOBSON LS, 1991, EXP BRAIN RES, V86, P199; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; JEANNEROD M, 1984, J MOTOR BEHAV, V16, P235; Jeannerod M., 1981, ATTENTION PERFORM, P153; Jung TP, 2000, CLIN NEUROPHYSIOL, V111, P1745, DOI 10.1016/S1388-2457(00)00386-2; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kalaska JF, 1997, CURR OPIN NEUROBIOL, V7, P849, DOI 10.1016/S0959-4388(97)80146-8; KOK A, 1986, BIOL PSYCHOL, V23, P21, DOI 10.1016/0301-0511(86)90087-6; Kourtis D, 2012, PSYCHOL RES-PSYCH FO, V76, P514, DOI 10.1007/s00426-012-0418-z; Kroliczak G, 2007, J NEUROPHYSIOL, V97, P2410, DOI 10.1152/jn.00778.2006; Leuthold H, 2004, J PSYCHOPHYSIOL, V18, P77, DOI 10.1027/0269-8803.18.23.77; Leuthold H, 2009, PSYCHOPHYSIOLOGY, V46, P539, DOI 10.1111/j.1469-8986.2009.00799.x; Loveless N E, 1974, Biol Psychol, V1, P303, DOI 10.1016/0301-0511(74)90005-2; MOLL L, 1977, SCIENCE, V198, P317, DOI 10.1126/science.410103; Muller-Gethmann H, 2000, PSYCHOPHYSIOLOGY, V37, P507, DOI 10.1111/1469-8986.3740507; Murata A, 1997, J NEUROPHYSIOL, V78, P2226, DOI 10.1152/jn.1997.78.4.2226; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olivier E, 2007, CURR OPIN NEUROBIOL, V17, P644, DOI 10.1016/j.conb.2008.01.008; PASSINGHAM RE, 1987, CIBA F SYMP, V132, P151; Prado J, 2005, NEURON, V48, P849, DOI 10.1016/j.neuron.2005.10.010; Raos V, 2006, J NEUROPHYSIOL, V95, P709, DOI 10.1152/jn.00463.2005; Raos V, 2004, J NEUROPHYSIOL, V92, P1990, DOI 10.1152/jn.00154.2004; Rice NJ, 2006, J NEUROSCI, V26, P8176, DOI 10.1523/JNEUROSCI.1641-06.2006; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Rohrbaugh J.W., 1983, TUTORIALS ERP RES EN, P269, DOI 10.1016/S0166-4115(08)62044-0; Shibasaki H, 2006, CLIN NEUROPHYSIOL, V117, P2341, DOI 10.1016/j.clinph.2006.04.025; Smeets JBJ, 1999, MOTOR CONTROL, V3, P237, DOI 10.1123/mcj.3.3.237; TAIRA M, 1990, EXP BRAIN RES, V83, P29; Tunik E, 2007, NEUROIMAGE, V36, pT77, DOI 10.1016/j.neuroimage.2007.03.026; Umilta MA, 2007, J NEUROPHYSIOL, V98, P488, DOI 10.1152/jn.01094.2006; Verhagen L, 2012, J NEUROSCI, V32, P4508, DOI 10.1523/JNEUROSCI.5451-11.2012; WALTER W G, 1964, Arch Psychiatr Nervenkr, V206, P309, DOI 10.1007/BF00341700; WEINRICH M, 1982, J NEUROSCI, V2, P1329; Wheaton LA, 2005, EXP BRAIN RES, V163, P535, DOI 10.1007/s00221-005-2314-x; Wheaton LA, 2005, CLIN NEUROPHYSIOL, V116, P1201, DOI 10.1016/j.clinph.2005.01.001; Xiao J, 2006, EXP BRAIN RES, V168, P106, DOI 10.1007/s00221-005-0074-2; Zaepffel M, 2012, PSYCHOPHYSIOLOGY, V49, P17, DOI 10.1111/j.1469-8986.2011.01277.x	83	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65508	10.1371/journal.pone.0065508	http://dx.doi.org/10.1371/journal.pone.0065508			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755241	Green Published, Green Submitted, gold			2022-12-27	WOS:000319872300085
J	Karasawa, T; Sibrian-Vazquez, M; Strongin, RM; Steyger, PS				Karasawa, Takatoshi; Sibrian-Vazquez, Martha; Strongin, Robert M.; Steyger, Peter S.			Identification of Cisplatin-Binding Proteins Using Agarose Conjugates of Platinum Compounds	PLOS ONE			English	Article							INDUCED OTOTOXICITY; CHAPERONE-ACTIVITY; STATISTICAL-MODEL; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; HAIR-CELLS; DNA; CHILDREN; CANCER; CARBOPLATIN	Cisplatin is widely used as an antineoplastic drug, but its ototoxic and nephrotoxic side-effects, as well as the inherent or acquired resistance of some cancers to cisplatin, remain significant clinical problems. Cisplatin's selectivity in killing rapidly proliferating cancer cells is largely dependent on covalent binding to DNA via cisplatin's chloride sites that had been aquated. We hypothesized that cisplatin's toxicity in slowly proliferating or terminally differentiated cells is primarily due to drug-protein interactions, instead of drug-DNA binding. To identify proteins that bind to cisplatin, we synthesized two different platinum-agarose conjugates, one with two amino groups and another with two chlorides attached to platinum that are available for protein binding, and conducted pull-down assays using cochlear and kidney cells. Mass spectrometric analysis on protein bands after gel electrophoresis and Coomassie blue staining identified several proteins, including myosin IIA, glucose-regulated protein 94 (GRP94), heat shock protein 90 (HSP90), calreticulin, valosin containing protein (VCP), and ribosomal protein L5, as cisplatin-binding proteins. Future studies on the interaction of these proteins with cisplatin will elucidate whether these drug-protein interactions are involved in ototoxicity and nephrotoxicity, or contribute to tumor sensitivity or resistance to cisplatin treatment.	[Karasawa, Takatoshi; Steyger, Peter S.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA; [Sibrian-Vazquez, Martha; Strongin, Robert M.] Portland State Univ, Dept Chem, Portland, OR 97207 USA	Oregon Health & Science University; Portland State University	Karasawa, T (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA.	karasawa@ohsu.edu	Strongin, Robert M./F-1026-2010; Steyger, Peter S./B-9147-2011	Steyger, Peter S./0000-0002-6103-5237	National Institute on Deafness and Other Communication Disorders at the National Institutes of Health [R21 DC010231]; Medical Research Foundation of Oregon; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC010231] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Medical Research Foundation of Oregon; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institute on Deafness and Other Communication Disorders at the National Institutes of Health (R21 DC010231) and Medical Research Foundation of Oregon grants to P.S.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acs K, 2011, NAT STRUCT MOL BIOL, V18, P1345, DOI 10.1038/nsmb.2188; APPLETON TG, 1970, INORG CHEM, V9, P1800, DOI 10.1021/ic50090a005; Argon Y, 1999, SEMIN CELL DEV BIOL, V10, P495, DOI 10.1006/scdb.1999.0320; Baliga R, 1999, DRUG METAB REV, V31, P971, DOI 10.1081/DMR-100101947; Benoist E, 1998, SYNTHESIS-STUTTGART, P1113; Bess FH, 1998, EAR HEARING, V19, P339, DOI 10.1097/00003446-199810000-00001; Campbell KCM, 1996, HEARING RES, V102, P90, DOI 10.1016/S0378-5955(96)00152-9; Casini A, 2007, CHEM COMMUN, P156, DOI 10.1039/b611122j; Chen XZ, 2010, ASIAN J CHEM, V22, P6493; Chinnaswamy G, 2008, BRIT J CANCER, V99, P894, DOI 10.1038/sj.bjc.6604612; Dickey DT, 2005, J PHARMACOL EXP THER, V314, P1052, DOI 10.1124/jpet.105.087601; Einhorn LH, 2002, P NATL ACAD SCI USA, V99, P4592, DOI 10.1073/pnas.072067999; Espreafico EM, 1998, P NATL ACAD SCI USA, V95, P8636, DOI 10.1073/pnas.95.15.8636; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; FICHTINGERSCHEPMAN AMJ, 1985, BIOCHEMISTRY-US, V24, P707, DOI 10.1021/bi00324a025; Francis SP, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.76; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Helliwell JR, 2013, ACTA CRYSTALLOGR D, V69, P121, DOI 10.1107/S090744491204423X; HILL JM, 1982, ANTICANCER RES, V2, P173; Horibe T, 2004, BIOCHEM BIOPH RES CO, V323, P281, DOI 10.1016/j.bbrc.2004.08.099; HUANG HF, 1995, SCIENCE, V270, P1842, DOI 10.1126/science.270.5243.1842; Ishida R, 2008, FEBS LETT, V582, P3879, DOI 10.1016/j.febslet.2008.10.029; ISHIKAWA T, 1993, J BIOL CHEM, V268, P20116; Itoh H, 1999, BIOCHEM J, V343, P697, DOI 10.1042/0264-6021:3430697; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Jiang CC, 2009, CARCINOGENESIS, V30, P197, DOI 10.1093/carcin/bgn220; Kalinec GM, 2003, AUDIOL NEURO-OTOL, V8, P177, DOI 10.1159/000071059; Karasawa T, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.80; Karasawa T, 2008, J CELL SCI, V121, P2871, DOI 10.1242/jcs.023705; Karasawa T, 2011, TOXICOL SCI, V124, P378, DOI 10.1093/toxsci/kfr196; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Knight KRG, 2005, J CLIN ONCOL, V23, P8588, DOI 10.1200/JCO.2004.00.5355; Knight KR, 2007, J CLIN ONCOL, V25, P1190, DOI 10.1200/JCO.2006.07.9723; KNOX RJ, 1986, CANCER RES, V46, P1972; KOCH G, 1986, J CELL SCI, V86, P217; Kopke RD, 1997, AM J OTOL, V18, P559; Lai MD, 2007, CURR GENOMICS, V8, P43; Lalwani AK, 2000, AM J HUM GENET, V67, P1121, DOI 10.1016/S0002-9297(07)62942-5; Lalwani AK, 2008, BRAIN RES, V1197, P13, DOI 10.1016/j.brainres.2007.12.058; Lin YD, 2011, LUNG CANCER, V71, P291, DOI 10.1016/j.lungcan.2010.06.004; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035800; Molenaar C, 2000, J BIOL INORG CHEM, V5, P655, DOI 10.1007/s007750000153; Mukherjea D, 2011, ANTIOXID REDOX SIGN, V14, P999, DOI 10.1089/ars.2010.3497; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Priqueler JRL, 2006, APPL SPECTROSC REV, V41, P185, DOI 10.1080/05704920600620311; Qaddoumi I, 2012, J CLIN ONCOL, V30, P1034, DOI 10.1200/JCO.2011.36.9744; Ramesh G, 2005, AM J PHYSIOL-RENAL, V289, pF166, DOI 10.1152/ajprenal.00401.2004; Seri M, 2000, NAT GENET, V26, P103; Skinner R, 1998, BRIT J CANCER, V77, P1677, DOI 10.1038/bjc.1998.276; TAKAHARA PM, 1995, NATURE, V377, P649, DOI 10.1038/377649a0; Thomas JP, 2006, MOL PHARMACOL, V70, P23, DOI 10.1124/mol.106.022244; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Valle CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029073; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wilmarth Phillip A, 2009, J Ocul Biol Dis Infor, V2, P223	55	39	39	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e66220	10.1371/journal.pone.0066220	http://dx.doi.org/10.1371/journal.pone.0066220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755301	Green Published, gold, Green Submitted			2022-12-27	WOS:000319872300104
J	Vera-Cabrera, L; Ortiz-Lopez, R; Elizondo-Gonzalez, R; Ocampo-Candiani, J				Vera-Cabrera, Lucio; Ortiz-Lopez, Rocio; Elizondo-Gonzalez, Ramiro; Ocampo-Candiani, Jorge			Complete Genome Sequence Analysis of Nocardia brasiliensis HUJEG-1 Reveals a Saprobic Lifestyle and the Genes Needed for Human Pathogenesis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PHOSPHOLIPASE-C; CELL-WALL; IN-VITRO; SUPEROXIDE-DISMUTASE; ACTINOMYCETOMA; SUSCEPTIBILITY; IDENTIFICATION; BIOGENESIS; RESISTANCE	Nocardia brasiliensis is an important etiologic agent of mycetoma. These bacteria live as a saprobe in soil or organic material and enter the tissue via minor trauma. Mycetoma is characterized by tumefaction and the production of fistula and abscesses, with no spontaneous cure. By using mass sequencing, we determined the complete genomic nucleotide sequence of the bacteria. According to our data, the genome is a circular chromosome 9,436,348-bp long with 68% G+C content that encodes 8,414 proteins. We observed orthologs for virulence factors, a higher number of genes involved in lipid biosynthesis and catabolism, and gene clusters for the synthesis of bioactive compounds, such as antibiotics, terpenes, and polyketides. An in silico analysis of the sequence supports the conclusion that the bacteria acquired diverse genes by horizontal transfer from other soil bacteria, even from eukaryotic organisms. The genome composition reflects the evolution of bacteria via the acquisition of a large amount of DNA, which allows it to survive in new ecological niches, including humans.	[Vera-Cabrera, Lucio; Ocampo-Candiani, Jorge] Univ Nacl Colombia, Univ Hosp, Serv Dermatol, Lab Interdisciplinario Invest Dermatol, Monterrey, NL, Mexico; [Ortiz-Lopez, Rocio] Univ Autonoma Nuevo Leon, Dept Bioquim & Med Mol, Monterrey, NL, Mexico; [Ortiz-Lopez, Rocio; Elizondo-Gonzalez, Ramiro] Univ Autonoma Nuevo Leon, Ctr Invest & Desarrollo Ciencias Salud, Monterrey, NL, Mexico	Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Universidad Autonoma de Nuevo Leon; Universidad Autonoma de Nuevo Leon	Vera-Cabrera, L (corresponding author), Univ Nacl Colombia, Univ Hosp, Serv Dermatol, Lab Interdisciplinario Invest Dermatol, Monterrey, NL, Mexico.	drluciovera@yahoo.com	Ocampo-Candiani, Jorge/B-6853-2015; Ortiz-Lopez, Rocio/N-4827-2018; Vera-Cabrera, Lucio/AAM-3641-2020; Ortiz-Lopez, Rocio/F-7020-2014	Ocampo-Candiani, Jorge/0000-0002-0213-0031; Ortiz-Lopez, Rocio/0000-0002-7783-026X; Vera-Cabrera, Lucio/0000-0002-0890-9660; Ortiz-Lopez, Rocio/0000-0002-7783-026X	CONACYT grant [155892]	CONACYT grant(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	CONACYT grant No. 155892. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038567; Al Akhrass F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032945; Almaguer-Chavez JA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-290; ARRUDA S, 1993, SCIENCE, V261, P1454, DOI 10.1126/science.8367727; Aziz RK, 2010, NUCLEIC ACIDS RES, V38, P4207, DOI 10.1093/nar/gkq140; Barkan D, 2012, INFECT IMMUN, V80, P1958, DOI 10.1128/IAI.00021-12; BEAMAN BL, 1985, INFECT IMMUN, V47, P135, DOI 10.1128/IAI.47.1.135-141.1985; Beisson F, 2012, NAT CHEM BIOL, V8, P603, DOI 10.1038/nchembio.1004; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; BORODOVSKY M, 1993, COMPUT CHEM, V17, P123, DOI 10.1016/0097-8485(93)85004-V; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Brown-Elliott BA, 2006, CLIN MICROBIOL REV, V19, P259, DOI 10.1128/CMR.19.2.259-282.2006; Bryant AE, 2000, J INFECT DIS, V182, P808, DOI 10.1086/315757; Chitale S, 2001, CELL MICROBIOL, V3, P247, DOI 10.1046/j.1462-5822.2001.00110.x; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Crawford JT, 2003, INT J TUBERC LUNG D, V7, pS453; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Doroghazi JR, 2010, ISME J, V4, P1136, DOI 10.1038/ismej.2010.45; Fairman JW, 2012, STRUCTURE, V20, P1233, DOI 10.1016/j.str.2012.04.011; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Gebhardt H, 2007, MICROBIOL-SGM, V153, P1424, DOI 10.1099/mic.0.2006/003541-0; Giguere S, 2011, J VET INTERN MED, V25, P1221, DOI 10.1111/j.1939-1676.2011.00804.x; Gioffre A, 2005, MICROBES INFECT, V7, P325, DOI 10.1016/j.micinf.2004.11.007; Gomez-Flores A, 2004, ANTIMICROB AGENTS CH, V48, P832, DOI 10.1128/AAC.48.3.832-837.2004; Gonzalez-Burgos E, 2012, CURR MED CHEM; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Hatfull GF, 2010, ANNU REV MICROBIOL, V64, P331, DOI 10.1146/annurev.micro.112408.134233; Hayashi Y, 2008, J ANTIBIOT, V61, P164, DOI 10.1038/ja.2008.126; HOPWOOD DA, 1990, ANNU REV GENET, V24, P37, DOI 10.1146/annurev.ge.24.120190.000345; Trevino-Villarreal JH, 2012, INFECT IMMUN, V80, P3587, DOI 10.1128/IAI.00446-12; Ishikawa J, 2004, P NATL ACAD SCI USA, V101, P14925, DOI 10.1073/pnas.0406410101; Kaltenpoth M, 2012, APPL ENVIRON MICROB, V78, P822, DOI 10.1128/AEM.06809-11; Lai CC, 2011, ANTIMICROB AGENTS CH, V55, P2084, DOI 10.1128/AAC.01808-10; Larruskain J, 2011, ANTIMICROB AGENTS CH, V55, P2995, DOI 10.1128/AAC.01279-10; Licon-Trillo A, 2003, FEMS IMMUNOL MED MIC, V37, P37, DOI 10.1016/S0928-8244(03)00102-0; Liu H, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00013; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Martinez-Reyes A, 2008, REV MED UV, V8, P19; McLean KJ, 2002, MICROBIOL-SGM, V148, P2937, DOI 10.1099/00221287-148-10-2937; Mendez C, 2001, RES MICROBIOL, V152, P341, DOI 10.1016/S0923-2508(01)01205-0; Mikami Yuzuru, 2010, Nihon Ishinkin Gakkai Zasshi, V51, P179; MISHRA SK, 1980, J CLIN MICROBIOL, V11, P728, DOI 10.1128/JCM.11.6.728-736.1980; N'Goma JCB, 2010, BBA-MOL CELL BIOL L, V1801, P1305, DOI 10.1016/j.bbalip.2010.08.007; Ni B, 2012, APPL MICROBIOL BIOTE; Perez-Pantoja D, 2012, ENVIRON MICROBIOL, V14, P1091, DOI 10.1111/j.1462-2920.2011.02613.x; Revol A, 2006, CAN J MICROBIOL, V52, P1255, DOI 10.1139/W06-075; Santos CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046758; Seo KS, 2012, INFECT IMMUN, V80, P3559, DOI 10.1128/IAI.00294-12; Stackebrandt E, 1997, INT J SYST BACTERIOL, V47, P479, DOI 10.1099/00207713-47-2-479; Strieker M, 2010, CURR OPIN STRUC BIOL, V20, P234, DOI 10.1016/j.sbi.2010.01.009; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Trost E, 2012, J BACTERIOL, V194, P3199, DOI 10.1128/JB.00183-12; Ubhayasekera Wimal, 2012, BMC Res Notes, V5, P581, DOI 10.1186/1756-0500-5-581; Vera-Cabrera L, 1999, J CLIN MICROBIOL, V37, P1971, DOI 10.1128/JCM.37.6.1971-1976.1999; Vera-Cabrera L, 2012, ANTIMICROB AGENTS CH, V56, P3984, DOI 10.1128/AAC.00115-12; Vera-Cabrera L, 2012, J BACTERIOL, V194, P2761, DOI 10.1128/JB.00210-12; Vera-Cabrera L, 2010, ANTIMICROB AGENTS CH, V54, P2191, DOI 10.1128/AAC.01520-09; Visca P, 2007, TRENDS MICROBIOL, V15, P22, DOI 10.1016/j.tim.2006.11.004; Waksman SA, 2010, ANN NY ACAD SCI, V1213, P112, DOI 10.1111/j.1749-6632.2010.05861.x; WALLACE RJ, 1988, ANTIMICROB AGENTS CH, V32, P1776, DOI 10.1128/AAC.32.12.1776; Wargo MJ, 2011, AM J RESP CRIT CARE, V184, P345, DOI 10.1164/rccm.201103-0374OC; Welsh O, 2012, CLIN DERMATOL, V30, P372, DOI 10.1016/j.clindermatol.2011.06.027; Welsh O, 2011, INT J DERMATOL, V50, P854, DOI 10.1111/j.1365-4632.2011.04874.x; Wilson JW, 2012, MAYO CLIN PROC, V87, P403, DOI 10.1016/j.mayocp.2011.11.016; Wu G, 2006, ANTON LEEUW INT J G, V89, P135, DOI 10.1007/s10482-005-9016-z; Zoropogui A, 2012, J BACTERIOL, V194, P2098, DOI 10.1128/JB.00161-12	68	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65425	10.1371/journal.pone.0065425	http://dx.doi.org/10.1371/journal.pone.0065425			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755230	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000319872300080
J	Vogel, JP; Souza, JP; Gulmezoglu, AM				Vogel, Joshua P.; Souza, Joao Paulo; Gulmezoglu, A. Metin			Patterns and Outcomes of Induction of Labour in Africa and Asia: A Secondary Analysis of the WHO Global Survey on Maternal and Neonatal Health	PLOS ONE			English	Article							ELECTIVE INDUCTION	Background: Labour induction should be performed where benefit outweighs potential harm, however epidemiology of induction in lower-income countries is not well described. We used the WHO Global Survey dataset to describe the epidemiology and outcomes of labour induction in 192,538 deliveries in 253 facilities across 16 countries in Africa and Asia. Methods: Data was analyzed separately for Africa and Asia. Prevalence of indications, methods, success and characteristics associated with labour induction were determined. Multilevel logistic regression was used to determine the relationship between induction (with medical indication and elective) and maternal/perinatal outcomes. Results: Induction accounted for 4.4% (Africa) and 12.1% (Asia) of deliveries. Oxytocin alone was the most common method (45.9% and 37.5%) and success rates were generally over 80%. Medically indicated inductions were associated with increased adjusted odds of Apgar <7 at 5 minutes, low birthweight, NICU admission and fresh stillbirth in both regions. The odds of caesarean section in Africa were reduced (Adj OR 0.61, 95% CI 0.42-0.88). Elective induction was associated with increased adjusted odds of NICU (Africa) and ICU (Asia) admissions. Discussion: Induction was generally less common than in higher-income countries. Prostaglandin use was uncommon despite evidence supporting use. Induction for medical indications may be associated with poorer outcomes due to maternal baseline risks. Despite one-third of elective inductions occurring at <39 weeks, the risk of maternal, fetal and neonatal mortality was not elevated following elective inductions.	[Vogel, Joshua P.] Univ Western Australia, Sch Populat Hlth, Fac Med, Dent & Hlth Sci, Perth, WA 6009, Australia; [Vogel, Joshua P.; Souza, Joao Paulo; Gulmezoglu, A. Metin] WHO, UNDP UNFPA UNICEF WHO World Bank Special Programm, Dev & Res Training Human Reprod HRP, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland	University of Western Australia; The World Bank; United Nations Population Fund; World Health Organization	Vogel, JP (corresponding author), Univ Western Australia, Sch Populat Hlth, Fac Med, Dent & Hlth Sci, Perth, WA 6009, Australia.	vogeljo@who.int	Souza, João Paulo/G-1982-2010; Vogel, Joshua/K-7649-2019	Souza, João Paulo/0000-0002-2288-4244; Vogel, Joshua/0000-0002-3214-7096	Australian Postgraduate Award; A & A Saw Scholarship; Government of China; Government of India; Government of Japan; United States Agency for International Development (USAID)	Australian Postgraduate Award(Australian Government); A & A Saw Scholarship; Government of China; Government of India; Government of Japan; United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	JPV is supported by an Australian Postgraduate Award and the A & A Saw Scholarship. The WHO Global Survey on Maternal and Perinatal Health was funded by the Governments of China, India and Japan, and the United States Agency for International Development (USAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Obstetricians and Gynecologists, 2009, OBSTET GYNECOL, P386; Blanchard K, 2002, OBSTET GYNECOL, V99, P316, DOI 10.1016/S0029-7844(01)01701-X; Bukola F, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-722; Cunningham F, 2009, WILLIAMS OBSTET, V23rd; Fernandez MM, 2009, INT J GYNECOL OBSTET, V105, P180, DOI 10.1016/j.ijgo.2008.12.016; Gibbons L, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.02.026; Guerra GV, 2009, BJOG-INT J OBSTET GY, V116, P1762, DOI 10.1111/j.1471-0528.2009.02348.x; Guerra GV, 2011, B WORLD HEALTH ORGAN, V89, P657, DOI 10.2471/BLT.08.061226; Gulmezoglu A, 2012, COCHRANE DB SYST REV; IBM Corporation, PASW STAT 20; Induction of Labour, 2008, IND LAB; Laughon SK, 2012, AM J OBSTET GYNECOL, V206, pS47, DOI 10.1016/j.ajog.2012.03.014; Lydon-Rochelle MT, 2007, MED CARE, V45, P505, DOI 10.1097/MLR.0b013e3180330e26; MACER JA, 1992, AM J OBSTET GYNECOL, V166, P1690, DOI 10.1016/0002-9378(92)91558-R; Mozurkewich E, 2009, BJOG-INT J OBSTET GY, V116, P626, DOI 10.1111/j.1471-0528.2008.02065.x; Nicholson J, 2007, ANN FAM MED; Rathnayake R, 2010, SRI LANKA J OBSTET G, V31, P97; Rayburn WF, 2002, OBSTET GYNECOL, V100, P164, DOI 10.1016/S0029-7844(02)02047-1; Reddy UM, 2011, OBSTET GYNECOL, V117, P1279, DOI 10.1097/AOG.0b013e3182179e28; Sanchez-Ramos L, 2005, OBSTET GYN CLIN N AM, V32, P181, DOI 10.1016/j.ogc.2004.12.004; Senanayake H, 2011, BJOG-INT J OBSTET GY, V118, P78, DOI 10.1111/j.1471-0528.2011.03115.x; Shah A, 2008, B WORLD HEALTH ORGAN, V86, P126, DOI 10.2471/BLT.06.039842; Souza JP, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-71; Stock SJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2838; WHO, 2011, WHO REC IND LAB; Yeast JD, 1999, AM J OBSTET GYNECOL, V180, P628, DOI 10.1016/S0002-9378(99)70265-6; Zhang J, 2002, J REPROD MED, V47, P120	27	61	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65612	10.1371/journal.pone.0065612	http://dx.doi.org/10.1371/journal.pone.0065612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755259	gold, Green Published			2022-12-27	WOS:000319872300087
J	Yang, YF; Gu, CQ; Liao, YH; Luo, QP; Hu, XY; Zhang, WP; Shao, HB; Cheng, GF				Yang, Yifei; Gu, Changqin; Liao, Yonghong; Luo, Qingping; Hu, Xueying; Zhang, Wanpo; Shao, Huabin; Cheng, Guofu			Protein Expressions and Their Immunogenicity from Riemerella anatipestifer Cultured in Iron Restriction Medium	PLOS ONE			English	Article							LEUCINE-RICH REPEAT; IMMOBILIZED PH GRADIENTS; 2-DIMENSIONAL ELECTROPHORESIS; IDENTIFICATION; SEQUENCE; ANTIGENS; GENES; MOTIF	Riemerella anatipestifer was cultured in both iron restriction media and normal media. Two-dimensional gel electrophoresis identified 23 proteins that significantly increased in the iron restriction media. Of them 12 proteins were analyzed with mass spectrography. Nine of 12 proteins belong to 6 different protein families: fibronectin type iii domain protein, secreted subtilase family protein, phosphoglycerate kinase, translation elongation factor, leucine-rich repeat-containing protein, and Galactose-binding domain-like protein. Other 3 proteins were novel with unknown function. Two novel proteins (Riean_1750 and Riean_1752) were expressed in prokaryotic expression systems. The specificities of these 2 novel proteins to R. anatipestifer were confirmed by western-blotting analysis. The ducks immunized with either protein had low mortality challenged by R. anatipestifer, 33.3% and 16.7%, respectively. The ducks developed 100% immunity when immunized with combined Riean_1750 and Riean_1752 proteins. The data suggested 2 novel proteins play important roles in the bacterial survival in the iron restricted environment. They could be used as subunit vaccines of R. anatipestifer.	[Yang, Yifei; Gu, Changqin; Hu, Xueying; Zhang, Wanpo; Cheng, Guofu] Huazhong Agr Univ, Coll Vet Med, Wuhan, Peoples R China; [Liao, Yonghong; Luo, Qingping; Shao, Huabin] Acad Agr Sci Hubei Prov, Inst Anim Sci, Wuhan, Peoples R China; [Yang, Yifei] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China	Huazhong Agricultural University; China Agricultural University	Shao, HB (corresponding author), Huazhong Agr Univ, Coll Vet Med, Wuhan, Peoples R China.	shb1961@yahoo.com.cn; chengguofu@mail.hzau.edu.cn	Cheng, GF/GRS-2598-2022		Chinese Special Fund for Agro-scientific Research in the Public Interest [201003012]	Chinese Special Fund for Agro-scientific Research in the Public Interest	This work was supported by Chinese Special Fund for Agro-scientific Research in the Public Interest (201003012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brogden K.A., 1989, PASTEURELLA PASTEURE, P115; Brown JS, 2002, MICROBES INFECT, V4, P1149, DOI 10.1016/S1286-4579(02)01640-4; Cheng AnChun, 2003, Chinese Journal of Veterinary Science, V23, P320; Enkhbayar P, 2004, PROTEINS, V54, P394, DOI 10.1002/prot.10605; GAY NJ, 1991, FEBS LETT, V291, P87, DOI 10.1016/0014-5793(91)81110-T; GOLDONI P, 1991, J MED MICROBIOL, V34, P113, DOI 10.1099/00222615-34-2-113; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Gorg A, 1997, ELECTROPHORESIS, V18, P328, DOI 10.1002/elps.1150180306; Hu QH, 2012, VET MICROBIOL, V157, P428, DOI 10.1016/j.vetmic.2012.01.009; Huang B, 1999, VET MICROBIOL, V67, P213, DOI 10.1016/S0378-1135(99)00032-2; Jung TS, 2007, J VET SCI, V8, P255, DOI 10.4142/jvs.2007.8.3.255; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Koide A, 1998, J MOL BIOL, V284, P1141, DOI 10.1006/jmbi.1998.2238; Lim Y, 1998, FEMS MICROBIOL LETT, V163, P19, DOI 10.1111/j.1574-6968.1998.tb13020.x; Mavromatis K, 2011, STAND GENOMIC SCI, V4, P144, DOI [10.4056/sigs.1553865, 10.4056/sigs.1553862]; Metcalf DS, 2007, CAN J VET RES, V71, P181; Mey AR, 2005, INFECT IMMUN, V73, P8167, DOI 10.1128/IAI.73.12.8167-8178.2005; Pathanasophon P, 2002, AVIAN PATHOL, V31, P267, DOI 10.1080/03079450220136576; Ratledge C, 2004, TUBERCULOSIS, V84, P110, DOI 10.1016/j.tube.2003.08.012; Ryll M, 2001, J VET MED B, V48, P537, DOI 10.1046/j.1439-0450.2001.00471.x; Sandhu T.S., 1997, DIS POULTRY, P161; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; SEGERS P, 1993, INT J SYST BACTERIOL, V43, P768, DOI 10.1099/00207713-43-4-768; WATSON HC, 1982, EMBO J, V1, P1635, DOI 10.1002/j.1460-2075.1982.tb01366.x; Wu ZF, 2012, J INTEGR AGR, V11, P1517; Xie QY, 2009, BIOMETALS, V22, P907, DOI 10.1007/s10534-009-9243-2; Xu Wen-liang, 2004, Wuhan University Journal of Natural Sciences, V9, P498, DOI 10.1007/BF02830451; [杨依霏 Yang Yifei], 2012, [动物医学进展, Progress in Veterinary Medicine], V33, P13; Zhai ZP, 2013, VET MICROBIOL, V162, P850, DOI 10.1016/j.vetmic.2012.11.002; Zhang AD, 2008, PROTEOMICS, V8, P3506, DOI 10.1002/pmic.200800007; Zhang H, 2010, THESIS HUAZHONG AGR, P24; Zhou ZT, 2009, AVIAN PATHOL, V38, P321, DOI 10.1080/03079450903071311	33	2	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65901	10.1371/journal.pone.0065901	http://dx.doi.org/10.1371/journal.pone.0065901			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755292	gold, Green Published, Green Submitted			2022-12-27	WOS:000319872300099
J	Del Lama, LS; de Goes, EG; Petchevist, PCD; Moretto, EL; Borges, JC; Covas, DT; de Almeida, A				Del Lama, Lucas Sacchini; de Goes, Evamberto Garcia; Dias Petchevist, Paulo Cesar; Moretto, Edson Lara; Borges, Jose Carlos; Covas, Dimas Tadeu; de Almeida, Adelaide			Prevention of Transfusion-Associated Graft-versus-Host Disease by Irradiation: Technical Aspect of a New Ferrous Sulphate Dosimetric System	PLOS ONE			English	Article							FRICKE XYLENOL GEL; RADIATION-DOSE DISTRIBUTIONS; NUCLEAR-MAGNETIC-RESONANCE; BLOOD IRRADIATION; IMMUNOCOMPETENT PATIENTS; OPTICAL TOMOGRAPHY; QUALITY-CONTROL; T-CELLS; LYMPHOCYTES; VALIDATION	Irradiation of whole blood and blood components before transfusion is currently the only accepted method to prevent Transfusion-Associated Graft-Versus-Host-Disease (TA-GVHD). However, choosing the appropriate technique to determine the dosimetric parameters associated with blood irradiation remains an issue. We propose a dosimetric system based on the standard Fricke Xylenol Gel (FXG) dosimeter and an appropriate phantom. The modified dosimeter was previously calibrated using a Co-60 teletherapy unit and its validation was accomplished with a Cs-137 blood irradiator. An ionization chamber, standard FXG, radiochromic film and thermoluminescent dosimeters (TLDs) were used as reference dosimeters to determine the dose response and dose rate of the Co-60 unit. The dose distributions in a blood irradiator were determined with the modified FXG, the radiochromic film, and measurements by TLD dosimeters. A linear response for absorbed doses up to 54 Gy was obtained with our system. Additionally, the dose rate uncertainties carried out with gel dosimetry were lower than 5% and differences lower than 4% were noted when the absorbed dose responses were compared with ionization chamber, film and TLDs.	[Del Lama, Lucas Sacchini; Dias Petchevist, Paulo Cesar; de Almeida, Adelaide] Univ Sao Paulo FFCLRP USP, Sch Philosophy Sci & Letters Ribeirao Preto, Dept Phys, Ribeirao Preto, SP, Brazil; [de Goes, Evamberto Garcia] Fed Univ Rio Grande IMEF FURG, Math Stat & Phys Inst, Rio Grande, RS, Brazil; [Moretto, Edson Lara; Borges, Jose Carlos; Covas, Dimas Tadeu] Reg Blood Ctr Ribeirao Preto, Ribeirao Preto, SP, Brazil; [Covas, Dimas Tadeu] Univ Sao Paulo, Sch Med Ribeirao Preto, Ctr Cell Based Therapy, BR-14049 Ribeirao Preto, SP, Brazil	Universidade Federal do Rio Grande; Universidade de Sao Paulo	Del Lama, LS (corresponding author), Univ Sao Paulo FFCLRP USP, Sch Philosophy Sci & Letters Ribeirao Preto, Dept Phys, Ribeirao Preto, SP, Brazil.	lucasdellama@gmail.com	Del Lama, Lucas/D-9232-2013; Covas, Dimas T/C-5431-2013; Covas, Dimas/AAL-8499-2021; CTC USP, CEPID 13 18/J-8951-2014	Covas, Dimas T/0000-0002-7364-2595; CTC USP, CEPID 13 18/0000-0002-7123-9524	CAPES; Regional Blood Center of Ribeirao Preto, Brazil	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Regional Blood Center of Ribeirao Preto, Brazil	This study was partially funded by CAPES (http://www.capes.gov.br/) and the Regional Blood Center of Ribeirao Preto, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AABB, 2011, TECHNICAL REPORT; Agbaht K, 2007, TRANSFUSION, V47, P1405, DOI 10.1111/j.1537-2995.2007.01282.x; Ahya R, 1998, HEART, V80, P299, DOI 10.1136/hrt.80.3.299; AKAHOSHI M, 1992, TRANSFUSION, V32, P169, DOI 10.1046/j.1537-2995.1992.32292180149.x; Almond PR, 1999, MED PHYS, V26, P1847, DOI 10.1118/1.598691; Alva M, 2010, J PHYS C SERIES, V250; ANDERSON KC, 1990, NEW ENGL J MED, V323, P315; ANDREWS HL, 1957, REV SCI INSTRUM, V28, P329, DOI 10.1063/1.1715877; [Anonymous], 1983, MED PHYS, V10, P741; [Anonymous], 1993, 50 ICRU; [Anonymous], 1998, PHYSICS; Aoun E, 2003, TRANSFUSION, V43, P1672, DOI 10.1046/j.0041-1132.2003.00578.x; ARSURA EL, 1988, ARCH INTERN MED, V148, P1941, DOI 10.1001/archinte.148.9.1941; Attix F.H., 2008, INTRO RADIOLOGICAL P; AUKETT RJ, 1991, BRIT J RADIOL, V64, P918, DOI 10.1259/0007-1285-64-766-918; BCSH, 2010, TECHNICAL REPORT; Bero M, 2009, J PHYS C SERIES, V164; Bero M. A., 2000, Journal of Radiological Protection, V20, P287, DOI 10.1088/0952-4746/20/3/303; Bero MA, 2001, RADIAT PHYS CHEM, V61, P433, DOI 10.1016/S0969-806X(01)00289-4; Bero MA, 2000, NUCL INSTRUM METH B, V166, P820, DOI 10.1016/S0168-583X(99)00873-3; Bero MA, 2004, J PHYS C SERIES, V3; Bogner L, 1998, STRAHLENTHER ONKOL, V174, P431, DOI 10.1007/BF03038566; BRUBAKER DB, 1983, VOX SANG, V45, P401, DOI 10.1111/j.1423-0410.1983.tb01937.x; BURNS LJ, 1984, ACTA HAEMATOL-BASEL, V71, P270, DOI 10.1159/000206599; Butson MJ, 1999, TRANSFUSION MED, V9, P205; Calcina CSG, 2007, PHYS MED BIOL, V52, P1431, DOI 10.1088/0031-9155/52/5/014; Caldeira AMF, 2007, NUCL INSTRUM METH A, V582, P484, DOI 10.1016/j.nima.2007.09.001; Caldeira AMF, 2007, APPL RADIAT ISOTOPES, V65, P605, DOI 10.1016/j.apradiso.2007.01.012; Cavinato CC, 2010, HELS SUC P 3 EUR IRP; Chapman J, 1996, TRANSFUSION MED, V6, P261, DOI 10.1111/j.1365-3148.1996.tb00078.x; Chen F, 2001, APPL RADIAT ISOTOPES, V55, P13, DOI 10.1016/S0969-8043(00)00379-1; Cheung T, 2001, PHYS MED BIOL, V46, pN241, DOI 10.1088/0031-9155/46/10/402; Council of Europe, 2011, TECHNICAL REPORT; CROWLEY JP, 1974, VOX SANG, V26, P513, DOI 10.1111/j.1423-0410.1974.tb02728.x; Czelusniak C, 2010, J PHYS C SERIES, V250; DAY MJ, 1990, PHYS MED BIOL, V35, P1605, DOI 10.1088/0031-9155/35/12/001; DAY MJ, 1950, NATURE, V166, P146, DOI 10.1038/166146a0; de Oliveiraa LN, 2007, BRAZ J PHYS, V37, P1141, DOI 10.1590/S0103-97332007000700012; Doran SJ, 2001, PHYS MED BIOL, V46, P3191, DOI 10.1088/0031-9155/46/12/309; DROBYSKI W, 1989, BLOOD, V74, P2285; Fainstein C, 2000, APPL RADIAT ISOTOPES, V52, P1195, DOI 10.1016/S0969-8043(00)00070-1; FDA, 1993, TECHNICAL REPORT; FERRARA JLM, 1991, NEW ENGL J MED, V324, P667; Fricke H, 1927, AM J ROENTGENOL RADI, V18, P430; Fricke H., 1966, RADIATION DOSIMETRY, V2, P167; GAMBARINI G, 1994, PHYS MED BIOL, V39, P703, DOI 10.1088/0031-9155/39/4/004; Gambarini G, 2004, NUCL INSTRUM METH B, V213, P321, DOI 10.1016/S0168-583X(03)01636-7; Gambarini G, 1999, NUCL INSTRUM METH A, V422, P643, DOI 10.1016/S0168-9002(98)00975-9; Goes EG, 2006, TRANSFUSION, V46, P34, DOI 10.1111/j.1537-2995.2005.00669.x; GORE JC, 1984, PHYS MED BIOL, V29, P1189, DOI 10.1088/0031-9155/29/10/002; Gorman TE, 2000, AM J CLIN PATHOL, V113, P732, DOI 10.1309/QE5G-N5QX-GQWX-N04M; GRAW RG, 1970, LANCET, V2, P338; GREENBAUM BH, 1991, J CLIN ONCOL, V9, P1889, DOI 10.1200/JCO.1991.9.10.1889; HAYASHI H, 1993, ANESTHESIOLOGY, V79, P1419, DOI 10.1097/00000542-199312000-00034; HAZLE JD, 1991, PHYS MED BIOL, V36, P1117, DOI 10.1088/0031-9155/36/8/007; HILLYER CD, 1993, TRANSFUSION, V33, P898, DOI 10.1046/j.1537-2995.1993.331194082379.x; HOLLAND PV, 1989, ARCH PATHOL LAB MED, V113, P285; IAEA, 2000, TECHNICAL REPORT SER, V398; Ibbott G. S., 2004, Journal of Physics: Conference Series, V3, P58, DOI 10.1088/1742-6596/3/1/007; ICRU, 1989, 44 ICRU; ICRU, 1984, 35 ICRU; ISO/ASTM, 2005, TECHNICAL REPORT; JAMIESON NV, 1991, TRANSPLANT INT, V4, P67, DOI 10.1111/j.1432-2277.1991.tb01950.x; Jenneson PM, 1999, IEEE NUCL SCI CONF R, P538, DOI 10.1109/NSSMIC.1999.842542; Johns HE, 1983, PHYS RADIOLOGY; Joint Committee for Guides in Metrology, 2008, TECHNICAL REPORT; JUJI T, 1989, NEW ENGL J MED, V321, P56; Kelly RG, 1998, MED PHYS, V25, P1741, DOI 10.1118/1.598356; KERNAN NA, 1986, BLOOD, V68, P770; Khan FM, 2009, PHYS RAD THERAPY; Kilic SS, 2010, J INVEST ALLERG CLIN, V20, P153; Klein HG, 2006, TRANSFUSION, V46, P878, DOI 10.1111/j.1537-2995.2006.00853.x; KOBAYASHI H, 1993, AM J HEMATOL, V43, P51, DOI 10.1002/ajh.2830430112; KORNGOLD R, 1993, AM J PEDIAT HEMATOL, V15, P18; Kron T, 1997, MAGN RESON IMAGING, V15, P211, DOI 10.1016/S0730-725X(96)00352-9; Kronholz HL, 1998, INFUSIONSTHERAPIE, V25, P56; Kumar TK, 1997, RADIAT PHYS CHEM, V50, P545, DOI 10.1016/S0969-806X(97)00089-3; LAW J, 1970, PHYS MED BIOL, V15, P741, DOI 10.1088/0031-9155/15/4/016; LEITMAN SF, 1993, TRANSFUSION, V33, P447, DOI 10.1046/j.1537-2995.1993.33693296804.x; LOWENTHAL RM, 1993, TRANSFUSION, V33, P524, DOI 10.1046/j.1537-2995.1993.33693296818.x; Luban NLC, 2000, TRANSFUSION, V40, P348, DOI 10.1046/j.1537-2995.2000.40030348.x; MASTERSON ME, 1992, MED PHYS, V19, P649, DOI 10.1118/1.596809; MATTSSON LO, 1982, ACTA RADIOL ONCOL, V21, P139, DOI 10.3109/02841868209133997; MCLAUGHLIN WL, 1996, APPL RADIAT ISOTOPES, pS67; Moroff G, 1997, TRANSFUS MED REV, V11, P15, DOI 10.1016/S0887-7963(97)80006-5; Moroff G, 1997, TRANSFUSION, V37, P1084, DOI 10.1046/j.1537-2995.1997.371098016450.x; Neves JF, 2010, TRANSFUSION, V50, P2484, DOI 10.1111/j.1537-2995.2010.02705.x; NIST, 2010, XRAY MASS ATT COEFF; Nollet KE, 2003, TRANSFUSION, V43, P1655, DOI 10.1111/j.0041-1132.2003.00635.x; OCONNOR NTJ, 1992, J CLIN PATHOL, V45, P621, DOI 10.1136/jcp.45.7.621; OHTO H, 1992, TRANSFUSION, V32, P691, DOI 10.1046/j.1537-2995.1992.32792391051.x; Ohto H, 1996, TRANSFUS MED REV, V10, P31, DOI 10.1016/S0887-7963(96)80121-0; OLSSON LE, 1989, PHYS MED BIOL, V34, P43, DOI 10.1088/0031-9155/34/1/004; Orlin J B, 1997, Curr Opin Hematol, V4, P442; Oto OA, 2006, EUR J INTERN MED, V17, P151, DOI 10.1016/j.ejim.2005.10.011; PARKMAN R, 1974, NEW ENGL J MED, V290, P359, DOI 10.1056/NEJM197402142900703; Patel KK, 2010, INDIAN J HEMATOL BLO, V26, P92, DOI 10.1007/s12288-010-0028-0; PELSZYNSKI MM, 1994, BLOOD, V83, P1683; PETZ LD, 1993, TRANSFUSION, V33, P742, DOI 10.1046/j.1537-2995.1993.33994025025.x; Podgorsak E.B., 2005, RAD ONCOLOGY PHYS; Przepiorka D, 1996, AM J CLIN PATHOL, V106, P6; ROSEN NR, 1993, TRANSFUSION, V33, P125, DOI 10.1046/j.1537-2995.1993.33293158043.x; Rososhansky S, 1999, VOX SANG, V76, P59, DOI 10.1046/j.1423-0410.1999.7610059.x; Sampaio FGA, 2013, IEEE T NUCL SCI, V60, P810, DOI 10.1109/TNS.2013.2240464; Sampaio FGA, 2011, NUCL INSTRUM METH B, V269, P3141, DOI 10.1016/j.nimb.2011.04.097; Sato R, 2009, NUCL INSTRUM METH B, V267, P842, DOI 10.1016/j.nimb.2008.12.012; Schreiner L. J., 2004, Journal of Physics: Conference Series, V3, P9, DOI 10.1088/1742-6596/3/1/003; Serefhanoglu K, 2005, J NATL MED ASSOC, V97, P418; SHORTT KR, 1989, PHYS MED BIOL, V34, P1923, DOI 10.1088/0031-9155/34/12/014; SPRENT J, 1974, EUR J IMMUNOL, V4, P204, DOI 10.1002/eji.1830040310; SPROUL AM, 1992, BRIT J HAEMATOL, V80, P251, DOI 10.1111/j.1365-2141.1992.tb08908.x; Tahler M, 1989, NEW ENGL J MED, V321, P25; Tarte BJ, 1997, MED PHYS, V24, P1521, DOI 10.1118/1.598041; Taylor ML, 2008, AUSTRALAS PHYS ENG S, V31, P131, DOI 10.1007/BF03178587; THOMAS ED, 1961, ARCH INTERN MED, V107, P829, DOI 10.1001/archinte.1961.03620060029006; Treleaven J, 2011, BRIT J HAEMATOL, V152, P35, DOI 10.1111/j.1365-2141.2010.08444.x; Triulzi D, 2006, TRANSFUSION, V46, P885, DOI 10.1111/j.1537-2995.2006.00819.x; VANDERMAST BJ, 1994, LANCET, V343, P753, DOI 10.1016/S0140-6736(94)91836-8; Vergote K, 2004, PHYS MED BIOL, V49, P287, DOI 10.1088/0031-9155/49/2/008; VONFLIEDNER V, 1982, AM J MED, V72, P951; Wolodzko JG, 1999, MED PHYS, V26, P2508, DOI 10.1118/1.598772	121	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65334	10.1371/journal.pone.0065334	http://dx.doi.org/10.1371/journal.pone.0065334			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762345	Green Published, gold			2022-12-27	WOS:000321094800041
J	Lian, H; Hu, W; Huang, R; Du, FK; Liao, LJ; Zhu, ZY; Wang, YP				Lian, Hao; Hu, Wei; Huang, Rong; Du, Fukuan; Liao, Lanjie; Zhu, Zuoyan; Wang, Yaping			Transgenic Common Carp Do Not Have the Ability to Expand Populations	PLOS ONE			English	Article							POSSIBLE ECOLOGICAL RISKS; ATLANTIC SALMON; GROWTH ENHANCEMENT; METABOLIC-RATE; NILE TILAPIA; FISH; PERFORMANCE; FOOD; COMPETE; SPERM	The ecological safety of transgenic organisms is an important issue of international public and political concern. The assessment of ecological risks is also crucial for realizing the beneficial industrial application of transgenic organisms. In this study, reproduction of common carp (Cyprinus carpio, CC) in isolated natural aquatic environments was analyzed. Using the method of paternity testing, a comparative analysis was conducted on the structure of an offspring population of "all-fish" growth hormone gene-transgenic common carp (afgh-CC) and of wild CC to evaluate their fertility and juvenile viability. Experimental results showed that in a natural aquatic environment, the ratio of comparative advantage in mating ability of afgh-CC over wild CC was 1: 1, showing nearly identical mating competitiveness. Juvenile viability of afgh-CC was low, and the average daily survival rate was less than 98.00%. After a possible accidental escape or release of transgenic CC into natural aquatic environments they are unable to monopolize resources from eggs of natural CC populations, leading to the extinction of transgenic CC. Transgenic CC are also unlikely to form dominant populations in natural aquatic environments due to their low juvenile viability. Thus, it is expected that the proportion of afgh-CC in the natural environment would remain low or gradually decline, and ultimately disappear.	[Lian, Hao; Hu, Wei; Huang, Rong; Du, Fukuan; Liao, Lanjie; Zhu, Zuoyan; Wang, Yaping] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China; [Lian, Hao] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, YP (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China.	Wangyp.ihb@gmail.com			Development Plan of the State Key Fundamental Research of China [2009CB118701]; National Natural Science Foundation of China [30771664]	Development Plan of the State Key Fundamental Research of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by grants from the Development Plan of the State Key Fundamental Research of China (Grant No. 2009CB118701), and the National Natural Science Foundation of China (Grant No. 30771664). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekkevold D, 2002, MOL ECOL, V11, P91, DOI 10.1046/j.0962-1083.2001.01424.x; Bessey C, 2004, T AM FISH SOC, V133, P1205, DOI 10.1577/T04-010.1; Cook JT, 2000, AQUACULTURE, V188, P15, DOI 10.1016/S0044-8486(00)00331-8; Cook JT, 2000, AQUACULTURE, V188, P33, DOI 10.1016/S0044-8486(00)00332-X; Crooijmans RPMA, 1997, ANIM GENET, V28, P129, DOI 10.1111/j.1365-2052.1997.00097.x; David L, 2001, MOL GENET GENOMICS, V266, P353, DOI 10.1007/s004380100569; Devlin R.H., 1992, TRANSGENIC FISH, P229, DOI DOI 10.1142/1678; Devlin RH, 1999, AQUAC RES, V30, P479, DOI 10.1046/j.1365-2109.1999.00359.x; Devlin RH, 2004, P NATL ACAD SCI USA, V101, P9303, DOI 10.1073/pnas.0400023101; DU SJ, 1992, BIO-TECHNOL, V10, P176, DOI 10.1038/nbt0292-176; Duan M, 2010, J APPL ICHTHYOL, V26, P908, DOI 10.1111/j.1439-0426.2010.01479.x; Duan M, 2009, J FISH BIOL, V75, P1459, DOI 10.1111/j.1095-8649.2009.02393.x; Duan M, 2011, AQUACULTURE, V317, P175, DOI 10.1016/j.aquaculture.2011.04.013; Farrell AP, 1997, CAN J ZOOL, V75, P335, DOI 10.1139/z97-043; Fitzpatrick JL, 2011, AQUACULTURE, V312, P185, DOI 10.1016/j.aquaculture.2010.11.044; Fu C, 2007, J FISH BIOL, V70, P347, DOI 10.1111/j.1095-8649.2007.01301.x; Gage MJG, 1995, PHILOS T R SOC B, V350, P391, DOI 10.1098/rstb.1995.0173; Guan B, 2010, CHINESE SCI BULL, V55, P4032, DOI 10.1007/s11434-010-4165-5; Guan B, 2008, AQUACULTURE, V284, P217, DOI 10.1016/j.aquaculture.2008.06.028; Hallennan EM, 2007, APPL ANIM BEHAV SCI, V104, P265, DOI 10.1016/j.applanim.2006.09.008; Howard RD, 2004, P NATL ACAD SCI USA, V101, P2934, DOI 10.1073/pnas.0306285101; Kobayashi SI, 2007, AQUACULTURE, V270, P427, DOI 10.1016/j.aquaculture.2007.05.016; Lee CG, 2003, J FISH BIOL, V62, P753, DOI 10.1046/j.1095-8649.2003.00057.x; Li D, 2009, J FISH BIOL, V74, P186, DOI 10.1111/j.1095-8649.2008.02128.x; Li DS, 1961, INLAND FISH FARMING, P11; Li MD, 1989, FISH ECOLOGY; Maclean N, 2000, FISH FISH, V1, P146, DOI 10.1046/j.1467-2979.2000.00014.x; McKenzie DJ, 2003, J FISH BIOL, V63, P398, DOI 10.1046/j.1095-8649.2003.00162.x; Muir WM, 2002, TRANSGENIC RES, V11, P101, DOI 10.1023/A:1015203812200; Muir WM, 1999, P NATL ACAD SCI USA, V96, P13853, DOI 10.1073/pnas.96.24.13853; Nam YK, 2001, TRANSGENIC RES, V10, P353, DOI 10.1023/A:1016696104185; Quan Ying-chun, 2005, Zoological Research, V26, P595; Rahman MA, 1998, TRANSGENIC RES, V7, P357, DOI 10.1023/A:1008837105299; Rahman MA, 2001, J FISH BIOL, V59, P62, DOI [10.1111/j.1095-8649.2001.tb02338.x, 10.1006/jfbi.2001.1622]; Rahman MA, 1999, AQUACULTURE, V173, P333, DOI 10.1016/S0044-8486(98)00456-6; Slate J, 2000, MOL ECOL, V9, P801, DOI 10.1046/j.1365-294x.2000.00930.x; Sundstrom LF, 2004, P ROY SOC B-BIOL SCI, V271, pS350, DOI 10.1098/rsbl.2004.0189; TSAI HJ, 1995, CAN J FISH AQUAT SCI, V52, P776, DOI 10.1139/f95-077; Wang YP, 2001, CHINESE SCI BULL, V46, P226; Yang, 1981, FRESHW FISH, V1, P31; Zhang T, 2006, 7 INT C BIOL FISH ST, P18; ZHU Z, 1985, Zeitschrift fuer Angewandte Ichthyologie, V1, P31; Zhu Z, 1986, CHINESE SCI BULL, V31, P387	43	7	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65506	10.1371/journal.pone.0065506	http://dx.doi.org/10.1371/journal.pone.0065506			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762383	Green Submitted, gold, Green Published			2022-12-27	WOS:000321094800056
J	Okumura, LM; Lesch, BJ; Page, DC				Okumura, Leah M.; Lesch, Bluma J.; Page, David C.			The Ligand Binding Domain of GCNF Is Not Required for Repression of Pluripotency Genes in Mouse Fetal Ovarian Germ Cells	PLOS ONE			English	Article							NUCLEAR FACTOR; TRANSCRIPTION FACTOR; PREIMPLANTATION EMBRYOS; MAMMALIAN EMBRYO; OCT4 EXPRESSION; STEM-CELLS; DIFFERENTIATION; NANOG; DYNAMICS; EPIBLAST	In mice, successful development and reproduction require that all cells, including germ cells, transition from a pluripotent to a differentiated state. This transition is associated with silencing of the pluripotency genes Oct4 and Nanog. Interestingly, these genes are repressed at different developmental timepoints in germ and somatic cells. Ovarian germ cells maintain their expression until about embryonic day (E) 14.5, whereas somatic cells silence them much earlier, at about E8.0. In both somatic cells and embryonic stem cells, silencing of Oct4 and Nanog requires the nuclear receptor GCNF. However, expression of the Gcnf gene has not been investigated in fetal ovarian germ cells, and whether it is required for silencing Oct4 and Nanog in that context is not known. Here we demonstrate that Gcnf is expressed in fetal ovarian germ cells, peaking at E14.5, when Oct4 and Nanog are silenced. However, conditional ablation of the ligand-binding domain of Gcnf using a ubiquitous, tamoxifen-inducible Cre indicates that Gcnf is not required for the down-regulation of pluripotency genes in fetal ovarian germ cells, nor is it required for initiation of meiosis and oogenesis. These results suggest that the silencing of Oct4 and Nanog in germ cells occurs via a different mechanism from that operating in somatic cells during gastrulation.	[Okumura, Leah M.; Lesch, Bluma J.; Page, David C.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Okumura, Leah M.; Lesch, Bluma J.; Page, David C.] Whitehead Inst, Cambridge, MA 02142 USA; [Okumura, Leah M.; Lesch, Bluma J.; Page, David C.] MIT, Dept Biol, Cambridge, MA USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Lesch, BJ (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	leschb@wi.mit.edu; dcpage@wi.mit.edu			Howard Hughes Medical Institute; National Institutes of Health/National Human Genome Research Institute [2R01HG00257-20]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000257] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health/National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by Howard Hughes Medical Institute and by National Institutes of Health/National Human Genome Research Institute (2R01HG00257-20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chung ACK, 2001, MOL CELL BIOL, V21, P663, DOI 10.1128/MCB.21.2.663-677.2001; Fuhrmann G, 2001, DEV CELL, V1, P377, DOI 10.1016/S1534-5807(01)00038-7; Gill ME, 2011, P NATL ACAD SCI USA, V108, P7443, DOI 10.1073/pnas.1104501108; Gu PL, 2005, MOL CELL BIOL, V25, P8507, DOI 10.1128/MCB.25.19.8507-8519.2005; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Lan ZJ, 2002, J BIOL CHEM, V277, P50660, DOI 10.1074/jbc.M209586200; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; Prieto I, 2004, CHROMOSOME RES, V12, P197, DOI 10.1023/B:CHRO.0000021945.83198.0e; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sato M, 2002, MECH DEVELOP, V113, P91, DOI 10.1016/S0925-4773(02)00002-3; Susens U, 1997, DEV NEUROSCI-BASEL, V19, P410, DOI 10.1159/000111238; TAM PPL, 1981, J EMBRYOL EXP MORPH, V64, P133; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001; Yamaguchi S, 2009, DEVELOPMENT, V136, P4011, DOI 10.1242/dev.041160; Yan ZJ, 2000, J BIOL CHEM, V275, P35077, DOI 10.1074/jbc.M005566200; Yang JX, 2005, P NATL ACAD SCI USA, V102, P5755, DOI 10.1073/pnas.0408718102; Yeom YI, 1996, DEVELOPMENT, V122, P881; Yu JY, 2001, BIOL REPROD, V65, P1260, DOI 10.1095/biolreprod65.4.1260	27	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66062	10.1371/journal.pone.0066062	http://dx.doi.org/10.1371/journal.pone.0066062			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762465	Green Published, gold, Green Submitted			2022-12-27	WOS:000321094800087
J	Overvliet, KE; Krampe, RT; Wagemans, J				Overvliet, Krista E.; Krampe, Ralf Th.; Wagemans, Johan			Grouping by Proximity in Haptic Contour Detection	PLOS ONE			English	Article							VISUAL-SEARCH; GESTALT PSYCHOLOGY; SERIAL SEARCH; PERCEPTION; TACTILE; HAND; RECOGNITION; SIMILARITY; MOVEMENTS; STIMULUS	We investigated the applicability of the Gestalt principle of perceptual grouping by proximity in the haptic modality. To do so, we investigated the influence of element proximity on haptic contour detection. In the course of four sessions ten participants performed a haptic contour detection task in which they freely explored a haptic random dot display that contained a contour in 50% of the trials. A contour was defined by a higher density of elements ( raised dots), relative to the background surface. Proximity of the contour elements as well as the average proximity of background elements was systematically varied. We hypothesized that if proximity of contour elements influences haptic contour detection, detection will be more likely when contour elements are in closer proximity. This should be irrespective of the ratio with the proximity of the background elements. Results showed indeed that the closer the contour elements were, the higher the detection rates. Moreover, this was the case independent of the contour/background ratio. We conclude that the Gestalt law of proximity applies to haptic contour detection.	[Overvliet, Krista E.; Krampe, Ralf Th.; Wagemans, Johan] Univ Leuven KU Leuven, Expt Psychol Lab, Louvain, Belgium	KU Leuven	Overvliet, KE (corresponding author), Univ Leuven KU Leuven, Expt Psychol Lab, Louvain, Belgium.	Krista.Overvliet@gmail.com	Wagemans, Johan/M-3878-2019; Overvliet, Krista/J-9214-2014	Overvliet, Krista/0000-0002-3537-8172; Krampe, Ralf/0000-0002-6150-2317; Wagemans, Johan/0000-0002-7970-1541	Flemish government [METH/08/02]; FWO [1.2.610.11.N.00]	Flemish government(European Commission); FWO(FWO)	The authors were supported by a Methusalem grant by the Flemish government (METH/08/02, awarded to JW) and an FWO post-doctoral fellowship (1.2.610.11.N.00, awarded to KO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azanon E, 2010, CURR BIOL, V20, P1304, DOI 10.1016/j.cub.2010.05.063; Chang D., 2007, 8 AUSTR US INT C AUI; Demeyer M, 2012, BEHAV RES METHODS, V44, P439, DOI 10.3758/s13428-011-0167-8; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Harrar V, 2007, PERCEPTION, V36, P1455, DOI 10.1068/p5844; Koffka K, 1922, PSYCHOL BULL, V19, P531, DOI 10.1037/h0072422; LEDERMAN SJ, 1990, PERCEPT PSYCHOPHYS, V47, P54, DOI 10.3758/BF03208164; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; Overvliet KE, 2008, ACTA PSYCHOL, V129, P83, DOI 10.1016/j.actpsy.2008.04.011; Overvliet KE, 2008, ACTA PSYCHOL, V127, P51, DOI 10.1016/j.actpsy.2007.01.001; Overvliet KE, 2007, PERCEPT PSYCHOPHYS, V69, P1059, DOI 10.3758/BF03193944; Overvliet KE, 2007, EXP BRAIN RES, V182, P427, DOI 10.1007/s00221-007-0998-9; Overvliet KE, PSYCHOL AGI IN PRESS; Overvliet KE, 2012, J EXP PSYCHOL HUMAN, V38, P817, DOI 10.1037/a0029222; Overvliet KE, 2011, NEUROPSYCHOLOGIA, V49, P3046, DOI 10.1016/j.neuropsychologia.2011.07.005; Overvliet KE, 2010, EXP BRAIN RES, V202, P261, DOI 10.1007/s00221-009-2127-4; Palmer SE, 2003, ACTA PSYCHOL, V114, P311, DOI 10.1016/j.actpsy.2003.06.003; PHILLIPS JR, 1992, J NEUROSCI, V12, P827; TREISMAN A, 1982, J EXP PSYCHOL HUMAN, V8, P194, DOI 10.1037/0096-1523.8.2.194; UTTAL WR, 1970, PERCEPT PSYCHOPHYS, V8, P385, DOI 10.3758/BF03207029; VALLBO AB, 1984, HUM NEUROBIOL, V3, P3; Wagemans J, 2012, PSYCHOL BULL, V138, P1172, DOI 10.1037/a0029333; Wagemans J, 2012, PSYCHOL BULL, V138, P1218, DOI 10.1037/a0029334; Wertheimer M, 1923, PSYCHOL FORSCH, V4, P301, DOI 10.1007/BF00410640; Wertheimer M, 1912, Z PSYCHOL PHYSIOL SI, V61, P161; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419	26	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65412	10.1371/journal.pone.0065412	http://dx.doi.org/10.1371/journal.pone.0065412			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	173QU	23762364	Green Submitted, Green Published, gold			2022-12-27	WOS:000321094800046
J	Lacruz, RS; de Castro, JMB; Martinon-Torres, M; O'Higgins, P; Paine, ML; Carbonell, E; Arsuaga, JL; Bromage, TG				Lacruz, Rodrigo S.; Bermudez de Castro, Jose Maria; Martinon-Torres, Maria; O'Higgins, Paul; Paine, Michael L.; Carbonell, Eudald; Luis Arsuaga, Juan; Bromage, Timothy G.			Facial Morphogenesis of the Earliest Europeans	PLOS ONE			English	Article							LOWER PLEISTOCENE; GEOMETRIC MORPHOMETRICS; ATAPUERCA; HOMININ; HOMO; AUSTRALOPITHECUS; MORPHOLOGY; ONTOGENY; GROWTH; ORIGIN	The modern human face differs from that of our early ancestors in that the facial profile is relatively retracted (orthognathic). This change in facial profile is associated with a characteristic spatial distribution of bone deposition and resorption: growth remodeling. For humans, surface resorption commonly dominates on anteriorly-facing areas of the subnasal region of the maxilla and mandible during development. We mapped the distribution of facial growth remodeling activities on the 900-800 ky maxilla ATD6-69 assigned to H. antecessor, and on the 1.5 My cranium KNM-WT 15000, part of an associated skeleton assigned to African H. erectus. We show that, as in H. sapiens, H. antecessor shows bone resorption over most of the subnasal region. This pattern contrasts with that seen in KNM-WT 15000 where evidence of bone deposition, not resorption, was identified. KNM-WT 15000 is similar to Australopithecus and the extant African apes in this localized area of bone deposition. These new data point to diversity of patterns of facial growth in fossil Homo. The similarities in facial growth in H. antecessor and H. sapiens suggest that one key developmental change responsible for the characteristic facial morphology of modern humans can be traced back at least to H. antecessor.	[Lacruz, Rodrigo S.; Paine, Michael L.] Univ So Calif, Ctr Craniofacial Mol Biol, Ostrow Sch Dent, Los Angeles, CA 90033 USA; [Lacruz, Rodrigo S.; Paine, Michael L.] Univ So Calif, Dept Anthropol, Los Angeles, CA USA; [Bermudez de Castro, Jose Maria; Martinon-Torres, Maria] Ctr Nacl Invest Evoluc Humana, Burgos, Spain; [O'Higgins, Paul] Univ York, Hull York Med Sch, Ctr Anat & Human Sci, York YO10 5DD, N Yorkshire, England; [Carbonell, Eudald] Inst Catala Paleoecol Humana & Evolucio Social, Tarragona, Spain; [Luis Arsuaga, Juan] Univ Complutense Madrid, Inst Carlos UCM ISCIII 3, Ctr Invest Evoluc & Comportamiento Humanos, Madrid, Spain; [Bromage, Timothy G.] NYU, Coll Dent, Dept Biomat & Biomimet, New York, NY USA; [Bromage, Timothy G.] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY USA	University of Southern California; University of Southern California; Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); University of Hull; University of York - UK; ICREA; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Complutense University of Madrid; New York University; New York University	Lacruz, RS (corresponding author), Univ So Calif, Ctr Craniofacial Mol Biol, Ostrow Sch Dent, 2250 Alcazar St, Los Angeles, CA 90033 USA.	rodrigo@usc.edu	Lacruz, Rodrigo/AGY-8090-2022; Carbonell, Eudald/G-3003-2015; bromage, timothy/H-8621-2015	Martinon-Torres, Maria/0000-0002-2750-4554; O'Higgins, Paul/0000-0002-9797-0809; Arsuaga, Juan Luis/0000-0001-5361-2295; LACRUZ, RODRIGO/0000-0002-0776-6143; Bermudez de Castro, Jose Maria/0000-0003-1314-3273; bromage, timothy/0000-0002-9843-7993	Leakey Foundation; National Institutes of Health (K99/R00 grant DE) [022799]; Spanish "Ministerio de Ciencia e Innovacion [CGL2009-12703-C03]; Junta de Castilla y Leon (JCyL) [GR249]; Max Planck Research Award; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K99DE022799, R00DE022799] Funding Source: NIH RePORTER	Leakey Foundation; National Institutes of Health (K99/R00 grant DE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish "Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Castilla y Leon (JCyL)(Junta de Castilla y Leon); Max Planck Research Award(Max Planck Society); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	RSL thanks the Leakey Foundation for financial support and the National Institutes of Health (K99/R00 grant DE # 022799). Research was also funded by Spanish "Ministerio de Ciencia e Innovacion (Project NoCGL2009-12703-C03) and from Junta de Castilla y Leon (JCyL) (Project GR249). Additional support provided to TGB and RSL by the 2010 Max Planck Research Award, administered by the Max Planck Society and the Alexander von Humboldt Foundation in respect of the Hard Tissue Research Program in Human Paleobiomics. Fieldwork supported by the Consejeria de Cultura y Turismo from the JCyL; Fundacion Atapuerca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsuaga JL, 1999, J HUM EVOL, V37, P431, DOI 10.1006/jhev.1999.0309; Begun D, 1993, ENDOCAST NARIOKOTOME, P326; Berger GW, 2008, J HUM EVOL, V55, P300, DOI 10.1016/j.jhevol.2008.02.012; Bermudez de Castro JM, 2010, P NATL ACAD SCI USA, V107, P4210; Boyde A, 1972, DEV ASPECTS ORAL BIO, P243; Brauer G, 2008, EVOL ANTHROPOL, V17, P22, DOI 10.1002/evan.20157; Bromage TG, 2009, SCANNING, V31, P1, DOI 10.1002/sca.20139; Bromage T.G., 1985, P239; Bromage T. G., 2008, ESSENTIALS FACIAL GR, P319; BROMAGE TG, 1985, J MICROSC-OXFORD, V137, P209, DOI 10.1111/j.1365-2818.1985.tb02578.x; BROMAGE TG, 1989, J HUM EVOL, V18, P751, DOI 10.1016/0047-2484(89)90088-2; Bromage TG, 2008, J CLIN PEDIATR DENT, V33, P43, DOI 10.17796/jcpd.33.1.8168115j12103nut; Carbonell E, 2005, P NATL ACAD SCI USA, V102, P5674, DOI 10.1073/pnas.0501841102; CARBONELL E, 1995, SCIENCE, V269, P826, DOI 10.1126/science.7638598; Carbonell E, 2008, NATURE, V452, P465, DOI 10.1038/nature06815; Cobb SN, 2004, J EXP ZOOL PART B, V302B, P302, DOI 10.1002/jez.b.21005; Dean C, 2001, NATURE, V414, P628, DOI 10.1038/414628a; Dean MC, 2008, GROWTH DEV NARIOKOTO, P101; deCastro JMB, 1997, SCIENCE, V276, P1392; ENLOW DH, 1965, AMER J ORTHODONTICS, V51, P446, DOI 10.1016/0002-9416(65)90242-3; ENLOW DH, 1966, AMER J ORTHODONTICS, V52, P283, DOI 10.1016/0002-9416(66)90169-2; Enlow DH, 1996, ESSENTIALS FACIAL GR; Harvati K, 2010, J HUM EVOL, V59, P445, DOI 10.1016/j.jhevol.2010.06.005; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; KURIHARA S, 1980, ANGLE ORTHOD, V50, P98; Lacruz RS, 2008, J ANAT, V213, P148, DOI 10.1111/j.1469-7580.2008.00938.x; Lieberman DE, 1999, J HUM EVOL, V36, P487, DOI 10.1006/jhev.1998.0287; Lieberman DE, 2003, P NATL ACAD SCI USA, V300, P1134; Marcucio RS, 2011, GENESIS, V49, P177, DOI 10.1002/dvg.20710; Martinon-Torres M, 2007, P NATL ACAD SCI USA, V104, P13279, DOI 10.1073/pnas.0706152104; McCollum MA, 1999, SCIENCE, V284, P301, DOI 10.1126/science.284.5412.301; McCollum MA, 2008, J HUM EVOL, V54, P2, DOI 10.1016/j.jhevol.2007.05.013; Mitteroecker P, 2005, EVOL DEV, V7, P244, DOI 10.1111/j.1525-142X.2005.05027.x; MOSS ML, 1969, AMER J ORTHODONTICS, V55, P566, DOI 10.1016/0002-9416(69)90034-7; O'Higgins P, 2013, EVOL BIOL IN PRESS; Rightmire GP, 2008, EVOL ANTHROPOL, V17, P8, DOI 10.1002/evan.20160; Rightmire GP, 2004, AM J PHYS ANTHROPOL, V124, P109, DOI 10.1002/ajpa.10346; Rightmire GP, 1998, AM J PHYS ANTHROPOL, V106, P61, DOI 10.1002/(SICI)1096-8644(199805)106:1<61::AID-AJPA5>3.3.CO;2-U; Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721; Rosas A, 2010, J HUM EVOL, V58, P127, DOI [10.1016/j.jhevol.2009.10.002, 10.1016/j.jhevo1.2009.10.002]; Smith A, 2008, J VERTEBR PALEONTOL, V28, p143A; Stringer C, 2002, PHILOS T R SOC B, V357, P563, DOI 10.1098/rstb.2001.1057; Walker A., 1993, NARIOKOTOME HOMO ERE; Wood Bernard, 1994, Courier Forschungsinstitut Senckenberg, V171, P159	44	31	33	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65199	10.1371/journal.pone.0065199	http://dx.doi.org/10.1371/journal.pone.0065199			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	173SK	23762314	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000321099000042
J	Wu, XF; Chen, G; Lu, JP; Zhu, WF; Qiu, JT; Chen, JX; Xie, SS; Zhuo, SM; Yan, J				Wu, Xiufeng; Chen, Gang; Lu, Jianping; Zhu, Weifeng; Qiu, Jingting; Chen, Jianxin; Xie, Shusen; Zhuo, Shuangmu; Yan, Jun			Label-Free Detection of Breast Masses Using Multiphoton Microscopy	PLOS ONE			English	Article							TUMOR-STROMA INTERACTIONS; IN-VIVO; ENDOSCOPY; CELLS	Histopathology forms the gold standard for the diagnosis of breast cancer. Multiphoton microscopy (MPM) has been proposed to be a potentially powerful adjunct to current histopathological techniques. A label-free imaging based on two-photon excited fluorescence and second-harmonic generation is developed for differentiating normal breast tissues, benign, as well as breast cancer tissues. Human breast biopsies (including human normal breast tissues, benign as well as breast cancer tissues) that are first imaged (fresh, unfixed, and unstained) with MPM and are then processed for routine H-E histopathology. Our results suggest that the MPM images, obtained from these unprocessed biopsies, can readily distinguish between benign lesions and breast cancers. In the tissues of breast cancers, MPM showed that the tumor cells displayed marked cellular and nuclear pleomorphism. The tumor cells, characterized by irregular size and shape, enlarged nuclei, and increased nuclear-cytoplasmic ratio, infiltrated into disrupted connective tissue, leading to the loss of second-harmonic generation signals. For breast cancer, MPM diagnosis was 100% correct because the tissues of breast cancers did not have second-harmonic generation signals in MPM imaging. On the contrary, in benign breast masses, second-harmonic generation signals could be seen easily in MPM imaging. These observations indicate that MPM could be an important potential tool to provide label-free noninvasive diagnostic impressions that can guide surgeon in biopsy and patient management.	[Wu, Xiufeng; Yan, Jun] Fujian Med Univ, Teaching Hosp, Fujian Prov Tumor Hosp, Dept Surg, Fuzhou, Fujian, Peoples R China; [Chen, Gang; Lu, Jianping; Zhu, Weifeng] Fujian Med Univ, Teaching Hosp, Fujian Prov Tumor Hosp, Dept Pathol, Fuzhou, Fujian, Peoples R China; [Qiu, Jingting; Chen, Jianxin; Xie, Shusen; Zhuo, Shuangmu] Fujian Normal Univ, Inst Laser & Optoelect Technol, Fujian Prov Key Lab Photon Technol, Key Lab OptoElect Sci & Technol Med,Minist Educ, Fuzhou, Peoples R China; [Chen, Gang; Yan, Jun] Fujian Univ Tradit Chinese Med, Fuzhou, Peoples R China	Fujian Medical University; Fujian Medical University; Fujian Normal University; Fujian University of Traditional Chinese Medicine	Zhuo, SM (corresponding author), Fujian Normal Univ, Inst Laser & Optoelect Technol, Fujian Prov Key Lab Photon Technol, Key Lab OptoElect Sci & Technol Med,Minist Educ, Fuzhou, Peoples R China.	shuangmuzhuo@gmail.com; ynjun@yahoo.com	Zhuo, Shuangmu/F-4826-2012	Zhuo, Shuangmu/0000-0001-5767-5197	National Natural Science Foundation of China [81272574, 61275006, 81271620]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1115]; Natural Science Foundation of Fujian Province [2010J01136, 2011J01341]; Education Bureau of Fujian Province [JA12057]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Education Bureau of Fujian Province	This work was supported by the National Natural Science Foundation of China (81272574, 61275006 and 81271620), the Program for Changjiang Scholars and Innovative Research Team in University (Grant No. IRT1115), the Natural Science Foundation of Fujian Province (2010J01136 and 2011J01341), and the Program from Education Bureau of Fujian Province (JA12057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao HC, 2009, OPT EXPRESS, V17, P10098, DOI 10.1364/OE.17.010098; Bird D, 2003, OPT LETT, V28, P1552, DOI 10.1364/OL.28.001552; Brown E, 2003, NAT MED, V9, P796, DOI 10.1038/nm879; Campagnola PJ, 2003, NAT BIOTECHNOL, V21, P1356, DOI 10.1038/nbt894; Georgakoudi I, 2002, AM J OBSTET GYNECOL, V186, P374, DOI 10.1067/mob.2002.121075; Helmchen F, 2002, CURR OPIN NEUROBIOL, V12, P593, DOI 10.1016/S0959-4388(02)00362-8; Helmchen F, 2001, NEURON, V31, P903, DOI 10.1016/S0896-6273(01)00421-4; Heppner KJ, 1996, AM J PATHOL, V149, P273; Jung JC, 2003, OPT LETT, V28, P902, DOI 10.1364/OL.28.000902; Koehler MJ, 2006, OPT LETT, V31, P2879, DOI 10.1364/OL.31.002879; Konig K, 2008, J BIOPHOTONICS, V1, P13, DOI 10.1002/jbio.200710022; Laiho LH, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1891370; Levene MJ, 2004, J NEUROPHYSIOL, V91, P1908, DOI 10.1152/jn.01007.2003; Liu GJ, 2009, OPT LETT, V34, P2249, DOI 10.1364/OL.34.002249; McLaughlin SA, 2008, J AM COLL SURGEONS, V206, P76, DOI 10.1016/j.jamcollsurg.2007.07.021; Mueller MM, 2002, DIFFERENTIATION, V70, P486, DOI 10.1046/j.1432-0436.2002.700903.x; Muller MG, 2003, CANCER-AM CANCER SOC, V97, P1681, DOI 10.1002/cncr.11255; Nguyen FT, 2009, CANCER RES, V69, P8790, DOI 10.1158/0008-5472.CAN-08-4340; Pavlova I, 2003, PHOTOCHEM PHOTOBIOL, V77, P550, DOI 10.1562/0031-8655(2003)077<0550:MABOON>2.0.CO;2; Schedin P, 2010, J MAMMARY GLAND BIOL, V15, P275, DOI 10.1007/s10911-010-9191-z; Tang S, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3127203; Turkoz FP, 2012, BREAST, V12, P00173; Wilder-Smith P, 2004, LASER SURG MED, V35, P96, DOI 10.1002/lsm.20079; Zhuo SM, 2006, OPT EXPRESS, V14, P7810, DOI 10.1364/OE.14.007810; Zhuo SM, 2007, PHYS MED BIOL, V52, P4967, DOI 10.1088/0031-9155/52/16/017; Zigrino P, 2005, BIOCHIMIE, V87, P321, DOI 10.1016/j.biochi.2004.10.025; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899; Zoumi A, 2002, P NATL ACAD SCI USA, V99, P11014, DOI 10.1073/pnas.172368799	28	34	36	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65933	10.1371/journal.pone.0065933	http://dx.doi.org/10.1371/journal.pone.0065933			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755295	Green Published, gold, Green Submitted			2022-12-27	WOS:000321099000120
J	Yu, HP; Liu, FC; Tsai, YF; Hwang, TL				Yu, Huang-Ping; Liu, Fu-Chao; Tsai, Yung-Fong; Hwang, Tsong-Long			Osthole Attenuates Hepatic Injury in a Rodent Model of Trauma-Hemorrhage	PLOS ONE			English	Article							INFLAMMATORY CYTOKINE PRODUCTION; RECEPTOR-RELATED PATHWAY; DEPENDENT UP-REGULATION; ACUTE LUNG INJURY; MEDIATED ATTENUATION; IMPROVES SURVIVAL; RATS; EXPRESSION; MECHANISM; HEMEOXYGENASE-1	Recent evidences show that osthole possesses anti-inflammatory properties and protective effects following shock-like states, but the mechanism of these effects remains unknown. The p38 mitogen-activated protein kinase (p38 MAPK) pathway exerts anti-inflammatory effects in injury. The aim of this study was to investigate whether p38 MAPK plays any role in the osthole-mediated attenuation of hepatic injury after trauma-hemorrhage. Male Sprague-Dawley rats underwent trauma-hemorrhage (mean blood pressure maintained at approximately 35-40 mmHg for 90 minutes), followed by fluid resuscitation. During resuscitation, a single dose of osthole (3 mg/kg, intravenously) with and without a p38 MAPK inhibitor SB-203580 (2 mg/kg, intravenously), SB-203580 or vehicle was administered. Plasma alanine aminotransferase (ALT) with aspartate aminotransferase (AST) concentrations and various hepatic parameters were measured (n = 8 rats/group) at 24 hours after resuscitation. The results showed that trauma-hemorrhage increased hepatic myeloperoxidase activity, intercellular adhesion molecule-1 and interleukin-6 levels, and plasma ALT and AST concentrations. These parameters were significantly improved in the osthole-treated rats subjected to trauma-hemorrhage. Osthole treatment also increased hepatic phospho-p38 MAPK expression compared with vehicle-treated trauma-hemorrhaged rats. Co-administration of SB-203580 with osthole abolished the osthole-induced beneficial effects on the above parameters and hepatic injury. These results suggest that the protective effect of osthole administration on alleviation of hepatic injury after trauma-hemorrhage, which is, at least in part, through p38 MAPK-dependent pathway.	[Yu, Huang-Ping; Liu, Fu-Chao; Tsai, Yung-Fong] Chang Gung Mem Hosp, Dept Anesthesiol, Tao Yuan, Taiwan; [Yu, Huang-Ping; Liu, Fu-Chao; Tsai, Yung-Fong] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Tsai, Yung-Fong] Chang Gung Univ, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Hwang, Tsong-Long] Chang Gung Univ, Grad Inst Nat Prod, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University	Yu, HP (corresponding author), Chang Gung Mem Hosp, Dept Anesthesiol, Tao Yuan, Taiwan.	yuhp2001@adm.cgmh.org.tw; htl@mail.cgu.edu.tw	Hwang, Tsong-Long/AAE-6944-2020; Liu, Fu-Chao/AAB-3780-2021	Hwang, Tsong-Long/0000-0002-5780-3977; Liu, F-C/0000-0003-1712-4053	National Science Council [NSC101-2314-B-182A-010]; Chang Gung Memorial Hospital [CMRPG3B1051]	National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was partially supported by grants from the National Science Council (NSC101-2314-B-182A-010) and Chang Gung Memorial Hospital (CMRPG3B1051) to HPY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chao XD, 2010, BRAIN RES, V1363, P206, DOI 10.1016/j.brainres.2010.09.052; Dong WP, 2013, INT J MOL MED, V31, P1367, DOI 10.3892/ijmm.2013.1347; Douzinas EE, 2012, CRIT CARE MED, V40, P1348, DOI 10.1097/CCM.0b013e31823e9501; Fang Y, 2011, J TRAUMA, V71, P1297, DOI 10.1097/TA.0b013e3182127d48; He YL, 2012, BRAIN RES, V1433, P127, DOI 10.1016/j.brainres.2011.11.027; Hsu JT, 2008, SHOCK, V30, P372, DOI 10.1097/SHK.0b013e318164f25c; Hsu JT, 2008, AM J PHYSIOL-REG I, V294, pR1825, DOI 10.1152/ajpregu.00112.2008; Huang YS, 2011, CHINESE J PHYSIOL, V54, P183, DOI 10.4077/CJP.2011.AMM024; Jang HJ, 2012, ANTIOXID REDOX SIGN, V17, P878, DOI 10.1089/ars.2011.3994; Jiang SY, 2012, MOL VIS, V18, P2096; Kim H, 2010, J TRAUMA, V69, P1266, DOI 10.1097/TA.0b013e3181dbb0b2; Li F, 2012, BIOL PHARM BULL, V35, P1686, DOI 10.1248/bpb.b12-00133; Liao PC, 2010, J AGR FOOD CHEM, V58, P10445, DOI 10.1021/jf102812t; Liu FC, 2008, ACTA ANAESTH SCAND, V52, P635, DOI 10.1111/j.1399-6576.2008.01592.x; Liu FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053203; Liu FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025907; Liu FC, 2011, RESUSCITATION, V82, P335, DOI 10.1016/j.resuscitation.2010.11.007; Liu FC, 2009, ANESTH ANALG, V108, P1855, DOI 10.1213/ane.0b013e3181a1a194; Selzner N, 2002, HEPATOLOGY, V36, P812, DOI 10.1053/jhep.2002.35535; Shah KG, 2010, J TRAUMA, V69, P1415, DOI 10.1097/TA.0b013e3181f661ba; Shi Y, 2013, EUR J PHARM SCI, V48, P819, DOI 10.1016/j.ejps.2012.12.031; Shimizu T, 2007, ANN SURG, V245, P297, DOI 10.1097/01.sla.0000232523.88621.17; Sperry JL, 2008, J TRAUMA, V64, P572, DOI 10.1097/TA.0b013e3181650fdf; Suda K, 2010, SHOCK, V33, P526, DOI 10.1097/SHK.0b013e3181cc064b; Yu HP, 2008, SHOCK, V30, P324, DOI 10.1097/SHK.0b013e318164f013; Yu HP, 2011, SHOCK, V35, P517, DOI 10.1097/SHK.0b013e318209e931; Yu HP, 2010, SURGERY, V148, P103, DOI 10.1016/j.surg.2009.12.008; Yu HP, 2006, J LEUKOCYTE BIOL, V79, P963, DOI 10.1189/jlb.1005596; Zheng Y, J SURG RES IN PRESS	29	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65916	10.1371/journal.pone.0065916	http://dx.doi.org/10.1371/journal.pone.0065916			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755293	Green Submitted, gold, Green Published			2022-12-27	WOS:000321099000118
J	Zerouali, Y; Lina, JM; Jemel, B				Zerouali, Younes; Lina, Jean-Marc; Jemel, Boutheina			Optimal Eye-Gaze Fixation Position for Face-Related Neural Responses	PLOS ONE			English	Article							RETINA; BRAIN; PARTS	It is generally agreed that some features of a face, namely the eyes, are more salient than others as indexed by behavioral diagnosticity, gaze-fixation patterns and evoked-neural responses. However, because previous studies used unnatural stimuli, there is no evidence so far that the early encoding of a whole face in the human brain is based on the eyes or other facial features. To address this issue, scalp electroencephalogram (EEG) and eye gaze-fixations were recorded simultaneously in a gaze-contingent paradigm while observers viewed faces. We found that the N170 indexing the earliest face-sensitive response in the human brain was the largest when the fixation position is located around the nasion. Interestingly, for inverted faces, this optimal fixation position was more variable, but mainly clustered in the upper part of the visual field (around the mouth). These observations extend the findings of recent behavioral studies, suggesting that the early encoding of a face, as indexed by the N170, is not driven by the eyes per se, but rather arises from a general perceptual setting (upper-visual field advantage) coupled with the alignment of a face stimulus to a stored face template.	[Zerouali, Younes] Ecole Technol Super, Montreal, PQ, Canada; [Zerouali, Younes; Lina, Jean-Marc; Jemel, Boutheina] Hop Riviere Prairies, Montreal, PQ, Canada; [Lina, Jean-Marc] Univ Montreal, Ctr Rech Math, Montreal, PQ H3C 3J7, Canada; [Jemel, Boutheina] Univ Montreal, Fac Med, Sch Speech Language Pathol, Montreal, PQ H3C 3J7, Canada	University of Quebec; Ecole de Technologie Superieure - Canada; Universite de Montreal; Universite de Montreal; Universite de Montreal	Zerouali, Y (corresponding author), Ecole Technol Super, Montreal, PQ, Canada.	youness.zerouali-boukhal.1@ens.etsmtl.ca		Jemel, Boutheina/0000-0003-3125-5914	Natural Sciences and Engineering Research Council of Canada [OGP0007551]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was supported by a grant from the Natural Sciences and Engineering Research Council of Canada, #OGP0007551, awarded to BJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlfors SP, 2010, BRAIN TOPOGR, V23, P227, DOI 10.1007/s10548-010-0154-x; Amblard C, 2004, IEEE T BIOMED ENG, V51; BANKS MS, 1991, J OPT SOC AM A, V8, P1775, DOI 10.1364/JOSAA.8.001775; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bindemann M, 2009, J VISION, V9, DOI 10.1167/9.2.7; Brewer AA, 2005, NAT NEUROSCI, V8, P1102, DOI 10.1038/nn1507; CURCIO CA, 1987, SCIENCE, V236, P579, DOI 10.1126/science.3576186; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; Danckert J, 2001, EXP BRAIN RES, V137, P303; de Xivry JJO, 2008, J NEUROPSYCHOL, V2, P245, DOI 10.1348/174866407X260199; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; Eimer M, 1998, NEUROREPORT, V9, P2945, DOI 10.1097/00001756-199809140-00005; Gramfort A, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-45; Grutzner C, 2010, J NEUROSCI, V30, P8342, DOI 10.1523/JNEUROSCI.5434-09.2010; Haig ND, 1986, PERCEPTION, V15, P505; Hills P, 2012, BR J PSYCHOL; Hsiao JHW, 2008, PSYCHOL SCI, V19, P998, DOI 10.1111/j.1467-9280.2008.02191.x; Itier RJ, 2007, J COGNITIVE NEUROSCI, V19, P1815, DOI 10.1162/jocn.2007.19.11.1815; Jacques C, 2007, CEREB CORTEX, V17, P1055, DOI 10.1093/cercor/bhl015; Jemel B, 2003, NEUROREPORT, V14, P2035, DOI 10.1097/00001756-200311140-00006; Levine MW, 2005, VISION RES, V45, P2820, DOI 10.1016/j.visres.2005.04.001; McPartland J, 2010, NEUROPSYCHOLOGIA, V48, P3657, DOI 10.1016/j.neuropsychologia.2010.07.020; NOWAGK R, 1996, ANN REPORT MAX PLANK; Perry JS, 2002, P SOC PHOTO-OPT INS, V4662, P57, DOI 10.1117/12.469554; PERRY VH, 1985, VISION RES, V25, P1795, DOI 10.1016/0042-6989(85)90004-5; Portin K, 1999, J OPT SOC M A, V16, P755; Rakover SS, 1997, PERCEPT PSYCHOPHYS, V59, P752, DOI 10.3758/BF03206021; Rossion B, 2008, NEUROIMAGE, V39, P1959, DOI 10.1016/j.neuroimage.2007.10.011; Rousselet GA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-98; Saether L, 2009, VISION RES, V49, P2870, DOI 10.1016/j.visres.2009.09.001; Schyns PG, 2007, CURR BIOL, V17, P1580, DOI 10.1016/j.cub.2007.08.048; Slotnick SD, 1999, CLIN NEUROPHYSIOL, V110, P1793, DOI 10.1016/S1388-2457(99)00135-2; Smith AT, 2001, CEREB CORTEX, V11, P1182, DOI 10.1093/cercor/11.12.1182; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Williams CC, 2007, MEM COGNITION, V35, P1977, DOI 10.3758/BF03192930	36	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e60128	10.1371/journal.pone.0060128	http://dx.doi.org/10.1371/journal.pone.0060128			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	173SK	23762224	Green Submitted, gold, Green Published			2022-12-27	WOS:000321099000001
J	Fogarty, AS; Chapman, S				Fogarty, Andrea S.; Chapman, Simon			"Like Throwing a Bowling Ball at a Battle Ship'' Audience Responses to Australian News Stories about Alcohol Pricing and Promotion Policies: A Qualitative Focus Group Study	PLOS ONE			English	Article							LICENSED PREMISES; PUBLIC-OPINION; HEALTH; TELEVISION; CODE; COVERAGE	Introduction: Policies affecting alcohol's price and promotion are effective measures to reduce harms. Yet policies targeting populations are unpopular with the public, whose views can be influenced by news framings of policy narratives. In Australia, alcohol taxation receives high news coverage, while advertising restrictions have not until recently, and narratives are highly contested for each. However, research specifically examining how audiences respond to such news stories is scant. We sought to explore audience understanding of news reports about two alcohol policy proposals. Method: From June to August 2012, 46 participants were recruited for 8 focus groups in age-brackets of young people aged 18-25 years, parents of young people, and adults aged 25 or older. Groups were split by education. Participants were asked their prior knowledge of alcohol policies, before watching and discussing four news stories about alcohol taxation and advertising. Results: Participants were clear that alcohol poses problems, yet thought policy solutions were ineffective in a drinking culture they viewed as unamenable to change and unaffected by alcohol's price or promotion. Without knowledge of its actual effect on consumption, they cited the 2008 alcopops tax as a policy failure, blaming cheaper substitution. Participants had low knowledge of advertising restrictions, yet were concerned about underage exposure. They offered conditional support for restrictions, while doubting its effectiveness. There was marked distrust of statistics and news actors in broadcasts, yet discussions matched previous research findings. Conclusions: News coverage has resulted in strong audience understanding of alcohol related problems but framed solutions have not always provided clear messages, despite audience support for policies. Future advocacy will need to continue recent moves to address the links between alcohol's price and promotion with the drinking culture, as well as facilitate understandings of how this culture is amenable to change through the use of evidence-based policies.	[Fogarty, Andrea S.; Chapman, Simon] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia	University of Sydney	Chapman, S (corresponding author), Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia.	simon.chapman@sydney.edu.au	Chapman, Simon/D-4114-2009	Fogarty, Andrea/0000-0002-2939-7027	NHMRC [571376]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	All authors are investigators on the NHMRC funded public health capacity building grant 'The Australian Health News Research Collaboration' (#571376). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advertising Standards Board, 2013, COMPL ADV STAND BOAR; Alcohol Education and Rehabilitation Foundation, 2011, ANN ALC POLL COMM AT; Alcohol Working Group of the Preventative Health Taskforce, 2009, PREV ALC REL HARM AU; Australian Drug Foundation, 2011, POLICYTALK ROL TAX R; Australian Government Treasury, 2008, AUSTR FUT TAX SYST R; Australian National Preventive Health Agency, 2012, EXPL PUBL INT CAS MI; Byrnes JM, 2010, MED J AUSTRALIA, V192, P439, DOI 10.5694/j.1326-5377.2010.tb03581.x; Carragher N, 2011, WHAT ARE OPTIONS PRI; Casswell S, 1997, HEALTH PROMOT INT, V12, P251, DOI 10.1093/heapro/12.3.251; Casswell S, 2012, ADDICTION, V107, P478, DOI 10.1111/j.1360-0443.2011.03701.x; Chapman S, 2009, MED J AUSTRALIA, V191, P620, DOI 10.5694/j.1326-5377.2009.tb03354.x; Chikritzhs TN, 2009, MED J AUSTRALIA, V190, P294, DOI 10.5694/j.1326-5377.2009.tb02415.x; Collins D., 2008, AVOIDABLE COSTS ALCO; Collins DJ, 2008, COSTS TOBACCO ALCOHO; D'Angelo P, 2002, J COMMUN, V52, P870, DOI 10.1111/j.1460-2466.2002.tb02578.x; D'Angelo Paul, 2010, DOING NEWS FRAMING A; Donovan K, 2007, DRUG ALCOHOL REV, V26, P73, DOI 10.1080/09595230601037026; Dorfman L, 1998, CONTEMP DRUG PROBL, V25, P65; ENTMAN RM, 1993, J COMMUN, V43, P51, DOI 10.1111/j.1460-2466.1993.tb01304.x; Fogarty A, 2013, WHAT SHOULD IN PRESS; Fogarty AS, 2012, AUST NZ J PUBL HEAL, V36, P530, DOI 10.1111/j.1753-6405.2012.00933.x; Fogarty AS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-727; Fogarty AS, 2010, DRUG ALCOHOL REV, P569; Hall W, 2011, LANCET, V377, P1136, DOI 10.1016/S0140-6736(10)61420-1; Hall WD, 2010, WAS ALCOPOPS TAX PUB; Hawkins N, 2009, AUST NZ J PUBL HEAL, V33, P160, DOI 10.1111/j.1753-6405.2009.00364.x; Henry K., 2010, AUSTR FUTURE TAX SYS; Hicks R, 2013, BOOZE AD WATCHDOG HI; Holder HD, 1997, ADDICTION, V92, pS189, DOI 10.1111/j.1360-0443.1997.tb02991.x; Jernigan DH, 2011, J PUBLIC HEALTH POL, V32, P165, DOI 10.1057/jphp.2011.5; Jones SC, 2008, DRUG ALCOHOL REV, V27, P29, DOI 10.1080/09595230701499175; Jones SC, 2007, DRUG ALCOHOL REV, V26, P477, DOI 10.1080/09595230701494390; Jones SC, 2002, J PUBLIC AFFAIRS, V2, P153, DOI DOI 10.1002/PA.105; Lloyd B, 2011, DRINKING CULTURES SO; Lubman DI, 2007, MED J AUSTRALIA, V187, P266, DOI 10.5694/j.1326-5377.2007.tb01239.x; Macdonald S, 2011, DRUG ALCOHOL REV, V30, P652, DOI 10.1111/j.1465-3362.2010.00259.x; McIntyre P., 2012, AUSTR FINANCIAL REV; Miller PG, 2011, ADDICTION, V106, P1560, DOI 10.1111/j.1360-0443.2011.03499.x; mUmBRELLA, 2013, SELF APP ALC WATCHD; National Alliance for Action on Alcohol, 2012, POS STAT ALC MARK PR; Skov SJ, 2011, MED J AUSTRALIA, V195, P84, DOI 10.5694/j.1326-5377.2011.tb03215.x; Tobin C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-58; Tobin CL, 2012, DRUG ALCOHOL REV, V31, P413, DOI 10.1111/j.1465-3362.2011.00388.x; Wilkinson C, 2009, DRUG ALCOHOL REV, V28, P263, DOI 10.1111/j.1465-3362.2009.00027.x; Winter MV, 2008, J STUD ALCOHOL DRUGS, V69, P676, DOI 10.15288/jsad.2008.69.676	45	7	7	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65261	10.1371/journal.pone.0065261	http://dx.doi.org/10.1371/journal.pone.0065261			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166TB	23755205	Green Published, Green Submitted, gold			2022-12-27	WOS:000320579400047
J	Nowak, MD; Smith, AB; Simpson, C; Zwickl, DJ				Nowak, Michael D.; Smith, Andrew B.; Simpson, Carl; Zwickl, Derrick J.			A Simple Method for Estimating Informative Node Age Priors for the Fossil Calibration of Molecular Divergence Time Analyses	PLOS ONE			English	Article							RELAXED PHYLOGENETICS; SOFTWARE PACKAGE; EVOLUTIONARY; ORIGINATION; UNCERTAINTY; EXTINCTION; CLOCK; DIVERSIFICATION; RECONSTRUCTION; TIMESCALES	Molecular divergence time analyses often rely on the age of fossil lineages to calibrate node age estimates. Most divergence time analyses are now performed in a Bayesian framework, where fossil calibrations are incorporated as parametric prior probabilities on node ages. It is widely accepted that an ideal parameterization of such node age prior probabilities should be based on a comprehensive analysis of the fossil record of the clade of interest, but there is currently no generally applicable approach for calculating such informative priors. We provide here a simple and easily implemented method that employs fossil data to estimate the likely amount of missing history prior to the oldest fossil occurrence of a clade, which can be used to fit an informative parametric prior probability distribution on a node age. Specifically, our method uses the extant diversity and the stratigraphic distribution of fossil lineages confidently assigned to a clade to fit a branching model of lineage diversification. Conditioning this on a simple model of fossil preservation, we estimate the likely amount of missing history prior to the oldest fossil occurrence of a clade. The likelihood surface of missing history can then be translated into a parametric prior probability distribution on the age of the clade of interest. We show that the method performs well with simulated fossil distribution data, but that the likelihood surface of missing history can at times be too complex for the distribution-fitting algorithm employed by our software tool. An empirical example of the application of our method is performed to estimate echinoid node ages. A simulation-based sensitivity analysis using the echinoid data set shows that node age prior distributions estimated under poor preservation rates are significantly less informative than those estimated under high preservation rates.	[Nowak, Michael D.] Univ Zurich, Inst Systemat Bot, Zurich, Switzerland; [Smith, Andrew B.] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; [Simpson, Carl] Humboldt Univ, Museum Nat Kunde, D-10099 Berlin, Germany; [Zwickl, Derrick J.] Univ Kansas, Dept Ecol & Evolut, Lawrence, KS 66045 USA	University of Zurich; Natural History Museum London; Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung; University of Kansas	Nowak, MD (corresponding author), Univ Zurich, Inst Systemat Bot, Zurich, Switzerland.	michael.nowak@systbot.uzh.ch	Smith, Andrew B/B-9849-2009; Nowak, Michael/M-3747-2017	Nowak, Michael/0000-0001-8924-6506; Simpson, Carl/0000-0003-0719-4437	Society of Systematic Biologists Graduate Student Research Award; National Evolutionary Synthesis Center (NESCent); Google Summer of Code	Society of Systematic Biologists Graduate Student Research Award; National Evolutionary Synthesis Center (NESCent)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Google Summer of Code(Google Incorporated)	This work was financially supported through a Society of Systematic Biologists Graduate Student Research Award to MN, the National Evolutionary Synthesis Center (NESCent), and Google Summer of Code. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro M, 2006, POSTERIOR PRIOR BAYE; Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Alroy J, 2008, P NATL ACAD SCI USA, V105, P11536, DOI 10.1073/pnas.0802597105; Alroy J, 2010, PALAEONTOLOGY, V53, P1211, DOI 10.1111/j.1475-4983.2010.01011.x; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Benton Michael J., 2009, P35; Clarke JT, 2011, NEW PHYTOL, V192, P266, DOI 10.1111/j.1469-8137.2011.03794.x; Clayton JW, 2009, SYST BIOL, V58, P395, DOI 10.1093/sysbio/syp041; Donoghue PCJ, 2007, TRENDS ECOL EVOL, V22, P424, DOI 10.1016/j.tree.2007.05.005; Dornburg A, 2011, SYST BIOL, V60, P519, DOI 10.1093/sysbio/syr019; dos Reis M, 2012, P ROY SOC B-BIOL SCI, V279, P3491, DOI 10.1098/rspb.2012.0683; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Foote M, 1999, SCIENCE, V283, P1310, DOI 10.1126/science.283.5406.1310; Foote M, 2003, J GEOL, V111, P125, DOI 10.1086/345841; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Foote M, 1996, FOSSIL PRESERVATION, P121; Friedman M, 2010, P R SOC B, V278, P439, DOI [10.1038/463040a, DOI 10.1038/463040A]; Gradstein F, 2009, TIMETREE LIFE; Graur D, 2004, TRENDS GENET, V20, P80, DOI 10.1016/j.tig.2003.12.003; Heads M, 2005, CLADISTICS, V21, P62, DOI 10.1111/j.1096-0031.2005.00052.x; Heled J, 2012, SYST BIOL, V61, P138, DOI 10.1093/sysbio/syr087; Himmelmann L, 2009, BIOINFORMATICS, V25, P2440, DOI 10.1093/bioinformatics/btp417; Ho SYW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001615; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Hugall AF, 2007, SYST BIOL, V56, P543, DOI 10.1080/10635150701477825; Inoue J, 2010, SYST BIOL, V59, P74, DOI 10.1093/sysbio/syp078; Kenrick P, 2011, NEW PHYTOL, V192, P3, DOI 10.1111/j.1469-8137.2011.03856.x; Kroh A, 2010, J SYST PALAEONTOL, V8, P147, DOI 10.1080/14772011003603556; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lee MSY, 2009, MOL PHYLOGENET EVOL, V50, P661, DOI 10.1016/j.ympev.2008.11.024; Liow LH, 2010, SYST BIOL, V59, P646, DOI 10.1093/sysbio/syq052; Marshall CR, 2008, AM NAT, V171, P726, DOI 10.1086/587523; Muller J, 2005, BIOESSAYS, V27, P1069, DOI 10.1002/bies.20286; Parham JF, 2008, AM NAT, V171, P132, DOI 10.1086/524198; Parham JF, 2012, SYST BIOL, V61, P346, DOI 10.1093/sysbio/syr107; Pyron RA, 2010, SYST BIOL, V59, P185, DOI 10.1093/sysbio/syp090; Rannala B, 2007, SYST BIOL, V56, P453, DOI 10.1080/10635150701420643; RAUP DM, 1985, PALEOBIOLOGY, V11, P42, DOI 10.1017/S0094837300011386; Renner SS, 2005, TRENDS PLANT SCI, V10, P550, DOI 10.1016/j.tplants.2005.09.010; Rutschmann F, 2007, SYST BIOL, V56, P591, DOI 10.1080/10635150701491156; Sallam HM, 2009, P NATL ACAD SCI USA, V106, P16722, DOI 10.1073/pnas.0908702106; Sauquet H, 2012, SYST BIOL, V61, P289, DOI 10.1093/sysbio/syr116; Shaul S, 2002, GENE, V300, P59, DOI 10.1016/S0378-1119(02)00851-X; Smith AB, 2006, MOL BIOL EVOL, V23, P1832, DOI 10.1093/molbev/msl039; Tavare S, 2002, NATURE, V416, P726, DOI 10.1038/416726a; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Warnock RCM, 2012, BIOL LETTERS, V8, P156, DOI 10.1098/rsbl.2011.0710; Wilkinson RD, 2011, SYST BIOL, V60, P16, DOI 10.1093/sysbio/syq054; Yang ZH, 2006, MOL BIOL EVOL, V23, P212, DOI 10.1093/molbev/msj024; Zuckerkandl E, 1965, EVOLVING GENES PROTE, V97, P166	51	35	35	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e66245	10.1371/journal.pone.0066245	http://dx.doi.org/10.1371/journal.pone.0066245			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755303	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000320579400083
J	Yamashita, A; Fujita, Y; Yamamoto, M				Yamashita, Akira; Fujita, Yoshihiro; Yamamoto, Masayuki			Proper Microtubule Structure Is Vital for Timely Progression through Meiosis in Fission Yeast	PLOS ONE			English	Article							SCHIZOSACCHAROMYCES-POMBE; NUCLEAR-MOVEMENT; BINDING PROTEIN; MUTANTS; COMPLEX; CYCLE; GENE; IDENTIFICATION; SPORULATION; JAPONICUS	Cells of the fission yeast Schizosaccharomyces pombe normally reproduce by mitotic division in the haploid state. When subjected to nutrient starvation, two haploid cells fuse and undergo karyogamy, forming a diploid cell that initiates meiosis to form four haploid spores. Here, we show that deletion of the mal3 gene, which encodes a homolog of microtubule regulator EB1, produces aberrant asci carrying more than four spores. The mal3 deletion mutant cells have a disordered cytoplasmic microtubule structure during karyogamy and initiate meiosis before completion of karyogamy, resulting in twin haploid meiosis in the zygote. Treatment with anti-microtubule drugs mimics this phenotype. Mutants defective in karyogamy or mutants prone to initiate haploid meiosis exaggerate the phenotype of the mal3 deletion mutant. Our results indicate that proper microtubule structure is required for ordered progression through the meiotic cycle. Furthermore, the results of our study suggest that fission yeast do not monitor ploidy during meiosis.	[Yamashita, Akira; Yamamoto, Masayuki] Kazusa DNA Res Inst, Lab Gene Fuct, Kisarazu, Chiba, Japan; [Fujita, Yoshihiro; Yamamoto, Masayuki] Univ Tokyo, Dept Biochem & Biophys, Grad Sch Sci, Tokyo, Japan	Kazusa DNA Research Institute; University of Tokyo	Yamashita, A (corresponding author), Kazusa DNA Res Inst, Lab Gene Fuct, Kisarazu, Chiba, Japan.	ymst@kazusa.or.jp	Yamashita, Akira/A-5278-2015	Yamashita, Akira/0000-0002-1805-1434	Japan Society for the Promotion of Science [23570223, 21227007]; Grants-in-Aid for Scientific Research [21227007] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (C) (23570223) to A. Y. and (S) (21227007) to M. Y. from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakawa K, 2005, EMBO REP, V6, P1194, DOI 10.1038/sj.embor.7400540; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Beinhauer JD, 1997, J CELL BIOL, V139, P717, DOI 10.1083/jcb.139.3.717; Busch KE, 2004, CURR BIOL, V14, P548, DOI 10.1016/j.cub.2004.03.029; EGEL R, 1974, EXP CELL RES, V88, P127, DOI 10.1016/0014-4827(74)90626-0; Fujita I, 2010, GENES CELLS, V15, P359, DOI 10.1111/j.1365-2443.2010.01386.x; Furuya K, 2009, YEAST, V26, P221, DOI 10.1002/yea.1662; Gibeaux R, 2013, GENE DEV, V27, P335, DOI 10.1101/gad.206318.112; GUTZ H, 1967, SCIENCE, V158, P796, DOI 10.1126/science.158.3802.796; Gutz H., 1974, HDB GENETICS; IINO Y, 1985, MOL GEN GENET, V198, P416, DOI 10.1007/BF00332932; Li P, 1996, CELL, V87, P869, DOI 10.1016/S0092-8674(00)81994-7; MCLEOD M, 1987, EMBO J, V6, P729, DOI 10.1002/j.1460-2075.1987.tb04814.x; Molk JN, 2006, J CELL BIOL, V172, P27, DOI 10.1083/jcb.200510032; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Niccoli T, 2004, J CELL SCI, V117, P5543, DOI 10.1242/jcs.01475; NURSE P, 1985, MOL GEN GENET, V198, P497, DOI 10.1007/BF00332946; Sawin KE, 2004, CURR BIOL, V14, P763, DOI 10.1016/j.cub.2004.03.042; Schwartz K, 1997, MOL BIOL CELL, V8, P2677, DOI 10.1091/mbc.8.12.2677; SU LK, 1995, CANCER RES, V55, P2972; TANAKA K, 1982, J CELL SCI, V56, P263; Troxell CL, 2001, MOL BIOL CELL, V12, P3476, DOI 10.1091/mbc.12.11.3476; Venkatram S, 2004, MOL BIOL CELL, V15, P2287, DOI 10.1091/mbc.E03-10-0728; Watanabe Y, 1997, NATURE, V386, P187, DOI 10.1038/386187a0; West RR, 1998, MOL BIOL CELL, V9, P2839, DOI 10.1091/mbc.9.10.2839; WILLER M, 1995, MOL CELL BIOL, V15, P4964; Yamamoto A, 1999, J CELL BIOL, V145, P1233, DOI 10.1083/jcb.145.6.1233; Yamamoto M, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P297; Yamamoto M., 1997, MATING SPORULATION S, P1037; Zimmerman S, 2005, MOL BIOL CELL, V16, P2719, DOI 10.1091/mbc.E04-08-0676	30	4	4	7	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65082	10.1371/journal.pone.0065082	http://dx.doi.org/10.1371/journal.pone.0065082			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755176	Green Published, gold, Green Submitted			2022-12-27	WOS:000320579400038
J	Yang, C; Ge, SN; Zhang, JR; Chen, L; Yan, ZQ; Heng, LJ; Zhao, TZ; Li, WX; Jia, D; Zhu, JL; Gao, GD				Yang, Chen; Ge, Shun-Nan; Zhang, Jia-Rui; Chen, Lei; Yan, Zhi-Qiang; Heng, Li-Jun; Zhao, Tian-Zhi; Li, Wei-Xin; Jia, Dong; Zhu, Jun-Ling; Gao, Guo-Dong			Systemic Blockade of Dopamine D2-Like Receptors Increases High-Voltage Spindles in the Globus Pallidus and Motor Cortex of Freely Moving Rats	PLOS ONE			English	Article							HZ CORTICAL OSCILLATIONS; BASAL GANGLIA NETWORK; BRAIN; MODULATION; NUCLEUS; SPIKE; THALAMUS; ORGANIZATION; DEPLETION; DYNAMICS	High-voltage spindles (HVSs) have been reported to appear spontaneously and widely in the cortical-basal ganglia networks of rats. Our previous study showed that dopamine depletion can significantly increase the power and coherence of HVSs in the globus pallidus (GP) and motor cortex of freely moving rats. However, it is unclear whether dopamine regulates HVS activity by acting on dopamine D-1-like receptors or D-2-like receptors. We employed local-field potential and electrocorticogram methods to simultaneously record the oscillatory activities in the GP and primary motor cortex (M1) in freely moving rats following systemic administration of dopamine receptor antagonists or saline. The results showed that the dopamine D-2-like receptor antagonists, raclopride and haloperidol, significantly increased the number and duration of HVSs, and the relative power associated with HVS activity in the GP and M1 cortex. Coherence values for HVS activity between the GP and M1 cortex area were also significantly increased by dopamine D-2-like receptor antagonists. On the contrary, the selective dopamine D-1-like receptor antagonist, SCH23390, had no significant effect on the number, duration, or relative power of HVSs, or HVS-related coherence between M1 and GP. In conclusion, dopamine D-2-like receptors, but not D1-like receptors, were involved in HVS regulation. This supports the important role of dopamine D-2-like receptors in the regulation of HVSs. An siRNA knock-down experiment on the striatum confirmed our conclusion.	[Yang, Chen; Ge, Shun-Nan; Chen, Lei; Heng, Li-Jun; Zhao, Tian-Zhi; Li, Wei-Xin; Jia, Dong; Zhu, Jun-Ling; Gao, Guo-Dong] Fourth Mil Med Univ, Dept Neurosurg, Xian 710032, Peoples R China; [Zhang, Jia-Rui] Fourth Mil Med Univ, Dept Pathol, Tangdu Hosp, Xian 710032, Peoples R China; [Yan, Zhi-Qiang] Lanzhou Mil Command, Urumqi Gen Hosp, Dept Neurosurg, Urumqi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Zhu, JL (corresponding author), Fourth Mil Med Univ, Dept Neurosurg, Xian 710032, Peoples R China.	zhujl65@fmmu.edu.cn; tdgguodong@163.com		yang, chen/0000-0002-3575-3163	Key Program of the National Science Foundation of China [30930095]	Key Program of the National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the Key Program of the National Science Foundation of China (No. 30930095, to GDG and JLZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berendse HW, 2007, PARKINSONISM RELAT D, V13, pS440, DOI 10.1016/S1353-8020(08)70046-4; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; BUONAMICI M, 1986, NEUROPHARMACOLOGY, V25, P323, DOI 10.1016/0028-3908(86)90259-5; BUZSAKI G, 1990, NEUROSCIENCE, V36, P1, DOI 10.1016/0306-4522(90)90345-5; BUZSAKI G, 1991, EUR J NEUROSCI, V3, P222, DOI 10.1111/j.1460-9568.1991.tb00083.x; BUZSAKI G, 1988, J NEUROSCI, V8, P4007; BUZSAKI G, 1990, NEUROSCIENCE, V38, P323, DOI 10.1016/0306-4522(90)90031-X; Dejean C, 2008, J NEUROPHYSIOL, V100, P385, DOI 10.1152/jn.90466.2008; Dejean C, 2007, EUR J NEUROSCI, V25, P772, DOI 10.1111/j.1460-9568.2007.05305.x; Dejean C, 2011, J NEUROSCI, V31, P6098, DOI 10.1523/JNEUROSCI.3311-09.2011; Fontanini A, 2005, J NEUROPHYSIOL, V93, P2832, DOI 10.1152/jn.01035.2004; Garcia-Cabezas MA, 2007, NEUROIMAGE, V34, P965, DOI 10.1016/j.neuroimage.2006.07.032; Gasca-Martinez D, 2010, NEUROSCIENCE, V169, P1672, DOI 10.1016/j.neuroscience.2010.05.048; Ge SN, 2012, BRAIN RES, V1465, P66, DOI 10.1016/j.brainres.2012.05.002; GINGRICH JA, 1993, ANNU REV NEUROSCI, V16, P299, DOI 10.1146/annurev.ne.16.030193.001503; Hommel JD, 2003, NAT MED, V9, P1539, DOI 10.1038/nm964; Hosp JA, 2009, NEUROSCIENCE, V159, P692, DOI 10.1016/j.neuroscience.2008.12.056; Magill PJ, 2005, NEUROSCIENCE, V132, P659, DOI 10.1016/j.neuroscience.2005.01.006; Magill PJ, 2004, J NEUROPHYSIOL, V92, P2122, DOI 10.1152/jn.00333.2004; Mallet N, 2012, NEURON, V74, P1075, DOI 10.1016/j.neuron.2012.04.027; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Nicolelis MAL, 2002, NAT NEUROSCI, V5, P517, DOI 10.1038/nn0602-517; Noori-Daloii MR, 2012, MOL BIOL REP, V39, P2003, DOI 10.1007/s11033-011-0947-3; Paz JT, 2005, J NEUROSCI, V25, P2092, DOI 10.1523/JNEUROSCI.4689-04.2005; Pinault D, 2003, J PHYSIOL-LONDON, V552, P881, DOI 10.1113/jphysiol.2003.046573; Rodriguez M, 2008, CANCER RES, V68, P7872, DOI 10.1158/0008-5472.CAN-08-0301; Sadek AR, 2007, J NEUROSCI, V27, P6352, DOI 10.1523/JNEUROSCI.0953-07.2007; Sakata S, 2005, NEUROSCIENCE, V134, P1099, DOI 10.1016/j.neuroscience.2005.05.018; Sanchez-Gonzalez MA, 2005, J NEUROSCI, V25, P6076, DOI 10.1523/JNEUROSCI.0968-05.2005; SEMBA K, 1984, NEUROSCIENCE, V12, P761, DOI 10.1016/0306-4522(84)90168-4; Shaw FZ, 2004, J NEUROPHYSIOL, V91, P63, DOI 10.1152/jn.00487.2003; Smith Y, 1998, NEUROSCIENCE, V86, P353; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Sun FT, 2005, NEUROIMAGE, V28, P227, DOI 10.1016/j.neuroimage.2005.05.043; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Tancredi V, 2000, J NEUROPHYSIOL, V84, P1093, DOI 10.1152/jn.2000.84.2.1093; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750; Wiest MC, 2003, NAT NEUROSCI, V6, P913, DOI 10.1038/nn1107; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	41	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64637	10.1371/journal.pone.0064637	http://dx.doi.org/10.1371/journal.pone.0064637			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755132	Green Submitted, gold, Green Published			2022-12-27	WOS:000320579400021
J	Mucksch, C; Urbassek, HM				Muecksch, Christian; Urbassek, Herbert M.			Enhancing Protein Adsorption Simulations by Using Accelerated Molecular Dynamics	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; HYDROPHOBIC SURFACE; GRAPHITE SURFACE; SOLID-SURFACES; LIQUID WATER; BMP-2; OSTEOINTEGRATION; EFFICIENT; LYSOZYME; SYSTEMS	The atomistic modeling of protein adsorption on surfaces is hampered by the different time scales of the simulation (<< 1 ms) and experiment (up to hours), and the accordingly different 'final' adsorption conformations. We provide evidence that the method of accelerated molecular dynamics is an efficient tool to obtain equilibrated adsorption states. As a model system we study the adsorption of the protein BMP-2 on graphite in an explicit salt water environment. We demonstrate that due to the considerably improved sampling of conformational space, accelerated molecular dynamics allows to observe the complete unfolding and spreading of the protein on the hydrophobic graphite surface. This result is in agreement with the general finding of protein denaturation upon contact with hydrophobic surfaces.	[Urbassek, Herbert M.] Univ Kaiserslautern, Dept Phys, D-67663 Kaiserslautern, Germany; Univ Kaiserslautern, Res Ctr OPTIMAS, D-67663 Kaiserslautern, Germany	University of Kaiserslautern; University of Kaiserslautern	Urbassek, HM (corresponding author), Univ Kaiserslautern, Dept Phys, D-67663 Kaiserslautern, Germany.	urbassek@rhrk.uni-kl.de	Urbassek, Herbert/D-4361-2019	Urbassek, Herbert/0000-0002-7739-4453				Aijun Zuo, 2008, 2008 2nd International Conference on Bioinformatics and Biomedical Engineering (ICBBE '08), P888; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Oliveira CAF, 2006, J PHYS CHEM B, V110, P22695, DOI 10.1021/jp062845o; Dong XL, 2007, BIOPHYS J, V93, P750, DOI 10.1529/biophysj.106.103168; Fowkes FM, 1940, J AM CHEM SOC, V62, P3377, DOI 10.1021/ja01869a029; Gray JJ, 2004, CURR OPIN STRUC BIOL, V14, P110, DOI 10.1016/j.sbi.2003.12.001; Grimme S., 2008, ANGEW CHEM, V120, P3478; GRUBMULLER H, 1995, PHYS REV E, V52, P2893, DOI 10.1103/PhysRevE.52.2893; Hamelberg D, 2004, J CHEM PHYS, V120, P11919, DOI 10.1063/1.1755656; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jennissen HP, 2002, ANN NY ACAD SCI, V961, P139, DOI 10.1111/j.1749-6632.2002.tb03067.x; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Lange OE, 2006, J COMPUT CHEM, V27, P1693, DOI 10.1002/jcc.20473; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mucksch C, 2011, CHEM PHYS LETT, V510, P252, DOI 10.1016/j.cplett.2011.05.036; Nakanishi K, 2001, J BIOSCI BIOENG, V91, P233, DOI 10.1016/S1389-1723(01)80127-4; Oliveira AF, 2010, MATERIALWISS WERKST, V41, P1048, DOI 10.1002/mawe.201000707; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pierce LCT, 2012, J CHEM THEORY COMPUT, V8, P2997, DOI 10.1021/ct300284c; Raffaini G, 2004, J PHYS CHEM B, V108, P13850, DOI 10.1021/jp0477452; Raffaini G, 2003, LANGMUIR, V19, P3403, DOI 10.1021/la026853h; Raffaini G, 2010, LANGMUIR, V26, P5679, DOI 10.1021/la903769c; Rajesh C., 2009, J CHEM PHYS, V130; Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sachse A, 2005, BONE, V37, P699, DOI 10.1016/j.bone.2005.06.011; Scheufler C, 1999, J MOL BIOL, V287, P103, DOI 10.1006/jmbi.1999.2590; Stone, 1998, EFFICIENT LIB PARALL; Sun Y, 2007, J COMPUT CHEM, V28, P1883, DOI 10.1002/jcc.20716; Svaldo-Lanero T, 2008, SOFT MATTER, V4, P965, DOI 10.1039/b800621k; Utesch T, 2011, LANGMUIR, V27, P13144, DOI 10.1021/la202489w; Voter AF, 1997, PHYS REV LETT, V78, P3908, DOI 10.1103/PhysRevLett.78.3908; Wang F, 2008, BIOINTERPHASES, V3, P9, DOI 10.1116/1.2840054; Wang Y, 2011, J CHEM THEORY COMPUT, V7, P3199, DOI 10.1021/ct200430c; Wang YK, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.015002; Wei T, 2011, LANGMUIR, V27, P12074, DOI 10.1021/la202622s; Werder T., 2002, J AM CHEM SOC, V107, P1345; Wereszczynski J, 2012, METHODS MOL BIOL, V819, P515, DOI 10.1007/978-1-61779-465-0_30; Winter M, 2009, CHIR MAIN, V28, P158, DOI 10.1016/j.main.2009.02.003; Xin Y, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3432761; Zuckerman DM, 2011, ANNU REV BIOPHYS, V40, P41, DOI 10.1146/annurev-biophys-042910-155255	43	28	28	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64883	10.1371/journal.pone.0064883	http://dx.doi.org/10.1371/journal.pone.0064883			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755156	Green Published, gold, Green Submitted			2022-12-27	WOS:000319872300035
J	Muscatello, DJ; Newall, AT; Dwyer, DE; MacIntyre, CR				Muscatello, David J.; Newall, Anthony T.; Dwyer, Dominic E.; MacIntyre, C. Raina			Mortality Attributable to Seasonal and Pandemic Influenza, Australia, 2003 to 2009, Using a Novel Time Series Smoothing Approach	PLOS ONE			English	Article							PARTICULATE AIR-POLLUTION; NEW-SOUTH-WALES; UNITED-STATES; DEATHS; PNEUMONIA; MATTER; VIRUS	Background: Official statistics under-estimate influenza deaths. Time series methods allow the estimation of influenza-attributable mortality. The methods often model background, non-influenza mortality using a cyclic, harmonic regression model based on the Serfling approach. This approach assumes that the seasonal pattern of non-influenza mortality is the same each year, which may not always be accurate. Aim: To estimate Australian seasonal and pandemic influenza-attributable mortality from 2003 to 2009, and to assess a more flexible influenza mortality estimation approach. Methods: We used a semi-parametric generalized additive model (GAM) to replace the conventional seasonal harmonic terms with a smoothing spline of time ('spline model') to estimate influenza-attributable respiratory, respiratory and circulatory, and all-cause mortality in persons aged <65 and >= 65 years. Influenza A(H1N1)pdm09, seasonal influenza A and B virus laboratory detection time series were used as independent variables. Model fit and estimates were compared with those of a harmonic model. Results: Compared with the harmonic model, the spline model improved model fit by up to 20%. In <65 year-olds, the estimated respiratory mortality attributable to pandemic influenza A(H1N1)pdm09 was 0.5 (95% confidence interval (CI), 0.3, 0.7) per 100,000; similar to that of the years with the highest seasonal influenza A mortality, 2003 and 2007 (A/H3N2 years). In >= 65 year-olds, the highest annual seasonal influenza A mortality estimate was 25.8 (95% CI 22.2, 29.5) per 100,000 in 2003, five-fold higher than the non-statistically significant 2009 pandemic influenza estimate in that age group. Seasonal influenza B mortality estimates were negligible. Conclusions: The spline model achieved a better model fit. The study provides additional evidence that seasonal influenza, particularly A/H3N2, remains an important cause of mortality in Australia and that the epidemic of pandemic influenza A (H1N1)pdm09 virus in 2009 did not result in mortality greater than seasonal A/H3N2 influenza mortality, even in younger age groups.	[Muscatello, David J.; Newall, Anthony T.; MacIntyre, C. Raina] Univ New S Wales, Sch Publ Hlth & Community Med, Kensington, NSW 2033, Australia; [Dwyer, Dominic E.] Univ Sydney, Ctr Infect Dis, Sydney, NSW 2006, Australia; [Dwyer, Dominic E.] Univ Sydney, Microbiol Lab Serv, Inst Clin Pathol & Med Res, Westmead Hosp, Sydney, NSW 2006, Australia; [Dwyer, Dominic E.] Univ Sydney, Sydney Inst Emerging Infect & Biosecur, Sydney, NSW 2006, Australia	University of New South Wales Sydney; University of Sydney; University of Sydney; University of Sydney	Muscatello, DJ (corresponding author), Univ New S Wales, Sch Publ Hlth & Community Med, POB 1, Kensington, NSW 2033, Australia.	dmusc@doh.health.nsw.gov.au	Muscatello, David/HDO-2537-2022; Muscatello, David/AAD-9134-2019	Newall, Anthony/0000-0003-0836-1065; MacIntyre, C Raina/0000-0002-3060-0555				*AUSTR GOV DEP HLT, 2009, INFL SURV REP, V23; *AUSTR GOV DEP HLT, 2009, INFL SURV REP, V32; Australian Bureau of Statistics, 2010, 3101 0 AUSTR DEM STA; Australian Bureau of Statistics, 2009, CAUS DEATH AUSTR 200; Barreca AI, 2012, AM J EPIDEMIOL, V176, pS114, DOI 10.1093/aje/kws259; Blyth CC, 2009, NEW ENGL J MED, V361, P2493, DOI 10.1056/NEJMc0909049; BOWIE C, 1981, INT J EPIDEMIOL, V10, P87, DOI 10.1093/ije/10.1.87; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Charu V, 2011, CLIN INFECT DIS, V53, P985, DOI 10.1093/cid/cir644; Chen RJ, 2012, AM J EPIDEMIOL, V175, P1173, DOI 10.1093/aje/kwr425; Collins SD, 1930, PUBLIC HEALTH REP, V45, P2277, DOI 10.2307/4579795; Davies A, 2009, JAMA-J AM MED ASSOC, V302, P1888, DOI 10.1001/jama.2009.1535; Dawood F., 2012, LANCET INFECT DIS; Diggle P, 1990, TIME SERIES BIOSTATI; Dominici F, 2002, AM J EPIDEMIOL, V156, P193, DOI 10.1093/aje/kwf062; FARR W, 1885, VITAL STATISTICS, P330; Goldstein E, 2012, EPIDEMIOLOGY, V23, P829, DOI 10.1097/EDE.0b013e31826c2dda; Hardelid P, 2012, INFLUENZA OTHER RESP; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Iwasenko JM, 2010, CLIN INFECT DIS, V51, P70, DOI 10.1086/653610; Kok J, 2010, J CLIN MICROBIOL, V48, P290, DOI 10.1128/JCM.01465-09; LANGMUIR AD, 1969, B WORLD HEALTH ORGAN, V41, P393; Lemaitre M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045051; McCullagh P, 1989, GEN LINEAR MODELS; Muscatello DJ, 2011, EMERG INFECT DIS, V17, P1240, DOI 10.3201/eid1707.101173; *NEW S WAL PUBL HL, 2009, EURO SURVEILL, V14; Newall AT, 2010, EPIDEMIOL INFECT, V138, P836, DOI 10.1017/S095026880999118X; Nicoll A, 2012, EURO SURVEILL, V3, P17; Nielsen J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-350; Nunes B, 2011, STAT METHODS MED RES, V20, P331, DOI 10.1177/0962280209340201; Nunes B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020661; Ostro B, 2006, ENVIRON HEALTH PERSP, V114, P29, DOI 10.1289/ehp.8335; Peng RD, 2006, J R STAT SOC A STAT, V169, P179, DOI 10.1111/j.1467-985X.2006.00410.x; Rizzo C, 2007, EMERG INFECT DIS, V13, P694, DOI 10.3201/eid1305.061309; Samoli E, 2005, ENVIRON HEALTH PERSP, V113, P88, DOI 10.1289/ehp.7387; *SAS I, 2008, GAM PROC; Schaffer A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-869; Schwartz J, 1996, J EPIDEMIOL COMMUN H, V50, pS3, DOI 10.1136/jech.50.Suppl_1.S3; SERFLING RE, 1963, PUBLIC HEALTH REP, V78, P494, DOI 10.2307/4591848; SHUMWAY RH, 2000, TIME SERIES ANAL ITS; Thompson WW, 2009, INFLUENZA OTHER RESP, V3, P37, DOI 10.1111/j.1750-2659.2009.00073.x; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; *UN DOEASA PD, 2011, WORLD POP PROSP 2010; *US CDCP, 2004, MMWR-MORBID MORTAL W, V53, P8; van den Wijngaard CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031197; Viboud C, 2004, EMERG INFECT DIS, V10, P32, DOI 10.3201/eid1001.020705; Vichit-Vadakan N, 2008, ENVIRON HEALTH PERSP, V116, P1179, DOI 10.1289/ehp.10849; World Health Organization, FLUNET; Yang L, 2011, EPIDEMIOL INFECT, P1; Yang L, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-342; Yohannes Keflemariam, 2004, Commun Dis Intell Q Rep, V28, P160; Yu WW, 2012, INT J BIOMETEOROL, V56, P569, DOI 10.1007/s00484-011-0497-3	52	33	34	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64734	10.1371/journal.pone.0064734	http://dx.doi.org/10.1371/journal.pone.0064734			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755139	gold, Green Published, Green Submitted			2022-12-27	WOS:000319872300026
J	Reddy, AS; Patel, JR; Vogler, C; Klein, RS; Sands, MS				Reddy, Adarsh S.; Patel, Jigisha R.; Vogler, Carole; Klein, Robyn S.; Sands, Mark S.			Central Nervous System Pathology Progresses Independently of KC and CXCR2 in Globoid-Cell Leukodystrophy	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; MURINE MODEL; ATHEROSCLEROTIC LESIONS; TWITCHER MOUSE; GENE-THERAPY; SPINAL-CORD; EXPRESSION; OLIGODENDROCYTES; MICE; INTERLEUKIN-8	Globoid-cell Leukodystrophy (GLD; Krabbes disease) is a rapidly progressing inherited demyelinating disease caused by a deficiency of the lysosomal enzyme Galactosylceramidase (GALC). Deficiency of GALC leads to altered catabolism of galactosylceramide and the cytotoxic lipid, galactosylsphingosine (psychosine). This leads to a rapidly progressive fatal disease with spasticity, cognitive disability and seizures. The murine model of GLD (Twitcher; GALC-/-) lacks the same enzyme and has similar clinical features. The deficiency of GALC leads to oligodendrocyte death, profound neuroinflammation, and the influx of activated macrophages into the CNS. We showed previously that keratinocyte chemoattractant factor (KC) is highly elevated in the CNS of untreated Twitcher mice and significantly decreases after receiving a relatively effective therapy (bone marrow transplantation combined with gene therapy). The action of KC is mediated through the CXCR2 receptor and is a potent chemoattractant for macrophages and microglia. KC is also involved in oligodendrocyte migration and proliferation. Based on the commonalities between the disease presentation and the functions of KC, we hypothesized that KC and/or CXCR2 contribute to the pathogenesis of GLD. Interestingly, the course of the disease is not significantly altered in KC- or CXCR2-deficient Twitcher mice. There is also no alteration in inflammation or demyelination patterns in these mice. Furthermore, transplantation of CXCR2-deficient bone marrow does not alter the progression of the disease as it does in other models of demyelination. This study highlights the role of multiple redundant cytokines and growth factors in the pathogenesis of GLD.	[Reddy, Adarsh S.; Klein, Robyn S.; Sands, Mark S.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Patel, Jigisha R.; Klein, Robyn S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Klein, Robyn S.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Vogler, Carole] St Louis Univ, Sch Med, Dept Pathol, St Louis, MO 63104 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Saint Louis University	Sands, MS (corresponding author), Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA.	msands@dom.wustl.edu		Sands, Mark/0000-0002-5559-0832	National Institutes of Health (NIH) [R01 HD055461]; NIH [R01 NS 043205]; Hunters Hope foundation; National Tay-Sachs and Allied Diseases Association [RG4371 NMSS, R01 NS 052632]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD055461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052632, R01NS084861, R01NS043205] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hunters Hope foundation; National Tay-Sachs and Allied Diseases Association; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health (NIH) R01 HD055461 and NIH R01 NS 043205 (MS), Hunters Hope foundation and National Tay-Sachs and Allied Diseases Association (AR), RG4371 NMSS grant and R01 NS 052632 (RK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGGIOLINI M, 1995, INT J IMMUNOPHARMACO, V17, P103, DOI 10.1016/0192-0561(94)00088-6; Biswas S, 2001, J NEUROSCI RES, V65, P298, DOI 10.1002/jnr.1154; Boisvert WA, 2006, AM J PATHOL, V168, P1385, DOI 10.2353/ajpath.2006.040748; Boisvert WA, 1998, J CLIN INVEST, V101, P353, DOI 10.1172/JCI1195; BOZIC CR, 1994, J BIOL CHEM, V269, P29355; Brat DJ, 2005, NEURO-ONCOLOGY, V7, P122, DOI 10.1215/S1152851704001061; Carlson T, 2008, J EXP MED, V205, P811, DOI 10.1084/jem.20072404; Clausen BH, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-46; Ezoe T, 2000, J NEUROSCI RES, V59, P179, DOI 10.1002/(SICI)1097-4547(20000115)59:2<179::AID-JNR4>3.3.CO;2-E; Giri S, 2006, J LIPID RES, V47, P1478, DOI 10.1194/jlr.M600084-JLR200; HOOGERBRUGGE PM, 1988, J CLIN INVEST, V81, P1790, DOI 10.1172/JCI113521; Horuk R, 1997, J IMMUNOL, V158, P2882; Hulse RE, 2004, J NEUROSCI METH, V136, P87, DOI 10.1016/j.jneumeth.2003.12.023; IDA H, 1990, MOL CHEM NEUROPATHOL, V13, P195, DOI 10.1007/BF03159922; IGISU H, 1984, SCIENCE, V224, P753, DOI 10.1126/science.6719111; KOBAYASHI T, 1980, BRAIN RES, V202, P479, DOI 10.1016/0006-8993(80)90159-6; LEVINE SM, 1992, BRAIN RES, V587, P348, DOI 10.1016/0006-8993(92)91018-A; LeVine SM, 1997, J NEUROIMMUNOL, V73, P47, DOI 10.1016/S0165-5728(96)00166-X; Lin DH, 2007, MOL THER, V15, P44, DOI 10.1038/sj.mt.6300026; Liu LP, 2010, J NEUROSCI, V30, P9074, DOI 10.1523/JNEUROSCI.1238-10.2010; Liu LP, 2010, NAT NEUROSCI, V13, P319, DOI 10.1038/nn.2491; Luzi P, 2009, BRAIN RES, V1300, P146, DOI 10.1016/j.brainres.2009.09.017; MATSUSHIMA GK, 1994, CELL, V78, P645, DOI 10.1016/0092-8674(94)90529-0; McCandless EE, 2006, J IMMUNOL, V177, P8053, DOI 10.4049/jimmunol.177.11.8053; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Patel JR, 2011, FEBS LETT, V585, P3730, DOI 10.1016/j.febslet.2011.04.037; Reddy AS, 2011, J NEUROSCI, V31, P9945, DOI 10.1523/JNEUROSCI.1802-11.2011; Ripoll CB, 2011, STEM CELLS, V29, P67, DOI 10.1002/stem.555; Robinson S, J NEUROSCIENCE OFF J, V18, P10457; Sakai N, 1996, J NEUROCHEM, V66, P1118, DOI 10.1046/j.1471-4159.1996.66031118.x; SANDS MS, 1993, LAB INVEST, V68, P676; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Tani M, 1996, J CLIN INVEST, V98, P529, DOI 10.1172/JCI118821; TANIIKE M, 1995, J NEUROSCI RES, V40, P325, DOI 10.1002/jnr.490400306; Taniike M, 1999, J NEUROPATH EXP NEUR, V58, P644, DOI 10.1097/00005072-199906000-00009; Tsai HH, 2002, CELL, V110, P373, DOI 10.1016/S0092-8674(02)00838-3; van Loo G, 2006, NAT IMMUNOL, V7, P954, DOI 10.1038/ni1372; Wenger DA, 2007, GALACTOSYLCERAMIDE L; Wenzel P, 2011, CIRCULATION, V124, P1370, DOI 10.1161/CIRCULATIONAHA.111.034470; Wu Q, 2000, J NEUROSCI, V20, P2609; Wu YP, 2001, J NEUROPATH EXP NEUR, V60, P1062, DOI 10.1093/jnen/60.11.1062; YEAGER AM, 1984, SCIENCE, V225, P1052, DOI 10.1126/science.6382609	42	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64647	10.1371/journal.pone.0064647	http://dx.doi.org/10.1371/journal.pone.0064647			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755134	Green Published, gold, Green Submitted			2022-12-27	WOS:000319872300022
J	Sharma, N; Sequea, DA; Castorena, CM; Arias, EB; Qi, NR; Cartee, GD				Sharma, Naveen; Sequea, Donel A.; Castorena, Carlos M.; Arias, Edward B.; Qi, Nathan R.; Cartee, Gregory D.			Heterogeneous Effects of Calorie Restriction on In Vivo Glucose Uptake and Insulin Signaling of Individual Rat Skeletal Muscles	PLOS ONE			English	Article							BRIEF DIETARY RESTRICTION; INCREASES INSULIN; AKT2 PHOSPHORYLATION; RECEPTOR SUBSTRATE-1; FOOD RESTRICTION; TRANSPORT; SENSITIVITY; EXERCISE; PROTEIN; GLUT4	Calorie restriction (CR) (consuming,60% of ad libitum, AL, intake) improves whole body insulin sensitivity and enhances insulin-stimulated glucose uptake by isolated skeletal muscles. However, little is known about CR-effects on in vivo glucose uptake and insulin signaling in muscle. Accordingly, 9-month-old male AL and CR (initiated when 3-months-old) Fischer 344xBrown Norway rats were studied using a euglycemic-hyperinsulinemic clamp with plasma insulin elevated to a similar level (similar to 140 mu U/ml) in each diet group. Glucose uptake (assessed by infusion of [C-14]-2-deoxyglucose, 2-DG), phosphorylation of key insulin signaling proteins (insulin receptor, Akt and Akt substrate of 160kDa, AS160), abundance of GLUT4 and hexokinase proteins, and muscle fiber type composition (myosin heavy chain, MHC, isoform percentages) were determined in four predominantly fast-twitch (epitrochlearis, gastrocnemius, tibialis anterior, plantaris) and two predominantly slow-twitch (soleus, adductor longus) muscles. CR did not result in greater GLUT4 or hexokinase abundance in any of the muscles, and there were no significant diet-related effects on percentages of MHC isoforms. Glucose infusion was greater for CR versus AL rats (P<0.05) concomitant with significantly (P<0.05) elevated 2-DG uptake in 3 of the 4 fast-twitch muscles (epitrochlearis, gastrocnemius, tibialis anterior), without a significant diet-effect on 2-DG uptake by the plantaris or either slow-twitch muscle. Each of the muscles with a CR-related increase in 2-DG uptake was also characterized by significant (P<0.05) increases in phosphorylation of both Akt and AS160. Among the 3 muscles without a CR-related increase in glucose uptake, only the soleus had significant (P<0.05) CR-related increases in Akt and AS160 phosphorylation. The current data revealed that CR leads to greater whole body glucose disposal in part attributable to elevated in vivo insulin-stimulated glucose uptake by fast-twitch muscles. The results also demonstrated that CR does not uniformly enhance either insulin signaling or insulin-stimulated glucose uptake in all muscles in vivo.	[Sharma, Naveen; Castorena, Carlos M.; Arias, Edward B.; Cartee, Gregory D.] Univ Michigan, Sch Kinesiol, Muscle Biol Lab, Ann Arbor, MI 48109 USA; [Sequea, Donel A.; Cartee, Gregory D.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Qi, Nathan R.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Cartee, Gregory D.] Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Cartee, GD (corresponding author), Univ Michigan, Sch Kinesiol, Muscle Biol Lab, Ann Arbor, MI 48109 USA.	gcartee@umich.edu	Sharma, Naveen/K-6672-2015	Sharma, Naveen/0000-0003-4705-5116; Cartee, Gregory/0000-0001-5311-1722	National Institutes of Health [AG-010026, AG-013283, T32-AG000114, DK-089503]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, P30DK089503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000114, R01AG010026, P30AG013283, R29AG010026] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants AG-010026, AG-013283, T32-AG000114, and DK-089503. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arciero PJ, 1999, J APPL PHYSIOL, V86, P1930, DOI 10.1152/jappl.1999.86.6.1930; CARTEE GD, 1994, AM J PHYSIOL, V266, pR1443, DOI 10.1152/ajpregu.1994.266.5.R1443; CARTEE GD, 1994, AM J PHYSIOL, V266, pE946, DOI 10.1152/ajpendo.1994.266.6.E946; Cartee GD, 2007, APPL PHYSIOL NUTR ME, V32, P557, DOI 10.1139/H07-026; Cartee GD, 2009, EXERC SPORT SCI REV, V37, P188, DOI 10.1097/JES.0b013e3181b7b7c5; Davidson RT, 2002, AM J PHYSIOL-ENDOC M, V282, pE270, DOI 10.1152/ajpendo.00232.2001; Dean DJ, 1996, J GERONTOL A-BIOL, V51, pB208, DOI 10.1093/gerona/51A.3.B208; Dean DJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE957, DOI 10.1152/ajpendo.1998.275.6.E957; Dean DJ, 1998, AGING-CLIN EXP RES, V10, P303, DOI 10.1007/BF03339792; Dean DJ, 2000, ACTA PHYSIOL SCAND, V169, P133, DOI 10.1046/j.1365-201x.2000.00723.x; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; Escriva F, 2007, J ENDOCRINOL, V194, P131, DOI 10.1677/joe.1.07043; Feuers RJ, 1995, DIETARY RESTRICTION, P181; Gazdag AC, 2000, J GERONTOL A-BIOL, V55, pB44; Gazdag AC, 2000, AM J PHYSIOL-REG I, V278, pR504, DOI 10.1152/ajpregu.2000.278.2.R504; Gazdag AC, 1999, DIABETES, V48, P1930, DOI 10.2337/diabetes.48.10.1930; Gazdag AC, 1998, BIOCHEM BIOPH RES CO, V252, P733, DOI 10.1006/bbrc.1998.9713; Geiger PC, 2003, J APPL PHYSIOL, V95, P611, DOI 10.1152/japplphysiol.00862.2002; Gupta G, 2000, AM J PHYSIOL-REG I, V278, pR111, DOI 10.1152/ajpregu.2000.278.1.R111; Halseth AE, 1999, AM J PHYSIOL-ENDOC M, V276, pE70, DOI 10.1152/ajpendo.1999.276.1.E70; Halseth AE, 2001, AM J PHYSIOL-ENDOC M, V280, pE994, DOI 10.1152/ajpendo.2001.280.6.E994; HENRIKSEN EJ, 1990, AM J PHYSIOL, V259, pE593, DOI 10.1152/ajpendo.1990.259.4.E593; IVY JL, 1991, MECH AGEING DEV, V61, P123, DOI 10.1016/0047-6374(91)90011-N; JAMES DE, 1985, AM J PHYSIOL, V248, pE567, DOI 10.1152/ajpendo.1985.248.5.E567; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; KEMNITZ JW, 1994, AM J PHYSIOL, V266, pE540, DOI 10.1152/ajpendo.1994.266.4.E540; Kramer HF, 2006, J BIOL CHEM, V281, P31478, DOI 10.1074/jbc.M605461200; Lang G., 1974, METHODS ENZYMATIC AN, P1238; Lawler DF, 2008, BRIT J NUTR, V99, P793, DOI 10.1017/S0007114507871686; McCurdy CE, 2005, DIABETES, V54, P1349, DOI 10.2337/diabetes.54.5.1349; McCurdy CE, 2005, AM J PHYSIOL-ENDOC M, V288, pE996, DOI 10.1152/ajpendo.00566.2004; McCurdy CE, 2003, AM J PHYSIOL-ENDOC M, V285, pE693, DOI 10.1152/ajpendo.00224.2003; Petersen HA, 2003, AM J PHYSIOL-ENDOC M, V284, pE541, DOI 10.1152/ajpendo.00323.2002; Petersen KF, 2012, P NATL ACAD SCI US; Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Schenk S, 2011, J CLIN INVEST, V121, P4281, DOI 10.1172/JCI58554; Sequea DA, 2012, J GERONTOL A; Sharma N, 2012, AM J PHYSL REGUL INT; Sharma N, 2012, BBA-MOL BASIS DIS, V1822, P1735, DOI 10.1016/j.bbadis.2012.07.012; Sharma N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038835; Sharma N, 2011, AM J PHYSIOL-ENDOC M, V300, pE966, DOI 10.1152/ajpendo.00659.2010; TALMADGE RJ, 1993, J APPL PHYSIOL, V75, P2337, DOI 10.1152/jappl.1993.75.5.2337; Tonge DP, 2010, OSTEOARTHR CARTILAGE, V18, P555, DOI 10.1016/j.joca.2009.11.014; WING RR, 1994, DIABETES CARE, V17, P30, DOI 10.2337/diacare.17.1.30	45	8	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65118	10.1371/journal.pone.0065118	http://dx.doi.org/10.1371/journal.pone.0065118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755179	gold, Green Published, Green Submitted			2022-12-27	WOS:000319872300049
J	Johnson, MS; Couto, EG; Pinto, OB; Milesi, J; Amorim, RSS; Messias, IAM; Biudes, MS				Johnson, Mark S.; Couto, Eduardo Guimaraes; Pinto, Osvaldo B., Jr.; Milesi, Juliana; Amorim, Ricardo S. Santos; Messias, Indira A. M.; Biudes, Marcelo Sacardi			Soil CO2 Dynamics in a Tree Island Soil of the Pantanal: The Role of Soil Water Potential	PLOS ONE			English	Article							CARBON-DIOXIDE; MATO-GROSSO; RESPIRATION; EFFLUX; FOREST; CONSERVATION; EVERGLADES; LITTERFALL; WETLAND; FLUXES	The Pantanal is a biodiversity hotspot comprised of a mosaic of landforms that differ in vegetative assemblages and flooding dynamics. Tree islands provide refuge for terrestrial fauna during the flooding period and are particularly important to the regional ecosystem structure. Little soil CO2 research has been conducted in this region. We evaluated soil CO2 dynamics in relation to primary controlling environmental parameters ( soil temperature and soil water). Soil respiration was computed using the gradient method using in situ infrared gas analyzers to directly measure CO2 concentration within the soil profile. Due to the cost of the sensors and associated equipment, this study was unreplicated. Rather, we focus on the temporal relationships between soil CO2 efflux and related environmental parameters. Soil CO2 efflux during the study averaged 3.53 mu mol CO2 m(-2) s(-1), and was equivalent to an annual soil respiration of 1220 g C m(-2) y(-1). This efflux value, integrated over a year, is comparable to soil C stocks for 0-20 cm. Soil water potential was the measured parameter most strongly associated with soil CO2 concentrations, with high CO2 values observed only once soil water potential at the 10 cm depth approached zero. This relationship was exhibited across a spectrum of timescales and was found to be significant at a daily timescale across all seasons using conditional nonparametric spectral Granger causality analysis. Hydrology plays a significant role in controlling CO2 efflux from the tree island soil, with soil CO2 dynamics differing by wetting mechanism. During the wet-up period, direct precipitation infiltrates soil from above and results in pulses of CO2 efflux from soil. The annual flood arrives later, and saturates soil from below. While CO2 concentrations in soil grew very high under both wetting mechanisms, the change in soil CO2 efflux was only significant when soils were wet from above.	[Johnson, Mark S.] Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC V5Z 1M9, Canada; [Johnson, Mark S.] Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC V5Z 1M9, Canada; [Couto, Eduardo Guimaraes; Milesi, Juliana; Amorim, Ricardo S. Santos; Messias, Indira A. M.] Univ Fed Mato Grosso, Dept Soil Sci, Cuiaba, MG, Brazil; [Couto, Eduardo Guimaraes] Univ Fed Mato Grosso, Program Trop Agr, Cuiaba, MG, Brazil; [Couto, Eduardo Guimaraes] Univ Fed Mato Grosso, Program Ecol & Biodivers, Cuiaba, MG, Brazil; [Pinto, Osvaldo B., Jr.; Biudes, Marcelo Sacardi] Univ Fed Mato Grosso, Dept Environm Biophys, Cuiaba, MG, Brazil	University of British Columbia; University of British Columbia; Universidade Federal de Mato Grosso; Universidade Federal de Mato Grosso; Universidade Federal de Mato Grosso; Universidade Federal de Mato Grosso	Johnson, MS (corresponding author), Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC V5Z 1M9, Canada.	mark.johnson@ubc.ca	Couto, Eduardo Guimarães/E-4240-2010; Biudes, Marcelo Sacardi/G-6900-2012; Pinto, Osvaldo/C-2756-2013; Johnson, Mark S./B-4445-2008; Couto, Eduardo Guimarães/AAF-5790-2019; AMORIM, RICARDO S S/K-2587-2012	Couto, Eduardo Guimarães/0000-0002-5271-9709; Biudes, Marcelo Sacardi/0000-0002-0795-8946; Pinto, Osvaldo/0000-0003-2653-5460; Johnson, Mark S./0000-0001-5070-7539; Couto, Eduardo Guimarães/0000-0002-5271-9709; AMORIM, RICARDO S S/0000-0002-4570-1770; Jose de Messias Reason, Iara/0000-0002-5573-260X	National Science and Engineering Research Council of Canada (NSERC); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico do Brasil (Brazilian National Council for Science and Technology (CNPq)) [MCT/CNPq 15/2007]; Brazilian National Research Institute for Humid Areas - Instituto Nacional de Areas Umidas (INAU)	National Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico do Brasil (Brazilian National Council for Science and Technology (CNPq))(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian National Research Institute for Humid Areas - Instituto Nacional de Areas Umidas (INAU)	The research was supported by Discovery Grant funding to MSJ from the National Science and Engineering Research Council of Canada (NSERC) and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico do Brasil (Brazilian National Council for Science and Technology (CNPq)) funding to EGC through the program Edital MCT/CNPq 15/2007. Funding was also provided by the Brazilian National Research Institute for Humid Areas - Instituto Nacional de Areas Umidas (INAU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldocchi D, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000063; Batalha M. A., 2005, Braz. J. Biol., V65, P735, DOI 10.1590/S1519-69842005000400021; Bauer J, 2012, BIOGEOCHEMISTRY, V108, P119, DOI 10.1007/s10533-011-9583-1; Bengtsson H, 2013, RBASIC R CLASS LIB S; Bond-Lamberty B, 2010, BIOGEOSCIENCES, V7, P1915, DOI 10.5194/bg-7-1915-2010; Cardoso EL, 2009, PESQUI AGROPECU BRAS, V44, P631, DOI 10.1590/S0100-204X2009000600012; Cook FJ, 2008, SOIL BIOL BIOCHEM, V40, P1013, DOI 10.1016/j.soilbio.2007.12.012; Couto E.G., 2011, PANTANAL ECOLOGY BIO, P71; Detto M, 2012, AM NAT, V179, P524, DOI 10.1086/664628; Dominguez E, 2011, J HYDROINFORM, V13, P429, DOI 10.2166/hydro.2010.116; Fierer N, 2003, SOIL SCI SOC AM J, V67, P798, DOI 10.2136/sssaj2003.0798; Fischer T, 2009, SOIL BIOL BIOCHEM, V41, P1577, DOI 10.1016/j.soilbio.2009.04.009; Flechard CR, 2007, AGR FOREST METEOROL, V142, P66, DOI 10.1016/j.agrformet.2006.11.006; Girard P, 2010, HYDROBIOLOGIA, V638, P223, DOI 10.1007/s10750-009-0046-9; Gouhier T. C., 2012, **DATA OBJECT**; GRANGER CWJ, 1988, J ECONOMETRICS, V39, P199, DOI 10.1016/0304-4076(88)90045-0; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Haase R, 1999, FOREST ECOL MANAG, V117, P129, DOI 10.1016/S0378-1127(98)00477-0; Hanan EJ, 2010, LANDSCAPE ECOL, V25, P463, DOI 10.1007/s10980-009-9426-9; Hatala JA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051303; Jassal R, 2005, AGR FOREST METEOROL, V130, P176, DOI 10.1016/j.agrformet.2005.03.005; Jassal RS, 2004, AGR FOREST METEOROL, V124, P219, DOI 10.1016/j.agrformet.2004.01.013; Jauhiainen J, 2005, GLOBAL CHANGE BIOL, V11, P1788, DOI 10.1111/j.1365-2486.2005.001031.x; Johnson MS, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034619; Junk WJ, 2005, ECOL ENG, V24, P391, DOI 10.1016/j.ecoleng.2004.11.012; Junk WJ, 2006, AQUAT SCI, V68, P278, DOI 10.1007/s00027-006-0851-4; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; Keddy PA, 2009, BIOSCIENCE, V59, P39, DOI 10.1525/bio.2009.59.1.8; Kim DG, 2012, BIOGEOSCIENCES, V9, P2459, DOI 10.5194/bg-9-2459-2012; Lafleur PM, 2009, GEOGR COMPASS, V3, P560, DOI 10.1111/j.1749-8198.2008.00212.x; Lambrakis N, 2004, WATER RES, V38, P1862, DOI 10.1016/j.watres.2004.01.009; Lavigne MB, 2004, TREE PHYSIOL, V24, P415, DOI 10.1093/treephys/24.4.415; Maia SMF, 2010, GLOBAL CHANGE BIOL, V16, P2775, DOI 10.1111/j.1365-2486.2009.02105.x; Maier M, 2011, AGR FOREST METEOROL, V151, P1723, DOI 10.1016/j.agrformet.2011.07.006; Milesi de Mello J, REV BRAS CIENC SOLO; Myklebust MC, 2008, AGR FOREST METEOROL, V148, P1894, DOI 10.1016/j.agrformet.2008.06.016; ORCHARD VA, 1983, SOIL BIOL BIOCHEM, V15, P447, DOI 10.1016/0038-0717(83)90010-X; Oyj Vaisala, 2008, VAISALA CARBOCAP CAR; PARLANGE JY, 1976, WATER RESOUR RES, V12, P224, DOI 10.1029/WR012i002p00224; Pasini A, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034020; Pingintha N, 2010, TELLUS B, V62, P47, DOI 10.1111/j.1600-0889.2009.00445.x; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RAICH JW, 1995, GLOBAL BIOGEOCHEM CY, V9, P23, DOI 10.1029/94GB02723; Riveros-Iregui DA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030938; Sanderman J, 2013, GLOBAL CHANGE BIOL, V19, P264, DOI 10.1111/gcb.12030; Selva EC, 2007, J TROP ECOL, V23, P329, DOI 10.1017/S0266467406003956; Singh BK, 2010, NAT REV MICROBIOL, V8, P779, DOI 10.1038/nrmicro2439; Soil Survey Staff, 2010, KEYS SOIL TAX; Stoy PC, 2014, PHOTOSYNTH RES, V119, P49, DOI 10.1007/s11120-013-9799-0; Tang JW, 2003, AGR FOREST METEOROL, V118, P207, DOI 10.1016/S0168-1923(03)00112-6; Tans P., 2012, TRENDS ATMOSPHERIC C; Troxler Gann TG, 2005, FOREST ECOL MANAG, V214, P11, DOI 10.1016/j.foreco.2005.03.065; Turcu VE, 2005, VADOSE ZONE J, V4, P1161, DOI 10.2136/vzj2004.0164; Unger S, 2010, SOIL BIOL BIOCHEM, V42, P1800, DOI 10.1016/j.soilbio.2010.06.019; van der Valk AG, 2009, PLANT ECOL, V200, P1, DOI 10.1007/s11258-008-9469-z; Vargas R, 2010, ECOL APPL, V20, P1569, DOI 10.1890/09-0693.1; Vourlitis GL, 2011, SOIL SCI SOC AM J, V75, P1554, DOI 10.2136/sssaj2010.0412; WEBSTER R, 1990, STAT METHODS SOIL LA; Wetzel PR, 2005, FRONT ECOL ENVIRON, V3, P370, DOI 10.1890/1540-9295(2005)003[0370:MTIITF]2.0.CO;2	59	31	33	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e64874	10.1371/journal.pone.0064874	http://dx.doi.org/10.1371/journal.pone.0064874			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762259	Green Published, gold, Green Submitted			2022-12-27	WOS:000320440500007
J	Clarke, SF; Murphy, EF; O'Sullivan, O; Ross, RP; O'Toole, PW; Shanahan, F; Cotter, PD				Clarke, Siobhan F.; Murphy, Eileen F.; O'Sullivan, Orla; Ross, R. Paul; O'Toole, Paul W.; Shanahan, Fergus; Cotter, Paul D.			Targeting the Microbiota to Address Diet-Induced Obesity: A Time Dependent Challenge	PLOS ONE			English	Article							HUMAN GUT MICROBIOTA; INTESTINAL MICROBIOTA; ANTIBIOTIC-TREATMENT; GENERATION; RESISTANCE; DIVERSITY; CAPACITY; ECOLOGY; IMPACT; TREES	Links between the gut microbiota and host metabolism have provided new perspectives on obesity. We previously showed that the link between the microbiota and fat deposition is age-and time-dependent subject to microbial adaptation to diet over time. We also demonstrated reduced weight gain in diet-induced obese (DIO) mice through manipulation of the gut microbiota with vancomycin or with the bacteriocin-producing probiotic Lactobacillus salivarius UCC118 (Bac(+)), with metabolic improvement achieved in DIO mice in receipt of vancomycin. However, two phases of weight gain were observed with effects most marked early in the intervention phase. Here, we compare the gut microbial populations at the early relative to the late stages of intervention using a high throughput sequencing-based analysis to understand the temporal relationship between the gut microbiota and obesity. This reveals several differences in microbiota composition over the intervening period. Vancomycin dramatically altered the gut microbiota composition, relative to controls, at the early stages of intervention after which time some recovery was evident. It was also revealed that Bac(+) treatment initially resulted in the presence of significantly higher proportions of Peptococcaceae and significantly lower proportions of Rikenellaceae and Porphyromonadaceae relative to the gut microbiota of L. salivarius UCC118 bacteriocin negative (Bac(-)) administered controls. These differences were no longer evident at the later time. The results highlight the resilience of the gut microbiota and suggest that interventions may need to be monitored and continually adjusted to ensure sustained modification of the gut microbiota.	[Clarke, Siobhan F.; Murphy, Eileen F.; Ross, R. Paul; O'Toole, Paul W.; Shanahan, Fergus; Cotter, Paul D.] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [Clarke, Siobhan F.; O'Sullivan, Orla; Ross, R. Paul; Cotter, Paul D.] Teagasc Food Res Ctr, Cork, Ireland; [Clarke, Siobhan F.; O'Toole, Paul W.] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; [Murphy, Eileen F.] Alimentary Hlth Ltd, Cork, Ireland; [Shanahan, Fergus] Natl Univ Ireland Univ Coll Cork, Dept Med, Cork, Ireland	University College Cork; Teagasc; University College Cork; University College Cork	Cotter, PD (corresponding author), Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland.	paul.cotter@teagasc.ie	O'Toole, Paul W/G-1593-2012; Cotter, Paul/B-7781-2008; Ross, Paul/A-7584-2015; O'Sullivan, Orla/ABE-5980-2020; Shanahan, Fergus/ABF-2390-2020; Cotter, Paul/AAX-5449-2021; STANTON, CATHERINE/A-9549-2015	O'Toole, Paul W/0000-0001-5377-0824; Cotter, Paul/0000-0002-5465-9068; Ross, Paul/0000-0003-4876-8839; O'Sullivan, Orla/0000-0002-4332-1109; Shanahan, Fergus/0000-0003-0467-0936; Cotter, Paul/0000-0002-5465-9068; STANTON, CATHERINE/0000-0002-6724-7011; Clarke, Siobhan/0000-0002-7050-3661	Teagasc, Science Foundation Ireland; Alimentary Health Ltd.	Teagasc, Science Foundation Ireland(Science Foundation Ireland); Alimentary Health Ltd.	The authors are supported in part by Teagasc, Science Foundation Ireland (in the form of a research centre grant to the Alimentary Pharmabiotic Centre and PI awards to PWOT and PC) and by Alimentary Health Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BARNA JCJ, 1984, ANNU REV MICROBIOL, V38, P339, DOI 10.1146/annurev.mi.38.100184.002011; Cani PD, 2011, PHARMACOL THERAPEUT, V130, P202, DOI 10.1016/j.pharmthera.2011.01.012; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang S, 2003, NEW ENGL J MED, V348, P1342, DOI 10.1056/NEJMoa025025; Chen VB, 2009, PROTEIN SCI, V18, P2403, DOI 10.1002/pro.250; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Clarke S, 2012, GUT MICROBES, V3; Cotter PD, 2012, DISCOV MED, V13, P193; D'Aimmo MR, 2007, INT J FOOD MICROBIOL, V115, P35, DOI 10.1016/j.ijfoodmicro.2006.10.003; Dewulf EM, 2013, GUT, V62, P1112, DOI 10.1136/gutjnl-2012-303304; Flint HJ, 2011, J CLIN GASTROENTEROL, V45, pS128, DOI 10.1097/MCG.0b013e31821f44c4; Flynn S, 2002, MICROBIOL-SGM, V148, P973, DOI 10.1099/00221287-148-4-973; Fouhy F, 2012, ANTIMICROB AGENTS CH, V56, P5811, DOI 10.1128/AAC.00789-12; Greiner T, 2011, TRENDS ENDOCRIN MET, V22, P117, DOI 10.1016/j.tem.2011.01.002; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Howden BP, 2013, INFECT GENET EVOL, pS1567; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Ley RE, 2010, CURR OPIN GASTROEN, V26, P5, DOI 10.1097/MOG.0b013e328333d751; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Murphy EF, 2013, GUT, V62, P220, DOI 10.1136/gutjnl-2011-300705; O'Mahony L, 2001, ALIMENT PHARM THER, V15, P1219, DOI 10.1046/j.1365-2036.2001.01027.x; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rea MC, 2011, P NATL ACAD SCI USA, V108, P4639, DOI 10.1073/pnas.1001224107; Salimnia H, 2011, TRANSPL INFECT DIS, V13, P294, DOI 10.1111/j.1399-3062.2010.00586.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Tims S, 2013, ISME J, V7, P707, DOI 10.1038/ismej.2012.146; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Zhang CH, 2012, ISME J, V6, P1848, DOI 10.1038/ismej.2012.27; Zhang H, 2013, J FOOD SAFETY; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	41	104	109	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65790	10.1371/journal.pone.0065790	http://dx.doi.org/10.1371/journal.pone.0065790			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762426	Green Submitted, gold, Green Published			2022-12-27	WOS:000321094800072
J	Faassen, EJ; Beekman, W; Lurling, M				Faassen, Elisabeth J.; Beekman, Wendy; Lurling, Miquel			Evaluation of a Commercial Enzyme Linked Immunosorbent Assay (ELISA) for the Determination of the Neurotoxin BMAA in Surface Waters	PLOS ONE			English	Article							METHYLAMINO-L-ALANINE; AMINO-ACIDS; CYANOBACTERIA; CHROMATOGRAPHY; SEEDS	The neurotoxin beta-N-methylamino-L-alanine (BMAA) is suspected to play a role in Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. Because BMAA seems to be produced by cyanobacteria, surface waters are screened for BMAA. However, reliable analysis of BMAA requires specialized and expensive equipment. In 2012, a commercial enzyme-linked immunosorbent assay (ELISA) for determination of BMAA in surface waters was released. This kit could enable fast and relatively cheap screening of surface waters for BMAA. The objective of this study was to determine whether the BMAA ELISA kit was suitable for the determination of BMAA concentrations in surface waters. We hypothesised that the recovery of spiked samples was close to 100% and that the results of unspiked sample analysis were comparable between ELISA and liquid chromatography tandem mass spectrometry (LC-MS/MS) analysis. However, we found that recovery was higher than 100% in most spiked samples, highest determined recovery was over 400%. Furthermore, the ELISA gave a positive signal for nearly each tested sample while no BMAA could be detected by LC-MS/MS. We therefore conclude that in its current state, the kit is not suitable for screening surface waters for BMAA.	[Faassen, Elisabeth J.; Beekman, Wendy; Lurling, Miquel] Wageningen Univ, Dept Environm Sci, NL-6700 AP Wageningen, Netherlands; [Lurling, Miquel] NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands	Wageningen University & Research; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Faassen, EJ (corresponding author), Wageningen Univ, Dept Environm Sci, NL-6700 AP Wageningen, Netherlands.	Els.Faassen@wur.nl	Faassen, Elisabeth/P-5411-2015; KNAW, NIOO-KNAW/A-4320-2012	Faassen, Elisabeth/0000-0001-9098-8662; KNAW, NIOO-KNAW/0000-0002-3835-159X	Netherlands Organization for Scientific Research (NWO) [817.02.019]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	EJF was supported by grant 817.02.019 from The Netherlands Organization for Scientific Research (NWO, www.nwo.nl). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradley WG, 2009, AMYOTROPH LATERAL SC, V10, P7, DOI 10.3109/17482960903286009; Cianca RCC, 2012, AMINO ACIDS, V42, P2473, DOI 10.1007/s00726-011-1057-1; Chiu AS, 2011, INT J ENV RES PUB HE, V8, P3728, DOI 10.3390/ijerph8093728; Cohen SA, 2012, ANALYST, V137, P1991, DOI 10.1039/c2an16250d; Cox PA, 2003, P NATL ACAD SCI USA, V100, P13380, DOI 10.1073/pnas.2235808100; Cox PA, 2005, P NATL ACAD SCI USA, V102, P5074, DOI 10.1073/pnas.0501526102; Dai RH, 2009, J HAZARD MATER, V161, P730, DOI 10.1016/j.jhazmat.2008.04.015; Esterhuizen M, 2008, ECOTOX ENVIRON SAFE, V71, P309, DOI 10.1016/j.ecoenv.2008.04.010; Faassen EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036667; Faassen EJ, 2009, AMYOTROPH LATERAL SC, V10, P79, DOI 10.3109/17482960903272967; Glover WB, 2012, ANAL CHEM, V84, P7946, DOI 10.1021/ac301691r; Jiang L, 2012, APPL COMPUT INTELL S, V2012, DOI 10.1155/2012/742461; Jonasson S, 2010, P NATL ACAD SCI USA, V107, P9252, DOI 10.1073/pnas.0914417107; Kruger T, 2010, TOXICON, V55, P547, DOI 10.1016/j.toxicon.2009.10.009; Metcalf JS, 2008, ENVIRON MICROBIOL, V10, P702, DOI 10.1111/j.1462-2920.2007.01492.x; Rosen J, 2008, ANALYST, V133, P1785, DOI 10.1039/b809231a; Spacil Z, 2010, ANALYST, V135, P127, DOI 10.1039/b921048b; VEGA A, 1967, PHYTOCHEMISTRY, V6, P759, DOI 10.1016/S0031-9422(00)86018-5; Zahradnickova H, 2007, ANAL BIOANAL CHEM, V388, P1815, DOI 10.1007/s00216-007-1411-z	19	17	17	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65260	10.1371/journal.pone.0065260	http://dx.doi.org/10.1371/journal.pone.0065260			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762331	Green Published, gold			2022-12-27	WOS:000321094800032
J	Silveira, KD; Barroso, LC; Vieira, AT; Cisalpino, D; Lima, CX; Bader, M; Arantes, RME; dos Santos, RAS; Simoes-e-Silva, AC; Teixeira, MM				Silveira, Katia Daniela; Barroso, Livia Correa; Vieira, Angelica Thomaz; Cisalpino, Daniel; Lima, Cristiano Xavier; Bader, Michael; Esteves Arantes, Rosa Maria; Souza dos Santos, Robson Augusto; Simoes-e-Silva, Ana Cristina; Teixeira, Mauro Martins			Beneficial Effects of the Activation of the Angiotensin-(1-7) Mas Receptor in a Murine Model of Adriamycin-Induced Nephropathy	PLOS ONE			English	Article							II TYPE-1 RECEPTOR; GROWTH-FACTOR-BETA; 1-7/MAS RECEPTOR; BLOOD-PRESSURE; SYSTEM; RATS; BLOCKADE; PROTEIN; PROGRESSION; TELMISARTAN	Angiotensin-(1-7) [Ang-(1-7)] is a biologically active heptapeptide that may counterbalance the physiological actions of angiotensin II (Ang II) within the renin-angiotensin system (RAS). Here, we evaluated whether activation of the Mas receptor with the oral agonist, AVE 0991, would have renoprotective effects in a model of adriamycin (ADR)-induced nephropathy. We also evaluated whether the Mas receptor contributed for the protective effects of treatment with AT(1) receptor blockers. ADR (10 mg/kg) induced significant renal injury and dysfunction that was maximal at day 14 after injection. Treatment with the Mas receptor agonist AVE 0991 improved renal function parameters, reduced urinary protein loss and attenuated histological changes. Renoprotection was associated with reduction in urinary levels of TGF-beta. Similar renoprotection was observed after treatment with the AT(1) receptor antagonist, Losartan. AT(1) and Mas receptor mRNA levels dropped after ADR administration and treatment with losartan reestablished the expression of Mas receptor and increased the expression of ACE2. ADR-induced nephropathy was similar in wild type (Mas(+/+)) and Mas knockout (Mas(-/-)) mice, suggesting there was no endogenous role for Mas receptor activation. However, treatment with Losartan was able to reduce renal injury only in Mas(+/+) , but not in Mas(-/-) mice. Therefore, these findings suggest that exogenous activation of the Mas receptor protects from ADR-induced nephropathy and contributes to the beneficial effects of AT(1) receptor blockade. Medications which target specifically the ACE2/Ang-(1-7)/Mas axis may offer new therapeutic opportunities to treat human nephropathies.	[Silveira, Katia Daniela; Barroso, Livia Correa; Vieira, Angelica Thomaz; Cisalpino, Daniel; Lima, Cristiano Xavier; Teixeira, Mauro Martins] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Esteves Arantes, Rosa Maria] Univ Fed Minas Gerais, Dept Patol Geral, Belo Horizonte, MG, Brazil; [Lima, Cristiano Xavier; Simoes-e-Silva, Ana Cristina; Teixeira, Mauro Martins] Univ Fed Minas Gerais, Fac Med, Dept Pediat, Belo Horizonte, MG, Brazil; [Souza dos Santos, Robson Augusto] Univ Fed Minas Gerais, Dept Fisiol & Biofis, Belo Horizonte, MG, Brazil; [Bader, Michael] Max Delbruck Ctr Mol Med, Berlin, Germany	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Simoes-e-Silva, AC (corresponding author), Univ Fed Minas Gerais, Fac Med, Dept Pediat, Belo Horizonte, MG, Brazil.	ana@medicina.ufmg.br; mmtex@icb.ufmg.br	Bader, Michael/K-2124-2013; Arantes, Rosa ME/C-5749-2013; LIMA, CRISTIANO/AAH-9402-2021; Santos, Robson A S/C-9336-2011; Vieira, Angelica T/A-6227-2015; Simões e Silva, Ana Cristina/A-4409-2013; Teixeira, Mauro M/A-4587-2008; SILVEIRA, KATIA D/N-3036-2013; Lima, Cristiano/B-1874-2013	Arantes, Rosa ME/0000-0003-1428-9717; Santos, Robson A S/0000-0001-8738-5852; Vieira, Angelica T/0000-0002-4556-7671; Simões e Silva, Ana Cristina/0000-0001-9222-3882; Teixeira, Mauro M/0000-0002-6944-3008; SILVEIRA, KATIA D/0000-0003-4955-3709; Cisalpino, Daniel/0000-0003-1611-0661; XAVIER LIMA, CRISTIANO/0000-0001-7724-890X; Bader, Michael/0000-0003-4780-4164	Coordenacao de Aperfeicoamento de Pessoal de Nivel 445 Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao do Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); European Union [LSHB-CT-2005-518167]; European Community [HEALTH-F4-2011-281608]	Coordenacao de Aperfeicoamento de Pessoal de Nivel 445 Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao do Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); European Union(European Commission); European Community(European Commission)	Coordenacao de Aperfeicoamento de Pessoal de Nivel 445 Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao do Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), the European Union's Sixth Framework Programme (INNOCHEM, project grant LSHB-CT-2005-518167) and the European Community's Seventh Framework Programme [FP7-2007-2013] under grant agreement HEALTH-F4-2011-281608. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averill DB, 2003, CIRCULATION, V108, P2141, DOI 10.1161/01.CIR.0000092888.63239.54; Barroso L. C., 2012, INT J HYPERTENS, V2012, DOI DOI 10.1155/2012/808726; Benter IF, 2008, AM J NEPHROL, V28, P25, DOI 10.1159/000108758; BENTER IF, 1995, AM J PHYSIOL-HEART C, V269, pH313, DOI 10.1152/ajpheart.1995.269.1.H313; BERTANI T, 1982, LAB INVEST, V46, P16; Border WA, 1998, HYPERTENSION, V31, P181, DOI 10.1161/01.HYP.31.1.181; Botelho-Santos GA, 2007, AM J PHYSIOL-HEART C, V292, pH2485, DOI 10.1152/ajpheart.01245.2006; Casas JP, 2005, LANCET, V366, P2026, DOI 10.1016/S0140-6736(05)67814-2; Chappell MC, 2004, CONTRIB NEPHROL, V143, P77; Chen A, 1998, NEPHRON, V78, P440, DOI 10.1159/000044974; Crowley SD, 2009, J CLIN INVEST, V119, P943, DOI 10.1172/JCI34862; da Silveira KD, 2010, CLIN SCI, V119, P385, DOI 10.1042/CS20090554; da Silveira KD, 2010, J IMMUNOL, V185, P5569, DOI 10.4049/jimmunol.1000314; Dhaunsi GS, EUR J PHARM, V638, P108; Dilauro M, 2009, THESCIENTIFICWORLDJO, V9, P522, DOI 10.1100/tsw.2009.70; Esteban V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005406; Ferrario CM, 2005, KIDNEY INT, V68, P2189, DOI 10.1111/j.1523-1755.2005.00675.x; Ferrario CM, 2005, CIRCULATION, V111, P2605, DOI 10.1161/CIRCULATIONAHA.104.510461; Gava E, 2009, NEPHROL DIAL TRANSPL, V24, P1766, DOI 10.1093/ndt/gfn736; Giani JF, 2011, AM J PHYSIOL-RENAL, V300, pF272, DOI 10.1152/ajprenal.00278.2010; He JG, 2010, HEART VESSELS, V25, P438, DOI 10.1007/s00380-009-1213-7; Igase Michiya, 2011, Ther Adv Cardiovasc Dis, V5, P297, DOI 10.1177/1753944711429343; Ishiyama Y, 2004, HYPERTENSION, V43, P970, DOI 10.1161/01.HYP.0000124667.34652.1a; Ji ZQ, 2005, CELL MOL IMMUNOL, V2, P150; KAGAMI S, 1994, J CLIN INVEST, V93, P2431, DOI 10.1172/JCI117251; Katovich MJ, 2008, CURR HYPERTENS REP, V10, P227, DOI 10.1007/s11906-008-0043-9; KREGE JH, 1995, HYPERTENSION, V25, P1111, DOI 10.1161/01.HYP.25.5.1111; LAN HY, 1995, KIDNEY INT, V48, P753, DOI 10.1038/ki.1995.347; Lara LS, 2010, ARCH BIOCHEM BIOPHYS, V496, P117, DOI 10.1016/j.abb.2010.02.005; Lee VWS, 2011, NEPHROLOGY, V16, P30, DOI 10.1111/j.1440-1797.2010.01383.x; Li YW, 2009, HYPERTENS RES, V32, P369, DOI 10.1038/hr.2009.25; Magaldi AJ, 2003, PFLUG ARCH EUR J PHY, V447, P223, DOI 10.1007/s00424-003-1173-1; Matsusaka T, 2010, HYPERTENSION, V55, P967, DOI 10.1161/HYPERTENSIONAHA.109.141994; Mihailovic-Stanojevic N, 2009, NEPHROL DIAL TRANSPL, V24, P1142, DOI 10.1093/ndt/gfn596; Naito T, 2010, AM J PHYSIOL-RENAL, V298, pF683, DOI 10.1152/ajprenal.00503.2009; Okada H, 2004, BIOCHEM BIOPH RES CO, V314, P403, DOI 10.1016/j.bbrc.2003.12.105; Pereira RM, 2007, J HEPATOL, V46, P674, DOI 10.1016/j.jhep.2006.10.018; Pinheiro SVB, 2009, KIDNEY INT, V75, P1184, DOI 10.1038/ki.2009.61; Pinheiro SVB, 2004, HYPERTENSION, V44, P490, DOI 10.1161/01.HYP.0000141438.64887.42; Ruilope LM, 2008, CURR MED RES OPIN, V24, P1285, DOI [10.1185/030079908X291921, 10.1185/030079908X291921 ]; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Santos RAS, 2006, HYPERTENSION, V47, P996, DOI 10.1161/01.HYP.0000215289.51180.5c; Santos RAS, 2008, EXP PHYSIOL, V93, P519, DOI 10.1113/expphysiol.2008.042002; Satoh M, 2001, J AM SOC NEPHROL, V12, P317, DOI 10.1681/ASN.V122317; Shao Y, 2008, ACTA PHARMACOL SIN, V29, P829, DOI 10.1111/j.1745-7254.2008.00812.x; Shimizu A, 2012, NEPHROL DIAL TRANSPL, V27, P3169, DOI 10.1093/ndt/gfs033; Silveira KD, 2010, PEDIATR NEPHROL, V25, P1795; Su Z, 2006, KIDNEY INT, V69, P2212, DOI 10.1038/sj.ki.5001509; Sukumaran V, 2012, LIFE SCI, V90, P289, DOI 10.1016/j.lfs.2011.11.018; Sukumaran V, 2011, INT J BIOL SCI, V7, P1077, DOI 10.7150/ijbs.7.1077; Sun Y, 2000, HYPERTENSION, V35, P1078, DOI 10.1161/01.HYP.35.5.1078; Tsakas S, 2006, AM J NEPHROL, V26, P186, DOI 10.1159/000093178; van der Wouden EA, 2005, J RENIN-ANGIO-ALDO S, V6, P96, DOI 10.3317/jraas.2005.016; Velkoska E, 2011, CLIN SCI, V120, P335, DOI 10.1042/CS20100280; Wang Y, 2000, KIDNEY INT, V58, P1797, DOI 10.1046/j.1523-1755.2000.00342.x; Zhang JD, 2010, AM J PHYSIOL-RENAL, V298, pF579, DOI 10.1152/ajprenal.00548.2009; Zimpelmann J, 2009, AM J PHYSIOL-RENAL, V296, pF337, DOI 10.1152/ajprenal.90437.2008; Zong WN, 2011, ACTA PHARMACOL SIN, V32, P1345, DOI 10.1038/aps.2011.96	58	40	42	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66082	10.1371/journal.pone.0066082	http://dx.doi.org/10.1371/journal.pone.0066082			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762470	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000321094800089
J	Williams, PT; Franklin, BA				Williams, Paul T.; Franklin, Barry A.			Reduced Incidence of Cardiac Arrhythmias in Walkers and Runners	PLOS ONE			English	Article							LONE ATRIAL-FIBRILLATION; HEART-DISEASE RISK; OF-SPORTS-MEDICINE; PHYSICAL-ACTIVITY; FOLLOW-UP; VIGOROUS EXERCISE; PUBLIC-HEALTH; OLDER-ADULTS; MEN; WALKING	Purpose: Walking is purported to reduce the risk of atrial fibrillation by 48%, whereas jogging is purported to increase its risk by 53%, suggesting a strong anti-arrhythmic benefit of walking over running. The purpose of these analyses is to compare incident self-reported physician-diagnosed cardiac arrhythmia to baseline energy expenditure (metabolic equivalent hours per day, METhr/d) from walking, running and other exercise. Methods: Proportional hazards analysis of 14,734 walkers and 32,073 runners. Results: There were 1,060 incident cardiac arrhythmias (412 walkers, 648 runners) during 6.2 years of follow-up. The risk for incident cardiac arrhythmias declined 4.4% per baseline METhr/d walked by the walkers, or running in the runners (P = 0.0001). Specifically, the risk declined 14.2% (hazard ratio: 0.858) for 1.8 to 3.6 METhr/d, 26.5% for 3.6 to 5.4 METhr/d, and 31.7% for >= 5.4 METhr/d, relative to <1.8 METhr/d. The risk reduction per METhr/d was significantly greater for walking than running (P < 0.01), but only because walkers were at 34% greater risk than runners who fell below contemporary physical activity guideline recommendations; otherwise the walkers and runners had similar risks for cardiac arrhythmias. Cardiac arrhythmias were unrelated to walking and running intensity, and unrelated to marathon participation and performance. Conclusions: The risk for cardiac arrhythmias was similar in walkers and runners who expended comparable METhr/d during structured exercise. We found no significant risk increase for self-reported cardiac arrhythmias associated with running distance, exercise intensity, or marathon participation. Rhythm abnormalities were based on self-report, precluding definitive categorization of the nature of the rhythm disturbance. However, even if the runners' arrhythmias include sinus bradycardia due to running itself, there was no increase in arrhythmias with greater running distance.	[Williams, Paul T.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Franklin, Barry A.] William Beaumont Hosp, Beaumont Hlth Ctr, Prevent Cardiol & Cardiac Rehabil, Royal Oak, MI 48072 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Beaumont Health	Williams, PT (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA.	ptwilliams@lbl.gov			National Heart, Lung and Blood Institute [HL094717]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094717] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grant HL094717 from the National Heart, Lung and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Aizer A, 2009, AM J CARDIOL, V103, P1572, DOI 10.1016/j.amjcard.2009.01.374; Baldesberger S, 2008, EUR HEART J, V29, P71, DOI 10.1093/eurheartj/ehm555; Camm AJ, 2012, AM J CARDIOL, V110, P270, DOI 10.1016/j.amjcard.2012.03.021; Elosua R, 2006, INT J CARDIOL, V108, P332, DOI 10.1016/j.ijcard.2005.05.020; Frost L, 2005, OCCUP ENVIRON MED, V62, P49, DOI 10.1136/oem.2004.014266; Furlanello F, 1998, J CARDIOVASC ELECTR, V9, pS63; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Heidbuchel H, 2006, INT J CARDIOL, V107, P67, DOI 10.1016/j.ijcard.2005.02.043; Heidbuchel H, 2006, EUR J CARDIOV PREV R, V13, P475, DOI 10.1097/01.hjr.0000216543.54066.72; Hoogsteen J, 2004, EUROPACE, V6, P222, DOI 10.1016/j.eupc.2004.01.004; Kannel WB, 1998, AM J CARDIOL, V82, p2N, DOI 10.1016/S0002-9149(98)00583-9; Karjalainen J, 1998, BMJ-BRIT MED J, V316, P1784, DOI 10.1136/bmj.316.7147.1784; Lee CD, 2002, MED SCI SPORT EXER, V34, P592; Leitzmann MF, 1998, ANN INTERN MED, V128, P417, DOI 10.7326/0003-4819-128-6-199803150-00001; Leitzmann MF, 1999, NEW ENGL J MED, V341, P777, DOI 10.1056/NEJM199909093411101; Link Mark S, 2002, Curr Sports Med Rep, V1, P75; Molina L, 2008, EUROPACE, V10, P618, DOI 10.1093/europace/eun071; Mont L, 2002, EUR HEART J, V23, P477, DOI 10.1053/euhj.2001.2802; Mont L, 2008, EUROPACE, V10, P15, DOI 10.1093/europace/eum263; Mozaffarian D, 2008, CIRCULATION, V118, P800, DOI 10.1161/CIRCULATIONAHA.108.785626; O'Keefe JH, 2013, HEART, V99, P516, DOI 10.1136/heartjnl-2012-302886; O'Keefe JH, 2012, MAYO CLIN PROC, V87, P587, DOI 10.1016/j.mayocp.2012.04.005; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pelliccia A, 2005, J AM COLL CARDIOL, V46, P690, DOI 10.1016/j.jacc.2005.04.052; Psaty BM, 1997, CIRCULATION, V96, P2455; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Walker J, 2010, AM J MED, V123, P1075, DOI 10.1016/j.amjmed.2010.05.008; Wilhelm M, 2011, AM J CARDIOL, V108, P1489, DOI 10.1016/j.amjcard.2011.06.073; Williams PT, 2008, MED SCI SPORT EXER, V40, P433, DOI 10.1249/MSS.0b013e31815f38f1; Williams PT, 2013, MED SCI SPORT EXER, V45, P706, DOI 10.1249/MSS.0b013e31827b0d0a; Williams PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041906; Williams PT, 2012, MED SCI SPORT EXER, V44, P1728, DOI 10.1249/MSS.0b013e318258af3f; Williams PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036360; Williams PT, 2010, ATHEROSCLEROSIS, V209, P524, DOI 10.1016/j.atherosclerosis.2009.09.018; Williams PT, 2004, INT J OBESITY, V28, P120, DOI 10.1038/sj.ijo.0802480; Williams PT, 2013, MED SCI SPO IN PRESS; Wolf PA, 1998, ARCH INTERN MED, V158, P229, DOI 10.1001/archinte.158.3.229; Zheng H, 2009, EUR J EPIDEMIOL, V24, P181, DOI 10.1007/s10654-009-9328-9	39	17	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65302	10.1371/journal.pone.0065302	http://dx.doi.org/10.1371/journal.pone.0065302			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762337	Green Submitted, Green Published, gold			2022-12-27	WOS:000321094800036
J	Gaikwad, NW				Gaikwad, Nilesh W.			Metabolomic Profiling Unravels DNA Adducts in Human Breast That Are Formed from Peroxidase Mediated Activation of Estrogens to Quinone Methides	PLOS ONE			English	Article							CANCER; BIOMARKERS; MECHANISMS; DISEASE; EXPRESSION; ETIOLOGY; OBESITY; DAMAGE; RISK	Currently there are three major hypotheses that have been proposed for estrogen induced carcinogenicity, however exact etiology remains unknown. Based on the chemical logic, studies were undertaken to investigate if estrogens could generate quinone methides in an oxidative environment which then could cause DNA damage in humans. In presence of MnO2 estrogens were oxidized to quinone methides. Surprisingly quinone methides were found to be stable with t(1/2) of 20.8 and 4.5 min respectively. Incubation of estrogens with lactoperoxidase (LPO) and H2O2 resulted in formation of respective quinone methides (E-1(E-2)-QM). Subsequent addition of adenine to the assay mixture lead to trapping of E1(E2)-QM, resulting in formation of adenine adducts of estrogens, E-1(E-2)-9-N-Ade. Targeted ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) based metabolomic analysis of the breast tissue extracts showed the presence of adenine adducts of estrogens, E-1(E-2)-9-N-Ade, along with other estrogen related metabolites. Identity of E-1(E-2)-N-Ade in LPO assay extracts and breast tissue extracts were confirmed by comparing them to pure synthesized E-1(E-2)-9-N-Ade standards. From these results, it is evident that peroxidase enzymes or peroxidase-like activity in human breast tissue could oxidize estrogens to electrophilic and stable quinone methides in a single step that covalently bind to DNA to form adducts. The error prone repair of the damaged DNA can result in mutation of critical genes and subsequently cancer. This article reports evidence for hitherto unknown estrogen metabolic pathway in human breast, catalyzed by peroxidase, which could initiate cancer.	[Gaikwad, Nilesh W.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Gaikwad, Nilesh W.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Gaikwad, NW (corresponding author), Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA.	ngaikwad@ucdavis.edu			Center for Health & Nutrition Research (CHNR), Department of Nutrition, University of California, Davis [CA-D-NTR-2104-H]; Hellman Foundation	Center for Health & Nutrition Research (CHNR), Department of Nutrition, University of California, Davis; Hellman Foundation	This research was supported by grant from Center for Health & Nutrition Research (CHNR), Department of Nutrition, University of California, Davis. # CA-D-NTR-2104-H and grant from Hellman Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bechlioulis A, 2010, CURR VASC PHARMACOL, V8, P249, DOI 10.2174/157016110790886974; BOYLAND E, 1969, ADV ENZYMOL RAMB, V32, P173; Carruba G, 2006, ANN NY ACAD SCI, V1089, P201, DOI 10.1196/annals.1386.027; Cavalieri E, 2006, BBA-REV CANCER, V1766, P63, DOI 10.1016/j.bbcan.2006.03.001; Chakraborti A, 2007, REV NEUROSCIENCE, V18, P395; Cleary MP, 2009, ENDOCRINOLOGY, V150, P2537, DOI 10.1210/en.2009-0070; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Feigelson HS, 1996, CARCINOGENESIS, V17, P2279, DOI 10.1093/carcin/17.11.2279; Fu D, 2012, NAT REV CANCER, V12, P104, DOI 10.1038/nrc3185; Gaikwad NW, 2008, INT J CANCER, V122, P1949, DOI 10.1002/ijc.23329; Gaikwad NW, 2009, BIOMARKERS, V14, P502, DOI 10.3109/13547500903121715; Gruber CJ, 2002, NEW ENGL J MED, V346, P340, DOI 10.1056/NEJMra000471; Hein A, 2013, EUR J CANCER PREV, V22, P52, DOI 10.1097/CEJ.0b013e328355ec22; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Khosla S, 2010, J CLIN ENDOCR METAB, V95, P3569, DOI 10.1210/jc.2010-0856; Liehr JG, 2000, ENDOCR REV, V21, P40, DOI 10.1210/er.21.1.40; Mayes J S, 2004, Obes Rev, V5, P197, DOI 10.1111/j.1467-789X.2004.00152.x; Persson I, 2000, J STEROID BIOCHEM, V74, P357, DOI 10.1016/S0960-0760(00)00113-8; Russo J, 2006, J STEROID BIOCHEM, V102, P89, DOI 10.1016/j.jsbmb.2006.09.004; Shang YF, 2006, NAT REV CANCER, V6, P360, DOI 10.1038/nrc1879; Simpson ER, 2011, EXPERT REV ENDOCRINO, V6, P383, DOI [10.1586/eem.11.35, 10.1586/EEM.11.35]; SWANECK GE, 1988, P NATL ACAD SCI USA, V85, P7831, DOI 10.1073/pnas.85.21.7831; TELANG NT, 1991, BREAST CANCER RES TR, V18, P155, DOI 10.1007/BF01990031; Williams JA, 2000, CANCER RES, V60, P4667; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Yang L, 2009, PROSTATE, V69, P41, DOI 10.1002/pros.20850	26	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65826	10.1371/journal.pone.0065826	http://dx.doi.org/10.1371/journal.pone.0065826			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762435	Green Published, Green Submitted, gold			2022-12-27	WOS:000321099000109
J	Nan, HW; Liu, Q; Chen, JS; Cheng, XY; Yin, HJ; Yin, CY; Zhao, CZ				Nan, Hongwei; Liu, Qing; Chen, Jinsong; Cheng, Xinying; Yin, Huajun; Yin, Chunying; Zhao, Chunzhang			Effects of Nutrient Heterogeneity and Competition on Root Architecture of Spruce Seedlings: Implications for an Essential Feature of Root Foraging	PLOS ONE			English	Article							NEIGHBORING PLANTS; GROWTH-RATE; RESPONSES; PHOSPHORUS; GRAVITROPISM; ARABIDOPSIS; RESOURCE; SURVIVAL; BEHAVIOR; SYSTEMS	Background: We have limited understanding of root foraging responses when plants were simultaneously exposed to nutrient heterogeneity and competition, and our goal was to determine whether and how plants integrate information about nutrients and neighbors in root foraging processes. Methodology/Principal Findings: The experiment was conducted in split-containers, wherein half of the roots of spruce (Picea asperata) seedlings were subjected to intraspecific root competition (the vegetated half), while the other half experienced no competition (the non-vegetated half). Experimental treatments included fertilization in the vegetated half (FV), the non-vegetated half (FNV), and both compartments (F), as well as no fertilization (NF). The root architecture indicators consisted of the number of root tips over the root surface (RTRS), the length percentage of diameter-based fine root subclasses to total fine root (SRLP), and the length percentage of each root order to total fine root (ROLP). The target plants used novel root foraging behaviors under different combinations of neighboring plant and localized fertilization. In addition, the significant increase in the RTRS of 0-0.2 mm fine roots after fertilization of the vegetated half alone and its significant decrease in fertilizer was applied throughout the plant clearly showed that plant root foraging behavior was regulated by local responses coupled with systemic control mechanisms. Conclusions/Significance: We measured the root foraging ability for woody plants by means of root architecture indicators constructed by the roots possessing essential nutrient uptake ability (i.e., the first three root orders), and provided new evidence that plants integrate multiple forms of environmental information, such as nutrient status and neighboring competitors, in a non-additive manner during the root foraging process. The interplay between the responses of individual root modules (repetitive root units) to localized environmental signals and the systemic control of these responses may well account for the non-additive features of the root foraging process.	[Liu, Qing] Chinese Acad Sci, Inst Biol, Key Lab Mt Ecol Restorat & Bioresource Utilizat, Chengdu, Peoples R China; Chinese Acad Sci, Inst Biol, Ecol Restorat Biodivers Conservat Key Lab Sichuan, Chengdu, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS	Liu, Q (corresponding author), Chinese Acad Sci, Inst Biol, Key Lab Mt Ecol Restorat & Bioresource Utilizat, Chengdu, Peoples R China.	liuqing@cib.ac.cn			Chinese Academy of Sciences [XDA05050303]; National Key Technology R D Program [2011BAC09B04]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Key Technology R D Program(National Key Technology R&D Program)	This research was supported by grants from the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA05050303) and the National Key Technology R & D Program (2011BAC09B04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blair Brent C., 1998, Biotropica, V30, P21; Bolte A, 2006, EUR J FOREST RES, V125, P15, DOI 10.1007/s10342-005-0075-5; Cahill JF, 2010, SCIENCE, V328, P1657, DOI 10.1126/science.1189736; Cheng S, 2005, PLANT SOIL, V270, P321, DOI 10.1007/s11104-004-1726-x; Comas LH, 2004, FUNCT ECOL, V18, P388, DOI 10.1111/j.0269-8463.2004.00835.x; Coomes DA, 2000, ECOL MONOGR, V70, P171, DOI 10.1890/0012-9615(2000)070[0171:IORCIF]2.0.CO;2; Day KJ, 2003, FUNCT ECOL, V17, P454, DOI 10.1046/j.1365-2435.2003.00758.x; De Kroon H, 2009, PLANT CELL ENVIRON, V32, P704, DOI 10.1111/j.1365-3040.2009.01936.x; Fang SQ, 2011, PLANT PHYSIOL, V155, P1277, DOI 10.1104/pp.110.167304; Farley RA, 1999, J ECOL, V87, P849, DOI 10.1046/j.1365-2745.1999.00396.x; Farley RA, 1999, J ECOL, V87, P688, DOI 10.1046/j.1365-2745.1999.00390.x; FITTER AH, 1991, NEW PHYTOL, V118, P383, DOI 10.1111/j.1469-8137.1991.tb00019.x; FITTER AH, 1991, NEW PHYTOL, V118, P375, DOI 10.1111/j.1469-8137.1991.tb00018.x; FITTER AH, 1987, NEW PHYTOL, V106, P61, DOI 10.1111/j.1469-8137.1987.tb04683.x; Fletcher EH, 2012, AGROFOREST SYST, V86, P49, DOI 10.1007/s10457-012-9507-7; Fujita H, 1996, PLANT CELL PHYSIOL, V37, P1094, DOI 10.1093/oxfordjournals.pcp.a029059; Garcia AL, 2006, J PLANT NUTR, V29, P2093, DOI 10.1080/01904160600972183; Gersani M, 2001, J ECOL, V89, P660, DOI 10.1046/j.0022-0477.2001.00609.x; Grabov A, 2005, NEW PHYTOL, V165, P641, DOI 10.1111/j.1469-8137.2004.01258.x; Grime JP, 2002, EVOL ECOL, V16, P299, DOI 10.1023/A:1019640813676; Gunaratne AMTA, 2011, FOREST ECOL MANAG, V262, P229, DOI 10.1016/j.foreco.2011.03.027; Guo DL, 2008, NEW PHYTOL, V180, P673, DOI 10.1111/j.1469-8137.2008.02573.x; Guo DL, 2004, OECOLOGIA, V140, P450, DOI 10.1007/s00442-004-1596-1; Hartnett DC, 2004, AFR J ECOL, V42, P328, DOI 10.1111/j.1365-2028.2004.00533.x; Hodge A, 2004, NEW PHYTOL, V162, P9, DOI 10.1111/j.1469-8137.2004.01015.x; Hodge A, 2009, PLANT CELL ENVIRON, V32, P628, DOI 10.1111/j.1365-3040.2008.01891.x; Hu Rong, 2011, Scientia Silvae Sinicae, V47, P23; Kembel SW, 2008, ANN BOT-LONDON, V101, P1295, DOI 10.1093/aob/mcn044; Lei PF, 2012, FOREST ECOL MANAG, V265, P191, DOI 10.1016/j.foreco.2011.10.033; Leuschner C, 2001, OECOLOGIA, V126, P276, DOI 10.1007/s004420000507; Lucash MS, 2007, TREES-STRUCT FUNCT, V21, P593, DOI 10.1007/s00468-007-0160-0; LYNCH J, 1995, PLANT PHYSIOL, V109, P7, DOI 10.1104/pp.109.1.7; Lynch JP, 2005, PLANT SOIL, V269, P45, DOI 10.1007/s11104-004-1096-4; Malamy JE, 2005, PLANT CELL ENVIRON, V28, P67, DOI 10.1111/j.1365-3040.2005.01306.x; Marchant A, 1999, EMBO J, V18, P2066, DOI 10.1093/emboj/18.8.2066; Messier C, 2009, J ECOL, V97, P548, DOI 10.1111/j.1365-2745.2009.01500.x; Mommer L, 2012, FUNCT ECOL, V26, P66, DOI 10.1111/j.1365-2435.2011.01916.x; Nord EA, 2011, FUNCT PLANT BIOL, V38, P941, DOI 10.1071/FP11130; O'Brien EE, 2008, J ECOL, V96, P438, DOI 10.1111/j.1365-2745.2008.01354.x; Ozier-Lafontaine H, 1999, PLANT SOIL, V209, P167, DOI 10.1023/A:1004461130561; Postma JA, 2012, ANN BOT-LONDON, V110, P521, DOI 10.1093/aob/mcs082; Pregitzer KS, 2002, ECOL MONOGR, V72, P293, DOI 10.1890/0012-9615(2002)072[0293:FRAONN]2.0.CO;2; Rubio G, 2003, CROP SCI, V43, P598, DOI 10.2135/cropsci2003.0598; Rubio G, 2001, ANN BOT-LONDON, V88, P929, DOI 10.1006/anbo.2001.1530; Wells CE, 2002, AM J BOT, V89, P79, DOI 10.3732/ajb.89.1.79; Zheng M, 2012, J ARID ENVIRON, V85, P105, DOI 10.1016/j.jaridenv.2012.05.006; Zhou J, 2012, ANN BOT-LONDON, V109, P813, DOI 10.1093/aob/mcr314	47	13	16	2	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65650	10.1371/journal.pone.0065650	http://dx.doi.org/10.1371/journal.pone.0065650			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762405	Green Submitted, Green Published, gold			2022-12-27	WOS:000321099000088
J	Wang, J; Zhao, Z; Lin, E; Zhao, W; Qian, XJ; Freire, D; Bilski, AE; Cheng, A; Vempati, P; Ho, L; Ono, K; Yamada, M; Pasinetti, GM				Wang, Jun; Zhao, Zhong; Lin, Emi; Zhao, Wei; Qian, Xianjuan; Freire, Daniel; Bilski, Amanda E.; Cheng, Alice; Vempati, Prashant; Ho, Lap; Ono, Kenjiro; Yamada, Masahito; Pasinetti, Giulio M.			Unintended Effects of Cardiovascular Drugs on the Pathogenesis of Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID-BETA-PROTEIN; ANTIHYPERTENSIVE-MEDICATION-USE; MOUSE MODEL; SYNAPTIC PLASTICITY; NATURAL OLIGOMERS; MEMORY; A-BETA(1-42); PREVENTION; DEMENTIA; THERAPY	Alzheimer's disease (AD) is rapidly becoming one of the leading causes of disability and mortality in the elderly. As life-expectancy increases, an increasing number of people will rely on modern medicines to treat age-associated disorders. Among these medications, some might benefit, while others might exacerbate, the pathogenesis of AD. We screened 1,600 FDA approved drugs for beta-amyloid (A beta)-modifying activity and identified drugs that can potentially influence amyloid precursor protein processing. In this study, we focused on cardiovascular drugs and demonstrated that some hypertensive medication can differentially modulate A beta, both in vitro and in vivo. Our study suggests that some commonly prescribed drugs might exert unintended effects and modulate AD and provides the basis for continuing investigation of the role of individual drugs on a case-by-case basis. This line of investigation will lead to the identification of common medications that are potentially beneficial or detrimental to AD as a reference for physicians to consider when prescribing the most appropriate drugs for their patients, particularly for treating chronic disorders among the growing geriatric population.	[Wang, Jun; Zhao, Zhong; Zhao, Wei; Qian, Xianjuan; Freire, Daniel; Bilski, Amanda E.; Cheng, Alice; Vempati, Prashant; Ho, Lap; Pasinetti, Giulio M.] Mt Sinai Sch Med, Dept Neurol, New York, NY USA; [Lin, Emi] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Wang, Jun; Ho, Lap; Pasinetti, Giulio M.] James J Peters Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, New York, NY USA; [Ono, Kenjiro; Yamada, Masahito] Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol & Aging, Kanazawa, Ishikawa, Japan	Icahn School of Medicine at Mount Sinai; Harvard University; Harvard Medical School; Geriatric Research Education & Clinical Center; Kanazawa University	Pasinetti, GM (corresponding author), Mt Sinai Sch Med, Dept Neurol, New York, NY USA.	giulio.pasinetti@mssm.edu		Ling, Emi/0000-0001-5287-0284; Pasinetti, Giulio/0000-0002-1524-5196; Zhao, Wei/0000-0002-3449-2395	National Institutes of Health [UO1 (AG29310)]; Department of Veterans Affairs; Altschul Foundation; NATIONAL INSTITUTE ON AGING [U01AG029310] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Altschul Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institutes of Health UO1 (AG29310) and Department of Veterans Affairs to GMP, and in part by Altschul Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrieta-Cruz I, 2010, J ALZHEIMERS DIS, V21, P649, DOI 10.3233/JAD-2010-100225; Braak H, 1997, Int Psychogeriatr, V9 Suppl 1, P257, DOI 10.1017/S1041610297004973; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Cummings Jeffrey L, 2004, Rev Neurol Dis, V1, P60; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Diaz-Ruiz C., 2009, CARDIOVASC PSYCHIAT, V2009; Emilien G, 2000, ARCH NEUROL-CHICAGO, V57, P176, DOI 10.1001/archneur.57.2.176; Forette F, 2002, ARCH INTERN MED, V162, P2046, DOI 10.1001/archinte.162.18.2046; Fox C, 2011, J AM GERIATR SOC, V59, P1477, DOI 10.1111/j.1532-5415.2011.03491.x; Guo ZC, 1999, ARCH NEUROL-CHICAGO, V56, P991, DOI 10.1001/archneur.56.8.991; Gylys KH, 2003, J NEUROCHEM, V84, P1442, DOI 10.1046/j.1471-4159.2003.01643.x; Hajjar I, 2012, ARCH NEUROL-CHICAGO, V10, P1; Hemming ML, 2005, J BIOL CHEM, V280, P37644, DOI 10.1074/jbc.M508460200; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Khachaturian AS, 2006, ARCH NEUROL-CHICAGO, V63, P686, DOI 10.1001/archneur.63.5.noc60013; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lonergan M. H., 2012, J PSYCHIATR NEUROSCI, V37; Lopez-Arrieta J. M., 2002, COCHRANE DB SYST REV, V3; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Sano M, 2003, CNS SPECTRUMS, V8, P846, DOI 10.1017/S1092852900019283; Schwabe L, 2013, BIOL PSYCHOL, V92, P227, DOI 10.1016/j.biopsycho.2012.10.003; Schwabe L, 2012, BIOL PSYCHIAT, V71, P380, DOI 10.1016/j.biopsych.2011.10.028; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Wang J, 2005, FASEB J, V19, P659, DOI 10.1096/fj.04-3182fje; Wang J, 2010, NEUROBIOL AGING; Wang J, 2007, J CLIN INVEST, V117, P3393, DOI 10.1172/JCI31547; Zou K, 2007, J NEUROSCI, V27, P8628, DOI 10.1523/JNEUROSCI.1549-07.2007	36	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65232	10.1371/journal.pone.0065232	http://dx.doi.org/10.1371/journal.pone.0065232			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762322	gold, Green Submitted, Green Published			2022-12-27	WOS:000321099000046
J	Wong, CE; Singh, MB; Bhalla, PL				Wong, Chui E.; Singh, Mohan B.; Bhalla, Prem L.			The Dynamics of Soybean Leaf and Shoot Apical Meristem Transcriptome Undergoing Floral Initiation Process	PLOS ONE			English	Article							FLOWERING-LOCUS-T; GIBBERELLIN 20-OXIDASE GENES; FALSE DISCOVERY RATE; ARABIDOPSIS-THALIANA; PLANT DEVELOPMENT; ABSCISIC-ACID; REPRODUCTIVE DEVELOPMENT; TREHALOSE 6-PHOSPHATE; VEGETATIVE GROWTH; IDENTITY GENES	Flowering process governs seed set and thus affects agricultural productivity. Soybean, a major legume crop, requires short-day photoperiod conditions for flowering. While leaf-derived signal(s) are essential for the photoperiod-induced floral initiation process at the shoot apical meristem, molecular events associated with early floral transition stages in either leaves or shoot apical meristems are not well understood. To provide novel insights into the molecular basis of floral initiation, RNA-Seq was used to characterize the soybean transcriptome of leaf and micro-dissected shoot apical meristem at different time points after short-day treatment. Shoot apical meristem expressed a higher number of transcripts in comparison to that of leaf highlighting greater diversity and abundance of transcripts expressed in the shoot apical meristem. A total of 2951 shoot apical meristem and 13,609 leaf sequences with significant profile changes during the time course examined were identified. Most changes in mRNA level occurred after 1short-day treatment. Transcripts involved in mediating responses to stimulus including hormones or in various metabolic processes represent the top enriched GO functional category for the SAM and leaf dataset, respectively. Transcripts associated with protein degradation were also significantly changing in leaf and SAM implicating their involvement in triggering the developmental switch. RNA-Seq analysis of shoot apical meristem and leaf from soybean undergoing floral transition reveal major reprogramming events in leaves and the SAM that point toward hormones gibberellins (GA) and cytokinin as key regulators in the production of systemic flowering signal(s) in leaves. These hormones may form part of the systemic signals in addition to the established florigen, FLOWERING LOCUS T (FT). Further, evidence is emerging that the conversion of shoot apical meristem to inflorescence meristem is linked with the interplay of auxin, cytokinin and GA creating a low cytokinin and high GA environment.	[Wong, Chui E.; Singh, Mohan B.; Bhalla, Prem L.] Univ Melbourne, Plant Mol Biol & Biotechnol Grp, ARC Ctr Excellence Integrat Legume Res, Melbourne Sch Land & Environm, Parkville, Vic 3052, Australia	University of Melbourne	Bhalla, PL (corresponding author), Univ Melbourne, Plant Mol Biol & Biotechnol Grp, ARC Ctr Excellence Integrat Legume Res, Melbourne Sch Land & Environm, Parkville, Vic 3052, Australia.	premlb@unimelb.edu.au		Bhalla, Prem/0000-0002-2910-0393; WONG, Chui Eng/0000-0003-3006-2176; Singh, Mohan/0000-0001-9427-8975	Australian Research Council in the form of the ARC Centre of Excellence for Integrative Legume Research [CE0348212]	Australian Research Council in the form of the ARC Centre of Excellence for Integrative Legume Research(Australian Research Council)	This work was supported by the Australian Research Council in the form of the ARC Centre of Excellence for Integrative Legume Research (CE0348212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2007, P NATL ACAD SCI USA, V104, P6484, DOI 10.1073/pnas.0610717104; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Avonce N, 2004, PLANT PHYSIOL, V136, P3649, DOI 10.1104/pp.104.052084; Bartrina I, 2011, PLANT CELL, V23, P69, DOI 10.1105/tpc.110.079079; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borner R, 2000, PLANT J, V24, P591, DOI 10.1046/j.1365-313x.2000.00906.x; Carabelli M, 2007, GENE DEV, V21, P1863, DOI 10.1101/gad.432607; Chiang GCK, 2009, P NATL ACAD SCI USA, V106, P11661, DOI 10.1073/pnas.0901367106; Citerne HL, 2003, PLANT PHYSIOL, V131, P1042, DOI 10.1104/pp.102.016311; Coles JP, 1999, PLANT J, V17, P547, DOI 10.1046/j.1365-313X.1999.00410.x; Corbesier L, 2003, J EXP BOT, V54, P2511, DOI 10.1093/jxb/erg276; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; D'Aloia M, 2011, PLANT J, V65, P972, DOI 10.1111/j.1365-313X.2011.04482.x; Das P, 2009, DEVELOPMENT, V136, P1605, DOI 10.1242/dev.035436; Davis SJ, 2009, PLANT CELL ENVIRON, V32, P1201, DOI 10.1111/j.1365-3040.2009.01968.x; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Eriksson S, 2006, PLANT CELL, V18, P2172, DOI 10.1105/tpc.106.042317; Fornara F, 2010, CELL, V141, DOI 10.1016/j.cell.2010.04.024; Gocal GFW, 2001, PLANT PHYSIOL, V125, P1788, DOI 10.1104/pp.125.4.1788; Gomez LD, 2010, PLANT J, V64, P1, DOI 10.1111/j.1365-313X.2010.04312.x; Gremski K, 2007, DEVELOPMENT, V134, P3593, DOI 10.1242/dev.011510; Haerizadeh F, 2009, PLANT MOL BIOL, V69, P711, DOI 10.1007/s11103-008-9450-1; Harberd NP, 2009, PLANT CELL, V21, P1328, DOI 10.1105/tpc.109.066969; Hisamatsu T, 2005, PLANT PHYSIOL, V138, P1106, DOI 10.1104/pp.104.059055; Hisamatsu T, 2008, J EXP BOT, V59, P3821, DOI 10.1093/jxb/ern232; Iqbal N, 2011, CURR SCI INDIA, V100, P998; Jasinski S, 2005, CURR BIOL, V15, P1560, DOI 10.1016/j.cub.2005.07.023; Jones B, 2010, PLANT CELL, V22, P2956, DOI 10.1105/tpc.110.074856; Jung CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038250; Kania T, 1997, PLANT CELL, V9, P1327, DOI 10.1105/tpc.9.8.1327; Karim MR, 2009, PLANT CELL, V21, P1360, DOI 10.1105/tpc.109.067025; Kong FJ, 2010, PLANT PHYSIOL, V154, P1220, DOI 10.1104/pp.110.160796; Laurie RE, 2011, PLANT PHYSIOL, V156, P2207, DOI 10.1104/pp.111.180182; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li YH, 2006, GENOME RES, V16, P414, DOI 10.1101/gr.4237406; Liang D, 2009, J EXP BOT, V60, P4201, DOI 10.1093/jxb/erp254; Lin MK, 2007, PLANT CELL, V19, P1488, DOI 10.1105/tpc.107.051920; Liu BH, 2010, PLANT PHYSIOL, V153, P198, DOI 10.1104/pp.109.150607; Lunn JE, 2006, BIOCHEM J, V397, P139, DOI 10.1042/BJ20060083; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Perilli S, 2010, CURR OPIN PLANT BIOL, V13, P21, DOI 10.1016/j.pbi.2009.09.018; PODOLNYI VZ, 1989, BIOL PLANTARUM, V31, P139, DOI 10.1007/BF02907247; Ramon M, 2007, PLANT MOL BIOL, V63, P195, DOI 10.1007/s11103-006-9082-2; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Satoh-Nagasawa N, 2006, NATURE, V441, P227, DOI 10.1038/nature04725; Shoemaker RC, 2006, CURR OPIN PLANT BIOL, V9, P104, DOI 10.1016/j.pbi.2006.01.007; Sohlberg JJ, 2006, PLANT J, V47, P112, DOI 10.1111/j.1365-313X.2006.02775.x; Tardif G, 2007, PLANT MOL BIOL, V63, P703, DOI 10.1007/s11103-006-9119-6; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tucker SC, 2003, PLANT PHYSIOL, V131, P911, DOI 10.1104/pp.102.017459; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; van Dijken AJH, 2004, PLANT PHYSIOL, V135, P969, DOI 10.1104/pp.104.039743; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Wasilewska A, 2008, MOL PLANT, V1, P198, DOI 10.1093/mp/ssm022; Weiss D, 2007, PLANT PHYSIOL, V144, P1240, DOI 10.1104/pp.107.100370; Wellmer F, 2006, PLOS GENET, V2, P1012, DOI 10.1371/journal.pgen.0020117; Wilmowicz E, 2008, J PLANT PHYSIOL, V165, P1917, DOI 10.1016/j.jplph.2008.04.009; WILSON RN, 1992, PLANT PHYSIOL, V100, P403, DOI 10.1104/pp.100.1.403; Wolbang CM, 2004, PLANT PHYSIOL, V134, P769, DOI 10.1104/pp.103.030460; Wolters H, 2009, NAT REV GENET, V10, P305, DOI 10.1038/nrg2558; Wong CE, 2009, PLANT SIGNALING BEHA, V4, P1; Wong CE, 2011, J EXP BOT, V62, P2495, DOI 10.1093/jxb/erq437; Wong CE, 2011, PLANTA, V233, P553, DOI 10.1007/s00425-010-1320-9; Wong CE, 2009, PLANT J, V57, P832, DOI 10.1111/j.1365-313X.2008.03730.x; Xu J, 2010, PLANT CELL, V22, P91, DOI 10.1105/tpc.109.071803; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Yoo SD, 2009, TRENDS PLANT SCI, V14, P270, DOI 10.1016/j.tplants.2009.02.007; Yoo SK, 2011, PLANT J, V65, P62, DOI 10.1111/j.1365-313X.2010.04402.x; Zhang QZ, 2008, P NATL ACAD SCI USA, V105, P21028, DOI 10.1073/pnas.0810585105	70	33	35	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65319	10.1371/journal.pone.0065319	http://dx.doi.org/10.1371/journal.pone.0065319			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762343	Green Submitted, gold, Green Published			2022-12-27	WOS:000321099000055
J	Xing, CS; Fu, XY; Sun, XD; Guo, P; Li, M; Dong, JT				Xing, Changsheng; Fu, Xiaoying; Sun, Xiaodong; Guo, Peng; Li, Mei; Dong, Jin-Tang			Different Expression Patterns and Functions of Acetylated and Unacetylated Klf5 in the Proliferation and Differentiation of Prostatic Epithelial Cells	PLOS ONE			English	Article							KRUPPEL-LIKE FACTOR-5; TRANSCRIPTION FACTORS; SELF-RENEWAL; STEM-CELLS; CANCER; BETA; GROWTH; MORPHOGENESIS; TUMORIGENESIS; DEGRADATION	KLF5 is a basic transcription factor that regulates multiple biological processes. While it was identified as a putative tumor suppressor in prostate cancer, likely due to its function as an effector of TGF-beta in the inhibition of cell proliferation, KLF5 is unacetylated and promotes cell proliferation in the absence of TGF-beta. In this study, we evaluated the expression and function of KLF5 in prostatic epithelial homeostasis and tumorigenesis using mouse prostates and human prostate epithelial cells in 3-D culture. Histological and molecular analyses demonstrated that unacetylated-Klf5 was expressed in basal or undifferentiated cells, whereas acetylated-Klf5 was expressed primarily in luminal and/or differentiated cells. Androgen depletion via castration increased both the level of Klf5 expression and the number of Klf5-positive cells in the remaining prostate. Functionally, knockdown of KLF5 in the human RWPE-1 prostate cell line decreased the number of spheres formed in 3-D culture. In addition, knockout of Klf5 in prostate epithelial cells, mediated by probasin promoter-driven Cre expression, did not cause neoplasia but promoted cell proliferation and induced hyperplasia when one Klf5 allele was knocked out. Knockout of both Klf5 alleles however, caused apoptosis rather than cell proliferation in the epithelium. In castrated mice, knockout of Klf5 resulted in more severe shrinkage of the prostate. These results suggest that KLF5 plays a role in the proliferation and differentiation of prostatic epithelial cells, yet loss of KLF5 alone is insufficient to induce malignant transformation in epithelial cells.	[Xing, Changsheng; Dong, Jin-Tang] Nankai Univ, Coll Life Sci, Dept Genet & Cell Biol, Tianjin 300071, Peoples R China; [Xing, Changsheng; Fu, Xiaoying; Sun, Xiaodong; Guo, Peng; Li, Mei; Dong, Jin-Tang] Emory Univ, Sch Med, Emory Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA USA; [Fu, Xiaoying] Tianjin Univ Tradit Chinese Med, Dept Pathol, Tianjin, Peoples R China	Nankai University; Emory University; Tianjin University of Traditional Chinese Medicine	Dong, JT (corresponding author), Nankai Univ, Coll Life Sci, Dept Genet & Cell Biol, Tianjin 300071, Peoples R China.	j.dong@emory.edu	guo, peng/AAG-4052-2019; Guo, Peng/GWC-0572-2022	Xing, Changsheng/0000-0001-6582-9037; Guo, Peng/0000-0002-4575-8443; Dong, Jin-Tang/0000-0003-2349-5782	National Cancer Institute, National Institutes of Health [R01CA87921, R01CA171189]; National Natural Science Foundation of China [81130044]; NATIONAL CANCER INSTITUTE [R01CA087921, R01CA171189] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants R01CA87921 and R01CA171189 from the National Cancer Institute, National Institutes of Health and grant 81130044 from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam PJ, 2000, J BIOL CHEM, V275, P37798, DOI 10.1074/jbc.M006323200; Bell SM, 2013, DEV BIOL, V375, P128, DOI 10.1016/j.ydbio.2012.12.010; Bell SM, 2011, DEV BIOL, V358, P79, DOI 10.1016/j.ydbio.2011.07.020; Chen C, 2002, ONCOGENE, V21, P6567, DOI 10.1038/sj.onc.1205817; Chen C, 2003, PROSTATE, V55, P81, DOI 10.1002/pros.10205; Chen CH, 2006, INT J CANCER, V118, P1346, DOI 10.1002/ijc.21533; Chen CS, 2005, J BIOL CHEM, V280, P41553, DOI 10.1074/jbc.M506183200; Chen CS, 2005, ONCOGENE, V24, P3319, DOI 10.1038/sj.onc.1208497; Chen CS, 2001, GENE CHROMOSOME CANC, V31, P333, DOI 10.1002/gcc.1152; Dang DT, 2000, INT J BIOCHEM CELL B, V32, P1103, DOI 10.1016/S1357-2725(00)00059-5; Dong JT, 2009, CELL MOL LIFE SCI, V66, P2691, DOI 10.1007/s00018-009-0045-z; Dong JT, 2001, CANCER METAST REV, V20, P173, DOI 10.1023/A:1015575125780; ENGLISH HF, 1987, PROSTATE, V11, P229, DOI 10.1002/pros.2990110304; Frigo DE, 2009, MOL ENDOCRINOL, V23, P1385, DOI 10.1210/me.2009-0010; Guo P, 2009, J BIOL CHEM, V284, P28243, DOI 10.1074/jbc.M109.036160; Guo P, 2009, J BIOL CHEM, V284, P18184, DOI 10.1074/jbc.M109.007096; Guo P, 2009, J BIOL CHEM, V284, P6071, DOI 10.1074/jbc.M806270200; Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296; Hudson DL, 2003, CYTOTECHNOLOGY, V41, P189, DOI 10.1023/A:1024887009081; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Knuutila S, 1999, AM J PATHOL, V155, P683, DOI 10.1016/S0002-9440(10)65166-8; Lang SH, 2001, BRIT J CANCER, V85, P590, DOI 10.1054/bjoc.2001.1967; Lang SH, 2006, IN VITRO CELL DEV-AN, V42, P273; Li XH, 2009, DIFFERENTIATION, V77, P95, DOI 10.1016/j.diff.2008.09.012; Litvinov IV, 2006, CANCER RES, V66, P8598, DOI 10.1158/0008-5472.CAN-06-1228; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; McConnell BB, 2011, GASTROENTEROLOGY, V141, P1302, DOI 10.1053/j.gastro.2011.06.086; Nakajima Y, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001551; Nandan MO, 2008, GASTROENTEROLOGY, V134, P120, DOI 10.1053/j.gastro.2007.10.023; Nandan MO, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-63; Nandan MO, 2004, ONCOGENE, V23, P3404, DOI 10.1038/sj.onc.1207397; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Oldridge EE, 2012, MOL CELL ENDOCRINOL, V360, P14, DOI 10.1016/j.mce.2011.07.008; Parisi S, 2008, J CELL SCI, V121, P2629, DOI 10.1242/jcs.027599; Parisi S, 2011, VITAM HORM, V87, P381, DOI 10.1016/B978-0-12-386015-6.00037-8; Park JH, 2002, AM J PATHOL, V161, P727, DOI 10.1016/S0002-9440(10)64228-9; Pascal LE, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-46; Salm SN, 2005, J CELL BIOL, V170, P81, DOI 10.1083/jcb.200412015; Shen MM, 2008, COLD SH Q B, V73, P529, DOI 10.1101/sqb.2008.73.050; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; SOGAWA K, 1993, NUCLEIC ACIDS RES, V21, P1527, DOI 10.1093/nar/21.7.1527; Sun XD, 2012, GENESIS, V50, P819, DOI 10.1002/dvg.22041; Sur I, 2006, J CELL SCI, V119, P3593, DOI 10.1242/jcs.03070; Turner J, 1999, TRENDS BIOCHEM SCI, V24, P236, DOI 10.1016/S0968-0004(99)01406-1; Tyson DR, 2007, PROSTATE, V67, P1601, DOI 10.1002/pros.20628; Valkenburg KC, 2011, PROSTATE CANCER, V2011, DOI 10.1155/2011/895238; van Leenders GJLH, 2001, J PATHOL, V195, P563, DOI 10.1002/path.993; Wan HJ, 2008, DEVELOPMENT, V135, P2563, DOI 10.1242/dev.021964; Wang XD, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r255; WAYMOUTH C, 1983, JNCI-J NATL CANCER I, V70, P199; Webber MM, 1997, CARCINOGENESIS, V18, P1225, DOI 10.1093/carcin/18.6.1225; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Yang YZ, 2005, CANCER BIOL THER, V4, P1216, DOI 10.4161/cbt.4.11.2090; Zhao KW, 2011, BIOCHEM J, V437, P323, DOI 10.1042/BJ20101388; Zhao Y, 2008, ONCOGENE, V27, P1, DOI 10.1038/sj.onc.1210625; Zhu NX, 2006, J BIOL CHEM, V281, P14711, DOI 10.1074/jbc.M513810200	56	18	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65538	10.1371/journal.pone.0065538	http://dx.doi.org/10.1371/journal.pone.0065538			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755247	Green Submitted, gold, Green Published			2022-12-27	WOS:000320579400063
J	Aouida, M; Texeira, MR; Thevelein, JM; Poulin, R; Ramotar, D				Aouida, Mustapha; Texeira, Marta Rubio; Thevelein, Johan M.; Poulin, Richard; Ramotar, Dindial			Agp2, a Member of the Yeast Amino Acid Permease Family, Positively Regulates Polyamine Transport at the Transcriptional Level	PLOS ONE			English	Article							SR PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; POTASSIUM TRANSPORTER; ION HOMEOSTASIS; DRUG BLEOMYCIN; BUDDING YEAST; PATHWAY; GENE; ACTIVATION; TOLERANCE	Agp2 is a plasma membrane protein of the Saccharomyces cerevisiae amino acid transporter family, involved in high-affinity uptake of various substrates including L-carnitine and polyamines. The discovery of two high affinity polyamine permeases, Dur3 and Sam3, prompted us to investigate whether Agp2 directly transports polyamines or acts instead as a regulator. Herein, we show that neither dur3 Delta nor sam3 Delta single mutant is defective in polyamine transport, while the dur3 Delta sam3 Delta double mutant exhibits a sharp decrease in polyamine uptake and an increased resistance to polyamine toxicity similar to the agp2 Delta mutant. Studies of Agp2 localization indicate that in the double mutant dur3 Delta sam3 Delta, Agp2-GFP remains plasma membrane-localized, even though transport of polyamines is strongly reduced. We further demonstrate that Agp2 controls the expression of several transporter genes including DUR3 and SAM3, the carnitine transporter HNM1 and several hexose, nucleoside and vitamin permease genes, in addition to SKY1 encoding a SR kinase that positively regulates low-affinity polyamine uptake. Furthermore, gene expression analysis clearly suggests that Agp2 is a strong positive regulator of additional biological processes. Collectively, our data suggest that Agp2 might respond to environmental cues and thus regulate the expression of several genes including those involved in polyamine transport.	[Aouida, Mustapha] King Abdullah Univ Sci & Technol, Ctr Desert Agr, Thuwal, Saudi Arabia; [Texeira, Marta Rubio; Thevelein, Johan M.] Inst Bot & Microbiol, Mol Cell Biol Lab, Louvain, Belgium; [Texeira, Marta Rubio; Thevelein, Johan M.] Flanders Inst Biotechnol, Dept Mol Microbiol, Flanders, Belgium; [Poulin, Richard] Univ Laval, Dept Mol Biol Med Biochem & Pathol, Quebec City, PQ G1K 7P4, Canada; [Ramotar, Dindial] Univ Montreal, Maisonneuve Rosemont Hosp, Res Ctr, Montreal, PQ, Canada	King Abdullah University of Science & Technology; Flanders Institute for Biotechnology (VIB); Laval University; Universite de Montreal	Aouida, M (corresponding author), King Abdullah Univ Sci & Technol, Ctr Desert Agr, Thuwal, Saudi Arabia.	Mustapha.aouida@kaust.edu.sa; dramotar.hmr@ssss.gouv.qc.ca	Aouida, Mustapha/AEJ-4513-2022; Thevelein, Johan M./AAK-4203-2021	Aouida, Mustapha/0000-0001-7945-5320; Thevelein, Johan/0000-0002-2626-0180	Canadian Institute of Health Research [MOP-93573, MOP-67196]; Fund for Scientific Research-Flanders, Interuniversity Attraction Poles Network [P6/14, P7]; Research Fund of the KU Leuven (Concerted Research Actions); Hercules Foundation (Flanders); EC-Marie-Curie; Fonds Wetenschappelijk Onderzoek (FWO); Flanders Institute of Biotechnology (VIB); King Abdullah University of Science and Technology, Saudi Arabia	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Fund for Scientific Research-Flanders, Interuniversity Attraction Poles Network(Belgian Federal Science Policy OfficeFWO); Research Fund of the KU Leuven (Concerted Research Actions); Hercules Foundation (Flanders); EC-Marie-Curie; Fonds Wetenschappelijk Onderzoek (FWO)(FWO); Flanders Institute of Biotechnology (VIB); King Abdullah University of Science and Technology, Saudi Arabia(King Abdullah University of Science & Technology)	This work was supported by the Canadian Institute of Health Research (MOP-93573 and MOP-67196 to DR) and by grants from the Fund for Scientific Research-Flanders, Interuniversity Attraction Poles Network P6/14 and P7, the Research Fund of the KU Leuven (Concerted Research Actions) and the Hercules Foundation (Flanders) to JMT. This work was also supported by EC-Marie-Curie, Fonds Wetenschappelijk Onderzoek (FWO) visiting fellowship and Flanders Institute of Biotechnology (VIB) contract all to MRT, and by the King Abdullah University of Science and Technology, Saudi Arabia, to MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aouida M, 2005, J BIOL CHEM, V280, P24267, DOI 10.1074/jbc.M503071200; Aouida M, 2004, CANCER RES, V64, P1102, DOI 10.1158/0008-5472.CAN-03-2729; Chang AB, 2004, MOL MEMBR BIOL, V21, P171, DOI 10.1080/09687680410001720830; Didion T, 1998, MOL MICROBIOL, V27, P643, DOI 10.1046/j.1365-2958.1998.00714.x; Donaton MCV, 2003, MOL MICROBIOL, V50, P911, DOI 10.1046/j.1365-2958.2003.03732.x; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Erez O, 2001, MOL CELL BIOL, V21, P175, DOI 10.1128/MCB.21.1.175-184.2001; Erez O, 2002, BIOCHEM BIOPH RES CO, V295, P1142, DOI 10.1016/S0006-291X(02)00823-9; Forment J, 2002, BBA-BIOMEMBRANES, V1565, P36, DOI 10.1016/S0005-2736(02)00503-5; Fox RJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-126; Gaber RF, 2003, EUKARYOT CELL, V2, P922, DOI 10.1128/EC.2.5.922-929.2003; Gautier L, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-111; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Goossens A, 2000, MOL CELL BIOL, V20, P7654, DOI 10.1128/MCB.20.20.7654-7661.2000; Guthrie C, 1991, METHOD ENZYMOL, P3; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hundal HS, 2009, AM J PHYSIOL-ENDOC M, V296, pE603, DOI 10.1152/ajpendo.91002.2008; Igarashi K, 2010, PLANT PHYSIOL BIOCH, V48, P506, DOI 10.1016/j.plaphy.2010.01.017; Iraqui I, 1999, MOL CELL BIOL, V19, P989; Kaouass M, 1997, MOL CELL BIOL, V17, P2994, DOI 10.1128/MCB.17.6.2994; Kriel J, 2011, BIOESSAYS, V33, P870, DOI 10.1002/bies.201100100; Lahav R, 2007, MOL CELL BIOL, V27, P818, DOI 10.1128/MCB.00439-06; Leduc A, 2003, MOL GENET GENOMICS, V269, P78, DOI 10.1007/s00438-003-0812-8; Lee J, 2002, MOL CELLS, V13, P407; Ljungdahl PO, 2009, BIOCHEM SOC T, V37, P242, DOI 10.1042/BST0370242; NIKAWA J, 1990, J BIOL CHEM, V265, P15996; Porat Z, 2005, CELL MOL LIFE SCI, V62, P3106, DOI 10.1007/s00018-005-5341-7; Poschmann J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023159; Proszynski TJ, 2005, P NATL ACAD SCI USA, V102, P17981, DOI 10.1073/pnas.0509107102; Roberg KJ, 1997, J CELL BIOL, V137, P1469, DOI 10.1083/jcb.137.7.1469; Rubio-Texeira M, 2006, MOL BIOL CELL, V17, P3031, DOI 10.1091/mbc.E05-07-0669; Rubio-Texeira M, 2010, FEMS YEAST RES, V10, P134, DOI 10.1111/j.1567-1364.2009.00587.x; Ruiz A, 2004, FEBS LETT, V578, P58, DOI 10.1016/j.febslet.2004.10.069; Schreve JL, 2004, BIOCHEM BIOPH RES CO, V313, P745, DOI 10.1016/j.bbrc.2003.11.172; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Shepard PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-242; SHERMAN F, 1983, LAB COURSE MANUAL ME; Strijbis K, 2010, EUKARYOT CELL, V9, P1809, DOI 10.1128/EC.00172-10; Strijbis K, 2010, IUBMB LIFE, V62, P357, DOI 10.1002/iub.323; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; Turcotte B, 2010, FEMS YEAST RES, V10, P2, DOI 10.1111/j.1567-1364.2009.00555.x; Uemura T, 2007, J BIOL CHEM, V282, P7733, DOI 10.1074/jbc.M611105200; Van Nuland A, 2006, MOL MICROBIOL, V59, P1485, DOI 10.1111/j.1365-2958.2005.05043.x; van Roermund CWT, 1999, EMBO J, V18, P5843, DOI 10.1093/emboj/18.21.5843; Van Zeebroeck G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024275; White WH, 2001, J BIOL CHEM, V276, P10794, DOI 10.1074/jbc.M009804200; Yenush L, 2005, MOL CELL BIOL, V25, P8683, DOI 10.1128/MCB.25.19.8683-8692.2005	47	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65717	10.1371/journal.pone.0065717	http://dx.doi.org/10.1371/journal.pone.0065717			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755272	gold, Green Published, Green Submitted			2022-12-27	WOS:000319872300093
J	Osawa, Y; Hoshi, M; Yasuda, I; Saibara, T; Moriwaki, H; Kozawa, O				Osawa, Yosuke; Hoshi, Masato; Yasuda, Ichiro; Saibara, Toshiji; Moriwaki, Hisataka; Kozawa, Osamu			Tumor Necrosis Factor-alpha Promotes Cholestasis-Induced Liver Fibrosis in the Mouse through Tissue Inhibitor of Metalloproteinase-1 Production in Hepatic Stellate Cells	PLOS ONE			English	Article							BILE-DUCT LIGATION; FAS-MEDIATED APOPTOSIS; HEPATOCYTE APOPTOSIS; FACTOR RECEPTOR; TNF-ALPHA; MATRIX METALLOPROTEINASES; CARBON-TETRACHLORIDE; GENE-EXPRESSION; MESSENGER-RNA; KUPFFER CELLS	Tumor necrosis factor (TNF)-alpha, which is a mediator of hepatotoxicity, has been implicated in liver fibrosis. However, the roles of TNF-alpha on hepatic stellate cell (HSC) activation and liver fibrosis are complicated and remain controversial. To explore this issue, the role of TNF-alpha in cholestasis-induced liver fibrosis was examined by comparing between TNF-alpha(-/-) mice and TNF-alpha(+/)+mice after bile duct ligation (BDL). Serum TNF-alpha levels in mice were increased by common BDL combined with cystic duct ligation (CBDL+CDL). TNF-alpha deficiency reduced liver fibrosis without affecting liver injury, inflammatory cell infiltration, and liver regeneration after CBDL+CDL. Increased expression levels of collagen a1(I) mRNA, transforming growth factor (TGF)-beta mRNA, and alpha-smooth muscle actin (alpha SMA) protein by CBDL+CDL in the livers of TNF-alpha(-/-) mice were comparable to those in TNF-alpha(+/)+mice. Exogenous administration of TNF-a decreased collagen alpha 1(I) mRNA expression in isolated rat HSCs. These results suggest that the reduced fibrosis in TNF-alpha(-/-) mice is regulated in post-transcriptional level. Tissue inhibitor of metalloproteinase (TIMP)-1 plays a crucial role in the pathogenesis of liver fibrosis. TIMP-1 expression in HSCs in the liver was increased by CBDL+CDL, and the induction was lower in TNF-alpha(-/-) mice than in TNF-alpha(+/)+mice. Fibrosis in the lobe of TIMP-1(-/-) mice with partial BDL was also reduced. These findings indicate that TNF-alpha produced by cholestasis can promote liver fibrosis via TIMP-1 production from HSCs. Thus, targeting TNF-alpha and TIMP-1 may become a new therapeutic strategy for treating liver fibrosis in cholestatic liver injury.	[Osawa, Yosuke; Kozawa, Osamu] Gifu Univ, Grad Sch Med, Dept Pharmacol, Gifu, Japan; [Osawa, Yosuke; Yasuda, Ichiro; Moriwaki, Hisataka] Gifu Univ, Grad Sch Med, Dept Gastroenterol, Gifu, Japan; [Hoshi, Masato] Suzuka Univ Med Sci, Fac Hlth Sci, Suzuka, Mie, Japan; [Saibara, Toshiji] Kochi Univ, Sch Med, Dept Gastroenterol & Hepatol, Nankoku, Kochi, Japan	Gifu University; Gifu University; Kochi University	Osawa, Y (corresponding author), Gifu Univ, Grad Sch Med, Dept Pharmacol, Gifu, Japan.	osawa-gif@umin.ac.jp			Takeda Science Foundation; Kondou Kinen Medical Foundation; Kurozumi Medical Foundation; Yasuda Medical Foundation; Senshin Medical Research Foundation; Ministry of Education, Science, Sports, and Culture of Japan [23790787]; Grants-in-Aid for Scientific Research [221S0001] Funding Source: KAKEN	Takeda Science Foundation(Takeda Science Foundation (TSF)); Kondou Kinen Medical Foundation; Kurozumi Medical Foundation(Kurozumi Medical Foundation); Yasuda Medical Foundation; Senshin Medical Research Foundation(SENSHIN Medical Research Foundation); Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Takeda Science Foundation, the Kondou Kinen Medical Foundation, the Kurozumi Medical Foundation, the Yasuda Medical Foundation, the Senshin Medical Research Foundation, and by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan (23790787). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur MJP, 2000, AM J PHYSIOL-GASTR L, V279, pG245; Bahr MJ, 1999, HEPATOLOGY, V29, P839, DOI 10.1002/hep.510290333; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bataller R, 2001, SEMIN LIVER DIS, V21, P437, DOI 10.1055/s-2001-17558; BEMELMANS MHA, 1992, HEPATOLOGY, V15, P1132, DOI 10.1002/hep.1840150626; Canbay A, 2002, GASTROENTEROLOGY, V123, P1323, DOI 10.1053/gast.2002.35953; Doyle GAR, 1997, BIOCHEMISTRY-US, V36, P2492, DOI 10.1021/bi962161e; Duarte S, 2012, HEPATOLOGY, V56, P1074, DOI 10.1002/hep.25710; Gabele E, 2009, BIOCHEM BIOPH RES CO, V378, P348, DOI 10.1016/j.bbrc.2008.10.155; HernandezMunoz I, 1997, GASTROENTEROLOGY, V113, P625, DOI 10.1053/gast.1997.v113.pm9247485; Higuchi H, 2003, AM J PHYSIOL-GASTR L, V284, pG734, DOI 10.1152/ajpgi.00491.2002; Houglum K, 1998, AM J PHYSIOL-GASTR L, V274, pG840, DOI 10.1152/ajpgi.1998.274.5.G840; Iredale JP, 1996, HEPATOLOGY, V24, P176, DOI 10.1002/hep.510240129; Jaeschke Hartmut, 2002, Hepatology, V35, P964, DOI 10.1053/jhep.2002.0350964; Jang JH, 2012, HEPATOLOGY, V56, P209, DOI 10.1002/hep.25626; Knittel T, 1999, J HEPATOL, V30, P48, DOI 10.1016/S0168-8278(99)80007-5; Mohammed FF, 2005, HEPATOLOGY, V41, P857, DOI 10.1002/hep.20618; Nagaki M, 1999, J HEPATOL, V31, P997, DOI 10.1016/S0168-8278(99)80311-0; Nagaki M, 2000, HEPATOLOGY, V32, P1272, DOI 10.1053/jhep.2000.20239; Osawa Y, 2005, HEPATOLOGY, V42, P1320, DOI 10.1002/hep.20967; Osawa Y, 2005, J BIOL CHEM, V280, P27879, DOI 10.1074/jbc.M503002200; Osawa Y, 2001, LIVER, V21, P309, DOI 10.1034/j.1600-0676.2001.210503.x; Osawa Y, 2001, J CELL PHYSIOL, V187, P374, DOI 10.1002/jcp.1088; Osawa Y, 2013, J CLIN INVEST; Osawa Y, 2006, LIVER INT, V26, P1138, DOI 10.1111/j.1478-3231.2006.01346.x; Osawa Y, 2010, HEPATOLOGY, V51, P237, DOI 10.1002/hep.23262; Park YJ, 2008, HEPATOLOGY, V47, P1578, DOI 10.1002/hep.22196; Parsons CJ, 2004, HEPATOLOGY, V40, P1106, DOI 10.1002/hep.20425; Reeves HL, 2000, J HEPATOL, V32, P465, DOI 10.1016/S0168-8278(00)80398-0; Roderfeld M, 2006, FASEB J, V20, P444, DOI 10.1096/fj.05-4828com; Roderfeld M, 2006, LIVER INT, V26, P579, DOI 10.1111/j.1478-3231.2006.01271.x; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Schwabe RF, 2003, AM J PHYSIOL-GASTR L, V285, pG949, DOI 10.1152/ajpgi.00215.2003; Simeonova PP, 2001, TOXICOL APPL PHARM, V177, P112, DOI 10.1006/taap.2001.9304; Sokol RJ, 2006, J PEDIATR GASTR NUTR, V43, pS4, DOI 10.1097/01.mpg.0000226384.71859.16; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Sudo K, 2005, CYTOKINE, V29, P236, DOI 10.1016/j.cyto.2004.11.001; Tarrats N, 2011, HEPATOLOGY, V54, P319, DOI 10.1002/hep.24388; Tomita K, 2006, GUT, V55, P415, DOI 10.1136/gut.2005.071118; Trim JE, 2000, J BIOL CHEM, V275, P6657, DOI 10.1074/jbc.275.9.6657; Varela-Rey M, 2007, CYTOKINE, V37, P212, DOI 10.1016/j.cyto.2007.03.013; Wang H, 2011, PROTECTING PRIVACY IN CHINA: A RESEARCH ON CHINAS PRIVACY STANDARDS AND THE POSSIBILITY OF ESTABLISHING THE RIGHT TO PRIVACY AND THE INFORMATION PRIVACY PROTECTION LEGISLATION IN MODERN CHINA, P1, DOI 10.1007/978-3-642-21750-0_1; Wielockx B, 2001, NAT MED, V7, P1202, DOI 10.1038/nm1101-1202; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441; Yerushalmi B, 2001, HEPATOLOGY, V33, P616, DOI 10.1053/jhep.2001.22702; Yoshiji H, 2000, HEPATOLOGY, V32, P1248, DOI 10.1053/jhep.2000.20521	46	51	55	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65251	10.1371/journal.pone.0065251	http://dx.doi.org/10.1371/journal.pone.0065251			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755201	gold, Green Published, Green Submitted			2022-12-27	WOS:000319872300064
J	Park, KH; Shin, JH; Lee, SY; Kim, SH; Jang, MO; Kang, SJ; Jung, SI; Chung, EK; Ko, KS; Jang, HC				Park, Kyung-Hwa; Shin, Jong-Hee; Lee, Seung Yeop; Kim, Soo Hyun; Jang, Mi Ok; Kang, Seung-Ji; Jung, Sook-In; Chung, Eun-Kyung; Ko, Kwan Soo; Jang, Hee-Chang			The Clinical Characteristics, Carbapenem Resistance, and Outcome of Acinetobacter Bacteremia According to Genospecies	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; INTENSIVE-CARE UNITS; BAUMANNII; COLISTIN; IDENTIFICATION; EMERGENCE; KOREA	Background: Few clinical data are available on the relationship between genospecies and outcome of Acinetobacter bacteremia, and the results are inconsistent. We performed this study to evaluate the relationship between genospecies and the outcome of Acinetobacter bacteremia. Methods: Clinical data from 180 patients who had Acinetobacter bacteremia from 2003 to 2010 were reviewed retrospectively. The genospecies were identified by rpoB gene sequence analysis. The clinical features and outcomes of 90 patients with A. baumannii bacteremia were compared to those of 90 patients with non-baumannii Acinetobacter bacteremia (60 with A. nosocomialis, 17 with Acinetobacter species "close to 13 TU'', 11 with A. pittii, and two with A. calcoaceticus). Results: A. baumannii bacteremia was associated with intensive care unit-onset, mechanical ventilation, pneumonia, carbapenem resistance, and higher APACHE II scores, compared to non-baumannii Acinetobacter bacteremia (P<0.05). In univariate analyses, age, pneumonia, multidrug resistance, carbapenem resistance, inappropriate empirical antibiotics, higher APACHE II scores, and A. baumannii genospecies were risk factors for mortality (P<0.05). Multivariate analysis revealed A. baumannii genospecies (OR, 3.60; 95% CI, 1.56-8.33), age, pneumonia, and higher APACHE II scores to be independent risk factors for mortality (P<0.05). Conclusion: A. baumannii genospecies was an independent risk factor for mortality in patients with Acinetobacter bacteremia. Our results emphasize the importance of correct species identification of Acinetobacter blood isolates.	[Park, Kyung-Hwa; Jang, Mi Ok; Kang, Seung-Ji; Jung, Sook-In; Jang, Hee-Chang] Chonnam Natl Univ, Sch Med, Dept Infect Dis, Kwangju, South Korea; [Shin, Jong-Hee; Lee, Seung Yeop; Kim, Soo Hyun] Chonnam Natl Univ, Sch Med, Dept Lab Med, Kwangju, South Korea; [Chung, Eun-Kyung] Chonnam Natl Univ, Sch Med, Dept Med Educ, Kwangju, South Korea; [Ko, Kwan Soo] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Sungkyunkwan University (SKKU)	Jang, HC (corresponding author), Chonnam Natl Univ, Sch Med, Dept Infect Dis, Kwangju, South Korea.	haroc153@naver.com		Kang, Seung ji/0000-0002-3298-0520; Ko, Kwan Soo/0000-0002-0978-1937; Jang, Hee-Chang/0000-0002-3407-8493				Cai Y, 2012, J ANTIMICROB CHEMOTH, V67, P1607, DOI 10.1093/jac/dks084; Chuang YC, 2011, CLIN INFECT DIS, V52, P352, DOI 10.1093/cid/ciq154; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; GERNERSMIDT P, 1991, J CLIN MICROBIOL, V29, P277, DOI 10.1128/JCM.29.2.277-282.1991; Houang ETS, 2003, ANTIMICROB AGENTS CH, V47, P1472, DOI 10.1128/AAC.47.4.1472-1475.2003; Jang HC, 2009, CLIN INFECT DIS, V49, P395, DOI 10.1086/600295; Karah N, 2011, J ANTIMICROB CHEMOTH, V66, P738, DOI 10.1093/jac/dkq521; Ko KS, 2007, J ANTIMICROB CHEMOTH, V60, P1163, DOI 10.1093/jac/dkm305; Kwon KT, 2007, J ANTIMICROB CHEMOTH, V59, P525, DOI 10.1093/jac/dkl499; Lee YC, 2011, J ANTIMICROB CHEMOTH, V66, P1839, DOI 10.1093/jac/dkr200; Lim YM, 2007, J CLIN MICROBIOL, V45, P902, DOI 10.1128/JCM.01573-06; Nemec A, 2011, RES MICROBIOL, V162, P393, DOI 10.1016/j.resmic.2011.02.006; Nemec A, 2009, INT J SYST EVOL MICR, V59, P118, DOI 10.1099/ijs.0.001230-0; Ntusi NBA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052452; Park YK, 2009, DIAGN MICR INFEC DIS, V64, P43, DOI 10.1016/j.diagmicrobio.2009.01.012; Paterson DL, 2006, CLIN INFECT DIS, V43, pS43, DOI 10.1086/504476; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Peleg AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046984; Sahl JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054287; Shields RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052349; Tabah A, 2012, INTENS CARE MED, V38, P1930, DOI 10.1007/s00134-012-2695-9; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Wisplinghoff H, 2012, J INFECTION, V64, P282, DOI 10.1016/j.jinf.2011.12.008	23	31	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65026	10.1371/journal.pone.0065026	http://dx.doi.org/10.1371/journal.pone.0065026			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755171	gold, Green Published, Green Submitted			2022-12-27	WOS:000319872300043
J	Argunhan, B; Farmer, S; Leung, WK; Terentyev, Y; Humphryes, N; Tsubouchi, T; Toyoizumi, H; Tsubouchi, H				Argunhan, Bilge; Farmer, Sarah; Leung, Wing-Kit; Terentyev, Yaroslav; Humphryes, Neil; Tsubouchi, Tomomi; Toyoizumi, Hiroshi; Tsubouchi, Hideo			Direct and Indirect Control of the Initiation of Meiotic Recombination by DNA Damage Checkpoint Mechanisms in Budding Yeast	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; MEIOSIS; PHOSPHORYLATION; LANDSCAPE; PACHYTENE; ATM	Meiotic recombination plays an essential role in the proper segregation of chromosomes at meiosis I in many sexually reproducing organisms. Meiotic recombination is initiated by the scheduled formation of genome-wide DNA double-strand breaks (DSBs). The timing of DSB formation is strictly controlled because unscheduled DSB formation is detrimental to genome integrity. Here, we investigated the role of DNA damage checkpoint mechanisms in the control of meiotic DSB formation using budding yeast. By using recombination defective mutants in which meiotic DSBs are not repaired, the effect of DNA damage checkpoint mutations on DSB formation was evaluated. The Tel1 (ATM) pathway mainly responds to unresected DSB ends, thus the sae2 mutant background in which DSB ends remain intact was employed. On the other hand, the Mec1 (ATR) pathway is primarily used when DSB ends are resected, thus the rad51 dmc1 double mutant background was employed in which highly resected DSBs accumulate. In order to separate the effect caused by unscheduled cell cycle progression, which is often associated with DNA damage checkpoint defects, we also employed the ndt80 mutation which permanently arrests the meiotic cell cycle at prophase I. In the absence of Tel1, DSB formation was reduced in larger chromosomes (IV, VII, II and XI) whereas no significant reduction was found in smaller chromosomes (III and VI). On the other hand, the absence of Rad17 (a critical component of the ATR pathway) lead to an increase in DSB formation (chromosomes VII and II were tested). We propose that, within prophase I, the Tel1 pathway facilitates DSB formation, especially in bigger chromosomes, while the Mec1 pathway negatively regulates DSB formation. We also identified prophase I exit, which is under the control of the DNA damage checkpoint machinery, to be a critical event associated with down-regulating meiotic DSB formation.	[Argunhan, Bilge; Farmer, Sarah; Leung, Wing-Kit; Terentyev, Yaroslav; Humphryes, Neil; Tsubouchi, Tomomi; Tsubouchi, Hideo] Univ Sussex, MRC Genome Damage & Stabil Ctr, Brighton, E Sussex, England; [Toyoizumi, Hiroshi] Waseda Univ, Grad Sch Accounting, Tokyo, Japan; [Toyoizumi, Hiroshi] Waseda Univ, Dept Appl Math, Tokyo, Japan	University of Sussex; Waseda University; Waseda University	Tsubouchi, H (corresponding author), Univ Sussex, MRC Genome Damage & Stabil Ctr, Brighton, E Sussex, England.	h.tsubouchi@sussex.ac.uk		Tsubouchi, Tomomi/0000-0001-9960-3888; Leung, Wing-Kit/0000-0003-3039-4904; Tsubouchi, Hideo/0000-0003-0814-8432	Marie Curie Cancer Care; Biotechnology and Biological Sciences Research Council; BBSRC [BB/I009159/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I009159/1] Funding Source: researchfish; Medical Research Council [G0801130B, 1094901] Funding Source: researchfish	Marie Curie Cancer Care; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Tsubouchi laboratory is supported by Marie Curie Cancer Care and the Biotechnology and Biological Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blitzblau HG, 2011, METHODS MOL BIOL, V745, P47, DOI 10.1007/978-1-61779-129-1_4; Bonilla CY, 2008, MOL CELL, V30, P267, DOI 10.1016/j.molcel.2008.03.023; Buhler C, 2007, PLOS BIOL, V5, P2797, DOI 10.1371/journal.pbio.0050324; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; Farmer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039724; Farmer S, 2011, METHODS MOL BIOL, V745, P33, DOI 10.1007/978-1-61779-129-1_3; Gerton JL, 2005, NAT REV GENET, V6, P477, DOI 10.1038/nrg1614; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Haber JE, 1998, CELL, V95, P583, DOI 10.1016/S0092-8674(00)81626-8; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Henderson KA, 2006, CELL, V125, P1321, DOI 10.1016/j.cell.2006.04.039; Ho HC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002351; Joyce EF, 2011, J CELL BIOL, V195, P359, DOI 10.1083/jcb.201104121; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Lange J, 2011, NATURE, V479, P237, DOI 10.1038/nature10508; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Lichten M, 2011, CELL, V147, P267, DOI 10.1016/j.cell.2011.09.038; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lydall D, 1996, MEIOTIC RECOMBINATIO; MacQueen AJ, 2011, TRENDS CELL BIOL, V21, P393, DOI 10.1016/j.tcb.2011.03.004; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Sasanuma H, 2008, GENE DEV, V22, P398, DOI 10.1101/gad.1626608; SUN H, 1991, CELL, V64, P1155, DOI 10.1016/0092-8674(91)90270-9; Toyoizumi H, 2012, J COMPUT BIOL, V19, P1277, DOI 10.1089/cmb.2012.0209; Tsubouchi H, 2006, GENE DEV, V20, P1766, DOI 10.1101/gad.1422506; Tung KS, 2000, P NATL ACAD SCI USA, V97, P12187, DOI 10.1073/pnas.220464597; Vader G, 2011, NATURE, V477, P115, DOI 10.1038/nature10331; Wan L, 2008, GENE DEV, V22, P386, DOI 10.1101/gad.1626408; Wu HY, 2006, CURR BIOL, V16, P2473, DOI 10.1016/j.cub.2006.10.069; XU LZ, 1995, MOL CELL BIOL, V15, P6572; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	33	21	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65875	10.1371/journal.pone.0065875	http://dx.doi.org/10.1371/journal.pone.0065875			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762445	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000320440500055
J	Clerget, E; Andres, M; Olivier, E				Clerget, Emeline; Andres, Michael; Olivier, Etienne			Deficit in Complex Sequence Processing after a Virtual Lesion of Left BA45	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; DORSAL PREMOTOR CORTEX; BROCAS AREA; HIERARCHICAL ORGANIZATION; PREFRONTAL CORTEX; COGNITIVE CONTROL; FRONTAL-CORTEX; LANGUAGE; BEHAVIOR; APHASIA	Although the contribution of Broca's area to motor cognition is generally accepted, its exact role remains controversial. A previous functional imaging study has suggested that Broca's area implements hierarchically organised motor behaviours and, in particular, that its anterior (Brodmann area 45, BA45) and posterior (BA44) parts process, respectively, higher and lower-level hierarchical elements. This function of Broca's area could generalize to other cognitive functions, including language. However, because of the correlative nature of functional imaging data, the causal relationship between Broca's region activation and its behavioural significance cannot be ascertained. To circumvent this limitation, we used on-line repetitive transcranial magnetic stimulation to disrupt neuronal processing in left BA45, left BA44 or left dorsal premotor cortex, three areas that have been shown to exhibit a phasic activation when participants performed hierarchically organised motor behaviours. The experiment was conducted in healthy volunteers performing the same two key-press sequences as those used in a previous imaging study, and which differed in terms of hierarchical organisation. The performance of the lower-order hierarchical task (Experiment #1) was unaffected by magnetic stimulation. In contrast, in the higher-order hierarchical task (Experiment #2, "superordinate" task), we found that a virtual lesion of the anterior part of Broca's area (left BA45) delayed the processing of the cue initiating the sequence in an effector-independent way. Interestingly, in this task, the initiation cue only informed the subjects about the rules to be applied to produce the appropriate response but did not allow them to anticipate the entire motor sequence. A second important finding was a RT decrease following left PMd virtual lesions in the superordinate task, a result compatible with the view that PMd plays a critical role in impulse control. The present study therefore demonstrates the role of left BA45 in planning the higher-order hierarchical levels of motor sequences.	[Clerget, Emeline; Olivier, Etienne] Catholic Univ Louvain, Neurophysiol Lab, Inst Neurosci, B-1200 Brussels, Belgium; [Andres, Michael] Univ Ghent, Fac Psychol, Dept Expt Psychol, B-9000 Ghent, Belgium	Universite Catholique Louvain; Ghent University	Olivier, E (corresponding author), Catholic Univ Louvain, Neurophysiol Lab, Inst Neurosci, B-1200 Brussels, Belgium.	etienne.olivier@uclouvain.be	Andres, Michael/I-2306-2019	Andres, Michael/0000-0002-7505-8157	Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA); Fonds Speciaux de Recherche (FSR) of the Universite Catholique de Louvain; Fonds de la Recherche Scientifique Medicale (FRSM); Actions de Recherche Concertees (ARC) [07/12-007]	Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA)(Fonds de la Recherche Scientifique - FNRS); Fonds Speciaux de Recherche (FSR) of the Universite Catholique de Louvain; Fonds de la Recherche Scientifique Medicale (FRSM)(Fonds de la Recherche Scientifique - FNRS); Actions de Recherche Concertees (ARC)	This work was supported by grants from the Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA), from the Actions de Recherche Concertees (ARC, grant 07/12-007, Communaute Francaise de Belgique), from the Fonds Speciaux de Recherche (FSR) of the Universite Catholique de Louvain, from the Fonds de la Recherche Scientifique Medicale (FRSM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badre D, 2008, TRENDS COGN SCI, V12, P193, DOI 10.1016/j.tics.2008.02.004; Badre D, 2007, J COGNITIVE NEUROSCI, V19, P2082, DOI 10.1162/jocn.2007.19.12.2082; Badre D, 2010, NEURON, V66, P315, DOI 10.1016/j.neuron.2010.03.025; Badre D, 2009, NAT REV NEUROSCI, V10, P659, DOI 10.1038/nrn2667; Bahlmann J, 2008, NEUROIMAGE, V42, P525, DOI 10.1016/j.neuroimage.2008.04.249; Bahlmann J, 2009, BRAIN RES, V1298, P161, DOI 10.1016/j.brainres.2009.08.017; Botvinick MM, 2008, TRENDS COGN SCI, V12, P201, DOI 10.1016/j.tics.2008.02.009; Botvinick MM, 2007, PHILOS T R SOC B, V362, P1615, DOI 10.1098/rstb.2007.2056; Burns MS, 2010, TOP STROKE REHABIL, V17, P401, DOI 10.1310/tsr1706-401; Clerget E, 2013, BROCAS AREA IN PRESS; Clerget E, 2012, J COGNITIVE NEUROSCI, V24, P80, DOI 10.1162/jocn_a_00108; Clerget E, 2011, NEUROREPORT, V22, P965, DOI 10.1097/WNR.0b013e32834d87cd; Clerget E, 2009, NEUROREPORT, V20, P1496, DOI 10.1097/WNR.0b013e3283329be8; Davare M, 2006, J NEUROSCI, V26, P2260, DOI 10.1523/JNEUROSCI.3386-05.2006; Davare M, 2007, J NEUROSCI, V27, P3974, DOI 10.1523/JNEUROSCI.0426-07.2007; Dehaene S, 1997, P NATL ACAD SCI USA, V94, P13293, DOI 10.1073/pnas.94.24.13293; Dominey PF, 2003, BRAIN LANG, V86, P207, DOI 10.1016/S0093-934X(02)00529-1; Duque J, 2012, J NEUROSCI, V32, P806, DOI 10.1523/JNEUROSCI.4299-12.2012; Duque J, 2010, J COGNITIVE NEUROSCI, V22, P526, DOI 10.1162/jocn.2009.21213; Fadiga L, 2009, ANN NY ACAD SCI, V1169, P448, DOI 10.1111/j.1749-6632.2009.04582.x; Fazio P, 2009, BRAIN, V132, P1980, DOI 10.1093/brain/awp118; Fedorenko E, 2012, CURR BIOL, V22, P2059, DOI 10.1016/j.cub.2012.09.011; Fedorenko E, 2011, LANG LINGUIST COMPAS, V5, P78, DOI 10.1111/j.1749-818x.2010.00264.x; Friederici AD, 2006, CEREB CORTEX, V16, P1709, DOI 10.1093/cercor/bhj106; Friederici AD, 2011, BIOLINGUISTICS, V5, P87; Friedrich R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005599; GROSSMAN M, 1980, NEUROPSYCHOLOGIA, V18, P299, DOI 10.1016/0028-3932(80)90125-6; Hickok G, 1996, NEUROCASE, V2, P373, DOI 10.1080/13554799608402412; Hoen M, 2006, CORTEX, V42, P605, DOI 10.1016/S0010-9452(08)70398-8; Keel JC, 2001, CLIN NEUROPHYSIOL, V112, P720, DOI 10.1016/S1388-2457(00)00518-6; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Koechlin E, 2006, NEURON, V50, P963, DOI 10.1016/j.neuron.2006.05.017; Maess B, 2001, NAT NEUROSCI, V4, P540, DOI 10.1038/87502; Musso M, 2003, NAT NEUROSCI, V6, P774, DOI 10.1038/nn1077; Noirhomme Q, 2004, IEEE T BIO-MED ENG, V51, P1994, DOI 10.1109/TBME.2004.834266; O'Shea J, 2007, EUR J NEUROSCI, V26, P2085, DOI 10.1111/j.1460-9568.2007.05795.x; O'Shea J, 2007, NEURON, V54, P479, DOI 10.1016/j.neuron.2007.04.021; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pallier C, 2011, P NATL ACAD SCI USA, V108, P2522, DOI 10.1073/pnas.1018711108; Pammi VSC, 2012, NEUROIMAGE, V59, P1180, DOI 10.1016/j.neuroimage.2011.08.006; Santi A, 2007, NEUROIMAGE, V37, P8, DOI 10.1016/j.neuroimage.2007.04.047; Schluter ND, 1998, BRAIN, V121, P785, DOI 10.1093/brain/121.5.785; Sparing R, 2008, HUM BRAIN MAPP, V29, P82, DOI 10.1002/hbm.20360; Terao Y, 1997, EXP BRAIN RES, V115, P541, DOI 10.1007/PL00005724; Tettamanti M, 2006, CORTEX, V42, P491, DOI 10.1016/S0010-9452(08)70384-8; Tyler LK, 2010, CEREB CORTEX, V20, P352, DOI 10.1093/cercor/bhp105; Verwey WB, 2001, ACTA PSYCHOL, V106, P69, DOI 10.1016/S0001-6918(00)00027-5; Ward NS, 2010, J NEUROSCI, V30, P9216, DOI 10.1523/JNEUROSCI.4499-09.2010; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Wymbs NF, 2012, NEURON, V74, P936, DOI 10.1016/j.neuron.2012.03.038	51	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e63722	10.1371/journal.pone.0063722	http://dx.doi.org/10.1371/journal.pone.0063722			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762232	Green Published, gold			2022-12-27	WOS:000320440500004
J	Phillips, M; Rogers, P; Haworth, J; Bayer, A; Tales, A				Phillips, Michelle; Rogers, Peter; Haworth, Judy; Bayer, Antony; Tales, Andrea			Intra-Individual Reaction Time Variability in Mild Cognitive Impairment and Alzheimer's Disease: Gender, Processing Load and Speed Factors	PLOS ONE			English	Article							WITHIN-PERSON VARIABILITY; EARLY-STAGE DEMENTIA; WHITE-MATTER VOLUME; PARKINSONS-DISEASE; SEX-DIFFERENCES; VISUAL-SEARCH; OLDER-ADULTS; ATTENTION; BRAIN; PERFORMANCE	Compared to cognitively healthy ageing (CH), intra-individual variability in reaction time (IIVRT), a behavioural marker of neurological integrity, is commonly reported to increase in both Alzheimer's disease (AD) and mild cognitive impairment (MCI). It varies in MCI with respect to whether it represents the pro-dromal stages of dementia or not; being greatest in those most likely to convert. Abnormal IIVRT in MCI therefore represents a potential measure of underlying functional integrity that may serve to differentiate MCI from CH and to help identify those patients for whom MCI is the result of a progressive pathological process. As the clinical approach to MCI is increasingly stratified with respect to gender, we investigated whether this factor could influence study outcome. The influence of RTSPEED and processing load upon IIVRT was also examined. Under low processing load conditions, IIVRT was significantly increased in both MCI and AD compared to CH. However, correcting for an individual's processing speed abolished this effect in MCI but not in AD, indicating that the increased IIVRT in MCI and AD may result from different factors. In MCI but not in CH, IIVRT was significantly greater for females. Increasing task processing load by adding distracting information, although increasing overall IIVRT, failed to improve the differentiation between CH and both MCI and AD, and in MCI resulted in a reduction in the influence of gender upon study outcome. The outcome of studies investigating IIVRT in MCI and AD compared to CH therefore appear influenced by the gender of the participants, by task-related processing load and processing speed.	[Phillips, Michelle] Avon & Wiltshire Mental Hlth Partnership NHS Trus, Ctr Res & Dev, Blackberry Hill Hosp, Bristol, Avon, England; [Rogers, Peter; Tales, Andrea] Univ Bristol, Sch Expt Psychol, Bristol, Avon, England; [Haworth, Judy] Frenchay Hosp, Memory Disorders Clin, Bristol BS16 1LE, Avon, England; [Bayer, Antony] Cardiff Univ, Univ Hosp Llandough, Sch Med, Cardiff CF10 3AX, S Glam, Wales; [Tales, Andrea] Swansea Univ, Coll Human & Hlth Sci, Dept Psychol, Swansea, W Glam, Wales	University of Bristol; Cardiff University; Swansea University	Tales, A (corresponding author), Univ Bristol, Sch Expt Psychol, Bristol, Avon, England.	A.Tales@Swansea.ac.uk	Bayer, Antony/H-4376-2019; Bayer, Antony/H-4434-2019	Bayer, Antony/0000-0002-7514-248X; Tales, Andrea/0000-0003-4825-4555	Sir Halley Stewart Trust [208491]; BRACE-Alzheimer's Research [297965]	Sir Halley Stewart Trust; BRACE-Alzheimer's Research	Funded by Sir Halley Stewart Trust (reg charity number 208491) (www.sirhalleystewart.org.uk) and BRACE-Alzheimer's Research (reg. charity number 297965) (www.alzheimers-brace.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADSHEAD F, 1992, BRIT MED J, V305, P397, DOI 10.1136/bmj.305.6850.397; Agneta Herlitz, 2009, [心理学报, Acta Psychologica Sinica], V41, P1081; Albinet CT, 2012, BRAIN COGNITION, V79, P1, DOI 10.1016/j.bandc.2012.02.001; Alonso-Nanclares L, 2008, P NATL ACAD SCI USA, V105, P14615, DOI 10.1073/pnas.0803652105; Amieva H, 2004, BRAIN COGNITION, V54, P212, DOI 10.1016/j.bandc.2004.02.003; Anstey KJ, 2007, NEUROPSYCHOLOGIA, V45, P1911, DOI 10.1016/j.neuropsychologia.2006.11.020; Artero S, 2008, J NEUROL NEUROSUR PS, V79, P979, DOI 10.1136/jnnp.2007.136903; Bai F, 2009, NEUROSCI LETT, V450, P85, DOI 10.1016/j.neulet.2008.11.055; Barnes LL, 2005, ARCH GEN PSYCHIAT, V62, P685, DOI 10.1001/archpsyc.62.6.685; Beinhoff U, 2008, J NEUROL, V255, P117, DOI 10.1007/s00415-008-0726-9; Benton AL, 1994, CONTRIBUTIONS NEUROP; Bielak AAM, 2010, NEUROPSYCHOLOGY, V24, P731, DOI 10.1037/a0019802; Bielak AAM, 2010, PSYCHOL AGING, V25, P575, DOI 10.1037/a0019503; Bodling AM, 2012, NEUROPSYCHOLOGY, V26, P357, DOI 10.1037/a0027972; Bosch B, 2010, CORTEX, V46, P451, DOI 10.1016/j.cortex.2009.05.006; Brandt J., 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; Bucks RS, 1996, AGE AGEING, V25, P113, DOI 10.1093/ageing/25.2.113; Bunce D, 2007, NEUROPSYCHOLOGIA, V45, P2009, DOI 10.1016/j.neuropsychologia.2007.02.006; Burgmans S, 2011, NEUROIMAGE, V55, P1287, DOI 10.1016/j.neuroimage.2011.01.002; Burton CL, 2006, J CLIN EXP NEUROPSYC, V28, P67, DOI 10.1080/13803390490918318; Camicioli RM, 2008, NEUROSCI LETT, V441, P77, DOI 10.1016/j.neulet.2008.06.004; Caselli L, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-32; Chapman RM, 2011, J INT NEUROPSYCH SOC, V17, P654, DOI 10.1017/S1355617711000452; Christensen H, 2005, NEUROPSYCHOLOGY, V19, P309, DOI 10.1037/0894-4105.19.3.309; Collins LF, 1996, ARCH CLIN NEUROPSYCH, V11, P613, DOI 10.1016/0887-6177(97)81255-3; Colzato LS, 2012, NEUROPSYCHOLOGIA, V50, P98, DOI 10.1016/j.neuropsychologia.2011.11.003; Coughlan AK., 1985, ADULT MEMORY INFORM; Counts SE, 2011, J CHEM NEUROANAT, V42, P111, DOI 10.1016/j.jchemneu.2011.02.004; de Frias CM, 2007, NEUROPSYCHOLOGIA, V45, P2499, DOI 10.1016/j.neuropsychologia.2007.03.022; de Frias CM, 2012, J INT NEUROPSYCH SOC, V18, P764, DOI 10.1017/S1355617712000422; Deary IJ, 2005, AGING NEUROPSYCHOL C, V12, P187, DOI 10.1080/13825580590969235; Der G, 2006, PSYCHOL AGING, V21, P62, DOI 10.1037/0882-7974.21.1.62; Dixon RA, 2007, NEUROPSYCHOLOGY, V21, P381, DOI 10.1037/0894-4105.21.3.381; Dubbelink KTEO, 2013, NEUROBIOL AGING, V34, P408, DOI 10.1016/j.neurobiolaging.2012.02.029; Duchek JM, 2009, NEUROPSYCHOLOGY, V23, P746, DOI 10.1037/a0016583; Dykiert D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045759; Dykiert D, 2012, DEV PSYCHOL, V48, P1262, DOI 10.1037/a0027550; Espeseth T, 2006, COGN AFFECT BEHAV NE, V6, P31, DOI 10.3758/CABN.6.1.31; Feng Q, 2011, BRAIN RES, V1401, P59, DOI 10.1016/j.brainres.2011.05.041; Ferris S, 2009, GENDER MED, V6, P345, DOI 10.1016/j.genm.2009.06.004; Fjell AM, 2011, J NEUROSCI, V31, P18060, DOI 10.1523/JNEUROSCI.4735-11.2011; Fjell AM, 2009, J NEUROSCI, V29, P8774, DOI 10.1523/JNEUROSCI.0115-09.2009; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gorus E, 2008, J GERIATR PSYCH NEUR, V21, P204, DOI 10.1177/0891988708320973; Hetherington CR, 1996, BRAIN INJURY, V10, P473, DOI 10.1080/026990596124197; Hogan MJ, 2006, BRAIN RES, V1119, P215, DOI 10.1016/j.brainres.2006.08.075; Holtzer R, 2008, JAMA-J AM MED ASSOC, V300, P823, DOI 10.1001/jama.300.7.823; Hultsch D.F., 2004, NEW FRONTIERS COGNIT, P65, DOI DOI 10.1093/ACPROF:OSO/9780198525691.003.0004; Hultsch DF, 2000, NEUROPSYCHOLOGY, V14, P588, DOI 10.1037/0894-4105.14.4.588; Hultsch DF, 2002, J GERONTOL B-PSYCHOL, V57, pP101, DOI 10.1093/geronb/57.2.P101; Hultsch DF., 2008, HDB AGING COGNITION, P491, DOI DOI 10.4324/9780203837665.CH10; Ikram MA, 2010, NEUROBIOL AGING, V31, P378, DOI 10.1016/j.neurobiolaging.2008.04.008; Jackson JD, 2012, NEUROPSYCHOLOGIA, V50, P357, DOI 10.1016/j.neuropsychologia.2011.11.024; Kang XJ, 2011, NEUROIMAGE, V56, P2011, DOI 10.1016/j.neuroimage.2011.03.016; Konrad A, 2009, NEUROPSYCHOBIOLOGY, V60, P55, DOI 10.1159/000236445; MacDonald SWS, 2009, PSYCHOL AGING, V24, P792, DOI 10.1037/a0017798; Manoach DS, 2003, SCHIZOPHR RES, V60, P285, DOI 10.1016/S0920-9964(02)00294-3; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McLaughlin PM, 2010, NEUROCASE, V16, P408, DOI 10.1080/13554791003620306; Meng XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038268; Menzler K, 2011, NEUROIMAGE, V54, P2557, DOI 10.1016/j.neuroimage.2010.11.029; Merritt P, 2007, PERS INDIV DIFFER, V43, P597, DOI 10.1016/j.paid.2007.01.016; Mickeviciene D, 2011, MEDICINA-LITHUANIA, V47, P497, DOI 10.3390/medicina47090073; Moy G, 2011, NEUROSCIENCE, V186, P88, DOI 10.1016/j.neuroscience.2011.04.028; Nelson HE, 1991, TEST MAN INCL NEW S; Papenberg G, 2011, NEUROPSYCHOLOGIA, V49, P1879, DOI 10.1016/j.neuropsychologia.2011.03.013; Peres K, 2011, J ALZHEIMERS DIS, V27, P39, DOI 10.3233/JAD-2011-110428; Perneczky R, 2007, J NEUROL, V254, P1395, DOI 10.1007/s00415-007-0558-z; PIROZZOLO FJ, 1981, NEUROBIOL AGING, V2, P113, DOI 10.1016/0197-4580(81)90008-7; Porter G, 2010, CORTEX, V46, P637, DOI 10.1016/j.cortex.2009.04.014; Prins MH, 2007, GENDER MED, V4, pS106, DOI 10.1016/S1550-8579(07)80051-9; Querbes O, 2009, BRAIN, V132, P2036, DOI 10.1093/brain/awp105; Roivainen E, 2011, LEARN INDIVID DIFFER, V21, P145, DOI 10.1016/j.lindif.2010.11.021; Royall DR, 1998, J NEUROL NEUROSUR PS, V64, P588, DOI 10.1136/jnnp.64.5.588; Schmiedek F, 2009, PSYCHOL AGING, V24, P841, DOI 10.1037/a0017799; Skup M, 2011, NEUROIMAGE, V56, P890, DOI 10.1016/j.neuroimage.2011.02.060; Spreen O, 1998, COMPENDIUM NEUROPSYC; Stoet G, 2010, Q J EXP PSYCHOL, V63, P633, DOI 10.1080/17470210903464253; Storandt M, 2004, ARCH CLIN NEUROPSYCH, V19, P119, DOI 10.1016/S0887-6177(02)00220-2; Strauss E, 2007, AGING NEUROPSYCHOL C, V14, P608, DOI 10.1080/13825580600932419; Sullivan EV, 2001, NEUROREPORT, V12, P99, DOI 10.1097/00001756-200101220-00027; Sylvain-Roy S, 2010, BRAIN COGNITION, V74, P255, DOI 10.1016/j.bandc.2010.08.004; Tales A, 2012, J ALZHEIMERS DIS, V32, P457, DOI 10.3233/JAD-2012-120505; Tales A, 2011, J ALZHEIMERS DIS, V24, P151, DOI 10.3233/JAD-2010-101818; Tamnes CK, 2012, J NEUROSCI, V32, P972, DOI 10.1523/JNEUROSCI.4779-11.2012; Teipel SJ, 2010, J ALZHEIMERS DIS, V22, P507, DOI 10.3233/JAD-2010-100234; Thiebaut de Schotten M, 2011, NEUROIMAGE, V54, P49, DOI 10.1016/j.neuroimage.2010.07.055; Tractenberg RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016973; Tse CS, 2010, NEUROPSYCHOLOGY, V24, P300, DOI 10.1037/a0018274; Tucker AM, 2011, CURR ALZHEIMER RES, V8, P354; van Deursen JA, 2009, BRAIN COGNITION, V69, P592, DOI 10.1016/j.bandc.2008.12.007; Walhovd KB, 2007, NEUROPSYCHOLOGIA, V45, P2277, DOI 10.1016/j.neuropsychologia.2007.02.022; Wechsler D, 1998, ADULT INTELLIGENCE S	93	41	41	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65712	10.1371/journal.pone.0065712	http://dx.doi.org/10.1371/journal.pone.0065712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762413	Green Published, gold, Green Submitted			2022-12-27	WOS:000320440500047
J	Kumar, SR; Khader, SMS; Kiener, TK; Szyporta, M; Kwang, J				Kumar, Subaschandrabose Rajesh; Khader, Syed Musthaq Syed; Kiener, Tanja K.; Szyporta, Milene; Kwang, Jimmy			Intranasal Immunization of Baculovirus Displayed Hemagglutinin Confers Complete Protection against Mouse Adapted Highly Pathogenic H7N7 Reassortant Influenza Virus	PLOS ONE			English	Article							A VIRUS; RECEPTOR SPECIFICITY; INFECTION; VACCINE; IMMUNITY; MICE; IMMUNOGENICITY; CONJUNCTIVITIS; INACTIVATION; CHALLENGE	Background: Avian influenza A H7N7 virus poses a pandemic threat to human health because of its ability for direct transmission from domestic poultry to humans and from human to human. The wide zoonotic potential of H7N7 combined with an antiviral immunity inhibition similar to pandemic 1918 H1N1 and 2009 H1N1 influenza viruses is disconcerting and increases the risk of a putative H7N7 pandemic in the future, underlining the urgent need for vaccine development against this virus. Methodology/Principal Findings: In this study, we developed a recombinant vaccine by expressing the H7N7-HA protein on the surface of baculovirus (Bac-HA). The protective efficacy of the live Bac-HA vaccine construct was evaluated in a mouse model by challenging mice immunized intranasally (i.n.) or subcutaneously (s.c.) with high pathogenic mouse adapted H7N7 reassorted strain. Although s.c. injection of live Bac-HA induced higher specific IgG than i.n. immunization, the later resulted in an elevated neutralization titer. Interestingly, 100% protection from the lethal viral challenge was only observed for the mice immunized intranasally with live Bac-HA, whereas no protection was achieved in any other s.c. or i.n. immunized mice groups. In addition, we also observed higher mucosal IgA as well as increased IFN-gamma and IL-4 responses in the splenocytes of the surviving mice coupled with a reduced viral titer and diminished histopathological signs in the lungs. Conclusion: Our results indicated that protection from high pathogenic H7N7 (NL/219/03) virus requires both mucosal and systemic immune responses in mice. The balance between Th1 and Th2 cytokines is also required for the protection against the H7N7 pathogen. Intranasal administration of live Bac-HA induced all these immune responses and protected the mice from lethal viral challenge. Therefore, live Bac-HA is an effective vaccine candidate against H7N7 viral infections.	[Kumar, Subaschandrabose Rajesh; Khader, Syed Musthaq Syed; Kiener, Tanja K.; Szyporta, Milene; Kwang, Jimmy] Natl Univ Singapore, Temasek Lifesci Lab, Singapore 117548, Singapore; [Kwang, Jimmy] Natl Univ Singapore, Fac Med, Dept Microbiol, Singapore 117548, Singapore	National University of Singapore; National University of Singapore	Kwang, J (corresponding author), Natl Univ Singapore, Temasek Lifesci Lab, Singapore 117548, Singapore.	kwang@tll.org.sg			Temasek Life Sciences laboratory	Temasek Life Sciences laboratory(National University of Singapore)	This study was supported by Temasek Life Sciences laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2005, J VIROL, V79, P2847, DOI 10.1128/JVI.79.5.2847-2858.2005; Abe T, 2003, J IMMUNOL, V171, P1133, DOI 10.4049/jimmunol.171.3.1133; Abe T, 2009, J VIROL, V83, P7629, DOI 10.1128/JVI.00679-09; BAHNEMANN HG, 1990, VACCINE, V8, P299, DOI 10.1016/0264-410X(90)90083-X; Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105; Belser JA, 2011, J INFECT DIS, V203, P40, DOI 10.1093/infdis/jiq018; Blissard GW, 1996, CYTOTECHNOLOGY, V20, P73, DOI 10.1007/BF00350390; BROWN EG, 1990, J VIROL, V64, P4523, DOI 10.1128/JVI.64.9.4523-4533.1990; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P547; Chen LH, 2004, INFECT IMMUN, V72, P238, DOI 10.1128/IAI.72.1.238-246.2004; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Cornelissen LAHM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010645; de Wit E, 2005, J VIROL, V79, P12401, DOI 10.1128/JVI.79.19.12401-12407.2005; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Fukushi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021207; Gambaryan A, 2006, VIROLOGY, V344, P432, DOI 10.1016/j.virol.2005.08.035; Giri PK, 2005, FEMS IMMUNOL MED MIC, V45, P87, DOI 10.1016/j.femsim.2005.02.009; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Gronowski AM, 1999, J VIROL, V73, P9944, DOI 10.1128/JVI.73.12.9944-9951.1999; Hatta M, 2007, PLOS PATHOG, V3, P1374, DOI 10.1371/journal.ppat.0030133; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Kiyono H, 2004, NAT REV IMMUNOL, V4, P699, DOI 10.1038/nri1439; Kurtz J, 1996, LANCET, V348, P901, DOI 10.1016/S0140-6736(05)64783-6; Madhan S, 2010, CURR GENE THER, V10, P201, DOI 10.2174/156652310791321233; MAGNUSSON KE, 1982, IMMUNOLOGY, V45, P239; MCINTOSH AH, 1980, INTERVIROLOGY, V13, P331; Meng T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021757; Mogens D, 1994, FUNCTION MUCOSAL IMM; Munster VJ, 2007, J INFECT DIS, V196, P258, DOI 10.1086/518792; Musthaq SS, 2009, VIROLOGY, V391, P315, DOI 10.1016/j.virol.2009.06.017; National Institutes of Health and Centers for Disease Control and Prevention, 1999, BIOS MICR BIOM LAB, P777; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Prabakaran M, 2008, VIROLOGY, V380, P412, DOI 10.1016/j.virol.2008.08.002; Prabakaran M, 2011, CLIN VACCINE IMMUNOL, V18, P1582, DOI 10.1128/CVI.05114-11; Prabakaran M, 2010, J VIROL, V84, P3201, DOI 10.1128/JVI.02175-09; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rueda P, 2000, VACCINE, V19, P726, DOI 10.1016/S0264-410X(00)00259-0; Sandra HS, 2007, J IMMUNOL, V178, P2361; Sarachai C, 2010, THAI J VET MED, V40, P41; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Shoji Y, 2009, VACCINE, V27, P1087, DOI 10.1016/j.vaccine.2008.11.108; Tang XC, 2010, VACCINE, V28, P6821, DOI 10.1016/j.vaccine.2010.08.040; van Riel D, 2010, AM J PATHOL, V176, P1614, DOI 10.2353/ajpath.2010.090949; Wang BZ, 2010, PLOS ONE, V5; WEBSTER RG, 1981, NEW ENGL J MED, V304, P911; WEBSTER RG, 1991, VACCINE, V9, P303, DOI 10.1016/0264-410X(91)90055-B	48	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e63856	10.1371/journal.pone.0063856	http://dx.doi.org/10.1371/journal.pone.0063856			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762234	Green Published, gold, Green Submitted			2022-12-27	WOS:000321094800004
J	Stettner, M; Wolffram, K; Mausberg, AK; Albrecht, P; Derksen, A; Methner, A; Dehmel, T; Hartung, HP; Dietrich, H; Kieseier, BC				Stettner, Mark; Wolffram, Kathleen; Mausberg, Anne K.; Albrecht, Philipp; Derksen, Angelika; Methner, Axel; Dehmel, Thomas; Hartung, Hans-Peter; Dietrich, Helmut; Kieseier, Bernd C.			Promoting Myelination in an In Vitro Mouse Model of the Peripheral Nerve System: The Effect of Wine Ingredients	PLOS ONE			English	Article							CONCORD GRAPE JUICE; SCHWANN-CELLS INVITRO; RED WINE; ANTIOXIDANT STATUS; OXIDATIVE STRESS; BLOOD-PRESSURE; RESVERATROL; SUPPLEMENTATION; CONSUMPTION; POLYPHENOLS	Protective properties of moderate wine consumption against cancers, cardiovascular, metabolic and degenerative diseases have been reported in various clinical studies. Here, we analysed the effect of red wine (RW) and white wine (WW) on myelination using an in vitro embryonic co-culture mouse model. The total amount of myelin was found to be significantly increased after RW and WW treatment, while only RW significantly increased the number of internodes. Both types of wine increased rat Schwann cell- (rSC) expression of the NAD+-dependent deacetylase sirtuin-two-homolog 2 (Sirt2), a protein known to be involved in myelination. Detailed chemical analysis of RW revealed a broad spectrum of anthocyanins, piceids, and phenolics, including resveratrol (RSV). In our assay system RSV in low concentrations induced myelination. Furthermore RSV raised intracellular glutathione concentrations in rSCs and in co-cultures and therefore augmented antioxidant capacity. We conclude that wine promotes myelination in a rodent in vitro model by controlling intracellular metabolism and SC plasticity. During this process, RSV exhibits protective properties; however, the fostering effect on myelinaton during exposure to wine appears to be a complex interaction of various compounds.	[Stettner, Mark; Wolffram, Kathleen; Mausberg, Anne K.; Albrecht, Philipp; Derksen, Angelika; Methner, Axel; Dehmel, Thomas; Hartung, Hans-Peter; Kieseier, Bernd C.] Univ Dusseldorf, Dept Neurol, Res Grp Clin & Expt Neuroimmunol, Fac Med, Dusseldorf, Germany; [Dietrich, Helmut] Geisenheim Res Ctr, Dept Wine Anal & Beverage Technol, Geisenheim, Germany	Heinrich Heine University Dusseldorf	Stettner, M (corresponding author), Univ Dusseldorf, Dept Neurol, Res Grp Clin & Expt Neuroimmunol, Fac Med, Dusseldorf, Germany.	mark.stettner@med.uni-duesseldorf.de	Stettner, Mark/GQY-7516-2022	Methner, Axel/0000-0002-8774-0057; Mausberg, Anne K/0000-0001-9026-1703				Albrecht P, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-163; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Beirowski B, 2011, P NATL ACAD SCI USA, V108, pE952, DOI 10.1073/pnas.1104969108; Block G, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-30; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Castilla P, 2008, AM J CLIN NUTR, V87, P1053, DOI 10.1093/ajcn/87.4.1053; Chopra K, 2012, BRIT J CLIN PHARMACO, V73, P348, DOI 10.1111/j.1365-2125.2011.04111.x; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Della-Morte D, 2009, NEUROSCIENCE, V159, P993, DOI 10.1016/j.neuroscience.2009.01.017; ELDRIDGE CF, 1987, J CELL BIOL, V105, P1023, DOI 10.1083/jcb.105.2.1023; ELDRIDGE CF, 1989, J NEUROSCI, V9, P625; Estruch R, 2011, NUTR METAB CARDIOVAS, V21, P46, DOI 10.1016/j.numecd.2009.07.006; Freedman JE, 2001, CIRCULATION, V103, P2792, DOI 10.1161/01.CIR.103.23.2792; FUHRMAN B, 1995, AM J CLIN NUTR, V61, P549, DOI 10.1093/ajcn/61.3.549; Goldberg DA, 2003, CLIN BIOCHEM, V36, P79, DOI 10.1016/S0009-9120(02)00397-1; Hansen AS, 2005, EUR J CLIN NUTR, V59, P449, DOI 10.1038/sj.ejcn.1602107; Hayek T, 1997, ARTERIOSCL THROM VAS, V17, P2744, DOI 10.1161/01.ATV.17.11.2744; Hollis JH, 2009, J AM COLL NUTR, V28, P574, DOI 10.1080/07315724.2009.10719789; Jessen K.R., 2010, F1000 BIOL REP, V2; Josuttis M, 2010, DEUT LEBENSM-RUNDSCH, V106, P254; Keevil JG, 2000, J NUTR, V130, P53; Kiviniemi TO, 2007, ATHEROSCLEROSIS, V195, pE176, DOI 10.1016/j.atherosclerosis.2007.06.004; Koike H, 2006, CURR OPIN NEUROL, V19, P481, DOI 10.1097/01.wco.0000245371.89941.eb; Krikorian R, 2010, BRIT J NUTR, V103, P730, DOI 10.1017/S0007114509992364; Kumar A, 2007, PHARMACOLOGY, V79, P17, DOI 10.1159/000097511; Kumar P, 2006, BEHAV PHARMACOL, V17, P485, DOI 10.1097/00008877-200609000-00014; Lehmann HC, 2009, GLIA, V57, P479, DOI 10.1002/glia.20774; Lewerenz J, 2009, J NEUROCHEM, V111, P332, DOI 10.1111/j.1471-4159.2009.06347.x; MCLANE JA, 1987, ALCOHOL, V4, P385, DOI 10.1016/0741-8329(87)90071-1; Medina-Remon A, 2011, NUTR METAB CARDIOVAS, V21, P323, DOI 10.1016/j.numecd.2009.10.019; Mellion M, 2011, MUSCLE NERVE, V43, P309, DOI 10.1002/mus.21946; Mladenka P, 2010, FREE RADICAL BIO MED, V49, P963, DOI 10.1016/j.freeradbiomed.2010.06.010; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Park YK, 2004, BIOFACTORS, V22, P145, DOI 10.1002/biof.5520220128; Patz CD, 2004, ANAL CHIM ACTA, V513, P81, DOI 10.1016/j.aca.2004.02.051; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Podratz JL, 2004, GLIA, V45, P54, DOI 10.1002/glia.10302; Podratz JL, 2001, GLIA, V35, P35, DOI 10.1002/glia.1068; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Rechner A, 1998, DEUT LEBENSM-RUNDSCH, V94, P363; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Spaak J, 2010, AM J PHYSIOL-HEART C, V298, pH2226, DOI 10.1152/ajpheart.00700.2009; Stettner M, 2011, J PERIPHER NERV SYST, V16, P250, DOI 10.1111/j.1529-8027.2011.00355.x; Trapp J, 2006, CURR DRUG TARGETS, V7, P1553, DOI 10.2174/1389450110607011553; Tsang C, 2005, BRIT J NUTR, V93, P233, DOI 10.1079/BJN20041311; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang Q, 2002, BRAIN RES, V958, P439, DOI 10.1016/S0006-8993(02)03543-6; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Yamagata K, 2009, BIOCHEM BIOPH RES CO, V390, P1355, DOI 10.1016/j.bbrc.2009.10.156; Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525	50	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66079	10.1371/journal.pone.0066079	http://dx.doi.org/10.1371/journal.pone.0066079			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762469	Green Submitted, Green Published, gold			2022-12-27	WOS:000321094800088
J	Yang, ZH; Zhang, YX; Wang, L				Yang, Zhihong; Zhang, Yuxia; Wang, Li			A Feedback Inhibition between miRNA-127 and TGF beta/c-Jun Cascade in HCC Cell Migration via MMP13	PLOS ONE			English	Article							SMALL HETERODIMER PARTNER; NUCLEAR RECEPTOR SHP; HEPATOCELLULAR-CARCINOMA; MICRORNA EXPRESSION; DOWN-REGULATION; MIR-127; CANCER; METASTASIS; MIR-433; LIVER	Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and is increasing in frequency in the U. S. The major reason for the low postoperative survival rate of HCC is widespread intrahepatic metastasis or invasion, and activation of TGF beta signaling is associated with the invasive phenotype. This study aims at determining the novel function of miR-127 in modulating HCC migration. Overexpression of miR-127 inhibits HCC cell migration, invasion and tumor growth in nude mice. MiR-127 directly represses matrix metalloproteinase 13 (MMP13) 3'UTR activity and protein expression, and diminishes MMP13/TGF beta-induced HCC migration. In turn, TGF beta decreases miR-127 expression by enhancing c-Jun-mediated inhibition of miR-127 promoter activity. In contrast, p53 transactivates miR-127 promoter and induces miR-127 expression, which is antagonized by c-Jun. The inhibition of miR-127 by c-Jun is through TGF beta-mediated ERK and JNK pathways. The lower miR-127 expression shows a negative correlation with the higher MMP13 expression in a subset of human HCC specimens. This is the first report elucidating a feedback regulation between miR-127 and the TGF beta/c-Jun cascade in HCC migration via MMP13 that involves a crosstalk between the oncogene c-Jun and tumor suppressor p53.	[Wang, Li] Univ Utah, Sch Med, Dept Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; Univ Utah, Sch Med, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Wang, L (corresponding author), Univ Utah, Sch Med, Dept Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.	l.wang@hsc.utah.edu			National Institutes of Health [R01 DK080440];  [P30 CA042014]; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is in part supported by National Institutes of Health R01 DK080440 to L. W. The authors acknowledge the use of core facilities (Cell Imaging Core, Flow Cytometry Core) supported by the P30 CA042014 grant to the Huntsman Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bianchi ME, 2005, CURR OPIN GENET DEV, V15, P496, DOI 10.1016/j.gde.2005.08.007; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Dixon-McIver A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002141; Fransvea E, 2008, HEPATOLOGY, V47, P1557, DOI 10.1002/hep.22201; He N, 2008, GASTROENTEROLOGY, V134, P793, DOI 10.1053/j.gastro.2008.01.006; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kircher M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-346; Lee CF, 2009, WORLD J GASTROENTERO, V15, P356, DOI 10.3748/wjg.15.356; Lee JW, 2008, CLIN CANCER RES, V14, P2535, DOI 10.1158/1078-0432.CCR-07-1231; Leivonen SK, 2006, ONCOGENE, V25, P2588, DOI 10.1038/sj.onc.1209291; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; Llovet JM, 2006, GASTROENTEROLOGY, V131, P1758, DOI 10.1053/j.gastro.2006.09.014; Lopez-Bergami P, 2007, CANCER CELL, V11, P447, DOI 10.1016/j.ccr.2007.03.009; Mosakhani N, 2012, GENE CHROMOSOME CANC, V51, P1, DOI 10.1002/gcc.20925; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Robertus JL, 2009, MODERN PATHOL, V22, P547, DOI 10.1038/modpathol.2009.10; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Song GS, 2008, NUCLEIC ACIDS RES, V36, P5727, DOI 10.1093/nar/gkn567; Song GS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007829; Song GS, 2009, J BIOL CHEM, V284, P31921, DOI 10.1074/jbc.M109.046862; Song GS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003574; Sume SS, 2010, AM J PATHOL, V177, P208, DOI 10.2353/ajpath.2010.090952; Tryndyak VP, 2009, MOL CARCINOGEN, V48, P479, DOI 10.1002/mc.20484; Xie T, 2012, J IMMUNOL, V188, P2437, DOI 10.4049/jimmunol.1101070; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yang JD, 2011, SEMIN CANCER BIOL, V21, P35, DOI 10.1016/j.semcancer.2010.10.007; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yang ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039789; Yang ZH, 2012, BIOCHEM BIOPH RES CO, V417, P744, DOI 10.1016/j.bbrc.2011.12.027; Zhang YX, 2008, HEPATOLOGY, V48, P289, DOI 10.1002/hep.22342; Zhang YX, 2011, BIOCHEM BIOPH RES CO, V416, P135, DOI 10.1016/j.bbrc.2011.11.011; Zhang YX, 2010, MOL CELL BIOL, V30, P1341, DOI 10.1128/MCB.01076-09; Zhou TF, 2010, J BIOL CHEM, V285, P24871, DOI 10.1074/jbc.M110.133280	35	38	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65256	10.1371/journal.pone.0065256	http://dx.doi.org/10.1371/journal.pone.0065256			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762330	Green Submitted, gold, Green Published			2022-12-27	WOS:000321094800031
J	Horikawa, DD; Cumbers, J; Sakakibara, I; Rogoff, D; Leuko, S; Harnoto, R; Arakawa, K; Katayama, T; Kunieda, T; Toyoda, A; Fujiyama, A; Rothschild, LJ				Horikawa, Daiki D.; Cumbers, John; Sakakibara, Iori; Rogoff, Dana; Leuko, Stefan; Harnoto, Raechel; Arakawa, Kazuharu; Katayama, Toshiaki; Kunieda, Takekazu; Toyoda, Atsushi; Fujiyama, Asao; Rothschild, Lynn J.			Analysis of DNA Repair and Protection in the Tardigrade Ramazzottius varieornatus and Hypsibius dujardini after Exposure to UVC Radiation	PLOS ONE			English	Article							THYMINE DIMERS; NEW-MODEL; IN-VIVO; TOLERANCE	Tardigrades inhabiting terrestrial environments exhibit extraordinary resistance to ionizing radiation and UV radiation although little is known about the mechanisms underlying the resistance. We found that the terrestrial tardigrade Ramazzottius varieornatus is able to tolerate massive doses of UVC irradiation by both being protected from forming UVC-induced thymine dimers in DNA in a desiccated, anhydrobiotic state as well as repairing the dimers that do form in the hydrated animals. In R. varieornatus accumulation of thymine dimers in DNA induced by irradiation with 2.5 kJ/m(2) of UVC radiation disappeared 18 h after the exposure when the animals were exposed to fluorescent light but not in the dark. Much higher UV radiation tolerance was observed in desiccated anhydrobiotic R. varieornatus compared to hydrated specimens of this species. On the other hand, the freshwater tardigrade species Hypsibius dujardini that was used as control, showed much weaker tolerance to UVC radiation than R. varieornatus, and it did not contain a putative phrA gene sequence. The anhydrobiotes of R. varieornatus accumulated much less UVC-induced thymine dimers in DNA than hydrated one. It suggests that anhydrobiosis efficiently avoids DNA damage accumulation in R. varieornatus and confers better UV radiation tolerance on this species. Thus we propose that UV radiation tolerance in tardigrades is due to the both high capacities of DNA damage repair and DNA protection, a two-pronged survival strategy.	[Horikawa, Daiki D.; Cumbers, John; Rogoff, Dana; Leuko, Stefan; Rothschild, Lynn J.] NASA Ames Res Ctr, Biospher Sci Branch, Moffett Field, CA USA; [Horikawa, Daiki D.; Rothschild, Lynn J.] Brown Univ, NASA Astrobiol Inst, Providence, RI 02912 USA; [Cumbers, John; Rothschild, Lynn J.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Sakakibara, Iori] Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France; [Sakakibara, Iori] CNRS, UMR 8104, Paris, France; [Sakakibara, Iori] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Harnoto, Raechel] Calif Polytech State Univ San Luis Obispo, San Luis Obispo, CA 93407 USA; [Arakawa, Kazuharu] Keio Univ, Inst Adv Biosci, Fujisawa, Kanagawa, Japan; [Katayama, Toshiaki] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan; [Kunieda, Takekazu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan; [Toyoda, Atsushi] Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka 411, Japan; [Fujiyama, Asao] Natl Inst Informat, Principles Informat Res Div, Tokyo, Japan	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Brown University; National Aeronautics & Space Administration (NASA); Brown University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; California State University System; California Polytechnic State University San Luis Obispo; Keio University; University of Tokyo; University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan	Horikawa, DD (corresponding author), NASA Ames Res Ctr, Biospher Sci Branch, Moffett Field, CA USA.	horikawadd@gmail.com; Lynn.J.Rothschild@nasa.gov	Kunieda, Takekazu/G-4946-2014	Arakawa, Kazuharu/0000-0002-2893-4919; Kunieda, Takekazu/0000-0002-6256-1335	NASA Ames Research Center; NASA	NASA Ames Research Center(National Aeronautics & Space Administration (NASA)); NASA(National Aeronautics & Space Administration (NASA))	This research was supported by an appointment to the NASA Postdoctoral Program at the NASA Ames Research Center, administered by Oak Ridge Associated Universities through a contract with NASA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altiero T, 2011, J ZOOL SYST EVOL RES, V49, P104, DOI 10.1111/j.1439-0469.2010.00607.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BOLLUM FJ, 1963, BIOCHIM BIOPHYS ACTA, V68, P599; Bonifacio A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050162; DONNELLAN JE, 1965, SCIENCE, V149, P308, DOI 10.1126/science.149.3681.308; Drummond AJ, 2008, GENEIOUS VERSION 4 6; Fredrickson JK, 2008, ISME J, V2, P393, DOI 10.1038/ismej.2007.116; Gabriel WN, 2007, DEV BIOL, V312, P545, DOI 10.1016/j.ydbio.2007.09.055; Gladyshev E, 2008, P NATL ACAD SCI USA, V105, P5139, DOI 10.1073/pnas.0800966105; Hengherr S, 2009, J EXP BIOL, V212, P802, DOI 10.1242/jeb.025973; Horikawa DD, 2008, ASTROBIOLOGY, V8, P549, DOI 10.1089/ast.2007.0139; Horikawa DD, 2006, INT J RADIAT BIOL, V82, P843, DOI 10.1080/09553000600972956; Johnson CG, 1940, ANN APPL BIOL, V27, P295, DOI 10.1111/j.1744-7348.1940.tb07499.x; Jonsson KI, 2008, CURR BIOL, V18, pR729, DOI 10.1016/j.cub.2008.06.048; Jonsson KI, 2005, INT J RADIAT BIOL, V81, P649, DOI 10.1080/09553000500368453; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Krisko A, 2010, P NATL ACAD SCI USA, V107, P14373, DOI 10.1073/pnas.1009312107; Mali B, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-168; MAY RAOUL-MICHEL, 1964, BULL BIOL FRANCE BELG, V98, P349; Ng WO, 2000, ARCH MICROBIOL, V173, P412, DOI 10.1007/s002030000164; Nilsson CEJ, 2011, INT J RADIAT BIOL, V86, P420; PROTICSABLJIC M, 1986, MOL CELL BIOL, V6, P3349, DOI 10.1128/MCB.6.10.3349; RIKLIS E, 1965, CAN J BIOCHEM CELL B, V43, P1207, DOI 10.1139/o65-132; Rizzo AM, 2010, COMP BIOCHEM PHYS B, V156, P115, DOI 10.1016/j.cbpb.2010.02.009; Rozen S, 2000, Methods Mol Biol, V132, P365; Sancar A, 2008, J BIOL CHEM, V283, P32153, DOI 10.1074/jbc.R800052200; SETLOW P, 1995, ANNU REV MICROBIOL, V49, P29, DOI 10.1146/annurev.mi.49.100195.000333; Sinha RP, 2001, ACTA PROTOZOOL, V40, P187; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; WESTH P, 1991, J EXP ZOOL, V258, P303, DOI 10.1002/jez.1402580305	31	50	51	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64793	10.1371/journal.pone.0064793	http://dx.doi.org/10.1371/journal.pone.0064793			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762256	Green Published, Green Submitted, gold			2022-12-27	WOS:000321099000023
J	Kasahara, DI; Williams, AS; Benedito, LA; Ranscht, B; Kobzik, L; Hug, C; Shore, SA				Kasahara, David I.; Williams, Alison S.; Benedito, Leandro A.; Ranscht, Barbara; Kobzik, Lester; Hug, Christopher; Shore, Stephanie A.			Role of the Adiponectin Binding Protein, T-Cadherin (cdh13), in Pulmonary Responses to Subacute Ozone	PLOS ONE			English	Article							INDUCED LUNG INFLAMMATION; AIRWAY INFLAMMATION; CELL-PROLIFERATION; B6C3F1 MICE; EXPOSURE; HYPERRESPONSIVENESS; RECEPTOR; SUSCEPTIBILITY; INHALATION; EXPRESSION	Adiponectin, an adipose derived hormone with pleiotropic functions, binds to several proteins, including T-cadherin. We have previously reported that adiponectin deficient (Adipo(-/-)) mice have increased IL-17A-dependent neutrophil accumulation in their lungs after subacute exposure to ozone (0.3 ppm for 72 hrs). The purpose of this study was to determine whether this anti-inflammatory effect of adiponectin required adiponectin binding to T-cadherin. Wildtype, Adipo(-/-), T-cadherin deficient (T-cad(-/-)), and bideficient (Adipo(-/-) /T-cad(-/-)) mice were exposed to subacute ozone or air. Compared to wildtype mice, ozone-induced increases in pulmonary IL-17A mRNA expression were augmented in T-cad(-/-) and Adipo(-/-) mice. Compared to T-cad(-/-) mice, there was no further increase in IL-17A in Adipo(-/-)/T-cad(-/-) mice, indicating that adiponectin binding to T-cadherin is required for suppression of ozone-induced IL-17A expression. Similar results were obtained for pulmonary mRNA expression of saa3, an acute phase protein capable of inducing IL-17A expression. Comparison of lung histological sections across genotypes also indicated that adiponectin attenuation of ozone-induced inflammatory lesions at bronchiolar branch points required T-cadherin. BAL neutrophils and G-CSF were augmented in T-cad(-/-) mice and further augmented in Adipo(-/-)/T-cad(-/-) mice. Taken together with previous observations indicating that augmentation of these moieties in ozone exposed Adipo(-/-) mice is partially IL-17A dependent, the results indicate that effects of T-cadherin deficiency on BAL neutrophils and G-CSF are likely secondary to changes in IL-17A, but that adiponectin also acts via T-cadherin independent pathways. Our results indicate that T-cadherin is required for the ability of adiponectin to suppress some but not all aspects of ozone-induced pulmonary inflammation.	[Kasahara, David I.; Williams, Alison S.; Benedito, Leandro A.; Kobzik, Lester; Shore, Stephanie A.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Ranscht, Barbara] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Hug, Christopher] Harvard Univ, Sch Med, Childrens Hosp Boston, Div Pulm Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Diego; Harvard University; Boston Children's Hospital; Harvard Medical School	Shore, SA (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	sshore@hsph.harvard.edu			U.S. National Institute of Health [HL-084044, ES-013307, ES-00002]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013307, P30ES000002] Funding Source: NIH RePORTER	U.S. National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the U.S. National Institute of Health [HL-084044, ES-013307, and ES-00002]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Ather JL, 2011, J IMMUNOL, V187, P64, DOI 10.4049/jimmunol.1100500; Backus GS, 2010, ENVIRON HEALTH PERSP, V118, P1721, DOI 10.1289/ehp.1002182; Bauer AK, 2011, ENVIRON HEALTH PERSP, V119, P1091, DOI 10.1289/ehp.1003326; Bothe GWM, 2004, GENES BRAIN BEHAV, V3, P149, DOI 10.1111/j.1601-183x.2004.00064.x; Cho HY, 2001, AM J PHYSIOL-LUNG C, V280, pL537, DOI 10.1152/ajplung.2001.280.3.L537; Denzel MS, 2010, J CLIN INVEST, V120, P4342, DOI 10.1172/JCI43464; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; Han CY, 2007, DIABETES, V56, P2260, DOI 10.2337/db07-0218; Hebbard LW, 2008, CANCER RES, V68, P1407, DOI 10.1158/0008-5472.CAN-07-2953; Herbert RA, 1996, TOXICOL PATHOL, V24, P539, DOI 10.1177/019262339602400502; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Johnston RA, 2005, AM J PHYSIOL-LUNG C, V288, pL390, DOI 10.1152/ajplung.00007.2004; Kasahara DI, 2012, J IMMUNOL, V188, P4558, DOI 10.4049/jimmunol.1102363; Kierstein S, 2008, ALLERGY, V63, P438, DOI 10.1111/j.1398-9995.2007.01587.x; Kleeberger SR, 1997, NAT GENET, V17, P475, DOI 10.1038/ng1297-475; KLEEBERGER SR, 1993, AM J PHYSIOL, V264, pL15, DOI 10.1152/ajplung.1993.264.1.L15; Koller E, 1996, J BIOL CHEM, V271, P30061, DOI 10.1074/jbc.271.47.30061; Konter JM, 2012, J IMMUNOL, V188, P854, DOI 10.4049/jimmunol.1100426; Kuzmenko YS, 1998, FEBS LETT, V434, P183, DOI 10.1016/S0014-5793(98)00977-6; Mautz WJ, 2001, TOXICOL SCI, V61, P331, DOI 10.1093/toxsci/61.2.331; Nakanishi K, 2011, AM J RESP CRIT CARE, V183, P1164, DOI 10.1164/rccm.201007-1091OC; Niermann T, 2000, BIOCHEM BIOPH RES CO, V276, P1240, DOI 10.1006/bbrc.2000.3465; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Philippova M, 2009, CELL SIGNAL, V21, P1035, DOI 10.1016/j.cellsig.2009.01.035; RANSCHT B, 1991, NEURON, V7, P391, DOI 10.1016/0896-6273(91)90291-7; Resink TJ, 1999, FEBS LETT, V463, P29, DOI 10.1016/S0014-5793(99)01594-X; Serino M, 2007, DIABETES, V56, P2541, DOI 10.2337/db07-0360; Shore SA, 2002, J APPL PHYSIOL, V92, P1019, DOI 10.1152/japplphysiol.00381.2001; Shore SA, 2006, J ALLERGY CLIN IMMUN, V118, P389, DOI 10.1016/j.jaci.2006.04.021; Takemura Y, 2007, J CLIN INVEST, V117, P375, DOI 10.1172/JCI29709; Takeuchi T, 2001, VIRCHOWS ARCH, V438, P370, DOI 10.1007/s004280000385; Wang Y, 2005, J BIOL CHEM, V280, P18341, DOI 10.1074/jbc.M501149200; Williams AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041088; Williams AS, 2012, PULM PHARMACOL THER; Wolf AM, 2004, BIOCHEM BIOPH RES CO, V323, P630, DOI 10.1016/j.bbrc.2004.08.145; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yu M, 2002, TOXICOL SCI, V65, P99, DOI 10.1093/toxsci/65.1.99; Zhao QY, 1998, AM J PHYSIOL-LUNG C, V274, pL39, DOI 10.1152/ajplung.1998.274.1.L39; Zhu M, 2010, AM J RESP CELL MOL, V43, P487, DOI 10.1165/rcmb.2009-0086OC	42	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65829	10.1371/journal.pone.0065829	http://dx.doi.org/10.1371/journal.pone.0065829			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755285	Green Published, gold, Green Submitted			2022-12-27	WOS:000321099000110
J	Yao, L; Meng, JJ; Zhang, DG; Sheng, XJ; Zhu, XY				Yao, Lin; Meng, Jianjun; Zhang, Dingguo; Sheng, Xinjun; Zhu, Xiangyang			Selective Sensation Based Brain-Computer Interface via Mechanical Vibrotactile Stimulation	PLOS ONE			English	Article							SOMATOSENSORY-EVOKED POTENTIALS; STEADY-STATE RESPONSES; MOTOR CORTEX; MEDIAN NERVE; EEG; SYNCHRONIZATION; TRANSIENT; MOVEMENT; INPUTS	In this work, mechanical vibrotactile stimulation was applied to subjects' left and right wrist skins with equal intensity, and a selective sensation perception task was performed to achieve two types of selections similar to motor imagery Brain-Computer Interface. The proposed system was based on event-related desynchronization/synchronization (ERD/ERS), which had a correlation with processing of afferent inflow in human somatosensory system, and attentional effect which modulated the ERD/ERS. The experiments were carried out on nine subjects (without experience in selective sensation), and six of them showed a discrimination accuracy above 80%, three of them above 95%. Comparative experiments with motor imagery (with and without presence of stimulation) were also carried out, which further showed the feasibility of selective sensation as an alternative BCI task complementary to motor imagery. Specifically there was significant improvement (P<0.01) from near 65% in motor imagery (with and without presence of stimulation) to above 80% in selective sensation on some subjects. The proposed BCI modality might well cooperate with existing BCI modalities in the literature in enlarging the widespread usage of BCI system.	[Yao, Lin; Meng, Jianjun; Zhang, Dingguo; Sheng, Xinjun; Zhu, Xiangyang] Shanghai Jiao Tong Univ, State Key Lab Mech Syst & Vibrat, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Sheng, XJ (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Mech Syst & Vibrat, Shanghai 200030, Peoples R China.	xjsheng@sjtu.edu.cn	Meng, Jianjun/T-3584-2019; Meng, Jianjun/ADC-6288-2022	Meng, Jianjun/0000-0003-0813-652X; Sheng, Xinjun/0000-0001-6124-8665; Yao, Lin/0000-0003-2065-7280	National Basic Research Program (973 Program) of China [2011CB013305]; National Natural Science Foundation of China [51075265]; Science and Technology Commission of Shanghai Municipality [11JC1406000]	National Basic Research Program (973 Program) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National Basic Research Program (973 Program) of China (Grant No. 2011CB013305), and the National Natural Science Foundation of China (Grant No. 51075265), and the Science and Technology Commission of Shanghai Municipality (Grant No. 11JC1406000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison BZ, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026007; Breitwieser C, 2012, MED BIOL ENG COMPUT, P1; Cassim F, 2000, CLIN NEUROPHYSIOL, V111, P2032, DOI 10.1016/S1388-2457(00)00455-7; Chen R, 1999, EXP BRAIN RES, V129, P77, DOI 10.1007/s002210050938; Colon E, 2012, NEUROPHYSIOLOGIE CLI; Delorme A, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/130714; Dockstader C., 2010, NEUROIMAGE; Fukunaga K., 1990, INTRO STAT PATTERN R, V1, P2; Giabbiconi CM, 2004, COGNITIVE BRAIN RES, V20, P58, DOI 10.1016/j.cogbrainres.2004.01.004; Hesterberg T, 2005, INTROD PRACT STAT, V5, P1; Houdayer E, 2006, CLIN NEUROPHYSIOL, V117, P628, DOI 10.1016/j.clinph.2005.12.001; Ishibashi H, 2000, CLIN NEUROPHYSIOL, V111, P1095, DOI 10.1016/S1388-2457(00)00266-2; Jurkiewicz MT, 2006, NEUROIMAGE, V32, P1281, DOI 10.1016/j.neuroimage.2006.06.005; Muller-Putz GR, 2006, IEEE T NEUR SYS REH, V14, P30, DOI 10.1109/TNSRE.2005.863842; Nangini C, 2006, NEUROIMAGE, V33, P252, DOI 10.1016/j.neuroimage.2006.05.045; Neuper C, 2001, INT J PSYCHOPHYSIOLO; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pfurtscheller G, 2000, CLIN NEUROPHYSIOL, V111, P1873, DOI 10.1016/S1388-2457(00)00428-4; Pfurtscheller G, 1997, ELECTROEN CLIN NEURO, V103, P642, DOI 10.1016/S0013-4694(97)00080-1; Pfurtscheller G, 2000, Suppl Clin Neurophysiol, V53, P196, DOI 10.1016/S1567-424X(09)70157-6; Pfurtscheller G, 2005, NEUROSCI LETT, V378, P156, DOI 10.1016/j.neulet.2004.12.034; Pfurtscheller G, 2002, NEUROSCI LETT, V323, P113, DOI 10.1016/S0304-3940(02)00119-2; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pfurtscheller G, 2010, FRONTIERS NEUROSCIEN, V4; Ramoser H, 2000, IEEE T REHABIL ENG, V8, P441, DOI 10.1109/86.895946; Roach BJ, 2008, SCHIZOPHRENIA BULL, V34, P907, DOI 10.1093/schbul/sbn093; Severens M, 2010, CLIN NEUROPHYSIOL, V121, P2090, DOI 10.1016/j.clinph.2010.05.016; Shenoy P, 2006, J NEURAL ENG, V3, pR13, DOI 10.1088/1741-2560/3/1/R02; Teplan M., 2002, MEAS SCI REV, V2; Tobimatsu S, 1999, CLIN NEUROPHYSIOL, V110, P1953, DOI 10.1016/S1388-2457(99)00146-7; Vidaurre C, 2011, NEURAL COMPUT, V23, P791, DOI 10.1162/NECO_a_00089; Vidaurre C, 2010, BRAIN TOPOGR, V23, P194, DOI 10.1007/s10548-009-0121-6; Voisin JIA, 2011, NEUROSCI LETT, V493, P33, DOI 10.1016/j.neulet.2011.02.015; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3	34	28	30	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64784	10.1371/journal.pone.0064784	http://dx.doi.org/10.1371/journal.pone.0064784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762253	Green Submitted, Green Published, gold			2022-12-27	WOS:000321099000020
J	Keizer, K; Lindenberg, S; Steg, L				Keizer, Kees; Lindenberg, Siegwart; Steg, Linda			The Importance of Demonstratively Restoring Order	PLOS ONE			English	Article							BEHAVIOR	Contrary to what is often assumed, order is not the strongest context for encouraging normative behavior. The strongest context effect on normative behavior comes from cues that clearly convey other people's respect for norms. Ironically, this show of respect necessitates some contrasting disrespect that is being restored. Using civic virtues (such as helping behavior) as a prototype of normative behavior, the three field experiments described in this paper reveal the impact of normative cues on civic virtues. Results show that the strongest effect on making people follow prosocial norms in public places emanates from seeing order being restored, rather than just order being present. The robust and surprisingly large effects show that observing other people's respect for one particular norm (as evidenced in their restoring physical order) makes it more likely that the onlooker follows other norms as well. This implies that prosocial behavior has the highest chance of spreading when people observe order being restored. There are clear policy implications: create low cost "normative respect cues'' wherever it is desirable to increase conformity to norms.	[Keizer, Kees; Lindenberg, Siegwart; Steg, Linda] Univ Groningen, Fac Behav & Social Sci, NL-9700 AB Groningen, Netherlands	University of Groningen	Keizer, K (corresponding author), Univ Groningen, Fac Behav & Social Sci, NL-9700 AB Groningen, Netherlands.	k.e.keizer@rug.nl	Steg, Linda/H-6878-2014; Lindenberg, Siegwart/E-2932-2013	Steg, Linda/0000-0002-8375-9607; Lindenberg, Siegwart/0000-0003-0053-3651	University of Groningen	University of Groningen	The University of Groningen provided the financial means for the present research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CIALDINI RB, 1990, J PERS SOC PSYCHOL, V58, P1015, DOI 10.1037/0022-3514.58.6.1015; Dunn EW, 2008, SCIENCE, V319, P1687, DOI 10.1126/science.1150952; Ellickson RC, 1996, YALE LAW J, V105, P1165, DOI 10.2307/797175; Keizer K, 2008, SCIENCE, V322, P1681, DOI 10.1126/science.1161405; Lindenberg S. M., 2012, ENV PSYCHOL INTRO, P119; Lindenberg S, 2007, J SOC ISSUES, V63, P117, DOI 10.1111/j.1540-4560.2007.00499.x; Meier S, 2008, ECONOMICA, V75, P39, DOI 10.1111/j.1468-0335.2007.00597.x; Nettle D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026922; Post S. G., 2007, ALTRUISM HLTH PERSPE; Schultz PW, 2013, ENVIRON BEHAV, V45, P35, DOI 10.1177/0013916511412179; Weinstein N, 2010, J PERS SOC PSYCHOL, V98, P222, DOI 10.1037/a0016984; [No title captured]	12	53	54	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65137	10.1371/journal.pone.0065137	http://dx.doi.org/10.1371/journal.pone.0065137			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166TB	23755182	Green Submitted, Green Published, gold			2022-12-27	WOS:000320579400040
J	Mao, ZP; Zhao, LJ; Pu, LC; Wang, MX; Zhang, Q; He, DZZ				Mao, Zhongping; Zhao, Lijun; Pu, Lichun; Wang, Mingxiao; Zhang, Qian; He, David Z. Z.			How Well Can Centenarians Hear?	PLOS ONE			English	Article							PRODUCT OTOACOUSTIC EMISSIONS; PURE-TONE THRESHOLDS; DPOAE GROWTH-BEHAVIOR; RISK-FACTORS; AUDITORY FUNCTION; ADULT-POPULATION; AGE; MICE; PRESBYCUSIS; PREVALENCE	With advancements in modern medicine and significant improvements in life conditions in the past four decades, the elderly population is rapidly expanding. There is a growing number of those aged 100 years and older. While many changes in the human body occur with physiological aging, as many as 35% to 50% of the population aged 65 to 75 years have presbycusis. Presbycusis is a progressive sensorineural hearing loss that occurs as people get older. There are many studies of the prevalence of age-related hearing loss in the United States, Europe, and Asia. However, no audiological assessment of the population aged 100 years and older has been done. Therefore, it is not clear how well centenarians can hear. We measured middle ear impedance, pure-tone behavioral thresholds, and distortion-product otoacoustic emission from 74 centenarians living in the city of Shaoxing, China, to evaluate their middle and inner ear functions. We show that most centenarian listeners had an "As" type tympanogram, suggesting reduced static compliance of the tympanic membrane. Hearing threshold tests using pure-tone audiometry show that all centenarian subjects had varying degrees of hearing loss. More than 90% suffered from moderate to severe (41 to 80 dB) hearing loss below 2,000 Hz, and profound (>81 dB) hearing loss at 4,000 and 8,000 Hz. Otoacoustic emission, which is generated by the active process of cochlear outer hair cells, was undetectable in the majority of listeners. Our study shows the extent and severity of hearing loss in the centenarian population and represents the first audiological assessment of their middle and inner ear functions.	[Mao, Zhongping; Zhao, Lijun; Pu, Lichun; Wang, Mingxiao] Shaoxing Second Hosp, Dept Otolaryngol Head & Neck Surg, Shaoxing, Peoples R China; [Zhang, Qian; He, David Z. Z.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA; [He, David Z. Z.] Ningbo Univ, Sch Med, Ningbo 315211, Zhejiang, Peoples R China	Creighton University; Ningbo University	Mao, ZP (corresponding author), Shaoxing Second Hosp, Dept Otolaryngol Head & Neck Surg, Shaoxing, Peoples R China.	mzp575@gmail.com; hed@creighton.edu	Zhang, Qian/P-7110-2015	He (he zhi zhou), Zhi-Zhou/0000-0001-8383-9634	Committee of Science and Technology of the city of Shaoxing, China; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004696] Funding Source: NIH RePORTER	Committee of Science and Technology of the city of Shaoxing, China; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The work has been supported by a grant from the Committee of Science and Technology of the city of Shaoxing, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal Y, 2009, OTOL NEUROTOL, V30, P139, DOI 10.1097/MAO.0b013e318192483c; Blanchet C, 2008, OTOL NEUROTOL, V29, P432, DOI 10.1097/MAO.0b013e3181719746; BONFILS P, 1988, AUDIOLOGY, V27, P27; BRANT LJ, 1990, J ACOUST SOC AM, V88, P813, DOI 10.1121/1.399731; Cilento BW, 2003, OTOLARYNG HEAD NECK, V129, P382, DOI 10.1016/S0194-5998(03)00637-5; COLLET L, 1990, ANN OTO RHINOL LARYN, V99, P993, DOI 10.1177/000348949009901212; Cruickshanks KJ, 1998, AM J EPIDEMIOL, V148, P879; Dazert S, 1996, HEARING RES, V100, P101, DOI 10.1016/0378-5955(96)00100-1; Deppe C, 2013, EAR HEARING, V34, P122, DOI 10.1097/AUD.0b013e31826709c3; Dom PA, 1998, J ACOUST SOC AM, V104, P964, DOI 10.1121/1.423339; Fransen E, 2003, EXP GERONTOL, V38, P353, DOI 10.1016/S0531-5565(03)00032-9; Frisina RD, 2006, HEARING RES, V216, P216, DOI 10.1016/j.heares.2006.02.003; Gates GA, 2005, LANCET, V366, P1111, DOI 10.1016/S0140-6736(05)67423-5; GATES GA, 1990, EAR HEARING, V11, P247, DOI 10.1097/00003446-199008000-00001; GATES GA, 1993, ARCH OTOLARYNGOL, V119, P156; Gehr DD, 2004, HEARING RES, V193, P9, DOI 10.1016/j.heares.2004.03.018; GORGA MP, 1993, J ACOUST SOC AM, V93, P2050, DOI 10.1121/1.406691; Helleman HW, 2010, INT J AUDIOL, V49, P410, DOI 10.3109/14992020903527616; Herzog M, 2001, EUR ARCH OTO-RHINO-L, V258, P61, DOI 10.1007/s004050000310; Hoffman HJ, 2012, EAR HEARING, V33, P437, DOI 10.1097/AUD.0b013e3182362790; Jimenez AM, 1999, HEARING RES, V138, P91, DOI 10.1016/S0378-5955(99)00154-9; Jonsson R, 1998, SCAND AUDIOL, V27, P81, DOI 10.1080/010503998420324; Jonsson R, 1998, AUDIOLOGY, V37, P207; KEAY DG, 1988, CLIN OTOLARYNGOL, V13, P31, DOI 10.1111/j.1365-2273.1988.tb00278.x; KEMP DT, 1978, J ACOUST SOC AM, V64, P1386, DOI 10.1121/1.382104; KIMBERLEY BP, 1994, EAR HEARING, V15, P199, DOI 10.1097/00003446-199406000-00001; Lee FS, 2005, EAR HEARING, V26, P1, DOI 10.1097/00003446-200502000-00001; Lin CY, 2007, INT J AUDIOL, V46, P732, DOI 10.1080/14992020701448986; LONSBURYMARTIN BL, 1991, J ACOUST SOC AM, V89, P1749, DOI 10.1121/1.401009; MARTIN GK, 1990, ANN OTO RHINOL LARYN, V99, P30, DOI 10.1177/00034894900990S503; Mathers C, 2000, GLOBAL BURDEN DIS, V2000, P1; Mazelova J, 2003, EXP GERONTOL, V38, P87, DOI 10.1016/S0531-5565(02)00155-9; Moller M B, 1981, Am J Otolaryngol, V2, P22, DOI 10.1016/S0196-0709(81)80005-1; MOSCICKI EK, 1985, EAR HEARING, V6, P184, DOI 10.1097/00003446-198507000-00003; National Center for Health Statistics, 1994, PREV CHAR PERS HEAR, V88; Olzowy B, 2010, J ACOUST SOC AM, V128, P1845, DOI 10.1121/1.3474898; Pacala JT, 2012, JAMA-J AM MED ASSOC, V307, P1185, DOI 10.1001/jama.2012.305; PEDERSEN KE, 1989, AUDIOLOGY, V28, P194; Pichora-Fuller MK, 2003, INT J AUDIOL, V42, pS11; Qin ZB, 2010, HEARING RES, V263, P93, DOI 10.1016/j.heares.2009.10.002; Roth TN, 2011, EUR ARCH OTO-RHINO-L, V268, P1101, DOI 10.1007/s00405-011-1597-8; Samuelsson SM, 1997, INT J AGING HUM DEV, V45, P223, DOI 10.2190/XKG9-YP7Y-QJTK-BGPG; Sanford CA, 2009, EAR HEARING, V30, P635, DOI 10.1097/AUD.0b013e3181b61cdc; Sha SH, 2008, HEARING RES, V243, P87, DOI 10.1016/j.heares.2008.06.001; Spongr VP, 1997, J ACOUST SOC AM, V101, P3546, DOI 10.1121/1.418315; STOVER L, 1993, J ACOUST SOC AM, V94, P2670, DOI 10.1121/1.407351; Tremblay KL, 2003, CLIN NEUROPHYSIOL, V114, P1332, DOI 10.1016/S1388-2457(03)00114-7; Uchida Y, 2008, EAR HEARING, V29, P176, DOI 10.1097/AUD.0b013e3181634eb8; WILLOTT JF, 1986, J NEUROPHYSIOL, V56, P391, DOI 10.1152/jn.1986.56.2.391; Zhang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062786	50	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65565	10.1371/journal.pone.0065565	http://dx.doi.org/10.1371/journal.pone.0065565			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755251	Green Published, gold, Green Submitted			2022-12-27	WOS:000320579400065
J	Poff, AM; Ari, C; Seyfried, TN; D'Agostino, DP				Poff, Angela M.; Ari, Csilla; Seyfried, Thomas N.; D'Agostino, Dominic P.			The Ketogenic Diet and Hyperbaric Oxygen Therapy Prolong Survival in Mice with Systemic Metastatic Cancer	PLOS ONE			English	Article							LOW-CARBOHYDRATE DIETS; KETONE-BODIES; TUMOR-GROWTH; WEIGHT-LOSS; PROSTATE-CANCER; GENE-EXPRESSION; BRAIN-TUMOR; MOUSE MODEL; ENERGY RESTRICTION; VASCULAR DENSITY	Introduction: Abnormal cancer metabolism creates a glycolytic-dependency which can be exploited by lowering glucose availability to the tumor. The ketogenic diet (KD) is a low carbohydrate, high fat diet which decreases blood glucose and elevates blood ketones and has been shown to slow cancer progression in animals and humans. Abnormal tumor vasculature creates hypoxic pockets which promote cancer progression and further increase the glycolytic-dependency of cancers. Hyperbaric oxygen therapy (HBO2T) saturates tumors with oxygen, reversing the cancer promoting effects of tumor hypoxia. Since these non-toxic therapies exploit overlapping metabolic deficiencies of cancer, we tested their combined effects on cancer progression in a natural model of metastatic disease. Methods: We used the firefly luciferase-tagged VM-M3 mouse model of metastatic cancer to compare tumor progression and survival in mice fed standard or KD ad libitum with or without HBO2T (2.5 ATM absolute, 90 min, 3x/week). Tumor growth was monitored by in vivo bioluminescent imaging. Results: KD alone significantly decreased blood glucose, slowed tumor growth, and increased mean survival time by 56.7% in mice with systemic metastatic cancer. While HBO2T alone did not influence cancer progression, combining the KD with HBO2T elicited a significant decrease in blood glucose, tumor growth rate, and 77.9% increase in mean survival time compared to controls. Conclusions: KD and HBO2T produce significant anti-cancer effects when combined in a natural model of systemic metastatic cancer. Our evidence suggests that these therapies should be further investigated as potential non-toxic treatments or adjuvant therapies to standard care for patients with systemic metastatic disease.	[Poff, Angela M.; Ari, Csilla; D'Agostino, Dominic P.] Univ S Florida, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA; [Seyfried, Thomas N.] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA	State University System of Florida; University of South Florida; Boston College	Poff, AM (corresponding author), Univ S Florida, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA.	abennett@health.usf.edu	D'Agostino, Dominic/I-6194-2012; D'Agostino, Dominic/GPJ-9744-2022	Seyfried, Thomas/0000-0003-1491-3989	Office of Naval Research, ONR [N000140610105, N000140210643]	Office of Naval Research, ONR(Office of Naval Research)	This work was supported by the Office of Naval Research, ONR grant N000140610105 and ONR-DURIP equipment grant N000140210643 (http://www.onr.navy.mil/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahab MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036197; Al-Waili NS, 2005, MED SCI MONITOR, V11, pRA279; Astrup A, 2000, BRIT J NUTR, V83, pS25; Aykin-Burns N, 2009, BIOCHEM J, V418, P29, DOI 10.1042/BJ20081258; Bayley JP, 2012, CURR OPIN ONCOL, V24, P62, DOI 10.1097/CCO.0b013e32834deb9e; Bennett A, 2012, FASEB J; Bennett M, 2008, CANCER TREAT REV, V34, P577, DOI 10.1016/j.ctrv.2008.01.001; Bergamo A, 1999, J PHARMACOL EXP THER, V289, P559; Bonuccelli G, 2010, CELL CYCLE, V9, P3506, DOI 10.4161/cc.9.17.12731; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Champ CE, 2012, INT J BREAST CANC, DOI DOI 10.1155/2012/506868; D'Agostino D, 2012, FASEB SAN DIEGO CA; D'agostino DP, 2009, NEUROSCIENCE, V159, P1011, DOI 10.1016/j.neuroscience.2009.01.062; D'Agostino DP, 2013, AM J PHYSL REGULATOR; Daruwalla J, 2006, WORLD J SURG, V30, P2112, DOI 10.1007/s00268-006-0190-6; Duranti L, 2012, TUMORI J, V98, P175, DOI 10.1700/1088.11927; Fine EJ, 2012, NUTRITION, V28, P1028, DOI 10.1016/j.nut.2012.05.001; Fomchenko EI, 2006, CLIN CANCER RES, V12, P5288, DOI 10.1158/1078-0432.CCR-06-0438; Frezza C, 2011, J MOL MED, V89, P213, DOI 10.1007/s00109-011-0728-4; Gill AL, 2004, QJM, V97; Graeme M, 2004, CLIN ONCOLOGY, V16, P549; GRAY LH, 1953, BRIT J RADIOL, V26, P638, DOI 10.1259/0007-1285-26-312-638; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hoogsteen IJ, 2007, CLIN ONCOL-UK, V19, P385, DOI 10.1016/j.clon.2007.03.001; Hursting SD, 2010, CARCINOGENESIS, V31, P83, DOI 10.1093/carcin/bgp280; Hussain TA, 2012, NUTRITION, V28, P1016, DOI 10.1016/j.nut.2012.01.016; Huysentruyt LC, 2008, INT J CANCER, V123, P73, DOI 10.1002/ijc.23492; Huysentruyt LC, 2011, ASN NEURO, V3, P183, DOI 10.1042/AN20110011; Huysentruyt LC, 2010, INT J CANCER, V126, P65, DOI 10.1002/ijc.24649; Johnstone AM, 2008, AM J CLIN NUTR, V87, P44, DOI 10.1093/ajcn/87.1.44; Kashiwaya Y, 2013, NEUROBIOL AGING, V34, P1530, DOI 10.1016/j.neurobiolaging.2012.11.023; Katyal NG, 2000, CLIN PEDIATR, V39, P153, DOI 10.1177/000992280003900303; Le QT, 2004, CANCER METAST REV, V23, P293, DOI 10.1023/B:CANC.0000031768.89246.d7; LOEHRER PJ, 1984, ANN INTERN MED, V100, P704, DOI 10.7326/0003-4819-100-5-704; MAGEE BA, 1979, AUST J EXP BIOL MED, V57, P529, DOI 10.1038/icb.1979.54; Manninen AH, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-9; Marsh J, 2008, CLIN CANCER RES, V14, P7751, DOI 10.1158/1078-0432.CCR-08-0213; Marsh J, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-33; Martinez-Outschoorn UE, 2012, CELL CYCLE, V11, P3964, DOI 10.4161/cc.22137; Martinez-Outschoorn UE, 2011, CELL CYCLE, V10, P1271, DOI 10.4161/cc.10.8.15330; Masko EM, 2010, CANCER PREV RES, V3, P1124, DOI 10.1158/1940-6207.CAPR-10-0071; Maurer GD, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-315; Mavropoulos JC, 2006, UROLOGY, V68, P15, DOI 10.1016/j.urology.2006.03.073; Mavropoulos JC, 2009, CANCER PREV RES, V2, P557, DOI 10.1158/1940-6207.CAPR-08-0188; McGuire WP, 1996, SEMIN ONCOL, V23, P40; Moen I, 2012, TARGET ONCOL, V7, P233, DOI 10.1007/s11523-012-0233-x; Moen I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006381; Mukherjee P, 1999, JNCI-J NATL CANCER I, V91, P512, DOI 10.1093/jnci/91.6.512; Mukherjee P, 2002, BRIT J CANCER, V86, P1615, DOI 10.1038/sj.bjc.6600298; Mukherjee P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-37; NEBELING LC, 1995, J AM DIET ASSOC, V95, P693, DOI 10.1016/S0002-8223(95)00189-1; NEBELING LC, 1995, J AM COLL NUTR, V14, P202; Otto C, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-122; Paoli A, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-34; Petre PM, 2003, J THORAC CARDIOV SUR, V125, P85, DOI 10.1067/mtc.2003.90; Pilla R, 2012, 3 INT S DIET THER EP; ROSSIFANELLI F, 1991, CLIN NUTR, V10, P228, DOI 10.1016/0261-5614(91)90043-C; Salem AF, 2012, CELL CYCLE, V11, P2545, DOI 10.4161/cc.20920; Sawai M, 2004, ANTICANCER RES, V24, P2213; Scheck AC, 2012, EPILEPSY RES, V100, P327, DOI 10.1016/j.eplepsyres.2011.09.022; Schmidt M, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-54; Seyfried IN, 2012, CANC METABOLIC DIS O; Seyfried TN, 2010, LANCET ONCOL, V11, P811, DOI 10.1016/S1470-2045(10)70166-2; Seyfried TN, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-7; Seyfried TN, 2003, BRIT J CANCER, V89, P1375, DOI 10.1038/sj.bjc.6601269; Shelton LM, 2010, J NEURO-ONCOL, V99, P165, DOI 10.1007/s11060-010-0115-y; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Skinner R, 2009, J PEDIATR SURG, V44, P212, DOI 10.1016/j.jpedsurg.2008.10.042; Stafford P, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-74; Stuhr LEB, 2004, CANCER LETT, V210, P35, DOI 10.1016/j.canlet.2004.02.012; Stuhr LEB, 2007, J NEURO-ONCOL, V85, P191, DOI 10.1007/s11060-007-9407-2; Sun Y, 2012, NAT MED, V18, P1359, DOI 10.1038/nm.2890; Takiguchi N, 2001, CANCER CHEMOTH PHARM, V47, P11, DOI 10.1007/s002800000190; Thompson HJ, 2004, CANCER RES, V64, P5643, DOI 10.1158/0008-5472.CAN-04-0787; Thompson HJ, 2004, CANCER RES, V64, P1541, DOI 10.1158/0008-5472.CAN-03-3108; Thompson HJ, 2003, J MAMMARY GLAND BIOL, V8, P133, DOI 10.1023/A:1025743607445; TISDALE MJ, 1987, BRIT J CANCER, V56, P39, DOI 10.1038/bjc.1987.149; TISDALE MJ, 1983, BRIT J CANCER, V47, P293, DOI 10.1038/bjc.1983.38; TISDALE MJ, 1988, BRIT J CANCER, V58, P580, DOI 10.1038/bjc.1988.263; Vaupel P, 2001, MED ONCOL, V18, P243, DOI 10.1385/MO:18:4:243; Vaupel P, 2004, ONCOLOGIST, V9, P4, DOI 10.1634/theoncologist.9-90005-4; Vaupel P, 2004, METHOD ENZYMOL, V381, P335; Veech RL, 2004, PROSTAG LEUKOTR ESS, V70, P309, DOI 10.1016/j.plefa.2003.09.007; Veech RL, 2001, IUBMB LIFE, V51, P241; Volek Js, 2004, Nutr Metab (Lond), V1, P13, DOI 10.1186/1743-7075-1-13; Volek JS, 2002, METABOLISM, V51, P864, DOI 10.1053/meta.2002.32037; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wheatley KE, 2008, NUTR CANCER, V60, P61, DOI 10.1080/01635580701510150; Wouters BG, 2004, DRUG RESIST UPDATE, V7, P25, DOI 10.1016/j.drup.2003.12.004; WU GY, 1988, BIOCHEM J, V255, P139, DOI 10.1042/bj2550139; Zhou WH, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-5; Zhu ZJ, 2005, MOL CARCINOGEN, V42, P170, DOI 10.1002/mc.20071; Zuccoli G, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-33	93	106	113	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65522	10.1371/journal.pone.0065522	http://dx.doi.org/10.1371/journal.pone.0065522			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755243	gold, Green Published, Green Submitted			2022-12-27	WOS:000320579400061
J	Ruskin, DN; Svedova, J; Cote, JL; Sandau, U; Rho, JM; Kawamura, M; Boison, D; Masino, SA				Ruskin, David N.; Svedova, Julia; Cote, Jessica L.; Sandau, Ursula; Rho, Jong M.; Kawamura, Masahito, Jr.; Boison, Detlev; Masino, Susan A.			Ketogenic Diet Improves Core Symptoms of Autism in BTBR Mice	PLOS ONE			English	Article							FATTY LIVER-DISEASE; K-ATP CHANNELS; LOW-CARBOHYDRATE; SPECTRUM DISORDERS; ADULT RATS; EPILEPSY; ADENOSINE; METABOLISM; CHILDREN; BRAIN	Autism spectrum disorders share three core symptoms: impaired sociability, repetitive behaviors and communication deficits. Incidence is rising, and current treatments are inadequate. Seizures are a common comorbidity, and since the 1920's a high-fat, low-carbohydrate ketogenic diet has been used to treat epilepsy. Evidence suggests the ketogenic diet and analogous metabolic approaches may benefit diverse neurological disorders. Here we show that a ketogenic diet improves autistic behaviors in the BTBR mouse. Juvenile BTBR mice were fed standard or ketogenic diet for three weeks and tested for sociability, self-directed repetitive behavior, and communication. In separate experiments, spontaneous intrahippocampal EEGs and tests of seizure susceptibility (6 Hz corneal stimulation, flurothyl, SKF83822, pentylenetetrazole) were compared between BTBR and control (C57Bl/6) mice. Ketogenic diet-fed BTBR mice showed increased sociability in a three-chamber test, decreased self-directed repetitive behavior, and improved social communication of a food preference. Although seizures are a common comorbidity with autism, BTBR mice fed a standard diet exhibit neither spontaneous seizures nor abnormal EEG, and have increased seizure susceptibility in just one of four tests. Thus, behavioral improvements are dissociable from any antiseizure effect. Our results suggest that a ketogenic diet improves multiple autistic behaviors in the BTBR mouse model. Therefore, ketogenic diets or analogous metabolic strategies may offer novel opportunities to improve core behavioral symptoms of autism spectrum disorders.	[Ruskin, David N.; Svedova, Julia; Cote, Jessica L.; Masino, Susan A.] Trinity Coll, Neurosci Program, Hartford, CT 06106 USA; [Ruskin, David N.; Masino, Susan A.] Trinity Coll, Dept Psychol, Hartford, CT 06106 USA; [Sandau, Ursula; Boison, Detlev] Legacy Res Inst, Robert Stone Dow Neurobiol Labs, Portland, OR USA; [Rho, Jong M.] Univ Calgary, Dept Pediat, Alberta Childrens Hosp, Fac Med, Calgary, AB T2N 1N4, Canada; [Rho, Jong M.] Univ Calgary, Dept Clin Neurosci, Alberta Childrens Hosp, Fac Med, Calgary, AB T2N 1N4, Canada; [Kawamura, Masahito, Jr.] Jikei Univ, Sch Med, Dept Pharmacol, Tokyo, Japan	Trinity College; Trinity College; Alberta Childrens Hospital; University of Calgary; Alberta Childrens Hospital; University of Calgary; Jikei University	Masino, SA (corresponding author), Trinity Coll, Neurosci Program, Hartford, CT 06106 USA.	susan.masino@trincoll.edu	Boison, Detlev/ABE-6302-2020	Cote, Jessica/0000-0001-8967-2396; Boison, Detlev/0000-0002-7740-5781	National Institutes of Health [R01 NS065957, R01 NS061844, R01 NS070267]; National Science Foundation [IOS-0843585]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061844, R01NS065957, R15NS066392, R01NS070267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by National Institutes of Health R01 NS065957, R01 NS061844 and R01 NS070267 (www.nih.gov), and National Science Foundation IOS-0843585 (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4; Baranano Kristin W, 2008, Curr Treat Options Neurol, V10, P410, DOI 10.1007/s11940-008-0043-8; Brinkworth GD, 2009, ARCH INTERN MED, V169, P1873, DOI 10.1001/archinternmed.2009.329; Burnstock G, 2011, PROG NEUROBIOL, V95, P229, DOI 10.1016/j.pneurobio.2011.08.006; Chadman KK, 2012, EXPERT OPIN DRUG DIS, V7, P407, DOI 10.1517/17460441.2012.678828; DIXON WJ, 1948, J AM STAT ASSOC, V43, P109, DOI 10.2307/2280071; Eapen V, 2011, AUTISM NEURODEVELOPM, P103; El-Ansary A, 2010, CLIN BIOCHEM, V43, P63, DOI 10.1016/j.clinbiochem.2009.09.008; Elsabbagh M, 2012, AUTISM RES, V5, P160, DOI 10.1002/aur.239; Evangeliou A, 2003, J CHILD NEUROL, V18, P113, DOI 10.1177/08830738030180020501; Forsythe CE, 2008, LIPIDS, V43, P65, DOI 10.1007/s11745-007-3132-7; Frye RE, 2011, PEDIATR RES, V69, p41R, DOI 10.1203/PDR.0b013e318212f16b; Gimenez-Cassina A, 2012, NEURON, V74, P719, DOI 10.1016/j.neuron.2012.03.032; Halyburton AK, 2007, AM J CLIN NUTR, V86, P580, DOI 10.1093/ajcn/86.3.580; Juge N, 2010, NEURON, V68, P99, DOI 10.1016/j.neuron.2010.09.002; Kawamura M, 2010, J NEUROSCI, V30, P3886, DOI 10.1523/JNEUROSCI.0055-10.2010; Kim DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035476; Lund TM, 2009, J NEUROCHEM, V110, P80, DOI 10.1111/j.1471-4159.2009.06115.x; Ma WY, 2007, J NEUROSCI, V27, P3618, DOI 10.1523/JNEUROSCI.0132-07.2007; Masino SA, 2009, CURR NEUROPHARMACOL, V7, P257, DOI 10.2174/157015909789152164; Masino SA, 2012, NEUROSCIENCE; Masino SA, 2013, NEUROPHARMACOLOGY, V68, P116, DOI 10.1016/j.neuropharm.2012.08.013; Masino Susan A, 2010, Open Neurosci J, V4, P58; Masino SA, 2011, NEUROSCI LETT, V500, P1, DOI 10.1016/j.neulet.2011.06.007; Masino SA, 2011, J CLIN INVEST, V121, P2679, DOI 10.1172/JCI57813; McFarlane HG, 2008, GENES BRAIN BEHAV, V7, P152, DOI 10.1111/j.1601-183X.2007.00330.x; Meidenbauer JJ, 2011, EPILEPSIA, V52, P347, DOI 10.1111/j.1528-1167.2010.02898.x; Milllward C, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003498.pub3; Neal EG, 2008, LANCET NEUROL, V7, P500, DOI 10.1016/S1474-4422(08)70092-9; Park CR, 2001, BIOL PSYCHIAT, V50, P994, DOI 10.1016/S0006-3223(01)01255-0; Patel A, 2010, EPILEPSIA, V51, P1277, DOI 10.1111/j.1528-1167.2009.02488.x; Patterson PH, 2011, PEDIATR RES, V69, p34R, DOI 10.1203/PDR.0b013e318212b80f; Perez-Guisado J, 2011, J MED FOOD, V14, P677, DOI 10.1089/jmf.2011.0075; Pobbe RLH, 2011, BEHAV BRAIN RES, V216, P446, DOI 10.1016/j.bbr.2010.08.039; Ruskin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008349; Sansa G, 2011, EPILEPSIA, V52, P1071, DOI 10.1111/j.1528-1167.2011.03069.x; Simonoff E, 2008, J AM ACAD CHILD PSY, V47, P921, DOI 10.1097/CHI.0b013e318179964f; Sirven J, 1999, EPILEPSIA, V40, P1721, DOI 10.1111/j.1528-1157.1999.tb01589.x; Spence SJ, 2009, PEDIATR RES, V65, P599, DOI 10.1203/PDR.0b013e31819e7168; Stafstrom CE, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00059; Sullivan PG, 2004, ANN NEUROL, V55, P576, DOI 10.1002/ana.20062; Tendler D, 2007, DIGEST DIS SCI, V52, P589, DOI 10.1007/s10620-006-9433-5; Tuchman R, 2002, LANCET NEUROL, V1, P352, DOI 10.1016/S1474-4422(02)00160-6; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Wilder R., 1921, MAY CLIN B, P308; Yudkoff M, 2007, ANNU REV NUTR, V27, P415, DOI 10.1146/annurev.nutr.27.061406.093722; Zhao Z, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-29	47	100	106	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65021	10.1371/journal.pone.0065021	http://dx.doi.org/10.1371/journal.pone.0065021			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755170	Green Published, gold			2022-12-27	WOS:000320579400036
J	Vilardo, E; Rossmanith, W				Vilardo, Elisa; Rossmanith, Walter			The Amyloid-beta-SDR5C1(ABAD) Interaction Does Not Mediate a Specific Inhibition of Mitochondrial RNase P	PLOS ONE			English	Article							AMYLOID-BETA-PEPTIDE; BINDING ALCOHOL-DEHYDROGENASE; ALZHEIMERS-DISEASE; A-BETA; PROTEIN; 17-BETA-HYDROXYSTEROID-DEHYDROGENASE; IDENTIFICATION; ACCUMULATION; ARABIDOPSIS; DYSFUNCTION	The amyloid-beta peptide (A beta) is suggested to cause mitochondrial dysfunction in Alzheimer's disease. The mitochondrial dehydrogenase SDR5C1 (also known as ABAD) was shown to bind A beta and was proposed to thereby mediate mitochondrial toxicity, but the molecular mechanism has not been clarified. We recently identified SDR5C1 as an essential component of human mitochondrial RNase P and its associated tRNA:m(1) R9 methyltransferase, the enzymes responsible for tRNA 5'-end processing and methylation of purines at tRNA position 9, respectively. With this work we investigated whether SDR5C1's role as a subunit of these two tRNA-maturation activities represents the mechanistic link between A beta and mitochondrial dysfunction. Using recombinant enzyme components, we tested RNase P and methyltransferase activity upon titration of A beta. Micromolar concentrations of monomeric or oligomerized A beta were required to inhibit tRNA 5'-end processing and position 9 methylation catalyzed by the SDR5C1-containing enzymes, yet similar concentrations of A beta also inhibited related RNase P and methyltransferase activities, which do not contain an SDR5C1 homolog. In conclusion, the proposed deleterious effect of A beta on mitochondrial function cannot be explained by a specific inhibition of mitochondrial RNase P or its tRNA:m(1) R9 methyltransferase subcomplex, and the molecular mechanism of SDR5C1-mediated A beta toxicity remains unclear.	[Vilardo, Elisa; Rossmanith, Walter] Med Univ Vienna, Ctr Anat & Cell Biol, Vienna, Austria	Medical University of Vienna	Rossmanith, W (corresponding author), Med Univ Vienna, Ctr Anat & Cell Biol, Vienna, Austria.	walter.rossmanith@meduniwien.ac.at	Rossmanith, Walter/F-3662-2010; Vilardo, Elisa/F-3656-2010	Rossmanith, Walter/0000-0003-2337-2248; Vilardo, Elisa/0000-0003-2733-6009	Agouron Institute [AI-ALZ2.10.1]	Agouron Institute(Pfizer)	This work was supported by research grant AI-ALZ2.10.1 from the Agouron Institute (www.agi.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Binstock J F, 1981, Methods Enzymol, V71 Pt C, P403; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Chen JX, 2010, J ALZHEIMERS DIS, V20, pS569, DOI 10.3233/JAD-2010-100357; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Du Yan S, 1999, J BIOL CHEM, V274, P2145, DOI 10.1074/jbc.274.4.2145; Gobert A, 2010, NAT STRUCT MOL BIOL, V17, P740, DOI 10.1038/nsmb.1812; Gutmann B, 2012, GENE DEV, V26, P1022, DOI 10.1101/gad.189514.112; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; He XY, 1998, J BIOL CHEM, V273, P10741, DOI 10.1074/jbc.273.17.10741; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Jackman JE, 2003, RNA, V9, P574, DOI 10.1261/rna.5070303; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Morais VA, 2010, J ALZHEIMERS DIS, V20, pS255, DOI 10.3233/JAD-2010-100345; Motorin Y, 2011, WIRES RNA, V2, P611, DOI 10.1002/wrna.79; Oppermann UCT, 1999, FEBS LETT, V451, P238, DOI 10.1016/S0014-5793(99)00586-4; Pavlova LV, 2012, CHEMBIOCHEM, V13, P2270, DOI 10.1002/cbic.201200434; Persson B, 2009, CHEM-BIOL INTERACT, V178, P94, DOI 10.1016/j.cbi.2008.10.040; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rauschenberger K, 2010, EMBO MOL MED, V2, P51, DOI 10.1002/emmm.200900055; Rossmanith W, 2012, BBA-GENE REGUL MECH, V1819, P1017, DOI 10.1016/j.bbagrm.2011.11.003; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Taschner A, 2012, CELL REP, V2, P19, DOI 10.1016/j.celrep.2012.05.021; Tillement L, 2011, MITOCHONDRION, V11, P13, DOI 10.1016/j.mito.2010.08.009; Vilardo E, 2012, NUCLEIC ACIDS RES, V40, P11583, DOI 10.1093/nar/gks910; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Yan SD, 1997, NATURE, V389, P689; Yan SD, 2000, J BIOL CHEM, V275, P27100; Yan YL, 2007, BIOCHEMISTRY-US, V46, P1724, DOI 10.1021/bi061314n; Yang SY, 2005, TRENDS ENDOCRIN MET, V16, P167, DOI 10.1016/j.tem.2005.03.006; Yao J, 2011, J NEUROSCI, V31, P2313, DOI 10.1523/JNEUROSCI.4717-10.2011; Yoon EJ, 2009, EXP MOL MED, V41, P611, DOI 10.3858/emm.2009.41.9.067	36	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65609	10.1371/journal.pone.0065609	http://dx.doi.org/10.1371/journal.pone.0065609			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755257	Green Published, gold, Green Submitted			2022-12-27	WOS:000320579400070
J	Yamazaki, T; Yamori, M; Asai, K; Nakano-Araki, I; Yamaguchi, A; Takahashi, K; Sekine, A; Matsuda, F; Kosugi, S; Nakayama, T; Inagaki, N; Bessho, K				Yamazaki, Toru; Yamori, Masashi; Asai, Keita; Nakano-Araki, Ikuko; Yamaguchi, Akihiko; Takahashi, Katsu; Sekine, Akihiro; Matsuda, Fumihiko; Kosugi, Shinji; Nakayama, Takeo; Inagaki, Nobuya; Bessho, Kazuhisa		Nagahama Study Collaboration Grp	Mastication and Risk for Diabetes in a Japanese Population: A Cross-Sectional Study	PLOS ONE			English	Article							CHANGEABLE CHEWING GUM; EATING FAST LEADS; BODY-MASS-INDEX; NUTRITIONAL-STATUS; MAGNESIUM INTAKE; NUTRIENT INTAKE; OCCLUSAL FORCE; FIBER INTAKE; ORAL HEALTH; PERFORMANCE	Background: Associations between mastication and insufficient nutrient intake, obesity, and glucose metabolism have been shown in previous studies. However, the association between mastication and diabetes has not been clarified. Our objective was to examine the association between mastication, namely masticatory performance or rate of eating, and diabetes in a population-based cohort. Methods: We conducted a cross-sectional study of the association between mastication and diabetes in the Nagahama Prospective Cohort Study, an ongoing study which recruits citizens of Nagahama City in Shiga Prefecture, central Japan. 2,283 male and 4,544 female residents aged 40-74 years were enrolled from July 2009 to November 2010. Masticatory performance was evaluated by spectrophotometric measurement of color changes after masticating color-changeable chewing gum. Categorical rate of eating (fast, intermediate or slow) was self-assessed using a questionnaire. Results: 177 males (7.7%) and 112 (2.4%) females were diagnosed with diabetes. We divided participants into four groups by quartile of masticatory performance, namely Q1 (lowest), 2, and 3 and 4 (highest). Compared to the lowest performance group, the multivariable adjusted odds ratio (OR) of diabetes was 0.91 (95% confidence interval (CI), 0.58-1.4) in Q2, 0.77 (95% CI, 0.48-1.2) in Q3, and 0.53 (95% CI, 0.31-0.90) in the highest group in males, and 1.2 (95% CI, 0.73-2.0), 0.95 (95% CI, 0.54-1.6) and 0.56 (95% CI, 0.30-1.0) in females. We also estimated ORs of diabetes by rate of eating. Compared to the fast eating group, ORs in males were 0.87 (95% CI, 0.61-1.2) in the intermediate group and 0.38 (95% CI, 0.16-0.91) in the slow group, and ORs in females were 0.92 (95% CI, 0.59-1.4) and 1.5 (95% CI, 0.73-3.0). Conclusions: These findings support the hypothesis that higher masticatory performance and slow eating prevent the occurrence of diabetes.	[Yamazaki, Toru; Yamori, Masashi; Asai, Keita; Takahashi, Katsu; Bessho, Kazuhisa] Kyoto Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kyoto, Japan; [Nakano-Araki, Ikuko; Yamaguchi, Akihiko] Nagahama City Hosp, Dept Oral & Maxillofacial Surg, Nagahama, Japan; [Sekine, Akihiro] Kyoto Univ, Grad Sch Med, EBM Res Ctr, Kyoto, Japan; [Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Unit Human Dis Genom, Ctr Genom Med, Kyoto, Japan; [Kosugi, Shinji] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Med Eth, Kyoto, Japan; [Nakayama, Takeo] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Hlth Informat, Kyoto, Japan; [Inagaki, Nobuya] Kyoto Univ, Grad Sch Med, Dept Diabet & Clin Nutr, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University	Yamori, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kyoto, Japan.	yamori@kuhp.kyoto-u.ac.jp	KOSUGI, Shinji/GYR-2946-2022; NAKAYAMA, Takeo/HCH-0537-2022; Kadotani, Hiroshi/A-7908-2015; KOSUGI, Shinji/HCH-0631-2022	Kadotani, Hiroshi/0000-0001-7474-3315; Nakayama, Takeo/0000-0002-7918-6252; Inagaki, Nobuya/0000-0001-8261-2593	Kyoto University; Takeda Science Foundation; Mitsui Sumitomo Insurance Welfare Foundation; Ministry of Health, Labour and Welfare, Japan; Grants-in-Aid for Scientific Research [24592985] Funding Source: KAKEN	Kyoto University; Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsui Sumitomo Insurance Welfare Foundation(Mitsui Sumitomo Insurance Welfare Foundation); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partially supported by the grants-in-aid from the following organizations: Kyoto University (2006), Takeda Science Foundation (2008), Mitsui Sumitomo Insurance Welfare Foundation (2010), and the Ministry of Health, Labour and Welfare, Japan (2009-2013). The chewing gum was provided by the Lion Foundation for Dental Health and Lotte Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; American Diabetes Association, 2011, Diabetes Care, V34 Suppl 1, pS4, DOI 10.2337/dc11-S004; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Corcodel N, 2010, EUR J ORAL SCI, V118, P311, DOI 10.1111/j.1600-0722.2010.00730.x; Dong JY, 2011, DIABETES CARE, V34, P2116, DOI 10.2337/dc11-0518; Endo T, 2012, ODONTOLOGY; Hayakawa I, 1998, INT J PROSTHODONT, V11, P173; Ikebe K, 2011, ARCH ORAL BIOL, V56, P991, DOI 10.1016/j.archoralbio.2011.03.019; Ikebe K, 2010, INT J PROSTHODONT, V23, P521; Ishikawa Yasutaka, 2007, Journal of Medical and Dental Sciences, V54, P65; Kamiyama M, 2010, J PROSTHODONT RES, V54, P24, DOI 10.1016/j.jpor.2009.08.001; Kokkinos A, 2010, J CLIN ENDOCR METAB, V95, P333, DOI 10.1210/jc.2009-1018; Komagamine Y, 2012, J ORAL REHABIL, V39, P847, DOI 10.1111/joor.12004; Komagamine Y, 2011, J ORAL REHABIL, V38, P555, DOI 10.1111/j.1365-2842.2011.02204.x; KUEHNI RG, 1976, J OPT SOC AM, V66, P497, DOI 10.1364/JOSA.66.000497; Lee JS, 2004, AM J CLIN NUTR, V79, P295; Marshall TA, 2002, J AM DENT ASSOC, V133, P1369, DOI 10.14219/jada.archive.2002.0052; Maruyama K, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2002; Mealey BL, 2007, PERIODONTOL 2000, V44, P127, DOI 10.1111/j.1600-0757.2006.00193.x; Montonen J, 2003, AM J CLIN NUTR, V77, P622, DOI 10.1093/ajcn/77.3.622; Moriya S, 2012, GERODONTOLOGY; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Murakami K, 2007, AM J CLIN NUTR, V86, P206, DOI 10.1093/ajcn/86.1.206; Nakayama Takeo, 2010, JAP J GENET COUNSEL, P31; Nojima K, 2006, DIABETES RES CLIN PR, V74, P1, DOI 10.1016/j.diabres.2006.03.031; Ohira A, 2011, INT J PAEDIAT DENT; Ohkuma T, 2013, DIABETOLOGIA, V56, P70, DOI 10.1007/s00125-012-2746-3; Oka K, 2003, J DENT RES, V82, P491, DOI 10.1177/154405910308200617; Okada K, 2010, GERIATR GERONTOL INT, V10, P56, DOI 10.1111/j.1447-0594.2009.00560.x; Orozco LJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003054.pub3; Otsuka R, 2008, PREV MED, V46, P154, DOI 10.1016/j.ypmed.2007.07.031; Otsuka R, 2006, J EPIDEMIOL, V16, P117, DOI 10.2188/jea.16.117; Oueis H, 2009, INT J PAEDIATR DENT, V19, P201, DOI 10.1111/j.1365-263X.2008.00965.x; Pedersen AM, 2002, ORAL DIS, V8, P117, DOI 10.1034/j.1601-0825.2002.02851.x; Reis JP, 2011, ANN INTERN MED, V155, P292, DOI 10.7326/0003-4819-155-5-201109060-00006; Saito A, 2012, APPETITE, V59, P252, DOI 10.1016/j.appet.2012.05.009; Sakata T, 1995, METHOD FIND EXP CLIN, V17, P51; Sakurai M, 2012, METABOLISM, V61, P1566, DOI 10.1016/j.metabol.2012.04.005; Schillinger T, 2006, STROKE, V37, P2271, DOI 10.1161/01.STR.0000236495.82545.2e; Schulze MB, 2007, ARCH INTERN MED, V167, P956, DOI 10.1001/archinte.167.9.956; Schulze MB, 2004, AM J CLIN NUTR, V80, P348, DOI 10.1093/ajcn/80.2.348; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Sheiham A, 2001, J DENT RES, V80, P408, DOI 10.1177/00220345010800020201; Slavin JL, 1999, AM J CLIN NUTR, V70, p459S, DOI 10.1093/ajcn/70.3.459s; Sonoki K, 2012, ENDOCR J; Suzuki H, 2005, METABOLISM, V54, P1593, DOI 10.1016/j.metabol.2005.06.006; Tanihara S, 2011, APPETITE, V57, P179, DOI 10.1016/j.appet.2011.04.017; Tong X, 2011, EUR J CLIN NUTR, V65, P1027, DOI 10.1038/ejcn.2011.62; Villegas R, 2009, AM J CLIN NUTR, V89, P1059, DOI 10.3945/ajcn.2008.27182; World Health Organization, 1997, WHO OR HLTH SURV BAS, V4th	51	30	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64113	10.1371/journal.pone.0064113	http://dx.doi.org/10.1371/journal.pone.0064113			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755114	gold, Green Published, Green Submitted			2022-12-27	WOS:000320579400007
J	Krieg, A; Werner, TA; Verde, PE; Stoecklein, NH; Knoefel, WT				Krieg, Andreas; Werner, Thomas A.; Verde, Pablo E.; Stoecklein, Nikolas H.; Knoefel, Wolfram T.			Prognostic and Clinicopathological Significance of Survivin in Colorectal Cancer: A Meta-Analysis	PLOS ONE			English	Article							ANTI-APOPTOSIS GENE; COLON-CANCER; GASTRIC CARCINOMAS; ANTIAPOPTOSIS GENE; ADJUVANT THERAPY; SPLICE VARIANTS; MESSENGER-RNA; EXPRESSION; ADENOCARCINOMA; LOCALIZATION	Survivin/BIRC5 is a potentially interesting prognostic marker and therapeutic target in colorectal cancer (CRC). However, the available data on survivin expression in CRC are heterogeneous. Thus, to clarify the prognostic relevance of survivin in patients with CRC and its association with clinicopathological parameters we performed a meta-analysis. We screened PubMed and EMBASE for those studies that investigated the prognostic value of survivin and its association with clinicopathological parameters in CRC. Data from eligible studies were extracted and included into the meta-analyses using a random effects model. Electronical literature search identified 15 studies including 1934 patients with CRC mostly detecting survivin by immunohistochemistry (IHC). Pooled hazard ratios of 11 studies that performed survival analysis revealed a positive correlation between survivin expression and poor prognosis (HR 1.93; 95% CI: 1.55-2.42; P<0.00001; I-2 = 23%). Subgroup analyses with respect to the detection method, HR estimation, global quality score and the country of origin in which the study was conducted supported the stability of this observation. In addition, meta-analyses revealed a significant association between expression of survivin and the presence of lymph node metastases (OR: 0.37; 95% CI: 0.19-0.75; I-2 = 61%) or blood vessel invasion (OR: 0.50; 95% CI: 0.28-0.90; I-2 = 0%). Expression of survivin indicates poor prognosis and a pro-metastatic phenotype and may be useful in identifying a subgroup of patients that could benefit from a targeted therapy against survivin in CRC.	[Krieg, Andreas; Werner, Thomas A.; Stoecklein, Nikolas H.; Knoefel, Wolfram T.] Univ Dusseldorf, Dept Surg A, Dusseldorf, Germany; [Krieg, Andreas; Werner, Thomas A.; Verde, Pablo E.; Stoecklein, Nikolas H.; Knoefel, Wolfram T.] Univ Hosp Duesseldorf, Dusseldorf, Germany; [Verde, Pablo E.] Univ Dusseldorf, Coordinat Ctr Clin Trials, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Krieg, A (corresponding author), Univ Dusseldorf, Dept Surg A, Dusseldorf, Germany.	andreas.krieg@med.uni-duesseldorf.de	Verde, Pablo Emilio/AAH-5462-2019		Deutsche Forschungsgemeinschaft DFG [KR3496/2-1]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	The study was in part supported by the Deutsche Forschungsgemeinschaft DFG (KR3496/2-1 to AK). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Hameed Amany, 2005, J Egypt Natl Canc Inst, V17, P42; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Bacolod MD, 2011, ANN SURG ONCOL, V18, P3694, DOI 10.1245/s10434-011-1615-5; Chang GJ, 2007, J NATL CANCER I, V99, P433, DOI 10.1093/jnci/djk092; Cheng Q, 2011, INT J BIOCH MOL BIOL, V3, P179; Cheson BD, 2011, CANCER, V118, P3128; Chok KSH, 2007, WORLD J SURG, V31, P1485, DOI 10.1007/s00268-007-9089-0; Chu XY, 2012, J SURG ONCOL, V105, P520, DOI 10.1002/jso.22134; de Almagro M. C., 2012, Experimental Oncology, V34, P200; de Gramont A, 2006, SEMIN ONCOL, V33, pS42, DOI 10.1053/j.seminoncol.2006.10.006; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dohi T, 2004, J BIOL CHEM, V279, P34087, DOI 10.1074/jbc.C400236200; Egger E, 1997, LANCET, V350, P326, DOI 10.1016/S0140-6736(97)02419-7; El Zouhairi Majed, 2011, Gastrointest Cancer Res, V4, P15; Ferlay J, INT J CANC, V127, P2893; Gill S, 2004, J CLIN ONCOL, V22, P1797, DOI 10.1200/JCO.2004.09.059; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hori M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055710; Hsiao HL, 2006, CARCINOGENESIS, V27, P936, DOI 10.1093/carcin/bgi316; Huang LN, 2013, MOL BIOL REP, V40, P917, DOI 10.1007/s11033-012-2132-8; Idenoue S, 2005, CLIN CANCER RES, V11, P1474, DOI 10.1158/1078-0432.CCR-03-0817; Ikeguchi M, 2002, DIAGN MOL PATHOL, V11, P33, DOI 10.1097/00019606-200203000-00007; Kalliakmanis JG, 2010, DIGEST DIS SCI, V55, P2958, DOI 10.1007/s10620-009-1088-6; Kawasaki H, 1998, CANCER RES, V58, P5071; Kim PJ, 2003, LANCET, V362, P205, DOI 10.1016/S0140-6736(03)13910-4; Knutsen A, 2004, INT J RADIAT ONCOL, V60, P149, DOI 10.1016/j.ijrobp.2004.02.007; Krieg A, 2002, BRIT J CANCER, V86, P737, DOI 10.1038/sj.bjc.6600153; Lam AKY, 2008, HUM PATHOL, V39, P1229, DOI 10.1016/j.humpath.2008.01.001; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lee YY, 2009, DIS MARKERS, V26, P9, DOI [10.3233/DMA-2009-0598, 10.1155/2009/821543]; Li CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044764; Li FZ, 2005, INT J CANCER, V114, P509, DOI 10.1002/ijc.20768; Liang QL, 2009, J ZHEJIANG UNIV-SC B, V10, P675, DOI 10.1631/jzus.B0920077; Lin LJ, 2003, WORLD J GASTROENTERO, V9, P974; Lu CD, 1998, CANCER RES, V58, P1808; Mahotka C, 2002, CELL DEATH DIFFER, V9, P1334, DOI 10.1038/sj.cdd.4401091; Mahotka C, 2002, INT J CANCER, V100, P30, DOI 10.1002/ijc.10450; Mehrotra S, CANC CELL, V17, P53; Monzo M, 1999, J CLIN ONCOL, V17, P2100, DOI 10.1200/JCO.1999.17.7.2100; Qi GY, 2009, ONCOL REP, V22, P557, DOI 10.3892/or_00000471; Sarela AI, 2000, GUT, V46, P645, DOI 10.1136/gut.46.5.645; Skoufias DA, 2000, J CELL BIOL, V151, P1575, DOI 10.1083/jcb.151.7.1575; Sobin LH, 2001, CANCER, V92, P452, DOI 10.1002/1097-0142(20010715)92:2<452::AID-CNCR1342>3.0.CO;2-B; Steels E, 2001, EUR RESPIR J, V18, P705, DOI 10.1183/09031936.01.00062201; Takasu C, 2012, INT J CLIN ONCOL; Tolcher AW, 2012, ANN ONCOL, V23, P968, DOI 10.1093/annonc/mdr353; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487; Wang Guo-Qiang, 2009, Ai Zheng, V28, P945; Xi RC, 2011, ONKOLOGIE, V34, P428, DOI 10.1159/000331132; Xiaoyuan C, 2012, IRISH J MED SCI, V179, P327; Zhang LQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034100; Zhang T, 2001, CANCER RES, V61, P8664; Zhang T, 2010, AM J PATHOL, V177, P2816, DOI 10.2353/ajpath.2010.100047	53	38	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65338	10.1371/journal.pone.0065338	http://dx.doi.org/10.1371/journal.pone.0065338			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755220	gold, Green Published			2022-12-27	WOS:000319872300076
J	Liao, Y; Miao, DM; Huan, Y; Yin, H; Xi, YB; Liu, XF				Liao, Yang; Miao, Danmin; Huan, Yi; Yin, Hong; Xi, Yibin; Liu, Xufeng			Altered Regional Homogeneity with Short-term Simulated Microgravity and Its Relationship with Changed Performance in Mental Transformation	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY MRI; PROLONGED WEIGHTLESSNESS; RESPONSE-INHIBITION; FRONTAL-CORTEX; BODY PARTS; BRAIN; ROTATION; FMRI; NETWORKS; SYSTEM	In order to further the insight into the explanation of changed performance in mental transformation under microgravity, we discuss the change of performance in mental transformation and its relationship with altered regional homogeneity (ReHo) in resting-state brain by using simulated weightlessness model. Twelve male subjects with age between 24 and 31 received resting-state fMRI scan and mental transformation test both in normal condition and immediately after 72 hours -6 degrees head down tilt (HDT). A paired sample t-test was used to test the difference of behavior performance and brain activity between these two conditions. Compare with normal condition, subjects showed a changed performance in mental transformation with short term simulated microgravity and appeared to be falling. Meanwhile, decreased ReHo were found in right inferior frontal gyrus (IFG) and left inferior parietal lobule (IPL) after 72 hours -6 degrees HDT, while increased ReHo were found in bilateral medial frontal gyrus (MFG) and left superior frontal gyrus (SFG) (P<0.05, corrected). Particularly, there was a significant correlation between ReHo values in left IPL and velocity index of mental transformation. Our findings indicate that gravity change may disrupt the function of right IFG and left IPL in the resting-state, among of which functional change in left IPL may contribute to changed abilities of mental transformation. In addition, the enhanced activity of the bilateral MFG and decreased activity of right IFG found in the current study maybe reflect a complementation effect on inhibitory control process.	[Liao, Yang; Miao, Danmin; Liu, Xufeng] Fourth Mil Med Univ, Dept Psychol, Xian 710032, Shaanxi, Peoples R China; [Huan, Yi; Yin, Hong; Xi, Yibin] Fourth Mil Med Univ, Xijing Hosp, Dept Radiol, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Miao, DM (corresponding author), Fourth Mil Med Univ, Dept Psychol, Xian 710032, Shaanxi, Peoples R China.	psych@fmmu.edu.cn; lllfmmu@fmmu.edu.cn	Yin, Hong/AAC-5784-2020; Yin, Hong/G-3877-2014; Liao, Yang/A-6479-2016	Yin, Hong/0000-0002-5215-1455; Liao, Yang/0000-0003-0969-235X	National Science Foundation of China [81071616, 81272174]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China, Grant No. 81071616 and No. 81272174. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; BAISCH F, 1992, ACTA PHYSIOL SCAND, V144, P1; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Crone EA, 2006, CEREB CORTEX, V16, P475, DOI 10.1093/cercor/bhi127; Cutini S, 2008, NEUROIMAGE, V42, P945, DOI 10.1016/j.neuroimage.2008.05.013; Dalecki M, 2012, HUM MOVEMENT SCI, V31, P1151, DOI 10.1016/j.humov.2011.12.001; Dehaene S, 2003, P NATL ACAD SCI USA, V100, P8520, DOI 10.1073/pnas.1332574100; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Eddy DR, 1998, ACTA ASTRONAUT, V43, P193, DOI 10.1016/S0094-5765(98)00154-4; Grabherr L, 2007, J VESTIBUL RES-EQUIL, V17, P279; Grigoriev A I, 1992, Adv Space Biol Med, V2, P1, DOI 10.1016/S1569-2574(08)60016-7; Horn NR, 2003, NEUROPSYCHOLOGIA, V41, P1959, DOI 10.1016/S0028-3932(03)00077-0; Jenkin MR, 2011, SEEING PERCEIVING, V24, P53, DOI 10.1163/187847511X555292; Kendall M.G., 1990, RANK CORRELATION MET, V5th; Kosslyn SM, 1998, PSYCHOPHYSIOLOGY, V35, P151, DOI 10.1017/S0048577298001516; Leone G, 1995, ACTA ASTRONAUT, V36, P743, DOI 10.1016/0094-5765(95)00165-4; Liang PP, 2011, CLIN NEUROPHYSIOL, V122, P121, DOI 10.1016/j.clinph.2010.05.026; Liao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052558; Lin XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043373; Liu CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048181; Liu DQ, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00024; Martino J, 2011, NEUROSCIENCE, V179, P131, DOI 10.1016/j.neuroscience.2011.01.047; MATSAKIS Y, 1993, EXP BRAIN RES, V94, P152; McLellan TL, 2012, NEUROSCI LETT, V531, P149, DOI 10.1016/j.neulet.2012.10.039; Messerotti Benvenuti S, 2011, PHYSIOL BEHAV, V104, P503, DOI 10.1016/j.physbeh.2011.05.019; Morphew M.E., 2001, MCGILL J MED, V6, P74; Newberg AB, 1998, ADV SPACE RES-SERIES, V22, P185, DOI 10.1016/S0273-1177(98)80010-0; Ni L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042016; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1990, MAGNET RESON MED, V14, P68, DOI 10.1002/mrm.1910140108; Overney  LS, 2005, COGNITIVE BRAIN RES, V25, P722, DOI 10.1016/j.cogbrainres.2005.09.024; Palinkas L A, 2001, Gravit Space Biol Bull, V14, P25; Pattyn N, 2009, ACTA ASTRONAUT, V65, P325, DOI 10.1016/j.actaastro.2009.01.063; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Qiu CJ, 2011, PSYCHIAT RES-NEUROIM, V194, P47, DOI 10.1016/j.pscychresns.2011.01.010; RAU H, 1993, PSYCHOPHYSIOLOGY, V30, P322, DOI 10.1111/j.1469-8986.1993.tb03359.x; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rubia K, 2003, NEUROIMAGE, V20, P351, DOI 10.1016/S1053-8119(03)00275-1; Sandal G M, 2001, Gravit Space Biol Bull, V14, P47; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Slagter HA, 2006, COGN AFFECT BEHAV NE, V6, P175, DOI 10.3758/CABN.6.3.175; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Talairach J., 1988, COPLANAR STEREOTAXIC; Vaitl D, 1996, BIOL PSYCHOL, V42, P87, DOI 10.1016/0301-0511(95)05148-1; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Villard E, 2005, NEUROREPORT, V16, P1395, DOI 10.1097/01.wnr.0000174060.34274.3e; Vingerhoets G, 2002, NEUROIMAGE, V17, P1623, DOI 10.1006/nimg.2002.1290; Wang DY, 2012, NEUROREPORT, V23, P873, DOI 10.1097/WNR.0b013e3283587c96; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; You H, 2011, NEUROSCI LETT, V502, P18, DOI 10.1016/j.neulet.2011.07.015; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zou QH, 2013, HUM BRAIN MAPP, V34, P3204, DOI 10.1002/hbm.22136; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017	57	14	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64931	10.1371/journal.pone.0064931	http://dx.doi.org/10.1371/journal.pone.0064931			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755162	Green Submitted, Green Published, gold			2022-12-27	WOS:000319872300039
J	Ellerbe, CN; Gebregziabher, M; Korte, JE; Mauldin, J; Hunt, KJ				Ellerbe, Caitlyn N.; Gebregziabher, Mulugeta; Korte, Jeffrey E.; Mauldin, Jill; Hunt, Kelly J.			Quantifying the Impact of Gestational Diabetes Mellitus, Maternal Weight and Race on Birthweight via Quantile Regression	PLOS ONE			English	Article							PIMA-INDIANS; INTRAUTERINE ENVIRONMENT; PREGNANCY OUTCOMES; GLUCOSE-TOLERANCE; NORTH-CAROLINA; WHITE INFANTS; UNITED-STATES; RISK-FACTORS; WOMEN; BLACK	Background: Quantile regression, a robust semi-parametric approach, was used to examine the impact of gestational diabetes mellitus (GDM) across birthweight quantiles with a focus on maternal prepregnancy body mass index (BMI) and gestational weight gain (GWG). Methods: Using linked birth certificate, inpatient hospital and prenatal claims data we examined live singleton births to non-Hispanic white (NHW, 135,119) and non-Hispanic black (NHB, 76,675) women in South Carolina who delivered 28-44 weeks gestation in 2004-2008. Results: At a maternal BMI of 30 kg/m(2) at the 90th quantile of birthweight, exposure to GDM was associated with birthweights 84 grams (95% CI 57, 112) higher in NHW and 132 grams (95% CI: 104, 161) higher in NHB. Results at the 50th quantile were 34 grams (95% CI: 17, 51) and 78 grams (95% CI: 56, 100), respectively. At a maternal GWG of 13.5 kg at the 90th quantile of birthweight, exposure to GDM was associated with birthweights 83 grams (95% CI: 57, 109) higher in NHW and 135 grams (95% CI: 103, 167) higher in NHB. Results at the 50th quantile were 55 grams (95% CI: 40, 71) and 69 grams (95% CI: 46, 92), respectively. Summary: Our findings indicate that GDM, maternal prepregnancy BMI and GWG increase birthweight more in NHW and NHB infants who are already at the greatest risk of macrosomia or being large for gestational age (LGA), that is those at the 90th rather than the median of the birthweight distribution.	[Ellerbe, Caitlyn N.; Gebregziabher, Mulugeta; Korte, Jeffrey E.; Hunt, Kelly J.] Med Univ S Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Gebregziabher, Mulugeta; Hunt, Kelly J.] Med Univ S Carolina, Ctr Hlth Dispar Res, Charleston, SC 29425 USA; [Mauldin, Jill] Med Univ S Carolina, Dept Obstet & Gynecol, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Hunt, KJ (corresponding author), Med Univ S Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA.	huntke@musc.edu		Gebregziabher, Mulugeta/0000-0002-4826-481X; Meinzer, Caitlyn/0000-0002-9905-4329	National Center on Minority Health and Health Disparities [R01-MD004251]; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [R01MD004251] Funding Source: NIH RePORTER	National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by a grant from the National Center on Minority Health and Health Disparities (R01-MD004251). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrevaya J., 2001, EMPIR ECON, V26, P247, DOI DOI 10.1007/S001810000052; Alexander G R, 1999, Matern Child Health J, V3, P71, DOI 10.1023/A:1021849209722; Alexander GR, 1996, PUBLIC HEALTH REP, V111, P408; Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; BERKOWITZ GS, 1992, AM J EPIDEMIOL, V135, P965, DOI 10.1093/oxfordjournals.aje.a116408; Boardman JD, 2002, DEMOGRAPHY, V39, P353, DOI 10.2307/3088343; BUESCHER PA, 1993, AM J PUBLIC HEALTH, V83, P1163, DOI 10.2105/AJPH.83.8.1163; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; DelPriore G, 1997, OBSTET GYNECOL, V89, P351, DOI 10.1016/S0029-7844(96)00504-2; DORNHORST A, 1992, DIABETIC MED, V9, P820, DOI 10.1111/j.1464-5491.1992.tb01900.x; FREINKEL N, 1980, DIABETES, V29, P1023, DOI 10.2337/diabetes.29.12.1023; Froslie KF, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-103; Gaete X, 2010, FERTIL STERIL, V94, P1822, DOI 10.1016/j.fertnstert.2009.08.039; Gebregziabher M, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-88; Goldenberg RL, 1996, AM J OBSTET GYNECOL, V175, P1317, DOI 10.1016/S0002-9378(96)70048-0; HANSON RL, 1995, AM J HUM GENET, V57, P160; Huber LRB, 2007, MATERN CHILD HLTH J, V11, P137, DOI 10.1007/s10995-006-0157-0; Hunt KJ, 2012, DIABETOLOGIA; Hunt KJ, 2012, MATERN CHILD HLTH J; *I MED NAT RES COU, 2009, WEIGHT GAIN PREGN RE; Kieffer EC, 1998, AM J EPIDEMIOL, V147, P1053; Kim SY, 2011, EXP DIABETES RES, DOI 10.1155/2011/541308; KOENKER R., 2010, QUANTREG QUANTILE RE; KRAMER MS, 1988, JAMA-J AM MED ASSOC, V260, P3306, DOI 10.1001/jama.260.22.3306; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Lawrence JM, 2008, DIABETES CARE, V31, P899, DOI 10.2337/dc07-2345; Lederman S A, 1998, Matern Child Health J, V2, P123; Lydon-Rochelle MT, 2005, AM J OBSTET GYNECOL, V193, P125, DOI 10.1016/j.ajog.2005.02.096; Metzger BE, 2010, BJOG-INT J OBSTET GY, V117, P575, DOI 10.1111/j.1471-0528.2009.02486.x; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Miller DR, 2004, DIABETES CARE, V27, pB10, DOI 10.2337/diacare.27.suppl_2.B10; Oken E, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.11.027; Oken Emily, 2003, BMC Pediatr, V3, P6, DOI 10.1186/1471-2431-3-6; OSULLIVAN JB, 1966, OBSTET GYNECOL, V27, P683; Park S, 2009, MATERN CHILD HLTH J; PETTITT DJ, 1980, DIABETES CARE, V3, P458, DOI 10.2337/diacare.3.3.458; PETTITT DJ, 1988, DIABETES, V37, P622, DOI 10.2337/diabetes.37.5.622; Pettitt DJ, 1998, DIABETES CARE, V21, pB138; PETTITT DJ, 1987, DIABETES CARE, V10, P76, DOI 10.2337/diacare.10.1.76; R Development Core Team R, 2009, R LANG ENV STAT COMP; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Saldana TM, 2003, DIABETES CARE, V26, P656, DOI 10.2337/diacare.26.3.656; Scholl TO, 2002, AM J EPIDEMIOL, V156, P498, DOI 10.1093/aje/kwf080; SILVERMAN BL, 1991, DIABETES, V40, P121, DOI 10.2337/diab.40.2.S121; Singh KA, 2010, OBSTET GYNECOL, V115, P998, DOI 10.1097/AOG.0b013e3181da901a; Solomon CG, 1997, JAMA-J AM MED ASSOC, V278, P1078, DOI 10.1001/jama.278.13.1078; Strotmeyer ES, 2003, DIABETES CARE, V26, P1016, DOI 10.2337/diacare.26.4.1016; Terry MB, 2007, AM J EPIDEMIOL, V166, P5, DOI 10.1093/aje/kwm094; Wei Y, 2006, STAT MED, V25, P1369, DOI 10.1002/sim.2271; WILCOX A, 1990, J PEDIATR-US, V116, P7, DOI 10.1016/S0022-3476(05)81638-5; ZHANG SM, 1995, BRIT MED J, V311, P1139, DOI 10.1136/bmj.311.7013.1139	51	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65017	10.1371/journal.pone.0065017	http://dx.doi.org/10.1371/journal.pone.0065017			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762279	gold, Green Published, Green Submitted			2022-12-27	WOS:000320440500018
J	Gaines, TA; Wright, AA; Molin, WT; Lorentz, L; Riggins, CW; Tranel, PJ; Beffa, R; Westra, P; Powles, SB				Gaines, Todd A.; Wright, Alice A.; Molin, William T.; Lorentz, Lothar; Riggins, Chance W.; Tranel, Patrick J.; Beffa, Roland; Westra, Philip; Powles, Stephen B.			Identification of Genetic Elements Associated with EPSPS Gene Amplification	PLOS ONE			English	Article							5-ENOLPYRUVYLSHIKIMATE-3-PHOSPHATE SYNTHASE; TRANSPOSABLE ELEMENTS; INSECTICIDE RESISTANCE; GLYPHOSATE RESISTANCE; ARABIDOPSIS-THALIANA; LTR-RETROTRANSPOSONS; EVOLUTION; GENOME; MITES; EXPRESSION	Weed populations can have high genetic plasticity and rapid responses to environmental selection pressures. For example, 100-fold amplification of the 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) gene evolved in the weed species Amaranthus palmeri to confer resistance to glyphosate, the world's most important herbicide. However, the gene amplification mechanism is unknown. We sequenced the EPSPS gene and genomic regions flanking EPSPS loci in A. palmeri, and searched for mobile genetic elements or repetitive sequences. The EPSPS gene was 10,229 bp, containing 8 exons and 7 introns. The gene amplification likely proceeded through a DNA-mediated mechanism, as introns exist in the amplified gene copies and the entire amplified sequence is at least 30 kb in length. Our data support the presence of two EPSPS loci in susceptible (S) A. palmeri, and that only one of these was amplified in glyphosate-resistant (R) A. palmeri. The EPSPS gene amplification event likely occurred recently, as no sequence polymorphisms were found within introns of amplified EPSPS copies from R individuals. Sequences with homology to miniature inverted-repeat transposable elements (MITEs) were identified next to EPSPS gene copies only in R individuals. Additionally, a putative Activator (Ac) transposase and a repetitive sequence region were associated with amplified EPSPS genes. The mechanism controlling this DNA-mediated amplification remains unknown. Further investigation is necessary to determine if the gene amplification may have proceeded via DNA transposon-mediated replication, and/or unequal recombination between different genomic regions resulting in replication of the EPSPS gene.	[Gaines, Todd A.; Powles, Stephen B.] Univ Western Australia, Sch Plant Biol, Australian Herbicide Resistance Initiat, Crawley, WA, Australia; [Gaines, Todd A.; Lorentz, Lothar; Beffa, Roland] Bayer CropSci, Weed Resistance Res, Frankfurt, Germany; [Wright, Alice A.; Molin, William T.] USDA, Crop Prod Syst Res Unit, Agr Res Serv, Stoneville, MS USA; [Riggins, Chance W.; Tranel, Patrick J.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Westra, Philip] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA	University of Western Australia; Bayer AG; Bayer CropScience; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign; Colorado State University	Gaines, TA (corresponding author), Univ Western Australia, Sch Plant Biol, Australian Herbicide Resistance Initiat, Crawley, WA, Australia.	todd.gaines@uwa.edu.au	Gaines, Todd/A-8998-2008; Tranel, Patrick J/AGW-1507-2022	Gaines, Todd/0000-0003-1485-7665; Tranel, Patrick J/0000-0003-0666-4564; Riggins, Chance/0000-0002-1926-022X; Westra, Philip/0000-0001-8488-8833; powles, stephen/0000-0001-6375-1977	United States Department of Agriculture-Agricultural Research Service (USDA-ARS) [6402-21000-050-00D]	United States Department of Agriculture-Agricultural Research Service (USDA-ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported in part by United States Department of Agriculture-Agricultural Research Service (USDA-ARS) project number 6402-21000-050-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	AMRHEIN N, 1980, NATURWISSENSCHAFTEN, V67, P356, DOI 10.1007/BF01106593; [Anonymous], GEN VERS 5 4; Bass C, 2011, PEST MANAG SCI, V67, P886, DOI 10.1002/ps.2189; Blackman RL, 1999, HEREDITY, V82, P180, DOI 10.1038/sj.hdy.6884580; Burgos NR, 2008, U ARKANSAS AGR EXPT, V573, P103; Casacuberta JM, 2003, GENE, V311, P1, DOI 10.1016/S0378-1119(03)00557-2; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Duke SO, 2008, PEST MANAG SCI, V64, P319, DOI 10.1002/ps.1518; ENGELS WR, 1990, CELL, V62, P515, DOI 10.1016/0092-8674(90)90016-8; Fedoroff N, 1989, MOBILE DNA, P377; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Flagel LE, 2009, NEW PHYTOL, V183, P557, DOI 10.1111/j.1469-8137.2009.02923.x; Gaines TA, 2012, EVOL APPL, V5, P29, DOI 10.1111/j.1752-4571.2011.00204.x; Gaines TA, 2011, J AGR FOOD CHEM, V59, P5886, DOI 10.1021/jf104719k; Gaines TA, 2010, P NATL ACAD SCI USA, V107, P1029, DOI 10.1073/pnas.0906649107; GASSER CS, 1988, J BIOL CHEM, V263, P4280; Hastings PJ, 2007, CRIT REV BIOCHEM MOL, V42, P271, DOI 10.1080/10409230701507757; Hyppa RW, 2010, CELL, V142, P243, DOI 10.1016/j.cell.2010.05.041; Itokawa K, 2010, INSECT BIOCHEM MOLEC, V40, P631, DOI 10.1016/j.ibmb.2010.06.001; Jiang N, 2004, NATURE, V431, P569, DOI 10.1038/nature02953; Jiang N, 2003, NATURE, V421, P163, DOI 10.1038/nature01214; KLEE HJ, 1987, MOL GEN GENET, V210, P437, DOI 10.1007/BF00327194; Lee RM, 2009, WEED SCI, V57, P463, DOI 10.1614/WS-09-021.1; LISCH D, 1995, GENETICS, V139, P1777; Lu C, 2012, MOL BIOL EVOL, V29, P1005, DOI 10.1093/molbev/msr282; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; MCCLINTOCK B, 1951, COLD SPRING HARB SYM, V16, P13, DOI 10.1101/SQB.1951.016.01.004; MOUCHES C, 1990, P NATL ACAD SCI USA, V87, P2574, DOI 10.1073/pnas.87.7.2574; Naito K, 2006, P NATL ACAD SCI USA, V103, P17620, DOI 10.1073/pnas.0605421103; Naito K, 2009, NATURE, V461, P1130, DOI 10.1038/nature08479; Ouyang S, 2004, NUCLEIC ACIDS RES, V32, pD360, DOI 10.1093/nar/gkh099; Rayburn AL, 2005, CROP SCI, V45, P2557, DOI 10.2135/cropsci2005.0163; Salas RA, 2012, PEST MANAG SCI, V68, P1223, DOI 10.1002/ps.3342; Sandegren L, 2009, NAT REV MICROBIOL, V7, P578, DOI 10.1038/nrmicro2174; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; Sarilar V, 2011, PLANT MOL BIOL, V77, P59, DOI 10.1007/s11103-011-9794-9; SCHIMKE RT, 1986, CANCER, V57, P1912, DOI 10.1002/1097-0142(19860515)57:10<1912::AID-CNCR2820571004>3.0.CO;2-O; Schmidt JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000998; SHAH DM, 1986, SCIENCE, V233, P478, DOI 10.1126/science.233.4762.478; Slack A, 2006, PLOS GENET, V2, P385, DOI 10.1371/journal.pgen.0020048; SUH H, 1993, PLANT MOL BIOL, V22, P195, DOI 10.1007/BF00014928; Tranel PJ, 2011, J AGR FOOD CHEM, V59, P5808, DOI 10.1021/jf103797n; Watanabe T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr442; WESSLER SR, 1995, CURR OPIN GENET DEV, V5, P814, DOI 10.1016/0959-437X(95)80016-X; Yu ZH, 2000, GENETICS, V156, P2019	46	42	44	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65819	10.1371/journal.pone.0065819	http://dx.doi.org/10.1371/journal.pone.0065819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762434	Green Submitted, Green Published, gold			2022-12-27	WOS:000320440500051
J	Lin, YH; Lin, SH; Li, P; Huang, WL; Chen, CY				Lin, Yu-Hsuan; Lin, Sheng-Hsuan; Li, Peng; Huang, Wei-Lieh; Chen, Ching-Yen			Prevalent Hallucinations during Medical Internships: Phantom Vibration and Ringing Syndromes	PLOS ONE			English	Article							TRIDIMENSIONAL PERSONALITY QUESTIONNAIRE; POSTTRAUMATIC-STRESS-DISORDER; AUDITORY HALLUCINATIONS; SCHIZOPHRENIA; EXPERIENCES; INVENTORY; ANXIETY; REWARD; MODEL	Background: Phantom vibration syndrome is a type of hallucination reported among mobile phone users in the general population. Another similar perception, phantom ringing syndrome, has not been previously described in the medical literature. Methods: A prospective longitudinal study of 74 medical interns (46 males, 28 females; mean age, 24.8 +/- 1.2 years) was conducted using repeated investigations of the prevalence and associated factors of phantom vibration and ringing. The accompanying symptoms of anxiety and depression were evaluated with the Beck Anxiety and Depression Inventories before the internship began, and again at the third, sixth, and twelfth internship months, and two weeks after the internship ended. Results: The baseline prevalence of phantom vibration was 78.1%, which increased to 95.9% and 93.2% in the third and sixth internship months. The prevalence returned to 80.8% at the twelfth month and decreased to 50.0% 2 weeks after the internship ended. The baseline prevalence of phantom ringing was 27.4%, which increased to 84.9%, 87.7%, and 86.3% in the third, sixth, and twelfth internship months, respectively. This returned to 54.2% two weeks after the internship ended. The anxiety and depression scores also increased during the internship, and returned to baseline two weeks after the internship. There was no significant correlation between phantom vibration/ringing and symptoms of anxiety or depression. The incidence of both phantom vibration and ringing syndromes significantly increased during the internship, and subsequent recovery. Conclusion: This study suggests that phantom vibration and ringing might be entities that are independent of anxiety or depression during evaluation of stress-associated experiences during medical internships.	[Lin, Yu-Hsuan; Huang, Wei-Lieh] Natl Taiwan Univ Hosp, Dept Psychiat, Yun Lin Branch, Yunlin, Taiwan; [Lin, Sheng-Hsuan] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Li, Peng; Chen, Ching-Yen] Chang Gung Univ, Sch Med, Tao Yuan, Taiwan; [Li, Peng; Chen, Ching-Yen] Chang Gung Mem Hosp Lin Kou, Dept Psychiat, Tao Yuan, Taiwan	National Taiwan University; National Taiwan University Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Chang Gung University; Chang Gung Memorial Hospital	Chen, CY (corresponding author), Chang Gung Univ, Sch Med, Tao Yuan, Taiwan.	psycychen@yahoo.com.tw	Huang, Wei-Lieh/AAB-4851-2022	Lin, Sheng-Hsuan/0000-0003-0714-2354; Lin, Yu-Hsuan/0000-0001-9393-3886	National Science Council in Taiwan [NSC 100-2815-C-182A-002-B]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a grant from the National Science Council in Taiwan (NSC 100-2815-C-182A-002-B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman A, 2003, SCHIZOPHR RES, V64, P175, DOI 10.1016/S0920-9964(03)00060-4; Baillie DWH, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d299; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bermpohl F, 2008, PSYCHIAT RES-NEUROIM, V164, P81, DOI 10.1016/j.pscychresns.2007.12.019; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Camm AJ, 1996, CIRCULATION, V93, P1043; Che HH, 2006, FORMOSAN J MED, V10, P447, DOI DOI 10.6320/FJM.2006.10(4).05; Chen WJ, 2002, COMPR PSYCHIAT, V43, P158, DOI 10.1053/comp.2002.30797; CLONINGER CR, 1986, PSYCHIAT DEV, V4, P167; CLONINGER CR, 1991, PSYCHOL REP, V69, P1047, DOI 10.2466/PR0.69.7.1047-1057; Cotter D, 2002, BRIT J PSYCHIAT, V181, P363, DOI 10.1192/bjp.181.5.363; EYSENCK HJ, 1992, PERS INDIV DIFFER, V13, P757, DOI 10.1016/0191-8869(92)90050-Y; Heinz A, 1999, NERVENARZT, V70, P391, DOI 10.1007/s001150050454; Javitt DC, 2008, NAT REV DRUG DISCOV, V7, P68, DOI 10.1038/nrd2463; Langer AI, 2011, INT J PSYCHOL, V46, P46, DOI 10.1080/00207594.2010.503760; Lin YH, 2013, PSYCHOPHYSIOLOGY, V50, P521, DOI 10.1111/psyp.12038; Lin YH, 2012, STRESS, V15, P21, DOI 10.3109/10253890.2011.572208; MUESER KT, 1987, AM J PSYCHIAT, V144, P299; PENNEBAKER JW, 1981, J PERS SOC PSYCHOL, V41, P213, DOI 10.1037/0022-3514.41.2.213; Read J, 2005, ACTA PSYCHIAT SCAND, V112, P330, DOI 10.1111/j.1600-0447.2005.00634.x; REES WD, 1971, BRIT MED J, V4, P37, DOI 10.1136/bmj.4.5778.37; Rothberg MB, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6914; SHEK DTL, 1990, J CLIN PSYCHOL, V46, P35, DOI 10.1002/1097-4679(199001)46:1<35::AID-JCLP2270460106>3.0.CO;2-W; Shizgal P, 1997, CURR OPIN NEUROBIOL, V7, P198, DOI 10.1016/S0959-4388(97)80008-6; Steel C, 2011, J NERV MENT DIS, V199, P709, DOI 10.1097/NMD.0b013e318229d6e8; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; van Os J, 2005, CURR OPIN PSYCHIATR, V18, P141, DOI 10.1097/00001504-200503000-00006; Vellante M, 2012, J NERV MENT DIS, V200, P310, DOI 10.1097/NMD.0b013e31824cb2ba; Waters F, 2012, SCHIZOPHRENIA BULL, V38, P683, DOI 10.1093/schbul/sbs045; Welham J, 2009, SCHIZOPHRENIA BULL, V35, P603, DOI 10.1093/schbul/sbn084; WILCOX J, 1991, COMPR PSYCHIAT, V32, P320, DOI 10.1016/0010-440X(91)90080-V; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	33	28	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65152	10.1371/journal.pone.0065152	http://dx.doi.org/10.1371/journal.pone.0065152			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	164VY	23762302	Green Published, gold, Green Submitted			2022-12-27	WOS:000320440500029
J	Liu, CF; Breidenbach, A; Aschbacher-Smith, L; Butler, D; Wylie, C				Liu, Chia-Feng; Breidenbach, Andrew; Aschbacher-Smith, Lindsey; Butler, David; Wylie, Christopher			A Role for Hedgehog Signaling in the Differentiation of the Insertion Site of the Patellar Tendon in the Mouse	PLOS ONE			English	Article							INDIAN-HEDGEHOG; ARTICULAR-CARTILAGE; ACHILLES-TENDON; GENE-EXPRESSION; CELL-MIGRATION; GROWTH; BONE; PATHWAY; OSTEOARTHRITIS; CHONDROCYTES	Tendons are typically composed of two histologically different regions: the midsubstance and insertion site. We previously showed that Gli1, a downstream effector of the hedgehog (Hh) signaling pathway, is expressed only in the insertion site of the mouse patellar tendon during its differentiation. To test for a functional role of Hh signaling, we targeted the Smoothened (Smo) gene in vivo using a Cre/Lox system. Constitutive activation of the Hh pathway in the mid-substance caused molecular markers of the insertion site, e. g. type II collagen, to be ectopically expressed or up-regulated in the midsubstance. This was confirmed using a novel organ culture method in vitro. Conversely, when Smo was excised in the scleraxis-positive cell population, the development of the fibrocartilaginous insertion site was affected. Whole transcriptome analysis revealed that the expression of genes involved in chondrogenesis and mineralization was down-regulated in the insertion site, and expression of insertion site markers was decreased. Biomechanical testing of murine adult patellar tendon, which developed in the absence of Hh signaling, showed impairment of tendon structural properties (lower linear stiffness and greater displacement) and material properties (greater strain), although the linear modulus of the mutant group was not significantly lower than controls. These studies provide new insights into the role of Hh signaling during tendon development.	[Liu, Chia-Feng; Aschbacher-Smith, Lindsey; Wylie, Christopher] Cincinnati Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH USA; [Breidenbach, Andrew; Butler, David] Univ Cincinnati, Biomed Engn Program, Sch Energy Environm Biol & Med Engn, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati	Wylie, C (corresponding author), Cincinnati Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH USA.	christopher.wylie@cchmc.org			National Institute of Health [AR056943]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056943] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study is supported by the National Institute of Health (AR056943)(http://www.nih.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Bai CB, 2002, DEVELOPMENT, V129, P4753; Benjamin M, 2000, INT REV CYTOL, V196, P85; Benjamin M, 2009, SCAND J MED SCI SPOR, V19, P520, DOI 10.1111/j.1600-0838.2009.00906.x; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Blitz E, 2009, DEV CELL, V17, P861, DOI 10.1016/j.devcel.2009.10.010; Brunskill EW, 2012, DEV BIOL, V368, P4, DOI 10.1016/j.ydbio.2012.05.030; BUTLER DL, 1990, J BIOMECH ENG-T ASME, V112, P38, DOI 10.1115/1.2891124; Chang CF, 2012, OSTEOARTHR CARTILAGE, V20, P152, DOI 10.1016/j.joca.2011.11.009; Chiquet-Ehrismann R, 2004, INT J BIOCHEM CELL B, V36, P1085, DOI 10.1016/j.biocel.2004.01.007; Dahia CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035944; Dwyer JR, 2007, J BIOL CHEM, V282, P8959, DOI 10.1074/jbc.M611741200; Dyment NA, 2012, J ORTHOP RES, V30, P28, DOI 10.1002/jor.21484; Ehlen Harald W. A., 2006, Birth Defects Research, V78, P267, DOI 10.1002/bdrc.20076; Eliasson P, 2009, J APPL PHYSIOL, V107, P399, DOI 10.1152/japplphysiol.91563.2008; Gu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025984; Gu Y, 2009, DEVELOPMENT, V136, P1295, DOI 10.1242/dev.030619; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; Karp SJ, 2000, DEVELOPMENT, V127, P543; Koyama E, 1996, DEV DYNAM, V207, P344, DOI 10.1002/(SICI)1097-0177(199611)207:3<344::AID-AJA11>3.0.CO;2-4; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Krull CE, 1998, CURR TOP DEV BIOL, V36, P145; Kwan KM, 2002, GENESIS, V32, P49, DOI 10.1002/gene.10068; Lazarenko OP, 2006, BONE, V38, P74, DOI 10.1016/j.bone.2005.07.008; Levangie PK, 2005, JOINT STRUCTURE FUNC, V4th; Lin AC, 2009, NAT MED, V15, P1421, DOI 10.1038/nm.2055; Liu CF, 2012, TISSUE ENG PT A, V18, P598, DOI [10.1089/ten.tea.2011.0338, 10.1089/ten.TEA.2011.0338]; Liu CF, 2011, TISSUE ENG PART B-RE, V17, P165, DOI 10.1089/ten.teb.2010.0662; Molyneaux KA, 2001, DEV BIOL, V240, P488, DOI 10.1006/dbio.2001.0436; PACIFICI M, 1993, DEV DYNAM, V198, P123, DOI 10.1002/aja.1001980206; Pryce BA, 2007, DEV DYNAM, V236, P1677, DOI 10.1002/dvdy.21179; ROUGHLEY PJ, 1994, MATRIX BIOL, V14, P51, DOI 10.1016/0945-053X(94)90029-9; Sharma P., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P181; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Steinert AF, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3921; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Waggett AD, 1998, MATRIX BIOL, V16, P457, DOI 10.1016/S0945-053X(98)90017-8; Wang M, 2012, J BONE MINERAL RES O; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201	40	38	38	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65411	10.1371/journal.pone.0065411	http://dx.doi.org/10.1371/journal.pone.0065411			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762363	Green Submitted, gold, Green Published			2022-12-27	WOS:000320440500037
J	Aouida, M; Kim, K; Shaikh, AR; Pardo, JM; Eppinger, J; Yun, DJ; Bressan, RA; Narasimhan, ML				Aouida, Mustapha; Kim, Kangchang; Shaikh, Abdul Rajjak; Pardo, Jose M.; Eppinger, Joerg; Yun, Dae-Jin; Bressan, Ray A.; Narasimhan, Meena L.			A Saccharomyces cerevisiae Assay System to Investigate Ligand/AdipoR1 Interactions That Lead to Cellular Signaling	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; ISCHEMIA-REPERFUSION INJURY; ADIPONECTIN RECEPTORS; CRYSTAL-STRUCTURE; THAUMATIN-LIKE; ANTIFUNGAL PROTEIN; ENERGY-METABOLISM; FORCE-FIELD; YEAST; OSMOTIN	Adiponectin is a mammalian hormone that exerts anti-diabetic, anti-cancer and cardioprotective effects through interaction with its major ubiquitously expressed plasma membrane localized receptors, AdipoR1 and AdipoR2. Here, we report a Saccharomyces cerevisiae based method for investigating agonist-AdipoR interactions that is amenable for high-throughput scale-up and can be used to study both AdipoRs separately. Agonist-AdipoR1 interactions are detected using a split firefly luciferase assay based on reconstitution of firefly luciferase (Luc) activity due to juxtaposition of its N- and C-terminal fragments, NLuc and CLuc, by ligand induced interaction of the chimeric proteins CLuc-AdipoR1 and APPL1-NLuc (adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif 1-NLuc) in a S. cerevisiae strain lacking the yeast homolog of AdipoRs (Izh2p). The assay monitors the earliest known step in the adiponectin-AdipoR anti-diabetic signaling cascade. We demonstrate that reconstituted Luc activity can be detected in colonies or cells using a CCD camera and quantified in cell suspensions using a microplate reader. AdipoR1-APPL1 interaction occurs in absence of ligand but can be stimulated specifically by agonists such as adiponectin and the tobacco protein osmotin that was shown to have AdipoR-dependent adiponectin-like biological activity in mammalian cells. To further validate this assay, we have modeled the three dimensional structures of receptor-ligand complexes of membrane-embedded AdipoR1 with cyclic peptides derived from osmotin or osmotin-like plant proteins. We demonstrate that the calculated AdipoR1-peptide binding energies correlate with the peptides' ability to behave as AdipoR1 agonists in the split luciferase assay. Further, we demonstrate agonist-AdipoR dependent activation of protein kinase A (PKA) signaling and AMP activated protein kinase (AMPK) phosphorylation in S. cerevisiae, which are homologous to important mammalian adiponectin-AdipoR1 signaling pathways. This system should facilitate the development of therapeutic inventions targeting adiponectin and/or AdipoR physiology.	[Aouida, Mustapha; Bressan, Ray A.; Narasimhan, Meena L.] King Abdullah Univ Sci & Technol, Plant Stress Genom Res Ctr, Thuwal, Saudi Arabia; [Kim, Kangchang; Yun, Dae-Jin] Gyeongsang Natl Univ, Plant Mol Biol & Biotechnol Res Ctr, Div Appl Life Sci, Brain Korea Program 21, Jinju, South Korea; [Shaikh, Abdul Rajjak; Eppinger, Joerg] King Abdullah Univ Sci & Technol, Div Phys Sci & Engn, KAUST Catalysis Ctr, Thuwal, Saudi Arabia; [Pardo, Jose M.] CSIC, Inst Recursos Nat & Agrobiol, E-41080 Seville, Spain; [Bressan, Ray A.] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA	King Abdullah University of Science & Technology; Gyeongsang National University; King Abdullah University of Science & Technology; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS); Purdue University System; Purdue University; Purdue University West Lafayette Campus	Narasimhan, ML (corresponding author), Biowrite LLC, W Lafayette, IN USA.	biowrite.mln@gmail.com	Eppinger, Jörg/AAJ-6924-2020; Eppinger, Jörg/F-2348-2010; Pardo, Jose M./B-4652-2009; Pardo, Jose M/AAB-5866-2022; Aouida, Mustapha/AEJ-4513-2022; Shaikh, Abdul Rajjak/C-5624-2012	Eppinger, Jörg/0000-0001-7886-7059; Eppinger, Jörg/0000-0001-7886-7059; Pardo, Jose M./0000-0003-4510-8624; Pardo, Jose M/0000-0003-4510-8624; Aouida, Mustapha/0000-0001-7945-5320; Shaikh, Abdul Rajjak/0000-0003-4444-0684; Bressan, Ray/0000-0002-8754-606X; Yun, Dae-Jin/0000-0002-3638-6043	King Abullah University of Science and Technology, KAUST-GCR [FIC/2010/07]; Rural Development Administration for the Next-Generation BioGreen 21 Program (Systems and Synthetic Agrobiotech Center), Republic of South Korea [PJ008025]; Ministry of Education, Science and Technology for the World Class University (WCU) program, Republic of South Korea [R32-10148]	King Abullah University of Science and Technology, KAUST-GCR; Rural Development Administration for the Next-Generation BioGreen 21 Program (Systems and Synthetic Agrobiotech Center), Republic of South Korea; Ministry of Education, Science and Technology for the World Class University (WCU) program, Republic of South Korea	This research was supported in part by funds from King Abullah University of Science and Technology, KAUST-GCR (stipend A.R.S.: FIC/2010/07), the Rural Development Administration for the Next-Generation BioGreen 21 Program (Systems and Synthetic Agrobiotech Center, no. PJ008025), Republic of South Korea, and the Ministry of Education, Science and Technology for the World Class University (WCU) program (R32-10148), Republic of South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batalia MA, 1996, NAT STRUCT BIOL, V3, P19, DOI 10.1038/nsb0196-19; BECKER DM, 1991, METHOD ENZYMOL, V194, P182; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chen HM, 2008, PLANT PHYSIOL, V146, P368, DOI 10.1104/pp.107.111740; Dalamaga M, 2012, ENDOCR REV, V33, P547, DOI 10.1210/er.2011-1015; Deepa SS, 2009, AM J PHYSIOL-ENDOC M, V296, pE22, DOI 10.1152/ajpendo.90731.2008; Dieudonne MN, 2006, BIOCHEM BIOPH RES CO, V345, P271, DOI 10.1016/j.bbrc.2006.04.076; Edman K, 2002, STRUCTURE, V10, P473, DOI 10.1016/S0969-2126(02)00736-0; Fang WL, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/401537; Fang X, 2006, BIOCHEM SOC T, V34, P798, DOI 10.1042/BST0340798; Fujikawa Y, 2007, PLANT J, V52, P185, DOI 10.1111/j.1365-313X.2007.03214.x; Garitaonandia I, 2009, J RECEPT SIG TRANSD, V29, P67, DOI 10.1080/10799890902729456; Gietz RD, 2007, NAT PROTOC, V2, P38, DOI 10.1038/nprot.2007.15; Goldstein BJ, 2009, NAT CLIN PRACT CARD, V6, P27, DOI 10.1038/ncpcardio1398; GRAHAM JS, 1992, PLANT PHYSIOL, V98, P163, DOI 10.1104/pp.98.1.163; Hara K, 2002, DIABETES, V51, P536, DOI 10.2337/diabetes.51.2.536; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Ishikawa M, 2007, CANCER SCI, V98, P1120, DOI 10.1111/j.1349-7006.2007.00486.x; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; Jortay J, 2012, AM J PATHOL, V181, P245, DOI 10.1016/j.ajpath.2012.03.035; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; KO TP, 1994, ACTA CRYSTALLOGR D, V50, P813, DOI 10.1107/S0907444994005512; Kondo H, 2002, DIABETES, V51, P2325, DOI 10.2337/diabetes.51.7.2325; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Kupchak BR, 2008, BIOCHEM BIOPH RES CO, V374, P210, DOI 10.1016/j.bbrc.2008.07.002; Kupchak BR, 2007, BBA-MOL CELL RES, V1773, P1124, DOI 10.1016/j.bbamcr.2007.04.003; Lee H, 2010, EUKARYOT CELL, V9, P558, DOI 10.1128/EC.00316-09; Leone P, 2006, BIOCHIMIE, V88, P45, DOI 10.1016/j.biochi.2005.07.001; LESAGE P, 1994, NUCLEIC ACIDS RES, V22, P597, DOI 10.1093/nar/22.4.597; Liu X, 2012, GUT; Lou Y, 2010, J BIOL CHEM, V285, P19384, DOI 10.1074/jbc.M110.125377; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Masson JY, 1997, MOL MICROBIOL, V24, P711, DOI 10.1046/j.1365-2958.1997.3841748.x; Matsuda M, 2002, J BIOL CHEM, V277, P37487, DOI 10.1074/jbc.M206083200; Matsuzawa Y, 2010, CURR PHARM DESIGN, V16, P1896, DOI 10.2174/138161210791208893; Miele M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016690; Min K, 2004, PROTEINS, V54, P170, DOI 10.1002/prot.10571; Min XS, 2012, FEBS LETT, V586, P912, DOI 10.1016/j.febslet.2012.02.024; Narasimhan ML, 2005, MOL CELL, V17, P171, DOI 10.1016/j.molcel.2004.11.050; Narasimhan ML, 2001, MOL CELL, V8, P921, DOI 10.1016/S1097-2765(01)00365-3; Neumeier M, 2006, J LEUKOCYTE BIOL, V79, P803, DOI 10.1189/jlb.0905521; Ohashi K, 2011, AM J HYPERTENS, V24, P263, DOI 10.1038/ajh.2010.216; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Palacin A, 2008, CLIN EXP ALLERGY, V38, P1220, DOI 10.1111/j.1365-2222.2007.02927.x; Paulmurugan R, 2005, ANAL CHEM, V77, P1295, DOI 10.1021/ac0484777; Petranovic D, 2010, FEMS YEAST RES, V10, P1046, DOI 10.1111/j.1567-1364.2010.00689.x; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Shklyaev S, 2003, P NATL ACAD SCI USA, V100, P14217, DOI 10.1073/pnas.2333912100; Tang YT, 2005, J MOL EVOL, V61, P372, DOI 10.1007/s00239-004-0375-2; Veronese P, 2003, PLANT PHYSIOL, V131, P1580, DOI 10.1104/pp.102.013417; Villa NY, 2009, MOL PHARMACOL, V75, P866, DOI 10.1124/mol.108.049809; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wang YJ, 2010, AM J PHYSIOL-ENDOC M, V298, pE663, DOI 10.1152/ajpendo.00663.2009; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Zhou LJ, 2009, J BIOL CHEM, V284, P22426, DOI 10.1074/jbc.M109.028357	61	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65454	10.1371/journal.pone.0065454	http://dx.doi.org/10.1371/journal.pone.0065454			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762377	Green Published, Green Submitted, gold			2022-12-27	WOS:000321094800052
J	Georgakopoulos, P; Lockington, RA; Kelly, JM				Georgakopoulos, Paraskevi; Lockington, Robin A.; Kelly, Joan M.			The Spt-Ada-Gcn5 Acetyltransferase (SAGA) Complex in Aspergillus nidulans	PLOS ONE			English	Article							CARBON CATABOLITE REPRESSION; HISTONE H3 ACETYLATION; SACCHAROMYCES-CEREVISIAE; NUCLEOSOME ACETYLATION; ELONGATION-FACTORS; YEAST; TRANSCRIPTION; DEUBIQUITINATION; COMPONENTS; GENE	A mutation screen in Aspergillus nidulans uncovered mutations in the acdX gene that led to altered repression by acetate, but not by glucose. AcdX of A. nidulans is highly conserved with Spt8p of Saccharomyces cerevisiae, and since Spt8p is a component of the Spt-Ada-Gcn5 Acetyltransferase (SAGA) complex, the SAGA complex may have a role in acetate repression in A. nidulans. We used a bioinformatic approach to identify genes encoding most members of the SAGA complex in A. nidulans, and a proteomic analysis to confirm that most protein components identified indeed exist as a complex in A. nidulans. No apparent compositional differences were detected in mycelia cultured in acetate compared to glucose medium. The methods used revealed apparent differences between Yeast and A. nidulans in the deubiquitination (DUB) module of the complex, which in S. cerevisiae consists of Sgf11p, Sus1p, and Ubp8p. Although a convincing homologue of S. cerevisiae Ubp8p was identified in the A. nidulans genome, there were no apparent homologues for Sus1p and Sgf11p. In addition, when the SAGA complex was purified from A. nidulans, members of the DUB module were not co-purified with the complex, indicating that functional homologues of Sus1p and Sgf11p were not part of the complex. Thus, deubiquitination of H2B-Ub in stress conditions is likely to be regulated differently in A. nidulans compared to S. cerevisiae.	[Georgakopoulos, Paraskevi; Lockington, Robin A.; Kelly, Joan M.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia	University of Adelaide	Kelly, JM (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia.	joan.kelly@adelaide.edu.au	Nagamune, Teruyuki/R-7708-2017; Lockington, Robin/F-3715-2013	Nagamune, Teruyuki/0000-0002-2435-0270; 	University of Adelaide; School of Molecular and Biomedical Science	University of Adelaide; School of Molecular and Biomedical Science	Paraskevi Georgakopolous was supported by a University of Adelaide Post-graduate Research Scholarship. The research was funded internally with School of Molecular and Biomedical Science funds, with no external sources of funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SP, 2007, ONCOGENE, V26, P5329, DOI 10.1038/sj.onc.1210603; Bian CB, 2011, EMBO J, V30, P2829, DOI 10.1038/emboj.2011.193; Busch S, 2007, P NATL ACAD SCI USA, V104, P8089, DOI 10.1073/pnas.0702108104; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; Daniel JA, 2004, J BIOL CHEM, V279, P1867, DOI 10.1074/jbc.C300494200; David H, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r108; DOWZER CEA, 1991, MOL CELL BIOL, V11, P5701, DOI 10.1128/MCB.11.11.5701; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Georgakopoulos P, 2012, G3-GENES GENOM GENET, V2, P1357, DOI 10.1534/g3.112.003913; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Grant PA, 1998, MOL CELL, V2, P863, DOI 10.1016/S1097-2765(00)80300-7; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Ingvarsdottir K, 2005, MOL CELL BIOL, V25, P1162, DOI 10.1128/MCB.25.3.1162-1172.2005; Kelly JM, 2004, MYCOTA, V3, P385; Kohler A, 2006, MOL BIOL CELL, V17, P4228, DOI 10.1091/mbc.E06-02-0098; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Lang G, 2011, MOL CELL BIOL, V31, P3734, DOI 10.1128/MCB.05231-11; Lee KK, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-2; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Liu XH, 2008, MOL CELL BIOL, V28, P108, DOI 10.1128/MCB.01402-07; Lockington RA, 2001, MOL MICROBIOL, V40, P1311, DOI 10.1046/j.1365-2958.2001.02474.x; Malavazi I, 2006, EUKARYOT CELL, V5, P1688, DOI 10.1128/EC.00167-06; Masuo S, 2010, MOL GENET GENOMICS, V284, P415, DOI 10.1007/s00438-010-0576-x; McMahon SJ, 2005, P NATL ACAD SCI USA, V102, P8478, DOI 10.1073/pnas.0503493102; Mutiu AI, 2007, GENETICS, V177, P151, DOI 10.1534/genetics.107.074476; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Nutzmann HW, 2011, P NATL ACAD SCI USA, V108, P14282, DOI 10.1073/pnas.1103523108; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Reyes-Dominguez Y, 2008, EUKARYOT CELL, V7, P656, DOI 10.1128/EC.00184-07; Rodriguez-Navarro S, 2004, CELL, V116, P75, DOI 10.1016/S0092-8674(03)01025-0; Sermwittayawong D, 2006, EMBO J, V25, P3791, DOI 10.1038/sj.emboj.7601265; Shukla A, 2006, MOL CELL BIOL, V26, P3339, DOI 10.1128/MCB.26.9.3339-3352.2006; Simic R, 2003, EMBO J, V22, P1846, DOI 10.1093/emboj/cdg179; Sterner DE, 1999, MOL CELL BIOL, V19, P86; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; TILBURN J, 1983, GENE, V26, P205, DOI 10.1016/0378-1119(83)90191-9; Tran HG, 2000, EMBO J, V19, P2323, DOI 10.1093/emboj/19.10.2323	38	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65221	10.1371/journal.pone.0065221	http://dx.doi.org/10.1371/journal.pone.0065221			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762321	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000321094800027
J	Haikarainen, T; Venkannagari, H; Narwal, M; Obaji, E; Lee, HW; Nkizinkiko, Y; Lehtio, L				Haikarainen, Teemu; Venkannagari, Harikanth; Narwal, Mohit; Obaji, Ezeogo; Lee, Hao-Wei; Nkizinkiko, Yves; Lehtio, Lari			Structural Basis and Selectivity of Tankyrase Inhibition by a Wnt Signaling Inhibitor WIKI4	PLOS ONE			English	Article							POLY(ADP-RIBOSE) POLYMERASE-1 PARP-1; CRYSTAL-STRUCTURE; ASSAY; ANTAGONISTS; POCKET; SAR	Recently a novel inhibitor of Wnt signaling was discovered. The compound, WIKI4, was found to act through tankyrase inhibition and regulate beta-catenin levels in many cancer cell lines and human embryonic stem cells. Here we confirm that WIKI4 is a high potency tankyrase inhibitor and that it selectively inhibits tankyrases over other ARTD enzymes tested. The binding mode of the compound to tankyrase 2 was determined by protein X-ray crystallography to 2.4 A degrees resolution. The structure revealed a novel binding mode to the adenosine subsite of the donor NAD(+) binding groove of the catalytic domain. Our results form a structural basis for further development of potent and selective tankyrase inhibitors based on the WIKI4 scaffold.	[Haikarainen, Teemu; Venkannagari, Harikanth; Narwal, Mohit; Obaji, Ezeogo; Lee, Hao-Wei; Lehtio, Lari] Univ Oulu, Dept Biochem, Bioctr Oulu, Oulu, Finland; [Narwal, Mohit; Nkizinkiko, Yves] Abo Akad Univ, Dept Biosci, Turku, Finland	Finland National Institute for Health & Welfare; University of Oulu; Abo Akademi University	Lehtio, L (corresponding author), Univ Oulu, Dept Biochem, Bioctr Oulu, Oulu, Finland.	lari.lehtio@oulu.fi	Venkannagari, Harikanth/AAX-6211-2021	Obaji, Ezeogo/0000-0001-9880-5664; Lehtio, Lari/0000-0001-7250-832X	Biocenter Oulu; Sigrid Juselius foundation; European Community under BioStruct-X [283570]	Biocenter Oulu; Sigrid Juselius foundation(Sigrid Juselius Foundation); European Community under BioStruct-X	The work was funded by Biocenter Oulu (http://www.oulu.fi/biocenter/) and by Sigrid Juselius foundation (http://www.sigridjuselius.fi/). MN and HV are members of the National Doctoral Programme of Informational and Structural Biology. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under BioStruct-X (grant agreement No283570). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Asher G, 2010, CELL, V142, P943, DOI 10.1016/j.cell.2010.08.016; Bell CE, 1996, BIOCHEMISTRY-US, V35, P1137, DOI 10.1021/bi9520848; Bregman H, 2013, J MED CHEM, V56, P1341, DOI 10.1021/jm301607v; Chang P, 2005, NAT CELL BIOL, V7, P1133, DOI 10.1038/ncb1322; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Dynek JN, 2004, SCIENCE, V304, P97, DOI 10.1126/science.1094754; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferraris DV, 2010, J MED CHEM, V53, P4561, DOI 10.1021/jm100012m; Guettler S, 2011, CELL, V147, P1340, DOI 10.1016/j.cell.2011.10.046; Hsiao SJ, 2009, J CELL BIOL, V184, P515, DOI 10.1083/jcb.200810132; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; James RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050457; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karlberg T, 2010, J MED CHEM, V53, P5352, DOI 10.1021/jm100249w; Karlberg T, 2010, BIOCHEMISTRY-US, V49, P1056, DOI 10.1021/bi902079y; Lehtio L, 2009, J MED CHEM, V52, P3108, DOI 10.1021/jm900052j; Miyashiro J, 2009, BIOORG MED CHEM LETT, V19, P4050, DOI 10.1016/j.bmcl.2009.06.016; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Narwal M, 2012, J BIOMOL SCREEN, V17, P593, DOI 10.1177/1087057112436558; Narwal M, 2012, J MED CHEM, V55, P1360, DOI 10.1021/jm201510p; Putt KS, 2004, ANAL BIOCHEM, V326, P78, DOI 10.1016/j.ab.2003.11.015; Riffell JL, 2012, NAT REV DRUG DISCOV, V11, P923, DOI 10.1038/nrd3868; Sbodio JI, 2002, BIOCHEM J, V361, P451, DOI 10.1042/0264-6021:3610451; Shultz MD, 2012, J MED CHEM, V55, P1127, DOI 10.1021/jm2011222; Smith S, 2000, CURR BIOL, V10, P1299, DOI 10.1016/S0960-9822(00)00752-1; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Venkannagari H, 2013, EUR J PHARM SCI, V49, P148, DOI 10.1016/j.ejps.2013.02.012; Voronkov A, 2013, J MED CHEM, V56, P3012, DOI 10.1021/jm4000566; Waaler J, 2011, CANCER RES, V71, P197, DOI 10.1158/0008-5472.CAN-10-1282	30	25	27	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65404	10.1371/journal.pone.0065404	http://dx.doi.org/10.1371/journal.pone.0065404			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762361	Green Published, gold, Green Submitted			2022-12-27	WOS:000321099000063
J	Furst, T; Ouattara, M; Silue, KD; N'Goran, DN; Adiossan, LG; Bogoch, II; N'Guessan, Y; Kone, S; Utzinger, J; N'Goran, EK				Fuerst, Thomas; Ouattara, Mamadou; Silue, Kigbafori D.; N'Goran, Dje N.; Adiossan, Lukas G.; Bogoch, Isaac I.; N'Guessan, Yao; Kone, Siaka; Utzinger, Juerg; N'Goran, Eliezer K.			Scope and Limits of an Anamnestic Questionnaire in a Control-Induced Low-Endemicity Helminthiasis Setting in South-Central Cote d'Ivoire	PLOS ONE			English	Article							NEGLECTED TROPICAL DISEASES; SOIL-TRANSMITTED HELMINTHIASIS; SELF-REPORTED MORBIDITY; CONTROL PROGRAMS; STRONGYLOIDES-STERCORALIS; SCHISTOSOMA-MANSONI; INTEGRATED CONTROL; PARASITIC INFECTIONS; RISK-FACTORS; AFRICA	Background: Schistosomiasis and soil-transmitted helminthiasis are two high-burden neglected tropical diseases. In highly endemic areas, control efforts emphasize preventive chemotherapy. However, as morbidity, infection, and transmission begin to decrease, more targeted treatment is likely to become more cost-effective, provided that comparatively cheap diagnostic methods with reasonable accuracy are available. Methodology: Adults were administered an anamnestic questionnaire in mid-2010 during a cross-sectional epidemiological survey in the Taabo health demographic surveillance system in south-central Cote d'Ivoire. Questions pertaining to risk factors and signs and symptoms for schistosomiasis and soil-transmitted helminthiasis were included. The individuals' helminth infection status and their belonging to three different anthelmintic treatment groups were compared with the questionnaire results (i) to inform the local health authorities about the epidemiological and clinical footprint of locally prevailing helminthiases, and (ii) to explore the scope and limits of an anamnestic questionnaire as monitoring tool, which eventually could help guiding the control of neglected tropical diseases in control-induced low-endemicity settings. Principal Findings: Our study sample consisted of 195 adults (101 males, 94 females). We found prevalences of hookworm, Trichuris trichiura, Schistosoma haematobium, and Schistosoma mansoni of 39.0%, 2.7%, 2.1%, and 2.1%, respectively. No Ascaris lumbricoides infection was found. Helminth infection intensities were generally very low. Seven, 74 and 79 participants belonged to three different treatment groups. Multivariable logistic regression models revealed statistically significant (p<0.05) associations between some risk factors, signs, and symptoms, and the different helminth infections and treatment groups. However, the risk factors, signs, and symptoms showed weak diagnostic properties. Conclusions/Significance: The generally low prevalence and intensity of helminth infection in this part of south-central Cote d'Ivoire indicates that recent control efforts have turned our study area into a low endemicity setting. Our anamnestic questionnaire had low sensitivity and specificity to identify infected individuals or treatment groups.	[Fuerst, Thomas; Utzinger, Juerg] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Fuerst, Thomas; Utzinger, Juerg] Univ Basel, Basel, Switzerland; [Ouattara, Mamadou; Silue, Kigbafori D.; N'Goran, Eliezer K.] Univ Felix Houphouet Boigny, Unite Format & Rech Biosci, Abidjan, Cote Ivoire; [Silue, Kigbafori D.; N'Guessan, Yao; Kone, Siaka; N'Goran, Eliezer K.] Ctr Suisse Rech Sci Cote Ivoire, Abidjan, Cote Ivoire; [N'Goran, Dje N.] Programme Natl Lutte Schistosomiase Geohelminthia, Abidjan, Cote Ivoire; [Adiossan, Lukas G.] Hop Gen Taabo, Taabo Cite, Cote Ivoire; [Bogoch, Isaac I.] Toronto Gen Hosp, Div Internal Med, Toronto, ON, Canada; [Bogoch, Isaac I.] Toronto Gen Hosp, Div Infect Dis, Toronto, ON, Canada	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Utzinger, J (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.	juerg.utzinger@unibas.ch	Bogoch, Isaac/AAS-9631-2020	Kigbafori Dieudonne, Silue/0000-0003-1003-9294; Ouattara, Mamadou/0000-0002-4650-9676	Pro*Doc Research Module from the Swiss National Science Foundation (SNSF) [PDFMP3-123185]; SNSF [IZ70Z-123900]	Pro*Doc Research Module from the Swiss National Science Foundation (SNSF); SNSF(Swiss National Science Foundation (SNSF))	The authors thank Fairmed for sustained funding that allowed us to establish and run the Taabo health demographic surveillance system in south-central Cote d'Ivoire, and the accompanying health interventions with the aim to reduce the mortality and morbidity due to malaria and neglected tropical diseases. TF is associated to the National Centre of Competence in Research North-South and received financial support through a Pro*Doc Research Module from the Swiss National Science Foundation (SNSF; project no. PDFMP3-123185). Furthermore, he is thankful for a personal stipend from the Freiwillige Akademische Gesellschaft Basel. JU and EKN are grateful to the SNSF (project no. IZ70Z-123900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acka CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000910; [Anonymous], 2006, PREV CHEM HUM HELM C; [Anonymous], 2010, 1 WHO; Becker SL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001292; Bergquist R, 2009, TRENDS PARASITOL, V25, P151, DOI 10.1016/j.pt.2009.01.004; Booth M, 1998, T ROY SOC TROP MED H, V92, P484, DOI 10.1016/S0035-9203(98)90884-7; Brooker S, 2004, TRENDS PARASITOL, V20, P537, DOI 10.1016/j.pt.2004.08.012; Brooker S, 2009, PARASITOLOGY, V136, P1707, DOI 10.1017/S0031182009005940; Brooker S, 2009, MANSONS TROPICAL DIS, P1515; Brooker S, 2007, GEOSPATIAL HEALTH, V1, P141, DOI 10.4081/gh.2007.262; Cairncross S, 2012, TRENDS PARASITOL, V28, P225, DOI 10.1016/j.pt.2012.03.003; Colley DG, 2013, AM J TROP MED HYG, V88, P426, DOI 10.4269/ajtmh.12-0639; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; Ehrenberg JP, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-119; Engels D, 2002, ACTA TROP, V82, P139, DOI 10.1016/S0001-706X(02)00045-1; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Furst T, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001855; Furst T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000513; Gabrielli AF, 2011, T ROY SOC TROP MED H, V105, P683, DOI 10.1016/j.trstmh.2011.08.013; Glinz D, 2010, J PARASITOL, V96, P431, DOI 10.1645/GE-2294.1; Gray DJ, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2651; Group, 1990, STAND INSTR US MEAS; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Guyatt HL, 1996, AM J TROP MED HYG, V55, P159, DOI 10.4269/ajtmh.1996.55.159; Hotez PJ, 2006, PLOS MED, V3, P576, DOI 10.1371/journal.pmed.0030102; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000485; Kabatereine NB, 2006, TRENDS PARASITOL, V22, P332, DOI 10.1016/j.pt.2006.05.001; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; King CH, 2008, CHRONIC ILLN, V4, P65, DOI 10.1177/1742395307084407; Knopp S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000681; Kolaczinski JH, 2007, TRENDS PARASITOL, V23, P485, DOI 10.1016/j.pt.2007.08.007; Lammie PJ, 2006, TRENDS PARASITOL, V22, P313, DOI 10.1016/j.pt.2006.05.009; Lengeler C, 2002, TRENDS PARASITOL, V18, P375, DOI 10.1016/S1471-4922(02)02318-8; Lengeler C, 2002, B WORLD HEALTH ORGAN, V80, P235; Molyneux DH, 2005, PLOS MED, V2, P1064, DOI 10.1371/journal.pmed.0020336; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; N'Goran EK, 1997, B WORLD HEALTH ORGAN, V75, P541; N'Goran EK, 2003, AM J TROP MED HYG, V68, P24, DOI 10.4269/ajtmh.2003.68.24; N'Goran EK, 2001, TROP MED INT HEALTH, V6, P817, DOI 10.1046/j.1365-3156.2001.00785.x; Olsen A, 2007, T ROY SOC TROP MED H, V101, P747, DOI 10.1016/j.trstmh.2007.03.006; QualityMetric, 2012, SF36 ORG COMM MEAS H; Raso G, 2005, TROP MED INT HEALTH, V10, P42, DOI 10.1111/j.1365-3156.2004.01352.x; Raso G, 2004, INT J EPIDEMIOL, V33, P1092, DOI 10.1093/ije/dyh241; Raso G, 2007, GEOSPATIAL HEALTH, V2, P85, DOI 10.4081/gh.2007.257; Righetti AA, 2013, J INFECT DIS, V207, P1604, DOI 10.1093/infdis/jit066; Rollinson D, 2012, ACTA TROP IN PRESS, DOI DOI 10.1016/J.ACTATR0PICA.2012.1004.1013); Silue K D, 2006, Med Trop (Mars), V66, P149; Steinmann P, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000322; Steinmann P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025003; Tan HZ, 2004, ACTA TROP, V90, P1, DOI 10.1016/j.actatropica.2003.09.008; Utzinger J, 2000, B WORLD HEALTH ORGAN, V78, P389; Utzinger J, 2009, PARASITOLOGY, V136, P1859, DOI 10.1017/S0031182009991600; WHO, 2008, ACTION WORMS; World Health Organization, 1991, BAS LAB METH MED PAR; World Health Organization, 2002, WHO TECHN REP SER, V912, P1; World Health Organization (WHO), 1998, WHOQOL US MAN	58	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64380	10.1371/journal.pone.0064380	http://dx.doi.org/10.1371/journal.pone.0064380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755120	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000319872300017
J	Hogan, CS; Mole, BM; Grant, SR; Willis, DK; Charkowski, AO				Hogan, Clifford S.; Mole, Beth M.; Grant, Sarah R.; Willis, David K.; Charkowski, Amy O.			The Type III Secreted Effector DspE Is Required Early in Solanum tuberosum Leaf Infection by Pectobacterium carotovorum to Cause Cell Death, and Requires Wx((3-6))D/E Motifs	PLOS ONE			English	Article							STEWARTII SUBSP STEWARTII; ROT ERWINIA BACTERIA; SIGMA-FACTOR; PECTATE LYASE; NUCLEOTIDE-SEQUENCE; GENES; HRP; EXPRESSION; FAMILY; AMYLOVORA	Pectobacterium species are enterobacterial plant-pathogens that cause soft rot disease in diverse plant species. Unlike hemi-biotrophic plant pathogenic bacteria, the type III secretion system (T3SS) of Pectobacterium carotovorum subsp. carotovorum (P. carotovorum) appears to secrete only one effector protein, DspE. Previously, we found that the T3SS regulator HrpL and the effector DspE are required for P. carotovorum pathogenesis on leaves. Here, we identified genes up-regulated by HrpL, visualized expression of dspE in leaves, and established that DspE causes host cell death. DspE required its full length and WxxxE-like motifs, which are characteristic of the AvrE-family effectors, for host cell death. We also examined expression in plant leaves and showed that hrpL is required for the expression of dspE and hrpN, and that the loss of a functional T3SS had unexpected effects on expression of other genes during leaf infection. These data support a model where P. carotovorum uses the T3SS early in leaf infection to initiate pathogenesis through elicitation of DspE-mediated host cell death.	[Hogan, Clifford S.; Willis, David K.; Charkowski, Amy O.] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; [Mole, Beth M.; Grant, Sarah R.] Univ N Carolina, Dept Biol & Curriculum Mol Biol & Genet, Chapel Hill, NC USA; [Willis, David K.] USDA ARS, Vegetable Crops Res Unit, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; University of North Carolina Chapel Hill; United States Department of Agriculture (USDA)	Charkowski, AO (corresponding author), Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA.	acharkowski@wisc.edu		Charkowski, Amy/0000-0002-8913-2071	National Science Foundation Environmental Genomics Program [0412599]; USDA-Hatch project the Wisconsin Potato and Vegetable Growers Association [WISO1637]	National Science Foundation Environmental Genomics Program(National Science Foundation (NSF)); USDA-Hatch project the Wisconsin Potato and Vegetable Growers Association	This work was funded by National Science Foundation Environmental Genomics Program through award number 0412599, USDA-Hatch project award WISO1637 the Wisconsin Potato and Vegetable Growers Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal GK, 2003, FEBS LETT, V546, P173, DOI 10.1016/S0014-5793(03)00646-X; Ahn IP, 2007, MOL PLANT PATHOL, V8, P747, DOI 10.1111/J.1364-3703.2007.00428.X; Alfano JR, 2000, P NATL ACAD SCI USA, V97, P4856, DOI 10.1073/pnas.97.9.4856; Bell KS, 2004, P NATL ACAD SCI USA, V101, P11105, DOI 10.1073/pnas.0402424101; Bogdanove AJ, 1998, J BACTERIOL, V180, P2244, DOI 10.1128/JB.180.8.2244-2247.1998; Boureau T, 2006, MOL PLANT MICROBE IN, V19, P16, DOI 10.1094/MPMI-19-0016; Cesbron S, 2006, FEMS MICROBIOL LETT, V257, P221, DOI 10.1111/j.1574-6968.2006.00172.x; Chang JH, 2005, P NATL ACAD SCI USA, V102, P2549, DOI 10.1073/pnas.0409660102; Chatterjee A, 2002, MOL PLANT PATHOL, V3, P359, DOI 10.1046/j.1364-3703.2002.00128.x; Chatterjee A, 2002, MOL PLANT MICROBE IN, V15, P971, DOI 10.1094/MPMI.2002.15.9.971; CHATTERJEE A, 1991, J BACTERIOL, V173, P1765, DOI 10.1128/jb.173.5.1765-1769.1991; DebRoy S, 2004, P NATL ACAD SCI USA, V101, P9927, DOI 10.1073/pnas.0401601101; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fouts DE, 2002, P NATL ACAD SCI USA, V99, P2275, DOI 10.1073/pnas.032514099; Glasner JD, 2008, MOL PLANT MICROBE IN, V21, P1549, DOI 10.1094/MPMI-21-12-1549; Ham JH, 2008, MOL PLANT PATHOL, V9, P633, DOI 10.1111/J.1364-3703.2008.00489.X; Ham JH, 2006, MOL PLANT MICROBE IN, V19, P1092, DOI 10.1094/MPMI-19-1092; Ham JH, 2009, MOL PLANT MICROBE IN, V22, P703, DOI 10.1094/MPMI-22-6-0703; HARRISON MD, 1987, J APPL BACTERIOL, V62, P565, DOI 10.1111/j.1365-2672.1987.tb02690.x; HINTON JCD, 1989, MOL MICROBIOL, V3, P1785, DOI 10.1111/j.1365-2958.1989.tb00164.x; Huang ZW, 2009, NAT STRUCT MOL BIOL, V16, P853, DOI 10.1038/nsmb.1647; Jahn CE, 2008, J MICROBIOL METH, V75, P318, DOI 10.1016/j.mimet.2008.07.004; Johansen LK, 2001, PLANT PHYSIOL, V126, P930, DOI 10.1104/pp.126.3.930; Kim HS, 2011, MOL PLANT MICROBE IN, V24, P773, DOI 10.1094/MPMI-06-10-0143; Kim HS, 2009, APPL ENVIRON MICROB, V75, P4539, DOI 10.1128/AEM.01336-08; LIU Y, 1994, APPL ENVIRON MICROB, V60, P2545, DOI 10.1128/AEM.60.7.2545-2552.1994; MAE A, 1995, MOL GEN GENET, V247, P17, DOI 10.1007/BF00425817; MCCARTERZORNER NJ, 1985, J APPL BACTERIOL, V59, P357, DOI 10.1111/j.1365-2672.1985.tb03331.x; MCCARTERZORNER NJ, 1984, J APPL BACTERIOL, V57, P95, DOI 10.1111/j.1365-2672.1984.tb02361.x; Meng XD, 2006, MOL PLANT MICROBE IN, V19, P53, DOI 10.1094/MPMI-19-0053; MOLINA JJ, 1974, AM POTATO J, V51, P245, DOI 10.1007/BF02851435; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nissan G, 2005, MOL PLANT MICROBE IN, V18, P634, DOI 10.1094/MPMI-18-0634; Ohlson MB, 2008, CELL HOST MICROBE, V4, P434, DOI 10.1016/j.chom.2008.08.012; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rotenberg D, 2006, J VIROL METHODS, V138, P49, DOI 10.1016/j.jviromet.2006.07.017; SAARILAHTI HT, 1990, MOL MICROBIOL, V4, P1037, DOI 10.1111/j.1365-2958.1990.tb00676.x; Sambrook J., 2001, MOL CLONING LAB MANU; Takle GW, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-50; Wang K, 2010, MOL PLANT PATHOL, V11, P597, DOI [10.1111/J.1364-3703.2010.00631.X, 10.1111/j.1364-3703.2010.00631.x]; WEI ZM, 1995, J BACTERIOL, V177, P6201, DOI 10.1128/jb.177.21.6201-6210.1995; XIAO YX, 1994, J BACTERIOL, V176, P1025, DOI 10.1128/JB.176.4.1025-1036.1994; Yap MN, 2008, MOL PLANT MICROBE IN, V21, P304, DOI 10.1094/MPMI-21-3-0304; Yap MN, 2005, J BACTERIOL, V187, P639, DOI 10.1128/JB.187.2.639-648.2005; YOSHIDA A, 1992, BIOSCI BIOTECH BIOCH, V56, P1596, DOI 10.1271/bbb.56.1596	45	18	18	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65534	10.1371/journal.pone.0065534	http://dx.doi.org/10.1371/journal.pone.0065534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755246	Green Submitted, Green Published, gold			2022-12-27	WOS:000319872300086
J	Li, LL; Wang, Z; Zuo, ZY				Li, Liaoliao; Wang, Zhi; Zuo, Zhiyi			Chronic Intermittent Fasting Improves Cognitive Functions and Brain Structures in Mice	PLOS ONE			English	Article							DIETARY RESTRICTION; OXIDATIVE STRESS; GLUCOSE-METABOLISM; DISEASE; PREVALENCE; RESISTANCE; OBESITY; RATS	Obesity is a major health issue. Obesity started from teenagers has become a major health concern in recent years. Intermittent fasting increases the life span. However, it is not known whether obesity and intermittent fasting affect brain functions and structures before brain aging. Here, we subjected 7-week old CD-1 wild type male mice to intermittent (alternate-day) fasting or high fat diet (45% caloric supplied by fat) for 11 months. Mice on intermittent fasting had better learning and memory assessed by the Barnes maze and fear conditioning, thicker CA1 pyramidal cell layer, higher expression of drebrin, a dendritic protein, and lower oxidative stress than mice that had free access to regular diet (control mice). Mice fed with high fat diet was obese and with hyperlipidemia. They also had poorer exercise tolerance. However, these obese mice did not present significant learning and memory impairment or changes in brain structures or oxidative stress compared with control mice. These results suggest that intermittent fasting improves brain functions and structures and that high fat diet feeding started early in life does not cause significant changes in brain functions and structures in obese middle-aged animals.	[Li, Liaoliao; Wang, Zhi; Zuo, Zhiyi] Univ Virginia, Dept Anesthesiol, Charlottesville, VA 22903 USA; [Wang, Zhi] Sun Yat Sen Univ, Sun Yat Sen Memory Hosp, Dept Anesthesiol, Guangzhou 510275, Guangdong, Peoples R China	University of Virginia; Sun Yat Sen University	Zuo, ZY (corresponding author), Univ Virginia, Dept Anesthesiol, Charlottesville, VA 22903 USA.	zz3c@virginia.edu	Zuo, Zhiyi/F-3950-2010	Zuo, Zhiyi/0000-0002-3542-5047	National Institutes of Health, Bethesda, MD [R01 GM065211, R01 GM098308]; International Anesthesia Research Society, Cleveland,OH; American Heart Association Mid-Atlantic Affiliate, Baltimore, MD [10GRNT3900019]; Robert M. Epstein Professorship endowment, University of Virginia, Charlottesville, VA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098308, R01GM065211] Funding Source: NIH RePORTER	National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Anesthesia Research Society, Cleveland,OH; American Heart Association Mid-Atlantic Affiliate, Baltimore, MD(American Heart Association); Robert M. Epstein Professorship endowment, University of Virginia, Charlottesville, VA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants (R01 GM065211 and R01 GM098308 to ZZ) from the National Institutes of Health, Bethesda, MD, by a grant from the International Anesthesia Research Society (2007 Frontiers in Anesthesia Research Award to ZZ), Cleveland,OH, by a Grant-in-Aid from the American Heart Association Mid-Atlantic Affiliate (10GRNT3900019 to ZZ), Baltimore, MD, and the Robert M. Epstein Professorship endowment, University of Virginia, Charlottesville, VA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100; Bhatnagar D, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a993; Butterfield DA, 2002, FREE RADICAL RES, V36, P1307, DOI 10.1080/1071576021000049890; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Djordjevic AM, 2010, NEUROCHEM INT, V56, P250, DOI 10.1016/j.neuint.2009.10.008; Duan WZ, 2003, P NATL ACAD SCI USA, V100, P2911, DOI 10.1073/pnas.0536856100; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; GOODRICK CL, 1983, EXP AGING RES, V9, P203, DOI 10.1080/03610738308258453; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; INGRAM DK, 1987, J GERONTOL, V42, P78, DOI 10.1093/geronj/42.1.78; Li JJ, 2012, PHARMACOL BIOCHEM BE, V101, P564, DOI 10.1016/j.pbb.2012.03.002; Li LL, 2011, J CEREBR BLOOD F MET, V31, P1283, DOI 10.1038/jcbfm.2010.222; Lin DW, 2012, BEHAV BRAIN RES, V228, P319, DOI 10.1016/j.bbr.2011.12.010; Liu RL, 2003, P NATL ACAD SCI USA, V100, P8526, DOI 10.1073/pnas.1332809100; MASORO EJ, 1982, P NATL ACAD SCI-BIOL, V79, P4239, DOI 10.1073/pnas.79.13.4239; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; Studzinski CM, 2009, J NEUROCHEM, V108, P860, DOI 10.1111/j.1471-4159.2008.05798.x; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Weindruch R, 1997, NEW ENGL J MED, V337, P986, DOI 10.1056/NEJM199710023371407; Witte AV, 2009, P NATL ACAD SCI USA, V106, P1255, DOI 10.1073/pnas.0808587106	21	75	76	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e66069	10.1371/journal.pone.0066069	http://dx.doi.org/10.1371/journal.pone.0066069			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755298	Green Published, gold, Green Submitted			2022-12-27	WOS:000319872300101
J	Visser, MB; Sun, CX; Koh, A; Ellen, RP; Glogauer, M				Visser, Michelle B.; Sun, Chun-Xiang; Koh, Adeline; Ellen, Richard P.; Glogauer, Michael			Treponema denticola Major Outer Sheath Protein Impairs the Cellular Phosphoinositide Balance That Regulates Neutrophil Chemotaxis	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; SURFACE PROTEIN; PTEN; PHOSPHATASE; RAC1; ACTIVATION; MOTILITY; POLARITY; LOCALIZATION; PTDINSP(3)	The major outer sheath protein (Msp) of Treponema denticola inhibits neutrophil polarization and directed chemotaxis together with actin dynamics in vitro in response to the chemoattractant N-formyl-methionine-leucine-phenylanine (fMLP). Msp disorients chemotaxis through inhibition of a Rac1-dependent signaling pathway, but the upstream mechanisms are unknown. We challenged murine bone marrow neutrophils with enriched native Msp to determine the role of phospholipid modifying enzymes in chemotaxis and actin assembly downstream of fMLP-stimulation. Msp modulated cellular phosphoinositide levels through inhibition of phosphatidylinositol 3-kinase (PI3-kinase) together with activation of the lipid phosphatase, phosphatase and tensin homolog deleted on chromosome 10 (PTEN). Impaired phosphatidylinositol[(3,4,5)]triphosphate (PIP3) levels prevented recruitment and activation of the downstream mediator Akt. Release of the actin capping proteins gelsolin and CapZ in response to fMLP was also inhibited by Msp exposure. Chemical inhibition of PTEN restored PIP3 signaling, as measured by Akt activation, Rac1 activation, actin uncapping, neutrophil polarization and chemotaxis in response to fMLP-stimulation, even in the presence of Msp. Transduction with active Rac1 also restored fMLP-mediated actin uncapping, suggesting that Msp acts at the level of PIP3 in the hierarchical feedback loop of PIP3 and Rac1 activation. Taken together, Msp alters the phosphoinositide balance in neutrophils, impairing the cell "compass", which leads to inhibition of downstream chemotactic events.	[Visser, Michelle B.; Sun, Chun-Xiang; Koh, Adeline; Ellen, Richard P.; Glogauer, Michael] Univ Toronto, Dent Res Inst, Matrix Dynam Grp, Toronto, ON, Canada	University of Toronto	Visser, MB (corresponding author), SUNY Buffalo, Dept Oral Biol, Buffalo, NY 14260 USA.	michelle.visser@utoronto.ca	Visser, Michelle/L-1262-2019; Glogauer, Michael/D-2504-2011	Visser, Michelle/0000-0002-6467-3314; Glogauer, Michael/0000-0002-6248-5977	Canadian Institutes of Health Research (CIHR) [MOP-86550, MOP-53136]; CIHR	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by operating grants MOP-86550 (R.P.E) and MOP-53136 (M.G) from the Canadian Institutes of Health Research (CIHR) and a CIHR Postdoctoral fellowship (M.B.V). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin M, 2004, INFECT IMMUN, V72, P3650, DOI 10.1128/IAI.72.6.3650-3654.2004; Caimano MJ, 1999, INFECT IMMUN, V67, P4072, DOI 10.1128/IAI.67.8.4072-4083.1999; Campbell RB, 2003, J BIOL CHEM, V278, P33617, DOI 10.1074/jbc.C300296200; Capone R, 2008, ORAL MICROBIOL IMMUN, V23, P165, DOI 10.1111/j.1399-302X.2007.00404.x; Cicchetti G, 2002, CRIT REV ORAL BIOL M, V13, P220, DOI 10.1177/154411130201300302; da Silva APB, 2004, CELL MICROBIOL, V6, P485, DOI 10.1111/j.1462-5822.2004.00377.x; Damen JE, 1996, P NATL ACAD SCI USA, V93, P1689, DOI 10.1073/pnas.93.4.1689; EGLI C, 1993, INFECT IMMUN, V61, P1694, DOI 10.1128/IAI.61.5.1694-1699.1993; Ellen RP, 2005, PERIODONTOL 2000, V38, P13, DOI 10.1111/j.1600-0757.2005.00108.x; Fenno JC, 1998, INFECT IMMUN, V66, P1869, DOI 10.1128/IAI.66.5.1869-1877.1998; Fenno JC, 2012, J ORAL MICROBIOL, V4; Fenteany G, 2004, CURR OPIN HEMATOL, V11, P15, DOI 10.1097/00062752-200401000-00004; Geny B, 2006, BIOL CELL, V98, P633, DOI 10.1042/BC20060038; Gericke A, 2006, GENE, V374, P1, DOI 10.1016/j.gene.2006.02.024; Godovikova V, 2011, INFECT IMMUN, V79, P4868, DOI 10.1128/IAI.05701-11; HAAPASALO M, 1992, INFECT IMMUN, V60, P2058, DOI 10.1128/IAI.60.5.2058-2065.1992; Hannigan M, 2002, P NATL ACAD SCI USA, V99, P3603, DOI 10.1073/pnas.052010699; Hawkins PT, 2010, CURR TOP MICROBIOL, V346, P183, DOI 10.1007/82_2010_40; Heit B, 2008, NAT IMMUNOL, V9, P743, DOI 10.1038/ni.1623; Heit B, 2008, J CELL SCI, V121, P205, DOI 10.1242/jcs.020412; Kuiper JWP, 2011, BLOOD, V118, P6164, DOI 10.1182/blood-2010-09-310383; Leslie NR, 2008, ONCOGENE, V27, P5464, DOI 10.1038/onc.2008.243; Li YT, 2011, BLOOD, V117, P6702, DOI 10.1182/blood-2010-09-309864; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Magalhaes MAO, 2008, CELL MICROBIOL, V10, P344, DOI 10.1111/j.1462-5822.2007.01045.x; Magalhaes MAO, 2010, J LEUKOCYTE BIOL, V87, P545, DOI 10.1189/jlb.0609390; Mathers DA, 1996, INFECT IMMUN, V64, P2904, DOI 10.1128/IAI.64.8.2904-2910.1996; McConnachie G, 2003, BIOCHEM J, V371, P947, DOI 10.1042/BJ20021848; Mondal S, 2012, MOL BIOL CELL, V23, P1219, DOI 10.1091/mbc.E11-10-0889; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; Papakonstanti EA, 2007, EMBO J, V26, P3050, DOI 10.1038/sj.emboj.7601763; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Rosivatz E, 2006, ACS CHEM BIOL, V1, P780, DOI 10.1021/cb600352f; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Sela MN, 2001, CRIT REV ORAL BIOL M, V12, P399, DOI 10.1177/10454411010120050301; Seshadri G, 2004, P NATL ACAD SCI USA, V101, P5646, DOI 10.1073/pnas.0307639101; Stephens L, 2002, CURR OPIN CELL BIOL, V14, P203, DOI 10.1016/S0955-0674(02)00311-3; Subramanian KK, 2007, BLOOD, V109, P4028, DOI 10.1182/blood-2006-10-055319; Sun CX, 2007, J CELL BIOL, V179, P239, DOI 10.1083/jcb.200705122; Sun CX, 2004, BLOOD, V104, P3758, DOI 10.1182/blood-2004-03-0781; Tamguney T, 2007, J CELL SCI, V120, P4071, DOI 10.1242/jcs.015230; Thomas BP, 2006, INFECT IMMUN, V74, P1954, DOI 10.1128/IAI.74.3.1954-1957.2006; Visser MB, 2011, CLIN MICROBIOL INFEC, V17, P502, DOI 10.1111/j.1469-0691.2011.03460.x; Visser MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023736; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Wang F, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002980; Wang Q, 2001, J BIOL CHEM, V276, P23056, DOI 10.1074/jbc.M011735200; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Weiner OD, 1999, NAT CELL BIOL, V1, P75, DOI 10.1038/10042	50	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e66209	10.1371/journal.pone.0066209	http://dx.doi.org/10.1371/journal.pone.0066209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755300	Green Published, gold, Green Submitted			2022-12-27	WOS:000319872300103
J	Breslau, N; Chen, QL; Luo, ZH				Breslau, Naomi; Chen, Qiaoling; Luo, Zhehui			The Role of Intelligence in Posttraumatic Stress Disorder: Does it Vary by Trauma Severity?	PLOS ONE			English	Article							EXPOSURE; EVENTS; SYMPTOMS	Background: Only a small minority of trauma victims develops post-traumatic stress disorder (PTSD), suggesting that victims vary in their predispositions to the PTSD response to stressors. It is assumed that the role of predispositions in PTSD varies by trauma severity: when stressors are less severe, predispositions play a bigger role. In this study, we test whether the role of intelligence in PTSD varies by trauma severity. Specifically, does low intelligence plays a bigger part among victims of lower magnitude stressors than among victims of extreme stressors? Methods: Data come from a longitudinal study of randomly selected sample in Southeast Michigan (n = 713). IQ was measured at age 6. PTSD was measured at age 17, using the NIMH-DIS for DSM-IV. Stressors were classified as extreme if they involved assaultive violence (e. g. rape, sexual assault, threatened with a weapon); other stressors in the list (e. g. disaster, accidents) were classified as lower magnitude. Assaultive violence victims had experienced assaultive violence plus other event types or only assaultive violence. Victims of other stressors were participants who had never experienced assaultive violence. We compared the influence of age 6 IQ on PTSD among persons exposed to assaultive violence vs. other stressors, using multinomial logistic regression. Results: Relative risk ratio (RRR) for PTSD associated with a one point drop in age 6 IQ among victims of assaultive violence was 1.04 (95% CI 1.01, 1.06); among victims of other stressors, it was 1.03 (95% CI 0.99, 1.06). A comparison of the two RRRs indicates no significant difference between the two estimates (p = 0.652). IQ does not play a bigger role in PTSD among victims of other stressors than it does among victims of assaultive violence. Conclusions: Lower IQ exerts an adverse PTSD effect on trauma victims, with no evidence of variability by the severity of trauma they have experienced.	[Breslau, Naomi; Chen, Qiaoling; Luo, Zhehui] Michigan State Univ, Coll Human Med, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA	Michigan State University; Michigan State University College of Human Medicine	Breslau, N (corresponding author), Michigan State Univ, Coll Human Med, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA.	breslau@msu.edu			National Institutes of Health [MH44586, MH071395, MH092737]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH044586, R01MH071395, RC4MH092737] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by grants MH44586 (Dr. Breslau), MH071395 (Dr. Breslau), and MH092737 (Dr. Luo) from the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Batty GD, 2005, BRIT J PSYCHIAT, V187, P180, DOI 10.1192/bjp.187.2.180; Bowman M.L., 2004, POSTTRAUMATIC STRESS, P15, DOI [https://doi.org/10.1002/9780470713570.ch2, DOI 10.1002/9780470713570]; BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P216; Breslau N, 1998, ARCH GEN PSYCHIAT, V55, P626, DOI 10.1001/archpsyc.55.7.626; Breslau N, 2004, J URBAN HEALTH, V81, P530, DOI 10.1093/jurban/jth138; Breslau N, 2013, PSYCHOL MED, V43, P381, DOI 10.1017/S0033291712001195; Breslau N, 2006, ARCH GEN PSYCHIAT, V63, P1238, DOI 10.1001/archpsyc.63.11.1238; Gilbertson MW, 2006, J ABNORM PSYCHOL, V115, P484, DOI 10.1037/0021-843X.115.3.484; Helzer JE, 1981, STRESSFUL LIFE EVENT, V2, P108; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Koenen KC, 2007, PSYCHOL MED, V37, P181, DOI 10.1017/S0033291706009019; Macklin ML, 1998, J CONSULT CLIN PSYCH, V66, P323, DOI 10.1037/0022-006X.66.2.323; McNally RJ, 2011, DEPRESS ANXIETY, V28, P1091, DOI 10.1002/da.20867; McNally RJ, 2009, DEPRESS ANXIETY, V26, P597, DOI 10.1002/da.20586; MCNALLY RJ, 1995, AM J PSYCHIAT, V152, P936; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; RABKIN JG, 1976, SCIENCE, V194, P1013, DOI 10.1126/science.790570; Robins L. N., 1989, NIMH DIAGNOSTIC INTE; Storr CL, 2007, AM J PSYCHIAT, V164, P119, DOI 10.1176/appi.ajp.164.1.119; Wechsler DW., 1999, INTELLIGENCE SCALE C; YEHUDA R, 1995, AM J PSYCHIAT, V152, P1705	22	24	24	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65391	10.1371/journal.pone.0065391	http://dx.doi.org/10.1371/journal.pone.0065391			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	164VY	23762357	gold, Green Published			2022-12-27	WOS:000320440500034
J	Leung, R; Proitsi, P; Simmons, A; Lunnon, K; Guntert, A; Kronenberg, D; Pritchard, M; Tsolaki, M; Mecocci, P; Kloszewska, I; Vellas, B; Soininen, H; Wahlund, LO; Lovestone, S				Leung, Rufina; Proitsi, Petroula; Simmons, Andrew; Lunnon, Katie; Guentert, Andreas; Kronenberg, Deborah; Pritchard, Megan; Tsolaki, Magda; Mecocci, Patrizia; Kloszewska, Iwona; Vellas, Bruno; Soininen, Hilkka; Wahlund, Lars-Olaf; Lovestone, Simon			Inflammatory Proteins in Plasma Are Associated with Severity of Alzheimer's Disease	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; TEMPORAL-LOBE ATROPHY; NEURODEGENERATIVE DISEASES; SENILE PLAQUES; BIOMARKERS; MICROGLIA; DIAGNOSIS; DEMENTIA; BRAIN; MRI	Markers of Alzheimer's disease (AD) are being widely sought with a number of studies suggesting blood measures of inflammatory proteins as putative biomarkers. Here we report findings from a panel of 27 cytokines and related proteins in over 350 subjects with AD, subjects with Mild Cognitive Impairment (MCI) and elderly normal controls where we also have measures of longitudinal change in cognition and baseline neuroimaging measures of atrophy. In this study, we identify five inflammatory proteins associated with evidence of atrophy on MR imaging data particularly in whole brain, ventricular and entorhinal cortex measures. In addition, we observed six analytes that showed significant change (over a period of one year) in people with fast cognitive decline compared to those with intermediate and slow decline. One of these (IL-10) was also associated with brain atrophy in AD. In conclusion, IL-10 was associated with both clinical and imaging evidence of severity of disease and might therefore have potential to act as biomarker of disease progression.	[Leung, Rufina; Simmons, Andrew; Kronenberg, Deborah; Pritchard, Megan; Lovestone, Simon] Kings Coll London, London WC2R 2LS, England; [Leung, Rufina; Simmons, Andrew; Kronenberg, Deborah; Pritchard, Megan; Lovestone, Simon] South London & Maudsley NHS Fdn Trust, Biomed Res Ctr, NIHR, London, England; [Leung, Rufina; Simmons, Andrew; Kronenberg, Deborah; Pritchard, Megan; Lovestone, Simon] Guys & St Thomas NHS Fdn Trust, London, England; [Proitsi, Petroula; Simmons, Andrew; Lunnon, Katie; Guentert, Andreas; Lovestone, Simon] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Tsolaki, Magda] Aristotle Univ Thessaloniki, G Papanicolaou Hosp, Dept Neurol 3, GR-54006 Thessaloniki, Greece; [Mecocci, Patrizia] Univ Perugia, Inst Gerontol & Geriatr, I-06100 Perugia, Italy; [Kloszewska, Iwona] Med Univ Lodz, Dept Old Age Psychiat & Psychot Disorders, Lodz, Poland; [Vellas, Bruno] Univ Toulouse, CHU Toulouse, INSERM, UMR Gerontopole 1027, Toulouse, France; [Soininen, Hilkka] Univ Eastern Finland, Kuopio, Finland; [Soininen, Hilkka] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Wahlund, Lars-Olaf] Karolinska Inst, Karolinska Univ Hosp, Dept Neurobiol Care Sci & Soc, Sect Clin Geriatr, Stockholm, Sweden	University of London; King's College London; South London & Maudsley NHS Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Aristotle University of Thessaloniki; George Papanikolaou General Hospital of Thessaloniki; University of Perugia; Medical University Lodz; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Karolinska Institutet; Karolinska University Hospital	Lovestone, S (corresponding author), Kings Coll London, London WC2R 2LS, England.	simon.lovestone@kcl.ac.uk	Kronenberg-Versteeg, Deborah/AAW-5442-2020; Mecocci, Patrizia/W-2116-2019; Lunnon, Katie/C-4638-2012; Simmons, Andrew/B-8848-2008	Kronenberg-Versteeg, Deborah/0000-0003-0965-9998; Mecocci, Patrizia/0000-0003-0729-5246; Lunnon, Katie/0000-0001-7570-6065; Simmons, Andrew/0000-0003-2306-5811; Lovestone, Simon/0000-0003-0473-4565; Proitsi, Petroula/0000-0002-2553-6974; wahlund, lars-olof/0000-0002-9905-8426; Tsolaki, Magda/0000-0002-2072-8010; Pritchard, Megan Ruth/0000-0001-8872-3614	National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre; Dementia Biomedical Research Unit at South London; Maudsley NHS Foundation Trust; King's College London; European Union [FP6-2004-LIFESCIHEALTH-5]; Alzheimers Research UK [ART-PG2010-4, ART-RF2007-3] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10053] Funding Source: researchfish	National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre; Dementia Biomedical Research Unit at South London; Maudsley NHS Foundation Trust; King's College London; European Union(European Commission); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); National Institute for Health Research(National Institute for Health Research (NIHR))	This research was conducted at, and part funded by, the National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre and Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. AddNeuroMed/InnoMed, (Innovative Medicines in Europe) is an Integrated Project funded by the European Union of the Sixth Framework program priority FP6-2004-LIFESCIHEALTH-5, Life Sciences, Genomics and Biotechnology for Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Arends YM, 2000, NEUROBIOL AGING, V21, P39, DOI 10.1016/S0197-4580(00)00094-4; Bailey P, 2007, CAN J NEUROL SCI, V34, pS72, DOI 10.1017/S0317167100005618; Banks WA, 2002, NEUROIMMUNOMODULAT, V10, P319, DOI 10.1159/000071472; Barber R, 1999, NEUROLOGY, V52, P1153, DOI 10.1212/WNL.52.6.1153; Bonifati DM, 2007, MOL IMMUNOL, V44, P999, DOI 10.1016/j.molimm.2006.03.007; Doecke JD, 2012, ARCH NEUROL-CHICAGO, V69, P1318, DOI 10.1001/archneurol.2012.1282; Dziedzic Tomasz, 2006, Am J Alzheimers Dis Other Demen, V21, P258, DOI 10.1177/1533317506289260; Eikelenboom P, 2006, J NEURAL TRANSM, V113, P1685, DOI 10.1007/s00702-006-0575-6; Eikelenboom P, 1996, NEUROBIOL AGING, V17, P673; FREI K, 1989, EUR J IMMUNOL, V19, P689, DOI 10.1002/eji.1830190418; Grammas P, 2001, NEUROBIOL AGING, V22, P837, DOI 10.1016/S0197-4580(01)00276-7; HAGA S, 1993, BRAIN RES, V601, P88, DOI 10.1016/0006-8993(93)91698-R; Ishizuka K, 1997, PSYCHIAT CLIN NEUROS, V51, P135, DOI 10.1111/j.1440-1819.1997.tb02375.x; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; JOBST KA, 1992, LANCET, V340, P1179; Konsman JP, 2002, TRENDS NEUROSCI, V25, P154, DOI 10.1016/S0166-2236(00)02088-9; Laske C, 2009, J ALZHEIMERS DIS, V17, P115, DOI 10.3233/JAD-2009-1017; Lovestone S, 2007, EXPERT REV PROTEOMIC, V4, P227, DOI 10.1586/14789450.4.2.227; Lovestone S, 2009, ANN NY ACAD SCI, V1180, P36, DOI 10.1111/j.1749-6632.2009.05064.x; McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; Meda L, 1999, J NEUROIMMUNOL, V93, P45, DOI 10.1016/S0165-5728(98)00188-X; Mrak RE, 2005, J ALZHEIMERS DIS, V8, P369; Noelker C, 2011, MOL DIAGN THER, V15, P83, DOI 10.2165/11534870-000000000-00000; O'Brien JT, 2007, BRIT J RADIOL, V80, pS71, DOI 10.1259/bjr/33117326; Perry VH, 2004, BRAIN BEHAV IMMUN, V18, P407, DOI 10.1016/j.bbi.2004.01.004; Petrella JR, 2003, RADIOLOGY, V226, P315, DOI 10.1148/radiol.2262011600; Ravetti MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003111; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; ROZEMULLER JM, 1989, J NEUROPATH EXP NEUR, V48, P674, DOI 10.1097/00005072-198911000-00009; Sanchez-Ramos J, 2009, NEUROSCIENCE, V163, P55, DOI 10.1016/j.neuroscience.2009.05.071; Scheltens P, 2002, LANCET NEUROL, V1, P13, DOI 10.1016/S1474-4422(02)00002-9; Shaw LM, 2007, NAT REV DRUG DISCOV, V6, P295, DOI 10.1038/nrd2176; Simmons A, 2011, INT J GERIATR PSYCH, V26, P75, DOI 10.1002/gps.2491; Simmons A, 2009, ANN NY ACAD SCI, V1180, P47, DOI 10.1111/j.1749-6632.2009.05063.x; Soares HD, 2012, ARCH NEUROL-CHICAGO, P1, DOI DOI 10.1001/ARCHNEUROL.2012.1070; Soares HD, 2012, ARCH NEUROL-CHICAGO, V69, P1310, DOI 10.1001/archneurol.2012.1070; Sue W, 2006, AM J CLIN NUTR, V83, p470S; Suo ZM, 1998, BRAIN RES, V807, P110, DOI 10.1016/S0006-8993(98)00780-X; Vehmas AK, 2003, NEUROBIOL AGING, V24, P321, DOI 10.1016/S0197-4580(02)00090-8; YAO JB, 1992, BRAIN RES, V591, P88, DOI 10.1016/0006-8993(92)90981-E; Zhao BY, 1998, J NEUROSCI RES, V52, P7, DOI 10.1002/(SICI)1097-4547(19980401)52:1<7::AID-JNR2>3.0.CO;2-I	44	92	93	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e64971	10.1371/journal.pone.0064971	http://dx.doi.org/10.1371/journal.pone.0064971			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762274	Green Published, gold, Green Submitted			2022-12-27	WOS:000320440500016
J	Bykova, NA; Favorov, AV; Mironov, AA				Bykova, Nadezda A.; Favorov, Alexander V.; Mironov, Andrey A.			Hidden Markov Models for Evolution and Comparative Genomics Analysis	PLOS ONE			English	Article							ANCESTRAL CHARACTER STATES; SIGNAL PEPTIDES; PREDICTION; SEQUENCES; ACCURACY	The problem of reconstruction of ancestral states given a phylogeny and data from extant species arises in a wide range of biological studies. The continuous-time Markov model for the discrete states evolution is generally used for the reconstruction of ancestral states. We modify this model to account for a case when the states of the extant species are uncertain. This situation appears, for example, if the states for extant species are predicted by some program and thus are known only with some level of reliability; it is common for bioinformatics field. The main idea is formulation of the problem as a hidden Markov model on a tree (tree HMM, tHMM), where the basic continuous-time Markov model is expanded with the introduction of emission probabilities of observed data (e. g. prediction scores) for each underlying discrete state. Our tHMM decoding algorithm allows us to predict states at the ancestral nodes as well as to refine states at the leaves on the basis of quantitative comparative genomics. The test on the simulated data shows that the tHMM approach applied to the continuous variable reflecting the probabilities of the states (i.e. prediction score) appears to be more accurate then the reconstruction from the discrete states assignment defined by the best score threshold. We provide examples of applying our model to the evolutionary analysis of N-terminal signal peptides and transcription factor binding sites in bacteria. The program is freely available at http://bioinf.fbb.msu.ru/nadya/tHMM and via web-service at http://bioinf.fbb.msu.ru/treehmmweb.	[Bykova, Nadezda A.; Mironov, Andrey A.] AA Kharkevich Inst Informat Transmiss Problems RA, Moscow, Russia; [Bykova, Nadezda A.; Mironov, Andrey A.] Moscow MV Lomonosov State Univ, Dept Bioengn & Bioinformat, Moscow, Russia; [Favorov, Alexander V.] Johns Hopkins Univ, Sch Med, Dept Oncol, Div Biostat & Bioinformat, Baltimore, MD 21205 USA; [Favorov, Alexander V.] State Res Inst Genet & Select Ind Microorganisms, Moscow, Russia; [Favorov, Alexander V.] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia	Kharkevich Institute for Information Transmission Problems of the RAS; Lomonosov Moscow State University; Johns Hopkins University; National Research Centre - Kurchatov Institute; Institute of Genetics & Selection of Industrial Microorganisms; Russian Academy of Sciences; Vavilov Institute of General Genetics	Bykova, NA (corresponding author), AA Kharkevich Inst Informat Transmiss Problems RA, Moscow, Russia.	nadya@bioinf.fbb.msu.ru	Favorov, Alexander V/K-2699-2018	Favorov, Alexander V/0000-0003-2595-1091				Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Choo KH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S15-S2; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; Doniger SW, 2007, PLOS COMPUT BIOL, V3, P932, DOI 10.1371/journal.pcbi.0030099; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Durbin R., 1998, BIOL SEQUENCE ANAL P; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ekman S, 2008, SYST BIOL, V57, P141, DOI 10.1080/10635150801910451; Eyre-Walker A, 1998, J MOL EVOL, V47, P686, DOI 10.1007/PL00006427; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gelfand M S, 2000, Brief Bioinform, V1, P357, DOI 10.1093/bib/1.4.357; Hughes WOH, 2008, SCIENCE, V320, P1213, DOI 10.1126/science.1156108; Klimke W, 2009, NUCLEIC ACIDS RES, V37, pD216, DOI 10.1093/nar/gkn734; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Montgomery SH, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-9; Mustonen V, 2005, P NATL ACAD SCI USA, V102, P15936, DOI 10.1073/pnas.0505537102; Novichkov PS, 2010, NUCLEIC ACIDS RES, V38, pD111, DOI 10.1093/nar/gkp894; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Pearl J, 1982, REVEREND BAYES INFER, P133; Ronquist F, 2004, TRENDS ECOL EVOL, V19, P475, DOI 10.1016/j.tree.2004.07.002; Rusch SL, 2007, BIOCHEMISTRY-US, V46, P9665, DOI 10.1021/bi7010064; Shimada T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020081; Tan K, 2001, GENOME RES, V11, P566, DOI 10.1101/gr.149301; Tuller T, 2010, GENOME RES, V20, P122, DOI 10.1101/gr.096115.109; Venditti C, 2011, NATURE, V479, P393, DOI 10.1038/nature10516; Xie D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002064; Zhang XC, 2010, INTRODUCTION TO THZ WAVE PHOTONICS, P1, DOI 10.1007/978-1-4419-0978-7_1	30	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65012	10.1371/journal.pone.0065012	http://dx.doi.org/10.1371/journal.pone.0065012			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762278	gold, Green Submitted, Green Published			2022-12-27	WOS:000321094800014
J	Cavassani, KA; Moreira, AP; Habiel, D; Ito, T; Coelho, AL; Allen, RM; Hu, B; Raphelson, J; Carson, WF; Schaller, MA; Lukacs, NW; Omary, MB; Hogaboam, CM; Kunkel, SL				Cavassani, Karen A.; Moreira, Ana Paula; Habiel, David; Ito, Toshihiro; Coelho, Ana Lucia; Allen, Ron M.; Hu, Bin; Raphelson, Janna; Carson, William F.; Schaller, Matthew A.; Lukacs, Nicholas W.; Omary, M. Bishr; Hogaboam, Cory M.; Kunkel, Steven L.			Toll Like Receptor 3 Plays a Critical Role in the Progression and Severity of Acetaminophen-Induced Hepatotoxicity	PLOS ONE			English	Article							INDUCED LIVER-INJURY; NECROSIS-FACTOR-ALPHA; TERMINAL KINASE; SUBCELLULAR-LOCALIZATION; EXPRESSION; TLR3; ACTIVATION; CELLS; MICE; RNA	Toll-like receptor (TLR) activation has been implicated in acetaminophen (APAP)-induced hepatotoxicity. Herein, we hypothesize that TLR3 activation significantly contributed to APAP-induced liver injury. In fasted wildtype (WT) mice, APAP caused significant cellular necrosis, edema, and inflammation in the liver, and the de novo expression and activation of TLR3 was found to be necessary for APAP-induced liver failure. Specifically, liver tissues from similarly fasted TLR3-deficient (tlr3(-/-)) mice exhibited significantly less histological and biochemical evidence of injury after APAP challenge. Similar protective effects were observed in WT mice in which TLR3 was targeted through immunoneutralization at 3 h post-APAP challenge. Among three important death ligands (i.e. TNF alpha, TRAIL, and FASL) known to promote hepatocyte death after APAP challenge, TNF alpha was the only ligand that was significantly reduced in APAP-challenged tlr3(-/-) mice compared with APAP-challenged WT controls. In vivo studies demonstrated that TLR3 activation contributed to TNFa production in the liver presumably via F4/80(+) and CD11c(+) immune cells. In vitro studies indicated that there was cooperation between TNF alpha and TLR3 in the activation of JNK signaling in isolated and cultured liver epithelial cells (i.e. nMuLi). Moreover, TLR3 activation enhanced the expression of phosphorylated JNK in APAP injured livers. Thus, the current study demonstrates that TLR3 activation contributes to APAP-induced hepatotoxicity.	[Cavassani, Karen A.; Moreira, Ana Paula; Habiel, David; Ito, Toshihiro; Coelho, Ana Lucia; Allen, Ron M.; Raphelson, Janna; Carson, William F.; Schaller, Matthew A.; Lukacs, Nicholas W.; Hogaboam, Cory M.; Kunkel, Steven L.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Hu, Bin] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Omary, M. Bishr] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Cavassani, KA (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.	kcavassa@med.umich.edu; slkunkel@med.umich.edu	Hogaboam, Cory M./AAI-1433-2021; Schaller, Matthew/AAL-7640-2020; hogaboam, cory/M-3578-2014; Lukacs, Nicholas W/ABH-5583-2020	Hogaboam, Cory M./0000-0003-3366-4850; Carson, William F/0000-0001-9459-3924; Omary, Bishr/0000-0002-8624-2347	National Institutes of Health [HL089216, HL31237, HL92845]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031237, R33HL092845, R01HL089216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047918, R01DK052951] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported through grant support from the National Institutes of Health (HL089216, HL31237, HL92845). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begon E, 2007, EUR J DERMATOL, V17, P497; Bernard J.J., 2012, NAT MED; Blazka ME, 1996, RES COMMUN MOL PATH, V92, P259; BLAZKA ME, 1995, TOXICOL APPL PHARM, V133, P43, DOI 10.1006/taap.1995.1125; Bone-Larson CL, 2001, J IMMUNOL, V167, P7077, DOI 10.4049/jimmunol.167.12.7077; Bourdi M, 2011, CHEM RES TOXICOL, V24, P794, DOI 10.1021/tx200143x; Brentano F, 2005, ARTHRITIS RHEUM-US, V52, P2656, DOI 10.1002/art.21273; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Cho WG, 2009, P NATL ACAD SCI USA, V106, P7137, DOI 10.1073/pnas.0812317106; Czaja MJ, 2003, AM J PHYSIOL-GASTR L, V284, pG875, DOI 10.1152/ajpgi.00549.2002; DAHLBERG JE, 2007, SCI STKE, pPE25; Farina C, 2005, J NEUROIMMUNOL, V159, P12, DOI 10.1016/j.jneuroim.2004.09.009; Ghaffari AA, 2011, HEPATOLOGY, V53, P2042, DOI 10.1002/hep.24316; Gunawan BK, 2006, GASTROENTEROLOGY, V131, P165, DOI 10.1053/j.gastro.2006.03.045; Henderson NC, 2007, GUT, V56, P982, DOI 10.1136/gut.2006.104372; Hogaboam CM, 2000, AM J PATHOL, V156, P1245, DOI 10.1016/S0002-9440(10)64995-4; Hu B, 2008, AM J PHYSIOL-GASTR L, V295, pG45, DOI 10.1152/ajpgi.00024.2008; Huys L, 2009, J EXP MED, V206, P1873, DOI 10.1084/jem.20090213; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; Ishida Y, 2004, J LEUKOCYTE BIOL, V75, P59, DOI 10.1189/jlb.0403152; Jiang W, 2005, P NATL ACAD SCI USA, V102, P17077, DOI 10.1073/pnas.0504570102; Kaplowitz N, 2004, HEPATOLOGY, V40, P23, DOI 10.1002/hep.20312; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Lang KS, 2006, J CLIN INVEST, V116, P2456, DOI 10.1172/JCI28349; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Lee H, 2006, BIOCHEM BIOPH RES CO, V350, P742, DOI 10.1016/j.bbrc.2006.09.108; Lee WM, 2007, HEPATOLOGY, V46, P966, DOI 10.1002/hep.21926; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Liu ZX, 2006, HEPATOLOGY, V43, P1220, DOI 10.1002/hep.21175; Liu ZX, 2004, GASTROENTEROLOGY, V127, P1760, DOI 10.1053/j.gastro.2004.08.053; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Matsumura T, 2000, J INTERF CYTOK RES, V20, P915, DOI 10.1089/10799900050163299; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; McGill MR, 2012, J CLIN INVEST, V122, P1574, DOI 10.1172/JCI59755; Mencin A, 2009, GUT, V58, P704, DOI 10.1136/gut.2008.156307; Murray LA, 2008, AM J RESP CRIT CARE, V178, P1227, DOI 10.1164/rccm.200807-1020OC; Neff SB, 2003, EXP MOL PATHOL, V75, P187, DOI 10.1016/S0014-4800(03)00096-0; Papa S, 2009, BIOL CHEM, V390, P965, DOI 10.1515/BC.2009.111; Patole PS, 2006, NEPHROL DIAL TRANSPL, V21, P3062, DOI 10.1093/ndt/gfl336; Patole PS, 2005, J AM SOC NEPHROL, V16, P1326, DOI 10.1681/ASN.2004100820; Rudd BD, 2005, J VIROL, V79, P3350, DOI 10.1128/JVI.79.6.3350-3357.2005; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-0388OC; Simpson KJ, 2000, J PATHOL, V190, P489; Swantek JL, 1997, MOL CELL BIOL, V17, P6274, DOI 10.1128/MCB.17.11.6274; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Wullaert A, 2006, BIOCHEM PHARMACOL, V72, P1090, DOI 10.1016/j.bcp.2006.07.003; Yin S, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/750904; Yohe HC, 2006, AM J PHYSIOL-GASTR L, V290, pG1269, DOI 10.1152/ajpgi.00239.2005; Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004	53	32	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65899	10.1371/journal.pone.0065899	http://dx.doi.org/10.1371/journal.pone.0065899			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762449	Green Published, gold, Green Submitted			2022-12-27	WOS:000321094800081
J	He, H; Liu, XL				He, Hua; Liu, Xiaolin			Characterization of Transcriptional Complexity during Longissimus Muscle Development in Bovines Using High-Throughput Sequencing	PLOS ONE			English	Article							GENE-EXPRESSION; RNA-SEQ; GLOBAL VIEW; TOOL	Background: Beef cattle are among the most economically important animals in the world because they are farmed for their meat and leather. However, a lack of genetic information remains an obstacle to understanding the mechanisms behind the development of this animal. Analysis of the beef cattle transcriptome and its expression profile data are essential to extending the genetic information resources for this species and would support studies on this animal. Results: RNA sequencing of beef cattle was performed using the Illumina High-Seq2000 platform. A total of 25,605,140 and 26,214,800 reads were sequenced for embryonic and adult pooled samples, respectively. We identified 24,464-29,994 novel transcript units in two pooled samples. In addition, 8,533-10,144 genes showed evidence of alternative splicing, in agreement with the finding that alternative 3' splicing is the most common type of alternative splicing event in cattle. We detected the expression levels of 16,174 genes, and 6,800 genes exhibited differential expression between the two pooled samples with a false discovery rate <= 0.001. Using GO enrichment and KEGG pathway analysis, multiple GO term and biological pathways were found to be significantly enriched for differentially expressed genes. In addition, we discovered that 30,618-31,334 putative single nucleotide polymorphisms were located in coding regions. Conclusions: We obtained a high-quality beef cattle reference transcriptome using a high throughput sequencing approach, thereby providing a valuable resource for better understanding the beef cattle genome. The transcriptome data will facilitate future functional studies on the beef cattle genome and can be applied to breeding programs for cattle and closely related mammals.	[He, Hua; Liu, Xiaolin] Northwest A& F Univ, Shaanxi Key Lab Mol Biol Agr, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Liu, XL (corresponding author), Northwest A& F Univ, Shaanxi Key Lab Mol Biol Agr, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.	liuxiaolin@nwsuaf.edu.cn			National Science and Technology Major Project of the Ministry of Science and Technology of China [2011AA100307, 2008AA101010]; "13115" Sci-Tech Innovation Program of Shaanxi Province [2008ZDKG-11]	National Science and Technology Major Project of the Ministry of Science and Technology of China; "13115" Sci-Tech Innovation Program of Shaanxi Province	This study was supported by the National Science and Technology Major Project of the Ministry of Science and Technology of China during the "12th Five-Year Plan" (2011AA100307), the National Science and Technology Major Project of the Ministry of Science and Technology of China during the "11th Five-Year Plan" (No. 2008AA101010), and the "13115" Sci-Tech Innovation Program of Shaanxi Province (2008ZDKG-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Chen CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-448; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-234; Driver AM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-118; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Lehnert SA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213x-7-95; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Maxfield EK, 1998, BIOL REPROD, V59, P321, DOI 10.1095/biolreprod59.2.321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Reddy ASN, 2007, ANNU REV PLANT BIOL, V58, P267, DOI 10.1146/annurev.arplant.58.032806.103754; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Werner T, 2010, BRIEF BIOINFORM, V11, P499, DOI 10.1093/bib/bbq018; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	27	56	60	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e64356	10.1371/journal.pone.0064356	http://dx.doi.org/10.1371/journal.pone.0064356			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762238	gold, Green Submitted, Green Published			2022-12-27	WOS:000321094800006
J	Klenke, C; Widera, D; Engelen, T; Muller, J; Noll, T; Niehaus, K; Schmitz, ML; Kaltschmidt, B; Kaltschmidt, C				Klenke, Christin; Widera, Darius; Engelen, Thomas; Mueller, Janine; Noll, Thomas; Niehaus, Karsten; Schmitz, M. Lienhard; Kaltschmidt, Barbara; Kaltschmidt, Christian			Hsc70 Is a Novel Interactor of NF-kappaB p65 in Living Hippocampal Neurons	PLOS ONE			English	Article							RETROGRADE TRANSPORT; B ACTIVITY; IN-VIVO; EXPRESSION; COMPLEX; HSP90; BRAIN; HSP70; ACTIVATION; PLASTICITY	Signaling via NF-kappa B in neurons depends on complex formation with interactors such as dynein/dynactin motor complex and can be triggered by synaptic activation. However, so far a detailed interaction map for the neuronal NF-kappa B is missing. In this study we used mass spectrometry to identify novel interactors of NF-kappa B p65 within the brain. Hsc70 was identified as a novel neuronal interactor of NF-kappa B p65. In HEK293 cells, a direct physical interaction was shown by co-immunoprecipitation and verified via in situ proximity ligation in healthy rat neurons. Pharmacological blockade of Hsc70 by deoxyspergualin (DSG) strongly decreased nuclear translocation of NF-kappa B p65 and transcriptional activity shown by reporter gene assays in neurons after stimulation with glutamate. In addition, knock down of Hsc70 via siRNA significantly reduced neuronal NF-kappa B activity. Taken together these data provide evidence for Hsc70 as a novel neuronal interactor of NF-kappa B p65.	[Klenke, Christin; Widera, Darius; Engelen, Thomas; Mueller, Janine; Niehaus, Karsten; Kaltschmidt, Barbara; Kaltschmidt, Christian] Univ Bielefeld, D-33615 Bielefeld, Germany; [Noll, Thomas] Univ Bielefeld, Cell Culture Technol, D-33615 Bielefeld, Germany; [Schmitz, M. Lienhard] Univ Giessen, Inst Biochem, Fac Med, D-35390 Giessen, Germany	University of Bielefeld; University of Bielefeld; Justus Liebig University Giessen	Kaltschmidt, C (corresponding author), Univ Bielefeld, D-33615 Bielefeld, Germany.	c.kaltschmidt@uni-bielefeld.de	Noll, Thomas/A-3539-2012; Widera, Darius/J-4237-2012; Schmitz, M. Lienhard/D-9328-2017	Noll, Thomas/0000-0003-0748-3423; Widera, Darius/0000-0003-1686-130X; Schmitz, M. Lienhard/0000-0002-6984-7192	Deutsche Forschungsgemeinschaft (DFG); Bielefeld University Library	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bielefeld University Library	This study was supported by the grant of the Deutsche Forschungsgemeinschaft (DFG) to CK. The authors acknowledge the support for the Article Processing Charge by the Deutsche Forschungsgemeinschaft (DFG) and the Open Access Publication Funds of Bielefeld University Library. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bharadwaj S, 1999, MOL CELL BIOL, V19, P8033; D'Souza SM, 1998, CELL STRESS CHAPERON, V3, P188, DOI 10.1379/1466-1268(1998)003<0188:CEOHSP>2.3.CO;2; DEWAEGH S, 1989, J NEUROSCI RES, V23, P433, DOI 10.1002/jnr.490230409; Dokladny K, 2010, CELL STRESS CHAPERON, V15, P153, DOI 10.1007/s12192-009-0129-6; Fridmacher V, 2003, J NEUROSCI, V23, P9403; Galigniana MD, 2004, MOL BRAIN RES, V123, P27, DOI 10.1016/j.molbrainres.2003.12.015; Kaltschmidt B, 2005, BBA-MOL CELL RES, V1745, P287, DOI 10.1016/j.bbamcr.2005.05.009; Kaltschmidt B, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001271; KALTSCHMIDT C, 1993, MECH DEVELOP, V43, P135, DOI 10.1016/0925-4773(93)90031-R; KALTSCHMIDT C, 1994, MOL CELL BIOL, V14, P3981, DOI 10.1128/MCB.14.6.3981; Marcora E, 2010, HUM MOL GENET, V19, P4373, DOI 10.1093/hmg/ddq358; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; Mattson MP, 2000, J NEUROCHEM, V74, P443, DOI 10.1046/j.1471-4159.2000.740443.x; Meffert MK, 2005, TRENDS NEUROSCI, V28, P37, DOI 10.1016/j.tins.2004.11.002; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Mikenberg I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000589; Morishima Y, 2001, BIOCHEMISTRY-US, V40, P1109, DOI 10.1021/bi002399+; Nadler SG, 1998, BIOCHEM BIOPH RES CO, V253, P176, DOI 10.1006/bbrc.1998.9775; Shrum CK, 2009, P NATL ACAD SCI USA, V106, P2647, DOI 10.1073/pnas.0806677106; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stetler RA, 2010, PROG NEUROBIOL, V92, P184, DOI 10.1016/j.pneurobio.2010.05.002; Sugawara A, 2009, CELL STRESS CHAPERON, V14, P133, DOI 10.1007/s12192-008-0064-y; Suzuki T, 1999, BRAIN RES, V816, P99, DOI 10.1016/S0006-8993(98)01083-X; TEPPER MA, 1995, J IMMUNOL, V155, P2427; Wellmann H, 2001, J BIOL CHEM, V276, P11821, DOI 10.1074/jbc.M009253200	25	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65280	10.1371/journal.pone.0065280	http://dx.doi.org/10.1371/journal.pone.0065280			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762333	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000321094800033
J	Vickers, DAL; Chory, EJ; Harless, MC; Murthy, SK				Vickers, Dwayne A. L.; Chory, Emma J.; Harless, Megan C.; Murthy, Shashi K.			p38 Signaling and Receptor Recycling Events in a Microfluidic Endothelial Cell Adhesion Assay	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FLUID SHEAR-STRESS; SMOOTH-MUSCLE; INHIBITOR; ENDOCYTOSIS; DEPLETION; FLOW; PHOSPHORYLATION; INTERNALIZATION; STIMULATION	Adhesion-based microfluidic cell separation has proven to be very useful in applications ranging from cancer diagnostics to tissue engineering. This process involves functionalizing microchannel surfaces with a capture molecule. High specificity and purity capture can be achieved using this method. Despite these advances, little is known about the mechanisms that govern cell capture within these devices and their relationships to basic process parameters such as fluid shear stress and the presence of soluble factors. This work examines how the adhesion of human endothelial cells (ECs) is influenced by a soluble tetrapeptide, Arg-Glu-Asp-Val (REDV) and fluidic shear stress. The ability of these ECs to bind within microchannels coated with REDV is shown to be governed by shear-and soluble-factor mediated changes in p38 mitogen-activated protein kinase expression together with recycling of adhesion receptors from the endosome.	[Vickers, Dwayne A. L.; Chory, Emma J.; Harless, Megan C.; Murthy, Shashi K.] Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA; [Murthy, Shashi K.] Northeastern Univ, Barnett Inst Chem & Biol Anal, Boston, MA 02115 USA	Northeastern University; Northeastern University	Murthy, SK (corresponding author), Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA.	smurthy@coe.neu.edu	Vickers, Dwayne/I-5819-2012	Vickers, Dwayne/0000-0002-9218-7348; Chory, Emma/0000-0001-8541-9289	U.S. National Science Foundation [CBET-0747166]; Directorate For Engineering [0747166] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	The authors gratefully acknowledge financial support from the U.S. National Science Foundation through grant CBET-0747166 (CAREER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Azenabor AA, 2011, IMMUNOBIOLOGY, V216, P1248, DOI 10.1016/j.imbio.2011.07.002; Azuma N, 2000, J VASC SURG, V32, P789, DOI 10.1067/mva.2000.107989; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; BOEYNAEMS JM, 1993, EUR J PHARMACOL, V233, P13, DOI 10.1016/0014-2999(93)90343-G; BORRAS M, 1994, J STEROID BIOCHEM, V48, P325, DOI 10.1016/0960-0760(94)90072-8; Byron A, 2009, J CELL SCI, V122, P4009, DOI 10.1242/jcs.056770; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Cheng XH, 2009, LAB CHIP, V9, P1357, DOI 10.1039/b818813k; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; GEIGER RV, 1992, AM J PHYSIOL, V262, pC1411, DOI 10.1152/ajpcell.1992.262.6.C1411; Hatch A, 2011, LANGMUIR, V27, P4257, DOI 10.1021/la105016a; Hendriks BS, 2003, BIOPHYS J, V85, P2732, DOI 10.1016/S0006-3495(03)74696-7; Humphries MJ, 2003, TRENDS BIOCHEM SCI, V28, P313, DOI 10.1016/S0968-0004(03)00112-9; Jin H, 2010, BLOOD COAGUL FIBRIN, V21, P420, DOI 10.1097/MBC.0b013e328337b475; Kurata S, 2000, J BIOL CHEM, V275, P23413, DOI 10.1074/jbc.C000308200; Kwan HY, 2003, CIRC RES, V92, P286, DOI 10.1161/01.RES.0000054625.24468.08; Lauffenburger D. A., 1993, RECEPTORS MODELS BIN; LAZAR DF, 1995, J BIOL CHEM, V270, P20801, DOI 10.1074/jbc.270.35.20801; Mace T, 2005, EMBO J, V24, P3235, DOI 10.1038/sj.emboj.7600799; MAGNUSSON S, 1993, EXP CELL RES, V205, P118, DOI 10.1006/excr.1993.1065; Manthey CL, 1998, J LEUKOCYTE BIOL, V64, P409, DOI 10.1002/jlb.64.3.409; Murthy SK, 2004, LANGMUIR, V20, P11649, DOI 10.1021/la048047b; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Okuda M, 1999, J BIOL CHEM, V274, P26803, DOI 10.1074/jbc.274.38.26803; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Plouffe BD, 2008, LAB CHIP, V8, P462, DOI 10.1039/b715707j; Plouffe BD, 2007, LANGMUIR, V23, P5050, DOI 10.1021/la0700220; Plouffe BD, 2009, FASEB J, V23, P3309, DOI 10.1096/fj.09-130260; Pratt ED, 2011, CHEM ENG SCI, V66, P1508, DOI 10.1016/j.ces.2010.09.012; Ptasinska A, 2007, FASEB J, V21, P950, DOI 10.1096/fj.06-6822com; Resnick N, 2003, PROG BIOPHYS MOL BIO, V81, P177, DOI 10.1016/S0079-6107(02)00052-4; Russom A, 2008, CLIN CHEM, V54, P891, DOI 10.1373/clinchem.2007.099150; Serge A, 2011, INTEGR BIOL-UK, V3, P675, DOI 10.1039/c0ib00121j; Shen KK, 2012, BIOCHEM PHARMACOL, V84, P784, DOI 10.1016/j.bcp.2012.05.024; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Spangler JB, 2010, P NATL ACAD SCI USA, V107, P13252, DOI 10.1073/pnas.0913476107; Stone MK, 2008, INFECT IMMUN, V76, P1115, DOI 10.1128/IAI.01300-07; Sumpio BE, 2005, J BIOL CHEM, V280, P11185, DOI 10.1074/jbc.M414631200; Surapisitchat J, 2001, P NATL ACAD SCI USA, V98, P6476, DOI 10.1073/pnas.101134098; SYMS AJ, 1985, J BIOL CHEM, V260, P455; Tandon V, 2012, BIOTECHNOLOGY ADV; Teis D, 2006, J CELL BIOL, V175, P861, DOI 10.1083/jcb.200607025; TSAVALER L, 1986, J CELL PHYSIOL, V128, P1, DOI 10.1002/jcp.1041280102; Tzima E, 2002, EMBO J, V21, P6791, DOI 10.1093/emboj/cdf688; Wankhede SP, 2006, BIOTECHNOL PROGR, V22, P1426, DOI 10.1021/bp060127d; Wiley HS, 2003, EXP CELL RES, V284, P78, DOI 10.1016/S0014-4827(03)00002-8; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Yasuda S, 2007, NEURON, V56, P456, DOI 10.1016/j.neuron.2007.08.020; Young EWK, 2010, LAB CHIP, V10, P143, DOI 10.1039/b913390a; Zhang BY, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494003; Zwang Y, 2006, EMBO J, V25, P4195, DOI 10.1038/sj.emboj.7601297	53	2	2	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65828	10.1371/journal.pone.0065828	http://dx.doi.org/10.1371/journal.pone.0065828			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762436	Green Submitted, gold, Green Published			2022-12-27	WOS:000321094800077
J	Wu, AC; Morell, MK; Gilbert, RG				Wu, Alex Chi; Morell, Matthew K.; Gilbert, Robert G.			A Parameterized Model of Amylopectin Synthesis Provides Key Insights into the Synthesis of Granular Starch	PLOS ONE			English	Article							ASSISTED CARBOHYDRATE ELECTROPHORESIS; BRANCHING-ENZYME; RICE ENDOSPERM; DISPROPORTIONATING ENZYME; DEBRANCHING ENZYMES; INTERNAL STRUCTURE; FINE-STRUCTURE; ARABIDOPSIS; BIOSYNTHESIS; MUTANTS	A core set of genes involved in starch synthesis has been defined by genetic studies, but the complexity of starch biosynthesis has frustrated attempts to elucidate the precise functional roles of the enzymes encoded. The chain-length distribution (CLD) of amylopectin in cereal endosperm is modeled here on the basis that the CLD is produced by concerted actions of three enzyme types: starch synthases, branching and debranching enzymes, including their respective isoforms. The model, together with fitting to experiment, provides four key insights. (1) To generate crystalline starch, defined restrictions on particular ratios of enzymatic activities apply. (2) An independent confirmation of the conclusion, previously reached solely from genetic studies, of the absolute requirement for debranching enzyme in crystalline amylopectin synthesis. (3) The model provides a mechanistic basis for understanding how successive arrays of crystalline lamellae are formed, based on the identification of two independent types of long amylopectin chains, one type remaining in the amorphous lamella, while the other propagates into, and is integral to the formation of, an adjacent crystalline lamella. (4) The model provides a means by which a small number of key parameters defining the core enzymatic activities can be derived from the amylopectin CLD, providing the basis for focusing studies on the enzymatic requirements for generating starches of a particular structure. The modeling approach provides both a new tool to accelerate efforts to understand granular starch biosynthesis and a basis for focusing efforts to manipulate starch structure and functionality using a series of testable predictions based on a robust mechanistic framework.	[Wu, Alex Chi; Gilbert, Robert G.] Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430074, Hubei Province, Peoples R China; [Wu, Alex Chi; Gilbert, Robert G.] Univ Queensland, Queensland Alliance Agr & Food Innovat, Ctr Nutr & Food Sci, Brisbane, Qld, Australia; [Morell, Matthew K.] CSIRO, Food Futures Natl Res Flagship, Canberra, ACT, Australia; [Morell, Matthew K.] CSIRO, Canberra, ACT, Australia	Huazhong University of Science & Technology; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Gilbert, RG (corresponding author), Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430074, Hubei Province, Peoples R China.	b.gilbert@uq.edu.au	Morell, Matthew/AAQ-5368-2021; Wu, Alex/C-3513-2017; Gilbert, Robert G/C-5660-2009	Morell, Matthew/0000-0003-4467-1626; Wu, Alex/0000-0002-6612-7691; Gilbert, Robert G/0000-0001-6988-114X	Australian Postgraduate Award; CSIRO Food Future Flagship Postgraduate scholarship	Australian Postgraduate Award(Australian Government); CSIRO Food Future Flagship Postgraduate scholarship	This work is supported by an Australian Postgraduate Award (http://www.innovation.gov.au/research/researchblockgrants/pages/australianpostgraduateawards.aspx) and CSIRO Food Future Flagship Postgraduate scholarship (http://www.csiro.au/Organisation-Structure/Flagships/Food-Futures-Flagship/Future-Grains-Theme.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao ZH, 2007, CARBOHYD POLYM, V67, P46, DOI 10.1016/j.carbpol.2006.04.013; ASAOKA M, 1985, AGR BIOL CHEM TOKYO, V49, P1973, DOI 10.1080/00021369.1985.10867028; Ball SG, 2003, ANNU REV PLANT BIOL, V54, P207, DOI 10.1146/annurev.arplant.54.031902.134927; Benmoussa M, 2007, J AGR FOOD CHEM, V55, P1475, DOI 10.1021/jf062349x; BOYER CD, 1978, CARBOHYD RES, V61, P321, DOI 10.1016/S0008-6215(00)84492-4; Bresolin NS, 2006, PLANTA, V224, P20, DOI 10.1007/s00425-005-0187-7; Burton RA, 2002, PLANT J, V31, P97, DOI 10.1046/j.1365-313X.2002.01339.x; Butardo VM, 2011, J EXP BOT, V62, P4927, DOI 10.1093/jxb/err188; Colleoni C, 1999, PLANT PHYSIOL, V120, P993, DOI 10.1104/pp.120.4.993; Commuri PD, 2001, PLANT J, V25, P475, DOI 10.1046/j.1365-313x.2001.00955.x; Critchley JH, 2001, PLANT J, V26, P89, DOI 10.1046/j.1365-313x.2001.01012.x; Delatte T, 2005, PLANT J, V41, P815, DOI 10.1111/j.1365-313X.2005.02348.x; Edner C, 2007, PLANT PHYSIOL, V145, P17, DOI 10.1104/pp.107.104224; Fujita N, 2006, PLANT PHYSIOL, V140, P1070, DOI 10.1104/pp.105.071845; Fujita N, 2007, PLANT PHYSIOL, V144, P2009, DOI 10.1104/pp.107.102533; Guan HP, 1997, ARCH BIOCHEM BIOPHYS, V342, P92, DOI 10.1006/abbi.1997.0115; HIZUKURI S, 1986, CARBOHYD RES, V147, P342, DOI 10.1016/S0008-6215(00)90643-8; INOUCHI N, 1983, STARKE, V35, P371, DOI 10.1002/star.19830351102; JAMES MG, 1995, PLANT CELL, V7, P417, DOI 10.1105/tpc.7.4.417; JANE JL, 1993, CARBOHYD RES, V247, P279, DOI 10.1016/0008-6215(93)84260-D; JENKINS JPJ, 1993, STARCH-STARKE, V45, P417; Jeon JS, 2010, PLANT PHYSIOL BIOCH, V48, P383, DOI 10.1016/j.plaphy.2010.03.006; Konik-Rose C, 2007, THEOR APPL GENET, V115, P1053, DOI 10.1007/s00122-007-0631-0; Lehmann U, 2007, TRENDS FOOD SCI TECH, V18, P346, DOI 10.1016/j.tifs.2007.02.009; Li L, 2007, CARBOHYD POLYM, V67, P630, DOI 10.1016/j.carbpol.2006.08.013; Morell MK, 1998, ELECTROPHORESIS, V19, P2603, DOI 10.1002/elps.1150191507; Mouille G, 1996, PLANT CELL, V8, P1353; Myers AM, 2000, PLANT PHYSIOL, V122, P989, DOI 10.1104/pp.122.4.989; Nakamura Y, 2002, PLANT CELL PHYSIOL, V43, P718, DOI 10.1093/pcp/pcf091; Nakamura Y, 2010, PLANT CELL PHYSIOL, V51, P776, DOI 10.1093/pcp/pcq035; Nielsen TH, 2002, J BIOL CHEM, V277, P20249, DOI 10.1074/jbc.M201866200; O'Shea MG, 1998, CARBOHYD RES, V307, P1, DOI 10.1016/S0008-6215(97)10085-4; Pan DD, 2000, BIOMACROMOLECULES, V1, P126, DOI 10.1021/bm990016l; Rahman S, 2001, PLANT PHYSIOL, V125, P1314, DOI 10.1104/pp.125.3.1314; Roldan I, 2007, PLANT J, V49, P492, DOI 10.1111/j.1365-313X.2006.02968.x; Rydberg U, 2001, EUR J BIOCHEM, V268, P6140, DOI 10.1046/j.0014-2956.2001.02568.x; Sharma A, 2008, FOOD REV INT, V24, P193, DOI 10.1080/87559120801926237; Streb S, 2008, PLANT CELL, V20, P3448, DOI 10.1105/tpc.108.063487; Szydlowski N, 2009, PLANT CELL, V21, P2443, DOI 10.1105/tpc.109.066522; Tetlow IJ, 2011, SEED SCI RES, V21, P5, DOI 10.1017/S0960258510000292; Tomlinson KL, 1997, PLANT J, V11, P31, DOI 10.1046/j.1365-313X.1997.11010031.x; Umemoto T, 2002, THEOR APPL GENET, V104, P1, DOI 10.1007/s001220200000; Vermeylen R, 2004, BIOMACROMOLECULES, V5, P1775, DOI 10.1021/bm0499132; Waters DLE, 2006, PLANT BIOTECHNOL J, V4, P115, DOI 10.1111/j.1467-7652.2005.00162.x; Wattebled F, 2008, PLANT PHYSIOL, V148, P1309, DOI 10.1104/pp.108.129379; Witt T, 2013, RELATIONS MOL UNPUB; Wu AC, 2013, PROGRAM APCLDFIT; Wu AC, 2010, BIOMACROMOLECULES, V11, P3539, DOI 10.1021/bm1010189; Yoo SH, 2002, CARBOHYD POLYM, V49, P307, DOI 10.1016/S0144-8617(01)00339-3; Zeeman SC, 1998, PLANT J, V15, P357, DOI 10.1046/j.1365-313X.1998.00213.x	50	88	89	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65768	10.1371/journal.pone.0065768	http://dx.doi.org/10.1371/journal.pone.0065768			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762422	gold, Green Submitted, Green Published			2022-12-27	WOS:000321094800070
J	Grum, D; Franke, S; Kraff, O; Heider, D; Schramm, A; Hoffmann, D; Bayer, P				Grum, Daniel; Franke, Stefan; Kraff, Oliver; Heider, Dominik; Schramm, Alexander; Hoffmann, Daniel; Bayer, Peter			Design of a Modular Protein-Based MRI Contrast Agent for Targeted Application	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; HIGHLY EFFICIENT; CARCINOMA-CELLS; BINDING; FLUORESCENCE; SIMULATION; GADOLINIUM; DOMAIN; FIELD; EGF	Magnetic resonance imaging (MRI) offers a non-radioactive alternative for the non-invasive detection of tumours. Low molecular weight MRI contrast agents currently in clinical use suffer either from a lack of specificity for tumour tissue or from low relaxivity and thus low contrast amplification. In this study, we present the newly designed two domain fusion protein Zarvin, which is able to bind to therapeutic IgG antibodies suitable for targeting, while facilitating contrast enhancement through high affinity binding sites for Gd3+. We show that the Zarvin fold is stable under serum conditions, specifically targets a cancer cell-line when bound to the Cetuximab IgG, and allows for imaging with high relaxivity, a property that would be advantageous for the detection of small tumours and metastases at 1.5 or 3 T.	[Grum, Daniel; Bayer, Peter] Univ Duisburg Essen, Res Grp Struct & Med Biochem, Ctr Med Biotechnol, Essen, Germany; [Franke, Stefan; Heider, Dominik; Hoffmann, Daniel] Univ Duisburg Essen, Res Grp Bioinformat, Ctr Med Biotechnol, Essen, Germany; [Kraff, Oliver] Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany; [Schramm, Alexander] Univ Childrens Hosp, Dept Pediat Hematol, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Hamburg; University Medical Center Hamburg-Eppendorf	Hoffmann, D (corresponding author), Univ Duisburg Essen, Res Grp Bioinformat, Ctr Med Biotechnol, Essen, Germany.	Daniel.Hoffmann@uni-due.de; Peter.Bayer@uni-due.de	Schramm, Alexander/G-5688-2010; Hoffmann, Daniel/P-5624-2019; Hoffmann, Daniel/B-1314-2018; Heider, Dominik/F-8545-2010; Bayer, Peter/B-8803-2009; Kraff, Oliver/AAE-2238-2020	Schramm, Alexander/0000-0001-7670-7529; Hoffmann, Daniel/0000-0003-2973-7869; Hoffmann, Daniel/0000-0003-2973-7869; Heider, Dominik/0000-0002-3108-8311; Bayer, Peter/0000-0003-0435-7202; Kraff, Oliver/0000-0002-6006-8934	"Bundesministerium fur Bildung und Forschung" (BMBF) [01EZ093 1-4]	"Bundesministerium fur Bildung und Forschung" (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the "Bundesministerium fur Bildung und Forschung" (BMBF; 01EZ093 1-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES DW, 1982, J CELL BIOL, V93, P1, DOI 10.1083/jcb.93.1.1; Basu G, 2003, J BIOL INORG CHEM, V8, P721, DOI 10.1007/s00775-003-0470-7; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; Bernstein MA, 2004, HDB MRI PULSE SEQUEN, P608; Brucher E, 2002, TOP CURR CHEM, V221, P103; Caravan P, 2006, CHEM SOC REV, V35, P512, DOI 10.1039/b510982p; Caravan P, 2009, CONTRAST MEDIA MOL I, V4, P89, DOI 10.1002/cmmi.267; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Daura X, 1998, J COMPUT CHEM, V19, P535, DOI 10.1002/(SICI)1096-987X(19980415)19:5<535::AID-JCC6>3.0.CO;2-N; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; Fasman G.D., 1976, HDB BIOCH MOL BIOL P, V1; Flacke S, 2001, CIRCULATION, V104, P1280, DOI 10.1161/hc3601.094303; Guenoun J, 2012, CELL TRANSPLANT, V21, P191, DOI 10.3727/096368911X593118; HAIGLER H, 1978, P NATL ACAD SCI USA, V75, P3317, DOI 10.1073/pnas.75.7.3317; Han LA, 2011, BIOMATERIALS, V32, P2989, DOI 10.1016/j.biomaterials.2011.01.005; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Histed SN, 2012, NUCL MED COMMUN, V33, P349, DOI 10.1097/MNM.0b013e32834ec8a5; HORROCKS WD, 1979, J AM CHEM SOC, V101, P334, DOI 10.1021/ja00496a010; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kim BH, 2011, J AM CHEM SOC, V133, P12624, DOI 10.1021/ja203340u; KWOK TT, 1991, BRIT J CANCER, V64, P251, DOI 10.1038/bjc.1991.286; Lee YH, 2004, BIOCHEMISTRY-US, V43, P10008, DOI 10.1021/bi0492915; Lide D. R., 1995, CRC HDB CHEM PHYS; MARTELL AE, 1993, NIST STANDARD REFERE; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MASUI H, 1993, J CELL BIOL, V120, P85, DOI 10.1083/jcb.120.1.85; NILSSON B, 1987, PROTEIN ENG, V1, P107, DOI 10.1093/protein/1.2.107; Plazinski W, 2012, APPL SURF SCI, V262, P153, DOI 10.1016/j.apsusc.2012.03.151; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Winter PM, 2003, CANCER RES, V63, P5838; Yang JJ, 2008, J AM CHEM SOC, V130, P9260, DOI 10.1021/ja800736h; Zheng DY, 2004, PROTEIN SCI, V13, P549, DOI 10.1110/ps.03351704	33	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65346	10.1371/journal.pone.0065346	http://dx.doi.org/10.1371/journal.pone.0065346			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762349	Green Submitted, gold, Green Published			2022-12-27	WOS:000321099000059
J	Zagaceta, J; Zulueta, JJ; Bastarrika, G; Colina, I; Alcaide, AB; Campo, A; Celli, BR; de Torres, JP				Zagaceta, Jorge; Zulueta, Javier J.; Bastarrika, Gorka; Colina, Inmaculada; Alcaide, Ana B.; Campo, Arantza; Celli, Bartolome R.; de Torres, Juan P.			Epicardial Adipose Tissue in Patients with Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							VISCERAL ABDOMINAL FAT; AIR-FLOW OBSTRUCTION; PERICARDIAL FAT; COMPUTED-TOMOGRAPHY; LUNG-CANCER; SLEEP-APNEA; RISK; MORTALITY; ASSOCIATION; ATHEROSCLEROSIS	Rationale: Epicardial Adipose Tissue (EAT) volume as determined by chest computed tomography (CT) is an independent marker of cardiovascular events in the general population. COPD patients have an increased risk of cardiovascular disease, however nothing is known about the EAT volume in this population. Objectives: To assess EAT volume in COPD and explore its association with clinical and physiological variables of disease severity. Methods: We measured EAT using low-dose CT in 171 stable COPD patients and 70 controls matched by age, smoking history and BMI. We determined blood pressure, cholesterol, glucose and HbA1c levels, microalbuminuria, lung function, BODE index, co-morbidity index and coronary artery calcium score (CAC). EAT volume were compared between groups. Uni and multivariate analyses explored the relationship between EAT volume and the COPD related variables. Results: COPD patients had a higher EAT volume [143.7 (P25-75, 108.3-196.6) vs 129.1 (P25-75, 91.3-170.8) cm(3), p = 0.02)] and the EAT volume was significantly associated with CAC (r = 0.38, p<0.001) and CRP (r = 0.32, p<0.001) but not with microalbuminuria (r = 0.12, p = 0.13). In COPD patients, EAT volume was associated with: age, pack-years, BMI, gender, FEV1%, 6 MWD, MMRC and HTN. Multivariate analysis showed that only pack-years (B = 0.6, 95% CI: 0.5-1.3), BMI (B = 7.8, 95% CI: 5.7-9.9) and 6 MWD (B = -0.2, 95% CI: -0.3--0.1), predicted EAT volume. Conclusions: EAT volume is increased in COPD patients and is independently associated with smoking history, BMI and exercise capacity, all modifiable risk factors of future cardiovascular events. EAT volume could be a non-invasive marker of COPD patients at high risk for future cardiovascular events.	[Zagaceta, Jorge; Zulueta, Javier J.; Alcaide, Ana B.; Campo, Arantza; de Torres, Juan P.] Univ Navarra Clin, Dept Pulm, Pamplona, Spain; [Bastarrika, Gorka] Univ Navarra Clin, Dept Radiol, Pamplona, Spain; [Colina, Inmaculada] Univ Navarra Clin, Dept Internal Med, Pamplona, Spain; [Celli, Bartolome R.] Brigham & Womens Hosp, Div Pulm, Boston, MA 02115 USA	University of Navarra; University of Navarra; University of Navarra; Harvard University; Brigham & Women's Hospital	de Torres, JP (corresponding author), Univ Navarra Clin, Dept Pulm, Pamplona, Spain.	jupa65@hotmail.com	Campo, Arantza/F-9487-2017; Zulueta, Javier J/H-5127-2011; Zulueta, Javier J/GXZ-5810-2022	Campo, Arantza/0000-0001-9700-4355; Zulueta, Javier J/0000-0003-3182-3555; de Torres, Juan Pablo/0000-0003-1231-4894	ISC III (Ministry of Health, Government of Spain) [PI070792, RD12/0036/0040, RD12/0036/0062]; Ramon Areces Foundation	ISC III (Ministry of Health, Government of Spain); Ramon Areces Foundation	Financially supported by ISC III (Ministry of Health, Government of Spain) research grants noPI070792, RD12/0036/0040, RD12/0036/0062 and a grant from the Ramon Areces Foundation. The founders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbara S, 2006, EUR J RADIOL, V57, P417, DOI 10.1016/j.ejrad.2005.12.030; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Agusti A, 2012, THORAX; Almendros I, 2011, SLEEP, V34, P1127, DOI 10.5665/SLEEP.1176; Martinez-Garcia MA, 2011, CHEST, V140, P1130, DOI 10.1378/chest.10-1758; [Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; Barr RG, 2012, EUR RESPIR J, V39, P846, DOI 10.1183/09031936.00165410; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Casanova C, 2010, AM J RESP CRIT CARE, V182, P1004, DOI 10.1164/rccm.201003-0360OC; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Dagvasumberel M, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-106; de Torres JP, 2011, AM J RESP CRIT CARE, V184, P913, DOI 10.1164/rccm.201103-0430OC; Diercks GFH, 2002, CAN J CARDIOL, V18, P525; Ding JZ, 2009, AM J CLIN NUTR, V90, P499, DOI 10.3945/ajcn.2008.27358; Divo M, 2012, AM J RESP CRIT CARE, V186, P155, DOI 10.1164/rccm.201201-0034OC; Furutate R, 2011, INT J CHRONIC OBSTR, V6, P423, DOI 10.2147/COPD.S22885; Iacobellis G, 2005, J CLIN ENDOCR METAB, V90, P6300, DOI 10.1210/jc.2005-1087; Iacobellis G, 2003, J CLIN ENDOCR METAB, V88, P5163, DOI 10.1210/jc.2003-030698; Iacobellis G, 2011, INT J BIOCHEM CELL B, V43, P1651, DOI 10.1016/j.biocel.2011.09.006; Iwamoto H, 2009, AM J RESP CRIT CARE, V179, P35, DOI 10.1164/rccm.200804-560OC; Kessels K, 2006, Heart, V92, P962, DOI 10.1136/hrt.2005.074872; Kim MK, 2009, J APPL PHYSIOL, V106, P5, DOI 10.1152/japplphysiol.90756.2008; Klimcakova E, 2011, DIABETOLOGIA, V54, P876, DOI 10.1007/s00125-010-2014-3; Mahabadi AA, 2009, EUR HEART J, V30, P850, DOI 10.1093/eurheartj/ehn573; MAHLER DA, 1988, CHEST, V93, P580, DOI 10.1378/chest.93.3.580; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; McAllister DA, 2007, AM J RESP CRIT CARE, V176, P1208, DOI 10.1164/rccm.200707-1080OC; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Nakagawa Y, 2011, J ATHEROSCLER THROMB, V18, P240, DOI 10.5551/jat.6593; Nakazato R, 2012, ATHEROSCLEROSIS, V220, P139, DOI 10.1016/j.atherosclerosis.2011.10.014; Nishimura M, 2012, AM J RESP CRIT CARE, V185, P44, DOI 10.1164/rccm.201106-0992OC; Pitta F, 2005, AM J RESP CRIT CARE, V171, P972, DOI 10.1164/rccm.200407-855OC; Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062; Sacks HS, 2007, AM HEART J, V153, P907, DOI 10.1016/j.ahj.2007.03.019; Samaras K, 2010, OBES SURG, V20, P108, DOI 10.1007/s11695-009-9952-1; Shemesh J, 2010, RADIOLOGY, V257, P541, DOI 10.1148/radiol.10100383; Sin DD, 2006, EUR RESPIR J, V28, P1245, DOI 10.1183/09031936.00133805; Sin DD, 2003, CIRCULATION, V107, P1514, DOI 10.1161/01.CIR.0000056767.69054.B3; Sin Don D, 2005, Proc Am Thorac Soc, V2, P8, DOI 10.1513/pats.200404-032MS; U.S. Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute, 2003, NIH PUBLICATION; van den Borst B, 2013, AM J RESP CRIT CARE, V187, P8, DOI 10.1164/rccm.201208-1441OE; van den Borst B, 2012, AM J CLIN NUTR, V96, P516, DOI 10.3945/ajcn.112.040774; van Gestel YRBM, 2010, RESP MED, V104, P712, DOI 10.1016/j.rmed.2009.10.027; Vestbo J, 2012, AM J RESP CRIT CARE; Wells JM, 2012, NEW ENGL J MED, V367, P913, DOI 10.1056/NEJMoa1203830; Willens HJ, 2007, AM J CARDIOL, V99, P1242, DOI 10.1016/j.amjcard.2006.12.042	48	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65593	10.1371/journal.pone.0065593	http://dx.doi.org/10.1371/journal.pone.0065593			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762399	Green Submitted, Green Published, gold			2022-12-27	WOS:000321099000081
J	Cheng, X; Xiang, Y; Xie, H; Xu, CL; Xie, TF; Zhang, C; Li, Y				Cheng, Xi; Xiang, Yu; Xie, Hui; Xu, Chun-Ling; Xie, Teng-Fei; Zhang, Chao; Li, Yu			Molecular Characterization and Functions of Fatty Acid and Retinoid Binding Protein Gene (Ab-far-1) in Aphelenchoides besseyi	PLOS ONE			English	Article							STRUCTURAL-CHARACTERIZATION; CAENORHABDITIS-ELEGANS; ONCHOCERCA-VOLVULUS; PARASITIC NEMATODE; FILARIAL NEMATODES; TRANSPORT PROTEINS; FAR PROTEINS; ASCARIS-SUUM; FAMILY; PHOSPHORYLATION	Rice white tip nematode, Aphelenchoides besseyi, is a kind of plant parasitic nematodes that cause serious losses in rice and many other crops. Fatty acid and retinoid binding protein (FAR) is a specific protein in nematodes and is related to development, reproduction, infection to the host, and disruption of plant defense reactions, so the inhibition of FAR function is the potential approach to control A. besseyi. The full-length of Ab-far-1 cDNA is 805 bp, including 546 bp of ORF that encodes 181 amino acids. Software analysis revealed that the Ab-FAR-1 was rich in a-helix structure, contained a predicted consensus casein kinase II phosphorylation site and a hydrophobic secretory signal peptide, but did not have glycosylation sites. The Ab-FAR-1 had 52% homology to Gp-FAR-1 protein. The Ab-FAR-1 and Gp-FAR-1 were grouped in the same branch according to the phylogenetic tree. Fluorescence-based ligand binding analysis confirmed that the recombinant Ab-FAR-1 (rAb-FAR-1) bound with the fluorescent analogues 11-((5-dimethylaminonaphthalene-1-sulfonyl)amino) undecannoic acid (DAUDA), cis-parinaric acid and retinol, but the oleic acid would compete with the binding site. Quantitative PCR (qPCR) was used to assess the expression level of Ab-far-1 at different development stages of A. besseyi, the highest expression was found in the females, followed by eggs, juveniles and males. Using in situ hybridization technique, Ab-far-1 mRNA was present in the hypodermis of juveniles and adults, the ovaries of females and the testes of males. When A. besseyi was treated with Ab-far-1 dsRNA for 48 h, the silencing efficiency of Ab-far-1 was the best and the number of nematodes on the carrot was the least. Thus FAR plays important roles in the development and reproduction of nematodes. This study is useful and helpful to figure out a new way to control the plant parasitic nematodes.	[Xie, Hui] South China Agr Univ, Coll Nat Resources & Environm, Lab Plant Nematol, Guangzhou, Guangdong, Peoples R China; South China Agr Univ, Coll Nat Resources & Environm, Res Ctr Nematodes Plant Quarantine, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; South China Agricultural University	Xie, H (corresponding author), South China Agr Univ, Coll Nat Resources & Environm, Lab Plant Nematol, Guangzhou, Guangdong, Peoples R China.	xiehui@scau.edu.cn			National Natural Science Foundation of China [30871629, 31071665]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by National Natural Science Foundation of China (Nos. 30871629 and 31071665). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANASZAK L, 1994, ADV PROTEIN CHEM, V45, P89; Basavaraju S, 2003, MOL BIOCHEM PARASIT, V126, P63, DOI 10.1016/S0166-6851(02)00253-0; Bath JL, 2009, J NEMATOL, V41, P228; Bradley JE, 2001, TRENDS PARASITOL, V17, P471, DOI 10.1016/S1471-4922(01)02036-0; Bridge J., 1990, P69; Brownlie P, 1997, STRUCTURE, V5, P509, DOI 10.1016/S0969-2126(97)00207-4; BUELT MK, 1992, BIOCHEMISTRY-US, V31, P3493, DOI 10.1021/bi00128a025; COWAN SW, 1993, J MOL BIOL, V230, P1225, DOI 10.1006/jmbi.1993.1238; de Boer JM, 1998, J NEMATOL, V30, P309; Fairfax KC, 2009, INT J PARASITOL, V39, P1561, DOI 10.1016/j.ijpara.2009.06.005; Flower DR, 1996, BIOCHEM J, V318, P1; Franklin M.T., 1972, CIH DESCRIPTIONS PLA, VVolume 1; GANJEIZADEH M, 1995, J BIOL CHEM, V270, P15707, DOI 10.1074/jbc.270.26.15707; Garofalo A, 2003, MED MICROBIOL IMMUN, V192, P47, DOI 10.1007/s00430-002-0158-6; Garofalo A, 2003, J BIOL CHEM, V278, P8065, DOI 10.1074/jbc.M206278200; Garofalo A, 2002, MOL BIOCHEM PARASIT, V122, P161, DOI 10.1016/S0166-6851(02)00097-X; Gasymov OK, 1999, BBA-PROTEIN STRUCT M, V1433, P307, DOI 10.1016/S0167-4838(99)00133-8; Kennedy MW, 2000, BBA-PROTEIN STRUCT M, V1476, P149, DOI 10.1016/S0167-4838(99)00249-6; Kennedy MW, 1997, J BIOL CHEM, V272, P29442, DOI 10.1074/jbc.272.47.29442; KENNEDY MW, 1995, BIOCHEMISTRY-US, V34, P6700, DOI 10.1021/bi00020a015; Kuang L, 2009, MOL BIOCHEM PARASIT, V168, P84, DOI 10.1016/j.molbiopara.2009.07.001; MACGREGOR RB, 1986, NATURE, V319, P70, DOI 10.1038/319070a0; MATTHEWS BW, 1987, BIOCHEMISTRY-US, V26, P6885, DOI 10.1021/bi00396a001; McDermott L, 1999, MOL CELL BIOCHEM, V192, P69, DOI 10.1023/A:1006822321081; Mei BS, 1997, J BIOL CHEM, V272, P9933, DOI 10.1074/jbc.272.15.9933; Nirmalan N, 1999, INFECT IMMUN, V67, P6329; Noy N, 2000, BIOCHEM J, V348, P481, DOI 10.1042/0264-6021:3480481; Olson JK, 1997, J VIROL, V71, P110, DOI 10.1128/JVI.71.1.110-119.1997; Pei Yan-yan, 2012, Zhongguo Shuidao Kexue, V26, P218, DOI 10.3969/j.issn.1001-7216.2012.02.012; Prior A, 2001, BIOCHEM J, V356, P387, DOI 10.1042/0264-6021:3560387; REISE RW, 1987, J NEMATOL, V19, P387; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Singh R, 2010, WORLD ACAD SCI ENG T, V72, P980; Suire S, 2001, BIOCHEM J, V356, P369, DOI 10.1042/0264-6021:3560369; Surette MG, 1996, J BIOL CHEM, V271, P939, DOI 10.1074/jbc.271.2.939; Szilak L, 1997, NAT STRUCT BIOL, V4, P112, DOI 10.1038/nsb0297-112; TREE TIM, 1995, MOL BIOCHEM PARASIT, V69, P185, DOI 10.1016/0166-6851(94)00204-Z; Urwin PE, 2002, MOL PLANT MICROBE IN, V15, P747, DOI 10.1094/MPMI.2002.15.8.747; WILKINSON TCI, 1986, BIOCHEM J, V238, P419, DOI 10.1042/bj2380419; Zhang C, 2012, EUR J PLANT PATHOL, V133, P899, DOI 10.1007/s10658-012-0015-4	40	41	45	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e66011	10.1371/journal.pone.0066011	http://dx.doi.org/10.1371/journal.pone.0066011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755297	Green Published, Green Submitted, gold			2022-12-27	WOS:000320579400082
J	Isoe, J; Scaraffia, PY				Isoe, Jun; Scaraffia, Patricia Y.			Urea Synthesis and Excretion in Aedes aegypti Mosquitoes Are Regulated by a Unique Cross-Talk Mechanism	PLOS ONE			English	Article							YELLOW-FEVER; GLOBAL DISTRIBUTION; PROTEIN CATABOLISM; AMMONIA METABOLISM; NITRIC-OXIDE; AMINO-ACIDS; GENE	Aedes aegypti mosquitoes do not have a typical functional urea cycle for ammonia disposal such as the one present in most terrestrial vertebrates. However, they can synthesize urea by two different pathways, argininolysis and uricolysis. We investigated how formation of urea by these two pathways is regulated in females of A. aegypti. The expression of arginase (AR) and urate oxidase (UO), either separately or simultaneously (ARUO) was silenced by RNAi. The amounts of several nitrogen compounds were quantified in excreta using mass spectrometry. Injection of mosquitoes with either dsRNA-AR or dsRNA-UO significantly decreased the expressions of AR or UO in the fat body (FB) and Malpighian tubules (MT). Surprisingly, the expression level of AR was increased when UO was silenced and vice versa, suggesting a cross-talk regulation between pathways. In agreement with these data, the amount of urea measured 48 h after blood feeding remained unchanged in those mosquitoes injected with dsRNA-AR or dsRNA-UO. However, allantoin significantly increased in the excreta of dsRNA-AR-injected females. The knockdown of ARUO mainly led to a decrease in urea and allantoin excretion, and an increase in arginine excretion. In addition, dsRNA-AR-injected mosquitoes treated with a specific nitric oxide synthase inhibitor showed an increase of UO expression in FB and MT and a significant increase in the excretion of nitrogen compounds. Interestingly, both a temporary delay in the digestion of a blood meal and a significant reduction in the expression of several genes involved in ammonia metabolism were observed in dsRNA-AR, UO or ARUO-injected females. These results reveal that urea synthesis and excretion in A. aegypti are tightly regulated by a unique cross-talk signaling mechanism. This process allows blood-fed mosquitoes to regulate the synthesis and/or excretion of nitrogen waste products, and avoid toxic effects that could result from a lethal concentration of ammonia in their tissues.	[Isoe, Jun; Scaraffia, Patricia Y.] Univ Arizona, Ctr Insect Sci, Dept Chem & Biochem, Tucson, AZ 85721 USA	University of Arizona	Scaraffia, PY (corresponding author), Univ Arizona, Ctr Insect Sci, Dept Chem & Biochem, Tucson, AZ 85721 USA.	scaraffi@email.arizona.edu		Scaraffia, Patricia/0000-0003-2985-933X	NIH/NIAID [R01AI088092]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088092] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was financially supported by NIH/NIAID Grant R01AI088092 (to PYS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454; Brackney DE, 2010, J INSECT PHYSIOL, V56, P736, DOI 10.1016/j.jinsphys.2010.01.003; Bush DR, 2012, J MASS SPECTROM, V47, P1364, DOI 10.1002/jms.3063; Gaines PJ, 2004, INSECT BIOCHEM MOLEC, V34, P203, DOI 10.1016/j.ibmb.2003.10.002; Griffith OW, 1996, METHOD ENZYMOL, V268, P375; Isoe J, 2009, INSECT BIOCHEM MOLEC, V39, P903, DOI 10.1016/j.ibmb.2009.10.008; Kramer LD, 2007, LANCET NEUROL, V6, P171, DOI 10.1016/S1474-4422(07)70030-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Murrell S, 2011, BIOTECHNOL ADV, V29, P239, DOI 10.1016/j.biotechadv.2010.11.008; Rogers DJ, 2006, ADV PARASIT, V62, P181, DOI 10.1016/S0065-308X(05)62006-4; Samson ML, 2000, J BIOL CHEM, V275, P31107, DOI 10.1074/jbc.M001346200; Scaraffia PY, 2008, P NATL ACAD SCI USA, V105, P518, DOI 10.1073/pnas.0708098105; Scaraffia PY, 2006, INSECT BIOCHEM MOLEC, V36, P614, DOI 10.1016/j.ibmb.2006.05.003; Scaraffia PY, 2010, J INSECT PHYSIOL, V56, P1040, DOI 10.1016/j.jinsphys.2010.02.016; Scaraffia PY, 2005, INSECT BIOCHEM MOLEC, V35, P491, DOI 10.1016/j.ibmb.2005.01.012; Scaraffia PY, 2003, J INSECT PHYSIOL, V49, P591, DOI 10.1016/S0022-1910(03)00031-3; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; von Dungern P, 2001, J INSECT PHYSIOL, V47, P73, DOI 10.1016/S0022-1910(00)00095-0; von Dungern P, 2001, J INSECT PHYSIOL, V47, P131, DOI 10.1016/S0022-1910(00)00096-2; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Wink DA, 1996, METHOD ENZYMOL, V268, P12; World Health Organization Special Programme for Research and Training in Tropical Diseases Department of Control of Neglected Tropical Diseases, 2009, EP PAND AL DENG GUID; WRIGHT PA, 1995, J EXP BIOL, V198, P273; Zhou GL, 2004, J INSECT PHYSIOL, V50, P337, DOI 10.1016/j.jinsphys.2004.02.003	24	31	31	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65393	10.1371/journal.pone.0065393	http://dx.doi.org/10.1371/journal.pone.0065393			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755226	Green Published, gold, Green Submitted			2022-12-27	WOS:000320579400057
J	Sidik, F; Lovelock, CE				Sidik, Frida; Lovelock, Catherine E.			CO2 Efflux from Shrimp Ponds in Indonesia	PLOS ONE			English	Article							CARBON-DIOXIDE EMISSIONS; SOIL RESPIRATION; TROPICAL PEATLANDS; VEGETATION; FORESTS; ISLAND; FLUX	The conversion of mangrove forest to aquaculture ponds has been increasing in recent decades. One of major concerns of this habitat loss is the release of stored 'blue' carbon from mangrove soils to the atmosphere. In this study, we assessed carbon dioxide (CO2) efflux from soil in intensive shrimp ponds in Bali, Indonesia. We measured CO2 efflux from the floors and walls of shrimp ponds. Rates of CO2 efflux within shrimp ponds were 4.37 kg CO2 m(-2) y(-1) from the walls and 1.60 kg CO2 m(-2) y(-1) from the floors. Combining our findings with published data of aquaculture land use in Indonesia, we estimated that shrimp ponds in this region result in CO2 emissions to the atmosphere between 5.76 and 13.95 Tg y(-1). The results indicate that conversion of mangrove forests to aquaculture ponds contributes to greenhouse gas emissions that are comparable to peat forest conversion to other land uses in Indonesia. Higher magnitudes of CO2 emission may be released to atmosphere where ponds are constructed in newly cleared mangrove forests. This study indicates the need for incentives that can meet the target of aquaculture industry without expanding the converted mangrove areas, which will lead to increased CO2 released to atmosphere.	[Sidik, Frida; Lovelock, Catherine E.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia	University of Queensland	Sidik, F (corresponding author), Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia.	f.sidik@uq.edu.au	Lovelock, Catherine E./AAF-7294-2020; Lovelock, Catherine E/G-7370-2012	Lovelock, Catherine E./0000-0002-2219-6855; Lovelock, Catherine E/0000-0002-2219-6855; Sidik, Frida/0000-0001-7329-9937	Graduate School International Travel Award (GSITA), University of Queensland, Australia	Graduate School International Travel Award (GSITA), University of Queensland, Australia	The funding of the travel of the first author to Indonesia was supported by Graduate School International Travel Award (GSITA), University of Queensland, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alongi DM, 2002, ENVIRON CONSERV, V29, P331, DOI 10.1017/S0376892902000231; [Anonymous], 2003, GLOBAL BIOGEOCHEM CY, DOI DOI 10.1029/2002GB001917; Burford MA, 2003, MAR POLLUT BULL, V46, P1456, DOI 10.1016/S0025-326X(03)00282-0; Burford MA, 2001, MAR ECOL PROG SER, V224, P187, DOI 10.3354/meps224187; Chimner RA, 2004, WETLANDS, V24, P51, DOI 10.1672/0277-5212(2004)024[0051:SRROTP]2.0.CO;2; Crooks S., 2011, 121 WORLD BANK ENV D; Donato DC, 2012, J ENVIRON MANAGE, V97, P89, DOI 10.1016/j.jenvman.2011.12.004; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; Duarte CM, 2005, BIOGEOSCIENCES, V2, P1, DOI 10.5194/bg-2-1-2005; Friess DA, 2011, ENVIRON CONSERV, V38, P1, DOI 10.1017/S0376892911000026; Giri C, 2011, GLOBAL ECOL BIOGEOGR, V20, P154, DOI 10.1111/j.1466-8238.2010.00584.x; Hadi A, 2005, NUTR CYCL AGROECOSYS, V71, P73, DOI 10.1007/s10705-004-0380-2; Inubushi K, 2003, CHEMOSPHERE, V52, P603, DOI 10.1016/S0045-6535(03)00242-X; Lovelock CE, 2008, ECOSYSTEMS, V11, P342, DOI 10.1007/s10021-008-9125-4; Lovelock CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021279; MCTAGGART WD, 1988, SINGAPORE J TROP GEO, V9, P96, DOI 10.1111/j.1467-9493.1988.tb00199.x; Melling L, 2005, TELLUS B, V57, P1, DOI 10.1111/j.1600-0889.2005.00129.x; Ministry of Forestry, 2002, LINGK UD BAL MANGR; Ministry of Marine Affairs, 2012, REV TAMB KKP PAC PRO; Pendleton L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043542; Puspita L, 2005, LAHAN BASAH BUATAN I; RAICH JW, 1995, GLOBAL BIOGEOCHEM CY, V9, P23, DOI 10.1029/94GB02723; Raich JW, 2000, BIOGEOCHEMISTRY, V48, P71, DOI 10.1023/A:1006112000616; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Reijnders L, 2008, J CLEAN PROD, V16, P477, DOI 10.1016/j.jclepro.2006.07.054; Siikamaki J, 2012, P NATL ACAD SCI USA, V109, P14369, DOI 10.1073/pnas.1200519109; TANAKA T, 1994, ENVIRON GEOL, V23, P182, DOI 10.1007/BF00771787; Wetlands International, 2012, REPL MANG AB SHRIMP	28	54	55	6	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e66329	10.1371/journal.pone.0066329	http://dx.doi.org/10.1371/journal.pone.0066329			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755306	gold, Green Published, Green Submitted			2022-12-27	WOS:000320579400086
J	Goldstien, SJ; Inglis, GJ; Schiel, DR; Gemmell, NJ				Goldstien, Sharyn J.; Inglis, Graeme J.; Schiel, David R.; Gemmell, Neil J.			Using Temporal Sampling to Improve Attribution of Source Populations for Invasive Species	PLOS ONE			English	Article							GENETIC DIVERSITY; STYELA-CLAVA; MICROSATELLITE MARKERS; COMPUTER-PROGRAM; NORTH-AMERICA; PHYLOGEOGRAPHY; INTRODUCTIONS; COLONIZATION; CONNECTIVITY; SIMILARITY	Numerous studies have applied genetic tools to the identification of source populations and transport pathways for invasive species. However, there are many gaps in the knowledge obtained from such studies because comprehensive and meaningful spatial sampling to meet these goals is difficult to achieve. Sampling populations as they arrive at the border should fill the gaps in source population identification, but such an advance has not yet been achieved with genetic data. Here we use previously acquired genetic data to assign new incursions as they invade populations within New Zealand ports and marinas. We also investigated allelelic frequency change in these recently established populations over a two-year period, and assessed the effect of temporal genetic sampling on our ability to assign new incursions to their population of source. We observed shifts in the allele frequencies among populations, as well as the complete loss of some alleles and the addition of alleles novel to New Zealand, within these recently established populations. There was no significant level of genetic differentiation observed in our samples between years, and the use of these temporal data did alter the assignment probability of new incursions. Our study further suggests that new incursions can add genetic variation to the population in a single introduction event as the founders themselves are often more genetically diverse than theory initially predicted.	[Goldstien, Sharyn J.; Schiel, David R.; Gemmell, Neil J.] Univ Canterbury, Sch Biol Sci, Marine Ecol Res Grp, Christchurch 1, New Zealand; [Inglis, Graeme J.] Natl Inst Water & Atmospher Res, Christchurch, New Zealand; [Gemmell, Neil J.] Univ Otago, Ctr Reprod & Genom, Dept Anat, Dunedin, New Zealand; [Gemmell, Neil J.] Univ Otago, Allan Wilson Ctr Mol Ecol & Evolut, Dunedin, New Zealand	University of Canterbury; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Otago; University of Otago	Goldstien, SJ (corresponding author), Univ Canterbury, Sch Biol Sci, Marine Ecol Res Grp, Christchurch 1, New Zealand.	sharyn.goldstien@canterbury.ac.nz	Gemmell, Neil J/C-6774-2009	Gemmell, Neil J/0000-0003-0671-3637	University of Canterbury Postdoctoral Fellowship; Ministry of Agriculture and Forestry, Biosecurity New Zealand [B0202]; National Institute of Water and Atmospheric Research; Biodiversity and Biosecurity OBI [C01X0502]	University of Canterbury Postdoctoral Fellowship; Ministry of Agriculture and Forestry, Biosecurity New Zealand; National Institute of Water and Atmospheric Research; Biodiversity and Biosecurity OBI	A University of Canterbury Postdoctoral Fellowship supported this study, with additional funding from the Ministry of Agriculture and Forestry, Biosecurity New Zealand (contract B0202), the National Institute of Water and Atmospheric Research, and a subcontract to NJG from the Biodiversity and Biosecurity OBI (C01X0502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew J, 1997, MAR ECOL PROG SER, V152, P131, DOI 10.3354/meps152131; Ashton GV, 2008, MOL ECOL, V17, P1293, DOI 10.1111/j.1365-294X.2007.03668.x; Audzijonyte A, 2008, DIVERS DISTRIB, V14, P179, DOI 10.1111/j.1472-4642.2007.00434.x; Bucciarelli G, 2002, J EXP MAR BIOL ECOL, V273, P143, DOI 10.1016/S0022-0981(02)00138-7; Cabaco S, 2011, MARINE ECOLOGY, V33, P280; Calderon I, 2009, MOL ECOL, V18, P3036, DOI 10.1111/j.1365-294X.2009.04239.x; Chandler EA, 2008, MOL ECOL, V17, P4079, DOI 10.1111/j.1365-294X.2008.03897.x; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chao A, 2006, BIOMETRICS, V62, P361, DOI 10.1111/j.1541-0420.2005.00489.x; Chen YH, 2010, GENETICA, V138, P1059, DOI 10.1007/s10709-010-9491-7; Clark GF, 2009, OIKOS, V118, P1679, DOI 10.1111/j.1600-0706.2009.17564.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Darling JA, 2007, BIOL INVASIONS, V9, P751, DOI 10.1007/s10530-006-9079-4; Darling JA, 2008, MOL ECOL, V17, P4992, DOI 10.1111/j.1365-294X.2008.03978.x; Dlugosch KM, 2008, MOL ECOL, V17, P4583, DOI 10.1111/j.1365-294X.2008.03932.x; Drake JM, 2004, P ROY SOC B-BIOL SCI, V271, P575, DOI 10.1098/rspb.2003.2629; Dupont L, 2006, MOL ECOL NOTES, V6, P101, DOI 10.1111/j.1471-8286.2005.01153.x; Dupont L, 2009, MOL ECOL, V18, P442, DOI 10.1111/j.1365-294X.2008.04045.x; DYER C, 1992, S AFR J BOT, V58, P117, DOI 10.1016/S0254-6299(16)30881-X; Elderkin CL, 2004, FRESHWATER BIOL, V49, P1487, DOI 10.1111/j.1365-2427.2004.01285.x; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Floerl O, 2009, J APPL ECOL, V46, P37, DOI 10.1111/j.1365-2664.2008.01540.x; Folino-Rorem NC, 2009, BIOL INVASIONS, V11, P1869, DOI 10.1007/s10530-008-9365-4; Geller J, 2008, MAR ECOL PROG SER, V358, P211, DOI 10.3354/meps07466; Geller JB, 2010, ANNU REV MAR SCI, V2, P367, DOI 10.1146/annurev.marine.010908.163745; Goldstien SJ, 2010, MOL ECOL, V19, P874, DOI 10.1111/j.1365-294X.2010.04527.x; Goldstien SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016755; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Grant PR, 2001, GENETICA, V112, P359, DOI 10.1023/A:1013363032724; Gust N, 2009, ASSESSMENT POPULATIO; Holland BS, 2004, MAR BIOL, V145, P1119, DOI 10.1007/s00227-004-1409-4; Holland BS, 2000, HYDROBIOLOGIA, V420, P63, DOI 10.1023/A:1003929519809; Hoos PM, 2010, DIVERS DISTRIB, V16, P582, DOI 10.1111/j.1472-4642.2010.00672.x; JOHNSON MS, 1984, MAR BIOL, V79, P295, DOI 10.1007/BF00393261; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kaluza P, 2010, J R SOC INTERFACE, V7, P1093, DOI 10.1098/rsif.2009.0495; Leberg PL, 2002, MOL ECOL, V11, P2445, DOI 10.1046/j.1365-294X.2002.01612.x; Muller J, 2001, ZOOL-ANAL COMPLEX SY, V104, P346, DOI 10.1078/0944-2006-00040; Ng WC, 2010, MAR BIOL, V157, P325, DOI 10.1007/s00227-009-1320-0; Patti FP, 2001, MAR ECOL PROG SER, V215, P169, DOI 10.3354/meps215169; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perez-Portela R, 2012, MAR ECOL PROG SER, V451, P93, DOI 10.3354/meps09560; Pineda MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025495; Pringle JM, 2011, P NATL ACAD SCI USA, V108, P15288, DOI 10.1073/pnas.1100473108; Provan J, 2005, MOL ECOL, V14, P189, DOI 10.1111/j.1365-294X.2004.02384.x; REYNOLDS J, 1983, GENETICS, V105, P767; Rius M, 2008, DIVERS DISTRIB, V14, P818, DOI 10.1111/j.1472-4642.2008.00485.x; Roman J, 2004, MOL ECOL, V13, P2891, DOI 10.1111/j.1365-294X.2004.02255.x; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Ruiz GM, 2000, ANNU REV ECOL SYST, V31, P481, DOI 10.1146/annurev.ecolsys.31.1.481; Ryland JS, 2009, ZOOTAXA, P43, DOI 10.11646/zootaxa.2093.1.3; Shefer S, 2004, MOL ECOL, V13, P2333, DOI 10.1111/j.1365-294X.2004.02227.x; Siegel DA, 2008, P NATL ACAD SCI USA, V105, P8974, DOI 10.1073/pnas.0802544105; SINNOCK P, 1975, AM NAT, V109, P565, DOI 10.1086/283027; SLATKIN M, 1995, GENETICS, V139, P457; Uwai SY, 2006, PHYCOLOGIA, V45, P687, DOI 10.2216/05-66.1; Wong NA, 2011, MAR BIOL, V158, P2775, DOI 10.1007/s00227-011-1776-6	58	11	11	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65656	10.1371/journal.pone.0065656	http://dx.doi.org/10.1371/journal.pone.0065656			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755264	Green Submitted, Green Published, gold			2022-12-27	WOS:000319872300089
J	Patel, MJ; Khan, MS; Ali, F; Kazmi, Z; Riaz, T; Awan, S; Sorathia, AL				Patel, Muhammad Junaid; Khan, Muhammad Shoaib; Ali, Farheen; Kazmi, Zehra; Riaz, Talha; Awan, Safia; Sorathia, Ayesha L.			Patients' Insight of Interpreting Prescriptions and Drug Labels - A Cross Sectional Study	PLOS ONE			English	Article							EVENTS; LITERACY	Background: Errors in consuming drugs are associated with significant morbidity and mortality, besides an impact on the already overburdened health-care system. Misunderstanding drug labels and prescriptions plays an important role in contributing to adverse drug events. Objective: To evaluate abilities to understand prescriptions and drug labels among patients attending tertiary care hospital in Karachi. Methods: A cross sectional study was conducted at the Aga Khan University Hospital (AKUH), from January to March 2009. After informed consent, 181 adult patients and their healthy attendants were interviewed at AKUH using a standardized questionnaire, which ascertained patient demographics, factors that might increase exposure to health-care personnel as well as the basic knowledge and understanding of prescriptions and drug labels. Results: Out of 181, majority 137(76%) had received graduate or post-graduate degrees. 16 (9%) had received no formal education; of which all were females and 89(84%) of the total females were housewives. Overall, 130(72%) followed only a single doctor's prescription. Majority failed to understand various medical terminologies related to dosage. In the high literacy group, 45(33%) understood once daily OD (p = 0.003), 27(20%) thrice daily TID (p = 0.05), 29(21%) twice daily BD (p = 0.01), 31(23%) thrice daily TDS (p = 0.002) and 43(31%) as needed SOS (p = 0.003) as compared to the group with no formal education, who were unable to comprehend the terms. The most common reason for using more than one prescription was decreased satisfaction with the doctor in 19(39%) and multiple co-morbids as responded by 17(35%) of patients. Knowledge regarding various medical terminologies used for dosage and routes of drug administration were also understood more frequently among the English medium respondents. The elderly identified medicine through color (47%, p<0.001), and were less likely to understand drug indications (p = 0.05) compared to younger subjects. Conclusion: Understanding of drug prescriptions is alarmingly low in the community, even amongst the educated. Care givers need to revisit this often ignored aspect of patient care.	[Patel, Muhammad Junaid; Khan, Muhammad Shoaib; Ali, Farheen; Kazmi, Zehra; Riaz, Talha; Awan, Safia; Sorathia, Ayesha L.] Aga Khan Univ, Dept Internal Med, Karachi, Pakistan	Aga Khan University	Patel, MJ (corresponding author), Aga Khan Univ, Dept Internal Med, Karachi, Pakistan.	junaid.patel@aku.edu						American Medical Association, 1999, JAMA-J AM MED ASSOC, V281, P552; [Anonymous], LAB FORC SURV 2007 2; Davis TC, 2006, J GEN INTERN MED, V21, P847, DOI 10.1111/j.1525-1497.2006.00529.x; Davis TC, 2009, J GEN INTERN MED, V24, P57, DOI 10.1007/s11606-008-0833-4; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Gupta AK, 2003, AM J MANAG CARE, V9, P548; Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107; Hanlon JT, 1997, J AM GERIATR SOC, V45, P945, DOI 10.1111/j.1532-5415.1997.tb02964.x; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Patel Muhammad Junaid, 2008, J Pak Med Assoc, V58, P298; Phillips DP, 1998, LANCET, V351, P643, DOI 10.1016/S0140-6736(98)24009-8; Safeer RS, 2005, AM FAM PHYSICIAN, V72, P463; Wolf MS, 2007, PATIENT EDUC COUNS, V67, P293, DOI 10.1016/j.pec.2007.03.024	13	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65019	10.1371/journal.pone.0065019	http://dx.doi.org/10.1371/journal.pone.0065019			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755168	Green Published, gold, Green Submitted			2022-12-27	WOS:000319872300041
J	Blackburn, MB; Martin, PAW; Kuhar, D; Farrar, RR; Gundersen-Rindal, DE				Blackburn, Michael B.; Martin, Phyllis A. W.; Kuhar, Daniel; Farrar, Robert R., Jr.; Gundersen-Rindal, Dawn E.			Phylogenetic Distribution of Phenotypic Traits in Bacillus thuringiensis Determined by Multilocus Sequence Analysis	PLOS ONE			English	Article							POPULATION-STRUCTURE; CEREUS; EVOLUTION	Diverse isolates from a world-wide collection of Bacillus thuringiensis were classified based on phenotypic profiles resulting from six biochemical tests; production of amylase (T), lecithinase (L), urease (U), acid from sucrose (S) and salicin (A), and the hydrolysis of esculin (E). Eighty two isolates representing the 15 most common phenotypic profiles were subjected to phylogenetic analysis by multilocus sequence typing; these were found to be distributed among 19 sequence types, 8 of which were novel. Approximately 70% of the isolates belonged to sequence types corresponding to the classical B. thuringiensis varieties kurstaki (20 isolates), finitimus (15 isolates), morrisoni (11 isolates) and israelensis (11 isolates). Generally, there was little apparent correlation between phenotypic traits and phylogenetic position, and phenotypic variation was often substantial within a sequence type. Isolates of the sequence type corresponding to kurstaki displayed the greatest apparent phenotypic variation with 6 of the 15 phenotypic profiles represented. Despite the phenotypic variation often observed within a given sequence type, certain phenotypes appeared highly correlated with particular sequence types. Isolates with the phenotypic profiles TLUAE and LSAE were found to be exclusively associated with sequence types associated with varieties kurstaki and finitimus, respectively, and 7 of 8 TS isolates were found to be associated with the morrisoni sequence type. Our results suggest that the B. thuringiensis varieties israelensis and kurstaki represent the most abundant varieties of Bt in soil.	[Blackburn, Michael B.; Martin, Phyllis A. W.; Kuhar, Daniel; Farrar, Robert R., Jr.; Gundersen-Rindal, Dawn E.] USDA, Invas Insect Biocontrol & Behav Lab, Agr Res Serv, Henry A Wallace Beltsville Agr Res Ctr, Beltsville, MD 20705 USA	United States Department of Agriculture (USDA)	Blackburn, MB (corresponding author), USDA, Invas Insect Biocontrol & Behav Lab, Agr Res Serv, Henry A Wallace Beltsville Agr Res Ctr, Beltsville, MD 20705 USA.	mike.blackburn@ars.usda.gov		Blackburn, Michael/0000-0001-5541-4831	Agricultural Research Service [1245-22000-273-00]	Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Research funded by the Agricultural Research Service, Project Number: 1245-22000-273-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Blackburn MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018122; DE BARJAC H., 1962, Entomophaga, V7, P5, DOI 10.1007/BF02375988; DEBARJAC H, 1981, MICROBIAL CONTROL PE, P35; Didelot X, 2009, SYST APPL MICROBIOL, V32, P81, DOI 10.1016/j.syapm.2009.01.001; Guinebretiere MH, 2008, ENVIRON MICROBIOL, V10, P851, DOI 10.1111/j.1462-2920.2007.01495.x; HEIMPEL AM, 1967, J INVERTEBR PATHOL, V9, P364, DOI 10.1016/0022-2011(67)90072-9; HEIMPEL AM, 1958, CAN J MICROBIOL, V4, P531, DOI 10.1139/m58-058; Helgason E, 2004, APPL ENVIRON MICROB, V70, P191, DOI 10.1128/AEM.70.1.191-201.2004; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Martin PAW, 2008, BIOCONTROL SCI TECHN, V18, P291, DOI 10.1080/09583150801899716; Martin PAW, 2010, SYST APPL MICROBIOL, V33, P204, DOI 10.1016/j.syapm.2010.04.002; Martin PAW, 2009, BIOL CONTROL, V51, P147, DOI 10.1016/j.biocontrol.2009.03.020; Mols M, 2008, APPL ENVIRON MICROB, V74, P2370, DOI 10.1128/AEM.02737-07; Priest FG, 2004, J BACTERIOL, V186, P7959, DOI 10.1128/JB.186.23.7959-7970.2004; Sorokin A, 2006, APPL ENVIRON MICROB, V72, P1569, DOI 10.1128/AEM.72.2.1569-1578.2006; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tourasse NJ, 2011, FOOD MICROBIOL, V28, P236, DOI 10.1016/j.fm.2010.06.014; TRAVERS RS, 1987, APPL ENVIRON MICROB, V53, P1263, DOI 10.1128/AEM.53.6.1263-1266.1987; Xu D, 2008, APPL ENVIRON MICROB, V74, P5524, DOI 10.1128/AEM.00951-08	20	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e66061	10.1371/journal.pone.0066061	http://dx.doi.org/10.1371/journal.pone.0066061			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762464	Green Submitted, Green Published, gold			2022-12-27	WOS:000320440500061
J	Shin, BH; Lim, Y; Oh, HJ; Park, SM; Lee, SK; Ahnn, J; Kim, DH; Song, WK; Kwak, TH; Park, WJ				Shin, Bae Hyun; Lim, Yunki; Oh, Hye Jin; Park, Sang Min; Lee, Sun-Kyung; Ahnn, Joohong; Kim, Do Han; Song, Woo Keun; Kwak, Tae Hwan; Park, Woo Jin			Pharmacological Activation of Sirt1 Ameliorates Polyglutamine-Induced Toxicity through the Regulation of Autophagy	PLOS ONE			English	Article							BREAST-CANCER CELLS; BETA-LAPACHONE; HUNTINGTONS-DISEASE; CAENORHABDITIS-ELEGANS; MUTANT HUNTINGTIN; INTRANUCLEAR INCLUSIONS; MOUSE MODELS; APOPTOSIS; AGGREGATION; INDUCTION	Intracellular accumulation of polyglutamine (polyQ)-expanded Huntingtin (Htt) protein is a hallmark of Huntington's disease (HD). This study evaluated whether activation of Sirt1 by the anti-cancer agent, beta-lapachone (beta-lap), induces autophagy in human neuroblastoma SH-SY5Y cells, thereby reducing intracellular levels of polyQ aggregates and their concomitant cytotoxicity. Treatment of cells with beta-lap markedly diminished the cytotoxicity induced by forced expression of Htt exon 1 containing a pathogenic polyQ stretch fused to green fluorescent protein (HttEx1(97Q)-GFP). beta-lap increased autophagy in SH-SY5Y cells, as evidenced by the increased formation of LC3-II and autolysosomes. Furthermore, beta-lap reduced HttEx1(97Q)-GFP aggregation, which was significantly prevented by co-incubation with 3-methyladenine, an inhibitor of autophagy. beta-lap increased Sirt1 activity, as shown by the increased deacetylation of the Sirt1 substrates, PARP-1 and Atg5, and the nuclear translocation of FOXO1. Both the induction of autophagy and attenuation of HttEx1(97Q)-GFP aggregation by beta-lap were significantly prevented by co-incubation with sirtinol, a general sirtuin inhibitor or by co-transfection with shRNA against Sirt1. The pro-autophagic actions of beta-lap were further investigated in a transgenic Caenorhabditis elegans (C. elegans) line that expressed Q67 fused to cyanine fluorescent protein (Q67). Notably, beta-lap reduced the number of Q67 puncta and restored Q67-induced defects in motility, which were largely prevented by pre-treatment with RNAi against sir-2.1, the C. elegans orthologue of Sirt1. Collectively, these data suggest that beta-lap induces autophagy through activation of Sirt1, which in turn leads to a reduction in polyQ aggregation and cellular toxicity. Thus, beta-lap provides a novel therapeutic opportunity for the treatment of HD.	[Shin, Bae Hyun; Park, Sang Min; Park, Woo Jin] GIST, Global Res Lab, Kwangju, South Korea; [Lim, Yunki; Oh, Hye Jin; Kim, Do Han; Song, Woo Keun] GIST, Coll Life Sci, Kwangju, South Korea; [Lee, Sun-Kyung; Ahnn, Joohong] Hanyang Univ, Dept Life Sci, Seoul 133791, South Korea; [Lee, Sun-Kyung] Hanyang Univ, Res Inst Nat Sci, Seoul 133791, South Korea; [Kwak, Tae Hwan] Mazence Inc, R&D Inst, Suwon, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Hanyang University; Hanyang University	Park, WJ (corresponding author), GIST, Global Res Lab, Kwangju, South Korea.	woojinpark@me.com		Im, Yunki/0000-0002-6440-2194	National Research Foundation of Korea [2009-0085747]; Global Research Laboratory Program [M6-0605-00-0001]; Korean government (MEST); Gwangju Institute of Science and Technology (GIST)	National Research Foundation of Korea(National Research Foundation of Korea); Global Research Laboratory Program; Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Gwangju Institute of Science and Technology (GIST)	This work was supported by a grant from the National Research Foundation of Korea (2009-0085747), a grant from the Global Research Laboratory Program (M6-0605-00-0001) funded by the Korean government (MEST), and a grant from the "Systems biology infrastructure establishment grant" provided by Gwangju Institute of Science and Technology (GIST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer PO, 2010, NAT BIOTECHNOL, V28, P256, DOI 10.1038/nbt.1608; Beal MF, 2004, NAT REV NEUROSCI, V5, P373, DOI 10.1038/nrn1386; BRENNER S, 1974, GENETICS, V77, P71; Brignull HR, 2006, J NEUROSCI, V26, P7597, DOI 10.1523/JNEUROSCI.0990-06.2006; Calixto A, 2010, NAT METHODS, V7, P554, DOI [10.1038/NMETH.1463, 10.1038/nmeth.1463]; Chiang MC, 2007, MOL CELL PROTEOMICS, V6, P781, DOI 10.1074/mcp.M600356-MCP200; Choi YH, 2003, J BIOCHEM MOL BIOL, V36, P223; CRUZ FS, 1978, ANTIMICROB AGENTS CH, V14, P630, DOI 10.1128/AAC.14.4.630; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Everett CM, 2004, BRAIN, V127, P2385, DOI 10.1093/brain/awh278; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; GUIRAUD P, 1994, PLANTA MED, V60, P373, DOI 10.1055/s-2006-959504; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hwang JH, 2009, DIABETES, V58, P965, DOI 10.2337/db08-1183; Jaiswal AK, 2000, FREE RADICAL BIO MED, V29, P254, DOI 10.1016/S0891-5849(00)00306-3; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Jeong H, 2012, NAT MED, V18, P159, DOI 10.1038/nm.2559; Jiang ML, 2012, NAT MED, V18, P153, DOI 10.1038/nm.2558; Kim SY, 2009, CIRC RES, V104, P842, DOI 10.1161/CIRCRESAHA.108.189837; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lee JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047122; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Miller J, 2010, J NEUROSCI, V30, P10541, DOI 10.1523/JNEUROSCI.0146-10.2010; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Parker JA, 2012, J NEUROSCI, V32, P12630, DOI 10.1523/JNEUROSCI.0277-12.2012; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Pink JJ, 2000, EXP CELL RES, V255, P144, DOI 10.1006/excr.1999.4790; Rajamohan SB, 2009, MOL CELL BIOL, V29, P4116, DOI 10.1128/MCB.00121-09; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rubinszfein DC, 2005, AUTOPHAGY, V1, P11, DOI 10.4161/auto.1.1.1513; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Salminen A, 2009, CELL SIGNAL, V21, P1356, DOI 10.1016/j.cellsig.2009.02.014; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; SCHAFFNERSABBA K, 1984, J MED CHEM, V27, P990, DOI 10.1021/jm00374a010; Sellamuthu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022554; Wang H, 2006, HUM MOL GENET, V15, P1025, DOI 10.1093/hmg/ddl017; Woo HJ, 2006, J MED FOOD, V9, P161, DOI 10.1089/jmf.2006.9.161; Wuerzberger SM, 1998, CANCER RES, V58, P1876; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	45	32	37	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e64953	10.1371/journal.pone.0064953	http://dx.doi.org/10.1371/journal.pone.0064953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762270	Green Published, Green Submitted, gold			2022-12-27	WOS:000320440500013
J	Kough, AS; Paris, CB; Butler, MJ				Kough, Andrew S.; Paris, Claire B.; Butler, Mark J.			Larval Connectivity and the International Management of Fisheries	PLOS ONE			English	Article							LOBSTER PANULIRUS-ARGUS; CARIBBEAN SPINY LOBSTER; WESTERN ROCK LOBSTER; REEF FISH; SPATIALLY-EXPLICIT; RECRUITMENT; POPULATIONS; DISPERSAL; ATLANTIC; CIRCULATION	Predicting the oceanic dispersal of planktonic larvae that connect scattered marine animal populations is difficult, yet crucial for management of species whose movements transcend international boundaries. Using multi-scale biophysical modeling techniques coupled with empirical estimates of larval behavior and gamete production, we predict and empirically verify spatio-temporal patterns of larval supply and describe the Caribbean-wide pattern of larval connectivity for the Caribbean spiny lobster (Panulirus argus), an iconic coral reef species whose commercial value approaches $1 billion USD annually. Our results provide long sought information needed for international cooperation in the management of marine resources by identifying lobster larval connectivity and dispersal pathways throughout the Caribbean. Moreover, we outline how large-scale fishery management could explicitly recognize metapopulation structure by considering larval transport dynamics and pelagic larval sanctuaries.	[Kough, Andrew S.; Paris, Claire B.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Butler, Mark J.] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA	University of Miami; Old Dominion University	Kough, AS (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	akough@rsmas.miami.edu		Kough, Andrew/0000-0001-8732-6588; Paris-Limouzy, Claire Beatrix/0000-0002-0637-1334	NSF [OCE-0928930]; Coral Reef Targeted Research Program, a part of the World Bank Global Environment Fund; NSF-RAPID program [OCE-1048697]	NSF(National Science Foundation (NSF)); Coral Reef Targeted Research Program, a part of the World Bank Global Environment Fund; NSF-RAPID program	The authors are grateful for funding to MJB and CBP from the NSF (OCE-0928930) and from the Coral Reef Targeted Research Program, a part of the World Bank Global Environment Fund. Code development was funded through the NSF-RAPID program (OCE-1048697) to CBP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Andrefouet S, 2004, P 10 INT COR REEF S, P1732; Becker BJ, 2007, P NATL ACAD SCI USA, V104, P3267, DOI 10.1073/pnas.0611651104; Beddington JR, 2007, SCIENCE, V316, P1713, DOI 10.1126/science.1137362; Bertelsen RD, 2001, MAR FRESHWATER RES, V52, P1559, DOI 10.1071/MF01214; Botsford LW, 2009, CORAL REEFS, V28, P327, DOI 10.1007/s00338-009-0466-z; Briones-Fourzan P, 2008, LIMNOL OCEANOGR, V53, P970, DOI 10.4319/lo.2008.53.3.0970; Butler MJ, 2011, MAR ECOL PROG SER, V422, P223, DOI 10.3354/meps08878; Butler MJ, 2005, ECOL APPL, V15, P902, DOI 10.1890/04-1081; Butler MJ, 2003, FISH RES, V65, P63, DOI 10.1016/j.fishres.2003.09.007; Butler MJ, 1997, CAN J FISH AQUAT SCI, V54, P452; CAPUTI N, 1995, CRUSTACEANA, V68, P245, DOI 10.1163/156854095X01402; Chavez EA, 2013, P 12 INT CO IN PRESS; Chavez EA, 2009, CRUSTACEANA, V82, P1393, DOI 10.1163/001121609X12481627024373; Cherubin LM, 2013, PROGR OCEAN IN PRESS; Chiswell SM, 2008, MAR ECOL PROG SER, V354, P201, DOI 10.3354/meps07217; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Cruz R, 2008, P 61 GULF CAR FISH I, V61, P433; Dataset from HYCOM Consortium, HYCOM NCODA GLOB 1 1; Dataset from HYCOM Consortium, HYCOM NCODA GULF MEX; Diniz FM, 2005, MAR BIOTECHNOL, V7, P462, DOI 10.1007/s10126-004-4062-5; Ehrhardt N.M., 2010, MARINE ECOSYSTEM BAS, P157; Ehrhardt NM, 2010, FISH OCEANOGR, V19, P434, DOI 10.1111/j.1365-2419.2010.00555.x; Ehrhardt NM, 2005, B MAR SCI, V76, P501; *FAO, 2006, 5 REG WORKSH ASS MAN; Feng M, 2011, CAN J FISH AQUAT SCI, V68, P1182, DOI 10.1139/F2011-065; Fratantoni DM, 2001, J GEOPHYS RES-OCEANS, V106, P22067, DOI 10.1029/2000JC000730; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Goldstein JS, 2008, J CRUSTACEAN BIOL, V28, P306, DOI 10.1651/0278-0372(2008)028[0306:TCDOLC]2.0.CO;2; Goldstein JS, 2009, LIMNOL OCEANOGR, V54, P1669, DOI 10.4319/lo.2009.54.5.1669; Graham EM, 2008, CORAL REEFS, V27, P529, DOI 10.1007/s00338-008-0361-z; Griffin DA, 2001, MAR FRESHWATER RES, V52, P1187, DOI 10.1071/MF01181; Hamilton SL, 2010, P NATL ACAD SCI USA, V107, P18272, DOI 10.1073/pnas.0908091107; Hidalgo M, 2012, P ROY SOC B-BIOL SCI, V279, P275, DOI 10.1098/rspb.2011.0750; Houde E, 2008, ICES COOPERATIVE RES, V295, P27; Incze L, 2010, FISH OCEANOGR, V19, P1, DOI 10.1111/j.1365-2419.2009.00522.x; Jeffs AG, 2005, NEW ZEAL J MAR FRESH, V39, P605, DOI 10.1080/00288330.2005.9517339; Kourafalou VH, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007383; Kritzer JP, 2004, FISH FISH, V5, P131, DOI 10.1111/j.1467-2979.2004.00131.x; Largier JL, 2003, ECOL APPL, V13, pS71; Lipcius R.N., 1994, P1; Lipcius RN, 1997, MAR FRESHWATER RES, V48, P807, DOI 10.1071/MF97194; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Marshall DJ, 2010, ECOL LETT, V13, P128, DOI 10.1111/j.1461-0248.2009.01408.x; Metaxas A, 2009, BIOL BULL-US, V216, P257, DOI 10.1086/BBLv216n3p257; Muller R, 2005, FWC COLLECTOR DATA 2; Naro-Maciel E, 2011, MAR BIOL, V158, P2027, DOI 10.1007/s00227-011-1710-y; National Oceanographic Atmospheric Administration, 2002, FISH COS HAB; North E. W., 2009, 295 ICES; Paris CB, 2005, MAR ECOL PROG SER, V296, P93, DOI 10.3354/meps296093; Paris CB, 2004, LIMNOL OCEANOGR, V49, P1964, DOI 10.4319/lo.2004.49.6.1964; Paris CB, 2002, DEEP-SEA RES PT I, V49, P1363, DOI 10.1016/S0967-0637(02)00033-X; Paris CB, 2009, P 2009 ANN SCI C SEP; Paris CB, 2013, ENVIRON MODELL SOFTW, V42, P47, DOI 10.1016/j.envsoft.2012.12.006; Pauly D, 2009, SCI MAR, V73, P215, DOI 10.3989/scimar.2009.73n2215; Pelc RA, 2010, P NATL ACAD SCI USA, V107, P18266, DOI 10.1073/pnas.0907368107; Petitgas P, 2009, ICES COOPERATIVE RES, P9; PHILLIPS BF, 1986, CAN J FISH AQUAT SCI, V43, P2126, DOI 10.1139/f86-261; Pineda J, 2009, POPUL ECOL, V51, P17, DOI 10.1007/s10144-008-0118-0; Planes S, 2009, P NATL ACAD SCI USA, V106, P5693, DOI 10.1073/pnas.0808007106; Puebla O, 2012, MOL ECOL, V21, P5675, DOI 10.1111/j.1365-294X.2012.05734.x; Rimmer DW, 1979, PANULIRUS CYGNUS, DOI [10.1007/BF00386590, DOI 10.1007/BF00386590]; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Rudorff CAG, 2009, FISH RES, V96, P206, DOI 10.1016/j.fishres.2008.11.005; Saenz-Agudelo P, 2011, P ROY SOC B-BIOL SCI, V278, P2954, DOI 10.1098/rspb.2010.2780; SILBERMAN JD, 1994, MAR BIOL, V120, P601, DOI 10.1007/BF00350081; Smith MD, 2010, P NATL ACAD SCI USA, V107, P18300, DOI 10.1073/pnas.0907365107; Sponaugle S, 2012, MAR ECOL PROG SER, V453, P201, DOI 10.3354/meps09641; Steneck RS, 2009, CORAL REEFS, V28, P367, DOI 10.1007/s00338-009-0470-3; Stockhausen WT, 2001, MAR FRESHWATER RES, V52, P1605, DOI 10.1071/MF01179; Tourinho JL, 2012, MAR BIOL, V159, P1897, DOI 10.1007/s00227-012-1977-7; *UN, 1998, KYOT PROT UN FRAM CO, DOI [10.51663/pnz.58.2.07, DOI 10.51663/PNZ.58.2.07]; Vikebo FB, 2011, PLOS ONE, DOI [10.1371/journal.pone.0027367, DOI 10.1371/J0URNAL.P0NE.0027367]; Waples RS, 2008, FISH FISH, V9, P423, DOI 10.1111/j.1467-2979.2008.00303.x; Wikramanayake E, 2011, CONSERV LETT, V00, P1	75	127	128	0	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e64970	10.1371/journal.pone.0064970	http://dx.doi.org/10.1371/journal.pone.0064970			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762273	Green Published, gold			2022-12-27	WOS:000321094800011
J	Ledee, D; Portman, MA; Kajimoto, M; Isern, N; Olson, AK				Ledee, Dolena; Portman, Michael A.; Kajimoto, Masaki; Isern, Nancy; Olson, Aaron K.			Thyroid Hormone Reverses Aging-Induced Myocardial Fatty Acid Oxidation Defects and Improves the Response to Acutely Increased Afterload	PLOS ONE			English	Article							C-13 ISOTOPOMER ANALYSIS; SUBSTRATE METABOLISM; HEART-FAILURE; RAT-HEART; CARDIAC-FUNCTION; FAILING HEART; ACETYL-COA; DYSFUNCTION; DISEASE; CARDIOMYOPATHY	Background: Subclinical hypothyroidism occurs during aging in humans and mice and may contribute to the development of heart failure. Aging also impairs myocardial fatty acid oxidation, causing increased reliance on flux through pyruvate dehydrogenase (PDH) to maintain function. We hypothesize that the metabolic changes in aged hearts make them less tolerant to acutely increased work and that thyroid hormone supplementation reverses these defects. Methods: Studies were performed on young (Young, 4-6 months) and aged (Old, 22-24 months) C57/BL6 mice at standard (50 mmHg) and high afterload (80 mmHg). Another aged group received thyroid hormone for 3 weeks (Old-TH, high afterload only). Function was measured in isolated working hearts along with substrate fractional contributions (Fc) to the citric acid cycle (CAC) using perfusate with C-13 labeled lactate, pyruvate, glucose and unlabeled palmitate and insulin. Results: Old mice maintained cardiac function under standard workload conditions, despite a marked decrease in unlabeled (presumably palmitate) Fc and relatively similar individual carbohydrate contributions. However, old mice exhibited reduced palmitate oxidation with diastolic dysfunction exemplified by lower -dP/dT. Thyroid hormone abrogated the functional and substrate flux abnormalities in aged mice. Conclusion: The aged heart shows diminished ability to increase cardiac work due to substrate limitations, primarily impaired fatty acid oxidation. The heart accommodates slightly by increasing efficiency through oxidation of carbohydrate substrates. Thyroid hormone supplementation in aged mice significantly improves cardiac function potentially through restoration of fatty acid oxidation.	[Ledee, Dolena; Portman, Michael A.; Kajimoto, Masaki; Olson, Aaron K.] Seattle Childrens Res Inst, Seattle, WA USA; [Portman, Michael A.; Olson, Aaron K.] Univ Washington, Dept Pediat, Div Cardiol, Seattle, WA 98195 USA; [Isern, Nancy] Pacific NW Natl Lab, EMSL, Richland, WA 99352 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Olson, AK (corresponding author), Seattle Childrens Res Inst, Seattle, WA USA.	Aaron.olson@seattlechildrens.org	Kajimoto, Masaki/GPJ-9489-2022; Isern, Nancy/J-8016-2013	Kajimoto, Masaki/0000-0001-9377-1354; Isern, Nancy/0000-0001-9571-8864; Ledee, Dolena/0000-0003-1041-4795; Olson, Aaron/0000-0002-5237-400X	National Heart, Lung, and Blood Institute [K08-HL-092333]; National Institute of Aging [R21-AG-033815]; Department of Energy's Office of Biological and Environmental Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007828, K08HL092333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG033815] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Department of Energy's Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Heart, Lung, and Blood Institute Grant K08-HL-092333 to A.K.O. and National Institute of Aging R21-AG-033815 to M.A.P. A portion of the research was performed using EMSL, a national scientific user facility sponsored by the Department of Energy's Office of Biological and Environmental Research and located at Pacific Northwest National Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUERREISH GM, 1977, AM J PHYSIOL, V232, pE258, DOI 10.1152/ajpendo.1977.232.3.E258; Biondi B, 2002, ANN INTERN MED, V137, P904, DOI 10.7326/0003-4819-137-11-200212030-00011; Biondi B, 2008, ENDOCR REV, V29, P76, DOI 10.1210/er.2006-0043; Biondi B, 2012, EUR J ENDOCRINOL, V167, P609, DOI 10.1530/EJE-12-0627; Chen YF, 2008, J MOL CELL CARDIOL, V44, P180, DOI 10.1016/j.yjmcc.2007.09.009; Fazio S, 2004, RECENT PROG HORM RES, V59, P31, DOI 10.1210/rp.59.1.31; Finck BN, 2003, P NATL ACAD SCI USA, V100, P1226, DOI 10.1073/pnas.0336724100; Gencer B, 2012, CIRCULATION, V126, P1040, DOI 10.1161/CIRCULATIONAHA.112.096024; Hyland KA, 2012, J CLIN ENDOCRINOL ME; Hyyti OM, 2006, AM J PHYSIOL-ENDOC M, V290, pE372, DOI 10.1152/ajpendo.00288.2005; Hyyti OM, 2008, AM J PHYSIOL-ENDOC M, V295, pE420, DOI 10.1152/ajpendo.90329.2008; Hyyti OM, 2010, AM J PHYSIOL-HEART C, V299, pH868, DOI 10.1152/ajpheart.00931.2009; Jeffrey FMH, 1996, AM J PHYSIOL-ENDOC M, V271, pE788, DOI 10.1152/ajpendo.1996.271.4.E788; Kates AM, 2003, J AM COLL CARDIOL, V41, P293, DOI 10.1016/S0735-1097(02)02714-6; Klein I, 2007, CIRCULATION, V116, P1725, DOI 10.1161/CIRCULATIONAHA.106.678326; Kolwicz SC, 2012, CIRC RES, V111, P728, DOI 10.1161/CIRCRESAHA.112.268128; Koonen DPY, 2007, CIRCULATION, V116, P2139, DOI 10.1161/CIRCULATIONAHA.107.712901; Krueger JJ, 2001, AM J PHYSIOL-ENDOC M, V281, pE983, DOI 10.1152/ajpendo.2001.281.5.E983; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Lehman JJ, 2002, CLIN EXP PHARMACOL P, V29, P339, DOI 10.1046/j.1440-1681.2002.03655.x; Lloyd S, 2003, AM J PHYSIOL-HEART C, V285, pH163, DOI 10.1152/ajpheart.01117.2002; Malloy CR, 1996, MAGN RESON MATER PHY, V4, P35, DOI 10.1007/BF01759778; MCMILLIN JB, 1993, CARDIOVASC RES, V27, P2222, DOI 10.1093/cvr/27.12.2222; Monzani F, 2001, J CLIN ENDOCR METAB, V86, P1110, DOI 10.1210/jc.86.3.1110; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Olson AK, 2012, J MOL CELL CARDIOL; Pantos C, 2009, J PHYSIOL PHARMACOL, V60, P49; ROHRER D, 1988, J BIOL CHEM, V263, P6941; SHIRANI J, 1993, AM J CARDIOL, V72, P365, DOI 10.1016/0002-9149(93)90691-5; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034	31	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65532	10.1371/journal.pone.0065532	http://dx.doi.org/10.1371/journal.pone.0065532			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762386	Green Published, gold, Green Submitted			2022-12-27	WOS:000321094800058
J	Lehti, S; Kakela, R; Horkko, S; Kummu, O; Helske-Suihko, S; Kupari, M; Werkkala, K; Kovanen, PT; Oorni, K				Lehti, Satu; Kakela, Reijo; Horkko, Sohvi; Kummu, Outi; Helske-Suihko, Satu; Kupari, Markku; Werkkala, Kalervo; Kovanen, Petri T.; Oorni, Katariina			Modified Lipoprotein-Derived Lipid Particles Accumulate in Human Stenotic Aortic Valves	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; PHOSPHOLIPASE A(2); ATHEROSCLEROTIC LESIONS; LDL PARTICLES; ATHEROGENIC LIPOPROTEINS; OXIDATIVE MODIFICATION; CARDIAC VALVES; OXIDIZED LDL; RETENTION; HEART	In aortic stenosis plasma lipoprotein-derived lipids accumulate in aortic valves. Here, we first compared the lipid compositions of stenotic aortic valves and atherosclerotic plaque cores. Both pathological tissues were found to be enriched in cholesteryl linoleate, a marker of extracellularly accumulated lipoproteins. In addition, a large proportion of the phospholipids were found to contain arachidonic acid, the common precursor of a number of proinflammatory lipid mediators. Next, we isolated and characterized extracellular lipid particles from human stenotic and non-stenotic control valves, and compared them to plasma lipoproteins from the same subjects. The extracellular valvular lipid particles were isolated from 15 stenotic and 14 non-stenotic aortic valves. Significantly more apoB-100-containing lipid particles were found in the stenotic than in the non-stenotic valves. The majority of the lipid particles isolated from the non-stenotic valves had sizes (23 +/- 6.2 nm in diameter) similar to those of plasma low density lipoprotein (LDL) (22 +/- 1.5 nm), while the lipid particles from stenotic valves were not of uniform size, their sizes ranging from 18 to more than 500 nm. The lipid particles showed signs of oxidative modifications, and when compared to isolated plasma LDL particles, the lipid particles isolated from the stenotic valves had a higher sphingomyelin/phosphatidylcholine -ratio, and also higher contents of lysophosphatidylcholine and unesterified cholesterol. The findings of the present study reveal, for the first time, that in stenotic human aortic valves, infiltrated plasma lipoproteins have undergone oxidative and lipolytic modifications, and become fused and aggregated. The generated large lipid particles may contribute to the pathogenesis of human aortic stenosis.	[Lehti, Satu; Helske-Suihko, Satu; Kovanen, Petri T.; Oorni, Katariina] Wihuri Res Inst, SF-00140 Helsinki, Finland; [Kakela, Reijo] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Helske-Suihko, Satu; Kupari, Markku] Univ Helsinki, Cent Hosp, Div Cardiol, Helsinki, Finland; [Werkkala, Kalervo] Univ Helsinki, Cent Hosp, Div Cardiothorac Surg, Helsinki, Finland; [Horkko, Sohvi; Kummu, Outi] Univ Oulu, Dept Med Microbiol & Immunol, Inst Diagnost, Oulu, Finland; [Horkko, Sohvi; Kummu, Outi] Oulu Univ Hosp, Clin Res Ctr, Oulu, Finland; [Horkko, Sohvi] Oulu Univ Hosp, NordLab Oulu, Oulu, Finland	Wihuri Research Institute; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Oulu; University of Oulu; University of Oulu	Oorni, K (corresponding author), Wihuri Res Inst, SF-00140 Helsinki, Finland.	kati.oorni@wri.fi	Oorni, Katariina/G-2484-2011	Oorni, Katariina/0000-0002-9525-0250; Kummu, Outi/0000-0003-0327-3496				BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; Boren J, 2000, CURR OPIN LIPIDOL, V11, P451, DOI 10.1097/00041433-200010000-00002; Butcher JT, 2008, J HEART VALVE DIS, V17, P62; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Camejo G, 2002, ATHEROSCLEROSIS SUPP, V3, P3, DOI 10.1016/S1567-5688(01)00005-8; CHAO FF, 1990, AM J PATHOL, V136, P169; Cowell SJ, 2005, NEW ENGL J MED, V352, P2389, DOI 10.1056/NEJMoa043876; Dichlberger A, 2007, J LIPID RES, V48, P1451, DOI 10.1194/jlr.C600026-JLR200; Dichlberger A, 2011, J LIPID RES, V52, P2198, DOI 10.1194/jlr.M019737; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; DYLEWSKI DP, 1984, EUR J CELL BIOL, V35, P99; Edep ME, 2000, CARDIOVASC PATHOL, V9, P281, DOI 10.1016/S1054-8807(00)00043-0; ESTERBAUER H, 1992, FREE RADICAL BIO MED, V13, P341, DOI 10.1016/0891-5849(92)90181-F; FILIP DA, 1987, ATHEROSCLEROSIS, V67, P199, DOI 10.1016/0021-9150(87)90280-2; Fogelstrand P, 2012, NUTR METAB CARDIOVAS, V22, P1, DOI 10.1016/j.numecd.2011.09.007; FOLCH J, 1957, J BIOL CHEM, V226, P497; Forte T, 1972, Adv Lipid Res, V10, P1; Gazi I, 2005, CLIN CHEM, V51, P2264, DOI 10.1373/clinchem.2005.058404; GOLDSTEIN JL, 1975, J BIOL CHEM, V250, P8487; Goncalves I, 2012, ARTERIOSCL THROM VAS, V32, P1505, DOI 10.1161/ATVBAHA.112.249854; GUYTON JR, 1994, ARTERIOSCLER THROMB, V14, P1305, DOI 10.1161/01.ATV.14.8.1305; Haimi P, 2006, ANAL CHEM, V78, P8324, DOI 10.1021/ac061390w; Hakala JK, 2003, ARTERIOSCL THROM VAS, V23, P1430, DOI 10.1161/01.ATV.0000077207.49221.06; Hakala JK, 2001, ARTERIOSCL THROM VAS, V21, P1053, DOI 10.1161/01.ATV.21.6.1053; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Helske S, 2004, J AM COLL CARDIOL, V44, P1859, DOI 10.1016/j.jacc.2004.07.054; Helske S, 2009, CIRCULATION, V119, P2653, DOI 10.1161/CIRCULATIONAHA.109.864421; Hurt-Camejo E, 2000, CURR OPIN LIPIDOL, V11, P465, DOI 10.1097/00041433-200010000-00004; Kolasa-Trela R, 2012, CLIN CHEM LAB MED, V50, P1825, DOI 10.1515/cclm-2012-0015; Kovanen PT, 1999, TRENDS CARDIOVAS MED, V9, P86, DOI 10.1016/S1050-1738(99)00013-4; Kupreishvili K, 2011, J HEART VALVE DIS, V20, P29; Li CM, 2005, INVEST OPHTH VIS SCI, V46, P2576, DOI 10.1167/iovs.05-0034; Lommi JI, 2011, ATHEROSCLEROSIS, V219, P538, DOI 10.1016/j.atherosclerosis.2011.08.027; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maskrey BH, 2011, ARTERIOSCL THROM VAS, V31, P1001, DOI 10.1161/ATVBAHA.110.213850; MCMURRAY HF, 1993, J CLIN INVEST, V92, P1004, DOI 10.1172/JCI116605; Miller JD, 2009, CIRCULATION, V119, P2693, DOI 10.1161/CIRCULATIONAHA.108.834614; Mohty D, 2008, ARTERIOSCL THROM VAS, V28, P187, DOI 10.1161/ATVBAHA.107.154989; Nakashima Y, 2007, ARTERIOSCL THROM VAS, V27, P1159, DOI 10.1161/ATVBAHA.106.134080; NIEVELSTEINPOST P, 1994, ARTERIOSCLER THROMB, V14, P1151, DOI 10.1161/01.ATV.14.7.1151; O'Brien KD, 1995, CIRCULATION, V92, pI; OBrien KD, 1996, ARTERIOSCL THROM VAS, V16, P523, DOI 10.1161/01.ATV.16.4.523; OLSSON M, 1994, J AM COLL CARDIOL, V23, P1162, DOI 10.1016/0735-1097(94)90606-8; Olsson M, 1999, ARTERIOSCL THROM VAS, V19, P1218, DOI 10.1161/01.ATV.19.5.1218; Oorni K, 2000, J LIPID RES, V41, P1703; Oorni K, 2005, ARTERIOSCL THROM VAS, V25, P1678, DOI 10.1161/01.ATV.0000168912.42941.60; Oorni K, 2004, J BIOL CHEM, V279, P34776, DOI 10.1074/jbc.M310814200; Oorni K, 1997, J BIOL CHEM, V272, P21303, DOI 10.1074/jbc.272.34.21303; OTTO CM, 1994, CIRCULATION, V90, P844, DOI 10.1161/01.CIR.90.2.844; Pentikainen MO, 1997, J BIOL CHEM, V272, P25283, DOI 10.1074/jbc.272.40.25283; Pentikainen MO, 2000, J INTERN MED, V247, P359, DOI 10.1046/j.1365-2796.2000.00655.x; Pentikainen MO, 2001, ARTERIOSCL THROM VAS, V21, P1902, DOI 10.1161/hq1201.099423; Plihtari R, 2010, J LIPID RES, V51, P1801, DOI 10.1194/jlr.M003103; QUINN MT, 1988, P NATL ACAD SCI USA, V85, P2805, DOI 10.1073/pnas.85.8.2805; RADDING CM, 1960, J CLIN INVEST, V39, P1560, DOI 10.1172/JCI104177; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Rajamannan NM, 2011, CIRCULATION, V124, P1783, DOI 10.1161/CIRCULATIONAHA.110.006767; Rajamannan NM, 2009, ARTERIOSCL THROM VAS, V29, P162, DOI 10.1161/ATVBAHA.107.156752; Rajamannan NM, 2002, CIRCULATION, V105, P2660, DOI 10.1161/01.CIR.0000017435.87463.72; Robenek H, 2005, J BIOL CHEM, V280, P5789, DOI 10.1074/jbc.M407194200; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Sacks MS, 2007, PHILOS T R SOC B, V362, P1369, DOI 10.1098/rstb.2007.2122; Sartipy P, 1996, J BIOL CHEM, V271, P26307, DOI 10.1074/jbc.271.42.26307; SIMIONESCU N, 1986, AM J PATHOL, V123, P109; Skalen K, 2002, NATURE, V417, P750, DOI 10.1038/nature00804; Stephens EH, 2008, ACTA BIOMATER, V4, P1148, DOI 10.1016/j.actbio.2008.03.014; Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890; Turunen SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034910; Veneskoski M, 2011, FREE RADICAL BIO MED, V51, P834, DOI 10.1016/j.freeradbiomed.2011.05.029; Vickers KC, 2010, ATHEROSCLEROSIS, V211, P122, DOI 10.1016/j.atherosclerosis.2010.04.005; Warnes CA, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; WITZTUM JL, 1991, J CLIN INVEST, V88, P1785, DOI 10.1172/JCI115499; Zeng Z, 2007, AM J PHYSIOL-HEART C, V292, pH2687, DOI 10.1152/ajpheart.00606.2006	75	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65810	10.1371/journal.pone.0065810	http://dx.doi.org/10.1371/journal.pone.0065810			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762432	Green Published, Green Submitted, gold			2022-12-27	WOS:000321094800075
J	Remon, N; Galan, P; Vila, M; Arribas, O; Naveira, H				Remon, Nuria; Galan, Pedro; Vila, Marta; Arribas, Oscar; Naveira, Horacio			Causes and Evolutionary Consequences of Population Subdivision of an Iberian Mountain Lizard, Iberolacerta monticola	PLOS ONE			English	Article							MITOCHONDRIAL GENETIC DIVERSITY; CYRENI-MARTINEZRICAI ARRIBAS; ROCK-LIZARDS; INBREEDING DEPRESSION; SOCIAL RELATIONSHIPS; MAXIMUM-LIKELIHOOD; COMPUTER-PROGRAM; F-STATISTICS; ICE AGES; DISPERSAL	Aim<bold>: </bold>The study of the factors that influence population connectivity and spatial distribution of genetic variation is crucial for understanding speciation and for predicting the effects of landscape modification and habitat fragmentation, which are considered severe threats to global biodiversity. This dual perspective is obtained from analyses of subalpine mountain species, whose present distribution may have been shaped both by cyclical climate changes over ice ages and anthropogenic perturbations of their habitats. Here, we examine the phylogeography, population structure and genetic diversity of the lacertid lizard Iberolacerta monticola, an endemism considered to be facing a high risk of extinction in several populations. Location<bold>: </bold>Northwestern quadrant of the Iberian Peninsula. Methods<bold>: </bold>We analyzed the mtDNA variation at the control region (454 bp) and the cytochrome b (598 bp) loci, as well as at 10 nuclear microsatellite loci from 17 populations throughout the distribution range of the species. Results<bold>: </bold>According to nuclear markers, most sampling sites are defined as distinct, genetically differentiated populations, and many of them show traces of recent bottlenecks. Mitochondrial data identify a relatively old, geographically restricted lineage, and four to six younger geographically vicariant sister clades, whose origin may be traced back to the mid-Pleistocene revolution, with several subclades possibly associated to the mid-Bruhnes transition. Geographic range fragmentation of one of these clades, which includes lowland sites, is very recent, and most likely due to the accelerated loss of Atlantic forests by human intervention. Main Conclusions<bold>: </bold>Altogether, the data fit a "refugia within refugia" model, some lack of pattern uniformity notwithstanding, and suggest that these mountains might be the cradles of new species of Iberolacerta. However, the changes operated during the Holocene severely compromise the long-term survival of those genetic lineages more exposed to the anthropogenic perturbations of their habitats.	[Remon, Nuria; Galan, Pedro] Univ A Coruna, Fac Ciencias, Dept Biol Anim Biol Vexetal & Ecol, La Coruna, Spain; [Vila, Marta; Naveira, Horacio] Univ A Coruna, Fac Ciencias, Dept Biol Celular & Mol, La Coruna, Spain	Universidade da Coruna; Universidade da Coruna	Naveira, H (corresponding author), Univ A Coruna, Fac Ciencias, Dept Biol Celular & Mol, La Coruna, Spain.	horacio.naveira.fachal@udc.es	Vila Taboada, Marta/F-6118-2016; Naveira, Horacio/H-7249-2014; Galán, Pedro/L-7002-2014; Naveira, Horacio/I-7802-2019	Vila Taboada, Marta/0000-0002-8803-9174; Naveira, Horacio/0000-0002-3840-1569; Galán, Pedro/0000-0002-1681-3343; Naveira, Horacio/0000-0002-3840-1569	(Ministerio de Ciencia y Tecnologia, Spain [REN2003-02931/GLO]; Xunta de Galicia, Spain [PGIDIT03RFO10301PR, PGIDIT06RFO10301PR]; Ministerio de Ciencia y Tecnologia, Spain [PTA2008-1366-P]	(Ministerio de Ciencia y Tecnologia, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Xunta de Galicia, Spain(Xunta de Galicia); Ministerio de Ciencia y Tecnologia, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grants REN2003-02931/GLO (Ministerio de Ciencia y Tecnologia, Spain), PGIDIT03RFO10301PR and PGIDIT06RFO10301PR (Xunta de Galicia, Spain), awarded to Horacio Naveira. Nuria Remon was also funded by grant PTA2008-1366-P (Ministerio de Ciencia y Tecnologia, Spain), awarded to Marta Vila. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida AP, 2002, J ZOOL SYST EVOL RES, V40, P57, DOI 10.1046/j.1439-0469.2002.00174.x; Aragon P, 2004, ETHOLOGY, V110, P1001, DOI 10.1111/j.1439-0310.2004.01046.x; Aragon P, 2001, CAN J ZOOL, V79, P1965, DOI 10.1139/cjz-79-11-1965; Arnold E.N., 1981, P217; Arnold EN, 2007, ZOOTAXA, P1, DOI 10.11646/zootaxa.1430.1.1; Arribas O, 2004, ZOOTAXA, P1; Arribas OJ, 2004, AMPHIBIA-REPTILIA, V25, P359, DOI 10.1163/1568538042788942; Arribas O, 2006, ZOOTAXA, P1; Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; Balloux F, 2004, MOL ECOL, V13, P3021, DOI 10.1111/j.1365-294X.2004.02318.x; Baselga A, 2008, ANN ENTOMOL SOC AM, V101, P402, DOI 10.1603/0013-8746(2008)101[402:CIARFO]2.0.CO;2; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Belkhir K, 2004, GENETIX 4 05 LOGICIE; Berec L, 2007, TRENDS ECOL EVOL, V22, P185, DOI 10.1016/j.tree.2006.12.002; Blomqvist D, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-33; Boudjemadi K, 1999, J ANIM ECOL, V68, P1207, DOI 10.1046/j.1365-2656.1999.00363.x; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Campos JL, 2007, FRESHWATER BIOL, V52, P510, DOI 10.1111/j.1365-2427.2006.01721.x; Carranza S., 2004, Systematics and Biodiversity, V2, P57, DOI 10.1017/S1477200004001355; Carrion Y, 2010, HOLOCENE, V20, P53, DOI 10.1177/0959683609348849; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Coltman DW, 2003, EVOLUTION, V57, P971, DOI 10.1111/j.0014-3820.2003.tb00309.x; COOPE GR, 1994, PHILOS T ROY SOC B, V344, P19, DOI 10.1098/rstb.1994.0046; Crochet PA, 2004, MOL PHYLOGENET EVOL, V30, P860, DOI 10.1016/j.ympev.2003.07.016; Crowley TJ, 1999, PALEOCLIMATOLOGY; Deffontaine V, 2005, MOL ECOL, V14, P1727, DOI 10.1111/j.1365-294X.2005.02506.x; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Eckstein RL, 2006, MOL ECOL, V15, P2367, DOI 10.1111/j.1365-294X.2006.02944.x; Ersts P.J, 2007, GEOGRAPHIC DISTANCE; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Felsenstein J., 2005, PHYLIP PHYLOGENETIC; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Fitze PS, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-347; Forsdyke Donald R., 2001, ORIGIN SPECIES REVIS; Galan P., 2000, Galemys, V12, P41; Galan P, 2007, MUNIBE S, V25, P34; Galan P., 2005, RECURSOS RURAIS SERI, V2, P51; Galan Pedro, 1999, Boletin de la Asociacion Herpetologica Espanola, V10, P47; Galan P, 2010, AMPHIBIA-REPTILIA, V31, P144, DOI 10.1163/156853810790457858; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Glemin S, 2003, GENETICS, V165, P2193; Glez-Pena D, 2010, NUCLEIC ACIDS RES, V38, pW14, DOI 10.1093/nar/gkq321; Godinho R, 2008, MOL ECOL, V17, P4670, DOI 10.1111/j.1365-294X.2008.03929.x; Godinho R, 2006, HEREDITY, V96, P454, DOI 10.1038/sj.hdy.6800823; GOLDSTEIN DB, 1995, GENETICS, V139, P463; Gomez A, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P155, DOI 10.1007/1-4020-4904-8_5; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Gu X, 1997, MOL BIOL EVOL, V14, P1106, DOI 10.1093/oxfordjournals.molbev.a025720; Helaers R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-379; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hewitt Godfrey M, 2004, Front Zool, V1, P4; Hipsley CA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-151; Hoffman JI, 2007, NATURE, V445, P912, DOI 10.1038/nature05558; Howard DJ., 1998, ENDLESS FORMS SPECIE; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jaquiery J, 2009, CONSERV BIOL, V23, P207, DOI 10.1111/j.1523-1739.2008.01052.x; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Johansson H, 2008, MOL ECOL, V17, P4425, DOI 10.1111/j.1365-294X.2008.03923.x; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kawamura K, 2007, CONSERV GENET, V8, P1163, DOI 10.1007/s10592-006-9271-1; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kropf M, 2003, MOL ECOL, V12, P931, DOI 10.1046/j.1365-294X.2003.01781.x; Lande R, 1998, RES POPUL ECOL, V40, P259, DOI 10.1007/BF02763457; Lee-Yaw JA, 2009, MOL ECOL, V18, P1863, DOI 10.1111/j.1365-294X.2009.04152.x; LYNCH M, 1995, AM NAT, V146, P489, DOI 10.1086/285812; MANTEL N, 1967, CANCER RES, V27, P209; Martinez Fernandez Aquilino, 2008, Boletin BIGA, V4, P87; Martinez-Solano I, 2006, MOL ECOL, V15, P3375, DOI 10.1111/j.1365-294X.2006.03013.x; Mayer W, 2003, J ZOOL SYST EVOL RES, V41, P157, DOI 10.1046/j.1439-0469.2003.00223.x; Mayer Werner, 1996, Herpetozoa, V9, P57; MICKEVICH MF, 1981, SYST ZOOL, V30, P351, DOI 10.2307/2413255; Monasterio C, 2009, J BIOGEOGR, V36, P1673, DOI 10.1111/j.1365-2699.2009.02113.x; Mosquera DF, 2000, NUCL INSTRUM METH B, V172, P832; Mouret V, 2011, J BIOGEOGR, V38, P1717, DOI 10.1111/j.1365-2699.2011.02514.x; Olsson M, 2003, BIOL J LINN SOC, V79, P277, DOI 10.1046/j.1095-8312.2003.00116.x; Park S.D.E., 2001, THESIS; Perez-Mellado V., 2009, IUCN RED LIST THREAT, V2009, pe.T17795A7481971, DOI [10.2305/IUCN.UK.2009.RLTS.T17795A7481971.en, DOI 10.2305/IUCN.UK.2009.RLTS.T17795A7481971.EN]; Pino Perez J.J., 2009, Boletin BIGA, V6, P125; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A., 2009, FIGTREE TREE FIGURE; Raymo ME, 2008, NATURE, V451, P284, DOI 10.1038/nature06589; Recuero E, 2011, MOL PHYLOGENET EVOL, V60, P170, DOI 10.1016/j.ympev.2011.04.006; Remon N, 2008, MOL ECOL RESOUR, V8, P1351, DOI 10.1111/j.1755-0998.2008.02271.x; Remon N, 2012, CONSERV GENET, V13, P131, DOI 10.1007/s10592-011-0272-3; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rodriguez T, 1997, J BIOGEOGR, V24, P893, DOI 10.1046/j.1365-2699.1997.00112.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rowe G, 2000, OIKOS, V88, P641, DOI 10.1034/j.1600-0706.2000.880321.x; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Schmitt T, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-9; Sinervo B, 2003, SCIENCE, V300, P1949, DOI 10.1126/science.1083109; Sobrino CM, 2007, VEG HIST ARCHAEOBOT, V16, P223, DOI 10.1007/s00334-006-0083-5; Sobrino CM, 2005, BOREAS, V34, P381, DOI 10.1080/03009480510013006; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Takezaki N, 1996, GENETICS, V144, P389; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Theodorou K, 2006, HEREDITY, V96, P69, DOI 10.1038/sj.hdy.6800762; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Vidal-Romani JR, 1994, CUATERNARIO GEOMORFO, V8, P33; Waldman Bruce, 1993, P250; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitlock MC, 2002, GENETICS, V160, P1191; Zamudio KR, 2003, LIZARD SOCIAL BEHAVIOR, P83	118	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66034	10.1371/journal.pone.0066034	http://dx.doi.org/10.1371/journal.pone.0066034			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762459	Green Published, Green Submitted, gold			2022-12-27	WOS:000321094800083
J	Higgins, PC; Prigerson, HG				Higgins, Philip C.; Prigerson, Holly G.			Caregiver Evaluation of the Quality of End-Of-Life Care (CEQUEL) Scale: The Caregiver's Perception of Patient Care Near Death	PLOS ONE			English	Article							EXPLORATORY FACTOR-ANALYSIS; BEREAVED FAMILY-MEMBERS; INITIAL VALIDATION; TERMINAL ILLNESS; CANCER-PATIENTS; MENTAL-HEALTH; MEDICAL-CARE; COMMUNICATION; PROVIDERS; PERSPECTIVES	Purpose: End-of-life (EOL) measures are limited in capturing caregiver assessment of the quality of EOL care. Because none include caregiver perception of patient suffering or prolongation of death, we sought to develop and validate the Caregiver Evaluation of Quality of End-of-Life Care (CEQUEL) scale to include these dimensions of caregiver-perceived quality of EOL care. Patients and Methods: Data were derived from Coping with Cancer (CwC), a multisite, prospective, longitudinal study of advanced cancer patients and their caregivers (N = 275 dyads). Caregivers were assessed before and after patient deaths. CEQUEL's factor structure was examined; reliability was evaluated using Cronbach's alpha, and convergent validity by the strength of associations between CEQUEL scores and key EOL outcomes. Results: Factor analysis revealed four distinct factors: Prolongation of Death, Perceived Suffering, Shared Decision-Making, and Preparation for the Death. Each item loaded strongly on only a single factor. The 13-item CEQUEL and its subscales showed moderate to acceptable Cronbach's alpha (range: 0.52-0.78). 53% of caregivers reported patients suffering more than expected. Higher CEQUEL scores were positively associated with therapeutic alliance (rho =. 13; p <=.05) and hospice enrollment (z = -2.09; p <=.05), and negatively associated with bereaved caregiver regret (rho = -.36, p <=.001) and a diagnosis of Posttraumatic Stress Disorder (z = -2.06; p <=.05). Conclusion: CEQUEL is a brief, valid measure of quality of EOL care from the caregiver's perspective. It is the first scale to include perceived suffering and prolongation of death. If validated in future work, it may prove a useful quality indicator for the delivery of EOL care and a risk indicator for poor bereavement adjustment.	[Higgins, Philip C.] Boston Coll, Grad Sch Social Work, Chestnut Hill, MA 02167 USA; [Higgins, Philip C.] Dana Farber Canc Inst, Dept Psychosocial Oncol & Palliat Care, Boston, MA 02115 USA; [Higgins, Philip C.; Prigerson, Holly G.] Dana Farber Canc Inst, Ctr Psychosocial Epidemiol & Outcomes Res, Boston, MA 02115 USA; [Prigerson, Holly G.] Dana Farber Canc Inst, Dept Med Oncol, Div Populat Sci, Boston, MA 02115 USA; [Prigerson, Holly G.] Brigham & Womens Hosp, Dept Psychiat, Boston, MA 02115 USA; [Prigerson, Holly G.] Harvard Univ, Sch Med, Boston, MA USA	Boston College; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Prigerson, HG (corresponding author), Dana Farber Canc Inst, Ctr Psychosocial Epidemiol & Outcomes Res, Boston, MA 02115 USA.	holly_prigerson@dfci.harvard.edu	Prigerson, Holly/GWV-3283-2022; Prigerson, Holly/L-3800-2019	Prigerson, Holly/0000-0002-7075-4268	American Cancer Society [DSW1009403SW]; National Institute of Mental Health [MH63892]; National Cancer Institute [CA106370, CA156732]; Center for Psychosocial Epidemiology and Outcomes Research, Dana-Farber Cancer Institute; NATIONAL CANCER INSTITUTE [U54CA156732, R01CA106370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063892] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Psychosocial Epidemiology and Outcomes Research, Dana-Farber Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported in part by the following grants to PCH: DSW1009403SW from the American Cancer Society; and to HGP: MH63892 from the National Institute of Mental Health and CA106370 and CA156732 from the National Cancer Institute; and the Center for Psychosocial Epidemiology and Outcomes Research, Dana-Farber Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington-Hall J, 2001, J PAIN SYMPTOM MANAG, V22, P784, DOI 10.1016/S0885-3924(01)00330-X; Akiyama A, 2010, ARCH GERONTOL GERIAT, V50, P175, DOI 10.1016/j.archger.2009.03.006; Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Barry LC, 2002, AM J GERIAT PSYCHIAT, V10, P447; BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; Byock IR, 1998, PALLIATIVE MED, V12, P231, DOI 10.1191/026921698670234618; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Cherlin E, 2005, J PALLIAT MED, V8, P1176, DOI 10.1089/jpm.2005.8.1176; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; Curtis JR, 2002, J PAIN SYMPTOM MANAG, V24, P17, DOI 10.1016/S0885-3924(02)00419-0; DeCoster J, 2005, SCALE CONSTRUCTION N; Emanuel L L, 2001, J Palliat Med, V4, P465, DOI 10.1089/109662101753381601; Emanuel L L, 2000, J Palliat Med, V3, P419, DOI 10.1089/jpm.2000.3.4.419; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; First M.B., 2016, STRUCTURED CLIN INTE; Fowler FJ, 1999, J PAIN SYMPTOM MANAG, V17, P114, DOI 10.1016/S0885-3924(98)00133-X; Fried TR, 2003, J AM GERIATR SOC, V51, P1398, DOI 10.1046/j.1532-5415.2003.51457.x; Ganzini L, 2009, J PAIN SYMPTOM MANAG, V38, P807, DOI 10.1016/j.jpainsymman.2009.04.026; Gries CJ, 2008, CHEST, V133, P704, DOI 10.1378/chest.07-1773; Hales S, 2010, PALLIATIVE MED, V24, P127, DOI 10.1177/0269216309351783; Hanson LC, 1997, J AM GERIATR SOC, V45, P1339, DOI 10.1111/j.1532-5415.1997.tb02933.x; Hayton JC, 2004, ORGAN RES METHODS, V7, P191, DOI 10.1177/1094428104263675; Hebert RS, 2008, J PALLIAT MED, V11, P476, DOI 10.1089/jpm.2007.0165; Heyland DK, 2006, CMAJ, V174; Hinton J, 1996, SOC SCI MED, V43, P1229, DOI 10.1016/0277-9536(95)00437-8; HOUTS P S, 1989, Journal of Psychosocial Oncology, V7, P113, DOI 10.1300/J077v07n03_08; Hudson PL, 2010, PALLIATIVE MED, V24, P656, DOI 10.1177/0269216310373167; Koop Priscilla M, 2003, Clin Nurs Res, V12, P127; Kris AE, 2006, AM J GERIAT PSYCHIAT, V14, P264, DOI 10.1097/01.JGP.0000194642.86116.ce; Latham AE, 2004, SUICIDE LIFE-THREAT, V34, P350, DOI 10.1521/suli.34.4.350.53737; Loggers ET, 2013, NEW ENGL J MED, V368, P1417, DOI 10.1056/NEJMsa1213398; Mack JW, 2009, CANCER-AM CANCER SOC, V115, P3302, DOI 10.1002/cncr.24360; McDonagh JR, 2004, CRIT CARE MED, V32, P1484, DOI 10.1097/01.CCM.0000127262.16690.65; Muthen B., 1997, ROBUST INFERENCE USI; Muthen LK, 2011, BINARY DATA FACTOR A; National Hospice and Palliative Care Organization, 2012, NHPCO FACTS FIG HOSP; Norton SA, 2003, AM J CRIT CARE, V12, P548, DOI 10.4037/ajcc2003.12.6.548; Ott CH, 2007, J NERV MENT DIS, V195, P332, DOI 10.1097/01.nmd.0000243890.93992.1e; Pargament KI, 2000, J CLIN PSYCHOL, V56, P519, DOI 10.1002/(SICI)1097-4679(200004)56:4<519::AID-JCLP6>3.0.CO;2-1; Pargament KI, 1998, J SCI STUD RELIG, V37, P710, DOI 10.2307/1388152; Patrick DL, 2001, J PAIN SYMPTOM MANAG, V22, P717, DOI 10.1016/S0885-3924(01)00333-5; Pearce MJ, 2006, J HEALTH PSYCHOL, V11, P743, DOI 10.1177/1359105306066629; Prigerson HG, 2003, AM J GERIAT PSYCHIAT, V11, P309, DOI 10.1176/appi.ajgp.11.3.309; Prigerson HG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000121; Russ AJ, 2005, CULT MED PSYCHIAT, V29, P103, DOI 10.1007/s11013-005-4625-6; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; Steinhauser Karen E, 2002, J Palliat Med, V5, P829, DOI 10.1089/10966210260499014; Steinhauser KE, 2000, ANN INTERN MED, V132, P825, DOI 10.7326/0003-4819-132-10-200005160-00011; Steinhauser KE, 2001, J PAIN SYMPTOM MANAG, V22, P727, DOI 10.1016/S0885-3924(01)00334-7; Teno JM, 2001, J PAIN SYMPTOM MANAG, V22, P752, DOI 10.1016/S0885-3924(01)00331-1; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; Teno JM, 2001, J PAIN SYMPTOM MANAG, V22, P738, DOI 10.1016/S0885-3924(01)00335-9; Tilden Virginia P, 2002, Gerontologist, V42 Spec No 3, P71; Torges CM, 2008, PSYCHOL AGING, V23, P169, DOI 10.1037/0882-7974.23.1.169; Wendler D, 2011, ANN INTERN MED, V154, P336, DOI 10.7326/0003-4819-154-5-201103010-00008; WILLIAMS JBW, 1992, ARCH GEN PSYCHIAT, V49, P630; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665; Wright AA, 2010, J CLIN ONCOL, V28, P4457, DOI 10.1200/JCO.2009.26.3863; Wright AA, 2010, CANCER-AM CANCER SOC, V116, P4656, DOI 10.1002/cncr.25217; Yu CY, 2002, EVALUATING CUTOFF CR; Zhang BH, 2012, ARCH INTERN MED, V172, P1133, DOI 10.1001/archinternmed.2012.2364	62	29	30	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e66066	10.1371/journal.pone.0066066	http://dx.doi.org/10.1371/journal.pone.0066066			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	173SK	23762467	Green Published, Green Submitted, gold			2022-12-27	WOS:000321099000125
J	Lin, SY; Wu, ET; Lin, CH; Shyu, MK; Lee, CN				Lin, Shin-Yu; Wu, En-Tzu; Lin, Chia-Hui; Shyu, Ming-Kwang; Lee, Chien-Nan			The Safety and Immunogenicity of Trivalent Inactivated Influenza Vaccination: A Study of Maternal-Cord Blood Pairs in Taiwan	PLOS ONE			English	Article							PREGNANT-WOMEN; IMMUNIZATION; HOSPITALIZATIONS; ANTIBODY; CHILDREN; VIRUS; PROTECTION; INFECTION; VACCINES; ILLNESS	Background: There are little data about adverse effects and immunogenicity of flu vaccine in Asian pregnant women. Methods: This prospective trial (NCT01514708) enrolled 46 pregnant women who received a single intramuscular dose of trivalent flu vaccine (AdimFlu-SH) containing 15 mcg of hemagglutinin for each strain/0.5 mL from influenza A (H1N1), influenza A (H3N2), and influenza B after the first trimester. Blood samples were collected at day 0 and 28 after vaccination, and at delivery. Cord blood was also collected. Hemagglutination inhibition (HAI) assays were performed to determine seroprotection and seroconversion rates and fold increase in the HAI geometric mean titer (GMT). Results: Twenty-eight days after vaccination the seroprotection rate against H1N1, H3N2, and influenza B was 91.3%, 84.8% and 56.5%, respectively. The GMT fold increase was 12.8, 8.4, and 4.6 for H1N1, H3N2, and influenza B, respectively. At delivery, both the seroprotection rate (86.4%, 68.2%, and 47.7%) and GMT fold increase (9.4, 5.7 and 3.8) were slightly lower than day 28. The seroprotection rate and GMT fold increase in maternal and cord blood samples were comparable. No significant adverse effects were detected. Conclusions: Trivalent flu vaccine induces a strong immune response in pregnant women and their infants without adverse effects.	[Lin, Shin-Yu] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Obstet & Gynecol, Hsinchu, Taiwan; [Lin, Shin-Yu] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Wu, En-Tzu; Lin, Chia-Hui; Shyu, Ming-Kwang; Lee, Chien-Nan] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Lee, CN (corresponding author), Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan.	leecn@ntu.edu.tw		SHYU, MING-KWANG/0000-0001-9057-4101; Lee, Chien-Nan/0000-0002-1725-0407; LIN, SHIN-YU/0000-0002-0753-2793	Adimmune Corporation	Adimmune Corporation	This was a study funded by Adimmune Corporation, but the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG Committee on Obstetric Practice, 2004, Obstet Gynecol, V104, P1125; Adegbola R, 2012, AM J OBSTET GYNECOL, V207, pS28, DOI 10.1016/j.ajog.2012.07.001; [Anonymous], 2005, Wkly Epidemiol Rec, V80, P279; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P86; [Anonymous], 2010, Obstet Gynecol, V116, P1006, DOI 10.1097/AOG.0b013e3181fae845; Bednarczyk RA, 2012, AM J OBSTET GYNECOL, V207, pS38, DOI 10.1016/j.ajog.2012.07.002; Bhat N, 2005, NEW ENGL J MED, V353, P2559, DOI 10.1056/NEJMoa051721; Cox S, 2006, OBSTET GYNECOL, V107, P1315, DOI 10.1097/01.AOG.0000218702.92005.bb; de Jong J C, 2003, Dev Biol (Basel), V115, P63; DEINARD AS, 1981, AM J OBSTET GYNECOL, V140, P240, DOI 10.1016/0002-9378(81)90267-2; Eick AA, 2011, ARCH PEDIAT ADOL MED, V165, P104, DOI 10.1001/archpediatrics.2010.192; ENGLUND JA, 1993, J INFECT DIS, V168, P647, DOI 10.1093/infdis/168.3.647; Englund JA, 2003, VACCINE, V21, P3460, DOI 10.1016/S0264-410X(03)00351-7; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Fisher BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033048; Gall SA, 2011, VACCINE, V29, P9411, DOI 10.1016/j.vaccine.2011.11.009; Hartert TV, 2003, AM J OBSTET GYNECOL, V189, P1705, DOI 10.1016/S0002-9378(03)00857-3; HEINONEN OP, 1973, INT J EPIDEMIOL, V2, P229, DOI 10.1093/ije/2.3.229; Jackson LA, 2011, J INFECT DIS, V204, P854, DOI 10.1093/infdis/jir440; Lin TH, 2012, VACCINE, V30, P2671, DOI 10.1016/j.vaccine.2012.02.008; Mak TK, 2008, LANCET INFECT DIS, V8, P44, DOI 10.1016/S1473-3099(07)70311-0; Manzoli L, 2012, HUM VACC IMMUNOTHER, V8, P851, DOI 10.4161/hv.19917; Marshall V, 2012, AM J OBSTET GYNECOL, V207, pS57, DOI 10.1016/j.ajog.2012.06.075; Mereckiene J, 2008, EURO SURVEILL, V13; Munoz FM, 2005, AM J OBSTET GYNECOL, V192, P1098, DOI 10.1016/j.ajog.2004.12.019; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Poehling KA, 2011, AM J OBSTET GYNECOL, V204, pS141, DOI 10.1016/j.ajog.2011.02.042; PUCK JM, 1980, J INFECT DIS, V142, P844, DOI 10.1093/infdis/142.6.844; REUMAN PD, 1987, PEDIATR INFECT DIS J, V6, P398, DOI 10.1097/00006454-198704000-00011; Steinhoff MC, 2010, NEW ENGL J MED, V362, P1644, DOI 10.1056/NEJMc0912599; SUMAYA CV, 1979, J INFECT DIS, V140, P141, DOI 10.1093/infdis/140.2.141; The European Agency for the Evaluation of Medicinal Products Human Medicines Evaluation Unit, 1997, NOT GUID HARM REQ IN; Tsatsaris V, 2011, ANN INTERN MED, V155, P733, DOI 10.7326/0003-4819-155-11-201112060-00005; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630	35	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e62983	10.1371/journal.pone.0062983	http://dx.doi.org/10.1371/journal.pone.0062983			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762229	gold, Green Published, Green Submitted			2022-12-27	WOS:000321099000004
J	Yu, Q; Sali, A; Van der Meulen, J; Creeden, BK; Gordish-Dressman, H; Rutkowski, A; Rayavarapu, S; Uaesoontrachoon, K; Huynh, T; Nagaraju, K; Spurney, CF				Yu, Qing; Sali, Arpana; Van der Meulen, Jack; Creeden, Brittany K.; Gordish-Dressman, Heather; Rutkowski, Anne; Rayavarapu, Sree; Uaesoontrachoon, Kitipong; Tony Huynh; Nagaraju, Kanneboyina; Spurney, Christopher F.			Omigapil Treatment Decreases Fibrosis and Improves Respiratory Rate in dy(2J) Mouse Model of Congenital Muscular Dystrophy	PLOS ONE			English	Article							ALPHA-GLUCOSIDASE GENE; TARGETED DISRUPTION; CGP 3466B; DISEASE; MICE; DEFICIENT; TCH346; TRIAL; DRUG	Introduction: Congenital muscular dystrophy is a distinct group of diseases presenting with weakness in infancy or childhood and no current therapy. One form, MDC1A, is the result of laminin alpha-2 deficiency and results in significant weakness, respiratory insufficiency and early death. Modification of apoptosis is one potential pathway for therapy in these patients. Methods: dy(2J) mice were treated with vehicle, 0.1 mg/kg or 1 mg/kg of omigapil daily via oral gavage over 17.5 weeks. Untreated age matched BL6 mice were used as controls. Functional, behavioral and histological measurements were collected. Results: dy(2J) mice treated with omigapil showed improved respiratory rates compared to vehicle treated dy(2J) mice (396 to 402 vs. 371 breaths per minute, p<0.03) and similar to control mice. There were no statistical differences in normalized forelimb grip strength between dy(2J) and controls at baseline or after 17.5 weeks and no significant differences seen among the dy(2J) treatment groups. At 30-33 weeks of age, dy(2J) mice treated with 0.1 mg/kg omigapil showed significantly more movement time and less rest time compared to vehicle treated. dy(2J) mice showed normal cardiac systolic function throughout the trial. dy(2J) mice had significantly lower hindlimb maximal (p<0.001) and specific force (p<0.002) compared to the control group at the end of the trial. There were no statistically significant differences in maximal or specific force among treatments. dy(2J) mice treated with 0.1 mg/kg/day omigapil showed decreased percent fibrosis in both gastrocnemius (p<0.03) and diaphragm (p<0.001) compared to vehicle, and in diaphragm (p<0.013) when compared to 1 mg/kg/day omigapil treated mice. Omigapil treated dy(2J) mice demonstrated decreased apoptosis. Conclusion: Omigapil therapy (0.1 mg/kg) improved respiratory rate and decreased skeletal and respiratory muscle fibrosis in dy(2J) mice. These results support a putative role for the use of omigapil in laminin deficient congenital muscular dystrophy patients.	[Yu, Qing; Sali, Arpana; Van der Meulen, Jack; Creeden, Brittany K.; Gordish-Dressman, Heather; Rayavarapu, Sree; Uaesoontrachoon, Kitipong; Tony Huynh; Nagaraju, Kanneboyina; Spurney, Christopher F.] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Spurney, Christopher F.] Childrens Natl Med Ctr, Div Cardiol, Washington, DC 20010 USA; [Rutkowski, Anne] Kaiser SCPMG, Cure CMD, Olathe, KS USA	Children's National Health System; Children's National Health System; Kaiser Permanente; Southern California Permanente Medical Group (SCPMG)	Spurney, CF (corresponding author), Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA.	cspurney@childrensnational.org	Nagaraju, Kanneboyina/AAV-7684-2021; Nagaraju, Kanneboyina/ABA-6525-2021; Huynh, Tony/AAU-9811-2020; Huynh, Tony/J-6783-2014	Huynh, Tony/0000-0002-7909-3670; Huynh, Tony/0000-0002-7909-3670	National Institutes of Health National Center for Research Resources [UL1TR000075]; Department of Defense USAMRAA [W81XWH-05-1-0616]; National Institutes of Health [K26RR032082, R01-AR050478, 1U54HD053177-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050846] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD053177] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000075] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR032082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050478] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K26OD011171] Funding Source: NIH RePORTER	National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Department of Defense USAMRAA(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was supported by Award Number UL1TR000075 from the National Institutes of Health National Center for Research Resources. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health; Department of Defense USAMRAA grant W81XWH-05-1-0616 (Mouse Drug Screening Core); W81XWH-11-1-0782; National Institutes of Health grants K26RR032082; R01-AR050478; 1U54HD053177-01A1 (Wellstone Muscular Dystrophy Center); 2R24HD050846-06 (Integrated Molecular Core for Rehabilitation Medicine); CureCMD (curecmd.org) and Muscular Dystrophy Association (mda.org). Co-Author, Dr. A Rutkowski, is a member of CureCMD and assisted with study design and preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Collins J, 2010, CURR NEUROL NEUROSCI, V10, P83, DOI 10.1007/s11910-010-0092-8; Dominov JA, 2005, HUM MOL GENET, V14, P1029, DOI 10.1093/hmg/ddi095; Erb M, 2009, J PHARMACOL EXP THER, V331, P787, DOI 10.1124/jpet.109.160754; Girgenrath M, 2004, J CLIN INVEST, V114, P1635, DOI 10.1172/JCI200422928; Hayashi YK, 2001, NEUROMUSCULAR DISORD, V11, P350, DOI 10.1016/S0960-8966(00)00203-0; Kuang W, 1998, J CLIN INVEST, V102, P844, DOI 10.1172/JCI3705; Miller R, 2007, NEUROLOGY, V69, P776, DOI 10.1212/01.wnl.0000269676.07319.09; Miyagoe Y, 1997, FEBS LETT, V415, P33, DOI 10.1016/S0014-5793(97)01007-7; Muntoni F, 2004, NEUROMUSCULAR DISORD, V14, P635, DOI 10.1016/j.nmd.2004.06.009; Nagaraju K, 2000, P NATL ACAD SCI USA, V97, P9209, DOI 10.1073/pnas.97.16.9209; Olanow CW, 2006, LANCET NEUROL, V5, P1013, DOI 10.1016/S1474-4422(06)70602-0; Raben N, 1998, J BIOL CHEM, V273, P19086, DOI 10.1074/jbc.273.30.19086; Raben N, 2000, NEUROMUSCULAR DISORD, V10, P283, DOI 10.1016/S0960-8966(99)00117-0; Sagot Y, 2000, BRIT J PHARMACOL, V131, P721, DOI 10.1038/sj.bjp.0703633; Spurney CF, 2011, J CARDIOVASC PHARM T, V16, P87, DOI 10.1177/1074248410381757; Spurney CF, 2009, MUSCLE NERVE, V39, P591, DOI 10.1002/mus.21211; TOME FMS, 1994, CR ACAD SCI III-VIE, V317, P351; Waldmeier PC, 2000, ADV RES NEURODEGENER, V8, P197; XU H, 1994, NAT GENET, V8, P297, DOI 10.1038/ng1194-297	19	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65468	10.1371/journal.pone.0065468	http://dx.doi.org/10.1371/journal.pone.0065468			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762378	gold, Green Submitted, Green Published			2022-12-27	WOS:000321099000071
J	Zhang, JJ; Zhou, JS; Zhang, P; Wang, WP; Tao, SH; Wang, MH				Zhang, Junjie; Zhou, Jingshi; Zhang, Ping; Wang, Weiping; Tao, Shiheng; Wang, Minghua			A Meta-Analysis of the Association between the hOGG1 Ser326Cys Polymorphism and the Risk of Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							BASE EXCISION-REPAIR; DAMAGED DNA; OGG1 GENE; CANCER; 8-HYDROXYGUANINE; CARCINOGENESIS; ADENOCARCINOMA; MUTATIONS; VARIANTS; ESTROGEN	Background: Genetic polymorphism of human 8-oxoguanine glycosylase 1 (hOGG1) Ser326Cys (rs1052133) has been implicated in the risk of Esophageal Squamous Cell Carcinoma (ESCC). However, the published findings are inconsistent. We therefore performed a meta-analysis to derive a more precise estimation of the association between the hOGG1 Ser326Cys polymorphism and ESCC risk. Methodology/Principal Findings: A comprehensive search was conducted to identify eligible studies of hOGG1 Ser326Cys polymorphism and the risk of the ESCC. Three English and two Chinese databases were used, and ten published case-control studies, including 1987 cases and 2926 controls were identified. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to assess the strength of the association in the dominant and recessive model. Pearson correlation coefficient (PCC) and standard error (SE) were used to assess the number of Cys allele and ESCC risk in the additive model. Overall, significant associations between the hOGG1 Ser326Cys polymorphism and ESCC risk were found in the recessive model: OR = 1.37 (95% CI: 1.06-1.76, p = 0.02). We also observed significant associations in the Caucasian, Chinese language, population based control and tissue subgroups. In the additive model, positive correlation was found between the number of Cys allele and the risk of ESCC in overall studies (PCC = 0.109, SE = 0.046, p = 0.02), Caucasian subgroup and population subgroup. Funnel plot and Egger's test indicate there was no publication bias in this meta-analysis. Conclusion: Under the published data, the hOGG1 Ser326Cys polymorphism is associated with ESCC risk in the recessive and additive model. Compared with the Ser/Ser and Ser/Cys genotype, Cys/Cys genotype might contribute to increased risk of ESCC. And the risk of ESCC is positively correlated with the number of Cys allele. A better case-control matched study should be designed in order to provide a more precise estimation.	[Zhang, Junjie; Tao, Shiheng] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Zhang, Junjie; Zhang, Ping; Wang, Weiping; Wang, Minghua] Soochow Univ, Coll Med, Dept Biochem & Mol Biol, Suzhou, Jiangsu, Peoples R China; [Zhou, Jingshi] Fourth Mil Med Univ, Xijing Hosp, Dept Hepatopancreaticobiliary Surg, Xian 710032, Shaanxi, Peoples R China; [Zhang, Junjie; Tao, Shiheng] Northwest A&F Univ, Bioinformat Ctr, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Soochow University - China; Air Force Military Medical University; Northwest A&F University - China	Tao, SH (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.	shihengt@nwsuaf.edu.cn; mhwang@suda.edu.cn			National Natural Science Foundation of China [81071957]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grant from the National Natural Science Foundation of China (Grant 81071957) (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Audebert M, 2000, NUCLEIC ACIDS RES, V28, P2672, DOI 10.1093/nar/28.14.2672; Bahmanyar S, 2007, GUT, V56, P464, DOI 10.1136/gut.2006.109082; Boiteux S, 2000, ARCH BIOCHEM BIOPHYS, V377, P1, DOI 10.1006/abbi.2000.1773; Boiteux S, 1999, BIOCHIMIE, V81, P59, DOI 10.1016/S0300-9084(99)80039-X; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dherin C, 1999, NUCLEIC ACIDS RES, V27, P4001, DOI 10.1093/nar/27.20.4001; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferguson HR, 2008, CANCER EPIDEM BIOMAR, V17, P736, DOI 10.1158/1055-9965.EPI-07-2832; Gao C, 2001, B CHINESE CANC, V10, P3; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Hall J, 2007, CARCINOGENESIS, V28, P665, DOI 10.1093/carcin/bgl160; Handoll HH, 2006, ARCH PHYS MED REHAB, V87, P875, DOI 10.1016/j.apmr.2006.04.006; Hao BT, 2004, CANCER RES, V64, P4378, DOI 10.1158/0008-5472.CAN-04-0372; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Hu H, 2010, SHANDONG MED J, V50, P2; Johnell O, 2004, OSTEOPOROSIS INT, V15, P897, DOI 10.1007/s00198-004-1627-0; Kohno T, 1998, ONCOGENE, V16, P3219, DOI 10.1038/sj.onc.1201872; Lagadu S, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-157; Li QD, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-74; Liu R, 2005, CHINA PUBLIC HLTH, V21, P3; MANTEL N, 1959, J NATL CANCER I, V22, P719; Minelli C, 2008, INT J EPIDEMIOL, V37, P136, DOI 10.1093/ije/dym234; Mohrenweiser HW, 2003, MUTAT RES-FUND MOL M, V526, P93, DOI 10.1016/S0027-5107(03)00049-6; Nishioka K, 1999, MOL BIOL CELL, V10, P1637, DOI 10.1091/mbc.10.5.1637; Roy D, 1999, MUTAT RES-FUND MOL M, V424, P107, DOI 10.1016/S0027-5107(99)00012-3; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Tse D, 2008, CANCER CAUSE CONTROL, V19, P1077, DOI 10.1007/s10552-008-9171-4; Umar SB, 2008, NAT CLIN PRACT GASTR, V5, P517, DOI 10.1038/ncpgasthep1223; Upadhyay Rohit, 2010, J Gastrointest Cancer, V41, P110, DOI 10.1007/s12029-009-9124-5; Wang Y, 2009, J XINJIANG MED U, V32, P4; Xing DY, 2001, INT J CANCER, V95, P140, DOI 10.1002/1097-0215(20010520)95:3&lt;140::AID-IJC1024&gt;3.0.CO;2-2; Yoshie Y, 1998, FREE RADICAL BIO MED, V24, P341, DOI 10.1016/S0891-5849(97)00269-4; Zhu X, 2009, J ENV OCCUPATIONAL M, V26, P4	35	5	6	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65742	10.1371/journal.pone.0065742	http://dx.doi.org/10.1371/journal.pone.0065742			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762419	Green Published, Green Submitted, gold			2022-12-27	WOS:000321099000099
J	Ebina, K; Shi, K; Hirao, M; Hashimoto, J; Kawato, Y; Kaneshiro, S; Morimoto, T; Koizumi, K; Yoshikawa, H				Ebina, Kosuke; Shi, Kenrin; Hirao, Makoto; Hashimoto, Jun; Kawato, Yoshitaka; Kaneshiro, Shoichi; Morimoto, Tokimitsu; Koizumi, Kota; Yoshikawa, Hideki			Oxygen and Air Nanobubble Water Solution Promote the Growth of Plants, Fishes, and Mice	PLOS ONE			English	Article							GAS BUBBLE; MICROBUBBLES; THERAPY	Nanobubbles (<200 nm in diameter) have several unique properties such as long lifetime in liquid owing to its negatively charged surface, and its high gas solubility into the liquid owing to its high internal pressure. They are used in variety of fields including diagnostic aids and drug delivery, while there are no reports assessing their effects on the growth of lives. Nanobubbles of air or oxygen gas were generated using a nanobubble aerator (BUVITAS; Ligaric Company Limited, Osaka, Japan). Brassica campestris were cultured hydroponically for 4 weeks within air-nanobubble water or within normal water. Sweetfish (for 3 weeks) and rainbow trout (for 6 weeks) were kept either within air-nanobubble water or within normal water. Finally, 5 week-old male DBA1/J mice were bred with normal free-chaw and free-drinking either of oxygen-nanobubble water or of normal water for 12 weeks. Oxygen-nanobubble significantly increased the dissolved oxygen concentration of water as well as concentration/size of nanobubbles which were relatively stable for 70 days. Air-nanobubble water significantly promoted the height (19.1 vs. 16.7 cm; P<0.05), length of leaves (24.4 vs. 22.4 cm; P<0.01), and aerial fresh weight (27.3 vs. 20.3 g; P<0.01) of Brassica campestris compared to normal water. Total weight of sweetfish increased from 3.0 to 6.4 kg in normal water, whereas it increased from 3.0 to 10.2 kg in air-nanobubble water. In addition, total weight of rainbow trout increased from 50.0 to 129.5 kg in normal water, whereas it increased from 50.0 to 148.0 kg in air-nanobubble water. Free oral intake of oxygen-nanobubble water significantly promoted the weight (23.5 vs. 21.8 g; P<0.01) and the length (17.0 vs. 16.1 cm; P<0.001) of mice compared to that of normal water. We have demonstrated for the first time that oxygen and air-nanobubble water may be potentially effective tools for the growth of lives.	[Ebina, Kosuke; Shi, Kenrin; Kawato, Yoshitaka; Kaneshiro, Shoichi; Morimoto, Tokimitsu; Koizumi, Kota; Yoshikawa, Hideki] Grad Sch Med, Dept Orthopaed Surg, Suita, Osaka, Japan; [Hirao, Makoto] Natl Hosp Org, Osaka Minami Med Ctr, Dept Orthopaed Surg, Kawachi Nagano, Osaka, Japan; [Hashimoto, Jun] Natl Hosp Org, Osaka Minami Med Ctr, Dept Immunol, Kawachi Nagano, Osaka, Japan		Ebina, K (corresponding author), Grad Sch Med, Dept Orthopaed Surg, Suita, Osaka, Japan.	k-ebina@umin.ac.jp	Ebina, Kosuke/AAH-6171-2019		Ligaric Company Limited; West Nippon Expressway Company; Grants-in-Aid for Scientific Research [24791542] Funding Source: KAKEN	Ligaric Company Limited; West Nippon Expressway Company; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was funded by Ligaric Company Limited and West Nippon Expressway Company. The funders had no role in study design, decision to publish, or preparation of the manuscript.	Abdelsalam M, 2010, RESP CARE, V55, P1483; Agarwal A, 2011, CHEMOSPHERE, V84, P1175, DOI 10.1016/j.chemosphere.2011.05.054; Barak M, 2005, CHEST, V128, P2918, DOI 10.1378/chest.128.4.2918; Barbosa FT, 2009, SAO PAULO MED J, V127, P97, DOI 10.1590/S1516-31802009000200008; Betit P, 2009, RESP CARE, V54, P1244; Bitterman H, 2009, CRIT CARE, V13, DOI 10.1186/cc7151; Cavalli R, 2009, INT J PHARMACEUT, V381, P160, DOI 10.1016/j.ijpharm.2009.07.010; Eriksson JC, 1999, COLLOID SURFACE A, V159, P159, DOI 10.1016/S0927-7757(99)00171-5; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Kulikovsky M, 2009, ISR MED ASSOC J, V11, P480; Li P, 2009, CHEMOSPHERE, V77, P1157, DOI 10.1016/j.chemosphere.2009.07.062; Ljunggren S, 1997, COLLOID SURFACE A, V129, P151, DOI 10.1016/S0927-7757(97)00033-2; Matsuki N, 2012, EUR BIOPHYS J BIOPHY, V41, P571, DOI 10.1007/s00249-012-0811-y; NUMAKO C, 1995, PHYSICA B, V208, P387, DOI 10.1016/0921-4526(94)00706-2; Owerkowicz T, 2009, J EXP BIOL, V212, P1237, DOI 10.1242/jeb.023945; Park JS, 2009, HORTTECHNOLOGY, V19, P212, DOI 10.21273/HORTSCI.19.1.212; Takahashi M, 2007, J PHYS CHEM B, V111, P1343, DOI 10.1021/jp0669254; Yoshida S, 1996, Acta Hortic, V440, P199; Zhao G, 2004, BIOPHYS CHEM, V107, P189, DOI 10.1016/S0301-4622(03)00211-4	19	193	201	14	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65339	10.1371/journal.pone.0065339	http://dx.doi.org/10.1371/journal.pone.0065339			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755221	Green Published, Green Submitted, gold			2022-12-27	WOS:000320579400053
J	Wu, LX; Dai, YR; Jiang, XL; Petchprayoon, C; Lee, JE; Jiang, T; Yan, YL; Marriott, G				Wu, Liangxing; Dai, Yingrui; Jiang, Xiaoli; Petchprayoon, Chutima; Lee, Jessie E.; Jiang, Tao; Yan, Yuling; Marriott, Gerard			High-Contrast Fluorescence Imaging in Fixed and Living Cells Using Optimized Optical Switches	PLOS ONE			English	Article							LOCK-IN DETECTION; MICROSCOPY; SPIROPYRAN	We present the design, synthesis and characterization of new functionalized fluorescent optical switches for rapid, all-visible light-mediated manipulation of fluorescence signals from labelled structures within living cells, and as probes for high-contrast optical lock-in detection (OLID) imaging microscopy. A triazole-substituted BIPS (TzBIPS) is identified from a rational synthetic design strategy that undergoes robust, rapid and reversible, visible light-driven transitions between a colorless spiro-(SP) and a far-red absorbing merocyanine (MC) state within living cells. The excited MC-state of TzBIPS may also decay to the MC-ground state emitting near infra-red fluorescence, which is used as a sensitive and quantitative read-out of the state of the optical switch in living cells. The SP to MC transition for a membrane-targeted TzBIPS probe (C-12-TzBIPS) is triggered at 405 nm at an energy level compatible with studies in living cells, while the action spectrum of the reverse transition (MC to SP) has a maximum at 650 nm. The SP to MC transition is complete within the 790 ns pixel dwell time of the confocal microscope, while a single cycle of optical switching between the SP and MC states in a region of interest is complete within 8 ms (125 Hz) within living cells, the fastest rate attained for any optical switch probe in a biological sample. This property can be exploited for real-time correction of background signals in living cells. A reactive form of TzBIPS is linked to secondary antibodies and used, in conjunction with an enhanced scope-based analysis of the modulated MC-fluorescence in immuno-stained cells, for high-contrast immunofluorescence microscopic analysis of the actin cytoskeleton.	[Wu, Liangxing; Dai, Yingrui; Jiang, Xiaoli; Petchprayoon, Chutima; Lee, Jessie E.; Marriott, Gerard] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Jiang, Tao; Yan, Yuling] Santa Clara Univ, Dept Bioengn, Santa Clara, CA 95053 USA	University of California System; University of California Berkeley; Santa Clara University	Marriott, G (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	marriott1@berkeley.edu		Marriott, Gerard/0000-0003-3197-4839	National Institutes of Health (Nanomedicine Development Center for the optical control of biological function) [PN2 EY018241, R01 GM086233-01, GM086233-01]; NATIONAL EYE INSTITUTE [PN2EY018241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086233] Funding Source: NIH RePORTER	National Institutes of Health (Nanomedicine Development Center for the optical control of biological function)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was financially supported by grants from the National Institutes of Health (PN2 EY018241 Nanomedicine Development Center for the optical control of biological function and R01 GM086233-01 to GM and GM086233-01 to YY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Berkovic G, 2000, CHEM REV, V100, P1741, DOI 10.1021/cr9800715; Bossi M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/11/275; Crano JC, 1999, T APPL CHEM, V1, P1; Du G., 2010, BIOINF BIOM ENG ICBB, P1; Jones WE, 1995, PHOTOCHROMISM MOL SY, V76; Lippincott-Schwartz J, 2009, TRENDS CELL BIOL, V19, P555, DOI 10.1016/j.tcb.2009.09.003; Mao S, 2008, BIOPHYS J, V94, P4515, DOI 10.1529/biophysj.107.124859; MARRIOTT G, 1992, BIOCHEM INT, V26, P943; Marriott G, 2008, P NATL ACAD SCI USA, V105, P17789, DOI 10.1073/pnas.0808882105; Minkin VI, 2004, CHEM REV, V104, P2751, DOI 10.1021/cr020088u; MOAN J, 1989, J PHOTOCH PHOTOBIO B, V4, P21, DOI 10.1016/1011-1344(89)80099-5; Petchprayoon C, 2011, BIOORGAN MED CHEM, V19, P1030, DOI 10.1016/j.bmc.2010.07.015; Petchprayoon C, 2010, TETRAHEDRON LETT, V51, P6753, DOI 10.1016/j.tetlet.2010.10.084; Raymo FM, 2012, ISRN PHYS CHEM, DOI [10.5402/2012/619251, DOI 10.5402/2012/619251]; Richards CI, 2009, J AM CHEM SOC, V131, P4619, DOI 10.1021/ja809785s; Sakata T, 2008, J ORG CHEM, V73, P227, DOI 10.1021/jo7019898; Samanta S, 2012, ANGEW CHEM INT EDIT, V51, P6452, DOI 10.1002/anie.201202383; Seefeldt B, 2010, PHOTOCH PHOTOBIO SCI, V9, P213, DOI 10.1039/b9pp00118b; Song L, 2002, J PHOTOCH PHOTOBIO A, V150, P177, DOI 10.1016/S1010-6030(02)00129-6; Tian ZY, 2009, CHEMPHYSCHEM, V10, P2577, DOI 10.1002/cphc.200900492; Tomasulo M, 2007, J ORG CHEM, V72, P595, DOI 10.1021/jo062004d; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; Wohl CJ, 2005, J PHYS CHEM B, V109, P22186, DOI 10.1021/jp053782x; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yan YL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0031; Yan YL, 2011, BIOCHEM J, V433, P411, DOI 10.1042/BJ20100992	27	8	8	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64738	10.1371/journal.pone.0064738	http://dx.doi.org/10.1371/journal.pone.0064738			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755140	gold, Green Published, Green Submitted			2022-12-27	WOS:000320579400023
J	Maciel-de-Freitas, R; Sylvestre, G; Gandini, M; Koella, JC				Maciel-de-Freitas, Rafael; Sylvestre, Gabriel; Gandini, Mariana; Koella, Jacob C.			The Influence of Dengue Virus Serotype-2 Infection on Aedes aegypti (Diptera: Culicidae) Motivation and Avidity to Blood Feed	PLOS ONE			English	Article							MALARIA PARASITE; TRADE-OFFS; MOSQUITO; BEHAVIOR; MANIPULATION; VECTOR; TRANSMISSION; FEMALES; SUCCESS; IMPACT	Background: Dengue virus (DENV) is transmitted by Aedes aegypti, a species that lives in close association with human dwellings. The behavior of DENV-infected mosquitoes needs further investigation, especially regarding the potential influence of DENV on mosquito biting motivation and avidity. Methodology/Principal findings: We orally challenged 4-5 day-old Ae. aegypti females with a low passage DENV serotype 2 (DENV-2) to test whether the virus influences motivation to feed (the likelihood that a mosquito obtains a blood-meal and the size of its blood meal) and avidity (the likelihood to re-feed after an interrupted first blood-meal). To assay motivation, we offered mosquitoes an anesthetized mouse for 2, 3, 4 or 5 minutes 7 or 14 days after the initial blood meals and measured the time they started feeding. 60.5% of the unexposed mosquitoes fed on the mouse, but only 40.5% of the positive ones did. Exposed but negative mosquitoes behaved similarly to unexposed ones (55.0% feeding). Thus DENV-2 infection decreased the mosquitoes' motivation to feed. To assay avidity, we offered the same mosquitoes a mouse two hours after the first round of feeding, and we measured the time at which they started probing. The exposed (positive or negative) mosquitoes were more likely to re-feed than the unexposed ones and, in particular, the size of the previous blood-meal that kept mosquitoes from re-feeding was larger in the exposed than in the unexposed mosquitoes. Thus, DENV-2 infection increased mosquito avidity. Conclusions/Significance: DENV-2 significantly decreased the mosquitoes' motivation to feed, but increased their avidity (even after taking account the amount of blood previously imbibed). As these are important components of transmission, we expect that the changes of the blood-feeding behaviour impact the vectorial capacity Ae. aegypti for dengue.	[Maciel-de-Freitas, Rafael; Sylvestre, Gabriel] Inst Oswaldo Cruz, Lab Transmissores Hematozoarios, Fiocruz, Brazil; [Gandini, Mariana] Inst Oswaldo Cruz, Lab Imunol Viral, Fiocruz, Brazil; [Koella, Jacob C.] Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; University of Neuchatel	Maciel-de-Freitas, R (corresponding author), Inst Oswaldo Cruz, Lab Transmissores Hematozoarios, Fiocruz, Brazil.	freitas@ioc.fiocruz.br	Kubelka, Claire F/C-5558-2009; Maciel-de-Freitas, Rafael/J-1997-2012; Gandini, Mariana/AAZ-6964-2021	Maciel-de-Freitas, Rafael/0000-0002-2198-6492; Gandini, Mariana/0000-0003-3603-6921				Anderson RA, 1996, J VECTOR ECOL, V21, P94; Anderson RA, 1999, ECOL LETT, V2, P98, DOI 10.1046/j.1461-0248.1999.22055.x; Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785; BRIEGEL H, 1979, J MED ENTOMOL, V15, P235, DOI 10.1093/jmedent/15.3.235; Clements A.N., 1999, BIOL MOSQUITOES SENS; Colisson R, 2010, BLOOD, V115, P2177, DOI 10.1182/blood-2009-06-224741; GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158; Halstead SB, 2003, AM J TROP MED HYG, V69, P5; Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326; Hurd H, 2003, ANNU REV ENTOMOL, V48, P141, DOI 10.1146/annurev.ento.48.091801.112722; Koella JC, 1998, P ROY SOC B-BIOL SCI, V265, P763, DOI 10.1098/rspb.1998.0358; Koella JC, 2005, BEHAV PROCESS, V68, P271, DOI 10.1016/j.beproc.2004.10.004; Koella JC, 2002, BEHAV ECOL, V13, P816, DOI 10.1093/beheco/13.6.816; Koella JC, 1996, PARASITOLOGY, V113, P105, DOI 10.1017/S0031182000066348; Kuno G, 1995, EPIDEMIOL REV, V17, P321, DOI 10.1093/oxfordjournals.epirev.a036196; Lambrechts L, 2012, MEM I OSWALDO CRUZ, V107, P1080, DOI 10.1590/S0074-02762012000800022; Lambrechts L, 2009, P R SOC B, V276, P1369, DOI 10.1098/rspb.2008.1709; Lima-Camara TN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017690; Luz PM, 2011, MEM I OSWALDO CRUZ, V106, P755, DOI 10.1590/S0074-02762011000600017; Maciel-de-Freitas R, 2011, T ROY SOC TROP MED H, V105, P452, DOI 10.1016/j.trstmh.2011.05.006; Maciel-De-Freitas R, 2007, MEM I OSWALDO CRUZ, V102, P489, DOI 10.1590/S0074-02762007005000056; Miagostovich Mariz P., 1993, Revista do Instituto de Medicina Tropical de Sao Paulo, V35, P149, DOI 10.1590/S0036-46651993000200006; Moreira LA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000568; Platt KB, 1997, AM J TROP MED HYG, V57, P119, DOI 10.4269/ajtmh.1997.57.119; PUTNAM JL, 1995, AM J TROP MED HYG, V52, P225, DOI 10.4269/ajtmh.1995.52.225; ROSSIGNOL PA, 1984, AM J TROP MED HYG, V33, P17, DOI 10.4269/ajtmh.1984.33.17; ROSSIGNOL PA, 1986, AM J TROP MED HYG, V35, P277, DOI 10.4269/ajtmh.1986.35.277; RUTLEDGE L. C., 1964, MOSQUITO NEWS, V24, P407; Schwartz A, 2001, TRENDS PARASITOL, V17, P189, DOI 10.1016/S1471-4922(00)01945-0; Sylvestre GR, 2013, PLOS ONE, V8; Torrentes-Carvalho A, 2009, MEM I OSWALDO CRUZ, V104, P1091, DOI 10.1590/S0074-02762009000800005; Turley AP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000516; Vazeille-Falcoz M, 1999, AM J TROP MED HYG, V60, P292, DOI 10.4269/ajtmh.1999.60.292	33	22	23	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65252	10.1371/journal.pone.0065252	http://dx.doi.org/10.1371/journal.pone.0065252			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755202	Green Submitted, Green Published, gold			2022-12-27	WOS:000319872300065
J	Nakagawa, T; Touhara, K				Nakagawa, Tatsuro; Touhara, Kazushige			Extracellular Modulation of the Silkmoth Sex Pheromone Receptor Activity by Cyclic Nucleotides	PLOS ONE			English	Article							DROSOPHILA ODORANT RECEPTORS; OLFACTORY RECEPTORS; BOMBYX-MORI; ANOPHELES-GAMBIAE; ION CHANNELS; GENE FAMILY; G-PROTEINS; GMP; MELANOGASTER; EXPRESSION	Odorants and pheromones are essential to insects as chemical cues for finding food or an appropriate mating partner. These volatile compounds bind to olfactory receptors (Ors) expressed by olfactory sensory neurons. Each insect Or functions as a ligand-gated ion channel and is a heteromeric complex that comprises one type of canonical Or and a highly conserved Orco subunit. Because there are many Or types, insect Ors can recognize with high specificity a myriad of chemical cues. Cyclic nucleotides can modulate the activity of insect Or-Orco complexes; however, the mechanism of action of these nucleotides is under debate. Here, we show that cyclic nucleotides, including cAMP and cGMP, interact with the silkmoth sex pheromone receptor complex, BmOr-1-BmOrco, from the outside of the cell and that these nucleotides act as antagonists at low concentrations and weak agonists at high concentrations. These cyclic nucleotides do not compete with the sex pheromone, bombykol, for binding to the BmOr-1 subunit. ATP and GTP also weakly inhibited BmOr-1-BmOrco activity, but D-ribose had no effect; these findings indicated that the purine moiety was crucial for the inhibition. Only the bombykol receptors have been so far shown to be subject to modulation by nucleotide-related compounds, indicating that this responsiveness to these compounds is not common for all insect Or-Orco complexes.	[Nakagawa, Tatsuro; Touhara, Kazushige] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Tokyo, Japan; [Touhara, Kazushige] Univ Tokyo, JST ERATO Touhara Chemosensory Signal Project, Grad Sch Agr & Life Sci, Tokyo, Japan	University of Tokyo; University of Tokyo	Touhara, K (corresponding author), Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Tokyo, Japan.	ktouhara@mail.ecc.u-tokyo.ac.jp			MEXT Japan; Japan-USA Cooperative Science Program from JSPS; ERATO Touhara Chemosensory Signal Project from JST	MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan-USA Cooperative Science Program from JSPS; ERATO Touhara Chemosensory Signal Project from JST	This work was supported in part by Grants-in-Aid for Scientific Research on Priority Areas from MEXT Japan, Japan-USA Cooperative Science Program funding from JSPS, and ERATO Touhara Chemosensory Signal Project from JST. TN was supported by a Grant-in-Aid for JSPS Fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Cervetto C, 2010, J PHARMACOL EXP THER, V332, P210, DOI 10.1124/jpet.109.154955; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050456, 10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763]; Engsontia P, 2008, INSECT BIOCHEM MOLEC, V38, P387, DOI 10.1016/j.ibmb.2007.10.005; Fox AN, 2001, P NATL ACAD SCI USA, V98, P14693, DOI 10.1073/pnas.261432998; GNATZY W, 1978, CELL TISSUE RES, V189, P549, DOI 10.1007/BF00209140; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Hofer AM, 2007, PHYSIOLOGY, V22, P320, DOI 10.1152/physiol.00019.2007; Jones PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030304; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Katada S, 2003, BIOCHEM BIOPH RES CO, V305, P964, DOI 10.1016/S0006-291X(03)00863-5; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Miura N, 2010, INSECT BIOCHEM MOLEC, V40, P64, DOI 10.1016/j.ibmb.2009.12.011; Miura N, 2009, INT J BIOL SCI, V5, P319; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Nakagawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032372; Nascimento NRF, 2011, HYPERTENSION, V58, P107, DOI 10.1161/HYPERTENSIONAHA.110.168708; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Nichols AS, 2011, CHEM SENSES, V36, P781, DOI 10.1093/chemse/bjr053; Nichols AS, 2010, J BIOL CHEM, V285, P11854, DOI 10.1074/jbc.M109.058321; PARK CS, 1995, BIOCHEMISTRY-US, V34, P13328, DOI 10.1021/bi00041a008; Pask GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028774; Pellegrino M, 2011, NATURE, V478, P511, DOI 10.1038/nature10438; Redkozubov A, 2000, CHEM SENSES, V25, P381, DOI 10.1093/chemse/25.4.381; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; Sargsyan V, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00005; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; SHABB JB, 1992, J BIOL CHEM, V267, P5723; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Stengl M, 2001, CELL TISSUE RES, V304, P409, DOI 10.1007/s004410000336; Tanaka K, 2009, CURR BIOL, V19, P881, DOI 10.1016/j.cub.2009.04.035; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; Wanner KW, 2007, INSECT MOL BIOL, V16, P107, DOI 10.1111/j.1365-2583.2007.00708.x; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Yao CA, 2010, J NEUROSCI, V30, P4562, DOI 10.1523/JNEUROSCI.6357-09.2010; ZIEGELBERGER G, 1990, J NEUROSCI, V10, P1217; ZUFALL F, 1991, P NATL ACAD SCI USA, V88, P8520, DOI 10.1073/pnas.88.19.8520	41	3	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e63774	10.1371/journal.pone.0063774	http://dx.doi.org/10.1371/journal.pone.0063774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755109	Green Published, Green Submitted, gold			2022-12-27	WOS:000319872300013
J	Tachibana, Y; Aida, N; Niwa, T; Nozawa, K; Kusagiri, K; Mori, K; Endo, K; Obata, T; Inoue, T				Tachibana, Yasuhiko; Aida, Noriko; Niwa, Tetsu; Nozawa, Kumiko; Kusagiri, Kouki; Mori, Kana; Endo, Kazuo; Obata, Takayuki; Inoue, Tomio			Analysis of Multiple B-Value Diffusion-Weighted Imaging in Pediatric Acute Encephalopathy	PLOS ONE			English	Article							ACUTE NECROTIZING ENCEPHALOPATHY; HUMAN BRAIN; REDUCED DIFFUSION; BIPHASIC SEIZURES; SIGNAL DECAY; MRI; COMPARTMENTATION; COEFFICIENTS; CHILDHOOD; INFLUENZA	Acute encephalopathy is a disease group more commonly seen in children. It is often severe and has neurological sequelae. Imaging is important for early diagnosis and prompt treatment to ameliorate an unfavorable outcome, but insufficient sensitivity/specificity is a problem. To overcome this, a new value (fraction of high b-pair (F-H)) that could be processed from clinically acceptable MR diffusion-weighted imaging (DWI) with three different b-values was designed on the basis of a two-compartment model of water diffusion signal attenuation. The purpose of this study is to compare F-H with the apparent diffusion coefficient (ADC) regarding the detectability of pediatric acute encephalopathy. We retrospectively compared the clinical DWI of 15 children (1-10 years old, mean 2.34, 8 boys, 7 girls) of acute encephalopathy with another 16 children (1-11 years old, mean 4.89, 9 boys, 7 girls) as control. A comparison was first made visually by mapping F-H on the brain images, and then a second comparison was made on the basis of 10 regions of interest (ROIs) set on cortical and subcortical areas of each child. F-H map visually revealed diffusely elevated F-H in cortical and subcortical areas of the patients with acute encephalopathy; the changes seemed more diffuse in F-H compared to DWI. The comparison based on ROI revealed elevated mean F-H in the cortical and subcortical areas of the acute encephalopathy patients compared to control with significant difference (P<0.05). Similar findings were observed even in regions where the findings of DWI were slight. The reduction of mean ADC was significant in regions with severe findings in DWI, but it was not constant in the areas with slighter DWI findings. The detectability of slight changes of cortical and subcortical lesions in acute encephalopathy may be superior in F-H compared to ADC.	[Tachibana, Yasuhiko; Obata, Takayuki] Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Inage Ku, Chiba 260, Japan; [Tachibana, Yasuhiko; Aida, Noriko; Obata, Takayuki; Inoue, Tomio] Yokohama City Univ, Dept Radiol, Grad Sch Med, Kanazawa Ku, Yokohama, Kanagawa 232, Japan; [Tachibana, Yasuhiko; Aida, Noriko; Niwa, Tetsu; Nozawa, Kumiko; Kusagiri, Kouki; Mori, Kana; Endo, Kazuo] Kanagawa Childrens Med Ctr, Dept Radiol, Minami Ku, Yokohama, Kanagawa, Japan; [Niwa, Tetsu] Tokai Univ, Sch Med, Dept Radiol, Isehara, Kanagawa 25911, Japan	National Institutes for Quantum Science & Technology; Yokohama City University; Tokai University	Obata, T (corresponding author), Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Inage Ku, Chiba 260, Japan.	t_obata@nirs.go.jp	Obata, Takayuki/AAR-9820-2020	Obata, Takayuki/0000-0001-7678-5033	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was funded by the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badaut T, 2002, J CEREBR BLOOD F MET, V22, P367, DOI 10.1097/00004647-200204000-00001; Benga O, 2012, MOL ASPECTS MED, V33, P562, DOI 10.1016/j.mam.2012.03.008; Brugieres P, 2004, AM J NEURORADIOL, V25, P692; Chen CI, 2011, PEDIATR NEUROL, V44, P389, DOI 10.1016/j.pediatrneurol.2010.12.007; Clark CA, 2000, MAGN RESON MED, V44, P852, DOI 10.1002/1522-2594(200012)44:6<852::AID-MRM5>3.0.CO;2-A; Hayashi N, 2012, BRAIN DEV-JPN, V34, P632, DOI 10.1016/j.braindev.2011.11.007; Hoshino A, 2012, BRAIN DEV-JPN, V34, P337, DOI 10.1016/j.braindev.2011.07.012; Ichiyama T, 2009, BRAIN DEV-JPN, V31, P731, DOI 10.1016/j.braindev.2008.11.005; Ichlyama T, 2008, BRAIN DEV-JPN, V30, P47, DOI 10.1016/j.braindev.2007.05.008; Kobayashi K, 2010, EPILEPSY RES, V91, P143, DOI 10.1016/j.eplepsyres.2010.07.005; Kozak LR, 2010, ACTA PAEDIATR, V99, P237, DOI 10.1111/j.1651-2227.2009.01528.x; Kuwata S, 2012, BRAIN DEV-JPN, V34, P529, DOI 10.1016/j.braindev.2011.08.010; Lee JH, 2003, MAGNET RESON MED, V49, P450, DOI 10.1002/mrm.10402; Maier SE, 2001, RADIOLOGY, V219, P842, DOI 10.1148/radiology.219.3.r01jn02842; Maier SE, 2008, MAGN RESON IMAGING, V26, P897, DOI 10.1016/j.mri.2008.01.042; Mardor Y, 2003, J CLIN ONCOL, V21, P1094, DOI 10.1200/JCO.2003.05.069; Matsushita T, 2009, MULT SCLER J, V15, P1113, DOI 10.1177/1352458509106613; Mizuguchi M, 2007, ACTA NEUROL SCAND, V115, P45, DOI 10.1111/j.1600-0404.2007.00809.x; Mizuguchi M, 1997, BRAIN DEV-JPN, V19, P81, DOI 10.1016/S0387-7604(96)00063-0; Morishima T, 2002, CLIN INFECT DIS, V35, P512, DOI 10.1086/341407; Mulkern RV, 1999, NMR BIOMED, V12, P51, DOI 10.1002/(SICI)1099-1492(199902)12:1<51::AID-NBM546>3.0.CO;2-E; Obata T, 2012, 20 ANN M INT SOC MAG, P1830; Okumura A, 2009, AM J NEURORADIOL, V30, P825, DOI 10.3174/ajnr.A1431; Okumura A, 2012, EPILEPSIA, V53, P79, DOI 10.1111/j.1528-1167.2011.03311.x; Ribeiro MD, 2006, J NEUROSCI RES, V83, P1231, DOI 10.1002/jnr.20819; Saitoh M, 2012, EPILEPSIA, V53, P558, DOI 10.1111/j.1528-1167.2011.03402.x; Sakai K, 2012, NMR BIOMED, V25, P340, DOI 10.1002/nbm.1755; Sakai K, 2011, NMR BIOMED, V24, P1063, DOI 10.1002/nbm.1656; Schwarcz A, 2004, MAGNET RESON MED, V51, P278, DOI 10.1002/mrm.10702; Shiihara T, 2012, PEDIATR INT, V54, P52, DOI 10.1111/j.1442-200X.2011.03454.x; ShinMoto H, 2009, MAGN RESON IMAGING, V27, P355, DOI 10.1016/j.mri.2008.07.008; Shinohara M, 2011, BRAIN DEV-JPN, V33, P512, DOI 10.1016/j.braindev.2010.09.002; Tadokoro R, 2010, BRAIN DEV-JPN, V32, P477, DOI 10.1016/j.braindev.2009.05.007; Takanashi J, 2006, NEUROLOGY, V66, P1304, DOI 10.1212/01.wnl.0000210487.36667.a5; Takanashi J, 2009, AM J NEURORADIOL, V30, P132, DOI 10.3174/ajnr.A1247; Takanashi J, 2009, BRAIN DEV-JPN, V31, P521, DOI 10.1016/j.braindev.2009.02.012; Tamura T, 2012, MAGN RESON MED, V68, P890, DOI 10.1002/mrm.23277; Tamura T, 2010, MAGN RESON MED SCI, V9, P195, DOI 10.2463/mrms.9.195; Traul DE, 2008, DEV MED CHILD NEUROL, V50, P717, DOI 10.1111/j.1469-8749.2008.03080.x; Wong AM, 2006, AM J NEURORADIOL, V27, P1919	40	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e63869	10.1371/journal.pone.0063869	http://dx.doi.org/10.1371/journal.pone.0063869			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755112	Green Submitted, gold, Green Published			2022-12-27	WOS:000319872300015
J	Huang, SH; Zhao, LX; Hong, C; Duo, CC; Guo, BN; Zhang, LJ; Gong, Z; Xiong, SD; Gong, FY; Gao, XM				Huang, Shang-Hui; Zhao, Li-Xiang; Hong, Chao; Duo, Cui-Cui; Guo, Bing-Nan; Zhang, Li-Juan; Gong, Zheng; Xiong, Si-Dong; Gong, Fang-Yuan; Gao, Xiao-Ming			Self-Oligomerization Is Essential for Enhanced Immunological Activities of Soluble Recombinant Calreticulin	PLOS ONE			English	Article							HUMAN PLACENTAL CALRETICULIN; CELL-SURFACE CALRETICULIN; HEAT-SHOCK PROTEINS; BINDING CHARACTERISTICS; MOLECULAR CHAPERONE; T-LYMPHOCYTES; ACTIVATION; LECTIN; PURIFICATION; ASSOCIATION	We have recently reported that calreticulin (CRT), a luminal resident protein, can be found in the sera of patients with rheumatoid arthritis and also that recombinant CRT (rCRT) exhibits extraordinarily strong immunological activities. We herein further demonstrate that rCRT fragments 18-412 (rCRT/18-412), rCRT/39-272, rCRT/120-308 and rCRT/120-250 can self-oligomerize in solution and are 50-100 fold more potent than native CRT (nCRT, isolated from mouse livers) in activating macrophages in vitro. We narrowed down the active site of CRT to residues 150-230, the activity of which also depends on dimerization. By contrast, rCRT/18-197 is almost completely inactive. When rCRT/18-412 is fractionated into oligomers and monomers by gel filtration, the oligomers maintain most of their immunological activities in terms of activating macrophages in vitro and inducing specific antibodies in vivo, while the monomers were much less active by comparison. Additionally, rCRT/18-412 oligomers are much better than monomers in binding to, and uptake by, macrophages. Inhibition of macrophage endocytosis partially blocks the stimulatory effect of rCRT/18-412. We conclude that the immunologically active site of CRT maps between residues 198-230 and that soluble CRT could acquire potent immuno-pathological activities in microenvironments favoring its oligomerization.	[Huang, Shang-Hui; Zhao, Li-Xiang; Hong, Chao; Duo, Cui-Cui; Guo, Bing-Nan; Zhang, Li-Juan; Gong, Zheng; Xiong, Si-Dong; Gong, Fang-Yuan; Gao, Xiao-Ming] Soochow Univ, Inst Biol & Med Sci, Suzhou, Jiangsu, Peoples R China	Soochow University - China	Gong, FY (corresponding author), Soochow Univ, Inst Biol & Med Sci, Suzhou, Jiangsu, Peoples R China.	gongfangyuan@suda.edu.cn; xmgao@suda.edu.cn	Zhang, Li/GWM-7501-2022		Program for Changjiang Scholars and Innovative Research Team PCSIRT [IRT1075]; National Foundation of Nature Science of China [30890142/31070781/31200649]; Priority Academic Program Development of Jiangsu Province Higher Education Institutions; National Key Basic Research Programs [2010CB529102]	Program for Changjiang Scholars and Innovative Research Team PCSIRT(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Foundation of Nature Science of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Province Higher Education Institutions; National Key Basic Research Programs(National Basic Research Program of China)	This study was supported by grants from the Program for Changjiang Scholars and Innovative Research Team PCSIRT (IRT1075), National Foundation of Nature Science of China (30890142/31070781/31200649), Priority Academic Program Development of Jiangsu Province Higher Education Institutions, and National Key Basic Research Programs (2010CB529102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arosa FA, 1999, J BIOL CHEM, V274, P16917, DOI 10.1074/jbc.274.24.16917; BURNS K, 1992, J BIOL CHEM, V267, P19039; Cho JH, 2001, CELL STRESS CHAPERON, V6, P148, DOI 10.1379/1466-1268(2001)006<0148:AOHMCL>2.0.CO;2; Chouquet A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017886; EGGLETON P, 1994, CLIN IMMUNOL IMMUNOP, V72, P405, DOI 10.1006/clin.1994.1160; Ellgaard L, 2002, J MOL BIOL, V322, P773, DOI 10.1016/S0022-2836(02)00812-4; Ellgaard L, 2001, P NATL ACAD SCI USA, V98, P3133, DOI 10.1073/pnas.051630098; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Gelebart P, 2005, INT J BIOCHEM CELL B, V37, P260, DOI 10.1016/j.biocel.2004.02.030; Goeb V, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2644; Goicoechea S, 2000, J BIOL CHEM, V275, P36358, DOI 10.1074/jbc.M005951200; Habich C, 2005, J IMMUNOL, V174, P1298, DOI 10.4049/jimmunol.174.3.1298; Hojrup P, 2001, EUR J BIOCHEM, V268, P2558, DOI 10.1046/j.1432-1327.2001.02138.x; Hong C, 2010, J IMMUNOL, V185, P4561, DOI 10.4049/jimmunol.1000536; HOUEN G, 1994, ACTA CHEM SCAND, V48, P905, DOI 10.3891/acta.chem.scand.48-0905; Jorgensen CS, 2003, EUR J BIOCHEM, V270, P4140, DOI 10.1046/j.1432-1033.2003.03808.x; Kozlov G, 2010, J BIOL CHEM, V285, P38612, DOI 10.1074/jbc.M110.168294; Krause KH, 1997, CELL, V88, P439, DOI 10.1016/S0092-8674(00)81884-X; Lamkanfi M, 2010, INT J BIOCHEM CELL B, V42, P792, DOI 10.1016/j.biocel.2010.01.008; LI WJ, 2013, CLIN VACCINE IMMUNOL; Li ZJ, 2001, BIOCHEMISTRY-US, V40, P11193, DOI 10.1021/bi010948l; Ling S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011703; Mancino L, 2002, P NATL ACAD SCI USA, V99, P5931, DOI 10.1073/pnas.092031799; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Nemoto TK, 2001, BIOCHEM J, V354, P663, DOI 10.1042/0264-6021:3540663; Pawaria S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1524; Pockley AG, 2003, LANCET, V362, P469, DOI 10.1016/S0140-6736(03)14075-5; Porcellini S, 2006, J EXP MED, V203, P461, DOI 10.1084/jem.20051519; Qiu X, 2012, MICROBIOL IMMUNOL, V56, P554, DOI 10.1111/j.1348-0421.2012.00467.x; ROWLING PJE, 1994, PROTEIN EXPRES PURIF, V5, P331, DOI 10.1006/prep.1994.1049; SCHLEGEL R, 1982, P NATL ACAD SCI-BIOL, V79, P2291, DOI 10.1073/pnas.79.7.2291; Spiro RG, 1996, J BIOL CHEM, V271, P11588, DOI 10.1074/jbc.271.19.11588; Thomson SP, 2005, CELL STRESS CHAPERON, V10, P242, DOI 10.1379/CSC-126.1; Vassilakos A, 1998, BIOCHEMISTRY-US, V37, P3480, DOI 10.1021/bi972465g; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; Wearsch PA, 1996, BIOCHEMISTRY-US, V35, P16760, DOI 10.1021/bi962068q; WHITE TK, 1995, J BIOL CHEM, V270, P15926, DOI 10.1074/jbc.270.27.15926; Wijeyesakere SJ, 2011, J BIOL CHEM, V286, P8771, DOI 10.1074/jbc.M110.169193; Yonehara M, 1996, J BIOL CHEM, V271, P2641, DOI 10.1074/jbc.271.5.2641	41	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e64951	10.1371/journal.pone.0064951	http://dx.doi.org/10.1371/journal.pone.0064951			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762269	Green Submitted, gold, Green Published			2022-12-27	WOS:000320440500012
J	Zhang, X; He, LM; Zhang, FL; Sun, W; Li, ZY				Zhang, Xia; He, Liming; Zhang, Fengli; Sun, Wei; Li, Zhiyong			The Different Potential of Sponge Bacterial Symbionts in N-2 Release Indicated by the Phylogenetic Diversity and Abundance Analyses of Denitrification Genes, nirK and nosZ	PLOS ONE			English	Article							NITRITE REDUCTASE GENES; AMMONIA-OXIDIZING ARCHAEA; COMPLETE GENOME SEQUENCE; OIL-DEGRADING BACTERIUM; MARINE SPONGE; DENITRIFYING BACTERIA; SPATIAL-DISTRIBUTION; NITROGEN-FIXATION; COMMUNITIES; NITRIFICATION	Nitrogen cycle is a critical biogeochemical process of the oceans. The nitrogen fixation by sponge cyanobacteria was early observed. Until recently, sponges were found to be able to release nitrogen gas. However the gene-level evidence for the role of bacterial symbionts from different species sponges in nitrogen gas release is limited. And meanwhile, the quanitative analysis of nitrogen cycle-related genes of sponge microbial symbionts is relatively lacking. The nirK gene encoding nitrite reductase which catalyzes soluble nitrite into gas NO and nosZ gene encoding nitrous oxide reductase which catalyzes N2O into N-2 are two key functional genes in the complete denitrification pathway. In this study, using nirK and nosZ genes as markers, the potential of bacterial symbionts in six species of sponges in the release of N-2 was investigated by phylogenetic analysis and real-time qPCR. As a result, totally, 2 OTUs of nirK and 5 OTUs of nosZ genes were detected by gene library-based saturated sequencing. Difference phylogenetic diversity of nirK and nosZ genes were observed at OTU level in sponges. Meanwhile, real-time qPCR analysis showed that Xestospongia testudinaria had the highest abundance of nosZ gene, while Cinachyrella sp. had the greatest abundance of nirK gene. Phylogenetic analysis showed that the nirK and nosZ genes were probably of Alpha-, Beta-, and Gammaproteobacteria origin. The results from this study suggest that the denitrification potential of bacteria varies among sponges because of the different phylogenetic diversity and relative abundance of nosZ and nirK genes in sponges. Totally, both the qualitative and quantitative analyses of nirK and nosZ genes indicated the different potential of sponge bacterial symbionts in the release of nitrogen gas.	[Zhang, Xia; He, Liming; Zhang, Fengli; Sun, Wei; Li, Zhiyong] Shanghai Jiao Tong Univ, Marine Biotechnol Lab, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Zhang, Xia; He, Liming; Zhang, Fengli; Sun, Wei; Li, Zhiyong] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Li, ZY (corresponding author), Shanghai Jiao Tong Univ, Marine Biotechnol Lab, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	zyli@sjtu.edu.cn			National Natural Science Foundation of China (NSFC) [41076077]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Financial support from National Natural Science Foundation of China (NSFC) (41076077) is greatly acknowledged [http://www.nsfc.gov.cn]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anceno AJ, 2009, BIORESOURCE TECHNOL, V100, P3678, DOI 10.1016/j.biortech.2009.02.045; Auclair J, 2012, MICROB ECOL, V63, P726, DOI 10.1007/s00248-011-9960-2; Bayer K, 2008, ENVIRON MICROBIOL, V10, P2942, DOI 10.1111/j.1462-2920.2008.01582.x; Braker G, 2000, APPL ENVIRON MICROB, V66, P2096, DOI 10.1128/AEM.66.5.2096-2104.2000; Braker G, 1998, APPL ENVIRON MICROB, V64, P3769; Cao BY, 2011, J BACTERIOL, V193, P4021, DOI 10.1128/JB.05242-11; Cassler M, 2008, MICROB ECOL, V55, P384, DOI 10.1007/s00248-007-9283-5; Chen Z, 2012, J SCI FOOD AGR, V92, P1064, DOI 10.1002/jsfa.4533; Chen Z, 2010, MICROB ECOL, V60, P850, DOI 10.1007/s00248-010-9700-z; Cuhel J, 2010, APPL ENVIRON MICROB, V76, P1870, DOI 10.1128/AEM.02484-09; Diaz MC, 1997, MAR ECOL PROG SER, V156, P97, DOI 10.3354/meps156097; Donaldson KA, 2002, WATER RES, V36, P2505, DOI 10.1016/S0043-1354(01)00479-1; Fan L, 2012, P NATL ACAD SCI USA, V109, pE1878, DOI 10.1073/pnas.1203287109; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Gruber N, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P1, DOI 10.1016/B978-0-12-372522-6.00001-3; Han MQ, 2013, MICROB ECOL, V66, P427, DOI 10.1007/s00248-013-0197-0; Hentschel U, 2006, FEMS MICROBIOL ECOL, V55, P167, DOI 10.1111/j.1574-6941.2005.00046.x; Heylen K, 2006, ENVIRON MICROBIOL, V8, P2012, DOI 10.1111/j.1462-2920.2006.01081.x; Hoffmann F, 2009, ENVIRON MICROBIOL, V11, P2228, DOI 10.1111/j.1462-2920.2009.01944.x; Holmes B, 2007, MAR BIOL, V150, P759, DOI 10.1007/s00227-006-0361-x; Kandeler E, 2006, APPL ENVIRON MICROB, V72, P5957, DOI 10.1128/AEM.00439-06; Kloos K, 2001, AUST J PLANT PHYSIOL, V28, P991; Lee OO, 2012, INT J SYST EVOL MICR, V62, P1980, DOI 10.1099/ijs.0.028811-0; Levy-Booth DJ, 2010, APPL ENVIRON MICROB, V76, P7116, DOI 10.1128/AEM.02188-09; Li CW, 1998, SCIENCE, V279, P879, DOI 10.1126/science.279.5352.879; Li SG, 2011, J BACTERIOL, V193, P2894, DOI 10.1128/JB.00333-11; Liu F, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI DOI 10.2174/157015911795017155; Liu XQ, 2008, FEMS MICROBIOL LETT, V289, P46, DOI 10.1111/j.1574-6968.2008.01362.x; Lopez-Legentil S, 2010, MICROB ECOL, V60, P561, DOI 10.1007/s00248-010-9662-1; Lund MB, 2012, ISME J, V6, P1966, DOI 10.1038/ismej.2012.40; Meyer B, 2008, MICROB ECOL, V56, P306, DOI 10.1007/s00248-007-9348-5; Michotey V, 2000, APPL ENVIRON MICROB, V66, P1564, DOI 10.1128/AEM.66.4.1564-1571.2000; Mohamed NM, 2008, ENVIRON MICROBIOL, V10, P2910, DOI 10.1111/j.1462-2920.2008.01704.x; Mohamed NM, 2010, ISME J, V4, P38, DOI 10.1038/ismej.2009.84; Muller WEG, 1999, TRANSPLANTATION, V68, P1215; Palmer K, 2012, ISME J, V6, P1058, DOI 10.1038/ismej.2011.172; Palmer K, 2009, APPL ENVIRON MICROB, V75, P5170, DOI 10.1128/AEM.00254-09; Philippot L, 2009, ENVIRON MICROBIOL, V11, P1518, DOI 10.1111/j.1462-2920.2009.01879.x; Radax R, 2012, ENVIRON MICROBIOL, V14, P909, DOI 10.1111/j.1462-2920.2011.02661.x; Ribes M, 2012, ENVIRON MICROBIOL, V14, P1224, DOI 10.1111/j.1462-2920.2012.02701.x; Schlappy ML, 2010, MAR BIOL, V157, P593, DOI 10.1007/s00227-009-1344-5; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Siegl A, 2011, ISME J, V5, P61, DOI 10.1038/ismej.2010.95; Skovhus TL, 2004, APPL ENVIRON MICROB, V70, P2373, DOI 10.1128/AEM.70.4.2373-2382.2004; Southwell MW, 2008, MAR CHEM, V108, P96, DOI 10.1016/j.marchem.2007.10.005; Spain AM, 2007, APPL ENVIRON MICROB, V73, P4892, DOI 10.1128/AEM.00331-07; Steger D, 2008, ENVIRON MICROBIOL, V10, P1087, DOI 10.1111/j.1462-2920.2007.01515.x; Stres B, 2004, APPL ENVIRON MICROB, V70, P301, DOI 10.1128/AEM.70.1.301-309.2004; Taylor MW, 2007, ISME J, V1, P187, DOI 10.1038/ismej.2007.32; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Taylor MW, 2013, ISME J, V7, P438, DOI 10.1038/ismej.2012.111; Turque AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015774; Webster NS, 2012, ENVIRON MICROBIOL, V14, P335, DOI 10.1111/j.1462-2920.2011.02460.x; Wilkinson C, 1999, AMBIO, V28, P188; Wilkinson C.R., 1979, Colloques Internationaux du Centre National de la Recherche Scientifique, P373; WILKINSON CR, 1983, SCIENCE, V219, P410, DOI 10.1126/science.219.4583.410; WILKINSON CR, 1979, NATURE, V279, P527, DOI 10.1038/279527a0; Wu L, 2012, ENVIRON MANAGE, V50, P861, DOI 10.1007/s00267-012-9929-z; Yang ZY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00528; Zehr JP, 2011, ANNU REV MAR SCI, V3, P197, DOI 10.1146/annurev-marine-120709-142819; Zehr JP, 2002, APPL ENVIRON MICROB, V68, P1015, DOI 10.1128/AEM.68.3.1015-1024.2002; Zhou K, 2011, MICROB ECOL, V62, P644, DOI 10.1007/s00248-011-9859-y; Zhou ZF, 2011, ENVIRON SCI POLLUT R, V18, P1644, DOI 10.1007/s11356-011-0482-8	63	10	11	4	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65142	10.1371/journal.pone.0065142	http://dx.doi.org/10.1371/journal.pone.0065142			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762300	gold, Green Submitted, Green Published			2022-12-27	WOS:000320440500028
J	Zhao, TC; Du, JF; Zhuang, SG; Liu, P; Zhang, LX				Zhao, Ting C.; Du, Jianfeng; Zhuang, Shugang; Liu, Paul; Zhang, Ling X.			HDAC Inhibition Elicits Myocardial Protective Effect through Modulation of MKK3/Akt-1	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITION; MESENCHYMAL STEM-CELLS; P38 MAP KINASE; NF-KAPPA-B; CARDIAC-HYPERTROPHY; INFARCTED HEARTS; IN-VITRO; AKT; ACTIVATION; ISCHEMIA	We and others have demonstrated that HDAC inhibition protects the heart against myocardial injury. It is known that Akt-1 and MAP kinase play an essential role in modulation of myocardial protection and cardiac preconditioning. Our recent observations have shown that Akt-1 was activated in post-myocardial infarction following HDAC inhibition. However, it remains unknown whether MKK3 and Akt-1 are involved in HDAC inhibition-induced myocardial protection in acute myocardial ischemia and reperfusion injury. We sought to investigate whether the genetic disruption of Akt-1 and MKK3 eliminate cardioprotection elicited by HDAC inhibition and whether Akt-1 is associated with MKK3 to ultimately achieve protective effects. Adult wild type and MKK3(-/-), Akt-1(-/-) mice received intraperitoneal injections of trichostatin A (0.1mg/kg), a potent inhibitor of HDACs. The hearts were subjected to 30 min myocardial ischemia/30 min reperfusion in the Langendorff perfused heart after twenty four hours to elicit pharmacologic preconditioning. Left ventricular function was measured, and infarct size was determined. Acetylation and phosphorylation of MKK3 were detected and disruption of Akt1 abolished both acetylation and phosphorylation of MKK3. HDAC inhibition produces an improvement in left ventricular functional recovery, but these effects were abrogated by disruption of either Akt-1 or MKK3. Disruption of Akt-1 or MKK3 abolished the effects of HDAC inhibition-induced reduction of infarct size. Trichostatin A treatment resulted in an increase in MKK3 phosphorylation or acetylation in myocardium. Taken together, these results indicate that stimulation of the MKK3 and Akt-1 pathway is a novel approach to HDAC inhibition -induced cardioprotection.	[Zhao, Ting C.; Du, Jianfeng] Boston Univ, Sch Med, Roger Williams Med Ctr, Dept Surg,Cardiovasc Res Lab, Providence, RI USA; [Zhuang, Shugang; Zhang, Ling X.] Brown Univ, Rhode Isl Hosp, Brown Med Sch, Dept Med, Providence, RI 02903 USA; [Liu, Paul] Brown Univ, Rhode Isl Hosp, Brown Med Sch, Dept Plast Surg, Providence, RI 02903 USA	Boston University; Roger Williams Medical Center; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Zhao, TC (corresponding author), Boston Univ, Sch Med, Roger Williams Med Ctr, Dept Surg,Cardiovasc Res Lab, Providence, RI USA.	tzhao@bu.edu			National Heart, Lung, and Blood Institute [R01 HL089405]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089405] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Heart, Lung, and Blood Institute Grant (R01 HL089405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antos CL, 2003, J BIOL CHEM, V278, P28930, DOI 10.1074/jbc.M303113200; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Dana A, 2000, CIRC RES, V86, P989, DOI 10.1161/01.RES.86.9.989; Fischle W, 1999, J BIOL CHEM, V274, P11713, DOI 10.1074/jbc.274.17.11713; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hansen JC, 1998, BIOCHEMISTRY-US, V37, P17637, DOI 10.1021/bi982409v; Hassig CA, 1998, P NATL ACAD SCI USA, V95, P3519, DOI 10.1073/pnas.95.7.3519; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCULATIONAHA.105.559724; Kong YL, 2006, CIRCULATION, V113, P2579, DOI 10.1161/CIRCULATIONAHA.106.625467; Lochner A, 2003, CARDIOVASC DRUG THER, V17, P217, DOI 10.1023/A:1026116022552; Loubani Mahmoud, 2002, BMC Physiol, V2, P10, DOI 10.1186/1472-6793-2-10; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Martindale JJ, 2005, J BIOL CHEM, V280, P669, DOI 10.1074/jbc.M406690200; Matsui T, 2001, CIRCULATION, V104, P330; Ren M, 2004, J NEUROCHEM, V89, P1358, DOI 10.1111/j.1471-4159.2004.02406.x; Schieven GL, 2005, CURR TOP MED CHEM, V5, P921, DOI 10.2174/1568026054985902; Schulz R, 2002, CARDIOVASC RES, V55, P690, DOI 10.1016/S0008-6363(02)00319-X; Shiojima I, 2002, J BIOL CHEM, V277, P37670, DOI 10.1074/jbc.M204572200; Shiraishi I, 2004, CIRC RES, V94, P884, DOI 10.1161/01.RES.0000124394.01180.BE; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sundaresan NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001465; Tseng A, 2010, CARDIOVASC RES, V87, P704, DOI 10.1093/cvr/cvq110; Tseng YT, 2005, AM J PHYSIOL-HEART C, V289, pH1834, DOI 10.1152/ajpheart.00435.2005; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Vigushin DM, 2004, CURR CANCER DRUG TAR, V4, P205, DOI 10.2174/1568009043481560; Wang AH, 1999, MOL CELL BIOL, V19, P7816; Wang YG, 2004, J MOL CELL CARDIOL, V37, P1041, DOI 10.1016/j.yjmcc.2004.09.004; Zhang L, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.379115; Zhang L, 2012, J PHARMACOL EXP THER, V341, P285, DOI 10.1124/jpet.111.189910; Zhao TC, 2003, AM J PHYSIOL-HEART C, V285, pH434, DOI 10.1152/ajpheart.00095.2003; Zhao TC, 2002, J MOL CELL CARDIOL, V34, P263, DOI 10.1006/jmcc.2001.1510; Zhao TC, 2001, CIRC RES, V89, P915, DOI 10.1161/hh2201.099452; Zhao TC, 2001, AM J PHYSIOL-HEART C, V280, pH1278, DOI 10.1152/ajpheart.2001.280.3.H1278; Zhao TC, 2007, CARDIOVASC RES, V76, P473, DOI 10.1016/j.cardiores.2007.08.010; Zhao TC, 2010, BBA-MOL CELL RES, V1803, P872, DOI 10.1016/j.bbamcr.2010.04.007; Zhao TC, 2006, J PHARMACOL EXP THER, V317, P1106, DOI 10.1124/jpet.106.100982	42	22	23	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65474	10.1371/journal.pone.0065474	http://dx.doi.org/10.1371/journal.pone.0065474			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762381	Green Submitted, Green Published, gold			2022-12-27	WOS:000320440500041
J	Fritz, S; Capitan, A; Djari, A; Rodriguez, SC; Barbat, A; Baur, A; Grohs, C; Weiss, B; Boussaha, M; Esquerre, D; Klopp, C; Rocha, D; Boichard, D				Fritz, Sebastien; Capitan, Aurelien; Djari, Anis; Rodriguez, Sabrina C.; Barbat, Anne; Baur, Aurelia; Grohs, Cecile; Weiss, Bernard; Boussaha, Mekki; Esquerre, Diane; Klopp, Christophe; Rocha, Dominique; Boichard, Didier			Detection of Haplotypes Associated with Prenatal Death in Dairy Cattle and Identification of Deleterious Mutations in GART, SHBG and SLC37A2	PLOS ONE			English	Article							MOUSE; DISRUPTION; DEFICIENCY; FERTILITY; DEFECTS; MODEL; GENE; DNA	The regular decrease of female fertility over time is a major concern in modern dairy cattle industry. Only half of this decrease is explained by indirect response to selection on milk production, suggesting the existence of other factors such as embryonic lethal genetic defects. Genomic regions harboring recessive deleterious mutations were detected in three dairy cattle breeds by identifying frequent haplotypes (>1%) showing a deficit in homozygotes among Illumina Bovine 50k Beadchip haplotyping data from the French genomic selection database (47,878 Holstein, 16,833 Montbeliarde, and 11,466 Normande animals). Thirty-four candidate haplotypes (p<10(-4)) including previously reported regions associated with Brachyspina, CVM, HH1, and HH3 in Holstein breed were identified. Haplotype length varied from 1 to 4.8 Mb and frequencies from 1.7 up to 9%. A significant negative effect on calving rate, consistent in heifers and in lactating cows, was observed for 9 of these haplotypes in matings between carrier bulls and daughters of carrier sires, confirming their association with embryonic lethal mutations. Eight regions were further investigated using whole genome sequencing data from heterozygous bull carriers and control animals (45 animals in total). Six strong candidate causative mutations including polymorphisms previously reported in FANCI (Brachyspina), SLC35A3 (CVM), APAF1 (HH1) and three novel mutations with very damaging effect on the protein structure, according to SIFT and Polyphen-2, were detected in GART, SHBG and SLC37A2 genes. In conclusion, this study reveals a yet hidden consequence of the important inbreeding rate observed in intensively selected and specialized cattle breeds. Counter-selection of these mutations and management of matings will have positive consequences on female fertility in dairy cattle.	[Fritz, Sebastien; Capitan, Aurelien; Baur, Aurelia] UNCEIA, Genet Team, Paris, France; [Fritz, Sebastien; Capitan, Aurelien; Rodriguez, Sabrina C.; Barbat, Anne; Baur, Aurelia; Grohs, Cecile; Weiss, Bernard; Boussaha, Mekki; Rocha, Dominique; Boichard, Didier] INRA, Anim Genet & Integrat Biol UMR1313, Jouy En Josas, France; [Djari, Anis; Rodriguez, Sabrina C.; Klopp, Christophe] INRA, Sigenae, Biometrie & Intelligence Artificielle UR875, F-31326 Castanet Tolosan, France; [Esquerre, Diane] INRA, GeT Genom Facil, Lab Genet Cellulaire UMR444, F-31326 Castanet Tolosan, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; INRAE	Boichard, D (corresponding author), INRA, Anim Genet & Integrat Biol UMR1313, Jouy En Josas, France.	didier.boichard@jouy.inra.fr	Rocha, Dominique/R-5546-2019; Capitan, Aurélien/M-3732-2015; Klopp, Christophe/J-3164-2019; Boichard, Didier/AAD-8675-2020	Rocha, Dominique/0000-0003-4998-9641; Klopp, Christophe/0000-0001-7126-5477; Boichard, Didier/0000-0003-0361-2961; boussaha, mekki/0000-0002-5432-4604; FRITZ, Sebastien/0000-0002-3378-1048	ANR (French National Research Agency) [ANR-05-GENANIMAL-007, ANR-08-GENM-030-01, ANR-08-GANI-034]; Creavia; Amelis; Genes Diffusion; Midatest; Umotest; Jura Betail; Interselection Normande; ANR [ANR-10-GENM-0018]; ApisGene [ANR-10-GENM-0018]	ANR (French National Research Agency)(French National Research Agency (ANR)); Creavia; Amelis; Genes Diffusion; Midatest; Umotest; Jura Betail; Interselection Normande; ANR(French National Research Agency (ANR)); ApisGene	Genotypes originated from the Cartofine (ANR-05-GENANIMAL-007), Amasgen (ANR-08-GENM-030-01) and Lactoscan (ANR-08-GANI-034) projects funded by ANR (French National Research Agency) and ApisGene, and from genomic selection activity generated by seven French cattle breeding companies (Creavia, Amelis, Genes Diffusion, Midatest, Umotest, Jura Betail, Interselection Normande). The whole genome sequence data originated from the CartoSeq (ANR-10-GENM-0018) project funded by ANR and ApisGene. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HA, 2012, PLANT AN GEN M JUN 1; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Agerholm Jorgen S, 2007, BMC Vet Res, V3, P8, DOI 10.1186/1746-6148-3-8; Agerholm JS, 2007, APMIS, V115, P1, DOI 10.1111/j.1600-0463.2007.apm_v115_s122.x; Agerholm JS, 2001, J VET DIAGN INVEST, V13, P283, DOI 10.1177/104063870101300401; Bair SR, 2004, MOL CELL BIOL, V24, P5383, DOI 10.1128/MCB.24.12.5383-5390.2004; BALI D, 1995, J BIOL CHEM, V270, P21464, DOI 10.1074/jbc.270.37.21464; Barbat A, 2010, J REPROD DEVELOP, V56, pS15, DOI 10.1262/jrd.1056S15; Boichard D, 2012, ANIM PROD SCI, V52, P115, DOI 10.1071/AN11119; Boichard D, 1996, PROD ANIM, V9, P323; Burstyn-Cohen T, 2009, J CLIN INVEST, V119, P2942, DOI 10.1172/JCI39325; Capel C, 2010, B TECHNIQUE INSEMINA, V132, P40; Charlier C, 2008, NAT GENET, V40, P449, DOI 10.1038/ng.96; Charlier C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043085; DeYoung RA, 2003, J BIOL CHEM, V278, P47104, DOI 10.1074/jbc.M307496200; Druet T, 2010, GENETICS, V184, P789, DOI 10.1534/genetics.109.108431; Duchesne A, 2006, GENOMICS, V88, P610, DOI 10.1016/j.ygeno.2006.05.007; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Kim IS, 2012, MOL CELL, V46, P260, DOI 10.1016/j.molcel.2012.03.021; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Longo L, 2002, EMBO J, V21, P4229, DOI 10.1093/emboj/cdf426; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miglior F., 2000, P 10 WORLD HOLST FRI, P108; Near RI, 2009, MOL VIS, V15, P685; Pan CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023157; PEARCE SR, 1995, MAMM GENOME, V6, P858, DOI 10.1007/BF00292435; Rantakari P, 2008, MOL ENDOCRINOL, V22, P665, DOI 10.1210/me.2007-0257; Rozen S, 2000, Methods Mol Biol, V132, P365; SHUSTER DE, 1992, P NATL ACAD SCI USA, V89, P9225, DOI 10.1073/pnas.89.19.9225; Sonstegard TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054872; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; VanRaden PM, 2011, J DAIRY SCI, V94, P6153, DOI 10.3168/jds.2011-4624; Weckx S, 2005, GENOME RES, V15, P436, DOI 10.1101/gr.2754005; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	37	114	125	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65550	10.1371/journal.pone.0065550	http://dx.doi.org/10.1371/journal.pone.0065550			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762392	Green Published, Green Submitted, gold			2022-12-27	WOS:000321094800063
J	Lauche, R; Materdey, S; Cramer, H; Haller, H; Stange, R; Dobos, G; Rampp, T				Lauche, Romy; Materdey, Svitlana; Cramer, Holger; Haller, Heidemarie; Stange, Rainer; Dobos, Gustav; Rampp, Thomas			Effectiveness of Home-Based Cupping Massage Compared to Progressive Muscle Relaxation in Patients with Chronic Neck Pain-A Randomized Controlled Trial	PLOS ONE			English	Article							2000-2010 TASK-FORCE; CLINICAL-TRIALS; DISABILITY; WORKERS; QUESTIONNAIRE; PREVALENCE; DISORDERS; VALIDITY; BONE	Chronic neck pain is a major public health problem with very few evidence-based complementary treatment options. This study aimed to test the efficacy of 12 weeks of a partner-delivered home-based cupping massage, compared to the same period of progressive muscle relaxation in patients with chronic non-specific neck pain. Patients were randomly assigned to self-directed cupping massage or progressive muscle relaxation. They were trained and asked to undertake the assigned treatment twice weekly for 12 weeks. Primary outcome measure was the current neck pain intensity (0-100 mm visual analog scale; VAS) after 12 weeks. Secondary outcome measures included pain on motion, affective pain perception, functional disability, psychological distress, wellbeing, health-related quality of life, pressure pain thresholds and adverse events. Sixty one patients (54.1+/-12.7 years; 73.8% female) were randomized to cupping massage (n = 30) or progressive muscle relaxation (n = 31). After treatment, both groups showed significantly less pain compared to baseline however without significant group differences. Significant effects in favor of cupping massage were only found for wellbeing and pressure pain thresholds. In conclusion, cupping massage is no more effective than progressive muscle relaxation in reducing chronic non-specific neck pain. Both therapies can be easily used at home and can reduce pain to a minimal clinically relevant extent. Cupping massage may however be better than PMR in improving well-being and decreasing pressure pain sensitivity but more studies with larger samples and longer follow-up periods are needed to confirm these results.	[Lauche, Romy; Materdey, Svitlana; Cramer, Holger; Haller, Heidemarie; Dobos, Gustav; Rampp, Thomas] Univ Duisburg Essen, Fac Med, Kliniken Essen Mitte, Dept Internal & Integrat Med, Essen, Germany; [Stange, Rainer] Immanuel Hosp Berlin, Dept Internal & Complementary Med, Berlin, Germany	Kliniken Essen-Mitte; University of Duisburg Essen	Lauche, R (corresponding author), Univ Duisburg Essen, Fac Med, Kliniken Essen Mitte, Dept Internal & Integrat Med, Essen, Germany.	r.lauche@kliniken-essen-mitte.de	Lauche, Romy/AAQ-7175-2021; Haller, Heidemarie/AAX-5927-2021; Cramer, Holger/AAH-1794-2019	Lauche, Romy/0000-0002-4171-7935; Haller, Heidemarie/0000-0001-7973-4071; Cramer, Holger/0000-0002-3640-8046	Karl and Veronica Carstens Foundation, Essen, Germany [KVC 0/0430/2011]	Karl and Veronica Carstens Foundation, Essen, Germany	The researchers received a grant for this study from the Karl and Veronica Carstens Foundation, Essen, Germany (grant number: KVC 0/0430/2011, wwww.carstens-stiftung.de). They also received free arnica massage oils from the WELEDA AG, Schwabisch Gmund, Germany (www.weleda.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele J., 2003, SCHROPFEN BEWAHRTE A; Ameen V, 2010, GASTROENTEROLOGY, V132, pA140; Bullinger M, 1998, SF 36 FRAGEBOGEN ZUM; Cao HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031793; Chirali I., 2007, TRADITIONAL CHINESE; Cote P, 1998, SPINE, V23, P1689, DOI 10.1097/00007632-199808010-00015; Cote P, 2008, SPINE, V33, pS60, DOI 10.1097/BRS.0b013e3181643ee4; Cramer H, 2012, EUR J INTEGR MED, V4, pE371, DOI 10.1016/j.eujim.2012.04.001; Cramer H, 2011, FORSCH KOMPLEMENTMED, V18, P327, DOI 10.1159/000335294; Deutsche Gesellschaft fur Allgemeinmedizin (DEGAM), 2009, LEITL 13 NACK; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Fejer R, 2006, EUR SPINE J, V15, P834, DOI 10.1007/s00586-004-0864-4; Fliege H, 2005, PSYCHOSOM MED, V67, P78, DOI 10.1097/01.psy.0000151491.80178.78; Geissner E, 1996, SCHMERZEMPFINDUNGSSK; Gustavsson C, 2006, J REHABIL MED, V38, P100, DOI 10.1080/16501970510044025; Hasenbring M, 1989, PATIENTENKONZEPTE KO, P25; Herrmann C., 1995, HOSP ANXIETY DEPRESS; Hurwitz EL, 2008, SPINE, V33, pS123, DOI 10.1097/BRS.0b013e3181644b1d; Irnich D, 2001, BMJ-BRIT MED J, V322, P1574, DOI 10.1136/bmj.322.7302.1574; Jacobson E., 1938, J ABNORM PSYCHOL; Jensen MP, 2003, J PAIN, V4, P407, DOI 10.1016/S1526-5900(03)00716-8; Johnston V, 2008, PAIN, V137, P257, DOI 10.1016/j.pain.2007.08.037; Kim Jong-In, 2011, Evid Based Complement Alternat Med, V2011, P467014, DOI 10.1093/ecam/nep035; Kolip P, 1999, Z GESUNDHEITSPSYCHOL, V7, P77, DOI DOI 10.1026//0943-8149.7.2.77; Korb J, 2003, SCHMERZ, V17, pS47; La Touche R, 2010, J PAIN, V11, P256, DOI 10.1016/j.jpain.2009.07.003; Lauche R, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/429718; Lauche R, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-63; Madeleine P, 2003, INT ARCH OCC ENV HEA, V76, P39, DOI 10.1007/s00420-002-0375-8; Nagel B, 2002, SCHMERZ, V16, P263, DOI 10.1007/s00482-002-0162-1; Peloso P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000319.pub4; Schumann S, 2012, BMC COMPLEM ALTERN M, V12, P80; Techniker Krankenkasse, 2013, PROGR MUSCL REL; Tiplady B, 1998, AGE AGEING, V27, P63, DOI 10.1093/ageing/27.1.63; Treede RD, 2002, PAIN, V98, P235, DOI 10.1016/S0304-3959(02)00203-8; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Viljanen M, 2003, BRIT MED J, V327, P475, DOI 10.1136/bmj.327.7413.475; Weerapong P, 2005, SPORTS MED, V35, P235, DOI 10.2165/00007256-200535030-00004	38	48	50	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65378	10.1371/journal.pone.0065378	http://dx.doi.org/10.1371/journal.pone.0065378			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762355	gold, Green Published, Green Submitted			2022-12-27	WOS:000321094800043
J	Chen, YB; Lv, LZ; Jiang, ZL; Yang, HJ; Li, S; Jiang, Y				Chen, Yongbiao; Lv, Lizhi; Jiang, Zhelong; Yang, Hejun; Li, Song; Jiang, Yi			Mitofusin 2 Protects Hepatocyte Mitochondrial Function from Damage Induced by GCDCA	PLOS ONE			English	Article							EXTRAHEPATIC CHOLESTASIS; OXIDATIVE STRESS; RAT HEPATOCYTES; LIVER-INJURY; IN-VITRO; FUSION; APOPTOSIS; BIOGENESIS; MORPHOLOGY; PROTEINS	Mitochondrial impairment is hypothesized to contribute to the pathogenesis of chronic cholestatic liver diseases. Mitofusin 2 (Mfn2) regulates mitochondrial morphology and signaling and is involved in the development of numerous mitochondrial-related diseases; however, a functional role for Mfn2 in chronic liver cholestasis which is characterized by increased levels of toxic bile acids remain unknown. Therefore, the aims of this study were to evaluate the expression levels of Mfn2 in liver samples from patients with extrahepatic cholestasis and to investigate the role Mfn2 during bile acid induced injury in vitro. Endogenous Mfn2 expression decreased in patients with extrahepatic cholestasis. Glycochenodeoxycholic acid (GCDCA) is the main toxic component of bile acid in patients with extrahepatic cholestasis. In human normal hepatocyte cells (L02), Mfn2 plays an important role in GCDCA-induced mitochondrial damage and changes in mitochondrial morphology. In line with the mitochondrial dysfunction, the expression of Mfn2 decreased significantly under GCDCA treatment conditions. Moreover, the overexpression of Mfn2 effectively attenuated mitochondrial fragmentation and reversed the mitochondrial damage observed in GCDCA-treated L02 cells. Notably, a truncated Mfn2 mutant that lacked the normal C-terminal domain lost the capacity to induce mitochondrial fusion. Increasing the expression of truncated Mfn2 also had a protective effect against the hepatotoxicity of GCDCA. Taken together, these findings indicate that the loss of Mfn2 may play a crucial role the pathogenesis of the liver damage that is observed in patients with extrahepatic cholestasis. The findings also indicate that Mfn2 may directly regulate mitochondrial metabolism independently of its primary fusion function. Therapeutic approaches that target Mfn2 may have protective effects against hepatotoxic of bile acids during cholestasis.	[Chen, Yongbiao; Lv, Lizhi; Jiang, Zhelong; Yang, Hejun; Li, Song; Jiang, Yi] Fuzhou Gen Hosp, Dept Hepatobiliary Surg, Fuzhou, Peoples R China		Chen, YB (corresponding author), Fuzhou Gen Hosp, Dept Hepatobiliary Surg, Fuzhou, Peoples R China.	cybiao717@sina.com.cn; chenyongbiaosci@163.com			Nanjing military region medicine and health research fund of China [09MA97]	Nanjing military region medicine and health research fund of China	Grant support was from Nanjing military region medicine and health research fund of China (No. 09MA97). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amati-Bonneau P, 2005, ANN NEUROL, V58, P958, DOI 10.1002/ana.20681; Arduini A, 2011, AM J PHYSIOL-GASTR L, V301, pG119, DOI 10.1152/ajpgi.00253.2010; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Brooks C, 2007, P NATL ACAD SCI USA, V104, P11649, DOI 10.1073/pnas.0703976104; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Eschenbacher WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044296; Esquivel Lopez A, 1982, Rev Gastroenterol Mex, V47, P9; Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150; Hernandez-Alvarez MI, 2012, ANTIOXID REDOX SIGNA; Hofmann AF, 2002, LIVER, V22, P14, DOI 10.1034/j.1600-0676.2002.00002.x; Huang PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020655; Jahani-Asl A, 2007, J BIOL CHEM, V282, P23788, DOI 10.1074/jbc.M703812200; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Lin KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029393; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Palmeira CM, 2004, TOXICOLOGY, V203, P1, DOI 10.1016/j.tox.2004.06.001; Perez MJ, 2009, WORLD J GASTROENTERO, V15, P1677, DOI 10.3748/wjg.15.1677; Pesce V, 2012, REJUV RES, V15, P136, DOI 10.1089/rej.2011.1255; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; Rolo AP, 2000, TOXICOL SCI, V57, P177, DOI 10.1093/toxsci/57.1.177; Schoemaker MH, 2003, J HEPATOL, V39, P153, DOI 10.1016/S0168-8278(03)00214-9; Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109; Shen T, 2007, J BIOL CHEM, V282, P23354, DOI 10.1074/jbc.M702657200; Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649; SOKOL RJ, 1995, GASTROENTEROLOGY, V109, P1249, DOI 10.1016/0016-5085(95)90585-5; Sorensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001; Tiao MM, 2009, APOPTOSIS, V14, P890, DOI 10.1007/s10495-009-0357-3; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Trottier J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022094; Vendemiale G, 2002, J HEPATOL, V37, P601, DOI 10.1016/S0168-8278(02)00234-9; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499; Xu S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.7; Xu SC, 2012, FREE RADICAL BIO MED, V52, P1543, DOI 10.1016/j.freeradbiomed.2012.01.007; Xu SC, 2010, J PINEAL RES, V49, P86, DOI 10.1111/j.1600-079X.2010.00770.x; Yamaura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030250; Yerushalmi B, 2001, HEPATOLOGY, V33, P616, DOI 10.1053/jhep.2001.22702; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zhang Y, 2011, METABOLISM, V60, P767, DOI 10.1016/j.metabol.2010.07.026; Zorzano A, 2010, SEMIN CELL DEV BIOL, V21, P566, DOI 10.1016/j.semcdb.2010.01.002	42	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65455	10.1371/journal.pone.0065455	http://dx.doi.org/10.1371/journal.pone.0065455			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755235	Green Submitted, Green Published, gold			2022-12-27	WOS:000321099000070
J	Godnic, I; Zorc, M; Skok, DJ; Calin, GA; Horvat, S; Dovc, P; Kovac, M; Kunej, T				Godnic, Irena; Zorc, Minja; Skok, Dasa Jevsinek; Calin, George Adrian; Horvat, Simon; Dovc, Peter; Kovac, Milena; Kunej, Tanja			Genome-Wide and Species-Wide In Silico Screening for Intragenic MicroRNAs in Human, Mouse and Chicken	PLOS ONE			English	Article							MEDIATED GENE-REGULATION; HOST GENES; DNA HYPERMETHYLATION; INTRONIC MICRORNAS; CELL-PROLIFERATION; DOWN-REGULATION; CANCER-CELLS; CHOLESTEROL HOMEOSTASIS; EXPRESSION PROFILES; COLORECTAL-CANCER	MicroRNAs (miRNAs) are non-coding RNAs (ncRNAs) involved in regulation of gene expression. Intragenic miRNAs, especially those exhibiting a high degree of evolutionary conservation, have been shown to be coordinately regulated and/or expressed with their host genes, either with synergistic or antagonistic correlation patterns. However, the degree of cross-species conservation of miRNA/host gene co-location is not known and co-expression information is incomplete and fragmented among several studies. Using the genomic resources (miRBase and Ensembl) we performed a genome-wide in silico screening (GWISS) for miRNA/host gene pairs in three well-annotated vertebrate species: human, mouse, and chicken. Approximately half of currently annotated miRNA genes resided within host genes: 53.0% (849/1,600) in human, 48.8% (418/855) in mouse, and 42.0% (210/499) in chicken, which we present in a central publicly available Catalog of intragenic miRNAs (http://www.integratomics-time.com/miR-host/catalog). The miRNA genes resided within either protein-coding or ncRNA genes, which include long intergenic ncRNAs (lincRNAs) and small nucleolar RNAs (snoRNAs). Twenty-seven miRNA genes were found to be located within the same host genes in all three species and the data integration from literature and databases showed that most (26/27) have been found to be co-expressed. Particularly interesting are miRNA genes located within genes encoding for miRNA silencing machinery (DGCR8, DICER1, and SND1 in human and Cnot3, Gdcr8, Eif4e, Tnrc6b, and Xpo5 in mouse). We furthermore discuss a potential for phenotype misattribution of miRNA host gene polymorphism or gene modification studies due to possible collateral effects on miRNAs hosted within them. In conclusion, the catalog of intragenic miRNAs and identified 27 miRNA/host gene pairs with cross-species conserved co-location, co-expression, and potential co-regulation, provide excellent candidates for further functional annotation of intragenic miRNAs in health and disease.	[Godnic, Irena; Zorc, Minja; Skok, Dasa Jevsinek; Horvat, Simon; Dovc, Peter; Kovac, Milena; Kunej, Tanja] Univ Ljubljana, Biotech Fac, Dept Anim Sci, Domzale, Slovenia; [Calin, George Adrian] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Calin, George Adrian] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNAs, Houston, TX 77030 USA; [Horvat, Simon] Natl Inst Chem, Ljubljana, Slovenia	University of Ljubljana; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; National Institute of Chemistry - Slovenia	Kunej, T (corresponding author), Univ Ljubljana, Biotech Fac, Dept Anim Sci, Domzale, Slovenia.	tanja.kunej@bf.uni-lj.si	Calin, George/E-9390-2011; Zorc, Minja/AGD-6914-2022; Kunej, Tanja/G-5957-2017	Zorc, Minja/0000-0003-3330-7909; Kunej, Tanja/0000-0002-0465-1762; Calin, George/0000-0002-7427-0578; Calin, George/0000-0001-6704-5615	Slovenian Research Agency (ARRS) through the Research programme Comparative genomics and genome biodiversity [P4-0220]; University of Texas M. D.; Anderson Research Trust; University of Texas System Regents Research Scholar; CLL Global Research Foundation; National Institutes of Health; Department of Defense; Developmental Research Awards in Breast Cancer, Ovarian Cancer and Leukemia SPOREs; Seena Magowitz - Pancreatic Cancer Action Network - AACR Pilot Grant	Slovenian Research Agency (ARRS) through the Research programme Comparative genomics and genome biodiversity; University of Texas M. D.; Anderson Research Trust; University of Texas System Regents Research Scholar; CLL Global Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Developmental Research Awards in Breast Cancer, Ovarian Cancer and Leukemia SPOREs; Seena Magowitz - Pancreatic Cancer Action Network - AACR Pilot Grant	This work was supported by the Slovenian Research Agency (ARRS) through the Research programme Comparative genomics and genome biodiversity [grant number P4-0220]. GAC is supported as a Fellow at The University of Texas M. D. Anderson Research Trust, as a Fellow of The University of Texas System Regents Research Scholar, and by the CLL Global Research Foundation. Work in Dr. Calin's laboratory is supported in part by National Institutes of Health, by Department of Defense, by Developmental Research Awards in Breast Cancer, Ovarian Cancer and Leukemia SPOREs, and by 2009 Seena Magowitz - Pancreatic Cancer Action Network - AACR Pilot Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anderton JA, 2008, NEURO-ONCOLOGY, V10, P981, DOI 10.1215/15228517-2008-048; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Bandyopadhyay S, 2012, MOL CELL BIOL, V32, P1202, DOI 10.1128/MCB.05977-11; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Beezhold K, 2011, TOXICOL SCI, V123, P411, DOI 10.1093/toxsci/kfr188; Bennett LB, 2009, GENE CHROMOSOME CANC, V48, P828, DOI 10.1002/gcc.20687; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Berteaux N, 2005, J BIOL CHEM, V280, P29625, DOI 10.1074/jbc.M504033200; Bohlig L, 2011, NUCLEIC ACIDS RES, V39, P440, DOI 10.1093/nar/gkq796; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Careccia S, 2009, ONCOGENE, V28, P4034, DOI 10.1038/onc.2009.255; Davalos A, 2011, P NATL ACAD SCI USA, V108, P9232, DOI 10.1073/pnas.1102281108; Dejeux E, 2009, ENDOCR-RELAT CANCER, V16, P939, DOI 10.1677/ERC-08-0331; Donzelli S, 2011, CELL DEATH DIFFER; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Fellig Y, 2005, J CLIN PATHOL, V58, P1064, DOI 10.1136/jcp.2004.023648; Ferdin J, 2010, TECHNOL CANCER RES T, V9, P123, DOI 10.1177/153303461000900202; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Georges M, 2007, CURR OPIN GENET DEV, V17, P166, DOI 10.1016/j.gde.2007.04.005; Golan D, 2010, BIOINFORMATICS, V26, P992, DOI 10.1093/bioinformatics/btq077; Grady WM, 2008, ONCOGENE, V27, P3880, DOI 10.1038/onc.2008.10; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hackler L, 2010, INVEST OPHTH VIS SCI, V51, P1823, DOI 10.1167/iovs.09-4657; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; He C., 2012, NUCL ACIDS RES; He YH, 2011, NEOPLASIA, V13, P841, DOI 10.1593/neo.11698; Hiard S, 2010, NUCLEIC ACIDS RES, V38, pD640, DOI 10.1093/nar/gkp926; Hibi K, 1996, CANCER RES, V56, P480; Hicks JA, 2010, PHYSIOL GENOMICS, V41, P185, DOI 10.1152/physiolgenomics.00156.2009; Horie T, 2010, P NATL ACAD SCI USA, V107, P17321, DOI 10.1073/pnas.1008499107; Huang Y, 2011, CELL DEATH DIFFER, V18, P1220, DOI 10.1038/cdd.2010.188; Hwang SH, 2011, CLIN CHEM LAB MED, V49, P699, DOI 10.1515/CCLM.2011.108; Issa J-P, 2009, DNA METHYLATION EPIG; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; Kozaki K, 2012, CANCER SCI, V103, P837, DOI 10.1111/j.1349-7006.2012.02236.x; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kron KJ, 2010, LAB INVEST, V90, P1060, DOI 10.1038/labinvest.2010.57; Kuhnert F, 2008, DEVELOPMENT, V135, P3989, DOI 10.1242/dev.029736; Kunej T, 2012, CANCER J, V18, P223, DOI 10.1097/PPO.0b013e318258b771; Kunej T, 2011, MUTAT RES-FUND MOL M, V717, P77, DOI 10.1016/j.mrfmmm.2011.03.008; Kunej T, 2010, INT J BIOL SCI, V6, P769; Lages E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020600; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lutter D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-224; Marquart TJ, 2010, P NATL ACAD SCI USA, V107, P12228, DOI 10.1073/pnas.1005191107; Matkovich SJ, 2012, CIRC RES, V111, P521, DOI 10.1161/CIRCRESAHA.112.265736; Matouk IJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000845; Musiyenko A, 2008, J MOL MED, V86, P313, DOI 10.1007/s00109-007-0296-9; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Polster BJ, 2010, MOL GENET METAB, V101, P292, DOI 10.1016/j.ymgme.2010.07.016; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Rearick D, 2011, NUCLEIC ACIDS RES, V39, P2357, DOI 10.1093/nar/gkq1080; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Saini HK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-564; Saito Y, 2009, BIOCHEM BIOPH RES CO, V379, P726, DOI 10.1016/j.bbrc.2008.12.098; Sakakura Y, 2001, BIOCHEM BIOPH RES CO, V286, P176, DOI 10.1006/bbrc.2001.5375; Sand M, 2011, MOL CARCINOG; Sand M, 2010, CANCER INVEST, V28, P649, DOI 10.3109/07357901003630918; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shen J, 2012, EPIGENETICS, V7; Shiohama A, 2003, BIOCHEM BIOPH RES CO, V304, P184, DOI 10.1016/S0006-291X(03)00554-0; Sikand K, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-21; Sun GH, 2009, RNA, V15, P1640, DOI 10.1261/rna.1560209; Tao J, 2012, MOL MED REP, V5, P167, DOI 10.3892/mmr.2011.591; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; Tokumaru S, 2008, CARCINOGENESIS, V29, P2073, DOI 10.1093/carcin/bgn187; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Tsang WP, 2010, CARCINOGENESIS, V31, P350, DOI 10.1093/carcin/bgp181; Tsuchiya N, 2007, CANCER RES, V67, P9568, DOI 10.1158/0008-5472.CAN-06-2707; Tsuruta T, 2011, CANCER RES, V71, P6450, DOI 10.1158/0008-5472.CAN-11-0364; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Wang GH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013798; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Wang YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-218; Watanabe K, 2012, INT J CANCER, V130, P2580, DOI 10.1002/ijc.26254; Wu Q, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-45; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Yan M, 2011, PATHOL ONCOL RES; Yang J, 2011, FEBS LETT, V585, P2992, DOI 10.1016/j.febslet.2011.08.013; Ying SY, 2005, BIOCHEM BIOPH RES CO, V326, P515, DOI 10.1016/j.bbrc.2004.10.215; Zhang X, 2003, J CLIN ENDOCR METAB, V88, P5119, DOI 10.1210/jc.2003-030222; Zhang YF, 2009, SCI CHINA SER C, V52, P261, DOI 10.1007/s11427-009-0032-5; Zheng Cui-Ling, 2009, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V17, P674; Zhou B, 2010, CLIN CHIM ACTA, V411, P1287, DOI 10.1016/j.cca.2010.05.010; Zorc M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030737	98	57	60	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65165	10.1371/journal.pone.0065165	http://dx.doi.org/10.1371/journal.pone.0065165			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762306	Green Published, gold, Green Submitted			2022-12-27	WOS:000321099000038
J	Shipton, C; Clarkson, C; Bernal, MA; Boivin, N; Finlayson, C; Finlayson, G; Fa, D; Pacheco, FG; Petraglia, M				Shipton, Ceri; Clarkson, Christopher; Antonio Bernal, Marco; Boivin, Nicole; Finlayson, Clive; Finlayson, Geraldine; Fa, Darren; Giles Pacheco, Francisco; Petraglia, Michael			Variation in Lithic Technological Strategies among the Neanderthals of Gibraltar	PLOS ONE			English	Article							GORHAMS CAVE; MIDDLE; EXPLOITATION; PLEISTOCENE; EVOLUTION; GAME	The evidence for Neanderthal lithic technology is reviewed and summarized for four caves on The Rock of Gibraltar: Vanguard, Beefsteak, Ibex and Gorham's. Some of the observed patterns in technology are statistically tested including raw material selection, platform preparation, and the use of formal and expedient technological schemas. The main parameters of technological variation are examined through detailed analysis of the Gibraltar cores and comparison with samples from the classic Mousterian sites of Le Moustier and Tabun C. The Gibraltar Mousterian, including the youngest assemblage from Layer IV of Gorham's Cave, spans the typical Middle Palaeolithic range of variation from radial Levallois to unidirectional and multi-platform flaking schemas, with characteristic emphasis on the former. A diachronic pattern of change in the Gorham's Cave sequence is documented, with the younger assemblages utilising more localized raw material and less formal flaking procedures. We attribute this change to a reduction in residential mobility as the climate deteriorated during Marine Isotope Stage 3 and the Neanderthal population contracted into a refugium.	[Shipton, Ceri; Clarkson, Christopher] Univ Queensland, Sch Social Sci, Brisbane, Qld, Australia; [Antonio Bernal, Marco; Boivin, Nicole; Petraglia, Michael] Univ Oxford, Sch Archaeol, Oxford, England; [Finlayson, Clive] Univ Toronto Scarborough, Dept Social Sci, Toronto, ON, Canada	University of Queensland; University of Oxford; University of Toronto; University Toronto Scarborough	Shipton, C (corresponding author), Univ Queensland, Sch Social Sci, Brisbane, Qld, Australia.	c.shipton@uq.edu.au	Fa, Darren A./F-1863-2015; Petraglia, Michael/ABA-9748-2021; Fa, Darren/Z-4376-2019	Fa, Darren A./0000-0002-5900-9814; Fa, Darren/0000-0002-5900-9814; BOIVIN, NICOLE/0000-0002-7783-4199; Clarkson, Chris/0000-0002-8938-8974; Petraglia, Michael/0000-0003-2522-5727	McDonald Institute for Archaeological Research; H.M. Government of Gibraltar; University of Queensland	McDonald Institute for Archaeological Research; H.M. Government of Gibraltar; University of Queensland(University of Queensland)	The data collection for this study was funded by the McDonald Institute for Archaeological Research. The wider project of which this study is a part, is funded by H.M. Government of Gibraltar who are also funding the publication costs. Shipton is supported by a University of Queensland Post-doctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler DS, 2006, CURR ANTHROPOL, V47, P89, DOI 10.1086/432455; BAMFORTH DB, 1986, AM ANTIQUITY, V51, P38, DOI 10.2307/280392; Barton Nick, 2000, P211; Barton R.N.E., 2012, NEANDERTHALS CONTEXT, P243; Barton RNE, 1998, CULTURAS PLEISTOCENO, P13; Barton RNE., 2012, NEANDERTHALS CONTEXT, P151; Barton RNE, 2000, GIBRALTAR QUATERNARY; BINFORD LR, 1979, J ANTHROPOL RES, V35, P255, DOI 10.1086/jar.35.3.3629902; Binford LR., 1977, STONE TOOLS CULTURAL, P24; Blain H.-A., 2013, J HUMAN EVOLUTION; Brown K, 2011, INTERD CONTRIB ARCH, P247, DOI 10.1007/978-1-4419-8219-3_10; Busk G., 1864, READER, V4, P109; Caceres I., 2012, P253; Carrion JS, 2008, QUATERNARY SCI REV, V27, P2118, DOI 10.1016/j.quascirev.2008.08.016; Clarkson C, 2006, J ARCHAEOL SCI, V33, P132, DOI 10.1016/j.jas.2005.07.007; Clarkson C, 2012, QUATERN INT, V258, P165, DOI 10.1016/j.quaint.2011.11.007; Colcutt SN, 2012, NEANDERTHALS CONTEXT, P15; Currant A.P., 2012, P141; Currant A.P., 2012, P236; Fernandez-Jalvo Yolanda, 2000, P171; Finlayson C, 2005, TRENDS ECOL EVOL, V20, P457, DOI 10.1016/j.tree.2005.05.019; Finlayson C, 2008, QUATERN INT, V181, P64, DOI 10.1016/j.quaint.2007.11.016; Finlayson C, 2007, TRENDS ECOL EVOL, V22, P213, DOI 10.1016/j.tree.2007.02.001; Finlayson C, 2006, NATURE, V443, P850, DOI 10.1038/nature05195; Finlayson G, 2008, QUATERN INT, V181, P55, DOI 10.1016/j.quaint.2007.01.009; FISH P R, 1981, Journal of Anthropological Research, V37, P374; Gale R., 2000, NEANDERTHALS EDGE, P207; GARROD DAE, 1928, J ROYAL ANTHR I, V58, P91; Geneste J.M., 1989, LHOMME NEANDERTAL, V6, P75; Giles F., 2007, GEOGACETA, V43, P131; Pacheco FG, 2012, QUATERN INT, V247, P151, DOI 10.1016/j.quaint.2011.02.026; Gleed-Owen C., 2012, P224; Gleed-Owen C.P., 2012, P102; Goldberg P., 2012, NEANDERTHALS CONTEXT, P50; Goodyear A.C., 1979, HYPOTHESIS USE CRYPT; Henrich J, 2004, AM ANTIQUITY, V69, P197, DOI 10.2307/4128416; Higham T.F.G., 2012, P62; Jennings R., 2006, THESIS U OXFORD; Jennings R.P., 2012, P281; Jennings R, 2011, J BIOGEOGR, V38, P1873, DOI 10.1111/j.1365-2699.2011.02536.x; Kuhn SL., 1995, MOUSTERIAN LITHIC TE, DOI [10.1515/9781400864034, DOI 10.1515/9781400864034]; LIEBERMAN DE, 1994, AM ANTHROPOL, V96, P300, DOI 10.1525/aa.1994.96.2.02a00030; Macphail R. I., 2012, NEANDERTHALS CONTEXT, P193; Macphail RI., 2000, NEANDERTHALS EDGE, P183; Marks A.E., 1977, PREHISTORY PALEOEN 2, P191; MEIGNEN L, 2005, TRANSITIONS TRANSITI, P149; Mellars Paul A., 1996, NEANDERTHAL LEGACY A; Nelson M.C., 1991, ARCHAEOLOGICAL METHO, P57, DOI DOI 10.2307/20170213; Oakley KP, 1964, B I ARCHAEOLOGY, V4, P219; Pacheco FG, 2010, MINERALES ROCAS SOC, P139; Parry WJ., 1987, ORG CORE TECHNOLOGY, P285; Petraglia M, 2007, SCIENCE, V317, P114, DOI 10.1126/science.1141564; Pettitt P.B., 2000, NEANDERTHALS EDGE, P155; Price C., 2012, P128; Rhodes E.J., 2012, MONOGRAPH, V75, P211; Rhodes E. J. C. B., 2000, GIBRALTAR QUATERNARY, P109; Rhodes EJ., 2012, NEANDERTHALS CONTEXT, P77; Rink W.J., 2000, P165; Rodriguez-Vidal J, 2004, QUATERNARY SCI REV, V23, P2017, DOI 10.1016/j.quascirev.2004.02.008; Rodriguez-Vidal J, 2013, GEOMORPHOLOGY, DOI [10.1016/j.geomorph.2013.02.015, DOI 10.1016/J.GE0M0RPH.2013.02.015]; SHOTT MJ, 1989, AM ANTIQUITY, V54, P9, DOI 10.2307/281329; STINER MC, 1992, AM ANTHROPOL, V94, P306, DOI 10.1525/aa.1992.94.2.02a00030; Stringer CB, 2008, P NATL ACAD SCI USA, V105, P14319, DOI 10.1073/pnas.0805474105; Stringer Chris, 2000, P133; Tarasov PE, 2000, J BIOGEOGR, V27, P609, DOI 10.1046/j.1365-2699.2000.00429.x; Torrence R, 1989, RETOOLING BEHAV THEO, P52; Volterra V., 2000, P163; Volterra V, 2000, NEANDERTHALS EDGE, P221; Waechter J.D.A., 1964, B INST ARCHAEOL, V4, P189; Wallace IJ, 2006, J ARCHAEOL SCI, V33, P1293, DOI 10.1016/j.jas.2006.01.005; Ward S., 2012, NEANDERTHALS CONTEXT, P89; Zilhao J., 2006, FARMING, V2006, P95	72	19	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65185	10.1371/journal.pone.0065185	http://dx.doi.org/10.1371/journal.pone.0065185			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	173SK	23762312	Green Published, Green Submitted, gold			2022-12-27	WOS:000321099000041
J	Swift, SL; Rivera, GC; Dussupt, V; Leadley, RM; Hudson, LC; de Ridder, CMA; Kraaij, R; Burns, JE; Maitland, NJ; Georgopoulos, LJ				Swift, Stephanie L.; Rivera, Guillermo C.; Dussupt, Vincent; Leadley, Regina M.; Hudson, Lucy C.; de Ridder, Corrina M. A.; Kraaij, Robert; Burns, Julie E.; Maitland, Norman J.; Georgopoulos, Lindsay J.			Evaluating Baculovirus as a Vector for Human Prostate Cancer Gene Therapy	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; IN-VITRO; TRICHOPLUSIA-NI; RECOMBINANT BACULOVIRUSES; CELLULAR-DIFFERENTIATION; TRANSGENE EXPRESSION; MAMMALIAN-CELLS; STEM-CELLS; GROWTH; NITROREDUCTASE	Gene therapy represents an attractive strategy for the non-invasive treatment of prostate cancer, where current clinical interventions show limited efficacy. Here, we evaluate the use of the insect virus, baculovirus (BV), as a novel vector for human prostate cancer gene therapy. Since prostate tumours represent a heterogeneous environment, a therapeutic approach that achieves long-term regression must be capable of targeting multiple transformed cell populations. Furthermore, discrimination in the targeting of malignant compared to non-malignant cells would have value in minimising side effects. We employed a number of prostate cancer models to analyse the potential for BV to achieve these goals. In vitro, both traditional prostate cell lines as well as primary epithelial or stromal cells derived from patient prostate biopsies, in two-or three-dimensional cultures, were used. We also evaluated BV in vivo in murine prostate cancer xenograft models. BV was capable of preferentially transducing invasive malignant prostate cancer cell lines compared to early stage cancers and non-malignant samples, a restriction that was not a function of nuclear import. Of more clinical relevance, primary patient-derived prostate cancer cells were also efficiently transduced by BV, with robust rates observed in epithelial cells of basal phenotype, which expressed BV-encoded transgenes faster than epithelial cells of a more differentiated, luminal phenotype. Maximum transduction capacity was observed in stromal cells. BV was able to penetrate through three-dimensional structures, including in vitro spheroids and in vivo orthotopic xenografts. BV vectors containing a nitroreductase transgene in a gene-directed enzyme pro-drug therapy approach were capable of efficiently killing malignant prostate targets following administration of the pro-drug, CB1954. Thus, BV is capable of transducing a large proportion of prostate cell types within a heterogeneous 3-D prostate tumour, can facilitate cell death using a pro-drug approach, and shows promise as a vector for the treatment of prostate cancer.	[Swift, Stephanie L.; Rivera, Guillermo C.; Dussupt, Vincent; Leadley, Regina M.; Hudson, Lucy C.; Burns, Julie E.; Maitland, Norman J.; Georgopoulos, Lindsay J.] Univ York, Dept Biol, Yorkshire Canc Res Unit, York YO10 5DD, N Yorkshire, England; [de Ridder, Corrina M. A.; Kraaij, Robert] Erasmus MC, Dept Urol, Rotterdam, Netherlands	University of York - UK; Erasmus University Rotterdam; Erasmus MC	Maitland, NJ (corresponding author), Univ York, Dept Biol, Yorkshire Canc Res Unit, York YO10 5DD, N Yorkshire, England.	n.j.maitland@york.ac.uk		Burns, Julie/0000-0003-1238-8826; Dussupt, Vincent/0000-0002-8579-6356; Rivera Gonzalez, Guillermo Cipactl/0000-0003-4645-0069; Maitland, Norman/0000-0003-1607-9035	EU; Yorkshire Cancer Research; MRC [G0900871] Funding Source: UKRI; Medical Research Council [G0900871] Funding Source: researchfish	EU(European Commission); Yorkshire Cancer Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was carried out under EU-funded collaborative projects: Prostate Initiative for Gene Therapy 'PIG' (FP5), Baculogenes (FP6) and Gene Therapy: An Integrated Approach to Neoplastic Treatment 'GIANT' (FP6), with additional support from Yorkshire Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Airenne KJ, 2010, CURR GENE THER, V10, P187; Batra RK, 1998, AM J RESP CELL MOL, V18, P402, DOI 10.1165/ajrcmb.18.3.2784; BERTHON P, 1995, INT J ONCOL, V6, P333; Blackwood L, 2001, VET J, V161, P269, DOI 10.1053/tvjl.2000.0557; Bridgewater JA, 1997, HUM GENE THER, V8, P709, DOI 10.1089/hum.1997.8.6-709; BURGES HD, 1980, ENTOMOPHAGA, V25, P329, DOI 10.1007/BF02374693; CARSON DD, 1991, J VIROL, V65, P945, DOI 10.1128/JVI.65.2.945-951.1991; Collins AT, 2001, J CELL SCI, V114, P3865; Cunha GR, 2004, J STEROID BIOCHEM, V92, P221, DOI 10.1016/j.jsbmb.2004.10.017; Cunha GR, 2001, REPROD FERT DEVELOP, V13, P285, DOI 10.1071/RD01010; Datta MW, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-9; DEKLERK DP, 1983, PROSTATE, V4, P73, DOI 10.1002/pros.2990040107; DEKLERK DP, 1984, J UROLOGY, V131, P1008, DOI 10.1016/S0022-5347(17)50750-8; Djeha AH, 2000, CANCER GENE THER, V7, P721, DOI 10.1038/sj.cgt.7700171; Duisit G, 1999, J GENE MED, V1, P93; El-Alfy M, 2000, MICROSC RES TECHNIQ, V51, P436, DOI 10.1002/1097-0029(20001201)51:5<436::AID-JEMT6>3.0.CO;2-T; Gao R, 2002, LIVER, V22, P15, DOI 10.1046/j.0106-9543.2001.01555.x; Georgopoulos LJ, 2009, MOL IMMUNOL, V46, P2911, DOI 10.1016/j.molimm.2009.07.008; Hanna NN, 1997, CANCER RES, V57, P4205; Ho YC, 2006, GENE THER, V13, P1471, DOI 10.1038/sj.gt.3302796; Hofmann C, 1998, GENE THER, V5, P531, DOI 10.1038/sj.gt.3300607; HOFMANN C, 1995, P NATL ACAD SCI USA, V92, P10099, DOI 10.1073/pnas.92.22.10099; Horoszewicz J S, 1980, Prog Clin Biol Res, V37, P115; Huang W, 2008, WORLD J GASTROENTERO, V14, P5810, DOI 10.3748/wjg.14.5810; Huser A, 2001, NAT BIOTECHNOL, V19, P451, DOI 10.1038/88122; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kaikkonen MU, 2010, MOL THER, V18, P987, DOI 10.1038/mt.2010.25; Kaname Y, 2010, J VIROL, V84, P3210, DOI 10.1128/JVI.02519-09; Kinnunen K, 2009, J GENE MED, V11, P382, DOI 10.1002/jgm.1311; KNUDSON DL, 1974, J VIROL, V14, P934, DOI 10.1128/JVI.14.4.934-944.1974; Kraaij R, 2002, LAB ANIM-UK, V36, P165, DOI 10.1258/0023677021912451; Lang SH, 2000, BRIT J CANCER, V82, P990, DOI 10.1054/bjoc.1999.1029; Lehtolainen P, 2002, GENE THER, V9, P1693, DOI 10.1038/sj.gt.3301854; Li Y, 2004, MOL THER, V10, P1121, DOI 10.1016/j.ymthe.2004.08.018; Maitland NJ, 2004, CURR PHARM DESIGN, V10, P531, DOI 10.2174/1381612043453252; Maitland NJ, 2001, RADIAT RES, V155, P133, DOI 10.1667/0033-7587(2001)155[0133:IVMTSC]2.0.CO;2; Maitland N, 2010, HUM GENE THER, V21, P815, DOI 10.1089/hum.2009.210; Marques RB, 2006, EUR UROL, V49, P245, DOI 10.1016/j.eururo.2005.12.035; Olumi AF, 1999, CANCER RES, V59, P5002; Rembrink K, 1997, PROSTATE, V31, P168; RUSSELL DW, 1994, P NATL ACAD SCI USA, V91, P8915, DOI 10.1073/pnas.91.19.8915; Sandig V, 1996, HUM GENE THER, V7, P1937, DOI 10.1089/hum.1996.7.16-1937; Sarkis C, 2000, P NATL ACAD SCI USA, V97, P14638, DOI 10.1073/pnas.260472897; Searle PF, 2004, CLIN EXP PHARMACOL P, V31, P811, DOI 10.1111/j.1440-1681.2004.04085.x; Shariat SF, 2008, BJU INT, V101, P232, DOI 10.1111/j.1464-410X.2007.07181.x; Swift SL, 2010, CANCER RES, V70, P347, DOI 10.1158/0008-5472.CAN-09-1252; Tani H, 2003, J VIROL, V77, P9799, DOI 10.1128/JVI.77.18.9799-9808.2003; van Leenders G, 2000, LAB INVEST, V80, P1251, DOI 10.1038/labinvest.3780133; van Loo ND, 2001, J VIROL, V75, P961, DOI 10.1128/JVI.75.2.961-970.2001; Vicente T, 2009, GENE THER, V16, P766, DOI 10.1038/gt.2009.33; VOLKMAN LE, 1976, J VIROL, V19, P820, DOI 10.1128/JVI.19.3.820-832.1976; VOLKMAN LE, 1983, APPL ENVIRON MICROB, V45, P1085, DOI 10.1128/AEM.45.3.1085-1093.1983; WANG X, 1985, J GEN VIROL, V66, P541, DOI 10.1099/0022-1317-66-3-541; Washburn JO, 2003, J VIROL, V77, P280, DOI 10.1128/JVI.77.1.280-290.2003; Washburn JO, 1999, J VIROL, V73, P411, DOI 10.1128/JVI.73.1.411-416.1999; WHITT MA, 1988, VIROLOGY, V163, P33, DOI 10.1016/0042-6822(88)90231-0; Wilson WR, 2002, CANCER RES, V62, P1425; ZACK JA, 1995, ADV EXP MED BIOL, V374, P27; Zeng JM, 2007, STEM CELLS, V25, P1055, DOI 10.1634/stemcells.2006-0616	60	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65557	10.1371/journal.pone.0065557	http://dx.doi.org/10.1371/journal.pone.0065557			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755250	Green Published, Green Submitted, gold			2022-12-27	WOS:000321099000078
J	Tie, XX; Han, S; Meng, LX; Wang, YJ; Wu, AH				Tie, Xinxin; Han, Sheng; Meng, Lingxuan; Wang, Yunjie; Wu, Anhua			NFAT1 Is Highly Expressed in, and Regulates the Invasion of, Glioblastoma Multiforme Cells	PLOS ONE			English	Article							ACTIVATED T-CELLS; TRANSCRIPTION FACTOR; NUCLEAR FACTOR; BREAST-CANCER; STEM-CELLS; TUMOR; CYCLOOXYGENASE-2; INDUCTION; CARCINOMA; GLIOMA	Members of the nuclear factor of activated T cells (NFAT) family have been identified as regulators of oncogenic transformation in several human malignancies. A prominent member of this family, NFAT1, is associated with tumor cell survival, apoptosis, migration and invasion. Here, we investigated the role of NFAT1 in glioma cells. In 111 clinical samples, microarray analysis demonstrated that NFAT1 was over-expressed in glioblastoma multiforme (GBM), compared with low-grade gliomas, a result confirmed by RT-PCR in 24 clinical samples and in the U87 and U251 cell lines. Immunohistochemistry and immunofluorescence stain indicated that over-expressed NFAT1 was mainly located in the nucleus, where it acted as a transcription factor. After treatment with the NFAT antagonist cyclosporin A (CsA) and FK506, levels of NFAT1 in the nuclei of U87 GBM cells were dramatically reduced. The invasive potential of U87 cells was reduced by the same treatment, as well as by inhibition of NFAT1 expression using small hairpin RNA. Proliferation of U87 cells was unaffected by CsA, FK506 and NFAT1 shRNA transfection. Clustering analysis and Pearson correlation analysis of microarray data showed that the expression of NFAT1 correlated with the expression of the invasion-related genes cyclooxygenase-2 (COX-2), matrix metalloproteinase-7 (MMP-7) and MMP-9, a result confirmed by in vitro analysis. These findings demonstrate that NFAT1 contributes to the invasive potential but not the proliferation of GBM cells, and suggest that CsA may find application as an adjuvant in combined treatment strategies for GBM.	[Tie, Xinxin; Han, Sheng; Meng, Lingxuan; Wang, Yunjie; Wu, Anhua] China Med Univ, Hosp 1, Dept Neurosurg, Shenyang, Peoples R China	China Medical University	Wu, AH (corresponding author), China Med Univ, Hosp 1, Dept Neurosurg, Shenyang, Peoples R China.	cmuwuanhua@yahoo.com.cn			National High Technology Research and Development Program of China (863) [2012AA02A508]; National Natural Science Foundation of China [81172409]; Science and Technology Department of Liaoning Province [2011225034]	National High Technology Research and Development Program of China (863)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Liaoning Province	This work was supported by grants from the National High Technology Research and Development Program of China (863) (No.2012AA02A508), National Natural Science Foundation of China (No.81172409) and Science and Technology Department of Liaoning Province (No.2011225034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir M, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-152; Chen LC, 2012, CARCINOGENESIS, V33, P2276, DOI 10.1093/carcin/bgs261; Crabtree GR, 2009, CELL, V138, DOI 10.1016/j.cell.2009.06.026; De Rosa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052113; Dikshit B, 2012, ONCOGENE, DOI [10.1038/onc.2012.393, DOI 10.1038/0NC.2012.393]; Duque J, 2005, J BIOL CHEM, V280, P8686, DOI 10.1074/jbc.M413076200; Faget DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047868; Flockhart RJ, 2008, FASEB J, V22, P4218, DOI 10.1096/fj.08-113076; Iniguez MA, 2000, J BIOL CHEM, V275, P23627, DOI 10.1074/jbc.M001381200; Jacobs VL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037955; Jacobs VL, 2012, NEURO-ONCOLOGY, V14, P119, DOI 10.1093/neuonc/nor194; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; John Anitha, 2001, Pathology and Oncology Research, V7, P14; Joseph JV, 2013, BIOCHEM PHARMACOL, V85, P478, DOI 10.1016/j.bcp.2012.11.005; Kim KH, 2013, NEURO-ONCOLOGY, V15, P161, DOI 10.1093/neuonc/nos299; Lee YS, 2009, EXP MOL MED, V41, P259, DOI 10.3858/emm.2009.41.4.029; Liao Q, 2012, NAN FANG YI KE DA XU, V32, P789; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Ma J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037297; Muellenhoff MW, 2012, J DERMATOL TREAT, V23, P290, DOI 10.3109/09546634.2011.590792; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Najbauer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035150; Oh MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047846; Qian XM, 2012, MOL PHARMACEUT, V9, P2636, DOI 10.1021/mp3002039; Rafferty P, 2012, J IMMUNOTOXICOL, V9, P43, DOI 10.3109/1547691X.2011.614646; Rath BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054752; Robbs BK, 2008, MOL CELL BIOL, V28, P7168, DOI 10.1128/MCB.00256-08; Schnell O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030429; Soroceanu L, 2012, CANC RES; Stechishin OD, 2013, NEURO-ONCOLOGY, V15, P198, DOI 10.1093/neuonc/nos302; Tsuda Masumi, 2012, Genes Cancer, V3, P334, DOI 10.1177/1947601912458687; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Vazquez-Cedeira M, 2012, J BIOL CHEM, V287, P42739, DOI 10.1074/jbc.M112.404285; Wu AH, 2010, CELL ONCOL, V32, P313, DOI 10.3233/CLO-2010-0524; Yiu GK, 2006, J BIOL CHEM, V281, P12210, DOI 10.1074/jbc.M600184200; Zhang CY, 2012, MAR DRUGS, V10, P119, DOI 10.3390/md10010119; Zheng JM, 2011, MOL ENDOCRINOL, V25, P2054, DOI 10.1210/me.2011-1141	37	45	46	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e66008	10.1371/journal.pone.0066008	http://dx.doi.org/10.1371/journal.pone.0066008			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762456	Green Submitted, Green Published, gold			2022-12-27	WOS:000321099000124
J	Tsyrlin, VA; Galagudza, MM; Kuzmenko, NV; Pliss, MG; Rubanova, NS; Shcherbin, YI				Tsyrlin, Vitaly A.; Galagudza, Michael M.; Kuzmenko, Nataly V.; Pliss, Michael G.; Rubanova, Nataly S.; Shcherbin, Yury I.			Arterial Baroreceptor Reflex Counteracts Long-Term Blood Pressure Increase in the Rat Model of Renovascular Hypertension	PLOS ONE			English	Article							SYMPATHETIC-NERVE ACTIVITY; CHRONIC RENAL-HYPERTENSION; ANGIOTENSIN-II; BAROREFLEX SENSITIVITY; CONSCIOUS DOGS; SYSTEM; DENERVATION; RECEPTORS; RABBITS; KIDNEY	Introduction: The present study tested the hypothesis that long-term effects of baroreceptor activation might contribute to the prevention of persistent arterial blood pressure (BP) increase in the rat model of renovascular hypertension (HTN). Methods: Repetitive arterial baroreflex (BR) testing was performed in normo- and hypertensive rats. The relationship between initial arterial BR sensitivity and severity of subsequently induced two-kidney one-clip (2K1C) renovascular HTN was studied in Wistar rats. Additionally, the time course of changes in systolic BP (SBP) and cardiac beat-to-beat (RR) interval was studied for 8 weeks after the induction of 2K1C renovascular HTN in the rats with and without sinoaortic denervation (SAD). In a separate experimental series, cervical sympathetic nerve activity (cSNA) was assessed in controls, 2K1C rats, WKY rats, and SHR. Results: The inverse correlation between arterial BR sensitivity and BP was observed in the hypertensive rats during repetitive arterial BR testing. The animals with greater initial arterial BR sensitivity developed lower BP values after renal artery clipping than those with lower initial arterial BR sensitivity. BP elevation during the first 8 weeks of renal artery clipping in 2K1C rats was associated with decreased sensitivity of arterial BR. Although SAD itself resulted only in greater BP variability but not in persistent BP rise, the subsequent renal artery clipping invariably resulted in the development of sustained HTN. The time to onset of HTN was found to be shorter in the rats with SAD than in those with intact baroreceptors. cSNA was significantly greater in the 2K1C rats than in controls. Conclusions: Arterial BR appears to be an important mechanism of long-term regulation of BP, and is believed to be involved in the prevention of BP rise in the rat model of renovascular HTN.	[Tsyrlin, Vitaly A.; Galagudza, Michael M.; Kuzmenko, Nataly V.; Pliss, Michael G.; Rubanova, Nataly S.; Shcherbin, Yury I.] VA Almazov Fed Heart Blood & Endocrinol Ctr, Inst Expt Med, St Petersburg, Russia; [Tsyrlin, Vitaly A.; Kuzmenko, Nataly V.; Pliss, Michael G.; Rubanova, Nataly S.; Shcherbin, Yury I.] IP Pavlov Fed Med Univ, Inst Cardiovasc Dis, St Petersburg, Russia	Almazov National Medical Research Centre; Institute of Experimental Medicine; Pavlov First Saint Petersburg State Medical University	Tsyrlin, VA (corresponding author), VA Almazov Fed Heart Blood & Endocrinol Ctr, Inst Expt Med, St Petersburg, Russia.	tsyrlin@almazovcentre.ru	pliss, mikhail/AAI-8745-2021	Galagudza, Michael/0000-0001-5129-9944				ANGELLJAMES JE, 1973, CIRC RES, V32, P149, DOI 10.1161/01.RES.32.2.149; BARRES C, 1992, AM J PHYSIOL, V263, pR639, DOI 10.1152/ajpregu.1992.263.3.R639; Barrett CJ, 2003, CIRC RES, V92, P1330, DOI 10.1161/01.RES.0000078346.60663.A0; BROWN AM, 1980, CIRC RES, V46, P1, DOI 10.1161/01.RES.46.1.1; Cooper VL, 2007, CLIN AUTON RES, V17, P26, DOI 10.1007/s10286-006-0390-z; COWLEY AW, 1973, CIRC RES, V32, P564, DOI 10.1161/01.RES.32.5.564; COWLEY AW, 1992, PHYSIOL REV, V72, P231, DOI 10.1152/physrev.1992.72.1.231; Franchini K.G., 1994, AM J PHYSIOL PT 2, V266, pH1056 ; Grassi G, 2012, CAN J CARDIOL, V28, P311, DOI 10.1016/j.cjca.2011.11.005; Guild SJ, 2010, EXP PHYSIOL, V95, P41, DOI 10.1113/expphysiol.2008.046300; GUYTON AC, 1972, ANN BIOMED ENG, V1, P254, DOI 10.1007/BF02584211; GUYTON AC, 1991, SCIENCE, V252, P1813, DOI 10.1126/science.2063193; Hall JE, 1996, KIDNEY INT S, V55, pS35; HEYMANS C., 1960, PERSPECTIVES IN BIOL AND MED, V3, P409; Heymans C., 1958, REFLEXOGENIC AREAS C; HOSSMANN V, 1980, CARDIOVASC RES, V14, P125, DOI 10.1093/cvr/14.3.125; Lohmeier TE, 2001, AM J HYPERTENS, V14, p147S, DOI 10.1016/S0895-7061(01)02082-9; LUNDGREN Y, 1974, ACTA PHYSIOL SCAND, V91, P103, DOI 10.1111/j.1748-1716.1974.tb05662.x; Malpas SC, 2004, AM J PHYSIOL-REG I, V286, pR1, DOI 10.1152/ajpregu.00496.2003; MCCUBBIN JW, 1956, CIRC RES, V4, P205, DOI 10.1161/01.RES.4.2.205; McMullan S, 2007, J PHYSIOL-LONDON, V582, P711, DOI 10.1113/jphysiol.2007.128983; OPARIL S, 1987, CAN J PHYSIOL PHARM, V65, P1548, DOI 10.1139/y87-244; OPARIL S, 1986, KIDNEY INT, V30, P437, DOI 10.1038/ki.1986.204; OSBORN JW, 1990, AM J PHYSIOL, V259, pR1172, DOI 10.1152/ajpregu.1990.259.6.R1172; Osborn JW, 2005, CLIN EXP PHARMACOL P, V32, P384, DOI 10.1111/j.1440-1681.2005.04200.x; Osborn JW, 2005, AM J PHYSIOL-REG I, V288, pR846, DOI 10.1152/ajpregu.00474.2004; PERSSON P, 1987, ACTA PHYSIOL SCAND, V130, P553, DOI 10.1111/j.1748-1716.1987.tb08176.x; PERSSON P, 1988, PFLUG ARCH EUR J PHY, V411, P160, DOI 10.1007/BF00582309; PLISS M G, 1983, Fiziologicheskii Zhurnal SSSR Imeni I M Sechenova, V69, P1510; SCHREIHOFER AM, 1992, AM J PHYSIOL, V263, pR258, DOI 10.1152/ajpregu.1992.263.2.R258; SLEIGHT P, 1977, CIRC RES, V41, P750, DOI 10.1161/01.RES.41.6.750; Sleight P, 1991, HYPERTENSION S3, V18, P31; SMYTH HS, 1969, CIRC RES, V24, P109, DOI 10.1161/01.RES.24.1.109; TAKESHITA A, 1980, CARDIOVASC RES, V14, P303, DOI 10.1093/cvr/14.5.303; TRIMARCO B, 1981, CARDIOVASC RES, V15, P436, DOI 10.1093/cvr/15.8.436; TSYRLIN VA, 1980, EUR J PHARMACOL, V67, P75, DOI 10.1016/0014-2999(80)90010-2; WEINSTOCK M, 1993, AM J PHYSIOL, V264, pH505, DOI 10.1152/ajpheart.1993.264.2.H505; Weinstock M, 1996, CLIN SCI, V90, P287, DOI 10.1042/cs0900287; WYSS JM, 1984, BRAIN RES, V298, P130, DOI 10.1016/0006-8993(84)91154-5; Yoshimoto M, 2010, HYPERTENSION, V55, P644, DOI 10.1161/HYPERTENSIONAHA.109.145110	40	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64788	10.1371/journal.pone.0064788	http://dx.doi.org/10.1371/journal.pone.0064788			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762254	Green Published, gold, Green Submitted			2022-12-27	WOS:000321099000021
J	Kannan, R; Santhoshkumar, P; Mooney, BP; Sharma, KK				Kannan, Rama; Santhoshkumar, Puttur; Mooney, Brian P.; Sharma, K. Krishna			Identification of Subunit-Subunit Interaction Sites in alpha A-WT Crystallin and Mutant alpha A-G98R Crystallin Using Isotope-Labeled Cross-Linker and Mass Spectrometry	PLOS ONE			English	Article							CHAPERONE ACTIVITY; CONGENITAL CATARACT; STRUCTURAL-ANALYSIS; PROTEIN STRUCTURES; LENS CRYSTALLINS; DOMAIN DIMERS; EYE LENS; LINKING; MUTATION; CRYAA	Cataract is characterized by progressive protein aggregation and loss of vision. alpha-Crystallins are the major proteins in the lens responsible for maintaining transparency. They exist in the lens as highly polydisperse oligomers with variable numbers of subunits, and mutations in alpha-crystallin are associated with some forms of cataract in humans. Because the stability of proteins is dependent on optimal subunit interactions, the structural transformations and aggregation of mutant proteins that underlie cataract formation can be understood best by identifying the residue-specific inter-and intra-subunit interactions. Chemical crosslinking combined with mass spectrometry is increasingly used to provide structural insights into intra-and inter-protein interactions. We used isotope-labeled cross-linker in combination with LC-MS/MS to determine the subunit-subunit interaction sites in cataract-causing mutant alpha A-G98R crystallin. Peptides cross-linked by isotope-labeled (heavy and light forms) cross-linkers appear as doublets in mass spectra, thus facilitating the identification of cross-linker-containing peptides. In this study, we cross-linked wild-type (alpha A-WT) and mutant (alpha A-G98R) crystallins using the homobifunctional amine-reactive, isotope-labeled (d(0) and d(4)) cross-linker-BS(2)G (bis[sulfosuccinimidyl]glutarate). Tryptic in-solution digest of cross-linked complexes generates a wide array of peptide mixtures. Cross-linked peptides were enriched using strong cation exchange (SCX) chromatography followed by both MS and MS/MS to identify the cross-linked sites. We identified a distinct intermolecular interaction site between K88 - K99 in the beta 5 strand of the mutant alpha A-G98R crystallin that is not found in wild-type alpha A-crystallin. This interaction could explain the conformational instability and aggregation nature of the mutant protein that results from incorrect folding and assembly.	[Kannan, Rama; Mooney, Brian P.; Sharma, K. Krishna] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Santhoshkumar, Puttur; Sharma, K. Krishna] Univ Missouri, Dept Ophthalmol, Columbia, MO USA; [Mooney, Brian P.] Univ Missouri, Charles W Gehrke Prote Ctr, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Sharma, KK (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.	Sharmak@health.missouri.edu	Santhoshkumar, Puttur/G-1798-2010	Santhoshkumar, Puttur/0000-0002-6897-7278; Kannan, Rama/0000-0002-1631-830X	National Institutes of Health [EY019878]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY019878] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grant EY019878 (http://www.nih.gov/) and an unrestricted grant-in-aid from Research to Prevent Blindness to the Department of Ophthalmology (http://www.rpbusa.org/rpb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagneris C, 2009, J MOL BIOL, V392, P1242, DOI 10.1016/j.jmb.2009.07.069; Baranova EV, 2011, J MOL BIOL, V411, P110, DOI 10.1016/j.jmb.2011.05.024; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; Chu FX, 2006, PROTEIN SCI, V15, P1260, DOI 10.1110/ps.052065106; Clark AR, 2011, J MOL BIOL, V408, P118, DOI 10.1016/j.jmb.2011.02.020; Clark AR, 2012, INT J BIOCHEM CELL B, V44, P1687, DOI 10.1016/j.biocel.2012.02.015; Du JL, 2010, BIOCHEMISTRY-US, V49, P8276, DOI 10.1021/bi101280t; Fritzsche R, 2012, RAPID COMMUN MASS SP, V26, P653, DOI 10.1002/rcm.6150; Graw J, 2006, GRAEF ARCH CLIN EXP, V244, P912, DOI 10.1007/s00417-005-0234-x; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 2009, EXP EYE RES, V88, P190, DOI 10.1016/j.exer.2008.07.007; Ihling C, 2006, J AM SOC MASS SPECTR, V17, P1100, DOI 10.1016/j.jasms.2006.04.020; Jaenicke R, 1997, ADV PROTEIN CHEM, V50, P1, DOI 10.1016/S0065-3233(08)60318-6; Kalkhof S, 2008, ANAL BIOANAL CHEM, V392, P305, DOI 10.1007/s00216-008-2231-5; Kang S, 2006, J PROTEOME RES, V5, P370, DOI 10.1021/pr050356f; Kore R, 2012, MOL CELL BIOCHEM, V362, P93, DOI 10.1007/s11010-011-1131-8; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Lambert W, 2013, CELL STRESS CHAPERON, V18, P75, DOI 10.1007/s12192-012-0360-4; Leitner A, 2010, MOL CELL PROTEOMICS, V9, P1634, DOI 10.1074/mcp.R000001-MCP201; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Maiolica A, 2007, MOL CELL PROTEOMICS, V6, P2200, DOI 10.1074/mcp.M700274-MCP200; Mornon JP, 1998, INT J BIOL MACROMOL, V22, P219, DOI 10.1016/S0141-8130(98)00019-1; Muller DR, 2001, ANAL CHEM, V73, P1927, DOI 10.1021/ac001379a; Murugesan R, 2007, MOL VIS, V13, P2301; Peterson JJ, 2004, MOL VIS, V10, P857; Raju M, 2011, MOL VIS, V17, P7; Rao PV, 1995, BBA-GEN SUBJECTS, V1245, P439, DOI 10.1016/0304-4165(95)00125-5; Rappsilber J, 2011, J STRUCT BIOL, V173, P530, DOI 10.1016/j.jsb.2010.10.014; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/nmeth.1192, 10.1038/NMETH.1192]; Santhiya S, 2006, MOL VIS, V12, P768; Singh D, 2007, J MOL BIOL, V373, P1293, DOI 10.1016/j.jmb.2007.08.062; Singh D, 2006, MOL VIS, V12, P1372; Sinz A, 2007, ANGEW CHEM INT EDIT, V46, P660, DOI 10.1002/anie.200602549; Sinz A, 2006, MASS SPECTROM REV, V25, P663, DOI 10.1002/mas.20082; Steen H, 2004, NAT REV MOL CELL BIO, V5, P699, DOI 10.1038/nrm1468; Swaim CL, 2004, PROTEIN SCI, V13, P2832, DOI 10.1110/ps.04910004; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; WANG KY, 1994, J BIOL CHEM, V269, P13601; Young MM, 2000, P NATL ACAD SCI USA, V97, P5802, DOI 10.1073/pnas.090099097; Zhao A, 2013, J PHARMACEUT BIOMED, V73, P99, DOI 10.1016/j.jpba.2012.05.006	42	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65610	10.1371/journal.pone.0065610	http://dx.doi.org/10.1371/journal.pone.0065610			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755258	Green Published, Green Submitted, gold			2022-12-27	WOS:000320579400071
J	Maskew, M; Fox, MP; van Cutsem, G; Chu, K; MacPhail, P; Boulle, A; Egger, M				Maskew, Mhairi; Fox, Matthew P.; van Cutsem, Gilles; Chu, Kathryn; MacPhail, Patrick; Boulle, Andrew; Egger, Matthias		IeDEA Southern Africa	Treatment Response and Mortality among Patients Starting Antiretroviral Therapy with and without Kaposi Sarcoma: A Cohort Study	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; FOLLOW-UP; PATIENTS LOST; ORAL ETOPOSIDE; AIDS; HIV; HAART; PROGRAMS; TRIALS; CANCER	Background: Improved survival among HIV-infected individuals on antiretroviral therapy (ART) has focused attention on AIDS-related cancers including Kaposi sarcoma (KS). However, the effect of KS on response to ART is not well-described in Southern Africa. We assessed the effect of KS on survival and immunologic and virologic treatment responses at 6- and 12months after initiation of ART. Methods: We analyzed prospectively collected data from a cohort of HIV-infected adults initiating ART in South Africa. Differences in mortality between those with and without KS at ART initiation were estimated with Cox proportional hazard models. Log-binomial models were used to assess differences in CD4 count response and HIV virologic suppression within a year of initiating treatment. Results: Between January 2001-January 2008, 13,847 HIV-infected adults initiated ART at the study clinics. Those with KS at ART initiation (n = 247, 2%) were similar to those without KS (n = 13600,98%) with respect to age (35 vs. 35yrs), presenting CD4 count (74 vs. 85cells/mm(3)) and proportion on TB treatment (37% vs. 30%). In models adjusted for sex, baseline CD4 count, age, treatment site, tuberculosis and year of ART initiation, KS patients were over three times more likely to have died at any time after ART initiation (hazard ratio[HR]: 3.62; 95% CI: 2.71-4.84) than those without KS. The increased risk was highest within the first year on ART (HR: 4.05; 95% CI: 2.95-5.55) and attenuated thereafter (HR: 2.30; 95% CI: 1.08-4.89). Those with KS also gained, on average, 29 fewer CD4 cells (95% CI: 7-52cells/mm(3)) and were less likely to increase their CD4 count by 50 cells from baseline (RR: 1.43; 95% CI: 0.99-2.06) within the first 6-months of treatment. Conclusions: HIV-infected adults presenting with KS have increased risk of mortality even after initiation of ART with the greatest risk in the first year. Among those who survive the first year on therapy, subjects with KS demonstrated a poorer immunologic response to ART than those without KS.	[Maskew, Mhairi; Fox, Matthew P.; MacPhail, Patrick] Univ Witwatersrand, Sch Clin Med, Dept Internal Med, Hlth Econ & Epidemiol Res Off,Fac Hlth Sci, Johannesburg, South Africa; [Fox, Matthew P.] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Fox, Matthew P.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [van Cutsem, Gilles] Medecins Sans Frontieres, Cape Town, South Africa; [van Cutsem, Gilles; Boulle, Andrew] Univ Cape Town, CIDER, ZA-7925 Cape Town, South Africa; [Chu, Kathryn] Medecins Sans Frontieres, SAMU, Johannesburg, South Africa; [Egger, Matthias] Univ Bern, ISPM, Bern, Switzerland	University of Witwatersrand; Boston University; Boston University; University of Cape Town; University of Bern	Maskew, M (corresponding author), Univ Witwatersrand, Sch Clin Med, Dept Internal Med, Hlth Econ & Epidemiol Res Off,Fac Hlth Sci, Johannesburg, South Africa.	mmaskew@heroza.org	Van Cutsem, Gilles/ABB-1171-2021; Boulle, Andrew/C-1413-2008; Fox, Matthew/K-2004-2019	Van Cutsem, Gilles/0000-0002-8972-4480; Boulle, Andrew/0000-0002-7713-8062; Fox, Matthew/0000-0001-9887-0634; Egger, Matthias/0000-0001-7462-5132; MASKEW, MHAIRI/0000-0003-4238-0200	National Institutes for Health [1 U01 AI069924-01]; IeDEA Southern Africa collaboration; United States Agency for International Development (USAID) [674-A-00-08-00007-00]; National Institute of Allergy and Infectious Diseases [K01AI083097]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069924, K01AI083097] Funding Source: NIH RePORTER	National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IeDEA Southern Africa collaboration; United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by a grant from the National Institutes for Health (Grant number 1 U01 AI069924-01) in collaboration with the IeDEA Southern Africa collaboration. Funding was also provided by the United States Agency for International Development (USAID) under the terms of agreement 674-A-00-08-00007-00 with Right to Care (RTC). The opinions expressed herein are those of the authors and do not necessarily reflect the views of USAID, the Themba Lethu Clinic, or Right to Care. Matthew Fox was also supported by Award Number K01AI083097 from the National Institute of Allergy and Infectious Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy And Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablashi D, 1999, BRIT J CANCER, V81, P893, DOI 10.1038/sj.bjc.6690782; Agaba PA, 2009, INT J STD AIDS, V20, P410, DOI 10.1258/ijsa.2008.008353; [Anonymous], LANCET; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Bower M, 1999, AIDS, V13, P2105, DOI 10.1097/00002030-199910220-00014; Bower M, 2009, AIDS, V23, P1701, DOI 10.1097/QAD.0b013e32832d080d; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Casper C, 2011, ANNU REV MED, V62, P157, DOI 10.1146/annurev-med-050409-103711; Chokunonga E, 2000, INT J CANCER, V85, P54, DOI 10.1002/(SICI)1097-0215(20000101)85:1&lt;54::AID-IJC10&gt;3.0.CO;2-D; Chu KM, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-23; Coetzee D, 2004, TROP MED INT HEALTH, V9, pA11, DOI 10.1111/j.1365-3156.2004.01259.x; Dal Maso L, 2001, EUR J CANCER, V37, P1188, DOI 10.1016/S0959-8049(01)00120-4; Egger M, 2012, INT J EPIDEMIOL, V41, P1256, DOI 10.1093/ije/dyr080; El Amari EB, 2008, AIDS, V22, P1019, DOI 10.1097/QAD.0b013e3282fc9c03; Evans SR, 2002, J CLIN ONCOL, V20, P3236, DOI 10.1200/JCO.2002.12.038; Fox MP, 2013, INT J EPIDEMIOL, V42, P430, DOI 10.1093/ije/dys029; Fox MP, 2010, TROP MED INT HEALTH, V15, P405, DOI 10.1111/j.1365-3156.2010.02473.x; Geng EH, 2008, JAMA-J AM MED ASSOC, V300, P506, DOI 10.1001/jama.300.5.506; Khammissa RAG, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/873171; Krown SE, 2004, J CLIN ONCOL, V22, P399, DOI 10.1200/JCO.2004.08.064; Lynen L, 2005, AIDS REV, V7, P13; Martinez V, 2006, BRIT J CANCER, V94, P1000, DOI 10.1038/sj.bjc.6603056; Mocroft A, 2004, CANCER-AM CANCER SOC, V100, P2644, DOI 10.1002/cncr.20309; Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9; Olweny CLM, 2005, INT J CANCER, V113, P632, DOI 10.1002/ijc.20606; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; PAREDES J, 1995, J ACQ IMMUN DEF SYND, V9, P138; Parkin DM, 2008, LANCET ONCOL, V9, P683, DOI 10.1016/S1470-2045(08)70175-X; Powles T, 2002, AIDS, V16, P531, DOI 10.1097/00002030-200203080-00003; Rabkin CS, 2001, EUR J CANCER, V37, P1316, DOI 10.1016/S0959-8049(01)00104-6; Rosen S, 2010, TROP MED INT HEALTH, V15, P98, DOI 10.1111/j.1365-3156.2010.02512.x; Sitas F, 2001, J Natl Cancer Inst Monogr, P1; [South African National Ministry of Health National Department of Health Republic of South Africa], 2004, S AFR NAT ANT TREATM; Stebbing J, 2006, LANCET, V367, P1495, DOI 10.1016/S0140-6736(06)68649-2; Stein L, 2008, INT J CANCER, V122, P2260, DOI 10.1002/ijc.23391; Tirelli U, 2001, EUR J CANCER, V37, P1320, DOI 10.1016/S0959-8049(01)00106-X; [WHO U UNAIDS], 2011, PROGR REP 2011 GLOB	37	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64392	10.1371/journal.pone.0064392	http://dx.doi.org/10.1371/journal.pone.0064392			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755122	Green Published, gold, Green Submitted			2022-12-27	WOS:000320579400014
J	Simon, UK; Polanschutz, LM; Koffler, BE; Zechmann, B				Simon, Uwe K.; Polanschuetz, Lisa M.; Koffler, Barbara E.; Zechmann, Bernd			High Resolution Imaging of Temporal and Spatial Changes of Subcellular Ascorbate, Glutathione and H2O2 Distribution during Botrytis cinerea Infection in Arabidopsis	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; FUNGAL PATHOGENS; LEAVES; CHLOROPLASTS; PLASTOGLOBULES; ACCUMULATION; MITOCHONDRIA; PLASTIDS; SPINACH; DEFENSE	In order to study the mechanisms behind the infection process of the necrotrophic fungus Botrytis cinerea, the subcellular distribution of hydrogen peroxide (H2O2) was monitored over a time frame of 96 h post inoculation (hpi) in Arabidopsis thaliana Col-0 leaves at the inoculation site (IS) and the area around the IS which was defined as area adjacent to the inoculation site (AIS). H2O2 accumulation was correlated with changes in the compartment-specific distribution of ascorbate and glutathione and chloroplast fine structure. This study revealed that the severe breakdown of the antioxidative system, indicated by a drop in ascorbate and glutathione contents at the IS at later stages of infection correlated with an accumulation of H2O2 in chloroplasts, mitochondria, cell walls, nuclei and the cytosol which resulted in the development of chlorosis and cell death, eventually visible as tissue necrosis. A steady increase of glutathione contents in most cell compartments within infected tissues (up to 600% in chloroplasts at 96 hpi) correlated with an accumulation of H2O2 in chloroplasts, mitochondria and cell walls at the AIS indicating that high glutathione levels could not prevent the accumulation of reactive oxygen species (ROS) which resulted in chlorosis. Summing up, this study reveals the intracellular sequence of events during Botrytis cinerea infection and shows that the breakdown of the antioxidative system correlated with the accumulation of H2O2 in the host cells. This resulted in the degeneration of the leaf indicated by severe changes in the number and ultrastructure of chloroplasts (e.g. decrease of chloroplast number, decrease of starch and thylakoid contents, increase of plastoglobuli size), chlorosis and necrosis of the leaves.	[Simon, Uwe K.; Polanschuetz, Lisa M.; Koffler, Barbara E.; Zechmann, Bernd] Graz Univ, Inst Plant Sci, Graz, Austria	University of Graz	Zechmann, B (corresponding author), Graz Univ, Inst Plant Sci, Graz, Austria.	bernd.zechmann@uni-graz.at	Simon, Uwe K./D-4555-2015	Simon, Uwe K./0000-0003-4164-8287; Zechmann, Bernd/0000-0002-7702-2588	Austrian Science Fund [FWF P22988-B16]; Austrian Science Fund (FWF) [P 22988] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF P22988-B16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselbergh B, 2007, PLANT PHYSIOL, V144, P1863, DOI 10.1104/pp.107.099226; Austin JR, 2006, PLANT CELL, V18, P1693, DOI 10.1105/tpc.105.039859; Blokhina OB, 2001, J EXP BOT, V52, P1179, DOI 10.1093/jexbot/52.359.1179; Cheeseman J.M., 2007, PLANT STRESS, V1, P4, DOI DOI 10.1371/J0URNAL.P0NE.0023776; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Deller S, 2011, J PLANT PHYSIOL, V168, P63, DOI 10.1016/j.jplph.2010.05.024; Foyer CH, 2009, ANTIOXID REDOX SIGN, V11, P861, DOI 10.1089/ars.2008.2177; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Gabara B, 2012, ENVIRON EXP BOT, V77, P33, DOI 10.1016/j.envexpbot.2011.10.010; Ghosh S, 2001, PLANT PHYSIOL BIOCH, V39, P777, DOI 10.1016/S0981-9428(01)01296-7; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; Grosskinsky DK, 2012, PHYTOPATHOLOGY, V102, P662, DOI 10.1094/PHYTO-02-12-0022-R; Heller J, 2011, ANNU REV PHYTOPATHOL, V49, P369, DOI 10.1146/annurev-phyto-072910-095355; Hernandez JA, 2004, PHYSIOL PLANTARUM, V122, P486, DOI 10.1111/j.1399-3054.2004.00431.x; Kulye MS, 2012, J INTEGR AGR, V11, P1305; Kuzniak E, 2005, PLANTA, V222, P192, DOI 10.1007/s00425-005-1514-8; Kuzniak E, 2005, J EXP BOT, V56, P921, DOI 10.1093/jxb/eri086; Kuzniak E, 2001, PLANT SCI, V160, P723, DOI 10.1016/S0168-9452(00)00457-X; Kuzniak E, 1999, PLANT SCI, V148, P69, DOI 10.1016/S0168-9452(99)00121-1; Lichtenthaler HK, 2007, PHOTOSYNTH RES, V92, P163, DOI 10.1007/s11120-007-9204-y; LICHTENTHALER HK, 1969, PROTOPLASMA, V68, P315, DOI 10.1007/BF01251616; Muckenschnabel I, 2002, J EXP BOT, V53, P207, DOI 10.1093/jexbot/53.367.207; Munne-Bosch S, 2004, FUNCT PLANT BIOL, V31, P203, DOI 10.1071/FP03236; Noctor G, 2012, PLANT CELL ENVIRON, V35, P454, DOI 10.1111/j.1365-3040.2011.02400.x; Quan LJ, 2008, J INTEGR PLANT BIOL, V50, P2, DOI 10.1111/j.1744-7909.2007.00599.x; Schouten A, 2002, MOL PLANT PATHOL, V3, P227, DOI 10.1046/j.1364-3703.2002.00114.x; Schumacher J, 2012, MORPHOGENESIS PATHOG, V22, P225, DOI DOI 10.1007/978-3-642-22916-9_11; Solymosi K, 2012, AGRON SUSTAIN DEV, V32, P245, DOI 10.1007/s13593-011-0019-z; Tenberge KB, 2004, BOTRYTIS: BIOLOGY, PATHOLOGY AND CONTROL, P67; Tenberge KB, 2002, MICROSC MICROANAL, V8, P250, DOI DOI 10.1091/MBC.E09-06-0501; van Baarlen P, 2007, MOL PLANT PATHOL, V8, P41, DOI 10.1111/j.1364-3703.2006.00367.x; van Kan JAL, 2006, TRENDS PLANT SCI, V11, P247, DOI 10.1016/j.tplants.2006.03.005; Williamson B, 2007, MOL PLANT PATHOL, V8, P561, DOI [10.1111/j.1364-3703.2007.00417.x, 10.1111/J.1364-3703.2007.00417.X]; Windram O, 2012, PLANT CELL, V24, P3530, DOI 10.1105/tpc.112.102046; WRISCHER M, 1975, J CELL SCI, V18, P509; Ytterberg AJ, 2006, PLANT PHYSIOL, V140, P984, DOI 10.1104/pp.105.076083; Zechmann B, 2008, J EXP BOT, V59, P4017, DOI 10.1093/jxb/ern243; Zechmann B, 2003, ARCH VIROL, V148, P1119, DOI 10.1007/s00705-003-0005-0; Zechmann B, 2011, PLANTA, V233, P1, DOI 10.1007/s00425-010-1275-x; Zechmann B, 2010, PROTOPLASMA, V246, P15, DOI 10.1007/s00709-010-0111-2; Zellnig G, 2004, PROTOPLASMA, V223, P221, DOI 10.1007/s00709-003-0034-2; Zellnig G, 2010, PROTOPLASMA, V243, P129, DOI 10.1007/s00709-009-0058-3	42	34	35	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65811	10.1371/journal.pone.0065811	http://dx.doi.org/10.1371/journal.pone.0065811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755284	Green Submitted, gold, Green Published			2022-12-27	WOS:000320579400079
J	Stoilova, B; Kowenz-Leutz, E; Scheller, M; Leutz, A				Stoilova, Bilyana; Kowenz-Leutz, Elisabeth; Scheller, Marina; Leutz, Achim			Lymphoid to Myeloid Cell Trans-Differentiation Is Determined by C/EBP beta Structure and Post-Translational Modifications	PLOS ONE			English	Article							BINDING PROTEIN-BETA; NF-M; DNA-BINDING; B-CELLS; MACROPHAGES; TRANSCRIPTION; LINEAGE; COMPLEX; GENES; TRANSDIFFERENTIATION	The transcription factor C/EBP beta controls differentiation, proliferation, and functionality of many cell types, including innate immune cells. A detailed molecular understanding of how C/EBP beta directs alternative cell fates remains largely elusive. A multitude of signal-dependent post-translational modifications (PTMs) differentially affect the protean C/EBP beta functions. In this study we apply an assay that converts primary mouse B lymphoid progenitors into myeloid cells in order to answer the question how C/EBP beta regulates (trans-)differentiation and determines myeloid cell fate. We found that structural alterations and various C/EBP beta PTMs determine the outcome of trans-differentiation of lymphoid into myeloid cells, including different types of monocytes/macrophages, dendritic cells, and granulocytes. The ability of C/EBP beta to recruit chromatin remodeling complexes is required for the granulocytic trans-differentiation outcome. These novel findings reveal that PTMs and structural plasticity of C/EBP beta are adaptable modular properties that integrate and rewire epigenetic functions to direct differentiation to diverse innate immune system cells, which are crucial for the organism survival.	[Stoilova, Bilyana; Kowenz-Leutz, Elisabeth; Scheller, Marina; Leutz, Achim] Max Delbruck Ctr Mol Med, Berlin, Germany; [Stoilova, Bilyana; Scheller, Marina; Leutz, Achim] Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany; [Leutz, Achim] Humboldt Univ, D-10099 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin	Leutz, A (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	aleutz@mdc-berlin.de	Leutz, Achim/K-9643-2013	Leutz, Achim/0000-0001-8259-927X; Stoilova, Bilyana/0000-0001-6192-9145; Scheller, Marina/0000-0001-6108-0831				Anastasov N, 2010, HAEMATOL-HEMATOL J, V95, P760, DOI 10.3324/haematol.2009.014050; Bussmann LH, 2009, CELL STEM CELL, V5, P554, DOI 10.1016/j.stem.2009.10.004; Calkhoven CF, 2000, GENE DEV, V14, P1920; COLLINS LS, 1987, J IMMUNOL, V138, P1082; CUMANO A, 1992, NATURE, V356, P612, DOI 10.1038/356612a0; Eaton EM, 2003, J BIOL CHEM, V278, P33416, DOI 10.1074/jbc.M305680200; Feldman AL, 2008, BLOOD, V111, P5433, DOI 10.1182/blood-2007-11-124792; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Fortina P, 2008, NAT BIOTECHNOL, V26, P293, DOI 10.1038/nbt0308-293; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Graf T, 2011, CELL STEM CELL, V9, P504, DOI 10.1016/j.stem.2011.11.012; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Hirai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054862; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Jundt F, 2005, BLOOD, V106, P1801, DOI 10.1182/blood-2004-11-4513; Katoh S, 1990, Dev Immunol, V1, P113, DOI 10.1155/1990/28760; Kawamoto H, 2009, TRENDS IMMUNOL, V30, P193, DOI 10.1016/j.it.2009.03.001; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; Kowenz-Leutz E, 2010, EMBO J, V29, P1105, DOI 10.1038/emboj.2010.3; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; Krysinska H, 2007, MOL CELL BIOL, V27, P878, DOI 10.1128/MCB.01915-06; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Lee S, 2010, J BIOL CHEM, V285, P21399, DOI 10.1074/jbc.M110.128413; Lee S, 2010, MOL CELL BIOL, V30, P2621, DOI 10.1128/MCB.00782-09; Leutz A, 2011, TRANSCR-AUSTIN, V2, P3, DOI 10.4161/trns.2.1.13510; Lichtinger M, 2012, EMBO J, V31, P4318, DOI 10.1038/emboj.2012.275; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; Mo XM, 2004, MOL CELL, V13, P241, DOI 10.1016/S1097-2765(03)00521-5; Muller C, 1995, EMBO J, V14, P6127, DOI 10.1002/j.1460-2075.1995.tb00303.x; MUROI K, 1995, INTERNAL MED, V34, P36, DOI 10.2169/internalmedicine.34.36; NERLOV C, 1995, EMBO J, V14, P4318, DOI 10.1002/j.1460-2075.1995.tb00106.x; Nerlov C, 1998, GENE DEV, V12, P2413, DOI 10.1101/gad.12.15.2413; Nerlov C, 2008, CURR OPIN CELL BIOL, V20, P180, DOI 10.1016/j.ceb.2008.02.002; NESS SA, 1993, GENE DEV, V7, P749, DOI 10.1101/gad.7.5.749; Piva R, 2006, J CLIN INVEST, V116, P3171, DOI 10.1172/JCI29401; Pless O, 2008, J BIOL CHEM, V283, P26357, DOI 10.1074/jbc.M802132200; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Steinberg XP, 2012, BIOCHEMISTRY-US, V51, P952, DOI 10.1021/bi201593q; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Takahashi K, 1998, AM J PATHOL, V152, P445; Tsukada J, 2011, CYTOKINE, V54, P6, DOI 10.1016/j.cyto.2010.12.019; Uematsu S, 2007, J IMMUNOL, V179, P5378, DOI 10.4049/jimmunol.179.8.5378; Vradii D, 2006, J CELL PHYSIOL, V206, P112, DOI 10.1002/jcp.20432; Wada T, 2009, J BIOL CHEM, V284, P30673, DOI 10.1074/jbc.M109.042242; WILLIAMS SC, 1995, EMBO J, V14, P3170, DOI 10.1002/j.1460-2075.1995.tb07319.x; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Zahnow CA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001033	50	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65169	10.1371/journal.pone.0065169	http://dx.doi.org/10.1371/journal.pone.0065169			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755188	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000320579400043
J	Huang, CJ; Teng, HW; Chien, CC; Lin, JK; Yang, SH				Huang, Chi-Jung; Teng, Hao-Wei; Chien, Chih-Cheng; Lin, Jen-Kou; Yang, Shung-Haur			Prognostic Significance of C-Reactive Protein Polymorphism and KRAS/BRAF in Synchronous Liver Metastasis from Colorectal Cancer	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CLINICOPATHOLOGICAL FEATURES; INFLAMMATORY RESPONSE; RISK; BRAF; TUMORIGENESIS; ACTIVATION; INVASION; CELLS	Background: The liver is the most common target organ in the metastasis of colorectal cancer (CRC). Synchronous liver metastases may confer a poorer prognosis than metachronous metastases, and genetic alterations and an inflammatory response have also been associated with a poor prognosis in cases of a liver metastasis arising from CRC. However, few studies have examined the relationship between KRAS mutations and inflammatory status in CRC, especially with respect to liver metastases. Methods: The effect of the activated mitogen-activated protein kinase pathway and another protein involved in inflammation, C-reactive protein, in liver metastases were examined. We aimed to determine the impact of the CRP-specific single nucleotide polymorphism (SNP) rs7553007 in liver metastasis on the CRC-specific survival (CSS) of patients after colorectal liver metastasectomy. Results: We found no significant differences in genotype distributions and allele frequencies at the CRP SNP rs7553007 between CRC patients with liver metastasis and the control group. CSS rates were low in the subgroup of patients with synchronous metastasis with the A-allele (A/A and A/G) at rs7553007 or mutated KRAS/BRAF in liver metastatic specimens. Furthermore, the CRP SNP rs7553007 (hazard ratio [HR] = 1.101; 95% confidence interval [CI] = 1.011-1.200; P = 0.027) and KRAS/BRAF mutations (HR = 2.377; 95% CI = 1.293-4.368; P = 0.005) remained predictive for the CSS of CRC patients with synchronous liver metastasis in multivariate analysis. Conclusions: Both the CRP SNP rs7553007 and KRAS/BRAF mutations were independent prognostic factors for CRC patients with synchronous liver metastasis.	[Huang, Chi-Jung; Chien, Chih-Cheng] Cathay Gen Hosp, Dept Med Res, Taipei, Taiwan; [Huang, Chi-Jung; Chien, Chih-Cheng] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan; [Huang, Chi-Jung] Natl Def Med Ctr, Dept Biochem, Taipei 10764, Taiwan; [Teng, Hao-Wei] Taipei Vet Gen Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan; [Teng, Hao-Wei] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Teng, Hao-Wei; Lin, Jen-Kou; Yang, Shung-Haur] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Chien, Chih-Cheng] Sijhih Cathay Gen Hosp, Dept Anesthesiol, New Taipei, Taiwan; [Lin, Jen-Kou; Yang, Shung-Haur] Taipei Vet Gen Hosp, Dept Surg, Taipei, Taiwan	Cathay General Hospital; Fu Jen Catholic University; National Defense Medical Center; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Cathay General Hospital; Taipei Veterans General Hospital	Yang, SH (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan.	yangsh@vghtpe.gov.tw		Chien, Chih-Cheng/0000-0002-8368-2005	Taipei Veterans General Hospital [V98C1-152, V99C1-109, V100C-170]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This work was supported by the grants (V98C1-152, V99C1-109, and V100C-170) from Taipei Veterans General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam R, 2007, BRIT J SURG, V94, P129, DOI 10.1002/bjs.5764; Ariake K, 2012, CANCER LETT, V325, P99, DOI 10.1016/j.canlet.2012.06.012; Barderas R, 2012, CANCER RES, V72, P2780, DOI 10.1158/0008-5472.CAN-11-4090; Bouchahda M, 2010, CANCER CHEMOTH PHARM, V66, P605, DOI 10.1007/s00280-010-1298-9; Braet F, 2007, WORLD J GASTROENTERO, V13, P821, DOI 10.3748/wjg.v13.i6.821; Chang KH, 2013, PLOS ONE, V8; Charpin C, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3165; Chiu HM, 2008, AM J GASTROENTEROL, V103, P2317, DOI 10.1111/j.1572-0241.2008.01952.x; Ding QQ, 2011, J CLIN INVEST, V121, P4526, DOI 10.1172/JCI45008; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Ferrone C, 2010, J CLIN ONCOL, V28, P4045, DOI 10.1200/JCO.2010.27.9992; Fransen K, 2004, CARCINOGENESIS, V25, P527, DOI 10.1093/carcin/bgh049; Fujita S, 2000, JPN J CLIN ONCOL, V30, P7, DOI 10.1093/jjco/hyd002; Granville CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005061; Hutchins G, 2011, J CLIN ONCOL, V29, P1261, DOI 10.1200/JCO.2010.30.1366; Ishizuka M, 2009, J SURG ONCOL, V100, P38, DOI 10.1002/jso.21294; Ji H, 2006, ONCOGENE, V25, P2105, DOI 10.1038/sj.onc.1209237; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Khatri VP, 2005, J CLIN ONCOL, V23, P8490, DOI 10.1200/JCO.2004.00.6155; Lawlor DA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003011; Li WQ, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-2; Mekenkamp LJM, 2010, BRIT J CANCER, V103, P159, DOI 10.1038/sj.bjc.6605737; Nikoloudis N, 2004, Tech Coloproctol, V8 Suppl 1, ps177, DOI 10.1007/s10151-004-0149-2; Nordlinger B, 2008, LANCET, V371, P1007, DOI 10.1016/S0140-6736(08)60455-9; Okumura T, 2010, CANCER RES, V70, P8435, DOI 10.1158/0008-5472.CAN-10-1506; Pai JK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001395; Poole EM, 2009, PHARMACOGENET GENOM, V19, P113, DOI 10.1097/FPC.0b013e32831bd976; Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a; Shiu YC, 2008, DIS COLON RECTUM, V51, P443, DOI 10.1007/s10350-007-9133-z; Tan EK, 2010, ANN ACAD MED SINGAP, V39, P719; Teng HW, 2012, J SURG ONCOL, V106, P123, DOI 10.1002/jso.23063; Tsai MS, 2007, ANN SURG ONCOL, V14, P786, DOI 10.1245/s10434-006-9215-5; Tsilidis KK, 2009, CANCER CAUSE CONTROL, V20, P1739, DOI 10.1007/s10552-009-9427-7; Vermeire S, 2005, NAT CLIN PRACT GASTR, V2, P580, DOI 10.1038/ncpgasthep0359; Yang SH, 2011, ANN SURG ONCOL, V18, P1907, DOI 10.1245/s10434-011-1575-9; Zlobec I, 2010, INT J CANCER, V127, P367, DOI 10.1002/ijc.25042	36	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65117	10.1371/journal.pone.0065117	http://dx.doi.org/10.1371/journal.pone.0065117			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755178	Green Submitted, Green Published, gold			2022-12-27	WOS:000319872300048
J	Kondo, Y; Hasegawa, G; Okada, H; Senmaru, T; Fukui, M; Nakamura, N; Sawada, M; Kitawaki, J; Okanoue, T; Kishimoto, Y; Amano, A; Maruyama, N; Obayashi, H; Ishigami, A				Kondo, Yoshitaka; Hasegawa, Goji; Okada, Hiroshi; Senmaru, Takafumi; Fukui, Michiaki; Nakamura, Naoto; Sawada, Morio; Kitawaki, Jo; Okanoue, Takeshi; Kishimoto, Yuki; Amano, Akiko; Maruyama, Naoki; Obayashi, Hiroshi; Ishigami, Akihito			Leprdb/db Mice with Senescence Marker Protein-30 Knockout (Leprdb/db Smp30Y/-) Exhibit Increases in Small Dense-LDL and Severe Fatty Liver Despite Being Fed a Standard Diet	PLOS ONE			English	Article							HEPATIC STEATOSIS; GENE-EXPRESSION; ACID; PLASMA; STEATOHEPATITIS; LIPOPROTEINS; ACCUMULATION; CHOLESTEROL; VALIDATION; DISEASE	Background/Aims: The senescence marker protein-30 (SMP30) is a 34 kDa protein originally identified in rat liver that shows decreased levels with age. Several functional studies using SMP30 knockout (Smp30(Y/-)) mice established that SMP30 functions as an antioxidant and protects against apoptosis. To address the potential role of SMP30 in nonalcoholic fatty liver disease (NAFLD) pathogenesis, we established Smp30(Y/-) mice on a Lepr(db/db) background (Lepr(db/db) Smp30(Y/-) mice). Research Design/Principal Findings: Male Lepr(db/db) Smp30(Y/-) mice were fed a standard diet (340 kcal/100 g, fat 5.6%) for 16 weeks whereupon the lipid/lipoprotein profiles, hepatic expression of genes related to lipid metabolism and endoplasmic reticulum stress markers were analyzed by HPLC, quantitative RT-PCR and western blotting, respectively. Changes in the liver at a histological level were also investigated. The amount of SMP30 mRNA and protein in livers was decreased in Lepr(db/db) Smp30(Y/+) mice compared with Lepr(db/+) Smp30(Y/+) mice. Compared with Lepr(db/db) Smp30(Y/+) mice, 24 week old Lepr(db/db) Smp30(Y/-) mice showed: i) increased small dense LDL-cho and decreased HDL-cho levels; ii) fatty liver accompanied by numerous inflammatory cells and increased oxidative stress; iii) decreased mRNA expression of genes involved in fatty acid oxidation (PPAR alpha) and lipoprotein uptake (LDLR and VLDLR) but increased CD36 levels; and iv) increased endoplasmic reticulum stress. Conclusion: Our data strongly suggest that SMP30 is closely associated with NAFLD pathogenesis, and might be a possible therapeutic target for NAFLD.	[Kondo, Yoshitaka; Kishimoto, Yuki; Amano, Akiko; Maruyama, Naoki; Ishigami, Akihito] Tokyo Metropolitan Inst Gerontol, Mol Regulat Aging, Tokyo, Japan; [Hasegawa, Goji; Okada, Hiroshi; Senmaru, Takafumi; Fukui, Michiaki; Nakamura, Naoto; Obayashi, Hiroshi] Kyoto Prefectural Univ Med, Dept Endocrinol & Metab, Kyoto, Japan; [Sawada, Morio; Kitawaki, Jo] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Obstet & Gynecol, Kyoto, Japan; [Okanoue, Takeshi] Saiseikai Suita Hosp, Dept Gastroenterol & Hepatol, Osaka, Japan; [Obayashi, Hiroshi] Inst Bioresponse Informat, Kyoto, Japan	Tokyo Metropolitan Institute of Gerontology; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine	Ishigami, A (corresponding author), Tokyo Metropolitan Inst Gerontol, Mol Regulat Aging, Tokyo, Japan.	ishigami@tmig.or.jp	Okada, Hiroshi/AAG-1588-2020; Yoshitaka, Kondo/AFK-7721-2022	Okada, Hiroshi/0000-0002-1707-970X; Yoshitaka, Kondo/0000-0002-0046-9429; Ishigami, Akihito/0000-0001-7875-7482; Amano, Akiko/0000-0003-4324-2758; Fukui, Michiaki/0000-0003-0903-1797	Japan Society for the Promotion of Science [24380073, 23590441, 23790122, 23591317]; Grants-in-Aid for Scientific Research [23790122] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study is supported by the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/e-grants/index.html) KAKENHI Grant Number 24380073 (A. Ishigami), 23590441 (N. Maruyama), 23790122 (Y. Kondo) and 23591317 (G. Hasegawa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiels M, 2005, ARTERIOSCL THROM VAS, V25, P1697, DOI 10.1161/01.ATV.0000172689.53992.25; Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Cali AMG, 2007, DIABETES CARE, V30, P3093, DOI 10.2337/dc07-1088; Charlton M, 2004, CLIN GASTROENTEROL H, V2, P1048, DOI 10.1016/S1542-3565(04)00440-9; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7; Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327; Fukui M, 2011, BIOCHEM BIOPH RES CO, V415, P252, DOI 10.1016/j.bbrc.2011.10.025; Handa S, 2009, BIOL PHARM BULL, V32, P1645, DOI 10.1248/bpb.32.1645; Harrison SA, 2003, AM J GASTROENTEROL, V98, P2485, DOI 10.1111/j.1572-0241.2003.08699.x; Hasegawa G, 2010, ENDOCRINOLOGY, V151, P529, DOI 10.1210/en.2009-1163; Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091; Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5; Ishigami T, 2001, PATHOL INT, V51, P491, DOI 10.1046/j.1440-1827.2001.01238.x; Iwama M, 2011, NUTRITION, V27, P471, DOI 10.1016/j.nut.2010.04.010; Jung KJ, 2004, EXP GERONTOL, V39, P1169, DOI 10.1016/j.exger.2004.04.005; Kim JC, 1997, LAB ANIM, V11, P113; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103; Kondo Y, 2008, BIOCHEM BIOPH RES CO, V377, P291, DOI 10.1016/j.bbrc.2008.09.132; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lv S, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-17; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Ong Janus P, 2007, Clin Liver Dis, V11, P1, DOI 10.1016/j.cld.2007.02.009; Park H, 2010, J GASTROENTEROL, V45, P426, DOI 10.1007/s00535-009-0154-3; Qiu SQ, 1998, J LIPID RES, V39, P1661; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Sato T, 2006, AM J RESP CRIT CARE, V174, P530, DOI 10.1164/rccm.200511-1816OC; Sato Y, 2010, BIOL PHARM BULL, V33, P364, DOI 10.1248/bpb.33.364; Senmaru T, 2013, METABOLISM; Sugino I, 2011, J ATHEROSCLER THROMB, V18, P1, DOI 10.5551/jat.5447; Takahashi Y, 2012, WORLD J GASTROENTERO, V18, P2300, DOI 10.3748/wjg.v18.i19.2300; Toledo FGS, 2006, DIABETES CARE, V29, P1845, DOI 10.2337/dc06-0455; Usui S, 2002, J LIPID RES, V43, P805	34	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65698	10.1371/journal.pone.0065698	http://dx.doi.org/10.1371/journal.pone.0065698			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755269	Green Published, gold, Green Submitted			2022-12-27	WOS:000319872300090
J	Mohring, MB; Kendrick, GA; Wernberg, T; Rule, MJ; Vanderklift, MA				Mohring, Margaret B.; Kendrick, Gary A.; Wernberg, Thomas; Rule, Michael J.; Vanderklift, Mathew A.			Environmental Influences on Kelp Performance across the Reproductive Period: An Ecological Trade-Off between Gametophyte Survival and Growth?	PLOS ONE			English	Article							ECKLONIA-RADIATA LAMINARIALES; MACROCYSTIS-PYRIFERA; UNDARIA-PINNATIFIDA; POPULATION BIOLOGY; SETTLEMENT DENSITY; MAXIMA ALARIACEAE; CLIMATE-CHANGE; LIFE-HISTORY; SEA-URCHINS; J-AGARDH	Most kelps (order Laminariales) exhibit distinct temporal patterns in zoospore production, gametogenesis and gametophyte reproduction. Natural fluctuations in ambient environmental conditions influence the intrinsic characteristics of gametes, which define their ability to tolerate varied conditions. The aim of this work was to document seasonal patterns in reproduction and gametophyte growth and survival of Ecklonia radiata (C. Agardh) J. Agardh in south-western Australia. These results were related to patterns in local environmental conditions in an attempt to ascertain which factors explain variation throughout the season. E. radiata was fertile (produced zoospores) for three and a half months over summer and autumn. Every two weeks during this time, gametophytes were grown in a range of temperatures (16-22 degrees C) in the laboratory. Zoospore densities were highly variable among sample periods; however, zoospores released early in the season produced gametophytes which had greater rates of growth and survival, and these rates declined towards the end of the reproductive season. Growth rates of gametophytes were positively related to day length, with the fastest growing recruits released when the days were longest. Gametophytes consistently survived best in the lowest temperature (16 degrees C), yet exhibited optimum growth in higher culture temperatures (20-22 degrees C). These results suggest that E. radiata releases gametes when conditions are favourable for growth, and E. radiata gametophytes are tolerant of the range of temperatures observed at this location. E. radiata releases the healthiest gametophytes when day length and temperature conditions are optimal for better germination, growth, and sporophyte production, perhaps as a mechanism to help compete against other species for space and other resources.	[Mohring, Margaret B.; Kendrick, Gary A.; Wernberg, Thomas; Rule, Michael J.] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia; [Mohring, Margaret B.; Kendrick, Gary A.; Wernberg, Thomas; Rule, Michael J.] Univ Western Australia, UWA Oceans Inst M096, Crawley, WA, Australia; [Wernberg, Thomas] Univ Western Australia, Australian Inst Marine Sci, Crawley, WA, Australia; [Rule, Michael J.] Dept Environm & Conservat, Kensington, NSW, Australia; [Vanderklift, Mathew A.] CSIRO Wealth Oceans Flagship, Floreat, WA, Australia	University of Western Australia; University of Western Australia; Australian Institute of Marine Science; University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Mohring, MB (corresponding author), Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia.	margie.mohring@gmail.com	Wernberg, Thomas/B-4172-2010; Vanderklift, Mathew A/B-1003-2008; Kendrick, Gary Andrew/B-3460-2011	Wernberg, Thomas/0000-0003-1185-9745; Vanderklift, Mathew A/0000-0002-5170-7546; Kendrick, Gary Andrew/0000-0002-0276-6064; Rule, Michael/0000-0001-7278-8317	University of Western Australia; Australian Geographic Society; Australian Research Council	University of Western Australia; Australian Geographic Society; Australian Research Council(Australian Research Council)	This study was supported by the University of Western Australia (Australian Postgraduate Award to MM), the Australian Geographic Society (Seed Grant to MM) and the Australian Research Council (Future Fellowship to TW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSLER CD, 1989, J EXP MAR BIOL ECOL, V134, P117, DOI 10.1016/0022-0981(90)90104-K; Bidwell JR, 1998, MAR ECOL PROG SER, V163, P259, DOI 10.3354/meps163259; BOLTON JJ, 1982, MAR BIOL, V66, P89, DOI 10.1007/BF00397259; BOLTON JJ, 1985, MAR BIOL, V87, P131, DOI 10.1007/BF00539420; Buchholz C, 1999, J APPL PHYCOL, V11, P579, DOI 10.1023/A:1008116828263; Buschmann AH, 2006, J APPL PHYCOL, V18, P575, DOI 10.1007/s10811-006-9063-5; Choi HG, 2005, J APPL PHYCOL, V17, P423, DOI 10.1007/s10811-005-0432-2; Coelho Susana M., 2000, Journal of Aquatic Ecosystem Stress and Recovery, V7, P317, DOI 10.1023/A:1009916129009; Crawley KR, 2007, MAR BIOL, V151, P1433, DOI 10.1007/s00227-006-0581-0; DIECK IT, 1993, MAR ECOL PROG SER, V100, P253; FLETCHER WJ, 1987, ECOL MONOGR, V57, P89, DOI 10.2307/1942640; Fredersdorf J, 2009, OECOLOGIA, V160, P483, DOI 10.1007/s00442-009-1326-9; Fritsch FE, 1942, ANN BOT-LONDON, V6, P533, DOI 10.1093/oxfordjournals.aob.a088420; Fritsch FE, 1952, STRUCTURE REPROD ALG; Graham MH, 2004, ECOSYSTEMS, V7, P341, DOI 10.1007/s10021-003-0245-6; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; JENNINGS R, 1967, Journal of the Royal Society of Western Australia, V50, P93; JOSKA MAP, 1987, BRIT PHYCOL J, V22, P209, DOI 10.1080/00071618700650251; KENNELLY SJ, 1983, AQUAT BOT, V17, P275, DOI 10.1016/0304-3770(83)90062-1; KIRKMAN H, 1981, J EXP MAR BIOL ECOL, V55, P243, DOI 10.1016/0022-0981(81)90115-5; Ladah LB, 2007, MAR BIOL, V152, P677, DOI 10.1007/s00227-007-0723-z; LARKUM AWD, 1986, J EXP MAR BIOL ECOL, V96, P177, DOI 10.1016/0022-0981(86)90241-8; LEE JA, 1988, J PHYCOL, V24, P181, DOI 10.1111/j.1529-8817.1988.tb04232.x; LUNING K, 1980, J PHYCOL, V16, P1; McConnico LA, 2005, J EXP MAR BIOL ECOL, V324, P61, DOI 10.1016/j.jembe.2005.04.006; Minitab Inc, 2000, MINITAB 13 1; Mohring MB, 2013, MAR BIOL, V160, P119, DOI 10.1007/s00227-012-2068-5; Nelson WA, 2005, J APPL PHYCOL, V17, P23, DOI 10.1007/s10811-005-5521-8; NOVACZEK I, 1984, MAR BIOL, V82, P241, DOI 10.1007/BF00392405; Provasoli L., 1968, CULTURES COLLECTIONS, P63; Rasband W. S., 2009, IMAGEJ 1 42Q; Reed DC, 1996, ECOLOGY, V77, P300, DOI 10.2307/2265679; REED DC, 1987, J EXP MAR BIOL ECOL, V113, P61, DOI 10.1016/0022-0981(87)90082-7; REED DC, 1991, J PHYCOL, V27, P361, DOI 10.1111/j.0022-3646.1991.00361.x; Reed DC, 1997, ECOLOGY, V78, P2443; Reed DC, 1999, MAR BIOL, V133, P737, DOI 10.1007/s002270050515; Russell BD, 2012, BIOL LETTERS, V8, P164, DOI 10.1098/rsbl.2011.0779; Schiel DR, 2006, ANNU REV ECOL EVOL S, V37, P343, DOI 10.1146/annurev.ecolsys.37.091305.110251; SCHIEL DR, 1986, OCEANOGR MAR BIOL, V24, P265; Smale DA, 2010, J EXP MAR BIOL ECOL, V384, P76, DOI 10.1016/j.jembe.2009.11.013; Smale DA, 2009, MAR ECOL PROG SER, V387, P27, DOI 10.3354/meps08132; Smith SDA, 1996, AUST J ECOL, V21, P81, DOI 10.1111/j.1442-9993.1996.tb00587.x; Steen H, 2003, BOT MAR, V46, P36, DOI 10.1515/BOT.2003.006; Steinberg P, 1999, SO SEAS ECOLOGY AUST, P60; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Tala F, 2004, NEW ZEAL J MAR FRESH, V38, P255, DOI 10.1080/00288330.2004.9517235; Thornber CS, 2004, MAR ECOL PROG SER, V268, P69, DOI 10.3354/meps268069; Tuya F, 2008, ESTUAR COAST SHELF S, V78, P774, DOI 10.1016/j.ecss.2008.02.017; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Underwood AJ, 1998, GMAV5 WINDOWS; Vanderklift MA, 2009, MAR ECOL PROG SER, V376, P203, DOI 10.3354/meps07811; Wernberg T, 2006, OECOLOGIA, V147, P692, DOI 10.1007/s00442-005-0318-7; Wernberg T, 2005, AQUAT ECOL, V39, P419, DOI 10.1007/s10452-005-9009-z; Wernberg T, 2003, DIVERS DISTRIB, V9, P427, DOI 10.1046/j.1472-4642.2003.00048.x; Wernberg T, 2011, J EXP MAR BIOL ECOL, V400, P7, DOI 10.1016/j.jembe.2011.02.021	55	28	28	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65310	10.1371/journal.pone.0065310	http://dx.doi.org/10.1371/journal.pone.0065310			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755217	Green Published, gold, Green Submitted			2022-12-27	WOS:000319872300074
J	Pironet, A; Dauby, PC; Paeme, S; Kosta, S; Chase, JG; Desaive, T				Pironet, Antoine; Dauby, Pierre C.; Paeme, Sabine; Kosta, Sarah; Chase, J. Geoffrey; Desaive, Thomas			Simulation of Left Atrial Function Using a Multi-Scale Model of the Cardiovascular System	PLOS ONE			English	Article							PRESSURE-VOLUME RELATIONS; LEFT-VENTRICLE; LOAD-DEPENDENCE; HEART-RATE; IN-VIVO; CONTRACTION; CURVILINEARITY; ELASTANCE; DIAGNOSIS; DYNAMICS	During a full cardiac cycle, the left atrium successively behaves as a reservoir, a conduit and a pump. This complex behavior makes it unrealistic to apply the time-varying elastance theory to characterize the left atrium, first, because this theory has known limitations, and second, because it is still uncertain whether the load independence hypothesis holds. In this study, we aim to bypass this uncertainty by relying on another kind of mathematical model of the cardiac chambers. In the present work, we describe both the left atrium and the left ventricle with a multi-scale model. The multi-scale property of this model comes from the fact that pressure inside a cardiac chamber is derived from a model of the sarcomere behavior. Macroscopic model parameters are identified from reference dog hemodynamic data. The multi-scale model of the cardiovascular system including the left atrium is then simulated to show that the physiological roles of the left atrium are correctly reproduced. This include a biphasic pressure wave and an eight-shaped pressure-volume loop. We also test the validity of our model in non basal conditions by reproducing a preload reduction experiment by inferior vena cava occlusion with the model. We compute the variation of eight indices before and after this experiment and obtain the same variation as experimentally observed for seven out of the eight indices. In summary, the multi-scale mathematical model presented in this work is able to correctly account for the three roles of the left atrium and also exhibits a realistic left atrial pressure-volume loop. Furthermore, the model has been previously presented and validated for the left ventricle. This makes it a proper alternative to the time-varying elastance theory if the focus is set on precisely representing the left atrial and left ventricular behaviors.	[Pironet, Antoine; Dauby, Pierre C.; Paeme, Sabine; Kosta, Sarah; Desaive, Thomas] Univ Liege ULg, GIGA Cardiovasc Sci, Liege, Belgium; [Chase, J. Geoffrey] Univ Canterbury, Dept Mech Engn, Christchurch 1, New Zealand	University of Liege; University of Canterbury	Pironet, A (corresponding author), Univ Liege ULg, GIGA Cardiovasc Sci, Liege, Belgium.	a.pironet@ulg.ac.be	Chase, James G/B-1584-2012; Stefanadis, Christodoulos/ABH-2232-2020	Chase, James G/0000-0001-9989-4849; Stefanadis, Christodoulos/0000-0001-5974-6454	Federation Wallonie-Bruxelles (Actions de Recherches Concertees - Academie Wallonie-Europe); F.R.I.A. (Belgium); FNRS (Belgium)	Federation Wallonie-Bruxelles (Actions de Recherches Concertees - Academie Wallonie-Europe); F.R.I.A. (Belgium)(Fonds de la Recherche Scientifique - FNRS); FNRS (Belgium)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the Federation Wallonie-Bruxelles (Actions de Recherches Concertees - Academie Wallonie-Europe, http://www.federation-wallonie-bruxelles.be), the F.R.I.A. (Belgium, http://www.frs-fnrs.be/) and the FNRS (Belgium, http://www.frs-fnrs.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER J, 1987, CIRC RES, V61, P209, DOI 10.1161/01.RES.61.2.209; BURKHOFF D, 1991, AM J PHYSIOL, V260, pH569, DOI 10.1152/ajpheart.1991.260.2.H569; BURKHOFF D, 1994, J MOL CELL CARDIOL, V26, P959, DOI 10.1006/jmcc.1994.1117; BURKHOFF D, 1993, AM J PHYSIOL, V265, pH1819, DOI 10.1152/ajpheart.1993.265.5.H1819; BURKHOFF D, 1987, AM J PHYSIOL, V252, pH1218, DOI 10.1152/ajpheart.1987.252.6.H1218; CHUNG DC, 1996, THESIS RICE U HOUSTO; COURTOIS M, 1988, CIRCULATION, V78, P661, DOI 10.1161/01.CIR.78.3.661; Dernellis JM, 1998, AM J CARDIOL, V81, P1138, DOI 10.1016/S0002-9149(98)00134-9; Ferasin L, 2010, J SMALL ANIM PRACT, V51, P412, DOI 10.1111/j.1748-5827.2010.00954.x; FINSTERER U, 1973, PFLUG ARCH EUR J PHY, V341, P63, DOI 10.1007/BF00587330; Gare M, 2001, ANESTHESIOLOGY, V95, P689, DOI 10.1097/00000542-200109000-00023; Guyton A.C., 2006, TXB MED PHYSL; HOIT BD, 1994, CIRCULATION, V89, P1829, DOI 10.1161/01.CIR.89.4.1829; KASS DA, 1989, CIRCULATION, V79, P167, DOI 10.1161/01.CIR.79.1.167; Kehl F, 2002, ANESTH ANALG, V94, P1421, DOI 10.1097/00000539-200206000-00008; Klabunde R., 2011, CARDIOVASCULAR PHYSL; Koon KTV, 2009, COMPUT CARDIOL, V36, P393; Korakianitis T, 2006, MED ENG PHYS, V28, P613, DOI 10.1016/j.medengphy.2005.10.004; Lamb Allison P, 2010, J Vet Cardiol, V12, P107, DOI 10.1016/j.jvc.2010.04.001; LAU VK, 1979, ANN BIOMED ENG, V7, P167, DOI 10.1007/BF02363133; Lu K, 2001, AM J PHYSIOL-HEART C, V281, pH2661, DOI 10.1152/ajpheart.2001.281.6.H2661; Luo C, 2008, CARDIOVASC ENG, V8, P174, DOI 10.1007/s10558-008-9054-z; MAUGHAN WL, 1979, CIRC RES, V44, P309, DOI 10.1161/01.RES.44.3.309; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Negroni JA, 1999, J MOL CELL CARDIOL, V31, P1509, DOI 10.1006/jmcc.1999.0984; Negroni JA, 1996, J MOL CELL CARDIOL, V28, P915, DOI 10.1006/jmcc.1996.0086; Nygren A, 1998, CIRC RES, V82, P63; Oh J.K., 2006, ECHO MANUAL; Olansen JB, 2000, COMPUT BIOMED RES, V33, P260, DOI 10.1006/cbmr.2000.1543; Paeme S, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-86; Pagel PS, 2003, ANESTHESIOLOGY, V98, P975, DOI 10.1097/00000542-200304000-00027; Pironet A, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-8; Revie JA, 2011, COMPUTER METHODS PRO; Revie JA, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-33; Rosca M, 2011, HEART, V97, P1982, DOI 10.1136/heartjnl-2011-300069; Saito S, 2006, EUR J CARDIO-THORAC, V30, P584, DOI 10.1016/j.ejcts.2006.07.021; Shim EB, 2006, PHILOS T R SOC A, V364, P1483, DOI 10.1098/rsta.2006.1782; SHROFF SG, 1985, AM J PHYSIOL, V249, pH358, DOI 10.1152/ajpheart.1985.249.2.H358; Smith BW, 2005, CONTROL ENG PRACT, V13, P1183, DOI 10.1016/j.conengprac.2004.10.014; Smith BW, 2004, MED ENG PHYS, V26, P131, DOI 10.1016/j.medengphy.2003.10.001; Starfinger C, 2007, COMPUT METH PROG BIO, V87, P46, DOI 10.1016/j.cmpb.2007.03.010; Starfinger C, 2008, MATH BIOSCI, V216, P132, DOI 10.1016/j.mbs.2008.08.014; Stefanadis C, 2001, EUR HEART J, V22, P22, DOI 10.1053/euhj.1999.2581; Stevenson D, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-73; Stevenson D, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-28; Stpeanek J, 1975, Bull Physiopathol Respir (Nancy), V11, P295; SUGA H, 1973, CIRC RES, V32, P314, DOI 10.1161/01.RES.32.3.314; VAARTJES SR, 1987, CIRC RES, V60, P727, DOI 10.1161/01.RES.60.5.727; van Meurs W., 2011, MODELING SIMULATION; Wong KKL, 2012, COMPUT MED IMAG GRAP, V36, P527, DOI 10.1016/j.compmedimag.2012.04.003; YUE DT, 1987, AM J PHYSIOL, V252, pH760, DOI 10.1152/ajpheart.1987.252.4.H760	51	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65146	10.1371/journal.pone.0065146	http://dx.doi.org/10.1371/journal.pone.0065146			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755183	Green Submitted, Green Published, gold			2022-12-27	WOS:000319872300051
J	Yen, FY; Chong, KMB; Ha, LM				Yen, Fang Yen; Chong, Khoo Michael Boon; Ha, Lee Ming			Synthetic-Type Control Charts for Time-Between-Events Monitoring	PLOS ONE			English	Article							HIGH-YIELD PROCESSES; CUSUM CHARTS; HEALTH-CARE; RUN-LENGTH; DESIGN; INSPECTION; INTERVALS; CCC	This paper proposes three synthetic-type control charts to monitor the mean time-between-events of a homogenous Poisson process. The first proposed chart combines an Erlang (cumulative time between events, T-r) chart and a conforming run length (CRL) chart, denoted as Synth-T-r chart. The second proposed chart combines an exponential (or T) chart and a group conforming run length (GCRL) chart, denoted as GR-T chart. The third proposed chart combines an Erlang chart and a GCRL chart, denoted as GR-T-r chart. By using a Markov chain approach, the zero- and steady-state average number of observations to signal (ANOS) of the proposed charts are obtained, in order to evaluate the performance of the three charts. The optimal design of the proposed charts is shown in this paper. The proposed charts are superior to the existing T chart, T-r chart, and Synth-T chart. As compared to the EWMA-T chart, the GR-T chart performs better in detecting large shifts, in terms of the zero- and steady-state performances. The zero-state Synth-T-4 and GR-T-r (r = 3 or 4) charts outperform the EWMA-T chart for all shifts, whereas the Synth-T-r (r = 2 or 3) and GR-T-2 charts perform better for moderate to large shifts. For the steady-state process, the Synth-T-r and GR-T-r charts are more efficient than the EWMA-T chart in detecting small to moderate shifts.	[Yen, Fang Yen; Chong, Khoo Michael Boon] Univ Sains Malaysia, Sch Math Sci, George Town, Malaysia; [Ha, Lee Ming] Swinburne Univ Technol, Sch Engn Comp & Sci, Kuching, Sarawak, Malaysia	Universiti Sains Malaysia; Swinburne University of Technology; Swinburne University of Technology Sarawak	Yen, FY (corresponding author), Univ Sains Malaysia, Sch Math Sci, George Town, Malaysia.	fangyenyen@hotmail.com	Khoo, Michael B.C./D-9033-2012; Lee, Ming Ha/I-9617-2014	Khoo, Michael B.C./0000-0002-3245-1127; Lee, Ming Ha/0000-0003-2096-5865; Fang, Yen Yen/0000-0003-2510-4116	MyBrain15 (MyPhD) Scholarship Program under the Ministry of Higher Education Malaysia; Fundamental Research Grant Scheme (FRGS) [203/PMATHS/6711232]	MyBrain15 (MyPhD) Scholarship Program under the Ministry of Higher Education Malaysia; Fundamental Research Grant Scheme (FRGS)	This research is supported by the MyBrain15 (MyPhD) Scholarship Program under the Ministry of Higher Education Malaysia and the Fundamental Research Grant Scheme (FRGS), no. 203/PMATHS/6711232. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers W, 2010, J STAT PLAN INFER, V140, P214, DOI 10.1016/j.jspi.2009.07.005; Alemi Farrokh, 2004, Jt Comm J Qual Saf, V30, P95; Borror CM, 2003, INT J PROD RES, V41, P3435, DOI 10.1080/0020754031000138321; BOURKE PD, 1991, J QUAL TECHNOL, V23, P225, DOI 10.1080/00224065.1991.11979328; Bourke PD, 2001, J APPL STAT, V28, P951, DOI 10.1080/02664760120076643; BROOK D, 1972, BIOMETRIKA, V59, P539; CALVIN TW, 1983, IEEE T COMPON HYBR, V6, P323, DOI 10.1109/TCHMT.1983.1136174; Chan LY, 2000, INT J PROD RES, V38, P397, DOI 10.1080/002075400189482; Davis RB, 2002, J QUAL TECHNOL, V34, P200; Dogu E, 2012, INT J QUAL RES, V6, P151; Gadre M. P., 2004, EC QUAL CONTROL, V19, P29, DOI DOI 10.1515/EQC.2004.29; GAN FF, 1994, J QUAL TECHNOL, V26, P109, DOI 10.1080/00224065.1994.11979511; Gan FF, 1998, J QUAL TECHNOL, V30, P55; Ghute VB, 2008, COMMUN STAT-THEOR M, V37, P2136, DOI 10.1080/03610920701824265; Goh T. N., 1987, Quality Assurance, V13, P18; JARRETT RG, 1979, BIOMETRIKA, V66, P191, DOI 10.1093/biomet/66.1.191; Jones LA, 2002, QUAL RELIAB ENG INT, V18, P479, DOI 10.1002/qre.496; Khilare SK, 2012, QUAL RELIAB ENG INT, V28, P193, DOI 10.1002/qre.1233; Khoo MBC, 2013, COMPUT IND ENG, V64, P179, DOI 10.1016/j.cie.2012.08.017; Khoo MBC, 2011, QUAL RELIAB ENG INT, V27, P981, DOI 10.1002/qre.1189; Khoo MBC, 2009, QUAL RELIAB ENG INT, V25, P805, DOI 10.1002/qre.977; Liu J. Y., 2006, QUALITY TECHNOLOGY Q, V3, P347, DOI DOI 10.1080/16843703.2006.11673120; Liu JY, 2006, ADV RELIABILITY MODE, P739; Liu JY, 2004, INT ENG MAN C, P1061; Luo P, 2012, HEALTH PHYS, V102, P637, DOI 10.1097/HP.0b013e3182430106; Montgomery, 2009, STAT QUALITY CONTROL; Ohta H, 2001, QUAL RELIAB ENG INT, V17, P439, DOI 10.1002/qre.428; Ozsan G, 2010, QUAL RELIAB ENG INT, V26, P555, DOI 10.1002/qre.1079; Pehlivan C, 2010, QUAL RELIAB ENG INT, V26, P177, DOI 10.1002/qre.1033; Prasad SR, 2011, INT J COMPUTER APPL, V18, P1; Qu L, 2011, QUAL RELIAB ENG INT, V27, P529, DOI 10.1002/qre.1153; Radaelli G, 1998, TOTAL QUAL MANAGE, V9, P133, DOI 10.1080/0954412989324; REYNOLDS MR, 1990, TECHNOMETRICS, V32, P371, DOI 10.2307/1270114; Scariano S. M., 2003, Quality Engineering, V15, P677, DOI 10.1081/QEN-120018399; Scariano S. M., 2009, SEQUENTIAL ANAL, V28, P54, DOI DOI 10.1080/07474940802619261; Sharma P. R., 2006, SERIES QUALITY RELIA, V9, P43, DOI [10.1142/9789812707147_0003, DOI 10.1142/9789812707147_0003]; Sun J, 2000, TOTAL QUAL MANAGE, V11, P235, DOI 10.1080/0954412006973; Thor J, 2007, QUAL SAF HEALTH CARE, V16, P387, DOI 10.1136/qshc.2006.022194; VARDEMAN S, 1985, TECHNOMETRICS, V27, P145, DOI 10.2307/1268762; Woodall WH, 2006, J QUAL TECHNOL, V38, P89, DOI 10.1080/00224065.2006.11918593; Wu Z, 2000, J QUAL TECHNOL, V32, P32; Wu Z, 2001, J QUAL TECHNOL, V33, P104; Xie M, 2002, RELIAB ENG SYST SAFE, V77, P143, DOI 10.1016/S0951-8320(02)00041-8; Xie M, 1998, QUAL RELIAB ENG INT, V14, P339, DOI 10.1002/(SICI)1099-1638(199809/10)14:5<339::AID-QRE185>3.0.CO;2-S; Xie M., 2002, STAT MODELS CONTROL; Xie M., 1997, INT J QUALITY RELIAB, V14, P64, DOI DOI 10.1108/02656719710156789; XIE W, 1995, QUAL RELIAB ENG INT, V11, P189, DOI 10.1002/qre.4680110309; Xie YJ, 2010, MONITORING TIME BETW, P1; Yeong WC, 2012, QUAL RELIAB ENG INT, V28, P725, DOI 10.1002/qre.1264; Zhang CW, 2007, INT J PROD RES, V45, P5649, DOI 10.1080/00207540701325082; Zhang CW, 2005, INT J PROD RES, V43, P5019, DOI 10.1080/00207540500219387; Zhang HY, 2007, IN C IND ENG ENG MAN, P1408, DOI 10.1109/IEEM.2007.4419424; Zhang HY, 2011, COMPUT IND ENG, V60, P485, DOI 10.1016/j.cie.2010.11.008; Zhang LY, 2009, QUAL RELIAB ENG INT, V25, P933, DOI 10.1002/qre.1012	54	29	29	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65440	10.1371/journal.pone.0065440	http://dx.doi.org/10.1371/journal.pone.0065440			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755231	Green Published, gold, Green Submitted			2022-12-27	WOS:000319872300081
J	Dhanasiri, AKS; Fernandes, JMO; Kiron, V				Dhanasiri, Anusha K. S.; Fernandes, Jorge M. O.; Kiron, Viswanath			Liver Transcriptome Changes in Zebrafish during Acclimation to Transport-Associated Stress	PLOS ONE			English	Article							HIGH STOCKING DENSITY; SOLE SOLEA-SENEGALENSIS; GILTHEAD SEA BREAM; RAINBOW-TROUT; PHYSIOLOGICAL-RESPONSES; GLUTAMINE-SYNTHETASE; OXIDATIVE STRESS; ORNAMENTAL FISH; GENE-EXPRESSION; P38 MAPK	Liver plays a key role during the stress acclimation, and liver transcriptome analysis of shipped zebrafish could reveal the molecular adjustments that occur in the organ. Transcriptional changes in liver were analyzed with a 44 K oligo array using total RNA from fish prior to transport and during a mock transport process - immediately after packing (0 h), at 48 and 72 h. Large numbers of genes related to a variety of biological processes and pathways were regulated, mainly during transport (at 48/72 h). Immediately after packing, transcripts of genes related to both gluconeogenesis and glycolysis were induced. During transport, induction of gluconeogenesis-linked genes and reduction of glycolysis-related genes may be supporting the increase in blood glucose levels. Inhibition of genes involved in fatty acid beta-oxidation may be pointing to the poor ability of fish to utilize energy from fatty acids, under transport conditions. Genes involved in some of the mechanisms that regulate body ammonia were also affected. Even though genes associated with certain transaminases were inhibited in liver, sustained glutamate deamination may have led to high ammonia accumulation in liver/body. Enhanced levels of gene transcripts in ubiquitination and MAPK signalling cascade and reduced levels of gene transcripts related to ROS generation via peroxisomal enzymes as well as xenobiotic metabolism may be signifying the importance of such cellular and tissue responses to maintain homeostasis. Furthermore, transcripts connected with stress and thyroid hormones were also regulated. Moreover, suppression of genes related to specific immune components may be denoting the deleterious impact of transport on fish health. Thus, this study has revealed the complex molecular -adjustments that occur in zebrafish when they are transported.	[Dhanasiri, Anusha K. S.; Fernandes, Jorge M. O.; Kiron, Viswanath] Univ Nordland, Fac Biosci & Aquaculture, Bodo, Norway	Nord University	Kiron, V (corresponding author), Univ Nordland, Fac Biosci & Aquaculture, Bodo, Norway.	kiron.viswanath@uin.no	Fernandes, Jorge MO/A-3526-2013; Fernandes, Jorge/AAC-4632-2022	Fernandes, Jorge MO/0000-0002-2550-1640; Fernandes, Jorge/0000-0002-2550-1640; Viswanath, Kiron/0000-0003-4640-1910	Norwegian Center for International Cooperation in Higher Education (SIU) [NUFUPRO-2007/10102]	Norwegian Center for International Cooperation in Higher Education (SIU)	The project "Developing an entrepreneurial university based on local opportunities and knowledge" (NUFUPRO-2007/10102) was funded by the Norwegian Center for International Cooperation in Higher Education (SIU)(http://siu.no/eng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluru N, 2007, PHYSIOL GENOMICS, V31, P483, DOI 10.1152/physiolgenomics.00118.2007; Alves RN, 2010, AQUACULTURE, V299, P57, DOI 10.1016/j.aquaculture.2009.11.014; BALLANTYNE JS, 2001, NITROGEN EXCRETION, P77; Barton BA, 2002, INTEGR COMP BIOL, V42, P517, DOI 10.1093/icb/42.3.517; Bendhack F, 2009, J APPL ICHTHYOL, V25, P201, DOI 10.1111/j.1439-0426.2008.01208.x; Bernier NJ, 2008, J ENDOCRINOL, V196, P637, DOI 10.1677/JOE-07-0568; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Cairns MT, 2008, COMP BIOCHEM PHYS D, V3, P51, DOI 10.1016/j.cbd.2007.04.009; Calduch-Giner JA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-193; Carneiro PCF, 2001, AQUAC RES, V32, P297, DOI 10.1046/j.1365-2109.2001.00558.x; Ching BY, 2009, AQUAT TOXICOL, V95, P203, DOI 10.1016/j.aquatox.2009.09.004; Cordeiro OD, 2012, MAR BIOTECHNOL, V14, P714, DOI 10.1007/s10126-012-9437-4; Costas B, 2011, AQUACULTURE, V316, P68, DOI 10.1016/j.aquaculture.2011.03.011; Davey GM, 2006, TISSUE ANTIGENS, V67, P1, DOI 10.1111/j.1399-0039.2005.00532.x; Dhanasiri AKS, 2011, J APPL MICROBIOL, V111, P278, DOI 10.1111/j.1365-2672.2011.05050.x; Dhanasiri AKS, 2013, ZEBRAFISH, V10, P87, DOI 10.1089/zeb.2012.0843; Dhanasiri AKS, 2012, COMP BIOCHEM PHYS B, V163, P274, DOI 10.1016/j.cbpb.2012.06.003; Draper N, 2005, J ENDOCRINOL, V186, P251, DOI 10.1677/joe.1.06019; Drew RE, 2008, PHYSIOL GENOMICS, V35, P283, DOI 10.1152/physiolgenomics.90213.2008; Encinas P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-518; Carneiro PCF, 2009, NEOTROP ICHTHYOL, V7, P283, DOI 10.1590/S1679-62252009000200021; Feidantsis K, 2012, J EXP ZOOL PART A, V317A, P303, DOI 10.1002/jez.1725; Fernandes JMO, 2008, COMP BIOCHEM PHYS B, V150, P23, DOI 10.1016/j.cbpb.2008.01.003; Fernandes JMO, 2007, GENE, V391, P178, DOI 10.1016/j.gene.2006.12.015; Fernandes JMO, 2006, COMP BIOCHEM PHYS D, V1, P35, DOI 10.1016/j.cbd.2005.09.003; Fuzzen MLM, 2010, ZEBRAFISH, V7, P349, DOI 10.1089/zeb.2010.0662; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goncalves AF, 2012, DEV COMP IMMUNOL, V36, P279, DOI 10.1016/j.dci.2011.04.008; Hegazi MM, 2010, AQUAT TOXICOL, V99, P118, DOI 10.1016/j.aquatox.2010.04.007; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hur JW, 2007, ICHTHYOL RES, V54, P32, DOI 10.1007/s10228-006-0370-2; Ings JS, 2012, COMP BIOCHEM PHYS C, V156, P67, DOI 10.1016/j.cbpc.2012.04.002; Ip Y.K., 2001, Fish Physiology, V20, P109; Ip YK, 2004, PHYSIOL BIOCHEM ZOOL, V77, P390, DOI 10.1086/383510; Ip YK, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00134; Iversen M, 1998, AQUACULTURE, V168, P387, DOI 10.1016/S0044-8486(98)00364-0; JENEY Z, 1992, AQUACULTURE, V104, P139, DOI 10.1016/0044-8486(92)90144-A; Jin HJ, 2008, MOL IMMUNOL, V45, P1258, DOI 10.1016/j.molimm.2007.09.015; Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102; Kiron V, 2011, CONDITIONS ENTREPREN, P315; Krishna M, 2008, CELL MOL LIFE SCI, V65, P3525, DOI 10.1007/s00018-008-8170-7; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lee PJ, 2003, FREE RADICAL BIO MED, V35, P341, DOI 10.1016/S0891-5849(03)00279-X; Lim LC, 2003, AQUAC RES, V34, P923, DOI 10.1046/j.1365-2109.2003.00946.x; LONG Y, 2012, PLOS ONE, V7; Lushchak VI, 2005, INT J BIOCHEM CELL B, V37, P1670, DOI 10.1016/j.biocel.2005.02.024; Lushchak VI, 2011, AQUAT TOXICOL, V101, P13, DOI 10.1016/j.aquatox.2010.10.006; Lygren B, 2000, AQUAC RES, V31, P401, DOI 10.1046/j.1365-2109.2000.00459.x; Marshall WS, 2005, J EXP BIOL, V208, P1063, DOI 10.1242/jeb.01491; Martin SA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-418; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; Momoda TS, 2007, COMP BIOCHEM PHYS D, V2, P303, DOI 10.1016/j.cbd.2007.06.002; Montero D, 1999, FISH PHYSIOL BIOCHEM, V20, P53, DOI 10.1023/A:1007719928905; Morse D, 2002, AM J RESP CELL MOL, V27, P8, DOI 10.1165/ajrcmb.27.1.4862; Obata T, 2000, CRIT CARE MED, V28, pN67, DOI 10.1097/00003246-200004001-00008; *ORN AQ TRAD ASS, 2008, WAT QUAL CRIT; Orozco A, 2005, THYROID, V15, P799, DOI 10.1089/thy.2005.15.799; Paterson BD, 2003, AQUACULTURE, V218, P717, DOI 10.1016/S0044-8486(02)00564-1; Peng XJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-26; Person-Le Ruyet J, 2002, AQUACULTURE, V205, P373, DOI 10.1016/S0044-8486(01)00689-5; Peter MCS, 2011, GEN COMP ENDOCR, V172, P198, DOI 10.1016/j.ygcen.2011.02.023; Peterson BC, 2004, DOMEST ANIM ENDOCRIN, V26, P231, DOI 10.1016/j.domaniend.2003.10.005; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; Puntarulo S, 1998, FREE RADICAL BIO MED, V24, P1324, DOI 10.1016/S0891-5849(97)00463-2; Rendic S, 2002, DRUG METAB REV, V34, P83, DOI 10.1081/DMR-120001392; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Salem M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-328; Sanderson LA, 2010, J EXP BIOL, V213, P2343, DOI 10.1242/jeb.039156; Sangiao-Alvarellos S, 2005, J EXP ZOOL PART A, V303A, P761, DOI 10.1002/jez.a.203; Schrader M, 2004, HISTOCHEM CELL BIOL, V122, P383, DOI 10.1007/s00418-004-0673-1; Urbinati EC, 2004, AQUACULTURE, V229, P389, DOI 10.1016/S0044-8486(03)00350-8; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VIJAYAN MM, 1990, AQUACULTURE, V88, P371, DOI 10.1016/0044-8486(90)90162-G; Walpita CN, 2007, GEN COMP ENDOCR, V150, P18, DOI 10.1016/j.ygcen.2006.07.002; Walsh Patrick J., 2001, Fish Physiology, V20, P1; Wicks BJ, 2002, AQUAT TOXICOL, V59, P71, DOI 10.1016/S0166-445X(01)00237-5; Wilkinson KD, 1999, J NUTR, V129, P1933, DOI 10.1093/jn/129.11.1933; Wiseman S, 2007, COMP BIOCHEM PHYS D, V2, P234, DOI 10.1016/j.cbd.2007.04.005; Wohr AC, 2005, BERL MUNCH TIERARZTL, V118, P177; Wright PA, 2007, J EXP BIOL, V210, P2905, DOI 10.1242/jeb.003905; Yang SH, 2013, GENE, V513, P1, DOI 10.1016/j.gene.2012.10.033; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	83	22	25	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65028	10.1371/journal.pone.0065028	http://dx.doi.org/10.1371/journal.pone.0065028			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762281	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000320440500019
J	Lacharite, M; Metaxas, A				Lacharite, Myriam; Metaxas, Anna			Early Life History of Deep-Water Gorgonian Corals May Limit Their Abundance	PLOS ONE			English	Article							PRIMNOA-RESEDAEFORMIS; NORTHEAST CHANNEL; CONTINENTAL-SLOPE; SEA CORALS; GENE FLOW; RECRUITMENT; HABITAT; GROWTH; ECOLOGY; REPRODUCTION	Deep-water gorgonian corals are long-lived organisms found worldwide off continental margins and seamounts, usually occurring at depths of similar to 200-1,000 m. Most corals undergo sexual reproduction by releasing a planktonic larval stage that disperses; however, recruitment rates and the environmental and biological factors influencing recruitment in deep-sea species are poorly known. Here, we present results from a 4-year field experiment conducted in the Gulf of Maine (northwest Atlantic) at depths >650 m that document recruitment for 2 species of deep-water gorgonian corals, Primnoa resedaeformis and Paragorgia arborea. The abundance of P. resedaeformis recruits was high, and influenced by the structural complexity of the recipient habitat, but very few recruits of P. arborea were found. We suggest that divergent reproductive modes (P. resedaeformis as a broadcast spawner and P. arborea as a brooder) may explain this pattern. Despite the high recruitment of P. resedaeformis, severe mortality early on in the benthic stage of this species may limit the abundance of adult colonies. Most recruits of this species (similar to 80%) were at the primary polyp stage, and less than 1% of recruits were at stage of 4 polyps or more. We propose that biological disturbance, possibly by the presence of suspension-feeding brittle stars, and limited food supply in the deep sea may cause this mortality. Our findings reinforce the vulnerability of these corals to anthropogenic disturbances, such as trawling with mobile gear, and the importance of incorporating knowledge on processes during the early life history stages in conservation decisions.	[Lacharite, Myriam; Metaxas, Anna] Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada	Dalhousie University	Lacharite, M (corresponding author), Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada.	myriam.lacharite@dal.ca			National Science and Engineering Research Council (NSERC) [222932-06, 372526-09]; Canadian Healthy Oceans Network [340843-06]; Canada Graduate Scholarship (NSERC); Dalhousie University	National Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Healthy Oceans Network; Canada Graduate Scholarship (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Dalhousie University	This study was funded by the National Science and Engineering Research Council (NSERC) through a Discovery Grant - ship time to AM (222932-06,372526-09) and the Canadian Healthy Oceans Network (340843-06). ML is the recipient of a Canada Graduate Scholarship (NSERC) and a fellowship from Dalhousie University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews AH, 2002, HYDROBIOLOGIA, V471, P101, DOI 10.1023/A:1016501320206; Auster PJ, 2005, ERLANGEN EARTH C SER, P747, DOI 10.1007/3-540-27673-4_39; Ayre DJ, 2000, EVOLUTION, V54, P1590; Breeze H, 1997, DISTRIBUTION STATUS; Bryan TL, 2006, DEEP-SEA RES PT I, V53, P1865, DOI 10.1016/j.dsr.2006.09.006; Buhl-Mortensen L, 2005, ERLANGEN EARTH C SER, P849, DOI 10.1007/3-540-27673-4_44; Buhl-Mortensen L, 2004, J NAT HIST, V38, P1233, DOI 10.1080/0022293031000155205; Canals M, 2006, NATURE, V444, P354, DOI 10.1038/nature05271; Cordes EE, 2001, MAR BIOL, V138, P491, DOI 10.1007/s002270000470; Du Preez C, 2011, MAR ECOL PROG SER, V425, P217, DOI 10.3354/meps09005; Edinger EN, 2011, CONT SHELF RES, V31, pS69, DOI 10.1016/j.csr.2010.07.004; ESSIM Planning Office, 2006, 200601 ESSIM PLANN O; Etnoyer P, 2005, ERLANGEN EARTH C SER, P331, DOI 10.1007/3-540-27673-4_16; Gass SE, 2005, ERLANGEN EARTH C SER, P223, DOI 10.1007/3-540-27673-4_11; Gass SE, 2006, MAR POLLUT BULL, V52, P549, DOI 10.1016/j.marpolbul.2005.10.002; GENIN A, 1986, NATURE, V322, P59, DOI 10.1038/322059a0; GRASSLE JF, 1977, NATURE, V265, P618, DOI 10.1038/265618a0; GRIGG RW, 1988, MAR ECOL PROG SER, V45, P121, DOI 10.3354/meps045121; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Heifetz J, 2009, MAR ECOL PROG SER, V397, P295, DOI 10.3354/meps08304; Hughes TP, 2000, ECOLOGY, V81, P2241, DOI 10.1890/0012-9658(2000)081[2241:SSEWBW]2.0.CO;2; Hunt HL, 1997, MAR ECOL PROG SER, V155, P269, DOI 10.3354/meps155269; Huvenne VAI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028755; Kahng SE, 2011, MAR ECOL PROG SER, V443, P265, DOI 10.3354/meps09414; Kelly N, 2007, AQUAT BIOL, V1, P1, DOI 10.3354/ab00001; Kovalenko KE, 2012, HYDROBIOLOGIA, V685, P1, DOI 10.1007/s10750-011-0974-z; Krieger KJ, 2001, P 1 INT S DEEP SEA C, P106; Levin LA, 2012, ANNU REV MAR SCI, V4, P79, DOI 10.1146/annurev-marine-120709-142714; Mercier A, 2011, CORAL REEFS, V30, P337, DOI 10.1007/s00338-011-0724-8; Metaxas A, 2004, DEEP-SEA RES PT I, V51, P1307, DOI 10.1016/j.dsr.2004.06.001; Mortensen P, 2005, MAR BIOL, V147, P775, DOI 10.1007/s00227-005-1604-y; Mortensen PB, 2004, MAR BIOL, V144, P1223, DOI 10.1007/s00227-003-1280-8; Mullineaux LS, 1998, DEEP-SEA RES PT II, V45, P441, DOI 10.1016/S0967-0645(97)00045-3; Murillo FJ, 2011, ICES J MAR SCI, V68, P319, DOI 10.1093/icesjms/fsq071; Nishikawa A, 2003, MAR ECOL PROG SER, V256, P87, DOI 10.3354/meps256087; Orejas C, 2002, MAR ECOL PROG SER, V231, P101, DOI 10.3354/meps231101; Orejas C, 2007, MAR BIOL, V150, P551, DOI 10.1007/s00227-006-0370-9; RAMP SR, 1985, J PHYS OCEANOGR, V15, P1790, DOI 10.1175/1520-0485(1985)015<1790:TDFTTN>2.0.CO;2; Richmond RH, 1997, LIFE DEATH CORAL REE, P1; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Rowden AA, 2010, MAR ECOL-EVOL PERSP, V31, P95, DOI 10.1111/j.1439-0485.2010.00369.x; SANDERS HL, 1979, SARSIA, V64, P1; Sherwood OA, 2008, DEEP-SEA RES PT I, V55, P1392, DOI 10.1016/j.dsr.2008.05.013; Smith CR, 2003, OCEANOGR MAR BIOL, V41, P311; Smith KL, 2009, P NATL ACAD SCI USA, V106, P19211, DOI 10.1073/pnas.0908322106; SNELGROVE PVR, 1994, J MAR RES, V52, P345, DOI 10.1357/0022240943077082; Sun Z, 2010, MAR BIOL, V157, P863, DOI 10.1007/s00227-009-1369-9; Thresher RE, 2011, CORAL REEFS, V30, P1063, DOI 10.1007/s00338-011-0806-7; Tong RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043534; Vermeij MJA, 2008, ECOLOGY, V89, P1994, DOI 10.1890/07-1296.1; Waller RG, 2005, ERLANGEN EARTH C SER, P691, DOI 10.1007/3-540-27673-4_35; Wareham VE, 2007, CONSERVATION AND ADAPTIVE MANAGEMENT OF SEAMOUNT AND DEEP-SEA CORAL ECOSYSTEMS, P289; Watanabe S, 2009, DEEP-SEA RES PT I, V56, P2235, DOI 10.1016/j.dsr.2009.09.003; Watling L, 1998, CONSERV BIOL, V12, P1180, DOI 10.1046/j.1523-1739.1998.0120061180.x; Young CM, 2003, ECOSY WORLD, V28, P381	55	36	38	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65394	10.1371/journal.pone.0065394	http://dx.doi.org/10.1371/journal.pone.0065394			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762358	Green Published, gold, Green Submitted			2022-12-27	WOS:000320440500035
J	Newman, S; Howarth, KD; Greenman, CD; Bignell, GR; Tavare, S; Edwards, PAW				Newman, Scott; Howarth, Karen D.; Greenman, Chris D.; Bignell, Graham R.; Tavare, Simon; Edwards, Paul A. W.			The Relative Timing of Mutations in a Breast Cancer Genome	PLOS ONE			English	Article							CELL-LINES; GERMLINE MUTATIONS; HETEROZYGOSITY; TRANSLOCATIONS; REARRANGEMENT; INSTABILITY; EVOLUTION; FUSION; BAP1; LANDSCAPES	Many tumors have highly rearranged genomes, but a major unknown is the relative importance and timing of genome rearrangements compared to sequence-level mutation. Chromosome instability might arise early, be a late event contributing little to cancer development, or happen as a single catastrophic event. Another unknown is which of the point mutations and rearrangements are selected. To address these questions we show, using the breast cancer cell line HCC1187 as a model, that we can reconstruct the likely history of a breast cancer genome. We assembled probably the most complete map to date of a cancer genome, by combining molecular cytogenetic analysis with sequence data. In particular, we assigned most sequence-level mutations to individual chromosomes by sequencing of flow sorted chromosomes. The parent of origin of each chromosome was assigned from SNP arrays. We were then able to classify most of the mutations as earlier or later according to whether they occurred before or after a landmark event in the evolution of the genome, endoreduplication (duplication of its entire genome). Genome rearrangements and sequence-level mutations were fairly evenly divided earlier and later, suggesting that genetic instability was relatively constant throughout the life of this tumor, and chromosome instability was not a late event. Mutations that caused chromosome instability would be in the earlier set. Strikingly, the great majority of inactivating mutations and in-frame gene fusions happened earlier. The non-random timing of some of the mutations may be evidence that they were selected.	[Newman, Scott; Howarth, Karen D.; Edwards, Paul A. W.] Univ Cambridge, Hutchison MRC Res Ctr, Cambridge, England; [Newman, Scott; Howarth, Karen D.; Edwards, Paul A. W.] Univ Cambridge, Dept Pathol, Cambridge, England; [Greenman, Chris D.; Bignell, Graham R.] Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge, England; [Tavare, Simon] Univ Cambridge, CRUK Cambridge Inst, Li Ka Shing Ctr, Cambridge, England	University of Cambridge; University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; CRUK Cambridge Institute; University of Cambridge	Edwards, PAW (corresponding author), Univ Cambridge, Hutchison MRC Res Ctr, Cambridge, England.	pawe1@cam.ac.uk	Edwards, Paul A/M-8291-2014	Edwards, Paul A/0000-0002-4789-3374	MRC; Cancer Research UK [C14303/A10825]; Breast Cancer Campaign; Wellcome Trust [077012/Z/05/Z]; BBSRC [BBS/E/T/000PR6193] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193] Funding Source: researchfish; Cancer Research UK [14545, 19556] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Breast Cancer Campaign; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)	SN was supported by an MRC studentship and the work was principally funded by Cancer Research UK and Breast Cancer Campaign. CDG and GB were supported by Wellcome Trust grant No.077012/Z/05/Z. ST was supported by Cancer Research UK grant C14303/A10825. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Davidson JM, 2000, BRIT J CANCER, V83, P1309, DOI 10.1054/bjoc.2000.1458; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Durinck S, 2011, CANCER DISCOV, V1, P137, DOI 10.1158/2159-8290.CD-11-0028; DUTRILLAUX B, 1991, BREAST CANCER RES TR, V19, P245, DOI 10.1007/BF01961161; Edwards PAW, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3122; Edwards PAW, 2010, J PATHOL, V220, P244, DOI 10.1002/path.2632; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Gazdar AF, 1998, INT J CANCER, V78, P766, DOI 10.1002/(SICI)1097-0215(19981209)78:6<766::AID-IJC15>3.0.CO;2-L; Greenman CD, 2012, GENOME RES, V22, P346, DOI 10.1101/gr.118414.110; Greenman CD, 2010, BIOSTATISTICS, V11, P164, DOI 10.1093/biostatistics/kxp045; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Ha G, 2012, GENOME RES, V22, P1995, DOI 10.1101/gr.137570.112; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Howarth KD, 2008, ONCOGENE, V27, P3345, DOI 10.1038/sj.onc.1210993; Howarth KD, 2011, GENOME RES, V21, P525, DOI 10.1101/gr.114116.110; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Johansson B, 1996, GENE CHROMOSOME CANC, V16, P155, DOI 10.1002/(SICI)1098-2264(199607)16:3<155::AID-GCC1>3.0.CO;2-Y; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Liu XJ, 2010, CANCER GENET CYTOGEN, V197, P152, DOI 10.1016/j.cancergencyto.2009.11.005; MULERIS M, 1988, CANCER GENET CYTOGEN, V32, P43, DOI 10.1016/0165-4608(88)90310-X; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Nishikawa H, 2009, CANCER RES, V69, P111, DOI 10.1158/0008-5472.CAN-08-3355; Nowak MA, 2002, P NATL ACAD SCI USA, V99, P16226, DOI 10.1073/pnas.202617399; Ogiwara H, 2008, ONCOGENE, V27, P4788, DOI 10.1038/onc.2008.113; Osborne J, 2005, INT J CANCER, V116, P646, DOI 10.1002/ijc.21036; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Robinson DR, 2011, NAT MED, V17, P1646, DOI 10.1038/nm.2580; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Sieber OM, 2003, NAT REV CANCER, V3, P701, DOI 10.1038/nrc1170; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Thiagalingam S, 2001, P NATL ACAD SCI USA, V98, P2698, DOI 10.1073/pnas.051625398; TINGLEY M, 1993, AM STAT, V47, P20, DOI 10.2307/2684776; Wiesner T, 2011, NAT GENET, V43, P1018, DOI 10.1038/ng.910; Wistuba II, 1998, CLIN CANCER RES, V4, P2931; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Woods NT, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002255	45	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e64991	10.1371/journal.pone.0064991	http://dx.doi.org/10.1371/journal.pone.0064991			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762276	Green Submitted, Green Published, gold			2022-12-27	WOS:000320440500017
J	Song, DQ; Li, YM; Cao, JT; Han, ZH; Gao, L; Xu, ZJ; Yin, ZF; Wang, GF; Fan, YQ; Wang, CQ				Song, Dongqiang; Li, Yuanmin; Cao, Jiatian; Han, Zhihua; Gao, Lin; Xu, Zuojun; Yin, Zhaofang; Wang, Guifang; Fan, Yuqi; Wang, Changqian			Effect of Iron Deficiency on c-kit(+) Cardiac Stem Cells In Vitro	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; REGENERATE INFARCTED MYOCARDIUM; MECHANISMS; EXPRESSION; CHELATION; ANEMIA; GROWTH; DIFFERENTIATION; DESFERRIOXAMINE; PROLIFERATION	Aim: Iron deficiency is a common comorbidity in chronic heart failure (CHF) which may exacerbate CHF. The c-kit(+) cardiac stem cells (CSCs) play a vital role in cardiac function repair. However, much is unknown regarding the role of iron deficiency in regulating c-kit(+) CSCs function. In this study, we investigated whether iron deficiency regulates c-kit(+) CSCs proliferation, migration, apoptosis, and differentiation in vitro. Method: All c-kit(+) CSCs were isolated from adult C57BL/6 mice. The c-kit(+) CSCs were cultured with deferoxamine (DFO, an iron chelator), mimosine (MIM, another iron chelator), or a complex of DFO and iron (Fe(III)), respectively. Cell migration was assayed using a 48-well chamber system. Proliferation, cell cycle, and apoptosis of c-kit(+) CSCs were analyzed with BrdU labeling, population doubling time assay, CCK-8 assay, and flow cytometry. Caspase-3 protein level and activity were examined with Western blotting and spectrophotometric detection. The changes in the expression of cardiac-specific proteins (GATA-4, TNI, and beta-MHC) and cell cycle-related proteins (cyclin D1, RB, and pRB) were detected with Western blotting. Result: DFO and MIM suppressed c-kit(+) CSCs proliferation and differentiation. They also modulated cell cycle and cardiac-specific protein expression. Iron chelators down-regulated the expression and phosphorylation of cell cycle-related proteins. Iron reversed those suppressive effects of DFO. DFO and MIM didn't affect c-kit(+) CSCs migration and apoptosis. Conclusion: Iron deficiency suppressed proliferation and differentiation of c-kit(+) CSCs. This may partly explain how iron deficiency affects CHF prognosis.	[Song, Dongqiang; Li, Yuanmin; Cao, Jiatian; Han, Zhihua; Gao, Lin; Xu, Zuojun; Yin, Zhaofang; Fan, Yuqi; Wang, Changqian] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Cardiol, Shanghai 200030, Peoples R China; [Wang, Guifang] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Shanghai Key Lab Stomatol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Fan, YQ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Cardiol, Shanghai 200030, Peoples R China.	moricizine@gmail.com; changqianwang@hotmail.com			Chinese National Natural Science Foundation [81270376, 31201010, 30971436]; Shanghai Jiaotong University Interdisciplinary Cooperation Grant [YG2011MS50, YG2012MS24]; Shanghai Jiaotong University School of Medicine Science Foundation [11XJ21025]; Shanghai Committee of Science and Technology of China [10JC1408900, 12401905200]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Jiaotong University Interdisciplinary Cooperation Grant; Shanghai Jiaotong University School of Medicine Science Foundation; Shanghai Committee of Science and Technology of China	This work was supported by the Chinese National Natural Science Foundation Grants 81270376, 31201010 and 30971436, the Shanghai Jiaotong University Interdisciplinary Cooperation Grant YG2011MS50 and YG2012MS24, the Shanghai Jiaotong University School of Medicine Science Foundation Grant 11XJ21025, and the Shanghai Committee of Science and Technology of China Grant 10JC1408900 and 12401905200. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Chamuleau SAF, 2009, NETH HEART J, V17, P199, DOI 10.1007/BF03086247; Coma S, 2011, CELL ADHES MIGR, V5, P266, DOI 10.4161/cam.5.3.16294; Dawn B, 2005, P NATL ACAD SCI USA, V102, P3766, DOI 10.1073/pnas.0405957102; Dayani PN, 2004, J NEURO-ONCOL, V67, P367, DOI 10.1023/B:NEON.0000024238.21349.37; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Gao J, 2001, BLOOD, V98, P842, DOI 10.1182/blood.V98.3.842; Ge Y, 2011, TRENDS CARDIOVAS MED, V21, P105, DOI 10.1016/j.tcm.2012.03.007; Gharagozloo M, 2008, EUR J PHARMACOL, V589, P1, DOI 10.1016/j.ejphar.2008.03.059; Guo JL, 2009, INT J EXP PATHOL, V90, P355, DOI 10.1111/j.1365-2613.2009.00659.x; Gutzwiller FS, 2012, EUR J HEART FAIL, V14, P782, DOI 10.1093/eurjhf/hfs083; Jankowska EA, 2010, EUR HEART J, V31, P1872, DOI 10.1093/eurheartj/ehq158; Jia Peng, 2012, Zhonghua Yi Xue Za Zhi, V92, P2214; Kajstura J, 2010, CIRC RES, V107, P1374, DOI 10.1161/CIRCRESAHA.110.231498; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lee S, 2012, J NEUROSCI RES, V90, P540, DOI 10.1002/jnr.22779; Li LX, 2009, ARTERIOSCL THROM VAS, V29, P732, DOI 10.1161/ATVBAHA.108.183210; Li M, 2008, CIRC RES, V102, P677, DOI 10.1161/CIRCRESAHA.107.161737; Li ZJ, 2009, J AM COLL CARDIOL, V53, P1229, DOI 10.1016/j.jacc.2008.12.036; Linke A, 2005, P NATL ACAD SCI USA, V102, P8966, DOI 10.1073/pnas.0502678102; Naito Y, 2009, AM J PHYSIOL-HEART C, V296, pH585, DOI 10.1152/ajpheart.00463.2008; Nanas JN, 2006, J AM COLL CARDIOL, V48, P2485, DOI 10.1016/j.jacc.2006.08.034; Nurtjahja-Tjendraputra E, 2007, BLOOD, V109, P4045, DOI 10.1182/blood-2006-10-047753; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Pahl PMB, 2000, J BIOL CHEM, V275, P17821, DOI 10.1074/jbc.M909918199; Pan YJ, 2004, BBA-MOL CELL RES, V1691, P41, DOI 10.1016/j.bbamcr.2003.12.003; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; Saletta F, 2011, J BIOL CHEM, V286, P35396, DOI 10.1074/jbc.M111.273060; Silverberg D, 2011, HYPERTENSION, V57, P381, DOI 10.1161/HYPERTENSIONAHA.110.166868; Tang JM, 2009, EXP CELL RES, V315, P3521, DOI 10.1016/j.yexcr.2009.09.026; Terrovitis JV, 2012, J AM COLL CARDIOL, V60, P2255, DOI 10.1016/j.jacc.2012.05.065; Urbanek K, 2006, P NATL ACAD SCI USA, V103, P9226, DOI 10.1073/pnas.0600635103; van Veldhuisen DJ, 2011, NAT REV CARDIOL, V8, P485, DOI 10.1038/nrcardio.2011.77; Zeng HL, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-32	35	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65721	10.1371/journal.pone.0065721	http://dx.doi.org/10.1371/journal.pone.0065721			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762416	Green Published, Green Submitted, gold			2022-12-27	WOS:000320440500048
J	Chen, L; Ge, Q; Black, JL; Deng, LH; Burgess, JK; Oliver, BGG				Chen, Ling; Ge, Qi; Black, Judith L.; Deng, Linhong; Burgess, Janette K.; Oliver, Brian G. G.			Differential Regulation of Extracellular Matrix and Soluble Fibulin-1 Levels by TGF-beta(1) in Airway Smooth Muscle Cells	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; GROWTH-FACTOR-BETA; EXPRESSION; PROLIFERATION; PROTEINS; LOCALIZATION; MECHANISMS; DEPOSITION; FIBROSIS; ASTHMA	Fibulin-1 (FBLN-1) is a secreted glycoprotein that is associated with extracellular matrix (ECM) formation and rebuilding. Abnormal and exaggerated deposition of ECM proteins is a hallmark of many fibrotic diseases, such as chronic obstructive pulmonary disease (COPD) where small airway fibrosis occurs. The aim of this study was to investigate the regulation of FBLN-1 by transforming growth factor beta 1 (TGF-beta(1)) (a pro-fibrotic stimulus) in primary human airway smooth muscle (ASM) cells from volunteers with and without COPD. Human ASM cells were seeded at a density of 1 x 10(4) cells/cm(2), and stimulated with or without TGF-beta(1) (10 ng/ml) for 72 hours before FBLN-1 deposition and soluble FBLN-1 were measured. Fold change in FBLN-1 mRNA was measured at 4, 8, 24, 48, 72 hours. In some experiments, cycloheximide (0.5 mu g/ml) was used to assess the regulation of FBLN-1 production. TGF-beta(1) decreased the amount of soluble FBLN-1 both from COPD and non-COPD ASM cells. In contrast, the deposition of FBLN-1 into the ECM was increased in ASM cells obtained from both groups. TGF-beta(1) did not increase FBLN-1 gene expression at any of the time points. There were no differences in the TGF-beta(1) induced FBLN-1 levels between cells from people with or without COPD. Cycloheximide treatment, which inhibits protein synthesis, decreased both the constitutive release of soluble FBLN-1, and TGF-beta(1) induced ECM FBLN-1 deposition. Furthermore, in cycloheximide treated cells addition of soluble FBLN-1 resulted in incorporation of FBLN-1 into the ECM. Therefore the increased deposition of FBLN-1 by ASM cells into the ECM following treatment with TGF-beta(1) is likely due to incorporation of soluble FBLN-1 rather than de-novo synthesis.	[Chen, Ling; Deng, Linhong] Chongqing Univ, Bioengn Coll, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing, Peoples R China; [Chen, Ling; Ge, Qi; Black, Judith L.; Burgess, Janette K.; Oliver, Brian G. G.] Woolcock Inst Med Res, Sydney, NSW, Australia; [Ge, Qi; Black, Judith L.; Burgess, Janette K.; Oliver, Brian G. G.] Univ Sydney, Discipline Pharmacol, Sydney, NSW 2006, Australia; [Deng, Linhong] Changzhou Univ, Inst Biomed Engn & Hlth Sci, Changzhou, Jiangsu, Peoples R China	Chongqing University; University of Sydney; Woolcock Institute of Medical Research; University of Sydney; Changzhou University	Deng, LH (corresponding author), Chongqing Univ, Bioengn Coll, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing, Peoples R China.	dlh@cczu.edu.cn	Burgess, Janette K/A-3597-2010; Ge, Qi/D-3988-2013; Oliver, Brian/E-7939-2010; Black, Judith L/C-6559-2008; Deng, Linhong/O-3218-2019; Deng, Linhong/C-1485-2009; Burgess, Janette/M-7117-2019	Oliver, Brian/0000-0002-7122-9262; Deng, Linhong/0000-0003-1970-8239; Burgess, Janette/0000-0001-9868-9966	National Health and Medical Research Council (NHMRC), Australia [570867]; Chinese State Scholarship Fund [2011605038]; NHMRC [571098, 1032695, 1026880]	National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); Chinese State Scholarship Fund; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council (NHMRC) Project grant number 570867, Australia (http://www.nhmrc.gov.au/). L. Chen is supported by a Chinese State Scholarship Fund number 2011605038, China (http://www.csc.edu.cn). J. L. Black is supported by a NHMRC senior Principal Research Fellowship number 571098. J. K. Burgess is supported by a NHMRC Career Development Fellowship number 1032695. B. Oliver is supported by a NHMRC Career Development Fellowship number 1026880. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annoni R, 2012, EUR RESP J; Argraves WS, 2003, EMBO REP, V4, P1127, DOI 10.1038/sj.embor.7400033; Carlin S, 1999, AM J PHYSIOL-LUNG C, V276, pL506, DOI 10.1152/ajplung.1999.276.3.L506; de Boer WI, 1998, AM J RESP CRIT CARE, V158, P1951, DOI 10.1164/ajrccm.158.6.9803053; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2013, GLOB STRAT DIAGN MAN; GODYNA S, 1995, MATRIX BIOL, V14, P467, DOI 10.1016/0945-053X(95)90004-7; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Ichimaru Y, 2012, AM J PHYSIOL-LUNG C, V302, pL325, DOI 10.1152/ajplung.00453.2010; Johnson PRA, 2000, AM J RESP CRIT CARE, V162, P2145, DOI 10.1164/ajrccm.162.6.9909111; Johnson PRA, 2006, AM J RESP CRIT CARE, V173, P32, DOI 10.1164/rccm.200406-703OC; Johnson PRA, 2004, J ALLERGY CLIN IMMUN, V113, P690, DOI 10.1016/j.jaci.2003.12.312; Johnson PRA, 2001, AM J RESP CRIT CARE, V164, P474, DOI 10.1164/ajrccm.164.3.2010109; KHALIL N, 1991, AM J RESP CELL MOL, V5, P155, DOI 10.1165/ajrcmb/5.2.155; Kranenburg AR, 2006, AM J CLIN PATHOL, V126, P725, DOI 10.1309/JC477FAEL1YKV54W; Lalor DJ, 2004, AM J PHYSIOL-LUNG C, V287, pL1007, DOI 10.1152/ajplung.00126.2004; Lau JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013360; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mak JCW, 2009, RESP MED, V103, P1083, DOI 10.1016/j.rmed.2009.01.005; McDonough JE, 2011, NEW ENGL J MED, V365, P1567, DOI 10.1056/NEJMoa1106955; Moir LM, 2008, J ALLERGY CLIN IMMUN, V121, P1034, DOI 10.1016/j.jaci.2007.12.1159; ROMAN J, 1993, AM J RESP CELL MOL, V8, P538, DOI 10.1165/ajrcmb/8.5.538; Rosenbloom J, 2010, ANN INTERN MED, V152, P159, DOI 10.7326/0003-4819-152-3-201002020-00007; SASAKI T, 1995, J MOL BIOL, V245, P241, DOI 10.1006/jmbi.1994.0020; Sturton G, 2008, TRENDS PHARMACOL SCI, V29, P340, DOI 10.1016/j.tips.2008.04.003; TIDDENS HAWM, 1995, AM J RESP CRIT CARE, V152, P260, DOI 10.1164/ajrccm.152.1.7599833; Timpl R, 2000, MATRIX BIOL, V19, P309, DOI 10.1016/S0945-053X(00)00072-X; Vignola AM, 1997, AM J RESP CRIT CARE, V156, P591, DOI 10.1164/ajrccm.156.2.9609066; ZHANG K, 1995, AM J PATHOL, V147, P352	28	9	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65544	10.1371/journal.pone.0065544	http://dx.doi.org/10.1371/journal.pone.0065544			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762390	gold, Green Submitted, Green Published			2022-12-27	WOS:000321094800061
J	Ford, KR; Ettinger, AK; Lundquist, JD; Raleigh, MS; Lambers, JHR				Ford, Kevin R.; Ettinger, Ailene K.; Lundquist, Jessica D.; Raleigh, Mark S.; Lambers, Janneke Hille Ris			Spatial Heterogeneity in Ecologically Important Climate Variables at Coarse and Fine Scales in a High-Snow Mountain Landscape	PLOS ONE			English	Article							SUB-ALPINE MEADOWS; PLANT DIVERSITY; RANGE SHIFTS; IMPACTS; MODELS; TERRAIN; PRECIPITATION; BIODIVERSITY; TEMPERATURE; COLORADO	Climate plays an important role in determining the geographic ranges of species. With rapid climate change expected in the coming decades, ecologists have predicted that species ranges will shift large distances in elevation and latitude. However, most range shift assessments are based on coarse-scale climate models that ignore fine-scale heterogeneity and could fail to capture important range shift dynamics. Moreover, if climate varies dramatically over short distances, some populations of certain species may only need to migrate tens of meters between microhabitats to track their climate as opposed to hundreds of meters upward or hundreds of kilometers poleward. To address these issues, we measured climate variables that are likely important determinants of plant species distributions and abundances (snow disappearance date and soil temperature) at coarse and fine scales at Mount Rainier National Park in Washington State, USA. Coarse-scale differences across the landscape such as large changes in elevation had expected effects on climatic variables, with later snow disappearance dates and lower temperatures at higher elevations. However, locations separated by small distances (similar to 20 m), but differing by vegetation structure or topographic position, often experienced differences in snow disappearance date and soil temperature as great as locations separated by large distances (>1 km). Tree canopy gaps and topographic depressions experienced later snow disappearance dates than corresponding locations under intact canopy and on ridges. Additionally, locations under vegetation and on topographic ridges experienced lower maximum and higher minimum soil temperatures. The large differences in climate we observed over small distances will likely lead to complex range shift dynamics and could buffer species from the negative effects of climate change.	[Ford, Kevin R.; Ettinger, Ailene K.; Lambers, Janneke Hille Ris] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Lundquist, Jessica D.; Raleigh, Mark S.] Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Ford, KR (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	kford10@gmail.com	Raleigh, Mark S/M-7687-2015	Raleigh, Mark S/0000-0002-1303-3472; Ettinger, Ailene/0000-0002-6228-6732	University of Washington Department of Biology; American Alpine Club; Seattle chapter of the ARCS Foundation; NSF Doctoral Dissertation Improvement Grant [DEB-1010787]; University of Washington Royalty Research Foundation; US Department of Energy (DOE) [DE-FC02 06ER64159]; NSF Graduate Research Fellowship Program [DGE-0718124]; NSF [CBET-0931780]; NASA Headquarters under the NASA Earth and Space Science Fellowship Program [NNX09AO22H]; Direct For Biological Sciences [1209661] Funding Source: National Science Foundation; Division Of Environmental Biology [1054012] Funding Source: National Science Foundation; Div Of Chem, Bioeng, Env, & Transp Sys [0931780] Funding Source: National Science Foundation	University of Washington Department of Biology(University of Washington); American Alpine Club; Seattle chapter of the ARCS Foundation; NSF Doctoral Dissertation Improvement Grant(National Science Foundation (NSF)); University of Washington Royalty Research Foundation(University of Washington); US Department of Energy (DOE)(United States Department of Energy (DOE)); NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NASA Headquarters under the NASA Earth and Space Science Fellowship Program(National Aeronautics & Space Administration (NASA)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	Research was supported by the University of Washington Department of Biology (KF, AE), the American Alpine Club (KF), the Seattle chapter of the ARCS Foundation (KF), an NSF Doctoral Dissertation Improvement Grant (DEB-1010787) (AE), the University of Washington Royalty Research Foundation (JH) and the US Department of Energy (DOE#DE-FC02 06ER64159) (JH). This material is based on work supported by the NSF Graduate Research Fellowship Program (DGE-0718124- KF, AE), NSF grant no. CBET-0931780 (JL) and by NASA Headquarters under the NASA Earth and Space Science Fellowship Program (NNX09AO22H) (MR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2007, CLIMATE CHANGE 2007; [Anonymous], 1975, COMMUNITIES ECOSYSTE; [Anonymous], CLIMATE CHANGE 2007; Austin MP, 2011, J BIOGEOGR, V38, P9, DOI 10.1111/j.1365-2699.2010.02415.x; Barrows CW, 2012, BIOL CONSERV, V152, P29, DOI 10.1016/j.biocon.2012.03.028; Bates D., 2011, PACKAGE LME4 LINEAR; Bennie JJ, 2010, AGR FOREST METEOROL, V150, P12, DOI 10.1016/j.agrformet.2009.07.014; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Clark MP, 2011, WATER RESOUR RES, V47, DOI 10.1029/2011WR010745; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Deems JS, 2008, J HYDROMETEOROL, V9, P977, DOI 10.1175/2008JHM901.1; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Dobrowski SZ, 2011, GLOBAL CHANGE BIOL, V17, P1022, DOI 10.1111/j.1365-2486.2010.02263.x; Egli L, 2012, HYDROL PROCESS, V26, P1574, DOI 10.1002/hyp.8244; Elsner M.M., 2009, WASHINGTON CLIMATE C, P69; Erickson TA, 2005, WATER RESOUR RES, V41, DOI 10.1029/2003WR002973; Franklin JF, 1988, SCI MONOGRAPH SERIES, V19; Fridley JD, 2009, J APPL METEOROL CLIM, V48, P1033, DOI 10.1175/2008JAMC2084.1; Geiger R., 2009, CLIMATE NEAR GROUND; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hof C, 2011, GLOBAL CHANGE BIOL, V17, P2987, DOI 10.1111/j.1365-2486.2011.02418.x; Humboldt A., 1807, ESSAY GEOGRAPHY PLAN; Huntley Brian, 2005, P109; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; Korner C, 2003, ALPINE PLANT LIFE FU, DOI DOI 10.1007/978-3-030-59538-8; Larcher W, 2003, PHYSL PLANT ECOLOGY; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Lundquist JD, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007561; Lundquist JD, 2010, J HYDROMETEOROL, V11, P1141, DOI 10.1175/2010JHM1264.1; Lundquist JD, 2008, WATER RESOUR RES, V44, DOI 10.1029/2008WR007035; Luoto M, 2008, GLOBAL CHANGE BIOL, V14, P483, DOI 10.1111/j.1365-2486.2007.01527.x; Merriam C.H., 1890, 3 USDA DIV ORN MAMM; Millar CI, 2010, ARCT ANTARCT ALP RES, V42, P76, DOI 10.1657/1938-4246-42.1.76; Mote P., 2009, WASHINGTON CLIMATE C; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Raleigh MS, 2013, REMOTE SENS ENVIRON, V128, P44, DOI 10.1016/j.rse.2012.09.016; Randin CF, 2009, GLOBAL CHANGE BIOL, V15, P1557, DOI 10.1111/j.1365-2486.2008.01766.x; Rochefort RM, 1996, ARCTIC ALPINE RES, V28, P52, DOI 10.2307/1552085; Rochefort RM, 2006, RESTORING PACIFIC NW, P241; Scherrer D, 2011, J BIOGEOGR, V38, P406, DOI 10.1111/j.1365-2699.2010.02407.x; Scherrer D, 2010, GLOBAL CHANGE BIOL, V16, P2602, DOI 10.1111/j.1365-2486.2009.02122.x; Sicart JE, 2004, J HYDROMETEOROL, V5, P774, DOI 10.1175/1525-7541(2004)005<0774:ASSODN>2.0.CO;2; Sturm M, 2010, WATER RESOUR RES, V46, DOI 10.1029/2010WR009434; Tamme R, 2010, J VEG SCI, V21, P796, DOI 10.1111/j.1654-1103.2010.01185.x; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Trivedi MR, 2008, GLOBAL CHANGE BIOL, V14, P1089, DOI 10.1111/j.1365-2486.2008.01553.x; Varhola A, 2010, J HYDROL, V392, P219, DOI 10.1016/j.jhydrol.2010.08.009; Willis KJ, 2009, SCIENCE, V326, P806, DOI 10.1126/science.1178838; Wipf S, 2010, POLAR RES-SWEDEN, V29, P95, DOI 10.1111/j.1751-8369.2010.00153.x; Wundram D, 2010, ARCT ANTARCT ALP RES, V42, P117, DOI 10.1657/1938-4246-42.1.117; Xu RH, 2003, STAT MED, V22, P3527, DOI 10.1002/sim.1572; Zald HSJ, 2012, LANDSCAPE ECOL, V27, P1197, DOI 10.1007/s10980-012-9774-8; Zuur Alain F., 2009, P1	60	47	48	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65008	10.1371/journal.pone.0065008	http://dx.doi.org/10.1371/journal.pone.0065008			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762277	gold, Green Submitted, Green Published			2022-12-27	WOS:000321094800013
J	Teto, G; Kanmogne, GD; Torimiro, JN; Alemnji, G; Nguemaim, FN; Takou, D; Nanfack, A; Tazoacha, A				Teto, Georges; Kanmogne, Georgette D.; Torimiro, Judith N.; Alemnji, George; Nguemaim, Flore N.; Takou, Desire; Nanfack, Aubin; Tazoacha, Asonganyi			Lipid Peroxidation and Total Cholesterol in HAART-Naive Patients Infected with Circulating Recombinant Forms of Human Immunodeficiency Virus Type-1 in Cameroon	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; FREE-RADICALS; HIV DISEASE; PLASMA	Background: HIV infection has commonly been found to affect lipid profile and antioxidant defense. Objectives: To determine the effects of Human Immunodeficiency Virus (HIV) infection and viral subtype on patient's cholesterol and oxidative stress markers, and determine whether in the absence of Highly Active Antiretroviral Therapy (HAART), these biochemical parameters could be useful in patient's management and monitoring disease progression in Cameroon. For this purpose, we measured total cholesterol (TC), LDL cholesterol (LDLC), HDL cholesterol (HDLC), total antioxidant ability (TAA), lipid peroxidation indices (LPI), and malondialdehyde (MDA) in HIV negative persons and HIV positive HAART-naive patients infected with HIV-1 group M subtypes. Methods: We measured serum TC, LDLC, HDLC, plasma MDA, and TAA concentrations, and calculated LPI indices in 151 HIV-positive HAART-naive patients and 134 seronegative controls. We also performed gene sequence analysis on samples from 30 patients to determine the effect of viral genotypes on these biochemical parameters. We also determined the correlation between CD4 cell count and the above biochemical parameters. Results: We obtained the following controls/patients values for TC (1.96+/-0.54/1.12+/-0.48 g/l), LDLC (0.67+/-0.46/0.43+/-0.36 g/l), HDLC (105.51+/-28.10/46.54+/-23.36 mg/dl) TAA (0.63+/-0.17/0.16+/-0.16 mM), MDA (0.20+/-0.07/0.41+/-0.10 mM) and LPI (0.34+/-0.14/26.02+/-74.40). In each case, the difference between the controls and patients was statistically significant (p<0.05). There was a positive and statistically significant Pearson correlation between CD4 cell count and HDLC (r = +0.272; p<0.01), TAA (r = +0.199; p<0.05) and a negative and statistically significant Pearson correlation between CD4 cell count and LPI (r = 20.166; p<0.05). Pearson correlation between CD4 cell count and TC, CD4cell count and LDLC was positive but not statistically significant while it was negative but not statistically significant with MDA. The different subtypes obtained after sequencing were CRF02_AG (43.3%), CRF01_AE (20%), A1 (23.3%), H (6.7%), and G (6.7%). None of the HIV-1 subtypes significantly influenced the levels of the biochemical parameters, but by grouping them as pure subtypes and circulating recombinant forms (CRFs), the CRF significantly influenced TC levels. TC was significantly lower in patients infected with CRF (0.87+/-0.27 g/l) compared to patients infected with pure HIV-1 subtypes (1.32+/-0.68 g/l) (p<0.017). MDA levels were also significantly higher in patients infected with HIV-1CRF01_AE (0.50+/-0.10 mM), compared to ;patients infected with CRF02_AG (0.38+/-0.08 mM) (p<0.018). Conclusion: These results show that HIV infection in Cameroon is associated with significant decrease in TAA, LDLC, HDLC and TC, and increased MDA concentration and LPI indices which seem to be linked to the severity of HIV infection as assessed by CD4 cell count. The data suggests increased oxidative stress and lipid peroxidation in HIV-infected patients in Cameroon, and an influence of CRFs on TC and MDA levels.	[Teto, Georges; Alemnji, George; Nguemaim, Flore N.; Tazoacha, Asonganyi] Univ Yaounde I, Lab Immunol Biochem & Biotechnol, Yaounde, Cameroon; [Torimiro, Judith N.; Takou, Desire; Nanfack, Aubin] CIRCB Chantal Biya Int Res Ctr, Yaounde, Cameroon; [Teto, Georges; Torimiro, Judith N.; Alemnji, George; Nguemaim, Flore N.; Tazoacha, Asonganyi] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon; [Kanmogne, Georgette D.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA	University of Yaounde I; University of Yaounde I; University of Nebraska System; University of Nebraska Medical Center	Teto, G (corresponding author), Univ Yaounde I, Lab Immunol Biochem & Biotechnol, Yaounde, Cameroon.	ggteto@yahoo.fr			United States National Institute of Health [R01 MH094160]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094160] Funding Source: NIH RePORTER	United States National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	CIRCB for the facilities put at our disposal for this project. Dr. Georgette Kanmogne is partially supported by the United States National Institute of Health grant R01 MH094160. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adje C, 2001, J ACQ IMMUN DEF SYND, V26, P501, DOI 10.1097/00126334-200104150-00018; Agwale SM, 2001, J CLIN MICROBIOL, V39, P2110, DOI 10.1128/JCM.39.6.2110-2114.2001; Ariel C, 1997, CARDIOLOGIE PATHOLOG; Belec L, 1993, MEDECINE, P9; Belec L, 2007, TRANSMISSION SEXUELL, P301; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Chaix M, 2007, LETT INFECT, V22, P56; Djinhi J, 2008, BIOL CLIN, P11; Ducobu J, 2000, Rev Med Brux, V21, P11; Fawzi WW, 2004, NEW ENGL J MED, V351, P23, DOI 10.1056/NEJMoa040541; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FULBERT JC, 1992, PATHOL BIOL, V40, P66; HALLIWELL B, 1991, ARCH INTERN MED, V151, P29, DOI 10.1001/archinte.151.1.29; HAMSTEN A, 1990, BAILLIERE CLIN ENDOC, V4, P895, DOI 10.1016/S0950-351X(05)80084-9; Heyndrickx L, 2000, AIDS, V14, P1862, DOI 10.1097/00002030-200008180-00028; Heyndrickx L, 2002, HETERODUPLEX MOBILIT; I-Favier Hinninger, 2011, LIPIDES DERIVES COUR; Jerri L, 1997, AM J CLIN PATHOL, V109, P268; Julian Falutz, 2010, J ACQUIR IMMUNE DEFI; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kohn HI, 1944, J PHARMACOL EXP THER, V82, P292; L'Henaff M, 2006, J SIDA; Lefevre G, 1998, ANN BIOL CLIN-PARIS, V56, P305; Levy JA, 2007, AM SOC MICROBIOLOGY, V3, P87; Lopez O, 1996, CLIN CHIM ACTA, V247, P181, DOI 10.1016/0009-8981(95)06249-1; Marston B, 2004, NEW ENGL J MED, V351, P78, DOI 10.1056/NEJMe048134; Montagnier L, 2003, APPORTS RECHERCHE LU; National AIDS Control Committee/National Statistique Institute, 2006, PREL REP CAM DEM HLT; Ndembi N, 2004, JAIDS-J ACQ IMM DEF, V37, P1641, DOI 10.1097/00126334-200412150-00019; Ndongmo CB, 2006, AIDS RES HUM RETROV, V22, P812, DOI 10.1089/aid.2006.22.812; Nguemaim N. F., 2012, Journal of Medical Sciences (Pakistan), V12, P131, DOI 10.3923/jms.2012.131.140; Nguemaim N, 2010, HIV MED, V11, P353, DOI 10.1111/j.1468-1293.2009.00784.x; Plantier JC, 2009, NAT MED, P1; Rabaud C, 1997, ANN BIOL CLIN-PARIS, V55, P565; Raisonnier A, 1988, ANN U SC SANTE, V5, P755; Rasheed Suraiya, 2008, OPEN ACCESS, V3, P1; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; Safrin S, 1999, AIDS, V13, P2493, DOI 10.1097/00002030-199912240-00002; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Suresh DR, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-61; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; UNAIDS, 2011, JOURN MOND SID 2011; UNAIDS, 2010, RAPP ONUSIDA EP MOND; Zabell Martin, 2011, NORMAL CHOLESTEROL L	45	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65126	10.1371/journal.pone.0065126	http://dx.doi.org/10.1371/journal.pone.0065126			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762297	Green Published, gold, Green Submitted			2022-12-27	WOS:000321094800020
J	Wang, M; Zhao, F; Li, SJ; Chang, AK; Jia, ZJ; Chen, Y; Xu, FX; Pan, HM; Wu, HJ				Wang, Miao; Zhao, Feng; Li, Shujing; Chang, Alan K.; Jia, Zhaojun; Chen, Yixuan; Xu, Feihong; Pan, Hongming; Wu, Huijian			AIB1 Cooperates with ER alpha to Promote Epithelial Mesenchymal Transition in Breast Cancer through SNAI1 Activation	PLOS ONE			English	Article							STEROID-RECEPTOR COACTIVATOR-3; E-CADHERIN; TRANSCRIPTIONAL ACTIVITY; CELL-PROLIFERATION; GENE-EXPRESSION; SRC FAMILY; CARCINOMA; METASTASIS; ESTROGEN; PATHWAY	Epithelial Mesenchymal Transition (EMT) plays a major role in cancer metastasis. SevER alpha l genes have been shown to play a role in EMT, and one of these is Amplified-in-breast cancer 1 (AIB1), which has oncogenic function and is known to be amplified in breast cancer. However, the role of AIB1 in EMT remains largely undefined at the molecular level. In this study, the effect of AIB1 overexpression on the EMT of the breast cancer cell line T47D was investigated. Overexpression of AIB1 disrupted the epithelial morphology of the cells. At the same time, the cells displayed a strong metastasis and reduced level of the epithelial marker E-cadherin. In contrast, knockdown of AIB1 in T47D cells increased cell-cell adhesion and produced weak metastasis, as well as a higher level of E-cadherin expression. We proposed that the regulation of EMT by AIB1 occurred through the action of the transcription factor SNAI1, and demonstrated that such interaction required the participation of ER alpha and the presence of ER alpha-binding site on SNAI1 promoter. The expression level of E-cadherin and the extent of cell migration and invasion in SNAI1-knocked down T47D cells that overexpressed AIB1 were similar to those of T47D cells that did not overexpress AIB1 and had no SNAI1 knockdown. Taken together, these results suggested that AIB1 exerted its effect on EMT through its interaction with ER alpha, which could directly bind to the ER alpha-binding site on the SNAI1 promoter, allowing the AIB1-ER alpha complex to promote the transcription of SNAI1 and eventually led to repression of E-cadherin expression, consistent with the loss of E-cadherin being a hallmark of EMT.	[Wang, Miao; Zhao, Feng; Li, Shujing; Chang, Alan K.; Jia, Zhaojun; Chen, Yixuan; Xu, Feihong; Pan, Hongming; Wu, Huijian] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Peoples R China	Dalian University of Technology	Wu, HJ (corresponding author), Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Peoples R China.	wuhj@dlut.edu.cn			National Natural Science Foundation of China [31171353, 31271500]; Ministry of Science and Technology of China [2011CB504201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This research was supported by grants (31171353, 31271500 to H. W.) from National Natural Science Foundation of China and grants (973 Program 2011CB504201 to H. W.) from the Ministry of Science and Technology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alan KC, 2012, ONCOLOGY LETT, V4, P588; Alexander NR, 2006, CANCER RES, V66, P3365, DOI 10.1158/0008-5472.CAN-05-3401; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Bautista S, 1998, CLIN CANCER RES, V4, P2925; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; de Mora JF, 2000, MOL CELL BIOL, V20, P5041, DOI 10.1128/MCB.20.14.5041-5047.2000; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; de Herreros AG, 2010, J MAMMARY GLAND BIOL, V15, P135, DOI 10.1007/s10911-010-9179-8; Hong YD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023046; Li H, 1997, P NATL ACAD SCI USA, V94, P8479, DOI 10.1073/pnas.94.16.8479; Li B, 2008, CANCER LETT, V261, P64, DOI 10.1016/j.canlet.2007.11.013; Li S, 2012, ONCOGENE, DOI [10.1038/onc.2012.1518, DOI 10.1038/0NC.2012.1518]; Li SJ, 2012, BIOL CELL, V104, P287, DOI 10.1111/boc.201100116; Long WW, 2010, MOL CELL, V37, P321, DOI 10.1016/j.molcel.2010.01.004; Louie MC, 2006, MOL CELL BIOL, V26, P3810, DOI 10.1128/MCB.26.10.3810-3823.2006; Louie MC, 2004, MOL CELL BIOL, V24, P5157, DOI 10.1128/MCB.24.12.5157-5171.2004; Lydon JP, 2011, ENDOCRINOLOGY, V152, P19, DOI 10.1210/en.2010-1012; Mikami S, 2011, LAB INVEST, V91, P1443, DOI 10.1038/labinvest.2011.111; Mussi P, 2006, MOL ENDOCRINOL, V20, P3105, DOI 10.1210/me.2005-0522; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; ONATE SA, 1995, SCIENCE, V270, P1354; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Qin L, 2008, MOL CELL BIOL, V28, P5937, DOI 10.1128/MCB.00579-08; Richmond PJM, 1997, CANCER RES, V57, P3189; ROSS JS, 1994, MODERN PATHOL, V7, P835; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; Takeshita A, 1997, J BIOL CHEM, V272, P27629, DOI 10.1074/jbc.272.44.27629; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Wang M, 2008, DNA CELL BIOL, V27, P307, DOI 10.1089/dna.2007.0692; Wang M, 2010, J CELL BIOCHEM, V111, P75, DOI 10.1002/jcb.22664; Welch DR, 2000, BREAST CANCER RES, V2, P408, DOI 10.1186/bcr87; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Wu HJ, 2006, J BIOL CHEM, V281, P21848, DOI 10.1074/jbc.M603772200; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Yan J, 2006, CANCER RES, V66, P11039, DOI 10.1158/0008-5472.CAN-06-2442; Yang CH, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-21; Zhang H, 2004, GENE DEV, V18, P1753, DOI 10.1101/gad.1194704; Zhou LA, 2010, IUBMB LIFE, V62, P825, DOI 10.1002/iub.390	43	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65556	10.1371/journal.pone.0065556	http://dx.doi.org/10.1371/journal.pone.0065556			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762395	Green Published, gold, Green Submitted			2022-12-27	WOS:000321094800066
J	Cornman, RS; Lopez, D; Evans, JD				Cornman, Robert Scott; Lopez, Dawn; Evans, Jay D.			Transcriptional Response of Honey Bee Larvae Infected with the Bacterial Pathogen Paenibacillus larvae	PLOS ONE			English	Article							AMERICAN FOULBROOD; APIS-MELLIFERA; DROSOPHILA-MELANOGASTER; EXTRACELLULAR-MATRIX; ANOPHELES-GAMBIAE; IMMUNE-RESPONSE; ZP DOMAIN; PROTEINS; DISEASE; GENES	American foulbrood disease of honey bees is caused by the bacterium Paenibacillus larvae. Infection occurs per os in larvae and systemic infection requires a breaching of the host peritrophic matrix and midgut epithelium. Genetic variation exists for both bacterial virulence and host resistance, and a general immunity is achieved by larvae as they age, the basis of which has not been identified. To quickly identify a pool of candidate genes responsive to P. larvae infection, we sequenced transcripts from larvae inoculated with P. larvae at 12 hours post-emergence and incubated for 72 hours, and compared expression levels to a control cohort. We identified 75 genes with significantly higher expression and six genes with significantly lower expression. In addition to several antimicrobial peptides, two genes encoding peritrophic-matrix domains were also up-regulated. Extracellular matrix proteins, proteases/protease inhibitors, and members of the Osiris gene family were prevalent among differentially regulated genes. However, analysis of Drosophila homologs of differentially expressed genes revealed spatial and temporal patterns consistent with developmental asynchrony as a likely confounder of our results. We therefore used qPCR to measure the consistency of gene expression changes for a subset of differentially expressed genes. A replicate experiment sampled at both 48 and 72 hours post infection allowed further discrimination of genes likely to be involved in host response. The consistently responsive genes in our test set included a hymenopteran-specific protein tyrosine kinase, a hymenopteran specific serine endopeptidase, a cytochrome P450 (CYP9Q1), and a homolog of trynity, a zona pellucida domain protein. Of the known honey bee antimicrobial peptides, apidaecin was responsive at both time-points studied whereas hymenoptaecin was more consistent in its level of change between biological replicates and had the greatest increase in expression by RNA-seq analysis.	[Cornman, Robert Scott; Lopez, Dawn; Evans, Jay D.] USDA ARS, Bee Res Lab, Beltsville, MD USA	United States Department of Agriculture (USDA)	Cornman, RS (corresponding author), USDA ARS, Bee Res Lab, Beltsville, MD USA.	scott.cornman@gmail.com	Evans, Jay D/C-8408-2012	Evans, Jay D/0000-0002-0036-4651	Coordinate Agricultural Project on Pollinator Health (USDA National Institute of Food and Agriculture)	Coordinate Agricultural Project on Pollinator Health (USDA National Institute of Food and Agriculture)	This project was supported by the Coordinate Agricultural Project on Pollinator Health (USDA National Institute of Food and Agriculture). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, GENOME BIOL, V11, pR106; Chan QWT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-387; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Cornman RS, 2009, INSECT MOL BIOL, V18, P607, DOI 10.1111/j.1365-2583.2009.00902.x; Cornman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012536; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Dorer DR, 2003, GENETICS, V165, P613; Eddy Sean R, 2009, Genome Inform, V23, P205; Emerson KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009574; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Evans JD, 2006, J INVERTEBR PATHOL, V93, P135, DOI 10.1016/j.jip.2006.04.004; Evans JD, 2005, EVOLUTION, V59, P2270, DOI 10.1111/j.0014-3820.2005.tb00935.x; Evans JD, 2004, J INVERTEBR PATHOL, V85, P105, DOI 10.1016/j.jip.2004.02.004; Evans JD, 2004, J ECON ENTOMOL, V97, P752, DOI 10.1603/0022-0493(2004)097[0752:BPIAIR]2.0.CO;2; Gallot A, 2010, INSECT BIOCHEM MOLEC, V40, P235, DOI 10.1016/j.ibmb.2009.12.001; Genersch E, 2005, APPL ENVIRON MICROB, V71, P7551, DOI 10.1128/AEM.71.11.7551-7555.2005; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hegedus D, 2009, ANNU REV ENTOMOL, V54, P285, DOI 10.1146/annurev.ento.54.110807.090559; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jazwinska A, 2004, GENE EXPR PATTERNS, V4, P413, DOI 10.1016/j.modgep.2004.01.003; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lehane MJ, 1997, ANNU REV ENTOMOL, V42, P525, DOI 10.1146/annurev.ento.42.1.525; Mao WF, 2011, P NATL ACAD SCI USA, V108, P12657, DOI 10.1073/pnas.1109535108; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Nelson JA, 1924, J AGRIC RES, V28, P1167; Ortiz de Montellano P.R., 2004, CYTOCHROME P450 STRU, V3rd; Rauch S, 2009, APPL ENVIRON MICROB, V75, P3344, DOI 10.1128/AEM.02839-08; Robertson CW, 1936, J MORPHOL, V59, P351, DOI 10.1002/jmor.1050590207; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roch F, 2003, J CELL SCI, V116, P1199, DOI 10.1242/jcs.00298; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SHIMANUKI H, 1990, HONEY BEE PESTS PRED, P27; Spivak M, 1998, BEE WORLD, V79, P124, DOI 10.1080/0005772X.1998.11099394; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Terra WR, 2001, ARCH INSECT BIOCHEM, V47, P47, DOI 10.1002/arch.1036; Togawa T, 2008, INSECT BIOCHEM MOLEC, V38, P508, DOI 10.1016/j.ibmb.2007.12.008; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VERCELLOTTI GM, 1985, AM J PATHOL, V120, P13; Vontas J, 2007, INSECT MOL BIOL, V16, P315, DOI 10.1111/j.1365-2583.2007.00728.x; WESTERLUND B, 1993, MOL MICROBIOL, V9, P687, DOI 10.1111/j.1365-2958.1993.tb01729.x; Willis JH, 2010, INSECT BIOCHEM MOLEC, V40, P189, DOI 10.1016/j.ibmb.2010.02.001; Winston M. L. L., 1991, BIOL HONEY BEE; Yue D, 2008, ENVIRON MICROBIOL, V10, P1612, DOI 10.1111/j.1462-2920.2008.01579.x	47	31	36	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65424	10.1371/journal.pone.0065424	http://dx.doi.org/10.1371/journal.pone.0065424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762370	Green Published, gold, Green Submitted			2022-12-27	WOS:000321099000066
J	Lee, D; Lee, GK; Yoon, KA; Lee, JS				Lee, Donghoon; Lee, Geon Kook; Yoon, Kyong-Ah; Lee, Jin Soo			Pathway-Based Analysis Using Genome-wide Association Data from a Korean Non-Small Cell Lung Cancer Study	PLOS ONE			English	Article							SET ENRICHMENT ANALYSIS; SUSCEPTIBILITY LOCUS; VARIANTS; 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE; CARCINOGEN; MORTALITY; DISEASE; GENES; POWER; SNPS	Pathway-based analysis, used in conjunction with genome-wide association study (GWAS) techniques, is a powerful tool to detect subtle but systematic patterns in genome that can help elucidate complex diseases, like cancers. Here, we stepped back from genetic polymorphisms at a single locus and examined how multiple association signals can be orchestrated to find pathways related to lung cancer susceptibility. We used single-nucleotide polymorphism (SNP) array data from 869 non-small cell lung cancer (NSCLC) cases from a previous GWAS at the National Cancer Center and 1,533 controls from the Korean Association Resource project for the pathway-based analysis. After mapping single-nucleotide polymorphisms to genes, considering their coding region and regulatory elements (+/- 20 kbp), multivariate logistic regression of additive and dominant genetic models were fitted against disease status, with adjustments for age, gender, and smoking status. Pathway statistics were evaluated using Gene Set Enrichment Analysis (GSEA) and Adaptive Rank Truncated Product (ARTP) methods. Among 880 pathways, 11 showed relatively significant statistics compared to our positive controls (P-GSEA <= 0.025, false discovery rate <= 0.25). Candidate pathways were validated using the ARTP method and similarities between pathways were computed against each other. The top-ranked pathways were ABC Transporters (PGSEA, < 0.001, P-ARTP = 0.001), VEGF Signaling Pathway (PG(SEA), 0.001, P-ARTP = 0.008), G1/S Check Point (P-GSEA = 0.004, P-ARTP = 0.013), and NRAGE Signals Death through JNK (P-GSEA = 0.006, P-ARTP = 0.001). Our results demonstrate that pathway analysis can shed light on post-GWAS research and help identify potential targets for cancer susceptibility.	[Lee, Donghoon; Lee, Geon Kook; Yoon, Kyong-Ah; Lee, Jin Soo] Natl Canc Ctr, Res Inst & Hosp, Lung Canc Branch, Gyeonggi, South Korea	National Cancer Center - Korea (NCC)	Yoon, KA (corresponding author), Natl Canc Ctr, Res Inst & Hosp, Lung Canc Branch, Gyeonggi, South Korea.	kayoon@ncc.re.kr	Lee, Donghoon/I-9967-2017; Lee, Donghoon/AAQ-9786-2021; Lee, Donghoon/AAH-2252-2020	Lee, Donghoon/0000-0003-0453-6059; Lee, Donghoon/0000-0003-0453-6059	National Cancer Center [1210360]	National Cancer Center	The research was supported by National Cancer Center research grant 1210360. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; CORREA E, 1990, CANCER RES, V50, P3435; Falvella FS, 2008, ONCOGENE, V27, P1650, DOI 10.1038/sj.onc.1210775; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; Gauderman WJ, 2007, GENET EPIDEMIOL, V31, P383, DOI 10.1002/gepi.20219; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Guo YF, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-429; Han JY, 2011, CANCER-AM CANCER SOC, V117, P3201, DOI 10.1002/cncr.25863; Holden M, 2008, BIOINFORMATICS, V24, P2784, DOI 10.1093/bioinformatics/btn516; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; In KH, 2009, LUNG CANCER, V64, P232, DOI 10.1016/j.lungcan.2008.08.005; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jung KW, 2012, CANCER RES TREAT, V44, P25, DOI 10.4143/crt.2012.44.1.25; Kwee LC, 2008, AM J HUM GENET, V82, P386, DOI 10.1016/j.ajhg.2007.10.010; Lee SJ, 2005, CANCER EPIDEM BIOMAR, V14, P571, DOI 10.1158/1055-9965.EPI-04-0472; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Marugame T, 2009, JPN J CLIN ONCOL, V39, P696, DOI 10.1093/jjco/hyp138; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Miki D, 2010, NAT GENET, V42, P893, DOI 10.1038/ng.667; Nam D, 2010, NUCLEIC ACIDS RES, V38, pW749, DOI 10.1093/nar/gkq428; Pao W, 2012, NAT MED, V18, P349, DOI 10.1038/nm.2697; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Roeder K, 2006, AM J HUM GENET, V78, P243, DOI 10.1086/500026; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; SCHULLER HM, 1990, CANCER RES, V50, P1960; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Truong T, 2010, CARCINOGENESIS, V31, P625, DOI 10.1093/carcin/bgq001; Wang HJ, 2009, CANCER-AM CANCER SOC, V115, P595, DOI 10.1002/cncr.24042; Wang K, 2008, GENET EPIDEMIOL, V32, P108, DOI 10.1002/gepi.20266; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang LL, 2011, GENOMICS, V98, P1, DOI 10.1016/j.ygeno.2011.04.006; Wang T, 2007, AM J HUM GENET, V80, P353, DOI 10.1086/511312; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Yoon KA, 2010, HUM MOL GENET, V19, P4948, DOI 10.1093/hmg/ddq421; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422; Zhang KL, 2010, NUCLEIC ACIDS RES, V38, pW90, DOI 10.1093/nar/gkq324	45	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65396	10.1371/journal.pone.0065396	http://dx.doi.org/10.1371/journal.pone.0065396			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762359	Green Published, Green Submitted, gold			2022-12-27	WOS:000321099000062
J	Simbolo, M; Gottardi, M; Corbo, V; Fassan, M; Mafficini, A; Malpeli, G; Lawlor, RT; Scarpa, A				Simbolo, Michele; Gottardi, Marisa; Corbo, Vincenzo; Fassan, Matteo; Mafficini, Andrea; Malpeli, Giorgio; Lawlor, Rita T.; Scarpa, Aldo			DNA Qualification Workflow for Next Generation Sequencing of Histopathological Samples	PLOS ONE			English	Article							EXTRACTION METHODS; GENOMIC DNA; CANCER; ABSORBENCY; MUTATIONS; EVOLUTION; QUALITY; TISSUE; RATIOS	Histopathological samples are a treasure-trove of DNA for clinical research. However, the quality of DNA can vary depending on the source or extraction method applied. Thus a standardized and cost-effective workflow for the qualification of DNA preparations is essential to guarantee interlaboratory reproducible results. The qualification process consists of the quantification of double strand DNA (dsDNA) and the assessment of its suitability for downstream applications, such as high-throughput next-generation sequencing. We tested the two most frequently used instrumentations to define their role in this process: NanoDrop, based on UV spectroscopy, and Qubit 2.0, which uses fluorochromes specifically binding dsDNA. Quantitative PCR (qPCR) was used as the reference technique as it simultaneously assesses DNA concentration and suitability for PCR amplification. We used 17 genomic DNAs from 6 fresh-frozen (FF) tissues, 6 formalin-fixed paraffin-embedded (FFPE) tissues, 3 cell lines, and 2 commercial preparations. Intra-and inter-operator variability was negligible, and intra-methodology variability was minimal, while consistent inter-methodology divergences were observed. In fact, NanoDrop measured DNA concentrations higher than Qubit and its consistency with dsDNA quantification by qPCR was limited to high molecular weight DNA from FF samples and cell lines, where total DNA and dsDNA quantity virtually coincide. In partially degraded DNA from FFPE samples, only Qubit proved highly reproducible and consistent with qPCR measurements. Multiplex PCR amplifying 191 regions of 46 cancer-related genes was designated the downstream application, using 40 ng dsDNA from FFPE samples calculated by Qubit. All but one sample produced amplicon libraries suitable for next-generation sequencing. NanoDrop UV-spectrum verified contamination of the unsuccessful sample. In conclusion, as qPCR has high costs and is labor intensive, an alternative effective standard workflow for qualification of DNA preparations should include the sequential combination of NanoDrop and Qubit to assess the purity and quantity of dsDNA, respectively.	[Simbolo, Michele; Gottardi, Marisa; Corbo, Vincenzo; Fassan, Matteo; Mafficini, Andrea; Lawlor, Rita T.; Scarpa, Aldo] Univ Verona, ARC NET Res Ctr, I-37100 Verona, Italy; [Simbolo, Michele; Scarpa, Aldo] Univ Verona, Dept Pathol & Diagnost, I-37100 Verona, Italy; [Malpeli, Giorgio; Scarpa, Aldo] Univ Integrata Verona, Azienda Osped, Dept Surg & Oncol, Verona, Italy	University of Verona; University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona	Scarpa, A (corresponding author), Univ Verona, ARC NET Res Ctr, I-37100 Verona, Italy.	aldo.scarpa@univr.it	Simbolo, Michele/AAB-1851-2019; Mafficini, Andrea/AAK-8158-2020; Fassan, Matteo/F-5152-2012; scarpa, aldo/K-6832-2016; Corbo, Vincenzo/J-7754-2016	Simbolo, Michele/0000-0002-0866-4499; Mafficini, Andrea/0000-0002-7471-3121; Fassan, Matteo/0000-0001-6515-5482; scarpa, aldo/0000-0003-1678-739X; Corbo, Vincenzo/0000-0002-6340-8009; Malpeli, Giorgio/0000-0002-2996-2903; lawlor, Rita/0000-0003-3160-0634	Associazione Italiana Ricerca sul Cancro 5xmille [12182]; Italian Cancer Genome Project grant from the Italian Ministry of Research [FIRB - RBAP10AHJB]	Associazione Italiana Ricerca sul Cancro 5xmille(Fondazione AIRC per la ricerca sul cancro); Italian Cancer Genome Project grant from the Italian Ministry of Research	This research has been supported financially by Associazione Italiana Ricerca sul Cancro 5xmille grant n. 12182; and an Italian Cancer Genome Project grant from the Italian Ministry of Research (FIRB - RBAP10AHJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Brosnan JA, 2012, SEMIN CELL DEV BIOL, V23, P237, DOI 10.1016/j.semcdb.2011.12.008; Corless CL, 2012, CANCER DISCOV, V2, P23, DOI 10.1158/2159-8290.CD-11-0319; Desjardins P, 2010, J VIS EXP; Dong Hui, 2012, Front Med, V6, P48, DOI 10.1007/s11684-012-0182-x; Foley C, 2011, J DAIRY SCI, V94, P3159, DOI 10.3168/jds.2010-3987; Gallagher S.R., 2006, CURR PROTOC MOL BIOL; GLASEL JA, 1995, BIOTECHNIQUES, V18, P62; Guo F, 2012, APPL MICROBIOL BIOTE; Haque KA, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-20; HUBERMAN JA, 1995, BIOTECHNIQUES, V18, P636; Lee JH, 2010, YONSEI MED J, V51, P104, DOI 10.3349/ymj.2010.51.1.104; Ma QLC, 2012, CURR OPIN GENET DEV, V22, P3, DOI 10.1016/j.gde.2012.01.008; Manchester KL, 1996, BIOTECHNIQUES, V20, P968; MANCHESTER KL, 1995, BIOTECHNIQUES, V19, P208; Mee BC, 2011, BIOPRESERV BIOBANK, V9, P389, DOI 10.1089/bio.2011.0034; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Moch H, 2012, VIRCHOWS ARCH, V460, P3, DOI 10.1007/s00428-011-1179-6; Moore PS, 2001, VIRCHOWS ARCH, V439, P798, DOI 10.1007/s004280100474; O'Neill M, 2011, J PHYS C SERIES, V307; Robertson C, 2003, SPECTROPHOTOMETRYS N; Ross JS, 2011, AM J CLIN PATHOL, V136, P527, DOI 10.1309/AJCPR1SVT1VHUGXW; Sironen A, 2011, AGR FOOD SCI, V20, P143, DOI 10.2137/145960611797215709; Su ZQ, 2011, EXPERT REV MOL DIAGN, V11, P333, DOI [10.1586/ERM.11.3, 10.1586/erm.11.3]; Tsongalis GJ, 2006, CLIN CHIM ACTA, V363, P127, DOI 10.1016/j.cccn.2005.05.043	25	169	173	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e62692	10.1371/journal.pone.0062692	http://dx.doi.org/10.1371/journal.pone.0062692			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762227	Green Published, gold			2022-12-27	WOS:000321099000003
J	Singer, E; Linehan, J; Babilonia, G; Imam, SA; Smith, D; Loera, S; Wilson, T; Smith, S				Singer, Elizabeth; Linehan, Jennifer; Babilonia, Gail; Imam, S. Ashraf; Smith, David; Loera, Sofia; Wilson, Timothy; Smith, Steven			Stromal Response to Prostate Cancer: Nanotechnology-Based Detection of Thioredoxin-Interacting Protein Partners Distinguishes Prostate Cancer Associated Stroma from That of Benign Prostatic Hyperplasia	PLOS ONE			English	Article							NUCLEOPROTEIN ASSEMBLIES; MITOCHONDRIA	Histological staining of reactive stroma has been shown to be a predictor of biochemical recurrence in prostate cancer, however, molecular markers of the stromal response to prostate cancer have not yet been fully delineated. The objective of this study was to determine whether or not the stromal biomarkers detected with a thioredoxin-targeted nanodevice could be used to distinguish the stroma associated with benign prostatic hyperplasia from that associated with PCA. In this regard, we recently demonstrated that a thioredoxin-targeted nanodevice selectively binds to reactive stroma in frozen prostate tumor tissue sections. To accomplish this, random frozen prostate tissue sections from each of 35 patients who underwent resection were incubated with the nanodevice and graded for fluorescent intensity. An adjacent section from each case was stained with Hematoxylin & Eosin to confirm the diagnosis. Select cases were stained with Masson's Trichrome or immunohistochemically using antibodies to thioredoxin reductase 1, thioredoxin reductase 2 or peroxiredoxin 1. Our results demonstrate that the graded intensity of nanodevice binding to the stroma associated with PCA was significantly higher (p = 0.0127) than that of benign prostatic hyperplasia using the t-test. Immunohistochemical staining of adjacent sections in representative cases showed that none of the two commonly studied thioredoxin interacting protein partners mirrored the fluorescence pattern seen with the nanodevice. However, thioredoxin reductase 2 protein was clearly shown to be a biomarker of prostate cancer-associated reactive stroma whose presence distinguishes the stroma associated with benign prostatic hyperplasia from that associated with prostate cancer. We conclude that the signal detected by the nanodevice, in contrast to individual targets detected with antibodies used in this study, originates from multiple thioredoxin interacting protein partners that distinguish the M2 neutrophil and macrophage associated inflammatory response in prostate cancer-associated stroma from the CD4+ T-Lymphocyte linked inflammation in benign prostatic hyperplasia.	[Singer, Elizabeth; Linehan, Jennifer; Babilonia, Gail; Smith, David; Loera, Sofia; Wilson, Timothy; Smith, Steven] City Hope Natl Med Ctr, Duarte, CA USA; [Imam, S. Ashraf] Huntington Med Res Inst, Pasadena, CA USA	City of Hope; Huntington Medical Research Institutes	Smith, S (corresponding author), City Hope Natl Med Ctr, Duarte, CA USA.	ssmith@coh.org	Smith, David/A-4115-2017	Smith, David/0000-0001-9644-2353	United States National Cancer Institute of the National Institutes of Health (NIH) [CA136055]; NIH National Cancer Institute; NATIONAL CANCER INSTITUTE [P30CA033572, R03CA136055] Funding Source: NIH RePORTER	United States National Cancer Institute of the National Institutes of Health (NIH); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grant CA136055 from the United States National Cancer Institute of the National Institutes of Health (NIH). This grant entitled: Thioredoxin Targeted Nanoparticles for Cancer Research, was peer reviewed and then funded based on merit by the NIH National Cancer Institute. The funders (the NIH itself) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala G, 2003, CLIN CANCER RES, V9, P2003; Ayala GE, 2011, AM J PATHOL, V178, P79, DOI 10.1016/j.ajpath.2010.09.042; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Bertini R, 1999, J EXP MED, V189, P1783, DOI 10.1084/jem.189.11.1783; Clark J, 2003, BIOTECHNIQUES, V35, P548, DOI 10.2144/03353rr01; Drechsel DA, 2010, J BIOL CHEM, V285, P27850, DOI 10.1074/jbc.M110.101196; Gromer S, 1998, J BIOL CHEM, V273, P20096, DOI 10.1074/jbc.273.32.20096; Huber D, 2005, J BACTERIOL, V187, P2983, DOI 10.1128/JB.187.9.2983-2991.2005; Klimp AH, 2001, CANCER RES, V61, P7305; Kramer G, 2007, EUR UROL, V51, P1202, DOI 10.1016/j.eururo.2006.12.011; Orsted DD, 2011, EUR UROL, V60, P691, DOI 10.1016/j.eururo.2011.06.016; Porta C, 2009, IMMUNOBIOLOGY, V214, P761, DOI 10.1016/j.imbio.2009.06.014; Schenk JM, 2011, AM J EPIDEMIOL, V173, P1419, DOI 10.1093/aje/kwq493; Singer EM, 2006, NANO LETT, V6, P1184, DOI 10.1021/nl060549h; Singer EM, 2011, NANOMEDICINE-UK, V6, P659, DOI [10.2217/nnm.11.22, 10.2217/NNM.11.22]; Smith SS, 1997, P NATL ACAD SCI USA, V94, P2162, DOI 10.1073/pnas.94.6.2162; Stanley BA, 2011, J BIOL CHEM, V286, P33669, DOI 10.1074/jbc.M111.284612; Wendel JA, 1998, NANOTECHNOLOGY, V9, P297, DOI 10.1088/0957-4484/9/3/021; Zhang P, 1997, J BIOL CHEM, V272, P30615, DOI 10.1074/jbc.272.49.30615	19	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e60562	10.1371/journal.pone.0060562	http://dx.doi.org/10.1371/journal.pone.0060562			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762225	Green Submitted, Green Published, gold			2022-12-27	WOS:000321099000002
J	Stephenson, JD; Hallis, LJ; Nagashima, K; Freeland, SJ				Stephenson, James D.; Hallis, Lydia J.; Nagashima, Kazuhide; Freeland, Stephen J.			Boron Enrichment in Martian Clay	PLOS ONE			English	Article							AQUEOUS ALTERATION; ADSORPTION; ISOTOPES; RIBOSE; SUGARS; SEA	We have detected a concentration of boron in martian clay far in excess of that in any previously reported extra-terrestrial object. This enrichment indicates that the chemistry necessary for the formation of ribose, a key component of RNA, could have existed on Mars since the formation of early clay deposits, contemporary to the emergence of life on Earth. Given the greater similarity of Earth and Mars early in their geological history, and the extensive disruption of Earth's earliest mineralogy by plate tectonics, we suggest that the conditions for prebiotic ribose synthesis may be better understood by further Mars exploration.	[Stephenson, James D.; Hallis, Lydia J.; Freeland, Stephen J.] Univ Hawaii, NASA Astrobiol Inst, Honolulu, HI 96822 USA; [Hallis, Lydia J.; Nagashima, Kazuhide] Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA	National Aeronautics & Space Administration (NASA); University of Hawaii System; University of Hawaii System	Stephenson, JD (corresponding author), Univ Hawaii, NASA Astrobiol Inst, Honolulu, HI 96822 USA.	jds@ifa.hawaii.edu		Nagashima, Kazuhide/0000-0002-9322-3187; Stephenson, James/0000-0002-6427-5703; hallis, lydia/0000-0001-6455-8415	National Aeronautics and Space Administration through the NASA Astrobiology Institute through the Office of Space Science [NNA09DA77A]	National Aeronautics and Space Administration through the NASA Astrobiology Institute through the Office of Space Science	This material is based upon work supported by the National Aeronautics and Space Administration through the NASA Astrobiology Institute under Cooperative Agreement No. NNA09DA77A issued through the Office of Space Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPEL PWU, 1995, PRECAMBRIAN RES, V72, P227, DOI 10.1016/0301-9268(94)00089-A; Boutlerow M.A., 1861, CR HEBD ACAD SCI, V53, P145; BRUMSACK HJ, 1992, EARTH PLANET SC LETT, V113, P427, DOI 10.1016/0012-821X(92)90143-J; Cairns-Smith AG, 1985, 7 CLUES ORIGIN LIFE; Changela HG, 2010, METEORIT PLANET SCI, V45, P1847, DOI 10.1111/j.1945-5100.2010.01123.x; Chaussidon M, 1997, CHEM GEOL, V136, P171, DOI 10.1016/S0009-2541(96)00140-4; Chitnis SR, 1997, REACT FUNCT POLYM, V32, P93, DOI 10.1016/S1381-5148(96)00074-0; COUCH EL, 1968, CLAY CLAY MINER, V16, P249, DOI 10.1346/CCMN.1968.0160307; Deamer D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004929; DECKER P, 1982, J CHROMATOGR, V244, P281, DOI 10.1016/S0021-9673(00)85692-7; Ehlmann BL, 2011, NATURE, V479, P53, DOI 10.1038/nature10582; Ferris JP, 1996, NATURE, V381, P59, DOI 10.1038/381059a0; FRIPIAT JJ, 1974, ANNU REV EARTH PL SC, V2, P239, DOI 10.1146/annurev.ea.02.050174.001323; GOODING JL, 1991, METEORITICS, V26, P135, DOI 10.1111/j.1945-5100.1991.tb01029.x; Grew ES, 2011, ORIGINS LIFE EVOL B, V41, P307, DOI 10.1007/s11084-010-9233-y; Hallis LJ, 2011, METEORIT PLANET SCI, V46, P1787, DOI 10.1111/j.1945-5100.2011.01293.x; Hanczyc MM, 2003, SCIENCE, V302, P618, DOI 10.1126/science.1089904; Hervig RL, 1996, REV MINERAL, V33, P789; HINGSTON F. J., 1964, AUSTRALIAN J SOIL RES, V2, P83, DOI 10.1071/SR9640083; Jenniskens P, 2012, SCIENCE, V338, P1583, DOI 10.1126/science.1227163; Jochum KP, 2005, GEOSTAND GEOANAL RES, V29, P285, DOI 10.1111/j.1751-908X.2005.tb00901.x; Joshi PC, 2009, J AM CHEM SOC, V131, P13369, DOI 10.1021/ja9036516; KEREN R, 1981, CLAY CLAY MINER, V29, P198, DOI 10.1346/CCMN.1981.0290305; Kim HJ, 2010, SCIENCE, V20, P5994; Kim HJ, 2011, J AM CHEM SOC, V133, P9457, DOI 10.1021/ja201769f; LARRALDE R, 1995, P NATL ACAD SCI USA, V92, P8158, DOI 10.1073/pnas.92.18.8158; Murchie S, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2009JE003343; Okazaki R, 2003, ANTARCTIC METEORITE, V16, P58; Pucci A., 2010, J COSMOLOGY, V10, P3398; Ricardo A, 2004, SCIENCE, V303, P196, DOI 10.1126/science.1092464; SCHWARCZ HP, 1969, EARTH PLANET SC LETT, V6, P1, DOI 10.1016/0012-821X(69)90084-3; SHAPIRO R, 1988, ORIGINS LIFE EVOL B, V18, P71, DOI 10.1007/BF01808782; Spivak-Birndorf LJ, 2008, GOLDSCHM C; STAUFFER H, 1962, J GEOPHYS RES, V67, P2023, DOI 10.1029/JZ067i005p02023; Sugiura N, 2001, METEORIT PLANET SCI, V36, P1397, DOI 10.1111/j.1945-5100.2001.tb01832.x; Szostak J. W., 2012, J SYST CHEM, V3, P2, DOI [10.1186/1759-2208-3-2, DOI 10.1186/1759-2208-3-2]; Thomson BJ, 2011, ICARUS, V214, P413, DOI 10.1016/j.icarus.2011.05.002; TREIMAN AH, 1993, METEORITICS, V28, P86, DOI 10.1111/j.1945-5100.1993.tb00251.x; Wielandt D, 2012, ASTROPHYS J LETT, V748, DOI 10.1088/2041-8205/748/2/L25; Williams LB, 2001, GEOCHIM COSMOCHIM AC, V65, P1783, DOI 10.1016/S0016-7037(01)00558-0; Wray JJ, 2013, INT J ASTROBIOL, V12, P25, DOI 10.1017/S1473550412000328	42	23	23	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64624	10.1371/journal.pone.0064624	http://dx.doi.org/10.1371/journal.pone.0064624			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762242	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000321099000009
J	Cany, J; van der Waart, AB; Tordoir, M; Franssen, GM; Hangalapura, BN; de Vries, J; Boerman, O; Schaap, N; van der Voort, R; Spanholtz, J; Dolstra, H				Cany, Jeannette; van der Waart, Anniek B.; Tordoir, Marleen; Franssen, Gerben M.; Hangalapura, Basav N.; de Vries, Jolanda; Boerman, Otto; Schaap, Nicolaas; van der Voort, Robbert; Spanholtz, Jan; Dolstra, Harry			Natural Killer Cells Generated from Cord Blood Hematopoietic Progenitor Cells Efficiently Target Bone Marrow-Residing Human Leukemia Cells in NOD/SCID/IL2Rg(null) Mice	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; NK CELLS; T-CELLS; EXPANSION; TRANSPLANTATION; INFUSION	Natural killer (NK) cell-based adoptive immunotherapy is an attractive adjuvant treatment option for patients with acute myeloid leukemia. Recently, we reported a clinical-grade, cytokine-based culture method for the generation of NK cells from umbilical cord blood (UCB) CD34(+) hematopoietic progenitor cells with high yield, purity and in vitro functionality. The present study was designed to evaluate the in vivo anti-leukemic potential of UCB-NK cells generated with our GMP-compliant culture system in terms of biodistribution, survival and cytolytic activity following adoptive transfer in immunodeficient NOD/SCID/IL2Rg(null) mice. Using single photon emission computed tomography, we first demonstrated active migration of UCB-NK cells to bone marrow, spleen and liver within 24 h after infusion. Analysis of the chemokine receptor expression profile of UCB-NK cells matched in vivo findings. Particularly, a firm proportion of UCB-NK cells functionally expressed CXCR4, what could trigger BM homing in response to its ligand CXCL12. In addition, high expression of CXCR3 and CCR6 supported the capacity of UCB-NK cells to migrate to inflamed tissues via the CXCR3/CXCL10-11 and CCR6/CCL20 axis. Thereafter, we showed that low dose IL-15 mediates efficient survival, expansion and maturation of UCB-NK cells in vivo. Most importantly, we demonstrate that a single UCB-NK cell infusion combined with supportive IL-15 administration efficiently inhibited growth of human leukemia cells implanted in the femur of mice, resulting in significant prolongation of mice survival. These preclinical studies strongly support the therapeutic potential of ex vivo-generated UCB-NK cells in the treatment of myeloid leukemia after immunosuppressive chemotherapy.	[Cany, Jeannette; van der Waart, Anniek B.; Tordoir, Marleen; Hangalapura, Basav N.; van der Voort, Robbert; Spanholtz, Jan; Dolstra, Harry] RUNMC, Hematol Lab, Dept Lab Med, Nijmegen, Netherlands; [Tordoir, Marleen; Spanholtz, Jan] Glycostem Therapeut, Nijmegen, Netherlands; [Franssen, Gerben M.; Boerman, Otto] RUNMC, Dept Nucl Med, Nijmegen, Netherlands; [de Vries, Jolanda] Nijmegen Ctr Mol Life Sci, Dept Tumor Immunol, Nijmegen, Netherlands; [Schaap, Nicolaas] RUNMC, Dept Hematol, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Dolstra, H (corresponding author), RUNMC, Hematol Lab, Dept Lab Med, Nijmegen, Netherlands.	H.Dolstra@labgk.umcn.nl	Cany, J.S./L-4244-2015; Schaap, Nicolaas/L-4625-2015; Dolstra, H./L-4276-2015; van der Waart, Anniek B/O-4185-2015; van der Waart, Anniek/AAD-9606-2020; Boerman, Otto C/A-8112-2014	Schaap, Nicolaas/0000-0001-7696-4752; Dolstra, H./0000-0002-3998-687X; van der Waart, Anniek B/0000-0001-5986-3060; van der Waart, Anniek/0000-0001-5986-3060; Boerman, Otto C/0000-0001-6832-101X; Spanholtz, Jan/0000-0001-7152-6956	ZonMW [40-41400-98-9018]; Radboud University Nijmegen Medical Centre	ZonMW(Netherlands Organization for Health Research and Development); Radboud University Nijmegen Medical Centre	This work was supported by ZonMW (40-41400-98-9018) and the Radboud University Nijmegen Medical Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayello J, 2006, BIOL BLOOD MARROW TR, V12, P608, DOI 10.1016/j.bbmt.2006.01.009; Beider K, 2003, BLOOD, V102, P1951, DOI 10.1182/blood-2002-10-3293; Berahovich RD, 2006, J IMMUNOL, V177, P7833, DOI 10.4049/jimmunol.177.11.7833; BOGGS DR, 1984, AM J HEMATOL, V16, P277, DOI 10.1002/ajh.2830160309; Brand JM, 2004, STEM CELLS DEV, V13, P307, DOI 10.1089/154732804323099235; Buchner T, 2005, CRIT REV ONCOL HEMAT, V56, P247, DOI 10.1016/j.critrevonc.2004.09.010; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Campbell JJ, 2001, J IMMUNOL, V166, P6477, DOI 10.4049/jimmunol.166.11.6477; Curti A, 2011, BLOOD, V118, P3273, DOI 10.1182/blood-2011-01-329508; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Fujisaki H, 2009, CANCER RES, V69, P4010, DOI 10.1158/0008-5472.CAN-08-3712; Guimaraes F, 2006, LEUKEMIA, V20, P833, DOI 10.1038/sj.leu.2404147; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Lehmann D, 2012, STEM CELLS DEV, V21, P2926, DOI 10.1089/scd.2011.0659; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Matera L, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-49; Miller JS, 2005, BLOOD, V105, P3051, DOI 10.1182/blood-2004-07-2974; Nguyen S, 2011, TRANSFUSION, V51, P1769, DOI 10.1111/j.1537-2995.2010.03058.x; Pinthus JH, 2004, J CLIN INVEST, V114, P1774, DOI 10.1172/JCI200422284; Rowe JM, 2009, BLOOD, V113, P4129, DOI 10.1182/blood-2008-12-192856; Rubnitz JE, 2010, J CLIN ONCOL, V28, P955, DOI 10.1200/JCO.2009.24.4590; Ruggeri L, 2007, BLOOD, V110, P433, DOI 10.1182/blood-2006-07-038687; Spanholtz J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020740; Spanholtz J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009221; Tanaka J, 2012, LEUKEMIA, V26, P1149, DOI 10.1038/leu.2011.345; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Woll PS, 2009, BLOOD, V113, P6094, DOI 10.1182/blood-2008-06-165225; Yoon SR, 2010, BONE MARROW TRANSPL, V45, P1038, DOI 10.1038/bmt.2009.304; Zhao ED, 2012, ONCOIMMUNOLOGY, V1, P152, DOI 10.4161/onci.1.2.18480	31	61	67	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64384	10.1371/journal.pone.0064384	http://dx.doi.org/10.1371/journal.pone.0064384			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755121	gold, Green Published, Green Submitted			2022-12-27	WOS:000320579400013
J	Compte, N; Boudjeltia, KZ; Vanhaeverbeek, M; De Breucker, S; Tassignon, J; Trelcat, A; Pepersack, T; Goriely, S				Compte, Nathalie; Boudjeltia, Karim Zouaoui; Vanhaeverbeek, Michel; De Breucker, Sandra; Tassignon, Joel; Trelcat, Anne; Pepersack, Thierry; Goriely, Stanislas			Frailty in Old Age Is Associated with Decreased Interleukin-12/23 Production in Response to Toll-Like Receptor Ligation	PLOS ONE			English	Article							ILLNESS RATING-SCALE; PLASMACYTOID DENDRITIC CELLS; LIPOPOLYSACCHARIDE LPS; INFLUENZA VACCINE; ELDERLY HUMANS; VALIDATION; PREDICTORS; CHALLENGES; SENIORS; ADULTS	Aging is associated with progressive alterations of immune functions, leading to higher susceptibility to bacterial and viral infections and reduced vaccine responses. Data concerning cytokine production in response to Toll-like receptor (TLR) ligands are highly variable in old people, reflecting the heterogeneity of the geriatric population. The aim of our study was to define the relative contribution of age and clinical status on TLR-induced interleukin (IL)-12p70 and IL-23 production as these cytokines play an important role in the protection against intracellular and extracellular pathogens, respectively. For this purpose, we recruited 100 subjects (aged 23-96 years) in the general population or hospitalized for chronic diseases. We collected information on clinical status (medical history, ongoing comorbidities, treatments and geriatric scales), biological parameters (biochemical and hematological tests, telomere length determination, cytomegalovirus serology). Whole blood samples were stimulated with a combination of TLR4 and TLR7/8 ligands. We performed univariate and stepwise backward multivariate analyses regression to define which set of clinical variables could be predictive for IL-12p70 and IL-23 production in these conditions. Our results indicated that age was not correlated with TLR-mediated IL-12p70 and IL-23 production. In contrast, poor nutritional status and frailty in subjects >75 years were associated with decreased IL12p70 and IL-23 production. By intracytoplasmic staining, we confirmed that production of IL-12/23p40 by conventional dendritic cells (DCs) upon TLR ligation was decreased in frail patients. However, proportion of DCs and monocytes subsets, phenotypic maturation and proximal signaling events were found to be comparable in frail and healthy old subjects. These results suggest the importance of age-associated clinical parameters and not age by itself in the alteration of innate immune responses in old individuals and emphasis the importance of innate immune responses in the susceptibility of frail geriatric patients to infections.	[Compte, Nathalie; Goriely, Stanislas] Univ Libre Brussels, Inst Med Immunol, Charleroi, Belgium; [Boudjeltia, Karim Zouaoui; Vanhaeverbeek, Michel] Univ Libre Brussels, Expt Med Lab, Unit 222, Hop A Vesale, Montignies le Tilleul, Belgium; [De Breucker, Sandra; Pepersack, Thierry] Hop Erasme, Serv Geriatrie, Brussels, Belgium; [Tassignon, Joel; Trelcat, Anne] ImmuneHlth, Charleroi, Belgium	Universite Libre de Bruxelles	Goriely, S (corresponding author), Univ Libre Brussels, Inst Med Immunol, Charleroi, Belgium.	stgoriel@ulb.ac.be	De Breucker, Sandra/AAZ-1759-2020	De Breucker, Sandra/0000-0003-4598-0295; Goriely, Stanislas/0000-0002-7005-6195; Pepersack, Thierry/0000-0001-6197-582X; compte, nathalie/0000-0002-1175-4153	government of the Walloon Region; GlaxoSmithKline Biologicals; Fonds National de la Recherche Scientifique (FRS-FNRS, Belgium); Interuniversity Attraction Pole of the Belgian Federal Science Policy; FRS-FNRS; Fonds Erasme	government of the Walloon Region; GlaxoSmithKline Biologicals(GlaxoSmithKline); Fonds National de la Recherche Scientifique (FRS-FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Pole of the Belgian Federal Science Policy(Belgian Federal Science Policy Office); FRS-FNRS(Fonds de la Recherche Scientifique - FNRS); Fonds Erasme	The Institute for Medical Immunology is sponsored by the government of the Walloon Region and GlaxoSmithKline Biologicals. This study was supported by the Fonds National de la Recherche Scientifique (FRS-FNRS, Belgium) and an Interuniversity Attraction Pole of the Belgian Federal Science Policy. NC was supported by the FRS-FNRS and Fonds Erasme. SG is a research associate of the FRS-FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2007, J IMMUNOL, V178, P6912, DOI 10.4049/jimmunol.178.11.6912; Anpalahan M, 2008, INTERN MED J, V38, P16, DOI 10.1111/j.1445-5994.2007.01398.x; Beasley JM, 2010, J AM GERIATR SOC, V58, P1063, DOI 10.1111/j.1532-5415.2010.02866.x; Bruunsgaard H, 1999, CLIN EXP IMMUNOL, V118, P235; Castle SC, 2000, CLIN INFECT DIS, V31, P578, DOI 10.1086/313947; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Corsini E, 2006, J LEUKOCYTE BIOL, V80, P376, DOI 10.1189/jlb.0306190; Della Bella S, 2007, CLIN IMMUNOL, V122, P220, DOI 10.1016/j.clim.2006.09.012; Fock RA, 2007, CYTOKINE, V40, P105, DOI 10.1016/j.cyto.2007.08.007; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freeman SL, 2010, ANN NY ACAD SCI, V1190, P97, DOI 10.1111/j.1749-6632.2009.05264.x; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Fulop T, 2010, BIOGERONTOLOGY, V11, P547, DOI 10.1007/s10522-010-9287-2; Goriely S, 2008, NAT REV IMMUNOL, V8, P81, DOI 10.1038/nri2225; GRAVENSTEIN S, 1994, J AM GERIATR SOC, V42, P245, DOI 10.1111/j.1532-5415.1994.tb01746.x; Grolleau-Julius A, 2010, CLIN REV ALLERG IMMU, V39, P42, DOI 10.1007/s12016-009-8169-3; Guigoz Y, 1996, NUTR REV, V54, pS59; Jing Y, 2009, HUM IMMUNOL, V70, P777, DOI 10.1016/j.humimm.2009.07.005; Kagansky N, 2005, AM J CLIN NUTR, V82, P784, DOI 10.1093/ajcn/82.4.784; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009; Langkamp-Henken B, 2004, J AM GERIATR SOC, V52, P3, DOI 10.1111/j.1532-5415.2004.52003.x; Langkamp-Henken B, 2006, J AM GERIATR SOC, V54, P1861, DOI 10.1111/j.1532-5415.2006.00982.x; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; McCusker J, 1998, ACAD EMERG MED, V5, P883, DOI 10.1111/j.1553-2712.1998.tb02818.x; Nagaratnam N, 2007, ARCH GERONTOL GERIAT, V44, P29, DOI 10.1016/j.archger.2006.02.002; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Nyugen J, 2010, J CLIN IMMUNOL, V30, P806, DOI 10.1007/s10875-010-9448-8; Ongradi Joseph, 2010, Immun Ageing, V7, P7, DOI 10.1186/1742-4933-7-7; Panda A, 2010, J IMMUNOL, V184, P2518, DOI 10.4049/jimmunol.0901022; PARMELEE PA, 1995, J AM GERIATR SOC, V43, P130, DOI 10.1111/j.1532-5415.1995.tb06377.x; Perez-Cabezas B, 2007, EXP GERONTOL, V42, P1033, DOI 10.1016/j.exger.2007.05.010; Pietschmann P, 2000, EXP GERONTOL, V35, P213, DOI 10.1016/S0531-5565(99)00089-3; Qian F, 2012, AGING CELL, V11, P104, DOI 10.1111/j.1474-9726.2011.00759.x; Sagawa M, 2011, GERIATR GERONTOL INT, V11, P63, DOI 10.1111/j.1447-0594.2010.00641.x; Shodell M, 2002, SCAND J IMMUNOL, V56, P518, DOI 10.1046/j.1365-3083.2002.01148.x; van den Biggelaar AHJ, 2004, EXP GERONTOL, V39, P1407, DOI 10.1016/j.exger.2004.06.009; van Duin D, 2007, J AM GERIATR SOC, V55, P1438, DOI 10.1111/j.1532-5415.2007.01300.x; Vellas B, 2006, J NUTR HEALTH AGING, V10, P456; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	44	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65325	10.1371/journal.pone.0065325	http://dx.doi.org/10.1371/journal.pone.0065325			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755218	Green Published, gold, Green Submitted			2022-12-27	WOS:000320579400052
J	Guo, JJ; Li, JZ; Zhang, Y; Jin, XJ; Liu, HX; Yao, XJ				Guo, Jingjing; Li, Jiazhong; Zhang, Yan; Jin, Xiaojie; Liu, Huanxiang; Yao, Xiaojun			Exploring the Influence of Carbon Nanoparticles on the Formation of beta-Sheet-Rich Oligomers of IAPP(22-28) Peptide by Molecular Dynamics Simulation	PLOS ONE			English	Article							AMYLOIDOGENIC HEXAPEPTIDE NFGAIL; PROTEIN AGGREGATION; ORDERED OLIGOMERS; BINDING-AFFINITY; EXPLICIT SOLVENT; AROMATIC CONTENT; DISEASE; SURFACE; TOXICITY; GRAPHENE	Recent advances in nanotechnologies have led to wide use of nanomaterials in biomedical field. However, nanoparticles are found to interfere with protein misfolding and aggregation associated with many human diseases. It is still a controversial issue whether nanoparticles inhibit or promote protein aggregation. In this study, we used molecular dynamics simulations to explore the effects of three kinds of carbon nanomaterials including graphene, carbon nanotube and C-60 on the aggregation behavior of islet amyloid polypeptide fragment 22-28 (IAPP(22-28)). The diverse behaviors of IAPP(22-28) peptides on the surfaces of carbon nanomaterials were studied. The results suggest these nanomaterials can prevent beta-sheet formation in differing degrees and further affect the aggregation of IAPP(22-28). The pi-pi stacking and hydrophobic interactions are different in the interactions between peptides and different nanoparticles. The subtle differences in the interaction are due to the difference in surface curvature and area. The results demonstrate the adsorption interaction has competitive advantages over the interactions between peptides. Therefore, the fibrillation of IAPP(22-28) may be inhibited at its early stage by graphene or SWCNT. Our study can not only enhance the understanding about potential effects of nanomaterials to amyloid formation, but also provide valuable information to develop potential beta-sheet formation inhibitors against type II diabetes.	[Guo, Jingjing; Li, Jiazhong; Zhang, Yan; Liu, Huanxiang] Lanzhou Univ, Sch Pharm, Lanzhou 730000, Peoples R China; [Guo, Jingjing; Jin, Xiaojie; Liu, Huanxiang; Yao, Xiaojun] Lanzhou Univ, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China; [Guo, Jingjing; Jin, Xiaojie; Liu, Huanxiang; Yao, Xiaojun] Lanzhou Univ, Dept Chem, Lanzhou 730000, Peoples R China	Lanzhou University; Lanzhou University; Lanzhou University	Liu, HX (corresponding author), Lanzhou Univ, Sch Pharm, Lanzhou 730000, Peoples R China.	hxliu@lzu.edu.cn; xjyao@lzu.edu.cn	Guo, Jingjing/GZL-0645-2022	Guo, Jingjing/0000-0002-4632-4364; Liu, Huanxiang/0000-0002-9284-3667	National Natural Science Foundation of China [21103075]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No: 21103075, http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, AMBER 10; Azriel R, 2001, J BIOL CHEM, V276, P34156, DOI 10.1074/jbc.M102883200; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Cabaleiro-Lago C, 2012, LANGMUIR, V28, P1852, DOI 10.1021/la203078w; Chan HM, 2012, BIOMATERIALS, V33, P4443, DOI 10.1016/j.biomaterials.2012.03.024; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Elsaesser A, 2012, ADV DRUG DELIVER REV, V64, P129, DOI 10.1016/j.addr.2011.09.001; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fan WJ, 2009, J CHEM THEORY COMPUT, V5, P2879, DOI 10.1021/ct9002493; Frishman D, 2004, PROTEIN-STRUCT FUNCT, V23, P566; Ge CC, 2011, P NATL ACAD SCI USA, V108, P16968, DOI 10.1073/pnas.1105270108; Gilbert N, 2009, NATURE, V460, P937, DOI 10.1038/460937a; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Hein K.L., 2009, ANGEW CHEM, V121, P2152; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang P, 2011, BIOPHYS J, V100, P1550, DOI 10.1016/j.bpj.2011.02.010; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim JE, 2003, BIOCHEM BIOPH RES CO, V303, P576, DOI 10.1016/S0006-291X(03)00393-0; Kowalewski T, 1999, P NATL ACAD SCI USA, V96, P3688, DOI 10.1073/pnas.96.7.3688; Lee CM, 2011, NANOMED-NANOTECHNOL, V7, P107, DOI 10.1016/j.nano.2010.06.009; Li HY, 2011, BIOPHYS J, V101, P2267, DOI 10.1016/j.bpj.2011.09.046; Lin CY, 2007, DIABETES, V56, P1324, DOI 10.2337/db06-1579; Linse S, 2007, P NATL ACAD SCI USA, V104, P8691, DOI 10.1073/pnas.0701250104; Liu G, 2005, BBA-MOL BASIS DIS, V1741, P246, DOI 10.1016/j.bbadis.2005.06.006; Mahmoudi M, 2012, NANOSCALE, V4, P7322, DOI 10.1039/c2nr31657a; Mahmoudi M, 2011, CHEM REV, V111, P5610, DOI 10.1021/cr100440g; Marsagishvili L.G., 2010, BIOPHYSICS, V55, P699, DOI [10.1134/S0006350910050027, DOI 10.1134/S0006350910050027]; Meier JJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE1317, DOI 10.1152/ajpendo.00082.2006; Melquiond A, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2435358; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Moriarty DF, 1999, BIOCHEMISTRY-US, V38, P1811, DOI 10.1021/bi981658g; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Ou LC, 2011, J PHYS CHEM B, V115, P9813, DOI 10.1021/jp201474m; Podlubnaya Z. A., 2006, Biophysics, V51, P701, DOI 10.1134/S0006350906050046; Ritzel RA, 2007, DIABETES, V56, P65, DOI 10.2337/db06-0734; Rosi NL, 2006, SCIENCE, V312, P1027, DOI 10.1126/science.1125559; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sahni JK, 2011, J CONTROL RELEASE, V152, P208, DOI 10.1016/j.jconrel.2010.11.033; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Sharifi S, 2012, CHEM SOC REV, V41, P2323, DOI 10.1039/c1cs15188f; Shemetov AA, 2012, ACS NANO, V6, P4585, DOI 10.1021/nn300415x; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Stefani M, 2007, NEUROSCIENTIST, V13, P519, DOI 10.1177/1073858407303428; Stefani M, 2010, METHODS MOL BIOL, V648, P25, DOI 10.1007/978-1-60761-756-3_2; Tomasio SM, 2009, J PHYS CHEM C, V113, P8778, DOI 10.1021/jp8087594; Wang SQ, 2003, NAT MATER, V2, P196, DOI 10.1038/nmat833; Wang X, 2008, CA-CANCER J CLIN, V58, P97, DOI 10.3322/CA.2007.0003; Wei L, 2011, J BIOL CHEM, V286, P6291, DOI 10.1074/jbc.M110.166678; Wu C, 2005, J AM CHEM SOC, V127, P13530, DOI 10.1021/ja050767x; Wu C, 2005, BIOPHYS J, V88, P2897, DOI 10.1529/biophysj.104.055574; Wu C, 2004, BIOPHYS J, V87, P3000, DOI 10.1529/biophysj.104.047076; Wu C, 2006, BIOPHYS J, V91, P3664, DOI 10.1529/biophysj.106.081877; Wu C, 2008, J MOL BIOL, V384, P718, DOI 10.1016/j.jmb.2008.09.062; Xiao LH, 2010, BIOMATERIALS, V31, P91, DOI 10.1016/j.biomaterials.2009.09.014; Yu X, 2012, LANGMUIR, V28, P6595, DOI 10.1021/la3002306; Zanuy D, 2003, BIOPHYS J, V84, P1884, DOI 10.1016/S0006-3495(03)74996-0; Zorbas V, 2005, J AM CHEM SOC, V127, P12323, DOI 10.1021/ja050747v; Zuo G, 2011, J PHYS CHEM C, V115, P23323, DOI 10.1021/jp208967t; Zuo GH, 2010, ACS NANO, V4, P7508, DOI 10.1021/nn101762b	63	39	39	0	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65579	10.1371/journal.pone.0065579	http://dx.doi.org/10.1371/journal.pone.0065579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755253	Green Published, gold			2022-12-27	WOS:000320579400067
J	Yang, CQ; Liu, YZ; An, JC; Li, S; Jin, LF; Zhou, GF; Wei, QJ; Yan, HQ; Wang, NN; Fu, LN; Liu, X; Hu, XM; Yan, TS; Peng, SA				Yang, Cheng-Quan; Liu, Yong-Zhong; An, Ji-Cui; Li, Shuang; Jin, Long-Fei; Zhou, Gao-Feng; Wei, Qing-Jiang; Yan, Hui-Qing; Wang, Nan-Nan; Fu, Li-Na; Liu, Xiao; Hu, Xiao-Mei; Yan, Ting-Shuai; Peng, Shu-Ang			Digital Gene Expression Analysis of Corky Split Vein Caused by Boron Deficiency in 'Newhall' Navel Orange (Citrus sinensis Osbeck) for Selecting Differentially Expressed Genes Related to Vascular Hypertrophy	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE; RHAMNOGALACTURONAN II; CELL-CYCLE; MEMBRANE-PERMEABILITY; ARABIDOPSIS-THALIANA; RESPONSE REGULATORS; SIGNAL-TRANSDUCTION; BORIC-ACID; LEAVES; TRANSPORT	Corky split vein caused by boron (B) deficiency in 'Newhall' Navel Orange was studied in the present research. The borondeficient citrus exhibited a symptom of corky split vein in mature leaves. Morphologic and anatomical surveys at four representative phases of corky split veins showed that the symptom was the result of vascular hypertrophy. Digital gene expression (DGE) analysis was performed based on the Illumina HiSeq (TM) 2000 platform, which was applied to analyze the gene expression profilings of corky split veins at four morphologic phases. Over 5.3 million clean reads per library were successfully mapped to the reference database and more than 22897 mapped genes per library were simultaneously obtained. Analysis of the differentially expressed genes (DEGs) revealed that the expressions of genes associated with cytokinin signal transduction, cell division, vascular development, lignin biosynthesis and photosynthesis in corky split veins were all affected. The expressions of WOL and ARR12 involved in the cytokinin signal transduction pathway were upregulated at 1st phase of corky split vein development. Furthermore, the expressions of some cell cycle genes, CYCs and CDKB, and vascular development genes, WOX4 and VND7, were up-regulated at the following 2nd and 3rd phases. These findings indicated that the cytokinin signal transduction pathway may play a role in initiating symptom observed in our study.	[Yang, Cheng-Quan; Liu, Yong-Zhong; An, Ji-Cui; Li, Shuang; Jin, Long-Fei; Zhou, Gao-Feng; Wei, Qing-Jiang; Yan, Hui-Qing; Wang, Nan-Nan; Fu, Li-Na; Liu, Xiao; Hu, Xiao-Mei; Yan, Ting-Shuai; Peng, Shu-Ang] Huazhong Agr Univ, Coll Hort & Forestry Sci, Minist Educ, Key Lab Hort Plant Biol, Wuhan, Peoples R China	Huazhong Agricultural University	Yang, CQ (corresponding author), Huazhong Agr Univ, Coll Hort & Forestry Sci, Minist Educ, Key Lab Hort Plant Biol, Wuhan, Peoples R China.	chqyang@webmail.hzau.edu.cn; shuangpeng428@126.com	Wang, Nan/GRY-3150-2022; Peng, shuang/GPX-0999-2022		National Natural Science Foundation of China [31071761]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was financially supported by the National Natural Science Foundation of China (NO. 31071761). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONI R, 1987, ANNU REV PLANT PHYS, V38, P179, DOI 10.1146/annurev.pp.38.060187.001143; Alves M, 2011, PHYSIOL PLANTARUM, V142, P224, DOI 10.1111/j.1399-3054.2011.01462.x; An JC, 2012, SCI HORTIC-AMSTERDAM, V142, P149, DOI 10.1016/j.scienta.2012.05.013; Andersen SU, 2008, PLANT CELL, V20, P88, DOI 10.1105/tpc.107.054676; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; BLASERGRILL J, 1989, PLANT PHYSIOL, V90, P280, DOI 10.1104/pp.90.1.280; Bolanos L, 1996, PLANT PHYSIOL, V110, P1249, DOI 10.1104/pp.110.4.1249; Brown PH, 2002, PLANT BIOLOGY, V4, P205, DOI 10.1055/s-2002-25740; CAKMAK I, 1995, PHYSIOL PLANTARUM, V95, P11, DOI 10.1111/j.1399-3054.1995.tb00801.x; Cara FA, 2002, PLANT PHYSIOL BIOCH, V40, P853, DOI 10.1016/S0981-9428(02)01447-X; da Silva DH, 2008, SCI AGR, V65, P659, DOI 10.1590/S0103-90162008000600014; Dai R, 2011, AGR SCI CHINA, V10, P1861, DOI 10.1016/S1671-2927(11)60186-7; Ferreira FJ, 2005, CURR OPIN PLANT BIOL, V8, P518, DOI 10.1016/j.pbi.2005.07.013; Fleischer A, 1999, PLANT PHYSIOL, V121, P829, DOI 10.1104/pp.121.3.829; Fukuda H, 1997, PLANT CELL, V9, P1147, DOI 10.1105/tpc.9.7.1147; GARG OK, 1979, PLANT SOIL, V52, P591, DOI 10.1007/BF02277956; Gmitter FG, 2012, PLANT ANIMAL GENOME; Han S, 2008, J PLANT PHYSIOL, V165, P1331, DOI 10.1016/j.jplph.2007.11.002; Heyl A, 2003, CURR OPIN PLANT BIOL, V6, P480, DOI 10.1016/S1369-5266(03)00087-6; Hirakawa Y, 2010, PLANT CELL, V22, P2618, DOI 10.1105/tpc.110.076083; Hoagland DR, 1950, 347 CAL AGR EXP STAT, V347; Inze D, 2006, ANNU REV GENET, V40, P77, DOI 10.1146/annurev.genet.40.110405.090431; Ishida K, 2008, PLANT CELL PHYSIOL, V49, P47, DOI 10.1093/pcp/pcm165; Ji JB, 2010, PLANT PHYSIOL, V152, P1346, DOI 10.1104/pp.109.149641; Jiang CunCang, 2009, Plant Nutrition and Fertilizer Science, V15, P656; Kakimoto T, 2003, ANNU REV PLANT BIOL, V54, P605, DOI 10.1146/annurev.arplant.54.031902.134802; Kasajima I, 2010, PHYSIOL PLANTARUM, V139, P80, DOI 10.1111/j.1399-3054.2010.01349.x; KASTORI R, 1995, J PLANT NUTR, V18, P1751, DOI 10.1080/01904169509365021; Kobayashi M, 1996, PLANT PHYSIOL, V110, P1017, DOI 10.1104/pp.110.3.1017; Komaki S, 2012, PLANT CELL PHYSIOL, V53, P953, DOI 10.1093/pcp/pcs070; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; Kubo M, 2004, J PLANT RES, V117, P121; Li HP, 2009, PLANT MICROSCOPY TEC; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu Z., 1980, Acta Pedologica Sinica, V17, P228; Liu Z, 1989, ACTA PEDOLOGICA SINI, V4, P006; Magyar Z, 1997, PLANT CELL, V9, P223, DOI 10.1105/tpc.9.2.223; Mahonen AP, 2000, GENE DEV, V14, P2938, DOI 10.1101/gad.189200; Main D, 2012, PLANT ANIMAL GENOME; Matsumoto-Kitano M, 2008, P NATL ACAD SCI USA, V105, P20027, DOI 10.1073/pnas.0805619105; Miwa K, 2006, PLANT J, V46, P1084, DOI 10.1111/j.1365-313X.2006.02763.x; Miwa K, 2010, ADV EXP MED BIOL, V679, P83; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muller B, 2007, SCIENCE, V318, P68, DOI 10.1126/science.1145461; Nakagawa Y, 2007, PLANT CELL, V19, P2624, DOI 10.1105/tpc.106.049015; Nieminen K, 2008, P NATL ACAD SCI USA, V105, P20032, DOI 10.1073/pnas.0805617106; O'Neill MA, 2004, ANNU REV PLANT BIOL, V55, P109, DOI 10.1146/annurev.arplant.55.031903.141750; OBREZA T.A, 2008, NUTR FLORIDA CITRUS; Papadakis IE, 2004, ENVIRON EXP BOT, V51, P247, DOI 10.1016/j.envexpbot.2003.11.004; Papadakis IE, 2004, PLANT SCI, V166, P539, DOI 10.1016/j.plantsci.2003.10.027; Porceddu A, 2001, J BIOL CHEM, V276, P36354, DOI 10.1074/jbc.M011060200; Reguera M, 2010, J PLANT PHYSIOL, V167, P625, DOI 10.1016/j.jplph.2009.11.017; Rerkasem B, 2004, FIELD CROP RES, V89, P173, DOI 10.1016/j.fcr.2004.01.022; Ruiz JM, 1998, PHYTOCHEMISTRY, V48, P269, DOI 10.1016/S0031-9422(97)01132-1; Ryden P, 2003, PLANT PHYSIOL, V132, P1033, DOI 10.1104/pp.103.021873; Sakai H, 2000, PLANT J, V24, P703, DOI 10.1046/j.1365-313x.2000.00909.x; SCHERES B, 1995, DEVELOPMENT, V121, P53; Sheng O, 2009, SCI HORTIC-AMSTERDAM, V121, P278, DOI 10.1016/j.scienta.2009.02.009; Shorrocks VM, 1997, PLANT SOIL, V193, P121, DOI 10.1023/A:1004216126069; Takano J, 2005, P NATL ACAD SCI USA, V102, P12276, DOI 10.1073/pnas.0502060102; Takano J, 2001, SOIL SCI PLANT NUTR, V47, P345, DOI 10.1080/00380768.2001.10408398; Takano J, 2006, PLANT CELL, V18, P1498, DOI 10.1105/tpc.106.041640; Tanaka M, 2008, PLANT CELL, V20, P2860, DOI 10.1105/tpc.108.058628; Tanaka M, 2008, PFLUG ARCH EUR J PHY, V456, P671, DOI 10.1007/s00424-007-0370-8; Tanaka M, 2011, PLANT CELL, V23, P3547, DOI 10.1105/tpc.111.088351; Tewari RK, 2010, TREE PHYSIOL, V30, P68, DOI 10.1093/treephys/tpp093; Wang HZ, 2012, MOL PLANT, V5, P297, DOI 10.1093/mp/ssr098; Warington K, 1923, ANN BOT-LONDON, V37, P629, DOI 10.1093/oxfordjournals.aob.a089871; Xiao JX, 2007, J PLANT NUTR, V30, P671, DOI 10.1080/01904160701289347; Yamaguchi M, 2008, PLANT J, V55, P652, DOI 10.1111/j.1365-313X.2008.03533.x; Yokoyama A, 2007, PLANT CELL PHYSIOL, V48, P84, DOI 10.1093/pcp/pcl040; Zhao ZK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045215	72	30	32	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65737	10.1371/journal.pone.0065737	http://dx.doi.org/10.1371/journal.pone.0065737			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755275	Green Submitted, Green Published, gold			2022-12-27	WOS:000320579400075
J	Li, QY; Zhang, ZY; Li, ZM; Zhou, M; Liu, B; Pan, L; Ma, ZX; Zheng, YF				Li, Qingyu; Zhang, Zhengyu; Li, Zengmin; Zhou, Mei; Liu, Bin; Pan, Le; Ma, Zhixing; Zheng, Yufang			ADAM17 Is Critical for Multipolar Exit and Radial Migration of Neuronal Intermediate Progenitor Cells in Mice Cerebral Cortex	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; POSTTRANSCRIPTIONAL UP-REGULATION; CONVERTING-ENZYME; NEURITE OUTGROWTH; CORTICAL-NEURONS; GENE-TRANSFER; EGFR LIGANDS; STEM-CELLS; RECEPTOR; BRAIN	The radial migration of neuronal progenitor cells is critical for the development of cerebral cortex layers. They go through a critical step transforming from multipolar to bipolar before outward migration. A Disintegrin and Metalloprotease 17 (ADAM17) is a transmembrane protease which can process many substrates involved in cell-cell interaction, including Notch, ligands of EGFR, and some cell adhesion molecules. In this study, we used in utero electroporation to knock down or overexpress ADAM17 at embryonic day 14.5 (E14.5) in neuronal progenitor cells to examine the role of ADAM17 in cortical embryonic neurogenesis. Our results showed that the radial migration of ADAM17-knocked down cells were normal till E16.5 and reached the intermediate zone (IZ). Then most transfected cells stopped migration and stayed at the IZ to inner cortical plate (CP) layer at E18.5, and there was higher percentage of multipolar cells at IZ layer in the ADAM17-knocked down group compared to the cells in control group. Marker staining revealed that those ADAM17-knocked down cells differentiated normally from neural stem cells (NSCs) to neuronal intermediate progenitor cells (nIPCs) but did not differentiate into mature neurons. The migration and multipolar exit defects caused by ADAM17 knockdown could be partially rescued by over-expressing an shRNA resistant ADAM17, while overexpressing ADAM17 alone did not affect the radial migration. Taken together, our results showed for the first time that, ADAM17 is critical in regulating the multipolar-stage exit and radial migration of the nIPCs during telencephalon cortex development in mice.	[Li, Qingyu; Zhang, Zhengyu; Li, Zengmin; Zhou, Mei; Liu, Bin; Pan, Le; Ma, Zhixing; Zheng, Yufang] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China	Fudan University	Zheng, YF (corresponding author), Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China.	zhengyf@fudan.edu.cn	Zheng, Yufang/F-1091-2011	Zheng, Yufang/0000-0002-0488-2624; Li, Zengmin/0000-0001-5870-6557	National Nature Science Foundation of China [30800322]; National Basic Research Program of China (973 Program) [2011CB503703, 2013CB945404]; Shanghai Leading Academic Discipline Project [B111]; Shanghai Pujiang Program [08PJ1401300]; Ministry of Education start fund; Ministry of Education Research Fund for New Teachers in Doctoral Program of Higher Educational Institutes [200802461050]; Zuoxue project of Fudan University	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Shanghai Pujiang Program(Shanghai Pujiang Program); Ministry of Education start fund; Ministry of Education Research Fund for New Teachers in Doctoral Program of Higher Educational Institutes; Zuoxue project of Fudan University	This work was supported by National Nature Science Foundation of China (grant number 30800322); National Basic Research Program of China (973 Program, grant number 2011CB503703 and 2013CB945404); the Shanghai Leading Academic Discipline Project (grant number B111); Shanghai Pujiang Program (grant number 08PJ1401300); Ministry of Education start fund to returned overseas scholars; Ministry of Education Research Fund for New Teachers in Doctoral Program of Higher Educational Institutes (grant number 200802461050); and Zuoxue project of Fudan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton ES, 1997, DEVELOPMENT, V124, P3501; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; BAUMRIND NL, 1992, DEV DYNAM, V194, P311, DOI 10.1002/aja.1001940407; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Bozkulak EC, 2009, MOL CELL BIOL, V29, P5679, DOI 10.1128/MCB.00406-09; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Bzowska M, 2004, EUR J BIOCHEM, V271, P2808, DOI 10.1111/j.1432-1033.2004.04215.x; Caric D, 2001, DEVELOPMENT, V128, P4203; Charbonneau M, 2007, J BIOL CHEM, V282, P33714, DOI 10.1074/jbc.M704041200; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Freeman MR, 2010, SCIENCE, V330, P774, DOI 10.1126/science.1190928; Ghashghaei HT, 2006, P NATL ACAD SCI USA, V103, P1930, DOI 10.1073/pnas.0510410103; Gordon WR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006613; Gordon WR, 2009, BLOOD, V113, P4381, DOI 10.1182/blood-2008-08-174748; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hinkle CL, 2004, J BIOL CHEM, V279, P24179, DOI 10.1074/jbc.M312141200; Ip JPK, 2012, NAT NEUROSCI, V15, P39, DOI 10.1038/nn.2972; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Jossin Y, 2011, NAT NEUROSCI, V14, P697, DOI 10.1038/nn.2816; Kalus I, 2006, J NEUROCHEM, V98, P78, DOI 10.1111/j.1471-4159.2006.03847.x; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lee DC, 2003, ANN NY ACAD SCI, V995, P22, DOI 10.1111/j.1749-6632.2003.tb03207.x; Li L, 2012, J NEUROSCI, V32, P12673, DOI 10.1523/JNEUROSCI.0016-12.2012; Liu WH, 2010, J CELL BIOCHEM, V111, P148, DOI 10.1002/jcb.22681; Liu XX, 2012, P NATL ACAD SCI USA, V109, P8280, DOI 10.1073/pnas.1205880109; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Nadarajah B, 2003, CEREB CORTEX, V13, P607, DOI 10.1093/cercor/13.6.607; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Nikolaidis NM, 2010, SHOCK, V33, P197, DOI 10.1097/SHK.0b013e3181ae8155; Okamura Y, 2011, NEUROSCI RES, V71, P63, DOI 10.1016/j.neures.2011.05.012; Oyagi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007461; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Poluch S, 2007, GLIA, V55, P822, DOI 10.1002/glia.20488; Pruessmeyer J, 2009, SEMIN CELL DEV BIOL, V20, P164, DOI 10.1016/j.semcdb.2008.09.005; Rakic P, 1998, J AM ACAD CHILD PSY, V37, P116, DOI 10.1097/00004583-199801000-00026; Ramasamy SK, 2010, MOL CELL BIOL, V30, P1946, DOI 10.1128/MCB.01419-09; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; Saftig P, 2010, EUR J CELL BIOL; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Santiago-Josefat B, 2007, J BIOL CHEM, V282, P8325, DOI 10.1074/jbc.M608826200; Shi W, 2003, DEV BIOL, V261, P371, DOI 10.1016/S0012-1606(03)00315-4; Shimogori T, 2010, NAT NEUROSCI, V13, P767, DOI 10.1038/nn.2545; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; Szalad A, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-129; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Takahashi M, 2002, DIFFERENTIATION, V70, P155, DOI 10.1046/j.1432-0436.2002.700405.x; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Tropepe V, 1997, J NEUROSCI, V17, P7850; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; Westerlund N, 2011, NAT NEUROSCI, V14, P305, DOI 10.1038/nn.2755; Yang P, 2006, PROG NEUROBIOL, V79, P73, DOI 10.1016/j.pneurobio.2006.05.001; Zhao JS, 2001, DEV BIOL, V232, P204, DOI 10.1006/dbio.2001.0176	57	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65703	10.1371/journal.pone.0065703	http://dx.doi.org/10.1371/journal.pone.0065703			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755270	gold, Green Published, Green Submitted			2022-12-27	WOS:000319872300091
J	Ronsholt, FF; Ullum, H; Katzenstein, TL; Gerstoft, J; Ostrowski, SR				Ronsholt, Frederikke F.; Ullum, Henrik; Katzenstein, Terese L.; Gerstoft, Jan; Ostrowski, Sisse R.			Persistent Inflammation and Endothelial Activation in HIV-1 Infected Patients after 12 Years of Antiretroviral Therapy	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; PLASMA-LEVELS; MARKERS	Objective: The study investigated markers of inflammation and endothelial activation in HIV infected patients after 12 years of successful combination antiretroviral treatment (cART). Methods: Inflammation and endothelial activation were assessed by measuring levels of immunoglobulins, beta 2-microglobulin, interleukin (IL) 8, tumor necrosis factor alpha (TNF alpha), vascular cell adhesion molecule-1 (sVCAM-1), intercellular adhesion molecule-1 (sICAM-1), sE-Selectin, and sP-Selectin. Results: HIV infected patients had higher levels of beta 2-microglobulin, IL-8, TNF alpha, and sICAM-1 than uninfected controls, and HIV infected patients lacked correlation between platelet counts and sP-Selectin levels found in uninfected controls. Conclusion: Discrete signs of systemic and vascular inflammation persist even after very long term cART.	[Ronsholt, Frederikke F.; Katzenstein, Terese L.; Gerstoft, Jan] Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Ullum, Henrik; Ostrowski, Sisse R.] Rigshosp, Dept Clin Immunol, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Ronsholt, FF (corresponding author), Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark.	frederikkefr@gmail.com	Ostrowski, Sisse R/E-7423-2011	Ostrowski, Sisse R/0000-0001-5288-3851; Ullum, Henrik/0000-0001-7306-9058; Katzenstein, Terese L/0000-0002-2233-500X; Ronsholt, Frederikke/0000-0002-1170-5896	Danish Medical Research Council; The Danish AIDS Foundation; A.P. Moller and wife Chastine Mc-Kinney Mollers Foundation (Fonden til Laegevidenskabens Fremme); Augustinus Foundation; Rigshospitalets Forskningspulje	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Danish AIDS Foundation; A.P. Moller and wife Chastine Mc-Kinney Mollers Foundation (Fonden til Laegevidenskabens Fremme); Augustinus Foundation; Rigshospitalets Forskningspulje	This work was supported by the Danish Medical Research Council, The Danish AIDS Foundation, A.P. Moller and wife Chastine Mc-Kinney Mollers Foundation (Fonden til Laegevidenskabens Fremme) and the Augustinus Foundation and Rigshospitalets Forskningspulje. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aukrust P, 1999, J INFECT DIS, V179, P74, DOI 10.1086/314572; Blake GJ, 2002, J INTERN MED, V252, P283, DOI 10.1046/j.1365-2796.2002.01019.x; Calza L, 2009, JAIDS-J ACQ IMM DEF, V50, P430, DOI 10.1097/QAI.0b013e31819a292c; Corrales-Medina VF, 2010, JAIDS-J ACQ IMM DEF, V54, P217, DOI 10.1097/QAI.0b013e3181c8f4c9; DEGAETANO DK, 2004, LANCET INFECT DIS, V4, P213, DOI DOI 10.1016/S1473-3099(04)00971-5; Fichtenbaum Carl J, 2011, Curr Infect Dis Rep, V13, P94, DOI 10.1007/s11908-010-0153-9; Franco JM, 1999, EUR J CLIN MICROBIOL, V18, P733, DOI 10.1007/s100960050388; Haissman JM, 2009, JAIDS-J ACQ IMM DEF, V52, P493, DOI 10.1097/QAI.0b013e3181b627dc; Hasse B, 2011, CLIN INFECT DIS, V53, P1130, DOI 10.1093/cid/cir626; Havlir DV, 2003, J VIROL, V77, P11212, DOI 10.1128/JVI.77.20.11212-11219.2003; Landro L, 2011, J THROMB HAEMOST, V9, P1075, DOI 10.1111/j.1538-7836.2011.04242.x; Regidor DL, 2011, AIDS, V25, P303, DOI 10.1097/QAD.0b013e32834273ad; Ronsholt FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039356; Sachdeva RK, 2010, J INTERF CYTOK RES, V30, P299, DOI 10.1089/jir.2009.0056; Sundd P, 2011, BIORHEOLOGY, V48, P1, DOI 10.3233/BIR-2011-0579; Wolf K, 2002, J INFECT DIS, V185, P456, DOI 10.1086/338572	16	59	60	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65182	10.1371/journal.pone.0065182	http://dx.doi.org/10.1371/journal.pone.0065182			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755191	gold, Green Published, Green Submitted			2022-12-27	WOS:000319872300055
J	Serra, L; Cercignani, M; Carlesimo, GA; Fadda, L; Tini, N; Giulietti, G; Caltagirone, C; Bozzali, M				Serra, Laura; Cercignani, Mara; Carlesimo, Giovanni A.; Fadda, Lucia; Tini, Nadia; Giulietti, Giovanni; Caltagirone, Carlo; Bozzali, Marco			Connectivity-Based Parcellation of the Thalamus Explains Specific Cognitive and Behavioural Symptoms in Patients with Bilateral Thalamic Infarct	PLOS ONE			English	Article							INTERNAL MEDULLARY LAMINA; DIFFUSION TENSOR; NORMATIVE DATA; MEMORY; LESIONS; NUCLEI; CORTEX; DISINHIBITION; SEGMENTATION; ASYMMETRIES	A novel approach based on diffusion tractography was used here to characterise the cortico-thalamic connectivity in two patients, both presenting with an isolated bilateral infarct in the thalamus, but exhibiting partially different cognitive and behavioural profiles. Both patients (G. P. and R. F.) had a pervasive deficit in episodic memory, but only one of them (R. F.) suffered also from a dysexecutive syndrome. Both patients had an MRI scan at 3T, including a T1-weighted volume. Their lesions were manually segmented. T1-volumes were normalised to standard space, and the same transformations were applied to the lesion masks. Nineteen healthy controls underwent a diffusion-tensor imaging (DTI) scan. Their DTI data were normalised to standard space and averaged. An atlas of Brodmann areas was used to parcellate the prefrontal cortex. Probabilistic tractography was used to assess the probability of connection between each voxel of the thalamus and a set of prefrontal areas. The resulting map of corticothalamic connections was superimposed onto the patients' lesion masks, to assess whether the location of the thalamic lesions in R.F. (but not in G. P.) implied connections with prefrontal areas involved in dysexecutive syndromes. In G.P., the lesion fell within areas of the thalamus poorly connected with prefrontal areas, showing only a modest probability of connection with the anterior cingulate cortex (ACC). Conversely, R.F.'s lesion fell within thalamic areas extensively connected with the ACC bilaterally, with the right dorsolateral prefrontal cortex, and with the left supplementary motor area. Despite a similar, bilateral involvement of the thalamus, the use of connectivity-based segmentation clarified that R.F.'s lesions only were located within nuclei highly connected with the prefrontal cortical areas, thus explaining the patient's frontal syndrome. This study confirms that DTI tractography is a useful tool to examine in vivo the effect of focal lesions on interconnectivity brain patterns.	[Serra, Laura; Cercignani, Mara; Giulietti, Giovanni; Bozzali, Marco] Santa Lucia Fdn, Neuroimaging Lab, IRCCS, Rome, Italy; [Cercignani, Mara] Brighton & Sussex Med Sch, Clin Imaging Sci Ctr, Falmer, England; [Carlesimo, Giovanni A.; Fadda, Lucia; Tini, Nadia; Caltagirone, Carlo] Santa Lucia Fdn, Dept Clin & Behav Neurol, IRCCS, Rome, Italy; [Carlesimo, Giovanni A.; Fadda, Lucia; Caltagirone, Carlo] Univ Roma Tor Vergata, Neurol Clin, Rome, Italy	IRCCS Santa Lucia; University of Brighton; University of Sussex; IRCCS Santa Lucia; University of Rome Tor Vergata	Bozzali, M (corresponding author), Santa Lucia Fdn, Neuroimaging Lab, IRCCS, Rome, Italy.	m.bozzali@hsantalucia.it	Serra, Laura/K-5637-2016; Giulietti, Giovanni/D-2771-2009; Bozzali, Marco/AAC-1031-2022	Serra, Laura/0000-0002-2717-1286; Fadda, Lucia/0000-0003-0659-9416; Cercignani, Mara/0000-0002-4550-2456; Bozzali, Marco/0000-0002-0568-2026				Alexander DC, 2001, IEEE T MED IMAGING, V20, P1131, DOI 10.1109/42.963816; Alkonyi B, 2011, AM J NEURORADIOL, V32, P962, DOI 10.3174/ajnr.A2417; Andersson J.L.R, 2007, TR07JA2 FMRIB; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Braver TS, 2002, NEUROIMAGE, V15, P523, DOI 10.1006/nimg.2001.1019; Burgess PW, 2011, NEUROPSYCHOLOGIA, V49, P2246, DOI 10.1016/j.neuropsychologia.2011.02.014; Carlesimo G., 2002, NUOVA RIV NEUROL, V12, P1, DOI DOI 10.1080/17408989.2016.1268591; Carlesimo GA, 2007, NEUROPSYCHOLOGIA, V45, P2467, DOI 10.1016/j.neuropsychologia.2007.03.025; Carlesimo GA, 2011, NEUROPSYCHOLOGIA, V49, P2199, DOI 10.1016/j.neuropsychologia.2010.11.013; Carlesimo GA, 1996, EUR NEUROL, V36, P378, DOI 10.1159/000117297; Carlesimo GA, 2011, NEUROPSYCHOLOGIA, V49, P777, DOI 10.1016/j.neuropsychologia.2011.01.026; Catani M, 2012, CORTEX, V48, P273, DOI 10.1016/j.cortex.2011.12.001; Cercignani M, 2012, NMR BIOMED, V25, P1224, DOI 10.1002/nbm.2793; Chase HW, 2008, NEUROPSYCHOLOGIA, V46, P2650, DOI 10.1016/j.neuropsychologia.2008.04.021; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Eckert U, 2012, HUM BRAIN MAPP, V33, P2627, DOI 10.1002/hbm.21389; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Hughes EJ, 2012, NEUROIMAGE, V63, P1134, DOI 10.1016/j.neuroimage.2012.07.043; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; Klein JC, 2010, NEUROIMAGE, V51, P555, DOI 10.1016/j.neuroimage.2010.02.062; Krause M, 2012, CORTEX, V48, P97, DOI 10.1016/j.cortex.2011.03.014; Liebermann D, 2011, DYSEXECUTIVE SYNDROM, DOI [10.1016/j.cortex.2011.11.005, DOI 10.1016/J.C0RTEX.2011.11.005]; Massimo L, 2009, DEMENT GERIATR COGN, V27, P96, DOI 10.1159/000194658; MORI E, 1986, ANN NEUROL, V20, P671, DOI 10.1002/ana.410200604; Niendam TA, 2012, COGN AFFECT BEHAV NE, V12, P241, DOI 10.3758/s13415-011-0083-5; Nocentini U., 2002, NUOVA RIV NEUROLOGIA, V12, P14, DOI DOI 10.1080/00336297.2015.1051236; Nyhus E, 2009, BRAIN COGNITION, V71, P437, DOI 10.1016/j.bandc.2009.03.005; ORSINI A, 1987, ITAL J NEUROL SCI, V8, P539; Parker GJM, 2003, J MAGN RESON IMAGING, V18, P242, DOI 10.1002/jmri.10350; Saenger VM, 2012, NEUROPSYCHOLOGIA, V50, P1308, DOI 10.1016/j.neuropsychologia.2012.02.014; Savage LM, 1998, BEHAV NEUROSCI, V112, P1339, DOI 10.1037/0735-7044.112.6.1339; Savage LM, 1997, BEHAV BRAIN RES, V82, P133, DOI 10.1016/S0166-4328(97)80983-7; SODEYAMA N, 1995, J NEUROL, V242, P289, DOI 10.1007/BF00878870; Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7; Van der Werf YD, 2003, NEUROPSYCHOLOGIA, V41, P1330, DOI 10.1016/S0028-3932(03)00059-9; Wiegell MR, 2003, NEUROIMAGE, V19, P391, DOI 10.1016/S1053-8119(03)00044-2; Zamboni G, 2008, NEUROLOGY, V71, P736, DOI 10.1212/01.wnl.0000324920.96835.95	39	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64578	10.1371/journal.pone.0064578	http://dx.doi.org/10.1371/journal.pone.0064578			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755128	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000319872300019
J	Zetterqvist, AV; Berglund, LM; Blanco, F; Garcia-Vaz, E; Wigren, M; Duner, P; Andersson, AMD; To, F; Spegel, P; Nilsson, J; Bengtsson, E; Gomez, MF				Zetterqvist, Anna V.; Berglund, Lisa M.; Blanco, Fabiana; Garcia-Vaz, Eliana; Wigren, Maria; Duner, Pontus; Andersson, Anna-Maria Dutius; To, Fong; Spegel, Peter; Nilsson, Jan; Bengtsson, Eva; Gomez, Maria F.			Inhibition of Nuclear Factor of Activated T-Cells (NFAT) Suppresses Accelerated Atherosclerosis in Diabetic Mice	PLOS ONE			English	Article							SMOOTH-MUSCLE; MYOCARDIAL-INFARCTION; RECEPTOR; EXPRESSION; GLUCOSE; RISK; GENE; INTERLEUKIN-6; PATHWAYS; LESIONS	Objective of the Study: Diabetic patients have a much more widespread and aggressive form of atherosclerosis and therefore, higher risk for myocardial infarction, peripheral vascular disease and stroke, but the molecular mechanisms leading to accelerated damage are still unclear. Recently, we showed that hyperglycemia activates the transcription factor NFAT in the arterial wall, inducing the expression of the pro-atherosclerotic protein osteopontin. Here we investigate whether NFAT activation may be a link between diabetes and atherogenesis. Methodology and Principal Findings: Streptozotocin (STZ)-induced diabetes in apolipoprotein E-/- mice resulted in 2.2 fold increased aortic atherosclerosis and enhanced pro-inflammatory burden, as evidenced by elevated blood monocytes, endothelial activation- and inflammatory markers in aorta, and pro-inflammatory cytokines in plasma. In vivo treatment with the NFAT blocker A-285222 for 4 weeks completely inhibited the diabetes-induced aggravation of atherosclerosis, having no effect in non-diabetic mice. STZ-treated mice exhibited hyperglycemia and higher plasma cholesterol and triglycerides, but these were unaffected by A-285222. NFAT-dependent transcriptional activity was examined in aorta, spleen, thymus, brain, heart, liver and kidney, but only augmented in the aorta of diabetic mice. A-285222 completely blocked this diabetes-driven NFAT activation, but had no impact on the other organs or on splenocyte proliferation or cytokine secretion, ruling out systemic immunosuppression as the mechanism behind reduced atherosclerosis. Instead, NFAT inhibition effectively reduced IL-6, osteopontin, monocyte chemotactic protein 1, intercellular adhesion molecule 1, CD68 and tissue factor expression in the arterial wall and lowered plasma IL-6 in diabetic mice. Conclusions: Targeting NFAT signaling may be a novel and attractive approach for the treatment of diabetic macrovascular complications.	[Zetterqvist, Anna V.; Berglund, Lisa M.; Blanco, Fabiana; Garcia-Vaz, Eliana; Wigren, Maria; Duner, Pontus; Andersson, Anna-Maria Dutius; To, Fong; Spegel, Peter; Nilsson, Jan; Bengtsson, Eva; Gomez, Maria F.] Lund Univ, Dept Clin Sci Malmo, Malmo, Sweden	Lund University	Gomez, MF (corresponding author), Lund Univ, Dept Clin Sci Malmo, Malmo, Sweden.	maria.gomez@med.lu.se	Gomez, Maria F/D-3696-2014; Spégel, Peter/G-9947-2018; Bengtsson, Eva/AAA-1968-2019; Bengtsson, Eva/AGH-2754-2022	Gomez, Maria F/0000-0001-6210-3142; Spégel, Peter/0000-0002-6092-2387; Bengtsson, Eva/0000-0001-7075-1772; Duner, Pontus/0000-0003-4171-5646; Blanco Camera, Fabiana/0000-0003-0027-8371; Berglund, Lisa/0000-0001-6440-116X	Swedish Heart and Lung Foundation [HLF20080843, HLF20100532]; Swedish Research Council [2009-4120, 2011-3900, 2009-1039]; Lund University Diabetes Centre; Swedish Medical Society; Swedish Society for Medical Research; Royal Physiographic Society in Lund; Skane Hospital Research Funds; Crafoord foundation; Albert Pahlsson foundation; Lars Hierta Memorial foundation; Knut & Alice Wallenberg foundation; Innovative Medicines Initiative Joint Undertaking [115006]; European Union's Seventh Framework Programme [FP7]; EFPIA	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Lund University Diabetes Centre; Swedish Medical Society; Swedish Society for Medical Research; Royal Physiographic Society in Lund; Skane Hospital Research Funds; Crafoord foundation; Albert Pahlsson foundation; Lars Hierta Memorial foundation; Knut & Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Innovative Medicines Initiative Joint Undertaking; European Union's Seventh Framework Programme [FP7]; EFPIA	This work was supported by the Swedish Heart and Lung Foundation [HLF20080843; HLF20100532]; the Swedish Research Council [#2009-4120; #2011-3900; #2009-1039], Lund University Diabetes Centre, the Swedish Medical Society; the Swedish Society for Medical Research, the Royal Physiographic Society in Lund, Skane Hospital Research Funds, and Crafoord; Albert Pahlsson; Lars Hierta Memorial; and the Knut & Alice Wallenberg foundations. This work was also supported by Innovative Medicines Initiative Joint Undertaking [#115006], comprising funds from the European Union's Seventh Framework Programme [FP7/2007-2013] and EFPIA companies' in kind contribution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KL, 2000, MOL PHARMACOL, V58, P946, DOI 10.1124/mol.58.5.946; Amberg GC, 2004, J BIOL CHEM, V279, P47326, DOI 10.1074/jbc.M408789200; Awla D, 2012, GASTROENTEROLOGY; Berglund LM, 2012, CARDIOVASC RES, V93, P414, DOI 10.1093/cvr/cvr309; Birsan T, 2004, TRANSPL INT, V17, P145, DOI 10.1007/s00147-003-0676-1; Bochkov VN, 2002, BLOOD, V99, P199, DOI 10.1182/blood.V99.1.199; Breitenstein A, 2010, CLIN SCI, V118, P159, DOI 10.1042/CS20080622; Brown A, 2010, NAT REV CARDIOL, V7, P369, DOI 10.1038/nrcardio.2010.35; Carmeliet P, 1997, NAT GENET, V17, P439, DOI 10.1038/ng1297-439; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Donners MMPC, 2005, AM J TRANSPLANT, V5, P1204, DOI 10.1111/j.1600-6143.2005.00821.x; Engelbertsen D, 2013, ARTERIOSCL THROM VAS, V33, P637, DOI 10.1161/ATVBAHA.112.300871; Fredrikson GN, 2003, ARTERIOSCL THROM VAS, V23, P879, DOI 10.1161/01.ATV.0000067937.93716.DB; Gustavsson C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012699; Karpurapu M, 2010, J BIOL CHEM, V285, P3510, DOI 10.1074/jbc.M109.063727; Kockx M, 2010, PHARMACOL THERAPEUT, V128, P106, DOI 10.1016/j.pharmthera.2010.06.001; Kolbus D, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-58; Lee MY, 2010, HUM MOL GENET, V19, P468, DOI 10.1093/hmg/ddp511; Lipskaia L, 2005, CIRC RES, V97, P488, DOI 10.1161/01.RES.0000180663.42594.aa; Lipskaia L, 2003, CIRC RES, V92, P1115, DOI 10.1161/01.RES.0000074880.25540.D0; Liu ZM, 2004, J BIOL CHEM, V279, P41218, DOI 10.1074/jbc.M406917200; Lohmann C, 2009, ATHEROSCLEROSIS, V207, P360, DOI 10.1016/j.atherosclerosis.2009.05.004; Maziere C, 2005, FREE RADICAL BIO MED, V38, P472, DOI 10.1016/j.freeradbiomed.2004.10.028; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Nieves-Cintron M, 2007, J BIOL CHEM, V282, P3231, DOI 10.1074/jbc.M608822200; Nilsson J, 2006, ARTERIOSCL THROM VAS, V26, P794, DOI 10.1161/01.ATV.0000209513.00765.13; Nilsson LM, 2008, CURR OPIN LIPIDOL, V19, P483, DOI 10.1097/MOL.0b013e32830dd545; Nilsson LM, 2007, AM J PHYSIOL-CELL PH, V292, pC1167, DOI 10.1152/ajpcell.00590.2005; Nilsson-Berglund LM, 2010, ARTERIOSCL THROM VAS, V30, P218, DOI 10.1161/ATVBAHA.109.199299; Norata GD, 2007, ATHEROSCLEROSIS, V193, P321, DOI 10.1016/j.atherosclerosis.2006.09.015; Orr AW, 2009, ARTERIOSCL THROM VAS, V29, P225, DOI 10.1161/ATVBAHA.108.178749; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; Prevost G, 2011, DIABETES METAB, V37, P106, DOI 10.1016/j.diabet.2010.08.005; Rahman S, 2007, DIABETES OBES METAB, V9, P767, DOI 10.1111/j.1463-1326.2006.00655.x; Rasmussen-Torvik LJ, 2011, DIABETES, V60, P331, DOI 10.2337/db10-0839; REDDICK RL, 1994, ARTERIOSCLER THROMB, V14, P141, DOI 10.1161/01.ATV.14.1.141; Schuett H, 2009, THROMB HAEMOSTASIS, V102, P215, DOI 10.1160/TH09-05-0297; Shi WB, 2003, ARTERIOSCL THROM VAS, V23, P1901, DOI 10.1161/01.ATV.0000091249.34404.B7; Takeda N, 2006, ARTERIOSCL THROM VAS, V26, P1177, DOI 10.1161/01.ATV.0000214296.94849.1c; Trevillyan JM, 2001, J BIOL CHEM, V276, P48118, DOI 10.1074/jbc.M107919200; Wigren M, 2012, ARTERIOSCL THROM VAS, V32, P2000, DOI 10.1161/ATVBAHA.112.251579; Wigren M, 2009, CIRC RES, V104, pE62, DOI 10.1161/CIRCRESAHA.109.196667; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18	43	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65020	10.1371/journal.pone.0065020	http://dx.doi.org/10.1371/journal.pone.0065020			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755169	gold, Green Published, Green Submitted			2022-12-27	WOS:000319872300042
J	Jiao, QJ; Huang, Y; Liu, W; Wang, XF; Chen, XS; Shen, HB				Jiao, Qing-Ju; Huang, Yan; Liu, Wei; Wang, Xiao-Fan; Chen, Xiao-Shuang; Shen, Hong-Bin			Revealing the Hidden Relationship by Sparse Modules in Complex Networks with a Large-Scale Analysis	PLOS ONE			English	Article							COMMUNITY STRUCTURE; GENE-COEXPRESSION; IDENTIFICATION; ORGANIZATION; MODULARITY; ONTOLOGY; TOOL	One of the remarkable features of networks is module that can provide useful insights into not only network organizations but also functional behaviors between their components. Comprehensive efforts have been devoted to investigating cohesive modules in the past decade. However, it is still not clear whether there are important structural characteristics of the nodes that do not belong to any cohesive module. In order to answer this question, we performed a large-scale analysis on 25 complex networks with different types and scales using our recently developed BTS (bintree seeking) algorithm, which is able to detect both cohesive and sparse modules in the network. Our results reveal that the sparse modules composed by the cohesively isolated nodes widely co-exist with the cohesive modules. Detailed analysis shows that both types of modules provide better characterization for the division of a network into functional units than merely cohesive modules, because the sparse modules possibly re-organize the nodes in the so-called cohesive modules, which lack obvious modular significance, into meaningful groups. Compared with cohesive modules, the sizes of sparse ones are generally smaller. Sparse modules are also found to have preferences in social and biological networks than others.	[Jiao, Qing-Ju; Liu, Wei; Wang, Xiao-Fan; Shen, Hong-Bin] Shanghai Jiao Tong Univ, Dept Automat, Shanghai 200030, Peoples R China; [Jiao, Qing-Ju; Liu, Wei; Wang, Xiao-Fan; Shen, Hong-Bin] Minist Educ China, Key Lab Syst Control & Informat Proc, Shanghai, Peoples R China; [Huang, Yan; Chen, Xiao-Shuang] Chinese Acad Sci, Natl Lab Infrared Phys, Shanghai Inst Tech Phys, Shanghai, Peoples R China	Shanghai Jiao Tong University; Ministry of Education, China; Chinese Academy of Sciences; Shanghai Institute of Technical Physics, CAS	Shen, HB (corresponding author), Shanghai Jiao Tong Univ, Dept Automat, Shanghai 200030, Peoples R China.	xfwang@sjtu.edu.cn; xschen@mail.sitp.ac.cn; hbshen@sjtu.edu.cn			National Natural Science Foundation of China [91130033, 61175024]; Shanghai Science and Technology Commission [11JC1404800]; A Foundation for the Author of National Excellent Doctoral Dissertation of PR China [201048]; Program for New Century Excellent Talents in University [NCET-11-0330]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); A Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Natural Science Foundation of China (No. 91130033, 61175024), Shanghai Science and Technology Commission (No. 11JC1404800), A Foundation for the Author of National Excellent Doctoral Dissertation of PR China (No. 201048), and Program for New Century Excellent Talents in University (NCET-11-0330). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Airoldi EM, 2008, J MACH LEARN RES, V9, P1981; [Anonymous], [No title captured]; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Bu DB, 2003, NUCLEIC ACIDS RES, V31, P2443, DOI 10.1093/nar/gkg340; Burt RS, 2005, BROKERAGE CLOSURE IN; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Coleman J. S., 1964, INTRO MATH SOCIOLOGY; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Davis A., 1941, DEEP S; De Nooy W., 2011, EXPLORATORY SOCIAL N, V2; Duch J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.027104; Flake GW, 2002, COMPUTER, V35, P66, DOI 10.1109/2.989932; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Fukushima A, 2012, PLANT PHYSIOL, V158, P1487, DOI 10.1104/pp.111.188367; Garfield E, 2001, S HON CAS BORK U PIT; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimera R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.025101; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Guimera R, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.065103; Jiao QJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027646; Knuth DE., 1993, STANFORD GRAPH BASE; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Leskovec J., 2008, P 17 INT C WORLD WID, P695, DOI DOI 10.1145/1367497.1367591; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Moody J, 2003, AM SOCIOL REV, V68, P103, DOI 10.2307/3088904; Newman MEJ, 2007, P NATL ACAD SCI USA, V104, P9564, DOI 10.1073/pnas.0610537104; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Obayashi T, 2011, PLANT CELL PHYSIOL, V52, P213, DOI 10.1093/pcp/pcq203; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Park YS, 2004, SCI TOTAL ENVIRON, V327, P105, DOI 10.1016/j.scitotenv.2004.01.014; Pinkert S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000659; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Reitz JM, 2010, ONLINE DICT LIB INFO; Richardson T, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.036111; Rosvall M, 2007, P NATL ACAD SCI USA, V104, P7327, DOI 10.1073/pnas.0611034104; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Scott J, 1980, ANATOMY SCOTTISH CAP; Small Mario Luis, 2009, UNANTICIPATED GAINS; Spangler JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045041; Srinivasasainagendra V, 2008, PLANT PHYSIOL, V147, P1004, DOI 10.1104/pp.107.115535; Stovel K, 2012, ANNU REV SOCIOL, V38, P139, DOI 10.1146/annurev-soc-081309-150054; Stovel K, 2011, P NATL ACAD SCI USA, V108, P21326, DOI 10.1073/pnas.1100920108; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Subelj L, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2011-20448-7; Subelj L, 2011, PHYSICA A, V390, P2968, DOI 10.1016/j.physa.2011.03.036; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Taube V., 2004, CONNECTIONS, V26, P29; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wei HR, 2006, PLANT PHYSIOL, V142, P762, DOI 10.1104/pp.106.080358; Weiss RS, 1955, AM SOCIOL REV, V20, P661, DOI 10.2307/2088670; Ye ZQ, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046115; Zhang XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043092	63	17	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e66020	10.1371/journal.pone.0066020	http://dx.doi.org/10.1371/journal.pone.0066020			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762457	Green Submitted, Green Published, gold			2022-12-27	WOS:000320440500058
J	Abu El-Asrar, AM; Mohammad, G; De Hertogh, G; Nawaz, MI; Van Den Eynde, K; Siddiquei, MM; Struyf, S; Opdenakker, G; Geboes, K				Abu El-Asrar, Ahmed M.; Mohammad, Ghulam; De Hertogh, Gert; Nawaz, Mohd Imtiaz; Van Den Eynde, Kathleen; Siddiquei, Mohammad Mairaj; Struyf, Sofie; Opdenakker, Ghislain; Geboes, Karel			Neurotrophins and Neurotrophin Receptors in Proliferative Diabetic Retinopathy	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; ENDOTHELIAL-CELLS; EXPRESSION; TRKA; SKIN; PATHOGENESIS; ACTIVATION; MIGRATION; SURVIVAL; CANCER	Neurotrophins (NTs) are emerging as important mediators of angiogenesis and fibrosis. We investigated the expression of the NTs nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and neurotrophin-4 (NT-4) and their receptors TrkA, TrkB, and TrkC in proliferative diabetic retinopathy (PDR). As a comparison, we examined the expression of NTs and their receptors in the retinas of diabetic rats. Vitreous samples from 16 PDR and 15 nondiabetic patients were studied by Western blot analysis and enzyme-linked immunosorbent assay (ELISA). Epiretinal membranes from 17 patients with PDR were studied by immunohistochemistry. Rats were made diabetic with a single high dose of streptozotocin and retinas of rats were examined by Western blot analysis. Western blot analysis revealed a significant increase in the expression of NT-3 and NT-4 and the shedding of receptors TrkA and TrkB in vitreous samples from PDR patients compared to nondiabetic controls, whereas NGF and BDNF and the receptor TrkC were not detected with the use of Western blot analysis and ELISA. In epiretinal membranes, vascular endothelial cells and myofibroblasts expressed NT-3 and the receptors TrkA, TrkB and TrkC in situ, whereas NT-4 was not detected. The expression levels of NT-3 and NT-4 and the receptors TrkA and TrkB, both in intact and solubilized forms, were upregulated in the retinas of diabetic rats, whereas the receptor TrkC was not detected. Co-immunoprecipitation studies revealed binding between NT-3 and the receptors TrkA and TrkB in the retinas of diabetic rats. Our findings in diabetic eyes from humans and rats suggest that the increased expression levels within the NT-3 and NT-4/Trk axis are associated with the progression of PDR.	[Abu El-Asrar, Ahmed M.; Mohammad, Ghulam; Nawaz, Mohd Imtiaz; Siddiquei, Mohammad Mairaj] King Saud Univ, Coll Med, Dept Ophthalmol, Riyadh 11461, Saudi Arabia; [De Hertogh, Gert; Van Den Eynde, Kathleen; Geboes, Karel] Univ Louvain, KU Leuven, Lab Histochem & Cytochem, Louvain, Belgium; [Struyf, Sofie; Opdenakker, Ghislain] Univ Louvain, KU Leuven, Rega Inst Med Res, Lab Mol Immunol, Louvain, Belgium; [Struyf, Sofie; Opdenakker, Ghislain] Univ Louvain, KU Leuven, Immunobiol Lab, Louvain, Belgium	King Saud University; KU Leuven; KU Leuven; KU Leuven	Abu El-Asrar, AM (corresponding author), King Saud Univ, Coll Med, Dept Ophthalmol, Riyadh 11461, Saudi Arabia.	abuasrar@KSU.edu.sa	NAWAZ, MOHD IMTIAZ/G-5193-2011; Abu El-Asrar, Ahmed/AAX-5055-2021; Opdenakker, Ghislain/Q-3130-2017; Mohammad, Ghulam/F-5623-2011; Struyf, Sofie/U-2455-2017; Opdenakker, Ghislain/V-8562-2019	NAWAZ, MOHD IMTIAZ/0000-0002-7040-9405; Opdenakker, Ghislain/0000-0003-1714-2294; Mohammad, Ghulam/0000-0002-6418-4772; Struyf, Sofie/0000-0003-4558-0769; Opdenakker, Ghislain/0000-0003-1714-2294; GHULAM, MOHAMMAD/0000-0001-7264-230X	Dr. Nasser Al-Rashid Research Chair in Ophthalmology; Fund for Scientific Research of Flanders (FWO-Vlaanderen, Belgium); Concerted Research Actions (G.O.A.) of the Regional Government of Flanders	Dr. Nasser Al-Rashid Research Chair in Ophthalmology; Fund for Scientific Research of Flanders (FWO-Vlaanderen, Belgium)(FWO); Concerted Research Actions (G.O.A.) of the Regional Government of Flanders	This work was supported by the Dr. Nasser Al-Rashid Research Chair in Ophthalmology. Research at the KU Leuven was supported by the Fund for Scientific Research of Flanders (FWO-Vlaanderen, Belgium) and the Concerted Research Actions (G.O.A.) of the Regional Government of Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu El-Asrar AM, 2006, EUR CYTOKINE NETW, V17, P155, DOI 10.1684/ecn.2006.0033; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Ali TK, 2008, DIABETES, V57, P889, DOI 10.2337/db07-1669; Avcuoglu S, 2011, AM J RESP CELL MOL, V45, P768, DOI 10.1165/rcmb.2010-0195OC; Birnbaum T, 2007, J NEURO-ONCOL, V83, P241, DOI 10.1007/s11060-007-9332-4; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; Cai F, 1999, NEUROSCI LETT, V263, P81, DOI 10.1016/S0304-3940(99)00124-X; Chen Y, 2007, J ANDROL, V28, P306, DOI 10.2164/jandrol.106.000794; Cristofaro B, 2010, ARTERIOSCL THROM VAS, V30, P1143, DOI 10.1161/ATVBAHA.109.205468; Dagnell C, 2007, TRANSL RES, V150, P303, DOI 10.1016/j.trsl.2007.05.001; Dagnell C, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-156; Diaz-Rodriguez E, 1999, EUR J NEUROSCI, V11, P1421, DOI 10.1046/j.1460-9568.1999.00552.x; Emanueli C, 2002, CIRCULATION, V106, P2257, DOI 10.1161/01.CIR.0000033971.56802.C5; Fragiadaki M, 2012, DIABETES, V61, P2280, DOI 10.2337/db11-1138; HAMMES HP, 1995, MOL MED, V1, P527, DOI 10.1007/BF03401589; Iannetti L, 2011, INVEST OPHTH VIS SCI, V52, P5786, DOI 10.1167/iovs.10-7116; Kennedy AJ, 1998, J NEUROL NEUROSUR PS, V65, P393, DOI 10.1136/jnnp.65.3.393; Kermani P, 2005, J CLIN INVEST, V115, P653, DOI 10.1172/JCI200522655; Kim H, 2004, J BIOL CHEM, V279, P33538, DOI 10.1074/jbc.M404115200; Kohyama T, 2002, J LAB CLIN MED, V140, P329, DOI 10.1067/mlc.2002.128347; Lagadec C, 2009, ONCOGENE, V28, P1960, DOI 10.1038/onc.2009.61; Lecht S, 2010, MOL CELL BIOCHEM, V339, P201, DOI 10.1007/s11010-010-0386-9; Micera A, 2001, P NATL ACAD SCI USA, V98, P6162, DOI 10.1073/pnas.101130898; Nakamura K, 2006, CANCER RES, V66, P4249, DOI 10.1158/0008-5472.CAN-05-2789; Nakamura K, 2011, MOL CELL NEUROSCI, V46, P498, DOI 10.1016/j.mcn.2010.12.002; Nawaz MI, 2013, EXP EYE RES, V109, P67, DOI 10.1016/j.exer.2013.01.008; Nico B, 2008, MICROVASC RES, V75, P135, DOI 10.1016/j.mvr.2007.07.004; Palazzo E, 2012, J CELL PHYSIOL, V227, P1017, DOI 10.1002/jcp.22811; Park KS, 2008, AM J OPHTHALMOL, V145, P432, DOI 10.1016/j.ajo.2007.11.011; Ricci A, 2001, AM J RESP CELL MOL, V25, P439, DOI 10.1165/ajrcmb.25.4.4470; Spranger J, 2001, EXP CLIN ENDOCR DIAB, V109, pS438, DOI 10.1055/s-2001-18601; Takeo C, 2003, BIOCHEM BIOPH RES CO, V305, P400, DOI 10.1016/S0006-291X(03)00770-8; Terenghi G, 1997, NEUROSCI LETT, V228, P33, DOI 10.1016/S0304-3940(97)00350-9; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277	34	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65472	10.1371/journal.pone.0065472	http://dx.doi.org/10.1371/journal.pone.0065472			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762379	Green Published, Green Submitted, gold			2022-12-27	WOS:000321094800053
J	Gao, MM; Bu, L; Ma, YJ; Liu, DX				Gao, Mingming; Bu, Le; Ma, Yongjie; Liu, Dexi			Concurrent Activation of Liver X Receptor and Peroxisome Proliferator-Activated Receptor Alpha Exacerbates Hepatic Steatosis in High Fat Diet-Induced Obese Mice	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; PPAR-ALPHA; LIPID-METABOLISM; INSULIN-RESISTANCE; CROSS-TALK; NUTRITIONAL REGULATION; ACID-METABOLISM; GENE-EXPRESSION; DIABETIC MICE; LXR	Liver X receptor (LXR) activation improves glucose homeostasis in obesity. This improvement, however, is associated with several side effects including hyperlipidemia and hepatic steatosis. Activation of peroxisome proliferator-activated receptor alpha (PPAR alpha), on the other hand, increases fatty acid oxidation, leading to a reduction of hyperlipidemia. The objective of this study was to investigate whether concurrent activation of LXR/PPAR alpha can produce synergistic benefits in treating obesity-associated metabolic disorders. Treatment of high fat diet-induced obese mice with T0901317, an LXR activator, or fenofibrate, the PPAR alpha agonist, or in combination alleviated insulin resistance and improved glucose tolerance. The combined treatment dramatically exacerbated hepatic steatosis. Gene expression analysis in the liver showed that combined treatment increased the expression of genes involved in lipogenesis and fatty acid transport, including srebp-1c, chrebp, acc1, fas, scd1 and cd36. Histochemistry and ex vivo glycerol releasing assay showed that combined treatment accelerated lipid mobilization in adipose tissue. Combined treatment also increased the transcription of glut4, hsl, atgl and adiponectin, and decreased that of plin1, cd11c, ifnc and leptin. Combined treatment markedly elevated the transcription of fgf21 in liver but not in adipose tissue. These results suggest that concurrent activation of LXR and PPAR alpha as a strategy to control glucose and lipid metabolism in obesity is beneficial but could lead to elevation of lipid accumulation in the liver.	[Gao, Mingming; Bu, Le; Ma, Yongjie; Liu, Dexi] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Liu, DX (corresponding author), Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA.	dliu@uga.edu	Gao, Mingming/F-4317-2016; MA, YONGJIE/O-3861-2015		National Institutes of Health (NIH) [RO1EB007357, RO1HL098295]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007357] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The work was supported in part by National Institutes of Health (NIH) (RO1EB007357, RO1HL098295) and no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer A, 2012, MOL ENDOCRINOL, V26, P1980, DOI 10.1210/me.2012-1151; Arsov T, 2006, BIOCHEM BIOPH RES CO, V342, P1152, DOI 10.1016/j.bbrc.2006.02.032; Baranowski M, 2008, J PHYSIOL PHARMACOL, V59, P31; Boergesen M, 2012, MOL CELL BIOL, V32, P852, DOI 10.1128/MCB.06175-11; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao GQ, 2003, J BIOL CHEM, V278, P1131, DOI 10.1074/jbc.M210208200; Carmona MC, 2005, INT J OBESITY, V29, P864, DOI 10.1038/sj.ijo.0802943; Chisholm JW, 2003, J LIPID RES, V44, P2039, DOI 10.1194/jlr.M300135-JLR200; Colin S, 2008, ENDOCRINOLOGY, V149, P5128, DOI 10.1210/en.2008-0637; Darimont C, 2006, BIOCHIMIE, V88, P309, DOI 10.1016/j.biochi.2005.08.010; Ducheix S, 2013, BIOCHIMIE, V95, P556, DOI 10.1016/j.biochi.2012.09.028; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Fernandez-Veledo S, 2006, DIABETOLOGIA, V49, P3038, DOI 10.1007/s00125-006-0472-4; Ferre P, 2004, DIABETES, V53, pS43, DOI 10.2337/diabetes.53.2007.S43; Gao MM, 2013, AAPS J, V15, P258, DOI 10.1208/s12248-012-9429-3; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Hirata A, 2009, CARDIOVASC RES, V84, P164, DOI 10.1093/cvr/cvp191; Ide T, 2003, MOL ENDOCRINOL, V17, P1255, DOI 10.1210/me.2002-0191; Im SS, 2011, CIRC RES, V108, P996, DOI 10.1161/CIRCRESAHA.110.226878; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904; Jeong S, 2009, EXP MOL MED, V41, P397, DOI 10.3858/emm.2009.41.6.045; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Juvet LK, 2003, MOL ENDOCRINOL, V17, P172, DOI 10.1210/me.2001-0210; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kidani Y, 2012, IMMUNOL REV, V249, P72, DOI 10.1111/j.1600-065X.2012.01153.x; Korach-Andre M, 2011, P NATL ACAD SCI USA, V108, P403, DOI 10.1073/pnas.1017884108; Kratzer A, 2009, J LIPID RES, V50, P312, DOI 10.1194/jlr.M800376-JLR200; Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100; Larter CZ, 2012, J GASTROEN HEPATOL, V27, P341, DOI 10.1111/j.1440-1746.2011.06939.x; Lenhard JM, 1999, DIABETOLOGIA, V42, P545, DOI 10.1007/s001250051193; Li AC, 2004, J LIPID RES, V45, P2161, DOI 10.1194/jlr.R400010-JLR200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Minnich A, 2001, AM J PHYSIOL-ENDOC M, V280, pE270, DOI 10.1152/ajpendo.2001.280.2.E270; Mitro N, 2007, FEBS LETT, V581, P1721, DOI 10.1016/j.febslet.2007.03.047; Oosterveer MH, 2009, J BIOL CHEM, V284, P34036, DOI 10.1074/jbc.M109.051052; Rosenson Robert S, 2008, Expert Rev Cardiovasc Ther, V6, P1319, DOI 10.1586/14779072.6.10.1319; Ross SE, 2002, MOL CELL BIOL, V22, P5989, DOI 10.1128/MCB.22.16.5989-5999.2002; Sekiya M, 2007, J LIPID RES, V48, P1581, DOI 10.1194/jlr.M700033-JLR200; Stenson BM, 2011, J BIOL CHEM, V286, P370, DOI 10.1074/jbc.M110.179499; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yoon M, 2009, PHARMACOL RES, V60, P151, DOI 10.1016/j.phrs.2009.02.004; Yoshikawa T, 2003, MOL ENDOCRINOL, V17, P1240, DOI 10.1210/me.2002-0190; Yue LD, 2005, PROTEIN SCI, V14, P812, DOI 10.1110/ps.04951405; Fokko ZA, 2007, BBA-MOL CELL BIOL L, V1771, P972, DOI 10.1016/j.bbalip.2007.04.021	48	43	43	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65641	10.1371/journal.pone.0065641	http://dx.doi.org/10.1371/journal.pone.0065641			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762402	gold, Green Submitted, Green Published			2022-12-27	WOS:000321094800067
J	Yang, B; Zhang, WC; Zhang, ZY; Fan, Y; Xie, XH; Ai, HS; Ma, JW; Xiao, SJ; Huang, LS; Ren, J				Yang, Bin; Zhang, Wanchang; Zhang, Zhiyan; Fan, Yin; Xie, Xianhua; Ai, Huashui; Ma, Junwu; Xiao, Shijun; Huang, Lusheng; Ren, Jun			Genome-Wide Association Analyses for Fatty Acid Composition in Porcine Muscle and Abdominal Fat Tissues	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; PHENOTYPE NETWORKS; MELTING-POINT; MEAT QUALITY; QTL; EXPRESSION; ELONGASE	Fatty acid composition is an important phenotypic trait in pigs as it affects nutritional, technical and sensory quality of pork. Here, we reported a genome-wide association study (GWAS) for fatty acid composition in the longissimus muscle and abdominal fat tissues of 591 White Duroc x Erhualian F-2 animals and in muscle samples of 282 Chinese Sutai pigs. A total of 46 loci surpassing the suggestive significance level were identified on 15 pig chromosomes (SSC) for 12 fatty acids, revealing the complex genetic architecture of fatty acid composition in pigs. Of the 46 loci, 15 on SSC5, 7, 14 and 16 reached the genome-wide significance level. The two most significant SNPs were ss131535508 (P = 2.48 x 10(-25)) at 41.39 Mb on SSC16 for C20:0 in abdominal fat and ss478935891 (P = 3.29 x 10(-13)) at 121.31 Mb on SSC14 for muscle C18:0. A meta-analysis of GWAS identified 4 novel loci and enhanced the association strength at 6 loci compared to those evidenced in a single population, suggesting the presence of common underlying variants. The longissimus muscle and abdominal fat showed consistent association profiles at most of the identified loci and distinct association signals at several loci. All loci have specific effects on fatty acid composition, except for two loci on SSC4 and SSC7 affecting multiple fatness traits. Several promising candidate genes were found in the neighboring regions of the lead SNPs at the genome-wide significant loci, such as SCD for C18:0 and C16:1 on SSC14 and ELOVL7 for C20:0 on SSC16. The findings provide insights into the molecular basis of fatty acid composition in pigs, and would benefit the final identification of the underlying mutations.	[Huang, Lusheng] Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China; Jiangxi Agr Univ, Minist Agr China, Nanchang, Peoples R China	Jiangxi Agricultural University; Jiangxi Agricultural University; Ministry of Agriculture & Rural Affairs	Huang, LS (corresponding author), Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China.	lushenghuang@hotmail.com; renjunjxau@hotmail.com	Ren, Jun/H-9793-2019		Program for Changjiang Scholars and Innovative Research Team in University [IRT1136]; National Natural Science Foundation of China [31230069]; National 973 Program [2012CB722502]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Program(National Basic Research Program of China)	This work was supported by the Program for Changjiang Scholars and Innovative Research Team in University (IRT1136), National Natural Science Foundation of China (31230069) and National 973 Program (2012CB722502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; BORKMAN M, 1993, NEW ENGL J MED, V328, P238, DOI 10.1056/NEJM199301283280404; ENOCH HG, 1976, J BIOL CHEM, V251, P5095; Fan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014726; FOLCH J, 1957, J BIOL CHEM, V226, P497; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Guo T, 2009, ANIM GENET, V40, P185, DOI 10.1111/j.1365-2052.2008.01819.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Karim L, 2011, NAT GENET, V43, P405, DOI 10.1038/ng.814; Li RH, 2006, PLOS GENET, V2, P1046, DOI 10.1371/journal.pgen.0020114; Ma J, 2009, ANIM GENET, V40, P637, DOI 10.1111/j.1365-2052.2009.01892.x; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Naganuma T, 2011, FEBS LETT, V585, P3337, DOI 10.1016/j.febslet.2011.09.024; Neto EC, 2008, GENETICS, V179, P1089, DOI 10.1534/genetics.107.085167; Nii M, 2006, ANIM GENET, V37, P342, DOI 10.1111/j.1365-2052.2006.01485.x; Perez-Enciso M, 2000, J ANIM SCI, V78, P2525; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramayo-Caldas Y, 2012, J ANIM SCI, V90, P2883, DOI 10.2527/jas.2011-4900; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Ren J, 2011, HEREDITY, V106, P862, DOI 10.1038/hdy.2010.129; Ren J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002043; Rothschild MF, 2011, GENETICS OF THE PIG, 2ND EDITION, P1, DOI 10.1079/9781845937560.0000; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Segura V, 2012, NAT GENET, V44, P825, DOI 10.1038/ng.2314; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; Steinberg SJ, 2000, J BIOL CHEM, V275, P35162, DOI 10.1074/jbc.M006403200; Uemoto Y, 2012, ANIM GENET, V43, P225, DOI 10.1111/j.1365-2052.2011.02236.x; Uemoto Y, 2012, ANIM GENET, V43, P27, DOI 10.1111/j.1365-2052.2011.02218.x; Webb EC, 2008, MEAT SCI, V80, P28, DOI 10.1016/j.meatsci.2008.05.029; Wernersson R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-70; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019; Yang B, 2011, J ANIM BREED GENET, V128, P329, DOI 10.1111/j.1439-0388.2011.00928.x; Yang KX, 2010, J ANIM SCI, V88, P3538, DOI 10.2527/jas.2009-2602; Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167	38	35	44	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65554	10.1371/journal.pone.0065554	http://dx.doi.org/10.1371/journal.pone.0065554			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762394	Green Published, Green Submitted, gold			2022-12-27	WOS:000321094800065
J	Pawela, L; Gawron, P; Puchala, Z; Sladkowski, J				Pawela, Lukasz; Gawron, Piotr; Puchala, Zbigniew; Sladkowski, Jan			Enhancing Pseudo-Telepathy in the Magic Square Game	PLOS ONE			English	Article							QUANTUM; ALGORITHM	We study the possibility of reversing an action of a quantum channel. Our principal objective is to find a specific channel that reverses as accurately as possible an action of a given quantum channel. To achieve this goal we use semidefinite programming. We show the benefits of our method using the quantum pseudo-telepathy Magic Square game with noise. Our strategy is to move the pseudo-telepathy region to higher noise values. We show that it is possible to reverse the action of a noise channel using semidefinite programming.	[Pawela, Lukasz; Gawron, Piotr; Puchala, Zbigniew] Polish Acad Sci, Inst Theoret & Appl Informat, Gliwice, Poland; [Puchala, Zbigniew] Jagiellonian Univ, Inst Phys, Krakow, Poland; [Sladkowski, Jan] Univ Silesia, Inst Phys, Katowice, Poland	Polish Academy of Sciences; Institute of Theoretical & Applied Informatics of the Polish Academy of Sciences; Jagiellonian University; University of Silesia in Katowice	Pawela, L (corresponding author), Polish Acad Sci, Inst Theoret & Appl Informat, Gliwice, Poland.	lpawela@iitis.pl	Sladkowski, Jan/AAF-3401-2019; Puchała, Zbigniew/F-2189-2011; Pawela, Łukasz/B-4629-2013; Sładkowski, Jan Antoni/I-2782-2019; Gawron, Piotr/F-2255-2011	Puchała, Zbigniew/0000-0002-4739-0400; Pawela, Łukasz/0000-0002-0476-7132; Sładkowski, Jan Antoni/0000-0002-1898-4824; Gawron, Piotr/0000-0001-7476-9160	Polish National Science Centre [N N516 481840, DEC-2011/01/B/ST6/07197]; Polish Ministry of Science and Higher Education [IP2011 014071, IP2011 044271]	Polish National Science Centre; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by the Polish National Science Centre: L. Pawela by the grant number N N516 481840, J. Sladkowski by the grant number DEC-2011/01/B/ST6/07197. Work was also supported by the Polish Ministry of Science and Higher Education: P. Gawron under the project number IP2011 014071, Z. Puchala under the project number IP2011 044271. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind PK, 2004, AM J PHYS, V72, P1303, DOI 10.1119/1.1773173; Bengtsson I., 2006, GEOMETRY QUANTUM STA; Brassard G, 2005, FOUND PHYS, V35, P1877, DOI 10.1007/s10701-005-7353-4; Burer S, 2005, MATH PROGRAM, V103, P427, DOI 10.1007/s10107-004-0564-1; Burer S, 2003, MATH PROGRAM, V95, P329, DOI 10.1007/s10107-002-0352-8; Eisert J, 1999, PHYS REV LETT, V83, P3077, DOI 10.1103/PhysRevLett.83.3077; Flitney AP, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.062318; Frackiewicz P, 2012, INT J QUANTUM INF, V10, DOI 10.1142/S0219749912500487; Gawron P, 2008, INT J QUANTUM INF, V6, P667, DOI 10.1142/S0219749908003931; Gawron P, 2012, INT J AP MAT COM-POL, V22, P493, DOI 10.2478/v10006-012-0037-2; Gawron P, 2010, FLUCT NOISE LETT, V9, P9, DOI 10.1142/S0219477510000034; MERMIN ND, 1990, PHYS REV LETT, V65, P3373, DOI 10.1103/PhysRevLett.65.3373; Miszczak JA, 2012, QUANTUM INF PROCESS, V11, P1571, DOI 10.1007/s11128-011-0322-2; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Piotrowski EW, 2008, PHYSICA A, V387, P3949, DOI 10.1016/j.physa.2008.02.071; Piotrowski EW, 2003, INT J THEOR PHYS, V42, P1089, DOI 10.1023/A:1025443111388; Puchala Z, 2011, QUANTUM INF PROCESS, V10, P1, DOI 10.1007/s11128-010-0166-1; Schmidt AGM, 2012, PHYSICA A; Watrous J., 2011, LECT NOTES	20	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64694	10.1371/journal.pone.0064694	http://dx.doi.org/10.1371/journal.pone.0064694			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762246	Green Published, gold, Green Submitted			2022-12-27	WOS:000321099000014
J	Tonga, C; Kimbi, HK; Anchang-Kimbi, JK; Nyabeyeu, HN; Bissemou, ZB; Lehman, LG				Tonga, Calvin; Kimbi, Helen Kuokuo; Anchang-Kimbi, Judith Kuoh; Nyabeyeu, Herve Nyabeyeu; Bissemou, Zacharie Bissemou; Lehman, Leopold G.			Malaria Risk Factors in Women on Intermittent Preventive Treatment at Delivery and Their Effects on Pregnancy Outcome in Sanaga-Maritime, Cameroon	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; SULFADOXINE-PYRIMETHAMINE; INFECTION; HIV; PREVALENCE; DIAGNOSIS; CHILDREN; BURDEN; BLOOD; AREA	Malaria is known to have a negative impact on pregnant women and their foetuses. The efficacy of Sulfadoxine-Pyrimethamine (SP) used for intermittent preventive treatment (IPT) is being threatened by increasing levels of resistance. This study assessed malaria risk factors in women on intermittent preventive treatment with SP (IPTp-SP) at delivery and their effects on pregnancy outcome in Sanaga-Maritime Division, Cameroon. Socio-economic and obstetrical data of mothers and neonate birth weights were documented. Peripheral blood from 201 mothers and newborns as well as placental and cord blood were used to prepare thick and thin blood films. Maternal haemoglobin concentration was measured. The overall malaria parasite prevalence was 22.9% and 6.0% in mothers and newborns respectively. Monthly income lower than 28000 FCFA and young age were significantly associated with higher prevalence of placental malaria infection (p = 0.0048 and p = 0.019 respectively). Maternal infection significantly increased the risk of infection in newborns (OR = 48.4; p<0.0001). Haemoglobin concentration and birth weight were lower in infected mothers, although not significant. HIV infection was recorded in 6.0% of mothers and increased by 5-folds the risk of malaria parasite infection (OR = 5.38, p = 0.007). Attendance at antenatal clinic and level of education significantly influenced the utilisation of IPTp-SP (p<0.0001 and p = 0.018 respectively). Use of SP and mosquito net resulted in improved pregnancy outcome especially in primiparous, though the difference was not significant. Malaria infection in pregnancy is common and increases the risk of neonatal malaria infection. Preventive strategies are poorly implemented and their utilization has overall reasonable effect on malaria infection and pregnancy outcome.	[Tonga, Calvin; Kimbi, Helen Kuokuo; Anchang-Kimbi, Judith Kuoh] Univ Buea, Dept Zool & Anim Physiol, Buea, South West Regi, Cameroon; [Nyabeyeu, Herve Nyabeyeu; Lehman, Leopold G.] Univ Douala, Dept Anim Biol, Douala, Littoral Region, Cameroon; [Bissemou, Zacharie Bissemou] Pouma Hlth Dist, Pouma Dist Hosp, Pouma, Littoral Region, Cameroon		Kimbi, HK (corresponding author), Univ Buea, Dept Zool & Anim Physiol, Buea, South West Regi, Cameroon.	hkimbi@yahoo.co.uk	Anchang-Kimbi, Judith/AAE-9802-2020; Calvin, TONGA/AAF-7496-2019	Calvin, TONGA/0000-0003-3157-8326				Achidi AE, 2005, J OBSTET GYNAECOL, V25, P235; Adebami OJ, 2007, AM J TROP MED HYG, V77, P209, DOI 10.4269/ajtmh.2007.77.209; Akum AE, 2005, ACTA PAEDIATR, V94, P917, DOI 10.1080/08035250510028605; Akum AE, 2005, J TROP PEDIATRICS, V51, P182, DOI 10.1093/tropej/fmi028; ALLEN SJ, 1992, T ROY SOC TROP MED H, V86, P494, DOI 10.1016/0035-9203(92)90083-O; Anchang-Kimbi JK, 2010, THESIS U BUEA; Anchang-Kimbi JK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-126; Barduagni P, 2003, TROP MED INT HEALTH, V8, P615, DOI 10.1046/j.1365-3156.2003.01062.x; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Cheesbrough M, 2000, PARASITOLOGICAL TE 2; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Falade CO, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-88; Fievet N, 2002, MALAR J, V1; Flateau C, 2011, LANCET INFECT DIS, V11, P541, DOI 10.1016/S1473-3099(11)70031-7; Gonzalez R, 2012, EXPERT REV ANTI-INFE, V10, P153, DOI [10.1586/ERI.11.167, 10.1586/eri.11.167]; Harrington WE, 2011, CLIN INFECT DIS, V53, P224, DOI 10.1093/cid/cir376; Iriemenam NC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-134; Leke RFG, 2010, AM J TROP MED HYG, V83, P996, DOI 10.4269/ajtmh.2010.10-0249; Lin TL, 2012, TROP MED IN IN PRESS; Manirakiza A, 2011, J TROP MED-US, V2011, DOI 10.1155/2011/434816; Marchesini P, 2004, REDUCING BURDEN MALA; Mbacham WF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-34; Mbu ER, 2008, REPROD HLTH, V5; Mockenhaupt FP, 2002, J CLIN MICROBIOL, V40, P306, DOI 10.1128/JCM.40.1.306-308.2002; Mockenhaupt FP, 2007, ANTIMICROB AGENTS CH, V51, P332, DOI 10.1128/AAC.00856-06; Mokuolu OA, 2009, INFECT DIS OBSTET GY; Monebenimp F, 2011, PAN AFRICAN MED J, V8; Mosha JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008707; Mount AM, 2004, LANCET, V363, P1860, DOI 10.1016/S0140-6736(04)16354-X; Napoleon R. P., 2011, Southern Sudan Medical Journal, V4, P33; National Institute of Statistics, 2011, ENQ DEM SANT IND MUL; Omalu ICJ, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/274142; Osungbade KO, 2012, J TROP MED, V2012; Ouedraogo A, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/109705; Ringwald P, 2011, TMIH, V5, P620; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Takem EN, 2009, ACTA TROP, V112, P54, DOI 10.1016/j.actatropica.2009.06.007; Tako EA, 2005, AM J TROP MED HYG, V72, P236, DOI 10.4269/ajtmh.2005.72.236; Tutterrow Yeung Lo, 2012, PLoS One, V7, pe40049, DOI 10.1371/journal.pone.0040049; Tutu EO, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-385; Umeh UA, 2012, TROPICAL DOCTOR, P1; Uneke Chigozie J, 2007, Yale J Biol Med, V80, P39; Uneke Chigozie J, 2007, Yale J Biol Med, V80, P95; Uneke Chigozie J, 2008, Yale J Biol Med, V81, P1; Vallely A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-16; Walker-Abbey A, 2005, AM J TROP MED HYG, V72, P229, DOI 10.4269/ajtmh.2005.72.229; WHO, 2004, AFRMALO401 WHO REG O; WHO, 2020, REP ANT DRUG EFF RES; Xi GL, 2003, INFECT IMMUN, V71, P1242, DOI 10.1128/IAI.71.3.1242-1246.2003	50	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65876	10.1371/journal.pone.0065876	http://dx.doi.org/10.1371/journal.pone.0065876			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762446	gold, Green Published			2022-12-27	WOS:000321099000115
J	Yaguchi, S; Ogawa, Y; Shimmura, S; Kawakita, T; Hatou, S; Satofuka, S; Nakamura, S; Imada, T; Miyashita, H; Yoshida, S; Yaguchi, T; Ozawa, Y; Mori, T; Okamoto, S; Kawakami, Y; Ishida, S; Tsubota, K				Yaguchi, Saori; Ogawa, Yoko; Shimmura, Shigeto; Kawakita, Tetsuya; Hatou, Shin; Satofuka, Shingo; Nakamura, Shigeru; Imada, Toshihiro; Miyashita, Hideyuki; Yoshida, Satoru; Yaguchi, Tomonori; Ozawa, Yoko; Mori, Takehiko; Okamoto, Shinichiro; Kawakami, Yutaka; Ishida, Susumu; Tsubota, Kazuo			Angiotensin II Type 1 Receptor Antagonist Attenuates Lacrimal Gland, Lung, and Liver Fibrosis in a Murine Model of Chronic Graft-Versus-Host Disease	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; SHOCK-PROTEIN 47; DRY EYE; SYSTEM; MECHANISMS; EXPRESSION; INFLAMMATION; FIBROBLASTS; INDUCTION; CHAPERONE	Chronic graft-versus-host disease (cGVHD), a serious complication following allogeneic HSCT (hematopoietic stem cell transplantation), is characterized by systemic fibrosis. The tissue renin-angiotensin system (RAS) is involved in the fibrotic pathogenesis, and an angiotensin II type 1 receptor (AT1R) antagonist can attenuate fibrosis. Tissue RAS is present in the lacrimal gland, lung, and liver, and is known to be involved in the fibrotic pathogenesis of the lung and liver. This study aimed to determine whether RAS is involved in fibrotic pathogenesis in the lacrimal gland and to assess the effect of an AT1R antagonist on preventing lacrimal gland, lung, and liver fibrosis in cGVHD model mice. We used the B10.D2-->BALB/c (H-2(d)) MHC-compatible, multiple minor histocompatibility antigen-mismatched model, which reflects clinical and pathological symptoms of human cGVHD. First, we examined the localization and expression of RAS components in the lacrimal glands using immunohistochemistry and quantitative real-time polymerase chain reaction (PCR). Next, we administered an AT1R antagonist (valsartan; 10 mg/kg) or angiotensin II type 2 receptor (AT2R) antagonist (PD123319; 10 mg/kg) intraperitoneally into cGVHD model mice and assessed the fibrotic change in the lacrimal gland, lung, and liver. We demonstrated that fibroblasts expressed angiotensin II, AT1R, and AT2R, and that the mRNA expression of angiotensinogen was greater in the lacrimal glands of cGVHD model mice than in controls generated by syngeneic-HSCT. The inhibition experiment revealed that fibrosis of the lacrimal gland, lung, and liver was suppressed in mice treated with the AT1R antagonist, but not the AT2R antagonist. We conclude that RAS is involved in fibrotic pathogenesis in the lacrimal gland and that AT1R antagonist has a therapeutic effect on lacrimal gland, lung, and liver fibrosis in cGVHD model mice. Our findings point to AT1R antagonist as a possible target for therapeutic intervention in cGVHD.	[Yaguchi, Saori; Ogawa, Yoko; Shimmura, Shigeto; Kawakita, Tetsuya; Hatou, Shin; Satofuka, Shingo; Nakamura, Shigeru; Imada, Toshihiro; Miyashita, Hideyuki; Yoshida, Satoru; Ozawa, Yoko; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Yaguchi, Tomonori; Kawakami, Yutaka] Keio Univ, Sch Med, Inst Adv Med Res, Div Cellular Signaling, Tokyo, Japan; [Mori, Takehiko; Okamoto, Shinichiro] Keio Univ, Sch Med, Div Hematol, Dept Internal Med, Tokyo, Japan; [Ishida, Susumu] Hokkaido Univ, Grad Sch Med, Dept Ophthalmol, Sapporo, Hokkaido, Japan	Keio University; Keio University; Keio University; Hokkaido University	Ogawa, Y (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan.	yoko@z7.keio.jp	Ogawa, Yoko/AAV-1932-2021; Ozawa, Yoko/AAH-9888-2020; Shimmura, Shigeto/J-4678-2013; Kawakami, Yutaka/E-7429-2013; Mori, Takehiko/AAD-7389-2019	Ogawa, Yoko/0000-0002-2906-9621; Kawakami, Yutaka/0000-0003-4836-2855; Mori, Takehiko/0000-0002-8176-4760; Hatou, Shin/0000-0001-9273-5909	Japanese Ministry of Education, Science, Sports, and Culture [23592590]; Grants-in-Aid for Scientific Research [25830122] Funding Source: KAKEN	Japanese Ministry of Education, Science, Sports, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Japanese Ministry of Education, Science, Sports, and Culture (#23592590) and Japan Medical Association 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BE, 2004, BLOOD, V104, P1565, DOI 10.1182/blood-2004-01-0328; Anderson G, 1996, CHURCHILL LIVING STO, P47; Bataller R, 2003, J CLIN INVEST, V112, P1383, DOI 10.1172/JCI200318212; Bataller R, 2003, GASTROENTEROLOGY, V125, P117, DOI 10.1016/S0016-5085(03)00695-4; Blazar BR, 2012, NAT REV IMMUNOL, V12, P443, DOI 10.1038/nri3212; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Bullock GR, 2001, HISTOCHEM CELL BIOL, V115, P117, DOI 10.1007/s004180000235; Chan YC, 2011, ANTIOXID REDOX SIGN, V15, P2743, DOI 10.1089/ars.2011.4071; Chou HC, 2012, J PHARMACOL EXP THER, V340, P169, DOI 10.1124/jpet.111.186288; Cole BK, 2010, HYPERTENSION, V55, P715, DOI 10.1161/HYPERTENSIONAHA.109.148049; Cooke KR, 2009, LUNG INJURY FOLLOWIN, P1456; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Hopwood J, 1996, FIXATION FIXTATIVE T, P23; KAGAMI S, 1994, J CLIN INVEST, V93, P2431, DOI 10.1172/JCI117251; Kawano H, 2000, CIRCULATION, V101, P1130, DOI 10.1161/01.CIR.101.10.1130; Kurihara T, 2006, INVEST OPHTH VIS SCI, V47, P5545, DOI 10.1167/iovs.06-0478; Lang YD, 2010, FREE RADICAL BIO MED, V49, P88, DOI 10.1016/j.freeradbiomed.2010.03.022; Lee SJ, 2005, BLOOD, V105, P4200, DOI 10.1182/blood-2004-10-4023; Li JA, 1996, TRANSPLANTATION, V62, P1621, DOI 10.1097/00007890-199612150-00016; Luft FC, 2012, ANN MED, V44, pS49, DOI 10.3109/07853890.2011.653396; Marshall RP, 2004, AM J PHYSIOL-LUNG C, V286, pL156, DOI 10.1152/ajplung.00313.2002; Marshall RP, 2000, AM J RESP CRIT CARE, V161, P1999, DOI 10.1164/ajrccm.161.6.9907004; McCormick LL, 1999, J IMMUNOL, V163, P5693; Munshi MK, 2011, EXP BIOL MED, V236, P557, DOI 10.1258/ebm.2011.010375; Nagai N, 2007, INVEST OPHTH VIS SCI, V48, P4342, DOI 10.1167/iovs.06-1473; Nagai N, 2006, ARTERIOSCL THROM VAS, V26, P2252, DOI 10.1161/01.ATV.0000240050.15321.fe; Nagata K, 1998, MATRIX BIOL, V16, P379, DOI 10.1016/S0945-053X(98)90011-7; Nonomura A, 1998, PATHOL INT, V48, P421, DOI 10.1111/j.1440-1827.1998.tb03927.x; Ogawa Y, 1999, BRIT J OPHTHALMOL, V83, P1125, DOI 10.1136/bjo.83.10.1125; Ogawa Y, 2001, INVEST OPHTH VIS SCI, V42, P111; Ogawa Y, 2007, INVEST OPHTH VIS SCI, V48, P1079, DOI 10.1167/iovs.06-0601; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; Paizis G, 2002, GASTROENTEROLOGY, V123, P1667, DOI 10.1053/gast.2002.36561; Papp M, 2002, AM J PHYSIOL-LUNG C, V282, pL713, DOI 10.1152/ajplung.00103.2001; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; PEACH MJ, 1977, PHYSIOL REV, V57, P313, DOI 10.1152/physrev.1977.57.2.313; Rasini E, 2006, REGUL PEPTIDES, V134, P69, DOI 10.1016/j.regpep.2006.01.007; REID IA, 1978, ANNU REV PHYSIOL, V40, P377, DOI 10.1146/annurev.ph.40.030178.002113; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Ruster C, 2011, J AM SOC NEPHROL, V22, P1189, DOI 10.1681/ASN.2010040384; Sabattini E, 1998, J CLIN PATHOL, V51, P506, DOI 10.1136/jcp.51.7.506; Sata M, 2011, INFLAMM REGEN, V31, P245; Satoh M, 2001, J AM SOC NEPHROL, V12, P317, DOI 10.1681/ASN.V122317; Strasser SI, 2009, GASTROINTESTINAL HEP, P1434; Taguchi T, 2011, ACTA HISTOCHEM CYTOC, V44, P35, DOI 10.1267/ahc.11001; TIMMERMANS PBMWM, 1993, PHARMACOL REV, V45, P205; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yaguchi S, 2012, INVEST OPHTH VIS SCI, V53, P5416, DOI 10.1167/iovs.12-9891; Yahata Y, 2006, J BIOL CHEM, V281, P13209, DOI 10.1074/jbc.M509771200; Yoshiji H, 2001, HEPATOLOGY, V34, P745, DOI 10.1053/jhep.2001.28231; Zhang Y, 2002, J IMMUNOL, V168, P3088, DOI 10.4049/jimmunol.168.6.3088	51	40	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64724	10.1371/journal.pone.0064724	http://dx.doi.org/10.1371/journal.pone.0064724			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762250	Green Published, Green Submitted, gold			2022-12-27	WOS:000321099000017
J	Arnold, K; Zuberbuhler, K				Arnold, Kate; Zuberbuehler, Klaus			Female Putty-Nosed Monkeys Use Experimentally Altered Contextual Information to Disambiguate the Cause of Male Alarm Calls	PLOS ONE			English	Article							NONHUMAN PRIMATE; DIANA MONKEYS; BABOONS; COMBINATIONS; BEHAVIOR; SYSTEM; COMMUNICATION; VOCALIZATIONS; SIGNALS	Many animal vocal signals are given in a wide range of contexts which can sometimes have little in common. Yet, to respond adaptively, listeners must find ways to identify the cause of a signal, or at least rule out alternatives. Here, we investigate the nature of this process in putty-nosed monkeys, a forest primate. In this species, adult males have a very restricted repertoire of vocalizations which are given in response to a wide variety of events occurring under conditions of limited visibility. We carried out a series of field playback experiments on females (N = 6) in a habituated group in Gashaka Gumti National Park, Nigeria, in which male alarm/loud calls were presented either alone, or following acoustic information that simulated the occurrence of natural disturbances. We demonstrate that listeners appear to integrate contextual information in order to distinguish among possible causes of calls. We conclude that, in many cases, pragmatic aspects of communication play a crucial role in call interpretation and place a premium on listeners' abilities to integrate information from different sources.	[Arnold, Kate; Zuberbuehler, Klaus] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland; [Zuberbuehler, Klaus] Univ Neuchatel, Ctr Cognit Sci, CH-2000 Neuchatel, Switzerland	University of St Andrews; University of Neuchatel	Arnold, K (corresponding author), Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland.	ka11@st-andrews.ac.uk	Zuberbühler, Klaus/A-9053-2011; Arnold, Kate/C-1129-2009; Arnold, Kate/B-2021-2014	Zuberbühler, Klaus/0000-0001-8378-088X; Arnold, Kate/0000-0002-5598-2174; Arnold, Kate/0000-0002-5598-2174	Leverhulme Trust	Leverhulme Trust(Leverhulme Trust)	Funding was provided by The Leverhulme Trust (http://www.leverhulme.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, NATURE, V441, P303, DOI 10.1038/441303a; Arnold K, 2008, BEHAV ECOL SOCIOBIOL, V62, P549, DOI 10.1007/s00265-007-0479-y; Arnold K, 2008, CURR BIOL, V18, pR202, DOI 10.1016/j.cub.2008.01.040; Arnold K, 2006, ANIM BEHAV, V72, P643, DOI 10.1016/j.anbehav.2005.11.017; Arnold K, 2012, BRAIN LANG, V120, P303, DOI 10.1016/j.bandl.2011.10.001; Arnold K, 2011, DEV PRIMATOL-PROG PR, P385, DOI 10.1007/978-1-4419-7403-7_11; Bergman TJ, 2003, SCIENCE, V302, P1234, DOI 10.1126/science.1087513; Clay Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018786; Crockford C, 2007, ANIM BEHAV, V73, P885, DOI 10.1016/j.anbehav.2006.10.016; Digweed SM, 2005, BEHAVIOUR, V142, P997, DOI 10.1163/156853905774405344; Engh AL, 2006, ANIM BEHAV, V71, P381, DOI 10.1016/j.anbehav.2005.05.009; EVANS CS, 1993, ANIM BEHAV, V46, P23, DOI 10.1006/anbe.1993.1158; Fichtel C, 2002, BEHAV ECOL SOCIOBIOL, V51, P262, DOI 10.1007/S00265-001-0436-0; FISCHER J, 1995, ETHOLOGY, V101, P51, DOI 10.1111/j.1439-0310.1995.tb00345.x; Fischer J, 2001, ETHOLOGY, V107, P33, DOI 10.1046/j.1439-0310.2001.00630.x; Fischer J, 2013, ANIMAL COMMUNICATION THEORY: INFORMATION AND INFLUENCE, P297; Gautier J.-P., 1977, ANIMALS COMMUNICATE, P890; MACEDONIA JM, 1993, ETHOLOGY, V93, P177, DOI 10.1111/j.1439-0310.1993.tb00988.x; Manser MB, 2002, TRENDS COGN SCI, V6, P55, DOI 10.1016/S1364-6613(00)01840-4; Marler P., 1977, P85; Price T, 2009, BEHAVIOUR, V146, P871, DOI 10.1163/156853908X396610; Rendall D, 1999, ANIM BEHAV, V57, P583, DOI 10.1006/anbe.1998.1031; Rendall D, 2009, ANIM BEHAV, V78, P233, DOI 10.1016/j.anbehav.2009.06.007; Ruxton GD, 2011, J EVOLUTION BIOL, V24, P2574, DOI 10.1111/j.1420-9101.2011.02386.x; Scarantino A, 2010, ANIM BEHAV, V79, pE1, DOI 10.1016/j.anbehav.2010.03.005; SEYFARTH RM, 1980, ANIM BEHAV, V28, P1070, DOI 10.1016/S0003-3472(80)80097-2; Seyfarth RM, 2010, ANIM BEHAV, V80, P3, DOI 10.1016/j.anbehav.2010.04.012; Shannon C. E., 1949, MATH THEORY COMMUNIC; Shultz S, 2001, FOLIA PRIMATOL, V72, P248, DOI 10.1159/000049945; Slocombe KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011473; Smith W.J., 1977, BEHAV COMMUNICATING; Wheeler BC, 2012, EVOL ANTHROPOL, V21, P195, DOI 10.1002/evan.21319; Wheeler Brandon C., 2011, P187; Zuberbuhler K, 1999, ETHOLOGY, V105, P477, DOI 10.1046/j.1439-0310.1999.00396.x; Zuberbuhler K, 2003, ADV STUD BEHAV, V33, P265, DOI 10.1016/S0065-3454(03)33006-2; Zuberbuhler K, 2000, COGNITION, V76, P195, DOI 10.1016/S0010-0277(00)00079-2; Zuberbuhler K, 1997, ANIM BEHAV, V53, P589, DOI 10.1006/anbe.1996.0334; Zuberbuhler K, 2000, ANIM BEHAV, V59, P917, DOI 10.1006/anbe.1999.1317	38	41	41	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65660	10.1371/journal.pone.0065660	http://dx.doi.org/10.1371/journal.pone.0065660			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755265	Green Published, gold			2022-12-27	WOS:000320579400072
J	Palermo, L; Nori, R; Piccardi, L; Zeri, F; Babino, A; Giusberti, F; Guariglia, C				Palermo, Liana; Nori, Raffaella; Piccardi, Laura; Zeri, Fabrizio; Babino, Antonio; Giusberti, Fiorella; Guariglia, Cecilia			Refractive Errors Affect the Vividness of Visual Mental Images	PLOS ONE			English	Article							CONGENITALLY BLIND; PERCEPTION; REPRESENTATIONS; INFORMATION; VISION; MEMORY; ADULTS; EYE	The hypothesis that visual perception and mental imagery are equivalent has never been explored in individuals with vision defects not preventing the visual perception of the world, such as refractive errors. Refractive error (i.e., myopia, hyperopia or astigmatism) is a condition where the refracting system of the eye fails to focus objects sharply on the retina. As a consequence refractive errors cause blurred vision. We subdivided 84 individuals according to their spherical equivalent refraction into Emmetropes (control individuals without refractive errors) and Ametropes (individuals with refractive errors). Participants performed a vividness task and completed a questionnaire that explored their cognitive style of thinking before their vision was checked by an ophthalmologist. Although results showed that Ametropes had less vivid mental images than Emmetropes this did not affect the development of their cognitive style of thinking; in fact, Ametropes were able to use both verbal and visual strategies to acquire and retrieve information. Present data are consistent with the hypothesis of equivalence between imagery and perception.	[Palermo, Liana; Guariglia, Cecilia] Sapienza Univ Roma, Dipartimento Psicol, Rome, Italy; [Palermo, Liana; Piccardi, Laura; Guariglia, Cecilia] Ist Ricovero, Sezione Neuropsicol, Rome, Italy; [Palermo, Liana; Piccardi, Laura; Guariglia, Cecilia] Carattere Scientifico Fdn Santa Lucia, Rome, Italy; [Nori, Raffaella; Giusberti, Fiorella] Univ Bologna, Dipartimento Psicol, Bologna, Italy; [Piccardi, Laura] Univ Aquila, Dipartimento Sci Salute, Coppito, Italy; [Zeri, Fabrizio] Fis & Sci Natur Univ Roma TRE, CdL Ott & Optometria, Fac Matemat, Rome, Italy; [Babino, Antonio] Casa Cura Tortorella, Salerno, Italy	Sapienza University Rome; IRCCS Santa Lucia; University of Bologna; University of L'Aquila	Palermo, L (corresponding author), Sapienza Univ Roma, Dipartimento Psicol, Rome, Italy.	liana.palermo@uniroma1.it	guariglia, cecilia/J-9898-2018; Palermo, Liana/ABG-2726-2021; Piccardi, laura/AAC-7587-2022	Palermo, Liana/0000-0001-8047-7201; guariglia, cecilia/0000-0001-7474-6030; Piccardi, Laura/0000-0002-1322-5538; Zeri, Fabrizio/0000-0003-0529-555X	Ministero della Salute (RC)	Ministero della Salute (RC)	This study was partially supported by funding from Ministero della Salute (RC 2010-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding were received for this study.	Amedi A, 2005, NEURON, V48, P859, DOI 10.1016/j.neuron.2005.10.032; ARDITI A, 1988, NEUROPSYCHOLOGIA, V26, P1, DOI 10.1016/0028-3932(88)90026-7; AUSBURN LJ, 1978, ECTJ-EDUC COMMUN TEC, V26, P337; Bailey IL, 1998, BORISHS CLIN REFRACT, P217; Bartolomeo P, 2002, CORTEX, V38, P357, DOI 10.1016/S0010-9452(08)70665-8; Bartolomeo P, 1998, NEUROPSYCHOLOGIA, V36, P239, DOI 10.1016/S0028-3932(97)00103-6; Blazhenkova O, 2009, APPL COGNITIVE PSYCH, V23, P638, DOI 10.1002/acp.1473; Cattaneo Z, 2008, NEUROSCI BIOBEHAV R, V32, P1346, DOI 10.1016/j.neubiorev.2008.05.002; Cornoldi C, 2000, DEBATES PSYCHOL, P143; Cornoldi C., 1989, RESEARCHGATE, V1, P321; Cornoldi C., 1992, J MENT IMAGERY, V16, P89; Cornoldi C, 2009, ACTA PSYCHOL, V130, P11, DOI 10.1016/j.actpsy.2008.09.012; CRAVERLEMLEY C, 1992, PSYCHOL REV, V99, P633, DOI 10.1037/0033-295X.99.4.633; Cui X, 2007, VISION RES, V47, P474, DOI 10.1016/j.visres.2006.11.013; D'Angiulli A, 2007, AM J PSYCHOL, V120, P521, DOI 10.2307/20445424; Denis M, 1999, CAH PSYCHOL COGN, V18, P409; Dulin D, 2008, NEUROSCI BIOBEHAV R, V32, P1396, DOI 10.1016/j.neubiorev.2008.04.007; FARAH MJ, 1988, BRAIN COGNITION, V8, P147, DOI 10.1016/0278-2626(88)90046-2; FARAH MJ, 1992, J EXP PSYCHOL HUMAN, V18, P241, DOI 10.1037/0096-1523.18.1.241; Ganis G, 2004, COGNITIVE BRAIN RES, V20, P226, DOI 10.1016/j.cogbrainres.2004.02.012; Gentaz, 2003, TOUCHING KNOWING COG, P173, DOI [DOI 10.1075/AICR.53.14COR, 10.1075/aicr.53]; GOLDENBERG G, 1992, NEUROPSYCHOLOGIA, V30, P1081, DOI 10.1016/0028-3932(92)90100-Z; GREEN KE, 1990, PSYCHOL REP, V66, P939, DOI 10.2466/PR0.66.3.939-945; HABER RN, 1993, PERCEPT PSYCHOPHYS, V54, P1, DOI 10.3758/BF03206932; Hatakeyama T, 1997, PERCEPT MOTOR SKILL, V84, P1315, DOI 10.2466/pms.1997.84.3c.1315; Jonassen D.H., 1993, HDB INDIVIDUAL DIFFE; KERR NH, 1983, J EXP PSYCHOL GEN, V112, P265, DOI 10.1037/0096-3445.112.2.265; KIRBY JR, 1988, CONTEMP EDUC PSYCHOL, V13, P169, DOI 10.1016/0361-476X(88)90017-3; Knauff M, 2000, NEUROREPORT, V11, P3957, DOI 10.1097/00001756-200012180-00011; Kosslyn S.M., 1994, IMAGE BRAIN RESOLUTI; Kosslyn SM, 2003, PSYCHOL BULL, V129, P723, DOI 10.1037/0033-2909.129.5.723; KOSSLYN SM, 1995, NATURE, V378, P496, DOI 10.1038/378496a0; Kosslyn SM, 2005, COGN NEUROPSYCHOL, V22, P333, DOI 10.1080/02643290442000130; Kosslyn SM, 1999, SCIENCE, V284, P167, DOI 10.1126/science.284.5411.167; KOSSLYN SM, 1987, PSYCHOL REV, V94, P148, DOI 10.1037/0033-295X.94.2.148; KOSSLYN SM, 1978, J EXP PSYCHOL HUMAN, V4, P47, DOI 10.1037/0096-1523.4.1.47; KOSSLYN SM, 1973, PERCEPT PSYCHOPHYS, V14, P90, DOI 10.3758/BF03198621; Kozhevnikov M, 2005, MEM COGNITION, V33, P710, DOI 10.3758/BF03195337; Kozhevnikov M, 2002, COGNITION INSTRUCT, V20, P47, DOI 10.1207/S1532690XCI2001_3; Kreiman G, 2000, NATURE, V408, P357, DOI 10.1038/35042575; Laeng B, 2002, COGNITIVE SCI, V26, P207, DOI 10.1016/S0364-0213(01)00065-9; Lean G., 1981, EDUC STUD MATH, V12, P267, DOI [10.1007/BF00311060, DOI 10.1007/BF00311060]; LEVINE DN, 1978, BRAIN LANG, V5, P341, DOI 10.1016/0093-934X(78)90031-7; Marks D., 1972, FUNCTION NATURE IMAG, P83; MARKS DF, 1973, BRIT J PSYCHOL, V64, P17, DOI 10.1111/j.2044-8295.1973.tb01322.x; MCKELVIE SJ, 1979, BRIT J PSYCHOL, V70, P51, DOI 10.1111/j.2044-8295.1979.tb02142.x; MCKELVIE SJ, 1994, BRIT J PSYCHOL, V85, P93, DOI 10.1111/j.2044-8295.1994.tb02510.x; Mellet E, 1996, J NEUROSCI, V16, P6504; Mellet E, 1998, NEUROIMAGE, V8, P129, DOI 10.1006/nimg.1998.0355; Messick S., 1976, INDIVIDUALITY LEARNI; Paivio A, 1971, IMAGERY VERBAL PROCE; Palermo L, 2010, COGN NEUROPSYCHOL, V27, P115, DOI 10.1080/02643294.2010.503478; Perky CW, 1910, AM J PSYCHOL, V21, P422, DOI 10.2307/1413350; Richardson A., 1977, J MENT IMAG, V1, P109; Roder B, 2003, INT J PSYCHOPHYSIOL, V50, P27, DOI 10.1016/S0167-8760(03)00122-3; Roder B, 1999, NATURE, V400, P162, DOI 10.1038/22106; Shepard R, 1988, MENTAL IMAGES THEIR; Thyagarajan S, 2007, OPHTHAL PHYSL OPT, V27, P315, DOI 10.1111/j.1475-1313.2007.00469.x; TROJANO L, 1994, BRAIN COGNITION, V24, P213, DOI 10.1006/brcg.1994.1012; Vanlierde A, 2004, ACTA PSYCHOL, V116, P205, DOI 10.1016/j.actpsy.2004.03.001; Vincenzi G, 2000, THESIS U BOLOGNA ITA; WITKIN HA, 1977, REV EDUC RES, V47, P1	62	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65161	10.1371/journal.pone.0065161	http://dx.doi.org/10.1371/journal.pone.0065161			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166TB	23755186	Green Submitted, gold, Green Published			2022-12-27	WOS:000320579400042
J	Santiago-Rodriguez, TM; Narganes-Storde, YM; Chanlatte, L; Crespo-Torres, E; Toranzos, GA; Jimenez-Flores, R; Hamrick, A; Cano, RJ				Santiago-Rodriguez, Tasha M.; Narganes-Storde, Yvonne M.; Chanlatte, Luis; Crespo-Torres, Edwin; Toranzos, Gary A.; Jimenez-Flores, Rafael; Hamrick, Alice; Cano, Raul J.			Microbial Communities in Pre-Columbian Coprolites	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; FECES; POPULATIONS; DELIVERY; PATTERN; GENES; TOOLS; AGE	The study of coprolites from earlier cultures represents a great opportunity to study an "unaltered'' composition of the intestinal microbiota. To test this, pre-Columbian coprolites from two cultures, the Huecoid and Saladoid, were evaluated for the presence of DNA, proteins and lipids by cytochemical staining, human and/or dog-specific Bacteroides spp. by PCR, as well as bacteria, fungi and archaea using Terminal Restriction Fragment analyses. DNA, proteins and lipids, and human-specific Bacteroides DNA were detected in all coprolites. Multidimensional scaling analyses resulted in spatial arrangements of microbial profiles by culture, further supported by cluster analysis and ANOSIM. Differences between the microbial communities were positively correlated with culture, and SIMPER analysis indicated 68.8% dissimilarity between the Huecoid and Saladoid. Proteobacteria, Bacteroidetes and methanogens were found in all coprolite samples. Propionebacteria, Shewanella and lactic acid bacteria dominated in the Huecoid samples, while Acidobacteria, and peptococci were dominant in Saladoid samples. Yeasts, including Candida albicans and Crypotococcus spp. were found in all samples. Basidiomycetes were the most notable fungi in Huecoid samples while Ascomycetes predominated in Saladoid samples, suggesting differences in dietary habits. Our study provides an approach for the study of the microbial communities of coprolite samples from various cultures.	[Santiago-Rodriguez, Tasha M.; Toranzos, Gary A.] Univ Puerto Rico, Dept Biol, San Juan, PR 00936 USA; [Narganes-Storde, Yvonne M.; Chanlatte, Luis; Crespo-Torres, Edwin] Univ Puerto Rico, Ctr Archaeol Res, San Juan, PR 00936 USA; [Jimenez-Flores, Rafael] Calif Polytech State Univ San Luis Obispo, Dairy Prod Technol Ctr, San Luis Obispo, CA 93407 USA; [Hamrick, Alice; Cano, Raul J.] Calif Polytech State Univ San Luis Obispo, Ctr Applicat Biotechnol, San Luis Obispo, CA 93407 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; California State University System; California Polytechnic State University San Luis Obispo; California State University System; California Polytechnic State University San Luis Obispo	Cano, RJ (corresponding author), Calif Polytech State Univ San Luis Obispo, Ctr Applicat Biotechnol, San Luis Obispo, CA 93407 USA.	rcano@calpoly.edu	Jimenez-Flores, Rafael/B-6830-2017; Jimenez-Flores, Rafael/I-5229-2013	Jimenez-Flores, Rafael/0000-0003-4905-5021; 	Center for Applied Biotechnology at the California Polytechnic State University	Center for Applied Biotechnology at the California Polytechnic State University	Funding for the project was provided by the Center for Applied Biotechnology at the California Polytechnic State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrne S, 2005, MICROBES INFECT, V7, P1256, DOI 10.1016/j.micinf.2005.04.011; Bernhard AE, 2000, APPL ENVIRON MICROB, V66, P4571, DOI 10.1128/AEM.66.10.4571-4574.2000; Blackwood CB, 2003, APPL ENVIRON MICROB, V69, P926, DOI 10.1128/AEM.69.2.926-932.2003; BRUNS TD, 1993, MOL ECOL, V2, P233, DOI 10.1111/j.1365-294X.1993.tb00013.x; Cabrera-Rubio R, 2012, AM J CLIN NUTR, V96, P544, DOI 10.3945/ajcn.112.037382; Chanlatte L, 1980, P 8 INT C CAR ARCH B, P501; CLARKE KR, 1994, MAR BIOL, V118, P167, DOI 10.1007/BF00699231; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Coleman D.C., 1991, CARBON ISOTOPE TECHN; DeAngelis KM, 2010, BIOENERG RES, V3, P146, DOI 10.1007/s12155-010-9089-z; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; DERMOUN Z, 1985, BIOTECHNOL BIOENG, V27, P1005, DOI 10.1002/bit.260270711; Frey JC, 2010, J APPL MICROBIOL, V108, P1982, DOI 10.1111/j.1365-2672.2009.04602.x; Gorley C.K., 2006, GETTING STARTED PRIM; Hamada M, 2009, INT J SYST EVOL MICR, V59, P2809, DOI 10.1099/ijs.0.011106-0; HOLDEMAN LV, 1976, APPL ENVIRON MICROB, V31, P359, DOI 10.1128/AEM.31.3.359-375.1976; Kaplan CW, 2004, APPL ENVIRON MICROB, V70, P1777, DOI 10.1128/AEM.70.3.1777-1786.2004; Kaplan CW, 2001, APPL ENVIRON MICROB, V67, P1935, DOI 10.1128/AEM.67.4.1935-1939.2001; Kendall AI, 1924, J INFECT DIS, V35, P67, DOI 10.1093/infdis/35.1.67; Kildare BJ, 2007, WATER RES, V41, P3701, DOI 10.1016/j.watres.2007.06.037; Kitts C L, 2001, Curr Issues Intest Microbiol, V2, P17; Kutschera U, 2007, PLANT SIGNAL BEHAV, V2, P74, DOI 10.4161/psb.2.2.4073; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006; Narganes-Storde Y, 1982, VERTEBRATE FAUNAL RE; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Pagan-Jimenez JR, 2009, MUNDO VIVIDO ANTIGUO; Pagan-Jimenez JR, 2007, ANTIGUOS PUEBLOS CUL; Reinhard KJ, 1992, PAPERS NATURAL RESOU; Reyes-Becerril M, 2008, FISH SHELLFISH IMMUN, V25, P731, DOI 10.1016/j.fsi.2008.02.010; Scott TM, 2002, APPL ENVIRON MICROB, V68, P5796, DOI 10.1128/AEM.68.12.5796-5803.2002; Sobolik KD, 1990, TEXAS J SCI, V42; Sorensen T, 1948, BIOL SKRIFTER, V5, P1; Tito RY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051146; Wasser MP, 1999, INT J MED MUSHROOMS, V1, P31; Wood JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040025; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	38	31	31	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65191	10.1371/journal.pone.0065191	http://dx.doi.org/10.1371/journal.pone.0065191			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755194	Green Published, gold, Green Submitted			2022-12-27	WOS:000320579400045
J	Turbelin, C; Souty, C; Pelat, C; Hanslik, T; Sarazin, M; Blanchon, T; Falchi, A				Turbelin, Clement; Souty, Cecile; Pelat, Camille; Hanslik, Thomas; Sarazin, Marianne; Blanchon, Thierry; Falchi, Alessandra			Age Distribution of Influenza Like Illness Cases during Post-Pandemic A(H3N2): Comparison with the Twelve Previous Seasons, in France	PLOS ONE			English	Article							COMMUNICABLE DISEASES; PATIENT AGE; SURVEILLANCE; EPIDEMICS; DETERMINANTS; VACCINATION; MORTALITY; A/H1N1; FIELD	In France, the 2011-2012 influenza epidemic was characterized by the circulation of antigenically drifted influenza A(H3N2) viruses and by an increased disease severity and mortality among the elderly, with respect to the A(H1N1) pdm09 pandemic and post-pandemic outbreaks. Whether the epidemiology of influenza in France differed between the 2011-2012 epidemic and the previous outbreaks is unclear. Here, we analyse the age distribution of influenza like illness (ILI) cases attended in general practice during the 2011-2012 epidemic, and compare it with that of the twelve previous epidemic seasons. Influenza like illness data were obtained through a nationwide surveillance system based on sentinel general practitioners. Vaccine effectiveness was also estimated. The estimated number of ILI cases attended in general practice during the 2011-2012 was lower than that of the past twelve epidemics. The age distribution was characteristic of previous A(H3N2)dominated outbreaks: school-age children were relatively spared compared to epidemics (co-) dominated by A(H1N1) and/or B viruses (including the 2009 pandemic and post-pandemic outbreaks), while the proportion of adults over 30 year-old was higher. The estimated vaccine effectiveness (54%, 95% CI (48, 60)) was in the lower range for A(H3N2) epidemics. In conclusion, the age distribution of ILI cases attended in general practice seems to be not different between the A(H3N2) pre-pandemic and post-pandemic epidemics. Future researches including a more important number of ILI epidemics and confirmed virological data of influenza and other respiratory pathogens are necessary to confirm these results.	[Turbelin, Clement; Souty, Cecile; Sarazin, Marianne; Blanchon, Thierry; Falchi, Alessandra] INSERM, U707, F-75012 Paris, France; [Turbelin, Clement; Souty, Cecile; Sarazin, Marianne; Blanchon, Thierry] Univ Paris 06, UMR S U707, F-75012 Paris, France; [Pelat, Camille] INSERM, U738, F-75018 Paris, France; [Pelat, Camille] Univ Paris Diderot, UMR S 738, F-75018 Paris, France; [Hanslik, Thomas] Univ Versailles St Quentin en Yvelines, Versailles, France; [Hanslik, Thomas] AP HP, Paris, France; [Hanslik, Thomas] Hop Ambroise Pare, Serv Med Interne, Boulogne, France; [Falchi, Alessandra] Univ Corse, Virol Lab, Corte, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP	Turbelin, C (corresponding author), INSERM, U707, F-75012 Paris, France.	turbelin@u707.jussieu.fr	BLANCHON, Thierry/AAK-6254-2020; FALCHI, Alessandra/AAQ-8039-2020	Alessandra, FALCHI/0000-0003-0799-1460	National Institute for Health	National Institute for Health	The study was funded by National Institute for Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belchior E., 2012, Bulletin Epidemiologique Hebdomadaire, P424; Belongia EA, 2009, J INFECT DIS, V199, P159, DOI 10.1086/595861; Bonmarin I, 2012, EUROSURVEILLANCE, V17; Carrat F, 1999, CLIN INFECT DIS, V28, P283, DOI 10.1086/515117; COSTAGLIOLA D, 1991, AM J PUBLIC HEALTH, V81, P97, DOI 10.2105/AJPH.81.1.97; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Dockrey M R, 2005, AMIA Annu Symp Proc, P940; European Centre for Disease Prevention and Control, 2012, SEAS INFL 2011 2012; FARRINGTON CP, 1993, INT J EPIDEMIOL, V22, P742, DOI 10.1093/ije/22.4.742; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; Flahault A, 2006, STAT METHODS MED RES, V15, P413, DOI 10.1177/0962280206071639; Fleming DM, 1999, EUR J EPIDEMIOL, V15, P467, DOI 10.1023/A:1007525402861; Fouillet A., 2012, Bulletin Epidemiologique Hebdomadaire, P375; FOX JP, 1982, AM J EPIDEMIOL, V116, P228, DOI 10.1093/oxfordjournals.aje.a113408; Fragoso G, 2004, COMP FUNCT GENOM, V5, P648, DOI 10.1002/cfg.445; GLEZEN WP, 1991, AM J EPIDEMIOL, V133, P296, DOI 10.1093/oxfordjournals.aje.a115874; Goldstein E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001051; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Heddini A, 2009, EUROSURVEILLANCE, V14; Kaji M, 2003, RESPIROLOGY, V8, P231, DOI 10.1046/j.1440-1843.2003.00457.x; Kataria, 2016, SAUDI J SPORTS MED, V16, P139; Khiabanian H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012658; Khiabanian H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006832; Kissling E, 2012, EUROSURVEILLANCE, V17; Lee BE, 2010, INFECT CONT HOSP EP, V31, P535, DOI 10.1086/652159; Legrand J, 2006, VACCINE, V24, P6605, DOI 10.1016/j.vaccine.2006.05.063; Lemaitre M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045051; Lemaitre M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-162; MONTO AS, 1993, EPIDEMIOL INFECT, V110, P145, DOI 10.1017/S0950268800050779; Olson DR, 2007, PLOS MED, V4, P1349, DOI 10.1371/journal.pmed.0040247; ORENSTEIN WA, 1988, EPIDEMIOL REV, V10, P212, DOI 10.1093/oxfordjournals.epirev.a036023; Pelat C, 2013, INFLUENZA OTHER RESP, V7, P74, DOI 10.1111/j.1750-2659.2012.00356.x; Pelat C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019621; Pelat C, 2007, BMC MED INFORM DECIS, V7, DOI 10.1186/1472-6947-7-29; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Simonsen L, 2007, LANCET INFECT DIS, V7, P658, DOI 10.1016/S1473-3099(07)70236-0; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Turbelin C, 2009, EURO SURVEILL, V14; VALLERON AJ, 1986, AM J PUBLIC HEALTH, V76, P1289, DOI 10.2105/AJPH.76.11.1289; Vaux S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-30; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Virtanen MJ, 2012, EURO SURVEILL, V17; Zambon MC, 2001, LANCET, V358, P1410, DOI 10.1016/S0140-6736(01)06528-X	44	28	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65919	10.1371/journal.pone.0065919	http://dx.doi.org/10.1371/journal.pone.0065919			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755294	Green Published, gold, Green Submitted			2022-12-27	WOS:000320579400081
J	Brouwers, J; Noviyanti, R; Fijnheer, R; de Groot, PG; Trianty, L; Mudaliana, S; Roest, M; Syafruddin, D; van der Ven, A; de Mast, Q				Brouwers, Judith; Noviyanti, Rintis; Fijnheer, Rob; de Groot, Philip G.; Trianty, Leily; Mudaliana, Siti; Roest, Mark; Syafruddin, Din; van der Ven, Andre; de Mast, Quirijn			Platelet Activation Determines Angiopoietin-1 and VEGF Levels in Malaria: Implications for Their Use as Biomarkers	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CEREBRAL MALARIA; UNCOMPLICATED MALARIA; FALCIPARUM-MALARIA; AFRICAN CHILDREN; WHOLE-BLOOD; PLASMA; RELEASE; CELLS; THROMBOCYTOPENIA	Introduction: The angiogenic proteins angiopoietin (Ang)-1, Ang-2 and vascular endothelial growth factor (VEGF) are regulators of endothelial inflammation and integrity. Since platelets store large amounts of Ang-1 and VEGF, measurement of circulation levels of these proteins is sensitive to platelet number, in vivo platelet activation and inadvertent platelet activation during blood processing. We studied plasma Ang-1, Ang-2 and VEGF levels in malaria patients, taking the necessary precautions to avoid ex vivo platelet activation, and related plasma levels to platelet count and the soluble platelet activation markers P-selectin and CXCL7. Methods: Plasma levels of Ang-1, Ang-2, VEGF, P-selectin and CXCL7 were measured in CTAD plasma, minimizing ex vivo platelet activation, in 27 patients with febrile Plasmodium falciparum malaria at presentation and day 2 and 5 of treatment and in 25 healthy controls. Results: Levels of Ang-1, Ang-2 and VEGF were higher at day 0 in malaria patients compared to healthy controls. Ang-2 levels, which is a marker of endothelial activation, decreased after start of antimalarial treatment. In contrast, Ang-1 and VEGF plasma levels increased and this corresponded with the increase in platelet number. Soluble P-selectin and CXCL7 levels followed the same trend as Ang-1 and VEGF levels. Plasma levels of these four proteins correlated strongly in malaria patients, but only moderately in controls. Conclusion: In contrast to previous studies, we found elevated plasma levels of Ang-1 and VEGF in patients with malaria resulting from in vivo platelet activation. Ang-1 release from platelets may be important to dampen the disturbing effects of Ang-2 on the endothelium. Evaluation of plasma levels of these angiogenic proteins requires close adherence to a stringent protocol to minimize ex vivo platelet activation.	[Brouwers, Judith; Fijnheer, Rob; de Groot, Philip G.; Roest, Mark; de Mast, Quirijn] Univ Med Ctr, Dept Clin Chem & Haematol, Utrecht, Netherlands; [Noviyanti, Rintis; Trianty, Leily; Mudaliana, Siti; Syafruddin, Din] Eijkman Inst Mol Biol, Jakarta, Indonesia; [van der Ven, Andre; de Mast, Quirijn] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands	Utrecht University; Utrecht University Medical Center; Eijkman Institute; Radboud University Nijmegen	de Mast, Q (corresponding author), Univ Med Ctr, Dept Clin Chem & Haematol, Utrecht, Netherlands.	q.demast@aig.umcn.nl	van der Ven, A.J.A.M./H-8102-2014; de Mast, Quirijn/H-3427-2015	van der Ven, A.J.A.M./0000-0003-1833-3391; Trianty, Leily/0000-0002-4368-476X; Syafruddin, din/0000-0001-7141-2545; Noviyanti, Rintis/0000-0003-1383-3274; de Mast, Quirijn/0000-0001-6056-157X	KNAW (Royal Academy of Sciences) through the SPIN Postdoc Research Programme; Noaber foundation; Augeo foundation	KNAW (Royal Academy of Sciences) through the SPIN Postdoc Research Programme; Noaber foundation; Augeo foundation	Research support from the KNAW (Royal Academy of Sciences) through the SPIN Postdoc Research Programme (RN) and the Noaber foundation and Augeo foundation (JB, QM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks RE, 1998, BRIT J CANCER, V77, P956, DOI 10.1038/bjc.1998.158; Casals-Pascual C, 2008, P NATL ACAD SCI USA, V105, P2634, DOI 10.1073/pnas.0709715105; Conroy AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015291; Conroy AL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-295; de Mast Q, 2007, J INFECT DIS, V196, P622, DOI 10.1086/519844; de Mast Q, 2010, BRIT J HAEMATOL, V151, P495, DOI 10.1111/j.1365-2141.2010.08399.x; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Fijnheer R, 1997, THROMB HAEMOSTASIS, V77, P1081; Golanski J, 1996, THROMB RES, V83, P199, DOI 10.1016/0049-3848(96)00129-6; Ho-Tin-Noe B, 2011, J THROMB HAEMOST, V9, P56, DOI 10.1111/j.1538-7836.2011.04317.x; Iannacone M, 2008, P NATL ACAD SCI USA, V105, P629, DOI 10.1073/pnas.0711200105; Jain V, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-83; Jain V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-383; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; KUHNE T, 1995, AM J HEMATOL, V50, P40, DOI 10.1002/ajh.2830500108; Lei H, 2009, CLIN BIOCHEM, V42, P1452, DOI 10.1016/j.clinbiochem.2009.06.012; Li JJ, 2001, THROMB HAEMOSTASIS, V85, P204, DOI 10.1055/s-0037-1615677; Lovegrove FE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004912; Mohle R, 1997, P NATL ACAD SCI USA, V94, P663, DOI 10.1073/pnas.94.2.663; Nachman RL, 2008, NEW ENGL J MED, V359, P1261, DOI 10.1056/NEJMra0800887; Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046; Ranieri G, 2004, ONCOL REP, V11, P435; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Starlinger P, 2011, DIS MARKERS, V31, P55, DOI [10.1155/2011/535109, 10.3233/DMA-2011-0798]; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Thurston G, 2005, EXP SUPPL, V94, P233; van Bladel ER, 2011, HAEMATOL-HEMATOL J, V96, P888, DOI 10.3324/haematol.2011.042663; Yeo TW, 2008, P NATL ACAD SCI USA, V105, P17097, DOI 10.1073/pnas.0805782105; Zimmermann R, 2005, CLIN CHEM, V51, P2365, DOI 10.1373/clinchem.2005.055558; Zimmermann R, 2003, VOX SANG, V85, P283, DOI 10.1111/j.0042-9007.2003.00361.x; Zimmermann R, 2009, J IMMUNOL METHODS, V347, P91, DOI 10.1016/j.jim.2009.04.010	31	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64850	10.1371/journal.pone.0064850	http://dx.doi.org/10.1371/journal.pone.0064850			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755151	Green Published, Green Submitted, gold			2022-12-27	WOS:000319872300031
J	Gast, CM; Skalski, JR; Isabelle, JL; Clawson, MV				Gast, Christopher M.; Skalski, John R.; Isabelle, Jason L.; Clawson, Michael V.			Random Effects Models and Multistage Estimation Procedures for Statistical Population Reconstruction of Small Game Populations	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; CATCH-EFFORT; INFERENCE; TRENDS; TESTS; RATIO	Recently, statistical population models using age-at-harvest data have seen increasing use for monitoring of harvested wildlife populations. Even more recently, detailed evaluation of model performance for long-lived, large game animals indicated that the use of random effects to incorporate unmeasured environmental variation, as well as second-stage Horvitz-Thompson-type estimators of abundance, provided more reliable estimates of total abundance than previous models. We adapt this new modeling framework to small game, age-at-harvest models with only young-of-the-year and adult age classes. Our Monte Carlo simulation results indicate superior model performance for the new modeling framework, evidenced by lower bias and proper confidence interval coverage. We apply this method to male wild turkey harvest in the East Ozarks turkey productivity region, Missouri, USA, where statistical population reconstruction indicates a relatively stationary population for 1996-2010.	[Gast, Christopher M.] Univ Washington, Seattle, WA 98195 USA; [Skalski, John R.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Isabelle, Jason L.] Missouri Dept Conservat, Columbia, MO USA; [Clawson, Michael V.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Missouri System; University of Missouri Columbia; University of Washington; University of Washington Seattle	Skalski, JR (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	skalski@uw.edu		Skalski, John/0000-0002-7070-2505; Clawson, Michael/0000-0002-8413-7009				Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; [Anonymous], 1982, ESTIMATION ANIMAL AB; Broms K, 2010, J WILDLIFE MANAGE, V74, P310, DOI 10.2193/2008-469; Buckland ST, 2010, BIOMETRICS, V66, P169, DOI 10.1111/j.1541-0420.2009.01239.x; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Conn PB, 2008, BIOMETRICS, V64, P1170, DOI 10.1111/j.1541-0420.2008.00987.x; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Diefenbach DR, 2010, TECHNICAL REPORT; DUPONT WD, 1983, BIOMETRICS, V39, P1021, DOI 10.2307/2531336; Fieberg JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012114; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Gast CM, 2013, J WILDLIFE IN PRESS; Gove NE, 2002, J WILDLIFE MANAGE, V66, P310, DOI 10.2307/3803163; Laake J. L., 2004, METHODS INCOMPLETE D; Leslie P. H., 1945, BIOMETRIKA, V33, P183, DOI [10.1093/biomet/33.3.183, DOI 10.1093/BIOMET/33.3.1832-S2.0-77956980711]; Molenberghs G, 2007, AM STAT, V61, P22, DOI 10.1198/000313007X171322; Nigh T.A., 2002, ATLAS MISSOURI ECORE; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Skalski JR, 2007, J WILDLIFE MANAGE, V71, P1309, DOI 10.2193/2005-707; Skalski JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033910; Skalski JR, 2011, J WILDLIFE MANAGE, V75, P1767, DOI 10.1002/jwmg.227; WARE S, 1992, AM MIDL NAT, V128, P40, DOI 10.2307/2426411; [No title captured]	23	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65244	10.1371/journal.pone.0065244	http://dx.doi.org/10.1371/journal.pone.0065244			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755199	gold, Green Published, Green Submitted			2022-12-27	WOS:000319872300062
J	Granado, M; Fernandez, N; Monge, L; Carreno-Tarragona, G; Figueras, JC; Amor, S; Garcia-Villalon, AL				Granado, Miriam; Fernandez, Nuria; Monge, Luis; Carreno-Tarragona, Gonzalo; Carlos Figueras, Juan; Amor, Sara; Luis Garcia-Villalon, Angel			Long-Term Effects of Early Overnutrition in the Heart of Male Adult Rats: Role of the Renin-Angiotensin System	PLOS ONE			English	Article							OBESE ZUCKER RATS; DEPENDENT APOPTOTIC PATHWAY; CARDIOVASCULAR-DISEASE; ENDOTHELIAL DYSFUNCTION; MYOCARDIAL-INFARCTION; ISCHEMIA-REPERFUSION; RENIN/PRORENIN RECEPTOR; VASCULAR INFLAMMATION; CORONARY-ARTERIES; OXIDATIVE STRESS	To analyze the long-term effects of early overfeeding on the heart and coronary circulation, the effect of ischemia-reperfusion (I/R) and the role of the renin-angiotensin system (RAS) was studied in isolated hearts from control and overfed rats during lactation. On the day of birth litters were adjusted to twelve pups per mother (controls) or to three pups per mother (overfed). At 5 months of age, the rats from reduced litters showed higher body weight and body fat than the controls. The hearts from these rats were perfused in a Langendorff system and subjected to 30 min of ischemia followed by 15 min of reperfusion (I/R). The myocardial contractility (dP/dt) and the coronary vasoconstriction to angiotensin II were lower, and the expression of the apoptotic marker was higher, in the hearts from overfed rats compared to controls. I/R reduced the myocardial contractily, the coronary vasoconstriction to angiotensin II and the vasodilatation to bradykinin, and increased the expression of (pro)renin receptor and of apoptotic and antiapoptotic markers, in both experimental groups. I/R also increased the expression of angiotensinogen in control but not in overfed rats. In summary, the results of this study suggest that early overnutrition induces reduced activity of the RAS and impairment of myocardial and coronary function in adult life, due to increased apoptosis. Ischemia-reperfusion produced myocardial and coronary impairment and apoptosis, which may be related to activation of RAS in control but not in overfed rats, and there may be protective mechanisms in both experimental groups.	[Granado, Miriam; Fernandez, Nuria; Monge, Luis; Carreno-Tarragona, Gonzalo; Carlos Figueras, Juan; Amor, Sara; Luis Garcia-Villalon, Angel] Univ Autonoma Madrid, Fac Med, Dept Physiol, E-28049 Madrid, Spain; [Granado, Miriam] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr, Madrid, Spain	Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Granado, M (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Physiol, E-28049 Madrid, Spain.	miriam.granado@uam.es	Granado, Miriam/B-8978-2017; Fernández, Nuria/AAM-7639-2021; Monge, Luis/M-3515-2014; Monge, Luis/O-6840-2019; Monsalve, Nuria Fernández/E-6235-2013; Garcia-Villalon, Angel/AAA-3067-2019	Granado, Miriam/0000-0001-9178-8822; Fernández, Nuria/0000-0002-9268-3333; Monge, Luis/0000-0001-7688-7531; Monge, Luis/0000-0001-7688-7531; Monsalve, Nuria Fernández/0000-0002-9268-3333; Carreno-Tarragona, Gonzalo/0000-0002-9570-5542	Fundacion Mapfre; Fondo de Investigaciones Sanitarias [PS09/00394]	Fundacion Mapfre; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III)	This work was financed by Fundacion Mapfre (2011) and Fondo de Investigaciones Sanitarias (PS09/00394). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altarche-Xifro W, 2009, STEM CELLS, V27, P2488, DOI 10.1002/stem.171; Barouch LA, 2006, CIRC RES, V98, P119, DOI 10.1161/01.RES.0000199348.10580.1d; Batenburg WW, 2012, CLIN SCI, V123, P121, DOI 10.1042/CS20120042; Black MJ, 2012, AM J PHYSIOL-REG I, V302, pR1101, DOI 10.1152/ajpregu.00030.2012; Bohlen HG, 2002, AM J PHYSIOL-HEART C, V283, pH391, DOI 10.1152/ajpheart.00019.2002; Busche S, 2000, AM J PATHOL, V157, P605, DOI 10.1016/S0002-9440(10)64571-3; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Danser AHJ, 2002, J MOL CELL CARDIOL, V34, P1463, DOI 10.1006/jmcc.2002.2078; Davidowa H, 2000, NEUROSCI LETT, V293, P21, DOI 10.1016/S0304-3940(00)01475-0; Davidowa H, 2007, NEUROREPORT, V18, P521, DOI 10.1097/WNR.0b013e32805dfb93; de Chantemele EJB, 2012, J MOL CELL CARDIOL, V52, P840, DOI 10.1016/j.yjmcc.2011.08.018; De Mello W, 2003, REGUL PEPTIDES, V114, P87, DOI 10.1016/S0167-0115(03)00121-6; De Mello WC, 2011, PEPTIDES, V32, P1774, DOI 10.1016/j.peptides.2011.06.018; Dimmeler S, 2000, REGUL PEPTIDES, V90, P19, DOI 10.1016/S0167-0115(00)00105-1; Dixon JL, 1999, ARTERIOSCL THROM VAS, V19, P2981, DOI 10.1161/01.ATV.19.12.2981; du Toit EF, 2005, BASIC RES CARDIOL, V100, P346, DOI 10.1007/s00395-005-0528-5; Dyntar D, 2001, DIABETES, V50, P2105, DOI 10.2337/diabetes.50.9.2105; Eisenmann JC, 2005, AM HEART J, V149, P46, DOI 10.1016/j.ahj.2004.07.016; Erdos B, 2004, DIABETES, V53, P1352, DOI 10.2337/diabetes.53.5.1352; Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581; Fowler JD, 2009, AM J PHYSIOL-ENDOC M, V296, pE343, DOI 10.1152/ajpendo.90693.2008; Frisbee JC, 2001, AM J PHYSIOL-HEART C, V281, pH1304, DOI 10.1152/ajpheart.2001.281.3.H1304; Fujiwara K, 1999, HYPERTENSION, V33, P1470, DOI 10.1161/01.HYP.33.6.1470; Galili O, 2007, AM J PHYSIOL-HEART C, V292, pH904, DOI 10.1152/ajpheart.00628.2006; Garcia-Villalon AL, 2005, EUR J PHARMACOL, V509, P165, DOI 10.1016/j.ejphar.2004.11.065; Garcia-Villalon AL, 2004, EXP BIOL MED, V229, P118, DOI 10.1177/153537020422900114; Garcia-Villalon AL, 2009, CARDIOVASC RES, V81, P336, DOI 10.1093/cvr/cvn321; GAVRAS H, 1971, LANCET, V2, P19; GAVRAS H, 1975, AM HEART J, V89, P321, DOI 10.1016/0002-8703(75)90082-4; GIACOMELLI F, 1976, AM J PATHOL, V84, P111; Goossens G H, 2003, Obes Rev, V4, P43; Granado M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054984; Hirose T, 2009, PEPTIDES, V30, P2316, DOI 10.1016/j.peptides.2009.09.015; Ichihara A, 2006, HYPERTENSION, V47, P894, DOI 10.1161/01.HYP.0000215838.48170.0b; Klein S, 2004, CIRCULATION, V110, P2952, DOI 10.1161/01.CIR.0000145546.97738.1E; Knudson JD, 2005, AM J PHYSIOL-HEART C, V289, pH1038, DOI 10.1152/ajpheart.00244.2005; KREMER D, 1981, CARDIOVASC RES, V15, P43, DOI 10.1093/cvr/15.1.43; Lamarche B, 1998, GROWTH HORM IGF RES, V8, P1, DOI 10.1016/S1096-6374(98)80018-X; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Lee SD, 2007, OBESITY, V15, P2407, DOI 10.1038/oby.2007.286; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Li ZL, 2012, ARTERIOSCL THROM VAS, V32, P1132, DOI 10.1161/ATVBAHA.111.244061; LINDPAINTNER K, 1990, CIRC RES, V67, P564, DOI 10.1161/01.RES.67.3.564; Listenberger LL, 2002, TRENDS CARDIOVAS MED, V12, P134, DOI 10.1016/S1050-1738(02)00152-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logue J, 2011, CLIN PHARMACOL THER, V90, P174, DOI 10.1038/clpt.2011.88; Lu MC, 2007, OBESITY, V15, P2634, DOI 10.1038/oby.2007.315; Marchesi C, 2008, TRENDS PHARMACOL SCI, V29, P367, DOI 10.1016/j.tips.2008.05.003; Miller AW, 1999, J VASC RES, V36, P385, DOI 10.1159/000025678; Muller DN, 1998, CIRC RES, V82, P13; Nguyen DM, 2010, GASTROENTEROL CLIN N, V39, P1, DOI 10.1016/j.gtc.2009.12.014; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; NIO Y, 1995, J CLIN INVEST, V95, P46, DOI 10.1172/JCI117675; Oltman CL, 2006, AM J PHYSIOL-HEART C, V291, pH1780, DOI 10.1152/ajpheart.01297.2005; Pascual M, 2003, HEART, V89, P1152, DOI 10.1136/heart.89.10.1152; Prakash R, 2006, MICROCIRCULATION, V13, P389, DOI 10.1080/10739680600745919; Saris JJ, 2006, HYPERTENSION, V48, P564, DOI 10.1161/01.HYP.0000240064.19301.1b; Schefe JH, 2006, CIRC RES, V99, P1355, DOI 10.1161/01.RES.0000251700.00994.0d; Schunkert H, 2002, INT J OBESITY, V26, pS15, DOI 10.1038/sj.ijo.0802214; Shimizu M, 1999, J CARDIOVASC PHARM, V34, P512, DOI 10.1097/00005344-199910000-00006; Sishi B, 2011, EXP PHYSIOL, V96, P179, DOI 10.1113/expphysiol.2010.054189; Stepp DW, 1999, CIRCULATION, V100, P1555, DOI 10.1161/01.CIR.100.14.1555; Trask AJ, 2008, AM J PHYSIOL-HEART C, V294, pH2242, DOI 10.1152/ajpheart.00175.2008; Trivedi PS, 2008, CURR HYPERTENS REP, V10, P454, DOI 10.1007/s11906-008-0085-z; Viner RM, 2006, INT J OBESITY, V30, P1368, DOI 10.1038/sj.ijo.0803183; Wang QD, 1999, EUR J PHARMACOL, V380, P13, DOI 10.1016/S0014-2999(99)00499-9; Werrmann JG, 1996, J CARDIOVASC PHARM, V27, P177, DOI 10.1097/00005344-199602000-00001; Yim HE, 2011, J NUTR BIOCH; Zhang CH, 2008, BASIC RES CARDIOL, V103, P407, DOI 10.1007/s00395-008-0725-0; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	70	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65172	10.1371/journal.pone.0065172	http://dx.doi.org/10.1371/journal.pone.0065172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755190	Green Published, Green Submitted, gold			2022-12-27	WOS:000319872300054
J	Jung, SB; Kim, CS; Kim, YR; Naqvi, A; Yamamori, T; Kumar, S; Kumar, A; Irani, K				Jung, Saet-Byel; Kim, Cuk-Seong; Kim, Young-Rae; Naqvi, Asma; Yamamori, Tohru; Kumar, Santosh; Kumar, Ajay; Irani, Kaikobad			Redox Factor-1 Activates Endothelial SIRTUIN1 through Reduction of Conserved Cysteine Sulfhydryls in Its Deacetylase Domain	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVITY; SIRT1; IDENTIFICATION; APE1/REF-1; REF-1; PROMOTES; HYPOXIA; PROTEIN	Apurinic/Apyrmidinic Endonuclease 1/Redox Factor-1 (APE1/Ref-1) is a reductant which is important for vascular homeostasis. SIRTUIN1 (SIRT1) is a lysine deacetylase that also promotes endothelium-dependent vasorelaxation. We asked if APE1/Ref-1 governs the redox state and activity of SIRT1, and whether SIRT1 mediates the effect of APE1/Ref-1 on endothelium-dependent vascular function. APE1/Ref-1 maintains sulfhydryl (thiol) groups of cysteine residues in SIRT1 in the reduced form and promotes endothelial SIRT1 activity. APE1/Ref-1 stimulates SIRT1 activity by targeting highly conserved vicinal thiols 371 and 374 which form a zinc tetra-thiolate motif in the deacetylase domain of SIRT1. Cysteine residues in the N-terminal redox domain of APE1/Ref-1 are essential for reducing SIRT1 and stimulating its activity. APE1/Ref-1 protects endothelial SIRT1 from hydrogen peroxide-induced oxidation of sulfhydryls and from inactivation. APE1/Ref-1 also promotes lysine deacetylation of the SIRT1 target endothelial nitric oxide synthase (eNOS). SIRT1 mutated at cysteines 371 and 374, which renders it non-reducible by APE1/Ref-1, prevents lysine deacetylation of eNOS by APE1/Ref-1. SIRT1 free thiol (reduced sulfhydryl) content and deacetylase activity are diminished in all examined tissues of APE1/Ref-1(+/-) mice, including the vasculature. Overexpression of SIRT1 in aortas of APE1/Ref-1(+/-) mice restores endothelium-dependent vasorelaxation and bioavailable nitric oxide (NO) to levels similar to those observed in wild-type mice. Thus, APE1/Ref-1, by maintaining functionally important cysteine sulfhydryls in SIRT1 in the reduced form, promotes endothelial SIRT1 activity. This reductive activation of endothelial SIRT1 by APE1/Ref-1 mediates the effect of APE1/Ref-1 on eNOS acetylation, promoting endothelium-derived NO and endothelium-dependent vasorelaxation.	[Jung, Saet-Byel; Kim, Cuk-Seong; Kim, Young-Rae; Naqvi, Asma; Yamamori, Tohru; Kumar, Santosh; Kumar, Ajay; Irani, Kaikobad] Univ Pittsburgh, Dept Med, Div Cardiol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Irani, K (corresponding author), Univ Iowa, Dept Internal Med, Carver Coll Med, Div Cardiovasc Med, Iowa City, IA 52242 USA.	iranik@upmc.edu	Yamamori, Tohru/A-7285-2012; Kumar, Santosh/N-9922-2014	Kumar, Santosh/0000-0003-1418-2020; Kim, Cuk-Seong/0000-0001-7647-6089; Irani, Kaikobad/0000-0001-9194-7387	Grants-in-Aid for Scientific Research [24654112] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Angkeow P, 2002, CELL DEATH DIFFER, V9, P717, DOI 10.1038/sj.cdd.4401025; Bhakat KK, 2009, ANTIOXID REDOX SIGN, V11, P621, DOI [10.1089/ars.2008.2198, 10.1089/ARS.2008.2198]; Caito S, 2010, FASEB J, V24, P3145, DOI 10.1096/fj.09-151308; Chen L, 2010, J INORG BIOCHEM, V104, P180, DOI 10.1016/j.jinorgbio.2009.10.021; Farci P, 2010, P NATL ACAD SCI USA, V107, P8766, DOI [10.1073/pnas.1003854107, 10.1073/pnas.1003833107]; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hirota K, 1997, P NATL ACAD SCI USA, V94, P3633, DOI 10.1073/pnas.94.8.3633; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Jayaraman L, 1997, GENE DEV, V11, P558, DOI 10.1101/gad.11.5.558; Jeon BH, 2004, CIRC RES, V95, P902, DOI 10.1161/01.RES.0000146947.84294.4c; Jiang AH, 2011, VISION RES, V51, P93, DOI 10.1016/j.visres.2010.10.008; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; Min JR, 2001, CELL, V105, P269, DOI 10.1016/S0092-8674(01)00317-8; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Sherman JM, 1999, MOL BIOL CELL, V10, P3045, DOI 10.1091/mbc.10.9.3045; Stein S, 2010, AGING-US, V2, P353, DOI 10.18632/aging.100162; Sung JS, 2006, FEBS J, V273, P1620, DOI 10.1111/j.1742-4658.2006.05192.x; Tell G, 2009, ANTIOXID REDOX SIGN, V11, P601, DOI 10.1089/ars.2008.2194; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; WALKER LJ, 1993, MOL CELL BIOL, V13, P5370, DOI 10.1128/MCB.13.9.5370; XANTHOUDAKIS S, 1992, EMBO J, V11, P653, DOI 10.1002/j.1460-2075.1992.tb05097.x; Yamamori T, 2010, NUCLEIC ACIDS RES, V38, P832, DOI 10.1093/nar/gkp1039; Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645; Zee RS, 2010, ANTIOXID REDOX SIGN, V13, P1023, DOI 10.1089/ars.2010.3251; Zhang QJ, 2008, CARDIOVASC RES, V80, P191, DOI 10.1093/cvr/cvn224; Zhang R, 2010, J BIOL CHEM, V285, P7097, DOI 10.1074/jbc.M109.038604	30	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65415	10.1371/journal.pone.0065415	http://dx.doi.org/10.1371/journal.pone.0065415			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755229	Green Published, gold, Green Accepted			2022-12-27	WOS:000319872300079
J	Sengupta, S; Powell, E; Kong, L; Blackard, JT				Sengupta, Satarupa; Powell, Eleanor; Kong, Ling; Blackard, Jason T.			Effects of HCV on Basal and Tat-Induced HIV LTR Activation	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; LONG TERMINAL REPEAT; BLOOD MONONUCLEAR-CELLS; ACTIVE ANTIRETROVIRAL THERAPY; HUMAN HEPATOMA-CELLS; CORE PROTEIN; FACTOR-ALPHA	Hepatitis C virus (HCV) co-infection occurs in similar to 30-40% of the HIV-infected population in the US. While a significant body of research suggests an adverse effect of HIV on HCV replication and disease progression, the impact of HCV on HIV infection has not been well studied. Increasing data suggest that hepatocytes and other liver cell populations can serve as reservoirs for HIV replication. Therefore, to gain insight into the impact of HCV on HIV, the effects of the HCV Core protein and infectious hepatitis C virions were evaluated on basal and Tat-induced activation of the HIV long terminal repeat (LTR) in hepatocytes. The HIV LTR was highly induced by the HIV transactivator protein Tat in hepatocytes. Activation varied according to the number of NF-kB binding sites present in the LTRs from different HIV subtypes. Involvement of the NF-kB binding pathway in LTR activation was demonstrated using an NF-kB inhibitor and deletion of the NF-kB binding sites. TNF alpha, a pro-inflammatory cytokine that plays an important role in HIV pathogenesis, also induced LTR activity in hepatocytes. However, HIV LTR activity was suppressed in hepatocytes in the presence of HCV Core protein, and the suppressive effect persisted in the presence of TNF alpha. In contrast, infectious hepatitis C virions upregulated HIV LTR activation and gene transcription. Core-mediated suppression remained unaltered in the presence of HCV NS3/4A protein, suggesting the involvement of other viral/cellular factors. These findings have significant clinical implications as they imply that HCV could accelerate HIV disease progression in HIV/HCV co-infected patients. Such analyses are important to elucidate the mechanisms by which these viruses interact and could facilitate the development of more effective therapies to treat HIV/HCV co-infection.	[Sengupta, Satarupa; Powell, Eleanor; Kong, Ling; Blackard, Jason T.] Univ Cincinnati, Coll Med, Dept Internal Med, Div Digest Dis, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Blackard, JT (corresponding author), Univ Cincinnati, Coll Med, Dept Internal Med, Div Digest Dis, Cincinnati, OH 45221 USA.	jason.blackard@uc.edu			University Research Council Postdoctoral Fellow Research Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	University Research Council Postdoctoral Fellow Research Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was partly supported by the University Research Council Postdoctoral Fellow Research Grant (to SS). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Anderson KB, 2004, CLIN INFECT DIS, V39, P1507, DOI 10.1086/425360; Babu CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004623; Backus LI, 2005, JAIDS-J ACQ IMM DEF, V39, P613; Balasubramanian A, 2005, CLIN INFECT DIS, V41, pS32, DOI 10.1086/429493; Balasubramanian A, 2003, J BIOL CHEM, V278, P35755, DOI 10.1074/jbc.M302889200; Balasubramanian A, 2006, J INFECT DIS, V194, P670, DOI 10.1086/505708; BESSHO R, 1994, BIOCHEM PHARMACOL, V48, P1883, DOI 10.1016/0006-2952(94)90586-X; Blackard JT, 2005, J INFECT DIS, V192, P258, DOI 10.1086/430949; Braitstein P, 2006, AIDS, V20, P323, DOI 10.1097/01.aids.0000198091.70325.f4; Bruno R, 2010, GUT, V59, P513, DOI 10.1136/gut.2008.163287; Cai ZH, 2005, J VIROL, V79, P13963, DOI 10.1128/JVI.79.22.13963-13973.2005; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Crotti Andrea, 2007, Open Virol J, V1, P26, DOI 10.2174/1874357900701010026; Daar ES, 2001, J INFECT DIS, V183, P589, DOI 10.1086/318539; De Baar MP, 2000, AIDS RES HUM RETROV, V16, P499; De Luca A, 2002, ARCH INTERN MED, V162, P2125, DOI 10.1001/archinte.162.18.2125; DUH EJ, 1989, P NATL ACAD SCI USA, V86, P5974, DOI 10.1073/pnas.86.15.5974; FRANKEL A, 1988, CELL DEATH DIFFER, V55, P118; Fromentin R, 2010, VIROLOGY, V398, P168, DOI 10.1016/j.virol.2009.12.008; Gao B, 2005, CELL MOL IMMUNOL, V2, P92; Gong GZ, 2001, P NATL ACAD SCI USA, V98, P9599, DOI 10.1073/pnas.171311298; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Guitart A, 2005, J GEN VIROL, V86, P3065, DOI 10.1099/vir.0.81273-0; Gupta N, 2007, AIDS, V21, P1491, DOI 10.1097/QAD.0b013e3281c616bb; Hassan M, 2007, CELL SIGNAL, V19, P301, DOI 10.1016/j.cellsig.2006.07.002; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Iser DM, 2010, J VIROL, V84, P5860, DOI 10.1128/JVI.02594-09; Jeeninga RE, 2000, J VIROL, V74, P3740, DOI 10.1128/JVI.74.8.3740-3751.2000; Kang L, 2012, VIRUS RES, V163, P74, DOI 10.1016/j.virusres.2011.08.011; Kato N, 1997, J VIROL, V71, P8856, DOI 10.1128/JVI.71.11.8856-8859.1997; Khabar KSA, 1997, J EXP MED, V186, P1077, DOI 10.1084/jem.186.7.1077; Kim AY, 2009, GASTROENTEROLOGY, V137, P795, DOI 10.1053/j.gastro.2009.06.040; Kondo Y, 2007, VIROLOGY, V361, P161, DOI 10.1016/j.virol.2006.11.009; Kong L, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-157; Laskus T, 1997, J GEN VIROL, V78, P2747, DOI 10.1099/0022-1317-78-11-2747; Laskus T, 1998, J INFECT DIS, V178, P1189, DOI 10.1086/515682; Laskus T, 2000, J INFECT DIS, V181, P442, DOI 10.1086/315283; Laskus T, 2004, BLOOD, V103, P3854, DOI 10.1182/blood-2003-08-2923; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Lerat H, 1996, J CLIN INVEST, V97, P845, DOI 10.1172/JCI118485; Lerat H, 1998, BLOOD, V91, P3841, DOI 10.1182/blood.V91.10.3841.3841_3841_3849; Lindenbach Brett D., 2009, V510, P329, DOI 10.1007/978-1-59745-394-3_24; Macias J, 2003, EUR J CLIN MICROBIOL, V22, P675, DOI 10.1007/s10096-003-1015-2; Mann EA, 2006, VIRUS RES, V121, P51, DOI 10.1016/j.virusres.2006.04.001; Montano MA, 1997, J VIROL, V71, P8657, DOI 10.1128/JVI.71.11.8657-8665.1997; Montano MA, 2000, J INFECT DIS, V181, P76, DOI 10.1086/315185; Munshi N, 2003, J INFECT DIS, V188, P1192, DOI 10.1086/378643; Murakami K, 2008, J GEN VIROL, V89, P1587, DOI 10.1099/vir.0.83618-0; Nelson DR, 1997, DIGEST DIS SCI, V42, P2487, DOI 10.1023/A:1018804426724; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; Pham TNQ, 2005, J GEN VIROL, V86, P657, DOI 10.1099/vir.0.80624-0; Piroth L, 1998, AIDS, V12, P381, DOI 10.1097/00002030-199804000-00006; Piroth L, 2000, J VIRAL HEPATITIS, V7, P302; PIZZELLA T, 1994, DNA CELL BIOL, V13, P67, DOI 10.1089/dna.1994.13.67; Polyak SJ, 2001, J VIROL, V75, P6095, DOI 10.1128/JVI.75.13.6095-6106.2001; Polyak SJ, 2001, J VIROL, V75, P6209, DOI 10.1128/JVI.75.13.6209-6211.2001; Raboud J, 2012, HIV CLIN TRIALS, V13, P90, DOI 10.1310/hct1302-90; Radkowski M, 2004, J GEN VIROL, V85, P47, DOI 10.1099/vir.0.19491-0; Radkowski M, 1998, TRANSPLANTATION, V66, P664, DOI 10.1097/00007890-199809150-00022; Ray RB, 2002, VIRUS RES, V87, P21, DOI 10.1016/S0168-1702(02)00046-1; RAY RB, 1995, VIRUS RES, V37, P209, DOI 10.1016/0168-1702(95)00034-N; Revie D, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-37; Sato Y, 2006, GUT, V55, P1801, DOI 10.1136/gut.2005.070417; Sherman KE, 2002, CLIN INFECT DIS, V34, P831, DOI 10.1086/339042; SHIH CM, 1993, J VIROL, V67, P5823, DOI 10.1128/JVI.67.10.5823-5832.1993; Shivraj SO, 2006, J TROP PEDIATRICS, V52, P206, DOI 10.1093/tropej/fmi103; Shrivastava A, 1998, J VIROL, V72, P9722, DOI 10.1128/JVI.72.12.9722-9728.1998; Srinivas RV, 1996, VIRUS RES, V45, P87, DOI 10.1016/S0168-1702(96)01361-5; Suzuki R, 2001, VIROLOGY, V280, P301, DOI 10.1006/viro.2000.0785; Tawadrous GA, 2012, J INVEST MED, V60, P878, DOI 10.2310/JIM.0b013e318254519e; Tuyama AC, 2010, HEPATOLOGY, V52, P612, DOI 10.1002/hep.23679; Verhoef K, 1999, J VIROL, V73, P1331, DOI 10.1128/JVI.73.2.1331-1340.1999; Reiche EMV, 2008, INT J MOL MED, V21, P387; Vlahakis SR, 2003, J INFECT DIS, V188, P1455, DOI 10.1086/379738; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Waris G, 2003, J BIOL CHEM, V278, P40778, DOI 10.1074/jbc.M303248200; Wu XY, 2008, VIRUS RES, V135, P155, DOI 10.1016/j.virusres.2008.03.006; Xiao P, 2008, AIDS, V22, P1749, DOI 10.1097/QAD.0b013e328308937c; Yan FM, 2000, WORLD J GASTROENTERO, V6, P805, DOI 10.3748/wjg.v6.i6.805; You LR, 1999, J VIROL, V73, P1672, DOI 10.1128/JVI.73.2.1672-1681.1999; Zhu MH, 1996, AIDS RES HUM RETROV, V12, P1093, DOI 10.1089/aid.1996.12.1093; Zignego AL, 2007, DIGEST LIVER DIS, V39, P2, DOI 10.1016/j.dld.2006.06.008	84	13	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e64956	10.1371/journal.pone.0064956	http://dx.doi.org/10.1371/journal.pone.0064956			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762271	Green Published, gold, Green Submitted			2022-12-27	WOS:000320440500014
J	Li, HS; Usas, A; Poddar, M; Chen, CW; Thompson, S; Ahani, B; Cummins, J; Lavasani, M; Huard, J				Li, Hongshuai; Usas, Arvydas; Poddar, Minakshi; Chen, Chien-Wen; Thompson, Seth; Ahani, Bahar; Cummins, James; Lavasani, Mitra; Huard, Johnny			Platelet-Rich Plasma Promotes the Proliferation of Human Muscle Derived Progenitor Cells and Maintains Their Stemness	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; HUMAN SKELETAL-MUSCLE; IN-VITRO EXPANSION; VIVO GENE-THERAPY; GROWTH-FACTOR; OSTEOGENIC DIFFERENTIATION; BONE-FORMATION; ANIMAL SERUM; RAT MODEL; PDGF-BB	Human muscle-derived progenitor cells (hMDPCs) offer great promise for muscle cell-based regenerative medicine; however, prolonged ex-vivo expansion using animal sera is necessary to acquire sufficient cells for transplantation. Due to the risks associated with the use of animal sera, the development of a strategy for the ex vivo expansion of hMDPCs is required. The purpose of this study was to investigate the efficacy of using platelet-rich plasma (PRP) for the ex-vivo expansion of hMDPCs. Pre-plated MDPCs, myoendothelial cells, and pericytes are three populations of hMDPCs that we isolated by the modified pre-plate technique and Fluorescence Activated Cell Sorting (FACS), respectively. Pooled allogeneic human PRP was obtained from a local blood bank, and the effect that thrombin-activated PRP-releasate supplemented media had on the ex-vivo expansion of the hMDPCs was tested against FBS supplemented media, both in vitro and in vivo. PRP significantly enhanced short and long-term cell proliferation, with or without FBS supplementation. Antibody-neutralization of PDGF significantly blocked the mitogenic/proliferative effects that PRP had on the hMDPCs. A more stable and sustained expression of markers associated with stemness, and a decreased expression of lineage specific markers was observed in the PRP-expanded cells when compared with the FBS-expanded cells. The in vitro osteogenic, chondrogenic, and myogenic differentiation capacities of the hMDPCs were not altered when expanded in media supplemented with PRP. All populations of hMDPCs that were expanded in PRP supplemented media retained their ability to regenerate myofibers in vivo. Our data demonstrated that PRP promoted the proliferation and maintained the multi-differentiation capacities of the hMDPCs during ex-vivo expansion by maintaining the cells in an undifferentiated state. Moreover, PDGF appears to be a key contributing factor to the beneficial effect that PRP has on the proliferation of hMDPCs.	[Li, Hongshuai; Usas, Arvydas; Poddar, Minakshi; Chen, Chien-Wen; Thompson, Seth; Ahani, Bahar; Cummins, James; Lavasani, Mitra; Huard, Johnny] Univ Pittsburgh, Stem Cell Res Ctr, Dept Orthoped Surg, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Huard, J (corresponding author), Univ Pittsburgh, Stem Cell Res Ctr, Dept Orthoped Surg, Pittsburgh, PA 15260 USA.	jhuard@pitt.edu		Chen, William CW/0000-0002-6891-3557; Li, hongshuai/0000-0002-9793-0540	Department of Defense [W81XWH-06-1-0406, W81XWH-08-2-0032]; William F. and Jean W. Donaldson Chair at Children's Hospital of Pittsburgh; Henry J. Mankin Endowed Chair at the University of Pittsburgh; NATIONAL INSTITUTE ON AGING [P30AG024827] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); William F. and Jean W. Donaldson Chair at Children's Hospital of Pittsburgh; Henry J. Mankin Endowed Chair at the University of Pittsburgh; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding support was provided in part by the Department of Defense (awarded to Dr. Johnny Huard, W81XWH-06-1-0406 and W81XWH-08-2-0032 (AFIRM)), the William F. and Jean W. Donaldson Chair at Children's Hospital of Pittsburgh, and the Henry J. Mankin Endowed Chair at the University of Pittsburgh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsousou J, 2009, J BONE JOINT SURG BR, V91B, P987, DOI 10.1302/0301-620X.91B8.22546; Bieback K, 2004, STEM CELLS, V22, P625, DOI 10.1634/stemcells.22-4-625; Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139; Borrione P, 2010, AM J PHYS MED REHAB, V89, P854, DOI 10.1097/PHM.0b013e3181f1c1c7; Cao BH, 2004, CELL CYCLE, V3, P104; Cassiede P, 1996, J BONE MINER RES, V11, P1264; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen LA, 2010, J BONE MINER RES, V25, P2447, DOI 10.1002/jbmr.133; Covas DT, 2008, EXP HEMATOL, V36, P642, DOI 10.1016/j.exphem.2007.12.015; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Deasy BM, 2001, BLOOD CELL MOL DIS, V27, P924, DOI 10.1006/bcmd.2001.0463; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Doucet C, 2005, J CELL PHYSIOL, V205, P228, DOI 10.1002/jcp.20391; Ehrenfest DMD, 2009, TRENDS BIOTECHNOL, V27, P158, DOI 10.1016/j.tibtech.2008.11.009; Fiedler J, 2002, J CELL BIOCHEM, V87, P305, DOI 10.1002/jcb.10309; Galing VLW, 2009, ORAL SURG ORAL MED O, V108, P48, DOI 10.1016/j.tripleo.2009.02.007; Garbayo E, 2011, J NEUROCHEM, V119, P972, DOI 10.1111/j.1471-4159.2011.07272.x; Gates CB, 2008, J AM ACAD ORTHOP SUR, V16, P68, DOI 10.5435/00124635-200802000-00004; Gruber R, 2004, PLATELETS, V15, P29, DOI 10.1080/09537100310001643999; Guo J, 2008, J BIOMED SCI, V15, P89, DOI 10.1007/s11373-007-9207-x; Huang Z, 2010, CYTOKINE, V51, P305, DOI 10.1016/j.cyto.2010.06.002; Kalen A, 2008, BIOCHEM BIOPH RES CO, V375, P261, DOI 10.1016/j.bbrc.2008.08.014; Kashyap V, 2009, STEM CELLS DEV, V18, P1093, DOI 10.1089/scd.2009.0113; Kasten P, 2006, CELLS TISSUES ORGANS, V183, P68, DOI 10.1159/000095511; KIEVITS F, 1988, J IMMUNOL, V140, P4253; Kocaoemer A, 2007, STEM CELLS, V25, P1270, DOI 10.1634/stemcells.2006-0627; Lange C, 2007, J CELL PHYSIOL, V213, P18, DOI 10.1002/jcp.21081; Lee JY, 2002, HUM GENE THER, V13, P1201, DOI 10.1089/104303402320138989; Lee KS, 2011, AM J ROENTGENOL, V196, P628, DOI 10.2214/AJR.10.5975; Lei H, 2009, CLIN BIOCHEM, V42, P1452, DOI 10.1016/j.clinbiochem.2009.06.012; Levy MM, 2001, BONE, V29, P317, DOI 10.1016/S8756-3282(01)00585-3; Linkhart TA, 1996, BONE, V19, pS1, DOI 10.1016/S8756-3282(96)00138-X; Lubowitz JH, 2011, ARTHROSCOPY, V27, P1453, DOI 10.1016/j.arthro.2011.08.291; Lucarelli E, 2003, BIOMATERIALS, V24, P3095, DOI 10.1016/S0142-9612(03)00114-5; MacDermott R P, 1983, Behring Inst Mitt, P122; MARTIN JF, 1983, BRIT MED J, V287, P456, DOI 10.1136/bmj.287.6390.456; Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4; Mastrogiacomo M, 2005, J CELL PHYSIOL, V204, P594, DOI 10.1002/jcp.20325; Mathur A, 2001, THROMB HAEMOSTASIS, V85, P989, DOI 10.1055/s-0037-1615952; Matsumoto T, 2009, ARTHRITIS RHEUM-US, V60, P1390, DOI 10.1002/art.24443; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Mazzucco L, 2009, VOX SANG, V97, P110, DOI 10.1111/j.1423-0410.2009.01188.x; Mishra A, 2011, CURR PHARM BIOTECHNO; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Musgrave DS, 2002, J BONE JOINT SURG BR, V84B, P120, DOI 10.1302/0301-620X.84B1.11708; Nguyen RT, 2011, PM&R, V3, P226, DOI 10.1016/j.pmrj.2010.11.007; Niemeyer P, 2010, BIOMATERIALS, V31, P3572, DOI 10.1016/j.biomaterials.2010.01.085; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Olson E N, 1992, Semin Cell Biol, V3, P127; Oshima H, 2005, MOL THER, V12, P1130, DOI 10.1016/j.ymthe.2005.07.686; Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019; Parsons P, 2008, J ORTHOP TRAUMA, V22, P595, DOI 10.1097/BOT.0b013e318188dbb7; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Petrenko O, 1999, IMMUNITY, V10, P691, DOI 10.1016/S1074-7613(00)80068-0; Pierantozzi E, 2011, STEM CELLS DEV, V20, P915, DOI 10.1089/scd.2010.0353; Qu ZQ, 1998, J CELL BIOL, V142, P1257, DOI 10.1083/jcb.142.5.1257; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Refaai MA, 2011, THROMB RES, V127, P287, DOI 10.1016/j.thromres.2010.10.012; Riekstina U, 2009, STEM CELL REV REP, V5, P378, DOI 10.1007/s12015-009-9094-9; Risau W, 1992, GROWTH FACTORS, V7, P261, DOI 10.3109/08977199209046408; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Scharf RE, 2011, HAMOSTASEOLOGIE, V31, P28, DOI 10.5482/ha-1145; Shahdadfar A, 2005, STEM CELLS, V23, P1357, DOI 10.1634/stemcells.2005-0094; SHEPRO D, 1993, FASEB J, V7, P1031, DOI 10.1096/fasebj.7.11.8370472; Soomekh DJ, 2011, CLIN PODIATR MED SUR, V28, P155, DOI 10.1016/j.cpm.2010.09.001; Tai MH, 2005, CARCINOGENESIS, V26, P495, DOI 10.1093/carcin/bgh321; Tamama K, 2006, STEM CELLS, V24, P686, DOI 10.1634/stemcells.2005-0176; Tamama K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/795385; TSCHOEPE D, 1991, SEMIN THROMB HEMOST, V17, P433, DOI 10.1055/s-2007-1002650; Urish KL, 2009, MOL BIOL CELL, V20, P509, DOI 10.1091/mbc.E08-03-0274; Vogel JP, 2006, PLATELETS, V17, P462, DOI 10.1080/09537100600758867; Weibrich G, 2002, J CRANIO MAXILL SURG, V30, P97, DOI 10.1054/jcms.2002.0285; Zaky SH, 2008, J TISSUE ENG REGEN M, V2, P472, DOI 10.1002/term.119; Zheng B, 2007, NAT BIOTECHNOL, V25, P1025, DOI 10.1038/nbt1334; Zhou SH, 2011, J CELL BIOCHEM, V112, P1651, DOI 10.1002/jcb.23079; Zong M, 2011, NAT REV RHEUMATOL, V7, P297, DOI 10.1038/nrrheum.2011.39	79	60	62	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e64923	10.1371/journal.pone.0064923	http://dx.doi.org/10.1371/journal.pone.0064923			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762264	Green Published, Green Accepted, gold			2022-12-27	WOS:000321094800009
J	Matsumoto, Y; Buemio, A; Chu, R; Vafaee, M; Crews, D				Matsumoto, Yuiko; Buemio, Alvin; Chu, Randy; Vafaee, Mozhgon; Crews, David			Epigenetic Control of Gonadal Aromatase (cyp19a1) in Temperature-Dependent Sex Determination of Red-Eared Slider Turtles	PLOS ONE			English	Article							HEAT-SHOCK FACTORS; P450 AROMATASE; TRACHEMYS-SCRIPTA; GENE-EXPRESSION; DNA METHYLATION; OREOCHROMIS-NILOTICUS; TRANSPOSON TAM3; GERM-CELLS; PROMOTER; DIFFERENTIATION	In the red-eared slider turtle (Trachemys scripta), a species with temperature-dependent sex determination (TSD), the expression of the aromatase gene during gonad development is strictly limited to the female-producing temperature. The underlying mechanism remains unknown. In this study, we identified the upstream 5'-flanking region of the aromatase gene, gonad-specific promoter, and the temperature-dependent DNA methylation signatures during gonad development in the red-eared slider turtle. The 5'-flanking region of the slider aromatase exhibited sequence similarities to the aromatase genes of the American alligator, chicken, quail, and zebra finch. A putative TATA box was located 31 bp upstream of the gonad-specific transcription start site. DNA methylation at the CpG sites between the putative binding sites of the fork head domain factor (FOX) and vertebrate steroidogenic factor 1 (SF1) and adjacent TATA box in the promoter region were significantly lower in embryonic gonads at the female-producing temperature compared the male-producing temperature. A shift from male-to female-, but not from female-to male-, producing temperature changed the level of DNA methylation in gonads. Taken together these results indicate that the temperature, particularly female-producing temperature, allows demethylation at the specific CpG sites of the promoter region which leads the temperature-specific expression of aromatase during gonad development.	[Matsumoto, Yuiko; Buemio, Alvin; Chu, Randy; Vafaee, Mozhgon; Crews, David] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Crews, D (corresponding author), Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA.	crews@austin.utexas.edu			National Science Foundation [IOS-1051623]; Direct For Biological Sciences [1051623] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation (grant number IOS-1051623). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abane R, 2010, FEBS J, V277, P4150, DOI 10.1111/j.1742-4658.2010.07830.x; Akatsuka N, 2005, J STEROID BIOCHEM, V96, P45, DOI 10.1016/j.jsbmb.2005.01.027; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Blazquez M, 2004, MOL CELL ENDOCRINOL, V219, P83, DOI 10.1016/j.mce.2004.01.006; Bohm RA, 2000, J EXP BIOL, V203, P693; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Brunner AL, 2009, GENOME RES, V19, P1044, DOI 10.1101/gr.088773.108; Bulun SE, 2005, PHARMACOL REV, V57, P359, DOI 10.1124/pr.57.3.6; Burdge GC, 2010, ANNU REV NUTR, V30, P315, DOI 10.1146/annurev.nutr.012809.104751; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Caron KM, 1997, STEROIDS, V62, P53, DOI 10.1016/S0039-128X(96)00159-6; Chiang EFL, 2001, J EXP ZOOL, V290, P709, DOI 10.1002/jez.1121; CREWS D, 1994, J ENDOCRINOL, V143, P279, DOI 10.1677/joe.0.1430279; Crews D, 1996, ZOOL SCI, V13, P1, DOI 10.2108/zsj.13.1; D'Cotta H, 2001, MOL REPROD DEV, V59, P265, DOI 10.1002/mrd.1031; ELBRECHT A, 1992, SCIENCE, V255, P467, DOI 10.1126/science.1734525; Fan WQ, 2007, ENVIRON HEALTH PERSP, V115, P720, DOI 10.1289/ehp.9758; Fleming NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014389; Gardner L, 2005, J STEROID BIOCHEM, V94, P395, DOI 10.1016/j.jsbmb.2004.12.045; Gilbert S. F., 2008, ECOLOGICAL DEV BIOL; Greenbaum E, 2002, CAN J ZOOL, V80, P1350, DOI 10.1139/Z02-111; Guillette LJ, 2000, AM ZOOL, V40, P438, DOI 10.1668/0003-1569(2000)040[0438:AAEDCA]2.0.CO;2; Hashida S, 2003, PLANT PHYSIOL, V132, P1207, DOI 10.1104/pp.102.017533; Hashida SN, 2006, PLANT CELL, V18, P104, DOI 10.1105/tpc.105.037655; Iwabuchi J, 2007, J STEROID BIOCHEM, V107, P149, DOI 10.1016/j.jsbmb.2007.01.007; Kitano T, 1999, J MOL ENDOCRINOL, V23, P167, DOI 10.1677/jme.0.0230167; Kitano T, 2000, AID MRDI 3 0 CO, P2; Kojima Y, 2008, GEN COMP ENDOCR, V156, P628, DOI 10.1016/j.ygcen.2008.02.003; Kudo Toshiyuki, 1996, Journal of Reproduction and Development, V42, P101, DOI 10.1262/jrd.42.101; Kuntz S, 2004, J MOL ENDOCRINOL, V33, P717, DOI 10.1677/jme.1.01588; Lei N, 2009, BIOL REPROD, V81, P118, DOI 10.1095/biolreprod.108.072314; Loffler KA, 2003, ENDOCRINOLOGY, V144, P3237, DOI 10.1210/en.2002-0095; Matson CK, 2011, NATURE, V476, P101, DOI 10.1038/nature10239; MATSUMINE H, 1991, J BIOL CHEM, V266, P19900; Matsumoto Y, 2012, MOL CELL ENDOCRINOL, V354, P103, DOI 10.1016/j.mce.2011.10.012; MEANS GD, 1991, MOL ENDOCRINOL, V5, P2005, DOI 10.1210/mend-5-12-2005; MICHAEL MD, 1995, J BIOL CHEM, V270, P13561, DOI 10.1074/jbc.270.22.13561; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Morohashi KI, 1996, FASEB J, V10, P1569, DOI 10.1096/fasebj.10.14.9002548; Murdock C, 2003, GEN COMP ENDOCR, V130, P109, DOI 10.1016/S0016-6480(02)00573-7; Navarro-Martin L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002447; O'Lone R, 2004, MOL ENDOCRINOL, V18, P1859, DOI 10.1210/me.2003-0044; Oshima Y, 2006, ZOOL SCI, V23, P79, DOI 10.2108/zsj.23.79; Ottolenghi C, 2007, HUM MOL GENET, V16, P2795, DOI 10.1093/hmg/ddm235; Ramachandran B, 1999, GENE, V240, P209, DOI 10.1016/S0378-1119(99)00399-6; Ramsey M, 2007, SEX DEV, V1, P181, DOI 10.1159/000102107; Ramsey M, 2007, DIFFERENTIATION, V75, P978, DOI 10.1111/j.1432-0436.2007.00182.x; RAZIN A, 1995, HUM MOL GENET, V4, P1751, DOI 10.1093/hmg/4.suppl_1.1751; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Sakata N, 2005, INT J DEV BIOL, V49, P417, DOI 10.1387/ijdb.041916ns; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Shoemaker C, 2007, DEV DYNAM, V236, P1055, DOI 10.1002/dvdy.21096; Shoemaker-Daly CM, 2010, DEV DYNAM, V239, P1061, DOI 10.1002/dvdy.22266; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Simpson ER, 2002, ANNU REV PHYSIOL, V64, P93, DOI 10.1146/annurev.physiol.64.081601.142703; Smith CA, 1997, J STEROID BIOCHEM, V60, P295, DOI 10.1016/S0960-0760(96)00196-3; St John JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-415; Straussman R, 2009, NAT STRUCT MOL BIOL, V16, P564, DOI 10.1038/nsmb.1594; Tchoudakova A, 2001, J STEROID BIOCHEM, V78, P427, DOI 10.1016/S0960-0760(01)00120-0; Tong SK, 2003, J STEROID BIOCHEM, V86, P381, DOI 10.1016/S0960-0760(03)00347-9; Wallace H, 1999, CELL MOL LIFE SCI, V55, P901, DOI 10.1007/s000180050343; Wang DS, 2007, MOL ENDOCRINOL, V21, P712, DOI 10.1210/me.2006-0248; Wang DS, 2010, ENDOCRINOLOGY, V151, P1331, DOI 10.1210/en.2009-0999; Watson JD, 2007, MOL BIOL GENE; WIBBELS T, 1991, J EXP ZOOL, V260, P371, DOI 10.1002/jez.1402600311; Wu GC, 2005, ANN NY ACAD SCI, V1040, P206, DOI 10.1196/annals.1327.026; Yao HHC, 2005, MOL CELL ENDOCRINOL, V230, P87, DOI 10.1016/j.mce.2004.11.003; Yoshiura Y, 2003, BIOL REPROD, V68, P1545, DOI 10.1095/biolreprod.102.010843	69	109	113	5	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e63599	10.1371/journal.pone.0063599	http://dx.doi.org/10.1371/journal.pone.0063599			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762231	Green Submitted, gold, Green Published			2022-12-27	WOS:000321094800002
J	Xiao, CT; Gimenez-Lirola, LG; Jiang, YH; Halbur, PG; Opriessnig, T				Xiao, Chao-Ting; Gimenez-Lirola, Luis G.; Jiang, Yong-Hou; Halbur, Patrick G.; Opriessnig, Tanja			Characterization of a Novel Porcine Parvovirus Tentatively Designated PPV5	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS; VIRAL EVOLUTION; CAPSID PROTEIN; DNA VIRUSES; IDENTIFICATION; BOCAVIRUSES; PREVALENCE; SWINE; TYPE-2; REPLICATION	A new porcine parvovirus (PPV), provisionally designated as PPV5, was identified in U. S. pigs. Cloning and sequencing from a circular or head-to-tail concatemeric array revealed that the PPV5 possesses the typical genomic organization of parvoviruses with two major predicted open reading frames (ORF1 and ORF2), and is most closely related to PPV4 with overall genomic identities of 64.1-67.3%. The amino acid identities between PPV5 and PPV4 were 84.6%-85.1% for ORF1 and 54.0%-54.3% for ORF2. Unlike PPV4, but similar to bovine parvovirus 2 (BPV2), PPV5 lacks the additional ORF3 and has a much longer ORF2. Moreover, the amino acid sequences of ORF1 and ORF2 of BPV2 showed higher homologies to PPV5 than to PPV4. The conserved motifs of the Ca2+ binding loop (YXGXG) and the catalytic center (HDXXY) of phospholipase A(2) (PLA(2)) were identified in VP1 (ORF2) of PPV5, as well as in BPV2, but were not present in PPV4. Phylogenetic analyses revealed that PPV5, PPV4 and BPV2 form a separate clade different from the genera Parvovirus and Bocavirus. Further epidemiologic investigations of PPV4 and PPV5 in U. S. pigs of different ages indicated a slightly higher prevalence for PPV5 (6.6%; 32/483) compared to PPV4 (4.1%; 20/483), with detection of concurrent PPV4 and PPV5 in 15.6% (7/45) of lungs of infected pigs. Evidence for potential vertical transmission or association with reproductive failure was minimal for both PPV4 and PPV5. The high similarity to PPV4 and the lack of ORF3 may suggest PPV5 is an intermediate of PPV4 during the evolution of parvoviruses in pigs.	[Xiao, Chao-Ting; Gimenez-Lirola, Luis G.; Jiang, Yong-Hou; Halbur, Patrick G.; Opriessnig, Tanja] Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Ames, IA 50011 USA	Iowa State University	Opriessnig, T (corresponding author), Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Ames, IA 50011 USA.	tanjaopr@iastate.edu	Opriessnig, Tanja/F-2984-2012; jiang, yonghou/GVS-6462-2022; , xiaocht/H-3997-2014	Opriessnig, Tanja/0000-0001-9642-0904; , xiaocht/0000-0001-5299-5650; Jiang, Yonghou/0000-0002-6669-2367	National Pork Board Checkoff Dollars	National Pork Board Checkoff Dollars	Funding for this study was provided by the National Pork Board Checkoff Dollars. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABINANTI FR, 1961, VIROLOGY, V14, P288, DOI 10.1016/0042-6822(61)90206-9; Adlhoch C, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-171; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; Arthur JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000391; Belyi VA, 2010, J VIROL, V84, P12458, DOI 10.1128/JVI.01789-10; BERNS KI, 1990, MICROBIOL REV, V54, P316, DOI 10.1128/MMBR.54.3.316-329.1990; Blomstrom AL, 2009, VIRUS RES, V146, P125, DOI 10.1016/j.virusres.2009.09.006; Blomstrom AL, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-192; CARTWRIGHT SF, 1967, VET REC, V81, P196; Cheng WX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013583; Cheung AK, 2010, ARCH VIROL, V155, P801, DOI 10.1007/s00705-010-0646-8; Cotmore SF, 2000, J VIROL, V74, P1332, DOI 10.1128/JVI.74.3.1332-1341.2000; Csagola A, 2012, ARCH VIROL, V157, P1003, DOI 10.1007/s00705-012-1257-3; Dorsch S, 2002, J VIROL, V76, P2014, DOI 10.1128/JVI.76.4.2014-2018.2002; Duan DS, 1998, J VIROL, V72, P8568, DOI 10.1128/JVI.72.11.8568-8577.1998; Duan DS, 1999, VIROLOGY, V261, P8, DOI 10.1006/viro.1999.9821; Gimenez-Lirola LG, 2012, J MICROBIOL METH, V91, P191, DOI 10.1016/j.mimet.2012.06.011; Girod A, 2002, J GEN VIROL, V83, P973, DOI 10.1099/0022-1317-83-5-973; Hijikata M, 2001, JPN J INFECT DIS, V54, P244; Huang L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-333; Jones MS, 2005, J VIROL, V79, P8230, DOI 10.1128/JVI.79.13.8230-8236.2005; Kapoor A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021362; Kapoor A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011948; KOCZOT FJ, 1973, P NATL ACAD SCI USA, V70, P215, DOI 10.1073/pnas.70.1.215; Lau SKP, 2008, J GEN VIROL, V89, P1840, DOI 10.1099/vir.0.2008/000380-0; Lau SKP, 2012, J GEN VIROL, V93, P1573, DOI 10.1099/vir.0.042531-0; Lau SKP, 2011, J GEN VIROL, V92, P2047, DOI 10.1099/vir.0.033688-0; Lusebrink J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019457; Manteufel J, 2008, INTERVIROLOGY, V51, P328, DOI 10.1159/000173734; McKillen J, 2011, VET MICROBIOL, V152, P39, DOI 10.1016/j.vetmic.2011.04.013; Mengeling WL, 2000, ANIM REPROD SCI, V60, P199, DOI 10.1016/S0378-4320(00)00135-4; MENGELING WL, 1988, J GEN VIROL, V69, P825, DOI 10.1099/0022-1317-69-4-825; O'Neill KC, 2011, CLIN VACCINE IMMUNOL, V18, P1865, DOI 10.1128/CVI.05318-11; Opriessnig T, 2013, VACCINE, V31, P487, DOI 10.1016/j.vaccine.2012.11.030; Schnepp BC, 2005, J VIROL, V79, P14793, DOI 10.1128/JVI.79.23.14793-14803.2005; Shackelton LA, 2006, J VIROL, V80, P3666, DOI 10.1128/JVI.80.7.3666-3669.2006; Shackelton LA, 2005, P NATL ACAD SCI USA, V102, P379, DOI 10.1073/pnas.0406765102; Shan TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017292; Streck AF, 2011, J GEN VIROL, V92, P2628, DOI 10.1099/vir.0.033662-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TATTERSALL P, 1976, NATURE, V263, P106, DOI 10.1038/263106a0; Tijssen P., 2011, VIRUS TAXONOMY, P405; Tse H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025619; Wang F, 2010, VIRUS GENES, V41, P305, DOI 10.1007/s11262-010-0506-3; Xiao CT, 2013, VET MICROBIOL, V161, P325, DOI 10.1016/j.vetmic.2012.07.038; Xiao CT, 2012, VET MICROBIOL, V160, P290, DOI 10.1016/j.vetmic.2012.05.038; Xiao CT, 2012, J VIROL METHODS, V183, P40, DOI 10.1016/j.jviromet.2012.03.026; Xiao CT, 2013, GENOME ANNOUNC, V1; Yang WZ, 2012, ARCH VIROL, V157, P2125, DOI 10.1007/s00705-012-1407-7; Zadori Z, 2001, DEV CELL, V1, P291, DOI 10.1016/S1534-5807(01)00031-4; Zeng SL, 2011, J GEN VIROL, V92, P784, DOI 10.1099/vir.0.028340-0; Zhai SL, 2010, ARCH VIROL, V155, P1313, DOI 10.1007/s00705-010-0698-9; Zhang HB, 2011, EPIDEMIOL INFECT, V139, P1581, DOI 10.1017/S0950268811000847; Zhao H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048980	55	47	58	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65312	10.1371/journal.pone.0065312	http://dx.doi.org/10.1371/journal.pone.0065312			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762339	Green Published, gold, Green Submitted			2022-12-27	WOS:000321094800038
J	Bradley, CK; Norton, CR; Chen, Y; Han, XH; Booth, CJ; Yoon, JK; Krebs, LT; Gridley, T				Bradley, Cara K.; Norton, Christine R.; Chen, Ying; Han, Xianghua; Booth, Carmen J.; Yoon, Jeong Kyo; Krebs, Luke T.; Gridley, Thomas			The Snail Family Gene Snai3 Is Not Essential for Embryogenesis in Mice	PLOS ONE			English	Article							EXPRESSION; TRANSCRIPTION; DIFFERENTIATION; MYOGENESIS; SMUC; MYOD	The Snail gene family encodes zinc finger-containing transcriptional repressor proteins. Three members of the Snail gene family have been described in mammals, encoded by the Snai1, Snai2, and Snai3 genes. The function of the Snai1 and Snai2 genes have been studied extensively during both vertebrate embryogenesis and tumor progression and metastasis, and play critically important roles during these processes. However, little is known about the function of the Snai3 gene and protein. We describe here generation and analysis of Snai3 conditional and null mutant mice. We also generated an EYFP-tagged Snai3 null allele that accurately reflects endogenous Snai3 gene expression, with the highest levels of expression detected in thymus and skeletal muscle. Snai3 null mutant homozygous mice are viable and fertile, and exhibit no obvious phenotypic defects. These results demonstrate that Snai3 gene function is not essential for embryogenesis in mice.	[Bradley, Cara K.; Norton, Christine R.; Chen, Ying; Han, Xianghua; Yoon, Jeong Kyo; Krebs, Luke T.; Gridley, Thomas] Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME USA; [Chen, Ying] Univ Maine, Grad Sch Biomed Sci, Orono, ME USA; [Booth, Carmen J.] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06510 USA	Maine Medical Center; University of Maine System; University of Maine Orono; Yale University	Gridley, T (corresponding author), Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME USA.	gridlt@mmc.org		Bradley, Cara/0000-0001-9677-3363	NIH [R01AR055278, R01HD034883, P20GM103465, P30GM103392]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD034883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103465, P30GM103392] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the NIH to JKY (R01AR055278) and TG (R01HD034883). In addition, the Molecular Phenotyping Core Facility was supported by NIH grant P20GM103465, and the Histopathology Core Facility was supported by NIH grants P20GM103465 and P30GM103392. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Barrallo-Gimeno A, 2009, TRENDS GENET, V25, P248, DOI 10.1016/j.tig.2009.04.001; Chen Y, 2013, J BONE MINE IN PRESS; Chiang C, 2012, CYTOKINE GROWTH FACT; Dahlem T, 2012, EUR J IMMUNOL, V42, P1038, DOI 10.1002/eji.201142193; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Kataoka H, 2000, NUCLEIC ACIDS RES, V28, P626, DOI 10.1093/nar/28.2.626; Katoh M, 2003, INT J MOL MED, V11, P383; Katoh M, 2005, ONCOL REP, V14, P1083; Krebs LT, 2012, GENESIS, V50, P366, DOI 10.1002/dvg.20813; Liedtke D, 2011, GENE EXPR PATTERNS, V11, P181, DOI 10.1016/j.gep.2010.11.003; Murray SA, 2007, DEVELOPMENT, V134, P1789, DOI 10.1242/dev.02837; Murray SA, 2006, P NATL ACAD SCI USA, V103, P10300, DOI 10.1073/pnas.0602234103; Soleimani VD, 2012, MOL CELL, V47, P457, DOI 10.1016/j.molcel.2012.05.046; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Yokoyama S, 2009, DEV CELL, V17, P836, DOI 10.1016/j.devcel.2009.10.011; Zhao P, 2002, J BIOL CHEM, V277, P30091, DOI 10.1074/jbc.M202668200; Zhuge X, 2005, INT J MOL MED, V15, P945	19	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65344	10.1371/journal.pone.0065344	http://dx.doi.org/10.1371/journal.pone.0065344			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762348	Green Published, Green Submitted, gold			2022-12-27	WOS:000321099000058
J	Camerlink, I; Turner, SP; Bijma, P; Bolhuis, JE				Camerlink, Irene; Turner, Simon P.; Bijma, Piter; Bolhuis, J. Elizabeth			Indirect Genetic Effects and Housing Conditions in Relation to Aggressive Behaviour in Pigs	PLOS ONE			English	Article							INDIVIDUAL COPING CHARACTERISTICS; ENVIRONMENTAL ENRICHMENT; VARIANCE-COMPONENTS; HERITABLE VARIATION; COGNITIVE BIAS; ANIMAL-WELFARE; SOCIAL STRESS; GROWING PIGS; LAYING HENS; COMPETITION	Indirect Genetic Effects (IGEs), also known as associative effects, are the heritable effects that an individual has on the phenotype of its social partners. Selection for IGEs has been proposed as a method to reduce harmful behaviours, in particular aggression, in livestock and aquaculture. The mechanisms behind IGEs, however, have rarely been studied. The objective was therefore to assess aggression in pigs which were divergently selected for IGEs on growth (IGEg). In a one generation selection experiment, we studied 480 offspring of pigs (Sus scrofa) that were selected for relatively high or low IGEg and housed in homogeneous IGEg groups in either barren or enriched environments. Skin lesion scores, a proxy measure of aggression, and aggressive behaviours were recorded. The two distinct IGEg groups did not differ in number of skin lesions, or in amount of reciprocal fighting, both under stable social conditions and in confrontation with unfamiliar pigs in a 24 h regrouping test. Pigs selected for a positive effect on the growth of their group members, however, performed less non-reciprocal biting and showed considerably less aggression at reunion with familiar group members after they had been separated during a 24 h regrouping test. The enriched environment was associated with more skin lesions but less non-reciprocal biting under stable social conditions. Changes in aggression between pigs selected for IGEg were not influenced by GxE interactions with regard to the level of environmental enrichment. It is likely that selection on IGEg targets a behavioural strategy, rather than a single behavioural trait such as aggressiveness.	[Camerlink, Irene; Bolhuis, J. Elizabeth] Wageningen Univ, Dept Anim Sci, Adaptat Physiol Grp, NL-6700 AP Wageningen, Netherlands; [Camerlink, Irene; Bijma, Piter] Wageningen Univ, Dept Anim Sci, Anim Breeding & Genom Ctr, NL-6700 AP Wageningen, Netherlands; [Turner, Simon P.] SRUC, Edinburgh, Midlothian, Scotland	Wageningen University & Research; Wageningen University & Research	Camerlink, I (corresponding author), Wageningen Univ, Dept Anim Sci, Adaptat Physiol Grp, NL-6700 AP Wageningen, Netherlands.	Irene.Camerlink@wur.nl	Bolhuis, J. Elizabeth/P-7978-2015; Baines, Andrew D/B-3491-2014; Camerlink, Irene/AAO-9931-2020	Bolhuis, J. Elizabeth/0000-0002-5172-7635; Turner, Simon/0000-0001-9198-9448; Camerlink, Irene/0000-0002-3427-2210	Netherlands Organisation for Scientific Research (NWO); Dutch Ministry of Economic Affairs; program 'The Value of Animal Welfare' of the Netherlands Organization for Scientific Research (NWO)	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); program 'The Value of Animal Welfare' of the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was financially supported by the Netherlands Organisation for Scientific Research (NWO) and the Dutch Ministry of Economic Affairs. This study is part of the project 'Seeking sociable swine? Incorporating social genetic effects into pig breeding programs to achieve balanced improvement in productivity and welfare' which is financially supported by the program 'The Value of Animal Welfare' of the Netherlands Organization for Scientific Research (NWO) and the Dutch Ministry of Economic Affairs. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Andersen IL, 2000, APPL ANIM BEHAV SCI, V68, P107, DOI 10.1016/S0168-1591(00)00092-7; Arango J, 2005, J ANIM SCI, V83, P1241; AREY DS, 1995, APPL ANIM BEHAV SCI, V45, P23, DOI 10.1016/0168-1591(95)00600-W; BENUS RF, 1991, EXPERIENTIA, V47, P1008, DOI 10.1007/BF01923336; Bergsma R, 2008, GENETICS, V178, P1559, DOI 10.1534/genetics.107.084236; Bergsma R., 2011, THESIS; Bielsky IF, 2004, NEUROPSYCHOPHARMACOL, V29, P483, DOI 10.1038/sj.npp.1300360; Bijma P, 2007, GENETICS, V175, P289, DOI 10.1534/genetics.106.062729; Bijma P, 2011, GENETICS, V189, P1347, DOI 10.1534/genetics.111.130617; Bolhuis JE, 2005, ANIM BEHAV, V69, P1085, DOI 10.1016/j.anbehav.2004.09.013; Bolhuis JE, 2003, PHYSIOL BEHAV, V79, P289, DOI 10.1016/S0031-9384(03)00090-8; Brotherstone S, 2011, SILVAE GENET, V60, P149, DOI 10.1515/sg-2011-0020; Brydges NM, 2011, ANIM BEHAV, V81, P169, DOI 10.1016/j.anbehav.2010.09.030; Canario L, 2012, J ANIM SCI; Cappa EP, 2008, SILVAE GENET, V57, P45, DOI 10.1515/sg-2008-0008; Chen CY, 2007, GENET MOL RES, V6, P594; Silva JCE, 2013, NEW PHYTOL, V197, P631, DOI 10.1111/nph.12035; Creel S, 2001, TRENDS ECOL EVOL, V16, P491, DOI 10.1016/S0169-5347(01)02227-3; CRUMP RE, 2004, AGBU PIG GEN WORKSH, P107; Cutts CJ, 1998, J FISH BIOL, V52, P1026, DOI 10.1111/j.1095-8649.1998.tb00601.x; D'Eath RB, 2009, ANIMAL, V3, P1544, DOI 10.1017/S1751731109990528; de Groot J, 2001, PHYSIOL BEHAV, V73, P145, DOI 10.1016/S0031-9384(01)00472-3; DEWAAL FBM, 1986, Q REV BIOL, V61, P459, DOI 10.1086/415144; DICKERSON G. E., 1947, Composition of hog carcasses as influenced by heritable differences in rate and economy of gain., P492; Dudink S, 2006, APPL ANIM BEHAV SCI, V101, P86, DOI 10.1016/j.applanim.2005.12.008; Ellen ED, 2008, POULTRY SCI, V87, P233, DOI 10.3382/ps.2007-00374; Elwood RW, 1998, NATURE, V393, P66, DOI 10.1038/29980; Falconer D. S., 1996, INTRO QUANTITATIVE G; Ferguson JN, 2002, FRONT NEUROENDOCRIN, V23, P200, DOI 10.1006/frne.2002.0229; GONYOU HW, 1994, J ANIM SCI, V72, P2171, DOI 10.2527/1994.7282171x; GRIFFING B, 1967, AUST J BIOL SCI, V20, P127, DOI 10.1071/BI9670127; Guy JH, 2002, LIVEST PROD SCI, V75, P233, DOI 10.1016/S0301-6226(01)00327-X; HAEMISCH A, 1994, PHYSIOL BEHAV, V56, P1041, DOI 10.1016/0031-9384(94)90341-7; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; HESSING MJC, 1993, APPL ANIM BEHAV SCI, V37, P285, DOI 10.1016/0168-1591(93)90118-9; Hyun Y, 1998, J ANIM SCI, V76, P721; Kadry VO, 2010, NEOTROP ICHTHYOL, V8, P329, DOI 10.1590/S1679-62252010000200011; KIRKPATRICK M, 1989, EVOLUTION, V43, P485, DOI 10.1111/j.1558-5646.1989.tb04247.x; LYONS CAP, 1995, LIVEST PROD SCI, V43, P265, DOI 10.1016/0301-6226(95)00050-U; Marchant-Forde J. N., 2005, Pig News and Information, V26, p63N; MARLER P, 1976, AM PSYCHOL, V31, P239, DOI 10.1037/0003-066X.31.3.239; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; Meyers RA., 2011, ENCY SUSTAINABILITY; Miles DR, 1997, J PERS SOC PSYCHOL, V72, P207, DOI 10.1037/0022-3514.72.1.207; Moore AJ, 1997, EVOLUTION, V51, P1352, DOI 10.1111/j.1558-5646.1997.tb01458.x; Morgan CA, 1998, APPL ANIM BEHAV SCI, V58, P23, DOI 10.1016/S0168-1591(97)00141-X; Muir WM, 2005, GENETICS, V170, P1247, DOI 10.1534/genetics.104.035956; Nelson RJ, 2007, NAT REV NEUROSCI, V8, P536, DOI 10.1038/nrn2174; Peeters K, 2012, GENETICS, V192, P705, DOI 10.1534/genetics.112.142554; PETHERICK JC, 1987, AUST J EXP AGR, V27, P605, DOI 10.1071/EA9870605; Rodenburg TB, 2010, ANIM WELFARE, V19, P77; Rodenburg TB, 2008, APPL ANIM BEHAV SCI, V110, P217, DOI 10.1016/j.applanim.2007.09.009; Ruis MAW, 2002, APPL ANIM BEHAV SCI, V75, P207, DOI 10.1016/S0168-1591(01)00191-5; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Scott JP, 1984, PHYSIOL ZOOL, V21, P31; Scott K, 2006, LIVEST SCI, V103, P104, DOI 10.1016/j.livsci.2006.01.008; Souza AS, 2008, APPL ANIM BEHAV SCI, V110, P182, DOI 10.1016/j.applanim.2007.03.023; Spoolder HAM, 2000, LIVEST PROD SCI, V64, P167, DOI 10.1016/S0301-6226(99)00152-9; STOOKEY JM, 1994, J ANIM SCI, V72, P2804, DOI 10.2527/1994.72112804x; Takahashi T, 2004, NEUROSCI LETT, V363, P125, DOI 10.1016/j.neulet.2004.03.062; Tanaka T, 1998, PHARMACOL BIOCHEM BE, V59, P27, DOI 10.1016/S0091-3057(97)00312-2; Turner SP, 2009, J ANIM SCI, V87, P3076, DOI 10.2527/jas.2008-1558; Turner SP, 2011, APPL ANIM BEHAV SCI, V134, P1, DOI 10.1016/j.applanim.2011.06.001; Turner SP, 2006, APPL ANIM BEHAV SCI, V96, P245, DOI 10.1016/j.applanim.2005.06.009; Tuyttens FAM, 2005, APPL ANIM BEHAV SCI, V92, P261, DOI 10.1016/j.applanim.2005.05.007; van de Weerd HA, 2009, APPL ANIM BEHAV SCI, V116, P1, DOI 10.1016/j.applanim.2008.08.001; Van Loo PLP, 2002, APPL ANIM BEHAV SCI, V76, P65, DOI 10.1016/S0168-1591(01)00200-3; Van Vleck LD, 2005, J ANIM SCI, V83, P68; Whittaker X, 1999, APPL ANIM BEHAV SCI, V63, P25, DOI 10.1016/S0168-1591(98)00243-3; WILLHAM RL, 1972, J ANIM SCI, V35, P1288; Wilson AJ, 2011, J EVOLUTION BIOL, V24, P772, DOI 10.1111/j.1420-9101.2010.02212.x; Wilson AJ, 2009, P ROY SOC B-BIOL SCI, V276, P533, DOI 10.1098/rspb.2008.1193; Wolf JB, 2011, PHILOS T R SOC B, V366, P1358, DOI 10.1098/rstb.2010.0239; Wolf JB, 1998, TRENDS ECOL EVOL, V13, P64, DOI 10.1016/S0169-5347(97)01233-0; ZAYAN R, 1990, CURR T VET, V53, P157	76	47	48	0	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65136	10.1371/journal.pone.0065136	http://dx.doi.org/10.1371/journal.pone.0065136			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762299	Green Published, gold, Green Submitted			2022-12-27	WOS:000321099000034
J	Schirm, S; Engel, C; Loeffler, M; Scholz, M				Schirm, Sibylle; Engel, Christoph; Loeffler, Markus; Scholz, Markus			A Biomathematical Model of Human Erythropoiesis under Erythropoietin and Chemotherapy Administration	PLOS ONE			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; 3-WEEKLY CHOP CHEMOTHERAPY; NON-HODGKINS-LYMPHOMA; MATHEMATICAL-MODEL; EPOETIN-ALPHA; PHARMACODYNAMIC ANALYSIS; AGGRESSIVE LYMPHOMAS; HUMAN GRANULOPOIESIS; ELDERLY-PATIENTS; YOUNG-PATIENTS	Anaemia is a common haematologic side effect of dose-dense multi-cycle cytotoxic polychemotherapy requiring erythrocyte transfusions or erythropoietin (EPO) administration. To simulate the effectiveness of different EPO application schedules, we performed both modelling of erythropoiesis under chemotherapy and pharmacokinetic and dynamic modelling of EPO applications in the framework of a single comprehensive biomathematical model. For this purpose, a cell kinetic model of bone marrow erythropoiesis was developed that is based on a set of differential compartment equations describing proliferation and maturation of erythropoietic cell stages. The system is regulated by several feedback loops comprising those mediated by EPO. We added a model of EPO absorption after injection at different sites and a pharmacokinetic model of EPO derivatives to account for the effects of external EPO applications. Chemotherapy is modelled by a transient depletion of bone marrow cell stages. Unknown model parameters were determined by fitting the predictions of the model to data sets of circulating erythrocytes, haemoglobin, haematocrit, percentage of reticulocytes or EPO serum concentrations derived from the literature or cooperating clinical study groups. Parameter fittings resulted in a good agreement of model and data. Depending on site of injection and derivative (Alfa, Beta, Delta, Darbepoetin), nine groups of EPO applications were distinguished differing in either absorption kinetics or pharmacokinetics. Finally, eight different chemotherapy protocols were modelled. The model was validated on the basis of scenarios not used for parameter fitting. Simulations were performed to analyze the impact of EPO applications on the risk of anaemia during chemotherapy. We conclude that we established a model of erythropoiesis under chemotherapy that explains a large set of time series data under EPO and chemotherapy applications. It allows predictions regarding yet untested EPO schedules. Prospective clinical studies are needed to validate model predictions and to explore the feasibility and effectiveness of the proposed schedules.	[Schirm, Sibylle; Engel, Christoph; Loeffler, Markus; Scholz, Markus] Univ Leipzig, Inst Med Informat Stat & Epidemiol, D-04109 Leipzig, Germany; [Schirm, Sibylle; Scholz, Markus] Univ Leipzig, LIFE Res Ctr Civilizat Dis, D-04109 Leipzig, Germany	Leipzig University; Leipzig University	Schirm, S (corresponding author), Univ Leipzig, Inst Med Informat Stat & Epidemiol, D-04109 Leipzig, Germany.	sibylle.schirm@imise.uni-leipzig.de		Engel, Christoph/0000-0002-7247-282X	Federal Ministry of Education and Research of the Federal Republic of Germany ("Haematosys'') [BMBF/PTJ0315452A]; LIFE - Leipzig Research Center for Civilization Diseases, University of Leipzig; European Union; European Regional Development Fund (ERDF); Free State of Saxony within the framework of the excellence initiative; LIFE	Federal Ministry of Education and Research of the Federal Republic of Germany ("Haematosys''); LIFE - Leipzig Research Center for Civilization Diseases, University of Leipzig; European Union(European Commission); European Regional Development Fund (ERDF)(European Commission); Free State of Saxony within the framework of the excellence initiative; LIFE	S. S. was partially funded by a grant of the Federal Ministry of Education and Research of the Federal Republic of Germany ("Haematosys'', BMBF/PTJ0315452A) and by LIFE - Leipzig Research Center for Civilization Diseases, University of Leipzig. LIFE is funded by means of the European Union, by the European Regional Development Fund (ERDF) and by means of the Free State of Saxony within the framework of the excellence initiative. M.S. was also funded by LIFE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoram B, 2007, BRIT J CLIN PHARMACO, V63, P41, DOI 10.1111/j.1365-2125.2006.02752.x; Ait-Oudhia S, 2010, J PHARMACOL EXP THER, V334, P897, DOI 10.1124/jpet.110.167304; Banks HT, 2004, MATH BIOSCI ENG, V1, P15, DOI 10.3934/mbe.2004.1.15; BELAIR J, 1995, MATH BIOSCI, V128, P317, DOI 10.1016/0025-5564(94)00078-E; Chapel SH, 2000, J PHARMACOL EXP THER, V295, P346; Cheung W, 1998, CLIN PHARMACOL THER, V8, P309; Crauste F, 2008, J THEOR BIOL, V250, P322, DOI 10.1016/j.jtbi.2007.09.041; Diehl V, 2003, NEW ENGL J MED, P348; Egrie JC, 2001, BRIT J CANCER, V84, P3, DOI 10.1054/bjoc.2001.1746; Elliott S, 2004, EXP HEMATOL, V32, P1146, DOI 10.1016/j.exphem.2004.08.004; Engel C, 2004, BLOOD, V104, P2323, DOI 10.1182/blood-2004-01-0306; Faris PM, 1998, CLIN ORTHOP RELAT R, P60; FLAHARTY KK, 1990, CLIN PHARMACOL THER, V47, P557, DOI 10.1038/clpt.1990.76; Fuertinger DH, 2013, J MATH BIOL, V66, P1209, DOI 10.1007/s00285-012-0530-0; Goldberg MA, 1995, AM J SURG, V170, pS37, DOI 10.1016/S0002-9610(99)80057-9; Guminski AD, 2001, CANCER CHEMOTH PHARM, V48, P229, DOI 10.1007/s002800100279; Hayashi N, 1998, BRIT J CLIN PHARMACO, V46, P11, DOI 10.1046/j.1365-2125.1998.00043.x; Jelkmann W, 2006, RECOMBINANT ERYTHROP; JENSEN JD, 1994, J AM SOC NEPHROL, V5, P177; Kota J, 2007, DRUG METAB DISPOS, V35, P2211, DOI 10.1124/dmd.107.015669; Krzyzanski W, 2005, EUR J PHARM SCI, V26, P295, DOI 10.1016/j.ejps.2005.06.010; Krzyzanski W, 2008, N-S ARCH PHARMACOL, V377, P637, DOI 10.1007/s00210-007-0225-z; LOEFFLER M, 1989, CELL TISSUE KINET, V22, P13, DOI 10.1111/j.1365-2184.1989.tb00198.x; Lohrmann H, 1982, CYOTOXIC DRUGS GRANU; Lundby C, 2007, J PHYSIOL-LONDON, V578, P309, DOI 10.1113/jphysiol.2006.122689; Macdougall IC, 2007, NEPHROL DIAL TRANSPL, V22, P2, DOI 10.1093/ndt/gfm160; Macdougall IC, 2002, NEPHROL DIAL TRANSPL, V17, P66, DOI 10.1093/ndt/17.suppl_5.66; MACDOUGALL IC, 1991, CONTRIB NEPHROL, V88, P152; Mahaffy JM, 1998, J THEOR BIOL, V190, P135, DOI 10.1006/jtbi.1997.0537; MARKHAM A, 1995, DRUGS, V49, P232, DOI 10.2165/00003495-199549020-00008; MCMAHON FG, 1990, BLOOD, V76, P1718; Meyer G, 2004, THESIS U LEIPZIG; PANTEL K, 1990, CELL TISSUE KINET, V23, P283, DOI 10.1111/j.1365-2184.1990.tb01125.x; Pantel K, 1987, THESIS U KOLN; Pfreundschuh M, 2008, ANN ONCOL, V19, P545, DOI 10.1093/annonc/mdm514; Pfreundschuh M, 2004, BLOOD, V104, P626, DOI 10.1182/blood-2003-06-2094; Pfreundschuh M, 2004, BLOOD, V104, P634, DOI 10.1182/blood-2003-06-2095; Pfreundschuh M, 2008, LANCET ONCOL, V9, P105, DOI 10.1016/S1470-2045(08)70002-0; Pirker R, 2008, J CLIN ONCOLOGY, P26; Rechenberg I., 1994, EVOLUTIONSSTRATEGIE; Savill NJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000416; SAWADA K, 1990, J CELL PHYSIOL, V142, P219, DOI 10.1002/jcp.1041420202; SAWADA K, 1987, J CLIN INVEST, V80, P357, DOI 10.1172/JCI113080; Scholz M, 2006, BRIT J HAEMATOL, V132, P723, DOI 10.1111/j.1365-2141.2005.05957.x; Scholz M, 2005, J MATH BIOL, V50, P397, DOI 10.1007/s00285-004-0295-1; Scholz M, 2009, CELL PROLIFERAT, V42, P823, DOI 10.1111/j.1365-2184.2009.00641.x; Scholz M, 2012, THEOR BIOL MED MODEL, V9, DOI 10.1186/1742-4682-9-32; Scholz M, 2010, J THEOR BIOL, V264, P287, DOI 10.1016/j.jtbi.2009.12.032; SCHWEFEL H, 1984, ANN OPER RES, V1, P65, DOI DOI 10.1007/BF01876146; Sieber M, 2003, J CLIN ONCOL, V21, P1734, DOI 10.1200/JCO.2003.06.028; Smith WB, 2007, CLIN THER, V29, P1368, DOI 10.1016/j.clinthera.2007.07.014; Sorgel F, 2009, PHARMACOLOGY, V83, P122, DOI 10.1159/000189027; Souillard A, 1996, BRIT J CLIN PHARMACO, V42, P355, DOI 10.1046/j.1365-2125.1996.41911.x; Togawa A, 2004, BRIT J CLIN PHARMACO, V58, P269, DOI 10.1111/j.1365-2125.2004.02151.x; Veng-Pedersen P, 2002, PHARM RES-DORDR, V19, P1630, DOI 10.1023/A:1020797110836; Wichmann H, 1985, MATH MODELING CELL P, V1, P2; Wichmann H, 1983, CURRENT CONCEPTS ERY; WICHMANN HE, 1989, CELL TISSUE KINET, V22, P31, DOI 10.1111/j.1365-2184.1989.tb00199.x; Woo S, 2008, CANCER CHEMOTH PHARM, V62, P123, DOI 10.1007/s00280-007-0582-9; Wunderlich A, 2003, ANN ONCOL, V14, P881, DOI 10.1093/annonc/mdg249; Zelenetz AD, 2003, ANN ONCOL, V14, P5, DOI 10.1093/annonc/mdg702; Zhu J, 2002, ONCOGENE, V21, P3295, DOI 10.1038/sj.onc.1205318	62	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65630	10.1371/journal.pone.0065630	http://dx.doi.org/10.1371/journal.pone.0065630			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755260	Green Published, Green Submitted, gold			2022-12-27	WOS:000321099000083
J	Yin, H; Park, SY; Wang, XJ; Misawa, R; Grossman, EJ; Tao, J; Zhong, R; Witkowski, P; Bell, GI; Chong, AS				Yin, Hao; Park, Soo-Young; Wang, Xiao-Jun; Misawa, Ryosuke; Grossman, Eric J.; Tao, Jing; Zhong, Rong; Witkowski, Piotr; Bell, Graeme I.; Chong, Anita S.			Enhancing Pancreatic Beta-Cell Regeneration In Vivo with Pioglitazone and Alogliptin	PLOS ONE			English	Article							CLINICAL ISLET TRANSPLANTATION; DEPENDENT DIABETES-MELLITUS; NOD MICE; GLYCEMIC CONTROL; DB/DB MICE; ANTILYMPHOCYTE-SERUM; ALLOGRAFT SURVIVAL; INSULIN-SECRETION; MOUSE MODEL; MASS	Aims/Hypothesis: Pancreatic beta-cells retain limited ability to regenerate and proliferate after various physiologic triggers. Identifying therapies that are able to enhance beta-cell regeneration may therefore be useful for the treatment of both type 1 and type 2 diabetes. Methods: In this study we investigated endogenous and transplanted beta-cell regeneration by serially quantifying changes in bioluminescence from beta-cells from transgenic mice expressing firefly luciferase under the control of the mouse insulin I promoter. We tested the ability of pioglitazone and alogliptin, two drugs developed for the treatment of type 2 diabetes, to enhance beta-cell regeneration, and also defined the effect of the immunosuppression with rapamycin and tacrolimus on transplanted islet beta mass. Results: Pioglitazone is a stimulator of nuclear receptor peroxisome proliferator-activated receptor gamma while alogliptin is a selective dipeptidyl peptidase IV inhibitor. Pioglitazone alone, or in combination with alogliptin, enhanced endogenous beta-cell regeneration in streptozotocin-treated mice, while alogliptin alone had modest effects. In a model of syngeneic islet transplantation, immunosuppression with rapamycin and tacrolimus induced an early loss of beta-cell mass, while treatment with insulin implants to maintain normoglycemia and pioglitazone plus alogliptin was able to partially promote beta-cell mass recovery. Conclusions/Interpretation: These data highlight the utility of bioluminescence for serially quantifying functional beta-cell mass in living mice. They also demonstrate the ability of pioglitazone, used either alone or in combination with alogliptin, to enhance regeneration of endogenous islet beta-cells as well as transplanted islets into recipients treated with rapamycin and tacrolimus.	[Yin, Hao; Wang, Xiao-Jun; Misawa, Ryosuke; Grossman, Eric J.; Tao, Jing; Zhong, Rong; Witkowski, Piotr; Chong, Anita S.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Park, Soo-Young; Bell, Graeme I.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Yin, Hao] Shanghai Changzheng Hosp, Transplant Ctr, Dept Surg, Shanghai, Peoples R China; [Wang, Xiao-Jun] Third Mil Med Univ, Southwest Hosp, Inst Hepatobiliary Surg, Chongqing, Peoples R China; [Misawa, Ryosuke] Univ Miami, Dept Cellular Transplantat, Coral Gables, FL 33124 USA; [Grossman, Eric J.] Northwestern Univ, Med Ctr, Chicago, IL 60611 USA; [Tao, Jing] First Peoples Hosp Yunnan Prov, Kunming, Peoples R China	University of Chicago; University of Chicago; Naval Medical University; Army Medical University; University of Miami; Northwestern University	Chong, AS (corresponding author), Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA.	achong@uchicago.edu			Takeda Pharmaceuticals United States of America [P60DK020595]; National Institute of Diabetes and Digestive And Kidney Diseases; State of Illinois Islet Transplantation; Cinkate Pharmaceutical Corp; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020595] Funding Source: NIH RePORTER	Takeda Pharmaceuticals United States of America; National Institute of Diabetes and Digestive And Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); State of Illinois Islet Transplantation; Cinkate Pharmaceutical Corp; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants from Takeda Pharmaceuticals United States of America to ASC and P60DK020595 (University of Chicago Diabetes Research and Training Center), the National Institute of Diabetes and Digestive And Kidney Diseases to GIB, the State of Illinois Islet Transplantation (PW) and an international visiting fellowship from Cinkate Pharmaceutical Corp (HY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjaneyulu M, 2003, METHOD FIND EXP CLIN, V25, P205, DOI 10.1358/mf.2003.25.3.769641; Baetta R, 2011, DRUGS, V71, P1441, DOI 10.2165/11591400-000000000-00000; Baggio LL, 2006, ANNU REV MED, V57, P265, DOI 10.1146/annurev.med.57.110104.115624; Barnett A, 2006, INT J CLIN PRACT, V60, P1454, DOI 10.1111/j.1742-1241.2006.01178.x; Barton FB, 2012, DIABETES CARE, V35, P1436, DOI 10.2337/dc12-0063; Barton FB, 2009, CELL TRANSPLANT, V18, P753, DOI 10.3727/096368909X470874; Bertera S, 2003, DIABETES, V52, P387, DOI 10.2337/diabetes.52.2.387; Buse JB, 2004, DIABETES CARE, V27, P2628, DOI 10.2337/diacare.27.11.2628; Chen XJ, 2008, TRANSPLANTATION, V85, P1246, DOI 10.1097/TP.0b013e31816b66b0; Chia CW, 2008, J CLIN ENDOCR METAB, V93, P3703, DOI 10.1210/jc.2007-2109; Chong AS, 2006, SCIENCE, V311, P1774, DOI 10.1126/science.1123510; Diani AR, 2004, AM J PHYSIOL-ENDOC M, V286, pE116, DOI 10.1152/ajpendo.00331.2003; Donath MY, 2008, ENDOCR REV, V29, P334, DOI 10.1210/er.2007-0033; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Faradji RN, 2009, CELL TRANSPLANT, V18, P1247, DOI 10.3727/096368909X474456; FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249; Fosgerau K, 2012, DIABETES OBES METAB; Fowler M, 2005, TRANSPLANTATION, V79, P768, DOI 10.1097/01.TP.0000152798.03204.5C; Grossman EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008749; Guz Y, 2001, ENDOCRINOLOGY, V142, P4956, DOI 10.1210/en.142.11.4956; Ishida H, 2004, METABOLISM, V53, P488, DOI 10.1016/j.metabol.2003.11.021; Kaku K, 2011, DIABETES OBES METAB, V13, P1028, DOI 10.1111/j.1463-1326.2011.01460.x; Karges B, 2004, DIABETES CARE, V27, P1207, DOI 10.2337/diacare.27.5.1207; Kawasaki F, 2005, AM J PHYSIOL-ENDOC M, V288, pE510, DOI 10.1152/ajpendo.00128.2004; Kawashima S, 2011, BIOCHEM BIOPH RES CO, V404, P534, DOI 10.1016/j.bbrc.2010.12.021; Kodama S, 2003, SCIENCE, V302, P1223, DOI 10.1126/science.1088949; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; Kushner JA, 2010, CELL METAB, V11, P2, DOI 10.1016/j.cmet.2009.12.005; LEE HC, 1989, ENDOCRINOLOGY, V124, P1571, DOI 10.1210/endo-124-3-1571; Li WC, 2010, J CELL SCI, V123, P2792, DOI 10.1242/jcs.065268; LOHR M, 1987, DIABETOLOGIA, V30, P757; Matsui J, 2004, DIABETES, V53, P2844, DOI 10.2337/diabetes.53.11.2844; Meier JJ, 2005, DIABETOLOGIA, V48, P2221, DOI 10.1007/s00125-005-1949-2; Molano RD, 2003, TRANSPLANTATION, V75, P1812, DOI 10.1097/01.TP.0000064622.54799.0E; Montanya E, 2000, DIABETES, V49, P1341, DOI 10.2337/diabetes.49.8.1341; Mooradian Arshag D, 2002, Treat Endocrinol, V1, P13, DOI 10.2165/00024677-200201010-00002; Moritoh Y, 2009, BRIT J PHARMACOL, V157, P415, DOI 10.1111/j.1476-5381.2009.00145.x; NAKANISHI K, 1993, METABOLISM, V42, P196, DOI 10.1016/0026-0495(93)90035-M; Nishio J, 2006, SCIENCE, V311, P1775, DOI 10.1126/science.1124004; Ogawa N, 2004, DIABETES, V53, P1700, DOI 10.2337/diabetes.53.7.1700; Park SY, 2009, HORM METAB RES, V41, P1, DOI 10.1055/s-0028-1087209; Park SY, 2005, GENESIS, V43, P80, DOI 10.1002/gene.20157; Pick A, 1998, DIABETES, V47, P358, DOI 10.2337/diabetes.47.3.358; Pileggi A, 2001, DIABETES, V50, P1983, DOI 10.2337/diabetes.50.9.1983; Pospisilik JA, 2003, DIABETES, V52, P741, DOI 10.2337/diabetes.52.3.741; Rankin MM, 2009, DIABETES, V58, P1365, DOI 10.2337/db08-1198; Rieck S, 2009, MOL ENDOCRINOL, V23, P1702, DOI 10.1210/me.2009-0144; Rother KI, 2004, J CLIN INVEST, V114, P877, DOI 10.1172/JC1200423235; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Ryu S, 2001, J CLIN INVEST, V108, P63, DOI 10.1172/JCI200112335; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Smith SJ, 2006, MOL IMAGING, V5, P65, DOI 10.2310/7290.2006.00007; Sorenson RL, 1997, HORM METAB RES, V29, P301, DOI 10.1055/s-2007-979040; Suarez-Pinzon WL, 2005, DIABETES, V54, P2596, DOI 10.2337/diabetes.54.9.2596; Suri A, 2006, SCIENCE, V311, P1778, DOI 10.1126/science.1123500; Takamura T, 1999, DIABETES RES CLIN PR, V44, P107, DOI 10.1016/S0168-8227(99)00030-3; Tschen SI, 2009, DIABETES, V58, P1312, DOI 10.2337/db08-1651; Virostko J, 2004, MOL IMAGING, V3, P333, DOI 10.1162/1535350042973508; Virostko J, 2010, MOL IMAGING BIOL, V12, P42, DOI 10.1007/s11307-009-0240-1; Wang M, 2012, SCI TRANSL MED, V4; Weir GC, 2004, NAT BIOTECHNOL, V22, P1095, DOI 10.1038/nbt0904-1095; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Wu T, 2002, TRANSPLANTATION, V74, P22, DOI 10.1097/00007890-200207150-00005; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Yang ZD, 2006, BIOCHEM BIOPH RES CO, V344, P1017, DOI 10.1016/j.bbrc.2006.03.177; Yin D, 2006, AM J TRANSPLANT, V6, P60, DOI 10.1111/j.1600-6143.2005.01157.x; Yin DP, 2006, DIABETES, V55, P3256, DOI 10.2337/db05-1275; Zhao YF, 2006, INT J BIOCHEM CELL B, V38, P804, DOI 10.1016/j.biocel.2005.11.008	68	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65777	10.1371/journal.pone.0065777	http://dx.doi.org/10.1371/journal.pone.0065777			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762423	Green Submitted, gold, Green Published			2022-12-27	WOS:000321099000104
J	Yuan, MQ; Lu, T; Li, CH; Lu, L				Yuan, Manqiong; Lu, Teng; Li, Chunhua; Lu, Ling			The Evolutionary Rates of HCV Estimated with Subtype 1a and 1b Sequences over the ORF Length and in Different Genomic Regions	PLOS ONE			English	Article							HEPATITIS-C VIRUS; MOLECULAR EPIDEMIOLOGY; GENETIC HISTORY; GENOTYPE 2; INFECTION; INFERENCE; TRANSMISSION; GLYCOPROTEIN	Background: Considerable progress has been made in the HCV evolutionary analysis, since the software BEAST was released. However, prior information, especially the prior evolutionary rate, which plays a critical role in BEAST analysis, is always difficult to ascertain due to various uncertainties. Providing a proper prior HCV evolutionary rate is thus of great importance. Methods/Results: 176 full-length sequences of HCV subtype 1a and 144 of 1b were assembled by taking into consideration the balance of the sampling dates and the even dispersion in phylogenetic trees. According to the HCV genomic organization and biological functions, each dataset was partitioned into nine genomic regions and two routinely amplified regions. A uniform prior rate was applied to the BEAST analysis for each region and also the entire ORF. All the obtained posterior rates for 1a are of a magnitude of 10 23 substitutions/site/year and in a bell-shaped distribution. Significantly lower rates were estimated for 1b and some of the rate distribution curves resulted in a one-sided truncation, particularly under the exponential model. This indicates that some of the rates for subtype 1b are less accurate, so they were adjusted by including more sequences to improve the temporal structure. Conclusion: Among the various HCV subtypes and genomic regions, the evolutionary patterns are dissimilar. Therefore, an applied estimation of the HCV epidemic history requires the proper selection of the rate priors, which should match the actual dataset so that they can fit for the subtype, the genomic region and even the length. By referencing the findings here, future evolutionary analysis of the HCV subtype 1a and 1b datasets may become more accurate and hence prove useful for tracing their patterns.	[Yuan, Manqiong; Li, Chunhua; Lu, Ling] Univ Kansas, Med Ctr, Ctr Viral Oncol, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Lu, Teng] Univ So Calif, Los Angeles, CA USA	University of Kansas; University of Kansas Medical Center; University of Southern California	Lu, L (corresponding author), Univ Kansas, Med Ctr, Ctr Viral Oncol, Dept Pathol & Lab Med, Kansas City, KS 66103 USA.	llu@kumc.edu			National Institute of Allergy and Infectious Diseases [5 R01 AI080734-03A]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080734] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a grant from The National Institute of Allergy and Infectious Diseases (5 R01 AI080734-03A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUKH J, 1995, SEMIN LIVER DIS, V15, P41, DOI 10.1055/s-2007-1007262; Drummond A, 2003, ADV PARASIT, V54, P331, DOI 10.1016/S0065-308X(03)54008-8; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edo-Matas D, 2011, MOL BIOL EVOL, V28, P1605, DOI 10.1093/molbev/msq326; Ferraro D, 2008, J MED VIROL, V80, P1723, DOI 10.1002/jmv.21276; Fu YSH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047324, 10.1371/journal.pone.0028006]; GOJOBORI T, 1990, P NATL ACAD SCI USA, V87, P10015, DOI 10.1073/pnas.87.24.10015; Gray RR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-131; HIJIKATA M, 1991, BIOCHEM BIOPH RES CO, V175, P220, DOI 10.1016/S0006-291X(05)81223-9; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; KUROSAKI M, 1993, HEPATOLOGY, V18, P1293, DOI 10.1002/hep.1840180602; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Lim PJ, 2012, J BIOL CHEM, V287, P30861, DOI 10.1074/jbc.M112.376822; Markov PV, 2009, J GEN VIROL, V90, P2086, DOI 10.1099/vir.0.011569-0; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Nakano T, 2006, J GEN VIROL, V87, P73, DOI 10.1099/vir.0.81360-0; Njouom R, 2009, J GEN VIROL, V90, P2452, DOI 10.1099/vir.0.011981-0; Pouillot R, 2008, INFECT GENET EVOL, V8, P676, DOI 10.1016/j.meegid.2008.06.001; POWER JP, 1995, LANCET, V345, P1211, DOI 10.1016/S0140-6736(95)91993-7; Pybus OG, 2003, MOL BIOL EVOL, V20, P381, DOI 10.1093/molbev/msg043; Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321; Pybus Oliver G, 2005, Infect Genet Evol, V5, P131, DOI 10.1016/j.meegid.2004.08.001; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Twiddy SS, 2003, MOL BIOL EVOL, V20, P122, DOI 10.1093/molbev/msg010; Veillon P, 2004, PATHOL BIOL, V52, P505, DOI 10.1016/j.patbio.2004.07.011; WEINER AJ, 1992, P NATL ACAD SCI USA, V89, P3468, DOI 10.1073/pnas.89.8.3468; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; Zhou XM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024889	33	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64698	10.1371/journal.pone.0064698	http://dx.doi.org/10.1371/journal.pone.0064698			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762247	Green Published, gold, Green Submitted			2022-12-27	WOS:000321099000015
J	de Juan, S; Thrush, SF; Hewitt, JE				de Juan, Silvia; Thrush, Simon F.; Hewitt, Judi E.			Counting on beta-Diversity to Safeguard the Resilience of Estuaries	PLOS ONE			English	Article							SPECIES-DIVERSITY; REGIME SHIFTS; DISPERSAL; HABITAT; SCALE; PATTERNS; COASTAL; HOMOGENIZATION; VARIABILITY; DISTURBANCE	Coastal ecosystems are often stressed by non-point source and cumulative effects that can lead to local-scale community homogenisation and a concomitant loss of large-scale ecological connectivity. Here we investigate the use of beta-diversity as a measure of both community heterogeneity and ecological connectivity. To understand the consequences of different environmental scenarios on heterogeneity and connectivity, it is necessary to understand the scale at which different environmental factors affect beta-diversity. We sampled macrofauna from intertidal sites in nine estuaries from New Zealand's North Island that represented different degrees of stress derived from land-use. We used multiple regression models to identify relationships between beta-diversity and local sediment variables, factors related to the estuarine and catchment hydrodynamics and morphology and land-based stressors. At local scales, we found higher beta-diversity at sites with a relatively high total richness. At larger scales, beta-diversity was positively related to gamma-diversity, suggesting that a large regional species pool was linked with large-scale heterogeneity in these systems. Local environmental heterogeneity influenced beta-diversity at both local and regional scales, although variables at the estuarine and catchment scales were both needed to explain large scale connectivity. The estuaries expected a priori to be the most stressed exhibited higher variance in community dissimilarity between sites and connectivity to the estuary species pool. This suggests that connectivity and heterogeneity metrics could be used to generate early warning signals of cumulative stress.	[de Juan, Silvia; Thrush, Simon F.; Hewitt, Judi E.] Natl Inst Water & Atmospher Res, Hamilton, New Zealand	National Institute of Water & Atmospheric Research (NIWA) - New Zealand	de Juan, S (corresponding author), Natl Inst Water & Atmospher Res, Hamilton, New Zealand.	Silvia.dejuan@niwa.co.nz	de Juan Mohan, Silvia/P-2899-2019	de Juan Mohan, Silvia/0000-0002-8891-8371; Thrush, Simon/0000-0002-4005-3882	Spanish Ministry of Education (Programa nacional de movilidad de recursos humanos del Plan Nacional I+D+i); MBIE [NIWA COMS1302, COER1201, C01X0501]	Spanish Ministry of Education (Programa nacional de movilidad de recursos humanos del Plan Nacional I+D+i); MBIE(New Zealand Ministry of Business, Innovation and Employment (MBIE))	SdJ was funded by a postdoctoral mobility grant from The Spanish Ministry of Education (Programa nacional de movilidad de recursos humanos del Plan Nacional I+D+i 2008-2011). This work was supported by funding from MBIE (NIWA COMS1302, COER1201 & C01X0501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Bevilacqua S, 2012, ECOL INDIC, V18, P140, DOI 10.1016/j.ecolind.2011.11.006; Bierschenk AM, 2012, ECOSYSTEMS, V15, P637, DOI 10.1007/s10021-012-9536-0; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brock WA, 2010, ECOL MONOGR, V80, P353, DOI 10.1890/09-1824.1; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Carpenter S, 2001, ECOSYSTEMS, V4, P765, DOI 10.1007/s10021-001-0045-9; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; Clarke K. R., 2001, CHANGES MARINE COMMU; Colwell R K, 2006, ESTIMATES BIODIVERSI; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Cottenie K, 2004, ECOLOGY, V85, P114, DOI 10.1890/03-3004; Dakos V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041010, 10.1371/journal.pone.0045586]; Dakos V, 2010, THEOR ECOL-NETH, V3, P163, DOI 10.1007/s12080-009-0060-6; de Juan S, 2011, MAR ECOL PROG SER, V423, P117, DOI 10.3354/meps08935; Edgar GJ, 2000, ESTUAR COAST SHELF S, V50, P639, DOI 10.1006/ecss.2000.0591; Ellingsen KE, 2002, MAR ECOL PROG SER, V232, P15, DOI 10.3354/meps232015; Freestone AL, 2006, ECOLOGY, V87, P2425, DOI 10.1890/0012-9658(2006)87[2425:DLAEHS]2.0.CO;2; Fujita R, 2013, MAR POLICY, V38, P538, DOI 10.1016/j.marpol.2012.05.025; Gering JC, 2003, CONSERV BIOL, V17, P488, DOI 10.1046/j.1523-1739.2003.01465.x; Guttal V, 2009, THEOR ECOL-NETH, V2, P3, DOI 10.1007/s12080-008-0033-1; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hastie T., 1986, STAT SCI, V1, P297; Hewitt JE, 2005, ECOLOGY, V86, P1619, DOI 10.1890/04-1099; Hewitt J, 2010, BIODIVERS CONSERV, V19, P1315, DOI 10.1007/s10531-009-9763-7; Hewitt JE, 2010, MAR ECOL PROG SER, V413, P267, DOI 10.3354/meps08626; Hume TM, 2007, OCEAN COAST MANAGE, V50, P905, DOI 10.1016/j.ocecoaman.2007.05.009; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Keil P, 2012, J BIOGEOGR, V39, P1473, DOI 10.1111/j.1365-2699.2012.02701.x; Koch EW, 2009, FRONT ECOL ENVIRON, V7, P29, DOI 10.1890/080126; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; LEVIN SA, 1974, P NATL ACAD SCI USA, V71, P2744, DOI 10.1073/pnas.71.7.2744; Lindegren M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038410; Loreau M, 2000, ECOL LETT, V3, P73, DOI 10.1046/j.1461-0248.2000.00127.x; Lundquist CJ, 2010, MAR ECOL PROG SER, V413, P217, DOI 10.3354/meps08578; Ricotta C, 2008, THEOR POPUL BIOL, V73, P244, DOI 10.1016/j.tpb.2007.10.005; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Shackell NL, 2012, ECOL APPL, V22, P336, DOI 10.1890/10-2093.1; Shurin JB, 2001, AM NAT, V158, P624, DOI 10.1086/323589; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Thrush SF, 2012, ECOL APPL, V22, P1213, DOI 10.1890/11-1403.1; Thrush SF, 2004, FRONT ECOL ENVIRON, V2, P299, DOI 10.1890/1540-9295(2004)002[0299:MWESIT]2.0.CO;2; Thrush SF, 2008, ECOL APPL, V18, P12, DOI 10.1890/07-0436.1; Thrush SF, 2006, ECOL APPL, V16, P1636, DOI 10.1890/1051-0761(2006)016[1636:PTEOHH]2.0.CO;2; Thrush SF, 2013, ECOL APPL, V23, P226, DOI 10.1890/12-0793.1; Thrush SF, 2011, MAR ECOL PROG SER, V424, P119, DOI 10.3354/meps08960; Thrush SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011899; Thrush SF, 2009, P ROY SOC B-BIOL SCI, V276, P3209, DOI 10.1098/rspb.2009.0661; Wood SN, 2002, ECOL MODEL, V157, P157, DOI 10.1016/S0304-3800(02)00193-X	53	34	34	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65575	10.1371/journal.pone.0065575	http://dx.doi.org/10.1371/journal.pone.0065575			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755252	Green Published, gold, Green Submitted			2022-12-27	WOS:000320579400066
J	Lee, SI; Hwang, S; Joe, YE; Cha, HK; Joo, GH; Lee, HJ; Kim, JW; Jablonski, PG				Lee, Sang-im; Hwang, Soyun; Joe, Young-eun; Cha, Hyun-kyung; Joo, Gun-ho; Lee, Hyeon-jeong; Kim, Ji-won; Jablonski, Piotr G.			Direct Look from a Predator Shortens the Risk-Assessment Time by Prey	PLOS ONE			English	Article							FLIGHT-INITIATION DISTANCE; ANCIENT ESCAPE CIRCUIT; DECISION-MAKING; AVIAN PREDATOR; MOTOR-ACTIVITY; VISUAL-FIELDS; ANIMALS; BIRDS; CUES; EXPLOITATION	Decision making process is an important component of information use by animals and has already been studied in natural situations. Decision making takes time, which is expressed as a cost in evolutionary explanations of decision making abilities of animals. However, the duration of information assessment and decision making process has not been measured in a natural situation. Here, we use responses of wild magpies (Pica pica) to predictably approaching humans to demonstrate that, regardless of whether the bird perceived high (decided to fly away) or low (resumed foraging) threat level, the bird assessed the situation faster when approaching humans looked directly at it than when the humans were not directly looking at it. This indicates that prey is able to extract more information about the predator's intentions and to respond sooner when the predator is continuously ("intently'') looking at the prey. The results generally illustrate how an increase of information available to an individual leads to a shorter assessment and decision making process, confirming one of central tenets of psychology of information use in a wild bird species in its natural habitat.	[Lee, Sang-im] Seoul Natl Univ, Inst Adv Machinery & Design, Seoul, South Korea; [Lee, Sang-im; Hwang, Soyun; Joe, Young-eun; Cha, Hyun-kyung; Joo, Gun-ho; Lee, Hyeon-jeong; Kim, Ji-won; Jablonski, Piotr G.] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; [Jablonski, Piotr G.] Polish Acad Sci, Ctr Ecol Studies, Dziekanow Lesny, Lomianki, Poland	Seoul National University (SNU); Seoul National University (SNU); Polish Academy of Sciences	Lee, SI (corresponding author), Seoul Natl Univ, Inst Adv Machinery & Design, Seoul, South Korea.	snulbee@behecolpiotrsangim.org; snulbee@behecolpiotrsangim.org	Jablonski, Piotr G/A-2753-2015	Cha, Hyunkyung/0000-0002-3462-3789; /0000-0002-8333-0106; Hwang, Soyun/0000-0002-4290-0213	National Research Foundation of Korea [313-2007-2-C00747, 2010-0025546, 2010-0009006, 2011-0030744]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was funded by the following grants of the National Research Foundation of Korea (www.nrf.re.kr); 313-2007-2-C00747, 2010-0025546, 2010-0009006 and 2011-0030744. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barret HC, 2005, HDB EVOLUTIONARY PSY, P210; Bateman PW, 2011, J ZOOL, V285, P316, DOI 10.1111/j.1469-7998.2011.00846.x; BERGSTROM BJ, 1985, J FIELD ORNITHOL, V56, P415; Blanchard DC, 2011, NEUROSCI BIOBEHAV R, V35, P991, DOI 10.1016/j.neubiorev.2010.10.016; Blumstein DT, 2003, J WILDLIFE MANAGE, V67, P852, DOI 10.2307/3802692; Blumstein DT, 1996, OIKOS, V77, P569, DOI 10.2307/3545948; BOUSKILA A, 1992, AM NAT, V139, P161, DOI 10.1086/285318; Bradbury Jack W., 1998, pi; Broom M, 2005, BEHAV ECOL, V16, P534, DOI 10.1093/beheco/ari024; Burrows M, 2006, J EXP BIOL, V209, P4607, DOI 10.1242/jeb.02539; Carrete M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018859; Carrete M, 2010, BIOL LETTERS, V6, P167, DOI 10.1098/rsbl.2009.0739; Carter J, 2008, P ROY SOC B-BIOL SCI, V275, P1709, DOI 10.1098/rspb.2008.0095; Castellano S, 2011, J THEOR BIOL, V274, P161, DOI 10.1016/j.jtbi.2011.01.001; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chittka L, 2009, TRENDS ECOL EVOL, V24, P400, DOI 10.1016/j.tree.2009.02.010; Cooper WE, 1998, BEHAVIOUR, V135, P55; Cooper WE, 2007, J THEOR BIOL, V244, P59, DOI 10.1016/j.jtbi.2006.07.011; Cooper WE, 2012, BEHAV ECOL, V23, P790, DOI 10.1093/beheco/ars032; Cooper WE, 2011, ETHOLOGY, V117, P620, DOI 10.1111/j.1439-0310.2011.01911.x; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Doshi A, 2009, IEEE T INTELL TRANSP, V10, P453, DOI 10.1109/TITS.2009.2026675; Dukas R, 1998, COGNITIVE ECOLOGY EV; Eason PK, 2006, J WILDLIFE MANAGE, V70, P1796, DOI 10.2193/0022-541X(2006)70[1796:FAFIDI]2.0.CO;2; Eaton R. L., 1970, Z TIERPSYCHOL, V27, P492, DOI DOI 10.1111/J.1439-0310.1970.TB01883X; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Fernandez-Juricic E, 2002, CAN J ZOOL, V80, P1212, DOI 10.1139/Z02-104; Fernandez-Juricic E, 2008, IBIS, V150, P779, DOI 10.1111/j.1474-919X.2008.00860.x; Fotowat H, 2007, J NEUROSCI, V27, P10047, DOI 10.1523/JNEUROSCI.1515-07.2007; Gibson RM, 1996, TRENDS ECOL EVOL, V11, P468, DOI 10.1016/0169-5347(96)10050-1; HAMPTON RR, 1994, BEHAVIOUR, V130, P41, DOI 10.1163/156853994X00136; Heylen D, 2010, HUMAN-CENTRIC INTERFACES FOR AMBIENT INTELLIGENCE, P49, DOI 10.1016/B978-0-12-374708-2.00003-6; Jablonski PG, 2001, BRAIN BEHAV EVOLUT, V58, P218, DOI 10.1159/000057565; Jablonski PG, 2000, BRAIN BEHAV EVOLUT, V56, P94, DOI 10.1159/000006680; Javurkova V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032522; Ji Q, 2002, REAL-TIME IMAGING, V8, P357, DOI 10.1006/rtim.2002.0279; Kavaliers M, 2001, NEUROSCI BIOBEHAV R, V25, P577, DOI 10.1016/S0149-7634(01)00042-2; Langton SRH, 2000, TRENDS COGN SCI, V4, P50, DOI 10.1016/S1364-6613(99)01436-9; Lee SI, 2011, J ETHOL, V29, P401, DOI 10.1007/s10164-011-0275-z; Lee WY, 2011, ANIM COGN, V14, P817, DOI 10.1007/s10071-011-0415-4; Luttbeg B, 1996, BEHAV ECOL, V7, P451, DOI 10.1093/beheco/7.4.451; MAININI B, 1993, BIOL CONSERV, V64, P161, DOI 10.1016/0006-3207(93)90653-I; Martin GR, 1999, P 22 INT ORN C DURB, P2711; Martin GR, 2007, J ORNITHOL, V148, pS547, DOI 10.1007/s10336-007-0213-6; Mendl M, 1999, APPL ANIM BEHAV SCI, V65, P221, DOI 10.1016/S0168-1591(99)00088-X; Miller SG, 2001, WILDLIFE SOC B, V29, P124; ORIANS GH, 1991, AM NAT, V137, pS29, DOI 10.1086/285138; Railsback SF, 2002, ECOLOGY, V83, P1817, DOI 10.2307/3071767; Ristau CA, 1991, COGNITIVE ETHOLOGY M; Ristau CA, 1991, NATURAL THEORIES MIN, P209; Rodriguez-Prieto I, 2008, BEHAVIOUR, V145, P1125, DOI 10.1163/156853908784474489; Runyan AM, 2004, J WILDLIFE MANAGE, V68, P1124, DOI 10.2193/0022-541X(2004)068[1124:DIDIFI]2.0.CO;2; Santer RD, 2005, J COMP PHYSIOL A, V191, P965, DOI 10.1007/s00359-005-0023-3; Schmidt KA, 2010, OIKOS, V119, P304, DOI 10.1111/j.1600-0706.2009.17573.x; SEIDENSTICKER J, 1993, SYM ZOOL S, P105; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Stankowich T, 2006, BEHAV ECOL, V17, P246, DOI 10.1093/beheco/arj020; Stankowich T, 2008, BIOL CONSERV, V141, P2159, DOI 10.1016/j.biocon.2008.06.026; Stephens D., 2007, FORAGING BEHAV ECOLO; Stephens D.W., 1986, pi; Sutton GP, 2008, J COMP PHYSIOL A, V194, P557, DOI 10.1007/s00359-008-0329-z; Swaisgood RR, 1999, ANIM BEHAV, V57, P1301, DOI 10.1006/anbe.1999.1095; Tijerina L, 2005, TRANSPORT RES REC, P37; Trimmer PC, 2011, ANIM COGN, V14, P465, DOI 10.1007/s10071-011-0387-4; von Bayern AMP, 2009, CURR BIOL, V19, P1; Watve M, 2002, ANIM COGN, V5, P253, DOI 10.1007/s10071-002-0155-6; Yang CH, 2008, SCIENCE, V319, P1679, DOI 10.1126/science.1151842; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8	68	15	15	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64977	10.1371/journal.pone.0064977	http://dx.doi.org/10.1371/journal.pone.0064977			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755164	gold, Green Published, Green Submitted			2022-12-27	WOS:000320579400033
J	Tempalski, B; Pouget, ER; Cleland, CM; Brady, JE; Cooper, HLF; Hall, HI; Lansky, A; West, BS; Friedman, SR				Tempalski, Barbara; Pouget, Enrique R.; Cleland, Charles M.; Brady, Joanne E.; Cooper, Hannah L. F.; Hall, H. Irene; Lansky, Amy; West, Brooke S.; Friedman, Samuel R.			Trends in the Population Prevalence of People Who Inject Drugs in US Metropolitan Areas 1992-2007	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; UNITED-STATES; HEROIN USERS; RISK-FACTORS; ESTIMATING NUMBERS; SUBSTANCE-ABUSE; HIV PREVALENCE; PUBLIC-HEALTH; YOUNG-ADULTS	Background: People who inject drugs (PWID) have increased risk of morbidity and mortality. We update and present estimates and trends of the prevalence of current PWID and PWID subpopulations in 96 US metropolitan statistical areas (MSAs) for 1992-2007. Current estimates of PWID and PWID subpopulations will help target services and help to understand long-term health trends among PWID populations. Methodology: We calculated the number of PWID in the US annually from 1992-2007 and apportioned estimates to MSAs using multiplier methods. We used four types of data indicating drug injection to allocate national annual totals to MSAs, creating four distinct series of component estimates of PWID in each MSA and year. The four component estimates are averaged to create the best estimate of PWID for each MSA and year. We estimated PWID prevalence rates for three subpopulations defined by gender, age, and race/ethnicity. We evaluated trends using multi-level polynomial models. Results: PWID per 10,000 persons aged 15-64 years varied across MSAs from 31 to 345 in 1992 (median 104.4) to 34 to 324 in 2007 (median 91.5). Trend analysis indicates that this rate declined during the early period and then was relatively stable in 2002-2007. Overall prevalence rates for non-Hispanic black PWID increased in 2005 as compared to other racial/ethnic groups. Hispanic prevalence, in contrast, declined across time. Importantly, results show a worrisome trend in young PWID prevalence since HAART was initiated - the mean prevalence was 90 to 100 per 10,000 youth in 1992-1996, but increased to >120 PWID per 10,000 youth in 2006-2007. Conclusions: Overall, PWID rates remained constant since 2002, but increased for two subpopulations: non-Hispanic black PWID and young PWID. Estimates of PWID are important for planning and evaluating public health programs to reduce harm among PWID and for understanding related trends in social and health outcomes.	[Tempalski, Barbara; Pouget, Enrique R.; Cleland, Charles M.; West, Brooke S.; Friedman, Samuel R.] Natl Dev & Res Inst Inc NDRI, Inst AIDS Res, New York, NY 10010 USA; [Cleland, Charles M.] NYU, Coll Nursing, New York, NY USA; [Brady, Joanne E.] Columbia Univ, Dept Epidemiol, New York, NY USA; [Cooper, Hannah L. F.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Hall, H. Irene] Ctr Dis Control, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA; [Lansky, Amy] Ctr Dis Control, Div HIV AIDS Prevent Surveillance Epidemiol & Lab, Atlanta, GA 30333 USA; [Friedman, Samuel R.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	National Development & Research Institutes, Inc; New York University; Columbia University; Emory University; Rollins School Public Health; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Tempalski, B (corresponding author), Natl Dev & Res Inst Inc NDRI, Inst AIDS Res, New York, NY 10010 USA.	tempalski@ndri.org	Pouget, Enrique Rodriguez/AAJ-5786-2020	Pouget, Enrique Rodriguez/0000-0002-5907-1909; West, Brooke S./0000-0003-0496-5769; Brady, Joanne/0000-0002-1730-2676; Tempalski, Barbara/0000-0002-6128-2510; Cleland, Charles/0000-0002-6931-9904; Friedman, Sam/0000-0003-2083-1226	National Institute of Drug Abuse [R01 DA13336]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013336] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The research described in this paper is supported by the National Institute of Drug Abuse grant # R01 DA13336. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro H, 2001, PUBLIC HEALTH REP, V116, P434, DOI 10.1016/S0033-3549(04)50072-9; Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P681; [Anonymous], NAT SURV DRUG US HLT; [Anonymous], 2010, HIV COUNS TEST PUBL; Arfken CL, 2010, J SUBST ABUSE TREAT, V39, P96, DOI 10.1016/j.jsat.2010.05.004; Balding DJ, 2004, APPL LONGITUDINAL AN; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Bargagli AM, 2006, EUR J PUBLIC HEALTH, V16, P198, DOI 10.1093/eurpub/cki168; Bjerg O, 2008, BODY SOC, V14, P1, DOI 10.1177/1357034X08090695; Bluthenthal R N, 1997, Med Anthropol, V18, P61, DOI 10.1080/01459740.1997.9966150; Bluthenthal RN, 1999, J DRUG ISSUES, V29, P1; Brady JE, 2008, J URBAN HEALTH, V85, P323, DOI 10.1007/s11524-007-9248-5; Brown L, 2003, AIDS EDUC PREV, V15, P49, DOI 10.1521/aeap.15.1.49.23844; Broz D, 2008, DRUG ALCOHOL DEPEN, V94, P221, DOI 10.1016/j.drugalcdep.2007.11.020; Cai R., 2010, Morbidity and Mortality Weekly Report, V59, P705; Centers for Disease Control and Prevention, 2010, AIDS SURV DAT; Centers for Disease Control and Prevention, MON SEL NAT HIV PR A, P17; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P636; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V61, P358; Chatterjee S, 2011, AIDS BEHAV, V15, P1570, DOI 10.1007/s10461-011-9992-0; Chen CM, 2007, ALCOHOL CLIN EXP RES, V31, P285, DOI 10.1111/j.1530-0277.2006.00304.x; Church D., 2011, Morbidity and Mortality Weekly Report, V60, P1457; Ciccarone D, 2003, SUBST USE MISUSE, V38, P2049, DOI 10.1081/JA-120025125; Cooper H, 2005, SOC SCI MED, V61, P673, DOI 10.1016/j.socscimed.2004.12.030; Cooper HLF, 2008, CLIN INFECT DIS, V46, P955, DOI 10.1086/528870; Cooper HLF, 2012, HEALTH PLACE, V18, P218, DOI 10.1016/j.healthplace.2011.09.005; Cooper HLF, 2008, J URBAN HEALTH, V85, P826, DOI 10.1007/s11524-008-9304-9; Cox S, 1997, SOC PSYCH PSYCH EPID, V32, P19, DOI 10.1007/BF00800663; Crum NF, 2006, JAIDS-J ACQ IMM DEF, V41, P194, DOI 10.1097/01.qai.0000179459.31562.16; Department of Justice, 2010, UN CRIM REP RPGR DAT; Des Jarlais DC, 2003, AM J EPIDEMIOL, V157, P467, DOI 10.1093/aje/kwf222; EMCDDA and Centre for Drug Misuse Research, 1999, METH GUID EST PREV P; European Monitoring Centre for Drugs and Drug Addiction, EMCDDA STAT B 2005; Fischer B, 2007, J URBAN HEALTH, V84, P552, DOI 10.1007/s11524-007-9198-y; Friedman S.R., 1988, CALIF SOCIOL, V11, P55; Friedman SR, 2007, INT J DRUG POLICY, V18, P475, DOI 10.1016/j.drugpo.2006.10.004; Friedman SR, 2011, AM J PUBLIC HEALTH, V101, P344, DOI 10.2105/AJPH.2010.191759; Friedman SR, 2009, AM J PUBLIC HEALTH, V99, P1002, DOI 10.2105/AJPH.2008.140327; Friedman SR, 2004, J URBAN HEALTH, V81, P377, DOI 10.1093/jurban/jth125; FRIEDMAN SR, 1987, MILBANK Q, V65, P455, DOI 10.2307/3349999; Friedman SR, 2001, AM J PUBLIC HEALTH, V91, P791, DOI 10.2105/AJPH.91.5.791; Frischer M, 2001, ADDICTION, V96, P1465, DOI 10.1046/j.1360-0443.2001.9610146510.x; Greenfield SF, 2010, PSYCHIAT CLIN N AM, V33, P339, DOI 10.1016/j.psc.2010.01.004; Grigoryan A., 2009, Morbidity and Mortality Weekly Report, V58, P1291; Habarta NM, 2010, COMMUNICATION; Hall HI, 2006, ANN EPIDEMIOL, V16, P824, DOI 10.1016/j.annepidem.2006.01.009; Harrison KM, 2010, JAIDS-J ACQ IMM DEF, V53, P124, DOI 10.1097/QAI.0b013e3181b563e7; Hickman M, 2003, J URBAN HEALTH, V80, P274, DOI 10.1093/jurban/jtg030; Hickman M, 1999, ADDICTION, V94, P1653, DOI 10.1046/j.1360-0443.1999.941116534.x; Holmberg SD, 1996, AM J PUBLIC HEALTH, V86, P642, DOI 10.2105/AJPH.86.5.642; Joint United Nations Program on HIV/AIDS, 2007, RED HIV STIGM DISCR; Jones CM, DRUG ALCOHO IN PRESS; Kaplan GA, 1996, BRIT MED J, V312, P999; Kelly JF, 2010, INT J DRUG POLICY, V21, P202, DOI 10.1016/j.drugpo.2009.10.010; Khan MR, 2008, ANN EPIDEMIOL, V18, P403, DOI 10.1016/j.annepidem.2007.12.003; Kimber J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3172; Klevens RM, 2012, CLIN INFECT DIS, V55, pS3, DOI 10.1093/cid/cis393; Koblin BA, 2006, AIDS, V20, P731, DOI 10.1097/01.aids.0000216374.61442.55; Kraus L, 2003, ADDICTION, V98, P471, DOI 10.1046/j.1360-0443.2003.00326.x; Kresina TF, 2011, INT J ENV RES PUB HE, V8, P4102, DOI 10.3390/ijerph8104102; Krusi A, 2010, INT J DRUG POLICY, V21, P4, DOI 10.1016/j.drugpo.2009.08.003; Lanehart R E, 1994, J Subst Abuse, V6, P441, DOI 10.1016/S0899-3289(94)90390-5; Lankenau SE, 2012, INT J DRUG POLICY, V23, P37, DOI 10.1016/j.drugpo.2011.05.014; Larson A, 1996, AUST NZ J PUBL HEAL, V20, P493, DOI 10.1111/j.1467-842X.1996.tb01628.x; LARSON A, 1994, SOC SCI MED, V39, P823, DOI 10.1016/0277-9536(94)90044-2; Latkin CA, 2001, J SUBST ABUSE, V13, P89, DOI 10.1016/S0899-3289(01)00070-0; Lert F, 2007, INT J DRUG POLICY, V18, P255, DOI 10.1016/j.drugpo.2007.05.002; LURIE P, 1993, PUBLIC HLTH IMPACT N, V1; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Lynch JW, 1998, AM J PUBLIC HEALTH, V88, P1074, DOI 10.2105/AJPH.88.7.1074; MacKellar DA, 2011, AIDS BEHAV, V15, P788, DOI 10.1007/s10461-010-9813-x; Mallory C, 1999, J Assoc Nurses AIDS Care, V10, P51, DOI 10.1016/S1055-3290(06)60232-X; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Metzger DS, 2010, JAIDS-J ACQ IMM DEF, V55, pS32, DOI 10.1097/QAI.0b013e3181f9c10b; Miller Cari L, 2007, Harm Reduct J, V4, P1, DOI 10.1186/1477-7517-4-1; Millett GA, 2012, LANCET, V380, P341, DOI 10.1016/S0140-6736(12)60899-X; Milloy MJ, 2009, AM J PUBLIC HLTH; Montaner JSG, 2010, JAIDS-J ACQ IMM DEF, V55, pS5, DOI 10.1097/QAI.0b013e3181f9c1f0; Morgan O, 2006, INT J EPIDEMIOL, V35, P1579, DOI 10.1093/ije/dyl207; [National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention Centers for Disease Control and Prevention], 2012, CDC FACT SHEET HIV A; National Institutes of Health HCV Virus Concensus Development Panel, 2002, MAN HCV 2002; NOVICK DM, 1997, SUBSTANCE ABUSE COMP, P534; Nurutdinova Diana, 2011, BMC Res Notes, V4, P126, DOI 10.1186/1756-0500-4-126; Office of Management and Budget, 2000, FED REG, V65, P8228; Ogden J., 2005, COMMON ITS CORE HIV; Okie S, 2010, NEW ENGL J MED, V363, P1981, DOI 10.1056/NEJMp1011512; Paulozzi LJ, 2007, INJURY PREV, V13, P130, DOI 10.1136/ip.2006.014357; Pezzotti P, 1999, J ACQ IMMUN DEF SYND, V20, P275, DOI 10.1097/00042560-199903010-00010; Pierce TG, 1999, SUBST USE MISUSE, V34, P2095, DOI 10.3109/10826089909039440; Pinkham S., 2007, WOMEN HARM REDUCTION; Porter K, 2003, LANCET, V362, P1267, DOI 10.1016/S0140-6736(03)14570-9; Pouget ER, 2012, J URBAN HEALTH, V89, P527, DOI 10.1007/s11524-012-9670-1; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Ritter A, 2006, INT J DRUG POLICY, V17, P453, DOI 10.1016/j.drugpo.2006.09.004; Roberts SCM, 2010, WOMEN HEALTH ISS, V20, P193, DOI 10.1016/j.whi.2010.02.003; SAS, 2002, SAS 9 2; SELIK RM, 1988, AM J PUBLIC HEALTH, V78, P1539, DOI 10.2105/AJPH.78.12.1539; SELIK RM, 1989, AM J PUBLIC HEALTH, V79, P836, DOI 10.2105/AJPH.79.7.836; Sherman SG, 2007, DRUG ALCOHOL DEPEN, V88, P182, DOI 10.1016/j.drugalcdep.2006.10.006; Shoptaw S, 2007, ADDICTION, V102, P130, DOI 10.1111/j.1360-0443.2006.01775.x; Spijkerman IJB, 1996, J CLIN EPIDEMIOL, V49, P1149, DOI 10.1016/0895-4356(96)00180-1; Spire B, 2007, INT J DRUG POLICY, V18, P262, DOI 10.1016/j.drugpo.2006.12.014; Strathdee Steffanie A, 2010, Curr HIV/AIDS Rep, V7, P99, DOI 10.1007/s11904-010-0043-7; Syed N, 2005, EUR J GASTROEN HEPAT, V15, P901; Tempalski B, 2009, J URBAN HEALTH, V86, P132, DOI 10.1007/s11524-008-9328-1; Tempalski B, 2010, SUBST ABUSE TREAT PR, V5, DOI 10.1186/1747-597X-5-23; U.S. Census Bureau Population Division Population Distribution Branch, 2005, HIST METR AR DEF; [U.S. Department of Health and Human Services National Center for Health Statistics], 2010, US DEP HLTH HUM SERV, V20; [U.S. Department of Health and Human Services Division of HIV/AIDS Prevention National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention Centers for Disease Control and Prevention], 2006, CDC FACT SHEET NEW E; [U.S. Department of Health and Human Services National Center for Health Statistics], 2009, US DEP HLTH HUM SERV, V20; [U.S. Department of Health and Human Services Division of HIV/AIDS Prevention National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention Centers for Disease Control and Prevention (CDC) Atlanta Georgia], 2009, TECHN NOT HIV SURV R, P22; [U.S. Department of Health and Human Services Division of HIV/AIDS Prevention National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention Centers for Disease Control and Prevention], 2010, POIS US FACT SHEET; [U.S. Department of Health and Human Services National Center for Health Statistics], 2007, US DEP HLTH HUM SERV, V20; [U.S. Department of Health and Human Services Division of HIV/AIDS Prevention National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention Centers for Disease Control and Prevention], 2011, HIV COUNS TEST CDC F; U.S. Department of Health and Human Services National Center for Health Statistics, 2004, MULT CAUS DEATH FIL; UN Office on Drugs and Crime (UNODC), 2006, HIV AIDS PREVENTION; [US Department of Health and Human Services Substance Abuse and Mental Health Services Administration Office of Applied Studies], 2010, NAT SURV SUBST AB TR; [US Department of Health and Human Services Substance Abuse and Mental Health Services Administration Office of Applied Studies], 2010, TREATM EP DAT SET 19; [US Department of Health and Human Services Substance Abuse and Mental Health Services Administration Office of Applied Studies], 2004, UN FAC DAT SET UFDS; [US Department of Health and Human Services Substance Abuse and Mental Health Services Administration Office of Applied Studies], UN FAC DAT SET UFDS; Vanhandel M, 2011, COMMUNICATION; Vlahov D, 2004, J URBAN HEALTH, V81, P14, DOI 10.1093/jurban/jth083; Vong S, 2004, HEPATOLOGY, V39, P476, DOI 10.1002/hep.20049; Wallace R, 1997, BRIT MED J, V314, P1341, DOI 10.1136/bmj.314.7090.1341; Wilton R, 2000, URBAN GEOGR, V21, P586, DOI 10.2747/0272-3638.21.7.586; Wise M, 2008, HEPATOLOGY, V47, P1128, DOI 10.1002/hep.22165	126	99	99	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64789	10.1371/journal.pone.0064789	http://dx.doi.org/10.1371/journal.pone.0064789			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166TB	23755143	gold, Green Published, Green Submitted			2022-12-27	WOS:000320579400025
J	Gvozdik, L; Cernicka, E; Van Damme, R				Gvozdik, Lumir; Cernicka, Eva; Van Damme, Raoul			Predator-Prey Interactions Shape Thermal Patch Use in a Newt Larvae-Dragonfly Nymph Model	PLOS ONE			English	Article							COST-BENEFIT MODEL; HABITAT SELECTION; VERTICAL MIGRATION; TEMPERATURE; THERMOREGULATION; PLASTICITY; BEHAVIOR; GAMES; HEAT; RISK	Thermal quality and predation risk are considered important factors influencing habitat patch use in ectothermic prey. However, how the predator's food requirement and the prey's necessity to avoid predation interact with their respective thermoregulatory strategies remains poorly understood. The recently developed 'thermal game model' predicts that in the face of imminent predation, prey should divide their time equally among a range of thermal patches. In contrast, predators should concentrate their hunting activities towards warmer patches. In this study, we test these predictions in a laboratory setup and an artificial environment that mimics more natural conditions. In both cases, we scored thermal patch use of newt larvae (prey) and free-ranging dragonfly nymphs (predators). Similar effects were seen in both settings. The newt larvae spent less time in the warm patch if dragonfly nymphs were present. The patch use of the dragonfly nymphs did not change as a function of prey availability, even when the nymphs were starved prior to the experiment. Our behavioral observations partially corroborate predictions of the thermal game model. In line with asymmetric fitness pay-offs in predator-prey interactions (the 'life-dinner' principle), the prey's thermal strategy is more sensitive to the presence of predators than vice versa.	[Gvozdik, Lumir; Cernicka, Eva] Inst Vertebrate Biol AS CR, Brno, Czech Republic; [Van Damme, Raoul] Univ Antwerp, Dept Biol, Antwerp, Belgium	Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; University of Antwerp	Gvozdik, L (corresponding author), Inst Vertebrate Biol AS CR, Brno, Czech Republic.	gvozdik@brno.cas.cz	Gvoždík, Lumír/G-1178-2014	Gvoždík, Lumír/0000-0002-6495-2233; Van Damme, Raoul/0000-0002-4585-6940	Czech Science Foundation [P506/10/2170];  [RVO:68081766]	Czech Science Foundation(Grant Agency of the Czech Republic); 	This study was funded by a grant from the Czech Science Foundation (P506/10/2170) and institutional support (RVO:68081766). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2006, PHYSIOL BIOCHEM ZOOL, V79, P282, DOI 10.1086/499990; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Bates D, 2012, LINEAR MIXED EFFECTS; BEITINGER TL, 1975, J FISH RES BOARD CAN, V32, P2133, DOI 10.1139/f75-251; BEUCHAT CA, 1987, ECOL MONOGR, V57, P45, DOI 10.2307/1942638; Bouskila A, 1998, EVOL ECOL, V12, P701, DOI 10.1023/A:1006585516023; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Crawley M.J., 2007, R BOOK; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; Dell AI, 2011, P NATL ACAD SCI USA, V108, P10591, DOI 10.1073/pnas.1015178108; Downes S, 1998, ANIM BEHAV, V55, P1387, DOI 10.1006/anbe.1997.0705; Downes S, 2001, ECOLOGY, V82, P2870, DOI 10.2307/2679967; Dvorak J, 2010, EVOL ECOL, V24, P1115, DOI 10.1007/s10682-010-9355-8; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; GLIWICZ MZ, 1986, NATURE, V320, P746, DOI 10.1038/320746a0; Gvozdik L, 2002, CAN J ZOOL, V80, P479, DOI 10.1139/SZ02-015; Herczeg G, 2008, OECOLOGIA, V155, P1, DOI 10.1007/s00442-007-0886-9; Hirvonen H, 1999, OIKOS, V86, P443, DOI 10.2307/3546649; HUEY RB, 1976, Q REV BIOL, V51, P363, DOI 10.1086/409470; HUGIE DM, 1994, J FISH BIOL, V45, P151, DOI 10.1111/j.1095-8649.1994.tb01090.x; Johnston I, 2006, COMP DEV PHYSL, P124; Kordas RL, 2011, J EXP MAR BIOL ECOL, V400, P218, DOI 10.1016/j.jembe.2011.02.029; KRAMER DL, 1988, CAN J ZOOL, V66, P89, DOI 10.1139/z88-012; Kurdikova V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023842; Lima SL, 2002, TRENDS ECOL EVOL, V17, P70, DOI 10.1016/S0169-5347(01)02393-X; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Luttbeg B, 2004, ISR J ZOOL, V50, P233, DOI 10.1560/L6QV-UA5T-RDR7-L7QG; Marek V, 2012, J ETHOL, V30, P35, DOI 10.1007/s10164-011-0287-8; Melville J, 2002, ECOL LETT, V5, P386, DOI 10.1046/j.1461-0248.2002.00328.x; Merakova E, 2009, FUNCT ECOL, V23, P989, DOI 10.1111/j.1365-2435.2009.01588.x; Mitchell WA, 2009, FUNCT ECOL, V23, P510, DOI 10.1111/j.1365-2435.2009.01542.x; Nonacs P, 2001, BEHAV ECOL, V12, P71, DOI 10.1093/oxfordjournals.beheco.a000381; Orizaola G, 2005, FRESHWATER BIOL, V50, P438, DOI 10.1111/j.1365-2427.2005.01332.x; Polo V, 2005, EVOL ECOL RES, V7, P23; R Core Team, 2021, R LANGUAGE ENV STAT; Schmidt BR, 2005, J EVOLUTION BIOL, V18, P415, DOI 10.1111/j.1420-9101.2004.00822.x; Sih Andrew, 2005, P240; Sih Andrew, 1998, P221; Smolinsky R, 2009, J ZOOL, V279, P180, DOI 10.1111/j.1469-7998.2009.00603.x; Smolinsky R, 2013, BIOL J LINN SOC, V108, P109, DOI 10.1111/j.1095-8312.2012.02004.x; Smolinsky R, 2012, OECOLOGIA, V170, P47, DOI 10.1007/s00442-012-2283-2; STICH HB, 1981, NATURE, V293, P396, DOI 10.1038/293396a0; Tattersall GJ, 2012, J EXP BIOL, V215, P1892, DOI 10.1242/jeb.065946; Turcotte MM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001332; Van Buskirk J, 2000, ECOLOGY, V81, P3009, DOI 10.1890/0012-9658(2000)081[3009:PIPPIL]2.0.CO;2; Venables WN., 2002, MODERN APPL STAT S, V4; Vickers M, 2011, AM NAT, V177, P452, DOI 10.1086/658150	48	7	7	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65079	10.1371/journal.pone.0065079	http://dx.doi.org/10.1371/journal.pone.0065079			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755175	Green Published, gold, Green Submitted			2022-12-27	WOS:000319872300046
J	Alvarez-Gallardo, H; Kjelland, ME; Moreno, JF; Welsh, TH; Randel, RD; Lammoglia, MA; Perez-Martinez, M; Lara-Sagahon, AV; Esperon-Sumano, E; Romo, S				Alvarez-Gallardo, Horacio; Kjelland, Michael E.; Moreno, Juan F.; Welsh, Thomas H., Jr.; Randel, Ronald D.; Lammoglia, Miguel A.; Perez-Martinez, Mario; Lara-Sagahon, Alma V.; Esperon-Sumano, Enrique; Romo, Salvador			Gamete Therapeutics: Recombinant Protein Adsorption by Sperm for Increasing Fertility via Artificial Insemination	PLOS ONE			English	Article							HEPARIN-BINDING PROTEINS; SEMINAL PLASMA-PROTEINS; SPERMATOZOA; BULLS	A decrease in fertility can have a negative economic impact, both locally and over a broader geographical scope, and this is especially the case with regard to the cattle industry. Therefore, much interest exists in evaluating proteins that might be able to increase the fertility of sperm. Heparin binding proteins (HBPs), specifically the fertility associated antigen (FAA) and the Type-2 tissue inhibitor of metalloproteinase (TIMP-2), act to favor the capacitation and acrosome reaction and perhaps even modulate the immune system's response toward the sperm. The objective of this research was to determine the effect on fertility of adding recombinant FAA (rFAA) and recombinant TIMP-2 (rTIMP-2) to bovine semen before cryopreservation for use in an artificial insemination (AI) program in a tropical environment. For this experiment, 100 crossbred (Bos taurus x Bos indicus) heifers were selected based on their estrus cycle, body condition score (BCS), of 4 to 6 on a scale of 1 to 9, and adequate anatomical conformation evaluated by pelvic and genital (normal) measurements. Heifers were synchronized using estradiol benzoate (EB), Celosil (R) (PGF2 alpha) (Shering-Plough) and a controlled internal drug release (CIDR) device was inserted that contained progesterone. Inseminations were performed in two groups at random, 50 animals per group. The control group was inseminated with conventional semen. The treatment group was inseminated with semen containing rFAA (25 mu g/mL) and rTIMP-2 (25 mu g/mL). In the control group a 16% pregnancy rate was obtained versus a 40% pregnancy rate for the HBP treatment group, resulting in a significant difference (P = 0.0037). Given the results herein, one may conclude that the HBPs can increase fertility and could be an option for cattle in tropical conditions; however, one needs to consider the environment, nutrition, and the genetic interaction affecting the final result in whatever reproductive program that is implemented.	[Alvarez-Gallardo, Horacio] Ctr Nacl Recursos Genet, Inst Nacl Invest Forestales Agr & Pecuarias, Tepatitlan De Morelos, Jalisco, Mexico; [Kjelland, Michael E.] Wayne State Coll, Wayne, NE USA; [Moreno, Juan F.] Sexing Technol, Navasota, TX USA; [Welsh, Thomas H., Jr.] Texas A&M Univ, College Stn, TX USA; [Randel, Ronald D.] Texas A&M AgriLife Res Overton, Overton, TX USA; [Lammoglia, Miguel A.] Univ Veracruzana, Fac Ciencias Biol & Agr, Tuxpan, Veracruz, Mexico; [Perez-Martinez, Mario] Univ Nacl Autonoma Mexico, Fac Med Vet & Zootecnia, Mexico City 04510, DF, Mexico; [Lara-Sagahon, Alma V.; Esperon-Sumano, Enrique; Romo, Salvador] Univ Nacl Autonoma Mexico, Fac Estudios Super Cuautitlan, Cuautitlan, Estado De Mexic, Mexico	Nebraska State College System; Wayne State College; Texas A&M University System; Texas A&M University College Station; Universidad Veracruzana; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Kjelland, ME (corresponding author), Wayne State Coll, Wayne, NE USA.	mkjelland@hotmail.com	Moreira, Nei/AAK-1357-2020; Randel, Ronald/W-2108-2019	Moreira, Nei/0000-0002-9236-667X; 	Texas A&M University-Conacyt Collaborative Research Grant Program [2009-004]	Texas A&M University-Conacyt Collaborative Research Grant Program	Funding for this research came from the Texas A&M University-Conacyt Collaborative Research Grant Program, Project Nr. 2009-004: Adaptation of Biotechnologies for Reproduction of Cattle in the Tropics (2009-2010), http://vpr.tamu.edu/funding/conacyt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Further, no individuals employed or contracted by the funders (other than the named authors) played any role in: study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agado BJ, 2011, J ANIM SCI S1, V89, P498; Agresti A, 2007, INTRO CATEGORICAL DA; Alghamdi AS, 2005, BIOL REPROD, V73, P1174, DOI 10.1095/biolreprod.105.045666; Alghamdi AS, 2004, REPRODUCTION, V127, P593, DOI 10.1530/rep.1.00096; Amann RP, 1999, J ANDROL, V20, P42; [Anonymous], 2010, GUID CAR US AGR AN R; Ax RL, 2002, FACTORS AFFECTING CALF CROP: BIOTECHNOLOGY OF REPRODUCTION, P287; Barrios B, 2000, BIOL REPROD, V63, P1531, DOI 10.1095/biolreprod63.5.1531; BELLIN ME, 1994, J ANIM SCI, V72, P2441, DOI 10.2527/1994.7292441x; Berg DK, 2010, THERIOGENOLOGY, V73, P250, DOI 10.1016/j.theriogenology.2009.09.005; Bo GA, 2003, ANIM REPROD SCI, V78, P307, DOI 10.1016/S0378-4320(03)00097-6; Cutaia LE, 2010, PROGRAMAS SINCRONIZA; Dawson GR, 2005, THESIS ARIZONA U US; Enciclopedia de los Municipios de Mexico, 2010, ENC MUN MEX; Galina CS, 2007, HORM BEHAV, V52, P32, DOI 10.1016/j.yhbeh.2007.03.025; Gene HD, 1992, BEEF CATTLE HDB; Harshan HM, 2006, ANIM REPROD SCI, V93, P124, DOI 10.1016/j.anireprosci.2005.07.010; HERD DB, 1986, EXTENSION B TEXAS A, V1526; KILLIAN GJ, 1993, BIOL REPROD, V49, P1202, DOI 10.1095/biolreprod49.6.1202; Lenz RW, 2011, J ANIM SCI, V89, P383, DOI 10.2527/jas.2010-3056; Lenz RW, 2000, BOVINE FERTILITY ASS; MARKS JL, 1985, J DAIRY SCI, V68, P2078, DOI 10.3168/jds.S0022-0302(85)81070-5; McCauley TC, 1999, MOL REPROD DEV, V54, P145, DOI 10.1002/(SICI)1098-2795(199910)54:2&lt;145::AID-MRD6&gt;3.0.CO;2-6; McCauley TC, 1996, J ANIM SCI, V74, P429; McCauley TC, 2001, MOL REPROD DEV, V58, P336, DOI 10.1002/1098-2795(200103)58:3&lt;336::AID-MRD12&gt;3.0.CO;2-Z; MILLER DJ, 1990, BIOL REPROD, V42, P899, DOI 10.1095/biolreprod42.6.899; Mogielnicka-Brzozowska M, 2011, POL J VET SCI, V14, P489, DOI 10.2478/v10181-011-0074-z; Mogielnicka-Brzozowska M, 2011, ACTA BIOCHIM POL, V58, P171; NASS SJ, 1990, MOL REPROD DEV, V25, P237, DOI 10.1002/mrd.1080250305; Nauc V, 2000, BIOL REPROD, V63, P1058, DOI 10.1095/biolreprod63.4.1058; Nikon, 2008, NIS EL BR 3 00; Ordonez-Leon EA, 2012, REPROD FERT DEVELOP, V24, P197, DOI 10.1071/RDv24n1Ab171; R Development Core Team, 2012, R LANG ENV STAT COMP; Rae DO, 2002, FACTORS AFFECTING CALF CROP: BIOTECHNOLOGY OF REPRODUCTION, P7; Rekawiecki R, 2008, J PHYSIOL PHARMACOL, V59, P75; Sprott LR, 2000, J ANIM SCI, V78, P795; TARONE RE, 1985, BIOMETRIKA, V72, P91, DOI 10.1093/biomet/72.1.91; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Waterman R. C., 2010, P GRAZ LIV NUTR C, P93; Zhang H, 2001, PLANT AN GEN 9 C SAN	40	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65083	10.1371/journal.pone.0065083	http://dx.doi.org/10.1371/journal.pone.0065083			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762288	gold, Green Published, Green Submitted			2022-12-27	WOS:000320440500023
J	Rusz, J; Klempir, J; Baborova, E; Tykalova, T; Majerova, V; Cmejla, R; Ruzicka, E; Roth, J				Rusz, Jan; Klempir, Jiri; Baborova, Eva; Tykalova, Tereza; Majerova, Veronika; Cmejla, Roman; Ruzicka, Evzen; Roth, Jan			Objective Acoustic Quantification of Phonatory Dysfunction in Huntington's Disease	PLOS ONE			English	Article							PARKINSONS-DISEASE; SPEECH; INDIVIDUALS; DYSARTHRIA; VOICE; DISORDERS; MARKER	Purpose: Although speech motor changes are reported as a common sign of Huntington's disease (HD), the most prominent signs of voice dysfunction remain unknown. The aim of the current study was to explore specific changes in phonatory function in subjects with HD. Method: 34 subjects with HD and 34 age- and sex-matched healthy controls were examined. Participants performed sustained vowel phonation for subsequent analyses of airflow insufficiency, aperiodicity, irregular vibrations of vocal folds, signal perturbations, increased noise, and articulation deficiency. In total, 272 phonations were collected and 12 voice parameters were extracted. Subsequently, a predictive model was built to find the most salient patterns of voice disorders in HD. The results were also correlated with disease severity according to the Unified HD Rating Scale (UHDRS) motor score. Results: Subjects with HD showed deterioration in all investigated phonatory functions. Irregular pitch fluctuations, sudden phonation interruption, increased noise, and misplacement of articulators were found to be most significant patterns of phonatory dysfunction in HD (p<0.001). The combination of these four dysphonia aspects contributed to the best classification performance of 94.1% (sensitivity: 95.1%; specificity: 93.2%) in the separation of HD patients from healthy participants. Our results further indicated stronger associations between sudden phonation interruption and voluntary components of the UHDRS (r = 20.48, p<0.01) and between misplacement of articulators and involuntary components of the UHDRS (r = 0.52, p<0.01). Conclusions: Our configuration of phonatory features can detect subtle voice abnormalities in subjects with HD. As impairment of phonatory function in HD was found to parallel increasing motor involvement, a qualitative description of voice dysfunction may be helpful to gain better insight into the pathophysiology of the vocal mechanism.	[Rusz, Jan; Tykalova, Tereza; Cmejla, Roman] Czech Tech Univ, Dept Circuit Theory, Fac Elect Engn, CR-16635 Prague, Czech Republic; [Rusz, Jan; Klempir, Jiri; Baborova, Eva; Majerova, Veronika; Ruzicka, Evzen; Roth, Jan] Charles Univ Prague, Dept Neurol, Fac Med 1, Prague, Czech Republic; [Rusz, Jan; Klempir, Jiri; Baborova, Eva; Majerova, Veronika; Ruzicka, Evzen; Roth, Jan] Charles Univ Prague, Ctr Clin Neurosci, Fac Med 1, Prague, Czech Republic	Czech Technical University Prague; Charles University Prague; Charles University Prague	Rusz, J (corresponding author), Czech Tech Univ, Dept Circuit Theory, Fac Elect Engn, CR-16635 Prague, Czech Republic.	ruszjan@fel.cvut.cz	Klempir, Jiri/P-3897-2017; Rusz, Jan/X-5427-2019; Růžička, Evžen/F-9299-2017; Tykalova, Tereza/AAU-9700-2020; Klempir, Jiri/AAI-7300-2021; Roth, Jan/O-1817-2017; Rusz, Jan/S-2054-2018	Klempir, Jiri/0000-0002-0735-7155; Rusz, Jan/0000-0002-1036-3054; Růžička, Evžen/0000-0002-4893-9661; Roth, Jan/0000-0002-5247-7746; Rusz, Jan/0000-0002-1036-3054; Tykalova, Tereza/0000-0003-1156-3709; Cmejla, Roman/0000-0002-8786-3823	Czech Science Foundation [GACR 102/12/2230]; Czech Ministry of Health [NT 11331-6/2010]; Czech Ministry of Education [MSM 0021620849]; Charles University in Prague [PRVOUK-P26/LF1/4]	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Ministry of Health(Ministry of Health, Czech Republic); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Charles University in Prague	This study was supported by the Czech Science Foundation (GACR 102/12/2230), Czech Ministry of Health (NT 11331-6/2010), Czech Ministry of Education (MSM 0021620849) and Charles University in Prague (PRVOUK-P26/LF1/4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berardelli A, 1999, MOVEMENT DISORD, V14, P398, DOI 10.1002/1531-8257(199905)14:3<398::AID-MDS1003>3.0.CO;2-F; Boersma Paul, 2002, GLOT INT, V5, P341; Brookes M., 2009, VOICEBOX SPEECH PROC; COLEMAN R, 1990, AM J MED GENET, V37, P36, DOI 10.1002/ajmg.1320370110; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P246, DOI 10.1044/jshr.1202.246; Duffy J. R., 2005, MOTOR SPEECH DISORDE, P592; Fraile R, 2009, FOLIA PHONIATR LOGO, V61, P146, DOI 10.1159/000219950; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Hartelius L, 2003, J MED SPEECH-LANG PA, V11, P1; Hayden MR, 1981, HUNTINGTONS CHOREA, P59, DOI [10.1007/978-1-4471-1308-9_5, DOI 10.1007/978-1-4471-1308-9_5]; HERTRICH I, 1993, CLIN LINGUIST PHONET, V7, P285, DOI 10.1080/02699209308985568; Kaploun LR, 2011, J MED SPEECH-LANG PA, V19, P49; Kent RD, 2000, J SPEECH LANG HEAR R, V43, P1275, DOI 10.1044/jslhr.4305.1275; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Kirkwood SC, 2000, J NEUROL NEUROSUR PS, V69, P773, DOI 10.1136/jnnp.69.6.773; Klempir J, 2009, J NEUROL, V256, P1629, DOI 10.1007/s00415-009-5164-9; KREMER B, 1994, NEW ENGL J MED, V330, P1401, DOI 10.1056/NEJM199405193302001; Lemay M, 2008, BEHAV BRAIN RES, V187, P153, DOI 10.1016/j.bbr.2007.09.016; Little MA, 2009, IEEE T BIO-MED ENG, V56, P1015, DOI 10.1109/TBME.2008.2005954; Little MA, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-23; Marder K, 2000, NEUROLOGY, V54, P452, DOI 10.1212/WNL.54.2.452; MCNEIL MR, 1997, CLIN MANAGEMENT SENS; PENNEY JB, 1990, MOVEMENT DISORD, V5, P93, DOI 10.1002/mds.870050202; Postuma RB, 2012, BRAIN, V135, P1860, DOI 10.1093/brain/aws093; RAMIG LA, 1988, ANN OTO RHINOL LARYN, V97, P164, DOI 10.1177/000348948809700214; RAMIG LA, 1986, ANN OTO RHINOL LARYN, V95, P288, DOI 10.1177/000348948609500315; Rusz J, 2011, J ACOUST SOC AM, V129, P350, DOI 10.1121/1.3514381; Rusz J, 2011, MOVEMENT DISORD, V26, P1951, DOI 10.1002/mds.23680; Skodda S, 2012, NEURODEGENER DIS MAN, V2, P535, DOI 10.2217/NMT.12.47; Skodda S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032132; Stout JC, 2011, NEUROPSYCHOLOGY, V25, P1, DOI 10.1037/a0020937; Tabrizi SJ, 2011, LANCET NEUROL, V10, P31, DOI 10.1016/S1474-4422(10)70276-3; Tsanas A, 2012, IEEE T BIO-MED ENG, V59, P1264, DOI 10.1109/TBME.2012.2183367; Garcia MJV, 2011, J VOICE, V25, P208, DOI 10.1016/j.jvoice.2009.08.007; Vogel AP, 2012, NEUROPSYCHOLOGIA, V50, P3273, DOI 10.1016/j.neuropsychologia.2012.09.011; ZWIRNER P, 1991, J COMMUN DISORD, V24, P287, DOI 10.1016/0021-9924(91)90004-3	37	18	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65881	10.1371/journal.pone.0065881	http://dx.doi.org/10.1371/journal.pone.0065881			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762447	Green Submitted, Green Published, gold			2022-12-27	WOS:000320440500056
J	Gavalda, S; Gallardo, M; Luna, R; Aguilera, A				Gavalda, Sandra; Gallardo, Mercedes; Luna, Rosa; Aguilera, Andres			R-Loop Mediated Transcription-Associated Recombination in trf4 Delta Mutants Reveals New Links between RNA Surveillance and Genome Integrity	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; TOPOISOMERASE-I; YEAST GENE; QUALITY-CONTROL; INSTABILITY; ELONGATION; COMPLEX; REPLICATION; POLYADENYLATION	To get further insight into the factors involved in the maintenance of genome integrity we performed a screening of Saccharomyces cerevisiae deletion strains inducing hyperrecombination. We have identified trf4, a gene encoding a non-canonical polyA-polymerase involved in RNA surveillance, as a factor that prevents recombination between DNA repeats. We show that trf4 Delta confers a transcription-associated recombination phenotype that is mediated by the nascent mRNA. In addition, trf4 Delta also leads to an increase in the mutation frequency. Both genetic instability phenotypes can be suppressed by overexpression of RNase H and are exacerbated by overexpression of the human cytidine deaminase AID. These results suggest that in the absence of Trf4 R-loops accumulate co-transcriptionally increasing the recombination and mutation frequencies. Altogether our data indicate that Trf4 is necessary for both mRNA surveillance and maintenance of genome integrity, serving as a link between RNA and DNA metabolism in S. cerevisiae.	[Gavalda, Sandra; Luna, Rosa; Aguilera, Andres] Univ Seville, Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Dept Biol Mol, Seville, Spain; [Gallardo, Mercedes; Luna, Rosa; Aguilera, Andres] Univ Seville, Dept Genet, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); University of Sevilla	Aguilera, A (corresponding author), Univ Seville, Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Dept Biol Mol, Seville, Spain.	aguilo@us.es	Aguilera, Andres/L-1825-2014; LUNA, ROSA/F-3974-2016	Aguilera, Andres/0000-0003-4782-1714; LUNA, ROSA/0000-0002-6131-6610	Spanish Ministry of Science and Research [BFU2010-16372, 2010 CSD2007-00015]; Junta de Andalucia [CVI-4567]; European Union (FEDER); Spanish Ministry of Health	Spanish Ministry of Science and Research(Spanish Government); Junta de Andalucia(Junta de Andalucia); European Union (FEDER)(European Commission); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government)	This work was supported by grants from the Spanish Ministry of Science and Research (BFU2010-16372 and Consolider Ingenio 2010 CSD2007-00015), Junta de Andalucia (CVI-4567) and European Union (FEDER). SG was the recipient of a predoctoral training grant from the Spanish Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILERA A, 1988, GENETICS, V119, P779; AGUILERA A, 1990, MOL CELL BIOL, V10, P1439, DOI 10.1128/MCB.10.4.1439; Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Alvaro D, 2007, PLOS GENET, V3, P2439, DOI 10.1371/journal.pgen.0030228; Basu U, 2011, CELL, V144, P353, DOI 10.1016/j.cell.2011.01.001; Bermejo R, 2012, MOL CELL, V45, P710, DOI 10.1016/j.molcel.2012.03.001; Castano IB, 1996, GENE DEV, V10, P2564, DOI 10.1101/gad.10.20.2564; Chavez S, 1997, GENE DEV, V11, P3459, DOI 10.1101/gad.11.24.3459; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; Dominguez-Sanchez MS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002386; Edwards S, 2003, MOL CELL BIOL, V23, P2733, DOI 10.1128/MCB.23.8.2733-2748.2003; Egecioglu DE, 2006, RNA, V12, P26, DOI 10.1261/rna.2207206; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; Gallardo M, 2001, GENETICS, V157, P79; Gan WJ, 2011, GENE DEV, V25, P2041, DOI 10.1101/gad.17010011; Garcia-Rubio M, 2003, GENETICS, V165, P457; Gomez-Gonzalez B, 2007, P NATL ACAD SCI USA, V104, P8409, DOI 10.1073/pnas.0702836104; Gomez-Gonzalez B, 2011, EMBO J, V30, P3106, DOI 10.1038/emboj.2011.206; Gonzalez-Aguilera C, 2008, MOL BIOL CELL, V19, P4310, DOI 10.1091/mbc.E08-04-0355; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Houseley J, 2008, BBA-GENE REGUL MECH, V1779, P239, DOI 10.1016/j.bbagrm.2007.12.008; Houseley J, 2007, EMBO J, V26, P4996, DOI 10.1038/sj.emboj.7601921; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Jimeno S, 2002, EMBO J, V21, P3526, DOI 10.1093/emboj/cdf335; Kadaba S, 2006, RNA, V12, P508, DOI 10.1261/rna.2305406; Kallstrom G, 2003, MOL CELL BIOL, V23, P4344, DOI 10.1128/MCB.23.12.4344-4355.2003; Kim N, 2012, NAT REV GENET, V13, P204, DOI 10.1038/nrg3152; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Luna R, 2005, MOL CELL, V18, P711, DOI 10.1016/j.molcel.2005.05.001; Luna R, 2008, CHROMOSOMA, V117, P319, DOI 10.1007/s00412-008-0158-4; Mischo HE, 2011, MOL CELL, V41, P21, DOI 10.1016/j.molcel.2010.12.007; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Paolo SS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000555; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; Piruat JI, 1998, EMBO J, V17, P4859, DOI 10.1093/emboj/17.16.4859; Planta RJ, 1998, YEAST, V14, P471, DOI 10.1002/(SICI)1097-0061(19980330)14:5<471::AID-YEA241>3.0.CO;2-U; Poltoratsky VP, 2004, J IMMUNOL, V172, P4308, DOI 10.4049/jimmunol.172.7.4308; PRADO F, 1995, GENETICS, V139, P109; Rondon AG, 2003, J BIOL CHEM, V278, P39037, DOI 10.1074/jbc.M305718200; Rougemaille M, 2007, EMBO J, V26, P2317, DOI 10.1038/sj.emboj.7601669; SADOFF BU, 1995, GENETICS, V141, P465; SANTOSROSA H, 1994, MOL GEN GENET, V245, P224, DOI 10.1007/BF00283271; Schmid M, 2008, CHROMOSOMA, V117, P419, DOI 10.1007/s00412-008-0166-4; Schmidt KH, 2006, MOL MICROBIOL, V60, P1251, DOI 10.1111/j.1365-2958.2006.05166.x; Stirling PC, 2012, GENE DEV, V26, P163, DOI 10.1101/gad.179721.111; Tous C, 2011, EMBO J, V30, P1953, DOI 10.1038/emboj.2011.109; Tuduri S, 2009, NAT CELL BIOL, V11, P1315, DOI 10.1038/ncb1984; Tutucci E, 2011, NAT REV MOL CELL BIO, V12, P376, DOI 10.1038/nrm3119; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Wahba L, 2011, MOL CELL, V44, P978, DOI 10.1016/j.molcel.2011.10.017; Wang ZH, 2002, GENETICS, V160, P381; Wellinger RE, 2006, MOL CELL BIOL, V26, P3327, DOI 10.1128/MCB.26.8.3327-3334.2006; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Yuen KWY, 2007, P NATL ACAD SCI USA, V104, P3925, DOI 10.1073/pnas.0610642104; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039	64	31	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65541	10.1371/journal.pone.0065541	http://dx.doi.org/10.1371/journal.pone.0065541			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762389	gold, Green Submitted, Green Published			2022-12-27	WOS:000321094800060
J	Jia, YX; Tao, FQ; Li, WQ				Jia, Yanxia; Tao, Faqing; Li, Weiqi			Lipid Profiling Demonstrates That Suppressing Arabidopsis Phospholipase D delta Retards ABA-Promoted Leaf Senescence by Attenuating Lipid Degradation	PLOS ONE			English	Article							PHOSPHATIDIC-ACID; D-ALPHA; MICROSOMAL-MEMBRANES; D ACTIVATION; PLD-DELTA; METABOLISM; STRESS; EXPRESSION; ORGANIZATION; INHIBITION	Senescence is the last phase of the plant life cycle and has an important role in plant development. Degradation of membrane lipids is an essential process during leaf senescence. Several studies have reported fundamental changes in membrane lipids and phospholipase D (PLD) activity as leaves senesce. Suppression of phospholipase D alpha 1 (PLD alpha 1) retards abscisic acid (ABA)-promoted senescence. However, given the absence of studies that have profiled changes in the compositions of membrane lipid molecules during leaf senescence, there is no direct evidence that PLD affects lipid composition during the process. Here, we show that application of n-butanol, an inhibitor of PLD, and N-Acylethanolamine (NAE) 12:0, a specific inhibitor of PLD alpha 1, retarded ABA-promoted senescence to different extents. Furthermore, phospholipase D delta (PLD delta) was induced in leaves treated with ABA, and suppression of PLD delta retarded ABA-promoted senescence in Arabidopsis. Lipid profiling revealed that detachment-induced senescence had different effects on plastidic and extraplastidic lipids. The accelerated degradation of plastidic lipids during ABA-induced senescence in wild-type plants was attenuated in PLD delta-knockout (PLD delta-KO) plants. Dramatic increases in phosphatidic acid (PA) and decreases in phosphatidylcholine (PC) during ABA-induced senescence were also suppressed in PLD delta-KO plants. Our results suggest that PLD delta-mediated hydrolysis of PC to PA plays a positive role in ABA-promoted senescence. The attenuation of PA formation resulting from suppression of PLD delta blocks the degradation of membrane lipids, which retards ABA-promoted senescence.	[Jia, Yanxia; Li, Weiqi] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Peoples R China; [Tao, Faqing; Li, Weiqi] Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Kunming, Peoples R China; [Jia, Yanxia] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, WQ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Peoples R China.	weiqili@mail.kib.ac.cn			National Natural Science Foundation of China [NSFC 30670474, 30870571, 31070262]; Fund of State Key Laboratory of Phytochemistry and Plant Resources in West China [0807B01211, 097C1211Z1]; Kunming Institute of Botany [KSCX2-EW-J-24]; Germplasm Bank of Wild Species; CAS Innovation Program of Kunming Institute, 100-Talents Program of CAS [540806321211]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund of State Key Laboratory of Phytochemistry and Plant Resources in West China; Kunming Institute of Botany; Germplasm Bank of Wild Species; CAS Innovation Program of Kunming Institute, 100-Talents Program of CAS	The research was supported by grants from the National Natural Science Foundation of China (NSFC 30670474, 30870571, and 31070262), Fund of State Key Laboratory of Phytochemistry and Plant Resources in West China (0807B01211 and 097C1211Z1), Kunming Institute of Botany (KSCX2-EW-J-24), Germplasm Bank of Wild Species, and CAS Innovation Program of Kunming Institute (540806321211), 100-Talents Program of CAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin-Brown SL, 2002, PLANT PHYSIOL, V129, P1892, DOI 10.1104/pp.001974; Bargmann BOR, 2009, PLANT CELL PHYSIOL, V50, P78, DOI 10.1093/pcp/pcn173; Bonfig KB, 2006, PLANTA, V225, P1, DOI 10.1007/s00425-006-0303-3; BOROCHOV A, 1982, PLANT PHYSIOL, V69, P296, DOI 10.1104/pp.69.2.296; BROWN JH, 1987, PLANT PHYSIOL, V85, P679, DOI 10.1104/pp.85.3.679; Buchanan B, 2002, BIOCH MOL BIOL PLANT, p[480, 491]; Buchanan-Wollaston V, 2003, PLANT BIOTECHNOL J, V1, P3, DOI 10.1046/j.1467-7652.2003.00004.x; BuchananWollaston V, 1997, J EXP BOT, V48, P181, DOI 10.1093/jxb/48.2.181; Dhonukshe P, 2003, PLANT CELL, V15, P2666, DOI 10.1105/tpc.014977; Espinoza C, 2007, J EXP BOT, V58, P3197, DOI 10.1093/jxb/erm165; Fan L, 1997, PLANT CELL, V9, P2183, DOI 10.1105/tpc.9.12.2183; GAN SS, 1995, SCIENCE, V270, P1986, DOI 10.1126/science.270.5244.1986; Gardiner J, 2003, PLANT CELL PHYSIOL, V44, P687, DOI 10.1093/pcp/pcg095; Gardiner JC, 2001, PLANT CELL, V13, P2143, DOI 10.1105/tpc.13.9.2143; Guo YF, 2005, CURR TOP DEV BIOL, V71, P83, DOI 10.1016/S0070-2153(05)71003-6; He YH, 2002, PLANT CELL, V14, P805, DOI 10.1105/tpc.010422; Hong YY, 2010, PLANT CELL ENVIRON, V33, P627, DOI 10.1111/j.1365-3040.2009.02087.x; Hong YY, 2008, MOL PLANT, V1, P262, DOI 10.1093/mp/ssm025; Jing HC, 2002, PLANT J, V32, P51, DOI 10.1046/j.1365-313X.2002.01400.x; Katagiri T, 2001, PLANT J, V26, P595, DOI 10.1046/j.1365-313x.2001.01060.x; Kim JI, 2011, J EXP BOT, V62, P3981, DOI 10.1093/jxb/err094; KOIWAI A, 1981, PLANT CELL PHYSIOL, V22, P1059; Krinke O, 2009, PLANT PHYSIOL, V150, P424, DOI 10.1104/pp.108.133595; Li MY, 2009, BBA-MOL CELL BIOL L, V1791, P927, DOI 10.1016/j.bbalip.2009.02.017; Li W, 2008, J BIOL CHEM, V283, P461, DOI 10.1074/jbc.M706692200; Li WQ, 2004, NAT BIOTECHNOL, V22, P427, DOI 10.1038/nbt949; Lim PO, 2005, CURR TOP DEV BIOL, V67, P49, DOI 10.1016/S0070-2153(05)67002-0; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Marechal E, 1997, PHYSIOL PLANTARUM, V100, P65, DOI 10.1034/j.1399-3054.1997.1000106.x; Martinez DE, 2008, PLANT J, V56, P196, DOI 10.1111/j.1365-313X.2008.03585.x; Motes CM, 2005, PROTOPLASMA, V226, P109, DOI 10.1007/s00709-005-0124-4; Munnik T, 1995, PLANT CELL, V7, P2197, DOI 10.1105/tpc.7.12.2197; Murphy DJ, 2005, BIOL SCI SER, P1; Page T, 2001, PLANT PHYSIOL, V125, P718, DOI 10.1104/pp.125.2.718; PALIYATH G, 1987, PLANT PHYSIOL, V83, P63, DOI 10.1104/pp.83.1.63; Potocky M, 2003, PLANTA, V217, P122, DOI 10.1007/s00425-002-0965-4; Qin CB, 2002, PLANT PHYSIOL, V128, P1057, DOI 10.1104/pp.010928; Quirino BF, 2000, TRENDS PLANT SCI, V5, P278, DOI 10.1016/S1360-1385(00)01655-1; Rea G, 2004, PLANT PHYSIOL, V134, P1414, DOI 10.1104/pp.103.036764; SMART CM, 1991, PLANT CELL, V3, P647, DOI 10.1105/tpc.3.7.647; Thompson J, 2000, BIOCHEM SOC T, V28, P775, DOI 10.1042/BST0280775; THOMPSON JE, 1982, PLANT PHYSIOL, V69, P859, DOI 10.1104/pp.69.4.859; Thompson JE, 1998, PROG LIPID RES, V37, P119, DOI 10.1016/S0163-7827(98)00006-X; Tocquin Pierre, 2003, BMC Plant Biology, V3, P2, DOI 10.1186/1471-2229-3-2; UEMURA M, 1995, PLANT PHYSIOL, V109, P15, DOI 10.1104/pp.109.1.15; Uraji M, 2012, PLANT PHYSIOL, V159, P450, DOI 10.1104/pp.112.195578; VERKLEIJ AJ, 1982, BIOCHIM BIOPHYS ACTA, V684, P255, DOI 10.1016/0005-2736(82)90014-1; Wang CX, 2001, PLANT PHYSIOL, V127, P1102, DOI 10.1104/pp.010444; Wang XM, 2002, CURR OPIN PLANT BIOL, V5, P408, DOI 10.1016/S1369-5266(02)00283-2; WANNER L, 1991, PLANT SCI, V78, P199, DOI 10.1016/0168-9452(91)90199-I; Weaver LM, 1998, PLANT MOL BIOL, V37, P455, DOI 10.1023/A:1005934428906; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; WOOLHOUSE HW, 1984, CAN J BOT, V62, P2934, DOI 10.1139/b84-392; Yamaoka Y, 2011, PLANT J, V67, P648, DOI 10.1111/j.1365-313X.2011.04624.x; YANG SF, 1967, J BIOL CHEM, V242, P477; Zhang WH, 2003, PLANT CELL, V15, P2285, DOI 10.1105/tpc.013961	56	41	48	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65687	10.1371/journal.pone.0065687	http://dx.doi.org/10.1371/journal.pone.0065687			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762411	Green Published, gold, Green Submitted			2022-12-27	WOS:000321094800069
J	Ryazantsev, S; Tischenko, V; Nguyen, C; Abramov, V; Zav'yalov, V				Ryazantsev, Sergey; Tischenko, Vladimir; Christopher Nguyen; Abramov, Vyacheslav; Zav'yalov, Vladimir			Three-Dimensional Structure of the Human Myeloma IgG2	PLOS ONE			English	Article							HUMAN-IMMUNOGLOBULIN; ELECTRON-MICROSCOPY; CRYOELECTRON MICROSCOPY; MONOCLONAL-ANTIBODIES; DISULFIDE ISOMERS; CORE HINGE; RESOLUTION; SUBCLASS; THERAPEUTICS; FLEXIBILITY	Human immunoglobulin G, subclass 2 (hIgG2), plays an important role in immunity to bacterial pathogens and in numerous pathological conditions. However, there is a lack of information regarding the three-dimensional (3D) structure of the hIgG2 molecule. We used electron microscopy (EM), differential scanning microcalorimetry (DSC) and fluorescence for structural analysis of the hIgG2. DSC and fluorescence indicated two types of interaction between C(H)1 domain of Fab (antigen-binding fragment/subunit) and C(H)2 domain of Fc (complement fixation fragment/subunit) simultaneously present in the sample: close interaction, which increases the thermostability of both, C(H)1 and C(H)2 domains, and weak (or no) interaction, which is typical for most IgGs but not hIgG2. Thermodynamics could not determine if both types of interactions are present within a single molecule. To address this question, EM was used. We employed a single-particle reconstruction and negative staining approach to reveal the three-dimensional structure of the hIgG2. A three-dimensional model of hIgG2 was created at 1.78 nm resolution. The hIgG2 is asymmetrical: one Fab subunit is in close proximity to the upper portion of the Fc subunit (C(H)2 domain) and the other Fab is distant from Fc. The plane of Fab subunits is nearly perpendicular to Fc. EM structure of the hIgG2 is in good agreement with thermodynamic data: a Fab distant from Fc should exhibit a lower melting temperature while a Fab interacting with Fc should exhibit a higher melting temperature. Both types of Fab subunits exist within one molecule resembling an A/B hIgG2 isoform introduced earlier on physicochemical level by Dillon et al. (2008). In such an arrangement, the access to the upper portion of Fc subunit is partially blocked by a Fab subunit. That might explain for instance why hIgG2 mildly activates complement and binds poorly to Fc receptors. Understanding of the three-dimensional structure of the hIgG2 should lead to better design of antibody-based therapeutics.	[Ryazantsev, Sergey; Christopher Nguyen] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Tischenko, Vladimir] Russian Acad Sci, Inst Theoret & Expt Biophys, Pushchino 142292, Russia; [Abramov, Vyacheslav] Inst Immunol Engn, Lyubuchany, Russia; [Zav'yalov, Vladimir] Univ Turku, Dept Chem, Math & Nat Sci Fac, Joint Biotechnol Lab, Turku, Finland	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Theoretical & Experimental Biophysics; University of Turku	Ryazantsev, S (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.	sryazant@ucla.edu	Abramov, Vyacheslav M./AAB-9462-2020	Zav'Yalov, Vladimir/0000-0001-5351-8741; Abramov, Vyacheslav M/0000-0001-6650-3936	European Commission/Research Executive Agency under a Marie Curie International Incoming Fellowship [235538]; Academy of Finland [112900]; Institute of Digital Research and Education, University of California Los Angeles; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER	European Commission/Research Executive Agency under a Marie Curie International Incoming Fellowship; Academy of Finland(Academy of Finland); Institute of Digital Research and Education, University of California Los Angeles; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a grant from the European Commission/Research Executive Agency under a Marie Curie International Incoming Fellowship (235538) and a grant from the Academy of Finland (112900) to V.Z. Molecular graphics images were produced using the UCSF Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California San Francisco [supported by National Institutes of Health (NIH) P41 RR001081]. This research was supported in part by Institute of Digital Research and Education, University of California Los Angeles through Hoffman2 computing resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMZEL LM, 1979, ANNU REV BIOCHEM, V48, P961, DOI 10.1146/annurev.bi.48.070179.004525; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; BREKKE OH, 1995, IMMUNOL TODAY, V16, P85, DOI 10.1016/0167-5699(95)80094-8; Burton DR, 1992, ADV IMMUNOL, V55, P1; DANGL JL, 1988, EMBO J, V7, P1989, DOI 10.1002/j.1460-2075.1988.tb03037.x; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.bi.59.070190.002255; DAVIES DR, 1975, ANNU REV BIOCHEM, V44, P639, DOI 10.1146/annurev.bi.44.070175.003231; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; DEROSIER DJ, 1968, NATURE, V217, P130, DOI 10.1038/217130a0; Dillon TM, 2008, J BIOL CHEM, V283, P16206, DOI 10.1074/jbc.M709988200; Frank J, 1996, 3 DIMENSIONAL ELECT, P208; Grassucci RA, 2007, NAT PROTOC, V2, P3239, DOI 10.1038/nprot.2007.452; GUDDAT LW, 1993, P NATL ACAD SCI USA, V90, P4271, DOI 10.1073/pnas.90.9.4271; Hezareh M, 2001, J VIROL, V75, P12161, DOI 10.1128/JVI.75.24.12161-12168.2001; Jefferis R, 2007, EXPERT OPIN BIOL TH, V7, P1401, DOI 10.1517/14712598.7.9.1401; Jonsson G, 2006, J IMMUNOL, V177, P722, DOI 10.4049/jimmunol.177.1.722; KLEIN M, 1981, P NATL ACAD SCI-BIOL, V78, P524, DOI 10.1073/pnas.78.1.524; KRATZIN HD, 1989, BIOL CHEM H-S, V370, P263, DOI 10.1515/bchm3.1989.370.1.263; Lai ZZ, 2005, VACCINE, V23, P3264, DOI 10.1016/j.vaccine.2005.01.088; Lightle S, 2010, PROTEIN SCI, V19, P753, DOI 10.1002/pro.352; Liu XY, 2008, IMMUNOL REV, V222, P9, DOI 10.1111/j.1600-065X.2008.00601.x; Liu YD, 2008, J BIOL CHEM, V283, P29266, DOI 10.1074/jbc.M804787200; LOSEVA OI, 1986, MOL IMMUNOL, V23, P743, DOI 10.1016/0161-5890(86)90085-4; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Nezlin R, 1990, Adv Immunol, V48, P1, DOI 10.1016/S0065-2776(08)60750-6; Pan Q, 2000, IMMUNOL REV, V178, P99, DOI 10.1034/j.1600-065X.2000.17815.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PHILLIPS ML, 1994, MOL IMMUNOL, V31, P1201, DOI 10.1016/0161-5890(94)90034-5; Pintilie GD, 2010, J STRUCT BIOL, V170, P427, DOI 10.1016/j.jsb.2010.03.007; Privalov P L, 1986, Methods Enzymol, V131, P4; Rodriguez ME, 1999, J INFECT DIS, V179, P423, DOI 10.1086/314603; Roux KH, 1997, J IMMUNOL, V159, P3372; RYAZANTSEV S, 1990, EUR J BIOCHEM, V190, P393, DOI 10.1111/j.1432-1033.1990.tb15588.x; Ryazantsev S, 2007, FEBS LETT, V581, P1898, DOI 10.1016/j.febslet.2007.03.088; RYAZANTSEV SN, 1989, FEBS LETT, V244, P291, DOI 10.1016/0014-5793(89)80548-4; RYAZANTSEV SN, 1990, FEBS LETT, V275, P221, DOI 10.1016/0014-5793(90)81476-5; Saltz Leonard, 2006, Nat Rev Drug Discov, V5, P987, DOI 10.1038/nrd2204; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; SARVAS H, 1990, INT IMMUNOL, V2, P317, DOI 10.1093/intimm/2.4.317; Smith CA, 1984, J ULTRASTRUCT RES, V89, P119; Tischenko VM, 2003, IMMUNOL LETT, V86, P281, DOI 10.1016/S0165-2478(03)00045-2; Tischenko VM, 2003, IMMUNOL LETT, V90, P43, DOI 10.1016/S0165-2478(03)00161-5; Tischenko VM, 1998, BIOCHEMISTRY-US, V37, P5576, DOI 10.1021/bi972647a; Tishchenko VM, 1982, EUR J BIOCHEM, V126, P517; VALENTINE RC, 1968, BIOCHEMISTRY-US, V7, P2143, DOI 10.1021/bi00846a017; van Dijk MA, 2001, CURR OPIN CHEM BIOL, V5, P368, DOI 10.1016/S1367-5931(00)00216-7; van Heel M, 2005, J STRUCT BIOL, V151, P250, DOI 10.1016/j.jsb.2005.05.009; Vasiliev V D, 1979, Methods Enzymol, V59, P612; Wang QA, 2010, J SEP SCI, V33, P2671, DOI 10.1002/jssc.201000230; Wypych J, 2008, J BIOL CHEM, V283, P16194, DOI 10.1074/jbc.M709987200; ZAVYALOV VP, 1991, SCAND J IMMUNOL, V33, P755, DOI 10.1111/j.1365-3083.1991.tb02550.x; Zhou ZH, 2008, CURR OPIN STRUC BIOL, V18, P218, DOI 10.1016/j.sbi.2008.03.004	52	24	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e64076	10.1371/journal.pone.0064076	http://dx.doi.org/10.1371/journal.pone.0064076			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762236	Green Published, Green Submitted, gold			2022-12-27	WOS:000321094800005
J	West, PA; Protopopoff, N; Rowland, M; Cumming, E; Rand, A; Drakeley, C; Wright, A; Kivaju, Z; Kirby, MJ; Mosha, FW; Kisinza, W; Kleinschmidt, I				West, Philippa A.; Protopopoff, Natacha; Rowland, Mark; Cumming, Emma; Rand, Alison; Drakeley, Chris; Wright, Alexandra; Kivaju, Zuhura; Kirby, Matthew J.; Mosha, Franklin W.; Kisinza, William; Kleinschmidt, Immo			Malaria Risk Factors in North West Tanzania: The Effect of Spraying, Nets and Wealth	PLOS ONE			English	Article							VECTOR-CONTROL INTERVENTIONS; BIOKO ISLAND; INSECTICIDE; TRANSMISSION; INFECTION; AREA; PREVALENCE; DISEASE	Malaria prevalence remains high in many African countries despite massive scaling-up of insecticide treated nets (ITN) and indoor residual spraying (IRS). This paper evaluates the protective effect of pyrethroid IRS and ITNs in relation to risk factors for malaria based on a study conducted in North-West Tanzania, where IRS has been conducted since 2007 and universal coverage of ITNs has been carried out recently. In 2011 community-based cross-sectional surveys were conducted in the two main malaria transmission periods that occur after the short and long rainy seasons. These included 5,152 and 4,325 children aged 0.5-14 years, respectively. Data on IRS and ITN coverage, household demographics and socio-economic status were collected using an adapted version of the Malaria Indicator Survey. Children were screened for malaria by rapid diagnostic test. In the second survey, haemoglobin density was measured and filter paper blood spots were collected to determine age-specific sero-prevalence in each community surveyed. Plasmodium falciparum infection prevalence in children 0.5-14 years old was 9.3% (95% CI: 5.9-14.5) and 22.8% (95% CI: 17.3-29.4) in the two surveys. Risk factors for infection after the short rains included households not being sprayed (OR = 0.39; 95% CI: 0.20-0.75); low community net ownership (OR = 0.45; 95% CI: 0.21-0.95); and low community SES (least poor vs. poorest tertile: OR = 0.13, 95% CI: 0.05-0.34). Risk factors after the long rains included household poverty (per quintile increase: OR = 0.89; 95% CI: 0.82-0.97) and community poverty (least poor vs. poorest tertile: OR = 0.26, 95% CI: 0.15-0.44); household IRS or high community ITN ownership were not protective. Despite high IRS coverage and equitable LLIN distribution, poverty was an important risk factor for malaria suggesting it could be beneficial to target additional malaria control activities to poor households and communities. High malaria prevalence in some clusters and the limited protection given by pyrethroid IRS and LLINs suggest that it may be necessary to enhance established vector control activities and consider additional interventions.	[West, Philippa A.; Cumming, Emma] Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England; [Protopopoff, Natacha; Rowland, Mark; Wright, Alexandra; Kirby, Matthew J.] Univ London London Sch Hyg & Trop Med, Dept Dis Control, London WC1E 7HT, England; [Rand, Alison; Drakeley, Chris] Univ London London Sch Hyg & Trop Med, Immunol & Infect Dept, London WC1E 7HT, England; [Kivaju, Zuhura; Kirby, Matthew J.; Kisinza, William] Amani Med Res Ctr, Natl Inst Med Res, Muheza, Tanzania; [Mosha, Franklin W.] Tumaini Univ, Kilimanjaro Christian Med Coll, Moshi, Tanzania; [Kleinschmidt, Immo] Univ London London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research; University of London; London School of Hygiene & Tropical Medicine	West, PA (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England.	philippa.west@lshtm.ac.uk		Protopopoff, Natacha/0000-0001-6698-4936	Malaria Centre at the London School of Hygiene and Tropical Medicine; United States Agency for International Development under Translating Research into Action [GHS-A-00-09-00015-00]; Medical Research Council [MR/K012126/1] Funding Source: researchfish	Malaria Centre at the London School of Hygiene and Tropical Medicine; United States Agency for International Development under Translating Research into Action(United States Agency for International Development (USAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	PW is funded by a Thorpe legacy studentship from the Malaria Centre at the London School of Hygiene and Tropical Medicine. This study was funded by the United States Agency for International Development under Translating Research into Action, Cooperative Agreement No. GHS-A-00-09-00015-00. This study was made possible by the support of the American people through the United States Agency for International Development (USAID). The findings of this study are the sole responsibility of the authors, and do not necessarily reflect the views of USAID or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, COCHRANE DB SYST REV; [Anonymous], J R SOC INTERFACE; [Anonymous], HIST WEATH DAT BUK; [Anonymous], MAL IND SURV HH QUES; [Anonymous], WHO REC INS IND RES; Bonner K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-73; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; BRADLEY DJ, 1991, DIS MORTALITY SUBSAH; Bradley J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-242; Carlstedt A, 1997, LANCET, V350, P1180, DOI 10.1016/S0140-6736(05)63830-5; Centers for Disease Control (CDC), 1989, MMWR Morb Mortal Wkly Rep, V38, P400; Chitnis N, 2010, AM J TROP MED HYG, V83, P230, DOI 10.4269/ajtmh.2010.09-0179; Cook J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025137; Corbel V, 2012, LANCET INFECT DIS, V12, P617, DOI 10.1016/S1473-3099(12)70081-6; Damien GB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-380; Dickinson KL, 2012, GLOB PUBLIC HEALTH, V7, P384, DOI 10.1080/17441692.2010.539573; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; DRAPER C. C, 1960, TRANS ROY SOC TROP MED AND HYG, V54, P342, DOI 10.1016/0035-9203(60)90115-2; DRAPER CC, 1972, T ROY SOC TROP MED H, V66, P905, DOI 10.1016/0035-9203(72)90126-5; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85; Graves PM, 2008, TROP MED INT HEALTH, V13, P218, DOI 10.1111/j.1365-3156.2007.01993.x; Graves PM, 2009, T ROY SOC TROP MED H, V103, P1211, DOI 10.1016/j.trstmh.2008.11.016; Greenwood B.M., 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene, V83, P25, DOI 10.1016/0035-9203(89)90599-3; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Kirkwood BR, 2003, ESSENTIAL MED STAT, P449; Kleinschmidt I, 2006, AM J TROP MED HYG, V74, P972, DOI 10.4269/ajtmh.2006.74.972; Kleinschmidt I, 2007, AM J TROP MED HYG, V76, P1027, DOI 10.4269/ajtmh.2007.76.1027; Kleinschmidt I, 2009, AM J TROP MED HYG, V81, P519, DOI 10.4269/ajtmh.2009.81.519; Lee PW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-264; Lee PW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-26; Mabaso MLH, 2004, TROP MED INT HEALTH, V9, P846, DOI 10.1111/j.1365-3156.2004.01263.x; Mboera L E, 2001, Afr J Health Sci, V8, P17; Molineaux L, 2020, GARKI PROJECT RES EP, V8; N'Guessan R, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-44; National Bureau of Statistics (NBS) Tanzania Measure DHS, 2012, TANZ HIV AIDS MAL IN; National Bureau of Statistics (NBS) Tanzania TCfAT Zanzibar AIDS Gommission (ZAG) Office of the Chief Government Statistician (OCGS) Macro Inc, 2008, TANZ HIV AIDS MAL IN; *NBS TANZ, 2005, TANZ DEM HLTH SURV 2; Over M, 2004, AM J TROP MED HYG, V71, P214, DOI 10.4269/ajtmh.2004.71.214; Pardo G, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-10; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Presidents Malaria Initiative, 2009, MAL OP PLAN TANZ FY2; Presidents Malaria Initiative USAID, 2011, PRES MAL IN 5 ANN RE; Protopopoff N, 2013, MALARIA J IN PRESS; Protopopoff N, 2012, AM J TROP MED HYG, P200; Protopopoff N, 2008, AM J TROP MED HYG, V79, P12, DOI 10.4269/ajtmh.2008.79.12; Roll Back Malaria Partnership, 2000, AB DECL PLAN ACT; Rozendaal JA, 1997, HOUSE SPRAYING RESID, P357; Stewart L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006083; Tanzania NBoS, 2006, TANZ CENS 2002 AN RE; Temu EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031409; THOMSON MC, 1994, T ROY SOC TROP MED H, V88, P638, DOI 10.1016/0035-9203(94)90204-6; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; West PA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-273; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2007, MAL EL FEILD MAN LOW; WHO, 2001, IRON DEFICIENCY ANAE; Williams GS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-168; Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770; World Health Organization Global Malaria Programme, 2007, INS TREAT MOSQ NETS; Worrall E, 2005, TROP MED INT HEALTH, V10, P1047, DOI 10.1111/j.1365-3156.2005.01476.x	63	29	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65787	10.1371/journal.pone.0065787	http://dx.doi.org/10.1371/journal.pone.0065787			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762425	gold, Green Published, Green Accepted			2022-12-27	WOS:000321094800071
J	Borssen, M; Palmqvist, L; Karrman, K; Abrahamsson, J; Behrendtz, M; Heldrup, J; Forestier, E; Roos, G; Degerman, S				Borssen, Magnus; Palmqvist, Lars; Karrman, Kristina; Abrahamsson, Jonas; Behrendtz, Mikael; Heldrup, Jesper; Forestier, Erik; Roos, Goran; Degerman, Sofie			Promoter DNA Methylation Pattern Identifies Prognostic Subgroups in Childhood T-Cell Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							POLYCOMB; GENE; CANCER; EXPRESSION; PHENOTYPE; PROTEINS; THERAPY; NOTCH1; LINES	Background: Treatment of pediatric T-cell acute lymphoblastic leukemia (T-ALL) has improved, but there is a considerable fraction of patients experiencing a poor outcome. There is a need for better prognostic markers and aberrant DNA methylation is a candidate in other malignancies, but its potential prognostic significance in T-ALL is hitherto undecided. Design and Methods: Genome wide promoter DNA methylation analysis was performed in pediatric T-ALL samples (n = 43) using arrays covering >27000 CpG sites. Clinical outcome was evaluated in relation to methylation status and compared with a contemporary T-ALL group not tested for methylation (n = 32). Results: Based on CpG island methylator phenotype (CIMP), T-ALL samples were subgrouped as CIMP+ (high methylation) and CIMP- (low methylation). CIMP- T-ALL patients had significantly worse overall and event free survival (p = 0.02 and p = 0.001, respectively) compared to CIMP+ cases. CIMP status was an independent factor for survival in multivariate analysis including age, gender and white blood cell count. Analysis of differently methylated genes in the CIMP subgroups showed an overrepresentation of transcription factors, ligands and polycomb target genes. Conclusions: We identified global promoter methylation profiling as being of relevance for subgrouping and prognostication of pediatric T-ALL.	[Borssen, Magnus; Forestier, Erik; Roos, Goran; Degerman, Sofie] Umea Univ, Dept Med Biosci, Umea, Sweden; [Palmqvist, Lars] Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Clin Chem & Transfus Med, Gothenburg, Sweden; [Karrman, Kristina] Lund Univ, Skane Univ Hosp, Univ & Reg Labs, Dept Clin Genet, Lund, Sweden; [Abrahamsson, Jonas] Sahlgrens Univ Hosp, Dept Pediat, Inst Clin Sci, Gothenburg, Sweden; [Behrendtz, Mikael] Linkoping Univ Hosp, Dept Pediat, S-58185 Linkoping, Sweden; [Heldrup, Jesper] Skane Univ Hosp, Dept Pediat, Lund, Sweden	Umea University; Sahlgrenska University Hospital; University of Gothenburg; Lund University; Skane University Hospital; Sahlgrenska University Hospital; Linkoping University; Lund University; Skane University Hospital	Degerman, S (corresponding author), Umea Univ, Dept Med Biosci, Umea, Sweden.	sofie.degerman@medbio.umu.se	Heldrup, Jesper/AAW-6836-2020; Abrahamsson, Jonas/I-5786-2012	Abrahamsson, Jonas/0000-0002-9240-3522; Heldrup, Jesper/0000-0002-6211-1967; Degerman, Sofie/0000-0002-2783-0712	Swedish Cancer Society; Swedish Research Council; Swedish Childhood Cancer Foundation; Medical Faculty, Umea University; Lion's Cancer Research Foundation, Umea; European Community [200950]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Childhood Cancer Foundation(European Commission); Medical Faculty, Umea University; Lion's Cancer Research Foundation, Umea; European Community(European Commission)	This work was supported by grants from the Swedish Cancer Society (GR), the Swedish Research Council (GR), the Swedish Childhood Cancer Foundation (GR, EF), the Medical Faculty, Umea University (GR) and Lion's Cancer Research Foundation, Umea (SD, MBo, GR). The research leading to these results has received funding from the European Community's Seventh Framework Programme FP7/2007-2011 under grant agreement no. 200950 (GR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecassis I, 2008, LEUKEMIA, V22, P511, DOI 10.1038/sj.leu.2405071; Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Ang PW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-227; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bibikova M, 2011, GENOMICS; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI [10.2217/epi.09.14, 10.2217/EPI.09.14]; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Coustan-Smith E, 2009, LANCET ONCOL, V10, P147, DOI 10.1016/S1470-2045(08)70314-0; Degerman S, 2010, AGING CELL; Deneberg S, 2011, BLOOD, V118, P5573, DOI 10.1182/blood-2011-01-332353; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Gustafsson G, 2000, LEUKEMIA, V14, P2267, DOI 10.1038/sj.leu.2401961; Gutierrez A, 2010, J CLIN ONCOL, V28, P3816, DOI 10.1200/JCO.2010.28.3390; Gutierrez MI, 2003, LEUKEMIA, V17, P1845, DOI 10.1038/sj.leu.2403060; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jung S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052626; Karrman K, 2009, GENE CHROMOSOME CANC, V48, P795, DOI 10.1002/gcc.20684; Kraszewska MD, 2012, LEUKEMIA, V26, P367, DOI 10.1038/leu.2011.208; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lucchi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020785; Ma JX, 2012, MOL BIOL REP, V39, P6095, DOI 10.1007/s11033-011-1424-8; Martin-Perez D, 2010, BLOOD, V116, P5465, DOI 10.1182/blood-2010-05-267096; Martin-Subero JI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006986; Milani L, 2010, BLOOD, V115, P1214, DOI 10.1182/blood-2009-04-214668; Milani L, 2009, GENOME RES, V19, P1, DOI 10.1101/gr.083931.108; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Prasad VVSR, 2011, EUR J PHARM SCI, V43, P217, DOI 10.1016/j.ejps.2011.04.010; Quintas-Cardama A, 2010, NAT REV CLIN ONCOL, V7, P433, DOI 10.1038/nrclinonc.2010.87; Roman-Gomez J, 2006, LEUKEMIA, V20, P1445, DOI 10.1038/sj.leu.2404257; Sanders YY, 2012, AM J RESP CRIT CARE, V186, P525, DOI 10.1164/rccm.201201-0077OC; Sandoval J, 2013, BRIT J HAEMATOL, V160, P406, DOI 10.1111/bjh.12113; Schmiegelow K, 2010, LEUKEMIA, V24, P345, DOI 10.1038/leu.2009.251; Shen LL, 2010, J CLIN ONCOL, V28, P605, DOI 10.1200/JCO.2009.23.4781; Simon C., 2012, GENES DEV; Siwicki JK, 2000, EXP GERONTOL, V35, P375, DOI 10.1016/S0531-5565(00)00088-7; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Van der Auwera I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012616; van Eijk KR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-636; Weisenberger DJ, 2008, NUCLEIC ACIDS RES, V36, P4689, DOI 10.1093/nar/gkn455; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	48	47	50	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65373	10.1371/journal.pone.0065373	http://dx.doi.org/10.1371/journal.pone.0065373			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762353	Green Published, gold, Green Submitted			2022-12-27	WOS:000321099000061
J	Chen, J; Ding, JL; Dai, YM; Xing, W; Sun, J; Zhang, ZS; Xuan, Y; Pilli, V; Haacke, EM; Hu, JN				Chen, Jie; Ding, Jiule; Dai, Yongming; Xing, Wei; Sun, Jun; Zhang, Zishu; Xuan, Yang; Pilli, Vasuki; Haacke, E. Mark; Hu, Jiani			Assessment of Intratumoral Micromorphology for Patients with Clear Cell Renal Cell Carcinoma Using Susceptibility-Weighted Imaging	PLOS ONE			English	Article							RADIOFREQUENCY ABLATION; HISTOLOGIC SUBTYPES; TUMOR ANGIOGENESIS; SIZE; CALCIFICATION; HEMORRHAGE; EXPERIENCE; MANAGEMENT; GLIOMAS; GRADE	Background: Multiple treatment options exist for the management of renal cell carcinomas. Preoperative evaluation of clear cell renal cell carcinoma (CRCC) grades is important for deciding upon the appropriate method of therapy. We hypothesize that susceptibility weighted imaging (SWI) is sensitive enough to detect intratumoral microvessles and microbleeding in renal cell carcinoma, which can be used to grade CRCC. Material and Methods: Retrospective reviews of 37 patients with pathologically proven CRCCs were evaluated. All patients underwent SWI examinations. The characteristics of intratumoral susceptibility signal intensity (ITSS) includes the likelihood of the presence of ITSS, morphology of ITSS, dominant structure of ITSS and ratio of ITSS area to tumor area, which were all assessed on SWI. The results were compared using the nonparametric Mann-Whitney test. Results: ITSS was seen in all patients except 4 patients with low-grade CRCCs. There was no significant difference between low and high-grade CRCCs when looking at the likelihood of the presence of ITSS. There was a significant difference in the mean score of dominant structures between low and high-grade CRCCs. Specifically, more dominant vascular structures and less hemorrhage were seen in low-grade tumors (2.15 +/- 1.05) compared to high-grade tumors (1.27 +/- 0.47) (P<0.005). The ratio of ITSS area to tumor area was also significantly higher for the high-grade group (1.55 +/- 0.52) than that for the low-grade group (0.88 +/- 0.43) on SWI (P<0.005). Conclusion: SWI is useful for grading CRCCs.	[Chen, Jie; Ding, Jiule; Xing, Wei; Sun, Jun] Suzhou Univ, Affiliated Hosp 3, Dept Radiol, Changzhou, Jiangsu, Peoples R China; [Chen, Jie; Xuan, Yang; Pilli, Vasuki; Haacke, E. Mark; Hu, Jiani] Wayne State Univ, Dept Radiol, Detroit, MI USA; [Dai, Yongming] Siemens Healthcare China, MR Collaborat NE Asia, Shanghai, Peoples R China; [Zhang, Zishu] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA	Wayne State University; Siemens AG; University of Michigan System; University of Michigan	Xing, W (corresponding author), Suzhou Univ, Affiliated Hosp 3, Dept Radiol, Changzhou, Jiangsu, Peoples R China.	suzhxingwei@sina.cn; jhu@med.wayne.edu		Chen, Jie/0000-0002-0110-1706				ARONEN HJ, 1994, RADIOLOGY, V191, P41, DOI 10.1148/radiology.191.1.8134596; Breen DJ, 2007, CARDIOVASC INTER RAD, V30, P936, DOI 10.1007/s00270-007-9090-x; Chen DYT, 2009, J NATL COMPR CANC NE, V7, P635, DOI 10.6004/jnccn.2009.0044; Chen W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036454; Dai YM, 2011, J MAGN RESON IMAGING, V34, P318, DOI 10.1002/jmri.22607; Fazekas F, 1999, AM J NEURORADIOL, V20, P637; Ficarra V, 2005, CANCER, V103, P68, DOI 10.1002/cncr.20749; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Gudbjartsson T, 2005, EUR UROL, V48, P593, DOI 10.1016/j.eururo.2005.04.016; Hori M, 2010, MAGN RESON IMAGING, V28, P594, DOI 10.1016/j.mri.2010.01.002; Kinouchi T, 2003, UROLOGY, V62, P765, DOI 10.1016/S0090-4295(03)00512-0; Kitagawa Y, 2011, JPN J CLIN ONCOL, V41, P637, DOI 10.1093/jjco/hyr007; Lam JS, 2009, INDIAN J UROL, V25, P446, DOI 10.4103/0970-1591.57906; Li XS, 2012, J CANCER RES CLIN, V138, P269, DOI 10.1007/s00432-011-1083-0; Nativ O, 1998, UROLOGY, V51, P693, DOI 10.1016/S0090-4295(98)00019-3; Pahernik S, 2007, J UROLOGY, V178, P414, DOI 10.1016/j.juro.2007.03.129; Park MJ, 2009, AM J NEURORADIOL, V30, P1402, DOI 10.3174/ajnr.A1593; Patard JJ, 2005, J CLIN ONCOL, V23, P2763, DOI 10.1200/JCO.2005.07.055; RECHT L, 1990, J NEUROSURG, V72, P941, DOI 10.3171/jns.1990.72.6.0941; Schachter LR, 2007, J ENDOUROL, V21, P819, DOI 10.1089/end.2006.9937; Song TR, 2012, UROL ANNALS, V4, P24, DOI 10.4103/0974-7796.91617; Sung HH, 2012, INT J HYPERTHER, V28, P227, DOI 10.3109/02656736.2012.666319; Thompson RH, 2009, J UROLOGY, V181, P2033, DOI 10.1016/j.juro.2009.01.027; Wu Z, 2009, J MAGN RESON IMAGING, V29, P177, DOI 10.1002/jmri.21617; Xing W, 2012, PLOS ONE, V8; Zhang C, 2012, BJU INT; Zhu WZ, 2008, CHINESE MED J-PEKING, V121, P2021, DOI 10.1097/00029330-200810020-00014	27	2	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65866	10.1371/journal.pone.0065866	http://dx.doi.org/10.1371/journal.pone.0065866			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755287	Green Submitted, gold, Green Published			2022-12-27	WOS:000321099000114
J	Hou, L; Kongsted, AH; Ghoreishi, SM; Takhtsabzy, TK; Friedrichsen, M; Hellgren, LI; Kadarmideen, HN; Vaag, A; Nielsen, MO				Hou, Lei; Kongsted, Anna H.; Ghoreishi, Seyed M.; Takhtsabzy, Tasnim K.; Friedrichsen, Martin; Hellgren, Lars I.; Kadarmideen, Haja N.; Vaag, Allan; Nielsen, Mette O.			Pre- and Early-Postnatal Nutrition Modify Gene and Protein Expressions of Muscle Energy Metabolism Markers and Phospholipid Fatty Acid Composition in a Muscle Type Specific Manner in Sheep	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; SKELETAL-MUSCLE; INSULIN-RESISTANCE; LATE-GESTATION; NUTRIENT RESTRICTION; GROWTH VELOCITY; ADIPOSE-TISSUE; OBESE SUBJECTS; PGC-1-ALPHA; HUMANS	We previously reported that undernutrition in late fetal life reduced whole-body insulin sensitivity in adult sheep, irrespective of dietary exposure in early postnatal life. Skeletal muscle may play an important role in control of insulin action. We therefore studied a range of putative key muscle determinants of insulin signalling in two types of skeletal muscles (longissimus dorsi (LD) and biceps femoris (BF)) and in the cardiac muscle (ventriculus sinister cordis (VSC)) of sheep from the same experiment. Twin-bearing ewes were fed either 100% (NORM) or 50% (LOW) of their energy and protein requirements during the last trimester of gestation. From day-3 postpartum to 6-months of age (around puberty), twin offspring received a high-carbohydrate-high-fat (HCHF) or a moderate-conventional (CONV) diet, whereafter all males were slaughtered. Females were subsequently raised on a moderate diet and slaughtered at 2-years of age (young adults). The only long-term consequences of fetal undernutrition observed in adult offspring were lower expressions of the insulin responsive glucose transporter 4 (GLUT4) protein and peroxisome proliferator-activated receptor gamma, coactivator 1 alpha (PGC1 alpha) mRNA in BF, but increased PGC1a expression in VSC. Interestingly, the HCHF diet in early postnatal life was associated with somewhat paradoxically increased expressions in LD of a range of genes (but not proteins) related to glucose uptake, insulin signalling and fatty acid oxidation. Except for fatty acid oxidation genes, these changes persisted into adulthood. No persistent expression changes were observed in BF and VSC. The HCHF diet increased phospholipid ratios of n-6/n-3 polyunsaturated fatty acids in all muscles, even in adults fed identical diets for 11/2 years. In conclusion, early postnatal, but not late gestation, nutrition had long-term consequences for a number of determinants of insulin action and metabolism in LD. Tissues other than muscle may account for reduced whole body insulin sensitivity in adult LOW sheep.	[Hou, Lei; Kongsted, Anna H.; Kadarmideen, Haja N.; Nielsen, Mette O.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, Frederiksberg, Denmark; [Takhtsabzy, Tasnim K.; Hellgren, Lars I.] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Friedrichsen, Martin; Vaag, Allan] Rigshosp, Dept Endocrinol, DK-2100 Copenhagen, Denmark; [Friedrichsen, Martin] Univ Copenhagen, August Krogh Ctr, Dept Nutr Exercise & Sports, Copenhagen, Denmark; [Ghoreishi, Seyed M.] Univ Jiroft, Dept Anim Sci, Jiroft, Iran; [Hou, Lei; Kongsted, Anna H.; Hellgren, Lars I.; Vaag, Allan; Nielsen, Mette O.] Ctr Fetal Programming, Copenhagen, Denmark	University of Copenhagen; Technical University of Denmark; Rigshospitalet; University of Copenhagen; University of Copenhagen	Nielsen, MO (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, Frederiksberg, Denmark.	mette.olaf.nielsen@sund.ku.dk	Friedrichsen, Martin/A-3638-2015; Hellgren, Lars/B-5137-2010; Nielsen, Mette O/I-5822-2012; Biguzzi, Felipe A/E-4724-2015	Friedrichsen, Martin/0000-0003-3383-9593; Hellgren, Lars/0000-0001-9215-4880; hou, lei/0000-0002-3030-5329; Kadarmideen, Haja/0000-0001-6294-382X; Ghoreishi, SeyedMehdi/0000-0002-6417-0848; Vaag, Allan Arthur/0000-0002-3690-2191; Kongsted, Anna/0000-0003-1959-8308	Danish Strategic Research Council [09-059921, 09-067124]; Steno Diabetes Center through Research School of Animal Nutrition, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark	Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Steno Diabetes Center through Research School of Animal Nutrition, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark	This study is supported by Danish Strategic Research Council Grant no. 09-059921 and 09-067124, and Steno Diabetes Center through Research School of Animal Nutrition, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/476279; Andersson A, 2002, AM J CLIN NUTR, V76, P1222, DOI 10.1093/ajcn/76.6.1222; Armitage JA, 2004, J PHYSIOL-LONDON, V561, P355, DOI 10.1113/jphysiol.2004.072009; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Bispham J, 2005, ENDOCRINOLOGY, V146, P3943, DOI 10.1210/en.2005-0246; Blachnio-Zabielska A, 2010, J CELL PHYSIOL, V225, P786, DOI 10.1002/jcp.22283; Borsting CF, 2003, KVAEGETS ERNAERING F; Brons C, 2010, J CLIN ENDOCR METAB, V95, P3048, DOI 10.1210/jc.2009-2413; Buhl ES, 2010, AM J PHYSIOL-ENDOC M, V298, pE920, DOI 10.1152/ajpendo.00606.2009; Burrage DM, 2009, J PHYSIOL-LONDON, V587, P611, DOI 10.1113/jphysiol.2008.165944; Chan LLY, 2009, AM J PHYSIOL-REG I, V296, pR1455, DOI 10.1152/ajpregu.91019.2008; Costello PM, 2008, J PHYSIOL-LONDON, V586, P2371, DOI 10.1113/jphysiol.2008.150987; Drachmann T, 2007, EUR J LIPID SCI TECH, V109, P1003, DOI 10.1002/ejlt.200600240; FOLCH J, 1957, J BIOL CHEM, V226, P497; Friedrichsen M, 2010, J CLIN ENDOCR METAB, V95, P414, DOI 10.1210/jc.2009-1147; GORSKI J, 1986, AM J PHYSIOL, V250, pE441, DOI 10.1152/ajpendo.1986.250.4.E441; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Haugaard SB, 2008, EUR J CLIN INVEST, V38, P494, DOI 10.1111/j.1365-2362.2008.01969.x; Haugaard SB, 2010, INT J OBESITY, V34, P500, DOI 10.1038/ijo.2009.264; Haugaard SB, 2006, CLIN ENDOCRINOL, V64, P169, DOI 10.1111/j.1365-2265.2006.02444.x; Huber K, 2009, ENDOCRINOLOGY, V150, P4135, DOI 10.1210/en.2009-0125; Hulbert AJ, 2005, BIOL REV, V80, P155, DOI 10.1017/S1464793104006578; Husted SM, 2007, AM J PHYSIOL-ENDOC M, V293, pE548, DOI 10.1152/ajpendo.00441.2006; Jaquet D, 2001, J CLIN ENDOCR METAB, V86, P3266, DOI 10.1210/jc.86.7.3266; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jorgensen W, 2009, AM J PHYSIOL-ENDOC M, V297, pE1349, DOI 10.1152/ajpendo.00505.2009; Kadarmideen HN, 2008, IET SYST BIOL, V2, P423, DOI 10.1049/iet-syb:20070072; Kadarmideen HN, 2007, PHYSIOL GENOMICS, V29, P57, DOI 10.1152/physiolgenomics.00144.2006; Kongsted AH, 2014, ACTA PHYSIOL, V210, P84, DOI 10.1111/apha.12080; Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Ling C, 2004, J CLIN INVEST, V114, P1518, DOI 10.1172/JCI200421889; LUCAS A, 1991, CIBA F SYMP, V156, P38; Marotta M, 2004, METABOLISM, V53, P1032, DOI 10.1016/j.metabol.2004.03.011; McLennan PL, 2007, J CARDIOVASC MED, V8, pS15, DOI 10.2459/01.JCM.0000289272.87803.ce; McMillen IC, 2009, ADV EXP MED BIOL, V646, P71, DOI 10.1007/978-1-4020-9173-5_8; Morrison JL, 2008, CLIN EXP PHARMACOL P, V35, P730, DOI 10.1111/j.1440-1681.2008.04975.x; Muhlhausler BS, 2009, ENDOCRINOLOGY, V150, P4287, DOI 10.1210/en.2009-0462; Nielsen MO, 2013, BRIT J NUTR, V109, P2098, DOI 10.1017/S0007114512004199; Norrbom J, 2004, J APPL PHYSIOL, V96, P189, DOI 10.1152/japplphysiol.00765.2003; Ozanne SE, 2005, DIABETOLOGIA, V48, P547, DOI 10.1007/s00125-005-1669-7; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Perseghin G, 1999, DIABETES, V48, P1600, DOI 10.2337/diabetes.48.8.1600; Pilgaard K, 2011, J CLIN ENDOCR METAB, V96, P2835, DOI 10.1210/jc.2011-0577; Price ER, 2009, AM J PHYSIOL-REG I, V297, pR775, DOI 10.1152/ajpregu.00150.2009; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; ROSS JJ, 1987, DEVELOPMENT, V100, P383; Rozen S, 2000, Methods Mol Biol, V132, P365; Safayi S, 2010, J DAIRY SCI, V93, P203, DOI 10.3168/jds.2009-2507; Sebert SP, 2010, REPRODUCTION, V139, P265, DOI 10.1530/REP-09-0173; Shortreed KE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007293; TOMANEK RJ, 1977, AM J ANAT, V149, P227, DOI 10.1002/aja.1001490207; Tygesen MP, 2008, ARCH ANIM NUTR, V62, P44, DOI 10.1080/17450390701780276; Valencak TG, 2011, J COMP PHYSIOL B, V181, P289, DOI 10.1007/s00360-010-0520-8; Vielwerth SE, 2008, DIABETOLOGIA, V51, P1483, DOI 10.1007/s00125-008-1037-5; WILSON SJ, 1992, J MUSCLE RES CELL M, V13, P534, DOI 10.1007/BF01737996	56	9	10	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65452	10.1371/journal.pone.0065452	http://dx.doi.org/10.1371/journal.pone.0065452			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755234	Green Published, gold, Green Submitted			2022-12-27	WOS:000321099000069
J	Lecocq, T; Vereecken, NJ; Michez, D; Dellicour, S; Lhomme, P; Valterova, I; Rasplus, JY; Rasmont, P				Lecocq, Thomas; Vereecken, Nicolas J.; Michez, Denis; Dellicour, Simon; Lhomme, Patrick; Valterova, Irena; Rasplus, Jean-Yves; Rasmont, Pierre			Patterns of Genetic and Reproductive Traits Differentiation in Mainland vs. Corsican Populations of Bumblebees	PLOS ONE			English	Article							SEX-PHEROMONE COMPONENTS; LABIAL GLAND SECRETIONS; BOMBUS-TERRESTRIS; ISLAND POPULATIONS; PHYLOGENETIC-RELATIONSHIPS; INTRASPECIFIC VARIATION; MATING PREFERENCES; JUVENILE-HORMONE; MATE RECOGNITION; TRUE ARMYWORM	Populations on islands often exhibit lower levels of genetic variation and ecomorphological divergence compared to their mainland relatives. While phenotypic differentiation in characters, such as size or shape among insular organisms, has been well studied, insular differentiation in quantitative reproductive traits involved in chemical communication has received very little attention to date. Here, we investigated the impact of insularity on two syntopic bumblebee species pairs: one including species that are phylogenetically related (Bombus terrestris and B. lucorum), and the other including species that interact ecologically (B. terrestris and its specific nest inquiline B. vestalis). For each bumblebee species, we characterized the patterns of variation and differentiation of insular (Corsican) vs. mainland (European) populations (i) with four genes (nuclear and mitochondrial, 3781 bp) and (ii) in the chemical composition of male marking secretions (MMS), a key trait for mate attraction in bumblebees, by gas chromatography-mass spectrometry (GC-MS). Our results provide evidence for genetic differentiation in Corsican bumblebees and show that, contrary to theoretical expectations, island populations of bumblebees exhibit levels of genetic variation similar to the mainland populations. Likewise, our comparative chemical analyses of MMS indicate that Corsican populations of bumblebees are significantly differentiated from the mainland yet they hold comparative levels of within-population MMS variability compared to the mainland. Therefore, insularity has led Corsican populations to diverge both genetically and chemically from their mainland relatives, presumably through genetic drift, but without a decrease of genetic diversity in island populations. We hypothesize that MMS divergence in Corsican bumblebees was driven by a persistent lack of gene flow with mainland populations and reinforced by the preference of Corsican females for sympatric (Corsican) MMS. The impoverished Corsican bumblebee fauna has not led to relaxation of stabilizing selection on MMS but to consistent differentiation chemical reproductive traits on the island.	[Lecocq, Thomas; Michez, Denis; Lhomme, Patrick; Rasmont, Pierre] Univ Mons, Zool Lab, B-7000 Mons, Belgium; [Vereecken, Nicolas J.; Dellicour, Simon] Univ Libre Bruxelles, Brussels, Belgium; [Valterova, Irena] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic; [Rasplus, Jean-Yves] INRA, UMR Ctr Biol Gest Populat, Montferrier Sur Lez, France	University of Mons; Universite Libre de Bruxelles; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; INRAE; Institut de Recherche pour le Developpement (IRD)	Lecocq, T (corresponding author), Univ Mons, Zool Lab, B-7000 Mons, Belgium.	thomas.lecocq@umons.ac.be	Rasplus, Jean-Yves/O-2873-2017; Lhomme, Patrick/AFN-5332-2022; Lhomme, Patrick/M-6395-2014; Michez, Denis/L-1370-2019; Dellicour, Simon/AAE-9054-2020	Rasplus, Jean-Yves/0000-0001-8614-6665; Lhomme, Patrick/0000-0001-6735-9104; Lhomme, Patrick/0000-0001-6735-9104; Michez, Denis/0000-0001-8880-1838; Dellicour, Simon/0000-0001-9558-1052; Vereecken, Nicolas/0000-0002-8858-4623; Lecocq, Thomas/0000-0002-4947-0332; Valterova, Irena/0000-0001-5723-6143	Fonds pour la recherche dans l'industrie et l'agriculture (FRIA); Fonds national pour la recherche scientifique (FRS-FNRS); Fonds pour la Formation a la Recherche Fondamentale et Collective (FNRS) [FRFC 2.4613.10]; Office de l'Environnement de la Corse; Direction Regionale de l'Environnement de Corse; Academy of Sciences of the Czech Republic [RVO: 61388963]; network Bibliotheque du Vivant; CNRS; Museum National d'Histoire Naturelle; Institut National de la recherche en Agronomie; FRIA; FRS-FNRS (Belgium)	Fonds pour la recherche dans l'industrie et l'agriculture (FRIA)(Fonds de la Recherche Scientifique - FNRS); Fonds national pour la recherche scientifique (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); Fonds pour la Formation a la Recherche Fondamentale et Collective (FNRS)(Fonds de la Recherche Scientifique - FNRS); Office de l'Environnement de la Corse(Region Corse); Direction Regionale de l'Environnement de Corse; Academy of Sciences of the Czech Republic(Czech Academy of Sciences); network Bibliotheque du Vivant; CNRS(Centre National de la Recherche Scientifique (CNRS)); Museum National d'Histoire Naturelle; Institut National de la recherche en Agronomie; FRIA(Fonds de la Recherche Scientifique - FNRS); FRS-FNRS (Belgium)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the Fonds pour la recherche dans l'industrie et l'agriculture (FRIA), the Fonds national pour la recherche scientifique (FRS-FNRS), the Fonds pour la Formation a la Recherche Fondamentale et Collective (FNRS, FRFC 2.4613.10), the Office de l'Environnement de la Corse, the Direction Regionale de l'Environnement de Corse, the Academy of Sciences of the Czech Republic (subvention for development of research organization RVO: 61388963), the network Bibliotheque du Vivant funded by the CNRS, the Museum National d'Histoire Naturelle and the Institut National de la recherche en Agronomie, and technically supported by the Genoscope. TL, PL and SD are FRIA grant holders. NJV received financial support from the FRS-FNRS (Belgium) through a post-doctoral grant (2008-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER GH, 1994, Q REV BIOL, V69, P473, DOI 10.1086/418744; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Andersson Malte, 1994; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Ayasse M, 2001, ANNU REV ENTOMOL, V46, P31, DOI 10.1146/annurev.ento.46.1.31; Baer B, 2003, BEHAV ECOL SOCIOBIOL, V54, P521, DOI 10.1007/s00265-003-0673-5; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beheregaray LB, 2003, CONSERV GENET, V4, P31, DOI 10.1023/A:1021864214375; Bergman P, 1997, CHEM COMMUNICATION B, P26; Bergstrom G., 1981, Biosystematics of social insects, P175; Bisconti R, 2011, BIOL J LINN SOC, V103, P159, DOI 10.1111/j.1095-8312.2011.01643.x; Blondel J, 2000, VIE MILIEU, V50, P205; Blondel J, 2010, MEDITERRANEAN REGION; Blondel J., 1995, BIOGEOGRAPHIE APPROC; Blyth JE, 2008, ETHOLOGY, V114, P728, DOI 10.1111/j.1439-0310.2008.01519.x; Boake CRB, 2002, GENETICA, V116, P205, DOI 10.1023/A:1021224207727; Bossio A, 2000, ATTIVITA SCI U PISA, P87; BOURSOT P, 1986, GENET SEL EVOL, V18, P73, DOI 10.1186/1297-9686-18-1-73; Burger R, 2006, EVOLUTION, V60, P2185; Cameron SA, 2007, BIOL J LINN SOC, V91, P161, DOI 10.1111/j.1095-8312.2007.00784.x; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; CARLQUIST S, 1974, P660; Carolan JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029251; CARSON HL, 1984, ANNU REV ECOL SYST, V15, P97, DOI 10.1146/annurev.es.15.110184.000525; CLEARWATER JR, 1991, J CHEM ECOL, V17, P413, DOI 10.1007/BF00994342; Clegg SM, 2002, P ROY SOC B-BIOL SCI, V269, P1359, DOI 10.1098/rspb.2002.2024; Cody ML, 2006, PLANTS ON ISLANDS: DIVERSITY AND DYNAMICS ON A CONTINENTAL ARCHIPELAGO, P1, DOI 10.1525/california/9780520247291.001.0001; CONOVER DO, 1995, TRENDS ECOL EVOL, V10, P248, DOI 10.1016/S0169-5347(00)89081-3; COOK JM, 1995, TRENDS ECOL EVOL, V10, P281, DOI 10.1016/0169-5347(95)90011-X; Coppee A, 2010, BOMBUS TERRESTRIS L; Coppee A, 2008, CHEM BIODIVERS, V5, P2654, DOI 10.1002/cbdv.200890219; Covas R, 2012, P ROY SOC B-BIOL SCI, V279, P1531, DOI 10.1098/rspb.2011.1785; Coyne J.A., 2004, SPECIATION; Damgaard J, 2005, INSECT SYST EVOL, V36, P395, DOI 10.1163/187631205788838537; Danforth BN, 1999, SYST ENTOMOL, V24, P377, DOI 10.1046/j.1365-3113.1999.00087.x; Dapporto L, 2010, BIOL J LINN SOC, V100, P195, DOI 10.1111/j.1095-8312.2010.01434.x; de Bellocq JG, 2003, PARASITOL RES, V90, P64, DOI 10.1007/s00436-002-0806-1; De Meulemeester T, 2011, INSECT SOC, V58, P227, DOI 10.1007/s00040-011-0146-1; Estoup A, 1996, MOL ECOL, V5, P19, DOI 10.1111/j.1365-294X.1996.tb00288.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Ferton C, 1901, COMPTES RENDUS IAFAS; Forchler MI, 2007, J BIOGEOGR, V34, P1591, DOI 10.1111/j.1365-2699.2007.01722.x; FOSTER JB, 1964, NATURE, V202, P234, DOI 10.1038/202234a0; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; Frankham R., 2002, INTRO CONSERVATION G, DOI 10.1017/CBO9780511808999; Friese H, 1904, ZOOL JB            S, V7, P551; Gee JM, 2005, INTEGR COMP BIOL, V45, P1000; GERHARDT HC, 1991, ANIM BEHAV, V42, P615, DOI 10.1016/S0003-3472(05)80245-3; Goulson D, 2011, CONSERV GENET, V12, P867, DOI 10.1007/s10592-011-0190-4; GOULSON D, 2003, BUMBLEBEES THEIR BEH; Grant BR, 1996, EVOLUTION, V50, P2471, DOI 10.1111/j.1558-5646.1996.tb03633.x; GRANT P. R., 1965, SYST ZOOL, V14, P47, DOI 10.2307/2411902; Grant PR, 1998, EVOLUTION ISLANDS; Grill A, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P273, DOI 10.1007/1-4020-4904-8_10; Groot AT, 2006, P NATL ACAD SCI USA, V103, P5858, DOI 10.1073/pnas.0508609103; HALKKA O, 1974, HEREDITAS, V78, P73; HANSSON BS, 1990, J CHEM ECOL, V16, P1611, DOI 10.1007/BF01014094; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hille SM, 2003, MOL ECOL, V12, P2145, DOI 10.1046/j.1365-294X.2003.01891.x; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hines HM, 2006, INVERTEBR SYST, V20, P289, DOI 10.1071/IS05028; Hinten G, 2003, CONSERV GENET, V4, P759, DOI 10.1023/B:COGE.0000006113.58749.ac; Hochberg ME, 2001, J EVOLUTION BIOL, V14, P539, DOI 10.1046/j.1420-9101.2001.00312.x; Hsieh HY, 2012, ECOL EVOL, V2, P2181, DOI 10.1002/ece3.322; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; Hulva P, 2007, FOLIA ZOOL, V56, P378; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Ings TC, 2005, ENTOMOL GEN, V28, P233; JAMES FC, 1983, SCIENCE, V221, P184, DOI 10.1126/science.221.4606.184; JEANMONOD D., 2007, FLORA CORSICA; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Johnstone RA, 1996, PHILOS T R SOC B, V351, P329, DOI 10.1098/rstb.1996.0026; Jonghe de R, 1986, PHEGEA, V14, P19; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kawakita A, 2004, MOL PHYLOGENET EVOL, V31, P799, DOI 10.1016/j.ympev.2003.12.003; Kawazu K, 2005, APPL ENTOMOL ZOOL, V40, P483, DOI 10.1303/aez.2005.483; Kirkpatrick M, 2002, AM NAT, V159, pS22, DOI 10.1086/338370; Knopp T, 2007, CONSERV GENET, V8, P45, DOI 10.1007/s10592-006-9147-4; Kodric-Brown A, 2001, BEHAV ECOL SOCIOBIOL, V50, P346, DOI 10.1007/s002650100374; Kraus FB, 2009, J ANIM ECOL, V78, P247, DOI 10.1111/j.1365-2656.2008.01479.x; Kreuter K, 2012, BEHAV ECOL SOCIOBIOL, V66, P475, DOI 10.1007/s00265-011-1294-z; Krieger GM, 2006, J CHEM ECOL, V32, P453, DOI 10.1007/s10886-005-9013-8; KULLENBERG B, 1973, ZOON Supplement, P23; Laenen B, 2011, J BIOGEOGR, V38, P631, DOI 10.1111/j.1365-2699.2010.02440.x; Lecocq T, 2011, SYST ENTOMOL, V36, P453, DOI 10.1111/j.1365-3113.2011.00576.x; Lepais O, 2010, MOL ECOL, V19, P819, DOI 10.1111/j.1365-294X.2009.04500.x; Lhomme P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043053; LOFSTEDT C, 1993, PHILOS T R SOC B, V340, P167, DOI 10.1098/rstb.1993.0055; LOFSTEDT C, 1986, OIKOS, V46, P250, DOI 10.2307/3565474; LOFSTEDT C, 1990, ENTOMOL EXP APPL, V54, P199, DOI 10.1007/BF00186789; LOFTUSHILLS JJ, 1992, EVOLUTION, V46, P896, DOI 10.1111/j.1558-5646.1992.tb00607.x; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; MacArthur R.H., 1967, THEORY ISLAND BIOGEO; Maddison WP, 2019, MESQUITE MODULAR SYS; Mardulyn P, 2009, EVOLUTION, V63, P2717, DOI 10.1111/j.1558-5646.2009.00755.x; Martens Jochen, 1996, P221; Mayr E., 1942, P1; McFrederick QS, 2009, OECOLOGIA, V160, P411, DOI 10.1007/s00442-009-1318-9; McNeil JN, 1996, ARCH INSECT BIOCHEM, V32, P575, DOI 10.1002/(SICI)1520-6327(1996)32:3/4&lt;575::AID-ARCH29&gt;3.0.CO;2-8; McNeil JN, 2000, PHYSIOL ENTOMOL, V25, P103, DOI 10.1046/j.1365-3032.2000.00171.x; Medail F, 1997, ANN MO BOT GARD, V84, P112, DOI 10.2307/2399957; Medail F, 2009, J BIOGEOGR, V36, P1333, DOI 10.1111/j.1365-2699.2008.02051.x; Mutun S, 2011, TURK J ZOOL, V35, P559, DOI 10.3906/zoo-1003-150; NEI M, 1983, GENETICS, V105, P207; Nei M., 1987, MOL EVOLUTIONARY GEN; Nieberding C, 2006, J BIOGEOGR, V33, P1212, DOI 10.1111/j.1365-2699.2006.01503.x; NILSON G, 1981, ZOOL J LINN SOC-LOND, V72, P355, DOI 10.1111/j.1096-3642.1981.tb01576.x; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pasquet E, 1997, IBIS, V139, P679, DOI 10.1111/j.1474-919X.1997.tb04691.x; Paterson H.E.H., 1993, EVOLUTION RECOGNITIO; Patricelli GL, 2003, P ROY SOC B-BIOL SCI, V270, P2389, DOI 10.1098/rspb.2003.2530; Pedersen BV, 2002, INSECT SYST EVOL, V33, P361, DOI 10.1163/187631202X00208; Phillimore AB, 2008, MOL ECOL, V17, P2839, DOI 10.1111/j.1365-294X.2008.03794.x; POPOV V. B., 1931, EOS, V7, P131; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Quammen David, 1996, P1; R Core Team, 2021, R LANGUAGE ENV STAT; Radoszkowski O., 1884, B MOSKOVSKOGO OBSHCH, V59, P51; Raia P, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-289; Rambaut A., 2007, TRACER V1 4; Rasmont P, 2005, APIDOLOGIE, V36, P571, DOI 10.1051/apido:2005047; RASMONT P, 1996, NOTES FAUNIQUES GEMB, V31, P1; Rasmont P, 2008, ANN SOC ENTOMOL FR, V44, P243, DOI 10.1080/00379271.2008.10697559; ROELOFS WL, 1982, ANNU REV ECOL SYST, V13, P395, DOI 10.1146/annurev.es.13.110182.002143; Roelofs WL, 2002, P NATL ACAD SCI USA, V99, P13621, DOI 10.1073/pnas.152445399; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 1997, COMPUT APPL BIOSCI, V13, P307; Salvi D, 2010, MOL PHYLOGENET EVOL, V56, P690, DOI 10.1016/j.ympev.2010.03.017; Segraves Kari A., 2010, Evolution Education and Outreach, V3, P62; Shao ZY, 2004, J HERED, V95, P46, DOI 10.1093/jhered/esh008; Shaw KL, 2002, AM NAT, V159, pS61, DOI 10.1086/338373; SIMMONS LW, 1989, ANIM BEHAV, V38, P68, DOI 10.1016/S0003-3472(89)80066-1; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Smith CI, 2008, P ROY SOC B-BIOL SCI, V275, P249, DOI 10.1098/rspb.2007.1405; STOWE MK, 1995, P NATL ACAD SCI USA, V92, P23, DOI 10.1073/pnas.92.1.23; Suzuki R, 2011, PVCLUST HIERARCHICAL; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Symonds MRE, 2009, BIOL J LINN SOC, V97, P594, DOI 10.1111/j.1095-8312.2009.01245.x; Symonds MRE, 2004, P ROY SOC B-BIOL SCI, V271, P839, DOI 10.1098/rspb.2003.2647; Takanashi T, 2005, BIOL J LINN SOC, V84, P143, DOI 10.1111/j.1095-8312.2005.00421.x; TEMPLETON AR, 1980, GENETICS, V94, P1011; Terzo M, 2005, APIDOLOGIE, V36, P85, DOI 10.1051/apido:2004072; Terzo M, 2007, CHEM BIODIVERS, V4, P1466, DOI 10.1002/cbdv.200790124; Thompson JD., 1994, COEVOLUTIONARY PROCE; Thompson JD, 2005, PLANT EVOLUTION MEDI; TOTH M, 1992, J CHEM ECOL, V18, P1337, DOI 10.1007/BF00994360; Urbanova K, 2004, BIOCHEM SYST ECOL, V32, P1025, DOI 10.1016/j.bse.2004.02.010; Urbanova K, 2001, EUR J ENTOMOL, V98, P111, DOI 10.14411/eje.2001.017; van den Eijnde J., 2000, Proceedings of the Section Experimental and Applied Entomology of the Netherlands Entomological Society (N.E.V.), V11, P159; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Velthuis HHW, 2002, POLLINATING BEES CON; Vereecken NJ, 2007, BEHAV ECOL SOCIOBIOL, V61, P811, DOI 10.1007/s00265-006-0312-z; Vogt O., 1909, SITZUNGSBERICHTE GES, V1909, P28; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY, V2nd; Whittaker RJ, 1998, ISLAND BIOGEOGRAPHY; Wickler W, 1986, DIALEKTE TIERREICH I; Wilcox TP, 2002, MOL PHYLOGENET EVOL, V25, P361, DOI 10.1016/S1055-7903(02)00244-0; Williams Paul H., 1998, Bulletin of the Natural History Museum Entomology Series, V67, P79; WILLIAMS PH, 1985, SYST ENTOMOL, V10, P239, DOI 10.1111/j.1365-3113.1985.tb00529.x; Wong BBM, 2004, J EVOLUTION BIOL, V17, P701, DOI 10.1046/j.1420-9101.2003.00651.x; WRIGHT S, 1951, ANN EUGENIC, V15, P323; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356; Wyatt T. D., 2003, PHEROMONES ANIMAL BE, DOI 10.1017/CBO9780511615061; Zacek P, 2013, CHEMBIOCHEM, V14, P361, DOI 10.1002/cbic.201200684; Zacek P, 2009, J CHEM ECOL, V35, P698, DOI 10.1007/s10886-009-9650-4; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhu JW, 1997, J INSECT BEHAV, V10, P805, DOI 10.1023/B:JOIR.0000010414.28494.9a; Zimma BO, 2003, J COMP PHYSIOL A, V189, P769, DOI 10.1007/s00359-003-0451-x; Zwickl D. J, 2006, GENETIC ALGORITHM AP	175	64	66	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65642	10.1371/journal.pone.0065642	http://dx.doi.org/10.1371/journal.pone.0065642			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755263	gold, Green Published, Green Submitted			2022-12-27	WOS:000321099000085
J	Mandal, P; Bhattacharjee, B; Das Ghosh, D; Mondal, NR; Chowdhury, RR; Roy, S; Sengupta, S				Mandal, Paramita; Bhattacharjee, Bornali; Das Ghosh, Damayanti; Mondal, Nidhu Ranjan; Chowdhury, Rahul Roy; Roy, Sudipta; Sengupta, Sharmila			Differential Expression of HPV16 L2 Gene in Cervical Cancers Harboring Episomal HPV16 Genomes: Influence of Synonymous and Non-Coding Region Variations	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; MESSENGER-RNAS; CAPSID PROTEIN; INDIAN WOMEN; PREVALENCE; INFECTION; IDENTIFICATION; CARCINOMA; MICRORNAS; E2	We tested the hypothesis that (i) synonymous variations within the coding regions, and (ii) variations within the non-coding regions of HPV, influence cervical cancer (CaCx) pathogenesis under the impact of intact HPV16 genomes. Whole genome sequence analysis of HPV16 isolates within 70 CaCx cases and 25 non-malignant samples revealed that synonymous variations were significantly higher within the E6 (p = 0.014), E5 (p = 0.001) and L2 (p = 0.0002) genes of HPV16 isolates within cases, compared to isolates within non-malignant samples. All of the 25 (100%) humanized codons identified within L2 ORF of the samples analyzed, were harbored by CaCx cases, while 8 out of 25 (32%) were harbored by HPV16 positive non-malignant samples (p = 3.87105E-07). L2 (mRNA and protein) expression was evident only among cases with episomal viral genomes and L2 mRNA expression correlated significantly with E2 gene copy numbers suggesting expression from all episomal genomes. Among such cases, Asian American (AA) isolates portrayed all of the humanized codons (100%; 4-6/sample) recorded within L2, which was significantly higher (p = 2.02E-7) compared to the European (E) isolates (22.8%; none or 1-2/sample). Additionally, majority of E variant isolates within cases (54/57; 94.7%) portrayed a variation (T4228C) within the short non-coding region (NCR2) between E5 and L2 genes, which portrays a weak promoter activity specific for L2 mRNA expression. This resulted in loss of 9 out of 14 miRNA binding sites (hsa-miR-548 family), despite the significant overexpression of miR548a-5p and miR548d-5p among such cases (28.64 and 36.25 folds, respectively), in comparison to HPV negative control samples. The findings exemplify the biological relevance of sequence variations in HPV16 genomes and highlight that episomal HPV16 in CaCx cases employ multiple mechanisms to sustain L2 expression, thereby justifying the potential role of L2 in such cancers, as opposed to those harboring viral integration.	[Mandal, Paramita; Sengupta, Sharmila] Natl Inst Biomed Genom, Kalyani, W Bengal, India; [Bhattacharjee, Bornali; Das Ghosh, Damayanti] Indian Stat Inst, Human Genet Unit, Kolkata, India; [Mondal, Nidhu Ranjan; Chowdhury, Rahul Roy] Saroj Gupta Canc Ctr & Res Inst, Dept Gynecol, Kolkata, India; [Roy, Sudipta] Kothari Med Ctr, Dept Pathol, Kolkata, India	Department of Biotechnology (DBT) India; National Institute of Biomedical Genomics (NIBMG); Indian Statistical Institute; Indian Statistical Institute Kolkata	Sengupta, S (corresponding author), Natl Inst Biomed Genom, Kalyani, W Bengal, India.	ssg1@nibmg.ac.in	Mandal, Paramita/ABC-3253-2021	Bhattacharjee, Bornali/0000-0002-0801-1543; MANDAL, PARAMITA/0000-0001-9971-342X; Roy Chowdhury, Rahul/0000-0002-4124-1017	Department of Biotechnology, Government of India [BT/PR8014/Med/14/1220/2006]; Indian Statistical Institute; National Institute of Biomedical Genomics	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Indian Statistical Institute; National Institute of Biomedical Genomics	This work was supported partially by Department of Biotechnology (Grant No. BT/PR8014/Med/14/1220/2006), Government of India, and partially by Indian Statistical Institute (Intramural), and National Institute of Biomedical Genomics (Core Grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER CC, 1987, EMBO J, V6, P1027, DOI 10.1002/j.1460-2075.1987.tb04855.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharjee B, 2006, GYNECOL ONCOL, V100, P372, DOI 10.1016/j.ygyno.2005.09.016; Bhattacharjee B, 2008, VIROLOGY, V377, P143, DOI 10.1016/j.virol.2008.04.007; Bhattacharjee B, 2006, VIROLOGY, V354, P280, DOI 10.1016/j.virol.2006.06.018; Bhattacharya P, 2007, TISSUE ANTIGENS, V70, P283, DOI 10.1111/j.1399-0039.2007.00894.x; Bogovac Z, 2011, ACTA DERMATOVEN ALP, V20, P135; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; CHOW LT, 1987, J VIROL, V61, P1913, DOI 10.1128/JVI.61.6.1913-1918.1987; CHOW LT, 1987, J VIROL, V61, P2581, DOI 10.1128/JVI.61.8.2581-2588.1987; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; CROMME FV, 1993, BRIT J CANCER, V67, P1372, DOI 10.1038/bjc.1993.254; Cumming SA, 2008, BIOCHEM SOC T, V36, P522, DOI 10.1042/BST0360522; Darshan MS, 2004, J VIROL, V78, P12179, DOI 10.1128/JVI.78.22.12179-12188.2004; Das BC, 2000, CURR SCI INDIA, V78, P52; Das D, 2010, VIROLOGY, V402, P197, DOI 10.1016/j.virol.2010.03.030; Das Ghosh D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044678; Day PM, 2004, P NATL ACAD SCI USA, V101, P14252, DOI 10.1073/pnas.0404229101; Day PM, 2003, VIROLOGY, V307, P1, DOI 10.1016/S0042-6822(02)00143-5; De Andrea M, 2007, VIRUS RES, V124, P220, DOI 10.1016/j.virusres.2006.09.010; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; Fahey LM, 2009, J IMMUNOL, V183, P6151, DOI 10.4049/jimmunol.0902145; Franceschi S, 2005, BRIT J CANCER, V92, P601, DOI 10.1038/sj.bjc.6602348; Gornemann J, 2002, VIROLOGY, V303, P69, DOI 10.1006/viro.2002.1670; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Halvorsen M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001074; HAWLEYNELSON P, 1989, EMBO J, V8, P3905, DOI 10.1002/j.1460-2075.1989.tb08570.x; Johansson C, 2012, EMBO J, V31, P3212, DOI 10.1038/emboj.2012.147; Kalantari M, 2001, DIAGN MOL PATHOL, V10, P46, DOI 10.1097/00019606-200103000-00008; Kim SH, 2010, J VIROL, V84, P2629, DOI 10.1128/JVI.02049-09; Klaes R, 1999, CANCER RES, V59, P6132; Laikangbam P, 2007, INT J GYNECOL CANCER, V17, P107, DOI 10.1111/j.1525-1438.2007.00827.x; Leifer Immanuel, 2011, BMC Res Notes, V4, P521, DOI 10.1186/1756-0500-4-521; Levy JP, 1996, NAT BIOTECHNOL, V14, P610, DOI 10.1038/nbt0596-610; Li YK, 2013, PROTEIN CELL, V4, P130, DOI 10.1007/s13238-012-2081-y; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Maki H, 1996, J GEN VIROL, V77, P453, DOI 10.1099/0022-1317-77-3-453; Milligan SG, 2007, VIROLOGY, V360, P172, DOI 10.1016/j.virol.2006.10.012; MUNGER K, 1989, J VIROL, V63, P4417; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Myers G, 1997, THEORETICAL BIOL BIO; O'Brien PM, 2003, TRENDS MICROBIOL, V11, P300, DOI 10.1016/S0966-842X(03)00145-8; Qian WF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002603; ROHLFS M, 1991, VIROLOGY, V183, P331, DOI 10.1016/0042-6822(91)90146-3; Sabol I, 2008, J MED VIROL, V80, P2134, DOI 10.1002/jmv.21304; Sathish N, 2004, GYNECOL ONCOL, V95, P363, DOI 10.1016/j.ygyno.2004.08.025; SCHWARZ E, 1985, NATURE, V314, P111, DOI 10.1038/314111a0; Singh RK, 2006, INT J GYNECOL CANCER, V16, P1048, DOI 10.1111/j.1525-1438.2006.00550.x; Sowjanya AP, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-116; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; Sun M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036577; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; Wells KD, 1999, TRANSGENIC RES, V8, P371, DOI 10.1023/A:1008952302539; Wentzensen N, 2004, CANCER RES, V64, P3878, DOI 10.1158/0008-5472.CAN-04-0009; YAMADA T, 1995, J VIROL, V69, P7743, DOI 10.1128/JVI.69.12.7743-7753.1995; Zhou J, 1999, J VIROL, V73, P4972, DOI 10.1128/JVI.73.6.4972-4982.1999; Zolotukhin S, 1996, J VIROL, V70, P4646, DOI 10.1128/JVI.70.7.4646-4654.1996; zurHausen H, 1996, BBA-REV CANCER, V1288, pF55	59	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65647	10.1371/journal.pone.0065647	http://dx.doi.org/10.1371/journal.pone.0065647			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762404	Green Submitted, Green Published, gold			2022-12-27	WOS:000321099000087
J	Weiss, RM; Lund, DD; Chu, Y; Brooks, RM; Zimmerman, KA; El Accaoui, R; Davis, MK; Hajj, GP; Zimmerman, MB; Heistad, DD				Weiss, Robert M.; Lund, Donald D.; Chu, Yi; Brooks, Robert M.; Zimmerman, Kathy A.; El Accaoui, Ramzi; Davis, Melissa K.; Hajj, Georges P.; Zimmerman, M. Bridget; Heistad, Donald D.			Osteoprotegerin Inhibits Aortic Valve Calcification and Preserves Valve Function in Hypercholesterolemic Mice	PLOS ONE			English	Article							VASCULAR CALCIFICATION; STENOSIS; PROGRESSION; ROSUVASTATIN; ARTERIAL	Background: There are no rigorously confirmed effective medical therapies for calcific aortic stenosis. Hypercholesterolemic Ldlr(-/-) Apob(100/100) mice develop calcific aortic stenosis and valvular cardiomyopathy in old age. Osteoprotegerin (OPG) modulates calcification in bone and blood vessels, but its effect on valve calcification and valve function is not known. Objectives: To determine the impact of pharmacologic treatment with OPG upon aortic valve calcification and valve function in aortic stenosis-prone hypercholesterolemic Ldlr(-/-) Apob(100/100) mice. Methods: Young Ldlr(-/-) Apob(100/100) mice (age 2 months) were fed a Western diet and received exogenous OPG or vehicle (N = 12 each) 3 times per week, until age 8 months. After echocardiographic evaluation of valve function, the aortic valve was evaluated histologically. Older Ldlr(-/-) Apob(100/100) mice were fed a Western diet beginning at age 2 months. OPG or vehicle (N = 12 each) was administered from 6 to 12 months of age, followed by echocardiographic evaluation of valve function, followed by histologic evaluation. Results: In Young Ldlr(-/-) Apob(100/100) mice, OPG significantly attenuated osteogenic transformation in the aortic valve, but did not affect lipid accumulation. In Older Ldlr(-/-) Apob(100/100) mice, OPG attenuated accumulation of the osteoblast-specific matrix protein osteocalcin by similar to 80%, and attenuated aortic valve calcification by similar to 70%. OPG also attenuated impairment of aortic valve function. Conclusions: OPG attenuates pro-calcific processes in the aortic valve, and protects against impairment of aortic valve function in hypercholesterolemic aortic stenosis-prone Ldlr(-/-) Apob(100/100) mice.	[Weiss, Robert M.; Lund, Donald D.; Chu, Yi; Brooks, Robert M.; Zimmerman, Kathy A.; El Accaoui, Ramzi; Davis, Melissa K.; Hajj, Georges P.; Heistad, Donald D.] Univ Iowa, Carver Coll Med, Div Cardiovasc Med, Iowa City, IA 52242 USA; [Zimmerman, M. Bridget] Univ Iowa, Coll Publ Hlth, Dept Biostat, Iowa City, IA USA; [Heistad, Donald D.] Univ Iowa, Dept Pharmacol, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Weiss, RM (corresponding author), Univ Iowa, Carver Coll Med, Div Cardiovasc Med, Iowa City, IA 52242 USA.	robert-weiss@uiowa.edu		Weiss, Robert/0000-0003-1307-2647; El Accaoui, Ramzi/0000-0002-5515-5427	National Institutes of Health [HL62984, NS24621, RR026293]; Amgen Corp (Thousand Oaks, CA); NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026293] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL062984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS024621] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amgen Corp (Thousand Oaks, CA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institutes of Health (HL62984, NS24621, RR026293; research grant from Amgen Corp (Thousand Oaks, CA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Chan KL, 2010, CIRCULATION, V121, P306, DOI 10.1161/CIRCULATIONAHA.109.900027; Cowell SJ, 2005, NEW ENGL J MED, V352, P2389, DOI 10.1056/NEJMoa043876; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Hjortnaes J, 2010, EUR HEART J, V31, P1975, DOI 10.1093/eurheartj/ehq237; Kaden JJ, 2004, J MOL CELL CARDIOL, V36, P57, DOI 10.1016/j.yjmcc.2003.09.015; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Miller JD, 2011, CIRC RES, V108, P1392, DOI 10.1161/CIRCRESAHA.110.234138; Miller JD, 2010, ARTERIOSCL THROM VAS, V30, P2482, DOI 10.1161/ATVBAHA.110.211029; Miller JD, 2009, CIRCULATION, V119, P2693, DOI 10.1161/CIRCULATIONAHA.108.834614; Morony S, 2008, CIRCULATION, V117, P411, DOI 10.1161/CIRCULATIONAHA.107.707380; Moura LM, 2007, J AM COLL CARDIOL, V49, P554, DOI 10.1016/j.jacc.2006.07.072; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Otto CM, 2008, NEW ENGL J MED, V359, P1395, DOI 10.1056/NEJMe0807001; OTTO CM, 1994, CIRCULATION, V90, P844, DOI 10.1161/01.CIR.90.2.844; Panizo S, 2009, CIRC RES, V104, P1041, DOI 10.1161/CIRCRESAHA.108.189001; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Shao JS, 2010, HYPERTENSION, V55, P579, DOI 10.1161/HYPERTENSIONAHA.109.134205; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Stein GS, 1996, PHYSIOL REV, V76, P593, DOI 10.1152/physrev.1996.76.2.593; Tintut Y, 2006, J INVEST MED, V54, P395, DOI 10.2310/6650.2006.06019; Wallby L, 2002, HEART, V88, P348, DOI 10.1136/heart.88.4.348; Warnes CA, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001; Weiss RM, 2006, CIRCULATION, V114, P2065, DOI 10.1161/CIRCULATIONAHA.106.634139	24	43	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65201	10.1371/journal.pone.0065201	http://dx.doi.org/10.1371/journal.pone.0065201			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762316	Green Published, Green Submitted, gold			2022-12-27	WOS:000321099000043
J	Tovar-Sanchez, A; Sanchez-Quiles, D; Basterretxea, G; Benede, JL; Chisvert, A; Salvador, A; Moreno-Garrido, I; Blasco, J				Tovar-Sanchez, Antonio; Sanchez-Quiles, David; Basterretxea, Gotzon; Benede, Juan L.; Chisvert, Alberto; Salvador, Amparo; Moreno-Garrido, Ignacio; Blasco, Julian			Sunscreen Products as Emerging Pollutants to Coastal Waters	PLOS ONE			English	Article							UV FILTERS; GROWTH; TOXICITY; TESTS; CYCLE; CELL	A growing awareness of the risks associated with skin exposure to ultraviolet (UV) radiation over the past decades has led to increased use of sunscreen cosmetic products leading the introduction of new chemical compounds in the marine environment. Although coastal tourism and recreation are the largest and most rapidly growing activities in the world, the evaluation of sunscreen as source of chemicals to the coastal marine system has not been addressed. Concentrations of chemical UV filters included in the formulation of sunscreens, such as benzophehone 3 (BZ-3), 4-methylbenzylidene camphor (4-MBC), TiO2 and ZnO, are detected in nearshore waters with variable concentrations along the day and mainly concentrated in the surface microlayer (i.e. 53.6-577.5 ng L-1 BZ-3; 51.4-113.4 ng L-1 4-MBC; 6.9-37.6 mu g L-1 Ti; 1.0-3.3 mu g L-1 Zn). The presence of these compounds in seawater suggests relevant effects on phytoplankton. Indeed, we provide evidences of the negative effect of sunblocks on the growth of the commonly found marine diatom Chaetoceros gracilis (mean EC50 = 125 +/- 71 mg L-1). Dissolution of sunscreens in seawater also releases inorganic nutrients (N, P and Si forms) that can fuel algal growth. In particular, PO43- is released by these products in notable amounts (up to 17 mu mol PO43- g(-1)). We conservatively estimate an increase of up to 100% background PO43- concentrations (0.12 mu mol L-1 over a background level of 0.06 mu mol L-1) in nearshore waters during low water renewal conditions in a populated beach in Majorca island. Our results show that sunscreen products are a significant source of organic and inorganic chemicals that reach the sea with potential ecological consequences on the coastal marine ecosystem.	[Tovar-Sanchez, Antonio; Sanchez-Quiles, David] Mediterranean Inst Adv Studies UIB CSIC, Dept Global Change Res, Esporles, Balearic Island, Spain; [Basterretxea, Gotzon] Mediterranean Inst Adv Studies UIB CSIC, Dept Ecol & Marine Resources, Esporles, Balearic Island, Spain; [Benede, Juan L.; Chisvert, Alberto; Salvador, Amparo] Univ Valencia, Dept Analyt Chem, Fac Quim, Valencia, Spain; [Moreno-Garrido, Ignacio; Blasco, Julian] CSIC, ICMAN Inst Ciencias Marinas Andalucia, Cadiz, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); University of Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Marinas de Andalucia (ICMAN)	Tovar-Sanchez, A (corresponding author), Mediterranean Inst Adv Studies UIB CSIC, Dept Global Change Res, Esporles, Balearic Island, Spain.	atovar@imedea.uib-csic.es	Salvador, Amparo/M-2383-2014; Basterretxea, Gotzon/D-2314-2011; Sánchez-Quiles, David/H-8031-2015; Chisvert, Alberto/M-2026-2014; Benedé, Juan Luis/C-8324-2018; Blasco, Julian/A-5319-2008; Tovar-Sánchez, Antonio/B-8003-2010; Sánchez-Quiles, D./K-1283-2019	Salvador, Amparo/0000-0003-1248-4076; Basterretxea, Gotzon/0000-0001-7466-1360; Sánchez-Quiles, David/0000-0003-4109-6136; Chisvert, Alberto/0000-0003-1349-0478; Benedé, Juan Luis/0000-0002-1888-7223; Blasco, Julian/0000-0002-9750-383X; Tovar-Sánchez, Antonio/0000-0003-4375-1982; Sánchez-Quiles, D./0000-0003-4109-6136; Moreno-Garrido, Ignacio/0000-0003-2664-8713	Spanish Ministries of Economy and Competitiveness and of Agriculture, Food and Environment [CTM2011-22645, 384/2011]	Spanish Ministries of Economy and Competitiveness and of Agriculture, Food and Environment	This work was funded by the ISUMAR project (CTM2011-22645) and CONCORDA project (384/2011) of the Spanish Ministries of Economy and Competitiveness and of Agriculture, Food and Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACNielsen Global Services, 2007, WHATS HOT GLOB INS P; [Anonymous], 1976, OFFICIAL J L, VL 262, P0169; ASTM, 2008, PRACT PREP SUBS OC W; Basterretxea G, 2007, MAR ECOL PROG SER, V352, P53, DOI 10.3354/meps07168; Bonnet S, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003213; Botta C, 2011, ENVIRON POLLUT, V159, P1543, DOI 10.1016/j.envpol.2011.03.003; Chen JY, 2011, AQUAT TOXICOL, V101, P493, DOI 10.1016/j.aquatox.2010.12.004; Coronado M, 2008, AQUAT TOXICOL, V90, P182, DOI 10.1016/j.aquatox.2008.08.018; Diffey B, 2001, J PHOTOCH PHOTOBIO B, V64, P105, DOI 10.1016/S1011-1344(01)00195-6; Division on Earth & Life Studies, 2012, OC REP AC FIND DIV E; Executive News Report from Nielsen Global Services, 2007, WHATS HOT GLOB INS P; Garin-Munoz T, 2007, TOURISM MANAGE, V28, P1224, DOI 10.1016/j.tourman.2005.07.020; Giokas DL, 2007, TRAC-TREND ANAL CHEM, V26, P360, DOI 10.1016/j.trac.2007.02.012; Grasshon K, 1976, METHODS SEAWATER ANA; Hampel M, 2001, ECOTOX ENVIRON SAFE, V48, P287, DOI 10.1006/eesa.2000.2028; Hernandez-Almeida I, 2011, MAR MICROPALEONTOL, V78, P14, DOI 10.1016/j.marmicro.2010.09.005; Kaiser D, 2012, ENVIRON POLLUT, V163, P84, DOI 10.1016/j.envpol.2011.12.014; Kunz PY, 2006, TOXICOL SCI, V93, P311, DOI 10.1093/toxsci/kfl070; Miller RJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030321, 10.1371/journal.pone.0033885]; Moreno-Garrido I, 2000, ECOTOX ENVIRON SAFE, V47, P112, DOI 10.1006/eesa.2000.1953; NYHOLM N, 1990, ARCH ENVIRON CON TOX, V19, P518, DOI 10.1007/BF01059070; Pascoa RNMJ, 2011, SENSOR ACTUAT B-CHEM, V157, P51, DOI 10.1016/j.snb.2011.03.025; Peck AM, 2006, ANAL BIOANAL CHEM, V386, P907, DOI 10.1007/s00216-006-0728-3; Poiger T, 2004, CHEMOSPHERE, V55, P951, DOI 10.1016/j.chemosphere.2004.01.012; Quartier S, 2006, CONTACT DERMATITIS, V55, P257, DOI 10.1111/j.1600-0536.2006.00960.x; Salvador A, 2007, ANALYSIS OF COSMETIC PRODUCTS, P1; Santos AJM, 2012, WATER RES, V46, P3167, DOI 10.1016/j.watres.2012.03.057; Sieratowicz A, 2011, J ENVIRON SCI HEAL A, V46, P1311, DOI 10.1080/10934529.2011.602936; Diaz-Cruz MS, 2009, TRAC-TREND ANAL CHEM, V28, P708, DOI 10.1016/j.trac.2009.03.010; Stortini A. M, 2012, COMPREHENSIVE SAMPLI, P223; Sundseth K., 2009, NATURA 2000 MEDITERR; Tonning K, 2009, SURVEY HLTH ASSESSME; Tovar- Sa 'nchezA, 2012, COMPREHENSIVE SAMPLI, P317; UNEP, 2009, SUST COAST TOUR INT; Vaulot D, 1996, APPL ENVIRON MICROB, V62, P2527, DOI 10.1128/AEM.62.7.2527-2533.1996; Weisz A, 2007, 4 2 COL AG COSM PROD, P153	36	133	135	10	156	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65451	10.1371/journal.pone.0065451	http://dx.doi.org/10.1371/journal.pone.0065451			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755233	Green Published, gold			2022-12-27	WOS:000320579400059
J	Zhang, C; Wu, XH; Zhang, MF; Zhu, LC; Zhao, R; Xu, DQ; Lin, ZH; Liang, CG; Chen, TP; Chen, L; Ren, Y; Zhang, J; Qin, N; Zhang, XW				Zhang, Chao; Wu, Xihan; Zhang, Meifang; Zhu, Liangcheng; Zhao, Rong; Xu, Danqing; Lin, Zhaohu; Liang, Chungen; Chen, Taiping; Chen, Li; Ren, Yi; Zhang, Joe; Qin, Ning; Zhang, Xiongwen			Small Molecule R1498 as a Well-Tolerated and Orally Active Kinase Inhibitor for Hepatocellular Carcinoma and Gastric Cancer Treatment via Targeting Angiogenesis and Mitosis Pathways	PLOS ONE			English	Article							SUPPRESSES TUMOR-GROWTH; FREQUENT OVEREXPRESSION; PHASE-II; SORAFENIB; POTENT; ACTIVATION; RECEPTOR; THERAPY	Protein kinases play important roles in tumor development and progression. Lots of kinase inhibitors have entered into market and show promising clinical benefits. Here we report the discovery of a novel small molecule, well-tolerated, orally active kinase inhibitor, R1498, majorly targeting both angiogenic and mitotic pathways for the treatment of hepatocellular carcinoma (HCC) and gastric cancer (GC). A series of biochemical and cell-based assays indicated that the target kinase cluster of R1498 included Aurora kinases and VEGFR2 et al. R1498 showed moderate in vitro growth inhibition on a panel of tumor cells with IC50 of micromole range. The in vivo anti-tumor efficacy of R1498 was evaluated on a panel of GC and HCC xenografts in a parallel comparison with another multikinase inhibitor sorafenib. R1498 demonstrated superior efficacy and toxicity profile over sorafenib in all test models with >80% tumor growth inhibition and tumor regression in some xenogratfts. The therapeutic potential of R1498 was also highlighted by its efficacy on three human GC primary tumor derived xenograft models with 10-30% tumor regression rate. R1498 was shown to actively inhibit the Aurora A activity in vivo, and decrease the vascularization in tumors. Furthermore, R1498 presented good in vivo exposure and therapeutic window in the pharmacokinetic and dose range finding studies. Theses evidences indicate that R1498 is a potent, well-tolerated, orally active multitarget kinase inhibitor with a unique antiangiogenic and antiproliferative profile, and provide strong confidence for further development for HCC and GC therapy.	[Zhang, Chao; Wu, Xihan; Zhang, Meifang; Zhu, Liangcheng; Zhao, Rong; Xu, Danqing; Lin, Zhaohu; Liang, Chungen; Chen, Li; Ren, Yi; Zhang, Joe; Qin, Ning; Zhang, Xiongwen] Roche Res & Early Dev China, Shanghai, Peoples R China; [Chen, Taiping] Crown Biosci Inc, Beijing, Peoples R China		Zhang, XW (corresponding author), Roche Res & Early Dev China, Shanghai, Peoples R China.	xwzhang@sat.ecnu.edu.cn						Arbab AS, 2012, HISTOL HISTOPATHOL, V27, P549, DOI 10.14670/HH-27.549; Bang YJ, 2010, LANCET, V376, P1302; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Dancey JE, 2006, NAT REV DRUG DISCOV, V5, P649, DOI 10.1038/nrd2089; Dar AA, 2008, CANCER-AM CANCER SOC, V112, P1688, DOI 10.1002/cncr.23371; Donate F, 2008, CLIN CANCER RES, V14, P2137, DOI 10.1158/1078-0432.CCR-07-4530; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Ferrara N, 2007, ANNU REV MED, V58, P491, DOI 10.1146/annurev.med.58.061705.145635; Ferrara Napoleone, 2011, Int J Dev Biol, V55, P383, DOI 10.1387/ijdb.103216dr; Fletcher GC, 2011, MOL CANCER THER, V10, P126, DOI 10.1158/1535-7163.MCT-10-0574; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Hata T, 2005, CANCER RES, V65, P2899, DOI 10.1158/0008-5472.CAN-04-3981; Herbst RS, 2005, BRIT J CANCER, V92, pS21, DOI 10.1038/sj.bjc.6602605; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Liu JJ, 2010, BIOORG MED CHEM LETT, V20, P5984, DOI 10.1016/j.bmcl.2010.08.079; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Minor DR, 2012, CLIN CANC RES; Motzer RJ, 2006, J CLIN ONCOL, V24, P16, DOI 10.1200/JCO.2005.02.2574; Nahta R, 2007, ONCOGENE, V26, P3637, DOI 10.1038/sj.onc.1210379; Pawlik TM, 2011, J CLIN ONCOL, V29, P3960, DOI 10.1200/JCO.2011.37.1021; Shojaei F, 2012, CANCER LETT, V320, P130, DOI 10.1016/j.canlet.2012.03.008; Sun WJ, 2010, J CLIN ONCOL, V28, P2947, DOI 10.1200/JCO.2009.27.7988; Vischioni B, 2006, MOL CANCER THER, V5, P2905, DOI 10.1158/1535-7163.MCT-06-0301; Wilhelm SM, 2011, INT J CANCER, V129, P245, DOI 10.1002/ijc.25864; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Xie BR, 2012, DIGEST DIS SCI, V57, P1122, DOI 10.1007/s10620-012-2136-1; Zhang C, 2006, BRIT J PHARMACOL, V148, P741, DOI 10.1038/sj.bjp.0706741; Zhang C, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0004881, 10.1371/journal.pone.0005429]	31	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65264	10.1371/journal.pone.0065264	http://dx.doi.org/10.1371/journal.pone.0065264			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755206	Green Published, Green Submitted, gold			2022-12-27	WOS:000320579400048
J	Kibret, KT; Yalew, AW; Belaineh, BG; Asres, MM				Kibret, Kelemu Tilahun; Yalew, Alemayehu Worku; Belaineh, Belaineh Girma; Asres, Muluken Melese			Determinant Factors Associated with Occurrence of Tuberculosis among Adult People Living with HIV after Antiretroviral Treatment Initiation in Addis Ababa, Ethiopia: A Case Control Study	PLOS ONE			English	Article							ISONIAZID PREVENTIVE THERAPY; RISK-FACTORS; INFECTED PATIENTS; COUNTRIES; MORTALITY; AFRICA; UGANDA; HAART	Introdugtion: Tuberculosis (TB) is a leading morbidity and mortality, and the first presenting sign in majority of people living with Human Immune deficiency Virus (PLWH). Determinants of active TB among HIV patients on anti retroviral treatment (ART) are not well described in resource limited settings. The aim of this study was to assess determinant factors for the occurrence of TB among people living with HIV after ART initiation in public hospitals and health centers in Addis Ababa, Ethiopia. Methods and Findings: A case control study was conducted from December 2011 to February 2012 in 2 public hospitals and 13 health centers in Addis Ababa. The study population consisted of 204 cases and 409 controls. Cases were adult people living with HIV who developed TB after ART initiation and controls were adult people living with HIV who did not develop TB after ART initiation. An interviewer administered structured questionnaire was used to collect information. After adjustment for potential confounders, presence of isoniazid prophylaxis (adjusted odd ratio [AOR] 0.35, 95% confidence interval [CI] 0.125, 0.69) and cotrimoxazole prophylaxis (AOR = 0.19; 95% CI: 0.06, 0.62) had protective benefit against risk of TB. In contrary, bedridden (AOR = 9.36; 95% CI: 3.39, 25.85), having World Health Organization (WHO) clinical stage III/IV (AOR = 3.40; 95% CI: 1.69, 6.87) and hemoglobin level < 10 mg/dl (AOR = 7.43; 95% CI; 3.04, 18.31) at enrollment to ART care were predictors for increased risk of tuberculosis in PLWH after ART initiation. Conclusion: Increasing coverage of isoniazid preventive therapy and cotrimoxazole preventive therapy reduced risk of TB among HIV patients who started treatment. All PLWH should be screened for TB, but for patients who have advanced disease condition (WHO clinical stage III/IV, being bedridden and having hemoglobin level < 10 mg/dl) intensified screening is highly recommended during treatment follow up.	[Kibret, Kelemu Tilahun] Wollega Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Nekemte, Ethiopia; [Yalew, Alemayehu Worku] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia; [Belaineh, Belaineh Girma; Asres, Muluken Melese] MSH USAID Management Sci Hlth MSH, Help Ethiopia Address Low TB HEAL TB Project, Addis Ababa, Ethiopia	Addis Ababa University	Kibret, KT (corresponding author), Wollega Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Nekemte, Ethiopia.	ktwu27@gmail.com	Kibret, Kelemu T/AAT-4813-2020; Belaineh, Belaineh Girma/HGD-1377-2022	Kibret, Kelemu T/0000-0002-4357-4122; 	Help Ethiopia Address Low TB Performance (HEAL TB) Project; USAID/Management Sciences for Health(MSH), Addis Ababa, Ethiopia	Help Ethiopia Address Low TB Performance (HEAL TB) Project; USAID/Management Sciences for Health(MSH), Addis Ababa, Ethiopia(United States Agency for International Development (USAID))	Help Ethiopia Address Low TB Performance (HEAL TB) Project, USAID/Management Sciences for Health(MSH), Addis Ababa, Ethiopia funded this article. The views expressed in this publication are the responsibility of authors and do not necessarily reflect the views of USAID. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; [Anonymous], 2004, INT HIV AIDS TB EFF; [Anonymous], 2011, GUID INT TUB CAS FIN; Baalwa J, 2008, AFR HEALTH SCI, V8, P190; Boccia D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020824; Bonnet MMB, 2006, AIDS, V20, P1275, DOI 10.1097/01.aids.0000232235.26630.ee; Churchyard GJ, 2003, AIDS, V17, P2063, DOI 10.1097/00002030-200309260-00007; Duchateau L, 2001, ETHIOP J HLTH SCI, V21, P131; Federal Ministry of Health Ethiopia, 2008, TUB LEPR TB HIV PREV; Federal Ministry of Health of Ethiopia, 2007, IMPL GUID TB HIV COL; Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441; Habib AG, 2009, ANN AFR MED, V8, P147, DOI 10.4103/1596-3519.57236; Hermans SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010527; Hill PC, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-156; Huruy K, 2008, JPN J INFECT DIS, V61, P205; Komati S, 2010, AIDS, V24, P1849, DOI 10.1097/QAD.0b013e32833a2507; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Lawn SD, 2010, LANCET INFECT DIS, V10, P489, DOI 10.1016/S1473-3099(10)70078-5; Lienhardt C, 2005, INT J EPIDEMIOL, V34, P914, DOI 10.1093/ije/dyi100; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Mayanja-Kizza H, 2008, AFR HEALTH SCI, V8, P190; Moore D, 2007, AIDS, V21, P713, DOI 10.1097/QAD.0b013e328013f632; Perez A, 2006, AM J TROP MED HYG, V74, P604, DOI 10.4269/ajtmh.2006.74.604; Rehm J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-450; Rodwell TC, 2010, AM J PUBLIC HEALTH, V100, pS178, DOI 10.2105/AJPH.2009.170142; Westerich D, 2007, RISK FACTORS INCIDEN; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2011, WHOHTMTB20107; WHO, 2011, GLOB TUB CONTR REP; *WHO, 2009, WHO GLOB TB REP; Wolday H, 2003, INT J TUBERC LUNG D, V7, P110; Worku A, 2011, EFFECT HAART I UNPUB; World Health Organization, 2010, WHOHTMTB20107	33	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64488	10.1371/journal.pone.0064488	http://dx.doi.org/10.1371/journal.pone.0064488			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23762214	Green Submitted, Green Published, gold			2022-12-27	WOS:000319330200142
J	Brandani, GB; Schor, M; MacPhee, CE; Grubmuller, H; Zachariae, U; Marenduzzo, D				Brandani, Giovanni B.; Schor, Marieke; MacPhee, Cait E.; Grubmueller, Helmut; Zachariae, Ulrich; Marenduzzo, Davide			Quantifying Disorder through Conditional Entropy: An Application to Fluid Mixing	PLOS ONE			English	Article							PHASE-DIAGRAMS; MODEL; DOMAIN; ALGORITHMS; MEMBRANES; DYNAMICS	In this paper, we present a method to quantify the extent of disorder in a system by using conditional entropies. Our approach is especially useful when other global, or mean field, measures of disorder fail. The method is equally suited for both continuum and lattice models, and it can be made rigorous for the latter. We apply it to mixing and demixing in multicomponent fluid membranes, and show that it has advantages over previous measures based on Shannon entropies, such as a much diminished dependence on binning and the ability to capture local correlations. Further potential applications are very diverse, and could include the study of local and global order in fluid mixtures, liquid crystals, magnetic materials, and particularly biomolecular systems.	[Brandani, Giovanni B.; Schor, Marieke; MacPhee, Cait E.; Zachariae, Ulrich; Marenduzzo, Davide] Univ Edinburgh, Sch Phys & Astron, SUPA, Edinburgh, Midlothian, Scotland; [Grubmueller, Helmut] Max Planck Inst Biophys Chem, Dept Theoret & Computat Biophys, D-37077 Gottingen, Germany; [Zachariae, Ulrich] Univ Dundee, Coll Life Sci, Div Computat Biol, Dundee, Scotland; [Zachariae, Ulrich] Univ Dundee, Div Phys, Sch Engn Phys & Math, Dundee, Scotland	University of Edinburgh; Max Planck Society; University of Dundee; University of Dundee	Zachariae, U (corresponding author), Univ Edinburgh, Sch Phys & Astron, SUPA, Edinburgh, Midlothian, Scotland.	u.zachariae@dundee.ac.uk; dmarendu@ed.ac.uk	Brandani, Giovanni/GPX-0510-2022; Brandani, Giovanni/AAX-9654-2021; MacPhee, Cait/F-6679-2013	Brandani, Giovanni/0000-0003-3379-0187; Marenduzzo, Davide/0000-0003-3974-4915; MacPhee, Cait/0000-0001-8313-8387; Zachariae, Ulrich/0000-0003-3287-8494; Schor, Marieke/0000-0002-1080-9546	Scottish Universities' Physics Alliance; UK National Physical Laboratory; Engineering and Physical Sciences Research Council [EP/J007404/1] Funding Source: researchfish; EPSRC [EP/J007404/1] Funding Source: UKRI	Scottish Universities' Physics Alliance; UK National Physical Laboratory; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	MS and UZ acknowledge support from the Scottish Universities' Physics Alliance (www.supa.ac.uk). MS, CM and UZ acknowledge external funding from the UK National Physical Laboratory (www.npl.co.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1987, STAT MECH; Atkins P., 2006, ATKINS PHYS CHEM; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bethe H. A., 1935, P ROY SOC A-MATH PHY, V150, P552, DOI DOI 10.1098/RSPA.1935.0122; Camesasca M, 2006, MACROMOL THEOR SIMUL, V15, P595, DOI 10.1002/mats.200600037; Chaikin P. M., 2000, PRINCIPLES CONDENSED, V1; Feigenson GW, 2009, BBA-BIOMEMBRANES, V1788, P47, DOI 10.1016/j.bbamem.2008.08.014; Fittipaldi A, 2003, J BIOL CHEM, V278, P34141, DOI 10.1074/jbc.M303045200; Goni FM, 2008, BBA-MOL CELL BIOL L, V1781, P665, DOI 10.1016/j.bbalip.2008.09.002; Gozdz WT, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4731646; Hac AE, 2005, BIOPHYS J, V88, P317, DOI 10.1529/biophysj.104.040444; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hinderliter A, 2001, BIOCHEMISTRY-US, V40, P4181, DOI 10.1021/bi0024299; Kawasaki K., 1972, PHASE TRANSITIONS CR; KERSTEN D, 1987, J OPT SOC AM A, V4, P2395, DOI 10.1364/JOSAA.4.002395; KIKUCHI R, 1951, PHYS REV, V81, P988, DOI 10.1103/PhysRev.81.988; Kiselev VY, 2011, BIOPHYS J, V100, P1261, DOI 10.1016/j.bpj.2011.01.025; KURATA M, 1953, J CHEM PHYS, V21, P434, DOI 10.1063/1.1698926; Laurent B, 2013, PURE APPL CHEM, V85, P1, DOI 10.1351/PAC-CON-12-04-10; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Onsager L, 1944, PHYS REV, V65, P117, DOI 10.1103/PhysRev.65.117; ORLANDINI E, 1995, EUROPHYS LETT, V32, P463, DOI 10.1209/0295-5075/32/6/001; Pelizzola A, 2005, J PHYS A-MATH GEN, V38, pR309, DOI 10.1088/0305-4470/38/33/R01; PERCUS JK, 1977, J STAT PHYS, V16, P299, DOI 10.1007/BF01020384; Pike LJ, 2009, J LIPID RES, V50, pS323, DOI 10.1194/jlr.R800040-JLR200; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; RonnovJessen L, 1996, PHYSIOL REV, V76, P69, DOI 10.1152/physrev.1996.76.1.69; Schafer LV, 2010, BIOPHYS J, V99, pL91, DOI 10.1016/j.bpj.2010.08.072; Shannon C.E., 1949, MATH THEORY COMMUNIC, V117; Sole RV, 2004, LECT NOTES PHYS, V650, P189; Sugar IP, 1999, BIOPHYS J, V76, P2099, DOI 10.1016/S0006-3495(99)77366-2	31	24	24	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65617	10.1371/journal.pone.0065617	http://dx.doi.org/10.1371/journal.pone.0065617			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762401	Green Published, gold			2022-12-27	WOS:000320440500046
J	Shen, L; Shao, NY; Liu, XC; Maze, I; Feng, J; Nestler, EJ				Shen, Li; Shao, Ning-Yi; Liu, Xiaochuan; Maze, Ian; Feng, Jian; Nestler, Eric J.			diffReps: Detecting Differential Chromatin Modification Sites from ChIP-seq Data with Biological Replicates	PLOS ONE			English	Article							EXPRESSION ANALYSIS; BIOCONDUCTOR PACKAGE; HUMAN GENOME; COCAINE; GENE	ChIP-seq is increasingly being used for genome-wide profiling of histone modification marks. It is of particular importance to compare ChIP-seq data of two different conditions, such as disease vs. control, and identify regions that show differences in ChIP enrichment. We have developed a powerful and easy to use program, called diffReps, to detect those differential sites from ChIP-seq data, with or without biological replicates. In addition, we have developed two useful tools for ChIP-seq analysis in the diffReps package: one for the annotation of the differential sites and the other for finding chromatin modification "hotspots". diffReps is developed in PERL programming language and runs on all platforms as a command line script. We tested diffReps on two different datasets. One is the comparison of H3K4me3 between two human cell lines from the ENCODE project. The other is the comparison of H3K9me3 in a discrete region of mouse brain between cocaine-and saline-treated conditions. The results indicated that diffReps is a highly sensitive program in detecting differential sites from ChIP-seq data.	[Shen, Li; Shao, Ning-Yi; Liu, Xiaochuan; Feng, Jian; Nestler, Eric J.] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY USA; [Shen, Li; Shao, Ning-Yi; Liu, Xiaochuan; Feng, Jian; Nestler, Eric J.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY USA; [Maze, Ian] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10021 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Rockefeller University	Shen, L (corresponding author), Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY USA.	li.shen@mssm.edu	Maze, Ian/P-8077-2018; SHAO, Ning-Yi/N-4947-2015; Shen, Li/B-3562-2008	SHAO, Ning-Yi/0000-0003-4231-828X; Shen, Li/0000-0002-5190-2851; Maze, Ian/0000-0003-1490-7781	Friedman Brain Institute; National Institutes of Health (NIH) [P01 DA008227, P50 MH096890]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH096890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA008227] Funding Source: NIH RePORTER	Friedman Brain Institute; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the seed grant from Friedman Brain Institute to Dr. Li Shen, National Institutes of Health (NIH) grants P01 DA008227 and P50 MH096890 (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2011, PLOS BIOL, V9, DOI [10.1371/journal.pbio.1001046, DOI 10.1371/JOURNAL.PBIO.1001046]; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Di Y, 2011, STAT APPL GENET MOL, V10, P1, DOI 10.2202/1544-6115.1637; Fasano S, 2009, BIOL PSYCHIAT, V66, P758, DOI 10.1016/j.biopsych.2009.03.014; Host L, 2011, J PSYCHOPHARMACOL, V25, P222, DOI 10.1177/0269881109348173; Kidder BL, 2011, NAT IMMUNOL, V12, P918, DOI 10.1038/ni.2117; Kramer OH, 2009, TRENDS PHARMACOL SCI, V30, P647, DOI 10.1016/j.tips.2009.09.007; Liang K, 2012, BIOINFORMATICS, V28, P121, DOI 10.1093/bioinformatics/btr605; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; Maze I, 2011, P NATL ACAD SCI USA, V108, P3035, DOI 10.1073/pnas.1015483108; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Pierce RC, 1999, J NEUROSCI, V19, P8685; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosenfeld JA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-143; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Sokal RR, 1995, BIOMETRY; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Szalkowski AM, 2010, BRIEFINGS BIOINFORMA; Taslim C, 2011, BIOINFORMATICS, V27, P1569, DOI 10.1093/bioinformatics/btr165; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Warren Derek T., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009294; Xu H, 2008, BIOINFORMATICS, V24, P2344, DOI 10.1093/bioinformatics/btn402; Xu H, 2010, BIOINFORMATICS, V26, P1199, DOI 10.1093/bioinformatics/btq128; Zhang GC, 2007, NEUROSCI LETT, V427, P117, DOI 10.1016/j.neulet.2007.09.010; Zhang Y., 2008, GENOME BIOL, V9; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237; Zhuravliova E, 2009, NEUROCHEM RES, V34, P1076, DOI 10.1007/s11064-008-9877-4	34	205	209	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65598	10.1371/journal.pone.0065598	http://dx.doi.org/10.1371/journal.pone.0065598			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762400	Green Published, Green Submitted, gold			2022-12-27	WOS:000320440500045
J	Dutia, R; Kim, AJ; Modes, M; Rothlein, R; Shen, JM; Tian, YE; Ihbais, J; Victory, SF; Valcarce, C; Wardlaw, SL				Dutia, Roxanne; Kim, Andrea J.; Modes, Matthew; Rothlein, Robert; Shen, Jane M.; Tian, Ye Edward; Ihbais, Jumana; Victory, Sam F.; Valcarce, Carmen; Wardlaw, Sharon L.			Effects of AgRP Inhibition on Energy Balance and Metabolism in Rodent Models	PLOS ONE			English	Article							AGOUTI-RELATED PROTEIN; CENTRAL-NERVOUS-SYSTEM; CENTRAL MELANOCORTIN SYSTEM; INCREASED DIETARY-FAT; MESSENGER-RNA; RAT HYPOTHALAMUS; INDUCED OBESITY; DEFICIENT MICE; NEUROPEPTIDE-Y; FOOD-INTAKE	Activation of brain melanocortin-4 receptors (MC4-R) by alpha-melanocyte-stimulating hormone (MSH) or inhibition by agouti-related protein (AgRP) regulates food intake and energy expenditure and can modulate neuroendocrine responses to changes in energy balance. To examine the effects of AgRP inhibition on energy balance, a small molecule, non-peptide compound, TTP2515, developed by TransTech Pharma, Inc., was studied in vitro and in rodent models in vivo. TTP2515 prevented AgRP from antagonizing alpha-MSH-induced increases in cAMP in HEK 293 cells overexpressing the human MC4-R. When administered to rats by oral gavage TTP2515 blocked icv AgRP-induced increases in food intake, weight gain and adiposity and suppression of T4 levels. In both diet-induced obese (DIO) and leptin-deficient mice, TTP2515 decreased food intake, weight gain, adiposity and respiratory quotient. TTP2515 potently suppressed food intake and weight gain in lean mice immediately after initiation of a high fat diet (HFD) but had no effect on these parameters in lean chow-fed mice. However, when tested in AgRP KO mice, TTP2515 also suppressed food intake and weight gain during HFD feeding. In several studies TTP2515 increased T4 but not T3 levels, however this was also observed in AgRP KO mice. TTP2515 also attenuated refeeding and weight gain after fasting, an effect not evident in AgRP KO mice when administered at moderate doses. This study shows that TTP2515 exerts many effects consistent with AgRP inhibition however experiments in AgRP KO mice indicate some off-target effects of this drug. TTP2515 was particularly effective during fasting and in mice with leptin deficiency, conditions in which AgRP is elevated, as well as during acute and chronic HFD feeding. Thus the usefulness of this drug in treating obesity deserves further exploration, to define the AgRP dependent and independent mechanisms by which TTP2515 exerts its effects on energy balance.	[Dutia, Roxanne; Kim, Andrea J.; Modes, Matthew; Wardlaw, Sharon L.] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; [Rothlein, Robert; Shen, Jane M.; Tian, Ye Edward; Ihbais, Jumana; Victory, Sam F.; Valcarce, Carmen] TransTech Pharma Inc, High Point, NC USA	Columbia University	Wardlaw, SL (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA.	sw22@columbia.edu			National Insitutes of Health [DK 080003]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687, R01DK080003] Funding Source: NIH RePORTER	National Insitutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by National Insitutes of Health grant DK 080003 to SLW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boghossian S, 2010, AM J PHYSIOL-REG I, V298, pR385, DOI 10.1152/ajpregu.00591.2009; Breen TL, 2005, BRAIN RES, V1032, P141, DOI 10.1016/j.brainres.2004.11.008; Butler AA, 2001, NAT NEUROSCI, V4, P605, DOI 10.1038/88423; Chai BX, 2003, PEPTIDES, V24, P603, DOI 10.1016/S0196-9781(03)00104-9; Clegg DJ, 2003, ENDOCRINOLOGY, V144, P2941, DOI 10.1210/en.2002-0218; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Fekete C, 2004, ENDOCRINOLOGY, V145, P4816, DOI 10.1210/en.2004-0476; Fekete C, 2002, ENDOCRINOLOGY, V143, P3846, DOI 10.1210/en.2002-220338; Goto K, 2003, INT J MOL MED, V12, P379; Graham M, 1997, NAT GENET, V17, P273, DOI 10.1038/ng1197-273; Greenfield JR, 2009, NEW ENGL J MED, V360, P44, DOI 10.1056/NEJMoa0803085; Hadley ME, 2006, PEPTIDES, V27, P921, DOI 10.1016/j.peptides.2005.01.029; Haskell-Luevano C, 1999, ENDOCRINOLOGY, V140, P1408, DOI 10.1210/en.140.3.1408; JACOBOWITZ DM, 1978, P NATL ACAD SCI USA, V75, P6300, DOI 10.1073/pnas.75.12.6300; Kishi T, 2003, J COMP NEUROL, V457, P213, DOI 10.1002/cne.10454; Koegler FH, 1999, PHYSIOL BEHAV, V67, P809, DOI 10.1016/S0031-9384(99)00104-3; Korner J, 2001, J NEUROENDOCRINOL, V13, P959, DOI 10.1046/j.1365-2826.2001.00716.x; Korner J, 2003, J NEUROENDOCRINOL, V15, P1116, DOI 10.1111/j.1365-2826.2003.01113.x; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Lee M, 2007, FRONT BIOSCI-LANDMRK, V12, P3994, DOI 10.2741/2366; Lee M, 2007, AM J PHYSIOL-ENDOC M, V293, pE121, DOI 10.1152/ajpendo.00555.2006; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Makimura H, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-18; McMinn JE, 2000, AM J PHYSIOL-REG I, V279, pR695, DOI 10.1152/ajpregu.2000.279.2.R695; Miltenberger RJ, 1997, J NUTR, V127, pS1902, DOI 10.1093/jn/127.9.1902S; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Mul JD, OBESITY SILVER SPRIN; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Palou M, 2009, CELL PHYSIOL BIOCHEM, V23, P115, DOI 10.1159/000204100; Pierroz DD, 2002, DIABETES, V51, P1337, DOI 10.2337/diabetes.51.5.1337; Qian S, 2002, MOL CELL BIOL, V22, P5027, DOI 10.1128/MCB.22.14.5027-5035.2002; Samama P, 2003, REGUL PEPTIDES, V113, P85, DOI 10.1016/S0167-0115(02)00299-9; Seeley RJ, 2005, ENDOCRINOLOGY, V146, P3732, DOI 10.1210/en.2004-1663; Shutter JR, 1997, GENE DEV, V11, P593, DOI 10.1101/gad.11.5.593; Small CJ, 2001, DIABETES, V50, P248, DOI 10.2337/diabetes.50.2.248; Srisai D, 2011, ENDOCRINOLOGY, V152, P890, DOI 10.1210/en.2010-0716; Swart I, 2002, AM J PHYSIOL-REG I, V283, pR1020, DOI 10.1152/ajpregu.00501.2001; Tolle V, 2008, DIABETES, V57, P86, DOI 10.2337/db07-0733; Tracy AL, 2008, PHARMACOL BIOCHEM BE, V89, P263, DOI 10.1016/j.pbb.2007.12.018; Wortley KE, 2005, CELL METAB, V2, P421, DOI 10.1016/j.cmet.2005.11.004; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022; Ziotopoulou M, 2000, AM J PHYSIOL-ENDOC M, V279, pE838, DOI 10.1152/ajpendo.2000.279.4.E838	42	10	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65317	10.1371/journal.pone.0065317	http://dx.doi.org/10.1371/journal.pone.0065317			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762342	Green Published, Green Submitted, gold			2022-12-27	WOS:000321099000054
J	Ge, XC; Rodriguez, R; Trinh, M; Gunsolley, J; Xu, P				Ge, Xiuchun; Rodriguez, Rafael; My Trinh; Gunsolley, John; Xu, Ping			Oral Microbiome of Deep and Shallow Dental Pockets In Chronic Periodontitis	PLOS ONE			English	Article							SUBGINGIVAL PLAQUE; DIVERSITY; PROFILES; HEALTH	We examined the subgingival bacterial biodiversity in untreated chronic periodontitis patients by sequencing 16S rRNA genes. The primary purpose of the study was to compare the oral microbiome in deep (diseased) and shallow (healthy) sites. A secondary purpose was to evaluate the influences of smoking, race and dental caries on this relationship. A total of 88 subjects from two clinics were recruited. Paired subgingival plaque samples were taken from each subject, one from a probing site depth >5 mm (deep site) and the other from a probing site depth <= 3mm (shallow site). A universal primer set was designed to amplify the V4-V6 region for oral microbial 16S rRNA sequences. Differences in genera and species attributable to deep and shallow sites were determined by statistical analysis using a two-part model and false discovery rate. Fifty-one of 170 genera and 200 of 746 species were found significantly different in abundances between shallow and deep sites. Besides previously identified periodontal disease-associated bacterial species, additional species were found markedly changed in diseased sites. Cluster analysis revealed that the microbiome difference between deep and shallow sites was influenced by patient-level effects such as clinic location, race and smoking. The differences between clinic locations may be influenced by racial distribution, in that all of the African Americans subjects were seen at the same clinic. Our results suggested that there were influences from the microbiome for caries and periodontal disease and these influences are independent.	[Ge, Xiuchun; My Trinh; Xu, Ping] Virginia Commonwealth Univ, VCU Philips Inst Oral & Craniofacial Mol Biol, Richmond, VA 23284 USA; [Rodriguez, Rafael; Gunsolley, John] Virginia Commonwealth Univ, Sch Dent, Dept Periodont, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University	Xu, P (corresponding author), Virginia Commonwealth Univ, VCU Philips Inst Oral & Craniofacial Mol Biol, Richmond, VA 23284 USA.	pxu@vcu.edu			National Institutes of Health [R01DE018138]; AD Williams Fund [6-48738]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023078, R01DE018138] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AD Williams Fund; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants R01DE018138 from the National Institutes of Health (PX) and by AD Williams Fund 6-48738 (JG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Axelsson P, 2004, J CLIN PERIODONTOL, V31, P749, DOI 10.1111/j.1600-051X.2004.00563.x; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Chhour KL, 2005, J CLIN MICROBIOL, V43, P843, DOI 10.1128/JCM.43.2.843-849.2005; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Duran-Pinedo AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028438; Figueredo CM, 2008, ORAL MICROBIOL IMMUN, V23, P173, DOI 10.1111/j.1399-302X.2007.00408.x; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Gross EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047722; Haffajee A D, 1994, Periodontol 2000, V5, P78, DOI 10.1111/j.1600-0757.1994.tb00020.x; Haffajee AD, 2005, PERIODONTOL 2000, V38, P9, DOI 10.1111/j.1600-0757.2005.00112.x; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Hummelen R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026602; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jenkinson HF, 2011, ENVIRON MICROBIOL, V13, P3077, DOI 10.1111/j.1462-2920.2011.02573.x; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037919; McLean JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032219; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Paster BJ, 2006, PERIODONTOL 2000, V42, P80, DOI 10.1111/j.1600-0757.2006.00174.x; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Rescala B, 2010, J PERIODONTOL, V81, P1308, DOI 10.1902/jop.2010.090643; Socransky S S, 1994, Periodontol 2000, V5, P7, DOI 10.1111/j.1600-0757.1994.tb00016.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Wagner BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020296; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Ward DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039315; Ximenez-Fyvie LA, 2000, J CLIN PERIODONTOL, V27, P648, DOI 10.1034/j.1600-051x.2000.027009648.x; Ximenez-Fyvie LA, 2000, J CLIN PERIODONTOL, V27, P722, DOI 10.1034/j.1600-051x.2000.027010722.x; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	29	76	82	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65520	10.1371/journal.pone.0065520	http://dx.doi.org/10.1371/journal.pone.0065520			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762384	gold, Green Submitted, Green Published			2022-12-27	WOS:000321099000075
J	Pollack, JB; Yoskowitz, D; Kim, HC; Montagna, PA				Pollack, Jennifer Beseres; Yoskowitz, David; Kim, Hae-Cheol; Montagna, Paul A.			Role and Value of Nitrogen Regulation Provided by Oysters (Crassostrea virginica) in the Mission-Aransas Estuary, Texas, USA	PLOS ONE			English	Article							NATURAL COASTAL WETLANDS; CHESAPEAKE BAY; WATER-QUALITY; RELATIVE VALUE; GALVESTON BAY; SOUTH TEXAS; REEFS; RESTORATION; POPULATIONS; PHOSPHORUS	Suspension-feeding activities of oysters impart a potentially significant benefit to estuarine ecosystems via reduction of water column nutrients, plankton and seston biomass, and primary productivity which can have a significant impact on human well-being. This study considered nitrogen regulation by eastern oysters Crassostrea virginica in the Mission-Aransas Estuary, Texas, USA, as a function of denitrification, burial, and physical transport from the system via harvest. Oyster reefs were estimated to remove 502.5 kg N km(-2) through denitrification of biodeposits and 251.3 kg N km(-2) in burial of biodeposits to sediments. Nitrogen is also physically transported out of the estuary via harvest of oysters. Commercial harvest of oysters in the Mission-Aransas Estuary can remove approximately 21,665 kg N per year via physical transport from the system. We developed a transferable method to value the service of nitrogen regulation by oysters, where the potential cost equivalent value of nitrogen regulation is quantified via cost estimates for a constructed biological nutrient removal (BNR) supplement to a wastewater treatment plant. The potential annual engineered cost equivalent of the service of nitrogen regulation and removal provided by reefs in the Mission-Aransas Estuary is $293,993 yr(-1). Monetizing ecosystem services can help increase awareness at the stakeholder level of the importance of oysters beyond commercial fishery values alone.	[Pollack, Jennifer Beseres] Texas A&M Univ, Dept Life Sci, Corpus Christi, TX USA; [Yoskowitz, David; Montagna, Paul A.] Texas A&M Univ, Harte Res Inst, Corpus Christi, TX USA; [Kim, Hae-Cheol] Natl Ocean Atmospher Adm, IM Syst Grp, Natl Ctr Environm Predict, College Pk, MD USA	Texas A&M University System; Texas A&M University System; National Oceanic Atmospheric Admin (NOAA) - USA	Pollack, JB (corresponding author), Texas A&M Univ, Dept Life Sci, Corpus Christi, TX USA.	jennifer.pollack@tamucc.edu	Montagna, Paul A./J-8208-2017	Montagna, Paul A./0000-0003-4199-3312	National Oceanic and Atmospheric Administration under the Comparative Assessment of Marine Ecosystem (CAMEO) program [NA09NMF4720179]; Texas General Land Office Coastal Management Program [12-142]; Texas A&M University-Corpus Christi; Harte Research Institute	National Oceanic and Atmospheric Administration under the Comparative Assessment of Marine Ecosystem (CAMEO) program; Texas General Land Office Coastal Management Program; Texas A&M University-Corpus Christi; Harte Research Institute	This study was partially supported by grant number NA09NMF4720179 from the National Oceanic and Atmospheric Administration under the Comparative Assessment of Marine Ecosystem (CAMEO) program, and by grant number 12-142 from the Texas General Land Office Coastal Management Program. Support was also provided by Texas A&M University-Corpus Christi and the Harte Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 3 INT C LIF CYCL MAN; Barbier EB, 2007, ECON POLICY, P178, DOI 10.1111/j.1468-0327.2007.00174.x; Bayne B.L., 1983, P407; Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5; BOYNTON WR, 1995, ESTUARIES, V18, P285, DOI 10.2307/1352640; BREAUX A, 1995, J ENVIRON MANAGE, V44, P285, DOI 10.1006/jema.1995.0046; Brumbaugh R. D., 2008, BASINS COASTS NEWS, V2, P8; Byers JE, 2006, TRENDS ECOL EVOL, V21, P493, DOI 10.1016/j.tree.2006.06.002; Bystrom O, 2000, ENVIRON RESOUR ECON, V16, P347, DOI 10.1023/A:1008316619355; Cerco CF, 2007, ESTUAR COAST, V30, P331, DOI 10.1007/BF02700175; Coen LD, 1998, AM FISH S S, V22, P438; Coen LD, 2007, MAR ECOL PROG SER, V341, P303, DOI 10.3354/meps341303; Craig LS, 2008, FRONT ECOL ENVIRON, V6, P529, DOI 10.1890/070080; DAME RF, 1989, MAR ECOL PROG SER, V54, P249, DOI 10.3354/meps054249; DAME RF, 1972, MAR BIOL, V17, P243, DOI 10.1007/BF00366299; Dame RF, 1996, ECOLOGY MARINE BIVAL; DELIA CF, 1992, WATER SCI TECHNOL, V26, P2635, DOI 10.2166/wst.1992.0365; DENNISON WC, 1993, BIOSCIENCE, V43, P86, DOI 10.2307/1311969; Environmental Protection Agency Office of Water, 2007, EPA823R07002 OFF WAT; Finkbeiner M, 2009, ATLAS SHALLOW WATER; Gaillard F, 2007, J AM HIST, V94, P856, DOI 10.2307/25095148; Grabowski JH, 2007, THEOR ECOL SER, P281; Grizzle RE, 2008, ESTUAR COAST, V31, P1208, DOI 10.1007/s12237-008-9098-8; Gunawardena M, 2005, ENVIRON MANAGE, V36, P535, DOI 10.1007/s00267-003-0286-9; Hicks R, 2004, WORKING PAPERS DEP E; Higgins CB, 2011, J ENVIRON QUAL, V40, P271, DOI 10.2134/jeq2010.0203; Hyun KH, 2001, AQUACULTURE, V199, P41, DOI 10.1016/S0044-8486(01)00509-9; Isaacs J, 2004, VALUE LOUISIAN UNPUB; Kasperski S, 2009, MAR RESOUR ECON, V24, P361, DOI 10.1086/mre.24.4.42629662; Kreeger DA, 2001, J EXP MAR BIOL ECOL, V260, P71, DOI 10.1016/S0022-0981(01)00242-8; Lindahl O, 2005, AMBIO, V34, P131, DOI 10.1639/0044-7447(2005)034[0131:IMWQBM]2.0.CO;2; Lipton D, 2008, J SHELLFISH RES, V27, P619, DOI 10.2983/0730-8000(2008)27[619:EBOARO]2.0.CO;2; McCay DPF, 2003, MAR ECOL PROG SER, V264, P197; Nelson KA, 2004, J EXP MAR BIOL ECOL, V298, P347, DOI 10.1016/S0022-0981(03)00367-8; NEWELL RIE, 1983, MAR ECOL PROG SER, V13, P47, DOI 10.3354/meps013047; Newell RIE, 2005, NATO SCI S SS IV EAR, V47, P93; Newell RIE, 2004, J SHELLFISH RES, V23, P51; Newell RIE, 2002, LIMNOL OCEANOGR, V47, P1367, DOI 10.4319/lo.2002.47.5.1367; Newell RIE, 1988, UNDERSTANDING ESTUAR, P536; NOAA Fisheries, 2011, OFF SCI TECHN ANN CO; NRC National Research Council., 2000, CLEAN COAST WAT UND; Parsons T.R., 1984, BIOL OCEANOGRAPHIC P, V3rd; Peterson CH, 2003, MAR ECOL PROG SER, V264, P297, DOI 10.3354/meps264297; Piazza BP, 2005, RESTOR ECOL, V13, P499, DOI 10.1111/j.1526-100X.2005.00062.x; Piehler MF, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00082.1; Pollack JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040839; Pollack JB, 2011, ESTUAR COAST, V34, P187, DOI 10.1007/s12237-010-9338-6; POWELL EN, 1995, FISH RES, V24, P199, DOI 10.1016/0165-7836(95)00370-P; Robillard MMR, 2010, J SHELLFISH RES, V29, P291, DOI 10.2983/035.029.0203; ROMBERGER HP, 1981, AQUACULTURE, V25, P77, DOI 10.1016/0044-8486(81)90101-0; ROTHSCHILD BJ, 1994, MAR ECOL PROG SER, V111, P29, DOI 10.3354/meps111029; Scranton Sewer Authority, 2006, LONG TERM CONTR PLAN; SHABMAN LA, 1978, COAST ZONE MANAGE J, V4, P231, DOI 10.1080/08920757809361777; Shumway S. E., 2012, WORLD AQUACULT, V34, P15, DOI DOI 10.1097/TA.0b013e318270160d; Smith KA, 2009, ESTUAR COAST, V32, P748, DOI 10.1007/s12237-009-9170-z; Smyth AR, 2013, ESTUAR COAST, V36, P44, DOI 10.1007/s12237-012-9554-3; SONIAT TM, 1984, CONTRIB MAR SCI, V27, P127; Stunz GW, 2010, MAR ECOL PROG SER, V406, P147, DOI 10.3354/meps08556; THOMPSON SP, 1995, ESTUARIES, V18, P399, DOI 10.2307/1352322; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; WELLS HW, 1961, ECOL MONOGR, V31, P239, DOI 10.2307/1948554; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; WilsonOrmond EA, 1997, MAR ECOL-P S Z N I, V18, P1, DOI 10.1111/j.1439-0485.1997.tb00424.x; YOON WB, 1992, MAR ECOL PROG SER, V90, P157, DOI 10.3354/meps090157	64	56	59	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65314	10.1371/journal.pone.0065314	http://dx.doi.org/10.1371/journal.pone.0065314			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762341	Green Published, Green Submitted, gold			2022-12-27	WOS:000321099000053
J	Tesorero, RA; Yu, N; Wright, JO; Svencionis, JP; Cheng, Q; Kim, JH; Cho, KH				Tesorero, Rafael A.; Yu, Ning; Wright, Jordan O.; Svencionis, Juan P.; Cheng, Qiang; Kim, Jeong-Ho; Cho, Kyu Hong			Novel Regulatory Small RNAs in Streptococcus pyogenes	PLOS ONE			English	Article							SMALL NONCODING RNAS; GROUP-A STREPTOCOCCUS; VIRULENCE FACTOR REGULATION; ESCHERICHIA-COLI; SOLUBLE-RNAS; OUTER-MEMBRANE; PREDICTION; IDENTIFICATION; SEQUENCE; GENES	Streptococcus pyogenes (Group A Streptococcus or GAS) is a Gram-positive bacterial pathogen that has shown complex modes of regulation of its virulence factors to cause diverse diseases. Bacterial small RNAs are regarded as novel widespread regulators of gene expression in response to environmental signals. Recent studies have revealed that several small RNAs (sRNAs) have an important role in S. pyogenes physiology and pathogenesis by regulating gene expression at the translational level. To search for new sRNAs in S. pyogenes, we performed a genomewide analysis through computational prediction followed by experimental verification. To overcome the limitation of low accuracy in computational prediction, we employed a combination of three different computational algorithms (sRNAPredict, eQRNA and RNAz). A total of 45 candidates were chosen based on the computational analysis, and their transcription was analyzed by reverse-transcriptase PCR and Northern blot. Through this process, we discovered 7 putative novel trans-acting sRNAs. Their abundance varied between different growth phases, suggesting that their expression is influenced by environmental or internal signals. Further, to screen target mRNAs of an sRNA, we employed differential RNA sequencing analysis. This study provides a significant resource for future study of small RNAs and their roles in physiology and pathogenesis of S. pyogenes.	[Tesorero, Rafael A.; Wright, Jordan O.; Svencionis, Juan P.; Cho, Kyu Hong] So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA; [Yu, Ning; Cheng, Qiang] So Illinois Univ, Dept Comp Sci, Carbondale, IL 62901 USA; [Kim, Jeong-Ho] George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; George Washington University	Cho, KH (corresponding author), So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA.	kyuhongcho@gmail.com		Tesorero, Rafael/0000-0002-1636-0954	American Heart Association [11SDG7440083]; NIH [GM087470]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087470] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Scientist Development Grant 11SDG7440083 from the American Heart Association to KHC and NIH grant GM087470 to JHK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman YM, 2011, NUCLEIC ACIDS RES, V39, P1843, DOI 10.1093/nar/gkq1065; Altuvia S, 2007, CURR OPIN MICROBIOL, V10, P257, DOI 10.1016/j.mib.2007.05.003; Backofen R, 2010, RNA BIOL, V7, P33, DOI 10.4161/rna.7.1.10655; Beres SB, 2002, P NATL ACAD SCI USA, V99, P10078, DOI 10.1073/pnas.152298499; Betschel SD, 1998, INFECT IMMUN, V66, P1671, DOI 10.1128/IAI.66.4.1671-1679.1998; Biswas I, 2001, INFECT IMMUN, V69, P7029, DOI 10.1128/IAI.69.11.7029-7038.2001; Busch A, 2008, BIOINFORMATICS, V24, P2849, DOI 10.1093/bioinformatics/btn544; BYEON WH, 1984, J BACTERIOL, V158, P543, DOI 10.1128/JB.158.2.543-550.1984; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Coventry A, 2004, P NATL ACAD SCI USA, V101, P12102, DOI 10.1073/pnas.0404193101; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Eggenhofer F, 2011, NUCLEIC ACIDS RES, V39, pW149, DOI 10.1093/nar/gkr467; Federle MJ, 2002, MOL MICROBIOL, V43, P1161, DOI 10.1046/j.1365-2958.2002.02810.x; Gottesman S, 2004, ANNU REV MICROBIOL, V58, P303, DOI 10.1146/annurev.micro.58.030603.123841; Granok AB, 2000, J BACTERIOL, V182, P1529, DOI 10.1128/JB.182.6.1529-1540.2000; Gripenland J, 2010, NAT REV MICROBIOL, V8, P857, DOI 10.1038/nrmicro2457; GRUNDY FJ, 1994, J MOL BIOL, V235, P798, DOI 10.1006/jmbi.1994.1038; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Guillier M, 2006, MOL MICROBIOL, V59, P231, DOI 10.1111/j.1365-2958.2005.04929.x; Ji YD, 1996, INFECT IMMUN, V64, P503, DOI 10.1128/IAI.64.2.503-510.1996; Johansen J, 2006, J MOL BIOL, V364, P1, DOI 10.1016/j.jmb.2006.09.004; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Knudsen B, 2003, NUCLEIC ACIDS RES, V31, P3423, DOI 10.1093/nar/gkg614; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; Kreikemeyer B, 2001, MOL MICROBIOL, V39, P392, DOI 10.1046/j.1365-2958.2001.02226.x; Landt SG, 2008, MOL MICROBIOL, V68, P600, DOI 10.1111/j.1365-2958.2008.06172.x; Lease RA, 2004, J BACTERIOL, V186, P6179, DOI 10.1128/JB.186.18.6179-6185.2004; Li ZQ, 1999, J BACTERIOL, V181, P6019, DOI 10.1128/JB.181.19.6019-6027.1999; Livny J, 2005, NUCLEIC ACIDS RES, V33, P4096, DOI 10.1093/nar/gki715; Livny J, 2006, NUCLEIC ACIDS RES, V34, P3484, DOI 10.1093/nar/gkl453; Livny J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003197; Lopez R, 2003, NUCLEIC ACIDS RES, V31, P3795, DOI 10.1093/nar/gkg573; Macke TJ, 2001, NUCLEIC ACIDS RES, V29, P4724, DOI 10.1093/nar/29.22.4724; Majdalani N, 2005, CRIT REV BIOCHEM MOL, V40, P93, DOI 10.1080/10409230590918702; Mangold M, 2004, MOL MICROBIOL, V53, P1515, DOI 10.1111/j.1365-2958.2004.04222.x; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Mraheil MA, 2010, MICROB BIOTECHNOL, V3, P658, DOI 10.1111/j.1751-7915.2010.00171.x; Nelson N, 2000, J EXP BIOL, V203, P89; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Papenfort K, 2006, MOL MICROBIOL, V62, P1674, DOI 10.1111/j.1365-2958.2006.05524.x; Patenge N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-550; Perez N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007668; Pichon C, 2003, BIOINFORMATICS, V19, P1707, DOI 10.1093/bioinformatics/btg235; Raasch P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-491; Ramirez-Pena E, 2010, MOL MICROBIOL, V78, P1332, DOI 10.1111/j.1365-2958.2010.07427.x; Repoila F, 2003, MOL MICROBIOL, V48, P855, DOI 10.1046/j.1365-2958.2003.03454.x; Rivas E, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-8; Roberts SA, 2007, MOL MICROBIOL, V66, P1506, DOI 10.1111/j.1365-2958.2007.06015.x; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; SOLIOZ M, 1994, J BIOL CHEM, V269, P9453; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Tapp J, 2003, INT J SYST EVOL MICR, V53, P1861, DOI 10.1099/ijs.0.02639-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tjaden B, 2006, NUCLEIC ACIDS RES, V34, P2791, DOI 10.1093/nar/gkl356; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trevino J, 2010, MICROBIOL-SGM, V156, P1342, DOI 10.1099/mic.0.036558-0; Udekwu KI, 2007, NUCLEIC ACIDS RES, V35, P1279, DOI 10.1093/nar/gkl1154; Vogel J, 2007, CURR OPIN MICROBIOL, V10, P262, DOI 10.1016/j.mib.2007.06.001; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Wassarman KM, 1999, TRENDS MICROBIOL, V7, P37; Yachie N, 2006, GENE, V372, P171, DOI 10.1016/j.gene.2005.12.034; Zhou YX, 2011, J CELL PHYSIOL, V226, P968, DOI 10.1002/jcp.22483	65	30	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64021	10.1371/journal.pone.0064021	http://dx.doi.org/10.1371/journal.pone.0064021			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762235	Green Submitted, Green Published, gold			2022-12-27	WOS:000321099000005
J	Watanabe, S				Watanabe, Shigeru			Preference for and Discrimination of Paintings by Mice	PLOS ONE			English	Article							MUSIC	I measured preference for paintings (Renoir vs. Picasso or Kandinsky vs. Mondrian) in mice. In general mice did not display a painting preference except for two mice: one preferred Renoir to Picasso, and the other preferred Kandinsky to Mondrian. Thereafter, I examined discrimination of paintings with new mice. When exposure to paintings of one artist was associated with an injection of morphine (3.0 mg/kg), mice displayed conditioned preference for those paintings, showing discrimination of paintings by Renoir from those by Picasso, and paintings by Kandinsky from those by Mondrian after the conditioning. They also exhibited generalization of the preference to novel paintings of the artists. After conditioning with morphine for a set of paintings consisting of two artists, mice showed discrimination between two sets of paintings also from the two artists but not in association with morphine. These results suggest that mice can discriminate not only between an artist's style but also among paintings of the same artist. When mice were trained to discriminate a pair of paintings by Kandinsky and Renoir in an operant chamber equipped with a touch screen, they showed transfer of the discrimination to new pairs of the artists, but did not show transfer of discrimination of paintings by other artists, suggesting generalization.	Keio Univ, Dept Psychol, Minato Ku, Tokyo, Japan	Keio University	Watanabe, S (corresponding author), Keio Univ, Dept Psychol, Minato Ku, Mita 2-15-45, Tokyo, Japan.	swat@flet.keio.ac.jp			Global COE Program by JSPS (Japan) [D-19]	Global COE Program by JSPS (Japan)	This work was supported by Global COE Program (D-19) by JSPS (Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awaya F, 2003, NEUROREPORT, V14, P1511, DOI 10.1097/00001756-200308060-00022; BORLONGAN CV, 1994, PHARMACOL BIOCHEM BE, V48, P677, DOI 10.1016/0091-3057(94)90331-X; Hauser MD, 2003, NAT NEUROSCI, V6, P663, DOI 10.1038/nn1080; Humphrey N K, 1972, Perception, V1, P395, DOI 10.1068/p010395; Ikkatai Y, 2011, ANIM COGN, V14, P227, DOI 10.1007/s10071-010-0356-3; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; Otsuka Y, 2009, BEHAV PROCESS, V80, P121, DOI 10.1016/j.beproc.2008.10.009; Pike AWG, 2012, SCIENCE, V336, P1409, DOI 10.1126/science.1219957; Rensch B., 1957, Zeitschrift fuer Tierpsychologie, V14, P71; Rensch B., 1958, Zeitschrift fuer Tierpsychologie, V15, P447; Shimozuka T, REINFORCING DI UNPUB; WATANABE S, 1995, J EXP ANAL BEHAV, V63, P165, DOI 10.1901/jeab.1995.63-165; Watanabe S, 1998, BEHAV PROCESS, V43, P211, DOI 10.1016/S0376-6357(98)00014-X; Watanabe S, 2001, Anim Cogn, V4, P147, DOI 10.1007/s100710100112; Watanabe S, 2009, PHILOSOPHY, V121, P1; Watanabe S, 2011, ANIM COGN, V14, P797, DOI 10.1007/s10071-011-0412-7; Watanabe S, 2010, ANIM COGN, V13, P75, DOI 10.1007/s10071-009-0246-8; Wilson FA, 1994, BEHAV	18	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65335	10.1371/journal.pone.0065335	http://dx.doi.org/10.1371/journal.pone.0065335			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762346	Green Published, gold, Green Submitted			2022-12-27	WOS:000321099000056
J	Shende, VR; Neuendorff, N; Earnest, DJ				Shende, Vikram R.; Neuendorff, Nichole; Earnest, David J.			Role of miR-142-3p in the Post-Transcriptional Regulation of the Clock Gene Bmal1 in the Mouse SCN	PLOS ONE			English	Article							CIRCADIAN-CLOCK; SUPRACHIASMATIC NUCLEUS; RHYTHMS; EXPRESSION; COMPONENT; PERIOD; TRANSCRIPTION; OSCILLATION; SPECIFICITY; MICRORNAS	MicroRNAs (miRNAs) are small non-coding RNAs that function as post-transcriptional modulators by regulating stability or translation of target mRNAs. Recent studies have implicated miRNAs in the regulation of mammalian circadian rhythms. To explore the role of miRNAs in the post-transcriptional modulation of core clock genes in the master circadian pacemaker, we examined miR-142-3p for evidence of circadian expression in the suprachiasmatic nuclei (SCN), regulation of its putative clock gene target Bmal1 via specific binding sites in the 3' UTR and overexpression-induced changes in the circadian rhythm of BMAL1 protein levels in SCN cells. In mice exposed to constant darkness (DD), miR-142-3p levels in the SCN were characterized by circadian rhythmicity with peak expression during early subjective day at CT 3. Mutagenesis studies indicate that two independent miRNA recognition elements located at nucleotides 1-7 and 335-357 contribute equally to miR-142-3p-induced repression of luciferase-reported Bmal1 3' UTR activity. Importantly, overexpression of miR-142-3p in immortalized SCN cells abolished circadian variation in endogenous BMAL1 protein levels in vitro. Collectively, our results suggest that miR-142-3p may play a role in the post-transcriptional modulation of Bmal1 and its oscillatory regulation in molecular feedback loops mediating SCN circadian function.	[Shende, Vikram R.; Earnest, David J.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Shende, Vikram R.; Earnest, David J.] Texas A&M Univ, Ctr Biol Clocks Res, College Stn, TX USA; [Neuendorff, Nichole; Earnest, David J.] Coll Med, Texas A&M Hlth Sci Ctr, Dept Neurosci & Expt Therapeut, Bryan, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Earnest, DJ (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	dearnest@medicine.tamhsc.edu	Shende, Vikram/M-2816-2017	Earnest, David/0000-0003-4433-6481	Texas A&M Health Science Center bridging funds	Texas A&M Health Science Center bridging funds	This work was supported by Texas A&M Health Science Center bridging funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GC, 2004, NEUROSCIENCE, V127, P989, DOI 10.1016/j.neuroscience.2004.06.003; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; BOS NPA, 1990, BRAIN RES, V511, P158, DOI 10.1016/0006-8993(90)90235-4; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; EARNEST DJ, 1986, BRAIN RES, V382, P129, DOI 10.1016/0006-8993(86)90119-8; Farnell YF, 2011, EUR J NEUROSCI, V33, P1533, DOI 10.1111/j.1460-9568.2011.07629.x; Farnell YZ, 2008, ALCOHOL CLIN EXP RES, V32, P544, DOI 10.1111/j.1530-0277.2007.00598.x; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; GROOS G, 1982, NEUROSCI LETT, V34, P283, DOI 10.1016/0304-3940(82)90189-6; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Honma S, 1998, BIOCHEM BIOPH RES CO, V250, P83, DOI 10.1006/bbrc.1998.9275; Huang B, 2009, EMBO REP, V10, P180, DOI 10.1038/embor.2008.224; Kadener S, 2009, GENE DEV, V23, P2179, DOI 10.1101/gad.1819509; Kojima S, 2011, J CELL SCI, V124, P311, DOI 10.1242/jcs.065771; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang FQ, 1998, NEUROSCI LETT, V242, P89, DOI 10.1016/S0304-3940(98)00062-7; Maywood ES, 2003, J NEUROENDOCRINOL, V15, P329, DOI 10.1046/j.1365-2826.2003.00971.x; Nagel R, 2009, FEBS J, V276, P5447, DOI 10.1111/j.1742-4658.2009.07229.x; Nahm SS, 2005, J NEUROSCI, V25, P9304, DOI 10.1523/jneurosci.2733-05.2005; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; PROSSER RA, 1989, J NEUROSCI, V9, P1073; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; SCHWARTZ WJ, 1980, J COMP NEUROL, V189, P157, DOI 10.1002/cne.901890109; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Shende VR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022586; SHIBATA S, 1982, BRAIN RES, V247, P154, DOI 10.1016/0006-8993(82)91041-1; Staiger D, 2011, CELL MOL LIFE SCI, V68, P71, DOI 10.1007/s00018-010-0513-5; TUREK FW, 1985, ANNU REV PHYSIOL, V47, P49, DOI 10.1146/annurev.ph.47.030185.000405; Yamamoto T, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-18; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	46	36	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65300	10.1371/journal.pone.0065300	http://dx.doi.org/10.1371/journal.pone.0065300			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755214	Green Published, gold, Green Submitted			2022-12-27	WOS:000320579400051
J	Abranches, J; Tijerina, P; Aviles-Reyes, A; Gaca, AO; Kajfasz, JK; Lemos, JA				Abranches, Jacqueline; Tijerina, Pamella; Aviles-Reyes, Alejandro; Gaca, Anthony O.; Kajfasz, Jessica K.; Lemos, Jose A.			The Cell Wall-Targeting Antibiotic Stimulon of Enterococcus faecalis	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; LISTERIA-MONOCYTOGENES; VANCOMYCIN RESISTANCE; LIPOTEICHOIC ACID; HISTIDINE KINASE; STRESS-RESPONSE; EXPRESSION; BIOSYNTHESIS; PHOSPHATASE; REVEALS	Enterococcus faecalis is an opportunistic nosocomial pathogen that is highly resistant to a variety of environmental insults, including an intrinsic tolerance to antimicrobials that target the cell wall (CW). With the goal of determining the CW-stress stimulon of E. faecalis, the global transcriptional profile of E. faecalis OG1RF exposed to ampicillin, bacitracin, cephalotin or vancomycin was obtained via microarrays. Exposure to the beta-lactams ampicillin and cephalotin resulted in the fewest transcriptional changes with 50 and 192 genes differentially expressed 60 min after treatment, respectively. On the other hand, treatment with bacitracin or vancomycin for 60 min affected the expression of, respectively, 377 and 297 genes. Despite the differences in the total number of genes affected, all antibiotics induced a very similar gene expression pattern with an overrepresentation of genes encoding hypothetical proteins, followed by genes encoding proteins associated with cell envelope metabolism as well as transport and binding proteins. In particular, all drug treatments, most notably bacitracin and vancomycin, resulted in an apparent metabolic downshift based on the repression of genes involved in translation, energy metabolism, transport and binding. Only 19 genes were up-regulated by all conditions at both the 30 and 60 min time points. Among those 19 genes, 4 genes encoding hypothetical proteins (EF0026, EF0797, EF1533 and EF3245) were inactivated and the respective mutant strains characterized in relation to antibiotic tolerance and virulence in the Galleria mellonella model. The phenotypes obtained for two of these mutants, DEF1533 and DEF3245, support further characterization of these genes as potential candidates for the development of novel preventive or therapeutic approaches.	[Abranches, Jacqueline; Tijerina, Pamella; Aviles-Reyes, Alejandro; Gaca, Anthony O.; Kajfasz, Jessica K.; Lemos, Jose A.] Univ Rochester, Med Ctr, Ctr Oral Biol, Rochester, NY 14642 USA; [Abranches, Jacqueline; Tijerina, Pamella; Aviles-Reyes, Alejandro; Gaca, Anthony O.; Lemos, Jose A.] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Lemos, JA (corresponding author), Univ Rochester, Med Ctr, Ctr Oral Biol, Rochester, NY 14642 USA.	jose_lemos@urmc.rochester.edu		Gaca, Anthony/0000-0003-3476-7034; Lemos, Jose/0000-0003-0791-5863	National Institutes of Health-National Institute of General Medical Sciences [R25 GM064133]; National Institutes of Health-National Institute of Dental and Craniofacial Research grant [T90 DE021985]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM064133] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health-National Institute of Dental and Craniofacial Research grant; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	PT was supported by National Institutes of Health-National Institute of General Medical Sciences grant R25 GM064133. AOG and AAR were supported by National Institutes of Health-National Institute of Dental and Craniofacial Research grant T90 DE021985. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aakra A, 2005, ANTIMICROB AGENTS CH, V49, P2246, DOI 10.1128/AAC.49.6.2246-2259.2005; Aakra A, 2010, INT J MICROBIOL, V2010; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Bearman GML, 2005, ARCH MED RES, V36, P646, DOI 10.1016/j.arcmed.2005.02.005; Bernard R, 2005, J BIOL CHEM, V280, P28852, DOI 10.1074/jbc.M413750200; Bitoun JP, 2012, APPL ENVIRON MICROB, V78, P2914, DOI 10.1128/AEM.07823-11; Bizzini A, 2009, J ANTIMICROB CHEMOTH, V64, P1196, DOI 10.1093/jac/dkp369; Bourgogne A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r110; Breidenstein EBM, 2012, ANTIMICROB AGENTS CH, V56, P2879, DOI 10.1128/AAC.06014-11; Brunskill EW, 1996, J BACTERIOL, V178, P5810, DOI 10.1128/jb.178.19.5810-5812.1996; Cao M, 2002, MOL MICROBIOL, V45, P1267, DOI 10.1046/j.1365-2958.2002.03050.x; Chatfield CH, 2005, MICROBIOL-SGM, V151, P625, DOI 10.1099/mic.0.27604-0; Collins B, 2012, APPL ENVIRON MICROB, V78, P2923, DOI 10.1128/AEM.07402-11; Doun SS, 2005, PROTEIN SCI, V14, P1134, DOI 10.1110/ps.041210405; Fontana R, 1996, MICROB DRUG RESIST, V2, P209, DOI 10.1089/mdr.1996.2.209; Fritsch F, 2011, MICROBIOL-SGM, V157, P373, DOI 10.1099/mic.0.044776-0; Gaca AO, 2012, MICROBIOL-SGM, V158, P1994, DOI 10.1099/mic.0.060236-0; Gutmann L, 1996, ANTIMICROB AGENTS CH, V40, P257, DOI 10.1128/AAC.40.1.257; Haas W, 2005, J BACTERIOL, V187, P8205, DOI 10.1128/JB.187.23.8205-8210.2005; Heuston S, 2012, MICROBIOL-SGM, V158, P1389, DOI 10.1099/mic.0.051599-0; Hollenbeck BL, 2012, VIRULENCE, V3, P421, DOI 10.4161/viru.21282; Hubscher J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-617; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kristich CJ, 2007, PLASMID, V57, P131, DOI 10.1016/j.plasmid.2006.08.003; Lebreton F, 2009, INFECT IMMUN, V77, P2832, DOI 10.1128/IAI.01218-08; Leenhouts K, 1996, MOL GEN GENET, V253, P217, DOI 10.1007/s004380050315; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Lopez G, 2012, BIOMETALS, V25, P737, DOI 10.1007/s10534-012-9539-5; McAleese F, 2006, J BACTERIOL, V188, P1120, DOI 10.1128/JB.188.3.1120-1133.2006; McCormick NE, 2011, MICROBIOL-SGM, V157, P2248, DOI 10.1099/mic.0.048140-0; de Oliveira NEM, 2011, MICROBIOL-SGM, V157, P656, DOI 10.1099/mic.0.041897-0; MURRAY BE, 1990, CLIN MICROBIOL REV, V3, P46, DOI 10.1128/CMR.3.1.46-65.1990; Muthaiyan A, 2008, ANTIMICROB AGENTS CH, V52, P980, DOI 10.1128/AAC.01121-07; PALLARES R, 1993, ARCH INTERN MED, V153, P1581, DOI 10.1001/archinte.153.13.1581; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Peschel A, 2000, ANTIMICROB AGENTS CH, V44, P2845, DOI 10.1128/AAC.44.10.2845-2847.2000; Ramarao N, 2012, JOVE-J VIS EXP, DOI 10.3791/4392; Reynolds PE, 2005, ANTIMICROB AGENTS CH, V49, P21, DOI 10.1128/AAC.49.1.21-25.2005; Rigottier-Gois L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029023; Rogers PD, 2007, J ANTIMICROB CHEMOTH, V59, P616, DOI 10.1093/jac/dkl560; Rossi J, 2003, ANTIMICROB AGENTS CH, V47, P2558, DOI 10.1128/AAC.47.8.2558-2564.2003; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Sigal YJ, 2005, BIOCHEM J, V387, P281, DOI 10.1042/BJ20041771; Solheim M, 2007, APPL ENVIRON MICROB, V73, P5767, DOI 10.1128/AEM.00651-07; Song Y, 2012, ANTIMICROB AGENTS CH, V56, P3157, DOI 10.1128/AAC.05403-11; STONE KJ, 1972, P NATL ACAD SCI USA, V69, P1287, DOI 10.1073/pnas.69.5.1287; TERLECKYJ B, 1975, INFECT IMMUN, V11, P649, DOI 10.1128/IAI.11.4.649-655.1975; Utaida S, 2003, MICROBIOL-SGM, V149, P2719, DOI 10.1099/mic.0.26426-0; Vebo HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012489; Vebo HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007660; Waggoner DW, 1996, J BIOL CHEM, V271, P16506, DOI 10.1074/jbc.271.28.16506; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956; Wen ZZT, 2006, J BACTERIOL, V188, P2983, DOI 10.1128/JB.188.8.2983-2992.2006; Zhang XL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002804; Zhang Y, 2008, BIOSCI BIOTECH BIOCH, V72, P3134, DOI 10.1271/bbb.80305	56	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64875	10.1371/journal.pone.0064875	http://dx.doi.org/10.1371/journal.pone.0064875			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755154	Green Submitted, Green Published, gold			2022-12-27	WOS:000319872300034
J	Claudio, ERG; Endlich, PW; Santos, RL; Moyses, MR; Bissoli, NS; Gouvea, SA; Silva, JF; Lemos, VS; Abreu, GR				Claudio, Erick R. G.; Endlich, Patrick W.; Santos, Roger L.; Moyses, Margareth R.; Bissoli, Nazare S.; Gouvea, Sonia A.; Silva, Josiane F.; Lemos, Virginia S.; Abreu, Glaucia R.			Effects of Chronic Swimming Training and Oestrogen Therapy on Coronary Vascular Reactivity and Expression of Antioxidant Enzymes in Ovariectomized Rats	PLOS ONE			English	Article							HORMONE REPLACEMENT THERAPY; CU/ZN-SUPEROXIDE-DISMUTASE; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; NITRIC-OXIDE; ANGIOTENSIN-II; ENDOTHELIAL DYSFUNCTION; BODY-COMPOSITION; BLOOD-PRESSURE; HEART-DISEASE	The aim of this study was to evaluate the effects of swimming training (SW) and oestrogen replacement therapy (ERT) on coronary vascular reactivity and the expression of antioxidant enzymes in ovariectomized rats. Animals were randomly assigned to one of five groups: sham (SH), ovariectomized (OVX), ovariectomized with E2 (OE2), ovariectomized with exercise (OSW), and ovariectomized with E2 plus exercise (OE2+SW). The SW protocol (5x/week, 60 min/day) and/or ERT were conducted for 8 weeks; the vasodilator response to bradykinin was analysed (Langendorff Method), and the expression of antioxidant enzymes (SOD-1 and 2, catalase) and eNOS and iNOS were evaluated by Western blotting. SW and ERT improved the vasodilator response to the highest dose of bradykinin (1000 ng). However, in the OSW group, this response was improved at 100, 300 and 1000 ng when compared to OVX (p<0,05). The SOD-1 expression was increased in all treated/trained groups compared to the OVX group (p<0,05), and catalase expression increased in the OSW group only. In the trained group, eNOS increased vs. OE2, and iNOS decreased vs. SHAM (p<0,05). SW may represent an alternative to ERT by improving coronary vasodilation, most likely by increasing antioxidant enzyme and eNOS expression and augmenting NO bioavailability.	[Claudio, Erick R. G.; Endlich, Patrick W.; Santos, Roger L.; Moyses, Margareth R.; Bissoli, Nazare S.; Gouvea, Sonia A.; Abreu, Glaucia R.] Univ Fed Espirito Santo, Hlth Sci Ctr, Dept Physiol Sci, Vitoria, ES, Brazil; [Silva, Josiane F.; Lemos, Virginia S.] Univ Fed Minas Gerais, Dept Physiol & Biophys, Inst Biol Sci, Belo Horizonte, MG, Brazil	Universidade Federal do Espirito Santo; Universidade Federal de Minas Gerais	Claudio, ERG (corresponding author), Univ Fed Espirito Santo, Hlth Sci Ctr, Dept Physiol Sci, Vitoria, ES, Brazil.	erick_edf@yahoo.com.br	dos Santos, Roger Lyrio/AAH-7100-2020; Bissoli, Nazare/ABA-2679-2021; Lemos, Virginia/B-7305-2018; Abreu, Glaucia/F-8610-2012; Silva, Josiane/AAC-8361-2019	dos Santos, Roger Lyrio/0000-0003-4316-7196; Lemos, Virginia/0000-0003-1234-9325; Silva, Josiane/0000-0002-6623-7946; Goncalves Claudio, Erick Roberto/0000-0001-7030-3558	Conselho Nacional de Pesquisa [139522/2010-7]	Conselho Nacional de Pesquisa	ERGC was supported by a fellowship from Conselho Nacional de Pesquisa - 139522/2010-7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas IA, 2006, HYPERTENSION, V48, P497, DOI 10.1161/01.HYP.0000235865.03528.f1; Boo YC, 2002, AM J PHYSIOL-HEART C, V283, pH1819, DOI 10.1152/ajpheart.00214.2002; Boo YC, 2002, J BIOL CHEM, V277, P3388, DOI 10.1074/jbc.M108789200; Borgo MV, 2011, BRAZ J MED BIOL RES, V44, P786, DOI 10.1590/S0100-879X2011000800008; Bourassa PAK, 1996, P NATL ACAD SCI USA, V93, P10022, DOI 10.1073/pnas.93.19.10022; Brandt C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/520258; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Cai H, 2001, ARTERIOSCL THROM VAS, V21, P1571, DOI 10.1161/hq1001.097028; Ceravolo GS, 2013, STEROIDS, V78, P341, DOI 10.1016/j.steroids.2012.11.018; Colditz GA, 1998, JNCI-J NATL CANCER I, V90, P814, DOI 10.1093/jnci/90.11.814; Davis ME, 2001, CIRC RES, V89, P1073, DOI 10.1161/hh2301.100806; de Moraes C, 2008, BMC PHYSL, V29, P8; Douchi T, 2000, MATURITAS, V35, P25, DOI 10.1016/S0378-5122(00)00094-3; Elhage R, 1997, ARTERIOSCL THROM VAS, V17, P2679, DOI 10.1161/01.ATV.17.11.2679; Endlich PW, 2011, PEPTIDES, V32, P1706, DOI 10.1016/j.peptides.2011.06.027; Faraci FM, 2004, ARTERIOSCL THROM VAS, V24, P1367, DOI 10.1161/01.ATV.0000133604.20182.cf; Ferrara CM, 2002, J CLIN ENDOCR METAB, V87, P4166, DOI 10.1210/jc.2001-012034; Forstermann U, 2010, PFLUG ARCH EUR J PHY, V459, P923, DOI 10.1007/s00424-010-0808-2; Genazzani AR, 2006, GYNECOL ENDOCRINOL, V22, P145, DOI 10.1080/09513590600629092; Goldhammer E, 2005, INT J CARDIOL, V100, P93, DOI 10.1016/j.ijcard.2004.08.073; Hernandez I, 2000, AM J PHYSIOL-REG I, V279, pR1599, DOI 10.1152/ajpregu.2000.279.5.R1599; Hsia J, 2006, ARCH INTERN MED; Inoue N, 1996, CIRC RES, V79, P32, DOI 10.1161/01.RES.79.1.32; Kang LS, 2011, AM J PHYSIOL-HEART C, V300, pH2105, DOI 10.1152/ajpheart.00349.2010; Karolkiewicz J, 2009, ARCH GERONTOL GERIAT, V49, pE67, DOI 10.1016/j.archger.2008.09.001; Kohno H, 2002, JPN HEART J, V43, P25, DOI 10.1536/jhj.43.25; Kuru O, 2009, J APPL PHYSIOL, V107, P896, DOI 10.1152/japplphysiol.91180.2008; Lauer N, 2005, CARDIOVASC RES, V65, P254, DOI 10.1016/j.cardiores.2004.09.010; Laughlin MH, 2003, J APPL PHYSIOL, V94, P234, DOI 10.1152/japplphysiol.00246.2002; LeBlanc AJ, 2009, AM J PHYSIOL-REG I, V297, pR1713, DOI 10.1152/ajpregu.00178.2009; Lee S, 2011, AM J PHYSIOL-HEART C, V301, pH306, DOI 10.1152/ajpheart.01306.2010; Liu JK, 2000, J APPL PHYSIOL, V89, P21; Liu YP, 2002, CIRC RES, V91, P1070, DOI 10.1161/01.RES.0000046003.14031.98; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matoba T, 2000, J CLIN INVEST, V106, P1521, DOI 10.1172/JCI10506; McAllister RM, 2010, EUR J APPL PHYSIOL, V110, P1019, DOI 10.1007/s00421-010-1584-6; Moraes AN, 2011, BASIC CLIN PHARMACOL, V109, P334, DOI 10.1111/j.1742-7843.2011.00734.x; Okabe T, 2007, CARDIOVASC RES, V74, P537, DOI 10.1016/j.cardiores.2007.02.019; Otake A, 2010, INT HEART J, V51, P125, DOI 10.1536/ihj.51.125; Park JH, 2008, ACTA PHYSIOL, V193, P47, DOI 10.1111/j.1748-1716.2007.01799.x; Ray P, 1997, FEBS LETT, V409, P79, DOI 10.1016/S0014-5793(97)00487-0; Roque FR, 2011, CLINICS, V66, P2105, DOI 10.1590/S1807-59322011001200017; Rush JWE, 2000, AM J PHYSIOL-HEART C, V279, pH2068, DOI 10.1152/ajpheart.2000.279.5.H2068; Saengsirisuwan V, 2009, METABOLISM, V58, P38, DOI 10.1016/j.metabol.2008.08.004; Santos RL, 2004, BRAZ J MED BIOL RES, V37, P569, DOI 10.1590/S0100-879X2004000400014; Senechal M, 2011, CLIN INTERV AGING, V6, P221, DOI 10.2147/CIA.S23574; Shimada K, 2007, CIRC J, V71, P1147, DOI 10.1253/circj.71.1147; Shimokawa H, 2010, PFLUG ARCH EUR J PHY, V459, P915, DOI 10.1007/s00424-010-0790-8; Shinoda M, 2002, INT J OBESITY, V26, P335, DOI 10.1038/sj.ijo.0801900; Silva-Antonialli MM, 2004, CARDIOVASC RES, V62, P587, DOI 10.1016/j.cardiores.2004.01.020; Stice JP, 2011, ENDOCRINOLOGY, V152, P1589, DOI 10.1210/en.2010-0627; Strehlow K, 2003, CIRC RES, V93, P170, DOI 10.1161/01.RES.0000082334.17947.11; Suvorava T, 2010, FREE RADICAL RES, V44, P199, DOI 10.3109/10715760903402898; Suvorava T, 2009, BBA-BIOENERGETICS, V1787, P802, DOI 10.1016/j.bbabio.2009.04.005; Ungvari Z, 2007, AM J PHYSIOL-HEART C, V293, pH37, DOI 10.1152/ajpheart.01346.2006; Velthuis MJ, 2009, MENOPAUSE, V16, P777, DOI [10.1097/GME.0b013e318197122a, 10.1097/gme.0b013e318197122a]; Weigt C, 2012, MOL CELL ENDOCRINOL, V351, P227, DOI 10.1016/j.mce.2011.12.013; Wenger NK, 1997, BMJ-BRIT MED J, V315, P1085, DOI 10.1136/bmj.315.7115.1085; White RE, 2002, VASC PHARMACOL, V38, P73, DOI 10.1016/S0306-3623(02)00129-5; Witte MM, 2010, GEN COMP ENDOCR, V166, P520, DOI 10.1016/j.ygcen.2010.01.006; Xu XH, 2010, EXP PHYSIOL, V95, P1008, DOI 10.1113/expphysiol.2010.054221; Xu Y, 2004, AM J PHYSIOL-HEART C, V287, pH165, DOI 10.1152/ajpheart.00037.2004; Yang H, 2004, CIRC RES, V95, P1075, DOI 10.1161/01.RES.0000149564.49410.0d; Yang H, 2009, ATHEROSCLEROSIS, V207, P51, DOI 10.1016/j.atherosclerosis.2009.03.052; Yuksel H, 2007, GYNECOL ENDOCRINOL, V23, P99, DOI 10.1080/09513590601152177; Zoth N, 2010, J STEROID BIOCHEM, V122, P100, DOI 10.1016/j.jsbmb.2010.03.029; Zou MH, 1996, FEBS LETT, V382, P101, DOI 10.1016/0014-5793(96)00160-3	67	22	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64806	10.1371/journal.pone.0064806	http://dx.doi.org/10.1371/journal.pone.0064806			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755145	gold, Green Submitted, Green Published			2022-12-27	WOS:000319872300028
J	Oliver, JC; Ramos, D; Prudic, KL; Monteiro, A				Oliver, Jeffrey C.; Ramos, Diane; Prudic, Kathleen L.; Monteiro, Antonia			Temporal Gene Expression Variation Associated with Eyespot Size Plasticity in Bicyclus anynana	PLOS ONE			English	Article							WING PATTERN; PHENOTYPIC PLASTICITY; REACTION NORMS; EVOLUTION; LEPIDOPTERA; LESS	Seasonal polyphenism demonstrates an organism's ability to respond to predictable environmental variation with alternative phenotypes, each presumably better suited to its respective environment. However, the molecular mechanisms linking environmental variation to alternative phenotypes via shifts in development remain relatively unknown. Here we investigate temporal gene expression variation in the seasonally polyphenic butterfly Bicyclus anynana. This species shows drastic changes in eyespot size depending on the temperature experienced during larval development. The wet season form (larvae reared over 24 degrees C) has large ventral wing eyespots while the dry season form (larvae reared under 19 degrees C) has much smaller eyespots. We compared the expression of three proteins, Notch, Engrailed, and Distal-less, in the future eyespot centers of the two forms to determine if eyespot size variation is associated with heterochronic shifts in the onset of their expression. For two of these proteins, Notch and Engrailed, expression in eyespot centers occurred earlier in dry season than in wet season larvae, while Distal-less showed no temporal difference between the two forms. These results suggest that differences between dry and wet season adult wings could be due to a delay in the onset of expression of these eyespot-associated genes. Early in eyespot development, Notch and Engrailed may be functioning as repressors rather than activators of the eyespot gene network. Alternatively, temporal variation in the onset of early expressed genes between forms may have no functional consequences to eyespot size regulation and may indicate the presence of an 'hourglass' model of development in butterfly eyespots.	[Oliver, Jeffrey C.; Prudic, Kathleen L.; Monteiro, Antonia] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Oliver, Jeffrey C.; Prudic, Kathleen L.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Ramos, Diane] Daemen Coll, Dept Nat Sci, Amherst, NY USA	Yale University; Oregon State University	Oliver, JC (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	jeffrey.oliver@science.oregonstate.edu	Monteiro, Antonia/J-6452-2013	Monteiro, Antonia/0000-0001-9696-459X; Oliver, Jeffrey/0000-0003-2160-1086; Prudic, Kathleen/0000-0001-8242-7769	National Science Foundation [IOS 0818731, IOS 1146933]	National Science Foundation(National Science Foundation (NSF))	This work was supported by funding from the National Science Foundation (IOS 0818731 and IOS 1146933). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beldade P, 2005, EVOL DEV, V7, P101, DOI 10.1111/j.1525-142X.2005.05011.x; Beldade P, 2002, NATURE, V415, P315, DOI 10.1038/415315a; BRAKEFIELD PM, 1991, ECOL ENTOMOL, V16, P291, DOI 10.1111/j.1365-2311.1991.tb00220.x; Brakefield PM, 1996, NATURE, V384, P236, DOI 10.1038/384236a0; Brunetti CR, 2001, CURR BIOL, V11, P1578, DOI 10.1016/S0960-9822(01)00502-4; DUBOULE D, 1994, DEVELOPMENT, P135; EMLEN DJ, 1994, P ROY SOC B-BIOL SCI, V256, P131, DOI 10.1098/rspb.1994.0060; FRENCH V, 1992, DEVELOPMENT, V116, P103; GWYNNE DT, 1984, EVOLUTION, V38, P1011, DOI 10.1111/j.1558-5646.1984.tb00371.x; Kalinka AT, 2010, NATURE, V468, P811, DOI 10.1038/nature09634; Kawajiri M, 2011, J THERM BIOL, V36, P306, DOI 10.1016/j.jtherbio.2011.06.003; Keys DN, 1999, SCIENCE, V283, P532, DOI 10.1126/science.283.5401.532; Koch PB, 1996, J INSECT PHYSIOL, V42, P223, DOI 10.1016/0022-1910(95)00103-4; Kooi RE, 1999, J INSECT PHYSIOL, V45, P201, DOI 10.1016/S0022-1910(98)00093-6; Mansouri A, 1996, DEVELOPMENT, V122, P831; Monteiro A, 2001, ACTA BIOTHEOR, V49, P77, DOI 10.1023/A:1010226223287; Monteiro A, 2010, TRENDS EVOL BIOL, V2, pe2, DOI DOI 10.4081/EB.2010.E2; Monteiro A, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-52; Monteiro A, 2013, J EXP ZOOL PART B, V320B, P321, DOI 10.1002/jez.b.22503; NIJHOUT HF, 1978, J EXP ZOOL, V206, P119, DOI 10.1002/jez.1402060202; Oliver JC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002893; Oostra V, 2011, P ROY SOC B-BIOL SCI, V278, P789, DOI 10.1098/rspb.2010.1560; Reed RD, 2004, CURR BIOL, V14, P1159, DOI 10.1016/j.cub.2004.06.046; Reed RD, 2007, EVOL DEV, V9, P2, DOI 10.1111/j.1525-142X.2006.00133.x; Saenko SV, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-9; Sakamoto K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005121; Schlichting CD, 2002, EVOL ECOL, V16, P189, DOI 10.1023/A:1019624425971; Sibthorpe D, 2006, COMP BIOCHEM PHYS B, V145, P371, DOI 10.1016/j.cbpb.2006.08.013; WHEELER DE, 1981, SCIENCE, V213, P361, DOI 10.1126/science.213.4505.361; WINDIG JJ, 1994, J EVOLUTION BIOL, V7, P665, DOI 10.1046/j.1420-9101.1994.7060665.x	30	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65830	10.1371/journal.pone.0065830	http://dx.doi.org/10.1371/journal.pone.0065830			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762437	Green Published, gold			2022-12-27	WOS:000320440500052
J	Liu, J; Dyer, D; Wang, JP; Wang, SQ; Du, XF; Xu, B; Zhang, HB; Wang, XN; Hu, W				Liu, Jian; Dyer, Dave; Wang, Jipeng; Wang, Shuqi; Du, Xiaofeng; Xu, Bin; Zhang, Haobing; Wang, Xiaoning; Hu, Wei			3-Oxoacyl-ACP Reductase from Schistosoma japonicum: Integrated In Silico-In Vitro Strategy for Discovering Antischistosomal Lead Compounds	PLOS ONE			English	Article							FATTY-ACID BIOSYNTHESIS; KETOACYL-ACP REDUCTASE; CARRIER PROTEIN REDUCTASE; MYCOBACTERIUM-TUBERCULOSIS; PLASMODIUM-FALCIPARUM; ESCHERICHIA-COLI; REDUCED SUSCEPTIBILITY; CHEMICAL MECHANISMS; CRYSTAL-STRUCTURE; DRUG DISCOVERY	Background: Schistosomiasis is a disease caused by parasitic worms and more than 200 million people are infected worldwide. The emergence of resistance to the most commonly used drug, praziquantel (PZQ), makes the development of novel drugs an urgent task. 3-oxoacyl-ACP reductase (OAR), a key enzyme involved in the fatty acid synthesis pathway, has been identified as a potential drug target against many pathogenic organisms. However, no research on Schistosoma japonicum OAR (SjOAR) has been reported. The characterization of the SjOAR protein will provide new strategies for screening antischistosomal drugs that target SjOAR. Methodology/Principal Findings: After cloning the SjOAR gene, recombinant SjOAR protein was purified and assayed for enzymatic activity. The tertiary structure of SjOAR was obtained by homology modeling and 27 inhibitor candidates were identified from 14,400 compounds through molecular docking based on the structure. All of these compounds were confirmed to be able to bind to the SjOAR protein by BIAcore analysis. Two compounds exhibited strong antischistosomal activity and inhibitory effects on the enzymatic activity of SjOAR. In contrast, these two compounds showed relatively low toxicity towards host cells. Conclusions/Significance: The work presented here shows the feasibility of isolation of new antischistosomal compounds using a combination of virtual screening and experimental validation. Based on this strategy, we successfully identified 2 compounds that target SjOAR with strong antischistosomal activity but relatively low cytotoxicity to host cells.	[Liu, Jian; Wang, Jipeng; Wang, Shuqi; Du, Xiaofeng; Wang, Xiaoning; Hu, Wei] Fudan Univ, Sch Life Sci, Dept Microbiol & Microbial Engn, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Liu, Jian; Xu, Bin; Zhang, Haobing; Hu, Wei] Chinese Ctr Dis Control & Prevent, Inst Parasit Dis, Minist Publ Hlth, Key Lab Parasite & Vector Biol, Shanghai, Peoples R China; [Dyer, Dave] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA	Fudan University; Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; University of Wisconsin System; University of Wisconsin Madison	Hu, W (corresponding author), Fudan Univ, Sch Life Sci, Dept Microbiol & Microbial Engn, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	huwwyz@163.com	Wang, Jipeng/AAF-2575-2020; HU, Wei/F-1004-2012	Wang, Jipeng/0000-0003-0107-424X; Wang, Shuqi/0000-0002-4460-7221	National Natural Science Foundation of China [30400562]; National Science and Technology Key Project on "Major Infectious Diseases such as HIV/AIDS, Viral Hepatitis Prevention and Treatment" [2009ZX10004-302]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Key Project on "Major Infectious Diseases such as HIV/AIDS, Viral Hepatitis Prevention and Treatment"	This work was supported by grants from The National Natural Science Foundation of China (grant no. 30400562, http://www.nsfc.gov.cn/) and The National Science and Technology Key Project on "Major Infectious Diseases such as HIV/AIDS, Viral Hepatitis Prevention and Treatment" (grant no. 2009ZX10004-302, http://www.nmp.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN D, 1987, MOL BIOCHEM PARASIT, V23, P123, DOI 10.1016/0166-6851(87)90147-2; Alonso D, 2006, AM J TROP MED HYG, V74, P342, DOI 10.4269/ajtmh.2006.74.342; Brouwers JFHM, 1998, BIOCHEM J, V334, P315, DOI 10.1042/bj3340315; Chebotareva M A, 2011, Zh Evol Biokhim Fiziol, V47, P383; Chen Hong-Chen, 2011, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V23, P5; Chen MG, 2005, ACTA TROP, V96, P168, DOI 10.1016/j.actatropica.2005.07.011; Cohen-Gonsaud M, 2002, J MOL BIOL, V320, P249, DOI 10.1016/S0022-2836(02)00463-1; Fawcett T, 2000, FEBS LETT, V484, P65, DOI 10.1016/S0014-5793(00)02128-1; Heath RJ, 2000, J BIOL CHEM, V275, P4654, DOI 10.1074/jbc.275.7.4654; Kanzok SM, 2000, J BIOL CHEM, V275, P40180, DOI 10.1074/jbc.M007633200; King CH, 2010, ACTA TROP, V113, P95, DOI 10.1016/j.actatropica.2009.11.012; Kumar NS, 2012, BIOORGAN MED CHEM, V20, P7069, DOI 10.1016/j.bmc.2012.10.002; Kuntz AN, 2007, PLOS MED, V4, P1071, DOI 10.1371/journal.pmed.0040206; Lee WG, 2012, J MED CHEM, V55, P3687, DOI 10.1021/jm2012326; Lepore R, 2011, J CHEM INF MODEL, V51, P3005, DOI 10.1021/ci2001764; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lykidis A, 2008, BIOENERGY, P407; Mariani V, 2011, PROTEINS, V79, P37, DOI 10.1002/prot.23177; Melman SD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000504; Patel MP, 2005, BIOCHEMISTRY-US, V44, P16753, DOI 10.1021/bi050947j; Payne DJ, 2001, DRUG DISCOV TODAY, V6, P537, DOI 10.1016/S1359-6446(01)01774-3; Pillai S, 2003, BIOCHEM BIOPH RES CO, V303, P387, DOI 10.1016/S0006-291X(03)00321-8; Poncet-Montange G, 2007, ACTA CRYSTALLOGR D, V63, P923, DOI 10.1107/S0907444907024158; Postigo MP, 2010, J CHEM INF MODEL, V50, P1693, DOI 10.1021/ci100128k; Price AC, 2001, BIOCHEMISTRY-US, V40, P12772, DOI 10.1021/bi010737g; Price AC, 2004, STRUCTURE, V12, P417, DOI 10.1016/j.str.2004.02.008; Rock CO, 1996, BBA-LIPID LIPID MET, V1302, P1, DOI 10.1016/0005-2760(96)00056-2; Salas JJ, 2011, J AGR FOOD CHEM, V59, P12486, DOI 10.1021/jf203366z; SCHULZ H, 1971, J BIOL CHEM, V246, P1895; Shimokawa T, 2002, P NATL ACAD SCI USA, V99, P66, DOI 10.1073/pnas.012606199; Silva RG, 2008, ARCH BIOCHEM BIOPHYS, V471, P1, DOI 10.1016/j.abb.2007.12.002; Silva RG, 2006, BIOCHEMISTRY-US, V45, P13064, DOI 10.1021/bi0611210; Simeonov A, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000127; Sogabe S, 2003, J BIOL CHEM, V278, P19387, DOI 10.1074/jbc.M208146200; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Utzinger J, 2003, ANTIMICROB AGENTS CH, V47, P1487, DOI 10.1128/AAC.47.5.1487-1495.2003; Vo MT, 2008, J BIOSCI BIOENG, V106, P95, DOI 10.1263/jbb.106.95; Wang W, 2010, PARASITOLOGY, V137, P1905, DOI 10.1017/S0031182010001204; Wickramasinghe SR, 2006, BIOCHEM J, V393, P447, DOI 10.1042/BJ20050832; Witkowski A, 2004, CHEM BIOL, V11, P1667, DOI 10.1016/j.chembiol.2004.09.016; Xiao SH, 2009, PARASITOL RES, V106, P237, DOI 10.1007/s00436-009-1656-x	42	15	16	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e64984	10.1371/journal.pone.0064984	http://dx.doi.org/10.1371/journal.pone.0064984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762275	Green Published, gold, Green Submitted			2022-12-27	WOS:000321094800012
J	Sutherland, MC; Binder, KA; Cualing, PY; Vogel, JP				Sutherland, Molly C.; Binder, Kelsey A.; Cualing, Phillip Y.; Vogel, Joseph P.			Reassessing the Role of DotF in the Legionella pneumophila Type IV Secretion System	PLOS ONE			English	Article							LEGIONNAIRES-DISEASE; PROTEIN; IDENTIFICATION; GENES; TRANSLOCATION; MANIPULATION; TRAFFICKING; BACTERIUM; COMPLEX	Legionella pneumophila, the causative agent of a severe pneumonia termed Legionnaires' Disease, survives and replicates within both protozoan hosts and human alveolar macrophages. Intracellular survival is dependent upon secretion of a plethora of protein effectors that function to form a replicative vacuole, evade the endocytic pathway and subvert host immune defenses. Export of these factors requires a type IV secretion system (T4SS) called Dot/Icm that is composed of twenty-seven proteins. This report focuses on the DotF protein, which was previously postulated to have several different functions, one of which centered on binding Dot/Icm substrates. In this report, we examined if DotF functions as the T4SS inner membrane receptor for Dot/Icm substrates. Although we were able to recapitulate the previously published bacterial two-hybrid interaction between DotF and several substrates, the interaction was not dependent on the Dot/Icm substrates' signal sequences as predicted for a substrate: receptor interaction. In addition, binding did not require the cytoplasmic domain of DotF, which was anticipated to be involved in recognizing substrates in the cytoplasm. Finally, inactivation of dotF did not abolish intracellular growth of L. pneumophila or translocation of substrates, two phenotypes dependent on the T4SS receptor. These data strongly suggest that DotF does not act as the major receptor for Dot/Icm substrates and therefore likely performs an accessory function within the core-transmembrane subcomplex of the L. pneumophila Dot/Icm type IV secretion system.	[Sutherland, Molly C.; Cualing, Phillip Y.; Vogel, Joseph P.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Binder, Kelsey A.] Rocky Mt Natl Inst Hlth Labs, Hamilton, MT USA	Washington University (WUSTL)	Vogel, JP (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	jvogel@borcim.wustl.edu		Sutherland, Molly/0000-0002-7932-5339	National Institutes of Health [AI48052]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048052] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AI48052 to JPV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Quadan T, 2012, TRENDS MICROBIOL, V20, P299, DOI 10.1016/j.tim.2012.03.005; Albers U, 2005, MICROBIOL-SGM, V151, P167, DOI 10.1099/mic.0.27563-0; Bardill JP, 2005, MOL MICROBIOL, V56, P90, DOI 10.1111/j.1365-2958.2005.04539.x; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Burstein D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000508; Buscher BA, 2005, J BACTERIOL, V187, P2927, DOI 10.1128/JB.187.9.2927-2938.2005; Cambronne ED, 2007, PLOS PATHOG, V3, P1837, DOI 10.1371/journal.ppat.0030188; Cascales E, 2004, P NATL ACAD SCI USA, V101, P17228, DOI 10.1073/pnas.0405843101; Coers J, 2000, MOL MICROBIOL, V38, P719, DOI 10.1046/j.1365-2958.2000.02176.x; Edelstein PH, 1999, P NATL ACAD SCI USA, V96, P8190, DOI 10.1073/pnas.96.14.8190; Ensminger AW, 2009, CURR OPIN MICROBIOL, V12, P67, DOI 10.1016/j.mib.2008.12.004; Faulkner G, 2008, J BACTERIOL, V190, P7728, DOI 10.1128/JB.00751-08; FEELEY JC, 1979, J CLIN MICROBIOL, V10, P437, DOI 10.1128/JCM.10.4.437-441.1979; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Ge JN, 2011, CELL MICROBIOL, V13, P1870, DOI 10.1111/j.1462-5822.2011.01710.x; Gomez-Valero L, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00208; Heidtman M, 2009, CELL MICROBIOL, V11, P230, DOI 10.1111/j.1462-5822.2008.01249.x; HORWITZ MA, 1980, J CLIN INVEST, V66, P441, DOI 10.1172/JCI109874; Huang L, 2011, CELL MICROBIOL, V13, P227, DOI 10.1111/j.1462-5822.2010.01531.x; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Lifshitz Z, 2013, P NATL ACAD SCI USA, V110, pE707, DOI 10.1073/pnas.1215278110; Luo ZQ, 2012, CELL MICROBIOL, V14, P19, DOI 10.1111/j.1462-5822.2011.01713.x; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Massis LM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00109; MCDADE JE, 1977, NEW ENGL J MED, V297, P1197, DOI 10.1056/NEJM197712012972202; Morozova I, 2004, PLASMID, V51, P127, DOI 10.1016/j.plasmid.2003.12.004; Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101; Ninio S, 2005, MOL MICROBIOL, V55, P912, DOI 10.1111/j.1365-2958.2004.04435.x; Ninio S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000278; Paumet F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007375; Purcell M, 1998, INFECT IMMUN, V66, P2245, DOI 10.1128/IAI.66.5.2245-2255.1998; Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669; Segal G, 1999, INFECT IMMUN, V67, P2117, DOI 10.1128/IAI.67.5.2117-2124.1999; Sexton JA, 2005, MOL MICROBIOL, V57, P70, DOI 10.1111/j.1365-2958.2005.04667.x; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Steinert M, 2005, CELL MICROBIOL, V7, P307, DOI 10.1111/j.1462-5822.2005.00493.x; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Sutherland MC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002910; Sutherland MC, 2012, APPL ENVIRON MICROB, V78, P5457, DOI 10.1128/AEM.00669-12; Vincent CD, 2006, MOL MICROBIOL, V62, P1278, DOI 10.1111/j.1365-2958.2006.05446.x; Vincent CD, 2006, J BACTERIOL, V188, P8231, DOI 10.1128/JB.00937-06; Vincent CD, 2012, MOL MICROBIOL, V85, P378, DOI 10.1111/j.1365-2958.2012.08118.x; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Wiener MC, 2005, CURR OPIN STRUC BIOL, V15, P394, DOI 10.1016/j.sbi.2005.07.001; Zhu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017638	48	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65529	10.1371/journal.pone.0065529	http://dx.doi.org/10.1371/journal.pone.0065529			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762385	Green Published, gold, Green Submitted			2022-12-27	WOS:000321094800057
J	Xu, Q; He, CY; Liu, JW; Yuan, Y				Xu, Qian; He, Cai-yun; Liu, Jing-wei; Yuan, Yuan			Pre-miR-27a rs895819A/G Polymorphisms in Cancer: A Meta-Analysis	PLOS ONE			English	Article							GENETIC VARIANT; RISK; MIR-27A; ASSOCIATION; CONTRIBUTES	Background: MicroRNAs (miRNAs) negatively regulate the 3' untranslated region (3'-UTR) of coding genes by suppressing translation or degrading mRNAs, and they act as oncogenes or tumor suppressors. Recently, several studies investigated the association between pre-miR-27a rs895819 polymorphism and the risks of various cancers, but the results were inconsistent. Methodology/Principal Findings: We conducted a meta-analysis of 13 studies that included 6501 cancer cases and 7571 controls to address this association. Overall, this meta-analysis showed that the pre-miR-27a rs895819 A/G polymorphism was not statistically associated with cancers risk in all genetic models. In the stratified analysis by cancer types, when compared with the ancestral A allele, individuals with the variant G allele was consistently associated with reduced risks of breast cancer (OR = 0.92, 95% CI = 0.85-0.99), renal cell cancer (OR = 0.81, 95% CI = 0.67-0.97) and nasopharyngeal cancer (OR = 0.84, 95% CI = 0.72-0.97). Inversely, individuals with the heterozygote AG was associated with an increased risk of digestive tract cancers compared with AA genotype (AG vs. AA: OR = 1.16, 95% CI = 1.01-1.32). In the stratified analysis by ethnicity, the pre-miR-27a rs895819 polymorphism showed statistically significant association with decreased risks of cancers in Caucasians (G vs. A allele: OR = 0.90, 95% CI = 0.83-0.97; AG vs. AA: OR = 0.84, 95% CI = 0.75-0.94; AG/GG vs. AA: OR = 0.85, 95% CI = 0.76-0.94) but not in Asians. Conclusion/Significance: This meta-analysis suggests that the pre-miR-27a rs895819 polymorphism may contribute to the susceptibilities of some specific-type of cancers, including breast cancer, renal cell cancer, nasopharyngeal cancer and digestive tract cancers, as well as the susceptibilities of cancers in Caucasians to some extent.	[Yuan, Yuan] China Med Univ, Key Lab Canc Etiol & Prevent Liaoning Prov, Affiliated Hosp 1, Inst Canc,Tumor Etiol & Screening Dept, Shenyang, Liaoning Provin, Peoples R China; China Med Univ, Key Lab Canc Etiol & Prevent Liaoning Prov, Affiliated Hosp 1, Shenyang, Liaoning Provin, Peoples R China	China Medical University; China Medical University	Yuan, Y (corresponding author), China Med Univ, Key Lab Canc Etiol & Prevent Liaoning Prov, Affiliated Hosp 1, Inst Canc,Tumor Etiol & Screening Dept, Shenyang, Liaoning Provin, Peoples R China.	yyuan3@mai.cmu.edu.cn	Yuan, Yuan/GVS-5120-2022		National Key Basic Research Program of China (973 Program) [2010CB529304]; National Natural Science Foundation of China [31200968]; Science Technology Project in Liaoning Province [2011225002]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Technology Project in Liaoning Province	This work is supported by grants from the National Key Basic Research Program of China (973 Program ref no. 2010CB529304, http://www.973.gov.cn/Default_3.aspx), the National Natural Science Foundation of China (Ref No. 31200968, http://www.nsfc.gov.cn/Portal0/default152.htm), and the Science Technology Project in Liaoning Province (Ref No. 2011225002, http://kjjh.lninfo.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arisawa T, 2007, DIGEST DIS SCI, V52, P1691, DOI 10.1007/s10620-006-9648-5; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Catucci I, 2012, BREAST CANCER RES TR, V133, P805, DOI 10.1007/s10549-012-2011-y; Chu H, 2011, PLOS ONE, V6; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Gao LB, 2011, BREAST CANCER RES TR, V125, P571, DOI 10.1007/s10549-010-0993-x; Hezova R, 2012, WORLD J GASTROENTERO, V18, P2827, DOI 10.3748/wjg.v18.i22.2827; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hirota T, 2012, LUNG CANCER, V77, P16, DOI 10.1016/j.lungcan.2011.12.018; Jahid S, 2012, CANCER DISCOV, V2, P540, DOI 10.1158/2159-8290.CD-11-0267; Jian Guo, 2012, International Journal of Mechatronics and Automation, V2, P15, DOI 10.1504/IJMA.2012.046583; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kontorovich T, 2010, INT J CANCER, V127, P589, DOI 10.1002/ijc.25065; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Li P., 2011, GENETIC ASS MIRNA SN; Lian H, 2012, PLOS ONE, V7, DOI DOI 10.1371/J0URNAL.P0NE.0031615; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Ma YH, 2010, CANCER LETT, V298, P150, DOI 10.1016/j.canlet.2010.06.012; MANTEL N, 1959, J NATL CANCER I, V22, P719; Qiu LX, 2011, CYTOKINE, V56, P695, DOI 10.1016/j.cyto.2011.09.001; Qiu LX, 2011, CYTOKINE, V56, P589, DOI 10.1016/j.cyto.2011.08.019; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Shi DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046566; Sun QM, 2010, CANCER SCI, V101, P2241, DOI 10.1111/j.1349-7006.2010.01667.x; Wang B, 2012, ASIAN PAC J CANCER P, V13, P6207, DOI 10.7314/APJCP.2012.13.12.6207; Wang F, 2012, MOL BIOL REP, V39, P269, DOI 10.1007/s11033-011-0735-0; Wang J, 2012, MOL BIOL REP, V39, P4571, DOI 10.1007/s11033-011-1247-7; Wang LN, 2012, GENE, V508, P9, DOI 10.1016/j.gene.2012.08.005; Wang Q, 2011, ONCOGENE, V30, P3875, DOI 10.1038/onc.2011.103; Wang WZ, 2011, ASS MIR 146A SINGLE; WHITEHEAD A, 1991, STAT MED, V10, P1665, DOI 10.1002/sim.4780101105; Xu WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019120; Yang Q, 2012, ONCOGENE; Yang RX, 2012, BREAST CANCER RES TR, V134, P899, DOI 10.1007/s10549-012-2140-3; Yang RX, 2010, BREAST CANCER RES TR, V121, P693, DOI 10.1007/s10549-009-0633-5; Yoon KA, 2012, J THORAC CARDIOV SUR, V144, P794, DOI 10.1016/j.jtcvs.2012.06.030; Zanetti KA, 2012, CANCER RES, V72, P1467, DOI 10.1158/0008-5472.CAN-11-3073; Zhang M, 2012, EUR J CANCER CARE, V21, P274, DOI 10.1111/j.1365-2354.2011.01308.x; Zhang M. W., 2012, STUDY ASS LIFESTYLE; Zhang P., 2011, POLYMORPHISMS MICROR, P74; Zhang Z, 2009, CANC GENET, V204, P486; Zhong SL, 2013, MOL BIOL REP, V40, P3181, DOI 10.1007/s11033-012-2392-3; Zhou Y, 2012, J CANCER RES CLIN, V138, P939, DOI 10.1007/s00432-012-1164-8	45	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65208	10.1371/journal.pone.0065208	http://dx.doi.org/10.1371/journal.pone.0065208			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762318	Green Published, gold, Green Submitted			2022-12-27	WOS:000321094800025
J	Cai, CY; Shi, WT; Zeng, Z; Zhang, MY; Ling, C; Chen, L; Cai, CQ; Zhang, BS; Li, WD				Cai, Chunyou; Shi, Wentao; Zeng, Zheng; Zhang, Meiyun; Ling, Chao; Chen, Lei; Cai, Chunquan; Zhang, Benshu; Li, Wei-Dong			GTP Cyclohydrolase I and Tyrosine Hydroxylase Gene Mutations in Familial and Sporadic Dopa-Responsive Dystonia Patients	PLOS ONE			English	Article							DELETION; GCH1; DEFICIENCY; PENETRANCE; PHENOTYPE; FREQUENCY; PROMOTER; DYT14; FORM	Dopa-responsive dystonia (DRD) is a rare inherited dystonia that responds very well to levodopa treatment. Genetic mutations of GTP cyclohydrolase I (GCH1) or tyrosine hydroxylase (TH) are disease-causing mutations in DRD. To evaluate the genotype-phenotype correlations and diagnostic values of GCH1 and TH mutation screening in DRD patients, we carried out a combined study of familial and sporadic cases in Chinese Han subjects. We collected 23 subjects, 8 patients with DRD, 5 unaffected family members, and 10 sporadic cases. We used PCR to sequence all exons and splicing sites of the GCH1 and TH genes. Three novel heterozygous GCH1 mutations (Tyr75Cys, Ala98Val, and Ile135Thr) were identified in three DRD pedigrees. We failed to identify any GCH1 or TH mutation in two affected sisters. Three symptom-free male GCH1 mutation carriers were found in two DRD pedigrees. For those DRD siblings that shared the same GCH1 mutation, symptoms and age of onset varied. In 10 sporadic cases, only two heterozygous TH mutations (Ser19Cys and Gly397Arg) were found in two subjects with unknown pathogenicity. No GCH1 and TH mutation was found in 40 unrelated normal Han Chinese controls. GCH1 mutation is the main etiology of familial DRD. Three novel GCH1 mutations were identified in this study. Genetic heterogeneity and incomplete penetrance were quite common in DRD patients, especially in sporadic cases. Genetic screening may help establish the diagnosis of DRD; however, a negative GCH1 and TH mutation test would not exclude the diagnosis.	[Cai, Chunyou; Shi, Wentao; Ling, Chao; Li, Wei-Dong] Tianjin Med Univ, Res Ctr Basic Med Sci, Tianjin, Peoples R China; [Zeng, Zheng] Tianjin Med Univ, Tianjin Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Zhang, Meiyun; Chen, Lei] Tianjin Peoples Hosp, Dept Neurol, Tianjin, Peoples R China; [Cai, Chunquan] Tianjin Childrens Hosp, Dept Surg, Tianjin, Peoples R China; [Zhang, Benshu] Tianjin Med Univ, Tianjin Gen Hosp, Dept Neurol, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Zhang, BS (corresponding author), Tianjin Med Univ, Tianjin Gen Hosp, Dept Neurol, Tianjin, Peoples R China.	zxdgmcp@sina.com; liweidong98@tijmu.edu.cn	LING, CHAO/W-3528-2019; SHI, wen/GPW-9531-2022	Li, Wei-Dong/0000-0003-0521-7412; LING, CHAO/0000-0001-5328-4906	National Natural Science Foundation of China (NSFC) [81070576]; Tianjin Municipal Science and Technology Commission [12JCZDJC24700]; Scientific Research Foundation of Tianjin Bureau of Public Health [09KY14, 2011KZ87]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Science and Technology Commission; Scientific Research Foundation of Tianjin Bureau of Public Health	This work was supported in part by grants (81070576) from the National Natural Science Foundation of China (NSFC) and (12JCZDJC24700) from Tianjin Municipal Science and Technology Commission to WDL, and a grant from the Scientific Research Foundation of Tianjin Bureau of Public Health (09KY14 and 2011KZ87) (both to CC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodzioch M, 2011, MOVEMENT DISORD, V26, P337, DOI 10.1002/mds.23364; Brautigam C, 1999, CLIN CHEM, V45, P2073; Brique S, 1999, NEUROREPORT, V10, P487, DOI 10.1097/00001756-199902250-00008; CALNE DB, 1994, ANN NEUROL, V35, P381, DOI 10.1002/ana.410350402; Chaila EC, 2006, ARCH NEUROL-CHICAGO, V63, P1185, DOI 10.1001/archneur.63.8.1185; Dionisi-Vici C, 2000, J PEDIATR-US, V136, P560, DOI 10.1016/S0022-3476(00)90027-1; Furukawa Y, 1998, NEUROLOGY, V50, P1015, DOI 10.1212/WNL.50.4.1015; Furukawa Y, 1999, MOVEMENT DISORD, V14, P709, DOI 10.1002/1531-8257(199909)14:5<709::AID-MDS1001>3.0.CO;2-T; Furukawa Y, 2000, ANN NEUROL, V47, P517; Grotzsch H, 2002, NEUROLOGY, V58, P1839, DOI 10.1212/WNL.58.12.1839; Hahn H, 2001, ARCH NEUROL-CHICAGO, V58, P749, DOI 10.1001/archneur.58.5.749; ICHINOSE H, 1994, NAT GENET, V8, P236, DOI 10.1038/ng1194-236; LUDECKE B, 1995, HUM GENET, V95, P123; NAR H, 1995, STRUCTURE, V3, P459, DOI 10.1016/S0969-2126(01)00179-4; Rozen S, 2000, Methods Mol Biol, V132, P365; Segawa M, 1976, Adv Neurol, V14, P215; Segawa Masaya, 2011, Handb Clin Neurol, V100, P539, DOI 10.1016/B978-0-444-52014-2.00039-2; Steinberger D, 1998, ANN NEUROL, V43, P634, DOI 10.1002/ana.410430512; Steinberger D, 2007, NEUROGENETICS, V8, P51, DOI 10.1007/s10048-006-0069-6; TAKAHASHI H, 1994, ANN NEUROL, V35, P354, DOI 10.1002/ana.410350317; Theuns J, 2012, MOVEMENT DISORD, V27, P1451, DOI 10.1002/mds.25147; Trender-Gerhard I, 2009, J NEUROL NEUROSUR PS, V80, P839, DOI 10.1136/jnnp.2008.155861; Van Hove JLK, 2006, J NEUROL NEUROSUR PS, V77, P18, DOI 10.1136/jnnp.2004.051664; Wevers RA, 1999, J INHERIT METAB DIS, V22, P364, DOI 10.1023/A:1005539803576; Wider C, 2008, NEUROLOGY, V70, P1377, DOI 10.1212/01.wnl.0000275527.35752.c5; Wu-Chou YH, 2010, AM J MED GENET B, V153B, P903, DOI 10.1002/ajmg.b.31058; Yu L, 2012, EUR J HUM GENET; Zirn B, 2008, J NEUROL NEUROSUR PS, V79, P183, DOI 10.1136/jnnp.2007.128413	28	8	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65215	10.1371/journal.pone.0065215	http://dx.doi.org/10.1371/journal.pone.0065215			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762320	Green Published, Green Submitted, gold			2022-12-27	WOS:000321099000045
J	Chang, DH; Rutledge, JR; Patel, AA; Heerdt, BG; Augenlicht, LH; Korst, RJ				Chang, David H.; Rutledge, John R.; Patel, Ankur A.; Heerdt, Barbara G.; Augenlicht, Leonard H.; Korst, Robert J.			The Effect of Lung Cancer on Cytokine Expression in Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article							INTERLEUKIN-8; IMMUNOTHERAPY; TRANSFUSION; CHEMOKINES; PROGNOSIS; SURVIVAL; PROTEIN; TUMORS; RISK	The purpose of this study is to evaluate cytokine expression by peripheral blood mononuclear cells (PBMC) from stage I lung cancer patients and to confirm these expression patterns by exposing PBMCs to lung cancer cells in vitro. Five altered cytokines in stage I lung cancer patients (CCL3, IL8, IL1 beta, CXCL10, sIL2R alpha) were identified in plasma from subjects (n = 15) before and after resection using a 30-plex panel protein assay. Gene expression studies using quantitative RT-qPCR were performed on PBMCs from stage I lung cancer patients (n = 62) before and after resection, and compared to non-cancer patients (n = 32) before and after surgery for benign disease. Co-culture experiments that exposed healthy donor PBMCs to lung cancer cells in vitro were performed to evaluate the effect on PBMC cytokine expression. PBMC gene expression of CCL3, IL8 and IL1 beta was higher in lung cancer patients compared to the same patients at each of four sequential timepoints after removal of their tumors, while CXCL10 and IL2R alpha were essentially unchanged. This pattern was also detected when lung cancer patients were compared to non-cancer patients. When non-cancer patients underwent surgery for benign diseases, these cytokine expression changes were not demonstrable. Lung cancer cell lines, but not benign bronchial epithelial cells, induced similar changes in cytokine gene and protein expression by healthy donor PBMCs in an in vitro coculture system. We conclude that PBMCs from stage I lung cancer patients possess distinct cytokine expression patterns compared to both non-cancer patients, and lung cancer patients following tumor removal. These expression patterns are replicated by healthy donor PBMCs exposed to lung cancer cell lines, but not benign bronchial epithelial cells in vitro. These findings have implications for understanding the immune response to lung cancer.	[Chang, David H.; Rutledge, John R.; Patel, Ankur A.; Heerdt, Barbara G.; Korst, Robert J.] Daniel & Gloria Blumenthal Canc Ctr, Ctr Canc Res & Genom Med, Paramus, NJ USA; [Korst, Robert J.] Valley Hosp, Dept Surg, Div Thorac Surg, Ridgewood, NJ USA; [Augenlicht, Leonard H.] Montefiore Med Ctr, Albert Einstein Canc Ctr, Bronx, NY 10467 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Korst, RJ (corresponding author), Daniel & Gloria Blumenthal Canc Ctr, Ctr Canc Res & Genom Med, Paramus, NJ USA.	korsro@valleyhealth.com			Valley Hospital Foundation	Valley Hospital Foundation	This work was supported by the Valley Hospital Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Chen JJW, 2003, CLIN CANCER RES, V9, P729; DAVATELIS G, 1988, J EXP MED, V167, P1939, DOI 10.1084/jem.167.6.1939; Ganepola GAP, 2010, CLIN EXP METASTAS, V27, P1, DOI 10.1007/s10585-009-9295-2; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Homey B, 2002, NAT REV IMMUNOL, V2, P175, DOI 10.1038/nri748; Kaminska J, 2006, ONCOLOGY-BASEL, V70, P115, DOI 10.1159/000093002; Kolesar L, 2012, IMMUNOL RES, V52, P269, DOI 10.1007/s12026-012-8338-y; Landvik NE, 2009, CARCINOGENESIS, V30, P1186, DOI 10.1093/carcin/bgp122; Lechner MG, 2011, IMMUNOTHERAPY-UK, V3, P1317, DOI [10.2217/imt.11.115, 10.2217/IMT.11.115]; Maheswaran S, 2010, CURR OPIN GENET DEV, V20, P96, DOI 10.1016/j.gde.2009.12.002; Millar HJ, 2008, CANCER EPIDEM BIOMAR, V17, P2180, DOI 10.1158/1055-9965.EPI-07-2915; Mocellin S, 2001, J IMMUNOTHER, V24, P392, DOI 10.1097/00002371-200109000-00002; MODI WS, 1990, HUM GENET, V84, P185; MOORES DWO, 1989, ANN THORAC SURG, V47, P346, DOI 10.1016/0003-4975(89)90371-8; NETER J, 1996, APPL LINEAR STAT MOD, P1164; Pakkala Suchita, 2010, J Thorac Oncol, V5, P1864, DOI 10.1097/JTO.0b013e3181f387fd; Penna F, 2010, EXPERT OPIN BIOL TH, V10, P1241, DOI 10.1517/14712598.2010.503773; Pine SR, 2011, JNCI-J NATL CANCER I, V103, P1112, DOI 10.1093/jnci/djr216; RUCKDESCHEL JC, 1972, NEW ENGL J MED, V287, P1013, DOI 10.1056/NEJM197211162872004; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; TARTTER PI, 1984, J THORAC CARDIOV SUR, V88, P659; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Whitson BA, 2008, ANN THORAC SURG, V86, P2008, DOI 10.1016/j.athoracsur.2008.07.009	26	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64456	10.1371/journal.pone.0064456	http://dx.doi.org/10.1371/journal.pone.0064456			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762239	gold, Green Published, Green Submitted			2022-12-27	WOS:000321099000007
J	Mulla, MJ; Salmon, JE; Chamley, LW; Brosens, JJ; Boeras, CM; Kavathas, PB; Abrahams, VM				Mulla, Melissa J.; Salmon, Jane E.; Chamley, Larry W.; Brosens, Jan J.; Boeras, Crina M.; Kavathas, Paula B.; Abrahams, Vikki M.			A Role for Uric Acid and the Nalp3 Inflammasome in Antiphospholipid Antibody-Induced IL-1 beta Production by Human First Trimester Trophoblast	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; XANTHINE-OXIDASE; PATHOGENIC ROLE; PREGNANCY; FETAL; ACTIVATION; INTERLEUKIN-1-BETA; SECRETION; INFECTION; INVASION	Women with antiphospholipid syndrome (APS) are at risk of recurrent pregnancy loss and obstetrical disorders, such as preeclampsia and intrauterine growth restriction (IUGR). Antiphospholipid antibodies (aPL) directly target the placenta by binding beta(2)-glycoprotein I (beta(2)GPI) expressed on the trophoblast. We recently demonstrated in human first trimester trophoblast cells that anti-beta(2)GPI antibodies (Abs) induce the secretion of IL-1 beta in a Toll-like receptor 4 (TLR4)-dependent manner. IL-1 beta secretion requires processing of pro-IL-1 beta and this is mediated by the inflammasome, a complex of Nalp3, apoptosis-associated speck-like protein containing a CARD (ASC) and caspase-1. The objective of this study was to determine if aPL induce IL-1 beta production in trophoblast via the inflammasome. Using a human first trimester trophoblast cell line, we demonstrated that a mouse anti-beta(2)GPI mAb and human polyclonal aPL-IgG induce IL-1 beta processing and secretion, which was partially blocked upon caspase-1 inhibition. Nalp3 and ASC knockdown also attenuated anti-beta(2)GPI Ab-induced IL-1 beta secretion. Furthermore, aPL stimulated the production of uric acid in a TLR4-dependent manner; and inhibition of uric acid prevented aPL-induced IL-1 beta production by the trophoblast. These findings demonstrate that aPL, via TLR4 activation, induce a uric acid response in human trophoblast, which in turn activates the Nalp3/ASC inflammasome leading to IL-1 beta processing and secretion. This novel mechanism may account for the inflammation at the maternal-fetal interface, which causes placental dysfunction and increases the risk of adverse pregnancy outcome in patients with APS.	[Mulla, Melissa J.; Abrahams, Vikki M.] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med, New Haven, CT 06520 USA; [Salmon, Jane E.] Hosp Special Surg, New York, NY 10021 USA; [Salmon, Jane E.] Weill Cornell Med Coll, New York, NY USA; [Chamley, Larry W.] Univ Auckland, Dept Obstet & Gynecol, Auckland 1, New Zealand; [Brosens, Jan J.] Univ Warwick, Clin Sci Res Inst, Div Reprod Hlth, Coventry CV4 7AL, W Midlands, England; [Boeras, Crina M.; Kavathas, Paula B.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA; [Boeras, Crina M.; Kavathas, Paula B.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA	Yale University; Cornell University; University of Auckland; University of Warwick; Yale University; Yale University	Abrahams, VM (corresponding author), Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med, New Haven, CT 06520 USA.	vikki.abrahams@yale.edu		Brosens, Jan/0000-0003-0116-9329; Chamley, Lawrence/0000-0002-7501-1340	American Heart Association; March of Dimes; NIH [RO1AR49772, RO1CA048511]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049772] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); March of Dimes(March of Dimes); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by grants from the American Heart Association and the March of Dimes (to VMA), grant RO1AR49772 from the NIH (to JES), and grant RO1CA048511 from the NIH (to PKB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams VM, 2009, THROMB RES, V124, P521, DOI 10.1016/j.thromres.2009.07.011; Berman J, 2005, J IMMUNOL, V174, P485, DOI 10.4049/jimmunol.174.1.485; Bose P, 2006, PLACENTA, V27, P869, DOI 10.1016/j.placenta.2005.09.007; BUTTERWORTH BH, 1991, BRIT J OBSTET GYNAEC, V98, P929, DOI 10.1111/j.1471-0528.1991.tb13516.x; Carroll TY, 2011, AM J REPROD IMMUNOL, V66, P286, DOI 10.1111/j.1600-0897.2011.01007.x; Chamley LW, 1999, CLIN EXP IMMUNOL, V115, P571; Chamley LW, 2001, FERTIL STERIL, V76, P700, DOI 10.1016/S0015-0282(01)01984-7; Coats SR, 2005, J IMMUNOL, V175, P4490, DOI 10.4049/jimmunol.175.7.4490; Correa-Costa M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029004; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Gasse P, 2009, AM J RESP CRIT CARE, V179, P903, DOI 10.1164/rccm.200808-1274OC; Girardi G, 2003, J CLIN INVEST, V112, P1644, DOI 10.1172/JCI200318817; Griffith JW, 2009, J IMMUNOL, V183, P5208, DOI 10.4049/jimmunol.0713552; Hirsch E, 1999, AM J OBSTET GYNECOL, V180, P429, DOI 10.1016/S0002-9378(99)70227-9; Holers VM, 2002, J EXP MED, V195, P211, DOI 10.1084/jem.200116116; Jin CC, 2010, J CLIN IMMUNOL, V30, P628, DOI 10.1007/s10875-010-9440-3; Kavathas PB, 2013, MUCOSAL IMMUNOL, V6, P235, DOI 10.1038/mi.2012.63; Keelan JA, 2004, BIOL REPROD, V70, P253, DOI 10.1095/biolreprod.103.016204; Lane T, 2011, CURR ALLERGY ASTHM R, V11, P361, DOI 10.1007/s11882-011-0207-6; Lockshin MD, 2012, ARTHRITIS RHEUM-US, V64, P2311, DOI 10.1002/art.34402; Many A, 1996, AM J OBSTET GYNECOL, V174, P288, DOI 10.1016/S0002-9378(96)70410-6; Martin AC, 2010, NAT REV NEPHROL, V6, P744, DOI 10.1038/nrneph.2010.125; Matsuura E, 2012, AUTOIMMUN REV, V12, P241, DOI 10.1016/j.autrev.2012.04.003; Meroni PL, 2011, NAT REV RHEUMATOL, V7, P330, DOI 10.1038/nrrheum.2011.52; Mulla MJ, 2011, AM J REPROD IMMUNOL, V65, P542, DOI 10.1111/j.1600-0897.2010.00960.x; Mulla MJ, 2010, AM J REPROD IMMUNOL, V63, P339, DOI 10.1111/j.1600-0897.2009.00805.x; Mulla MJ, 2009, AM J REPROD IMMUNOL, V62, P96, DOI 10.1111/j.1600-0897.2009.00717.x; Munno I, 1999, AM J REPROD IMMUNOL, V42, P369; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Netea MG, 2008, EXPERT OPIN BIOL TH, V8, P1867, DOI [10.1517/14712590802494212, 10.1517/14712590802494212 ]; Nicholas SA, 2011, CELL MOL LIFE SCI, V68, P151, DOI 10.1007/s00018-010-0450-3; Redecha P, 2007, BLOOD, V110, P2423, DOI 10.1182/blood-2007-01-070631; Reister F, 2001, LAB INVEST, V81, P1143, DOI 10.1038/labinvest.3780326; Rinehart BK, 1999, AM J OBSTET GYNECOL, V181, P915, DOI 10.1016/S0002-9378(99)70325-X; Salmon JE, 2008, LUPUS, V17, P405, DOI 10.1177/0961203308090025; Salmon JE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001013; Sebire NJ, 2002, HUM REPROD, V17, P1067, DOI 10.1093/humrep/17.4.1067; Stallmach T, 1999, VIRCHOWS ARCH, V434, P207, DOI 10.1007/s004280050329; Straszewski-Chavez SL, 2009, PLACENTA, V30, P939, DOI 10.1016/j.placenta.2009.08.007; Tincani A, 2008, SEMIN THROMB HEMOST, V34, P267, DOI 10.1055/s-0028-1082270; Wilczynski JR, 2003, EUR J OBSTET GYN R B, V109, P8, DOI 10.1016/S0301-2115(02)00350-0	41	73	78	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65237	10.1371/journal.pone.0065237	http://dx.doi.org/10.1371/journal.pone.0065237			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762324	gold, Green Published, Green Submitted			2022-12-27	WOS:000321099000047
J	Tajiri, T; Matsumoto, H; Niimi, A; Ito, I; Oguma, T; Nakaji, H; Inoue, H; Iwata, T; Nagasaki, T; Kanemitsu, Y; Petrova, G; Mishima, M				Tajiri, Tomoko; Matsumoto, Hisako; Niimi, Akio; Ito, Isao; Oguma, Tsuyoshi; Nakaji, Hitoshi; Inoue, Hideki; Iwata, Toshiyuki; Nagasaki, Tadao; Kanemitsu, Yoshihiro; Petrova, Guergana; Mishima, Michiaki			Association of Eosinophilic Inflammation with FKBP51 Expression in Sputum Cells in Asthma	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; GLUCOCORTICOID-RECEPTOR; FK506-BINDING PROTEIN-51; IMMUNOPHILIN FKBP51; SQUIRREL-MONKEY; CORTICOSTEROIDS; RESISTANCE; INHIBITOR; APOPTOSIS; GENES	Background: Airway eosinophilia is a predictor of steroid responsiveness in steroid-naive asthma. However, the relationship between airway eosinophilia and the expression of FK506-binding protein 51 (FKBP51), a glucocorticoid receptor cochaperone that plays a role in steroid insensitivity in asthma, remains unknown. Objective: To evaluate the relationship between eosinophilic inflammation and FKBP51 expression in sputum cells in asthma. Methods: The FKBP51 mRNA levels in sputum cells from steroid-naive patients with asthma (n = 31) and stable asthmatic patients on inhaled corticosteroid (ICS) (n = 28) were cross-sectionally examined using real-time PCR. Associations between FKBP51 levels and clinical indices were analyzed. Results: In steroid-naive patients, the FKBP51 levels were negatively correlated with eosinophil proportions in blood (r = -0.52) and sputum (r = -0.57), and exhaled nitric oxide levels (r = -0.42) (all p<0.05). No such associations were observed in patients on ICS. In steroid-naive patients, improvement in forced expiratory volume in one second after ICS initiation was correlated with baseline eosinophil proportions in blood (r = 0.74) and sputum (r = 0.76) and negatively correlated with FKBP51 levels (r = -0.73) (all p<0.0001) (n = 20). Lastly, the FKBP51 levels were the lowest in steroid-naive asthmatic patients, followed by mild to moderate persistent asthmatic patients on ICS, and the highest in severe persistent asthmatic patients on ICS (p<0.0001). Conclusions: Lower FKBP51 expression in sputum cells may reflect eosinophilic inflammation and glucocorticoid responsiveness in steroid-naive asthmatic patients.	[Tajiri, Tomoko; Matsumoto, Hisako; Niimi, Akio; Ito, Isao; Oguma, Tsuyoshi; Nakaji, Hitoshi; Inoue, Hideki; Iwata, Toshiyuki; Nagasaki, Tadao; Kanemitsu, Yoshihiro; Petrova, Guergana; Mishima, Michiaki] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan; [Niimi, Akio] Nagoya City Univ, Dept Med Oncol & Immunol, Sch Med Sci, Div Resp Med, Nagoya, Aichi, Japan; [Nakaji, Hitoshi] Japanese Red Cross Wakayama Med Ctr, Dept Resp Med, Wakayama, Japan	Kyoto University; Nagoya City University	Matsumoto, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan.	hmatsumo@kuhp.kyoto-u.ac.jp		Ito, Isao/0000-0003-3109-898X; Inoue, Hideki/0000-0002-8624-6524; Petrova, Guergana/0000-0001-8168-742X				American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; [Anonymous], 1987, AM REV RESPIR DIS, V136, P225; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Baughman G, 1997, BIOCHEM BIOPH RES CO, V232, P437, DOI 10.1006/bbrc.1997.6307; Caldwell JM, 2010, J ALLERGY CLIN IMMUN, V125, P879, DOI 10.1016/j.jaci.2010.01.038; Chun E, 2011, J CLIN IMMUNOL, V31, P122, DOI 10.1007/s10875-010-9463-9; Cowan DC, 2010, THORAX, V65, P384, DOI 10.1136/thx.2009.126722; Denny WB, 2000, ENDOCRINOLOGY, V141, P4107, DOI 10.1210/en.141.11.4107; Druilhe A, 2003, APOPTOSIS, V8, P481, DOI 10.1023/A:1025590308147; Foresi A, 2000, ANN ALLERG ASTHMA IM, V84, P411, DOI 10.1016/S1081-1206(10)62274-0; Fukushima H, 2007, EUR J PHARMACOL, V570, P222, DOI 10.1016/j.ejphar.2007.05.021; HANSEL TT, 1989, J IMMUNOL METHODS, V122, P97, DOI 10.1016/0022-1759(89)90339-6; Jana AS, 2005, CHEST, V128, P1140; Kobayashi Y, 2005, J IMMUNOL, V175, P5744, DOI 10.4049/jimmunol.175.9.5744; Matsumoto H, 2005, THORAX, V60, P277, DOI 10.1136/thx.2004.028936; Matsumoto H, 2011, RESPIRATION, V81, P311, DOI 10.1159/000319566; Meijer RJ, 2002, CLIN EXP ALLERGY, V32, P1096, DOI 10.1046/j.1365-2222.2002.01412.x; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; National Institutes of Health NH Lung and Blood Institute, 2002, GLOB IN ASTHM MAN PR; Reynolds PD, 1999, J CLIN ENDOCR METAB, V84, P663, DOI 10.1210/jc.84.2.663; ROSEWICZ S, 1988, J BIOL CHEM, V263, P2581; Simpson JL, 2013, CLIN EXP ALLERGY, V43, P29, DOI 10.1111/j.1365-2222.2012.04075.x; SMITH DF, 1993, J BIOL CHEM, V268, P18365; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; Vermeer H, 2003, J CLIN ENDOCR METAB, V88, P277, DOI 10.1210/jc.2002-020354; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Yang N, 2012, STEROIDS, V77, P1041, DOI 10.1016/j.steroids.2012.05.007; Zhang XY, 2008, INVEST OPHTH VIS SCI, V49, P1037, DOI 10.1167/iovs.07-1279	29	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65284	10.1371/journal.pone.0065284	http://dx.doi.org/10.1371/journal.pone.0065284			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762334	gold, Green Published, Green Submitted			2022-12-27	WOS:000321099000052
J	Todaro, M; Orlando, V; Cicero, G; Caccamo, N; Meraviglia, S; Stassi, G; Dieli, F				Todaro, Matilde; Orlando, Valentina; Cicero, Giuseppe; Caccamo, Nadia; Meraviglia, Serena; Stassi, Giorgio; Dieli, Francesco			Chemotherapy Sensitizes Colon Cancer Initiating Cells to V gamma 9V delta 2 T Cell- Mediated Cytotoxicity	PLOS ONE			English	Article							GAMMA-DELTA CELLS; TRAIL-INDUCED APOPTOSIS; STEM-CELLS; TUMOR-CELLS; MONOCLONAL-ANTIBODY; HUMAN GLIOBLASTOMA; RECEPTOR; LINES; IMMUNOTHERAPY; ACTIVATION	Colon cancer comprises a small population of cancer initiating stem cells (CIC) that is responsible for tumor maintenance and resistance to anti-cancer therapies, possibly allowing for tumor recapitulation once treatment stops. Combinations of immune-based therapies with chemotherapy and other anti-tumor agents may be of significant clinical benefit in the treatment of colon cancer. However, cellular immune-based therapies have not been experimented yet in the population of colon CICs. Here, we demonstrate that treatment with low concentrations of commonly used chemotherapeutic agents, 5-fluorouracyl and doxorubicin, sensitize colon CICs to V gamma 9V delta 2 T cell cytotoxicity. V gamma 9V delta 2 T cell cytotoxicity was largely mediated by TRAIL interaction with DR5, following NKG2D-dependent recognition of colon CIC targets. We conclude that in vivo activation of V gamma 9V delta 2 T cells or adoptive administration of ex-vivo expanded V gamma 9V delta 2 T cells at suitable intervals after chemotherapy may substantially increase anti-tumor activities and represent a novel strategy for colon cancer immunotherapy.	[Todaro, Matilde; Cicero, Giuseppe; Stassi, Giorgio] Univ Palermo, Dipartimento Discipline Chirurg & Anat, Palermo, Italy; [Todaro, Matilde; Orlando, Valentina; Caccamo, Nadia; Dieli, Francesco] Univ Palermo, Biomed Res Ctr, Palermo, Italy; [Orlando, Valentina; Caccamo, Nadia; Meraviglia, Serena; Dieli, Francesco] Univ Palermo, Dipartimento Biopatol & Biotecnol Med & Forensi, Palermo, Italy	University of Palermo; University of Palermo; University of Palermo	Dieli, F (corresponding author), Univ Palermo, Biomed Res Ctr, Palermo, Italy.	francesco.dieli@unipa.it	Caccamo, Nadia/J-6808-2018; Stassi, Giorgio/AAC-1175-2022; todaro, matilde/AAC-1003-2022; Meraviglia, Serena/K-5164-2016	todaro, matilde/0000-0001-8686-8043; Cicero, Giuseppe/0000-0002-4717-437X; CACCAMO, Nadia Rosalia/0000-0002-1018-5710; Dieli, Francesco/0000-0002-6685-352X	Italian Ministry for Instruction, University and Research [2008L57JXW]; Italian Ministry of Health; Istituto Superiore di Sanita Oncoproteomic Project [2007-527/B/3A/3]; University of Palermo	Italian Ministry for Instruction, University and Research; Italian Ministry of Health(Ministry of Health, Italy); Istituto Superiore di Sanita Oncoproteomic Project; University of Palermo	This work has been supported by grants from the Italian Ministry for Instruction, University and Research (contract no. 2008L57JXW to FD), the Italian Ministry of Health (Progetto Ricerca Finalizzata 2007 "Stem cells in different pathological conditions: innovative therapeutical approches'' to FD), Istituto Superiore di Sanita Oncoproteomic Project 2007-527/B/3A/3 (to GS and FD) and the University of Palermo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal RR, 2012, EUR J IMMUNOL, V42, P110, DOI 10.1002/eji.201142017; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Caccamo N, 2006, J IMMUNOL, V177, P5290, DOI 10.4049/jimmunol.177.8.5290; Caccamo N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041940; Caccamo N, 2011, BLOOD, V118, P129, DOI 10.1182/blood-2011-01-331298; CONSTANT P, 1994, SCIENCE, V264, P267, DOI 10.1126/science.8146660; Corvaisier M, 2005, J IMMUNOL, V175, P5481, DOI 10.4049/jimmunol.175.8.5481; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Deniger DC, 2013, MOL THER, V21, P638, DOI 10.1038/mt.2012.267; Eberl M, 2003, FEBS LETT, V544, P4, DOI 10.1016/S0014-5793(03)00483-6; Eberl M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000308; Evdokiou A, 2002, INT J CANCER, V99, P491, DOI 10.1002/ijc.10376; Feldman EJ, 2005, J CLIN ONCOL, V23, P4110, DOI 10.1200/JCO.2005.09.133; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gober HJ, 2003, J EXP MED, V197, P163, DOI 10.1084/jem.20021500; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; GROH V, 1989, J EXP MED, V169, P1277, DOI 10.1084/jem.169.4.1277; Guo RT, 2007, P NATL ACAD SCI USA, V104, P10022, DOI 10.1073/pnas.0702254104; Hannani D, 2012, TRENDS IMMUNOL, V33, P199, DOI 10.1016/j.it.2012.01.006; Kang J, 2005, PROSTATE CANCER P D, V8, P274, DOI 10.1038/sj.pcan.4500798; Keane MM, 1999, CANCER RES, V59, P734; Kirkwood JM, 2012, CA-CANCER J CLIN, V62, P309, DOI 10.3322/caac.20132; Kistowska M, 2008, EUR J IMMUNOL, V38, P2200, DOI 10.1002/eji.200838366; Koch U, 2010, SEMIN CANCER BIOL, V20, P116, DOI 10.1016/j.semcancer.2010.02.003; Lake RA, 2005, NAT REV CANCER, V5, P397, DOI 10.1038/nrc1613; Linck D, 2005, LEUKEMIA LYMPHOMA, V46, P285, DOI 10.1080/10428190400015535; Ma YT, 2011, J EXP MED, V208, P491, DOI 10.1084/jem.20100269; Mattarollo SR, 2007, CANCER IMMUNOL IMMUN, V56, P1285, DOI 10.1007/s00262-007-0279-2; Mattarollo SR, 2006, INT J CANCER, V119, P1630, DOI 10.1002/ijc.22019; Mazzoleni S, 2010, CANCER RES, V70, P7500, DOI 10.1158/0008-5472.CAN-10-2353; Meraviglia S, 2010, J IMMUNOL, V185, P1770, DOI 10.4049/jimmunol.1000966; Sireci G, 2001, EUR J IMMUNOL, V31, P1628, DOI 10.1002/1521-4141(200105)31:5<1628::AID-IMMU1628>3.0.CO;2-T; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Todaro M, 2009, J IMMUNOL, V182, P7287, DOI 10.4049/jimmunol.0804288; Tong HX, 2011, EUR J PEDIATR SURG, V21, P304, DOI 10.1055/s-0031-1279762; Vermeulen L, 2008, CELL DEATH DIFFER, V15, P947, DOI 10.1038/cdd.2008.20; Vermijlen D, 2007, J IMMUNOL, V178, P4304, DOI 10.4049/jimmunol.178.7.4304; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wen JH, 2000, BLOOD, V96, P3900, DOI 10.1182/blood.V96.12.3900.h8003900_3900_3906; Wesch D, 2001, CELL IMMUNOL, V212, P110, DOI 10.1006/cimm.2001.1850; Wrobel P, 2007, SCAND J IMMUNOL, V66, P320, DOI 10.1111/j.1365-3083.2007.01963.x; Wu XX, 2007, CANCER SCI, V98, P1969, DOI 10.1111/j.1349-7006.2007.00632.x; Yoshida S, 2003, PEDIATR RES, V54, P709, DOI 10.1203/01.PDR.0000085038.53151.D0	47	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							0065145	10.1371/journal.pone.0065145	http://dx.doi.org/10.1371/journal.pone.0065145			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762301	Green Published, gold, Green Submitted			2022-12-27	WOS:000321099000035
J	Wallner, S; Lutz-Nicoladoni, C; Tripp, CH; Gastl, G; Baier, G; Penninger, JM; Stoitzner, P; Wolf, D				Wallner, Stephanie; Lutz-Nicoladoni, Christina; Tripp, Christoph H.; Gastl, Guenther; Baier, Gottfried; Penninger, Josef M.; Stoitzner, Patrizia; Wolf, Dominik			The Role of the E3 Ligase Cbl-B in Murine Dendritic Cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TOLL-LIKE RECEPTORS; REGULATORY T-CELLS; IN-VIVO; ANTIGEN PRESENTATION; NEGATIVE REGULATION; TGF-BETA; TOLERANCE; LIPOPOLYSACCHARIDE; UNRESPONSIVENESS	Dendritic cells (DCs) are potent antigen-presenting cells with a promising potential in cancer immunotherapy. Cbl proteins are E3 ubiquitin ligases and have been implicated in regulating the functional activity of various immune cells. As an example, c-Cbl negatively affects DC activation. We here describe that another member of the Cbl-protein family (i.e. Cbl-b) is highly expressed in murine bone-marrow-derived DCs (BMDCs). Differentiation of cblb-/- bone marrow mononuclear cells into classical BMDCs is unaltered, except enhanced induction of DEC-205 (CD205) expression. When tested in mixed-lymphocyte reaction (MLR), cblb-/- BMDCs exhibit increased allo-stimulatory capacity in vitro. BMDCs were next in vitro stimulated by various toll like receptor (TLR)-agonists (LPS, Poly(I: C), CpG) and exposed to FITC-labeled dextran. Upon TLR-stimulation, cblb-/- BMDCs produce higher levels of proinflammatory cytokines (IL-1 alpha, IL-6 and TNF-alpha) and exhibit a slightly higher level of FITC-dextran uptake. To further characterize the functional significance of cblb-/- BMDCs we tested them in antigen-specific T cell responses against ovalbumin (OVA) protein and peptides, activating either CD8(+) OT-I or CD4(+) OT-II transgenic T cells. However, cblb-/- BMDCs are equally effective in inducing antigen-specific T cell responses when compared to wildtype BMDCs both in vitro and in vivo. The migratory capacity into lymph nodes during inflammation was similarly not affected by the absence of Cbl-b. In line with these observations, cblb-/- peptide-pulsed BMDCs are equally effective vaccines against OVA-expressing B16 tumors in vivo when compared to wildtype BMDCs. We conclude that in contrast to c-Cbl, Cbl-b plays only a limited role in the induction of Ag-specific T cell responses by murine BMDCs in vitro and in vivo.	[Wallner, Stephanie; Lutz-Nicoladoni, Christina; Gastl, Guenther; Wolf, Dominik] Tyrolean Canc Res Inst, Lab Tumor Immunol, Innsbruck, Austria; [Tripp, Christoph H.; Stoitzner, Patrizia] Med Univ Innsbruck, Dept Dermatol & Venereol, A-6020 Innsbruck, Austria; [Baier, Gottfried] Med Univ Innsbruck, Dept Med Genet Mol & Clin Pharmacol, A-6020 Innsbruck, Austria; [Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1010 Vienna, Austria; [Wolf, Dominik] Univ Hosp Bonn, Dept Hematol & Oncol, Bonn, Germany	Medical University of Innsbruck; Medical University of Innsbruck; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Bonn	Wolf, D (corresponding author), Tyrolean Canc Res Inst, Lab Tumor Immunol, Innsbruck, Austria.	dominik.wolf@ukb.uni-bonn.de	; Penninger, Josef/I-6860-2013	Tripp, Christoph/0000-0001-5502-7241; Penninger, Josef/0000-0002-8194-3777; stoitzner, patrizia/0000-0002-8488-6704; Baier, Gottfried/0000-0002-2085-8325	FWF Austrian Sience Fund [T550-B19]; MFF Tirol; Tiroler Landeskrankenanstalten GmbH; DFG German Research Foundation [WO1877/1-1]; Austrian Science Fund (FWF) [P 25044] Funding Source: researchfish	FWF Austrian Sience Fund; MFF Tirol; Tiroler Landeskrankenanstalten GmbH; DFG German Research Foundation(German Research Foundation (DFG)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported from the FWF Austrian Sience Fund (T550-B19), the MFF Tirol, the Tiroler Landeskrankenanstalten GmbH and the DFG German Research Foundation (WO1877/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Bauer B, 2000, EUR J IMMUNOL, V30, P3645, DOI 10.1002/1521-4141(200012)30:12<3645::AID-IMMU3645>3.0.CO;2-#; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Burgdorf S, 2012, J IMMUNOL, V176, P6770; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Chiou S-H, 2011, EMBO REPORTS, P1; Curtsinger JM, 2003, J EXP MED, V197, P1141, DOI 10.1084/jem.20021910; Delamarre L, 2011, SEMIN IMMUNOL, V23, P2, DOI 10.1016/j.smim.2011.02.001; den Brok MHMGM, 2005, EXPERT REV VACCINES, V4, P699, DOI 10.1586/14760584.4.5.699; Engell-Noerregaard L, 2009, CANCER IMMUNOL IMMUN, V58, P1, DOI 10.1007/s00262-008-0568-4; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Huang F, 2008, IMMUNOL REV, V224, P229, DOI 10.1111/j.1600-065X.2008.00655.x; Idzko M, 2004, J IMMUNOL, V172, P6011, DOI 10.4049/jimmunol.172.10.6011; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Kaisho T, 2002, BBA-MOL CELL RES, V1589, P1, DOI 10.1016/S0167-4889(01)00182-3; Kamala T, 2007, J IMMUNOL METHODS, V328, P204, DOI 10.1016/j.jim.2007.08.004; Karwacz K, 2011, EMBO MOL MED, V3, P581, DOI 10.1002/emmm.201100165; Kojo S, 2009, P NATL ACAD SCI USA, V106, P17847, DOI 10.1073/pnas.0904078106; Krawczyk CM, 2005, J IMMUNOL, V174, P1472, DOI 10.4049/jimmunol.174.3.1472; LANZAVECCHIA A, 1990, ANNU REV IMMUNOL, V8, P773, DOI 10.1146/annurev.immunol.8.1.773; Liechtenstein T, 2013, IMMUNOLOGY ENDOCRINE, V12, P1; Loeser S, 2007, J EXP MED, V204, P879, DOI 10.1084/jem.20061699; Lugade AA, 2012, J IMMUNOL, P7516; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Lutz- Nicoladoni C, 2011, IMMUNOL CELL BIOL, V2011, P1; Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3; Mahnke K, 2003, BLOOD, V101, P4862, DOI 10.1182/blood-2002-10-3229; McLellan AD, 2002, BLOOD, V99, P2084, DOI 10.1182/blood.V99.6.2084; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Morelli AE, 2001, BLOOD, V98, P1512, DOI 10.1182/blood.V98.5.1512; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Mukhopadhaya A, 2008, P NATL ACAD SCI USA, V105, P6374, DOI 10.1073/pnas.0802644105; Nau MM, 2003, GENE, V308, P103, DOI 10.1016/S0378-1119(03)00471-2; Nurieva R, 2006, EMBO J, V25, P2623, DOI 10.1038/sj.emboj.7601146; O'Connell PJ, 2006, BLOOD, V107, P1010, DOI 10.1182/blood-2005-07-2903; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Paolino M, 2011, J IMMUNOL, V186, P2138, DOI 10.4049/jimmunol.1003390; Purev E, 2009, MOL BIOL CELL, V20, P4021, DOI 10.1091/mbc.E09-03-0248; ROAKE JA, 1995, J EXP MED, V181, P2237, DOI 10.1084/jem.181.6.2237; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schuler G, 2010, EUR J IMMUNOL, V40, P2123, DOI 10.1002/eji.201040630; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeda Kiyoshi, 2005, Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, V4, P3, DOI 10.2174/1568014053005336; Tjoa BA, 1998, PROSTATE, V36, P39; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Wallner S, 2012, DEV CLIN IMMUNOLOGY, V2012, P1; Wanping J, 1995, NATURE, V375, P151; Wohlfert EA, 2006, J IMMUNOL, V176, P1316, DOI 10.4049/jimmunol.176.3.1316; Wohlfert EA, 2004, J IMMUNOL, V173, P1059, DOI 10.4049/jimmunol.173.2.1059	57	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65178	10.1371/journal.pone.0065178	http://dx.doi.org/10.1371/journal.pone.0065178			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762309	gold, Green Published, Green Submitted			2022-12-27	WOS:000321099000040
J	Andersen, MLM; Rasmussen, MA; Porksen, S; Svensson, J; Vikre-Jorgensen, J; Thomsen, J; Hertel, NT; Johannesen, J; Pociot, F; Petersen, JS; Hansen, L; Mortensen, HB; Nielsen, LB				Andersen, Marie Louise Max; Rasmussen, Morten Arendt; Porksen, Sven; Svensson, Jannet; Vikre-Jorgensen, Jennifer; Thomsen, Jane; Hertel, Niels Thomas; Johannesen, Jesper; Pociot, Flemming; Petersen, Jacob Sten; Hansen, Lars; Mortensen, Henrik Bindesbol; Nielsen, Lotte Brondum			Complex Multi-Block Analysis Identifies New Immunologic and Genetic Disease Progression Patterns Associated with the Residual beta-Cell Function 1 Year after Diagnosis of Type 1 Diabetes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PARTIAL REMISSION; GLYCEMIC CONTROL; CHILDREN; ADOLESCENTS; GLUCAGON; AUTOANTIBODIES; GLUCOSE; ZINC; SUSCEPTIBILITY	The purpose of the present study is to explore the progression of type 1 diabetes (T1D) in Danish children 12 months after diagnosis using Latent Factor Modelling. We include three data blocks of dynamic paraclinical biomarkers, baseline clinical characteristics and genetic profiles of diabetes related SNPs in the analyses. This method identified a model explaining 21.6% of the total variation in the data set. The model consists of two components: (1) A pattern of declining residual beta-cell function positively associated with young age, presence of diabetic ketoacidosis and long duration of disease symptoms (P = 0.0004), and with risk alleles of WFS1, CDKN2A/2B and RNLS (P = 0.006). (2) A second pattern of high ZnT8 autoantibody levels and low postprandial glucagon levels associated with risk alleles of IFIH1, TCF2, TAF5L, IL2RA and PTPN2 and protective alleles of ERBB3 gene (P = 0.0005). These results demonstrate that Latent Factor Modelling can identify associating patterns in clinical prospective data - future functional studies will be needed to clarify the relevance of these patterns.	[Andersen, Marie Louise Max; Porksen, Sven; Svensson, Jannet; Johannesen, Jesper; Hansen, Lars; Mortensen, Henrik Bindesbol; Nielsen, Lotte Brondum] Univ Copenhagen, Herlev Hosp, Dept Pediat, Fac Hlth Sci, Copenhagen, Denmark; [Rasmussen, Morten Arendt] Dept Food Sci Qual & Technol, Copenhagen, Denmark; [Vikre-Jorgensen, Jennifer] Skejby Univ Hosp, Dept Pediat, Aarhus, Denmark; [Thomsen, Jane] Kolding Cty Hosp, Dept Pediat, Kolding, Denmark; [Hertel, Niels Thomas] Odense Univ Hosp, HC Andersen Childrens Hosp, DK-5000 Odense, Denmark; [Pociot, Flemming] Glostrup Univ Hosp, Diagnost Unit, Dept Biochem, Glostrup, Denmark; [Petersen, Jacob Sten] Novo Nordisk AS, Diabet Pharmacol & Bioanal, Malov, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; Aarhus University; Kolding Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Copenhagen; Novo Nordisk	Andersen, MLM (corresponding author), Univ Copenhagen, Herlev Hosp, Dept Pediat, Fac Hlth Sci, Copenhagen, Denmark.	ml.max.andersen@dadlnet.dk	Svensson, Jannet/AAI-9913-2021; Rasmussen, Morten/AAE-9517-2020; Arendt, Morten/S-8843-2017	Svensson, Jannet/0000-0002-9365-0728; Rasmussen, Morten/0000-0001-7431-5206; Arendt, Morten/0000-0001-7431-5206; Johannesen, Jesper/0000-0003-2772-2567; Pociot, Flemming/0000-0003-3274-5448; Mortensen, Henrik Bindesbol/0000-0001-9231-8363; Thomsen, Jane Valentin/0000-0003-2143-8274; Porksen, Sven/0000-0003-1868-356X	Novo Nordisk A/S; Danish Agency for Science, Technology and Innovation	Novo Nordisk A/S(Novo Nordisk); Danish Agency for Science, Technology and Innovation	The present study is a part of an industrial PhD project funded by Novo Nordisk A/S and the Danish Agency for Science, Technology and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar E, 2011, ARXIV11053422; Acar E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032227; Andersen MLM, 2012, PEDIAT DIABETES; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; Bergholdt R, 2012, DIABETES, P1; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; Cooper JD, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-71; COUPER JJ, 1991, DIABETES RES CLIN PR, V11, P9, DOI 10.1016/0168-8227(91)90135-Z; Diabet Control Complications Trial Res Grp, 1998, ANN INTERN MED, V128, P517, DOI 10.7326/0003-4819-128-7-199804010-00001; Dien J, 2005, CLIN NEUROPHYSIOL, V116, P1808, DOI 10.1016/j.clinph.2004.11.025; Egefjord L, 2010, CURR DIABETES REV, V6, P52, DOI 10.2174/157339910790442655; GREENBAUM CJ, 1992, DIABETES, V41, P1570, DOI 10.2337/diabetes.41.12.1570; GREENBAUM CJ, 1991, J CLIN INVEST, V88, P767, DOI 10.1172/JCI115375; Hanley AJG, 2002, DIABETES, V51, P2642, DOI 10.2337/diabetes.51.8.2642; HOLST JJ, 1982, BIOCHEM J, V207, P381, DOI 10.1042/bj2070381; Howson JMM, 2012, DIABETOLOGIA, V55, P1978, DOI 10.1007/s00125-012-2540-2; Howson JMM, 2012, DIABETES; Kaas A, 2012, PEDIATR DIABETES, V13, P51, DOI 10.1111/j.1399-5448.2011.00812.x; Kahn R, 2003, DIABETES CARE, V26, P3168, DOI 10.2337/diacare.26.11.3168; Keene KL, 2012, GENES IMMUN, V13, P66, DOI 10.1038/gene.2011.56; Komulainen J, 1999, DIABETES CARE, V22, P1950, DOI 10.2337/diacare.22.12.1950; Marselli L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011499; Mortensen HB, 2010, PEDIATR DIABETES, V11, P218, DOI 10.1111/j.1399-5448.2009.00566.x; Mortensen HB, 2009, DIABETES CARE, V32, P1384, DOI 10.2337/dc08-1987; Nielsen LB, 2006, DIABETOLOGIA, V49, P71, DOI 10.1007/s00125-005-0042-1; Nielsen LB, 2011, AUTOIMMUNITY, V44, P616, DOI 10.3109/08916934.2011.576724; Petrone A, 2008, DIABETES CARE, V31, P1214, DOI 10.2337/dc07-1158; Pociot F, 2004, AM J HUM GENET, V74, P647, DOI 10.1086/383095; Porksen S, 2007, J CLIN ENDOCR METAB, V92, P2910, DOI 10.1210/jc.2007-0244; Rasmussen MA, 2010, BRIT J CLIN PHARMACO, V69, P379, DOI 10.1111/j.1365-2125.2009.03600.x; Savola K, 1998, DIABETOLOGIA, V41, P1293, DOI 10.1007/s001250051067; Scholin A, 2011, DIABETIC MED, V28, P156, DOI 10.1111/j.1464-5491.2010.03191.x; SJOROOS M, 1995, BIOTECHNIQUES, V18, P870; Smilde AK, 2012, J CHEMOMETR, V17, P323; Thomson G, 2007, TISSUE ANTIGENS, V70, P110, DOI 10.1111/j.1399-0039.2007.00867.x; Torn C, 2000, J CLIN ENDOCR METAB, V85, P4619, DOI 10.1210/jc.85.12.4619; Wang LM, 2012, DIABETES CARE, V35, P465, DOI 10.2337/dc11-1236; Wei FY, 2011, ENDOCR J, V58, P819, DOI 10.1507/endocrj.EJ11-0099; Wolfsdorf J, 2009, PEDIATR DIABETES, V10, P118, DOI 10.1111/j.1399-5448.2009.00569.x; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	41	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64632	10.1371/journal.pone.0064632	http://dx.doi.org/10.1371/journal.pone.0064632			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755131	Green Published, Green Submitted, gold			2022-12-27	WOS:000320579400020
J	Keville, MP; Reed, SC; Cleveland, CC				Keville, Megan P.; Reed, Sasha C.; Cleveland, Cory C.			Nitrogen Cycling Responses to Mountain Pine Beetle Disturbance in a High Elevation Whitebark Pine Ecosystem	PLOS ONE			English	Article							GREATER YELLOWSTONE ECOSYSTEM; INSECT DEFOLIATION; FOREST ECOSYSTEMS; EXTRACTION METHOD; SOIL PROPERTIES; TREE MORTALITY; FIR FOREST; LOSSES; CARBON; EXPORT	Ecological disturbances can significantly affect biogeochemical cycles in terrestrial ecosystems, but the biogeochemical consequences of the extensive mountain pine beetle outbreak in high elevation whitebark pine (WbP) (Pinus albicaulis) ecosystems of western North America have not been previously investigated. Mountain pine beetle attack has driven widespread WbP mortality, which could drive shifts in both the pools and fluxes of nitrogen (N) within these ecosystems. Because N availability can limit forest regrowth, understanding how beetle-induced mortality affects N cycling in WbP stands may be critical to understanding the trajectory of ecosystem recovery. Thus, we measured above-and belowground N pools and fluxes for trees representing three different times since beetle attack, including unattacked trees. Litterfall N inputs were more than ten times higher under recently attacked trees compared to unattacked trees. Soil inorganic N concentrations also increased following beetle attack, potentially driven by a more than two-fold increase in ammonium (NH4+) concentrations in the surface soil organic horizon. However, there were no significant differences in mineral soil inorganic N or soil microbial biomass N concentrations between attacked and unattacked trees, implying that short-term changes in N cycling in response to the initial stages of WbP attack were restricted to the organic horizon. Our results suggest that while mountain pine beetle attack drives a pulse of N from the canopy to the forest floor, changes in litterfall quality and quantity do not have profound effects on soil biogeochemical cycling, at least in the short-term. However, continuous observation of these important ecosystems will be crucial to determining the long-term biogeochemical effects of mountain pine beetle outbreaks.	[Keville, Megan P.; Cleveland, Cory C.] Univ Montana, Dept Ecosyst & Conservat Sci, Missoula, MT 59812 USA; [Reed, Sasha C.] US Geol Survey, Southwest Biol Sci Ctr, Moab, UT USA	University of Montana System; University of Montana; United States Department of the Interior; United States Geological Survey	Cleveland, CC (corresponding author), Univ Montana, Dept Ecosyst & Conservat Sci, Missoula, MT 59812 USA.	Cory.Cleveland@umontana.edu	Reed, Sasha C/ABE-9476-2020	Reed, Sasha C/0000-0002-8597-8619; Cleveland, Cory/0000-0002-8804-4248	United States Department of Agriculture National Needs Fellowship [USDA-CSREES 2008-38420-19524]; McIntire-Stennis Cooperative Forestry Research Program	United States Department of Agriculture National Needs Fellowship; McIntire-Stennis Cooperative Forestry Research Program	Funding sources include a United States Department of Agriculture National Needs Fellowship (USDA-CSREES 2008-38420-19524)(http://www.csrees.usda.gov/fo/nationalneedsgraduatefellowships.cfm) and a grant from the McIntire-Stennis Cooperative Forestry Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aber JD, 2002, ECOSYSTEMS, V5, P648, DOI 10.1007/s10021-002-0203-8; Aber JD, 1982, ENV BIOGEOCHEM, V35, P179; Arno S.F., 2001, WHITEBARK PINE COMMU, P74; BORMANN FH, 1969, BIOSCIENCE, V19, P600, DOI 10.2307/1294934; Bormann FH., 1994, PATTERN PROCESS FORE; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Chapin F.S., 2002, PRINCIPLES TERRESTRI, DOI 10.1007/978-1-4419-9504-9; Clow DW, 2011, APPL GEOCHEM, V26, pS174, DOI 10.1016/j.apgeochem.2011.03.096; Concilio A, 2005, CAN J FOREST RES, V35, P1581, DOI 10.1139/X05-091; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; DAVIDSON EA, 1986, APPL ENVIRON MICROB, V52, P1287, DOI 10.1128/AEM.52.6.1287-1292.1986; Doane TA, 2003, ANAL LETT, V36, P2713, DOI 10.1081/AL-120024647; Eshleman KN, 1998, WATER RESOUR RES, V34, P2005, DOI 10.1029/98WR01198; FARNES PE, 1990, USDA INTERM, V270, P302; Frost CJ, 2004, ECOLOGY, V85, P3335, DOI 10.1890/04-0003; Gough L, 2000, OIKOS, V89, P428, DOI 10.1034/j.1600-0706.2000.890302.x; Griffin JM, 2011, FOREST ECOL MANAG, V261, P1077, DOI 10.1016/j.foreco.2010.12.031; Griffiths RP, 2010, NORTHWEST SCI, V84, P33, DOI 10.3955/046.084.0104; GUTSCHICK VP, 1981, AM NAT, V118, P607, DOI 10.1086/283858; Houle D, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009057; Huber C, 2005, J ENVIRON QUAL, V34, P1772, DOI 10.2134/jeq2004.0210; Jenkins JC, 1999, CAN J FOREST RES, V29, P630, DOI 10.1139/cjfr-29-5-630; Johnson EA, 2008, ECOL LETT, V11, P419, DOI 10.1111/j.1461-0248.2008.01173.x; LANNER RM, 1980, P 6 N AM FOR BIOL WO, P15; le Mellec A, 2008, CAN J FOREST RES, V38, P1829, DOI 10.1139/X08-045; Logan JA, 2009, IFOREST, V2, P19, DOI 10.3832/ifor0477-002; Logan JA, 2010, ECOL APPL, V20, P895, DOI 10.1890/09-0655.1; Lovett GM, 2010, ECOSYSTEMS, V13, P1188, DOI 10.1007/s10021-010-9381-y; Lovett GM, 2002, BIOSCIENCE, V52, P335, DOI 10.1641/0006-3568(2002)052[0335:IDANCI]2.0.CO;2; McCambridge WF, 1982, RM416 USDA FOR SERV; Metzger KL, 2006, FOREST ECOL MANAG, V227, P22, DOI 10.1016/j.foreco.2006.02.005; Morehouse K, 2008, FOREST ECOL MANAG, V255, P2698, DOI 10.1016/j.foreco.2008.01.050; Nave LE, 2011, J GEOPHYS RES-BIOGEO, V116, DOI [10.1029/2011JG001758, 10.1029/20113G001758]; Orwig DA, 2008, CAN J FOREST RES, V38, P834, DOI 10.1139/X07-196; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Reynolds Barbara C., 2000, Selbyana, V21, P74; Riscassi AL, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000860; SAFRANYIK L, 1999, BCX386 PAC FOR CTR C, P35; Stone JE, 1999, RESTOR ECOL, V7, P172, DOI 10.1046/j.1526-100X.1999.72009.x; Stone WE, 1996, VEGETATIO, V122, P1, DOI 10.1007/BF00052811; SWANK WT, 1981, OECOLOGIA, V51, P297, DOI 10.1007/BF00540897; Tomback DF, 2001, WHITEBARK PINE COMMU, P88; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; VITOUSEK PM, 1982, ECOL MONOGR, V52, P155, DOI 10.2307/1942609; VITOUSEK PM, 1979, SCIENCE, V204, P469, DOI 10.1126/science.204.4392.469; WEATHERBURN MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045; Webb JR, 1995, WATER AIR SOIL POLL, V85, P535, DOI 10.1007/BF00476884; ZINKE PJ, 1962, ECOLOGY, V43, P130, DOI 10.2307/1932049	49	12	12	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65004	10.1371/journal.pone.0065004	http://dx.doi.org/10.1371/journal.pone.0065004			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755166	gold, Green Submitted, Green Published			2022-12-27	WOS:000320579400034
J	Pedroso, SS; Barber, I; Svensson, O; Fonseca, PJ; Amorim, MCP				Pedroso, Silvia S.; Barber, Iain; Svensson, Ola; Fonseca, Paulo J.; Amorim, Maria Clara P.			Courtship Sounds Advertise Species Identity and Male Quality in Sympatric Pomatoschistus spp. Gobies	PLOS ONE			English	Article							SAND GOBY; ACOUSTIC-SIGNALS; SEXUAL SELECTION; INTERSPECIFIC VARIATION; REPRODUCTIVE SUCCESS; LUSITANIAN TOADFISH; PAINTED GOBY; MATE CHOICE; MALE SIZE; RECOGNITION	Acoustic signals can encode crucial information about species identity and individual quality. We recorded and compared male courtship drum sounds of the sand goby Pomatoschistus minutus and the painted goby P. pictus and examined if they can function in species recognition within sympatric populations. We also examined which acoustic features are related to male quality and the factors that affect female courtship in the sand goby, to determine whether vocalisations potentially play a role in mate assessment. Drums produced by the painted goby showed significantly higher dominant frequencies, higher sound pulse repetition rates and longer intervals between sounds than those of the sand goby. In the sand goby, male quality was predicted by visual and acoustic courtship signals. Regression analyses showed that sound amplitude was a good predictor of male length, whereas the duration of nest behaviour and active calling rate (i.e. excluding silent periods) were good predictors of male condition factor and fat reserves respectively. In addition, the level of female courtship was predicted by male nest behaviour. The results suggest that the frequency and temporal patterns of sounds can encode species identity, whereas sound amplitude and calling activity reflects male size and fat reserves. Visual courtship duration (nest-related behaviour) also seems relevant to mate choice, since it reflects male condition and is related to female courtship. Our work suggests that acoustic communication can contribute to mate choice in the sand goby group, and invites further study.	[Pedroso, Silvia S.; Amorim, Maria Clara P.] Inst Univ, Inst Super Psicol Aplicada, Unidade Invest Ecoetol, Lisbon, Portugal; [Barber, Iain] Univ Leicester, Dept Biol, Coll Med Biol Sci & Psychol, Leicester, Leics, England; [Svensson, Ola] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [Fonseca, Paulo J.] Univ Lisbon, Fac Ciencias, Dept Biol Anim, Lisbon, Portugal; [Fonseca, Paulo J.] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Lisbon, Portugal	Instituto Superior Psicologia Aplicada (ISPA); Instituto Universitario de Lisboa; University of Leicester; University of Gothenburg; Universidade de Lisboa; Universidade de Lisboa	Amorim, MCP (corresponding author), Inst Univ, Inst Super Psicol Aplicada, Unidade Invest Ecoetol, Lisbon, Portugal.	amorim@ispa.pt	Amorim, M. Clara P./K-1889-2012; Fonseca, Paulo J/K-1537-2012; Svensson, Ola/F-5232-2013; Barber, Iain/B-8872-2008	Amorim, M. Clara P./0000-0002-2453-6999; Fonseca, Paulo J/0000-0002-2663-9385; Svensson, Ola/0000-0003-3752-3131; Barber, Iain/0000-0003-3955-6674	Portuguese Science and Technology Foundation [PTDC/MAR/68868/2006, UID 331/94, UID 329, SFRH/BPD/41489/2007]; ASSEMBLE grant [227799]; Fisheries Society of the British Isles; Banco Santander; Centre for Marine Evolutionary Biology, University of Gothenburg, Sweden	Portuguese Science and Technology Foundation(Portuguese Foundation for Science and Technology); ASSEMBLE grant; Fisheries Society of the British Isles; Banco Santander; Centre for Marine Evolutionary Biology, University of Gothenburg, Sweden	SSP, PJF and MCPA acknowledge the financial support of the Portuguese Science and Technology Foundation (project PTDC/MAR/68868/2006, pluriannual programs UI&D 331/94 and UI&D 329, grants SFRH/BPD/41489/2007) and of an ASSEMBLE grant (no. 227799). IB received financial support from the Fisheries Society of the British Isles (a research grant) and from Banco Santander (a travel grant). OS was funded by the Centre for Marine Evolutionary Biology, University of Gothenburg, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim MCP, 2008, J MAR BIOL ASSOC UK, V88, P1069, DOI 10.1017/S0025315408001677; Amorim MCP, 2008, J FISH BIOL, V72, P1355, DOI 10.1111/j.1095-8649.2008.01802.x; Amorim MCP, 2007, J MAR BIOL ASSOC UK, V87, P1017, DOI 10.1017/S0025315407056822; Amorim MCP, 2010, J EXP BIOL, V213, P2997, DOI 10.1242/jeb.044586; Amorim MCP, 2013, FUNCT ECOL, V27, P289, DOI 10.1111/1365-2435.12032; Amorim MCP, 2004, J FISH BIOL, V65, P1358, DOI 10.1111/j.0022-1112.2004.00535.x; Amundsen T, 2003, BEHAV ECOL SOCIOBIOL, V54, P55, DOI 10.1007/s00265-003-0593-4; Barber I, 2002, J FISH BIOL, V61, P185, DOI 10.1006/jfbi.2002.2031; Bertram SM, 2012, ETHOLOGY, V118, P360, DOI 10.1111/j.1439-0310.2011.02019.x; Bolgan M, 2012, ADV EXP MED BIOL, V730, P109, DOI 10.1007/978-1-4419-7311-5_24; Boul KE, 2007, P ROY SOC B-BIOL SCI, V274, P399, DOI 10.1098/rspb.2006.3736; Bradbury Jack W., 1998, pi; CHELLAPPA S, 1995, J FISH BIOL, V47, P775, DOI 10.1111/j.1095-8649.1995.tb06002.x; Colleye O, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-365; Connaughton MA, 2002, J EXP BIOL, V205, P2183; Crawford JD, 1997, J ACOUST SOC AM, V102, P1200, DOI 10.1121/1.419923; Cure C, 2012, ANIM BEHAV, V84, DOI 10.1016/j.anbehav.2012.04.039; De Jong K, 2007, ANIM BEHAV, V74, P1285, DOI 10.1016/j.anbehav.2007.02.023; EDLUND AM, 1980, SARSIA, V65, P239; FONSECA PJ, 2011, Patent No. 105933; Forsgren E, 1997, P ROY SOC B-BIOL SCI, V264, P1283, DOI 10.1098/rspb.1997.0177; Forsgren E, 1999, BEHAV CONSERVATION L, P249; Gentner TQ, 2000, ANIM BEHAV, V59, P443, DOI 10.1006/anbe.1999.1313; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Groning J, 2008, Q REV BIOL, V83, P257, DOI 10.1086/590510; Hochkirch A, 2011, BEHAV ECOL SOCIOBIOL, V65, P1637, DOI 10.1007/s00265-011-1174-6; Johnston CE, 2007, ENVIRON BIOL FISH, V78, P183, DOI 10.1007/s10641-006-9087-3; Jones AG, 2001, P NATL ACAD SCI USA, V98, P9151, DOI 10.1073/pnas.171310198; Judge KA, 2001, ANIM BEHAV, V62, P849, DOI 10.1006/anbe.2001.1801; Kihslinger RL, 2002, J COMP PSYCHOL, V116, P210, DOI 10.1037//0735-7036.116.2.210; Kotiaho JS, 1998, P ROY SOC B-BIOL SCI, V265, P2203, DOI 10.1098/rspb.1998.0560; Kvarnemo C, 2000, BEHAV ECOL SOCIOBIOL, V48, P378, DOI 10.1007/s002650000246; Lehtonen TK, 2008, ANIM BEHAV, V75, P55, DOI 10.1016/j.anbehav.2007.04.011; Lehtonen TK, 2012, ANIM BEHAV, V83, P1153, DOI 10.1016/j.anbehav.2012.01.040; Lindstrom K, 2000, ENVIRON BIOL FISH, V58, P411, DOI 10.1023/A:1007695526177; LINDSTROM K, 1993, ETHOL ECOL EVOL, V5, P97, DOI 10.1080/08927014.1993.9523117; LONGRIE N, 2008, J ZOOL, V276, P266; Luttbeg B, 2001, ETHOLOGY, V107, P545, DOI 10.1046/j.1439-0310.2001.00694.x; MAGNHAGEN C, 1989, J FISH BIOL, V35, P755, DOI 10.1111/j.1095-8649.1989.tb03027.x; Malavasi S, 2008, BIOL J LINN SOC, V93, P763, DOI 10.1111/j.1095-8312.2008.00947.x; Mendelson TC, 2005, NATURE, V433, P375, DOI 10.1038/433375a; Miller P.J., 1986, P1019; Myrberg A.A. Jr, 1978, P137; MYRBERG AA, 1986, ANIM BEHAV, V34, P913, DOI 10.1016/S0003-3472(86)80077-X; Nemeth E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043259; Olsson KH, 2009, ANIM BEHAV, V77, P541, DOI 10.1016/j.anbehav.2008.10.021; Ottoni EB, 2000, BEHAV RES METH INS C, V32, P446, DOI 10.3758/BF03200814; Parmentier E, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-12; RAND AS, 1992, AM ZOOL, V32, P81; Rice AN, 2011, P ROY SOC B-BIOL SCI, V278, P3762, DOI 10.1098/rspb.2011.0656; Rice AN, 2009, J EXP BIOL, V212, P1377, DOI 10.1242/jeb.028506; Ritschard M, 2010, ANIM BEHAV, V79, P877, DOI 10.1016/j.anbehav.2009.12.038; RYAN MJ, 1993, EVOLUTION, V47, P647, DOI 10.1111/j.1558-5646.1993.tb02118.x; Saarikettu M, 2005, BEHAV GENET, V35, P257, DOI 10.1007/s10519-005-3218-z; SEARCY WA, 1981, ANIM BEHAV, V29, P997, DOI 10.1016/S0003-3472(81)80053-X; Searcy WA, 1996, ETHOLOGY, V102, P187; SPANIER E, 1979, Z TIERPSYCHOL, V51, P301; Svensson O, 2004, J FISH BIOL, V64, P1425, DOI 10.1111/j.0022-1112.2004.00381.x; Svensson O, 2007, BEHAV ECOL, V18, P410, DOI 10.1093/beheco/arl098; Vasconcelos RO, 2012, BEHAV ECOL, V23, P375, DOI 10.1093/beheco/arr199; Verzijden MN, 2010, BEHAV ECOL, V21, P548, DOI 10.1093/beheco/arq018; WALLIS GP, 1980, MAR ECOL PROG SER, V3, P309, DOI 10.3354/meps003309; Welling PP, 1997, BEHAVIOUR, V134, P891, DOI 10.1163/156853997X00214; Zar JH, 1999, BIOSTATISTICAL ANAL; Zelick R., 1999, COMP HEARING FISH AM	65	30	30	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64620	10.1371/journal.pone.0064620	http://dx.doi.org/10.1371/journal.pone.0064620			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755129	gold, Green Published, Green Submitted			2022-12-27	WOS:000320579400019
J	Platte, P; Herbert, C; Pauli, P; Breslin, PAS				Platte, Petra; Herbert, Cornelia; Pauli, Paul; Breslin, Paul A. S.			Oral Perceptions of Fat and Taste Stimuli Are Modulated by Affect and Mood Induction	PLOS ONE			English	Article							FOOD-INTAKE; DEPRESSIVE SYMPTOMS; HEALTHY-SUBJECTS; NEGATIVE AFFECT; SWEET TASTE; SENSITIVITY; RESPONSES; OBESE; MAGNITUDE; SUCROSE	This study examined the impact of three clinical psychological variables (non-pathological levels of depression and anxiety, as well as experimentally manipulated mood) on fat and taste perception in healthy subjects. After a baseline orosensory evaluation, 'sad', 'happy' and 'neutral' video clips were presented to induce corresponding moods in eighty participants. Following mood manipulation, subjects rated five different oral stimuli, appearing sweet, umami, sour, bitter, fatty, which were delivered at five different concentrations each. Depression levels were assessed with Beck's Depression Inventory (BDI) and anxiety levels were assessed via the Spielberger's STAI-trait and state questionnaire. Overall, subjects were able to track the concentrations of the stimuli correctly, yet depression level affected taste ratings. First, depression scores were positively correlated with sucrose ratings. Second, subjects with depression scores above the sample median rated sucrose and quinine as more intense after mood induction (positive, negative and neutral). Third and most important, the group with enhanced depression scores did not rate low and high fat stimuli differently after positive or negative mood induction, whereas, during baseline or during the non-emotional neutral condition they rated the fat intensity as increasing with concentration. Consistent with others' prior observations we also found that sweet and bitter stimuli at baseline were rated as more intense by participants with higher anxiety scores and that after positive and negative mood induction, citric acid was rated as stronger tasting compared to baseline. The observation that subjects with mild subclinical depression rated low and high fat stimuli similarly when in positive or negative mood is novel and likely has potential implications for unhealthy eating patterns. This deficit may foster unconscious eating of fatty foods in sub-clinical mildly depressed populations.	[Platte, Petra; Herbert, Cornelia; Pauli, Paul] Univ Wurzburg, Dept Physiol, Wurzburg, Germany; [Herbert, Cornelia] German Sport Univ Cologne, Inst Psychol, Cologne, Germany; [Breslin, Paul A. S.] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08903 USA; [Breslin, Paul A. S.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	University of Wurzburg; German Sport University Cologne; Rutgers State University New Brunswick; Monell Chemical Senses Center	Platte, P (corresponding author), Univ Wurzburg, Dept Physiol, Wurzburg, Germany.	platte@psychologie.uni-wuerzburg.de		Breslin, Paul/0000-0001-5988-8401; Pauli, Paul/0000-0003-0692-6720	National Institutes of Health (NIH) [DC 02995, DC 011393]; German Reserarch Foundation (DFG) [HE 5880/3-1]; University of Wuerzburg; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R29DC002995, R21DC011393, R01DC002995] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Reserarch Foundation (DFG); University of Wuerzburg; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by National Institutes of Health (NIH) grants DC 02995, DC 011393 (PASB) and DFG grant HE 5880/3-1. This publication was funded by the German Reserarch Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al'absi M, 2012, PSYCHOPHYSIOLOGY, V49, P96, DOI 10.1111/j.1469-8986.2011.01289.x; AMSTERDAM JD, 1987, BIOL PSYCHIAT, V22, P1481, DOI 10.1016/0006-3223(87)90108-9; Bartoshuk LM, 2000, CHEM SENSES, V25, P447, DOI 10.1093/chemse/25.4.447; Bartoshuk LM, 2004, PHYSIOL BEHAV, V82, P109, DOI 10.1016/j.physbeh.2004.02.033; Beauchamp GK, 2009, AM J CLIN NUTR, V90, p723S, DOI 10.3945/ajcn.2009.27462E; Beck AT, 1971, BECK DEPRESSION INVE; Berlin I, 1998, EUR PSYCHIAT, V13, P303, DOI 10.1016/S0924-9338(98)80048-5; BRAUCHLI P, 1995, CHEM SENSES, V20, P505, DOI 10.1093/chemse/20.5.505; Chen D, 2005, CHEM SENSES, V30, P345, DOI 10.1093/chemse/bji029; DESS NK, 1990, BRAIN RES BULL, V24, P669, DOI 10.1016/0361-9230(90)90006-L; Dess NK, 1998, BIOL PSYCHOL, V48, P103, DOI 10.1016/S0301-0511(98)00014-3; Dichter GS, 2010, DEPRESS ANXIETY, V27, P859, DOI 10.1002/da.20690; Donaldson LF, 2009, AM J CLIN NUTR, V90, p800S, DOI 10.3945/ajcn.2009.27462Q; FUJIMURA A, 1990, AM J PHYSIOL, V259, pR931, DOI 10.1152/ajpregu.1990.259.5.R931; Galindo MM, 2012, CHEM SENSES, V37, P123, DOI 10.1093/chemse/bjr069; Goldschmidt AB, 2011, EAT BEHAV, V12, P37, DOI 10.1016/j.eatbeh.2010.11.001; Goris AHC, 2000, AM J CLIN NUTR, V71, P130; Green BG, 1996, CHEM SENSES, V21, P323, DOI 10.1093/chemse/21.3.323; GREEN BG, 1993, CHEM SENSES, V18, P683, DOI 10.1093/chemse/18.6.683; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Heath TP, 2006, J NEUROSCI, V26, P12664, DOI 10.1523/JNEUROSCI.3459-06.2006; Hewig J, 2005, COGNITION EMOTION, V19, P1095, DOI 10.1080/02699930541000084; Hoefling A, 2010, APPETITE, V54, P603, DOI 10.1016/j.appet.2010.02.016; Ileri-Gurel E, 2012, CHEM SENSES; Jansen A, 2008, APPETITE, V51, P556, DOI 10.1016/j.appet.2008.04.009; Keller KL, 2012, J FOOD SCI, V77, pS143, DOI 10.1111/j.1750-3841.2011.02585.x; Kessler RC, 1996, BRIT J PSYCHIAT, V168, P17, DOI 10.1192/S0007125000298371; Kobayashi C, 2006, CHEM SENSES, V31, P301, DOI 10.1093/chemse/bjj033; Kuga M, 1999, PHYSIOL BEHAV, V66, P317, DOI 10.1016/S0031-9384(98)00307-2; Kuga M, 2002, ACTA OTO-LARYNGOL, V122, P146, DOI 10.1080/00016480260046544; Laeger I, 2012, BEHAV BRAIN RES, V233, P508, DOI 10.1016/j.bbr.2012.05.036; Mata-Garcia M, 2007, J SENS STUD, V22, P187, DOI 10.1111/j.1745-459X.2007.00101.x; Mathes CM, 2013, CHEM SENSES, V38, P211, DOI 10.1093/chemse/bjs096; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; MOGG K, 1990, BRIT J CLIN PSYCHOL, V29, P227, DOI 10.1111/j.2044-8260.1990.tb00874.x; Mojet J, 2001, CHEM SENSES, V26, P845, DOI 10.1093/chemse/26.7.845; Moser JS, 2008, BIOL PSYCHOL, V78, P93, DOI 10.1016/j.biopsycho.2008.01.005; Pepino MY, 2012, J LIPID RES, V53, P561, DOI 10.1194/jlr.M021873; PLATTE P, 1995, INT J EAT DISORDER, V17, P51, DOI 10.1002/1098-108X(199501)17:1&lt;51::AID-EAT2260170107&gt;3.0.CO;2-Q; Potts AJ, 1997, CAN J EXP PSYCHOL, V51, P57, DOI 10.1037/1196-1961.51.1.57; Scinska A, 2004, PHYSIOL BEHAV, V82, P899, DOI 10.1016/j.physbeh.2004.07.012; Spielberger C. D., 1973, MANUAL STATE TRAIT I; STEINER JE, 1969, ISR J PSYCHIAT REL D, V7, P223; Stewart JE, 2010, BRIT J NUTR, V104, P145, DOI 10.1017/S0007114510000267; Szalay C, 2010, PSYCHIAT CLIN NEUROS, V64, P403, DOI 10.1111/j.1440-1819.2010.02106.x; Thompson T, 2008, PAIN, V134, P187, DOI 10.1016/j.pain.2007.04.018; TOMARKEN AJ, 1990, J PERS SOC PSYCHOL, V59, P791, DOI 10.1037/0022-3514.59.4.791; Tucker RM, 2013, CHEM SENSES; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WesterterpPlantenga MS, 1996, EUR J CLIN NUTR, V50, P401; Wilson GD, 2000, PERS INDIV DIFFER, V29, P1077, DOI 10.1016/S0191-8869(99)00255-X	51	43	44	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65006	10.1371/journal.pone.0065006	http://dx.doi.org/10.1371/journal.pone.0065006			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166TB	23755167	Green Published, gold			2022-12-27	WOS:000320579400035
J	Alonso, J; Vilagut, G; Adroher, ND; Chatterji, S; He, YL; Andrade, LH; Bromet, E; Bruffaerts, R; Fayyad, J; Florescu, S; de Girolamo, G; Gureje, O; Haro, JM; Hinkov, H; Hu, CY; Iwata, N; Lee, S; Levinson, D; Lepine, JP; Matschinger, H; Medina-Mora, ME; O'Neill, S; Hormel, J; Posada-Villa, JA; Taib, NI; Xavier, M; Kessler, RC				Alonso, Jordi; Vilagut, Gemma; Adroher, Nuria D.; Chatterji, Somnath; He, Yanling; Andrade, Laura Helena; Bromet, Evelyn; Bruffaerts, Ronny; Fayyad, John; Florescu, Silvia; de Girolamo, Giovanni; Gureje, Oye; Maria Haro, Josep; Hinkov, Hristo; Hu, Chiyi; Iwata, Noboru; Lee, Sing; Levinson, Daphna; Lepine, Jean Pierre; Matschinger, Herbert; Elena Medina-Mora, Maria; O'Neill, Siobhan; Hormel, J.; Posada-Villa, Jose A.; Taib, Nezar Ismet; Xavier, Miguel; Kessler, Ronald C.			Disability Mediates the Impact of Common Conditions on Perceived Health	PLOS ONE			English	Article							SELF-RATED HEALTH; QUALITY-OF-LIFE; CHRONIC MEDICAL CONDITIONS; MENTAL-HEALTH; OLDER-PEOPLE; CHRONIC DISEASES; REPORTED HEALTH; WORLD; MODEL; REHABILITATION	Background: We examined the extent to which disability mediates the observed associations of common mental and physical conditions with perceived health. Methods and Findings: WHO World Mental Health (WMH) Surveys carried out in 22 countries worldwide (n = 51,344 respondents, 72.0% response rate). We assessed nine common mental conditions with the WHO Composite International Diagnostic Interview (CIDI), and ten chronic physical with a checklist. A visual analog scale (VAS) score (0, worst to 100, best) measured perceived health in the previous 30 days. Disability was assessed using a modified WHO Disability Assessment Schedule (WHODAS), including: cognition, mobility, self-care, getting along, role functioning (life activities), family burden, stigma, and discrimination. Path analysis was used to estimate total effects of conditions on perceived health VAS and their separate direct and indirect (through the WHODAS dimensions) effects. Twelve-month prevalence was 14.4% for any mental and 51.4% for any physical condition. 31.7% of respondents reported difficulties in role functioning, 11.4% in mobility, 8.3% in stigma, 8.1% in family burden and 6.9% in cognition. Other difficulties were much less common. Mean VAS score was 81.0 (SD = 0.1). Decrements in VAS scores were highest for neurological conditions (9.8), depression (8.2) and bipolar disorder (8.1). Across conditions, 36.8% (IQR: 31.2-51.5%) of the total decrement in perceived health associated with the condition were mediated by WHODAS disabilities (significant for 17 of 19 conditions). Role functioning was the dominant mediator for both mental and physical conditions. Stigma and family burden were also important mediators for mental conditions, and mobility for physical conditions. Conclusions: More than a third of the decrement in perceived health associated with common conditions is mediated by disability. Although the decrement is similar for physical and mental conditions, the pattern of mediation is different. Research is needed on the benefits for perceived health of targeted interventions aimed at particular disability dimensions.	[Alonso, Jordi; Vilagut, Gemma; Adroher, Nuria D.] IMIM Inst Hosp Mar Invest Med, Barcelona, Spain; [Alonso, Jordi] Pompeu Fabra Univ, Barcelona, Spain; [Alonso, Jordi; Adroher, Nuria D.] CIBER Epidemiol & Salud Publ, Barcelona, Spain; [Chatterji, Somnath] WHO, CH-1211 Geneva, Switzerland; [He, Yanling] Shangai Mental Hlth Ctr, Shanghai, Peoples R China; [Andrade, Laura Helena] Univ Sao Paulo, Sch Med, Inst Psychiat, Sao Paulo, Brazil; [Bromet, Evelyn] SUNY Stony Brook, Stony Brook, NY 11794 USA; [Bruffaerts, Ronny] Katholieke Univ Leuven, Univ Psychiat Ctr, Louvain, Belgium; [Fayyad, John] Inst Dev Res Advocacy & Appl Care, Beirut, Lebanon; [Fayyad, John] St George Hosp Univ Med Ctr, Beirut, Lebanon; [Florescu, Silvia] Natl Sch Publ Hlth Management & Profess Dev, Bucharest, Romania; [de Girolamo, Giovanni] IRCCS Ctr S Giovanni Dio Fatebenefratelli, Brescia, Italy; [Gureje, Oye] Univ Coll Hosp, Ibadan, Nigeria; [Maria Haro, Josep] Parc Sanitari St Joan de Deu, Barcelona, Spain; [Maria Haro, Josep] CIBERSAM, Barcelona, Spain; [Hinkov, Hristo] Natl Ctr Publ Hlth Protect, Sofia, Bulgaria; [Hu, Chiyi] Shenzhen Inst Mental Hlth, Shenzhen, Guangdong, Peoples R China; [Hu, Chiyi] Shenzhen Kangning Hosp, Shenzhen, Guangdong, Peoples R China; [Iwata, Noboru] Hiroshima Int Univ, Higashihiroshima, Japan; [Lee, Sing] Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China; [Levinson, Daphna] Minist Hlth, Jerusalem, Israel; [Lepine, Jean Pierre] Hop St Louis Lariboisiere Fernand Widal, Paris, France; [Matschinger, Herbert] Univ Leipzig, D-04109 Leipzig, Germany; [Elena Medina-Mora, Maria] Inst Nacl Psiquiatria Ramon de la Fuente, Mexico City, DF, Mexico; [O'Neill, Siobhan] Univ Ulster, Coleraine BT52 1SA, Londonderry, North Ireland; [Hormel, J.] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Posada-Villa, Jose A.] Pontificia Univ Javeriana, Bogota, Colombia; [Xavier, Miguel] Univ Nova Lisboa, P-1200 Lisbon, Portugal; [Kessler, Ronald C.] Harvard Univ, Sch Med, Boston, MA USA	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; World Health Organization; Universidade de Sao Paulo; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; KU Leuven; IRCCS Fatebenefratelli; University of Ibadan; University College Hospital, Ibadan; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Medical University Sofia; Chinese University of Hong Kong; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Leipzig University; Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz; Ulster University; University of Groningen; Pontificia Universidad Javeriana; Universidade Nova de Lisboa; Harvard University; Harvard Medical School	Alonso, J (corresponding author), IMIM Inst Hosp Mar Invest Med, Barcelona, Spain.	jalonso@imim.es	BRUFFAERTS, RONNY/AAA-2364-2021; Ormel, Johan/C-6094-2013; CHATTERJI, Somnath/ABE-6832-2020; Andrade, Laura Helena S. G./F-3023-2010; Alonso, Jordi/A-5514-2010; de Girolamo, Giovanni/K-3062-2016; Medina-Mora, María Elena I/T-5937-2018; Adewuya, Abiodun/N-4997-2017; Lee, Sing/O-2136-2015; Gureje, Oye/J-1183-2014; Posada-Villa, Jose/AAA-2355-2019; Florescu, Silvia/AAX-7951-2020; Vilagut, Gemma/N-8718-2014; Haro, Josep Maria/D-1423-2011	BRUFFAERTS, RONNY/0000-0002-0330-3694; Andrade, Laura Helena S. G./0000-0002-2362-3521; Alonso, Jordi/0000-0001-8627-9636; de Girolamo, Giovanni/0000-0002-1611-8324; Medina-Mora, María Elena I/0000-0001-9300-0752; Adewuya, Abiodun/0000-0002-7611-6953; Gureje, Oye/0000-0003-0094-5947; Posada-Villa, Jose/0000-0001-5840-3118; Vilagut, Gemma/0000-0002-3714-226X; Haro, Josep Maria/0000-0002-3984-277X; Xavier, Miguel/0000-0003-2698-1284; Matschinger, Herbert/0000-0001-7146-6770; Adroher, Nuria D/0000-0003-2668-1820; O'Neill, Siobhan/0000-0002-8786-2118	National Institute of Mental Health (NIMH) [R01 MH070884, U01-MH60220]; John D. and Catherine T. MacArthur Foundation; Pfizer Foundation; US Public Health Service [R13-MH066849, R01-MH069864, R01 DA016558]; Fogarty International Center [FIRCA R03-TW006481]; Pan American Health Organization; Eli Lilly and Company; Ortho-McNeil Pharmaceutical, Inc.; GlaxoSmithKline; Bristol-Myers Squibb; State of Sao Paulo Research Foundation Thematic Project [03/00204-3]; Ministry of Health; National Center for Public Health Protection; Shenzhen Bureau of Health; Shenzhen Bureau of Science, Technology, and Information; Ministry of Social Protection; European Commission [QLG5-1999-01042, SANCO 2004123, EAHC 20081308]; Piedmont Region (Italy); Fondo de Investigacion Sanitaria; Instituto de Salud Carlos III, Spain [FIS 00/0028]; Ministerio de Ciencia y Tecnologia, Spain [SAF 2000-158-CE]; Departament de Salut; Generalitat de Catalunya, Spain; Instituto de Salud Carlos III [CIBER CB06/02/0046, RETICS RD06/0011 REM-TAP]; Government of India; World Health Organization (WHO). Implementation of the Iraq Mental Health Survey (IMHS); United Nations Development Group Iraq Trust Fund; Israel National Institute for Health Policy and Health Services Research; National Insurance Institute of Israel; Japan Ministry of Health, Labour and Welfare [H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013]; Lebanese Ministry of Public Health; WHO (Lebanon); National Institute of Health/Fogarty International Center [R03 TW006481-01]; Janssen Cilag; Eli Lilly; Astra Zeneca; Hikma Pharm; Novartis; National Institute of Psychiatry Ramon de la Fuente [INPRFMDIES 4280]; National Council on Science and Technology [CONACyT-G30544-H]; WHO (Geneva); WHO (Nigeria); Federal Ministry of Health, Abuja, Nigeria; Health & Social Care Research & Development Division of the Public Health Agency; Champalimaud Foundation; Gulbenkian Foundation; Foundation for Science and Technology; US National Institute of Mental Health [RO1-MH61905]; Robert Wood Johnson Foundation (RWJF) [044708]; FOGARTY INTERNATIONAL CENTER [R03TW006481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061905, R01MH069864, R13MH066849, U01MH060220, R01MH070884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016558] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); John D. and Catherine T. MacArthur Foundation; Pfizer Foundation; US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Pan American Health Organization; Eli Lilly and Company(Eli Lilly); Ortho-McNeil Pharmaceutical, Inc.; GlaxoSmithKline(GlaxoSmithKline); Bristol-Myers Squibb(Bristol-Myers Squibb); State of Sao Paulo Research Foundation Thematic Project; Ministry of Health; National Center for Public Health Protection; Shenzhen Bureau of Health; Shenzhen Bureau of Science, Technology, and Information; Ministry of Social Protection; European Commission(European CommissionEuropean Commission Joint Research Centre); Piedmont Region (Italy)(Regione PiemonteInstituto de Salud Carlos III); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Ministerio de Ciencia y Tecnologia, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Departament de Salut; Generalitat de Catalunya, Spain(Generalitat de Catalunya); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Government of India; World Health Organization (WHO). Implementation of the Iraq Mental Health Survey (IMHS); United Nations Development Group Iraq Trust Fund; Israel National Institute for Health Policy and Health Services Research; National Insurance Institute of Israel; Japan Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Lebanese Ministry of Public Health; WHO (Lebanon)(World Health Organization); National Institute of Health/Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Janssen Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Eli Lilly(Eli Lilly); Astra Zeneca(AstraZeneca); Hikma Pharm; Novartis(Novartis); National Institute of Psychiatry Ramon de la Fuente; National Council on Science and Technology; WHO (Geneva)(World Health Organization); WHO (Nigeria)(World Health Organization); Federal Ministry of Health, Abuja, Nigeria; Health & Social Care Research & Development Division of the Public Health Agency; Champalimaud Foundation; Gulbenkian Foundation; Foundation for Science and Technology; US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Robert Wood Johnson Foundation (RWJF)(Robert Wood Johnson Foundation (RWJF)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The World Health Organization World Mental Health (WMH) Survey Initiative is supported by the National Institute of Mental Health (NIMH; R01 MH070884), the John D. and Catherine T. MacArthur Foundation, the Pfizer Foundation, the US Public Health Service (R13-MH066849, R01-MH069864, and R01 DA016558), the Fogarty International Center (FIRCA R03-TW006481), the Pan American Health Organization, Eli Lilly and Company, Ortho-McNeil Pharmaceutical, Inc., GlaxoSmithKline, and Bristol-Myers Squibb. Each WMH country obtained funding for its own survey. The Sao Paulo Megacity Mental Health Survey is supported by the State of Sao Paulo Research Foundation Thematic Project Grant 03/00204-3. The Bulgarian Epidemiological Study of common mental disorders EPIBUL is supported by the Ministry of Health and the National Center for Public Health Protection. The Chinese World Mental Health Survey Initiative is supported by the Pfizer Foundation. The Shenzhen Mental Health Survey is supported by the Shenzhen Bureau of Health and the Shenzhen Bureau of Science, Technology, and Information. The Colombian National Study of Mental Health is supported by the Ministry of Social Protection. The ESEMeD project is funded by the European Commission (Contracts QLG5-1999-01042; SANCO 2004123, and EAHC 20081308), the Piedmont Region (Italy), Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain (FIS 00/0028), Ministerio de Ciencia y Tecnologia, Spain (SAF 2000-158-CE), Departament de Salut, Generalitat de Catalunya, Spain, Instituto de Salud Carlos III (CIBER CB06/02/0046, RETICS RD06/0011 REM-TAP), and other local agencies and by an unrestricted educational grant from GlaxoSmithKline. The Epidemiological Study on Mental Disorders in India was funded jointly by the Government of India and the World Health Organization (WHO). Implementation of the Iraq Mental Health Survey (IMHS) and data entry were carried out by the staff of the Iraqi MOH and MOP with direct support from the Iraqi IMHS team with funding from both the Japanese and European Funds through United Nations Development Group Iraq Trust Fund. The Israel National Health Survey is funded by the Ministry of Health with support from the Israel National Institute for Health Policy and Health Services Research and the National Insurance Institute of Israel. The World Mental Health Japan Survey is supported by the Grant for Research on Psychiatric and Neurological Diseases and Mental Health (H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013) from the Japan Ministry of Health, Labour and Welfare. The Lebanese National Mental Health Survey is supported by the Lebanese Ministry of Public Health, the WHO (Lebanon), National Institute of Health/Fogarty International Center (R03 TW006481-01), anonymous private donations to IDRAAC, Lebanon, and unrestricted grants from Janssen Cilag, Eli Lilly, GlaxoSmithKline, Astra Zeneca, Hikma Pharm and Novartis. The Mexican National Comorbidity Survey is supported by The National Institute of Psychiatry Ramon de la Fuente (INPRFMDIES 4280) and by the National Council on Science and Technology (CONACyT-G30544-H), with supplemental support from the PanAmerican Health Organization (PAHO). The Nigerian Survey of Mental Health and Wellbeing is supported by the WHO (Geneva), the WHO (Nigeria), and the Federal Ministry of Health, Abuja, Nigeria. The Northern Ireland Study of Mental Health was funded by the Health & Social Care Research & Development Division of the Public Health Agency.; The Portuguese Mental Health Study was carried out by the Department of Mental Health, Faculty of Medical Sciences, NOVA University of Lisbon, with collaboration of the Portuguese Catholic University, and was funded by Champalimaud Foundation, Gulbenkian Foundation, Foundation for Science and Technology and Ministry of Health. The Romania WMH study projects "Policies in Mental Health Area" and "National Study regarding Mental Health and Services Use" were carried out by National School of Public Health & Health Services Management (former National Institute for Research & Development in Health, present National School of Public Health Management & Professional Development, Bucharest), with technical support of Metro Media Transilvania, the National Institute of Statistics - National Centre for Training in Statistics, SC. Cheyenne Services SRL, Statistics Netherlands and were funded by Ministry of Public Health (former Ministry of Health) with supplemental support of Eli Lilly Romania SRL. The Ukraine Comorbid Mental Disorders during Periods of Social Disruption study is funded by the US National Institute of Mental Health (RO1-MH61905). The US National Comorbidity Survey Replication is supported by the National Institute of Mental Health (NIMH; U01-MH60220) with supplemental support from the National Institute of Drug Abuse, the Substance Abuse and Mental Health Services Administration, the Robert Wood Johnson Foundation (RWJF; Grant 044708), and the John W. Alden Trust. All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso J, 2004, QUAL LIFE RES, V13, P283, DOI 10.1023/B:QURE.0000018472.46236.05; Alonso J, 2011, PSYCHOL MED, V41, P873, DOI 10.1017/S0033291710001212; Alonso J, 2000, Gac Sanit, V14, P163; [Anonymous], 2008, WHO WORLD MENTAL HLT; Ashburner JM, 2011, AM J EPIDEMIOL, V173, P882, DOI 10.1093/aje/kwq445; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Baumeister H, 2010, J CLIN EPIDEMIOL, V63, P558, DOI 10.1016/j.jclinepi.2009.08.009; Blain H, 2010, J NUTR HEALTH AGING, V14, P595, DOI 10.1007/s12603-010-0111-0; Boot CRL, 2011, J OCCUP REHABIL, V21, P211, DOI 10.1007/s10926-010-9273-1; Buist-Bouwman MA, 2008, ACTA PSYCHIAT SCAND, V118, P451, DOI 10.1111/j.1600-0447.2008.01285.x; Carlson B, 2012, J CARDIOVAS IN PRESS; Coggon D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039820; Damian Javier, 2008, BMC Geriatr, V8, P5, DOI 10.1186/1471-2318-8-5; DeSalvo KB, 2005, HEALTH SERV RES, V40, P1234, DOI 10.1111/j.1475-6773.2005.00404.x; Fowler F.J., 1990, STANDARDIZED SURVEY, VVolume 18; Garin O, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-51; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; Haro JM, 2006, INT J METH PSYCH RES, V15, P167, DOI 10.1002/mpr.196; Heistaro S, 1996, PREV MED, V25, P625, DOI 10.1006/pmed.1996.0098; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Imrie R, 1997, DISABIL REHABIL, V19, P263, DOI 10.3109/09638289709166537; Jamoom EW, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-10; Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0; Lee HY, 2008, INT J NURS STUD, V45, P1042, DOI 10.1016/j.ijnurstu.2007.05.007; Lee Y, 2003, ARCH GERONTOL GERIAT, V37, P63, DOI 10.1016/S0167-4943(03)00021-9; LEFLEY HP, 1990, HOSP COMMUNITY PSYCH, V41, P277; Leinonen R, 2001, SOC SCI MED, V52, P1329, DOI 10.1016/S0277-9536(00)00249-5; Machacova K, 2011, J SPINAL CORD MED, V34, P265, DOI 10.1179/107902610X12883422813660; Madan I, 2008, INT J EPIDEMIOL, V37, P1181, DOI 10.1093/ije/dyn085; Mavaddat N, 2011, J EPIDEMIOL COMMUN H, V65, P800, DOI 10.1136/jech.2009.090845; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; Ormel J, 1997, PSYCHOL MED, V27, P1065, DOI 10.1017/S0033291797005321; Ormel J, 1998, J AM GERIATR SOC, V46, P39, DOI 10.1111/j.1532-5415.1998.tb01011.x; Ormel J, 2008, BRIT J PSYCHIAT, V192, P368, DOI 10.1192/bjp.bp.107.039107; Pearl J, 2012, PREV SCI, V13, P426, DOI 10.1007/s11121-011-0270-1; Pennell B. E., 2008, The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders, P33; Perruccio AV, 2007, J EPIDEMIOL COMMUN H, V61, P1056, DOI 10.1136/jech.2006.047308; Rohrer JE, 2007, J EVAL CLIN PRACT, V13, P150, DOI 10.1111/j.1365-2753.2006.00692.x; Saarni SI, 2006, QUAL LIFE RES, V15, P1403, DOI 10.1007/s11136-006-0020-1; Salomon JA, 2004, BMJ-BRIT MED J, V328, P258, DOI 10.1136/bmj.37963.691632.44; Schootman M, 2012, ANN EPIDEMIOL, V22, P79, DOI 10.1016/j.annepidem.2011.10.011; Schultz Susan E, 2003, Health Rep, V14, P41; Sen A, 2002, BRIT MED J, V324, P860, DOI 10.1136/bmj.324.7342.860; Sokka T, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2951; Steiner WA, 2002, PHYS THER, V82, P1098, DOI 10.1093/ptj/82.11.1098; Ustun B., 2010, MEASURING HLTH DISAB; Valderas JM, 2008, QUAL LIFE RES, V17, P1125, DOI 10.1007/s11136-008-9396-4; van Dijk A, 2008, PAIN RES MANAG, V13, P407, DOI 10.1155/2008/419073; Von Korff M, 2008, J CLIN EPIDEMIOL, V61, P1132, DOI 10.1016/j.jclinepi.2007.12.009; Wang PP, 2006, DISABIL REHABIL, V28, P135, DOI 10.1080/09638280500167761; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1	52	25	26	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65858	10.1371/journal.pone.0065858	http://dx.doi.org/10.1371/journal.pone.0065858			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	173SK	23762442	Green Published, Green Submitted, gold			2022-12-27	WOS:000321099000112
J	Gonzalez, M; Brito, N; Frias, M; Gonzalez, C				Gonzalez, Mario; Brito, Nelida; Frias, Marcos; Gonzalez, Celedonio			Botrytis cinerea Protein O-Mannosyltransferases Play Critical Roles in Morphogenesis, Growth, and Virulence	PLOS ONE			English	Article							PMT GENE FAMILY; CELL-WALL; SACCHAROMYCES-CEREVISIAE; TRANSMEMBRANE TOPOLOGY; ENZYMATIC-ACTIVITY; MANNOSYLATION; GLYCOSYLATION; FUNGAL; EXPRESSION; MODEL	Protein O-glycosylation is crucial in determining the structure and function of numerous secreted and membrane-bound proteins. In fungi, this process begins with the addition of a mannose residue by protein O-mannosyltransferases (PMTs) in the lumen side of the ER membrane. We have generated mutants of the three Botrytis cinerea pmt genes to study their role in the virulence of this wide-range plant pathogen. B. cinerea PMTs, especially PMT2, are critical for the stability of the cell wall and are necessary for sporulation and for the generation of the extracellular matrix. PMTs are also individually required for full virulence in a variety of hosts, with a special role in the penetration of intact plant leaves. The most significant case is that of grapevine leaves, whose penetration requires the three functional PMTs. Furthermore, PMT2 also contributes significantly to fungal adherence on grapevine and tobacco leaves. Analysis of extracellular and membrane proteins showed significant changes in the pattern of protein secretion and glycosylation by the pmt mutants, and allowed the identification of new protein substrates putatively glycosylated by specific PMTs. Since plants do no possess these enzymes, PMTs constitute a promising target in the development of novel control strategies against B. cinerea.	[Gonzalez, Mario; Brito, Nelida; Frias, Marcos; Gonzalez, Celedonio] Univ La Laguna, Dept Bioquim & Biol Mol, E-38207 San Cristobal la Laguna, Tenerife, Spain	Universidad de la Laguna	Gonzalez, C (corresponding author), Univ La Laguna, Dept Bioquim & Biol Mol, E-38207 San Cristobal la Laguna, Tenerife, Spain.	cglez@ull.es	Gonzalez, Celedonio/K-8728-2014; ALAYÓN, NÉLIDA BRITO/K-8861-2014	Gonzalez, Celedonio/0000-0002-5859-6957; Gonzalez, Mario/0000-0003-1386-0571	Ministerio de Economia y Competitividad [AGL2010-22222]; Agencia Canaria de Investigacion, Innovacion y Sociedad de la Informacion (ACIISI) [PI2007/009]; ACIISI; European Regional Development Fund	Ministerio de Economia y Competitividad(Spanish Government); Agencia Canaria de Investigacion, Innovacion y Sociedad de la Informacion (ACIISI); ACIISI; European Regional Development Fund(European Commission)	Support for this research was provided by grants AGL2010-22222 from the Ministerio de Economia y Competitividad (http:www.mineco.gob.es) and PI2007/009 from the Agencia Canaria de Investigacion, Innovacion y Sociedad de la Informacion (ACIISI; http:agencia.itccanarias.org). MG and MF were supported by ACIISI. 85% of ACIISI funding came from the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Applied Biosystems, 2008, GUID PERF REL QUANT; Benito EP, 1998, EUR J PLANT PATHOL, V104, P207, DOI 10.1023/A:1008698116106; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; Bowman SM, 2005, MYCOLOGIA, V97, P872, DOI 10.3852/mycologia.97.4.872; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; BUTTNER P, 1994, CURR GENET, V25, P445, DOI 10.1007/BF00351784; Christiansen MN, 2010, ANAL CHEM, V82, P3500, DOI 10.1021/ac901717n; Delcan J, 2002, J PLANT PATHOL, V84, P3; DOSS RP, 1995, APPL ENVIRON MICROB, V61, P260, DOI 10.1128/AEM.61.1.260-265.1995; Doss RP, 1999, APPL ENVIRON MICROB, V65, P404; Espino JJ, 2005, PHYSIOL MOL PLANT P, V66, P213, DOI 10.1016/j.pmpp.2005.06.005; Espino JJ, 2010, PROTEOMICS, V10, P3020, DOI 10.1002/pmic.201000037; Fang WX, 2010, GLYCOBIOLOGY, V20, P542, DOI 10.1093/glycob/cwp206; Fernandez-Alvarez A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002563; Fernandez-Alvarez A, 2009, PLANT CELL, V21, P3397, DOI 10.1105/tpc.109.065839; Frias M, 2011, NEW PHYTOL, V192, P483, DOI 10.1111/j.1469-8137.2011.03802.x; Gentzsch M, 1996, EMBO J, V15, P5752, DOI 10.1002/j.1460-2075.1996.tb00961.x; Gil-ad NL, 2001, FEMS MICROBIOL LETT, V199, P109, DOI 10.1111/j.1574-6968.2001.tb10659.x; Girrbach V, 2003, J BIOL CHEM, V278, P12554, DOI 10.1074/jbc.M212582200; Girrbach V, 2000, J BIOL CHEM, V275, P19288, DOI 10.1074/jbc.M001771200; Gonzalez C, 2008, BIOTECHNOL LETT, V30, P1989, DOI 10.1007/s10529-008-9790-6; Gonzalez M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-213; Goto M, 2007, BIOSCI BIOTECH BIOCH, V71, P1415, DOI 10.1271/bbb.70080; Goto M, 2009, EUKARYOT CELL, V8, P1465, DOI 10.1128/EC.00371-08; Gravel Patricia, 1996, P603, DOI 10.1007/978-1-60327-259-9_97; Halligan Brian D., 2009, V527, P283, DOI 10.1007/978-1-60327-834-8_21; HAMADA W, 1994, CURR GENET, V26, P251, DOI 10.1007/BF00309556; Hirayama H, 2008, J BIOCHEM, V143, P555, DOI 10.1093/jb/mvm249; Hutzler J, 2007, P NATL ACAD SCI USA, V104, P7827, DOI 10.1073/pnas.0700374104; Illergard K, 2009, PROTEINS, V77, P499, DOI 10.1002/prot.22458; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kriangkripipat T, 2009, EUKARYOT CELL, V8, P1475, DOI 10.1128/EC.00040-09; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laspidou CS, 2002, WATER RES, V36, P2711, DOI 10.1016/S0043-1354(01)00413-4; Lehle L, 2006, ANGEW CHEM INT EDIT, V45, P6802, DOI 10.1002/anie.200601645; Liu WW, 2011, FUNGAL GENET BIOL, V48, P377, DOI 10.1016/j.fgb.2010.12.004; Lommel M, 2004, MOL CELL BIOL, V24, P46, DOI 10.1128/MCB.24.1.46-57.2004; Lommel M, 2011, J BIOL CHEM, V286, P39768, DOI 10.1074/jbc.M111.281196; Lommel M, 2009, GLYCOBIOLOGY, V19, P816, DOI 10.1093/glycob/cwp066; Lussier M, 1999, BBA-GEN SUBJECTS, V1426, P323, DOI 10.1016/S0304-4165(98)00133-0; Mouyna I, 2010, MOL MICROBIOL, V76, P1205, DOI 10.1111/j.1365-2958.2010.07164.x; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Oka T, 2005, MICROBIOL-SGM, V151, P3657, DOI 10.1099/mic.0.28088-0; Oka T, 2004, MICROBIOL-SGM, V150, P1973, DOI 10.1099/mic.0.27005-0; Olson GM, 2007, EUKARYOT CELL, V6, P222, DOI 10.1128/EC.00182-06; Prill SKH, 2005, MOL MICROBIOL, V55, P546, DOI 10.1111/j.1365-2958.2004.04401.x; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; ROST B, 1995, PROTEIN SCI, V4, P521; Sambrook J., 2001, MOL CLONING LAB MANU; Sanders SL, 1999, J CELL BIOL, V145, P1177, DOI 10.1083/jcb.145.6.1177; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schumacher J, 2012, MORPHOGENESIS PATHOG, V22, P225, DOI DOI 10.1007/978-3-642-22916-9_11; Shevchuk NA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh014; Strahl-Bolsinger S, 1999, J BIOL CHEM, V274, P9068, DOI 10.1074/jbc.274.13.9068; Strahl-Bolsinger S, 1999, BBA-GEN SUBJECTS, V1426, P297, DOI 10.1016/S0304-4165(98)00131-7; Tanaka N, 2005, BIOCHEM BIOPH RES CO, V330, P813, DOI 10.1016/j.bbrc.2005.03.033; ten Have A, 1998, MOL PLANT MICROBE IN, V11, P1009, DOI 10.1094/MPMI.1998.11.10.1009; ten Have A, 2010, FUNGAL GENET BIOL, V47, P53, DOI 10.1016/j.fgb.2009.10.008; Timpel C, 1998, J BIOL CHEM, V273, P20837, DOI 10.1074/jbc.273.33.20837; vanderVlugtBergmans CJB, 1997, MOL PLANT MICROBE IN, V10, P21, DOI 10.1094/MPMI.1997.10.1.21; vanKan JAL, 1997, MOL PLANT MICROBE IN, V10, P30, DOI 10.1094/MPMI.1997.10.1.30; Varela C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-7; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Willer T, 2002, GLYCOBIOLOGY, V12, P771, DOI 10.1093/glycob/cwf086; Willer T, 2005, MOL MICROBIOL, V57, P156, DOI 10.1111/j.1365-2958.2005.04692.x; Willger SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006321; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zheng L, 2000, MOL PLANT MICROBE IN, V13, P724, DOI 10.1094/MPMI.2000.13.7.724	70	32	33	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65924	10.1371/journal.pone.0065924	http://dx.doi.org/10.1371/journal.pone.0065924			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762450	gold, Green Published			2022-12-27	WOS:000321099000119
J	Rampton, M; Walton, SF; Holt, DC; Pasay, C; Kelly, A; Currie, BJ; McCarthy, JS; Mounsey, KE				Rampton, Melanie; Walton, Shelley F.; Holt, Deborah C.; Pasay, Cielo; Kelly, Andrew; Currie, Bart J.; McCarthy, James S.; Mounsey, Kate E.			Antibody Responses to Sarcoptes scabiei Apolipoprotein in a Porcine Model: Relevance to Immunodiagnosis of Recent Infection	PLOS ONE			English	Article							IMMUNOSORBENT-ASSAY ELISA; IMMUNE-RESPONSE; SEROLOGICAL DIAGNOSIS; CYTOKINE EXPRESSION; MANGE; MITE; PIGS; IGG; DERMOSCOPY; ANTIGENS	No commercial immunodiagnostic tests for human scabies are currently available, and existing animal tests are not sufficiently sensitive. The recombinant Sarcoptes scabiei apolipoprotein antigen Sar s 14.3 is a promising immunodiagnostic, eliciting high levels of IgE and IgG in infected people. Limited data are available regarding the temporal development of antibodies to Sar s 14.3, an issue of relevance in terms of immunodiagnosis. We utilised a porcine model to prospectively compare specific antibody responses to a primary infestation by ELISA, to Sar s 14.3 and to S. scabiei whole mite antigen extract (WMA). Differences in the antibody profile between antigens were apparent, with Sar s 14.3 responses detected earlier, and declining significantly after peak infestation compared to WMA. Both antigens resulted in >90% diagnostic sensitivity from weeks 8-16 post infestation. These data provide important information on the temporal development of humoral immune responses in scabies and further supports the development of recombinant antigen based immunodiagnostic tests for recent scabies infestations.	[Rampton, Melanie; Walton, Shelley F.; Mounsey, Kate E.] Univ Sunshine Coast, Sch Hlth & Sport Sci, Maroochydore, Qld, Australia; [Rampton, Melanie; Pasay, Cielo; McCarthy, James S.; Mounsey, Kate E.] Queensland Inst Med Res, Div Infect Dis, Herston, Qld 4006, Australia; [Holt, Deborah C.; Currie, Bart J.] Charles Darwin Univ, Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT 0909, Australia; [Kelly, Andrew] Univ Queensland, Dept Agr Forestry & Fisheries, Ctr Adv Anim Sci, Gatton, Qld, Australia; [McCarthy, James S.] Univ Queensland, Sch Med, Herston, Qld, Australia	University of the Sunshine Coast; QIMR Berghofer Medical Research Institute; Charles Darwin University; Menzies School of Health Research; Queensland Department of Agriculture & Fisheries; University of Queensland; University of Queensland	Mounsey, KE (corresponding author), Univ Sunshine Coast, Sch Hlth & Sport Sci, Maroochydore, Qld, Australia.	kmounsey@usc.edu.au	Holt, Deborah/A-8002-2012; McCarthy, James S/C-1681-2009; Walton, Shelley/A-9767-2012	Walton, Shelley/0000-0002-5857-6913; McCarthy, James/0000-0001-6596-9718; Holt, Deborah/0000-0003-4951-1891; Mounsey, Kate/0000-0003-0579-9424	Australian Research Council Discovery Early Career Researcher Award; NHMRC Practitioner Fellowship; Queensland Government Clinical Research Fellowship; NHMRC Project Grant	Australian Research Council Discovery Early Career Researcher Award(Australian Research Council); NHMRC Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Queensland Government Clinical Research Fellowship; NHMRC Project Grant(National Health and Medical Research Council (NHMRC) of Australia)	KM is supported by an Australian Research Council Discovery Early Career Researcher Award (www.arc.gov.au). JMC is supported by an NHMRC Practitioner Fellowship and Queensland Government Clinical Research Fellowship. This project was also supported by an NHMRC Project Grant (www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlian LG, 2007, J MED ENTOMOL, V44, P1054, DOI 10.1603/0022-2585(2007)44[1054:IVETSS]2.0.CO;2; Arlian LG, 2004, J MED ENTOMOL, V41, P69, DOI 10.1603/0022-2585-41.1.69; Arlian LG, 2004, J MED ENTOMOL, V41, P74, DOI 10.1603/0022-2585-41.1.74; Arlian LG, 2003, AM J TROP MED HYG, V69, P652, DOI 10.4269/ajtmh.2003.69.652; ARLIAN LG, 1994, EXP PARASITOL, V78, P37, DOI 10.1006/expr.1994.1004; Arlian LG, 2006, J MED ENTOMOL, V43, P283, DOI 10.1603/0022-2585(2006)043[0283:ETSMAS]2.0.CO;2; Bergstrom FC, 2009, J IMMUNOL, V182, P7809, DOI 10.4049/jimmunol.0804205; Bornstein S., 1993, Veterinary Dermatology, V4, P107, DOI 10.1111/j.1365-3164.1993.tb00202.x; Bornstein S, 1996, VET DERMATOL, V7, P21, DOI 10.1111/j.1365-3164.1996.tb00222.x; Bornstein S, 1997, VET REC, V141, P8; Bornstein S, 1993, VET DERMATOL, V4, P123; Butler JE, 2009, IMMUNOGENETICS, V61, P209, DOI 10.1007/s00251-008-0336-9; Butler JE, 2009, DEV COMP IMMUNOL, V33, P321, DOI 10.1016/j.dci.2008.06.015; CARGILL CF, 1979, VET REC, V104, P11, DOI 10.1136/vr.104.1.11; Crawley A, 2003, VACCINE, V21, P2911, DOI 10.1016/S0264-410X(03)00142-7; DAVIES PR, 1995, VET PARASITOL, V60, P249, DOI 10.1016/0304-4017(95)00795-3; DAVIS DP, 1990, J MED ENTOMOL, V27, P727, DOI 10.1093/jmedent/27.5.727; Dougall A, 2005, AM J TROP MED HYG, V73, P977, DOI 10.4269/ajtmh.2005.73.977; Dupuy A, 2007, J AM ACAD DERMATOL, V56, P53, DOI 10.1016/j.jaad.2006.07.025; FAIN A, 1978, INT J DERMATOL, V17, P20, DOI 10.1111/j.1365-4362.1978.tb06040.x; Femenia F, 2005, LIFE SCI, V77, P808, DOI 10.1016/j.lfs.2005.01.017; FLAMING KP, 1994, COMP HAEMATOL INT, V4, P218, DOI 10.1007/BF00185177; Fukuyama S, 2010, BRIT J DERMATOL, V163, P892, DOI 10.1111/j.1365-2133.2010.09913.x; Haas N, 2005, ARCH DERMATOL RES, V296, P327, DOI 10.1007/s00403-004-0524-x; Harumal P, 2003, AM J TROP MED HYG, V68, P54, DOI 10.4269/ajtmh.2003.68.54; HILL PB, 1995, VET IMMUNOL IMMUNOP, V44, P105, DOI 10.1016/0165-2427(94)05298-7; Hollanders W, 1997, VET PARASITOL, V69, P117, DOI 10.1016/S0304-4017(96)01117-X; Inagaki N, 2006, EUR J PHARMACOL, V546, P189, DOI 10.1016/j.ejphar.2006.07.019; Jayaraj R, 2011, DIAGN MICR INFEC DIS, V71, P403, DOI 10.1016/j.diagmicrobio.2011.09.007; Juul-Madsen HR, 2010, VET IMMUNOL IMMUNOP, V133, P95, DOI 10.1016/j.vetimm.2009.07.006; Klein SL, 2004, PARASITE IMMUNOL, V26, P247, DOI 10.1111/j.0141-9838.2004.00710.x; Kuhn C, 2008, VET PARASITOL, V153, P329, DOI 10.1016/j.vetpar.2008.02.007; Lalli PN, 2004, J PARASITOL, V90, P711, DOI 10.1645/GE-214R; Lowenstein M, 2004, PARASITOL RES, V94, P24, DOI 10.1007/s00436-004-1168-7; Markowska-Daniel I, 2010, POL J VET SCI, V13, P21; Martin M, 2005, REPROD FERT DEVELOP, V17, P439, DOI 10.1071/RD04064; McDonald M, 2004, LANCET INFECT DIS, V4, P240, DOI 10.1016/S1473-3099(04)00975-2; MORSY GH, 1989, VET PARASITOL, V33, P165, DOI 10.1016/0304-4017(89)90064-2; Morsy Tosson A., 1993, Journal of the Egyptian Society of Parasitology, V23, P221; Mounsey K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000756; Park JH, 2012, ANN DERMATOL, V24, P194, DOI 10.5021/ad.2012.24.2.194; Pence DB, 2002, REV SCI TECH OIE, V21, P385, DOI 10.20506/rst.21.2.1335; PENCE DB, 1994, J WILDLIFE MANAGE, V58, P624, DOI 10.2307/3809675; Perez JM, 2011, VET PARASITOL, V176, P258, DOI 10.1016/j.vetpar.2010.11.002; PORTER P, 1970, IMMUNOLOGY, V18, P565; Potocnjak D, 2012, VET ARHIV, V82, P167; Rambozzi L, 2004, VET RES, V35, P701, DOI 10.1051/vetres:2004039; Rasero R, 2010, BIOL CONSERV, V143, P1269, DOI 10.1016/j.biocon.2010.03.001; Roberts LJ, 2005, J INFECTION, V50, P375, DOI 10.1016/j.jinf.2004.08.033; Rodriguez-Cadenas F, 2010, VET IMMUNOL IMMUNOP, V133, P109, DOI 10.1016/j.vetimm.2009.07.004; ROTH JA, 1984, IMMUNOPHARMACOLOGY, V8, P121, DOI 10.1016/0162-3109(84)90015-8; Rupa P, 2009, VET IMMUNOL IMMUNOP, V132, P41, DOI 10.1016/j.vetimm.2009.09.013; Sarasa M, 2011, VET PARASITOL, V175, P306, DOI 10.1016/j.vetpar.2010.10.024; Sarasa M, 2010, EXP PARASITOL, V124, P265, DOI 10.1016/j.exppara.2009.10.008; Sivasubramanian G, 2012, AM J MED SCI, V343, P248, DOI 10.1097/MAJ.0b013e31823aff28; Smets K, 2000, VET PARASITOL, V90, P137, DOI 10.1016/S0304-4017(00)00222-3; Steer AC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000467; Tarigan S, 2005, VET PARASITOL, V133, P101, DOI 10.1016/j.vetpar.2005.03.044; VANNESTE DJJ, 1986, AM J DERMATOPATH, V8, P267, DOI 10.1097/00000372-198606000-00018; Walter B, 2011, ARCH DERMATOL, V147, P468, DOI 10.1001/archdermatol.2011.51; Walton SF, 2010, PARASITE IMMUNOL, V32, P532, DOI 10.1111/j.1365-3024.2010.01218.x; Walton SF, 2004, ADV PARASIT, V57, P309, DOI 10.1016/S0065-308X(04)57005-7; Walton SF, 2004, INT J PARASITOL, V34, P839, DOI 10.1016/j.ijpara.2004.04.002; Walton SF, 2007, CLIN MICROBIOL REV, V20, P268, DOI 10.1128/CMR.00042-06; Walton SF, 2010, CLIN VACCINE IMMUNOL, V17, P1428, DOI 10.1128/CVI.00195-10	65	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65354	10.1371/journal.pone.0065354	http://dx.doi.org/10.1371/journal.pone.0065354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762351	Green Submitted, Green Published, gold			2022-12-27	WOS:000321099000060
J	Wilson, AL; Schrecengost, RS; Guerrero, MS; Thomas, KS; Bouton, AH				Wilson, Ashley L.; Schrecengost, Randy S.; Guerrero, Michael S.; Thomas, Keena S.; Bouton, Amy H.			Breast Cancer Antiestrogen Resistance 3 (BCAR3) Promotes Cell Motility by Regulating Actin Cytoskeletal and Adhesion Remodeling in Invasive Breast Cancer Cells	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CYCLIN D1 PROMOTER; C-SRC; TAMOXIFEN RESISTANCE; FOCAL ADHESIONS; RAC-GEF; PROTEIN; RHO; MIGRATION; CAS	Metastatic breast cancer is incurable. In order to improve patient survival, it is critical to develop a better understanding of the molecular mechanisms that regulate metastasis and the underlying process of cell motility. Here, we focus on the role of the adaptor molecule Breast Cancer Antiestrogen Resistance 3 (BCAR3) in cellular processes that contribute to cell motility, including protrusion, adhesion remodeling, and contractility. Previous work from our group showed that elevated BCAR3 protein levels enhance cell migration, while depletion of BCAR3 reduces the migratory and invasive capacities of breast cancer cells. In the current study, we show that BCAR3 is necessary for membrane protrusiveness, Rac1 activity, and adhesion disassembly in invasive breast cancer cells. We further demonstrate that, in the absence of BCAR3, RhoA-dependent signaling pathways appear to predominate, as evidenced by an increase in RhoA activity, ROCK-mediated phosphorylation of myosin light chain II, and large ROCK/mDia1-dependent focal adhesions. Taken together, these data establish that BCAR3 functions as a positive regulator of cytoskeletal remodeling and adhesion turnover in invasive breast cancer cells through its ability to influence the balance between Rac1 and RhoA signaling. Considering that BCAR3 protein levels are elevated in advanced breast cancer cell lines and enhance breast cancer cell motility, we propose that BCAR3 functions in the transition to advanced disease by triggering intracellular signaling events that are essential to the metastatic process.	[Wilson, Ashley L.; Guerrero, Michael S.; Thomas, Keena S.; Bouton, Amy H.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA; [Schrecengost, Randy S.] Thomas Jefferson Univ, Dept Canc Biol, Philadelphia, PA 19107 USA	University of Virginia; Jefferson University	Bouton, AH (corresponding author), Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA.	ahb8y@virginia.edu			National Cancer Institute [R01 CA096846, F31 CA165703, F31 CA130168, T32 CA009109]; Department of Defense [BC050339]; UVA Cancer Center through their NCI Cancer Center [P30 CA44579]; NIH; UVA Cancer Center; NATIONAL CANCER INSTITUTE [T32CA009109, F31CA165703, R01CA096846, P30CA044579] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); UVA Cancer Center through their NCI Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UVA Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute (R01 CA096846 [AHB]; F31 CA165703 Predoctoral Fellowship [ALW]; F31 CA130168 Predoctoral Fellowship [MSG]; Institutional Cancer Training Grant T32 CA009109 [ALW, RSS, MSG]), Department of Defense Breast Cancer Research Program (BC050339 Predoctoral Fellowship [RSS]), and by the UVA Cancer Center through their NCI Cancer Center Support Grant (P30 CA44579). URLs for these agencies/sources are as follows: NIH: http://grants.nih.gov/grants/oer.htm; DOD BCRP: http://cdmrp.army.mil/bcrp/; UVA Cancer Center: http://www.medicine.virginia.edu/research/research-centers/cancer-center/home.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akakura S, 2005, J CELL PHYSIOL, V204, P344, DOI 10.1002/jcp.20288; Biscardi JS, 1999, ADV CANCER RES, V76, P61; Borre PV, 2011, CELL SIGNAL, V23, P1030, DOI 10.1016/j.cellsig.2011.01.018; Bouton AH, 1997, HYBRIDOMA, V16, P403, DOI 10.1089/hyb.1997.16.403; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Burnham MR, 2000, MOL CELL BIOL, V20, P5865, DOI 10.1128/MCB.20.16.5865-5878.2000; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Cai DP, 1999, J IMMUNOL, V163, P2104; Cai DP, 2003, CANCER RES, V63, P6802; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; CHANG JH, 1995, J CELL BIOL, V130, P355, DOI 10.1083/jcb.130.2.355; Cho SY, 2002, J CELL BIOL, V156, P725, DOI 10.1083/jcb.200111032; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Corkery B, 2009, ANN ONCOL, V20, P862, DOI 10.1093/annonc/mdn710; Finn RS, 2008, ANN ONCOL, V19, P1379, DOI 10.1093/annonc/mdn291; Guerrero MS, 2012, GENES CANC; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Guilluy C, 2011, NAT CELL BIOL, V13, P722, DOI 10.1038/ncb2254; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Mace PD, 2011, NAT STRUCT MOL BIOL, V18, P1381, DOI 10.1038/nsmb.2152; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Makkinje A, 2012, J BIOL CHEM; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Near RI, 2007, J CELL PHYSIOL, V212, P655, DOI 10.1002/jcp.21059; Near RI, 2009, MOL VIS, V15, P685; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Oakes PW, 2012, J CELL BIOL, V196, P363, DOI 10.1083/jcb.201107042; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Riggins RB, 2003, J BIOL CHEM, V278, P28264, DOI 10.1074/jbc.M303535200; Riggins RB, 2007, CANCER LETT, V256, P1, DOI 10.1016/j.canlet.2007.03.016; Riggins RB, 2006, CANCER RES, V66, P7007, DOI 10.1158/0008-5472.CAN-05-3952; Schrecengost RS, 2007, CANCER RES, V67, P6174, DOI 10.1158/0008-5472.CAN-06-3455; Schuh NR, 2010, J BIOL CHEM, V285, P2309, DOI 10.1074/jbc.M109.046631; Sun GB, 2012, MOL CELL BIOL, V32, P3776, DOI 10.1128/MCB.00214-12; van der Flier S, 2000, JNCI-J NATL CANCER I, V92, P120, DOI 10.1093/jnci/92.2.120; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Vervoort VS, 2007, GENE, V391, P161, DOI 10.1016/j.gene.2006.12.016; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366	48	27	28	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65678	10.1371/journal.pone.0065678	http://dx.doi.org/10.1371/journal.pone.0065678			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762409	gold, Green Published, Green Submitted			2022-12-27	WOS:000321099000092
J	Heneidi, S; Simerman, AA; Keller, E; Singh, P; Li, XM; Dumesic, DA; Chazenbalk, G				Heneidi, Saleh; Simerman, Ariel A.; Keller, Erica; Singh, Prapti; Li, Xinmin; Dumesic, Daniel A.; Chazenbalk, Gregorio			Awakened by Cellular Stress: Isolation and Characterization of a Novel Population of Pluripotent Stem Cells Derived from Human Adipose Tissue	PLOS ONE			English	Article							PROGENITOR CELLS; ENDOTHELIAL-CELLS; NEURAL PRECURSORS; DIFFERENTIATION; EXPRESSION; PURIFICATION; ENGRAFTMENT; GENERATION; RECEPTOR; MARKERS	Advances in stem cell therapy face major clinical limitations, particularly challenged by low rates of post-transplant cell survival. Hostile host factors of the engraftment microenvironment such as hypoxia, nutrition deprivation, pro-inflammatory cytokines, and reactive oxygen species can each contribute to unwanted differentiation or apoptosis. In this report, we describe the isolation and characterization of a new population of adipose tissue (AT) derived pluripotent stem cells, termed Multilineage Differentiating Stress-Enduring (Muse) Cells, which are isolated using severe cellular stress conditions, including long-term exposure to the proteolytic enzyme collagenase, serum deprivation, low temperatures and hypoxia. Under these conditions, a highly purified population of Muse-AT cells is isolated without the utilization of cell sorting methods. Muse-AT cells grow in suspension as cell spheres reminiscent of embryonic stem cell clusters. Muse-AT cells are positive for the pluripotency markers SSEA3, TR-1-60, Oct3/4, Nanog and Sox2, and can spontaneously differentiate into mesenchymal, endodermal and ectodermal cell lineages with an efficiency of 23%, 20% and 22%, respectively. When using specific differentiation media, differentiation efficiency is greatly enhanced in Muse-AT cells (82% for mesenchymal, 75% for endodermal and 78% for ectodermal). When compared to adipose stem cells (ASCs), microarray data indicate a substantial up-regulation of Sox2, Oct3/4, and Rex1. Muse-ATs also exhibit gene expression patterns associated with the down-regulation of genes involved in cell death and survival, embryonic development, DNA replication and repair, cell cycle and potential factors related to oncogenecity. Gene expression analysis indicates that Muse-ATs and ASCs are mesenchymal in origin; however, Muse-ATs also express numerous lymphocytic and hematopoietic genes, such as CCR1 and CXCL2, encoding chemokine receptors and ligands involved in stem cell homing. Being highly resistant to severe cellular stress, Muse-AT cells have the potential to make a critical impact on the field of regenerative medicine and cell-based therapy.	[Heneidi, Saleh] Georgetown Univ, Med Ctr, Dept Physiol & Pharmacol, Washington, DC 20007 USA; [Simerman, Ariel A.; Keller, Erica; Singh, Prapti; Dumesic, Daniel A.; Chazenbalk, Gregorio] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA; [Li, Xinmin] Univ Calif Los Angeles, David Geffen Sch Med, Clin Microarray Core, Los Angeles, CA 90095 USA	Georgetown University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Chazenbalk, G (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA.	gchazenbalk@mednet.ucla.edu		Dumesic, Daniel/0000-0003-0387-1277	Department of Obstetrics/Gynecology at University of California Los Angeles; Eunice Kennedy Shriver National Institute of Child Health & Human Development, National Institutes of Health [U54 HD071836]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD071836, P50HD071836] Funding Source: NIH RePORTER	Department of Obstetrics/Gynecology at University of California Los Angeles; Eunice Kennedy Shriver National Institute of Child Health & Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Part of these studies were supported by the Department of Obstetrics/Gynecology at University of California Los Angeles and by the Eunice Kennedy Shriver National Institute of Child Health & Human Development, National Institutes of Health through cooperative agreement U54 HD071836. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi H, 2011, J SURG RES, V165, P112, DOI 10.1016/j.jss.2009.09.057; Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Banas A, 2007, HEPATOLOGY, V46, P219, DOI 10.1002/hep.21704; Behbahan IS, 2011, STEM CELL REV REP, V7, P748, DOI 10.1007/s12015-010-9216-4; Beier JP, 2011, CELL BIOL INT, V35, P397, DOI 10.1042/CBI20100417; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; Carlini P, 2007, BIOMETALS, V20, P869, DOI 10.1007/s10534-006-9080-5; Chacko SM, 2010, AM J PHYSIOL-CELL PH, V299, pC1562, DOI 10.1152/ajpcell.00221.2010; Chazenbalk G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017834; Couture JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004743; Csete M, 2005, ANN NY ACAD SCI, V1049, P1, DOI 10.1196/annals.1334.001; Dayem Ahmed Abdal, 2010, Cancers (Basel), V2, P859, DOI 10.3390/cancers2020859; del Castillo FJ, 2010, HUM MOL GENET, V19, P262, DOI 10.1093/hmg/ddp490; Di Rocco G, 2006, J CELL SCI, V119, P2945, DOI 10.1242/jcs.03029; Eliasson P, 2010, EXP HEMATOL, V38, P301, DOI 10.1016/j.exphem.2010.01.005; Fink T, 2011, METHODS MOL BIOL, V698, P243, DOI 10.1007/978-1-60761-999-4_19; Fulda S, 2009, INT J CELL BIOL, V2010; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Gottlieb DI, 1999, CELLS TISSUES ORGANS, V165, P165, DOI 10.1159/000016696; Grayson WL, 2007, BIOCHEM BIOPH RES CO, V358, P948, DOI 10.1016/j.bbrc.2007.05.054; Hamazaki T, 2001, FEBS LETT, V497, P15, DOI 10.1016/S0014-5793(01)02423-1; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Hodgetts SI, 2000, CELL TRANSPLANT, V9, P489, DOI 10.1177/096368970000900406; Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA; Hollenbeck ST, 2012, WOUND REPAIR REGEN, V20, P872, DOI 10.1111/j.1524-475X.2012.00854.x; Hristov M, 2007, CIRC RES, V100, P590, DOI 10.1161/01.RES.0000259043.42571.68; Hu AB, 2004, LIVER INT, V24, P237, DOI 10.1111/j.1478-3231.2004.00910.x; Huang J, 2010, CIRC RES, V106, P1753, DOI 10.1161/CIRCRESAHA.109.196030; Kang KS, 2011, TOXICOL SCI, V120, pS269, DOI 10.1093/toxsci/kfq370; Karumbayaram S, 2009, STEM CELLS, V27, P806, DOI 10.1002/stem.31; Kuhlmann WD, 2006, INT J EXP PATHOL, V87, P343, DOI 10.1111/j.1365-2613.2006.00485.x; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Kuroda Y, 2010, P NATL ACAD SCI USA, V107, P8639, DOI 10.1073/pnas.0911647107; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; KUZNETSOV SA, 1981, FEBS LETT, V135, P237, DOI 10.1016/0014-5793(81)80790-9; Levy YS, 2003, J MOL NEUROSCI, V21, P121, DOI 10.1385/JMN:21:2:121; Li L, 2011, CLIN CANCER RES, V17, P4936, DOI 10.1158/1078-0432.CCR-10-1499; Li M, 1998, CURR BIOL, V8, P971, DOI 10.1016/S0960-9822(98)70399-9; Listenberger LL, 2007, CURR PROTOC CELL BIO, DOI [DOI 10.1002/0471143030.CB2402S35, 10.1002/0471143030.cb2402s35]; Liu LP, 2008, J BIOL CHEM, V283, P31153, DOI 10.1074/jbc.M805056200; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; MacPherson PA, 1997, NEUROSCIENCE, V80, P487, DOI 10.1016/S0306-4522(97)00102-4; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Mingliang R, 2011, STEM CELLS INT, V2011; Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076; MOLNAR E, 1993, NEUROSCIENCE, V53, P307, DOI 10.1016/0306-4522(93)90198-O; Oh JS, 2011, CELL TRANSPLANT, V20, P837, DOI 10.3727/096368910X539083; Oyagi S, 2006, J HEPATOL, V44, P742, DOI 10.1016/j.jhep.2005.10.026; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Sarugaser R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006498; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Suzuki S, 2010, J HISTOCHEM CYTOCHEM, V58, P721, DOI 10.1369/jhc.2010.955609; Teramoto K, 2005, J HEPATO-BILIARY-PAN, V12, P196, DOI 10.1007/s00534-005-0980-5; Thompson SA, 2011, CIRCULATION, V123, P2083, DOI 10.1161/CIRCULATIONAHA.110.015057; Trosko JE, 2000, METHODS, V20, P245, DOI 10.1006/meth.1999.0941; Vasiliou Vasilis, 2005, Human Genomics, V2, P138; Wakao S, 2011, P NATL ACAD SCI USA, V108, P9875, DOI 10.1073/pnas.1100816108; Woodbury D, 2002, J NEUROSCI RES, V69, P908, DOI 10.1002/jnr.10365; Xiao N, 2012, BLOOD, V119, P4898, DOI 10.1182/blood-2012-01-403089; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Zamule SM, 2011, CHEM-BIOL INTERACT, V190, P62, DOI 10.1016/j.cbi.2011.01.009; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	67	90	95	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64752	10.1371/journal.pone.0064752	http://dx.doi.org/10.1371/journal.pone.0064752			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755141	Green Published, gold, Green Submitted			2022-12-27	WOS:000320579400024
J	Kim, HJ; Son, YK; An, WS				Kim, Hyun Jeong; Son, Young Ki; An, Won Suk			Effect of Sodium Bicarbonate Administration on Mortality in Patients with Lactic Acidosis: A Retrospective Analysis	PLOS ONE			English	Article							HEMODYNAMICS; ARTERIAL; THERAPY; FAILURE; LACTATE; DISEASE; BLOOD	Background: Lactic acidosis is a common cause of high anion gap metabolic acidosis. Sodium bicarbonate may be considered for an arterial pH <7.15 but paradoxically depresses cardiac performance and exacerbates acidosis by enhancing lactate production. This study aimed to evaluate the cause and mortality rate of lactic acidosis and to investigate the effect of factors, including sodium bicarbonate use, on death. Methods: We conducted a single center analysis from May 2011 through April 2012. We retrospectively analyzed 103 patients with lactic acidosis among 207 patients with metabolic acidosis. We used SOFA and APACHE II as severity scores to estimate illness severity. Multivariate logistic regression analysis and Cox regression analysis models were used to identify factors that affect mortality. Results: Of the 103 patients with a mean age of 66.1 +/- 11.4 years, eighty-three patients (80.6%) died from sepsis (61.4%), hepatic failure, cardiogenic shock and other causes. The percentage of sodium bicarbonate administration (p = 0.006), catecholamine use, ventilator care and male gender were higher in the non-survival group than the survival group. The non-survival group had significantly higher initial and follow-up lactic acid levels, lower initial albumin, higher SOFA scores and APACHE II scores than the survival group. The mortality rate was significantly higher in patients who received sodium bicarbonate. Sodium bicarbonate administration (p = 0.016) was associated with higher mortality. Independent factors that affected mortality were SOFA score (Exp (B) = 1.72, 95% CI = 1.12-2.63, p = 0.013) and sodium bicarbonate administration (Exp (B) = 6.27, 95% CI = 1.10-35.78, p = 0.039). Conclusions: Lactic acidosis, which has a high mortality rate, should be evaluated in patients with metabolic acidosis. In addition, sodium bicarbonate should be prescribed with caution in the case of lactic acidosis because sodium bicarbonate administration may affect mortality.	[Kim, Hyun Jeong; Son, Young Ki; An, Won Suk] Dong A Univ, Dept Internal Med, Coll Med, Pusan, South Korea; [An, Won Suk] Dong A Univ, Inst Med Sci, Coll Med, Pusan, South Korea	Dong A University; Dong A University	An, WS (corresponding author), Dong A Univ, Dept Internal Med, Coll Med, Pusan, South Korea.	anws@dau.ac.kr			Dong-A University	Dong-A University	This study was supported by research funds from Dong-A University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADROGUE HJ, 1989, NEW ENGL J MED, V320, P1312, DOI 10.1056/NEJM198905183202004; COOPER DJ, 1990, ANN INTERN MED, V112, P492, DOI 10.7326/0003-4819-112-7-492; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Forsythe SM, 2000, CHEST, V117, P260, DOI 10.1378/chest.117.1.260; Jansen TC, 2009, CRIT CARE MED, V37, P2369, DOI 10.1097/CCM.0b013e3181a0f919; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kraut Jeffrey A, 2006, Clin Exp Nephrol, V10, P111, DOI 10.1007/s10157-006-0408-9; Luft FC, 2001, J AM SOC NEPHROL, V12, pS15; MADIAS NE, 1986, KIDNEY INT, V29, P752, DOI 10.1038/ki.1986.62; MATHIEU D, 1991, CRIT CARE MED, V19, P1352, DOI 10.1097/00003246-199111000-00008; MITCHELL JH, 1972, KIDNEY INT, V1, P375, DOI 10.1038/ki.1972.48; Rachoin JS, 2011, J HOSP MED, V6, pE1, DOI 10.1002/jhm.703; STACPOOLE PW, 1994, AM J MED, V97, P47, DOI 10.1016/0002-9343(94)90047-7; Susantitaphong P, 2012, AM J NEPHROL, V35, P540, DOI 10.1159/000339329; Trzeciak S, 2007, INTENS CARE MED, V33, P970, DOI 10.1007/s00134-007-0563-9; Valenza F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046035; WEIL MH, 1986, NEW ENGL J MED, V315, P153, DOI 10.1056/NEJM198607173150303; WILDENTH.K, 1968, AM J PHYSIOL, V214, P1352, DOI 10.1152/ajplegacy.1968.214.6.1352	18	45	49	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65283	10.1371/journal.pone.0065283	http://dx.doi.org/10.1371/journal.pone.0065283			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755210	Green Published, gold, Green Submitted			2022-12-27	WOS:000320579400050
J	Han, HY; Zhang, JP; Ji, SQ; Liang, QM; Kang, HC; Tang, RH; Zhu, SQ; Xue, Z				Han, Hai-Yan; Zhang, Jin-Ping; Ji, Su-Qiong; Liang, Qi-Ming; Kang, Hui-Cong; Tang, Rong-Hua; Zhu, Sui-Qiang; Xue, Zheng			alpha nu and beta 1 Integrins Mediate A beta-Induced Neurotoxicity in Hippocampal Neurons via the FAK Signaling Pathway	PLOS ONE			English	Article							FOCAL ADHESION KINASE; ALZHEIMERS-DISEASE; TYROSINE PHOSPHORYLATION; SYNAPTIC PLASTICITY; TERMINAL DOMAIN; CELL-SURVIVAL; INTEGRIN; PEPTIDE; INHIBITION; PROTEIN	alpha nu and beta 1 integrins mediate A beta-induced neurotoxicity in primary hippocampal neurons. We treated hippocampal neurons with 2.5 mu g/mL 17E6 and 5 mu g/mL ab58524, which are specific alpha nu and beta 1 integrin antagonists, respectively, for 42 h prior to 10 mu M A beta treatment. Next, we employed small interfering RNA (siRNA) to silence focal adhesion kinase (FAK), a downstream target gene of integrins. The siRNAs were designed with a target sequence, an MOI of 10 and the addition of 5 mu g/mL polybrene. Under these conditions, the neurons were transfected and the apoptosis of different cell types was detected. Moreover, we used real-time PCR and Western blotting analyses to detect the expression of FAK and rho FAK genes in different cell types and investigated the underlying mechanism and signal pathway by which alpha nu and beta 1 integrins mediate A beta-induced neurotoxicity in hippocampal neurons. An MTT assay showed that both 17E6 and ab58524 significantly increased cell viability compared with the A beta-treated neurons (P<0.01 and P<0.05, respectively). However, this protective effect was markedly attenuated after transfection with silencing FAK (siFAK). Moreover, TUNEL immunostaining and flow cytometry indicated that both 17E6 and ab58524 significantly protected hippocampal neurons against apoptosis induced by A beta (P<0.05) compared with the A beta-treated cells. However, this protective effect was reversed with siFAK treatment. Both the gene and protein expression of FAK increased after A beta treatment. Interestingly, as the gene and protein levels of FAK decreased, the rho FAK protein expression markedly increased. Furthermore, both the gene and protein expression of FAK and rho FAK were significantly diminished. Thus, we concluded that both alpha nu and beta 1 integrins interfered with A beta-induced neurotoxicity in hippocampal neurons and that this mechanism partially contributes to the activation of the Integrin-FAK signaling pathway.	[Han, Hai-Yan; Ji, Su-Qiong; Liang, Qi-Ming; Kang, Hui-Cong; Tang, Rong-Hua; Zhu, Sui-Qiang; Xue, Zheng] Huazhong Univ Sci & Technol, Dept Neurol, Tongji Hosp, Wuhan 430074, Hubei Province, Peoples R China; [Zhang, Jin-Ping] Shan Dong Univ, Qianfoshan Hosp, Dept Neurol, Jinan, Shandong, Peoples R China	Huazhong University of Science & Technology; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Xue, Z (corresponding author), Huazhong Univ Sci & Technol, Dept Neurol, Tongji Hosp, Wuhan 430074, Hubei Province, Peoples R China.	xuezheng@hotmail.com	Kang, Huicong/AAA-8606-2019; zhang, jin/GXV-9154-2022		National Natural Science Fundation [30700244]	National Natural Science Fundation(National Natural Science Foundation of China (NSFC))	The work was supported by National Natural Science Fundation (No. 30700244). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul HM, 2006, J NEUROSCI RES, V84, P398, DOI 10.1002/jnr.20877; Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; Annaert W, 2002, ANNU REV CELL DEV BI, V18, P25, DOI 10.1146/annurev.cellbio.18.020402.142302; Aplin AE, 2003, FEBS LETT, V534, P11, DOI 10.1016/S0014-5793(02)03840-1; Azizi Z, 2010, ALZ DIS ASSOC DIS, V24, P204, DOI 10.1097/WAD.0b013e3181a7c8fd; Choi YA, 2009, BIOCHIMIE, V91, P624, DOI 10.1016/j.biochi.2009.03.006; Cordes N, 2004, J MOL HISTOL, V35, P327; Creed MC, 2010, AGE, V32, P365, DOI 10.1007/s11357-010-9142-z; Golubovskaya V, 2004, BBA-GENE STRUCT EXPR, V1678, P111, DOI 10.1016/j.bbaexp.2004.03.002; Golubovskaya VM, 2005, J BIOL CHEM, V280, P25008, DOI 10.1074/jbc.M414172200; Grace EA, 2003, J NEUROSCI, V23, P493, DOI 10.1523/JNEUROSCI.23-02-00493.2003; Gupta A, 2009, MOL CELL ENDOCRINOL, V309, P55, DOI 10.1016/j.mce.2009.05.018; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; Jiang XH, 2007, CELL SIGNAL, V19, P1000, DOI 10.1016/j.cellsig.2006.11.004; Juhasz G, 2008, BRAIN RES, V1233, P20, DOI 10.1016/j.brainres.2008.05.032; Kasahara T, 2002, ANTIOXID REDOX SIGN, V4, P491, DOI 10.1089/15230860260196290; Kelly BL, 2007, NEUROSCIENCE, V147, P60, DOI 10.1016/j.neuroscience.2007.03.047; Lee FT, 2005, CLIN CANCER RES, V11, p7080S, DOI 10.1158/1078-0432.CCR-1004-0019; Leu ST, 2004, DEV BIOL, V276, P416, DOI 10.1016/j.ydbio.2004.09.003; Lim M, 2005, HUM PATHOL, V36, P665, DOI 10.1016/j.humpath.2005.03.014; Luo M, 2010, CANCER LETT, V289, P127, DOI 10.1016/j.canlet.2009.07.005; Matter ML, 1998, J CELL BIOL, V141, P1019, DOI 10.1083/jcb.141.4.1019; Monferran S, 2008, INT J CANCER, V123, P357, DOI 10.1002/ijc.23498; Ramjaun AR, 2009, INT J BIOCHEM CELL B, V41, P521, DOI 10.1016/j.biocel.2008.05.030; Richardson A, 1997, MOL CELL BIOL, V17, P6906, DOI 10.1128/MCB.17.12.6906; Rowan MJ, 2005, BIOCHEM SOC T, V33, P563, DOI 10.1042/BST0330563; Schwartz MA, 2001, J CELL SCI, V114, P2553; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Takahashi RH, 2010, NEUROBIOL AGING, V31, P1145, DOI 10.1016/j.neurobiolaging.2008.07.021; van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417; Verdier Y, 2004, J PEPT SCI, V10, P229, DOI 10.1002/psc.573; Wang PY, 2010, J NUTR BIOCHEM, V21, P345, DOI 10.1016/j.jnutbio.2009.01.012; Wang QW, 2008, NEUROBIOL AGING, V29, P1485, DOI 10.1016/j.neurobiolaging.2007.03.018; Williamson R, 2002, J NEUROSCI, V22, P10, DOI 10.1523/JNEUROSCI.22-01-00010.2002; Wright S, 2007, NEUROBIOL AGING, V28, P226, DOI 10.1016/j.neurobiolaging.2005.12.002; Yu QS, 2013, ANTIINFLAMM ANTIALLE; Yu YX, 2009, HIPPOCAMPUS, V19, P1247, DOI 10.1002/hipo.20587; ZHANG C, 1994, J BIOL CHEM, V269, P25247; Zhao-Yang Z, 2008, CANCER LETT, V266, P209, DOI 10.1016/j.canlet.2008.02.054; Zhu J, 2009, EXP EYE RES, V88, P910, DOI 10.1016/j.exer.2008.11.034	42	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64839	10.1371/journal.pone.0064839	http://dx.doi.org/10.1371/journal.pone.0064839			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755149	Green Submitted, gold, Green Published			2022-12-27	WOS:000319872300029
J	Ortega-Recalde, O; Vergara, JI; Fonseca, DJ; Rios, X; Mosquera, H; Bermudez, OM; Medina, CL; Vargas, CI; Pallares, AE; Restrepo, CM; Laissue, P				Ortega-Recalde, Oscar; Ines Vergara, Jessica; Janeth Fonseca, Dora; Rios, Xiomara; Mosquera, Hernando; Maria Bermudez, Olga; Liliana Medina, Claudia; Ines Vargas, Clara; Enrique Pallares, Argemiro; Martin Restrepo, Carlos; Laissue, Paul			Whole-Exome Sequencing Enables Rapid Determination of Xeroderma Pigmentosum Molecular Etiology	PLOS ONE			English	Article							DNA-POLYMERASE-ETA; NUCLEOTIDE EXCISION-REPAIR; Y-FAMILY; MUTATIONS; GENE; LOCALIZATION; DISORDERS; CAPTURE; EUROPE	Xeroderma pigmentosum (XP) is a rare autosomal recessive disorder characterized by extreme sensitivity to actinic pigmentation changes in the skin and increased incidence of skin cancer. In some cases, patients are affected by neurological alterations. XP is caused by mutations in 8 distinct genes (XPA through XPG and XPV). The XP-V (variant) subtype of the disease results from mutations in a gene (XPV, also named POLH) which encodes for Pol eta, a member of the Y-DNA polymerase family. Although the presence and severity of skin and neurological dysfunctions differ between XP subtypes, there are overlapping clinical features among subtypes such that the sub-type cannot be deduced from the clinical features. In this study, in order to overcome this drawback, we undertook whole-exome sequencing in two XP sibs and their father. We identified a novel homozygous nonsense mutation (c.897T>G, p.Y299X) in POLH which causes the disease. Our results demonstrate that next generation sequencing is a powerful approach to rapid determination of XP genetic etiology.	[Ortega-Recalde, Oscar; Janeth Fonseca, Dora; Maria Bermudez, Olga; Martin Restrepo, Carlos; Laissue, Paul] Univ Rosario, Unidad Genet, Escuela Med & Ciencias Salud, Bogota, Colombia; [Ines Vergara, Jessica; Rios, Xiomara; Mosquera, Hernando; Liliana Medina, Claudia; Enrique Pallares, Argemiro] Univ Autonoma Bucaramanga, Dept Dermatol, Bucaramanga, Colombia; [Ines Vergara, Jessica; Rios, Xiomara; Mosquera, Hernando; Liliana Medina, Claudia; Enrique Pallares, Argemiro] Clin Carlos Ardila Lulle, Unidad Dermatol, Bucaramanga, Colombia; [Janeth Fonseca, Dora; Martin Restrepo, Carlos; Laissue, Paul] Dept Biol Mol Genet Mol Colombia, Bogota, Colombia; [Ines Vargas, Clara] Univ Ind Santander, Bucaramanga, Colombia	Universidad del Rosario; Universidad Industrial de Santander	Laissue, P (corresponding author), Univ Rosario, Unidad Genet, Escuela Med & Ciencias Salud, Bogota, Colombia.	paul.laissue@urosario.edu.co	Laissue, Paul/C-6787-2012; Restrepo, Carlos M./K-2830-2016; Fonseca-Mendoza, Dora Janeth/K-3286-2016	Laissue, Paul/0000-0003-4180-4796; Restrepo, Carlos M./0000-0001-6410-0084; Ortega-Recalde, Oscar/0000-0002-8076-0346; Fonseca-Mendoza, Dora Janeth/0000-0002-7323-6570	Universidad del Rosario	Universidad del Rosario	This study was supported by the Universidad del Rosario, grant CS/Genetics 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anttinen A, 2008, BRAIN, V131, P1979, DOI 10.1093/brain/awn126; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Ben Rekaya M, 2011, J GENET, V90, P483; Boudsocq F, 2002, DNA REPAIR, V1, P343, DOI 10.1016/S1568-7864(02)00019-8; Bradford PT, 2011, J MED GENET, V48, P168, DOI 10.1136/jmg.2010.083022; Broughton BC, 2002, P NATL ACAD SCI USA, V99, P815, DOI 10.1073/pnas.022473899; Chin ELH, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-6; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663; Cordonnier AM, 1999, MOL CELL BIOL, V19, P2206; Diggle CP, 2012, HUM MUTAT, V33, P1175, DOI 10.1002/humu.22111; DiGiovanna JJ, 2012, J INVEST DERMATOL, V132, P785, DOI 10.1038/jid.2011.426; Gratchev A, 2003, EXP DERMATOL, V12, P529, DOI 10.1034/j.1600-0625.2003.00124.x; Hirai Y, 2006, MUTAT RES-FUND MOL M, V601, P171, DOI 10.1016/j.mrfmmm.2006.06.010; Inui H, 2008, J INVEST DERMATOL, V128, P2055, DOI 10.1038/jid.2008.48; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Kannouche P, 2001, GENE DEV, V15, P158, DOI 10.1101/gad.187501; Khan SG, 2009, DNA REPAIR, V8, P114, DOI 10.1016/j.dnarep.2008.09.007; Kleijer WJ, 2008, DNA REPAIR, V7, P744, DOI 10.1016/j.dnarep.2008.01.014; Lehmann AR, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-70; LEHMANN AR, 1975, P NATL ACAD SCI USA, V72, P219, DOI 10.1073/pnas.72.1.219; Leibeling D, 2006, J MOL HISTOL, V37, P225, DOI 10.1007/s10735-006-9041-x; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Lower M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002714; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Nakazawa Y, 2012, NAT GENET, V44, P586, DOI 10.1038/ng.2229; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Niedernhofer Laura J, 2011, Mech Ageing Dev, V132, P340, DOI 10.1016/j.mad.2011.06.004; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Schafer A, 2013, EXP DERMATOL, V22, P24, DOI 10.1111/exd.12052; Shyr D, 2013, BIOL PROCED ONLINE, V15, DOI 10.1186/1480-9222-15-4; Tanioka M, 2007, J INVEST DERMATOL, V127, P1745, DOI 10.1038/sj.jid.5700759; Ware JS, 2013, J CARDIOVASC TRANSL, V6, P94, DOI 10.1007/s12265-012-9401-8; Yuasa M, 2000, ONCOGENE, V19, P4721, DOI 10.1038/sj.onc.1203842	35	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64692	10.1371/journal.pone.0064692	http://dx.doi.org/10.1371/journal.pone.0064692			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755135	Green Published, gold			2022-12-27	WOS:000319872300023
J	Shishido, SN; Faulkner, EB; Beck, A; Nguyen, TA				Shishido, Stephanie N.; Faulkner, Emma B.; Beck, Amanda; Nguyen, Thu A.			The Effect of Antineoplastic Drugs in a Male Spontaneous Mammary Tumor Model	PLOS ONE			English	Article							MALE BREAST-CANCER; ESTROGEN-RECEPTOR-BETA; ANTI-APOPTOSIS GENE; CYCLIN D1; EXPRESSION; SURVIVIN; CELLS; CARCINOMA; DISEASE; BCL-2	Male breast cancer is a rare disease. The limited number of clinical cases has led to the primary treatments for men being derived from female breast cancer studies. Here the transgenic strain FVB/N-Tg(MMTV-PyVT)634Mul/J ( also known as PyVT) was used as a model system for measuring tumor burden and drug sensitivity of the antineoplastic drugs tamoxifen, cisplatin, and paclitaxel on tumorigenesis at an early stage of mammary carcinoma development in a male mouse model. Cisplatin treatment significantly reduced tumor volume, while paclitaxel and tamoxifen did not attenuate tumor growth. Cisplatin treatment was shown to induce apoptosis, grossly observed by reduced tumor formation, through reduced Bcl-2 and survivin protein expression levels with an increase in caspase 3 expression compared to control tumors. Tamoxifen treatment significantly altered the hormone receptor expression levels of the tumor, while additionally upregulating Bcl-2 and Cyclin D1. This suggests an importance in hormonal signaling in male breast cancer pathogenesis. The results of this study provide valuable information toward the better understanding of male breast cancer and may help guide treatment decisions.	[Shishido, Stephanie N.; Faulkner, Emma B.; Beck, Amanda; Nguyen, Thu A.] Kansas State Univ, Coll Vet Med, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA	Kansas State University	Nguyen, TA (corresponding author), Kansas State Univ, Coll Vet Med, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA.	tnguyen@vet.k-state.edu	Beck, Amanda P/H-9573-2017	Beck, Amanda P/0000-0003-1867-4110	Johnson Center for Basic Cancer Research;  [NIH-1R15CA152922]; NATIONAL CANCER INSTITUTE [R15CA152922] Funding Source: NIH RePORTER	Johnson Center for Basic Cancer Research; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors gratefully acknowledge financial support from NIH-1R15CA152922 (Nguyen) and The Johnson Center for Basic Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adida C, 1998, AM J PATHOL, V152, P43; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Anderson WF, 2004, BREAST CANCER RES TR, V83, P77, DOI 10.1023/B:BREA.0000010701.08825.2d; Appelbaum AH, 1999, RADIOGRAPHICS, V19, P559, DOI 10.1148/radiographics.19.3.g99ma01559; Bloom KJ, 2001, AM J SURG, V182, P389, DOI 10.1016/S0002-9610(01)00733-4; Callagy GM, 2006, CLIN CANCER RES, V12, P2468, DOI 10.1158/1078-0432.CCR-05-2719; Covaleda AMS, 2008, TOXICOL SCI, V105, P303, DOI 10.1093/toxsci/kfn141; Dohi T, 2004, J CLIN INVEST, V114, P1117, DOI 10.1172/JCI200422222; EASTMAN A, 1987, PHARMACOL THERAPEUT, V34, P155, DOI 10.1016/0163-7258(87)90009-X; Esslimani-Sahla M, 2004, CLIN CANCER RES, V10, P5769, DOI 10.1158/1078-0432.CCR-04-0389; Foerster R, 2009, CANCER RES, V69, p628S; Formby B, 1999, MOL CELL BIOCHEM, V202, P53, DOI 10.1023/A:1007081021483; FUCHS DA, 1978, CANCER TREAT REP, V62, P1219; Giordano SH, 2004, CANCER, V101, P51, DOI 10.1002/cncr.20312; Giordano SH, 2002, ANN INTERN MED, V137, P678, DOI 10.7326/0003-4819-137-8-200210150-00013; Goss PE, 1999, CANCER-AM CANCER SOC, V85, P629, DOI 10.1002/(SICI)1097-0142(19990201)85:3<629::AID-CNCR13>3.0.CO;2-V; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Howlader N, 2012, SEER CANC STAT REV 1; JIANG W, 1993, ONCOGENE, V8, P3447; Kandouz M, 1996, INT J CANCER, V68, P120, DOI 10.1002/(SICI)1097-0215(19960927)68:1<120::AID-IJC21>3.0.CO;2-E; Kari B, DIS BREAST; Korde LA, 2010, J CLIN ONCOL, V28, P2114, DOI 10.1200/JCO.2009.25.5729; Kornegoor R, 2012, HISTOPATHOLOGY; Kornegoor R, 2012, MODERN PATHOL, V25, P398, DOI 10.1038/modpathol.2011.174; Lazennec G, 2001, ENDOCRINOLOGY, V142, P4120, DOI 10.1210/en.142.9.4120; Lu CD, 1998, CANCER RES, V58, P1808; Maglione JE, 2001, CANCER RES, V61, P8298; Mann S, 2001, HUM PATHOL, V32, P113, DOI 10.1053/hupa.2001.21506; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Muir D, 2003, ARCH PATHOL LAB MED, V127, P36; Nahleh ZA, 2006, CANCER TREAT REV, V32, P101, DOI 10.1016/j.ctrv.2005.12.007; Nilsson C, 2012, MOD PATHOL; Osborne CK, 1998, NEW ENGL J MED, V339, P1609, DOI 10.1056/NEJM199811263392207; Rayson D, 1998, CANCER, V83, P1947, DOI 10.1002/(SICI)1097-0142(19981101)83:9<1947::AID-CNCR10>3.0.CO;2-J; RIBEIRO G, 1992, BRIT J CANCER, V65, P252, DOI 10.1038/bjc.1992.50; Saibara T, 1998, LANCET, V352, P404, DOI 10.1016/S0140-6736(05)60502-8; Sanchez-Munoz A, 2012, ONCOLOGY-BASEL, V83, P228, DOI 10.1159/000341537; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; Secreto FJ, 2007, J CELL BIOCHEM, V101, P1125, DOI 10.1002/jcb.21205; Shaaban AM, 2012, BREAST CANCER RES TR, V133, P949, DOI 10.1007/s10549-011-1856-9; Skliris GP, 2006, BRIT J CANCER, V95, P616, DOI 10.1038/sj.bjc.6603295; Speirs V, 1999, CANCER RES, V59, P525; Stossi F, 2004, ENDOCRINOLOGY, V145, P3473, DOI 10.1210/en.2003-1682; Sugiura H, 2007, JPN J CLIN ONCOL, V37, P820, DOI 10.1093/jjco/hym114; Taber KAJ, 2010, ONCOL REP, V24, P1115, DOI 10.3892/or_00000962; Tischkowitz MD, 2002, INT J CLIN PRACT, V56, P750; vanDiest PJ, 1997, AM J PATHOL, V150, P705; Volm Matthew D, 2003, Curr Treat Options Oncol, V4, P159, DOI 10.1007/s11864-003-0017-8; Wang-Rodriguez J, 2002, MODERN PATHOL, V15, P853, DOI 10.1097/01.MP.0000022251.61944.1D; Waters KM, 2001, J CELL BIOCHEM, V83, P448, DOI 10.1002/jcb.1242; WeberChappuis K, 1996, EUR J CANCER, V32A, P1686, DOI 10.1016/0959-8049(96)00154-2; Weiss JR, 2005, CANCER EPIDEM BIOMAR, V14, P20, DOI 10.1158/1055-9965.EPI-05-0414; Young IE, 1999, BRIT J CANCER, V81, P141, DOI 10.1038/sj.bjc.6690663; ZAMBLE DB, 1995, TRENDS BIOCHEM SCI, V20, P435, DOI 10.1016/S0968-0004(00)89095-7; ZHANG SY, 1994, AM J CLIN PATHOL, V102, P695, DOI 10.1093/ajcp/102.5.695	57	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64866	10.1371/journal.pone.0064866	http://dx.doi.org/10.1371/journal.pone.0064866			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755153	Green Published, Green Submitted, gold			2022-12-27	WOS:000319872300033
J	Wu, JB; Guan, DX; Yuan, FH; Wang, AZ; Jin, CJ				Wu, Jiabing; Guan, Dexin; Yuan, Fenhui; Wang, Anzhi; Jin, Changjie			Soil Temperature Triggers the Onset of Photosynthesis in Korean Pine	PLOS ONE			English	Article							CARBON-DIOXIDE; WATER-VAPOR; SCOTS PINE; NORWAY SPRUCE; SEASONAL AIR; BOREAL; RECOVERY; ECOSYSTEM; FOREST; PRODUCTIVITY	In forest ecosystems, the onset of spring photosynthesis may have an important influence on the annual carbon balance. However, triggers for the onset of photosynthesis have yet to be clearly identified, especially for temperate evergreen conifers. The effects of climatic factors on recovery of photosynthetic capacity in a Korean pine forest were investigated in the field. No photosynthesis was detectable when the soil temperature was below 0 degrees C even if the air temperature was far beyond 15 degrees C. The onset of photosynthesis and sap flow was coincident with the time of soil thawing. The rates of recovery of photosynthetic capacity highly fluctuated with air temperature after onset of photosynthesis, and intermittent frost events remarkably inhibited the photosynthetic capacity of the needles. The results suggest that earlier soil thawing is more important than air temperature increases in triggering the onset of photosynthesis in Korean pine in temperate zones under global warming scenarios.	[Wu, Jiabing; Guan, Dexin; Yuan, Fenhui; Wang, Anzhi; Jin, Changjie] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS	Guan, DX (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	bjfu_1999@hotmail.com	Yuan, Fenghui/W-3609-2019; Guan, Dexin/I-4184-2018; Yuan, Fenghui/M-7424-2013	Yuan, Fenghui/0000-0003-1004-873X; Guan, Dexin/0000-0002-2183-3779; Yuan, Fenghui/0000-0003-1004-873X	State Key Development Program of Basic Research (SKDPBR) [2009CB421101]; Youth Fund for Creative Research Groups, Institute of Applied Ecology, Chinese Academy of Sciences	State Key Development Program of Basic Research (SKDPBR); Youth Fund for Creative Research Groups, Institute of Applied Ecology, Chinese Academy of Sciences	This study was jointly financed by State Key Development Program of Basic Research (SKDPBR) (2009CB421101), and the Youth Fund for Creative Research Groups, Institute of Applied Ecology, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADGER MR, 1982, PLANT CELL ENVIRON, V5, P85; Bergh J, 1998, FOREST ECOL MANAG, V110, P127, DOI 10.1016/S0378-1127(98)00280-1; Bergh J, 1999, GLOB CHANGE BIOL, V5, P245, DOI 10.1046/j.1365-2486.1999.00205.x; Davidson NJ, 2004, TREES-STRUCT FUNCT, V18, P245, DOI 10.1007/s00468-003-0298-3; DELUCIA EH, 1987, CAN J FOREST RES, V17, P527, DOI 10.1139/x87-088; Ellsworth DS, 2000, TREE PHYSIOL, V20, P435; Ensminger I, 2004, GLOBAL CHANGE BIOL, V10, P995, DOI 10.1111/j.1365-2486.2004.00781.x; Ensminger I, 2006, PHYSIOL PLANTARUM, V126, P28, DOI 10.1111/j.1399-3054.2006.00627.x; Ensminger I, 2008, NEW PHYTOL, V177, P428, DOI 10.1111/j.1469-8137.2007.02273.x; Falge E, 2001, AGR FOREST METEOROL, V107, P43, DOI 10.1016/S0168-1923(00)00225-2; Foken T, 1996, AGR FOREST METEOROL, V78, P83, DOI 10.1016/0168-1923(95)02248-1; Goulden ML, 1998, SCIENCE, V279, P214, DOI 10.1126/science.279.5348.214; Ham JM, 1998, AGR FOREST METEOROL, V89, P1, DOI 10.1016/S0168-1923(97)00062-2; Hannerz M, 1999, CAN J FOREST RES, V29, P9, DOI 10.1139/cjfr-29-1-9; Havranek W., 1995, ECOPHYSIOLOGY CONIFE, P95, DOI DOI 10.1016/B978-0-08-092593-6.50010-4; Hollinger DY, 1999, GLOB CHANGE BIOL, V5, P891, DOI 10.1046/j.1365-2486.1999.00281.x; HUNTER AF, 1992, J APPL ECOL, V29, P597, DOI 10.2307/2404467; Idso CD, 2000, ENVIRON EXP BOT, V43, P91, DOI 10.1016/S0098-8472(99)00054-4; Janssens IA, 2001, GLOBAL CHANGE BIOL, V7, P269, DOI 10.1046/j.1365-2486.2001.00412.x; Jarvis P, 2000, NATURE, V405, P904, DOI 10.1038/35016154; Linkosalo T, 2000, CAN J FOREST RES, V30, P667, DOI 10.1139/x99-243; Lundmark T, 1988, TREES-STRUCT FUNCT, V2, P110, DOI 10.1007/BF00196757; Monson RK, 2005, OECOLOGIA, V146, P130, DOI 10.1007/s00442-005-0169-2; MOORE CJ, 1986, BOUND-LAY METEOROL, V37, P17, DOI 10.1007/BF00122754; Moore TR, 2006, GLOBAL CHANGE BIOL, V12, P2323, DOI 10.1111/j.1365-2486.2006.01247.x; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Oksanen E, 2005, CAN J FOREST RES, V35, P703, DOI 10.1139/X05-007; OTTANDER C, 1991, PLANT CELL ENVIRON, V14, P345, DOI 10.1111/j.1365-3040.1991.tb01511.x; OTTANDER C, 1995, PLANTA, V197, P176, DOI 10.1007/BF00239954; Saitoh TM, 2010, J PLANT RES, V123, P473, DOI 10.1007/s10265-009-0308-7; Saxe H, 2001, NEW PHYTOL, V149, P369, DOI 10.1046/j.1469-8137.2001.00057.x; SCHULTZ PA, 1993, ADV SPACE RES-SERIES, V13, P277, DOI 10.1016/0273-1177(93)90559-T; Schwarz PA, 1997, TREE PHYSIOL, V17, P187; Sevanto S, 2006, TREE PHYSIOL, V26, P749, DOI 10.1093/treephys/26.6.749; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Strand M, 2002, TREE PHYSIOL, V22, P839, DOI 10.1093/treephys/22.12.839; Tanja S, 2003, GLOBAL CHANGE BIOL, V9, P1410, DOI 10.1046/j.1365-2486.2003.00597.x; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; White MA, 1997, GLOBAL BIOGEOCHEM CY, V11, P217, DOI 10.1029/97GB00330; Wilczak JM, 2001, BOUND-LAY METEOROL, V99, P127, DOI 10.1023/A:1018966204465; Wu JB, 2012, ATMOS ENVIRON, V61, P9, DOI 10.1016/j.atmosenv.2012.07.013; Yuan FM, 2008, GLOBAL CHANGE BIOL, V14, P1765, DOI 10.1111/j.1365-2486.2008.01612.x; Zheng YP, 2012, SCAND J FOREST RES, V27, P520, DOI 10.1080/02827581.2012.683532; Zhou Yong-bin, 2007, Shengtaixue Zazhi, V26, P793	44	16	16	5	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65401	10.1371/journal.pone.0065401	http://dx.doi.org/10.1371/journal.pone.0065401			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755227	Green Published, Green Submitted, gold			2022-12-27	WOS:000319872300078
J	Zhen, Y; Ye, YF; Yu, XL; Mai, CP; Zhou, Y; Chen, Y; Yang, HL; Lyu, XM; Song, Y; Wu, QY; Fu, QF; Zhao, MY; Hua, SN; Wang, H; Liu, Z; Zhang, YJ; Fang, WY				Zhen, Yan; Ye, Yanfen; Yu, Xiaoli; Mai, Chunping; Zhou, Ying; Chen, Yan; Yang, Huiling; Lyu, Xiaoming; Song, Ye; Wu, Qiangyun; Fu, Qiaofen; Zhao, Mengyang; Hua, Shengni; Wang, Hao; Liu, Zhen; Zhang, Yajie; Fang, Weiyi			Reduced CTGF Expression Promotes Cell Growth, Migration, and Invasion in Nasopharyngeal Carcinoma (Publication with Expression of Concern. See vol. 15, 2020)	PLOS ONE			English	Article; Publication with Expression of Concern							FACTOR CTGF/CCN2; DOWN-REGULATION; CANCER CELLS; SURVIVAL; CYR61; PROLIFERATION; INVASIVENESS; INHIBITION; DECREASES; PROGNOSIS	Background: The role of CTGF varies in different types of cancer. The purpose of this study is to investigate the involvement of CTGF in tumor progression and prognosis of human nasopharyngeal carcinoma (NPC). Experimental design: CTGF expression levels were examined in NPC tissues and cells, nasopharynx (NP) tissues, and NP69 cells. The effects and molecular mechanisms of CTGF expression on cell proliferation, migration, invasion, and cell cycle were also explored. Results: NPC cells exhibited decreased mRNA expression of CTGF compared to immortalized human nasopharyngeal epithelial cell line NP69. Similarly, CTGF was observed to be downregulated in NPC compared to normal tissues at mRNA and protein levels. Furthermore, reduced CTGF was negatively associated with the progression of NPC. Knocking down CTGF expression enhanced the colony formation, cell migration, invasion, and G1/S cell cycle transition. Mechanistic analysis revealed that CTGF suppression activated FAK/PI3K/AKT and its downstream signals regulating the cell cycle, epithelialmesenchymal transition (EMT) and MMPs. Finally, DNA methylation microarray revealed a lack of hypermethylation at the CTGF promoter, suggesting other mechanisms are associated with suppression of CTGF in NPC. Conclusion: Our study demonstrates that reduced expression of CTGF promoted cell proliferation, migration, invasion and cell cycle progression through FAK/PI3K/AKT, EMT and MMP pathways in NPC.	[Zhen, Yan; Ye, Yanfen; Yu, Xiaoli; Mai, Chunping; Zhou, Ying; Chen, Yan; Lyu, Xiaoming; Wu, Qiangyun; Fu, Qiaofen; Zhao, Mengyang; Hua, Shengni; Wang, Hao; Liu, Zhen; Zhang, Yajie; Fang, Weiyi] Southern Med Univ, Basic Med Sch, Canc Res Inst, Guangzhou, Guangdong, Peoples R China; [Liu, Zhen; Zhang, Yajie] Med Univ Guangzhou, Basic Sch, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Yang, Huiling] Guangdong Med Coll, Sch Pharm, Dongguan, Peoples R China; [Song, Ye] Southern Med Univ, Nanfang Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Guangdong Medical University; Southern Medical University - China	Liu, Z (corresponding author), Southern Med Univ, Basic Med Sch, Canc Res Inst, Guangzhou, Guangdong, Peoples R China.	narcissus_jane@163.com; yajie.zhang@163.com; fangweiyi1975@yahoo.com.cn	Lyu, Xiaoming/AAC-8564-2020; hua, shengni/HDN-5084-2022	Lyu, Xiaoming/0000-0002-6243-3536; 	National Nature Science Fund of China [81272268]; Yangcheng scholar research projects from Universities of Guangzhou [12A011D]; Natural science fund of Guangdong Province [S2012010009583]; New star plan of Pearl River Science and Technology from Guangzhou City [2011J2200009]; Guangdong Province Breeding Project Plan [LYM11102]	National Nature Science Fund of China(National Natural Science Foundation of China (NSFC)); Yangcheng scholar research projects from Universities of Guangzhou; Natural science fund of Guangdong Province(National Natural Science Foundation of Guangdong Province); New star plan of Pearl River Science and Technology from Guangzhou City; Guangdong Province Breeding Project Plan	This study was supported by National Nature Science Fund of China (No. 81272268), Yangcheng scholar research projects from Universities of Guangzhou(No. 12A011D), Natural science fund of Guangdong Province (No. S2012010009583), New star plan of Pearl River Science and Technology from Guangzhou City (No. 2011J2200009), and Guangdong Province Breeding Project Plan (LYM11102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alajez NM, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.64; Barbolina MV, 2009, INT J CANCER, V125, P816, DOI 10.1002/ijc.24347; Bennewith KL, 2009, CANCER RES, V69, P775, DOI 10.1158/0008-5472.CAN-08-0987; Braig S, 2011, BRIT J CANCER, V105, P231, DOI 10.1038/bjc.2011.226; Chang CC, 2004, JNCI-J NATL CANCER I, V96, P364, DOI 10.1093/jnci/djh059; Chen PP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000534; Cheng JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034071; Chien WW, 2011, INT J ONCOL, V38, P1741, DOI 10.3892/ijo.2011.985; Chu CY, 2008, J BIOMED SCI, V15, P675, DOI 10.1007/s11373-008-9264-9; Chuang JY, 2011, INT IMMUNOPHARMACOL, V11, P948, DOI 10.1016/j.intimp.2011.02.008; Croci S, 2004, CANCER RES, V64, P1730, DOI 10.1158/0008-5472.CAN-3502-02; Cui L, 2011, TUMOR BIOL, V32, P721, DOI 10.1007/s13277-011-0173-6; Fang WY, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-32; Jackson TC, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.187; Jang JY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-391; Jia XQ, 2011, CHINESE MED J-PEKING, V124, P3794, DOI 10.3760/cma.j.issn.0366-6999.2011.22.034; Jiang CG, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-122; Kikuchi R, 2007, CANCER RES, V67, P7095, DOI 10.1158/0008-5472.CAN-06-4567; Koga Y, 2009, GENOME RES, V19, P1462, DOI 10.1101/gr.091447.109; Liu LY, 2007, PATHOL INT, V57, P712, DOI 10.1111/j.1440-1827.2007.02162.x; Liu Z, 2012, ACTA BIOCH BIOPH SIN, V44, P503, DOI 10.1093/abbs/gms030; Liu Z, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0027887, 10.1371/journal.pone.0019001]; Ma B, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.100; Wang GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055298; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Wang SA, 2011, HISTOPATHOLOGY, V58, P217, DOI 10.1111/j.1365-2559.2010.03739.x; Wong YF, 2006, INT J CANCER, V118, P2461, DOI 10.1002/ijc.21660; Xie JJ, 2010, AM J PATHOL, V176, P939, DOI 10.2353/ajpath.2010.090118; Yang F, 2005, CANCER RES, V65, P8887, DOI 10.1158/0008-5472.CAN-05-1702; Yang MH, 2012, ONCOGENE, V31, P2401, DOI 10.1038/onc.2011.423; Zhou ZQ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-291	31	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64976	10.1371/journal.pone.0064976	http://dx.doi.org/10.1371/journal.pone.0064976			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755163	Green Submitted, gold, Green Published			2022-12-27	WOS:000319872300040
J	Bloise, E; Bhuiyan, M; Audette, MC; Petropoulos, S; Javam, M; Gibb, W; Matthews, SG				Bloise, Enrrico; Bhuiyan, Manzerul; Audette, Melanie C.; Petropoulos, Sophie; Javam, Mohsen; Gibb, William; Matthews, Stephen G.			Prenatal Endotoxemia and Placental Drug Transport in The Mouse: Placental Size-Specific Effects	PLOS ONE			English	Article							P-GLYCOPROTEIN EXPRESSION; RESISTANCE PHOSPHOGLYCOPROTEIN ABCB1; ADVANCING GESTATION; FETAL PROTECTION; GENE-PRODUCT; CHORIOAMNIONITIS; PREGNANCY; PROTEIN; MODEL; GROWTH	Lipopolysaccharide (LPS) in high doses inhibits placental multidrug resistance P-glycoprotein (P-gp - Abcb1a/b) and breast cancer resistance protein (BCRP - Abcg2). This potentially impairs fetal protection against harmful factors in the maternal circulation. However, it is unknown whether LPS exposure, at doses that mimic sub-lethal clinical infection, alters placental multidrug resistance. We hypothesized that sub-lethal (fetal) LPS exposure reduces placental P-gp activity. Acute LPS (n = 19; 150 mu g/kg; ip) or vehicle (n = 19) were given to C57BL/6 mice at E15.5 and E17.5. Placentas and fetal-units were collected 4 and 24 h following injection. Chronic LPS (n = 6; 5 mu g/kg/day; ip) or vehicle (n = 5) were administered from E11.5-15.5 and tissues were collected 4 h after final treatment. P-gp activity was assessed by [3 H] digoxin accumulation. Placental Abcb1a/b, Abcg2, interleukin-6 (Il-6), Tnf-alpha, Il-10 and toll-like receptor-4 (Tlr-4) mRNA were measured by qPCR. Maternal plasma IL-6 was determined. At E15.5, maternal IL-6 was elevated 4 h after single (p < 0.001) and chronic (p < 0.05) LPS, but levels had returned to baseline by 24 h. Placental Il-6 mRNA was also increased after acute and chronic LPS treatments (p < 0.05), whereas Abcb1a/b and Abcg2 mRNA were unaffected. However, fetal [3 H] digoxin accumulation was increased (p < 0.05) 4 h after acute LPS, and maternal [H-3]digoxin myocardial accumulation was increased (p < 0.05) in mice exposed to chronic LPS treatments. There was a negative correlation between fetal [H-3]digoxin accumulation and placental size (p < 0.0001). Acute and chronic sub-lethal LPS exposure resulted in a robust inflammatory response in the maternal systemic circulation and placenta. Acute infection decreased placental P-gp activity in a time-and gestational age-dependent manner. Chronic LPS decreased P-gp activity in the maternal myocardium and there was a trend for fetuses with smaller placentas to accumulate more P-gp substrate than their larger counterparts. Collectively, we demonstrate that acute sub-lethal LPS exposure during pregnancy impairs fetal protection against potentially harmful xenobiotics in the maternal circulation.	[Bloise, Enrrico; Bhuiyan, Manzerul; Audette, Melanie C.; Javam, Mohsen; Matthews, Stephen G.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Petropoulos, Sophie] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Gibb, William] Univ Ottawa, Dept Obstet & Gynecol, Ottawa, ON, Canada; [Gibb, William] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Matthews, Stephen G.] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada; [Matthews, Stephen G.] Univ Toronto, Fac Med, Dept Med, Toronto, ON, Canada	University of Toronto; McGill University; University of Ottawa; University of Ottawa; University of Toronto; University of Toronto	Bloise, E (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON, Canada.	enrrico.bloise@utoronto.ca	Petropoulos, Sophie/D-6861-2016; Petropoulos, Sophie/M-3090-2017; Matthews, Stephen/R-5147-2019; Bloise, Enrrico/O-6710-2018; Matthews, Stephen G/N-7555-2018	Petropoulos, Sophie/0000-0003-2293-8238; Matthews, Stephen/0000-0002-9654-9940; Bloise, Enrrico/0000-0003-0275-8686; Matthews, Stephen G/0000-0002-9654-9940	Canadian Institutes for Health Research [452740]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes for Health Research (grant: 452740; to S. G. M. and W. G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bataineh MM, 2010, BIOPHARM DRUG DISPOS, V31, P506, DOI 10.1002/bdd.731; Audette MC, 2011, ENDOCRINOLOGY, V152, P3561, DOI 10.1210/en.2011-0104; Bayraktar M, 2009, AM J REPROD IMMUNOL, V62, P390, DOI 10.1111/j.1600-0897.2009.00756.x; Bloise E, 2010, PLACENTA, V31, P867, DOI 10.1016/j.placenta.2010.04.007; Bloise E, 2012, ENDOCRINOLOGY, V153, P3457, DOI 10.1210/en.2011-1921; Burton GJ, 2012, PLACENTA, V33, pS23, DOI 10.1016/j.placenta.2011.11.013; Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095; Chong YT, 2012, MOL MED REP, V5, P812, DOI 10.3892/mmr.2011.691; Coan PM, 2008, J PHYSIOL-LONDON, V586, P4567, DOI 10.1113/jphysiol.2008.156133; DELANNOY IAM, 1992, BIOCHEM BIOPH RES CO, V189, P551, DOI 10.1016/0006-291X(92)91593-F; Desforges M, 2010, INT J DEV BIOL, V54, P377, DOI 10.1387/ijdb.082765md; Dopp JM, 2009, PHARMACOTHERAPY, V29, P365, DOI 10.1592/phco.29.4.365; Drewlo S, 2012, PLACENTA, V33, P952, DOI 10.1016/j.placenta.2012.09.007; Evseenko DA, 2007, DRUG METAB DISPOS, V35, P595, DOI 10.1124/dmd.106.011478; Griffin AJ, 2011, MUCOSAL IMMUNOL, V4, P371, DOI 10.1038/mi.2011.2; Gulati S, 2012, AM J REPROD IMMUNOL, V67, P235, DOI 10.1111/j.1600-0897.2011.01084.x; Iqbal M, 2012, PLACENTA, V33, P137, DOI 10.1016/j.placenta.2012.01.008; Iqbal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043022; Jones KL, 2007, P NATL ACAD SCI USA, V104, P16239, DOI 10.1073/pnas.0705971104; Kalabis GM, 2007, PLACENTA, V28, P1073, DOI 10.1016/j.placenta.2007.03.010; Kalabis GM, 2005, BIOL REPROD, V73, P591, DOI 10.1095/biolreprod.105.042242; Kaukola T, 2004, ANN NEUROL, V55, P186, DOI 10.1002/ana.10809; Koga K, 2010, AM J REPROD IMMUNOL, V63, P587, DOI 10.1111/j.1600-0897.2010.00848.x; Kumazaki K, 2004, HUM PATHOL, V35, P47, DOI 10.1016/j.humpath.2003.08.027; Ma YH, 2006, AM J REPROD IMMUNOL, V55, P12, DOI 10.1111/j.1600-0897.2005.00347.x; Malassine A, 2003, HUM REPROD UPDATE, V9, P531, DOI 10.1093/humupd/dmg043; Mason CW, 2011, DRUG METAB DISPOS, V39, P1000, DOI 10.1124/dmd.111.038166; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Menon R, 2010, PLACENTA, V31, P113, DOI 10.1016/j.placenta.2009.11.012; Novembri R, 2011, PLACENTA, V32, P969, DOI 10.1016/j.placenta.2011.09.013; Omanwar Swati, 2004, Hepatobiliary Pancreat Dis Int, V3, P417; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Petropoulos S, 2010, PLACENTA, V31, P803, DOI 10.1016/j.placenta.2010.06.014; Petropoulos S, 2007, REPROD SCI, V14, P321, DOI 10.1177/1933719107303856; Petrovic V, 2008, DRUG METAB DISPOS, V36, P1944, DOI 10.1124/dmd.107.019851; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Renaud SJ, 2011, J IMMUNOL, V186, P1799, DOI 10.4049/jimmunol.1002679; SCHINKEL AH, 1995, J CLIN INVEST, V96, P1698, DOI 10.1172/JCI118214; Sun M, 2006, PLACENTA, V27, P602, DOI 10.1016/j.placenta.2005.05.007; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; Tomita M, 2009, J PHARM PHARMACOL, V61, P1319, DOI 10.1211/jpp/61.10.0007; Torricelli M, 2009, AM J REPROD IMMUNOL, V62, P224, DOI 10.1111/j.1600-0897.2009.00729.x; Wang JH, 2005, J NUCL MED, V46, P1537; Willoughby RE, 2002, CLIN PERINATOL, V29, P603, DOI 10.1016/S0095-5108(02)00058-1; Yeboah D, 2006, CAN J PHYSIOL PHARM, V84, P1251, DOI 10.1139/Y06-078; Zhou SF, 2008, XENOBIOTICA, V38, P802, DOI 10.1080/00498250701867889 	47	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65728	10.1371/journal.pone.0065728	http://dx.doi.org/10.1371/journal.pone.0065728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762418	Green Submitted, Green Published, gold			2022-12-27	WOS:000320440500049
J	Tannieres, M; Beury-Cirou, A; Vigouroux, A; Mondy, S; Pellissier, F; Dessaux, Y; Faure, D				Tannieres, Melanie; Beury-Cirou, Amelie; Vigouroux, Armelle; Mondy, Samuel; Pellissier, Franck; Dessaux, Yves; Faure, Denis			A Metagenomic Study Highlights Phylogenetic Proximity of Quorum-Quenching and Xenobiotic-Degrading Amidases of the AS-Family	PLOS ONE			English	Article							N-ACYLHOMOSERINE LACTONASE; HOMOSERINE LACTONE; SP STRAIN; SENSING SIGNALS; BACTERIA; GENE; IDENTIFICATION; DISCOVERY; HYDROLASE; MECHANISM	Quorum-sensing (QS) signals of the N-acylhomoserine lactone (NAHL) class are cleaved by quorum-quenching enzymes, collectively named NAHLases. Here, functional metagenomics allowed the discovery of a novel bacterial NAHLase in a rhizosphere that was treated with gamma-caprolactone. As revealed by rrs-DGGE and rrs-pyrosequencing, this treatment increased the percentage of the NAHL-degrading bacteria and strongly biased the structure of the bacterial community, among which Azospirillum dominated. Among the 29 760 fosmids of the metagenomic library, a single one was detected that expressed the qsdB gene conferring NAHL-degradation upon E. coli and decreased QS-regulated virulence in Pectobacterium. Phylogenetic analysis of the 34 orfs of the fosmid suggested that it would belong to an unknown Proteobacterium - probably a gamma-proteobacterium. qPCR quantification of the NAHLase-encoding genes attM, qsdA, and qsdB revealed their higher abundance in the gamma-caprolactone-treated rhizosphere as compared to an untreated control. The purified QsdB enzyme exhibited amidase activity. QsdB is the first amidase signature (AS) family member exhibiting NAHLase-activity. Point mutations in the AS-family catalytic triad K-S-S abolished the NAHLase activity of QsdB. This study extends the diversity of NAHLases and highlights a common phylogenic origin of AS-family enzymes involved in the degradation of natural compounds, such as NAHLs, and xenobiotics, such as nylon and linuron.	[Tannieres, Melanie; Beury-Cirou, Amelie; Mondy, Samuel; Dessaux, Yves; Faure, Denis] Ctr Natl Rech Sci, UPR2355, Inst Sci Vegetal, Gif Sur Yvette, France; [Beury-Cirou, Amelie] CNPPT, Achicourt, France; [Vigouroux, Armelle] Ctr Natl Rech Sci, UPR3082, LEBS, Gif Sur Yvette, France; [Pellissier, Franck] Ctr Natl Rech Sci, UPR2301, Inst Chim Subst Nat, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC)	Faure, D (corresponding author), Ctr Natl Rech Sci, UPR2355, Inst Sci Vegetal, Gif Sur Yvette, France.	faure@isv.cnrs-gif.fr	Mondy, Samuel/AAG-8805-2019	Mondy, Samuel/0000-0002-9203-6398; TANNIERES, Melanie/0000-0003-2335-3776	Reseau de Recherche sur le Developpement Soutenable (R2DS, Region Ile-de-France); Comite Nord Plants de Pommes de Terre (CNPPT, France); Centre de la Recherche Scientifique (CNRS); program Ecosphere Continentale et Cotiere (EC2CO, CNRS); French programs Ingenierie Ecologique (CNRS); Projets innovants (Fondation pour la Recherche sur la Biodiversite, FRB); PESTICIDES (Ministere de l'ecologie, du developpement durable, des transports et du logement)	Reseau de Recherche sur le Developpement Soutenable (R2DS, Region Ile-de-France); Comite Nord Plants de Pommes de Terre (CNPPT, France); Centre de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); program Ecosphere Continentale et Cotiere (EC2CO, CNRS); French programs Ingenierie Ecologique (CNRS); Projets innovants (Fondation pour la Recherche sur la Biodiversite, FRB); PESTICIDES (Ministere de l'ecologie, du developpement durable, des transports et du logement)	MT was supported by a PhD grant from Reseau de Recherche sur le Developpement Soutenable (R2DS, Region Ile-de-France), AB-C by a post-doctoral fellowship from Comite Nord Plants de Pommes de Terre (CNPPT, France). YD and DF were funded by Centre de la Recherche Scientifique (CNRS) and program Ecosphere Continentale et Cotiere (EC2CO, CNRS); DF received financial support from the French programs Ingenierie Ecologique (CNRS), Projets innovants (Fondation pour la Recherche sur la Biodiversite, FRB), and PESTICIDES (Ministere de l'ecologie, du developpement durable, des transports et du logement). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbey C, 2012, J PROTEOME RES, V11, P206, DOI 10.1021/pr200936q; Bers K, 2011, APPL ENVIRON MICROB, V77, P8754, DOI 10.1128/AEM.06162-11; Bijtenhoorn P, 2011, J BIOTECHNOL, V155, P86, DOI 10.1016/j.jbiotec.2010.12.016; Bijtenhoorn P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026278; Boyer M, 2009, FEMS MICROBIOL ECOL, V70, P1, DOI 10.1111/j.1574-6941.2009.00745.x; Carlier A, 2003, APPL ENVIRON MICROB, V69, P4989, DOI 10.1128/AEM.69.8.4989-4993.2003; Cha C, 1998, MOL PLANT MICROBE IN, V11, P1119, DOI 10.1094/MPMI.1998.11.11.1119; Cirou A, 2007, ENVIRON MICROBIOL, V9, P1511, DOI 10.1111/j.1462-2920.2007.01270.x; Cirou A, 2012, APPL ENVIRON MICROB, V78, P481, DOI 10.1128/AEM.06159-11; Cirou A, 2011, RES MICROBIOL, V162, P945, DOI 10.1016/j.resmic.2011.01.010; d'Angelo-Picard C, 2004, FEMS MICROBIOL ECOL, V51, P19, DOI 10.1016/j.femsec.2004.07.008; Dong YH, 2004, APPL ENVIRON MICROB, V70, P954, DOI 10.1128/AEM.70.2.954-960.2004; Dong YH, 2000, P NATL ACAD SCI USA, V97, P3526, DOI 10.1073/pnas.060023897; Dong YH, 2001, NATURE, V411, P813, DOI 10.1038/35081101; Faure D, 2011, METAGENOMICS: CURRENT INNOVATIONS AND FUTURE TRENDS, P253; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fukuta Y, 2010, ENZYME MICROB TECH, V46, P237, DOI 10.1016/j.enzmictec.2009.09.010; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Gabor EM, 2004, ENVIRON MICROBIOL, V6, P948, DOI 10.1111/j.1462-2920.2004.00643.x; Guan CH, 2007, APPL ENVIRON MICROB, V73, P3669, DOI 10.1128/AEM.02617-06; Hao YA, 2010, ENVIRON MICROBIOL, V12, P105, DOI 10.1111/j.1462-2920.2009.02049.x; Haudecoeur E, 2009, P NATL ACAD SCI USA, V106, P14587, DOI 10.1073/pnas.0808005106; Haudecoeur E, 2009, MOL PLANT MICROBE IN, V22, P529, DOI 10.1094/MPMI-22-5-0529; Huang JJ, 2006, APPL ENVIRON MICROB, V72, P1190, DOI 10.1128/AEM.72.2.1190-1197.2006; Huang JJ, 2003, APPL ENVIRON MICROB, V69, P5941, DOI 10.1128/AEM.69.10.5941-5949.2003; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KANAGAWA K, 1989, J BACTERIOL, V171, P3181, DOI 10.1128/jb.171.6.3181-3186.1989; Kaufmann GF, 2005, P NATL ACAD SCI USA, V102, P309, DOI 10.1073/pnas.0408639102; Kennedy J, 2011, J APPL MICROBIOL, V111, P787, DOI 10.1111/j.1365-2672.2011.05106.x; Labahn J, 2002, J MOL BIOL, V322, P1053, DOI 10.1016/S0022-2836(02)00886-0; Leveau JHJ, 2008, FEMS MICROBIOL ECOL, V65, P238, DOI 10.1111/j.1574-6941.2008.00436.x; Lin YH, 2003, MOL MICROBIOL, V47, P849, DOI 10.1046/j.1365-2958.2003.03351.x; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; Mei GY, 2010, APPL ENVIRON MICROB, V76, P4933, DOI 10.1128/AEM.00477-10; Monier JM, 2011, CURR OPIN MICROBIOL, V14, P229, DOI 10.1016/j.mib.2011.04.010; Negoro S, 2012, J BIOL CHEM, V287, P5079, DOI 10.1074/jbc.M111.321992; OKADA H, 1983, NATURE, V306, P203, DOI 10.1038/306203a0; Park SY, 2005, APPL ENVIRON MICROB, V71, P2632, DOI 10.1128/AEM.71.5.2632-2641.2005; Park SY, 2003, MICROBIOL-SGM, V149, P1541, DOI 10.1099/mic.0.26269-0; Piel J, 2011, ANNU REV MICROBIOL, V65, P431, DOI 10.1146/annurev-micro-090110-102805; Riaz K, 2008, ENVIRON MICROBIOL, V10, P560, DOI 10.1111/j.1462-2920.2007.01475.x; Romero M, 2008, FEMS MICROBIOL LETT, V280, P73, DOI 10.1111/j.1574-6968.2007.01046.x; Schipper C, 2009, APPL ENVIRON MICROB, V75, P224, DOI 10.1128/AEM.01389-08; Smadja B, 2004, MOL PLANT MICROBE IN, V17, P1269, DOI 10.1094/MPMI.2004.17.11.1269; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taupp M, 2011, CURR OPIN BIOTECH, V22, P465, DOI 10.1016/j.copbio.2011.02.010; TSUCHIYA K, 1989, J BACTERIOL, V171, P3187, DOI 10.1128/jb.171.6.3187-3191.1989; Uroz S, 2003, MICROBIOL-SGM, V149, P1981, DOI 10.1099/mic.0.26375-0; Uroz S, 2008, APPL ENVIRON MICROB, V74, P1357, DOI 10.1128/AEM.02014-07; Uroz S, 2009, CHEMBIOCHEM, V10, P205, DOI 10.1002/cbic.200800521; Valina ALB, 2004, BIOCHEMISTRY-US, V43, P15657, DOI 10.1021/bi049025r; Wang WZ, 2010, APPL ENVIRON MICROB, V76, P2524, DOI 10.1128/AEM.02738-09; Wisniewski-Dye F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002430; Zhang HB, 2002, P NATL ACAD SCI USA, V99, P4638, DOI 10.1073/pnas.022056699; Zhang LH, 2003, TRENDS PLANT SCI, V8, P238, DOI 10.1016/S1360-1385(03)00063-3	55	20	22	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65473	10.1371/journal.pone.0065473	http://dx.doi.org/10.1371/journal.pone.0065473			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762380	Green Published, Green Submitted, gold			2022-12-27	WOS:000321094800054
J	Welter, S; Dolle, S; Lehmann, K; Schwarz, D; Weckwerth, W; Worm, M; Franken, P				Welter, Saskia; Doelle, Sabine; Lehmann, Karola; Schwarz, Dietmar; Weckwerth, Wolfram; Worm, Margitta; Franken, Philipp			Pepino mosaic virus Infection of Tomato Affects Allergen Expression, but Not the Allergenic Potential of Fruits	PLOS ONE			English	Article							PATHOGENESIS-RELATED PROTEINS; DEFENSE-RELATED PROTEINS; RESPONSES; LEAVES; PLANTS; IDENTIFICATION; CAROTENOIDS; CULTIVARS; EUROPE; GENES	The plant pathogen Pepino mosaic virus (PepMV) is a major disease of greenhouse tomato crops worldwide. Plant pathogens can induce expression of defence- or pathogenesis-related proteins, including identified allergens. Therefore we hypothesised that PepMV infection results in the expression of allergens leading to a higher allergenic potential of tomato fruits. Transcript level analyses showed differential expression of 17 known and putative tomato fruit allergen encoding genes at early and late time points after PepMV inoculation, but no general induction was detected. Immunoblot analyses were conducted and IgEs from a serum pool of tomato allergic subjects reacted with 20 proteins, of which ten have not yet been described. In parallel, skin prick tests with a group of tomato allergic subjects did not show a general difference between PepMV infected and non-infected tomato fruits and basophil activation tests confirmed these results. In summary, PepMV infection of tomato plants can lead to long-lasting up-regulation of particular allergens in fruits, but the hypothesis that this results in a higher allergenic potential of the fruits proved invalid.	[Welter, Saskia; Schwarz, Dietmar; Franken, Philipp] Leibniz Inst Vegetable & Ornamental Crops Grossbe, Dept Plant Nutr, Grossbeeren, Germany; [Doelle, Sabine; Worm, Margitta] Charite, Dept Dermatol & Allergol, D-13353 Berlin, Germany; [Lehmann, Karola] Proteome Factory AG, Berlin, Germany; [Weckwerth, Wolfram] Univ Vienna, Dept Mol Syst Biol, Vienna, Austria	Leibniz Institut fur Gemuse- und Zierpflanzenbau (IGZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Vienna	Welter, S (corresponding author), Leibniz Inst Vegetable & Ornamental Crops Grossbe, Dept Plant Nutr, Grossbeeren, Germany.	welter@igzev.de	Scwarz, Dietmar/X-3671-2019; Weckwerth, Wolfram/G-5811-2010	Scwarz, Dietmar/0000-0002-7742-7227; Worm, Margitta/0000-0002-3449-1245; Dolle-Bierke, Sabine/0000-0002-3339-0709; Weckwerth, Wolfram/0000-0002-9719-6358	Leibniz association (SAW process) IGZ [23.3.3]	Leibniz association (SAW process) IGZ	This work was supported by Leibniz association (SAW process) IGZ project number: 23.3.3 (http://www.leibniz-gemeinschaft.de/ueber-uns/leibniz-wettbewerb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONIW JF, 1980, J GEN VIROL, V47, P79, DOI 10.1099/0022-1317-47-1-79; BOL JF, 1990, ANNU REV PHYTOPATHOL, V28, P113, DOI 10.1146/annurev.py.28.090190.000553; BOWLER C, 1994, CRIT REV PLANT SCI, V13, P199, DOI 10.1080/713608062; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cheng L, 2012, J ZHEJIANG UNIV-SC B, V13, P283, DOI 10.1631/jzus.B1100060; Dardick C, 2007, MOL PLANT MICROBE IN, V20, P1004, DOI 10.1094/MPMI-20-8-1004; De-la-Pena C, 2010, J BIOL CHEM, V285, P30654, DOI 10.1074/jbc.M110.119040; Diaz-Perales A, 1999, J ALLERGY CLIN IMMUN, V104, P681, DOI 10.1016/S0091-6749(99)70342-8; Dolle S, 2011, CLIN EXP ALLERGY, V41, P1643, DOI 10.1111/j.1365-2222.2011.03841.x; Ebner C, 2001, ALLERGY, V56, P43, DOI 10.1034/j.1398-9995.2001.00913.x; Edreva A., 2005, General and Applied Plant Physiology, V31, P105; Fakhro A, 2011, EUR J PLANT PATHOL, V129, P579, DOI 10.1007/s10658-010-9722-x; Foetisch K, 2001, EUR FOOD RES TECHNOL, V213, P259, DOI 10.1007/s002170100343; Hammerschmidt R, 2009, ADV BOT RES, V51, P173, DOI 10.1016/S0065-2296(09)51005-1; Hanssen IM, 2010, PLANT PATHOL, V59, P13, DOI 10.1111/j.1365-3059.2009.02190.x; Hanssen IM, 2009, PLANT PATHOL, V58, P450, DOI 10.1111/j.1365-3059.2008.02018.x; Hanssen IM, 2008, EUR J PLANT PATHOL, V121, P131, DOI 10.1007/s10658-007-9255-0; Hanssen IM, 2011, PLANT PHYSIOL, V156, P301, DOI 10.1104/pp.111.173906; Hanssen IM, 2010, MOL PLANT PATHOL, V11, P179, DOI 10.1111/j.1364-3703.2009.00600.x; Heinzerling L, 2005, ALLERGY, V60, P1287, DOI 10.1111/j.1398-9995.2005.00895.x; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Elvira MI, 2008, J EXP BOT, V59, P1253, DOI 10.1093/jxb/ern032; JONES DR, 2005, PEST RISK ANAL PEPIN; KLOSE J, 1995, ELECTROPHORESIS, V16, P1034, DOI 10.1002/elps.11501601175; Kondo Y, 2001, INT ARCH ALLERGY IMM, V126, P294, DOI 10.1159/000049526; LECOQ H, 1991, PLANT DIS, V75, P208, DOI 10.1094/PD-75-0208; Mayer M, 2011, EUR J PLANT PATHOL, V131, P1, DOI 10.1007/s10658-011-9784-4; McKinney HH, 1929, J AGRIC RES, V39, P0557; Midoro-Horiuti T, 2001, ANN ALLERG ASTHMA IM, V87, P261, DOI 10.1016/S1081-1206(10)62238-7; Mumford RA, 2001, ARCH VIROL, V146, P2455, DOI 10.1007/s007050170015; Naqvi AR, 2011, VIRUS RES, V160, P395, DOI 10.1016/j.virusres.2011.05.002; Nishino H, 2002, CANCER METAST REV, V21, P257, DOI 10.1023/A:1021206826750; Palomares O, 2005, CLIN EXP ALLERGY, V35, P345, DOI 10.1111/j.1365-2222.2004.02186.x; Pastorello EA, 2004, MOL NUTR FOOD RES, V48, P356, DOI 10.1002/mnfr.200400047; Puthoff DP, 2010, J CHEM ECOL, V36, P1271, DOI 10.1007/s10886-010-9868-1; Quintero C, 2011, J CHEM ECOL, V37, P992, DOI 10.1007/s10886-011-0007-4; Riccioni G, 2009, CURR ATHEROSCLER REP, V11, P434, DOI 10.1007/s11883-009-0065-z; Schwarz D, 2010, PLANT PATHOL, V59, P443, DOI 10.1111/j.1365-3059.2009.02229.x; Schwarz D, 2011, MYCORRHIZA, V21, P341, DOI 10.1007/s00572-010-0345-z; Spence NJ, 2006, PLANT PATHOL, V55, P595, DOI 10.1111/j.1365-3059.2006.01406.x; van der Vlugt R A A, 2000, Plant Dis, V84, P103, DOI 10.1094/PDIS.2000.84.1.103C; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Weangsripanaval T, 2003, BIOSCI BIOTECH BIOCH, V67, P1299, DOI 10.1271/bbb.67.1299; Whitley D, 1999, J VASC SURG, V29, P748, DOI 10.1016/S0741-5214(99)70329-0; Worm M, 2012, ALLERGY, V67, P691, DOI 10.1111/j.1398-9995.2012.02795.x; Worm M, 2009, CLIN EXP ALLERGY, V39, P159, DOI 10.1111/j.1365-2222.2008.03143.x; Yang JW, 2011, J ECOL, V99, P46, DOI 10.1111/j.1365-2745.2010.01756.x; Zeier J, 2005, PHYSIOL MOL PLANT P, V66, P30, DOI 10.1016/j.pmpp.2005.03.007; Zhu Z, 2012, SCI HORTIC-AMSTERDAM, V142, P38, DOI 10.1016/j.scienta.2012.05.002	50	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65116	10.1371/journal.pone.0065116	http://dx.doi.org/10.1371/journal.pone.0065116			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762294	Green Published, gold, Green Submitted			2022-12-27	WOS:000321094800019
J	Youngchim, S; Nosanchuk, JD; Pornsuwan, S; Kajiwara, S; Vanittanakom, N				Youngchim, Sirida; Nosanchuk, Joshua D.; Pornsuwan, Soraya; Kajiwara, Susumu; Vanittanakom, Nongnuch			The Role of L-DOPA on Melanization and Mycelial Production in Malassezia Furfur	PLOS ONE			English	Article							CONIDIAL PIGMENT BIOSYNTHESIS; MELANIN-LIKE PIGMENTS; SPECIES IN-VITRO; ASPERGILLUS-FUMIGATUS; CRYPTOCOCCUS-NEOFORMANS; PITYROSPORUM-ORBICULARE; MAMMALIAN INFECTION; CYTOKINE PRODUCTION; TINEA VERSICOLOR; STRATUM-CORNEUM	Melanins are synthesized by organisms of all biological kingdoms and comprise a heterogeneous class of natural pigments. Certain of these polymers have been implicated in the pathogenesis of several important human fungal pathogens. This study investigated whether the fungal skin pathogen Malassezia furfur produces melanin or melanin-like compounds. A melanin-binding monoclonal antibody (MAb) labelled in vitro cultivated yeast cells of M. furfur. In addition, melanization of Malassezia yeasts and hyphae was detected by anti-melanin MAb in scrapings from patients with pityriasis versicolor. Treatment of Malassezia yeasts with proteolytic enzymes, denaturant and concentrated hot acid yielded dark particles and electron spin resonance spectroscopy revealed that these particles contained a stable free radical compound, consistent with their identification as melanins. Malassezia yeasts required phenolic compounds, such as L-DOPA, in order to synthesize melanin. L-DOPA also triggered hyphal formation in vitro when combined with kojic acid, a tyrosinase inhibitor, in a dose-dependent manner. In this respect, L-DOPA is thought to be an essential substance that is linked to both melanization and yeast-mycelial transformation in M. furfur. In summary, M. furfur can produce melanin or melanin-like compounds in vitro and in vivo, and the DOPA melanin pathway is involved in cell wall melanization.	[Youngchim, Sirida; Vanittanakom, Nongnuch] Chiang Mai Univ, Fac Med, Dept Microbiol, Chiang Mai 50000, Thailand; [Nosanchuk, Joshua D.] Albert Einstein Coll Med, Dept Med Infect Dis, Bronx, NY 10467 USA; [Nosanchuk, Joshua D.] Albert Einstein Coll Med, Dept Microbiol Immunol, Bronx, NY 10467 USA; [Pornsuwan, Soraya] Mahidol Univ, Fac Sci, Dept Phys Chem, Bangkok 10400, Thailand; [Kajiwara, Susumu] Tokyo Inst Technol, Dept Life Sci, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan	Chiang Mai University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Mahidol University; Tokyo Institute of Technology	Youngchim, S (corresponding author), Chiang Mai Univ, Fac Med, Dept Microbiol, Chiang Mai 50000, Thailand.	syoungchim@gmail.com	KAJIWARA, SUSUMU/D-3405-2014; Nosanchuk, Joshua/AAS-7801-2021	KAJIWARA, SUSUMU/0000-0001-6732-5043; 	Research Fund of Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; NIH [AI52733]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052733] Funding Source: NIH RePORTER	Research Fund of Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Research Fund of Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand. JDN is partially supported by NIH AI52733. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affes M, 2009, MYCOSES, V52, P251, DOI 10.1111/j.1439-0507.2008.01589.x; Brunke S, 2006, MICROBIOL-SGM, V152, P547, DOI 10.1099/mic.0.28501-0; Casadevall A, 2000, CURR OPIN MICROBIOL, V3, P354, DOI 10.1016/S1369-5274(00)00103-X; Chee Hee Youn, 2003, Mycobiology, V31, P248; Crespo-Erchiga V, 2006, CURR OPIN INFECT DIS, V19, P139, DOI 10.1097/01.qco.0000216624.21069.61; Crowe JD, 2001, APPL ENVIRON MICROB, V67, P2088, DOI 10.1128/AEM.67.5.2088-2094.2001; Dadachova E, 2008, PIGM CELL MELANOMA R, V21, P192, DOI 10.1111/j.1755-148X.2007.00430.x; DeAngelis YM, 2007, J INVEST DERMATOL, V127, P2138, DOI 10.1038/sj.jid.5700844; DORN M, 1977, J INVEST DERMATOL, V69, P244, DOI 10.1111/1523-1747.ep12506384; Eisenhofer G, 2003, FASEB J, V17, P1248, DOI 10.1096/fj.02-0736com; EL-KHADEM M, 1976, Zentralblatt fuer Bakteriologie Parasitenkunde Infektionskrankheiten und Hygiene Zweite Naturwissenschaftliche Abteilung Allgemeine Landwirtschaftliche und Technische Mikrobiologie, V131, P497; ENOCHS WS, 1993, PIGM CELL RES, V6, P91, DOI 10.1111/j.1600-0749.1993.tb00587.x; FAERGEMANN J, 1989, J INVEST DERMATOL, V92, P117, DOI 10.1111/1523-1747.ep13071328; FAERGEMANN J, 1981, J INVEST DERMATOL, V77, P314, DOI 10.1111/1523-1747.ep12482488; Faergemann J, 1981, SABOURAUDIA, V19, P171; Falck B, 2003, EXP DERMATOL, V12, P602, DOI 10.1034/j.1600-0625.2003.00019.x; Gaitanis G, 2005, J CLIN MICROBIOL, V43, P4147, DOI 10.1128/JCM.43.8.4147-4151.2005; Gueho E, 1996, ANTON LEEUW INT J G, V69, P337, DOI 10.1007/BF00399623; Guillot J, 1998, J VET DIAGN INVEST, V10, P384, DOI 10.1177/104063879801000418; Gupta AK, 2000, J CLIN MICROBIOL, V38, P1869, DOI 10.1128/JCM.38.5.1869-1875.2000; Gupta AK, 2003, CLIN DERMATOL, V21, P417, DOI 10.1016/j.clindermatol.2003.08.003; Hamilton AJ, 2002, J MED MICROBIOL, V51, P189, DOI 10.1099/0022-1317-51-3-189; Jahn B, 1997, INFECT IMMUN, V65, P5110, DOI 10.1128/IAI.65.12.5110-5117.1997; Kahn V, 1995, PIGM CELL RES, V8, P234, DOI 10.1111/j.1600-0749.1995.tb00669.x; Kesavan S, 1998, MED MYCOL, V36, P97, DOI 10.1080/02681219880000161; Kesavan S, 2000, MED MYCOL, V38, P239, DOI 10.1080/714030945; KWONCHUNG KJ, 1981, J CLIN MICROBIOL, V13, P383, DOI 10.1128/JCM.13.2.383-387.1981; Langfelder K, 1998, MED MICROBIOL IMMUN, V187, P79, DOI 10.1007/s004300050077; LEEMING JP, 1989, J APPL BACTERIOL, V67, P47, DOI 10.1111/j.1365-2672.1989.tb04953.x; MARINARO RE, 1978, J CUTAN PATHOL, V5, P15, DOI 10.1111/j.1600-0560.1978.tb00932.x; Mayser P, 2004, MYCOSES, V47, P34, DOI 10.1046/j.1439-0507.2003.00957.x; Mayser P, 1998, ANTON LEEUW INT J G, V73, P315, DOI 10.1023/A:1001500310537; Mayser P, 1998, MYCOSES, V41, P265, DOI 10.1111/j.1439-0507.1998.tb00336.x; MONTES LF, 1970, J AMER MED ASSOC, V213, P1469, DOI 10.1001/jama.213.9.1469; Morris-Jones R, 2003, INFECT IMMUN, V71, P4026, DOI 10.1128/IAI.71.7.4026-4033.2003; NAZZAROPORRO M, 1978, J INVEST DERMATOL, V71, P205, DOI 10.1111/1523-1747.ep12547184; Nosanchuk JD, 2000, LANCET, V355, P2049, DOI 10.1016/S0140-6736(00)02356-4; Nosanchuk JD, 1998, J IMMUNOL, V160, P6026; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; Nosanchuk JD, 2002, INFECT IMMUN, V70, P5124, DOI 10.1128/IAI.70.9.5124-5131.2002; Nosanchuk JD, 2006, ANTIMICROB AGENTS CH, V50, P3519, DOI 10.1128/AAC.00545-06; Rosas AL, 2000, INFECT IMMUN, V68, P2845, DOI 10.1128/IAI.68.5.2845-2853.2000; Shibata N, 2006, FEMS MICROBIOL LETT, V256, P137, DOI 10.1111/j.1574-6968.2006.00106.x; SRINIVASAN C, 1995, APPL ENVIRON MICROB, V61, P4274, DOI 10.1128/AEM.61.12.4274-4277.1995; Tarazooie B., 2004, BMC DERMATOL, V1, P4; Thomas DS, 2008, FEMS IMMUNOL MED MIC, V54, P203, DOI 10.1111/j.1574-695X.2008.00468.x; TOSTI A, 1972, J INVEST DERMATOL, V59, P233, DOI 10.1111/1523-1747.ep12627257; Tsai HF, 1999, J BACTERIOL, V181, P6469, DOI 10.1128/JB.181.20.6469-6477.1999; Tsai HF, 1998, J BACTERIOL, V180, P3031, DOI 10.1128/JB.180.12.3031-3038.1998; Wang Y, 1996, J BACTERIOL, V176, P656; Wheeler M H, 1988, Curr Top Med Mycol, V2, P338; Youngchim S, 2005, MICROBIOL-SGM, V151, P291, DOI 10.1099/mic.0.27433-0; Youngchim S, 2004, J MED MICROBIOL, V53, P175, DOI 10.1099/jmm.0.05421-0; Youngchim S, 2011, MICROBIOL-SGM, V157, P2348, DOI 10.1099/mic.0.047928-0	54	16	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e63764	10.1371/journal.pone.0063764	http://dx.doi.org/10.1371/journal.pone.0063764			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762233	Green Submitted, Green Published, gold			2022-12-27	WOS:000321094800003
J	Yue, GF; Wei, J; Qian, XP; Yu, LX; Zou, ZY; Guan, WX; Wang, H; Shen, J; Liu, BR				Yue, Guofeng; Wei, Jia; Qian, Xiaoping; Yu, Lixia; Zou, Zhengyun; Guan, Wenxian; Wang, Hao; Shen, Jie; Liu, Baorui			Synergistic Anticancer Effects of Polyphyllin I and Evodiamine on Freshly-Removed Human Gastric Tumors	PLOS ONE			English	Article							THYMIDYLATE SYNTHASE GENE; MESSENGER-RNA EXPRESSION; DRUG RESPONSE ASSAY; PROTEIN EXPRESSION; GROWTH-INHIBITION; CANCER PATIENTS; MITOTIC ARREST; LUNG-CANCER; APOPTOSIS; CELLS	Objective: The present study was designed to examine the anticancer effect of Traditional Chinese Medicine of polyphyllin I (PPI) and evodiamine (EVO) on freshly-removed gastric tumor tissues. Methods: Sixty freshly-removed gastric tumor tissues were collected. Their sensitivity to PPI, EVO, platinum (Pt), 5-FU, irinotecan (CPT-11) were determined by histoculture drug response assay (HDRA). Those samples were also formalin-fixed and paraffin-embedded, which were used to examine the mRNA expression levels of aprataxin(APTX), excision repair cross-complementing 1(ERCC1), thymidylate synthase(TS) and topoisomerase I(TOPO1) by quantitative RT-PCR. The association of the gene expression levels and in vitro sensitivity were analyzed. Results: PPI, EVO, Pt, 5-FU and CPT-11 had anticancer effects on the freshly-removed gastric tumor tissues with average inhibition rates of 20.64%+/-14.25% for PPI, 21.14%+/-13.43% for EVO, 50.57%+/-22.37% for Pt, 53.54%+/-22.03% for 5-FU, and 39.33%+/-24.79% for CPT-11, respectively. Combination of PPI and Pt, EVO and Pt, EVO and 5-FU had higher inhibition rates than any single drug of them (P<0.001, P = 0.028, P = 0.017, respectively). The mRNA expression levels of ERCC1 were correlated with Pt sensitivity (rho = -0.645, P<0.001); the mRNA expression levels of TS were correlated with 5-FU sensitivity (rho = -0.803, P<0.001). There were also weak but significant correlations between APTX mRNA expression levels and CPT-11 sensitivity (rho = -0.376, P = 0.017) or EVO sensitivity (rho = -0.322, P = 0.036). ERCC1 mRNA expression levels was markedly suppressed by the presentation of PPI (P = 0.001) and slightly suppressed by the presentation of EVO (P = 0.04); whereas, TS mRNA expression levels was markedly decreased by the presentation of EVO (P = 0.017) and slightly decreased by the presentation of PPI (P = 0.047). Conclusion: PPI and EVO both could inhibit the activity of freshly-removed gastric tumor, and they could enhance the anticancer effect of Pt and 5-FU by reducing the mRNA expression levels of ERCC1 and TS.	[Yue, Guofeng; Wei, Jia; Qian, Xiaoping; Yu, Lixia; Zou, Zhengyun; Shen, Jie; Liu, Baorui] Nanjing Univ Chinese Med, Drum Tower Clin Med Coll, Ctr Comprehens Canc, Nanjing, Jiangsu, Peoples R China; [Wei, Jia; Qian, Xiaoping; Yu, Lixia; Zou, Zhengyun; Shen, Jie; Liu, Baorui] Nanjing Univ, Clin Canc Inst, Sch Med, Drum Tower Hosp,Comprehens Canc Ctr, Nanjing 210008, Jiangsu, Peoples R China; [Guan, Wenxian; Wang, Hao] Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Surg, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine; Nanjing University; Nanjing University	Shen, J (corresponding author), Nanjing Univ Chinese Med, Drum Tower Clin Med Coll, Ctr Comprehens Canc, Nanjing, Jiangsu, Peoples R China.	shenjie2008nju@163.com; baoruiliu@nju.edu.cn	Wei, Jia/AAE-9973-2020		National Natural Science Foundation of China [81172094]; Top Six Talents Project of Jiangsu Province [2011ws005]; Medical Science and Technology Development Projects of Nanjing [ZKX10011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Top Six Talents Project of Jiangsu Province; Medical Science and Technology Development Projects of Nanjing	Supported by grants from the National Natural Science Foundation of China (Grant No. 81172094), Top Six Talents Project of Jiangsu Province (Grant No. 2011ws005), and Medical Science and Technology Development Projects of Nanjing (Grant No. ZKX10011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2007, PLANTA MED, V73, P1554, DOI 10.1055/s-2007-993743; Ariyoshi Y, 2003, ORAL ONCOL, V39, P701, DOI 10.1016/S1368-8375(03)00082-4; Bathe OF, 1999, CANCER J SCI AM, V5, P34; Cascinu S, 1999, CLIN CANCER RES, V5, P1996; Cecere F, 2006, NEW ENGL J MED, V355, P2590; Chan ALF, 2009, MOLECULES, V14, P1342, DOI 10.3390/molecules14041342; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Dopeso H, 2010, CLIN CANCER RES, V16, P2375, DOI 10.1158/1078-0432.CCR-09-3275; Fujita Y, 2009, ONCOL REP, V21, P499, DOI 10.3892/or_00000250; FURUKAWA T, 1995, CLIN CANCER RES, V1, P305; Hasegawa Y, 2007, ORAL ONCOL, V43, P749, DOI 10.1016/j.oraloncology.2006.09.003; Huang DM, 2005, J UROLOGY, V173, P256, DOI 10.1097/01.ju.0000141587.72429.e3; Huang YC, 2004, LIFE SCI, V75, P35, DOI 10.1016/j.lfs.2003.11.025; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; JOHNSTON PG, 1995, CANCER RES, V55, P1407; Kong MJ, 2010, ACTA BIOCH BIOPH SIN, V42, P827, DOI 10.1093/abbs/gmq091; Lee MS, 2005, CANCER BIOL THER, V4, P1248, DOI 10.4161/cbt.4.11.2136; Lenz HJ, 1996, J CLIN ONCOL, V14, P176, DOI 10.1200/JCO.1996.14.1.176; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Margeli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009499; MILLER BE, 1984, J CELL PHYSIOL, P105; Ong RCY, 2008, CANCER LETT, V261, P158, DOI 10.1016/j.canlet.2007.11.005; Pan XB, 2012, PHYTOMEDICINE, V19, P618, DOI 10.1016/j.phymed.2012.02.003; Rosell R, 2004, CLIN CANCER RES, V10, p4215S, DOI 10.1158/1078-0432.CCR-040006; Shen J, 2012, INT J CANCER, V131, pE938, DOI 10.1002/ijc.27530; Sun J, 2007, PHYTOTHER RES, V21, P1102, DOI 10.1002/ptr.2196; Tanino H, 2001, ANTICANCER RES, V21, P4083; Wagner AD, 2006, J CLIN ONCOL, V24, P2903, DOI 10.1200/JCO.2005.05.0245; Wei J, 2008, BRIT J CANCER, V98, P1398, DOI 10.1038/sj.bjc.6604317; Wei J, 2011, J NATL CANCER I, V103, P1552, DOI 10.1093/jnci/djr326; Zhang Y, 2004, J ASIAN NAT PROD RES, V6, P19, DOI 10.1080/1028602031000119772; Zhang Y, 2003, BIOL PHARM BULL, V26, P1543, DOI 10.1248/bpb.26.1543	33	40	46	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65164	10.1371/journal.pone.0065164	http://dx.doi.org/10.1371/journal.pone.0065164			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762305	Green Published, gold, Green Submitted			2022-12-27	WOS:000321094800021
J	Juvet, SC; Thomson, CW; Kim, EY; Han, M; Zhang, L				Juvet, Stephen C.; Thomson, Christopher W.; Kim, Edward Y.; Han, Mei; Zhang, Li			FcR gamma Controls the Fas-Dependent Regulatory Function of Lymphoproliferative Double Negative T Cells	PLOS ONE			English	Article							CARDIAC ALLOGRAFT SURVIVAL; NATURAL-KILLER-CELLS; CD95 CO-STIMULATION; VERSUS-HOST-DISEASE; EPSILON-RI-GAMMA; LPR LPR MICE; ZETA-CHAIN; SURFACE EXPRESSION; LUPUS NEPHRITIS; NK CELLS	Patients with autoimmune lymphoproliferative syndrome (ALPS) and lymphoproliferation (LPR) mice are deficient in Fas, and accumulate large numbers of alpha beta-TCR+, CD4(-), CD8(-) double negative (DN) T cells. The function of these DN T cells remains largely unknown. The common gamma subunit of the activating Fc receptors, FcR gamma, plays an important role in mediating innate immune responses. We have shown previously that a significant proportion of DN T cells express FcR gamma, and that this molecule is required for TCR transgenic DN T cells to suppress allogeneic immune responses. Whether FcR gamma plays a critical role in LPR DN T cell-mediated suppression of immune responses to auto and allo-antigens is not known. Here, we demonstrated that FcR gamma(+), but not FcR gamma(-) LPR DN T cells could suppress Fas(+) CD4(+) and CD8(+) T cell proliferation in vitro and attenuated CD4(+) T cell-mediated graft-versus host disease. Although FcR gamma expression did not allow LPR DN T cells to inhibit the expansion of Fas-deficient cells within the LPR context, adoptive transfer of FcR gamma(+), but not FcR gamma(-), DN T cells inhibited lymphoproliferation in generalized lymphoproliferative disease (GLD) mice. Furthermore, FcR gamma acted in a cell-intrinsic fashion to limit DN T cell accumulation by increasing the rate of apoptosis in proliferated cells. These results indicate that FcR gamma can confer Fas-dependent regulatory properties on LPR DN T cells, and suggest that FcR gamma may be a novel marker for functional DN Tregs.	[Juvet, Stephen C.; Zhang, Li] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Juvet, Stephen C.] Univ Toronto, Dept Med, Univ Hlth Network, Div Respirol, Toronto, ON, Canada; [Juvet, Stephen C.] Univ Toronto, Dept Med, Univ Hlth Network, Toronto Lung Transplant Program, Toronto, ON, Canada; [Juvet, Stephen C.] Univ Toronto, Dept Med, Clinician Scientist Training Program, Toronto, ON, Canada; [Thomson, Christopher W.; Kim, Edward Y.; Han, Mei; Zhang, Li] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Zhang, Li] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Juvet, Stephen C.; Thomson, Christopher W.; Kim, Edward Y.; Han, Mei; Zhang, Li] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Zhang, L (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.	lzhang@uhnres.utoronto.ca		Juvet, Stephen/0000-0002-7243-556X	Canadian Institutes of Health Research [MOP-14431]; Canadian Cancer Society [020516]; Clinician-Scientist Training Program, Department of Medicine, University of Toronto	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Clinician-Scientist Training Program, Department of Medicine, University of Toronto	This work was funded by the Canadian Institutes of Health Research (grant number MOP-14431) and Canadian Cancer Society ( grant number 020516). S.C.J. received salary support from the Clinician-Scientist Training Program, Department of Medicine, University of Toronto. L.Z. is the Maria H. Bacardi Chair in Transplantation at the University Health Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZZONI L, 1995, J IMMUNOL, V154, P491; Bossi G, 1999, NAT MED, V5, P90, DOI 10.1038/4779; Chen W, 2003, TRANSPL P, V35, P2479, DOI 10.1016/j.transproceed.2003.08.030; CHU JL, 1995, J EXP MED, V181, P393, DOI 10.1084/jem.181.1.393; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; DAVIDSON WF, 1986, J IMMUNOL, V136, P4075; Eischen CM, 1996, J IMMUNOL, V156, P2693; Enyedy EJ, 2001, ARTHRITIS RHEUM, V44, P1114, DOI 10.1002/1529-0131(200105)44:5<1114::AID-ANR192>3.0.CO;2-B; Fischer K, 2005, BLOOD, V105, P2828, DOI 10.1182/blood-2004-07-2583; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Ford MS, 2002, J EXP MED, V196, P261, DOI 10.1084/jem.20020029; Gao JF, 2011, EUR J IMMUNOL; Gonzalez-Quintial R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027528; Gupta S, 2012, J CLIN INVEST, V122, P2395, DOI 10.1172/JCI45138; Hamad ARA, 2003, J IMMUNOL, V171, P2421, DOI 10.4049/jimmunol.171.5.2421; Hastings WD, 2009, EUR J IMMUNOL, V39, P2492, DOI 10.1002/eji.200939274; HILLHOUSE EE, 2012, J AUTOIMMUN, P45237; JEVNIKAR AM, 1994, J EXP MED, V179, P1137, DOI 10.1084/jem.179.4.1137; Juvet SC, 2013, J AUTOIMMUN IN PRESS; Juvet SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047732; Juvet SC, 2012, J MOL CELL BIOL, V4, P48, DOI 10.1093/jmcb/mjr043; KAKKANAIAH VN, 1990, CELL IMMUNOL, V127, P442, DOI 10.1016/0008-8749(90)90145-H; KLINMAN DM, 1990, J IMMUNOL, V144, P506; Krishnan S, 2003, J IMMUNOL, V170, P4189, DOI 10.4049/jimmunol.170.8.4189; Kyttaris VC, 2010, J IMMUNOL, V184, P4605, DOI 10.4049/jimmunol.0903595; Lee BPL, 2005, J IMMUNOL, V174, P4535, DOI 10.4049/jimmunol.174.8.4535; LETTAU M, 2004, SIGNAL TRANSDUCT, V4, P206, DOI DOI 10.1002/SITA.200400037; MERINO R, 1995, J AUTOIMMUN, V8, P33, DOI 10.1006/jaut.1995.0003; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Nambiar MP, 2003, J IMMUNOL, V170, P2871, DOI 10.4049/jimmunol.170.6.2871; Nimmerjahn F, 2007, ADV IMMUNOL, V96, P179, DOI 10.1016/S0065-2776(07)96005-8; OHNO H, 1993, INT IMMUNOL, V5, P1403, DOI 10.1093/intimm/5.11.1403; OHNO H, 1994, J EXP MED, V179, P365, DOI 10.1084/jem.179.1.365; Okoye FI, 2007, CLIN IMMUNOL, V125, P5, DOI 10.1016/j.clim.2007.07.002; ORLOFF DG, 1990, NATURE, V347, P189, DOI 10.1038/347189a0; ORTALDO JR, 1995, J EXP MED, V181, P339, DOI 10.1084/jem.181.1.339; PARK SY, 1995, EUR J IMMUNOL, V25, P2107, DOI 10.1002/eji.1830250746; Paulsen M, 2011, CELL DEATH DIFFER, V18, P619, DOI 10.1038/cdd.2010.134; RODEWALD HR, 1991, J BIOL CHEM, V266, P15974; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Shores E, 1997, J IMMUNOL, V159, P222; Strauss G, 2009, J EXP MED, V206, P1379, DOI 10.1084/jem.20082363; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Thomson CW, 2006, J IMMUNOL, V177, P2250, DOI 10.4049/jimmunol.177.4.2250; Voelkl S, 2011, EUR J IMMUNOL, V41, P739, DOI 10.1002/eji.201040982; WATANABE D, 1995, EMBO J, V14, P12, DOI 10.1002/j.1460-2075.1995.tb06970.x; Young KJ, 2003, J IMMUNOL, V171, P134, DOI 10.4049/jimmunol.171.1.134; Young KJ, 2002, BLOOD, V100, P3408, DOI 10.1182/blood-2002-01-0235; Zhang Z, 2009, J IMMUNOL, V183, P3160, DOI 10.4049/jimmunol.0900385; Zhang ZX, 2000, NAT MED, V6, P782, DOI 10.1038/77513	50	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65253	10.1371/journal.pone.0065253	http://dx.doi.org/10.1371/journal.pone.0065253			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762329	Green Published, gold, Green Submitted			2022-12-27	WOS:000321099000050
J	Li, YG; Ji, DF; Zhong, S; Lv, ZQ; Lin, TB				Li, You-Gui; Ji, Dong-Feng; Zhong, Shi; Lv, Zhi-Qiang; Lin, Tian-Bao			Cooperative Anti-Diabetic Effects of Deoxynojirimycin-Polysaccharide by Inhibiting Glucose Absorption and Modulating Glucose Metabolism in Streptozotocin-Induced Diabetic Mice	PLOS ONE			English	Article							CARBOHYDRATE-METABOLISM; KEY ENZYMES; NA+/GLUCOSE COTRANSPORTER; MECHANISMS; EXPRESSION; TISSUES; CORTEX; RATS	We had previously shown that deoxynojirimycin-polysaccharide mixture (DPM) not only decreased blood glucose but also reversed the damage to pancreatic beta-cells in diabetic mice, and that the anti-hyperglycemic efficacy of this combination was better than that of 1-deoxynojirimycin (DNJ) or polysachharide alone. However, the mechanisms behind these effects were not fully understood. The present study aimed to evaluate the therapeutic effects of DPM on streptozotocin (STZ)-induced diabetic symptoms and their potential mechanisms. Diabetic mice were treated with DPM (150 mg/kg body weight) for 90 days and continued to be fed without DPM for an additional 30 days. Strikingly, decrease of blood glucose levels was observed in all DPM treated diabetic mice, which persisted 30 days after cessation of DPM administration. Significant decrease of glycosylated hemoglobin and hepatic pyruvate concentrations, along with marked increase of serum insulin and hepatic glycogen levels were detected in DPM treated diabetic mice. Results of a labeled C-13(6)-glucose uptake assay indicated that DPM can restrain glucose absorption. Additionally, DPM down-regulated the mRNA and protein expression of jejunal Na+/glucose cotransporter, Na+/K+-ATPase and glucose transporter 2, and enhanced the activities as well as mRNA and protein levels of hepatic glycolysis enzymes (glucokinase, phosphofructokinase, private kinase and pyruvate decarboxylas E1). Activity and expression of hepatic gluconeogenesis enzymes (phosphoenolpyruvate carboxykinase and glucose-6-phosphatase) were also found to be attenuated in diabetic mice treated with DPM. Purified enzyme activity assays verified that the increased activities of glucose glycolysis enzymes resulted not from their direct activation, but from the relative increase in protein expression. Importantly, our histopathological observations support the results of our biochemical analyses and validate the protective effects of DPM on STZ-induced damage to the pancreas. Thus, DPM has significant potential as a therapeutic agent against diabetes.	[Li, You-Gui; Ji, Dong-Feng; Zhong, Shi; Lv, Zhi-Qiang; Lin, Tian-Bao] Zhejiang Acad Agr Sci, Sericultural Res Inst, Hangzhou, Zhejiang, Peoples R China	Zhejiang Academy of Agricultural Sciences	Ji, DF (corresponding author), Zhejiang Acad Agr Sci, Sericultural Res Inst, Hangzhou, Zhejiang, Peoples R China.	dongfeng_ji@126.com			earmarked fund for Modern Agro-industry Technology Research System of China; Science and Technology Department of Zhejiang Province [2011C220621/4CE2012C12910]; Natural Science Foundation of Zhejiang Province [LQ12H31002]; Zhejiang Sericultural Sci-Tech Innovation Team [2011R50028]	earmarked fund for Modern Agro-industry Technology Research System of China; Science and Technology Department of Zhejiang Province; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Zhejiang Sericultural Sci-Tech Innovation Team	This study was supported by the earmarked fund for Modern Agro-industry Technology Research System of China, by Science and Technology Department of Zhejiang Province (2011C220621/4CE2012C12910), by the Natural Science Foundation of Zhejiang Province (LQ12H31002) and by the Zhejiang Sericultural Sci-Tech Innovation Team (2011R50028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS42; Andallu B, 2001, CLIN CHIM ACTA, V314, P47, DOI 10.1016/S0009-8981(01)00632-5; Asano T, 2004, CURR MED CHEM, V11, P2717, DOI 10.2174/0929867043364360; Asgary S, 1999, Pharm Acta Helv, V73, P223, DOI 10.1016/S0031-6865(98)00025-9; Baldea LAN, 2010, J ETHNOPHARMACOL, V132, P473, DOI 10.1016/j.jep.2010.07.055; Berendzen K, 2006, MITOCHONDRION, V6, P126, DOI 10.1016/j.mito.2006.04.001; Bouche C, 2004, ENDOCR REV, V25, P807, DOI 10.1210/er.2003-0026; Boyer S, 1996, FEBS LETT, V396, P218, DOI 10.1016/0014-5793(96)01102-7; Burns N, 2007, TOXICOL SCI, V95, P391, DOI 10.1093/toxsci/kfl164; Drozdowski LA, 2006, WORLD J GASTROENTERO, V12, P1657, DOI 10.3748/wjg.v12.i11.1657; Ducroc R, 2007, DIABETES, V56, P2494, DOI 10.2337/db07-0614; Feksa LR, 2005, INT J DEV NEUROSCI, V23, P509, DOI 10.1016/j.ijdevneu.2005.06.002; Fu JF, 2012, CARBOHYD POLYM, V87, P2327, DOI 10.1016/j.carbpol.2011.10.068; Giaccari A, 2009, NUTR METAB CARDIOVAS, V19, P365, DOI 10.1016/j.numecd.2009.03.018; Ito M, 2001, ENVIRON TOXICOL PHAR, V9, P71, DOI 10.1016/S1382-6689(00)00064-8; Klover PJ, 2004, INT J BIOCHEM CELL B, V36, P753, DOI 10.1016/j.biocel.2003.10.002; KOIDE H, 1959, CLIN CHIM ACTA, V4, P554; Kuriyama C, 2008, BIOORGAN MED CHEM, V16, P7330, DOI 10.1016/j.bmc.2008.06.026; Lei H, 2013, CARBOHYD POLYM, V92, P1211, DOI 10.1016/j.carbpol.2012.10.037; Li JM, 2006, INT J BIOCHEM CELL B, V38, P985, DOI 10.1016/j.biocel.2005.10.002; Li YG, 2011, J ETHNOPHARMACOL, V134, P961, DOI 10.1016/j.jep.2011.02.009; [李有贵 Li Yougui], 2010, [蚕业科学, Acta Sericologica Sinica], V36, P885; Mohammad S, 2004, CLIN CHIM ACTA, V342, P105, DOI 10.1016/j.cccn.2003.12.005; Naowaboot J., 2006, NUTR RES, V29, P602; Ozeki T, 1999, COMP BIOCHEM PHYS B, V124, P327, DOI 10.1016/S0305-0491(99)00127-3; Palsamy P, 2009, CHEM-BIOL INTERACT, V179, P356, DOI 10.1016/j.cbi.2008.11.008; Pari L, 2010, BIOMED PHARMACOTHER, V64, P477, DOI 10.1016/j.biopha.2010.02.001; Pederson BA, 2005, DIABETES, V54, P3466, DOI 10.2337/diabetes.54.12.3466; Prasath GS, 2011, EUR J PHARMACOL, V668, P492, DOI 10.1016/j.ejphar.2011.07.021; Robinson B.H., 1995, METABOLIC MOL BASES, P1479; Sundaram R, 2012, EUR J PHARMACOL, V674, P460, DOI 10.1016/j.ejphar.2011.10.039; Ugochukwu NH, 2006, PHARMACOL RES, V54, P172, DOI 10.1016/j.phrs.2006.04.004; Vats V, 2003, J ETHNOPHARMACOL, V85, P237, DOI 10.1016/S0378-8741(03)00022-9; Wild GE, 1997, J NUTR BIOCHEM, V8, P673, DOI 10.1016/S0955-2863(97)00118-6; Winchester BG, 2009, TETRAHEDRON ASYMMETR; Xue SX, 2009, CARBOHYD POLYM, V75, P415, DOI 10.1016/j.carbpol.2008.08.003; Zhang XM, 2009, BIOMED PHARMACOTHER, V63, P180, DOI 10.1016/j.biopha.2007.07.006; Zheng Y, 2012, SURGERY, V151, P13, DOI 10.1016/j.surg.2011.07.010; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	39	18	23	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65892	10.1371/journal.pone.0065892	http://dx.doi.org/10.1371/journal.pone.0065892			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755289	gold, Green Submitted, Green Published			2022-12-27	WOS:000321099000117
J	Handford, C; Lemon, J; Grimm, MC; Vollmer-Conna, U				Handford, Cameron; Lemon, Jim; Grimm, Michael C.; Vollmer-Conna, Ute			Empathy as a Function of Clinical Exposure - Reading Emotion in the Eyes	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; ASPERGER-SYNDROME; DECLINE; BEHAVIOR; ADULTS	Background: Evidence based largely on self-report data suggests that factors associated with medical education erode the critical human quality of empathy. These reports have caused serious concern among medical educators and clinicians and have led to changes in medical curricula around the world. This study aims to provide a more objective index of possible changes in empathy across the spectrum of clinical exposure, by using a behavioural test of empathic accuracy in addition to self-report questionnaires. Moreover, non-medical groups were used to control for maturation effects. Methods: Three medical groups (N = 3x20) representing a spectrum of clinical exposure, and two non-medical groups (N = 2x20) matched for age, sex and educational achievements completed self-report measures of empathy, and tests of empathic accuracy and interoceptive sensitivity. Results: Between-group differences in reported empathy related to maturation rather than clinical training/exposure. Conversely, analyses of the "eyes'' test results specifically identified clinical practice, but not medical education, as the key influence on performance. The data from the interoception task did not support a link between visceral feedback and empathic processes. Conclusions: Clinical practice, but not medical education, impacts on empathy development and seems instrumental in maintaining empathetic skills against the general trend of declining empathic accuracy with age.	[Handford, Cameron; Lemon, Jim; Vollmer-Conna, Ute] Univ NSW, Sch Psychiat, Sydney, NSW, Australia; [Grimm, Michael C.] Univ NSW, St George Clin Sch, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Vollmer-Conna, U (corresponding author), Univ NSW, Sch Psychiat, Sydney, NSW, Australia.	ute@unsw.edu.au		Grimm, Michael/0000-0001-9426-3917				Adams RB, 2010, J COGNITIVE NEUROSCI, V22, P97, DOI 10.1162/jocn.2009.21187; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Barrett L.F., 2002, WISDOM FEELING PSYCH; Bellini LM, 2005, ACAD MED, V80, P164, DOI 10.1097/00001888-200502000-00013; Chen D, 2007, J GEN INTERN MED, V22, P1434, DOI 10.1007/s11606-007-0298-x; Chen DCR, 2010, J GEN INTERN MED, V25, P200, DOI 10.1007/s11606-009-1193-4; Colliver JA, 2010, ACAD MED, V85, P588, DOI 10.1097/ACM.0b013e3181d281dc; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2009, INT J PSYCHOPHYSIOL, V73, P88, DOI 10.1016/j.ijpsycho.2009.01.012; Darwin C., 2002, EXPRESSION EMOTIONS; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; EISENBERG N, 1994, J PERS SOC PSYCHOL, V66, P776, DOI 10.1037/0022-3514.66.4.776; Ekman P, 2009, PHILOS T R SOC B, V364, P3449, DOI 10.1098/rstb.2009.0189; Eysenck H.J., 1964, MANUAL EYSENCK PERSO, DOI DOI 10.1007/SPRINGERREFERENCE_184643; Fabes RA, 1999, J EARLY ADOLESCENCE, V19, P5, DOI 10.1177/0272431699019001001; Fukushima H, 2011, INT J PSYCHOPHYSIOL, V79, P259, DOI 10.1016/j.ijpsycho.2010.10.015; Hojat M, 2004, MED EDUC, V38, P934, DOI 10.1111/j.1365-2929.2004.01911.x; Hojat M, 2009, ACAD MED, V84, P1182, DOI 10.1097/ACM.0b013e3181b17e55; JAMES W, 1994, PSYCHOL REV, V101, P205, DOI 10.1037/0033-295X.101.2.205; Kadota Y, 2010, BIOL PSYCHOL, V85, P97, DOI 10.1016/j.biopsycho.2010.05.009; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Lawrence EJ, 2004, PSYCHOL MED, V34, P911, DOI 10.1017/S0033291703001624; Lee SA, 2010, PERS INDIV DIFFER, V49, P68, DOI 10.1016/j.paid.2010.03.016; LEVENSTEIN S, 1993, J PSYCHOSOM RES, V37, P19, DOI 10.1016/0022-3999(93)90120-5; NADELSON CC, 1993, AM J PSYCHIAT, V150, P1309; Neumann M, 2011, ACAD MED, V86, P996, DOI 10.1097/ACM.0b013e318221e615; Newton BW, 2008, ACAD MED, V83, P244, DOI 10.1097/ACM.0b013e3181637837; Pedersen R, 2009, PATIENT EDUC COUNS, V76, P307, DOI 10.1016/j.pec.2009.06.012; Peisah C, 2009, AGING MENT HEALTH, V13, P300, DOI 10.1080/13607860802459831; Pollatos O, 2008, COGNITION EMOTION, V22, P272, DOI 10.1080/02699930701357535; Shapiro Johanna, 2008, Philos Ethics Humanit Med, V3, P10, DOI 10.1186/1747-5341-3-10; Singer T, 2009, TRENDS COGN SCI, V13, P334, DOI 10.1016/j.tics.2009.05.001; Vellante M, 2013, COGN NEUROPSYCHIATRY, V18, P326, DOI 10.1080/13546805.2012.721728	34	37	38	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65159	10.1371/journal.pone.0065159	http://dx.doi.org/10.1371/journal.pone.0065159			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166TB	23755185	Green Published, Green Submitted, gold			2022-12-27	WOS:000320579400041
J	Matsuda, YT; Okanoya, K; Myowa-Yamakoshi, M				Matsuda, Yoshi-Taka; Okanoya, Kazuo; Myowa-Yamakoshi, Masako			Shyness in Early Infancy: Approach-Avoidance Conflicts in Temperament and Hypersensitivity to Eyes during Initial Gazes to Faces	PLOS ONE			English	Article							BEHAVIORAL-INHIBITION; EARLY-CHILDHOOD; SOCIAL WITHDRAWAL; FEAR; SOCIABILITY; STRANGERS; FAMILIARITY; PREFERENCE; ATTENTION; PATTERNS	A growing awareness of the risks associated with skin exposure to ultraviolet (UV) radiation over the past decades has led to increased use of sunscreen cosmetic products leading the introduction of new chemical compounds in the marine environment. Although coastal tourism and recreation are the largest and most rapidly growing activities in the world, the evaluation of sunscreen as source of chemicals to the coastal marine system has not been addressed. Concentrations of chemical UV filters included in the formulation of sunscreens, such as benzophehone 3 (BZ-3), 4-methylbenzylidene camphor (4-MBC), TiO2 and ZnO, are detected in nearshore waters with variable concentrations along the day and mainly concentrated in the surface microlayer (i.e. 53.6-577.5 ng L-1 BZ-3; 51.4-113.4 ng L-1 4-MBC; 6.9-37.6 mu g L-1 Ti; 1.0-3.3 mu g L-1 Zn). The presence of these compounds in seawater suggests relevant effects on phytoplankton. Indeed, we provide evidences of the negative effect of sunblocks on the growth of the commonly found marine diatom Chaetoceros gracilis (mean EC50 = 125 +/- 71 mu g L-1). Dissolution of sunscreens in seawater also releases inorganic nutrients (N, P and Si forms) that can fuel algal growth. In particular, PO43- is released by these products in notable amounts (up to 17 mu mol PO43- g(-1)). We conservatively estimate an increase of up to 100% background PO43- concentrations (0.12 mu mol L-1 over a background level of 0.06 mu mol L-1) in nearshore waters during low water renewal conditions in a populated beach in Majorca island. Our results show that sunscreen products are a significant source of organic and inorganic chemicals that reach the sea with potential ecological consequences on the coastal marine ecosystem.	[Matsuda, Yoshi-Taka; Okanoya, Kazuo; Myowa-Yamakoshi, Masako] Japan Sci & Technol Agcy JST, Exploratory Res Adv Technol ERATO, Okanoya Emot Informat Project, Saitama, Japan; [Matsuda, Yoshi-Taka; Okanoya, Kazuo] RIKEN, Brain Sci Inst, Emot Informat Joint Res Lab, Saitama, Japan; [Matsuda, Yoshi-Taka] Doshisha Univ, Ctr Baby Sci, Kyoto 602, Japan; [Okanoya, Kazuo] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan; [Myowa-Yamakoshi, Masako] Kyoto Univ, Grad Sch Educ, Kyoto, Japan	Japan Science & Technology Agency (JST); RIKEN; Doshisha University; University of Tokyo; Kyoto University	Matsuda, YT (corresponding author), Japan Sci & Technol Agcy JST, Exploratory Res Adv Technol ERATO, Okanoya Emot Informat Project, Saitama, Japan.	matsuda@brain.riken.jp; myowa@educ.kyoto-u.ac.jp	Myowa, Masako/E-8965-2010		Spanish Ministries of Economy and Competitiveness and of Agriculture, Food and Environment	Spanish Ministries of Economy and Competitiveness and of Agriculture, Food and Environment	This work was funded by the ISUMAR project (CTM2011-22645) and CONCORDA project (384/2011) of the Spanish Ministries of Economy and Competitiveness and of Agriculture, Food and Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RB, 2003, SCIENCE, V300, P1536, DOI 10.1126/science.1082244; Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; [Anonymous], 2003, PSYCHOLOGY; Asendorpf J. B., 2010, DEV SHYNESS SOCIAL W, P157; ASENDORPF JB, 1993, J CHILD PSYCHOL PSYC, V34, P1069, DOI 10.1111/j.1469-7610.1993.tb01774.x; ASENDORPF JB, 1990, HUM DEV, V33, P250, DOI 10.1159/000276522; ASENDORPF JB, 1990, DEV PSYCHOL, V26, P721, DOI 10.1037/0012-1649.26.5.721; Bridges KMB, 1932, CHILD DEV, V3, P324, DOI 10.2307/1125359; Brunet PM, 2009, J ANXIETY DISORD, V23, P909, DOI 10.1016/j.janxdis.2009.05.009; Buehler C, 1930, 1 YEAR LIFE; Buss A., 1984, TEMPERAMENT EARLY DE; Cassia VM, 2004, PSYCHOL SCI, V15, P379, DOI 10.1111/j.0956-7976.2004.00688.x; CHEEK JM, 1981, J PERS SOC PSYCHOL, V41, P330, DOI 10.1037/0022-3514.41.2.330; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; Colonnesi C, 2013, INFANCY, V18, P202, DOI 10.1111/j.1532-7078.2012.00117.x; Coplan RJ, 2004, DEV PSYCHOL, V40, P244, DOI 10.1037/0012-1649.40.2.244; Coplan RJ, 2007, CHILD DEV PERSPECT, V1, P26, DOI 10.1111/j.1750-8606.2007.00006.x; Davidson RJ, 2000, AM PSYCHOL, V55, P1196, DOI 10.1037/0003-066X.55.11.1196; DEPUE RA, 1989, ANNU REV PSYCHOL, V40, P457, DOI 10.1146/annurev.ps.40.020189.002325; Eggum ND, 2009, INFANCY, V14, P325, DOI 10.1080/15250000902839971; Fox NA, 2001, CHILD DEV, V72, P1, DOI 10.1111/1467-8624.00262; FREEDMAN DG, 1961, J CHILD PSYCHOL PSYC, V2, P242, DOI 10.1111/j.1469-7610.1961.tb02028.x; GARCIA S, 1991, J PERS SOC PSYCHOL, V61, P35, DOI 10.1037/0022-3514.61.1.35; Garcia-Coll C, 1984, CHILD DEV, V55; Gartstein MA, 2003, INFANT BEHAV DEV, V26, P64, DOI 10.1016/S0163-6383(02)00169-8; GRAY JA, 1982, BEHAV BRAIN SCI, V5, P469, DOI 10.1017/S0140525X00013066; Gredeback G, 2010, DEV NEUROPSYCHOL, V35, P1, DOI 10.1080/87565640903325758; HAITH MM, 1977, SCIENCE, V198, P853, DOI 10.1126/science.918670; Houston-Price C, 2004, INFANT CHILD DEV, V13, P341, DOI 10.1002/icd.364; Hunnius S, 2004, INFANCY, V6, P231, DOI 10.1207/s15327078in0602_5; KAGAN J, 1984, CHILD DEV, V55, P2212, DOI 10.1111/j.1467-8624.1984.tb03916.x; KAGAN J, 1988, SCIENCE, V240, P167, DOI 10.1126/science.3353713; Kagan J, 1999, SER AFFECTIVE SCI, P3; Kagan J., 1994, GALENS PROPHECY TEMP, DOI DOI 10.4324/9780429500282; Kawashima R, 1999, BRAIN, V122, P779, DOI 10.1093/brain/122.4.779; Kinsbourne M., 1978, ASYMMETRICAL FUNCTIO, P3; Lewis M, 2008, HDB EMOTIONS, pxvi; Lewkowicz DJ, 2012, P NATL ACAD SCI USA, V109, P1431, DOI 10.1073/pnas.1114783109; Marshall P. J., 2001, INT HDB SOCIAL ANXIE, P53; Matsuda YT, 2012, BIOL LETTERS, V8, P725, DOI 10.1098/rsbl.2012.0346; Merin N, 2007, J AUTISM DEV DISORD, V37, P108, DOI 10.1007/s10803-006-0342-4; Morris JS, 2002, NEUROIMAGE, V17, P214, DOI 10.1006/nimg.2002.1220; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; PANKSEPP J, 1982, BEHAV BRAIN SCI, V5, P407, DOI 10.1017/S0140525X00012759; PILKONIS PA, 1977, J PERS, V45, P596, DOI 10.1111/j.1467-6494.1977.tb00174.x; Preyer WT, 1888, MIND CHILD; Putnam SP, 2005, CHILD DEV, V76, P212, DOI 10.1111/j.1467-8624.2005.00840.x; Putnam SP, 2002, DEVELOPMENTAL SCI, V5, P441, DOI 10.1111/1467-7687.00239; Reddy V, 2005, EMOTIONAL DEV, P183; ROTHBART MK, 1988, CHILD DEV, V59, P1241, DOI 10.1111/j.1467-8624.1988.tb01493.x; ROWE DC, 1977, J PERS ASSESS, V41, P150, DOI 10.1207/s15327752jpa4102_5; Sato W, 2004, COGNITION EMOTION, V18, P701, DOI 10.1080/02699930341000176; SCHAFFER HR, 1966, J CHILD PSYCHOL PSYC, V7, P95, DOI 10.1111/j.1469-7610.1966.tb02167.x; SCHAFFER HR, 1972, CHILD DEV, V43, P165, DOI 10.1111/j.1467-8624.1972.tb01088.x; Schmidt L.A., 1999, EXTREME FEAR SHYNESS, DOI [10.1093/acprof:oso/9780195118872.001.0001, DOI 10.1093/ACPROF:OSO/9780195118872.001.0001]; Schmidt LA, 1999, PSYCHOL SCI, V10, P316, DOI 10.1111/1467-9280.00161; SCHMIDT LA, 1994, BIOL PSYCHOL, V38, P183, DOI 10.1016/0301-0511(94)90038-8; Spitz RA, 1950, INT J PSYCHOANAL, V31, P138; TENNES KH, 1964, J NERV MENT DIS, V139, P247, DOI 10.1097/00005053-196409000-00005; von Hofsten C, 2005, INFANCY, V8, P217, DOI 10.1207/s15327078in0803_2; WILCOX BM, 1968, J EXP CHILD PSYCHOL, V6, P22, DOI 10.1016/0022-0965(68)90068-4	61	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65476	10.1371/journal.pone.0065476	http://dx.doi.org/10.1371/journal.pone.0065476			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166TB	23755238	gold, Green Submitted, Green Published			2022-12-27	WOS:000320579400060
J	Monge, J; Kricun, M; Radovcic, J; Radovcic, D; Mann, A; Frayer, DW				Monge, Janet; Kricun, Morrie; Radovcic, Jakov; Radovcic, Davorka; Mann, Alan; Frayer, David W.			Fibrous Dysplasia in a 120,000+Year Old Neandertal from Krapina, Croatia	PLOS ONE			English	Article							ENAMEL HYPOPLASIA; CANCER; RIBS; BONE	We describe the first definitive case of a fibrous dysplastic neoplasm in a Neandertal rib (120.71) from the site of Krapina in present-day Croatia. The tumor predates other evidence for these kinds of tumor by well over 100,000 years. Tumors of any sort are a rare occurrence in recent archaeological periods or in living primates, but especially in the human fossil record. Several studies have surveyed bone diseases in past human populations and living primates and fibrous dysplasias occur in a low incidence. Within the class of bone tumors of the rib, fibrous dysplasia is present in living humans at a higher frequency than other bone tumors. The bony features leading to our diagnosis are described in detail. In living humans effects of the neoplasm present a broad spectrum of symptoms, from asymptomatic to debilitating. Given the incomplete nature of this rib and the lack of associated skeletal elements, we resist commenting on the health effects the tumor had on the individual. Yet, the occurrence of this neoplasm shows that at least one Neandertal suffered a common bone tumor found in modern humans.	[Monge, Janet] Univ Penn, Univ Penn Museum, Philadelphia, PA 19104 USA; [Kricun, Morrie] Univ Penn, Dept Radiol, Univ Penn Museum, Philadelphia, PA 19104 USA; [Radovcic, Jakov; Radovcic, Davorka] Croatian Nat Hist Museum, Zagreb, Croatia; [Mann, Alan] Princeton Univ, Dept Anthropol, Princeton, NJ 08544 USA; [Frayer, David W.] Univ Kansas, Dept Anthropol, Lawrence, KS 66045 USA	University of Pennsylvania; University of Pennsylvania; Princeton University; University of Kansas	Frayer, DW (corresponding author), Univ Kansas, Dept Anthropol, Lawrence, KS 66045 USA.	frayer@ku.edu						American Cancer Society, 2012, BON CANC OV; Aufderheide A. C., 1998, HUMAN PALEOPATHOLOGY; BAXTER AD, 1995, NUCL MED COMMUN, V16, P834, DOI 10.1097/00006231-199510000-00006; Capasso LL, 2005, INT J CANCER, V113, P2, DOI 10.1002/ijc.20610; Caspari R, 2004, P NATL ACAD SCI USA, V101, P10895, DOI 10.1073/pnas.0402857101; Gardner JC, 2008, NEW INSIGHTS KRAPINA, P237; GIBSON MJ, 1971, BRIT J RADIOL, V44, P1; Gorjanovic-Kramberger D, 1908, KORR DTSCH GES ANTHR, V38, P108; Gorjanovic-Kramberger D, 1908, UMSCHAU, V12, P623; Gorjanovic-Kramberger G, 1906, STUDIEN ENTWICKLUNGS, VII, P59; Guatelli-Steinberg D, 2004, J HUM EVOL, V47, P65, DOI 10.1016/j.jhevol.2004.05.004; Halperin EC, 2004, PERSPECT BIOL MED, V47, P1, DOI 10.1353/pbm.2004.0010; HARRIS WH, 1962, J BONE JOINT SURG AM, V44, P207, DOI 10.2106/00004623-196244020-00001; Hauber EJ, 2009, BONE CANC PROGR THER, P3; HOCHBERG LA, 1953, AMA ARCH SURG, V67, P566, DOI 10.1001/archsurg.1953.01260040575011; Hutchinson DL, 1997, CURR ANTHROPOL, V38, P904, DOI 10.1086/204681; Hutton Estabrook V, 2013, BIOARCHAEOLOGY HUMAN; Kricun M, 1999, KRAPINA HOMINIDS RAD; Kricun ME, 1993, IMAGE BONE TUMORS, P6; Kricun ME, 1993, IMAGE BONE TUMORS, P311; Mann A, 2008, NEW INSIGHTS KRAPINA, P261; Miracle P.T, 2007, KRAPINA PALEOLITHIC; Mirra JM, 1980, BONE TUMORS DIAGNOSI, P125; MOLNAR S, 1985, AM ANTHROPOL, V87, P536, DOI 10.1525/aa.1985.87.3.02a00020; Monge Janet, 2007, P673, DOI 10.1007/978-3-540-33761-4_22; Ortner DJ, 1981, IDENTIFICATION PATHO, V28, P365; PASCUZZI CA, 1957, SURG GYNECOL OBSTET, V104, P390; Radovcic J, 1988, DRAGUTIN GORJANOVIC; Radovcic J, 2008, KRAPINA HOMINIDS ILL; RINK WJ, 1995, NATURE, V378, P24, DOI 10.1038/378024a0; Rodenberg J, 1996, SKELETAL RADIOL, V25, P682, DOI 10.1007/s002560050159; RUSSELL MD, 1987, AM J PHYS ANTHROPOL, V72, P381, DOI 10.1002/ajpa.1330720311; Schajowicz F, 1994, TUMORS TUMORLIKE LES, P567; Simek JF, 1997, J HUM EVOL, V32, P561, DOI 10.1006/jhev.1996.0129; The Netherlands Committee on Bone Tumors, 1973, RAD ATL BON TUM, V2, p[X, XII]	35	19	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64539	10.1371/journal.pone.0064539	http://dx.doi.org/10.1371/journal.pone.0064539			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166TB	23755126	Green Published, Green Submitted, gold			2022-12-27	WOS:000320579400017
J	Shroufi, A; Mafara, E; Saint-Sauveur, JF; Taziwa, F; Vinoles, MC				Shroufi, Amir; Mafara, Emma; Saint-Sauveur, Jean Francis; Taziwa, Fabian; Vinoles, Mari Carmen			Mother to Mother (M2M) Peer Support for Women in Prevention of Mother to Child Transmission (PMTCT) Programmes: A Qualitative Study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; HIV TRANSMISSION; BEHAVIORAL INTERVENTION; RANDOMIZED-TRIAL; RURAL ZIMBABWE; PREGNANT-WOMEN; SOUTH-AFRICA; ADHERENCE; BOTSWANA	Introduction: Mother-to-Mother (M2M) or "Mentor Mother" programmes utilise HIV positive mothers to provide support and advice to HIV positive pregnant women and mothers of HIV exposed babies. Medecins Sans Frontieres (MSF) supported a Mentor Mother programme in Bulawayo, Zimbabwe from 2009 to 2012; with programme beneficiaries observed to have far higher retention at 6-8 weeks (99% vs 50%, p<0.0005) and to have higher adherence to Prevention of Mother to Child Transmission (PMTCT) guidelines, compared to those not opting in. In this study we explore how the M2M progamme may have contributed to these findings. Methods: In this qualitative study we used thematic analysis of in-depth interviews (n = 79). This study was conducted in 2 urban districts of Bulawayo, Zimbabwe's second largest city. Results: Interviews were completed by 14 mentor mothers, 10 mentor mother family members, 30 beneficiaries (women enrolled both in PMTCT and M2M), 10 beneficiary family members, 5 women enrolled in PMTCT but who had declined to take part in the M2M programme and 10 health care staff members. All beneficiaries and health care staff reported that the programme had improved retention and provided rich information on how this was achieved. Additionally respondents described how the programme had helped bring about beneficial behaviour change. Conclusions: M2M programmes offer great potential to empower communities affected by HIV to catalyse positive behaviour change. Our results illustrate how M2M involvement may increase retention in PMTCT programmes. Nondisclosure to one's partner, as well as some cultural practices prevalent in Zimbabwe appear to be major barriers to participation in M2M programmes.	[Shroufi, Amir; Mafara, Emma; Saint-Sauveur, Jean Francis; Taziwa, Fabian; Vinoles, Mari Carmen] Medecins Sans Frontieres, Operat Ctr Barcelona Athens, Harare, Zimbabwe		Shroufi, A (corresponding author), Medecins Sans Frontieres, Operat Ctr Barcelona Athens, Harare, Zimbabwe.	amir.shroufi@doctors.org.uk						Aizire J, 2013, CURR HIV RES, V11, P144, DOI 10.2174/1570162X11311020007; Albrecht S, 2006, JAIDS-J ACQ IMM DEF, V41, P114, DOI 10.1097/01.qai.0000179425.27036.d7; [Anonymous], 2002, UN PROGR HIV AIDS UN; Bajunirwe Francis, 2005, AIDS Res Ther, V2, P10, DOI 10.1186/1742-6405-2-10; Busza J, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.4.17373; Byamugisha R, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-12; Coutsoudis A, 2004, J INFECT DIS, V189, P2154, DOI 10.1086/420834; COX AD, 1991, J ROY SOC MED, V84, P217, DOI 10.1177/014107689108400411; Dabis F, 2002, LANCET, V359, P2097, DOI 10.1016/S0140-6736(02)08909-2; Decroo T, 2010, J ACQ IMMUN DEF SYND; Decroo T, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/749718; Decroo T, 2011, JAIDS-J ACQ IMM DEF, V56, pE39, DOI 10.1097/QAI.0b013e3182055138; Dryden-Peterson S, 2011, JAIDS-J ACQ IMM DEF, V58, P353, DOI 10.1097/QAI.0b013e31822d4063; Dube S, 2008, JAIDS-J ACQ IMM DEF, V48, P72, DOI 10.1097/QAI.0b013e31816bcdbb; Futterman D, 2010, AIDS CARE, V22, P1093, DOI 10.1080/09540121003600352; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2011, GLOB PLAN EL NEW HIV; Leroy V, 2005, AIDS, V19, P1865, DOI 10.1097/01.aids.0000188423.02786.55; Manzi M, 2005, TROP MED INT HEALTH, V10, P1242, DOI 10.1111/j.1365-3156.2005.01526.x; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Meldrum A, 2008, LANCET, V371, P1059, DOI 10.1016/S0140-6736(08)60468-7; Mepham S, 2011, AIDS CARE, V23, P741, DOI 10.1080/09540121.2010.516341; Merten S, 2010, TROP MED INT HEALTH, V15, P16, DOI 10.1111/j.1365-3156.2010.02510.x; Ministry of Health and Child Welfare Zimbabwe, 2011, MOHCW 2011 NAT STRAT; Msuya SE, 2008, AIDS CARE, V20, P700, DOI 10.1080/09540120701687059; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; Orne-Gliemann J, 2006, TROP MED INT HEALTH, V11, P341, DOI 10.1111/j.1365-3156.2006.01563.x; Peltzer K, 2010, ACTA PAEDIATR, V99, P699, DOI 10.1111/j.1651-2227.2010.01699.x; Perez F, 2004, BRIT MED J, V329, P1147, DOI 10.1136/bmj.329.7475.1147; Perez F, 2004, IMPLEMENTING RURAL P; Raine P, 2003, HEALTH SOC CARE COMM, V11, P463, DOI 10.1046/j.1365-2524.2003.00449.x; Roura M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-427; Selke HM, 2010, JAIDS-J ACQ IMM DEF, V55, P483, DOI 10.1097/QAI.0b013e3181eb5edb; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Shapiro RL, 2003, AIDS EDUC PREV, V15, P221, DOI 10.1521/aeap.15.4.221.23830; Shetty AK, 2010, J PERINATOL, V30, P763, DOI 10.1038/jp.2010.104; Shetty AK, 2005, INT J STD AIDS, V16, P755, DOI 10.1258/095646205774763090; Skovdal M, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-29; Skovdal M, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-13; Tchendjou PT, 2011, JAIDS-J ACQ IMM DEF, V57, pS9, DOI 10.1097/QAI.0b013e31821ec6e2; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; Wanyama J, 2007, AIDS, V21, P1486, DOI 10.1097/QAD.0b013e32823ecf7f; Wools-Kaloustian KK, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-22; World Health Organization, 2021, ANT DRUGS TREAT PREG; Wringe A, 2012, TROP MED INT HEALTH, V17, pe38, DOI 10.1111/j.1365-3156.2011.02925.x; Zimbabwe National AIDS Council, 2010, 2010 ZIMBABWE AN HIV	45	53	54	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64717	10.1371/journal.pone.0064717	http://dx.doi.org/10.1371/journal.pone.0064717			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166TB	23755137	gold, Green Published, Green Submitted			2022-12-27	WOS:000320579400022
J	Alter, DA; Franklin, B; Ko, DT; Austin, PC; Lee, DS; Oh, PI; Stukel, TA; Tu, JV				Alter, David A.; Franklin, Barry; Ko, Dennis T.; Austin, Peter C.; Lee, Douglas S.; Oh, Paul I.; Stukel, Therese A.; Tu, Jack V.			Socioeconomic Status, Functional Recovery, and Long-Term Mortality among Patients Surviving Acute Myocardial Infarction	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PHYSICAL-ACTIVITY; CARDIAC REHABILITATION; SECONDARY PREVENTION; DEPRESSIVE SYMPTOMS; EXERCISE CAPACITY; ELDERLY-PATIENTS; HEALTH-SERVICES; YOUNG-ADULTS; FOLLOW-UP	Objectives: To examine the relationship between socio-economic status (SES), functional recovery and long-term mortality following acute myocardial infarction (AMI). Background: The extent to which SES mortality disparities are explained by differences in functional recovery following AMI is unclear. Methods: We prospectively examined 1368 patients who survived at least one-year following an index AMI between 1999 and 2003 in Ontario, Canada. Each patient was linked to administrative data and followed over 9.6 years to track mortality. All patients underwent medical chart abstraction and telephone interviews following AMI to identify individual-level SES, clinical factors, processes of care (i.e., use of, and adherence, to evidence-based medications, physician visits, invasive cardiac procedures, referrals to cardiac rehabilitation), as well as changes in psychosocial stressors, quality of life, and self-reported functional capacity. Results: As compared with their lower SES counterparts, higher SES patients experienced greater functional recovery (1.80 ml/kg/min average increase in peak V02, P<0.001) after adjusting for all baseline clinical factors. Post-AMI functional recovery was the strongest modifiable predictor of long-term mortality (Adjusted HR for each ml/kg/min increase in functional capacity: 0.91; 95% CI: 0.87-0.94, P<0.001) irrespective of SES (P = 0.51 for interaction between SES, functional recovery, and mortality). SES-mortality associations were attenuated by 27% after adjustments for functional recovery, rendering the residual SES-mortality association no longer statistically significant (Adjusted HR: 0.84; 95% CI: 0.70-1.00, P = 0.05). The effects of functional recovery on SES-mortality associations were not explained by access inequities to physician specialists or cardiac rehabilitation. Conclusions: Functional recovery may play an important role in explaining SES-mortality gradients following AMI.	[Alter, David A.; Ko, Dennis T.; Austin, Peter C.; Lee, Douglas S.; Stukel, Therese A.; Tu, Jack V.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Alter, David A.; Oh, Paul I.] Toronto Rehabil Inst, Cardiac Rehabil & Secondary Prevent Program, Toronto, ON, Canada; [Ko, Dennis T.; Tu, Jack V.] Schulich Heart Ctr, Toronto, ON, Canada; [Ko, Dennis T.; Tu, Jack V.] Sunnybrook Hlth Sci Ctr, Clin Epidemiol Unit, Toronto, ON M4N 3M5, Canada; [Alter, David A.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Alter, David A.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Franklin, Barry] William Beaumont Hosp, Cardiac Rehabil & Exercise Labs, Royal Oak, MI 48072 USA; [Alter, David A.; Ko, Dennis T.; Austin, Peter C.; Lee, Douglas S.; Stukel, Therese A.; Tu, Jack V.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Beaumont Health; University of Toronto	Alter, DA (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.	david.alter@ices.on.ca		Lee, Douglas/0000-0001-7078-745X; Ko, Dennis/0000-0001-6840-8051; Austin, Peter/0000-0003-3337-233X; Stukel, Therese/0000-0002-2951-1360	Canadian Institute for Health Research (MOP) [119956]	Canadian Institute for Health Research (MOP)(Canadian Institutes of Health Research (CIHR))	This study was supported by a grant from the Canadian Institute for Health Research (MOP #119956). The Institute for Clinical Evaluative Sciences is supported in part by a grant from the Ontario Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison KR, 1999, CAN J PUBLIC HEALTH, V90, P85, DOI 10.1007/BF03404107; Alter DA, 2004, JAMA-J AM MED ASSOC, V291, P1100, DOI 10.1001/jama.291.9.1100; Alter DA, 2006, AM HEART J, V151, P323, DOI 10.1016/j.ahj.2005.07.013; Alter DA, 2006, ANN INTERN MED, V144, P82, DOI 10.7326/0003-4819-144-2-200601170-00005; Alter DA, 2004, CAN J CARDIOL, V20, P1219; Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; Alter DA, 2011, HEALTH AFFAIR, V30, P274, DOI 10.1377/hlthaff.2009.0669; Ayanian JZ, 2002, NEW ENGL J MED, V347, P1678, DOI 10.1056/NEJMsa020080; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Bloch Katia Vergetti, 2003, Arq. Bras. Cardiol., V80, P179, DOI 10.1590/S0066-782X2003000200006; Brownson RC, 2005, ANNU REV PUBL HEALTH, V26, P421, DOI 10.1146/annurev.publhealth.26.021304.144437; Buurman BM, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-296; Candido E, 2011, CAN J CARDIOL, V27, P200, DOI 10.1016/j.cjca.2011.01.008; Candido E, 2011, J CLIN EPIDEMIOL, V64, P213, DOI 10.1016/j.jclinepi.2010.03.010; Carter Rick, 2002, J Cardiopulm Rehabil, V22, P298, DOI 10.1097/00008483-200207000-00014; Clark AM, 2005, ANN INTERN MED, V143, P659, DOI 10.7326/0003-4819-143-9-200511010-00010; Clark RA, 2012, CIRCULATION, V125, P2006, DOI 10.1161/CIRCULATIONAHA.111.083394; Cohen B, 2008, AM J CARDIOL, V101, P462, DOI 10.1016/j.amjcard.2007.09.093; Danenberg HD, 2009, ISR MED ASSOC J, V11, P529; Ganova-Iolovska M, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-15; Gerber Y, 2010, CIRCULATION, V121, P375, DOI 10.1161/CIRCULATIONAHA.109.882555; Gerber Y, 2009, MED CARE, V47, P342, DOI 10.1097/MLR.0b013e3181894270; Ghosh R, 2009, CURR OPIN CRIT CARE, V15, P279, DOI 10.1097/MCC.0b013e32832faef2; Harkins C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-391; Hillier FC, 2012, PUBLIC HEALTH NUTR, V15, P1446, DOI 10.1017/S1368980011002862; HLATKY MA, 1989, AM J CARDIOL, V64, P651, DOI 10.1016/0002-9149(89)90496-7; Hunt J, 2008, HEALTH PROMOT J AUST, V19, P102, DOI 10.1071/HE08102; Ko DT, 2004, JAMA-J AM MED ASSOC, V291, P1864, DOI 10.1001/jama.291.15.1864; Koenig HG, 1999, AM J GERIAT PSYCHIAT, V7, P124; Kokkinos P, 2010, CIRCULATION, V122, P790, DOI 10.1161/CIRCULATIONAHA.110.938852; Kurdyak PA, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-200; Lee DS, 2010, CIRCULATION, V122, P1806, DOI 10.1161/CIRCULATIONAHA.110.940262; Lynch JW, 1996, AM J EPIDEMIOL, V144, P934, DOI 10.1093/oxfordjournals.aje.a008863; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Melville MR, 2003, HEART, V89, P1445, DOI 10.1136/heart.89.12.1445; Menec VH, 2001, CAN J PUBLIC HEALTH, V92, P299, DOI 10.1007/BF03404965; Merz CNB, 2000, J WOMEN HEALTH GEN-B, V9, P769, DOI 10.1089/15246090050147745; Morey MC, 2002, J AM GERIATR SOC, V50, P1929, DOI 10.1046/j.1532-5415.2002.50602.x; Oberg EB, 2009, PREV CHRONIC DIS, V6; Pitsavos C, 2008, J AM COLL CARDIOL, V51, P2034, DOI 10.1016/j.jacc.2008.01.053; Raine R, 2003, HEALTH POLICY, V63, P63, DOI 10.1016/S0168-8510(02)00056-8; Rosvall M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-44; Sainio P, 2007, J EPIDEMIOL COMMUN H, V61, P401, DOI 10.1136/jech.2006.048306; Shishehbor MH, 2008, AM HEART J, V155, P699, DOI 10.1016/j.ahj.2007.07.055; Shishehbor MH, 2006, JAMA-J AM MED ASSOC, V295, P784, DOI 10.1001/jama.295.7.784; SIHM I, 1991, EUR HEART J, V12, P203, DOI 10.1093/oxfordjournals.eurheartj.a059869; Statistics Canada, 1999, 1996 NAT POP HLTH SU; Suaya JA, 2007, CIRCULATION, V116, P1653, DOI 10.1161/CIRCULATIONAHA.107.701466; Sulander T, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-78; Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009	50	65	65	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65130	10.1371/journal.pone.0065130	http://dx.doi.org/10.1371/journal.pone.0065130			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	157CD	23755180	Green Published, gold, Green Submitted			2022-12-27	WOS:000319872300050
J	Reiss, R; Ihssen, J; Richter, M; Eichhorn, E; Schilling, B; Thony-Meyer, L				Reiss, Renate; Ihssen, Julian; Richter, Michael; Eichhorn, Eric; Schilling, Boris; Thony-Meyer, Linda			Laccase versus Laccase-Like Multi-Copper Oxidase: A Comparative Study of Similar Enzymes with Diverse Substrate Spectra	PLOS ONE			English	Article							MULTICOPPER OXIDASE; BACILLUS-SUBTILIS; BILIRUBIN OXIDASE; CRYSTAL-STRUCTURE; FUNGAL LACCASES; CUEO; OXIDATION; COMPONENT; CLONING	Laccases (EC 1.10.3.2) are multi-copper oxidases that catalyse the one-electron oxidation of a broad range of compounds including substituted phenols, arylamines and aromatic thiols to the corresponding radicals. Owing to their broad substrate range, copper-containing laccases are versatile biocatalysts, capable of oxidizing numerous natural and non-natural industry-relevant compounds, with water as the sole by-product. In the present study, 10 of the 11 multi-copper oxidases, hitherto considered to be laccases, from fungi, plant and bacterial origin were compared. A substrate screen of 91 natural and non-natural compounds was recorded and revealed a fairly broad but distinctive substrate spectrum amongst the enzymes. Even though the enzymes share conserved active site residues we found that the substrate ranges of the individual enzymes varied considerably. The EC classification is based on the type of chemical reaction performed and the actual name of the enzyme often refers to the physiological substrate. However, for the enzymes studied in this work such classification is not feasible, even more so as their prime substrates or natural functions are mainly unknown. The classification of multi-copper oxidases assigned as laccases remains a challenge. For the sake of simplicity we propose to introduce the term "laccase-like multi-copper oxidase" (LMCO) in addition to the term laccase that we use exclusively for the enzyme originally identified from the sap of the lacquer tree Rhus vernicifera.	[Reiss, Renate; Ihssen, Julian; Richter, Michael; Thony-Meyer, Linda] Swiss Fed Labs Mat Sci & Technol, Lab Biomat, Empa, St Galllen, Switzerland; [Eichhorn, Eric; Schilling, Boris] Givaudan Schweiz AG, Dubendorf, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Givaudan SA	Thony-Meyer, L (corresponding author), Swiss Fed Labs Mat Sci & Technol, Lab Biomat, Empa, St Galllen, Switzerland.	Thoeny@empa.ch		Eichhorn, Eric/0000-0003-2113-6305	CTI project [11647.2 PFLS-LS]; CTI grant of the Swiss Federation	CTI project; CTI grant of the Swiss Federation	This work was supported by the CTI project 11647.2 PFLS-LS, http://www.kti.admin.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Eric Eichhorn and Boris Schilling are employed by Givaudan Schweiz AG. The results reported in this paper, in particular the substrate screen, were obtained in a collaboration between Empa and Givaudan, which was financed by the mentioned CTI grant of the Swiss Federation to support industrially relevant research. The company holds a patent on the production of natural flavors by laccase catalysis (EP 1 083 233 B1) with the priority date of 08.09.1999 from US 391785 application. However, the results of the present study did not result in the discovery of new flavors and are not connected to this IP in any way, which made it possible to publish them. Givaudan agrees with this policy, as there are no patent applications pending or planned on the subject of the authors' results and no products in development or marketed products to declare. The fact, that part of the authors' results stem from this industry collaboration, therefore, and in agreement with Givaudan, does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ausec L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025724; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Beloqui A, 2006, J BIOL CHEM, V281, P22933, DOI 10.1074/jbc.M600577200; Bertrand T, 2002, BIOCHEMISTRY-US, V41, P7325, DOI 10.1021/bi0201318; Durand F, 2012, BIOSENS BIOELECTRON, V35, P140, DOI 10.1016/j.bios.2012.02.033; Durao P, 2008, J BIOL INORG CHEM, V13, P183, DOI 10.1007/s00775-007-0312-0; Endo K, 2003, J BIOCHEM, V133, P671, DOI 10.1093/jb/mvg086; Enguita FJ, 2003, J BIOL CHEM, V278, P19416, DOI 10.1074/jbc.M301251200; Fernandes AT, 2007, FEBS J, V274, P2683, DOI 10.1111/j.1742-4658.2007.05803.x; Galai S, 2011, J APPL MICROBIOL, V111, P1394, DOI 10.1111/j.1365-2672.2011.05164.x; Galhaup C, 2002, MICROBIOL-SGM, V148, P2159, DOI 10.1099/00221287-148-7-2159; Garzillo AMV, 1998, APPL MICROBIOL BIOT, V49, P545, DOI 10.1007/s002530051211; Giardina P, 2010, CELL MOL LIFE SCI, V67, P369, DOI 10.1007/s00018-009-0169-1; Hoegger PJ, 2006, FEBS J, V273, P2308, DOI 10.1111/j.1742-4658.2006.05247.x; Hoopes JT, 2004, PLANT PHYSIOL BIOCH, V42, P27, DOI 10.1016/j.plaphy.2003.10.011; Kataoka K, 2007, J MOL BIOL, V373, P141, DOI 10.1016/j.jmb.2007.07.041; Kim JM, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-18; Koschorreck K, 2008, APPL MICROBIOL BIOT, V79, P217, DOI 10.1007/s00253-008-1417-2; Kues U, 2011, CURR GENOMICS, V12, P72, DOI 10.2174/138920211795564377; Kunamneni Adinarayana, 2008, Recent Pat Biotechnol, V2, P10, DOI 10.2174/187220808783330965; Madhavi V, 2009, BIORESOURCES, V4, P1694; Martins LO, 2002, J BIOL CHEM, V277, P18849, DOI 10.1074/jbc.M200827200; McCaig BC, 2005, PLANTA, V221, P619, DOI 10.1007/s00425-004-1472-6; Medina F, 2013, ENZYME MICROB TECH, V52, P68, DOI 10.1016/j.enzmictec.2012.10.009; Meyer HP, 2013, CATAL SCI TECHNOL, V3, P29, DOI 10.1039/c2cy20350b; Morozova V, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1136, DOI 10.1134/S0006297907100112; Nakamura K, 2003, FEBS LETT, V553, P239, DOI 10.1016/S0014-5793(03)01000-7; Quintanar L, 2007, ACCOUNTS CHEM RES, V40, P445, DOI 10.1021/ar600051a; Reiss R, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-9; Roberts SA, 2003, J BIOL CHEM, V278, P31958, DOI 10.1074/jbc.M302963200; Sakasegawa S, 2006, APPL ENVIRON MICROB, V72, P972, DOI 10.1128/AEM.72.1.972-975.2006; Sakurai T, 2007, CHEM REC, V7, P220, DOI 10.1002/tcr.20125; Singh SK, 2004, J BACTERIOL, V186, P7815, DOI 10.1128/JB.186.22.7815-7817.2004; Sirim D, 2011, DATABASE OXFORD, V2011; Smirnov SA, 2001, BIOCHEMISTRY-MOSCOW+, V66, P774, DOI 10.1023/A:1010216829856; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Witayakran S, 2009, ADV SYNTH CATAL, V351, P1187, DOI 10.1002/adsc.200800775; Xu F, 1996, BIOCHEMISTRY-US, V35, P7608, DOI 10.1021/bi952971a; Xu F, 2000, APPL ENVIRON MICROB, V66, P2052, DOI 10.1128/AEM.66.5.2052-2056.2000	39	145	150	3	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65633	10.1371/journal.pone.0065633	http://dx.doi.org/10.1371/journal.pone.0065633			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755261	Green Published, gold			2022-12-27	WOS:000319872300088
J	Bian, S; Navaratnam, D; Santos-Sacchi, J				Bian, Shumin; Navaratnam, Dhasakumar; Santos-Sacchi, Joseph			Real Time Measures of Prestin Charge and Fluorescence during Plasma Membrane Trafficking Reveal Sub-Tetrameric Activity	PLOS ONE			English	Article							OUTER HAIR CELL; MOTILITY-RELATED CHARGE; MOTOR; CAPACITANCE; EXPRESSION; DEPENDENCE; TEMPERATURE; DENSITY; PROTEIN	Prestin (SLC26a5) is the outer hair cell integral membrane motor protein that drives cochlear amplification, and has been described as an obligate tetramer. We studied in real time the delivery of YFP-prestin to the plasma membrane of cells from a tetracycline-inducible cell line. Following the release of temperature block to reinstate trans Golgi network delivery of the integral membrane protein, we measured nonlinear capacitance (NLC) and membrane fluorescence during voltage clamp. Prestin was delivered exponentially to the plasma membrane with a time constant of less than 10 minutes, with both electrical and fluorescence methods showing high temporal correlation. However, based on disparity between estimates of prestin density derived from either fluorescence or NLC, we conclude that sub-tetrameric forms of prestin contribute to our electrical and fluorescence measures. Thus, in agreement with previous observations we find that functional prestin is not an obligate tetramer.	[Bian, Shumin; Navaratnam, Dhasakumar; Santos-Sacchi, Joseph] Yale Univ, Sch Med, Dept Surg Otolaryngol, New Haven, CT 06520 USA; [Navaratnam, Dhasakumar; Santos-Sacchi, Joseph] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Navaratnam, Dhasakumar] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Santos-Sacchi, Joseph] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University	Santos-Sacchi, J (corresponding author), Yale Univ, Sch Med, Dept Surg Otolaryngol, New Haven, CT 06520 USA.	joseph.santos-sacchi@yale.edu			National Institutes of Health National Institute on Deafness and Other Communication Disorders [DC 000273, DC 008130]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000273, R01DC008130] Funding Source: NIH RePORTER	National Institutes of Health National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Support was provided by National Institutes of Health National Institute on Deafness and Other Communication Disorders grants DC 000273 (to JSS) and DC 008130 (to JSS and DN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2007, J MEMBRANE BIOL, V215, P49, DOI 10.1007/s00232-007-9004-5; Andreose JS, 1996, P NATL ACAD SCI USA, V93, P7661, DOI 10.1073/pnas.93.15.7661; Ashmore J. F, 1990, NEUROSCI RES       S, V12, pS39, DOI DOI 10.1016/0921-8696(90)90007-P; Bian SM, 2010, AM J PHYSIOL-CELL PH, V299, pC828, DOI 10.1152/ajpcell.00182.2010; Detro-Dassen S, 2008, J BIOL CHEM, V283, P4177, DOI 10.1074/jbc.M704924200; GRIFFITHS G, 1985, J CELL BIOL, V101, P949, DOI 10.1083/jcb.101.3.949; Hallworth R, 2012, J NEUROPHYSIOL, V107, P5, DOI 10.1152/jn.00728.2011; IWASA KH, 1993, BIOPHYS J, V65, P492, DOI 10.1016/S0006-3495(93)81053-1; Kakehata S, 1996, J NEUROSCI, V16, P4881; Klann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029645; Meltzer J, 2001, NEUROSCI LETT, V313, P141, DOI 10.1016/S0304-3940(01)02266-2; Navaratnam D, 2005, BIOPHYS J, V89, P3345, DOI 10.1529/biophysj.105.068759; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Oliver D, 1999, J PHYSIOL-LONDON, V519, P791, DOI 10.1111/j.1469-7793.1999.0791n.x; Rajagopalan L, 2007, J BIOL CHEM, V282, P36659, DOI 10.1074/jbc.M705078200; Santos-Sacchi J, 2004, BIOPHYS J, V87, P714, DOI 10.1529/biophysj.103.033993; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; Santos-Sacchi J, 1998, J PHYSIOL-LONDON, V510, P225, DOI 10.1111/j.1469-7793.1998.225bz.x; Santos-Sacchi J, 1998, NEUROSCI LETT, V256, P155, DOI 10.1016/S0304-3940(98)00788-5; SCHROER TA, 1991, ANNU REV PHYSIOL, V53, P629, DOI 10.1146/annurev.ph.53.030191.003213; Song L, 2005, BIOPHYS J, V88, P2350, DOI 10.1529/biophysj.104.053579; Song L, 2010, BIOPHYS J, V98, P371, DOI 10.1016/j.bpj.2009.10.027; Sturm AK, 2007, OTOLARYNG HEAD NECK, V136, P434, DOI 10.1016/j.otohns.2006.10.030; TARTAKOFF AM, 1986, EMBO J, V5, P1477, DOI 10.1002/j.1460-2075.1986.tb04385.x; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Wang X, 2010, BRAIN RES, V1333, P28, DOI 10.1016/j.brainres.2010.03.070	26	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e66078	10.1371/journal.pone.0066078	http://dx.doi.org/10.1371/journal.pone.0066078			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762468	Green Submitted, gold, Green Published			2022-12-27	WOS:000320440500063
J	Chen, SQ; Huang, ZF; Dai, Y; Qin, SW; Gao, YY; Zhang, LL; Gao, Y; Chen, JM				Chen, Shiqiang; Huang, Zefeng; Dai, Yi; Qin, Shuwen; Gao, Yingying; Zhang, Lulu; Gao, Yong; Chen, Jianmin			The Development of 7E Chromosome-Specific Molecular Markers for Thinopyrum elongatum Based on SLAF-seq Technology	PLOS ONE			English	Article							FUSARIUM HEAD BLIGHT; CYTOGENETIC CHARACTERIZATION; LEAF RUST; RESISTANCE; WHEAT; ADDITIONS; LINES; LR19	Thinopyrum elongatum is an important relative of wheat, it is favored by many researchers for the disease resistant genes that exist in its E genome. Some studies have showed that the 7E chromosome of Th. elongatum contains resistance genes related to Fusarium head blight and wheat rust. Therefore, developing 7E chromosome-specific molecular markers linked to resistance genes will provide an important tool for exploring and using the resistant genes of Th. elongatum. In addition, it would greatly contribute in the effort to cultivate disease-resistant wheat varieties. Featured in high throughput, high-accuracy and low-cost, SLAF-seq technology has been widely used in molecular breeding, system evolution, and germplasm resource detection. Based on SLAF-seq, 518 specific fragments on the 7E chromosome of Th. elongatum were successfully amplified. A total of 135 primers were designed according to 135 randomly selected fragments, and 89 specific molecular markers of Th. elongatum were developed, with efficiencies up to 65.9%. These markers were all detected in a variety of materials, and they are all proved to be specific and stable. These markers can be used not only for detecting the 7E chromosome of Th. elongatum but also for providing an important theoretical and practical basis for wheat breeding by marker-assisted selection (MAS). This paper reports the first application of SLAF-seq technology with a high success rate in developing specific molecular markers for Th. elongatum, providing a strong case for the application of this new technology.	[Chen, Shiqiang; Huang, Zefeng; Dai, Yi; Qin, Shuwen; Gao, Yingying; Zhang, Lulu; Gao, Yong; Chen, Jianmin] Yangzhou Univ, Coll Biosci & Biotechnol, Yangzhou, Peoples R China	Yangzhou University	Chen, JM (corresponding author), Yangzhou Univ, Coll Biosci & Biotechnol, Yangzhou, Peoples R China.	jmchen@yzu.edu.cn			National Natural Science Foundation of China [31071406]; Specialized Research Fund for the Doctoral Program of Higher Education [20123250110010]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This study was supported by the National Natural Science Foundation of China (31071406), Specialized Research Fund for the Doctoral Program of Higher Education (20123250110010) and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen GuoYue, 2007, Acta Agronomica Sinica, V33, P1782; Chen ShiQiang, 2012, Journal of Triticeae Crops, V32, P839; Cuthbert PA, 2007, THEOR APPL GENET, V114, P429, DOI 10.1007/s00122-006-0439-3; Du JunKai, 2010, Journal of Triticeae Crops, V30, P829; DVORAK J, 1974, CAN J GENET CYTOL, V16, P627; DVORAK J, 1974, CAN J GENET CYTOL, V16, P399, DOI 10.1139/g74-043; Fu SL, 2012, J GENET GENOMICS, V39, P103, DOI 10.1016/j.jgg.2011.11.008; Garg M, 2009, J CEREAL SCI, V50, P358, DOI 10.1016/j.jcs.2009.06.012; Ge JiangYan, 2012, Acta Agronomica Sinica, V38, P1818; Gennaro A, 2009, FUNCT INTEGR GENOMIC, V9, P325, DOI 10.1007/s10142-009-0115-1; Jauhar PP, 2009, GENOME, V52, P467, DOI [10.1139/G09-014, 10.1139/g09-014]; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Lammer D, 2004, J EXP BOT, V55, P1715, DOI 10.1093/jxb/erh209; Li Na, 2005, Acta Genetica Sinica, V32, P571; Li XM, 2007, GENOME, V50, P400, DOI 10.1139/G07-025; Li ZS, 1977, ACTA GENETIC SINICA, V4, P279; Liu Shu-Bing, 1999, Acta Genetica Sinica, V26, P37; Liu ShuBing, 1998, Acta Agronomica Sinica, V24, P687; Ma J.X., 1999, CHINESE SCI BULL, V44, P65, DOI [10.1007/BF02885488, DOI 10.1007/BF02885488]; Mao PS, 2010, AGR SCI CHINA, V9, P1553, DOI 10.1016/S1671-2927(09)60251-0; McDonald MP, 2001, ANN BOT-LONDON, V88, P215, DOI 10.1006/anbo.2001.1444; Oliver RE, 2006, THEOR APPL GENET, V112, P1473, DOI 10.1007/s00122-006-0250-1; Prabhu KV, 2004, PLANT BREEDING, V123, P417, DOI 10.1111/j.1439-0523.2004.00971.x; Prins R, 2001, THEOR APPL GENET, V103, P618, DOI 10.1007/PL00002918; Qi LL, 2008, THEOR APPL GENET, V117, P1155, DOI 10.1007/s00122-008-0853-9; SEARS ER, 1993, CROP SCI, V33, P897, DOI 10.2135/cropsci1993.0011183X003300050004x; Shen X, 2006, PLANT BREEDING, V125, P424, DOI 10.1111/j.1439-0523.2006.01274.x; Shen XR, 2007, MOL BREEDING, V20, P131, DOI 10.1007/s11032-007-9079-9; Wang JR, 2010, CAN J PLANT PATHOL, V32, P188, DOI 10.1080/07060661003740512; Wang Jing-xue, 2000, J SHANXI U, V23, P271; Yan HongFei, 2009, Acta Phytopathologica Sinica, V39, P76; [闫小丹 Yan Xiaodan], 2010, [生物技术通报, Biotechnology Bulletin], P18; You MingShan, 2003, Journal of Agricultural Biotechnology, V11, P577; You MingShan, 2002, Journal of China Agricultural University, V7, P1; Zhang Li, 2008, Journal of Agricultural Biotechnology, V16, P465; Zhang XL, 2011, THEOR APPL GENET, V122, P263, DOI 10.1007/s00122-010-1441-3	36	79	94	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65122	10.1371/journal.pone.0065122	http://dx.doi.org/10.1371/journal.pone.0065122			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762296	Green Published, Green Submitted, gold			2022-12-27	WOS:000320440500027
J	Gotschel, F; Berg, D; Gruber, W; Bender, C; Eberl, M; Friedel, M; Sonntag, J; Rungeler, E; Hache, H; Wierling, C; Nietfeld, W; Lehrach, H; Frischauf, A; Schwartz-Albiez, R; Aberger, F; Korf, U				Goetschel, Frank; Berg, Daniela; Gruber, Wolfgang; Bender, Christian; Eberl, Markus; Friedel, Myriam; Sonntag, Johanna; Ruengeler, Elena; Hache, Hendrik; Wierling, Christoph; Nietfeld, Wilfried; Lehrach, Hans; Frischauf, Annemarie; Schwartz-Albiez, Reinhard; Aberger, Fritz; Korf, Ulrike			Synergism between Hedgehog-GLI and EGFR Signaling in Hedgehog-Responsive Human Medulloblastoma Cells Induces Downregulation of Canonical Hedgehog-Target Genes and Stabilized Expression of GLI1	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SONIC-HEDGEHOG; CANCER; PATHWAY; TRANSCRIPTION; DEGRADATION; COOPERATION; MECHANISMS; PHENOTYPE; BEHAVIOR	Aberrant activation of Hedgehog (HH) signaling has been identified as a key etiologic factor in many human malignancies. Signal strength, target gene specificity, and oncogenic activity of HH signaling depend profoundly on interactions with other pathways, such as epidermal growth factor receptor-mediated signaling, which has been shown to cooperate with HH/GLI in basal cell carcinoma and pancreatic cancer. Our experimental data demonstrated that the Daoy human medulloblastoma cell line possesses a fully inducible endogenous HH pathway. Treatment of Daoy cells with Sonic HH or Smoothened agonist induced expression of GLI1 protein and simultaneously prevented the processing of GLI3 to its repressor form. To study interactions between HH- and EGF-induced signaling in greater detail, time-resolved measurements were carried out and analyzed at the transcriptomic and proteomic levels. The Daoy cells responded to the HH/EGF co-treatment by downregulating GLI1, PTCH, and HHIP at the transcript level; this was also observed when Amphiregulin (AREG) was used instead of EGF. We identified a novel crosstalk mechanism whereby EGFR signaling silences proteins acting as negative regulators of HH signaling, as AKT- and ERK-signaling independent process. EGFR/HH signaling maintained high GLI1 protein levels which contrasted the GLI1 downregulation on the transcript level. Conversely, a high-level synergism was also observed, due to a strong and significant upregulation of numerous canonical EGF-targets with putative tumor-promoting properties such as MMP7, VEGFA, and IL-8. In conclusion, synergistic effects between EGFR and HH signaling can selectively induce a switch from a canonical HH/GLI profile to a modulated specific target gene profile. This suggests that there are more wide-spread, yet context-dependent interactions, between HH/GLI and growth factor receptor signaling in human malignancies.	[Goetschel, Frank; Berg, Daniela; Bender, Christian; Sonntag, Johanna; Ruengeler, Elena; Korf, Ulrike] German Canc Res Ctr, Div Mol Genome Anal, Heidelberg, Germany; [Gruber, Wolfgang; Eberl, Markus; Frischauf, Annemarie; Aberger, Fritz] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Friedel, Myriam; Schwartz-Albiez, Reinhard] German Canc Res Ctr, Div Translat Immunol, Heidelberg, Germany; [Hache, Hendrik; Wierling, Christoph; Nietfeld, Wilfried; Lehrach, Hans] Max Planck Inst Mol Genet, Dept Vertebrate Genom, D-14195 Berlin, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Salzburg University; Helmholtz Association; German Cancer Research Center (DKFZ); Max Planck Society	Aberger, F (corresponding author), Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria.	fritz.aberger@sbg.ac.at; u.korf@dkfz.de	Aberger, Fritz/B-6357-2012	Aberger, Fritz/0000-0003-2009-6305; Wierling, Christoph/0000-0002-8856-8412	German Federal Ministry of Education and Science (BMBF); Austrian Genome Research Program GEN-AU/Austrian Science Fund FWF [0315394A/0315394B, P20652]; Medical Systems Biology project [0315396B]	German Federal Ministry of Education and Science (BMBF)(Federal Ministry of Education & Research (BMBF)); Austrian Genome Research Program GEN-AU/Austrian Science Fund FWF; Medical Systems Biology project	Work was funded by the German Federal Ministry of Education and Science (BMBF) and by the Austrian Genome Research Program GEN-AU/Austrian Science Fund FWF as bi-national Medical Systems Biology projects 0315394A/0315394B and P20652, respectively (http://pybios.molgen.mpg.de/MoGLI). Further funding was received from the Medical Systems Biology project 0315396B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharonov O, 1993, Ocul Immunol Inflamm, V1, P135, DOI 10.3109/09273949309086550; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigelow RLH, 2005, J INVEST DERMATOL, V124, P457, DOI 10.1111/j.0022-202X.2004.23590.x; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; De Larco JE, 2004, CLIN CANCER RES, V10, P4895, DOI 10.1158/1078-0432.CCR-03-0760; Eberl M, 2012, EMBO MOL MED, V4, P218, DOI 10.1002/emmm.201100201; Ericson J, 1995, INT J DEV BIOL, V39, P809; Fogarty MP, 2007, P NATL ACAD SCI USA, V104, P2973, DOI 10.1073/pnas.0605770104; Grizzi F, 2008, PEDIATR RES, V63, P584, DOI 10.1203/01.pdr.0000305884.29279.6b; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hartmann W, 2005, AM J PATHOL, V166, P1153, DOI 10.1016/S0002-9440(10)62335-8; Henjes F, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.16; Hua H, 2011, CELL MOL LIFE SCI, V68, P3853, DOI 10.1007/s00018-011-0763-x; Huber H, 2001, EUR J CANCER, V37, P2064, DOI 10.1016/S0959-8049(01)00225-8; Ito TK, 2007, ONCOGENE, V26, P7194, DOI 10.1038/sj.onc.1210535; Ito TK, 2009, BLOOD, V113, P2363, DOI 10.1182/blood-2008-08-172742; Ji ZY, 2007, J BIOL CHEM, V282, P14048, DOI 10.1074/jbc.M611089200; Jr HRJ, 2012, PLOS ONE, V7; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Laner-Plamberger S, 2009, ONCOGENE, V28, P1639, DOI 10.1038/onc.2009.10; Lauth M, 2007, ONCOGENE, V26, P5163, DOI 10.1038/sj.onc.1210321; Lauth M, 2011, FRONT BIOSCI-LANDMRK, V16, P2259, DOI 10.2741/3852; Loebke C, 2007, PROTEOMICS, V7, P558, DOI 10.1002/pmic.200600757; Mangelberger D, 2012, FRONT BIOSCI-LANDMRK, V17, P90, DOI 10.2741/3917; McMurray HR, 2008, NATURE, V453, P1112, DOI 10.1038/nature06973; Mimeault M, 2010, PHARMACOL REV, V62, P497, DOI 10.1124/pr.109.002329; Miyamoto S, 2004, CANCER RES, V64, P665, DOI 10.1158/0008-5472.CAN-03-1916; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Palma V, 2004, DEVELOPMENT, V131, P337, DOI 10.1242/dev.00930; RDevelopmentCoreTeam, 2011, R LANG ENV STAT COMP; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Riobo NA, 2006, CELL CYCLE, V5, P1612, DOI 10.4161/cc.5.15.3130; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Schnidar H, 2009, CANCER RES, V69, P1284, DOI 10.1158/0008-5472.CAN-08-2331; Seto M, 2009, MOL CARCINOGEN, V48, P703, DOI 10.1002/mc.20516; Simonini A, 2000, CIRCULATION, V101, P1519, DOI 10.1161/01.CIR.101.13.1519; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang Y, 2012, CANCER CELL, V21, P374, DOI 10.1016/j.ccr.2011.12.028; Wei LY, 2011, INT J CANCER, V129, P275, DOI 10.1002/ijc.25673; Wen XH, 2010, MOL CELL BIOL, V30, P1910, DOI 10.1128/MCB.01089-09; Whisenant TC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000908; Willmarth NE, 2009, CELL SIGNAL, V21, P212, DOI 10.1016/j.cellsig.2008.10.003; Yarden Y, 2001, EUR J CANCER, V37, pS3	47	63	65	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65403	10.1371/journal.pone.0065403	http://dx.doi.org/10.1371/journal.pone.0065403			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762360	Green Published, gold			2022-12-27	WOS:000320440500036
J	Wang, LJ; Shi, SJ; Guo, ZY; Zhang, X; Han, SX; Yang, AG; Wen, WH; Zhu, Q				Wang, Lijuan; Shi, Shengjia; Guo, Zhangyan; Zhang, Xiang; Han, Suxia; Yang, Angang; Wen, Weihong; Zhu, Qing			Overexpression of YAP and TAZ Is an Independent Predictor of Prognosis in Colorectal Cancer and Related to the Proliferation and Metastasis of Colon Cancer Cells	PLOS ONE			English	Article							YES-ASSOCIATED PROTEIN; TUMOR-SUPPRESSOR; HIPPO PATHWAY; ORGAN SIZE; GROWTH-CONTROL; BREAST-CANCER; TRANSCRIPTION; ONCOGENE; DOMAIN; MICE	Background and Objective: Yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding motif (TAZ) are nuclear effectors of the Hippo pathway. Although they are abundantly expressed in the cytoplasm and nuclei of human colorectal cancer (CRC), and related to tumor proliferation status, there have been few studies on the predictive role of YAP and TAZ expression on the overall survival of patients with CRC. This study investigated YAP and TAZ expression in both CRC patients and colon cancer cell lines, and assessed their prognostic value. Methods: Paraffin-embedded specimens from 168 eligible patients were used to investigate YAP and TAZ expression by immunohistochemistry, and compared with experimental results in colon cancer HCT116 cell line to explore their clinical significance in CRC. Results: Statistically significant positive correlations were found between protein expression of YAP and TAZ in CRC tissues. Patients with higher YAP or TAZ expression showed a trend of shorter survival times; more importantly, our cohort study indicated that patients with both YAP and TAZ overexpression presented the worst outcomes. This was supported by multivariate analysis. In HCT116 colon cancer cells, the capacity for proliferation, metastasis, and invasion was dramatically reduced by knockdown of YAP and TAZ expressions by siRNA. Conclusions: Co-overexpression of YAP and TAZ is an independent predictor of prognosis for patients with CRC, and may account for the higher proliferation, metastasis, and poor survival outcome of these patients.	[Wang, Lijuan; Han, Suxia; Zhu, Qing] Xi An Jiao Tong Univ, Affiliated Hosp 1, Coll Med, Dept Oncol, Xian 710049, Peoples R China; [Shi, Shengjia; Guo, Zhangyan; Zhang, Xiang; Yang, Angang; Wen, Weihong] Fourth Mil Med Univ, Dept Immunol, State Key Lab Canc Biol, Xian 710032, Peoples R China	Xi'an Jiaotong University; Air Force Military Medical University	Wen, WH (corresponding author), Fourth Mil Med Univ, Dept Immunol, State Key Lab Canc Biol, Xian 710032, Peoples R China.	wenweih@fmmu.edu.cn; newzhuqing1972@yohoo.com	温, 家琦/GYV-3177-2022	Han, Suxia/0000-0002-1513-7427	National Natural Science Foundation of China [81072117]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81072117). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avruch J, 2012, CELL CYCLE, V11, P1090, DOI 10.4161/cc.11.6.19453; Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chan SW, 2011, ONCOGENE, V30, P600, DOI 10.1038/onc.2010.438; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chan SW, 2009, J BIOL CHEM, V284, P14347, DOI 10.1074/jbc.M901568200; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hong WJ, 2012, SEMIN CELL DEV BIOL, V23, P785, DOI 10.1016/j.semcdb.2012.05.004; Hossain Z, 2007, P NATL ACAD SCI USA, V104, P1631, DOI 10.1073/pnas.0605266104; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; Makita R, 2008, AM J PHYSIOL-RENAL, V294, pF542, DOI 10.1152/ajprenal.00201.2007; Morin-Kensicki EM, 2006, MOL CELL BIOL, V26, P77, DOI 10.1128/MCB.26.1.77-87.2006; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Olson Michael F, 2005, Cancer Res, V65, P11247, DOI 10.1158/0008-5472.CAN-05-2713; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Rosenberg R, 2008, ANN SURG, V248, P968, DOI 10.1097/SLA.0b013e318190eddc; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wang XD, 2012, EUR J CANCER, V48, P1227, DOI 10.1016/j.ejca.2011.10.001; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Yuen HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054211; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhang X, 2011, CELL DEATH DIFFER, V18, P1346, DOI 10.1038/cdd.2011.6; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001; Zhou Z, 2011, ONCOGENE, V30, P2181, DOI 10.1038/onc.2010.606	38	220	235	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65539	10.1371/journal.pone.0065539	http://dx.doi.org/10.1371/journal.pone.0065539			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762387	Green Published, gold, Green Submitted			2022-12-27	WOS:000320440500043
J	Egan, CE; Daugherity, EK; Rogers, AB; Abdallah, DSA; Denkers, EY; Maurer, KJ				Egan, Charlotte E.; Daugherity, Erin K.; Rogers, Arlin B.; Abdallah, Delbert S. Abi; Denkers, Eric Y.; Maurer, Kirk J.			CCR2 and CD44 Promote Inflammatory Cell Recruitment during Fatty Liver Formation in a Lithogenic Diet Fed Mouse Model	PLOS ONE			English	Article							NONALCOHOLIC STEATOHEPATITIS; HEPATIC STEATOSIS; TNF-ALPHA; CYTOKINE INDUCTION; HYALURONAN-BINDING; INSULIN-RESISTANCE; MONOCYTE CD44; MICE; EXPRESSION; DISEASE	Non-alcoholic fatty liver disease (NAFLD) is a common disease with a spectrum of presentations. The current study utilized a lithogenic diet model of NAFLD. The diet was fed to mice that are either resistant (AKR) or susceptible (BALB/c and C57BL/6) to hepatitis followed by molecular and flow cytometric analysis. Following this, a similar approach was taken in congenic mice with specific mutations in immunological genes. The initial study identified a significant and profound increase in multiple ligands for the chemokine receptor CCR2 and an increase in CD44 expression in susceptible C57BL/6 (B6) but not resistant AKR mice. Ccr2(-/-) mice were completely protected from hepatitis and Cd44(-/-) mice were partially protected. Despite protection from inflammation, both strains displayed similar histological steatosis scores and significant increases in serum liver enzymes. CD45(+)CD44(+) cells bound to hyaluronic acid (HA) in diet fed B6 mice but not Cd44(-/-) or Ccr2(-/-) mice. Ccr2(-/-) mice displayed a diminished HA binding phenotype most notably in monocytes, and CD8(+) T-cells. In conclusion, this study demonstrates that absence of CCR2 completely and CD44 partially reduces hepatic leukocyte recruitment. These data also provide evidence that there are multiple redundant CCR2 ligands produced during hepatic lipid accumulation and describes the induction of a strong HA binding phenotype in response to LD feeding in some subsets of leukocytes from susceptible strains.	[Egan, Charlotte E.; Abdallah, Delbert S. Abi; Denkers, Eric Y.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; [Daugherity, Erin K.; Maurer, Kirk J.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Daugherity, Erin K.; Maurer, Kirk J.] Cornell Univ, Coll Vet Med, Ctr Anim Resources & Educ, Ithaca, NY 14853 USA; [Rogers, Arlin B.] Univ N Carolina, Dept Pathol, Chapel Hill, NC USA; [Rogers, Arlin B.] Univ N Carolina, Lab Med, Chapel Hill, NC USA	Cornell University; Cornell University; Cornell University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Maurer, KJ (corresponding author), Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA.	Kirk.J.Maurer@Dartmouth.edu	denkers, eric/Q-3173-2019; Egan, Charlotte/F-4468-2012	Egan, Charlotte/0000-0003-3238-4574	National Institutes of Heath [DK077728, AI083526]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK077728] Funding Source: NIH RePORTER	National Institutes of Heath(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Heath grants DK077728 and AI083526. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarapurkar Deepak N, 2004, Trop Gastroenterol, V25, P130; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008; Bertola A, 2009, DIABETES, V58, P125, DOI 10.2337/db08-0400; Bertola A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013577; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Charatcharoenwitthaya P, 2012, DIGEST DIS SCI, V57, P1925, DOI 10.1007/s10620-012-2098-3; Daugherity EK, 2012, CELL CYCLE, V11, P1918, DOI 10.4161/cc.20259; Davies JP, 2005, J BIOL CHEM, V280, P12710, DOI 10.1074/jbc.M409110200; Egan CE, 2011, MUCOSAL IMMUNOL, V4, P658, DOI 10.1038/mi.2011.31; Egan CE, 2009, MUCOSAL IMMUNOL, V2, P527, DOI 10.1038/mi.2009.105; Egan C.E., 2011, IMMUNOL CELL BIOL; Gee K, 2004, ARCH IMMUNOL THER EX, V52, P13; Gee K, 2002, J IMMUNOL, V169, P5660, DOI 10.4049/jimmunol.169.10.5660; Harmon RC, 2011, EXPERT REV GASTROENT, V5, P189, DOI [10.1586/egh.11.21, 10.1586/EGH.11.21]; Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011; Ibrahim J, 2012, GASTROENTEROLOGY, V143, P1061, DOI 10.1053/j.gastro.2012.06.003; Kamada Y, 2011, AM J PHYSIOL-GASTR L, V301, pG1031, DOI 10.1152/ajpgi.00211.2011; Kang HH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058417, 10.1371/journal.pone.0084097]; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Kassel KM, 2010, LAB INVEST, V90, P1794, DOI 10.1038/labinvest.2010.143; Kim CH, 2002, BLOOD, V100, P11, DOI 10.1182/blood-2001-12-0196; Le YY, 2004, CELL MOL IMMUNOL, V1, P95; Legras S, 1997, BLOOD, V89, P1905, DOI 10.1182/blood.V89.6.1905; Levesque MC, 1997, J IMMUNOL, V159, P6184; Levesque MC, 2001, J IMMUNOL, V166, P188, DOI 10.4049/jimmunol.166.1.188; LIAO HX, 1995, J IMMUNOL, V155, P3938; Maiti A, 1998, SCIENCE, V282, P941, DOI 10.1126/science.282.5390.941; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Matsuzawa N, 2007, HEPATOLOGY, V46, P1392, DOI 10.1002/hep.21874; Mbitikon-Kobo FM, 2009, J IMMUNOL, V182, P3846, DOI 10.4049/jimmunol.0802438; McDonald B, 2008, J EXP MED, V205, P915, DOI 10.1084/jem.20071765; Miura K, 2012, AM J PHYSIOL-GASTR L, V302, pG1310, DOI 10.1152/ajpgi.00365.2011; Mofrad P, 2003, HEPATOLOGY, V37, P1286, DOI 10.1053/jhep.2003.50229; Moschetta A, 2004, NAT MED, V10, P1352, DOI 10.1038/nm1138; Sahai A, 2004, AM J PHYSIOL-GASTR L, V287, pG264, DOI 10.1152/ajpgi.00002.2004; Schreyer SA, 1998, ATHEROSCLEROSIS, V136, P17, DOI 10.1016/S0021-9150(97)00165-2; Serbina NV, 2009, J IMMUNOL, V183, P1900, DOI 10.4049/jimmunol.0900612; Spruss A, 2009, HEPATOLOGY, V50, P1094, DOI 10.1002/hep.23122; Syn WK, 2012, GUT, V61, P1323, DOI 10.1136/gutjnl-2011-301857; Syn WK, 2011, HEPATOLOGY, V53, P106, DOI 10.1002/hep.23998; Tamura Y, 2008, ARTERIOSCL THROM VAS, V28, P2195, DOI 10.1161/ATVBAHA.108.168633; Tamura Y, 2010, J ATHEROSCLER THROMB, V17, P219, DOI 10.5551/jat.3368; Termeer C, 2001, J LEUKOCYTE BIOL, V70, P715; Torres DM, 2008, GASTROENTEROLOGY, V134, P1682, DOI 10.1053/j.gastro.2008.02.077; Uppal H, 2008, HEPATOLOGY, V47, P1331, DOI 10.1002/hep.22175; Vanbervliet A, 2002, EUR J IMMUNOL, V32, P231, DOI 10.1002/1521-4141(200201)32:1<231::AID-IMMU231>3.0.CO;2-8; Vicari Alain P, 2004, Novartis Found Symp, V256, P241; Wang DQH, 2005, BBA-MOL CELL BIOL L, V1733, P90, DOI 10.1016/j.bbalip.2004.12.005; Wang DQH, 2002, BBA-MOL CELL BIOL L, V1583, P141, DOI 10.1016/S1388-1981(02)00194-4; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Wittenburg H, 2002, PHYSIOL GENOMICS, V8, P67, DOI 10.1152/physiolgenomics.00097.2001; WOLPE SD, 1988, J EXP MED, V167, P570, DOI 10.1084/jem.167.2.570; WOO J, 1994, TRANSPLANTATION, V58, P484, DOI 10.1097/00007890-199408270-00015; Yamawaki H, 2009, GLYCOBIOLOGY, V19, P83, DOI 10.1093/glycob/cwn109; Zaldivar MM, 2010, HEPATOLOGY, V51, P1345, DOI 10.1002/hep.23435	56	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65247	10.1371/journal.pone.0065247	http://dx.doi.org/10.1371/journal.pone.0065247			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762326	Green Published, gold, Green Submitted			2022-12-27	WOS:000321094800030
J	Seike, K; Shirai, K; Kogure, Y				Seike, Koji; Shirai, Kotaro; Kogure, Yukihisa			Disturbance of Shallow Marine Soft-Bottom Environments and Megabenthos Assemblages by a Huge Tsunami Induced by the 2011 M9.0 Tohoku-Oki Earthquake	PLOS ONE			English	Article							POLYCHAETE EUZONUS SP; YOLDIA-NOTABILIS; ANDAMAN SEA; IMPACT; SEDIMENTS; RECOVERY; BEHAVIOR; BURROWS; HASAKI; FAUNA	Huge tsunami waves associated with megathrust earthquakes have a severe impact on shallow marine ecosystems. We investigated the impact of a tsunami generated by the 2011 M9.0 Tohoku-Oki earthquake on the seafloor and large benthic animals in muddy and sandy ria coasts (Otsuchi and Funakoshi bays) in northeastern Japan. We conducted underwater field surveys using scuba equipment in water depths of <20 m before the tsunami (September 2010) and after the tsunami (September 2011 and September 2012). During the study period, episodic changes in topography and grain-size composition occurred on the seafloor of the study area. Megabenthos sampling revealed a distinct pattern of distribution succession for each benthic species. For example, the protobranch bivalve Yoldia notabilis (Bivalvia: Nuculanidae) and the heterodont bivalve Felaniella usta (Bivalvia: Ungulinidae) disappeared after the tsunami event, whereas the distribution of the venus clam Gomphina melanaegis (Bivalvia: Veneridae) remained unchanged. In addition, the patterns of succession for a single species, such as the giant button top shell Umbonium costatum (Gastropoda: Trochidae) and the heart urchin Echinocardium cordatum (Echinoidea: Loveniidae), varied between the two bays studied. Our data also show that reestablishment of some benthic animal populations began within 18 months of the tsunami disturbance.	[Seike, Koji; Shirai, Kotaro; Kogure, Yukihisa] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan	University of Tokyo	Seike, K (corresponding author), Univ Tokyo, Atmosphere & Ocean Res Inst, 5-1-5 Kashiwanoha, Kashiwa, Chiba, Japan.	seike@aori.u-tokyo.ac.jp	Shirai, Kotaro/B-5758-2012; Seike, Koji/G-1050-2012	Shirai, Kotaro/0000-0003-3922-5971; Seike, Koji/0000-0002-6938-0350	Atmosphere and Ocean Research Institute, the University of Tokyo [113, 102, 137, 122]; Japan Society for the Promotion of Science [22-10734]; Tohoku Ecosystem-Associated Marine Sciences (TEAMS) project	Atmosphere and Ocean Research Institute, the University of Tokyo; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tohoku Ecosystem-Associated Marine Sciences (TEAMS) project	This research was supported by the Cooperative Program of the Atmosphere and Ocean Research Institute, the University of Tokyo (number 113 in 2010; numbers 102 and 137 in 2011; and number 122 in 2012 to KSe), and was partly supported by a Research Fellowship of the Japan Society for the Promotion of Science (22-10734 to KSe) and the Tohoku Ecosystem-Associated Marine Sciences (TEAMS) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, J JAPAN SOC CIVIL EN; Chavanich S, 2005, CORAL REEFS, V24, P535, DOI 10.1007/s00338-005-0016-2; Chavanich S, 2008, J NAT HIST, V42, P177, DOI 10.1080/00222930701847915; Feldens P, 2009, POL J ENVIRON STUD, V18, P63; Fujikura K, 2012, JPN J BENTHOL, V66, P129; Fujioka K, 1988, OTSUCHI MAR RES CENT, V14, P15; Furota T, 2012, JPN J BENTHOL, V66, P126; Geospatial Information Authority of Japan, 2012, DIG JAP PORT WEB SIT; Goto K, 2012, SEDIMENT GEOL, V282, P1, DOI 10.1016/j.sedgeo.2012.08.003; Goto K, 2011, MAR GEOL, V290, P46, DOI 10.1016/j.margeo.2011.10.004; Goto K, 2011, GEOMORPHOLOGY, V127, P107, DOI 10.1016/j.geomorph.2010.12.011; Higano Junya, 1993, Bulletin of National Research Institute of Fisheries Engineering, V14, P65; Hinata H, 2011, ESTUAR COAST SHELF S, V95, P268, DOI 10.1016/j.ecss.2011.08.009; Horikoshi M, 1977, OTSUCHI MAR RES CENT, V3, P41; Horikoshi M, 1978, OTSUCHI MAR RES CEN, V4, P53; Horikoshi M, 1976, OTSUCHI MAR RES CENT, V2, P65; Horikoshi M, 1979, OTSUCHI MAR RES CENT, V5, P37; Ide S, 2011, SCIENCE, V332, P1426, DOI 10.1126/science.1207020; Inoue M, 1988, OTSUCHI MAR RES CENT, V14, P11; Jaramillo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035348; Kanaya Gen, 2012, Japanese Journal of Benthology, V67, P20; Kathiresan K, 2005, ESTUAR COAST SHELF S, V65, P601, DOI 10.1016/j.ecss.2005.06.022; Kendall MA, 2009, POL J ENVIRON STUD, V18, P69; Kristensen E, 2012, MAR ECOL PROG SER, V446, P285, DOI 10.3354/meps09506; Kuriyama Y, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC000899; Kuriyama Y, 2008, MAR GEOL, V248, P1, DOI 10.1016/j.margeo.2007.10.006; McLachlan A, 2006, ECOLOGY SANDY SHORES; Miura O, 2012, J MOLLUS STUD, V78, P377, DOI 10.1093/mollus/eys025; Mori N, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049210; NAKAOKA M, 1992, MAR ECOL PROG SER, V88, P215, DOI 10.3354/meps088215; NAKAOKA M, 1994, MAR ECOL PROG SER, V114, P129, DOI 10.3354/meps114129; Nakaoka M, 2006, NAGISA WORLD C 2006, V2006, P49; Noda A, 2007, SEDIMENT GEOL, V200, P314, DOI 10.1016/j.sedgeo.2007.01.010; Okoshi K, 2012, JPN J BENTHOLOGY, V66, P117; Ozawa S, 2011, NATURE, V475, P373, DOI 10.1038/nature10227; Sato M, 2011, SCIENCE, V332, P1395, DOI 10.1126/science.1207401; Sato S., 2012, JPN J BENTHOL, V66, P122; Sato-Okoshi W, 2012, JPN J BENTHOL, V66, P124; Sawai Y, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053692; Sawall Y, 2010, HELGOLAND MAR RES, V64, P357, DOI 10.1007/s10152-010-0192-5; Seike K, 2008, MAR BIOL, V153, P1199, DOI 10.1007/s00227-007-0893-8; Seike K, 2009, PALAIOS, V24, P799, DOI 10.2110/palo.2009.p09-007r; SHORT AD, 1979, J GEOL, V87, P553, DOI 10.1086/628445; Short AD, 1979, HDB BEACH SHOREFACE; Simons M, 2011, SCIENCE, V332, P1421, DOI 10.1126/science.1206731; Suzuki T, 2012, JPN J BENTHOL, V66, P120; The 2011 Tohoku Earthquake Tsunami Joint Survey Group, 2012, TOH EARTHQ TSUN INF; The 2011 Tohoku Earthquake Tsunami Joint Survey Group (TETJSG), 2011, J JAPAN SOC CIVIL B, V67, P63, DOI DOI 10.2208/KAIGAN.67.63; Tsuchida E, 1990, OTSUCHI MAR RES CENT, V16, P1; TSUCHIDA E., 1993, OTSUCHI MAR RES CENT, V19, P1; Tsuchida Eiji, 1996, Otsuchi Marine Research Center Report, V21, P1; Udo K, 2012, COAST ENG J, V54, DOI 10.1142/S057856341250009X; Whanpetch N, 2010, ESTUAR COAST SHELF S, V87, P246, DOI 10.1016/j.ecss.2010.01.001; Ziebis W, 1996, NATURE, V382, P619, DOI 10.1038/382619a0	54	84	85	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65417	10.1371/journal.pone.0065417	http://dx.doi.org/10.1371/journal.pone.0065417			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762365	Green Submitted, Green Published, gold			2022-12-27	WOS:000321094800047
J	Jia, XM; Han, B; Onengut-Gumuscu, S; Chen, WM; Concannon, PJ; Rich, SS; Raychaudhuri, S; de Bakker, PIW				Jia, Xiaoming; Han, Buhm; Onengut-Gumuscu, Suna; Chen, Wei-Min; Concannon, Patrick J.; Rich, Stephen S.; Raychaudhuri, Soumya; de Bakker, Paul I. W.			Imputing Amino Acid Polymorphisms in Human Leukocyte Antigens	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MAJOR HISTOCOMPATIBILITY COMPLEX; CLASSICAL HLA ALLELES; EXTENDED HUMAN MHC; GENOTYPE IMPUTATION; DISEASE ASSOCIATION; COMMON DISEASES; HAPLOTYPE; SUSCEPTIBILITY; INFERENCE	DNA sequence variation within human leukocyte antigen (HLA) genes mediate susceptibility to a wide range of human diseases. The complex genetic structure of the major histocompatibility complex (MHC) makes it difficult, however, to collect genotyping data in large cohorts. Long-range linkage disequilibrium between HLA loci and SNP markers across the major histocompatibility complex (MHC) region offers an alternative approach through imputation to interrogate HLA variation in existing GWAS data sets. Here we describe a computational strategy, SNP2HLA, to impute classical alleles and amino acid polymorphisms at class I (HLA-A, -B, -C) and class II (-DPA1, -DPB1, -DQA1, -DQB1, and -DRB1) loci. To characterize performance of SNP2HLA, we constructed two European ancestry reference panels, one based on data collected in HapMap-CEPH pedigrees (90 individuals) and another based on data collected by the Type 1 Diabetes Genetics Consortium (T1DGC, 5,225 individuals). We imputed HLA alleles in an independent data set from the British 1958 Birth Cohort (N = 918) with gold standard four-digit HLA types and SNPs genotyped using the Affymetrix GeneChip 500 K and Illumina Immunochip microarrays. We demonstrate that the sample size of the reference panel, rather than SNP density of the genotyping platform, is critical to achieve high imputation accuracy. Using the larger T1DGC reference panel, the average accuracy at four-digit resolution is 94.7% using the low-density Affymetrix GeneChip 500 K, and 96.7% using the high-density Illumina Immunochip. For amino acid polymorphisms within HLA genes, we achieve 98.6% and 99.3% accuracy using the Affymetrix GeneChip 500 K and Illumina Immunochip, respectively. Finally, we demonstrate how imputation and association testing at amino acid resolution can facilitate fine-mapping of primary MHC association signals, giving a specific example from type 1 diabetes.	[Jia, Xiaoming] Harvard MIT Massachusetts Inst Technol, Div Hlth Sci & Technol, Boston, MA USA; [Han, Buhm; Raychaudhuri, Soumya; de Bakker, Paul I. W.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet, Boston, MA 02115 USA; [Han, Buhm; Raychaudhuri, Soumya; de Bakker, Paul I. W.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Han, Buhm; Raychaudhuri, Soumya] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol, Boston, MA 02115 USA; [Onengut-Gumuscu, Suna; Chen, Wei-Min; Concannon, Patrick J.; Rich, Stephen S.] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; [Raychaudhuri, Soumya] Partners HealthCare Ctr Personalized Genet Med, Boston, MA USA; [Raychaudhuri, Soumya] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Epidemiol, Utrecht, Netherlands; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Virginia; Partners Healthcare System; University of Manchester; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Raychaudhuri, S (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet, Boston, MA 02115 USA.	soumya@broadinstitute.org; pdebakker@umcutrecht.nl	de Bakker, Paul IW/B-8730-2009; Han, Buhm/AAQ-9672-2020	de Bakker, Paul IW/0000-0001-7735-7858; Rich, Stephen/0000-0003-3872-7793; Jia, Xiaoming/0000-0002-5104-5431; Raychaudhuri, Soumya/0000-0002-1901-8265; Concannon, Patrick/0000-0002-5801-1859	Howard Hughes Medical Institute; Bill and Melinda Gates Foundation; National Institutes of Health [K08AR055688, 1R01AR062886-01]; Medical Research Council [G0000934]; Wellcome Trust [068545/Z/02]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Allergy and Infectious Diseases (NIAID); National Human Genome Research Institute (NHGRI); National Institute of Child Health and Human Development; Juvenile Diabetes Research Foundation International (JDRF); Netherlands Organization for Scientific Research (NWO);  [U01 DK062418]; Medical Research Council [G1001799] Funding Source: researchfish; MRC [G0000934, G1001799] Funding Source: UKRI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062886, K08AR055688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062418] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Juvenile Diabetes Research Foundation International (JDRF)(Juvenile Diabetes Research Foundation); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was made possible by the Howard Hughes Medical Institute (Research Fellowship for Medical Students to XJ), the Bill and Melinda Gates Foundation (Collaboration for AIDS Vaccine Discovery sub-award to PIWdB), and the National Institutes of Health (K08AR055688 to SR and 1R01AR062886-01 to PIWdB). The authors acknowledge use of the British 1958 Birth Cohort DNA collection, funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02. This research uses resources provided by the Type 1 Diabetes Genetics Consortium (T1DGC); a collaborative clinical study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Allergy and Infectious Diseases (NIAID); National Human Genome Research Institute (NHGRI); National Institute of Child Health and Human Development; Juvenile Diabetes Research Foundation International (JDRF), supported by U01 DK062418. PIWdB is the recipient of a VIDI Award from the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achkar JP, 2012, GENES IMMUN, V13, P245, DOI 10.1038/gene.2011.79; Bharadwaj M, 2012, ANNU REV PHARMACOL, V52, P401, DOI 10.1146/annurev-pharmtox-010611-134701; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Cucca F, 2001, HUM MOL GENET, V10, P2025, DOI 10.1093/hmg/10.19.2025; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; de Bakker PIW, 2012, HUM MOL GENET, V21, pR29, DOI 10.1093/hmg/dds384; Dilthey AT, 2011, BIOINFORMATICS, V27, P968, DOI 10.1093/bioinformatics/btr061; Erlich H, 2012, TISSUE ANTIGENS, V80, P1, DOI 10.1111/j.1399-0039.2012.01881.x; Erlich RL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-42; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Gregersen PK, 2012, ANN NEUROLOGY; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Horton R, 2008, IMMUNOGENETICS, V60, P1, DOI 10.1007/s00251-007-0262-2; Invernizzi P, 2012, GENES IMMUNITY; Leslie S, 2008, AM J HUM GENET, V82, P48, DOI 10.1016/j.ajhg.2007.09.001; Li SP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002791; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; McCormack M, 2011, NEW ENGL J MED, V364, P1134, DOI 10.1056/NEJMoa1013297; McLaren PJ, 2012, HUMAN MOL GENETICS; Monsuur AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002270; Morishima S, 2010, BLOOD, V115, P4664, DOI 10.1182/blood-2009-10-251157; Moutsianas L, 2011, BLOOD, V118, P670, DOI 10.1182/blood-2011-03-339630; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Robinson J, 2009, NUCLEIC ACIDS RES, V37, pD1013, DOI 10.1093/nar/gkn662; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Setty MN, 2011, J COMPUT BIOL, V18, P483, DOI 10.1089/cmb.2010.0258; Stewart CA, 2004, GENOME RES, V14, P1176, DOI 10.1101/gr.2188104; Strachan DP, 2007, INT J EPIDEMIOL, V36, P522, DOI 10.1093/ije/dyl309; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; Traherne JA, 2008, INT J IMMUNOGENET, V35, P179, DOI 10.1111/j.1744-313X.2008.00765.x; Traherne JA, 2006, PLOS GENET, V2, P81, DOI 10.1371/journal.pgen.0020009; Xie MZ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S11-S10	40	179	186	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64683	10.1371/journal.pone.0064683	http://dx.doi.org/10.1371/journal.pone.0064683			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762245	gold, Green Submitted, Green Published			2022-12-27	WOS:000321099000013
J	Shen, FX; Yao, MS				Shen, Fangxia; Yao, Maosheng			Are We Biologically Safe with Snow Precipitation? A Case Study in Beijing	PLOS ONE			English	Article							MICROBIAL COMMUNITY STRUCTURE; SACCHAROMYCES-CEREVISIAE; AIRBORNE MICROORGANISMS; SIZE DISTRIBUTION; FUNGAL SPORES; MOUTH-DISEASE; DESERT DUST; BACTERIA; AEROSOL; CULTURABILITY	In this study, the bacterial and fungal abundances, diversities, conductance levels as well as total organic carbon (TOC) were investigated in the snow samples collected from five different snow occurrences in Beijing between January and March, 2010. The collected snow samples were melted and cultured at three different temperatures (4, 26 and 37 degrees C). The culturable bacterial concentrations were manually counted and the resulting colony forming units (CFUs) at 26 degrees C were further studied using V3 region of 16 S rRNA gene-targeted polymerase chain reaction -denaturing gradient gel electrophoresis (PCR-DGGE). The clone library was constructed after the liquid culturing of snow samples at 26 degrees C. And microscopic method was employed to investigate the fungal diversity in the samples. In addition, outdoor air samples were also collected using mixed cellulose ester (MCE) filters and compared with snow samples with respect to described characteristics. The results revealed that snow samples had bacterial concentrations as much as 16000 CFU/ml for those cultured at 26 degrees C, and the conductance levels ranged from 5.6x10(-6) to 2.4x10(-5) S. PCR-DGGE, sequencing and microscopic analysis revealed remarkable bacterial and fungal diversity differences between the snow samples and the outdoor air samples. In addition, DGGE banding profiles for the snow samples collected were also shown distinctly different from one another. Absent from the outdoor air, certain human, plant, and insect fungal pathogens were found in the snow samples. By calculation, culturable bacteria accounted for an average of 3.38% (+/- 1.96%) of TOC for the snow samples, and 0.01% for that of outdoor air samples. The results here suggest that snow precipitations are important sources of fungal pathogens and ice nucleators, thus could affect local climate, human health and agriculture security.	[Shen, Fangxia; Yao, Maosheng] Peking Univ, Coll Environm Sci & Engn, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100871, Peoples R China	Peking University	Yao, MS (corresponding author), Peking Univ, Coll Environm Sci & Engn, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100871, Peoples R China.	yao@pku.edu.cn	Shen, Fangxia/I-5774-2016; Shen, Fangxia/F-3718-2018; shen, fangxia/HGA-6200-2022	Shen, Fangxia/0000-0003-4166-4615; shen, fangxia/0000-0003-4166-4615	National Science Foundation of China [21277007, 41121004]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Science Foundation of China (Grants 21277007 and 41121004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony R, 2012, ENVIRON MONIT ASSESS, V184, P5929, DOI 10.1007/s10661-011-2391-1; Ariya PA, 2009, INT REV PHYS CHEM, V28, P1, DOI 10.1080/01442350802597438; AUCOTT JN, 1990, REV INFECT DIS, V12, P406; Bauer H, 2002, ATMOS RES, V64, P109, DOI 10.1016/S0169-8095(02)00084-4; Bauer H, 2010, GEOPH RES ABSTR, V12, P15472; Bold HC, 1980, MORPHOLOGY PLANTS FU; Bouillon S, 2004, FEMS MICROBIOL ECOL, V49, P171, DOI 10.1016/j.femsec.2004.03.004; Bowers RM, 2009, APPL ENVIRON MICROB, V75, P5121, DOI 10.1128/AEM.00447-09; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Brown JKM, 2002, SCIENCE, V297, P537, DOI 10.1126/science.1072678; Carpenter EJ, 2000, APPL ENVIRON MICROB, V66, P4514, DOI 10.1128/AEM.66.10.4514-4517.2000; Casareto BE, 1996, GEOPHYS RES LETT, V23, P173, DOI 10.1029/95GL03785; Christner BC, 2008, SCIENCE, V319, P1214, DOI 10.1126/science.1149757; Douwes J, 2003, ANN OCCUP HYG, V47, P187, DOI 10.1093/annhyg/meg032; Elster J., 2007, BIOGEOSCIENCES DISCU, V4, P1779, DOI [10.5194/bgd-4-1779-2007, DOI 10.5194/BGD-4-1779-2007, DOI 10.5194/bgd-4-1779-2007]; Fuzzi S, 1997, ATMOS ENVIRON, V31, P287, DOI 10.1016/1352-2310(96)00160-4; Griffin D.W., 2001, AEROBIOLOGIA BOLOGNA, V17, P203, DOI [10.1023/A:1011868218901, DOI 10.1023/A:1011868218901]; Griffin DW, 2007, CLIN MICROBIOL REV, V20, P459, DOI 10.1128/CMR.00039-06; Griffin DW, 2006, AEROBIOLOGIA, V22, P211, DOI 10.1007/s10453-006-9033-z; Grollert C, 2000, WATER AIR SOIL POLL, V117, P157, DOI 10.1023/A:1005192901234; Heidelberg JF, 1997, APPL ENVIRON MICROB, V63, P3585, DOI 10.1128/AEM.63.9.3585-3588.1997; Hsueh PR, 1998, J CLIN MICROBIOL, V36, P2914, DOI 10.1128/JCM.36.10.2914-2917.1998; IMSHENETSKY AA, 1978, APPL ENVIRON MICROB, V35, P1; Jones AM, 2004, SCI TOTAL ENVIRON, V326, P151, DOI 10.1016/j.scitotenv.2003.11.021; Joo YS, 2002, CAN J VET RES, V66, P122; Kellogg CA, 2006, TRENDS ECOL EVOL, V21, P638, DOI 10.1016/j.tree.2006.07.004; La Duc MT, 2003, ENVIRON MICROBIOL, V5, P977, DOI 10.1046/j.1462-2920.2003.00496.x; Larose C, 2010, EXTREMOPHILES, V14, P205, DOI 10.1007/s00792-009-0299-2; Lee T, 2006, ATMOS ENVIRON, V40, P2902, DOI 10.1016/j.atmosenv.2006.01.011; Li KJ, 2010, AEROBIOLOGIA, V26, P233, DOI 10.1007/s10453-010-9159-x; Liebers V, 2006, AM J IND MED, V49, P474, DOI 10.1002/ajim.20310; Liu YQ, 2007, CHINESE SCI BULL, V52, P2350, DOI 10.1007/s11434-007-0360-4; Liu YQ, 2006, CHINESE SCI BULL, V51, P1476, DOI 10.1007/s11434-006-1476-7; MAKI LR, 1978, J APPL METEOROL, V17, P1049, DOI 10.1175/1520-0450(1978)017<1049:BABSOF>2.0.CO;2; Matthias-Maser S, 2000, ATOMOS ENV, V34, P279; MatthiasMaser S, 1995, ATMOS RES, V39, P279, DOI 10.1016/0169-8095(95)00017-8; Mohler O, 2007, BIOGEOSCIENCES, V4, P1059; Morris CE, 2004, J PHYS IV, V121, P87, DOI 10.1051/jp4:2004121004; Morris CE, 2007, INFECT GENET EVOL, V7, P84, DOI 10.1016/j.meegid.2006.05.002; Murphy A, 1999, ENZYME MICROB TECH, V25, P551, DOI 10.1016/S0141-0229(99)00086-1; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Ozawa H, 2003, REV GEOPHYS, V41, DOI 10.1029/2002RG000113; Polymenakou PN, 2008, ENVIRON HEALTH PERSP, V116, P292, DOI 10.1289/ehp.10684; Pratt KA, 2009, NAT GEOSCI, V2, P397, DOI 10.1038/NGEO521; Prospero JM, 2005, AEROBIOLOGIA, V21, P1, DOI 10.1007/s10453-004-5872-7; Sakamoto K, 2002, REV SCI TECH OIE, V21, P459, DOI 10.20506/rst.21.3.1347; Sattler B, 2001, GEOPHYS RES LETT, V28, P239, DOI 10.1029/2000GL011684; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shelton BG, 2002, APPL ENVIRON MICROB, V68, P1743, DOI 10.1128/AEM.68.4.1743-1753.2002; Shen FX, 2013, CHINESE SCI BULL, V58, P440, DOI 10.1007/s11434-012-5621-1; Suehiro J, 2006, SENSOR ACTUAT B-CHEM, V119, P319, DOI 10.1016/j.snb.2005.12.027; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; VALI G, 1976, J ATMOS SCI, V33, P1565, DOI 10.1175/1520-0469(1976)033<1565:BINPIB>2.0.CO;2; Womack AM, 2010, PHILOS T R SOC B, V365, P3645, DOI 10.1098/rstb.2010.0283; Wu PC, 2004, ATMOS ENVIRON, V38, P4879, DOI 10.1016/j.atmosenv.2004.05.039; Xu ZQ, 2011, AEROSOL SCI TECH, V45, P1143, DOI 10.1080/02786826.2011.582195; YANKOFSKY SA, 1981, CURR MICROBIOL, V5, P213, DOI 10.1007/BF01571149	58	7	7	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65249	10.1371/journal.pone.0065249	http://dx.doi.org/10.1371/journal.pone.0065249			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762327	gold, Green Published, Green Submitted			2022-12-27	WOS:000321099000048
J	Liu, QX; Talbot, M; Llewellyn, DJ				Liu, Qinxiang; Talbot, Mark; Llewellyn, Danny J.			Pectin Methylesterase and Pectin Remodelling Differ in the Fibre Walls of Two Gossypium Species with Very Different Fibre Properties	PLOS ONE			English	Article							CELL-WALL; PLANT-CELL; METHYL ESTERASE; COTTON FIBER; GENE-EXPRESSION; IN-VITRO; GROWTH; PECTINMETHYLESTERASE; POLYGALACTURONASE; HOMOGALACTURONAN	Pectin, a major component of the primary cell walls of dicot plants, is synthesized in Golgi, secreted into the wall as methylesters and subsequently de-esterified by pectin methylesterase (PME). Pectin remodelling by PMEs is known to be important in regulating cell expansion in plants, but has been poorly studied in cotton. In this study, genome-wide analysis showed that PMEs are a large multi-gene family (81 genes) in diploid cotton (Gossypium raimondii), an expansion over the 66 in Arabidopsis and suggests the evolution of new functions in cotton. Relatively few PME genes are expressed highly in fibres based on EST abundance and the five most abundant in fibres were cloned and sequenced from two cotton species. Their significant sequence differences and their stage-specific expression in fibres within a species suggest sub-specialisation during fibre development. We determined the transcript abundance of the five fibre PMEs, total PME enzyme activity, pectin content and extent of de-methylesterification of the pectin in fibre walls of the two cotton species over the first 25-30 days of fibre growth. There was a higher transcript abundance of fibre-PMEs and a higher total PME enzyme activity in G. barbadense (Gb) than in G. hirsutum (Gh) fibres, particularly during late fibre elongation. Total pectin was high, but de-esterified pectin was low during fibre elongation (5-12 dpa) in both Gh and Gb. De-esterified pectin levels rose thereafter when total PME activity increased and this occurred earlier in Gb fibres resulting in a lower degree of esterification in Gb fibres between 17 and 22 dpa. Gb fibres are finer and longer than those of Gh, so differences in pectin remodelling during the transition to wall thickening may be an important factor in influencing final fibre diameter and length, two key quality attributes of cotton fibres.	[Liu, Qinxiang; Talbot, Mark; Llewellyn, Danny J.] CSIRO, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Llewellyn, DJ (corresponding author), CSIRO, Canberra, ACT, Australia.	Danny.Llewellyn@csiro.au	Llewellyn, Danny J/D-5230-2009; liu, qinxiang/A-1763-2010	Llewellyn, Danny J/0000-0001-9535-8707; 	Cotton Breeding Australia; joint venture between the Australian Government research organisation CSIRO	Cotton Breeding Australia(Cotton R&D Corp); joint venture between the Australian Government research organisation CSIRO	This work was supported by Cotton Breeding Australia, a joint venture between the Australian Government research organisation CSIRO and Cotton Seed Distributors a grower owned and controlled co-operative of Australian cotton farmers. All authors are employees of the Australian government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ghazi Y, 2009, PLANT CELL PHYSIOL, V50, P1364, DOI 10.1093/pcp/pcp084; Avci U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056315; BASRA AS, 1984, INT REV CYTOL, V89, P65, DOI 10.1016/S0074-7696(08)61300-5; BORDENAVE M, 1993, PHYTOCHEMISTRY, V33, P999, DOI 10.1016/0031-9422(93)85011-F; Bosch M, 2005, PLANT CELL, V17, P3219, DOI 10.1105/tpc.105.037473; Bosch M, 2005, PLANT PHYSIOL, V138, P1334, DOI 10.1104/pp.105.059865; Carpin S, 2001, PLANT CELL, V13, P511, DOI 10.1105/tpc.13.3.511; Catoire L, 1998, J BIOL CHEM, V273, P33150, DOI 10.1074/jbc.273.50.33150; Clausen MH, 2003, CARBOHYD RES, V338, P1797, DOI 10.1016/S0008-6215(03)00272-6; Cosgrove DJ, 2000, PLANT PHYSIOL BIOCH, V38, P109, DOI 10.1016/S0981-9428(00)00164-9; D'Avino R, 2003, PROTEINS, V53, P830, DOI 10.1002/prot.10487; DANG MH, 1989, POLYM BULL, V22, P599; Di Matteo A, 2005, PLANT CELL, V17, P849, DOI 10.1105/tpc.104.028886; Dorokhov YL, 2006, FEBS LETT, V580, P3329, DOI 10.1016/j.febslet.2006.04.090; FILISETTICOZZI TMCC, 1991, ANAL BIOCHEM, V197, P157, DOI 10.1016/0003-2697(91)90372-Z; Gaffe J, 1997, PLANT PHYSIOL, V114, P1547, DOI 10.1104/pp.114.4.1547; Geisler-Lee J, 2006, PLANT PHYSIOL, V140, P946, DOI 10.1104/pp.105.072652; Grsic-Rausch S, 2004, ANAL BIOCHEM, V333, P14, DOI 10.1016/j.ab.2004.04.042; HAKE KD, 1996, COTTON PRODUCTION MA, P134; JARVIS MC, 1984, PLANT CELL ENVIRON, V7, P153, DOI 10.1111/1365-3040.ep11614586; Jenkins J, 2001, J MOL BIOL, V305, P951, DOI 10.1006/jmbi.2000.4324; Johansson K, 2002, FEBS LETT, V514, P243, DOI 10.1016/S0014-5793(02)02372-4; Jolie RP, 2010, CARBOHYD RES, V345, P2583, DOI 10.1016/j.carres.2010.10.002; KaganZur V, 1995, PLANT MOL BIOL, V29, P1101, DOI 10.1007/BF00020455; Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.010724; KOCH JL, 1989, PLANT PHYSIOL, V91, P816, DOI 10.1104/pp.91.3.816; KOTOUJANSKY A, 1987, ANNU REV PHYTOPATHOL, V25, P405, DOI 10.1146/annurev.py.25.090187.002201; Louvet R, 2006, PLANTA, V224, P782, DOI 10.1007/s00425-006-0261-9; Markovic O, 2004, CARBOHYD RES, V339, P2281, DOI 10.1016/j.carres.2004.06.023; MEINERT MC, 1977, PLANT PHYSIOL, V59, P1088, DOI 10.1104/pp.59.6.1088; Micheli F, 2001, TRENDS PLANT SCI, V6, P414, DOI 10.1016/S1360-1385(01)02045-3; Micheli F, 2000, PLANT PHYSIOL, V124, P191, DOI 10.1104/pp.124.1.191; Mohnen D, 1999, COMPREHENSIVE NATURA, V3, P497; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Monsoor MA, 2001, FOOD CHEM, V74, P233, DOI 10.1016/S0308-8146(01)00100-5; NARI J, 1986, EUR J BIOCHEM, V155, P199, DOI 10.1111/j.1432-1033.1986.tb09477.x; NIR I, 1964, ANAL BIOCHEM, V8, P20, DOI 10.1016/0003-2697(64)90164-2; ONeill MA, 1996, J BIOL CHEM, V271, P22923, DOI 10.1074/jbc.271.37.22923; Pang CY, 2010, MOL CELL PROTEOMICS, V9, P2019, DOI 10.1074/mcp.M110.000349; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Peaucelle A, 2011, CURR BIOL, V21, P1720, DOI 10.1016/j.cub.2011.08.057; Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001; Perez S, 2000, PLANT PHYSIOL BIOCH, V38, P37, DOI 10.1016/S0981-9428(00)00169-8; Pilling J, 2000, PLANTA, V210, P391, DOI 10.1007/PL00008147; Qin M-Y, 2010, CURR OPIN PLANT BIOL, V14, P1; Ruan YL, 2007, FUNCT PLANT BIOL, V34, P1, DOI 10.1071/FP06234; RYSER U, 1985, EUR J CELL BIOL, V39, P236; Siedlecka A, 2008, PLANT PHYSIOL, V146, P554, DOI 10.1104/pp.107.111963; Singh B, 2009, PLANT PHYSIOL, V150, P684, DOI 10.1104/pp.109.135459; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vaughn KC, 1999, PROTOPLASMA, V209, P226, DOI 10.1007/BF01453451; VAZQUEZBLANCO ME, 1993, J CHROMATOGR SCI, V31, P477, DOI 10.1093/chromsci/31.11.477; Wen FS, 1999, PLANT CELL, V11, P1129, DOI 10.1105/tpc.11.6.1129; Willats WGT, 2001, PLANT MOL BIOL, V47, P9, DOI 10.1023/A:1010662911148; Willats WGT, 2001, J BIOL CHEM, V276, P19404, DOI 10.1074/jbc.M011242200; Wu YR, 2002, PLANT MOL BIOL REP, V20, P213, DOI 10.1007/BF02782456; Zhan DF, 1998, CARBOHYD RES, V308, P373, DOI 10.1016/S0008-6215(98)00096-2	57	33	35	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65131	10.1371/journal.pone.0065131	http://dx.doi.org/10.1371/journal.pone.0065131			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755181	Green Submitted, Green Published, gold			2022-12-27	WOS:000320579400039
J	Seekatz, AM; Panda, A; Rasko, DA; Toapanta, FR; Eloe-Fadrosh, EA; Khan, AQ; Liu, ZQ; Shipley, ST; DeTolla, LJ; Sztein, MB; Fraser, CM				Seekatz, Anna M.; Panda, Aruna; Rasko, David A.; Toapanta, Franklin R.; Eloe-Fadrosh, Emiley A.; Khan, Abdul Q.; Liu, Zhenqiu; Shipley, Steven T.; DeTolla, Louis J.; Sztein, Marcelo B.; Fraser, Claire M.			Differential Response of the Cynomolgus Macaque Gut Microbiota to Shigella Infection	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; FLEXNERI 2A; MAURITIAN CYNOMOLGUS; GENETIC-VARIATION; IMMUNE-RESPONSES; BREEDING COLONY; MHC HAPLOTYPES; VACCINE; POPULATIONS; HEALTH	Little is known about the role of gut microbiota in response to live oral vaccines against enteric pathogens. We examined the effect of immunization with an oral live-attenuated Shigella dysenteriae 1 vaccine and challenge with wild-type S. dysenteriae 1 on the fecal microbiota of cynomolgus macaques using 16 S rRNA analysis of fecal samples. Multi-dimensional cluster analysis identified different bacterial community types within macaques from geographically distinct locations. The fecal microbiota of Mauritian macaques, observed to be genetically distinct, harbored a high-diversity community and responded differently to Shigella immunization, as well as challenge compared to the microbiota in non-Mauritian macaques. While both macaque populations exhibited anti-Shigella antibody responses, clinical shigellosis was observed only among non-Mauritian macaques. These studies highlight the importance of further investigation into the possible protective role of the microbiota against enteric pathogens and consideration of host genetic backgrounds in conducting vaccine studies.	[Seekatz, Anna M.; Rasko, David A.; Eloe-Fadrosh, Emiley A.; Liu, Zhenqiu; Fraser, Claire M.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Panda, Aruna; Shipley, Steven T.; DeTolla, Louis J.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Toapanta, Franklin R.; Sztein, Marcelo B.] Univ Maryland, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Rasko, David A.; Fraser, Claire M.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Sztein, Marcelo B.] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [DeTolla, Louis J.; Fraser, Claire M.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Liu, Zhenqiu; DeTolla, Louis J.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Khan, Abdul Q.] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Uniformed Services University of the Health Sciences - USA	Fraser, CM (corresponding author), Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA.	cmfraser@som.umaryland.edu	Eloe-Fadrosh, Emiley/AAP-8019-2021; Toapanta, Franklin/Y-1774-2019	David, Rasko/0000-0002-7337-7154; Eloe-Fadrosh, Emiley/0000-0002-8162-1276; Fraser, Claire/0000-0003-1462-2428	National Institutes of Health (CCHI) [U19 AI082655]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082655] Funding Source: NIH RePORTER	National Institutes of Health (CCHI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health grant U19 AI082655 (CCHI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bailey MT, 2010, INFECT IMMUN, V78, P1509, DOI 10.1128/IAI.00862-09; Bailey MT, 2004, J PEDIATR GASTR NUTR, V38, P414, DOI 10.1097/00005176-200404000-00009; Bien J, 2011, BIOMETRIKA, V98, P807, DOI 10.1093/biomet/asr054; Bonhomme M, 2007, TISSUE ANTIGENS, V70, P398, DOI 10.1111/j.1399-0039.2007.00925.x; Bonhomme M, 2005, AM J PRIMATOL, V67, P385, DOI 10.1002/ajp.20193; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Clark LV, 2011, MOL ECOL RESOUR, V11, P562, DOI 10.1111/j.1755-0998.2011.02985.x; Coster TS, 1999, INFECT IMMUN, V67, P3437, DOI 10.1128/IAI.67.7.3437-3443.1999; Degnan PH, 2012, P NATL ACAD SCI USA, V109, P13034, DOI 10.1073/pnas.1110994109; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Ferreira RBR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001190; Florese RH, 2008, VACCINE, V26, P3312, DOI 10.1016/j.vaccine.2008.03.100; FORMAL SB, 1991, J INFECT DIS, V164, P533, DOI 10.1093/infdis/164.3.533; Gevers D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001377; Hallander HO, 2002, VACCINE, V21, P138, DOI 10.1016/S0264-410X(02)00348-1; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Huurre A, 2008, NEONATOLOGY, V93, P236, DOI 10.1159/000111102; Kanthaswamy S, 2008, INT J PRIMATOL, V29, P1295, DOI 10.1007/s10764-008-9295-0; Katz DE, 2004, INFECT IMMUN, V72, P923, DOI 10.1128/IAI.72.2.923-930.2004; Konturek PC, 2011, J PHYSIOL PHARMACOL, V62, P591; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Krebs KC, 2005, J IMMUNOL, V175, P5230, DOI 10.4049/jimmunol.175.8.5230; Kweon MN, 2008, CURR OPIN INFECT DIS, V21, P313, DOI 10.1097/QCO.0b013e3282f88b92; Levine MM, 2007, NAT REV MICROBIOL, V5, P540, DOI 10.1038/nrmicro1662; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Mee ET, 2009, J MED PRIMATOL, V38, P1, DOI 10.1111/j.1600-0684.2008.00299.x; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Migot-Nabias F, 1999, EXP PARASITOL, V91, P30, DOI 10.1006/expr.1999.4342; Mitchell JL, 2012, IMMUNOGENETICS, V64, P123, DOI 10.1007/s00251-011-0567-z; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; Penedo MCT, 2005, IMMUNOGENETICS, V57, P198, DOI 10.1007/s00251-005-0787-1; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rahman KM, 2011, VACCINE, V29, P1347, DOI 10.1016/j.vaccine.2010.10.035; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shipley ST, 2010, COMPARATIVE MED, V60, P54; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; SUHARYONO, 1992, LANCET, V340, P689, DOI 10.1016/0140-6736(92)92231-4; Suleyman Y, 2010, PLOS ONE, V5; Toivanen P, 2001, INFECT IMMUN, V69, P2372, DOI 10.1128/IAI.69.4.2372-2377.2001; Wiseman RW, 2007, J VIROL, V81, P349, DOI 10.1128/JVI.01841-06; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wu T, 2011, INFECT IMMUN, V79, P4912, DOI 10.1128/IAI.05814-11; Xia LC, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S2-S15	48	42	42	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64212	10.1371/journal.pone.0064212	http://dx.doi.org/10.1371/journal.pone.0064212			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755118	gold, Green Submitted, Green Published			2022-12-27	WOS:000320579400011
J	Cook, GW; Konkel, MK; Walker, JA; Bourgeois, MG; Fullerton, ML; Fussell, JT; Herbold, HD; Batzer, MA				Cook, George W.; Konkel, Miriam K.; Walker, Jerilyn A.; Bourgeois, Matthew G.; Fullerton, Mitchell L.; Fussell, John T.; Herbold, Heath D.; Batzer, Mark A.			A Comparison of 100 Human Genes Using an Alu Element-Based Instability Model	PLOS ONE			English	Article							HUMAN GENOME; RECOMBINATION; DELETIONS; CONVERSION; REPEATS; CANCER; RETROTRANSPOSONS; STABILITY; DISEASE	The human retrotransposon with the highest copy number is the Alu element. The human genome contains over one million Alu elements that collectively account for over ten percent of our DNA. Full-length Alu elements are randomly distributed throughout the genome in both forward and reverse orientations. However, full-length widely spaced Alu pairs having two Alus in the same (direct) orientation are statistically more prevalent than Alu pairs having two Alus in the opposite (inverted) orientation. The cause of this phenomenon is unknown. It has been hypothesized that this imbalance is the consequence of anomalous inverted Alu pair interactions. One proposed mechanism suggests that inverted Alu pairs can ectopically interact, exposing both ends of each Alu element making up the pair to a potential double-strand break, or "hit". This hypothesized "two-hit" (two double-strand breaks) potential per Alu element was used to develop a model for comparing the relative instabilities of human genes. The model incorporates both 1) the two-hit double-strand break potential of Alu elements and 2) the probability of exon-damaging deletions extending from these double-strand breaks. This model was used to compare the relative instabilities of 50 deletion-prone cancer genes and 50 randomly selected genes from the human genome. The output of the Alu element-based genomic instability model developed here is shown to coincide with the observed instability of deletion-prone cancer genes. The 50 cancer genes are collectively estimated to be 58% more unstable than the randomly chosen genes using this model. Seven of the deletion-prone cancer genes, ATM, BRCA1, FANCA, FANCD2, MSH2, NCOR1 and PBRM1, were among the most unstable 10% of the 100 genes analyzed. This algorithm may lay the foundation for comparing genetic risks posed by structural variations that are unique to specific individuals, families and people groups.	[Cook, George W.; Konkel, Miriam K.; Walker, Jerilyn A.; Bourgeois, Matthew G.; Batzer, Mark A.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Fullerton, Mitchell L.] Clemson Univ, Dept Bioengn, Clemson, SC USA; [Fussell, John T.] Louisiana Business & Technol Ctr, Baton Rouge, LA USA; [Herbold, Heath D.] Albemarle Corp, Pasadena, TX USA	Louisiana State University System; Louisiana State University; Clemson University; Albemarle Corporation	Batzer, MA (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	mbatzer@lsu.edu	Fullerton, Mitchell/HIK-2189-2022		National Institutes of Health [RO1 GM59290]; Louisiana Board of Regents Governor's Biotechnology Initiative GBI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059290] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Board of Regents Governor's Biotechnology Initiative GBI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institutes of Health (http://www.nih.gov/)RO1 GM59290 (MAB), and the Louisiana Board of Regents Governor's Biotechnology Initiative GBI (http://web.laregents.org/programs/special-programs/) (2002-005) (MAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleshin A, 2010, MOL BIOL EVOL, V27, P2300, DOI 10.1093/molbev/msq116; Bailey JA, 2003, AM J HUM GENET, V73, P823, DOI 10.1086/378594; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Cook GW, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-10; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; de Smith AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003104; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Elliott B, 2005, MOL CELL, V17, P885, DOI 10.1016/j.molcel.2005.02.028; Fogedby HC, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.061915; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Franke G, 2009, HUM MUTAT, V30, P776, DOI 10.1002/humu.20948; Girirajan S, 2011, ANNU REV GENET, V45, P203, DOI 10.1146/annurev-genet-102209-163544; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Han K, 2007, PLOS GENET, V3, P1939, DOI 10.1371/journal.pgen.0030184; Hedges DJ, 2007, MUTAT RES-FUND MOL M, V616, P46, DOI 10.1016/j.mrfmmm.2006.11.021; Jeon JH, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2192774; Jurka J, 2004, P NATL ACAD SCI USA, V101, P1268, DOI 10.1073/pnas.0308084100; KASS DH, 1995, MOL CELL BIOL, V15, P19, DOI 10.1128/MCB.15.1.19; Kitada K, 2012, CYTOGENET GENOME RES; Konkel MK, 2010, SEMIN CANCER BIOL, V20, P211, DOI 10.1016/j.semcancer.2010.03.001; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004047; Lev-Maor G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000204; Lobachev KS, 2000, EMBO J, V19, P3822, DOI 10.1093/emboj/19.14.3822; Lupski JR, 2010, CELL, V141, P1110, DOI 10.1016/j.cell.2010.06.014; Mills RE, 2011, GENOME RES, V21, P830, DOI 10.1101/gr.115907.110; Roy AM, 2000, GENOME RES, V10, P1485, DOI 10.1101/gr.152300; Seal RL, 2011, NUCLEIC ACIDS RES, V39, pD514, DOI 10.1093/nar/gkq892; Sen SK, 2006, AM J HUM GENET, V79, P41, DOI 10.1086/504600; Serrano M, 2010, NATURE, V464, P363, DOI 10.1038/464363a; Smit A, 1996, REPEATMASKER OPEN 30; Solimini NL, 2012, SCIENCE, V337, P104, DOI 10.1126/science.1219580; Stenger JE, 2001, GENOME RES, V11, P12, DOI 10.1101/gr.158801; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Witherspoon DJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-530; Zhang Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002046; Zhi DG, 2007, GENE, V390, P117, DOI 10.1016/j.gene.2006.09.030	38	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65188	10.1371/journal.pone.0065188	http://dx.doi.org/10.1371/journal.pone.0065188			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755193	Green Published, Green Submitted, gold			2022-12-27	WOS:000319872300057
J	Hosek, J; Novotna, R; Babula, P; Vanco, J; Travnicek, Z				Hosek, Jan; Novotna, Radka; Babula, Petr; Vanco, Jan; Travnicek, Zdenek			Zn(II)-Chlorido Complexes of Phytohormone Kinetin and Its Derivatives Modulate Expression of Inflammatory Mediators in THP-1 Cells	PLOS ONE			English	Article							X-RAY STRUCTURES; ZINC(II) COMPLEXES; IN-VITRO; KAPPA-B; MATRIX METALLOPROTEINASES; ACID; ACTIVATION; INHIBITION; LIPOPOLYSACCHARIDE; PROLIFERATION	Kinetin (N6-furfuryladenine) belongs to a group of plant growth hormones involved in cell division, differentiation and other physiological processes. One of the possible ways to obtain biologically active compounds is to complex biologically relevant natural compounds to suitable metal atoms. In this work, two structural groups of Zn(II) complexes [Zn(L-n)(2)Cl-2]center dot Solv (1-5) and [Zn(HLn)Cl-3]center dot xL(n) (6-7); n = 1-5, Solv = CH3OH for 1 and 2H(2)O for 2; x = 1 for 6 and 2 for 7; involving a phytohormone kinetin and its derivatives (L-n) were evaluated for their ability to modulate secretion of tumour necrosis factor (TNF)-alpha, interleukin (IL)-1 beta and matrix metalloproteinase (MMP)-2 in a lipopolysaccharide (LPS)-activated macrophage-like THP-1 cell model. The penetration of the complexes to cells was also detected. The mechanism of interactions of the zinc(II) complexes with a fluorescent sensor N-(6-methoxy-8-quinolyl)-p-toluene sulphonamide (TSQ) and sulfur-containing biomolecules (l-cysteine and reduced glutathione) was studied by electrospray-ionization mass spectrometry and flow-injection analysis with fluorescence detection. The present study showed that the tested complexes exhibited a low cytotoxic effect on the THP-1 cell line (IC50>40 mu M), apart from complex 4, with an IC50 = 10.9 +/- 1.1 mu M. Regarding the inflammation-related processes, the Zn(II) complexes significantly decreased IL-1 beta production by a factor of 1.47-2.22 compared with the control (DMSO), but did not affect TNF-alpha and MMP-2 secretions. However, application of the Zn(II) complexes noticeably changed the pro-MMP-2/MMP-2 ratio towards a higher amount of maturated MMP-2, when they induced a 4-times higher production of maturated MMP-2 in comparison with the vehicle-treated cells under LPS stimulation. These results indicated that the complexes are able to modulate an inflammatory response by influencing secretion and activity of several inflammation-related cytokines and enzymes.	[Hosek, Jan; Novotna, Radka; Vanco, Jan; Travnicek, Zdenek] Palacky Univ, Fac Sci, Reg Ctr Adv Technol & Mat, Dept Inorgan Chem, CR-77147 Olomouc, Czech Republic; [Babula, Petr] Univ Vet & Pharmaceut Sci Brno, Fac Pharm, Dept Nat Drugs, Brno, Czech Republic	Palacky University Olomouc; University of Veterinary Sciences Brno	Travnicek, Z (corresponding author), Palacky Univ, Fac Sci, Reg Ctr Adv Technol & Mat, Dept Inorgan Chem, CR-77147 Olomouc, Czech Republic.	zdenek.travnicek@upol.cz	KŘIKAVOVÁ, Radka/CAG-6109-2022; Vanco, Jan/H-2705-2013; Hosek, Jan/B-6274-2009; Babula, Petr/AAL-6510-2020	KŘIKAVOVÁ, Radka/0000-0002-8466-4829; Vanco, Jan/0000-0003-3351-1192; Hosek, Jan/0000-0003-0975-1671; Travnicek, Zdenek/0000-0002-5890-7874	Operational Program Research and Development for Innovations - European Regional Development Fund [CZ.1.05/2.1.00/03.0058]; Operational Program Education for Competitiveness - European Social Fund [CZ.1.07/2.3.00/20.0017]; Palacky University [IGA PrF_2013_015]	Operational Program Research and Development for Innovations - European Regional Development Fund; Operational Program Education for Competitiveness - European Social Fund(European Social Fund (ESF)); Palacky University	The authors would like to thank the Operational Program Research and Development for Innovations - European Regional Development Fund (CZ.1.05/2.1.00/03.0058), the Operational Program Education for Competitiveness - European Social Fund (CZ.1.07/2.3.00/20.0017) and Palacky University (IGA PrF_2013_015) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barciszewski J, 2007, INT J BIOL MACROMOL, V40, P182, DOI 10.1016/j.ijbiomac.2006.06.024; Berge U, 2006, ANN NY ACAD SCI, V1067, P332, DOI 10.1196/annals.1354.045; Bispo W, 2011, MOLECULES, V16, P6902, DOI 10.3390/molecules16086902; Buchtik R, 2012, J INORG BIOCHEM, V116, P163, DOI 10.1016/j.jinorgbio.2012.07.009; Casati S, 2011, ANTICANCER RES, V31, P3401; Celik I, 2006, PESTIC BIOCHEM PHYS, V86, P180, DOI 10.1016/j.pestbp.2006.03.007; de Souza AP, 2000, DENT MATER, V16, P103, DOI 10.1016/S0109-5641(99)00084-6; Denes A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.86; DRIESSEN C, 1995, IMMUNOLOGY, V84, P272; Dudzik P, 2011, J CELL BIOCHEM, V112, P2115, DOI 10.1002/jcb.23132; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Fahrni CJ, 1999, J AM CHEM SOC, V121, P11448, DOI 10.1021/ja992709f; Campos PMBGM, 2012, PHOTOCHEM PHOTOBIOL, V88, P748, DOI 10.1111/j.1751-1097.2012.01086.x; Haase H, 2008, J IMMUNOL, V181, P6491, DOI 10.4049/jimmunol.181.9.6491; Hirose N, 2008, J EXP BOT, V59, P75, DOI 10.1093/jxb/erm157; Jeon KI, 2000, J IMMUNOL, V164, P5981, DOI 10.4049/jimmunol.164.11.5981; Kim YM, 2007, CELL SIGNAL, V19, P538, DOI 10.1016/j.cellsig.2006.08.003; Knoell DL, 2010, INT J VITAM NUTR RES, V80, P271, DOI 10.1024/0300-9831/a000034; Li HH, 2011, BIOCHEM PHARMACOL, V82, P701, DOI 10.1016/j.bcp.2011.06.042; Lu KV, 2004, LAB INVEST, V84, P8, DOI 10.1038/labinvest.3700003; Meeusen JW, 2012, INORG CHEM, V51, P3625, DOI 10.1021/ic2025236; Meeusen JW, 2011, INORG CHEM, V50, P7563, DOI 10.1021/ic200478q; Mei XT, 2012, CHEM-BIOL INTERACT, V197, P31, DOI 10.1016/j.cbi.2012.03.006; Morad Y, 2005, INVEST OPHTH VIS SCI, V46, P1640, DOI 10.1167/iovs.04-1165; Moreira-Tabaka H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034184; Morrison CJ, 2001, J BIOL CHEM, V276, P47402, DOI 10.1074/jbc.M108643200; Nasir MS, 1999, J BIOL INORG CHEM, V4, P775, DOI 10.1007/s007750050350; Novotna R, 2011, INORG CHIM ACTA, V365, P113, DOI 10.1016/j.ica.2010.08.040; Novotna R, 2010, INORG CHIM ACTA, V363, P2071, DOI 10.1016/j.ica.2010.02.004; Okumura S, 2004, Japan Patent, Patent No. [JP 2004083435 A, 2004083435]; Pavlica S, 2010, NEUROCHEM INT, V56, P84, DOI 10.1016/j.neuint.2009.09.005; Pencikova K, 2012, PHYTOMEDICINE, V19, P890, DOI 10.1016/j.phymed.2012.04.001; Plum LM, 2010, INT J ENV RES PUB HE, V7, P1342, DOI 10.3390/ijerph7041342; Prasad AS, 2008, EXP GERONTOL, V43, P370, DOI 10.1016/j.exger.2007.10.013; Prasad AS, 2011, NUTRITION, V27, P816, DOI 10.1016/j.nut.2010.08.010; Prasad AS, 2009, CURR OPIN CLIN NUTR, V12, P646, DOI 10.1097/MCO.0b013e3283312956; RAINSFORD KD, 1992, J PHARM PHARMACOL, V44, P476, DOI 10.1111/j.2042-7158.1992.tb03650.x; Rajagopalan S, 1996, J CLIN INVEST, V98, P2572, DOI 10.1172/JCI119076; RATTAN SIS, 1994, BIOCHEM BIOPH RES CO, V201, P665, DOI 10.1006/bbrc.1994.1752; Rattan SIS, 2002, J ANTI-AGING MED, V5, P113, DOI 10.1089/109454502317629336; REINHOLD JG, 1975, CLIN CHEM, V21, P476; Reyes Juan G., 1994, Biological Research, V27, P49; Salemi G, 2009, NEUROL SCI, V30, P361, DOI 10.1007/s10072-009-0090-2; SHARMA SP, 1995, BIOCHEM BIOPH RES CO, V216, P1067, DOI 10.1006/bbrc.1995.2729; Snoek-van Beurden PAM, 2005, BIOTECHNIQUES, V38, P73, DOI 10.2144/05381RV01; Suh SW, 2000, BRAIN RES, V852, P274, DOI 10.1016/S0006-8993(99)02096-X; Takashima A, 2003, Japan Patent, Patent No. [JP 2003155238 A, 2003155238]; TOROPTSE.IV, 1972, TSITOLOGIYA+, V14, P805; Travnicek Z, 2006, J INORG BIOCHEM, V100, P214, DOI 10.1016/j.jinorgbio.2005.07.006; Travnicek Z, 2012, J MED CHEM, V55, P4568, DOI 10.1021/jm201416p; Valiante N, 2006, WIPO Patent, Patent No. [2006002422, WO 2006/002422 A2]; von Bulow V, 2005, J IMMUNOL, V175, P4697, DOI 10.4049/jimmunol.175.7.4697; Waddell FE, 1992, US Patent, Patent No. [US 5151425, 5151425]; Wong CP, 2012, MOL NUTR FOOD RES, V56, P77, DOI 10.1002/mnfr.201100511; Wu JJ, 2007, CLIN EXP DERMATOL, V32, P693, DOI 10.1111/j.1365-2230.2007.02513.x	55	10	11	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65214	10.1371/journal.pone.0065214	http://dx.doi.org/10.1371/journal.pone.0065214			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755195	Green Submitted, gold, Green Published			2022-12-27	WOS:000319872300058
J	Jin, QY; Liu, GM; Domeier, PP; Ding, W; Mulder, KM				Jin, Qunyan; Liu, Guangming; Domeier, Phillip P.; Ding, Wei; Mulder, Kathleen M.			Decreased Tumor Progression and Invasion by a Novel Anti-Cell Motility Target for Human Colorectal Carcinoma Cells	PLOS ONE			English	Article							RECEPTOR-INTERACTING PROTEIN; TGF-BETA RECEPTOR; LIGHT-CHAIN; SIGNALING PATHWAY; CANCER CELLS; COLON-CANCER; KINASE-A; TERNARY COMPLEX; GROWTH; MIGRATION	We have previously described a novel modulator of the actin cytoskeleton that also regulates Ras and mitogen-activated protein kinase activities in TGF beta-sensitive epithelial cells. Here we examined the functional role of this signaling regulatory protein (km23-1) in mediating the migration, invasion, and tumor growth of human colorectal carcinoma (CRC) cells. We show that small interfering RNA (siRNA) depletion of km23-1 in human CRC cells inhibited constitutive extracellular signal-regulated kinase (ERK) activation, as well as pro-invasive ERK effector functions that include phosphorylation of Elk-1, constitutive regulation of c-Fos-DNA binding, TGF beta 1 promoter transactivation, and TGF beta 1 secretion. In addition, knockdown of km23-1 reduced the paracrine effects of CRC cell-secreted factors in conditioned medium and in fibroblast co-cultures. Moreover, km23-1 depletion in human CRC cells reduced cell migration and invasion, as well as expression of the ERK-regulated, metastasis-associated scaffold protein Ezrin. Finally, km23-1 inhibition significantly suppressed tumor formation in vivo. Thus, our results implicate km23-1 as a novel anti-metastasis target for human colon carcinoma cells, capable of decreasing tumor growth and invasion via a mechanism involving suppression of various pro-migratory features of CRC. These include a reduction in ERK signaling, diminished TGF beta 1 production, decreased expression of the plasma membrane-cytoskeletal linker Ezrin, as well as attenuation of the paracrine effects of colon carcinoma-secreted factors on fibroblast migration and mitogenesis. As such, km23-1 inhibitors may represent a viable therapeutic strategy for interfering with colon cancer progression and invasion.	[Jin, Qunyan; Liu, Guangming; Domeier, Phillip P.; Mulder, Kathleen M.] Penn State Hershey Coll Med, Dept Biochem & Mol Biol, Hershey, PA USA; [Ding, Wei] Penn State Hershey Coll Med, Dept Pediat, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Mulder, KM (corresponding author), Penn State Hershey Coll Med, Dept Biochem & Mol Biol, Hershey, PA USA.	kmm15@psu.edu		Domeier, Phillip/0000-0002-9937-8251	National Institutes of Health [CA090765, CA092889]; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE [R01CA092889, R01CA090765] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants CA090765 and CA092889 to K.M.M. This work was also funded, in part, under a grant from the Pennsylvania Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Bahassi EM, 2004, CLIN EXP METASTAS, V21, P293, DOI 10.1023/B:CLIN.0000046132.46946.dd; Besnard A, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00035; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Biname F, 2008, MOL BIOL CELL, V19, P945, DOI 10.1091/mbc.E07-09-0967; Briggs JW, 2012, NEOPLASIA, V14, P297, DOI 10.1593/neo.11518; Buard A, 1996, INT J CANCER, V67, P539, DOI 10.1002/(SICI)1097-0215(19960807)67:4<539::AID-IJC13>3.0.CO;2-2; Chen HM, 2009, CANCER RES, V69, P9228, DOI 10.1158/0008-5472.CAN-09-1950; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Gao SY, 2009, J BIOL CHEM, V284, P7995, DOI 10.1074/jbc.M809734200; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Hall J, 2010, J BIOL CHEM, V285, P22566, DOI 10.1074/jbc.M110.103861; Hayashi Y, 2010, NEOPLASIA, V12, P1013, DOI 10.1593/neo.10780; Heldin CH, 2012, FEBS LETT, V586, P1959, DOI 10.1016/j.febslet.2012.02.037; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Ilangovan U, 2005, J MOL BIOL, V352, P338, DOI 10.1016/j.jmb.2005.07.002; Jarnaess E, 2008, J BIOL CHEM, V283, P33708, DOI 10.1074/jbc.M804807200; Jin Q, 2007, J BIOL CHEM, V282, P19122, DOI 10.1074/jbc.M609915200; Jin QY, 2013, EXP CELL RES, V319, P897, DOI 10.1016/j.yexcr.2012.12.029; Jin QY, 2012, BIOCHEM BIOPH RES CO, V428, P333, DOI 10.1016/j.bbrc.2012.10.047; Jin QY, 2012, J BIOL CHEM, V287, P26453, DOI 10.1074/jbc.M112.344887; Jin QY, 2009, J CELL PHYSIOL, V221, P707, DOI 10.1002/jcp.21910; Jin QY, 2005, CELL SIGNAL, V17, P1363, DOI 10.1016/j.cellsig.2005.02.004; Kanthan, 2012, PATHOLOG RES INT, V2012, DOI [10.1155/2012/597497, DOI 10.1155/2012/597497]; Karydis A, 2009, MOL BIOL CELL, V20, P2327, DOI 10.1091/mbc.E08-08-0842; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; KIM SJ, 1990, MOL CELL BIOL, V10, P1492, DOI 10.1128/MCB.10.4.1492; Kohno M, 2006, ANN MED, V38, P200, DOI 10.1080/07853890600551037; Link A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008146; Liu GM, 2006, MOL CARCINOGEN, V45, P582, DOI 10.1002/mc.20189; Loboda A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-9; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Meng YX, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-61; Miertzschke M, 2011, EMBO J, V30, P4185, DOI 10.1038/emboj.2011.291; Mulder K. M., 1989, CELL MOL BIOL COLON, P45; Naumovski L, 2006, MOL CANCER THER, V5, P2798, DOI 10.1158/1535-7163.MCT-06-0246; Nowak D, 2010, EUR J HISTOCHEM, V54, P59, DOI 10.4081/ejh.2010.e14; Odrowaz Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049892; Oliveira C, 2003, ONCOGENE, V22, P9192, DOI 10.1038/sj.onc.1207061; Ono H, 2012, ONCOGENE, V31, P4923, DOI 10.1038/onc.2011.646; Ozanne BW, 2007, ONCOGENE, V26, P1, DOI 10.1038/sj.onc.1209759; Pandey MK, 2012, INT J CANCER, V130, P213, DOI 10.1002/ijc.25997; Pullikuth AK, 2007, CELL SIGNAL, V19, P1621, DOI 10.1016/j.cellsig.2007.04.012; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Ren L, 2012, CANCER RES, V72, P1001, DOI 10.1158/0008-5472.CAN-11-0210; Roberts AB, 1990, PEPTIDE GROWTH FACTO, P419; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Simms NAK, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-221; Singh N, 2013, INT J CANCER, V132, P1996, DOI 10.1002/ijc.27902; Sperka T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027511; Takakura M, 2005, MOL CELL BIOL, V25, P8037, DOI 10.1128/MCB.25.18.8037-8043.2005; Tang Q, 2002, MOL BIOL CELL, V13, P4484, DOI 10.1091/mbc.e02-05-0245; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tkachenko E, 2011, NAT CELL BIOL, V13, P660, DOI 10.1038/ncb2231; Vial E, 2003, J CELL SCI, V116, P4957, DOI 10.1242/jcs.00812; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wang B, 2012, J BIOL CHEM, V287, P24148, DOI 10.1074/jbc.M112.369405; Wang HJ, 2009, WORLD J GASTROENTERO, V15, P2016, DOI 10.3748/wjg.15.2016; Xie JJ, 2009, INT J CANCER, V124, P2549, DOI 10.1002/ijc.24216; Yang HS, 2006, MOL CELL BIOL, V26, P1297, DOI 10.1128/MCB.26.4.1297-1306.2006; YANG SH, 2006, BIOCHEM SOC SYMP, P121; Yu XZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030605; Yue JB, 2000, J BIOL CHEM, V275, P30765, DOI 10.1074/jbc.M000039200; Yue JB, 2001, PHARMACOL THERAPEUT, V91, P1, DOI 10.1016/S0163-7258(01)00143-7	70	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e66439	10.1371/journal.pone.0066439	http://dx.doi.org/10.1371/journal.pone.0066439			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755307	Green Published, Green Submitted, gold			2022-12-27	WOS:000319872300106
J	Wang, C; Deng, PY; Chen, LL; Wang, XT; Ma, H; Hu, W; Yao, NC; Feng, Y; Chai, RH; Yang, GX; He, GY				Wang, Chen; Deng, Pengyi; Chen, Liulin; Wang, Xiatian; Ma, Hui; Hu, Wei; Yao, Ningcong; Feng, Ying; Chai, Ruihong; Yang, Guangxiao; He, Guangyuan			A Wheat WRKY Transcription Factor TaWRKY10 Confers Tolerance to Multiple Abiotic Stresses in Transgenic Tobacco	PLOS ONE			English	Article							OXYGEN GENE NETWORK; PLANT-RESPONSES; SALT-STRESS; SEED-GERMINATION; ABSCISIC-ACID; EXPRESSION; ARABIDOPSIS; PROTEIN; OVEREXPRESSION; DROUGHT	WRKY transcription factors are reported to be involved in defense regulation, stress response and plant growth and development. However, the precise role of WRKY transcription factors in abiotic stress tolerance is not completely understood, especially in crops. In this study, we identified and cloned 10 WRKY genes from genome of wheat (Triticum aestivum L.). TaWRKY10, a gene induced by multiple stresses, was selected for further investigation. TaWRKY10 was upregulated by treatment with polyethylene glycol, NaCl, cold and H2O2. Result of Southern blot indicates that the wheat genome contains three copies of TaWRKY10. The TaWRKY10 protein is localized in the nucleus and functions as a transcriptional activator. Overexpression of TaWRKY10 in tobacco (Nicotiana tabacum L.) resulted in enhanced drought and salt stress tolerance, mainly demonstrated by the transgenic plants exhibiting of increased germination rate, root length, survival rate, and relative water content under these stress conditions. Further investigation showed that transgenic plants also retained higher proline and soluble sugar contents, and lower reactive oxygen species and malonaldehyde contents. Moreover, overexpression of the TaWRKY10 regulated the expression of a series of stress related genes. Taken together, our results indicate that TaWRKY10 functions as a positive factor under drought and salt stresses by regulating the osmotic balance, ROS scavenging and transcription of stress related genes.	[Wang, Chen; Deng, Pengyi; Chen, Liulin; Wang, Xiatian; Ma, Hui; Hu, Wei; Yao, Ningcong; Feng, Ying; Chai, Ruihong; Yang, Guangxiao; He, Guangyuan] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Chinese Natl Ctr Plant Gene Res Wuhan HUST Part, Chinese Minist Educ,Key Lab Mol Biophys,Chinese M, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Yang, GX (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Chinese Natl Ctr Plant Gene Res Wuhan HUST Part, Chinese Minist Educ,Key Lab Mol Biophys,Chinese M, Wuhan 430074, Peoples R China.	ygx@hust.edu.cn; hegy@hust.edu.cn			Ministry of Science and Technology of China [2009DFB30340]; National Genetically Modified New Varieties of Major Projects of China [2011ZX08002-004, 2011ZX08010-004]; Key Projects of Science and Technology Research of the Ministry of Education of China [109105]; Wuhan Municipal Science and Technology research project [201120922286]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Genetically Modified New Varieties of Major Projects of China; Key Projects of Science and Technology Research of the Ministry of Education of China(Ministry of Education, China); Wuhan Municipal Science and Technology research project	This work was supported by the International Science and Technology Cooperation Key Projects of the Ministry of Science and Technology of China (Grant No. 2009DFB30340), the National Genetically Modified New Varieties of Major Projects of China (2011ZX08002-004, 2011ZX08010-004), the Key Projects of Science and Technology Research of the Ministry of Education of China (Grant No. 109105) and the Wuhan Municipal Science and Technology research project (Grant No. 201120922286). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoni R, 2011, CURR OPIN PLANT BIOL, V14, P547, DOI 10.1016/j.pbi.2011.06.004; Baxter CJ, 2001, ANN APPL BIOL, V138, P47, DOI 10.1111/j.1744-7348.2001.tb00084.x; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; Bray EA, 1997, TRENDS PLANT SCI, V2, P48, DOI 10.1016/S1360-1385(97)82562-9; Chen H, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-281; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Chen L, 2010, MOL BIOL REP, V37, P737, DOI 10.1007/s11033-009-9582-7; Chen P, 2008, J CEREAL SCI, V48, P734, DOI 10.1016/j.jcs.2008.04.002; Chen S, 2005, PLANT PHYSIOL, V139, P1163, DOI 10.1104/pp.105.069468; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; DRAPER HH, 1993, FREE RADICAL BIO MED, V15, P353, DOI 10.1016/0891-5849(93)90035-S; Eshdat Y, 1997, PHYSIOL PLANTARUM, V100, P234, DOI 10.1034/j.1399-3054.1997.1000204.x; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Gadjev I, 2006, PLANT PHYSIOL, V141, P436, DOI 10.1104/pp.106.078717; Garay-Arroyo A, 1999, YEAST, V15, P879, DOI 10.1002/(SICI)1097-0061(199907)15:10A<879::AID-YEA428>3.3.CO;2-H; Guillaumie S, 2010, PLANT MOL BIOL, V72, P215, DOI 10.1007/s11103-009-9563-1; Han QQ, 2012, MOL BIOL REP, V39, P1713, DOI 10.1007/s11033-011-0911-2; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hong JP, 2005, PLANTA, V220, P875, DOI 10.1007/s00425-004-1412-5; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Hu W, 2012, PLANT CELL PHYSIOL, V53, P2127, DOI 10.1093/pcp/pcs154; ISHIGURO S, 1994, MOL GEN GENET, V244, P563, DOI 10.1007/BF00282746; Ishihama N, 2011, PLANT CELL, V23, P1153, DOI 10.1105/tpc.110.081794; Jiang WB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-96; Johnson CS, 2002, PLANT CELL, V14, P1359, DOI 10.1105/tpc.001404; Kong XP, 2011, PLANT CELL ENVIRON, V34, P1291, DOI 10.1111/j.1365-3040.2011.02329.x; Lagace M, 2004, PLANTA, V219, P185, DOI 10.1007/s00425-004-1253-2; LATCHMAN DS, 1993, INT J EXP PATHOL, V74, P417; Lee BH, 2002, PLANT CELL, V14, P1235, DOI 10.1105/tpc.010433; Liu JP, 1997, PLANT PHYSIOL, V114, P591, DOI 10.1104/pp.114.2.591; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makandar R, 2010, MOL PLANT MICROBE IN, V23, P861, DOI 10.1094/MPMI-23-7-0861; Mao GH, 2011, PLANT CELL, V23, P1639, DOI 10.1105/tpc.111.084996; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nevo E., 2002, EVOLUTION WILD EMMER; Niu CF, 2012, PLANT CELL ENVIRON, V35, P1156, DOI 10.1111/j.1365-3040.2012.02480.x; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Podell S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-37; Proietti S, 2011, J EXP BOT, V62, P1975, DOI 10.1093/jxb/erq396; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Sathiyaraj G, 2011, MOL BIOL REP, V38, P2761, DOI 10.1007/s11033-010-0421-7; Shao HB, 2006, COLLOID SURFACE B, V53, P113, DOI 10.1016/j.colsurfb.2006.08.008; Shewry PR, 2009, J EXP BOT, V60, P1537, DOI 10.1093/jxb/erp058; SHIEH MW, 1993, PLANT PHYSIOL, V101, P353, DOI 10.1104/pp.101.2.353; SKRIVER K, 1990, PLANT CELL, V2, P503, DOI 10.1105/tpc.2.6.503; Song Y, 2009, CHINESE SCI BULL, V54, P4671, DOI 10.1007/s11434-009-0710-5; Takemoto D, 2003, PHYSIOL PLANTARUM, V118, P545, DOI 10.1034/j.1399-3054.2003.00145.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tseng MJ, 2007, PLANT PHYSIOL BIOCH, V45, P822, DOI 10.1016/j.plaphy.2007.07.011; Ueda M, 2011, DEV CELL, V20, P264, DOI 10.1016/j.devcel.2011.01.009; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Wan JR, 2004, MOL PLANT PATHOL, V5, P125, DOI [10.1111/j.1364-3703.2004.00215.x, 10.1111/J.1364-3703.2004.00215.X]; Wang F, 2012, MOL BIOL REP, V39, P4553, DOI 10.1007/s11033-011-1245-9; Wang HH, 2007, PLANT MOL BIOL, V65, P799, DOI 10.1007/s11103-007-9244-x; Wilkinson MD, 2013, J CEREAL SCI, V57, P1, DOI 10.1016/j.jcs.2012.09.005; Wu LJ, 2008, PLANT PHYSIOL, V148, P1953, DOI 10.1104/pp.108.126813; Xie Z, 2007, PLANT MOL BIOL, V64, P293, DOI 10.1007/s11103-007-9152-0; Xiong L, 2002, PLANT CELL ENVIRON, V25, P131, DOI 10.1046/j.1365-3040.2002.00782.x; Xiong X, 2010, MOL BREEDING, V25, P419, DOI 10.1007/s11032-009-9341-4; Xiong YQ, 2005, PLANT MOL BIOL, V59, P191, DOI 10.1007/s11103-005-6503-6; Yang YO, 1997, GENE DEV, V11, P1621, DOI 10.1101/gad.11.13.1621; Zhang GY, 2009, J EXP BOT, V60, P3781, DOI 10.1093/jxb/erp214; Zhang YJ, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-1; Zhou QY, 2008, PLANT BIOTECHNOL J, V6, P486, DOI 10.1111/j.1467-7652.2008.00336.x; Zhou SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052439; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zou CS, 2010, J EXP BOT, V61, P3901, DOI 10.1093/jxb/erq204	71	334	360	17	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65120	10.1371/journal.pone.0065120	http://dx.doi.org/10.1371/journal.pone.0065120			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762295	Green Published, gold, Green Submitted			2022-12-27	WOS:000320440500026
J	Wang, HLS; Yu, RJ; Wu, YT; Lee, WY; Lin, MF; Chen, CY; Shen, EY				Wang, Hsiao-Lan Sharon; Yu, Rongjun; Wu, Yu-Tzu; Lee, Wen-Yuan; Lin, Ming-Fan; Chen, Chia-Yuan; Shen, Ein-Yiao			The Changes of Cerebral Morphology Related to Aging in Taiwanese Population	PLOS ONE			English	Article							AGE-RELATED-CHANGES; WHITE-MATTER; PHYSICAL-ACTIVITY; CHILDREN-A; BRAIN; MR; VOLUME; ADULT; MECHANISMS; PATTERNS	A cross-sectional study with the 3-dimensional (3D) MRI reconstruction technique was conducted to investigate cerebral complexity changes related to age differences in native Taiwanese population. In our sample of 85 participants aged between 25 and 81, age was associated with gradual ventricular expansion. A nonlinear quadratic relationship between white matter volume and age was found overall in the brain. Widespread age-related reduction in white matter was detected from late adulthood onwards. However, no significant age-related changes in the cortex and whole brain volume were determined throughout adulthood. These findings provided information in describing brain structural complexity, which might in the future serve as an objective diagnostic index or as a predictive parameter for neurological diseases. Our method then may be used for cross-cultural longitudinal studies to evaluate the effect of disease, environment and aging on the brain.	[Wang, Hsiao-Lan Sharon] Natl Taiwan Normal Univ, Dept Special Educ, Taipei, Taiwan; [Yu, Rongjun] S China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China; [Yu, Rongjun] S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China; [Wu, Yu-Tzu] Univ Cambridge, Inst Publ Hlth, Cambridge, England; [Lee, Wen-Yuan; Shen, Ein-Yiao] China Med Univ Hosp, Taipei Branch, Taipei, Taiwan; [Lin, Ming-Fan; Chen, Chia-Yuan; Shen, Ein-Yiao] China Med Univ, Grad Inst Acupuncture Sci, Taichung, Taiwan	National Taiwan Normal University; South China Normal University; South China Normal University; University of Cambridge; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Shen, EY (corresponding author), China Med Univ Hosp, Taipei Branch, Taipei, Taiwan.	acupmoxi123@gmail.com	Chen, Chia-Yuan/N-7780-2014; Yu, Rongjun/AAV-2615-2020	Yu, Rongjun/0000-0003-0123-1524; Chen, Chun-Hong/0000-0002-5166-9017; Wang, Hui-Min/0000-0002-4692-4917; Ho, Mei-Ling/0000-0001-8064-8488; Wu, Yu-Tzu/0000-0002-0874-4448	National Science Council in Taiwan, NSC [99-2320-B-039-018-MY2]	National Science Council in Taiwan, NSC	This study was supported the National Science Council in Taiwan, NSC 99-2320-B-039-018-MY2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendlin BB, 2010, DEV NEUROPSYCHOL, V35, P257, DOI 10.1080/87565641003696775; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Blanton RE, 2001, PSYCHIAT RES-NEUROIM, V107, P29, DOI 10.1016/S0925-4927(01)00091-9; BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; Boss B J, 1991, SCI Nurs, V8, P42; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; DEKABAN AS, 1978, ANN NEUROL, V4, P345, DOI 10.1002/ana.410040410; Fabel K, 2008, NEUROMOL MED, V10, P59, DOI 10.1007/s12017-008-8031-4; Fjell AM, 2010, REV NEUROSCIENCE, V21, P187, DOI 10.1515/revneuro.2010.21.3.187; Free SL, 1996, CEREB CORTEX, V6, P830, DOI 10.1093/cercor/6.6.830; Ge YL, 2002, AM J NEURORADIOL, V23, P1327; Goh JO, 2007, COGN AFFECT BEHAV NE, V7, P44, DOI 10.3758/CABN.7.1.44; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Grieve SM, 2011, NEUROIMAGE, V55, P868, DOI 10.1016/j.neuroimage.2010.12.087; Gunning-Dixon FM, 1998, AM J NEURORADIOL, V19, P1501; Hillman CH, 2006, HEALTH PSYCHOL, V25, P678, DOI 10.1037/0278-6133.25.6.678; Hobbs F, 2000, CENSUS 2000 SPECIAL; Hof PR, 2004, TRENDS NEUROSCI, V27, P607, DOI 10.1016/j.tins.2004.07.013; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; Jernigan TL, 2001, NEUROBIOL AGING, V22, P581, DOI 10.1016/S0197-4580(01)00217-2; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Lemaitre H, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.07.013; Luders E, 2004, NAT NEUROSCI, V7, P799, DOI 10.1038/nn1277; Maillet D, 2011, BRAIN RES, V1420, P68, DOI 10.1016/j.brainres.2011.08.071; MILLER AKH, 1980, NEUROPATH APPL NEURO, V6, P119, DOI 10.1111/j.1365-2990.1980.tb00283.x; Mrak RE, 1997, J NEUROPATH EXP NEUR, V56, P1269, DOI 10.1097/00005072-199712000-00001; Shen EY, 2010, CHILD NERV SYST, V26, P1619, DOI 10.1007/s00381-010-1280-1; SKULLERUD K, 1985, ACTA NEUROL SCAND, V71, P5; Terribilli D, 2011, NEUROBIOL AGING, V32, P354, DOI 10.1016/j.neurobiolaging.2009.02.008; Walhovd KB, 2011, NEUROBIOL AGING, V32, P916, DOI 10.1016/j.neurobiolaging.2009.05.013; Wang X, 1985, Popul Res, V2, P24; Webb SJ, 2001, DEV NEUROPSYCHOL, V19, P147, DOI 10.1207/S15326942DN1902_2; Wu KH, 2011, PEDIATR RES, V69, P80, DOI 10.1203/PDR.0b013e3181ff2f6c; Xu J, 2000, AM J NEURORADIOL, V21, P112	35	81	85	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55241	10.1371/journal.pone.0055241	http://dx.doi.org/10.1371/journal.pone.0055241			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23762223	gold, Green Submitted, Green Published			2022-12-27	WOS:000314023600161
J	Lee, JK; So, KA; Piyathilake, CJ; Kim, MK				Lee, Jae Kwan; So, Kyeong A.; Piyathilake, Chandrika J.; Kim, Mi Kyung			Mild Obesity, Physical Activity, Calorie Intake, and the Risks of Cervical Intraepithelial Neoplasia and Cervical Cancer	PLOS ONE			English	Article							BODY-MASS INDEX; POSTMENOPAUSAL BREAST-CANCER; NIH-AARP DIET; OVARIAN-CANCER; WOMEN; ASSOCIATION; PROSTATE; IMPACT; COHORT; EPIDEMIOLOGY	Objective: We investigated whether obesity, physical activity, and calorie intake are associated with the risks of cervical intraepithelial neoplasia (CIN) and cervical cancer. Methods: We enrolled 1125 women (age, 18-65 years) into a human papillomavirus cohort study established from 2006 to 2012. Multinomial logistic regression models were used to estimate crude and multivariate odds ratios (ORs) and the corresponding 95% confidence intervals (95% CIs), and to assess whether body mass index (BMI), height, weight, total calorie intake, and physical activity were associated with the risks of CIN and cervical cancer. Results: Cervical cancer risk was positively associated with BMI and inversely associated with physical activity. When compared with women with a normal BMI (18.5-23 kg/m(2)), the multivariate ORs (95% CIs) for those overweight (23-25 kg/m(2)) and mild obesity (>= 25 kg/m(2)) were 1.25 (0.79-2.00) and 1.70 (1.10-2.63), respectively. When compared with women with the lowest tertile of physical activity (<38.5 MET-hours/week), the ORs (95% CIs) for cervical cancer were 0.95 (0.61-1.48) and 0.61 (0.38-0.98) for women with medium physical activity (38.5-71.9 MET-hours/week) and those with high physical activity (72 MET-hours/week), respectively (p for linear trend = 0.03). The CIN2/3 risk was inversely associated with physical activity after adjustment for confounders. Compared with women with low physical activity (< 38.5 MET-hours/week), the ORs (95% CIs) for CIN2/3 were 0.64 (0.40-1.01) and 0.58 (0.36-0.93) for the medium and high physical activity groups, respectively (p for linear trend = 0.02). Total calorie intake was not statistically associated with the risks of CIN and cervical cancer after adjustment for confounders. Conclusion: Our results indicate that in addition to screening for and treatment of CIN, recommendations on the maintenance of an appropriate BMI with an emphasis on physical activity could be an important preventive strategy against the development of cervical cancer.	[Lee, Jae Kwan; So, Kyeong A.] Korea Univ, Coll Med, Dept Obstet & Gynecol, Seoul 136705, South Korea; [Piyathilake, Chandrika J.] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; [Kim, Mi Kyung] Natl Canc Ctr, Canc Epidemiol Branch, Goyang, South Korea	Korea University; Korea University Medicine (KU Medicine); University of Alabama System; University of Alabama Birmingham; National Cancer Center - Korea (NCC)	Kim, MK (corresponding author), Natl Canc Ctr, Canc Epidemiol Branch, Goyang, South Korea.	alrud@ncc.re.kr	Auger, Cyril/N-4702-2016; Kang, Moonkyu/AAR-8974-2021; Oak, Min-Ho/AAE-7405-2020	LEE, Jae Kwan/0000-0003-3101-6403; Kang, Moonkyu/0000-0002-2039-4866	Korea National Cancer Center [NCC-1110320, NCC-1310361]	Korea National Cancer Center	This study was supported by a grant-in-aid from the Korea National Cancer Center (grant no. NCC-1110320, NCC-1310361). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Aldrich T, 2010, J MIDWIFERY WOM HEAL, V55, P344, DOI 10.1016/j.jmwh.2009.10.001; [Anonymous], 2002, WEIGHT CONTR PHYS AC; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Brown Pamela, 2002, W V Med J, V98, P271; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Castellsague Xavier, 2003, J Natl Cancer Inst Monogr, P20; Castle Philip E, 2003, J Natl Cancer Inst Monogr, P29; Chang SC, 2006, CANCER EPIDEM BIOMAR, V15, P334, DOI 10.1158/1055-9965.EPI-05-0479; Choo V, 2002, LANCET, V360, P235, DOI 10.1016/S0140-6736(02)09512-0; Deurenberg-Yap M, 2001, INT J OBESITY, V25, P1554, DOI 10.1038/sj.ijo.0801739; Gierach GL, 2009, INT J CANCER, V124, P2139, DOI 10.1002/ijc.24059; Hwang JH, 2010, INT J GYNECOL CANCER, V20, P398, DOI 10.1111/IGC.0b013e3181d02ff2; Hwang JH, 2010, CANCER CAUSE CONTROL, V21, P51, DOI 10.1007/s10552-009-9433-9; Inoue M, 2008, AM J EPIDEMIOL, V168, P391, DOI 10.1093/aje/kwn146; James PT, 2001, OBES RES, V9, p228S, DOI 10.1038/oby.2001.123; Kim YO, 2009, BRIT J NUTR, V101, P1218, DOI 10.1017/S0007114508061497; Ko GTC, 1999, INT J OBESITY, V23, P1136, DOI 10.1038/sj.ijo.0801043; Korea Health Industry Development Institute Ministry of Health and Welfare, 2000, DEV NUTR DAT REC PRO; Lacey JV, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-84; Lacey JV, 2003, CANCER-AM CANCER SOC, V98, P814, DOI 10.1002/cncr.11567; Lane Geoffrey, 2008, Menopause Int, V14, P33, DOI 10.1258/mi.2007.007036; Lee GJ, 2005, J KOREAN MED SCI, V20, P267, DOI 10.3346/jkms.2005.20.2.267; Lundqvist E, 2007, INT J CANCER, V121, P810, DOI 10.1002/ijc.22746; Maruthur NM, 2009, OBESITY, V17, P375, DOI 10.1038/oby.2008.480; Mitchell RS, 2008, AM J PREV MED, V35, P127, DOI 10.1016/j.amepre.2008.03.031; Modesitt SC, 2005, OBSTET GYNECOL SURV, V60, P683, DOI 10.1097/01.ogx.0000180866.62409.01; Nobbenhuis MAE, 1999, LANCET, V354, P20, DOI 10.1016/S0140-6736(98)12490-X; Patil V, 2006, Indian J Public Health, V50, P38; Pereira M A, 1997, Med Sci Sports Exerc, V29, pS1; Peters TM, 2009, CANCER EPIDEM BIOMAR, V18, P289, DOI 10.1158/1055-9965.EPI-08-0768; PRENTICE RL, 1979, BIOMETRIKA, V66, P403, DOI 10.1093/biomet/66.3.403; Rajkumar T, 2003, BRIT J CANCER, V88, P1388, DOI 10.1038/sj.bjc.6600902; Regional Office for the Western Pacific/World Health Organization International Obesity TaskForce/International Association for the Study of Obesity, 2000, AS PAC PERSP RED OB; Rieck G, 2006, BEST PRACT RES CL OB, V20, P227, DOI 10.1016/j.bpobgyn.2005.10.010; SALLIS JF, 1985, AM J EPIDEMIOL, V121, P91, DOI 10.1093/oxfordjournals.aje.a113987; SCHIFFMAN MH, 1995, CANCER-AM CANCER SOC, V76, P1888, DOI 10.1002/1097-0142(19951115)76:10+<1888::AID-CNCR2820761305>3.0.CO;2-H; SCHILL W, 1993, BIOMETRIKA, V80, P339, DOI 10.2307/2337204; Schouten LJ, 2008, CANCER EPIDEM BIOMAR, V17, P902, DOI 10.1158/1055-9965.EPI-07-2524; Schouten LJ, 2004, JNCI-J NATL CANCER I, V96, P1635, DOI 10.1093/jnci/djh291; SHEPHARD RJ, 1995, CAN J APPL PHYSIOL, V20, P1, DOI 10.1139/h95-001; Song SH, 2008, GYNECOL ONCOL, V108, P543, DOI 10.1016/j.ygyno.2007.11.006; Song YM, 2004, STROKE, V35, P831, DOI 10.1161/01.STR.0000119386.22691.1C; Stefanescu B I, 2007, Rev Med Chir Soc Med Nat Iasi, V111, P155; Stein CJ, 2004, BRIT J CANCER, V90, P299, DOI 10.1038/sj.bjc.6601509; Tong SY, 2010, CANCER CAUSE CONTROL, V21, P23, DOI 10.1007/s10552-009-9430-z; TORNBERG SA, 1994, BRIT J CANCER, V69, P358, DOI 10.1038/bjc.1994.65; Ulmer H, 2012, GYNECOL ONCOL, V125, P330, DOI 10.1016/j.ygyno.2012.01.052; van Gils CH, 2009, CANCER EPIDEM BIOMAR, V18, P377, DOI 10.1158/1055-9965.EPI-08-0823; Velthuis MJ, 2009, MENOPAUSE, V16, P777, DOI [10.1097/GME.0b013e318197122a, 10.1097/gme.0b013e318197122a]; WANG SS, 2003, J NATL CANC I MONOGR, V31, P35, DOI DOI 10.1093/OXFORDJOURNALS.JNCIMONOGRAPHS.A003480; WHO, 2004, LANCET, V363, P902; Wolin KY, 2009, BRIT J CANCER, V100, P611, DOI 10.1038/sj.bjc.6604917; Wolk A, 2001, CANCER CAUSE CONTROL, V12, P13, DOI 10.1023/A:1008995217664; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; World Health Organization, 2000, INT ASS STUD OB INT; Yajnik C S, 2002, Obes Rev, V3, P217, DOI 10.1046/j.1467-789X.2002.00072.x; Yoo K Y, 1997, J Epidemiol, V7, P117; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	60	41	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66555	10.1371/journal.pone.0066555	http://dx.doi.org/10.1371/journal.pone.0066555			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23755196	Green Published, Green Submitted, gold			2022-12-27	WOS:000320322400111
J	Dahal, N; Abdelhamed, H; Lu, JJ; Karsi, A; Lawrence, ML				Dahal, Neeti; Abdelhamed, Hossam; Lu, Jingjun; Karsi, Attila; Lawrence, Mark L.			Tricarboxylic Acid Cycle and One-Carbon Metabolism Pathways Are Important in Edwardsiella ictaluri Virulence	PLOS ONE			English	Article							ESCHERICHIA-COLI; FUMARATE REDUCTASE; CHANNEL CATFISH; SUCCINATE-DEHYDROGENASE; MUTANT; REPLACEMENT; EXPRESSION; VACCINE; GENES; LIVE	Edwardsiella ictaluri is a Gram-negative facultative intracellular pathogen causing enteric septicemia of channel catfish (ESC). The disease causes considerable economic losses in the commercial catfish industry in the United States. Although antibiotics are used as feed additive, vaccination is a better alternative for prevention of the disease. Here we report the development and characterization of novel live attenuated E. ictaluri mutants. To accomplish this, several tricarboxylic acid cycle (sdhC, mdh, and frdA) and one-carbon metabolism genes (gcvP and glyA) were deleted in wild type E. ictaluri strain 93146 by allelic exchange. Following bioluminescence tagging of the E. ictaluri Delta sdhC, Delta mdh, Delta frdA, Delta gcvP, and Delta glyA mutants, their dissemination, attenuation, and vaccine efficacy were determined in catfish fingerlings by in vivo imaging technology. Immunogenicity of each mutant was also determined in catfish fingerlings. Results indicated that all of the E. ictaluri mutants were attenuated significantly in catfish compared to the parent strain as evidenced by 2,265-fold average reduction in bioluminescence signal from all the mutants at 144 h post-infection. Catfish immunized with the E. ictaluri Delta sdhC, Delta mdh, Delta frdA, and Delta glyA mutants had 100% relative percent survival (RPS), while E. ictaluri Delta gcvP vaccinated catfish had 31.23% RPS after re-challenge with the wild type E. ictaluri.	[Dahal, Neeti; Lu, Jingjun; Karsi, Attila; Lawrence, Mark L.] Mississippi State Univ, Coll Vet Med Sci, Dept Basic Sci, Mississippi State, MS 39762 USA; [Abdelhamed, Hossam] Benha Univ, Fac Vet Med, Dept Fish Dis & Management, Moshtohor Toukh, Egypt	Mississippi State University; Egyptian Knowledge Bank (EKB); Benha University	Karsi, A (corresponding author), Mississippi State Univ, Coll Vet Med Sci, Dept Basic Sci, Mississippi State, MS 39762 USA.	karsi@cvm.msstate.edu; lawrence@cvm.msstate.edu	Karsi, Attila/AAG-5046-2019; Dahanukar, Neelesh/B-2816-2012	Karsi, Attila/0000-0001-6845-3346; Dahanukar, Neelesh/0000-0001-7162-9023; Padhye, Anand/0000-0002-5971-4759; Molur, Sanjay/0000-0001-8230-518X; Modak, Nikhil/0000-0003-3303-7056	United States Department of Agriculture [2009-65119-05671]	United States Department of Agriculture(United States Department of Agriculture (USDA))	The research reported herein was supported by United States Department of Agriculture grant #2009-65119-05671 to MLL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhamed H, 2013, VET MICROBIOL, V162, P858, DOI 10.1016/j.vetmic.2012.11.006; AINSWORTH AJ, 1990, DEV COMP IMMUNOL, V14, P201, DOI 10.1016/0145-305X(90)90091-R; Amend D.F., 1981, FISH BIOL SERODIAGNO, V49, P447; [Anonymous], 2006, CASE SUMMARY REPORT; Arias CR, 2003, J FISH DIS, V26, P415, DOI 10.1046/j.1365-2761.2003.00475.x; Barker HC, 2000, MOL MICROBIOL, V35, P1518, DOI 10.1046/j.1365-2958.2000.01820.x; Booth NJ, 2006, J AQUAT ANIM HEALTH, V18, P101, DOI 10.1577/H05-025.1; Cooper Richard K. Ii, 1996, Journal of Aquatic Animal Health, V8, P319, DOI 10.1577/1548-8667(1996)008&lt;0319:UOAMTT&gt;2.3.CO;2; Dozois CM, 2003, P NATL ACAD SCI USA, V100, P247, DOI 10.1073/pnas.232686799; Dung TT, 2008, MICROB DRUG RESIST, V14, P311, DOI 10.1089/mdr.2008.0848; Ge ZM, 2000, MICROB PATHOGENESIS, V29, P279, DOI 10.1006/mpat.2000.0391; GUEST JR, 1981, J GEN MICROBIOL, V122, P171; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Karsi A, 2007, PLASMID, V57, P286, DOI 10.1016/j.plasmid.2006.11.002; Karsi A, 2006, FEMS MICROBIOL LETT, V260, P216, DOI 10.1111/j.1574-6968.2006.00310.x; Karsi A, 2009, APPL ENVIRON MICROB, V75, P2166, DOI 10.1128/AEM.02449-08; Klesius PH, 1997, AQUACULTURE, V157, P147, DOI 10.1016/S0044-8486(97)00076-8; Klesius PH, 1999, ADV VETER MED AP, V41, P523; Lan MZ, 2007, FISH SHELLFISH IMMUN, V23, P521, DOI 10.1016/j.fsi.2006.11.002; Lawrence ML, 1997, INFECT IMMUN, V65, P4642, DOI 10.1128/IAI.65.11.4642-4651.1997; Lawrence ML, 1997, VET MICROBIOLOGY PAR; Maklashina E, 1998, J BACTERIOL, V180, P5989, DOI 10.1128/JB.180.22.5989-5996.1998; MEEDEL TH, 1974, J BACTERIOL, V118, P905, DOI 10.1128/JB.118.3.905-910.1974; Mercado-Lubo R, 2008, INFECT IMMUN, V76, P1128, DOI 10.1128/IAI.01226-07; METCALF WW, 1994, GENE, V138, P1, DOI 10.1016/0378-1119(94)90776-5; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; PLAMANN MD, 1983, MOL GEN GENET, V192, P15, DOI 10.1007/BF00327641; Santander J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015944; STAUFFER LT, 1994, GENE, V142, P17, DOI 10.1016/0378-1119(94)90349-2; Thune RL, 1999, J AQUAT ANIM HEALTH, V11, P358, DOI 10.1577/1548-8667(1999)011&lt;0358:AAMOEI&gt;2.0.CO;2; USDA, 2003, HIGHL NAHMS CATF 2 2; Waterstrat PR, 1988, J FISH DIS, V289-294; WOOD WI, 1984, NATURE, V312, P330, DOI 10.1038/312330a0; Yimga MT, 2006, INFECT IMMUN, V74, P1130, DOI 10.1128/IAI.74.2.1130-1140.2006	35	31	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65973	10.1371/journal.pone.0065973	http://dx.doi.org/10.1371/journal.pone.0065973			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762452	gold, Green Published, Green Submitted			2022-12-27	WOS:000321094800082
J	Moreira, GF; Batista, ESD; Campos, HBN; Lemos, RE; Ferreira, MD				Moreira, Grazielle Furtado; de Paula Batista, Elder Simoes; Neves Campos, Henrique Borges; Lemos, Raphael Emilio; Ferreira, Marcelo da Costa			Spray Nozzles, Pressures, Additives and Stirring Time on Viability and Pathogenicity of Entomopathogenic Nematodes (Nematoda: Rhabditida) for Greenhouses	PLOS ONE			English	Article							STEINERNEMA-FELTIAE; HETERORHABDITIDAE; INFECTIVITY; LARVAE	The objective of this study was to evaluate different strategies for the application of entomopathogenic nematodes (EPN). Three different models of spray nozzles with air induction (AI 11003, TTI 11003 and AD-IA 11004), three spray pressures (207, 413 and 720 kPa), four different additives for tank mixtures (cane molasses, mineral oil, vegetable oil and glycerin) and the influence of tank mixture stirring time were all evaluated for their effect on EPN (Steinernema feltiae) viability and pathogenicity. The different nozzles, at pressures of up to 620 kPa, were found to be compatible with S. feltiae. Vegetable oil, mineral oil and molasses were found to be compatible adjuvants for S. feltiae, and stirring in a motorized backpack sprayer for 30 minutes did not impact the viability or pathogenicity of this nematode. Appropriate techniques for the application of nematodes with backpack sprayers are discussed.	[Moreira, Grazielle Furtado; de Paula Batista, Elder Simoes; Neves Campos, Henrique Borges; Lemos, Raphael Emilio; Ferreira, Marcelo da Costa] Univ Estadual Paulista UNESP, Dept Fitossanidade, Sao Paulo, Brazil	Universidade Estadual Paulista	Moreira, GF (corresponding author), Univ Estadual Paulista UNESP, Dept Fitossanidade, Jaboticabal Campus, Sao Paulo, Brazil.	grabiologia@yahoo.com.br	C, Ferreira M/C-6165-2012; Batista, Elder/D-3077-2014; McBride, Alan/D-4106-2012	C, Ferreira M/0000-0002-0159-7422; Batista, Elder/0000-0003-2794-0468; McBride, Alan/0000-0001-9682-540X				Adams Byron J., 2002, P1, DOI 10.1079/9780851995670.0001; Andalo V., 2009, Nematologia Mediterranea, V37, P11; Cunha J.P.A.R., 2003, Planta daninha, V21, P325, DOI 10.1590/S0100-83582003000200019; Cunha JPAR, 2010, PLANTA DANINHA, V28, P1153, DOI 10.1590/S0100-83582010000500023; Da Camara FT, 2008, ENG AGR-JABOTICABAL, V28, P740, DOI 10.1590/S0100-69162008000400014; DUTKY SR, 1964, J INSECT PATHOL, V6, P417; Fernandes Ana P., 2007, Eng. Agríc., V27, P728, DOI 10.1590/S0100-69162007000400016; Ferraz L.C.C.B, 2008, CONTROLE MICROBIANO, V14, P171; Ferraz LCCB, 1998, CONTROLE MICROBIANO, P541; Fife JP, 2007, APPL ENG AGRIC, V23, P405; Fife JP, 2005, T ASAE, V48, P45, DOI 10.13031/2013.17939; Fife JP, 2004, BIOTECHNOL BIOENG, V86, P96, DOI 10.1002/bit.10879; Fife JP, 2003, BIOL CONTROL, V27, P65, DOI 10.1016/S1049-9644(02)00183-4; Garcia Luiz C., 2005, Eng. Agríc., V25, P783; Garcia LC, 2008, NEOTROP ENTOMOL, V37, P305, DOI 10.1590/S1519-566X2008000300010; Gaugler R., 2002, Entomopathogenic nematology, P289, DOI 10.1079/9780851995670.0289; Grewal P. S., 2002, Entomopathogenic nematology, P265, DOI 10.1079/9780851995670.0265; Lara JC, 2008, SCI AGR, V65, P433, DOI 10.1590/S0103-90162008000400017; Mahmoud M. F., 2007, Nematologia Mediterranea, V35, P221; Matthews G. A., 2000, PESTICIDE APPL METHO, V3; Miller P.C.H., 2008, 22 ILASS EUROPE; Molina Acevedo Juan Pablo, 2001, Revista Colombiana de Entomologia, V27, P73; Nilsson U, 1999, CROP PROT, V18, P53, DOI 10.1016/S0261-2194(98)00095-7; Parra JRP, 1998, CONTROLE MICROBIANO, P1015; Queiroz AA, 2008, BIOSCI J, V24, P8; Scheepmaker JWA, 1998, BIOCONTROL, V43, P201, DOI 10.1023/A:1009954401065; Susurluk IA, 2011, TURK J AGRIC FOR, V35, P413, DOI 10.3906/tar-1002-715; WHITE G. F., 1927, SCIENCE, V66, P302, DOI 10.1126/science.66.1709.302-a	28	13	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65759	10.1371/journal.pone.0065759	http://dx.doi.org/10.1371/journal.pone.0065759			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	24260572	Green Submitted, gold, Green Published			2022-12-27	WOS:000321099000103
J	Messe, A; Caplain, S; Pelegrini-Issac, M; Blancho, S; Levy, R; Aghakhani, N; Montreuil, M; Benali, H; Lehericy, S				Messe, Arnaud; Caplain, Sophie; Pelegrini-Issac, Melanie; Blancho, Sophie; Levy, Richard; Aghakhani, Nozar; Montreuil, Michele; Benali, Habib; Lehericy, Stephane			Specific and Evolving Resting-State Network Alterations in Post-Concussion Syndrome Following Mild Traumatic Brain Injury	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; DEFAULT MODE NETWORK; FUNCTIONAL CONNECTIVITY; HEAD-INJURY; SYMPTOMS; SUBJECT; LEVEL; PHASE	Post-concussion syndrome has been related to axonal damage in patients with mild traumatic brain injury, but little is known about the consequences of injury on brain networks. In the present study, our aim was to characterize changes in functional brain networks following mild traumatic brain injury in patients with post-concussion syndrome using resting-state functional magnetic resonance imaging data. We investigated 17 injured patients with persistent post-concussion syndrome (under the DSM-IV criteria) at 6 months post-injury compared with 38 mild traumatic brain injury patients with no post-concussion syndrome and 34 healthy controls. All patients underwent magnetic resonance imaging examinations at the subacute (1-3 weeks) and late (6 months) phases after injury. Group-wise differences in functional brain networks were analyzed using graph theory measures. Patterns of long-range functional networks alterations were found in all mild traumatic brain injury patients. Mild traumatic brain injury patients with post-concussion syndrome had greater alterations than patients without post-concussion syndrome. In patients with post-concussion syndrome, changes specifically affected temporal and thalamic regions predominantly at the subacute stage and frontal regions at the late phase. Our results suggest that the post-concussion syndrome is associated with specific abnormalities in functional brain network that may contribute to explain deficits typically observed in PCS patients.	[Messe, Arnaud; Pelegrini-Issac, Melanie; Benali, Habib] Univ Paris 06, INSERM, Lab Imagerie Fonct, UMRS 678, Paris, France; [Messe, Arnaud; Pelegrini-Issac, Melanie; Benali, Habib; Lehericy, Stephane] Univ Paris 11, IFR49, DSV NeuroSpin I2BM, Gif Sur Yvette, France; [Caplain, Sophie; Montreuil, Michele] Univ Paris 08, EA 2027, St Denis, France; [Blancho, Sophie] Inst Rech Moelle Epiniere & Encephale, Paris, France; [Levy, Richard; Lehericy, Stephane] Univ Paris 06, INSERM, Grp Hosp Pitie Salpetriere, UMRS 975,CNRS UMR 7225,CRICM, Paris, France; [Levy, Richard] Hop St Antoine, Assistance Publ Hop Paris, F-75571 Paris, France; [Aghakhani, Nozar] Hop Univ Bicetre, Assistance Publ Hop Paris, Neurosurg Dept, Le Kremlin Bicetre, France; [Benali, Habib] Univ Montreal, MIC UNF, Montreal, PQ, Canada; [Lehericy, Stephane] Univ Paris 06, CHU Pitie Salpetriere, CENIR, Ctr Neuroimaging Res, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; Universite Paris-VIII; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite de Montreal; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Messe, A (corresponding author), Univ Paris 06, INSERM, Lab Imagerie Fonct, UMRS 678, Paris, France.	Arnaud.Messe@imed.jussieu.fr	aghakhani, nozar/ABF-7908-2021; Levy, Richard/D-8411-2011; Messé, Arnaud/I-1738-2019	Messé, Arnaud/0000-0001-9081-3088; aghakhani, nozar/0000-0001-8389-8167; Pelegrini-Issac, Melanie/0000-0003-3260-5795	IRME (Institut pour la Recherche sur la Moelle Epiniere et l'Encephale); GMF (Garantie Mutuelle des Fonctionnaires); program "Investissements d'avenir" [ANR-10-IAIHU-06]	IRME (Institut pour la Recherche sur la Moelle Epiniere et l'Encephale); GMF (Garantie Mutuelle des Fonctionnaires); program "Investissements d'avenir"(French National Research Agency (ANR))	This study was initiated by the IRME (Institut pour la Recherche sur la Moelle Epiniere et l'Encephale) and supported by a grant from the GMF (Garantie Mutuelle des Fonctionnaires). The research leading to these results has received funding from the program "Investissements d'avenir" ANR-10-IAIHU-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00010]; APA, 1994, DIAGN STAT MAN MENT; Azouvi P, 2001, REV NEUROPSYCHOL, V11, P383; Bassett DS, 2012, NEUROIMAGE, V59, P2196, DOI 10.1016/j.neuroimage.2011.10.002; Bassett DS, 2011, NEUROIMAGE, V54, P1262, DOI 10.1016/j.neuroimage.2010.09.006; Bassett DS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000748; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Benjamini Y, 2001, ANN STAT, V29, P1165; Bigler ED, 2010, NEUROLOGY, V74, P626, DOI 10.1212/WNL.0b013e3181d3e43a; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Bressler SL, 2006, INT J PSYCHOPHYSIOL, V60, P139, DOI 10.1016/j.ijpsycho.2005.12.008; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; FitzGerald DB, 2011, INT J PSYCHOPHYSIOL, V82, P79, DOI 10.1016/j.ijpsycho.2011.02.011; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Ginestet CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021570; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Hou R, 2011, J NEUROL NEUROSUR PS, V83, P217; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Irimia A, 2012, NEUROIMAGE, V60, P1340, DOI 10.1016/j.neuroimage.2012.01.107; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Legome E, 2006, POSTCONCUSSION SYNDR; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Messe A, 2012, BRAIN IMAGING BEHAV, V6, P283, DOI 10.1007/s11682-012-9159-2; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Raichle ME, 2011, BRAIN CONNECT, V1, P3, DOI 10.1089/brain.2011.0019; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; Reijneveld JC, 2007, CLIN NEUROPHYSIOL, V118, P2317, DOI 10.1016/j.clinph.2007.08.010; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sandrone S, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00261; Sandrone S, 2012, J NEUROSCI, V32, P1915, DOI 10.1523/JNEUROSCI.5637-11.2012; Schwarz AJ, 2011, NEUROIMAGE, V55, P1132, DOI 10.1016/j.neuroimage.2010.12.047; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O., 2011, NETWORKS BRAIN; Sporns O, 2006, P NATL ACAD SCI USA, V103, P19219, DOI 10.1073/pnas.0609523103; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; von Wild KRH, 2008, ACT NEUR S, V101, P55; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Xia M, 2011, P 17 INT C FUNCT MAP; Zalesky A, 2012, NEUROIMAGE, V60, P1055, DOI 10.1016/j.neuroimage.2012.01.068	69	90	93	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65470	10.1371/journal.pone.0065470	http://dx.doi.org/10.1371/journal.pone.0065470			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755237	Green Published, Green Submitted, gold			2022-12-27	WOS:000321099000072
J	Lee, JO; Auger, C; Park, DH; Kang, M; Oak, MH; Kim, KR; Schini-Kerth, VB				Lee, Jung-Ok; Auger, Cyril; Park, Dong Hyun; Kang, Moonkyu; Oak, Min-Ho; Kim, Kyoung Rak; Schini-Kerth, Valerie B.			An Ethanolic Extract of Lindera obtusiloba Stems, YJP-14, Improves Endothelial Dysfunction, Metabolic Parameters and Physical Performance in Diabetic db/db Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; II-INDUCED HYPERTENSION; OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; VASCULAR REACTIVITY; PIOGLITAZONE; PREVALENCE; CELLS; RISK; RATS	Lindera obtusiloba is a medicinal herb traditionally used in Asia for improvement of blood circulation, treatment of inflammation, and prevention of liver damage. A previous study has shown that an ethanolic extract of Lindera obtusiloba stems (LOE) has vasoprotective and antihypertensive effects. The possibility that Lindera obtusiloba improves endothelial function and metabolic parameters in type 2 diabetes mellitus (T2DM) remains to be examined. Therefore, the aim of the present study was to determine the potential of LOE to prevent the development of an endothelial dysfunction, and improve metabolic parameters including hyperglycemia, albuminuria and physical exercise capacity in db/db mice, an experimental model of T2DM. The effect of LOE (100 mg/kg/day by gavage for 8 weeks) on these parameters was compared to that of an oral antidiabetic drug, pioglitazone (30 mg/kg/day by gavage). Reduced blood glucose level, body weight and albumin-creatinine ratio were observed in the group receiving LOE compared to the control db/db group. The LOE treatment improved endothelium-dependent relaxations, abolished endothelium-dependent contractions to acetylcholine in the aorta, and normalized the increased vascular oxidative stress and expression of NADPH oxidase, cyclooxygenases, angiotensin II, angiotensin type 1 receptors and peroxynitrite and the decreased expression of endothelial NO synthase in db/db mice. The angiotensin-converting enzyme (ACE) activity was reduced in the LOE group compared to that in the control db/db group. LOE also inhibited the activity of purified ACE, COX-1 and COX-2 in a dose-dependent manner. In addition, LOE improved physical exercise capacity. Thus, the present findings indicate that LOE has a beneficial effect on the vascular system in db/db mice by improving endothelium-dependent relaxations and vascular oxidative stress most likely by normalizing the angiotensin system, and also on metabolic parameters, and these effects are associated with an enhanced physical exercise capacity.	[Lee, Jung-Ok; Auger, Cyril; Schini-Kerth, Valerie B.] Univ Strasbourg, CNRS, Fac Pharm, Lab Biophoton & Pharmacol,UMR 7213, Illkirch Graffenstaden, France; [Lee, Jung-Ok; Kang, Moonkyu; Kim, Kyoung Rak] Hanwha Pharma Co Ltd, Ctr Res & Dev, Chunchon, South Korea; [Park, Dong Hyun] YangJi Chem, Res Ctr, Suwon, South Korea; [Oak, Min-Ho] Mokpo Natl Univ, Coll Pharm, Muan, Jeonam, South Korea	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Mokpo National University	Schini-Kerth, VB (corresponding author), Univ Strasbourg, CNRS, Fac Pharm, Lab Biophoton & Pharmacol,UMR 7213, Illkirch Graffenstaden, France.	valerie.schini-kerth@unistra.fr	Auger, Cyril/N-4702-2016; Kang, Moonkyu/AAR-8974-2021; Oak, Min-Ho/AAE-7405-2020	LEE, Jae Kwan/0000-0003-3101-6403; Kang, Moonkyu/0000-0002-2039-4866	The Ministry of Knowledge Economy, Republic of Korea, under the Leading Industry Development for Gangwon Economic Region (LIDGER) program [70007579]; Hanwha Pharma. Co., Ltd; Hanwha Pharma. Co., Ltd, Chuncheon, Republic of Korea	The Ministry of Knowledge Economy, Republic of Korea, under the Leading Industry Development for Gangwon Economic Region (LIDGER) program(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Hanwha Pharma. Co., Ltd; Hanwha Pharma. Co., Ltd, Chuncheon, Republic of Korea	The study was supported, in part, by The Ministry of Knowledge Economy, Republic of Korea, under the Leading Industry Development for Gangwon Economic Region (LIDGER) program (number 70007579), and by Hanwha Pharma. Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Jung-Ok Lee, Moonkyu Kang and Kyoung Rak Kim are all employees of Hanwha Pharma. Co., Ltd, Chuncheon, Republic of Korea, whose company provided funding toward this study. Dong Hyun Park is an employee of YangJi Chemicals, Suwon, Republic of Korea, which is a daughter company of Hanwha. Hanwha has filed a European and US patent on YJP14 and endothelial dysfunction. The Korean FDA have approved further clinical studies regarding YJP-14 and endothelial dysfunction in diabetes. At present there are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.	Ajay M, 2006, VASC PHARMACOL, V45, P127, DOI 10.1016/j.vph.2006.05.001; Alhaider AA, 2011, CHEM-BIOL INTERACT, V192, P233, DOI 10.1016/j.cbi.2011.03.014; Bakker W, 2009, CELL TISSUE RES, V335, P165, DOI 10.1007/s00441-008-0685-6; Balletshofer BM, 2000, CIRCULATION, V101, P1780, DOI 10.1161/01.CIR.101.15.1780; Capellini VK, 2010, CURR VASC PHARMACOL, V8, P526; CHANG KC, 1993, J PHARMACOL EXP THER, V266, P992; Chen WG, 2010, BIOCHEMISTRY-US, V49, P3129, DOI 10.1021/bi9016632; Cohen RA, 2010, J CARDIOVASC PHARM, V55, P308, DOI 10.1097/FJC.0b013e3181d89670; Ding H, 2010, PFLUG ARCH EUR J PHY, V459, P977, DOI 10.1007/s00424-010-0807-3; Dunstan DW, 2002, DIABETES CARE, V25, P829, DOI 10.2337/diacare.25.5.829; Feletou M, 2010, CURR HYPERTENS REP, V12, P267, DOI 10.1007/s11906-010-0118-2; Fowler MJ, 2008, CLIN DIABETES, V26, P77, DOI [DOI 10.2337/DIACLIN.26.2.77, 10.2337/diaclin.26.2.77]; Freise C, 2010, J NUTR BIOCHEM, V21, P1170, DOI 10.1016/j.jnutbio.2009.09.013; Gao L, 2009, CARDIOVASC RES, V82, P9, DOI 10.1093/cvr/cvp031; Grundy SM, 1999, CIRCULATION, V100, P1134, DOI 10.1161/01.CIR.100.10.1134; Hartge Martin M, 2007, Diab Vasc Dis Res, V4, P84; Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485; Henry RMA, 2004, ATHEROSCLEROSIS, V174, P49, DOI 10.1016/j.atherosclerosis.2004.01.002; Idris-Khodja N, 2012, N-S ARCH PHARMACOL, V385, P749, DOI 10.1007/s00210-012-0749-8; Ihm SH, 2009, ATHEROSCLEROSIS, V206, P47, DOI 10.1016/j.atherosclerosis.2009.01.036; Jimenez R, 2007, FREE RADICAL BIO MED, V43, P462, DOI 10.1016/j.freeradbiomed.2007.05.007; Johnson DK, 2002, ENDOTHELIUM-J ENDOTH, V9, P191, DOI 10.1080/10623320213638; Junker N, 2005, CANCER SCI, V96, P183, DOI 10.1111/j.1349-7006.2005.00026.x; Kanda Y, 2010, AM J PHYSIOL-ENDOC M, V298, pE278, DOI 10.1152/ajpendo.00388.2009; Kusunoki M, 2011, EUR J PHARMACOL, V668, P486, DOI 10.1016/j.ejphar.2011.07.030; Lee JO, 2011, N-S ARCH PHARMACOL, V383, P635, DOI 10.1007/s00210-011-0643-9; Lewis TV, 1999, J AM COLL CARDIOL, V33, P805, DOI 10.1016/S0735-1097(98)00667-6; Liang W, 2008, J PHYSIOL SCI, V58, P405, DOI 10.2170/physiolsci.RP012808; Lim YK, 2002, ATHEROSCLEROSIS, V160, P311, DOI 10.1016/S0021-9150(01)00576-7; Mohan S, 2008, LAB INVEST, V88, P515, DOI 10.1038/labinvest.2008.23; Musicki B, 2010, J SEX MED, V7, P3023, DOI 10.1111/j.1743-6109.2010.01880.x; Nichols GA, 2001, DIABETES CARE, V24, P1614, DOI 10.2337/diacare.24.9.1614; ODriscoll G, 1997, J CLIN INVEST, V100, P678, DOI 10.1172/JCI119580; Okudan N, 2011, J MED FOOD, V14, P1298, DOI 10.1089/jmf.2010.0030; Ota H, 2010, ARTERIOSCL THROM VAS, V30, P2205, DOI 10.1161/ATVBAHA.110.210500; Park JH, 2011, J BIOCHEM MOL TOXIC, V25, P238, DOI 10.1002/jbt.20381; Park Y, 2008, AM J PHYSIOL-HEART C, V295, pH1982, DOI 10.1152/ajpheart.01261.2007; Plutzky J, 2011, AM J CARDIOL, V108, p25B, DOI 10.1016/j.amjcard.2011.03.014; Regensteiner JG, 2003, VASC MED, V8, P169, DOI 10.1191/1358863x03vm489oa; Sallam N, 2011, N-S ARCH PHARMACOL, V383, P483, DOI 10.1007/s00210-011-0614-1; Sarr M, 2006, CARDIOVASC RES, V71, P794, DOI 10.1016/j.cardiores.2006.05.022; Savage S, 1996, DIABETES CARE, V19, P1243, DOI 10.2337/diacare.19.11.1243; Schalkwijk CG, 2005, CLIN SCI, V109, P143, DOI 10.1042/CS20050025; Schmidt TS, 2007, CLIN SCI, V113, P47, DOI 10.1042/CS20070108; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Senador D, 2009, EXP PHYSIOL, V94, P648, DOI 10.1113/expphysiol.2008.046474; Sharma A, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/750126; Smith SR, 2005, METABOLISM, V54, P24, DOI 10.1016/j.metabol.2004.07.008; Sowers JR, 2001, HYPERTENSION, V37, P1053, DOI 10.1161/01.HYP.37.4.1053; Sridulyakul P, 2006, CLIN HEMORHEOL MICRO, V34, P315; Stapleton PA, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-54; Thompson D, 2001, Obes Rev, V2, P189, DOI 10.1046/j.1467-789x.2001.00037.x; Ting HH, 1996, J CLIN INVEST, V97, P22, DOI 10.1172/JCI118394; Title LM, 2000, J AM COLL CARDIOL, V36, P758, DOI 10.1016/S0735-1097(00)00809-3; Urso C, 2011, MINERVA MED, V102, P59; W.H. Organization, 1999, DEFINITION DIAGNOSIS; Wang XR, 2011, AM J PHYSIOL-ENDOC M, V300, pE1135, DOI 10.1152/ajpendo.00001.2011; Wong WT, 2010, ANTIOXID REDOX SIGN, V13, P757, DOI 10.1089/ars.2009.2831; Ying CJ, 2003, HYPERTENS RES, V26, P823, DOI 10.1291/hypres.26.823; Yook C., 1997, COLORED MED PLANTS K, P588; Zanetti M, 2010, EXP GERONTOL, V45, P848, DOI 10.1016/j.exger.2010.07.002; Zhang HR, 2010, AM J PHYSIOL-HEART C, V299, pH985, DOI 10.1152/ajpheart.00489.2010; Zhang SL, 2007, PEDIATR NEPHROL, V22, P813, DOI 10.1007/s00467-007-0444-z; Zheng Z, 2011, DIABETES	64	41	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65227	10.1371/journal.pone.0065227	http://dx.doi.org/10.1371/journal.pone.0065227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755196	gold, Green Published, Green Submitted			2022-12-27	WOS:000319872300059
